PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Guan, D; Factor, D; Liu, Y; Wang, Z; Kao, HY				Guan, D.; Factor, D.; Liu, Yu; Wang, Z.; Kao, H-Y			The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein	ONCOGENE			English	Article						UHRF1; PML; ubiquitination; cell migration; capillary tube formation	HEMI-METHYLATED DNA; BREAST-CANCER; SRA DOMAIN; PML; LIGASE; RECOGNITION; GENE; ICBP90; ALPHA; ACETYLATION	The promyelocytic leukemia (PML) protein is a tumor suppressor originally identified in acute promyelocytic leukemia and implicated in tumorigenesis in multiple forms of cancer. Here, we demonstrate that the PML protein undergoes ubiquitination-mediated degradation facilitated by an E3 ligase UHRF1 (ubiquitin-like with PHD and RING finger domains 1), which is commonly upregulated in various human malignancies. Furthermore, UHRF1 negatively regulates PML protein accumulation in primary human umbilical vein endothelial cells (HUVECs), HEK 293 cells and cancer cells. Knockdown of UHRF1 upregulates whereas ectopic overexpression of UHRF1 downregulates protein abundance of endogenous or exogenous PML, doing so through its binding to the N-terminus of PML. Overexpression of wild-type UHRF1 shortens PML protein half-life and promotes PML polyubiquitination, whereas deletion of the RING domain or coexpression of the dominant-negative E2 ubiquitin-conjugating enzyme, E2D2, attenuates this modification to PML. Finally, knockdown of UHRF1 prolongs PML half-life and increases PML protein accumulation, yet inhibits cell migration and in vitro capillary tube formation, whereas co-knockdown of PML compromises this inhibitory effect. These findings suggest that UHRF1 promotes the turnover of PML protein, and thus targeting UHRF1 to restore PML-mediated tumor suppression represents a promising, novel, anticancer strategy.	[Guan, D.; Factor, D.; Liu, Yu; Kao, H-Y] Dept Biochem, Cleveland, OH 44106 USA; [Guan, D.; Factor, D.; Liu, Yu; Kao, H-Y] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Wang, Z.] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Wang, Z.; Kao, H-Y] Case Western Reserve Univ, Ctr Comprehens Canc, Cleveland, OH USA; [Wang, Z.; Kao, H-Y] Univ Hosp Cleveland, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Kao, HY (corresponding author), Dept Biochem, 10900 Euclid Ave, Cleveland, OH 44106 USA.	hxk43@cwru.edu		Factor, Daniel/0000-0002-3200-7560	NIH [R01 DK078965, HL093269]; Case Comprehensive Cancer Center Program in Aging and Energy Balance, NCI [P20 CA103767, CA127590];  [T32HD07104]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007104] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA043703, R01CA127590, P50CA150964, P20CA103736] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093269] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062985, R01DK078965] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Comprehensive Cancer Center Program in Aging and Energy Balance, NCI; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr David Samols for his comments on the manuscript. D Factor is supported by training Grant T32HD07104. This project is supported by the NIH through R01 DK078965, HL093269 and Case Comprehensive Cancer Center Program in Aging and Energy Balance, NCI P20 CA103767 to H-Y Kao and CA127590 to Z Wang.	Alhosin M, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-41; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Babbio F, 2012, ONCOGENE, V31, P4878, DOI 10.1038/onc.2011.641; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Boutell C, 2005, J VIROL, V79, P12342, DOI 10.1128/JVI.79.19.12342-12354.2005; Canning M, 2004, J BIOL CHEM, V279, P38160, DOI 10.1074/jbc.M402885200; Cheng XW, 2012, J BIOL CHEM, V287, P23356, DOI 10.1074/jbc.M112.340505; Citterio E, 2004, MOL CELL BIOL, V24, P2526, DOI 10.1128/MCB.24.6.2526-2535.2004; Daskalos A, 2010, CANCER, V117, P1027; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Fanelli M, 2004, J BIOL CHEM, V279, P5374, DOI 10.1074/jbc.M306407200; Felle M, 2011, NUCLEIC ACIDS RES, V39, P8355, DOI 10.1093/nar/gkr528; Gao CZ, 2008, MOL BIOL CELL, V19, P3020, DOI 10.1091/mbc.E07-11-1203; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Hu LL, 2011, CELL RES, V21, P1374, DOI 10.1038/cr.2011.124; Jeanblanc M, 2005, ONCOGENE, V24, P7337, DOI 10.1038/sj.onc.1208878; Jenkins Y, 2005, MOL BIOL CELL, V16, P5621, DOI 10.1091/mbc.E05-03-0194; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Jin W, 2010, BREAST CANCER RES TR, V123, P359, DOI 10.1007/s10549-009-0652-2; Khurana S, 2011, J BIOL CHEM, V286, P1850, DOI 10.1074/jbc.M110.162107; Kim JK, 2009, NUCLEIC ACIDS RES, V37, P493, DOI 10.1093/nar/gkn961; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li XL, 2011, INT J RADIAT BIOL, V87, P263, DOI 10.3109/09553002.2011.530335; Lim JH, 2011, J BIOL CHEM, V286, P44403, DOI 10.1074/jbc.M111.289512; Louria-Hayon I, 2009, CELL DEATH DIFFER, V16, P1156, DOI 10.1038/cdd.2009.31; Ma HH, 2012, P NATL ACAD SCI USA, V109, P4828, DOI 10.1073/pnas.1116349109; Nady N, 2011, J BIOL CHEM, V286, P24300, DOI 10.1074/jbc.M111.234104; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Rajakumara E, 2011, MOL CELL, V43, P275, DOI 10.1016/j.molcel.2011.07.006; Reineke EL, 2008, MOL CELL BIOL, V28, P997, DOI 10.1128/MCB.01848-07; Reineke EL, 2010, J BIOL CHEM, V285, P9485, DOI 10.1074/jbc.M109.063362; Reineke EL, 2009, INT J BIOL SCI, V5, P366; Sabatino L, 2012, ONCOGENE, V31, P5061, DOI 10.1038/onc.2012.3; Sarkari F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016598; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; TERRIS B, 1995, CANCER RES, V55, P1590; Un F, 2006, ANTICANCER RES, V26, P2761; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Unoki M, 2010, BRIT J CANCER, V103, P217, DOI 10.1038/sj.bjc.6605717; Unoki M, 2009, BRIT J CANCER, V101, P98, DOI 10.1038/sj.bjc.6605123; Unoki M, 2009, BIOCHEM PHARMACOL, V78, P1279, DOI 10.1016/j.bcp.2009.05.035; van Wijk SJL, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.55; Wang DY, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3017; Wang F, 2012, ANN SURG ONCOL, V19, P2753, DOI 10.1245/s10434-011-2194-1; Xie S, 2012, J MOL BIOL, V415, P318, DOI 10.1016/j.jmb.2011.11.012; Yan F, 2011, CANCER BIOTHER RADIO, V26, P183, DOI 10.1089/cbr.2010.0886; Yang GL, 2012, MED ONCOL, V29, P842, DOI 10.1007/s12032-011-9983-z; Yuan WC, 2011, CANCER CELL, V20, P214, DOI 10.1016/j.ccr.2011.07.008	53	48	52	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 15	2013	32	33					3819	3828		10.1038/onc.2012.406	http://dx.doi.org/10.1038/onc.2012.406			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	202JH	22945642	Green Accepted			2022-12-25	WOS:000323210200004
J	Villacorte, M; Suzuki, K; Hirasawa, A; Ohkawa, Y; Suyama, M; Maruyama, T; Aoki, D; Ogino, Y; Miyagawa, S; Terabayashi, T; Tomooka, Y; Nakagata, N; Yamada, G				Villacorte, M.; Suzuki, K.; Hirasawa, A.; Ohkawa, Y.; Suyama, M.; Maruyama, T.; Aoki, D.; Ogino, Y.; Miyagawa, S.; Terabayashi, T.; Tomooka, Y.; Nakagata, N.; Yamada, G.			beta-Catenin signaling regulates Foxa2 expression during endometrial hyperplasia formation	ONCOGENE			English	Article						uterine gland; Wnt/beta-catenin; Foxa2; cyclin; endometrial hyperplasia	CONDITIONAL LOSS; GENE-EXPRESSION; ALPHA-CATENIN; CANCER; UTERUS; MICE; MORPHOGENESIS; CARCINOMA; CYTODIFFERENTIATION; DIFFERENTIATION	The Wnt/beta-catenin signaling is essential for various organogenesis and is often implicated during tumorigenesis. Dysregulated beta-catenin signaling is associated with the formation of endometrial adenocarcinomas (EACs), which is considered as the common form of endometrial cancer in women. In the current study, we investigate the downstream target of Wnt/beta-catenin signaling in the uterine epithelia and the mechanism leading to the formation of endometrial hyperplasia. We report that conditional ablation and activation of beta-catenin in the uterine epithelia lead to aberrant epithelial structures and endometrial hyperplasia formation, respectively. We demonstrate that beta-catenin regulates Foxa2 with its candidate upstream region for the uterine epithelia. Furthermore, knockdown of Foxa2 leads to defects in cell cycle regulation, suggesting a possible function of Foxa2 in the control of cell proliferation. We also observe that beta-catenin and Foxa2 expression levels are augmented in the human specimens of complex atypical endometrial hyperplasia, which is considered to have a greater risk of progression to EACs. Thus, our study indicates that beta-catenin regulates Foxa2 expression, and this interaction is possibly essential to control cell cycle progression during endometrial hyperplasia formation. Altogether, the augmented expression levels of beta-catenin and Foxa2 are essential features during the formation of endometrial hyperplasia.	[Villacorte, M.; Suzuki, K.; Yamada, G.] Wakayama Med Univ, Dept Dev Genet, Inst Adv Med, Wakayama, Kansai 6418509, Japan; [Villacorte, M.; Suzuki, K.; Terabayashi, T.; Yamada, G.] Kumamoto Univ, Global COE Cell Fate Regulat Res & Educ Unit, Kumamoto, Japan; [Villacorte, M.; Suzuki, K.; Yamada, G.] Kumamoto Univ, Dept Organ Format, IMEG, Kumamoto, Japan; [Hirasawa, A.; Maruyama, T.; Aoki, D.] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan; [Ohkawa, Y.] Kyushu Univ, Fac Med, SSP Stem Cell Unit, Dept Epigenet,Inst Adv Study, Fukuoka 812, Japan; [Suyama, M.] Kyoto Univ, Dept Genome Informat, Ctr Genom Med, Grad Sch Med, Kyoto, Japan; [Ogino, Y.; Miyagawa, S.] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi, Japan; [Tomooka, Y.] Tokyo Univ Sci, Dept Biol Sci & Technol, Chiba, Japan; [Tomooka, Y.] Tokyo Univ Sci, Tissue Engn Res Ctr, Chiba, Japan; [Nakagata, N.] Kumamoto Univ, CARD, Kumamoto, Japan	Wakayama Medical University; Kumamoto University; Kumamoto University; Keio University; Kyushu University; Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Tokyo University of Science; Tokyo University of Science; Kumamoto University	Yamada, G (corresponding author), Wakayama Med Univ, Dept Dev Genet, Inst Adv Med, 811-1 Kimiidera, Wakayama, Kansai 6418509, Japan.	gensan7@wakayama-med.ac.jp	Ohkawa, Yasuyuki/C-4087-2016; Tabelin, Mylah/AGG-4616-2022; Ohkawa, Yasuyuki/ABG-1839-2021; Aoki, Daisuke/E-6650-2014	Ohkawa, Yasuyuki/0000-0001-6440-9954; Tabelin, Mylah/0000-0002-6383-7049; Ohkawa, Yasuyuki/0000-0001-6440-9954; Terabayashi, Takeshi/0000-0001-7102-784X; Suyama, Mikita/0000-0001-9526-3193; Nakagata, Naomi/0000-0002-5737-9993	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [22132006]; National Institutes Health [R01ES016597-01A1]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016597] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22132005, 23570085] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Drs R Behringer, H Sasaki, M M Taketo, W Birchmeier, A Santin, R Nishinakamura, Y Yoshimura, T Kurita, N Shiraki, K Maehara, H Nishida-Fukuda, K Yoshinaga, MA Suico, S Ohta, A Murashima, L Liu, A Omori, M Harada and D Matsumaru for their constructive criticisms We also thank E Chun, Y Sakamoto, Y Yamakawa, T Seki, M Aoki, S Usuki, M Matsumuto, M Etoh, S Fujikawa, Y Endo, S Miyaji and T Iba for technical help. This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas: molecular mechanisms for the establishment of Sex Differences (22132006), Global Center of Excellence program 'Cell Fate Regulation Research and Education Unit' and Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. This work was also supported by the National Institutes Health grant R01ES016597-01A1.	Armaiz-Pena GN, 2009, CLIN CANCER RES, V15, P2971, DOI 10.1158/1078-0432.CCR-08-2525; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; BERCHUCK A, 1995, CANCER, V76, P2034, DOI 10.1002/1097-0142(19951115)76:10+<2034::AID-CNCR2820761321>3.0.CO;2-U; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; CUNHA GR, 1976, INT REV CYTOL, V47, P137, DOI 10.1016/S0074-7696(08)60088-1; CUNHA GR, 1976, J EXP ZOOL, V196, P361, DOI 10.1002/jez.1401960310; Daikoku T, 2008, NAT MED, V14, P1192, DOI 10.1038/nm1108-1192; Daikoku T, 2008, CANCER RES, V68, P5619, DOI 10.1158/0008-5472.CAN-08-1274; Daikoku T, 2011, GYNECOL ONCOL, V122, P424, DOI 10.1016/j.ygyno.2011.04.022; Eeckhoute J, 2006, GENE DEV, V20, P2513, DOI 10.1101/gad.1446006; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Fyles A, 2008, GYNECOL ONCOL, V108, P395, DOI 10.1016/j.ygyno.2007.10.033; Giannini A, 2004, EXP CELL RES, V295, P150, DOI 10.1016/j.yexcr.2003.12.012; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Guzzo F, 2012, INT J GYNECOL PATHOL, V31, P211, DOI 10.1097/PGP.0b013e31823bb24d; Hanazono R, 1997, IN VITRO CELL DEV-AN, V33, P668; Hayashi K, 2006, BIOL REPROD, V74, P721, DOI 10.1095/biolreprod.105.049718; Huang WW, 2005, MOL ENDOCRINOL, V19, P669, DOI 10.1210/me.2004-0155; Jeong JW, 2009, ONCOGENE, V28, P31, DOI 10.1038/onc.2008.363; Jeong JW, 2010, BIOL REPROD, V83, P396, DOI 10.1095/biolreprod.109.083154; Kaestner KH, 2010, CURR OPIN GENET DEV, V20, P527, DOI 10.1016/j.gde.2010.06.005; Kawano Y, 2006, ONCOGENE, V25, P6528, DOI 10.1038/sj.onc.1209661; Kobayashi A, 2003, NAT REV GENET, V4, P969, DOI 10.1038/nrg1225; Kurita T, 2001, DEV BIOL, V240, P194, DOI 10.1006/dbio.2001.0458; Matias-Guiu X, 2001, HUM PATHOL, V32, P569, DOI 10.1053/hupa.2001.25929; Mo B, 2006, BIOL REPROD, V75, P387, DOI 10.1095/biolreprod.106.051870; Nei H, 1999, MOL CARCINOGEN, V25, P207, DOI 10.1002/(SICI)1098-2744(199907)25:3<207::AID-MC7>3.3.CO;2-W; Ojalvo LS, 2010, J IMMUNOL, V184, P702, DOI 10.4049/jimmunol.0902360; Perantoni AO, 2003, SEMIN CELL DEV BIOL, V14, P201, DOI 10.1016/S1084-9521(03)00022-3; Rhodes DR, 2005, NAT GENET, V37, P579, DOI 10.1038/ng1578; Sasaki H, 1996, GENES CELLS, V1, P59, DOI 10.1046/j.1365-2443.1996.04004.x; Scholten AN, 2003, J PATHOL, V201, P460, DOI 10.1002/path.1402; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Silverberg SG, 1999, ARCH PATHOL LAB MED, V123, P1035; Suzuki K, 2009, DEVELOPMENT, V136, P367, DOI 10.1242/dev.021295; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Wang YY, 2009, CLIN CANCER RES, V15, P5784, DOI 10.1158/1078-0432.CCR-09-0814; Williamson EA, 2006, ONCOGENE, V25, P1391, DOI 10.1038/sj.onc.1209170; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yu X, 2011, ONCOGENE, V30, P1868, DOI 10.1038/onc.2010.560; Yue XA, 2010, BRAIN RES, V1366, P27, DOI 10.1016/j.brainres.2010.10.032; Zhu HN, 2004, CANCER RES, V64, P7918, DOI 10.1158/0008-5472.CAN-04-2704	42	39	40	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 18	2013	32	29					3477	3482		10.1038/onc.2012.376	http://dx.doi.org/10.1038/onc.2012.376			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	186AZ	22945641				2022-12-25	WOS:000322014900009
J	Dermer, J; Fuchs, G				Dermer, Juri; Fuchs, Georg			Molybdoenzyme That Catalyzes the Anaerobic Hydroxylation of a Tertiary Carbon Atom in the Side Chain of Cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETHYLBENZENE DEHYDROGENASE; INITIAL STEPS; DEGRADATION; CLASSIFICATION; IDENTIFICATION; BIOSYNTHESIS; METABOLISM; MECHANISM; MEMBRANE; PROTEINS	Cholesterol is a ubiquitous hydrocarbon compound that can serve as substrate for microbial growth. This steroid and related cyclic compounds are recalcitrant due to their low solubility in water, complex ring structure, the presence of quaternary carbon atoms, and the low number of functional groups. Aerobic metabolism therefore makes use of reactive molecular oxygen as co-substrate of oxygenases to hydroxylate and cleave the sterane ring system. Consequently, anaerobic metabolism must substitute oxygenase-catalyzed steps by O-2-independent hydroxylases. Here we show that one of the initial reactions of anaerobic cholesterol metabolism in the beta-proteobacterium Sterolibacterium denitrificans is catalyzed by an unprecedented enzyme that hydroxylates the tertiary C25 atom of the side chain without molecular oxygen forming a tertiary alcohol. This steroid C25 dehydrogenase belongs to the dimethyl sulfoxide dehydrogenase molybdoenzyme family, the closest relative being ethylbenzene dehydrogenase. It is a heterotrimer, which is probably located at the periplasmic side of the membrane and contains one molybdenum cofactor, five [Fe-S] clusters, and one heme b. The draft genome of the organism contains several genes coding for related enzymes that probably replace oxygenases in steroid metabolism.	[Dermer, Juri; Fuchs, Georg] Univ Freiburg, Lehrstuhl Mikrobiol, Fak Biol, D-79104 Freiburg, Germany	University of Freiburg	Fuchs, G (corresponding author), Univ Freiburg, Lehrstuhl Mikrobiol, Fak Biol, Schanzlestr 1, D-79104 Freiburg, Germany.	georg.fuchs@biologie.uni-freiburg.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Behrman EJ, 2005, J CHEM EDUC, V82, P1791, DOI 10.1021/ed082p1791; Bender KS, 2005, J BACTERIOL, V187, P5090, DOI 10.1128/JB.187.15.5090-5096.2005; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Bode HB, 2003, MOL MICROBIOL, V47, P471, DOI 10.1046/j.1365-2958.2003.03309.x; Chiang YR, 2008, J BACTERIOL, V190, P905, DOI 10.1128/JB.01525-07; Chiang YR, 2008, APPL ENVIRON MICROB, V74, P107, DOI 10.1128/AEM.01968-07; Chiang YR, 2007, J BIOL CHEM, V282, P13240, DOI 10.1074/jbc.M610963200; Chiang YR, 2010, MICROBIOL-SGM, V156, P2253, DOI 10.1099/mic.0.037788-0; Drummond A. J., 2011, GENEIOUS VERSION 5 4; Ferrato F, 1997, METHOD ENZYMOL, V286, P327; Gallien S, 2009, GENOME RES, V19, P128, DOI 10.1101/gr.081901.108; GENNIS RB, 1977, ANNU REV BIOPHYS BIO, V6, P195, DOI 10.1146/annurev.bb.06.060177.001211; Hanlon SP, 1996, EUR J BIOCHEM, V239, P391, DOI 10.1111/j.1432-1033.1996.0391u.x; Harder J, 1997, ARCH MICROBIOL, V167, P269, DOI 10.1007/s002030050442; Jormakka M, 2004, STRUCTURE, V12, P95, DOI 10.1016/j.str.2003.11.020; KIESLICH K, 1985, J BASIC MICROB, V25, P461, DOI 10.1002/jobm.3620250713; KIESLICH K, 1980, BIOTECHNOL LETT, V2, P211, DOI 10.1007/BF01209435; Kloer DP, 2006, STRUCTURE, V14, P1377, DOI 10.1016/j.str.2006.07.001; Kniemeyer O, 2001, J BIOL CHEM, V276, P21381, DOI 10.1074/jbc.M101679200; Krafft T, 2000, DNA Seq, V10, P365, DOI 10.3109/10425170009015604; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOVENBERG W, 1963, J BIOL CHEM, V238, P3899; MACKENZIE AS, 1982, SCIENCE, V217, P491, DOI 10.1126/science.217.4559.491; McDevitt CA, 2002, MOL MICROBIOL, V44, P1575, DOI 10.1046/j.1365-2958.2002.02978.x; Olkkonen VM, 2009, MOL ASPECTS MED, V30, P123, DOI 10.1016/j.mam.2009.02.004; Ouellet H, 2010, MOL MICROBIOL, V77, P730, DOI 10.1111/j.1365-2958.2010.07243.x; PRUTZ WA, 1993, FREE RADICAL RES COM, V18, P159, DOI 10.3109/10715769309147489; Rabus R, 2002, ARCH MICROBIOL, V178, P506, DOI 10.1007/s00203-002-0487-2; Ramos-Vera WH, 2010, J BACTERIOL, V192, P5329, DOI 10.1128/JB.00729-10; Rosloniec KZ, 2009, MOL MICROBIOL, V74, P1031, DOI 10.1111/j.1365-2958.2009.06915.x; Rothery RA, 2008, BBA-BIOMEMBRANES, V1778, P1897, DOI 10.1016/j.bbamem.2007.09.002; ROTHMAN JE, 1972, NATURE-NEW BIOL, V237, P42, DOI 10.1038/newbio237042a0; Sachelaru P, 2006, APPL ENVIRON MICROB, V72, P5126, DOI 10.1128/AEM.00437-06; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SEYBERT DW, 1979, J BIOL CHEM, V254, P2088; Szaleniec M, 2007, BIOCHEMISTRY-US, V46, P7637, DOI 10.1021/bi700633c; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarlera S, 2003, INT J SYST EVOL MICR, V53, P1085, DOI 10.1099/ijs.0.02039-0; WITTENBERG C, 1985, J BIOL CHEM, V260, P2535	42	39	40	0	28	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36905	36916		10.1074/jbc.M112.407304	http://dx.doi.org/10.1074/jbc.M112.407304			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22942275	Green Published, hybrid			2022-12-25	WOS:000310588500027
J	Grassie, ME; Sutherland, C; Ulke-Lemee, A; Chappellaz, M; Kiss, E; Walsh, MP; MacDonald, JA				Grassie, Michael E.; Sutherland, Cindy; Ulke-Lemee, Annegret; Chappellaz, Mona; Kiss, Enikoe; Walsh, Michael P.; MacDonald, Justin A.			Cross-talk between Rho-associated Kinase and Cyclic Nucleotide-dependent Kinase Signaling Pathways in the Regulation of Smooth Muscle Myosin Light Chain Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ SENSITIZATION; SUBSTRATE-SPECIFICITY; PHOSPHORYLATION SITES; TARGET SUBUNIT; MECHANISM; CONTRACTION; DIPHOSPHORYLATION; IDENTIFICATION; INHIBITION; RELAXATION	Ca2+ sensitization of smooth muscle contraction depends upon the activities of protein kinases, including Rho-associated kinase, that phosphorylate the myosin phosphatase targeting subunit (MYPT1) at Thr(697) and/or Thr(855) (rat sequence numbering) to inhibit phosphatase activity and increase contractile force. Both Thr residues are preceded by the sequence RRS, and it has been suggested that phosphorylation at Ser(696) prevents phosphorylation at Thr(697). However, the effects of Ser(854) and dual Ser(696)-Thr(697) and Ser(854)-Thr(855) phosphorylations on myosin phosphatase activity and contraction are unknown. We characterized a suite of MYPT1 proteins and phosphospecific antibodies for specificity toward monophosphorylation events (Ser(696), Thr(697), Ser(854), and Thr(855)), Ser phosphorylation events (Ser(696)/Ser(854)) and dual Ser/Thr phosphorylation events (Ser(696)-Thr(697) and Ser(854)-Thr(855)). Dual phosphorylation at Ser(696)-Thr(697) and Ser(854)-Thr(855) by cyclic nucleotide-dependent protein kinases had no effect on myosin phosphatase activity, whereas phosphorylation at Thr(697) and Thr(855) by Rho-associated kinase inhibited phosphatase activity and prevented phosphorylation by cAMP-dependent protein kinase at the neighboring Ser residues. Forskolin induced phosphorylation at Ser(696), Thr(697), Ser(854), and Thr(855) in rat caudal artery, whereas U46619 induced Thr(697) and Thr(855) phosphorylation and prevented the Ser phosphorylation induced by forskolin. Furthermore, pretreatment with forskolin prevented U46619-induced Thr phosphorylations. We conclude that cross-talk between cyclic nucleotide and RhoA signaling pathways dictates the phosphorylation status of the Ser(696)-Thr(697) and Ser(854)-Thr(855) inhibitory regions of MYPT1 in situ, thereby regulating the activity of myosin phosphatase and contraction.	Univ Calgary, Smooth Muscle Res Grp, Calgary, AB T2N 4Z6, Canada; Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4Z6, Canada	University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary	MacDonald, JA (corresponding author), 3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	jmacdo@ucalgary.ca		MacDonald, Justin/0000-0002-9238-8473	Canadian Institutes of Health Research [MOP-72720, MOP-111262]; Heart and Stroke Foundation of Canada; Alberta Innovates-Health Solutions (AIHS) Scientist Award; Canada Research Chair in Vascular Smooth Muscle Research; Alberta Innovates-Health Solutions (AIHS) Senior Scholar Award; Canada Research Chair in Smooth Muscle Pathophysiology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Alberta Innovates-Health Solutions (AIHS) Scientist Award; Canada Research Chair in Vascular Smooth Muscle Research; Alberta Innovates-Health Solutions (AIHS) Senior Scholar Award; Canada Research Chair in Smooth Muscle Pathophysiology	This work was supported in part by Canadian Institutes of Health Research Grants MOP-72720 (to J. A. M.) and MOP-111262 (to M. P. W.).; Holds a Heart and Stroke Foundation of Canada fellowship.; Holds an Alberta Innovates-Health Solutions (AIHS) Scientist Award and Canada Research Chair in Vascular Smooth Muscle Research.; Holds an Alberta Innovates-Health Solutions (AIHS) Senior Scholar Award and Canada Research Chair in Smooth Muscle Pathophysiology. To whom correspondence should be addressed: 3280 Hospital Dr. NW, Calgary, Alberta T2N 4Z6, Canada. Tel.: 403-210-8433; Fax: 403-270-2211; E-mail: jmacdo@ucalgary.ca.	Bolz SS, 2003, CIRCULATION, V107, P3081, DOI 10.1161/01.CIR.0000074202.19612.8C; Borman MA, 2002, J BIOL CHEM, V277, P23441, DOI 10.1074/jbc.M201597200; Borman MA, 2009, MOL CELL BIOCHEM, V327, P93, DOI 10.1007/s11010-009-0047-z; Borysova L, 2011, CELL CALCIUM, V50, P393, DOI 10.1016/j.ceca.2011.07.003; Bridges D, 2006, BIOCHEM BIOPH RES CO, V346, P351, DOI 10.1016/j.bbrc.2006.05.138; Carvajal JA, 2000, J CELL PHYSIOL, V184, P409, DOI 10.1002/1097-4652(200009)184:3<409::AID-JCP16>3.3.CO;2-B; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; GONG MC, 1992, J BIOL CHEM, V267, P14662; Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018; Ichikawa K, 1996, J BIOL CHEM, V271, P4733; INAGAKI M, 1990, J BIOL CHEM, V265, P4722; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Khromov A, 2009, J BIOL CHEM, V284, P21569, DOI 10.1074/jbc.M109.019729; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; MacDonald JA, 2001, P NATL ACAD SCI USA, V98, P2419, DOI 10.1073/pnas.041331498; MacDonald JA, 2001, FEBS LETT, V493, P91, DOI 10.1016/S0014-5793(01)02277-3; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; Miller JL, 2008, PROTEIN SCI, V17, P251, DOI 10.1110/ps.073185608; Moffat LD, 2011, J BIOL CHEM, V286, P36978, DOI 10.1074/jbc.M111.257949; Morgado M, 2012, CELL MOL LIFE SCI, V69, P247, DOI 10.1007/s00018-011-0815-2; Muranyi A, 2005, FEBS LETT, V579, P6611, DOI 10.1016/j.febslet.2005.10.055; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Nakamura K, 2007, CIRC RES, V101, P712, DOI 10.1161/CIRCRESAHA.107.153981; Patwardhan P, 2007, CELL SIGNAL, V19, P2218, DOI 10.1016/j.cellsig.2007.06.006; Sanders KM, 2001, J APPL PHYSIOL, V91, P1438, DOI 10.1152/jappl.2001.91.3.1438; Shin HM, 2002, CIRC RES, V90, P546, DOI 10.1161/01.RES.0000012822.23273.EC; SHIRAZI A, 1994, J BIOL CHEM, V269, P31598; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Sriwai W, 2008, BIOCHEM J, V411, P543, DOI [10.1042/BJ20071299, 10.1042/bj20071299]; Sutherland C, 2012, J BIOL CHEM, V287, P24064, DOI 10.1074/jbc.M112.371609; Tan I, 2001, J BIOL CHEM, V276, P21209, DOI 10.1074/jbc.M102615200; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Walsh MP, 2011, IUBMB LIFE, V63, P987, DOI 10.1002/iub.527; Webb RC, 2003, ADV PHYSIOL EDUC, V27, P201, DOI 10.1152/advan.00025.2003; Weber LP, 1999, J PHYSIOL-LONDON, V516, P805, DOI 10.1111/j.1469-7793.1999.0805u.x; Wilson DP, 2005, BIOCHEM J, V392, P641, DOI 10.1042/BJ20051173; Wilson DP, 2005, BIOCHEM J, V389, P763, DOI 10.1042/BJ20050237; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; Wu XQ, 1996, BIOCHEM BIOPH RES CO, V220, P658, DOI 10.1006/bbrc.1996.0460	40	31	32	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36356	36369		10.1074/jbc.M112.398479	http://dx.doi.org/10.1074/jbc.M112.398479			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948155	Green Published, hybrid			2022-12-25	WOS:000310364000056
J	Kim, YW; Kwon, C; Liu, JL; Kim, SH; Kim, S				Kim, Yong-Wan; Kwon, ChangHyuk; Liu, Juinn-Lin; Kim, Se Hoon; Kim, Sunghoon			Cancer Association Study of Aminoacyl-tRNA Synthetase Signaling Network in Glioblastoma	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; HIGH-GRADE GLIOMA; GENE-EXPRESSION; MOLECULAR PHARMACOLOGY; CORE PATHWAYS; REVEALS; PROFILES; SURVIVAL; DISEASE; MICROARRAY	Aminoacyl-tRNA synthetases (ARSs) and ARS-interacting multifunctional proteins (AIMPs) exhibit remarkable functional versatility beyond their catalytic activities in protein synthesis. Their non-canonical functions have been pathologically linked to cancers. Here we described our integrative genome-wide analysis of ARSs to show cancer-associated activities in glioblastoma multiforme (GBM), the most aggressive malignant primary brain tumor. We first selected 23 ARS/AIMPs (together referred to as ARSN), 124 cancer-associated druggable target genes (DTGs) and 404 protein-protein interactors (PPIs) of ARSs using NCI's cancer gene index. 254 GBM affymetrix microarray data in The Cancer Genome Atlas (TCGA) were used to identify the probe sets whose expression were most strongly correlated with survival (Kaplan-Meier plots versus survival times, log-rank t-test <0.05). The analysis identified 122 probe sets as survival signatures, including 5 of ARSN (VARS, QARS, CARS, NARS, FARS), and 115 of DTGs and PPIs (PARD3, RXRB, ATP5C1, HSP90AA1, CD44, THRA, TRAF2, KRT10, MED12, etc). Of note, 61 survival-related probes were differentially expressed in three different prognosis subgroups in GBM patients and showed correlation with established prognosis markers such as age and phenotypic molecular signatures. CARS and FARS also showed significantly higher association with different molecular networks in GBM patients. Taken together, our findings demonstrate evidence for an ARSN biology-dominant contribution in the biology of GBM.	[Kim, Yong-Wan] Catholic Univ Korea, Coll Med, Catholic Res Inst Med Sci, Seoul, South Korea; [Kwon, ChangHyuk] Seoul Natl Univ, Syst Biomed Informat Natl Core Res Ctr, Seoul, South Korea; [Liu, Juinn-Lin] Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Kim, Se Hoon] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Kim, Sunghoon] Seoul Natl Univ, Med Bioconvergence Res Ctr, Seoul, South Korea; [Kim, Sunghoon] Seoul Natl Univ, WCU Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea	Catholic University of Korea; Seoul National University (SNU); University of Texas System; UTMD Anderson Cancer Center; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Seoul National University (SNU)	Kim, YW (corresponding author), Catholic Univ Korea, Coll Med, Catholic Res Inst Med Sci, Seoul, South Korea.	sungkim@snu.ac.kr	Kim, Sunghoon/AAE-8314-2020	Kim, Se Hoon/0000-0001-7516-7372; kim, sunghoon/0000-0002-1570-3230	National Research Foundation [NRF-M1AXA002-2010-0029785]; Ministry of Education, Science and Technology of Korea	National Research Foundation; Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Global Frontier Project grant (NRF-M1AXA002-2010-0029785) of the National Research Foundation funded by the Ministry of Education, Science and Technology of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel TW, 2009, MOL CANCER RES, V7, P645, DOI 10.1158/1541-7786.MCR-08-0477; Anderson LL, 2009, SCIENCE, V323, P630, DOI 10.1126/science.1166175; [Anonymous], 2008, NATURE, V455, P1061; Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Arsham AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006068; Bogdahn U, 2011, NEURO-ONCOLOGY, V13, P132, DOI 10.1093/neuonc/noq142; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Cavenee WK, 2002, CARCINOGENESIS, V23, P683, DOI 10.1093/carcin/23.5.683; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; CHRISTODOULOU K, 1995, HUM MOL GENET, V4, P1629, DOI 10.1093/hmg/4.9.1629; Ducray F, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-41; Frank I, 2003, J UROLOGY, V170, P2225, DOI 10.1097/01.ju.0000095541.10333.a7; Gemma A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-174; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Gursel Demirkan B, 2011, Cancers (Basel), V3, P2655, DOI 10.3390/cancers3022655; Hjelmeland AB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000319; Huttner AJ, 2010, PEDIATR BLOOD CANCER, V54, P890, DOI 10.1002/pbc.22462; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Kayton M L, 2001, Curr Opin Investig Drugs, V2, P136; Kim S, 2011, Novel uses of GRS proteins or fragments thereof, Patent No. 0905829; Kim S, 2011, NAT REV CANCER, V11, P708, DOI 10.1038/nrc3124; Ko YG, 2001, J BIOL CHEM, V276, P23028, DOI 10.1074/jbc.M101544200; KUSHNER JP, 1976, P SOC EXP BIOL MED, V153, P273; Ladha J, 2010, CANCER RES, V70, P6437, DOI 10.1158/0008-5472.CAN-10-0819; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; MATHEWS MB, 1984, J EXP MED, V160, P420, DOI 10.1084/jem.160.2.420; Micallef J, 2009, CANCER RES, V69, P7548, DOI 10.1158/0008-5472.CAN-08-4783; Obayashi T, 2009, DNA RES, V16, P249, DOI 10.1093/dnares/dsp016; Park MC, 2012, P NATL ACAD SCI USA, V109, pE640, DOI 10.1073/pnas.1200194109; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Pasternak K, 1997, Ann Univ Mariae Curie Sklodowska Med, V52, P29; Patard JJ, 2004, J CLIN ONCOL, V22, P3316, DOI 10.1200/JCO.2004.09.104; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Ray PS, 2007, EMBO J, V26, P3360, DOI 10.1038/sj.emboj.7601774; Reifenberger G, 1996, CANCER RES, V56, P5141; Scandurro AB, 2001, INT J ONCOL, V19, P129; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Suh KS, 2010, EXPERT REV MOL DIAGN, V10, P1069, DOI 10.1586/ERM.10.87; Tzima E, 2006, TRENDS BIOCHEM SCI, V31, P7, DOI 10.1016/j.tibs.2005.11.002; Vasselli JR, 2003, P NATL ACAD SCI USA, V100, P6958, DOI 10.1073/pnas.1131754100; Vellaichamy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007075; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022566; Wasenius VM, 2003, CLIN CANCER RES, V9, P68; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019; Zanzoni A, 2009, FEBS LETT, V583, P1759, DOI 10.1016/j.febslet.2009.03.001; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	51	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e40960	10.1371/journal.pone.0040960	http://dx.doi.org/10.1371/journal.pone.0040960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952576	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300002
J	Wei, CZ; Zheng, HF; Li, Q; Lu, XT; Yu, Q; Zhang, HY; Chen, QS; He, NP; Kardol, P; Liang, WJ; Han, XG				Wei, Cunzheng; Zheng, Huifen; Li, Qi; Lu, Xiaotao; Yu, Qiang; Zhang, Haiyang; Chen, Quansheng; He, Nianpeng; Kardol, Paul; Liang, Wenju; Han, Xingguo			Nitrogen Addition Regulates Soil Nematode Community Composition through Ammonium Suppression	PLOS ONE			English	Article							FOREST ECOSYSTEMS; PLANT-COMMUNITIES; FOOD-WEBS; DIVERSITY; MINERALIZATION; BIODIVERSITY; INDICATORS; DEPOSITION; AGROECOSYSTEMS; FERTILIZATION	Nitrogen (N) enrichment resulting from anthropogenic activities has greatly changed the composition and functioning of soil communities. Nematodes are one of the most abundant and diverse groups of soil organisms, and they occupy key trophic positions in the soil detritus food web. Nematodes have therefore been proposed as useful indicators for shifts in soil ecosystem functioning under N enrichment. Here, we monitored temporal dynamics of the soil nematode community using a multi-level N addition experiment in an Inner Mongolia grassland. Measurements were made three years after the start of the experiment. We used structural equation modeling (SEM) to explore the mechanisms regulating nematode responses to N enrichment. Across the N enrichment gradient, significant reductions in total nematode abundance, diversity (H' and taxonomic richness), maturity index (MI), and the abundance of root herbivores, fungivores and omnivores-predators were found in August. Root herbivores recovered in September, contributing to the temporal variation of total nematode abundance across the N gradient. Bacterivores showed a hump-shaped relationship with N addition rate, both in August and September. Ammonium concentration was negatively correlated with the abundance of total and herbivorous nematodes in August, but not in September. Ammonium suppression explained 61% of the variation in nematode richness and 43% of the variation in nematode trophic group composition. Ammonium toxicity may occur when herbivorous nematodes feed on root fluid, providing a possible explanation for the negative relationship between herbivorous nematodes and ammonium concentration in August. We found a significantly positive relationship between fungivores and fungal phospholipid fatty acids (PLFA), suggesting bottom-up control of fungivores. No such relationship was found between bacterivorous nematodes and bacterial PLFA. Our findings contribute to the understanding of effects of N enrichment in semiarid grassland on soil nematode trophic groups, and the cascading effects in the detrital soil food web.	[Wei, Cunzheng; Zheng, Huifen; Chen, Quansheng; Han, Xingguo] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Wei, Cunzheng; Li, Qi; Lu, Xiaotao; Yu, Qiang; Zhang, Haiyang; Liang, Wenju; Han, Xingguo] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China; [Wei, Cunzheng; Zheng, Huifen] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [He, Nianpeng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Kardol, Paul] Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90183 Umea, Sweden	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Swedish University of Agricultural Sciences	Wei, CZ (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	weicunzheng@ibcas.ac.cn; xghan@ibcas.ac.cn	Kardol, Paul/A-2600-2010; Chen, Quansheng/AGH-8083-2022; Kardol, Paul/N-8383-2015; LI, Qi/N-2673-2017; Han, Xingguo/K-7552-2016; Yu, Qiang/E-2097-2011; Lu (ü), Xiao-Tao/B-3905-2008; Cunzheng, Wei/A-4360-2009	Chen, Quansheng/0000-0003-2498-3278; Kardol, Paul/0000-0001-7065-3435; LI, Qi/0000-0002-8652-8396; Han, Xingguo/0000-0002-1836-975X; Yu, Qiang/0000-0002-5480-0623; Lu (ü), Xiao-Tao/0000-0001-5571-1895; Cunzheng, Wei/0000-0001-9309-2722; he, nianpeng/0000-0002-0458-5953	Key Project of National Natural Science Foundation of China [30830026]; State Key Basic Research Development Program [2007CB106801]	Key Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Basic Research Development Program	This work was supported by the Key Project of National Natural Science Foundation of China (30830026, http://www.nsfc.gov.cn/), the State Key Basic Research Development Program (2007CB106801, http://www.973.gov.cn/Default_3.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; ABER JD, 1989, BIOSCIENCE, V39, P378, DOI 10.2307/1311067; [Anonymous], 1960, NEMATOLOGY; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Bardgett RD, 1999, FUNCT ECOL, V13, P650, DOI 10.1046/j.1365-2435.1999.00362.x; Bongers T, 1999, TRENDS ECOL EVOL, V14, P224, DOI 10.1016/S0169-5347(98)01583-3; BONGERS T, 1990, OECOLOGIA, V83, P14, DOI 10.1007/BF00324627; Clark CM, 2007, ECOL LETT, V10, P596, DOI 10.1111/j.1461-0248.2007.01053.x; Collange B, 2011, CROP PROT, V30, P1251, DOI 10.1016/j.cropro.2011.04.016; De Deyn GB, 2004, OIKOS, V106, P576, DOI 10.1111/j.0030-1299.2004.13265.x; DERUITER PC, 1993, J APPL ECOL, V30, P95, DOI 10.2307/2404274; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Grace JB., 2015, STRUCTURAL EQUATION; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Hu C, 2010, EUR J SOIL BIOL, V46, P230, DOI 10.1016/j.ejsobi.2010.04.002; JOHNSON DW, 1980, SOIL SCI SOC AM J, V44, P610, DOI 10.2136/sssaj1980.03615995004400030036x; Kardol P, 2005, BIOL CONSERV, V126, P317, DOI 10.1016/j.biocon.2005.06.005; Li Q, 2010, APPL SOIL ECOL, V46, P111, DOI 10.1016/j.apsoil.2010.06.016; Liang WJ, 2009, SOIL BIOL BIOCHEM, V41, P883, DOI 10.1016/j.soilbio.2008.06.018; Manning P, 2006, ECOL LETT, V9, P1015, DOI 10.1111/j.1461-0248.2006.00959.x; Manning P, 2008, SOIL BIOL BIOCHEM, V40, P688, DOI 10.1016/j.soilbio.2007.08.023; Mulder C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003573; Murray PJ, 2006, APPL SOIL ECOL, V33, P199, DOI 10.1016/j.apsoil.2005.11.004; Neher DA, 2001, J NEMATOL, V33, P161; Oka Y, 2007, CROP PROT, V26, P1556, DOI 10.1016/j.cropro.2007.01.003; PERSSON H, 1980, Acta Phytogeographica Suecica, V68, P101; [齐莎 Qi Sha], 2010, [生态学报, Acta Ecologica Sinica], V30, P5518; RODRIGUEZKABANA R, 1986, J NEMATOL, V18, P129; Sarathchandra SU, 2001, SOIL BIOL BIOCHEM, V33, P953, DOI 10.1016/S0038-0717(00)00245-5; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; SOHLENIUS B, 1984, J APPL ECOL, V21, P327, DOI 10.2307/2403057; TILMAN D, 1987, ECOL MONOGR, V57, P189, DOI 10.2307/2937080; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; Veen GF, 2010, ECOLOGY, V91, P828, DOI 10.1890/09-0134.1; VERHOEF HA, 1990, BIOGEOCHEMISTRY, V11, P175, DOI 10.1007/BF00004496; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wall ME, 1940, SCIENCE, V91, P221, DOI 10.1126/science.91.2357.221-a; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; WARDLE DA, 1993, OECOLOGIA, V93, P303, DOI 10.1007/BF00317685; WARDLE DA, 1995, PLANT SOIL, V170, P35, DOI 10.1007/BF02183053; Wardle DA, 2002, COMMUNITIES ECOSYSTE; WARREN KS, 1962, NATURE, V195, P47, DOI 10.1038/195047a0; Wu TH, 2011, P NATL ACAD SCI USA, V108, P17720, DOI 10.1073/pnas.1103824108; Xia JY, 2008, NEW PHYTOL, V179, P428, DOI 10.1111/j.1469-8137.2008.02488.x; Xu GL, 2007, J ENVIRON SCI-CHINA, V19, P603, DOI 10.1016/S1001-0742(07)60100-4; Yeates GW, 1999, ANNU REV PHYTOPATHOL, V37, P127, DOI 10.1146/annurev.phyto.37.1.127; Yeates GW, 2003, BIOL FERT SOILS, V37, P199, DOI 10.1007/s00374-003-0586-5; YEATES GW, 1993, J NEMATOL, V25, P315; Yu Q, 2010, ECOL LETT, V13, P1390, DOI 10.1111/j.1461-0248.2010.01532.x	50	64	75	19	183	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43384	10.1371/journal.pone.0043384	http://dx.doi.org/10.1371/journal.pone.0043384			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952671	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000308221300013
J	Pezzulo, AA; Hornick, EE; Rector, MV; Estin, M; Reisetter, AC; Taft, PJ; Butcher, SC; Carter, AB; Manak, JR; Stoltz, DA; Zabner, J				Pezzulo, Alejandro A.; Hornick, Emma E.; Rector, Michael V.; Estin, Miriam; Reisetter, Anna C.; Taft, Peter J.; Butcher, Stephen C.; Carter, A. Brent; Manak, J. Robert; Stoltz, David A.; Zabner, Joseph			Expression of Human Paraoxonase 1 Decreases Superoxide Levels and Alters Bacterial Colonization in the Gut of Drosophila melanogaster	PLOS ONE			English	Article							HUMAN SERUM PARAOXONASE; LOW-DENSITY-LIPOPROTEIN; PATTERN-RECOGNITION RECEPTOR; MICROBIAL COLONIZATION; BIOLOGICAL-ACTIVITY; IMMUNE HOMEOSTASIS; GENE-EXPRESSION; NADPH OXIDASE; INFECTION; HOST	Paraoxonases (PON) are a family of proteins (PON1, 2 and 3) with multiple enzymatic activities. PON1 interferes with homoserine lactone-mediated quorum sensing in bacteria and with reactive oxygen species (ROS) in humans and mice. PON1 gene mutations have been linked to multiple traits, including aging, and diseases of the cardiovascular, nervous and gastrointestinal system. The overlapping enzymatic activities in the PON family members and high linkage disequilibrium rates within their polymorphisms confound animal and human studies of PON1 function. In contrast, arthropods such as Drosophila melanogaster have no PON homologs, resulting in an ideal model to study interactions between PON genotype and host phenotypes. We hypothesized that expression of PON1 in D. melanogaster would alter ROS. We found that PON1 alters expression of multiple oxidative stress genes and decreases superoxide anion levels in normal and germ-free D. melanogaster. We also found differences in the composition of the gut microbiota, with a remarkable increase in levels of Lactobacillus plantarum and associated changes in expression of antimicrobial and cuticle-related genes. PON1 expression directly decreased superoxide anion levels and altered bacterial colonization of the gut and its gene expression profile, highlighting the complex nature of the interaction between host genotype and gut microbiota. We speculate that the interaction between some genotypes and human diseases may be mediated by the presence of certain gut bacteria that can induce specific immune responses in the gut and other host tissues.	[Pezzulo, Alejandro A.; Hornick, Emma E.; Rector, Michael V.; Estin, Miriam; Reisetter, Anna C.; Taft, Peter J.; Carter, A. Brent; Stoltz, David A.; Zabner, Joseph] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Manak, J. Robert] Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA; [Butcher, Stephen C.; Manak, J. Robert] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Carter, A. Brent] Univ Iowa, Free Rad & Radiat Biol Program, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Pezzulo, AA (corresponding author), Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA.	joseph-zabner@uiowa.edu		Zabner, Joseph/0000-0002-9606-1339; Pezzulo, Alejandro/0000-0001-7544-5109; Stoltz, David/0000-0003-0893-9015; Manak, John/0000-0002-6562-7694	National Institutes of Health [NIHLPPG HL091842-02, ES015981, ES014871]; Insitutional Commitment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015981, R01ES014871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Insitutional Commitment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding from the National Institute of Health and Insitutional Commitment to JZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by the National Institutes of Health, NIHLPPG HL091842-02 (JZ) and ES015981 and ES014871 (ABC)	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ALDRIDGE WN, 1953, BIOCHEM J, V53, P117, DOI 10.1042/bj0530117; Altura MA, 2011, CELL MICROBIOL, V13, P527, DOI 10.1111/j.1462-5822.2010.01552.x; Apidianakis Y, 2011, DIS MODEL MECH, V4, P21, DOI 10.1242/dmm.003970; Aviram M, 1998, ARTERIOSCL THROM VAS, V18, P1617, DOI 10.1161/01.ATV.18.10.1617; Aviram M, 1999, FREE RADICAL BIO MED, V26, P892, DOI 10.1016/S0891-5849(98)00272-X; BAKULA M, 1969, J INVERTEBR PATHOL, V14, P365, DOI 10.1016/0022-2011(69)90163-3; Billeclke S, 2000, DRUG METAB DISPOS, V28, P1335; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Boehm D, 2009, INFLAMM BOWEL DIS, V15, P93, DOI 10.1002/ibd.20582; BRAND AH, 1993, DEVELOPMENT, V118, P401; Caesar R, 2010, J INTERN MED, V268, P320, DOI 10.1111/j.1365-2796.2010.02270.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chun CK, 2004, P NATL ACAD SCI USA, V101, P3587, DOI 10.1073/pnas.0308750101; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Erlich PM, 2006, HUM MOL GENET, V15, P77, DOI 10.1093/hmg/ddi428; Estin ML, 2010, ADV EXP MED BIOL, V660, P183, DOI 10.1007/978-1-60761-350-3_17; Goswami B, 2009, CLIN CHIM ACTA, V410, P1, DOI 10.1016/j.cca.2009.09.025; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; He C, 2011, J BIOL CHEM, V286, P15597, DOI 10.1074/jbc.M110.187377; Huen K, 2011, ENVIRON MOL MUTAGEN, V52, P105, DOI 10.1002/em.20567; Hughes DT, 2010, P NATL ACAD SCI USA, V107, P9831, DOI 10.1073/pnas.1002551107; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jakubowski H, 2010, ADV EXP MED BIOL, V660, P113, DOI 10.1007/978-1-60761-350-3_11; Jarvik GP, 2003, ARTERIOSCL THROM VAS, V23, P1465, DOI 10.1161/01.ATV.0000081635.96290.D3; Kabaroglu C, 2004, ACTA CARDIOL, V59, P606, DOI 10.2143/AC.59.6.2005242; Kanther M, 2011, GASTROENTEROLOGY, V141, P197, DOI 10.1053/j.gastro.2011.03.042; Kellermayer R, 2011, FASEB J, V25, P1449, DOI 10.1096/fj.10-172205; Khersonsky O, 2005, BIOCHEMISTRY-US, V44, P6371, DOI 10.1021/bi047440d; Kim YS, 2000, J BIOL CHEM, V275, P32721, DOI 10.1074/jbc.M003934200; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kuraishi T, 2011, P NATL ACAD SCI USA, V108, P15966, DOI 10.1073/pnas.1105994108; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2009, NAT IMMUNOL, V10, P936, DOI 10.1038/ni0909-936; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Mackness B, 2004, BIOCHEM BIOPH RES CO, V318, P680, DOI 10.1016/j.bbrc.2004.04.056; Motulsky H., 1995, INTUITIVE BIOSTATIST; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Ozer EA, 2005, FEMS MICROBIOL LETT, V253, P29, DOI 10.1016/j.femsle.2005.09.023; Peng Y, 2008, APPL ENVIRON MICROB, V74, P3943, DOI 10.1128/AEM.02607-07; Peshavariya HM, 2007, FREE RADICAL RES, V41, P699, DOI 10.1080/10715760701297354; PrimoParmo SL, 1996, GENOMICS, V33, P498, DOI 10.1006/geno.1996.0225; Reddy ST, 2001, ARTERIOSCL THROM VAS, V21, P542, DOI 10.1161/01.ATV.21.4.542; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rodrigo L, 2001, BIOCHEM J, V354, P1, DOI 10.1042/0264-6021:3540001; Rothem L, 2007, FREE RADICAL BIO MED, V43, P730, DOI 10.1016/j.freeradbiomed.2007.05.003; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Ryu JH, 2010, DEV COMP IMMUNOL, V34, P369, DOI 10.1016/j.dci.2009.11.010; Shih DM, 2010, ADV EXP MED BIOL, V660, P73, DOI 10.1007/978-1-60761-350-3_8; Stoltz D, 2008, J CLIN INVEST; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Tephly LA, 2007, AM J PHYSIOL-LUNG C, V293, pL1143, DOI 10.1152/ajplung.00114.2007; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359	66	10	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43777	10.1371/journal.pone.0043777	http://dx.doi.org/10.1371/journal.pone.0043777			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952763	gold, Green Published, Green Submitted			2022-12-25	WOS:000308206500022
J	Arora, T; Loo, RL; Anastasovska, J; Gibson, GR; Tuohy, KM; Sharma, RK; Swann, JR; Deaville, ER; Sleeth, ML; Thomas, EL; Holmes, E; Bell, JD; Frost, G				Arora, Tulika; Loo, Ruey Leng; Anastasovska, Jelena; Gibson, Glenn R.; Tuohy, Kieran M.; Sharma, Raj Kumar; Swann, Jonathan R.; Deaville, Eddie R.; Sleeth, Michele L.; Thomas, E. Louise; Holmes, Elaine; Bell, Jimmy D.; Frost, Gary			Differential Effects of Two Fermentable Carbohydrates on Central Appetite Regulation and Body Composition	PLOS ONE			English	Article							HIGH-FAT-DIET; GLUCAGON-LIKE PEPTIDE-1; CORONARY-HEART-DISEASE; GUT MICROBIAL ECOLOGY; IN-SITU HYBRIDIZATION; INULIN-TYPE FRUCTANS; INSULIN SENSITIVITY; RESISTANT STARCH; NERVOUS-SYSTEM; MICE	Background: Obesity is rising at an alarming rate globally. Different fermentable carbohydrates have been shown to reduce obesity. The aim of the present study was to investigate if two different fermentable carbohydrates (inulin and beta-glucan) exert similar effects on body composition and central appetite regulation in high fat fed mice. Methodology/Principal Findings: Thirty six C57BL/6 male mice were randomized and maintained for 8 weeks on a high fat diet containing 0% (w/w) fermentable carbohydrate, 10% (w/w) inulin or 10% (w/w) beta-glucan individually. Fecal and cecal microbial changes were measured using fluorescent in situ hybridization, fecal metabolic profiling was obtained by proton nuclear magnetic resonance (H-1 NMR), colonic short chain fatty acids were measured by gas chromatography, body composition and hypothalamic neuronal activation were measured using magnetic resonance imaging (MRI) and manganese enhanced MRI (MEMRI), respectively, PYY (peptide YY) concentration was determined by radioimmunoassay, adipocyte cell size and number were also measured. Both inulin and beta-glucan fed groups revealed significantly lower cumulative body weight gain compared with high fat controls. Energy intake was significantly lower in beta-glucan than inulin fed mice, with the latter having the greatest effect on total adipose tissue content. Both groups also showed an increase in the numbers of Bifidobacterium and Lactobacillus-Enterococcus in cecal contents as well as feces. beta-glucan appeared to have marked effects on suppressing MEMRI associated neuronal signals in the arcuate nucleus, ventromedial hypothalamus, paraventricular nucleus, periventricular nucleus and the nucleus of the tractus solitarius, suggesting a satiated state. Conclusions/Significance: Although both fermentable carbohydrates are protective against increased body weight gain, the lower body fat content induced by inulin may be metabolically advantageous. beta-glucan appears to suppress neuronal activity in the hypothalamic appetite centers. Differential effects of fermentable carbohydrates open new possibilities for nutritionally targeting appetite regulation and body composition.	[Arora, Tulika; Sleeth, Michele L.; Frost, Gary] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Invest Med, Nutr & Dietet Res Grp, London, England; [Anastasovska, Jelena; Thomas, E. Louise; Bell, Jimmy D.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC Clin Sci Ctr, Metab & Mol Imaging Grp, London, England; [Gibson, Glenn R.; Tuohy, Kieran M.; Swann, Jonathan R.; Deaville, Eddie R.] Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England; [Loo, Ruey Leng; Holmes, Elaine] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Arora, Tulika; Sharma, Raj Kumar] Natl Dairy Res Inst, Div Anim Biochem, Karnal 132001, Haryana, India; [Tuohy, Kieran M.] Fdn Edmund Mach San Michele allAdige, Res & Innovat Ctr, Nutr & Nutrigen Grp, Dept Food Qual & Nutr, Trento, Italy; [Loo, Ruey Leng] Univ Kent & Greenwich, Medway Sch Pharm, Kent, England	Imperial College London; Imperial College London; University of Reading; Imperial College London; Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute; Fondazione Edmund Mach	Arora, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Invest Med, Nutr & Dietet Res Grp, London, England.	g.frost@imperial.ac.uk	Holmes, Elaine/ABE-6606-2020; Tuohy, Kieran M/G-9142-2011; Thomas, Elizabeth Louise/AIF-0055-2022; Holmes, Elaine/A-2189-2015	Holmes, Elaine/0000-0002-0556-8389; Tuohy, Kieran M/0000-0001-6882-7192; Arora, Tulika/0000-0001-8821-8191; Bell, Jimmy/0000-0003-3804-1281; Swann, Jonathan/0000-0002-6485-4529; Loo, Ruey Leng/0000-0001-5307-5709; Thomas, Elizabeth/0000-0003-4235-4694	MRC; BBSRC; NIHR; Integrative Mammalian Biology (IMB) Capacity Building Award; NIHR Imperial Biomedical Research Centre Funding Scheme; NIHR senior investigator award; Commonwealth split site scholarship;  [FP7-HEALTH-2009-241592 EurOCHIP]; BBSRC [BB/I023054/1, BB/H004971/1] Funding Source: UKRI; MRC [G1002151, MC_U120061305] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I023054/1, BB/H004971/1] Funding Source: researchfish; Medical Research Council [G0801056B, G1002151, MC_U120061305] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIHR(National Institute for Health Research (NIHR)); Integrative Mammalian Biology (IMB) Capacity Building Award; NIHR Imperial Biomedical Research Centre Funding Scheme; NIHR senior investigator award; Commonwealth split site scholarship; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Department is funded by grants from the MRC, BBSRC, NIHR, an Integrative Mammalian Biology (IMB) Capacity Building Award, an FP7-HEALTH-2009-241592 EurOCHIP grant and funding from the NIHR Imperial Biomedical Research Centre Funding Scheme. Gary Frost is supported by an NIHR senior investigator award, Tulika Arora was supported by a Commonwealth split site scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN TE, 1985, GASTROENTEROLOGY, V89, P1070, DOI 10.1016/0016-5085(85)90211-2; Anastasovska J, 2012, OBESITY; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2004, BRIT J NUTR, V92, P521, DOI 10.1079/BJN20041225; Cani PD, 2005, OBES RES, V13, P1000, DOI 10.1038/oby.2005.117; Choi JS, 2010, MOL NUTR FOOD RES, V54, P1004, DOI 10.1002/mnfr.200900127; Cloarec O, 2005, ANAL CHEM, V77, P1282, DOI 10.1021/ac048630x; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; Dewulf EM, 2011, J NUTR BIOCHEM, V22, P712, DOI 10.1016/j.jnutbio.2010.05.009; Eriksson L., 2002, MULTI MEGAVARIATE DA; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; Frost G, 1998, METABOLISM, V47, P1245, DOI 10.1016/S0026-0495(98)90331-6; Frost GS, 1998, DIABETIC MED, V15, P1003, DOI 10.1002/(SICI)1096-9136(1998120)15:12<1003::AID-DIA715>3.0.CO;2-2; Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059; Harmsen Hermie J.M., 1999, Microbial Ecology in Health and Disease, V11, P3, DOI 10.1080/089106099435862; Kaji I, 2010, J MOL HISTOL; Kimura I, 2011, P NATL ACAD SCI USA, V108, P8030, DOI 10.1073/pnas.1016088108; Kleessen B, 2001, BRIT J NUTR, V86, P291, DOI 10.1079/BJN2001403; Kuo YT, 2006, NMR BIOMED, V19, P1028, DOI 10.1002/nbm.1070; LANGENDIJK PS, 1995, APPL ENVIRON MICROB, V61, P3069, DOI 10.1128/AEM.61.8.3069-3075.1995; le Roux CW, 2006, ENDOCRINOLOGY, V147, P3, DOI 10.1210/en.2005-0972; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Martin-Pelaez S, 2008, FEMS MICROBIOL ECOL, V66, P608, DOI 10.1111/j.1574-6941.2008.00610.x; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Parkinson JRC, 2008, AM J PHYSIOL-ENDOC M, V294, pE698, DOI 10.1152/ajpendo.00405.2007; Parkinson JRC, 2009, NEUROENDOCRINOLOGY, V89, P121, DOI 10.1159/000163751; Parkinson JRC, 2009, NEUROIMAGE, V44, P1022, DOI 10.1016/j.neuroimage.2008.09.047; Parnell JA, 2009, AM J CLIN NUTR, V89, P1751, DOI 10.3945/ajcn.2009.27465; Patel AD, 2006, REGUL PEPTIDES, V134, P17, DOI 10.1016/j.regpep.2005.11.001; RICHARDSON AJ, 1989, LETT APPL MICROBIOL, V9, P5, DOI 10.1111/j.1472-765X.1989.tb00278.x; Salzman NH, 2002, MICROBIOL-SGM, V148, P3651, DOI 10.1099/00221287-148-11-3651; Saric J, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000254; Snart J, 2006, APPL ENVIRON MICROB, V72, P1925, DOI 10.1128/AEM.72.3.1925-1931.2006; So PW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001309; Tuohy KM, 2001, BRIT J NUTR, V86, P341, DOI 10.1079/BJN2001394; Vitaglione P, 2009, APPETITE, V53, P338, DOI 10.1016/j.appet.2009.07.013; Wanders AJ, 2011, OBES REV, V12, P724, DOI 10.1111/j.1467-789X.2011.00895.x; Zhou J, 2006, OBESITY, V14, P683, DOI 10.1038/oby.2006.77; Zhou J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1160, DOI 10.1152/ajpendo.90637.2008	42	55	60	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43263	10.1371/journal.pone.0043263	http://dx.doi.org/10.1371/journal.pone.0043263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952656	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000308206000028
J	Pashler, H; Coburn, N; Harris, CR				Pashler, Harold; Coburn, Noriko; Harris, Christine R.			Priming of Social Distance? Failure to Replicate Effects on Social and Food Judgments	PLOS ONE			English	Article							IDENTIFICATION; FACILITATION; RECOGNITION; BEHAVIOR; CONTEXT; WORDS; FALSE; BIAS	Williams and Bargh (2008) reported an experiment in which participants were simply asked to plot a single pair of points on a piece of graph paper, with the coordinates provided by the experimenter specifying a pair of points that lay at one of three different distances (close, intermediate, or far, relative to the range available on the graph paper). The participants who had graphed a more distant pair reported themselves as being significantly less close to members of their own family than did those who had plotted a more closely-situated pair. In another experiment, people's estimates of the caloric content of different foods were reportedly altered by the same type of spatial distance priming. Direct replications of both results were attempted, with precautions to ensure that the experimenter did not know what condition the participant was assigned to. The results showed no hint of the priming effects reported by Williams and Bargh (2008).	[Pashler, Harold; Coburn, Noriko; Harris, Christine R.] Univ Calif San Diego, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Pashler, H (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	hpashler@ucsd.edu		Lauwereyns, Jan/0000-0003-0551-2550	James S. McDonnell Foundation; National Science Foundation [SBE-5820542013]	James S. McDonnell Foundation; National Science Foundation(National Science Foundation (NSF))	This work was supported a collaborative activity grant from the James S. McDonnell Foundation and by the National Science Foundation (Grant SBE-5820542013 to the University of California San Diego Temporal Dynamics of Learning Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; Bargh JA, 2012, PSYCHOL TODAY B 0511; Bartlett Tom, 2012, CHRONICLE HIGHER ED; Bower B, 2012, SCI NEWS, P181; Carter TJ, 2011, PSYCHOL SCI, V22, P1011, DOI 10.1177/0956797611414726; Doyen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029081; Fujita K, 2008, J EXP SOC PSYCHOL, V44, P562, DOI 10.1016/j.jesp.2007.10.005; Huber DE, 2002, MEM COGNITION, V30, P745, DOI 10.3758/BF03196430; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; JOHNSTON JC, 1984, ATTENTION PERFORM, V10, P243; McGraw AP, 2010, PSYCHOL SCI, V21, P1141, DOI 10.1177/0956797610376073; MEYER DE, 1971, J EXP PSYCHOL, V90, P227, DOI 10.1037/h0031564; MORTON J, 1969, PSYCHOL REV, V76, P165, DOI 10.1037/h0027366; Pashler HE, 1998, PSYCHOL ATTENTION; Pautasso M, 2010, SCIENTOMETRICS, V85, P193, DOI 10.1007/s11192-010-0233-5; RATCLIFF R, 1989, J EXP PSYCHOL LEARN, V15, P378, DOI 10.1037/0278-7393.15.3.378; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; SCHVANEVELDT RW, 1981, J EXP PSYCHOL HUMAN, V7, P673, DOI 10.1037/0096-1523.7.3.673; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; Vohs KD, 2006, SCIENCE, V314, P1154, DOI 10.1126/science.1132491; Williams LE, 2008, PSYCHOL SCI, V19, P302, DOI 10.1111/j.1467-9280.2008.02084.x; Yap MJ, 2013, J EXP PSYCHOL LEARN, V39, P140, DOI 10.1037/a0028520; Yong E., 2012, DISCOVER MAGAZINE; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201	26	91	91	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e42510	10.1371/journal.pone.0042510	http://dx.doi.org/10.1371/journal.pone.0042510			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	997ZC	22952597	Green Published, Green Submitted, gold			2022-12-25	WOS:000308206000008
J	Paredes-Sabja, D; Cofre-Araneda, G; Brito-Silva, C; Pizarro-Guajardo, M; Sarker, MR				Paredes-Sabja, Daniel; Cofre-Araneda, Glenda; Brito-Silva, Christian; Pizarro-Guajardo, Marjorie; Sarker, Mahfuzur R.			Clostridium difficile Spore-Macrophage Interactions: Spore Survival	PLOS ONE			English	Article							BACILLUS-ANTHRACIS SPORES; PERFRINGENS SPORES; MURINE MACROPHAGES; UV-RADIATION; MOIST HEAT; GERMINATION; PROTEINS; RESISTANCE; ACID; PHAGOCYTOSIS	Background: Clostridium difficile is the main cause of nosocomial infections including antibiotic associated diarrhea, pseudomembranous colitis and toxic megacolon. During the course of Clostridium difficile infections (CDI), C. difficile undergoes sporulation and releases spores to the colonic environment. The elevated relapse rates of CDI suggest that C. difficile spores has a mechanism(s) to efficiently persist in the host colonic environment. Methodology/Principal Findings: In this work, we provide evidence that C. difficile spores are well suited to survive the host's innate immune system. Electron microscopy results show that C. difficile spores are recognized by discrete patchy regions on the surface of macrophage Raw 264.7 cells, and phagocytosis was actin polymerization dependent. Fluorescence microscopy results show that >80% of Raw 264.7 cells had at least one C. difficile spore adhered, and that similar to 60% of C. difficile spores were phagocytosed by Raw 264.7 cells. Strikingly, presence of complement decreased Raw 264.7 cells' ability to phagocytose C. difficile spores. Due to the ability of C. difficile spores to remain dormant inside Raw 264.7 cells, they were able to survive up to 72 h of macrophage infection. Interestingly, transmission electron micrographs showed interactions between the surface proteins of C. difficile spores and the phagosome membrane of Raw 264.7 cells. In addition, infection of Raw 264.7 cells with C. difficile spores for 48 h produced significant Raw 264.7 cell death as demonstrated by trypan blue assay, and nuclei staining by ethidium homodimer-1. Conclusions/Significance: These results demonstrate that despite efficient recognition and phagocytosis of C. difficile spores by Raw 264.7 cells, spores remain dormant and are able to survive and produce cytotoxic effects on Raw 264.7 cells.	[Paredes-Sabja, Daniel; Cofre-Araneda, Glenda; Brito-Silva, Christian; Pizarro-Guajardo, Marjorie] Univ Andres Bello, Dept Ciencias Biol, Fac Ciencias Biol, Lab Mecanismos Patogenesis Bacteriana, Santiago, Chile; [Paredes-Sabja, Daniel; Sarker, Mahfuzur R.] Oregon State Univ, Dept Biomed Sci, Corvallis, OR 97331 USA; [Sarker, Mahfuzur R.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA	Universidad Andres Bello; Oregon State University; Oregon State University	Paredes-Sabja, D (corresponding author), Univ Andres Bello, Dept Ciencias Biol, Fac Ciencias Biol, Lab Mecanismos Patogenesis Bacteriana, Santiago, Chile.	daniel.paredes.sabja@gmail.com; sarkerm@oregonstate.edu	Paredes-Sabja, Daniel/ABI-4293-2020; Pizarro-Guajardo, Marjorie/ABG-8107-2020	Pizarro-Guajardo, Marjorie/0000-0002-8089-5398	MECESUP [UAB0802]; Fondo Nacional de Ciencia y Tecnologia de Chile [FONDECYT REGULAR 1110569]; Research Office of Universidad Andres Bello [DI-35-11/R]; Agricultural Research Foundation of Oregon State University; Department of Defense Multi-disciplinary University Research Initiative (MURI) award through the U.S. Army Research Laboratory; U.S. Army Research Office [W911NF-09-1-0286]	MECESUP; Fondo Nacional de Ciencia y Tecnologia de Chile; Research Office of Universidad Andres Bello; Agricultural Research Foundation of Oregon State University; Department of Defense Multi-disciplinary University Research Initiative (MURI) award through the U.S. Army Research Laboratory; U.S. Army Research Office	MECESUP UAB0802, Fondo Nacional de Ciencia y Tecnologia de Chile (FONDECYT REGULAR 1110569), by a grant from the Research Office of Universidad Andres Bello (DI-35-11/R) (to D.P.-S); grant from the Agricultural Research Foundation of Oregon State University and by a Department of Defense Multi-disciplinary University Research Initiative (MURI) award through the U.S. Army Research Laboratory and the U.S. Army Research Office under contract number W911NF-09-1-0286 (to MRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LAH, 1996, J EXP MED, V184, P627, DOI 10.1084/jem.184.2.627; Baines SD, 2009, J ANTIMICROB CHEMOTH, V63, P520, DOI 10.1093/jac/dkn502; Chung MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018119; Deneve C, 2009, INT J ANTIMICROB AG, V33, pS24, DOI 10.1016/S0924-8579(09)70012-3; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Giebel JD, 2009, J BACTERIOL, V191, P5569, DOI 10.1128/JB.00408-09; Goulding D, 2009, INFECT IMMUN, V77, P5478, DOI 10.1128/IAI.00551-09; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4; Guidi-Rontani C, 1999, MOL MICROBIOL, V31, P9, DOI 10.1046/j.1365-2958.1999.01137.x; Guidi-Rontani C, 1999, MOL MICROBIOL, V33, P407, DOI 10.1046/j.1365-2958.1999.01485.x; Guidi-Rontani C, 2001, MOL MICROBIOL, V42, P931, DOI 10.1046/j.1365-2958.2001.02695.x; Hasegawa M, 2011, J IMMUNOL, V186, P4872, DOI 10.4049/jimmunol.1003761; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; HORWITZ MA, 1984, CELL, V36, P27, DOI 10.1016/0092-8674(84)90070-9; Hu HJ, 2007, FEMS MICROBIOL LETT, V272, P245, DOI 10.1111/j.1574-6968.2007.00766.x; Kang TJ, 2005, INFECT IMMUN, V73, P7495, DOI 10.1128/IAI.73.11.7495-7501.2005; Lahteenmaki K, 2005, TRENDS MICROBIOL, V13, P79, DOI 10.1016/j.tim.2004.12.003; Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09; Lawley TD, 2009, J BACTERIOL, V191, P5377, DOI 10.1128/JB.00597-09; May JA, 1998, PLATELETS, V9, P227, DOI 10.1080/09537109876744; McEllistrem MC, 2005, CLIN INFECT DIS, V40, P265, DOI 10.1086/427113; Mueller-Ortiz SL, 2001, INFECT IMMUN, V69, P7501, DOI 10.1128/IAI.69.12.7501-7511.2001; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; O'Brien DK, 2000, CELL MICROBIOL, V2, P505, DOI 10.1046/j.1462-5822.2000.00074.x; Okumura Y, 1999, FEBS LETT, V442, P39, DOI 10.1016/S0014-5793(98)01612-3; Paredes-Sabja D, 2012, J MED MICRO IN PRESS; Paredes-Sabja D, 2011, J MED MICRO IN PRESS; Paredes-Sabja D, 2008, J BACTERIOL, V190, P4648, DOI 10.1128/JB.00325-08; Paredes-Sabja D, 2008, APPL ENVIRON MICROB, V74, P3730, DOI 10.1128/AEM.00169-08; Paredes-Sabja D, 2008, INT J FOOD MICROBIOL, V122, P333, DOI 10.1016/j.ijfoodmicro.2007.12.006; Paredes-Sabja D, 2012, ANAEROBE, V18, P148, DOI 10.1016/j.anaerobe.2011.12.019; Paredes-Sabja D, 2011, ANAEROBE, V17, P78, DOI 10.1016/j.anaerobe.2011.02.001; Pelczar PL, 2007, J BACTERIOL, V189, P1090, DOI 10.1128/JB.01606-06; Raju D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-50; Raju D, 2007, APPL ENVIRON MICROB, V73, P2048, DOI 10.1128/AEM.02500-06; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Ryan A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002076; Sarker MR, 2012, FUTURE MICR IN PRESS; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Sethi AK, 2010, INFECT CONT HOSP EP, V31, P21, DOI 10.1086/649016; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Sorg JA, 2009, J BACTERIOL, V191, P1115, DOI 10.1128/JB.01260-08; Stie J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005780; Wheeldon LJ, 2011, J APPL MICROBIOL; WUST J, 1982, J CLIN MICROBIOL, V16, P1096	47	43	44	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43635	10.1371/journal.pone.0043635	http://dx.doi.org/10.1371/journal.pone.0043635			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952726	Green Published, gold, Green Submitted			2022-12-25	WOS:000308044800048
J	Pearson, VM; Miller, CR; Rokyta, DR				Pearson, Victoria M.; Miller, Craig R.; Rokyta, Darin R.			The Consistency of Beneficial Fitness Effects of Mutations across Diverse Genetic Backgrounds	PLOS ONE			English	Article							DIMINISHING RETURNS; PARALLEL EVOLUTION; LANDSCAPE MODEL; RNA VIRUS; ADAPTATION; EPISTASIS; BACTERIOPHAGE; RESISTANCE; TRAJECTORIES; ARCHITECTURE	Parallel and convergent evolution have been remarkably common observations in molecular adaptation but primarily in the context of the same genotype adapting to the same conditions. These phenomena therefore tell us about the stochasticity and limitations of adaptation. The limited data on convergence and parallelism in the adaptation of different genotypes conflict as to the importance of such events. If the effects of beneficial mutations are highly context dependent (i.e., if they are epistatic), different genotypes should adapt through different mutations. Epistasis for beneficial mutations has been investigated but mainly through measurement of interactions between individually beneficial mutations for the same genotype. We examine epistasis for beneficial mutations at a broader genetic scale by measuring the fitness effects of two mutations beneficial for the ssDNA bacteriophage ID11 in eight different, related genotypes showing 0.3-3.7% nucleotide divergence from ID11. We found no evidence for sign epistasis, but the mutations tended to have much smaller or no effects on fitness in the new genotypes. We found evidence for diminishing-returns epistasis; the effects were more beneficial for lower-fitness genotypes. The patterns of epistasis were not determined by phylogenetic relationships to the original genotype. To improve our understanding of the patterns of epistasis, we fit the data to a model in which each mutation had a constant, nonepistatic phenotypic effect across genotypes and the phenotype-fitness map had a single optimum. This model fit the data well, suggesting that epistasis for these mutations was due to nonlinearity in the phenotype-fitness mapping and that the likelihood of parallel evolution depends more on phenotype than on genotype.	[Pearson, Victoria M.; Rokyta, Darin R.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Miller, Craig R.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Miller, Craig R.] Univ Idaho, Dept Math, Moscow, ID 83843 USA	State University System of Florida; Florida State University; Idaho; University of Idaho; Idaho; University of Idaho	Pearson, VM (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	drokyta@bio.fsu.edu	Miller, Craig/GWQ-5012-2022	Rokyta, Darin/0000-0002-0356-2178	Florida State University; United States National Institutes of Health [NIH R01 GM076040]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076040] Funding Source: NIH RePORTER	Florida State University; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by Florida State University. Funding for CRM was provided by the United States National Institutes of Health (NIH R01 GM076040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bollback JP, 2009, GENETICS, V181, P225, DOI 10.1534/genetics.107.085225; Bull JJ, 2000, MOL BIOL EVOL, V17, P942, DOI 10.1093/oxfordjournals.molbev.a026375; Bull JJ, 1997, GENETICS, V147, P1497; Burch CL, 1999, GENETICS, V151, P921; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Dobzhansky T, 1936, GENETICS, V21, P113; Fisher R.A., 1930, GENETICAL THEORY NAT; Hartl DL, 1998, GENETICA, V102-3, P525, DOI 10.1023/A:1017071901530; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kvitek DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002056; Lozovsky ER, 2009, P NATL ACAD SCI USA, V106, P12025, DOI 10.1073/pnas.0905922106; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; MacLean RC, 2010, GENETICS, V186, P1345, DOI 10.1534/genetics.110.123083; Manna F, 2011, GENETICS, V189, P923, DOI 10.1534/genetics.111.132944; Martin G, 2008, GENETICS, V179, P907, DOI 10.1534/genetics.108.087122; Martin G, 2007, NAT GENET, V39, P555, DOI 10.1038/ng1998; MCKENNA R, 1992, NATURE, V355, P137, DOI 10.1038/355137a0; MCKENNA R, 1994, J MOL BIOL, V237, P517, DOI 10.1006/jmbi.1994.1253; Muller HJ, 1939, BIOL REV CAMB PHILOS, V14, P261, DOI 10.1111/j.1469-185X.1939.tb00934.x; Orr HA, 2005, EVOLUTION, V59, P216; Orr HA, 2000, EVOLUTION, V54, P13, DOI 10.1111/j.0014-3820.2000.tb00002.x; ORR HA, 1992, AM NAT, V140, P725, DOI 10.1086/285437; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.2307/2411226, 10.1111/j.1558-5646.1998.tb01823.x]; Otto SP, 2009, AM NAT, V174, pS1, DOI 10.1086/599084; Otto SP, 1997, THEOR POPUL BIOL, V51, P134, DOI 10.1006/tpbi.1997.1301; Peck JR, 1997, GENETICS, V145, P1171; Pepin KM, 2007, EVOLUTION, V61, P1710, DOI 10.1111/j.1558-5646.2007.00143.x; Pepin KM, 2006, GENETICS, V172, P2047, DOI 10.1534/genetics.105.049817; R Development Core Team, 2006, R LANG ENV STAT COMP; RICE SH, 1990, J THEOR BIOL, V143, P319, DOI 10.1016/S0022-5193(05)80033-5; Rokyta D, 2002, MOL BIOL EVOL, V19, P230, DOI 10.1093/oxfordjournals.molbev.a004076; Rokyta DR, 2008, J MOL EVOL, V67, P368, DOI 10.1007/s00239-008-9153-x; Rokyta DR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002075; Rokyta DR, 2009, J MOL EVOL, V69, P229, DOI 10.1007/s00239-009-9267-9; Rokyta DR, 2006, J BACTERIOL, V188, P1134, DOI 10.1128/JB.188.3.1134-1142.2006; Rokyta DR, 2005, NAT GENET, V37, P441, DOI 10.1038/ng1535; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; Sousa A, 2012, MOL BIOL EVOL, V29, P1417, DOI 10.1093/molbev/msr302; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Weinreich DM, 2005, EVOLUTION, V59, P1165; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; Wichman HA, 2000, PHILOS T R SOC B, V355, P1677, DOI 10.1098/rstb.2000.0731	43	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43864	10.1371/journal.pone.0043864	http://dx.doi.org/10.1371/journal.pone.0043864			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937113	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500115
J	Li, SX; Sun, GQ; Murai, K; Ye, P; Shi, YH				Li, Shengxiu; Sun, Guoqiang; Murai, Kiyohito; Ye, Peng; Shi, Yanhong			Characterization of TLX Expression in Neural Stem Cells and Progenitor Cells in Adult Brains	PLOS ONE			English	Article							NUCLEAR RECEPTOR TLX; SUBVENTRICULAR ZONE; REGULATORY LOOP; NEUROGENESIS; TAILLESS; PROLIFERATION; BROMODEOXYURIDINE; DIFFERENTIATION; MIGRATION; NEURONS	TLX has been shown to play an important role in regulating the self-renewal and proliferation of neural stem cells in adult brains. However, the cellular distribution of endogenous TLX protein in adult brains remains to be elucidated. In this study, we used immunostaining with a TLX-specific antibody to show that TLX is expressed in both neural stem cells and transit-amplifying neural progenitor cells in the subventricular zone (SVZ) of adult mouse brains. Then, using a double thymidine analog labeling approach, we showed that almost all of the self-renewing neural stem cells expressed TLX. Interestingly, most of the TLX-positive cells in the SVZ represented the thymidine analog-negative, relatively quiescent neural stem cell population. Using cell type markers and short-term BrdU labeling, we demonstrated that TLX was also expressed in the Mash1+ rapidly dividing type C cells. Furthermore, loss of TLX expression dramatically reduced BrdU label-retaining neural stem cells and the actively dividing neural progenitor cells in the SVZ, but substantially increased GFAP staining and extended GFAP processes. These results suggest that TLX is essential to maintain the self-renewing neural stem cells in the SVZ and that the GFAP+ cells in the SVZ lose neural stem cell property upon loss of TLX expression. Understanding the cellular distribution of TLX and its function in specific cell types may provide insights into the development of therapeutic tools for neurodegenerative diseases by targeting TLX in neural stem/progenitors cells.	[Li, Shengxiu; Sun, Guoqiang; Murai, Kiyohito; Ye, Peng; Shi, Yanhong] Beckman Res Inst City Hope, Ctr Canc, Dept Neurosci, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope	Li, SX (corresponding author), Beckman Res Inst City Hope, Ctr Canc, Dept Neurosci, Duarte, CA USA.	yshi@coh.org		Shi, Yanhong/0000-0002-3938-5839	NIH NINDS [R01 NS059546, RC1 NS068370]; California Institute for Regenerative medicine [TR2-01832]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059546, RC1NS068370] Funding Source: NIH RePORTER	NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); California Institute for Regenerative medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH NINDS R01 NS059546, RC1 NS068370 and California Institute for Regenerative medicine TR2-01832. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1962, SCIENCE, V135, P1127, DOI 10.1126/science.135.3509.1127; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Bauer S, 2006, J NEUROSCI, V26, P12089, DOI 10.1523/JNEUROSCI.3047-06.2006; Burns KA, 2005, EUR J NEUROSCI, V21, P803, DOI 10.1111/j.1460-9568.2005.03907.x; Chavali PL, 2011, J BIOL CHEM, V286, P9393, DOI 10.1074/jbc.M110.167445; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Elmi M, 2010, MOL CELL NEUROSCI, V45, P121, DOI 10.1016/j.mcn.2010.06.003; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Leuner B, 2009, J COMP NEUROL, V517, P123, DOI 10.1002/cne.22107; Li WW, 2008, MOL ENDOCRINOL, V22, P56, DOI 10.1210/me.2007-0290; Liu HK, 2008, GENE DEV, V22, P2473, DOI 10.1101/gad.479308; Liu HK, 2010, GENE DEV, V24, P683, DOI 10.1101/gad.560310; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; MILLER MW, 1988, BRAIN RES, V457, P44, DOI 10.1016/0006-8993(88)90055-8; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Monaghan AP, 1997, NATURE, V390, P515, DOI 10.1038/37364; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Obernier K, 2011, STEM CELLS, V29, P1415, DOI 10.1002/stem.682; Qu QH, 2010, NAT CELL BIOL, V12, P31, DOI 10.1038/ncb2001; Roy K, 2004, J NEUROSCI, V24, P8333, DOI 10.1523/JNEUROSCI.1148-04.2004; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Stenman JM, 2003, J NEUROSCI, V23, P10568; Sun GQ, 2007, P NATL ACAD SCI USA, V104, P15282, DOI 10.1073/pnas.0704089104; Sun GQ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1532; Sun GQ, 2010, MOL CELL BIOL, V30, P1997, DOI 10.1128/MCB.01116-09; TAKAHASHI T, 1992, J NEUROCYTOL, V21, P185, DOI 10.1007/BF01194977; Thomas RM, 2007, J NEUROSCI, V27, P2734, DOI 10.1523/JNEUROSCI.3849-06.2007; Vega CJ, 2005, NAT METHODS, V2, P167, DOI 10.1038/NMETH741; Wojtowicz JM, 2006, NAT PROTOC, V1, P1399, DOI 10.1038/nprot.2006.224; YU RT, 1994, NATURE, V370, P375, DOI 10.1038/370375a0; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576	39	26	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43324	10.1371/journal.pone.0043324	http://dx.doi.org/10.1371/journal.pone.0043324			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952666	Green Published, Green Submitted, gold			2022-12-25	WOS:000308206500010
J	Tophkhane, C; Yang, SH; Jiang, YB; Ma, ZK; Subramaniam, D; Anant, S; Yogosawa, S; Sakai, T; Liu, WG; Edgerton, S; Thor, A; Yang, XH				Tophkhane, Chaitali; Yang, Shi-He; Jiang, Yunbo; Ma, Zhikun; Subramaniam, Dharmalingam; Anant, Shrikant; Yogosawa, Shingo; Sakai, Toshiyuki; Liu, Wan-Guo; Edgerton, Susan; Thor, Ann; Yang, Xiaohe			p53 Inactivation Upregulates p73 Expression through E2F-1 Mediated Transcription	PLOS ONE			English	Article							BREAST-CANCER; DNA-DAMAGE; TUMOR-SUPPRESSOR; FEEDBACK LOOP; GENE; OVEREXPRESSION; APOPTOSIS; ISOFORMS; CELLS; IDENTIFICATION	While p73 overexpression has been associated with increased apoptosis in cancer tissues, p73 overexpressing tumors appear to be of high grade malignancy. Why this putative tumor suppressor is overexpressed in cancer cells and what the function of overexpressed p73 is in breast cancers are critical questions to be addressed. By investigating the effect of p53 inactivation on p73 expression, we found that both protein and mRNA levels of TAp73 were increased in MCF-7/p53siRNA cells, MCF-7/p53mt135 cells and HCT-116/p532/2 cells, as compared to wild type control, suggesting that p53 inactivation by various forms upregulates p73. We showed that p53 knockdown induced p73 was mainly regulated at the transcriptional level. However, although p53 has a putative binding site in the TAp73 promoter, deletion of this binding site did not affect p53 knockdown mediated activation of TAp73 promoter. Chromatin immuno-precipitation (ChIP) data demonstrated that loss of p53 results in enhanced occupancy of E2F-1 in the TAp73 promoter. The responsive sequence of p53 inactivation mediated p73 upregulation was mapped to the proximal promoter region of the TAp73 gene. To test the role of E2F-1 in p53 inactivation mediated regulation of p73 transcription, we found that p53 knockdown enhanced E2F-1 dependent p73 transcription, and mutations in E2F-1 binding sites in the TAp73 promoter abrogated p53 knockdown mediated activation of TAp73 promoter. Moreover, we demonstrated that p21 is a mediator of p53-E2F crosstalk in the regulation of p73 transcription. We concluded that p53 knockdown/inactivation may upregulate TAp73 expression through E2F-1 mediated transcriptional regulation. p53 inactivation mediated upregulation of p73 suggests an intrinsic rescuing mechanism in response to p53 mutation/inactivation. These findings support further analysis of the correlation between p53 status and p73 expression and its prognostic/predictive significance in human cancers.	[Tophkhane, Chaitali; Yang, Shi-He; Jiang, Yunbo; Yang, Xiaohe] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Subramaniam, Dharmalingam; Anant, Shrikant] Univ Kansas, KU Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS USA; [Yogosawa, Shingo; Sakai, Toshiyuki] Kyoto Prefectural Univ Med, Dept Prevent Med, Kyoto, Japan; [Liu, Wan-Guo] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA; [Edgerton, Susan; Thor, Ann] Univ Colorado, Denver Sch Med, Dept Pathol, Aurora, CO USA; [Ma, Zhikun; Yang, Xiaohe] N Carolina Cent Univ, Julius L Chambers Biomed Biotechnol Res Inst, Kannapolis, NC USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Kansas; University of Kansas Medical Center; Kyoto Prefectural University of Medicine; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Colorado System; University of Colorado Anschutz Medical Campus; University of North Carolina; North Carolina Central University	Tophkhane, C (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA.	xyang@nccu.edu	Anant, Shrikant/AAF-8020-2020		Seed Grant from the University of Oklahoma Cancer Center Institutional Research Grant from the American Cancer Society ASC-IRG [IRG-05-066-01]; Research Scholar Grant from American Cancer Society [RSG-08-138-01-CNE]	Seed Grant from the University of Oklahoma Cancer Center Institutional Research Grant from the American Cancer Society ASC-IRG; Research Scholar Grant from American Cancer Society	This work was supported in part by a Seed Grant to Dr. XH Yang from the University of Oklahoma Cancer Center Institutional Research Grant from the American Cancer Society ASC-IRG #IRG-05-066-01 (http://www.cancer.org/), and by a Research Scholar Grant from American Cancer Society (RSG-08-138-01-CNE, http://www.cancer.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai YYC, 2000, CARCINOGENESIS, V21, P683, DOI 10.1093/carcin/21.4.683; CERUTTI P, 1994, CANCER RES, V54, pS1934; Chen XB, 2001, ONCOGENE, V20, P769, DOI 10.1038/sj.onc.1204149; Corn PG, 1999, CANCER RES, V59, P3352; De Laurenzi V, 1999, CELL DEATH DIFFER, V6, P389, DOI 10.1038/sj.cdd.4400521; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Ding Y, 1999, DNA Res, V6, P347, DOI 10.1093/dnares/6.5.347; Dominguez G, 2006, J CLIN ONCOL, V24, P805, DOI 10.1200/JCO.2005.02.2350; Dominguez G, 2001, BREAST CANCER RES TR, V66, P183, DOI 10.1023/A:1010624717311; Dulloo I, 2005, J BIOL CHEM, V280, P28203, DOI 10.1074/jbc.M501702200; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Guan M, 2003, JPN J CLIN ONCOL, V33, P215, DOI 10.1093/jjco/hyg045; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Kartasheva NN, 2002, ONCOGENE, V21, P4715, DOI 10.1038/sj.onc.1205584; Kawano S, 1999, BLOOD, V94, P1113; Lee CW, 1998, ONCOGENE, V16, P2695, DOI 10.1038/sj.onc.1201818; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; MILNER J, 1995, NAT MED, V1, P879, DOI 10.1038/nm0995-879; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Oberst A, 2005, BIOCHEM BIOPH RES CO, V331, P707, DOI 10.1016/j.bbrc.2005.03.158; Ozaki T, 2005, CANCER SCI, V96, P729, DOI 10.1111/j.1349-7006.2005.00116.x; Pediconi N, 2003, NAT CELL BIOL, V5, P552, DOI 10.1038/ncb998; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Seelan RS, 2002, NEOPLASIA, V4, P195, DOI 10.1038/sj.neo.7900237; Sigal A, 2000, CANCER RES, V60, P6788; Strano S, 2000, J BIOL CHEM, V275, P29503, DOI 10.1074/jbc.M003360200; Taylor WR, 2001, J BIOL CHEM, V276, P1998, DOI 10.1074/jbc.M005101200; Tsai KKC, 2003, CANCER RES, V63, P3418; Willis AC, 2003, ONCOGENE, V22, P5481, DOI 10.1038/sj.onc.1206505; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yamamoto T, 2002, ONCOL REP, V9, P729; Yokomizo A, 1999, ONCOGENE, V18, P1629, DOI 10.1038/sj.onc.1202474; Zaika AI, 1999, CANCER RES, V59, P3257	42	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43564	10.1371/journal.pone.0043564	http://dx.doi.org/10.1371/journal.pone.0043564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952705	Green Submitted, Green Published, gold			2022-12-25	WOS:000308206500013
J	Akatsuka, S; Yamashita, Y; Ohara, H; Liu, YT; Izumiya, M; Abe, K; Ochiai, M; Jiang, L; Nagai, H; Okazaki, Y; Murakami, H; Sekido, Y; Arai, E; Kanai, Y; Hino, O; Takahashi, T; Nakagama, H; Toyokuni, S				Akatsuka, Shinya; Yamashita, Yoriko; Ohara, Hiroki; Liu, Yu-Ting; Izumiya, Masashi; Abe, Koichiro; Ochiai, Masako; Jiang, Li; Nagai, Hirotaka; Okazaki, Yasumasa; Murakami, Hideki; Sekido, Yoshitaka; Arai, Eri; Kanai, Yae; Hino, Okio; Takahashi, Takashi; Nakagama, Hitoshi; Toyokuni, Shinya			Fenton Reaction Induced Cancer in Wild Type Rats Recapitulates Genomic Alterations Observed in Human Cancer	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; TUMOR-SUPPRESSOR GENE; WISTAR RATS; INDUCED CARCINOGENESIS; DOWN-REGULATION; ALLELIC LOSS; IRON; DNA; NITRILOTRIACETATE; AMPLIFICATION	Iron overload has been associated with carcinogenesis in humans. Intraperitoneal administration of ferric nitrilotriacetate initiates a Fenton reaction in renal proximal tubules of rodents that ultimately leads to a high incidence of renal cell carcinoma (RCC) after repeated treatments. We performed high-resolution microarray comparative genomic hybridization to identify characteristics in the genomic profiles of this oxidative stress-induced rat RCCs. The results revealed extensive large-scale genomic alterations with a preference for deletions. Deletions and amplifications were numerous and sometimes fragmented, demonstrating that a Fenton reaction is a cause of such genomic alterations in vivo. Frequency plotting indicated that two of the most commonly altered loci corresponded to a Cdkn2a/2b deletion and a Met amplification. Tumor sizes were proportionally associated with Met expression and/or amplification, and clustering analysis confirmed our results. Furthermore, we developed a procedure to compare whole genomic patterns of the copy number alterations among different species based on chromosomal syntenic relationship. Patterns of the rat RCCs showed the strongest similarity to the human RCCs among five types of human cancers, followed by human malignant mesothelioma, an iron overload-associated cancer. Therefore, an iron-dependent Fenton chemical reaction causes large-scale genomic alterations during carcinogenesis, which may result in distinct genomic profiles. Based on the characteristics of extensive genome alterations in human cancer, our results suggest that this chemical reaction may play a major role during human carcinogenesis.	[Akatsuka, Shinya; Yamashita, Yoriko; Ohara, Hiroki; Jiang, Li; Nagai, Hirotaka; Okazaki, Yasumasa; Toyokuni, Shinya] Nagoya Univ, Grad Sch Med, Dept Pathol, Showa Ku, Nagoya, Aichi 4648601, Japan; [Akatsuka, Shinya; Yamashita, Yoriko; Ohara, Hiroki; Jiang, Li; Nagai, Hirotaka; Okazaki, Yasumasa; Toyokuni, Shinya] Nagoya Univ, Grad Sch Med, Dept Biol Responses, Showa Ku, Nagoya, Aichi 4648601, Japan; [Liu, Yu-Ting; Nagai, Hirotaka] Kyoto Univ, Grad Sch Med, Sakyo Ku, Dept Pathol & Biol Dis, Kyoto, Japan; [Izumiya, Masashi; Abe, Koichiro; Ochiai, Masako; Nakagama, Hitoshi] Natl Canc Ctr, Div Canc Dev Syst, Chuo Ku, Res Inst, Tokyo 104, Japan; [Abe, Koichiro] Teikyo Univ, Sch Med, Dept Internal Med, Itabashi Ku, Tokyo 173, Japan; [Murakami, Hideki; Sekido, Yoshitaka] Aichi Canc Ctr, Div Mol Oncol, Chikusa Ku, Res Inst, Nagoya, Aichi 464, Japan; [Arai, Eri; Kanai, Yae] Natl Canc Ctr, Res Inst, Div Mol Pathol, Chuo Ku, Tokyo 104, Japan; [Hino, Okio] Juntendo Univ, Sch Med, Dept Pathol & Oncol, Bunkyo Ku, Tokyo 113, Japan	Nagoya University; Nagoya University; Kyoto University; National Cancer Center - Japan; Teikyo University; Aichi Cancer Center; National Cancer Center - Japan; Juntendo University	Akatsuka, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Pathol, Showa Ku, Nagoya, Aichi 4648601, Japan.	toyokuni@med.nagoya-u.ac.jp	Izumiya, Masashi/AAL-3763-2020; Kanai, Yae/AAE-6987-2019; Sekido, Yoshitaka/P-9756-2015; Nagai, Hirotaka/GYJ-4926-2022; Akatsuka, Shinya/C-9806-2010; Toyokuni, Shinya/C-1358-2010; Takahashi, Takashi/I-7262-2014; Yamashita, Yoriko/B-9810-2011; Nagai, Hirotaka/C-9713-2010; OKAZAKI, Yasumasa/E-7895-2010; Toyokuni, Shinya/ABE-7714-2021	Nagai, Hirotaka/0000-0003-0983-8670; Akatsuka, Shinya/0000-0002-9944-8803; Toyokuni, Shinya/0000-0002-5757-1109; Takahashi, Takashi/0000-0003-0615-7001; Nagai, Hirotaka/0000-0003-0983-8670; OKAZAKI, Yasumasa/0000-0003-1054-9403; Toyokuni, Shinya/0000-0002-5757-1109; Sekido, Yoshitaka/0000-0002-2428-3848	Princess Takamatsu Cancer Research Fund [10-24213]; Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [23790456] Funding Source: KAKEN	Princess Takamatsu Cancer Research Fund; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Princess Takamatsu Cancer Research Fund (10-24213); a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan; and a Grant-in Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamovic T, 2009, CANCER RES, V69, P5159, DOI 10.1158/0008-5472.CAN-08-4038; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Arai E, 2008, CLIN CANCER RES, V14, P5531, DOI 10.1158/1078-0432.CCR-08-0443; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Campbell JM, 2008, GENOME, V51, P1032, DOI 10.1139/G08-086; CHENG JQ, 1994, CANCER RES, V54, P5547; EBINA Y, 1986, J NATL CANCER I, V76, P107; Evangelou K, 2004, BIOTECH HISTOCHEM, V79, P5, DOI 10.1080/10520290310001659466; Femia AP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-194; Fenton H., 1894, J CHEM SOC T, V65, P899, DOI [10.1039/CT8946500899, DOI 10.1039/CT8946500899]; Filion GJP, 2006, MOL CELL BIOL, V26, P169, DOI 10.1128/MCB.26.1.169-181.2006; GRUIS NA, 1995, NAT GENET, V10, P351, DOI 10.1038/ng0795-351; GUTTERIDGE JMC, 1981, BIOCHEM J, V199, P263, DOI 10.1042/bj1990263; Halliwell B., 2007, FREE RADICALS BIOL M; Hellman A, 2002, CANCER CELL, V1, P89, DOI 10.1016/S1535-6108(02)00017-X; Herzog CR, 2006, BIOCHEM BIOPH RES CO, V341, P856, DOI 10.1016/j.bbrc.2006.01.043; Hino O, 2004, CURR MOL MED, V4, P807, DOI 10.2174/1566524043359692; Hiroyasu M, 2002, AM J PATHOL, V160, P419, DOI 10.1016/S0002-9440(10)64860-2; Hisada M, 1998, JNCI-J NATL CANCER I, V90, P606, DOI 10.1093/jnci/90.8.606; Hu Q, 2010, LAB INVEST, V90, P360, DOI 10.1038/labinvest.2009.140; Huang X, 2003, MUTAT RES-FUND MOL M, V533, P153, DOI 10.1016/j.mrfmmm.2003.08.023; Jean D, 2011, AM J PATHOL, V178, P881, DOI 10.1016/j.ajpath.2010.10.039; Kai WC, 2001, AM J PATHOL, V159, P1635, DOI 10.1016/S0002-9440(10)63010-6; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Klijn C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1143; KOBAYASHI T, 1995, NAT GENET, V9, P70, DOI 10.1038/ng0195-70; LI JL, 1987, CANCER RES, V47, P1867; LIU YP, 2007, J JISHOU UNIV, V28, P1; Loeb LA, 2008, CANCER RES, V68, P3551, DOI 10.1158/0008-5472.CAN-07-5835; MacConaill LE, 2011, CANCER DISCOV, V1, P297, DOI 10.1158/2159-8290.CD-11-0110; Martinez C, 2010, CELL CYCLE, V9, P2275, DOI 10.4161/cc.9.12.11865; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Murakami H, 2011, CANCER RES, V71, P873, DOI 10.1158/0008-5472.CAN-10-2164; Nagai H, 2011, P NATL ACAD SCI US; Nagai H, 2011, CANCER SCI, V102, P2118, DOI 10.1111/j.1349-7006.2011.02087.x; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Nishiyama Y, 1995, JPN J CANCER RES, V86, P1150, DOI 10.1111/j.1349-7006.1995.tb03308.x; Oikawa Y, 2008, J BIOL CHEM, V283, P14242, DOI 10.1074/jbc.M802257200; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pfeifer GP, 2011, CURR OPIN ONCOL, V23, P62, DOI 10.1097/CCO.0b013e3283414d00; Reuschenbach M, 2008, INT J CANCER, V123, P2626, DOI 10.1002/ijc.23837; Romagosa C, 2011, ONCOGENE, V30, P2087, DOI 10.1038/onc.2010.614; Sasaki K, 2011, MOL MED REP, V4, P913, DOI 10.3892/mmr.2011.518; Takabatake T, 2006, RADIAT RES, V166, P61, DOI 10.1667/RR3575.1; Tanaka T, 2004, ONCOGENE, V23, P3980, DOI 10.1038/sj.onc.1207555; Tanaka T, 1999, ONCOGENE, V18, P3793, DOI 10.1038/sj.onc.1202707; Torres EM, 2010, COLD SH Q B, V75, P445, DOI 10.1101/sqb.2010.75.025; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; TOYOKUNI S, 1990, CANCER RES, V50, P5574; Toyokuni S, 1999, PATHOL INT, V49, P91, DOI 10.1046/j.1440-1827.1999.00829.x; TOYOKUNI S, 1994, INT J CANCER, V57, P123, DOI 10.1002/ijc.2910570122; Toyokuni S, 1996, FREE RADICAL BIO MED, V20, P553, DOI 10.1016/0891-5849(95)02111-6; Toyokuni S, 1997, LAB INVEST, V76, P365; TOYOKUNI S, 1992, J INORG BIOCHEM, V47, P241, DOI 10.1016/0162-0134(92)84069-Y; TOYOKUNI S, 1994, P NATL ACAD SCI USA, V91, P2616, DOI 10.1073/pnas.91.7.2616; Toyokuni S, 1997, FREE RADICAL BIO MED, V22, P1019, DOI 10.1016/S0891-5849(96)00489-3; Toyokuni S, 2006, J CLIN BIOCHEM NUTR, V39, P3, DOI 10.3164/jcbn.39.3; Toyokuni S, 2009, NAGOYA J MED SCI, V71, P1; Toyokuni S, 2009, CANCER SCI, V100, P9, DOI 10.1111/j.1349-7006.2008.01001.x; Weinberg RA, 2007, BIOL CANC; Wiechen K, 2001, AM J PATHOL, V158, P833, DOI 10.1016/S0002-9440(10)64031-X; Wiedemeyer R, 2008, CANCER CELL, V13, P355, DOI 10.1016/j.ccr.2008.02.010; WULLICH B, 1994, ANTICANCER RES, V14, P577; XIAO S, 1995, ONCOGENE, V11, P511; Yeung RS, 2004, CURR MOL MED, V4, P799, DOI 10.2174/1566524043359791; Zhang DX, 1997, CANCER RES, V57, P2410	68	74	74	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43403	10.1371/journal.pone.0043403	http://dx.doi.org/10.1371/journal.pone.0043403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952676	gold, Green Submitted, Green Published			2022-12-25	WOS:000308206000033
J	Chakrabarty, P; Davis, MP; Sparks, JS				Chakrabarty, Prosanta; Davis, Matthew P.; Sparks, John S.			The First Record of a Trans-Oceanic Sister-Group Relationship between Obligate Vertebrate Troglobites	PLOS ONE			English	Article							DIVERGENCE; TELEOSTEI; FISHES; MODEL; ELEOTRIDAE; SPECIATION; DISPERSAL; EVOLUTION; PATTERNS; CAVEFISH	We show using the most complete phylogeny of one of the most species-rich orders of vertebrates (Gobiiformes), and calibrations from the rich fossil record of teleost fishes, that the genus Typhleotris, endemic to subterranean karst habitats in southwestern Madagascar, is the sister group to Milyeringa, endemic to similar subterranean systems in northwestern Australia. Both groups are eyeless, and our phylogenetic and biogeographic results show that these obligate cave fishes now found on opposite ends of the Indian Ocean (separated by nearly 7,000 km) are each others closest relatives and owe their origins to the break up of the southern supercontinent, Gondwana, at the end of the Cretaceous period. Trans-oceanic sister-group relationships are otherwise unknown between blind, cave-adapted vertebrates and our results provide an extraordinary case of Gondwanan vicariance.	[Chakrabarty, Prosanta] Louisiana State Univ, Museum Nat Sci, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Davis, Matthew P.] Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA; [Sparks, John S.] Amer Museum Nat Hist, Dept Ichthyol, Div Vertebrate Zool, New York, NY 10024 USA	Louisiana State University System; Louisiana State University; Field Museum of Natural History (Chicago); American Museum of Natural History (AMNH)	Chakrabarty, P (corresponding author), Louisiana State Univ, Museum Nat Sci, Dept Biol Sci, Baton Rouge, LA 70803 USA.	prosanta@lsu.edu	Chakrabarty, Prosanta/E-3307-2010		Niarchos family (Niarchos Expedition Fund, AMNH) in Madagascar; Niarchos family (Niarchos Expedition Fund, AMNH) in New York	Niarchos family (Niarchos Expedition Fund, AMNH) in Madagascar; Niarchos family (Niarchos Expedition Fund, AMNH) in New York	JSS wishes to express his gratitude to the Niarchos family (Niarchos Expedition Fund, AMNH) for providing funding for this project in Madagascar and New York. PC would like to thank Sue Morrison, and Darren Brooks and his family for help with fieldwork and collections work in Australia. We thank Steve Goodman (FMNH, Vahatra.org) for providing a great deal of logistical support and for sharing his extensive knowledge of Malagasy karst formations and their inhabitants; this study would not have been possible without his generous assistance. Collecting efforts in Madagascar were facilitated by the efforts of Benjamin Andriamahaja and the MICET (Institute for the Conservation of Tropical Environments, Madagascar) staff, and we are grateful for their continued support of ichthyological research. Collection permits were obtained from the Direction des Eaux et Forets and the Association National pour la Gestion des Aires Protegees (ANGAP) in Madagascar and the Department of Environment and Conservation in Western Australia. We also thank Jason Ali for providing the paleomap in Figure 3, and Christine Thacker for several helpful discussions. We would also like to thank Philip Willink and Scott Holtz for their considerable assistance in the field.	Ali JR, 2011, J BIOGEOGR, V38, P1855, DOI 10.1111/j.1365-2699.2011.02546.x; Ali JR, 2009, J BIOGEOGR, V36, P1778, DOI 10.1111/j.1365-2699.2009.02105.x; Arratia Gloria, 1999, P265; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Blum S.D., 1988, THESIS U HAWAII HONO; Bradic M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-9; Brandley MC, 2011, SYST BIOL, V60, P3, DOI 10.1093/sysbio/syq045; Case Judd A., 2002, Journal of Vertebrate Paleontology, V22, p42A; Chakrabarty P, 2010, ZOOTAXA, P67, DOI 10.11646/zootaxa.2632.1.4; Chakrabarty P, 2010, ZOOTAXA, P19; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Darwin C., 1859, ORIGIN SPECIES MEANS; Davis MP, 2010, MOL PHYLOGENET EVOL, V57, P1194, DOI 10.1016/j.ympev.2010.09.003; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; Finston TL, 2007, MOL ECOL, V16, P355, DOI 10.1111/j.1365-294X.2006.03123.x; Guyot L., 2002, THESIS U NANTES; Hamilton-Smith E, 1998, KARST MANAGEMENT CON; Hay WW, 1999, GEOL S AM S, P1; Humphreys WF, 2001, ENVIRON BIOL FISH, V62, P297, DOI 10.1023/A:1011880726946; Johnson GD, 2012, P ROY SOC B-BIOL SCI, V279, P934, DOI 10.1098/rspb.2011.1289; Jokat W, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045117; Juan C, 2010, MOL ECOL, V19, P3865, DOI 10.1111/j.1365-294X.2010.04759.x; Kallersjo M, 1999, CLADISTICS, V15, P91; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Konig M, 2010, GEOPHYS J INT, V180, P158, DOI [10.1111/J.1365-246X.2009.04433.X, 10.1111/j.1365-246X.2009.04433.x]; Lamoreux J, 2004, J CAVE KARST STUD, V66, P18; Maddison, 2019, MESQUITE MODULAR SYS; MILLER PJ, 1973, J ZOOL, V171, P397; Miya M, 2003, MOL PHYLOGENET EVOL, V26, P121, DOI 10.1016/S1055-7903(02)00332-9; Neiber MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019627; Niemiller ML, 2012, EVOLUTION, V66, P846, DOI 10.1111/j.1558-5646.2011.01480.x; Patterson C., 1993, P621; Porter ML, 2007, J CAVE KARST STUD, V69, P179; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prasad GVR, 2009, B SOC GEOL FR, V180, P369, DOI 10.2113/gssgfbull.180.4.369; Proudlove G. S., 2006, SUBTERRANEAN FISHES; Proudlove GS, 2010, BIOLOGY OF SUBTERRANEAN FISHES, P41, DOI 10.1201/EBK1578086702-c2; Rambaut A., 2007, TRACER V1 5; Ribera I, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-29; ROSEN DE, 1975, SYST ZOOL, V24, P431, DOI 10.2307/2412905; Ruber L, 2012, BIOLOGY OF GOBIES, P23; Saitoh K, 2011, ZOOL J LINN SOC-LOND, V161, P633, DOI 10.1111/j.1096-3642.2010.00651.x; Sparks JS, 2005, SYST BIOL, V54, P158, DOI 10.1080/10635150590906019; Sparks JS, AM MUS NOVI IN PRESS; Thacker CE, 2005, MOL PHYLOGENET EVOL, V37, P858, DOI 10.1016/j.ympev.2005.05.004; Thacker C, 2012, Biology of Gobies, P79; Thacker CE, 2009, COPEIA, P93, DOI 10.1643/CI-08-004; Upchurch P, 2008, TRENDS ECOL EVOL, V23, P229, DOI 10.1016/j.tree.2007.11.006; WILEY EO, 1985, ANN MO BOT GARD, V72, P596, DOI 10.2307/2399217; Yamanoue Y, 2006, GENES GENET SYST, V81, P29, DOI 10.1266/ggs.81.29; Zander CD, 2012, Biology of Gobies, P345; Zwickl D., 2006, GARLI GENETIC ALGORI	53	43	44	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44083	10.1371/journal.pone.0044083	http://dx.doi.org/10.1371/journal.pone.0044083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937155	Green Published, gold			2022-12-25	WOS:000308213600075
J	Hudson, C; Howe, PDL; Little, DR				Hudson, Charlotte; Howe, Piers D. L.; Little, Daniel R.			Hemifield Effects in Multiple Identity Tracking	PLOS ONE			English	Article							SHORT-TERM-MEMORY; OBJECT TRACKING; ATTENTIONAL TRACKING; BINDING; RESOURCES; TARGETS; SPEED	In everyday life, we often need to attentively track moving objects. A previous study has claimed that this tracking occurs independently in the left and right visual hemifields (Alvarez & Cavanagh, 2005, Psychological Science, 16, 637-647). Specifically, it was shown that observers were much more accurate at tracking objects that were spread over both visual hemifields as opposed to when all were confined to a single visual hemifield. In that study, observers were not required to remember the identities of the objects. Conversely, in real life, there is seldom any benefit to tracking an object unless you can also recall its identity. It has been predicted that when observers are required to remember the identities of the tracked objects a bilateral advantage should no longer be observed (Oksama & Hyona, 2008, Cognitive Psychology, 56, 237-283). We tested this prediction and found that a bilateral advantage still occurred, though it was not as strong as when observers were not required to remember the identities of the targets. Even in the later case we found that tracking was not completely independent in the two visual hemifields. We present a combined model of multiple object tracking and multiple identity tracking that can explain our data.	[Hudson, Charlotte; Howe, Piers D. L.; Little, Daniel R.] Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic 3052, Australia	University of Melbourne	Hudson, C (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic 3052, Australia.	pdhowe@unimelb.edu.au	Little, Daniel/J-5034-2019	Little, Daniel/0000-0003-3607-5525; Howe, Piers/0000-0001-6171-1381				Allen R, 2004, APPL COGNITIVE PSYCH, V18, P337, DOI 10.1002/acp.975; Alvarez GA, 2005, PSYCHOL SCI, V16, P637, DOI 10.1111/j.1467-9280.2005.01587.x; Alvarez GA, 2007, J VISION, V7, DOI 10.1167/7.13.14; Barker K, 2010, EXP PSYCHOL, V57, P208, DOI 10.1027/1618-3169/a000026; Battelli L, 2009, J COGNITIVE NEUROSCI, V21, P1946, DOI 10.1162/jocn.2008.21149; Bettencourt KC, 2009, J VISION, V9, DOI 10.1167/9.7.9; Botterill K, 2011, EXP PSYCHOL, V58, P196, DOI 10.1027/1618-3169/a000085; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cavanagh P, 2005, TRENDS COGN SCI, V9, P349, DOI 10.1016/j.tics.2005.05.009; Cohen MA, 2011, ATTEN PERCEPT PSYCHO, V73, P1422, DOI 10.3758/s13414-011-0089-7; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Delvenne JF, 2005, COGNITION, V96, pB79, DOI 10.1016/j.cognition.2004.12.007; Franconeri SL, 2008, PSYCHON B REV, V15, P802, DOI 10.3758/PBR.15.4.802; Franconeri SL, 2010, PSYCHOL SCI, V21, P920, DOI 10.1177/0956797610373935; Holcombe AO, 2012, COGNITION, V123, P218, DOI 10.1016/j.cognition.2011.10.003; Horowitz TS, 2007, PERCEPT PSYCHOPHYS, V69, P172, DOI 10.3758/BF03193740; Howe P, 2009, ENCY CONSCIOUSNESS, P61; HUBEL DH, 1979, SCI AM, V241, P150, DOI 10.1038/scientificamerican0979-150; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; King-Smith PE, 1993, VISION RES, V34, P885; LEVIN JR, 1994, PSYCHOL BULL, V115, P153, DOI 10.1037/0033-2909.115.1.153; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Oksama L, 2004, VIS COGN, V11, P631, DOI 10.1080/13506280344000473; Oksama L, 2008, COGNITIVE PSYCHOL, V56, P237, DOI 10.1016/j.cogpsych.2007.03.001; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pinto Y, 2010, J VISION, V10, DOI 10.1167/10.10.4; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Pylyshyn ZW, 2004, VIS COGN, V11, P801, DOI 10.1080/13506280344000518; Scholl BJ, 2001, COGNITION, V80, P159, DOI 10.1016/S0010-0277(00)00157-8; Scholl BJ, 2009, COMPUTATION, COGNITION, AND PYLYSHYN, P49; Shim WM, 2008, PSYCHON B REV, V15, P390, DOI 10.3758/PBR.15.2.390; Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Wheeler ME, 2002, J EXP PSYCHOL GEN, V131, P48, DOI 10.1037//0096-3445.131.1.48; YANTIS S, 1992, COGNITIVE PSYCHOL, V24, P295, DOI 10.1016/0010-0285(92)90010-Y	37	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43796	10.1371/journal.pone.0043796	http://dx.doi.org/10.1371/journal.pone.0043796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998CA	22952767	Green Published, gold			2022-12-25	WOS:000308213600043
J	Mao, NY; Ji, YX; Xie, ZD; Wang, HH; Wang, HL; An, JJ; Zhang, XX; Zhang, Y; Zhu, Z; Cui, AL; Xu, ST; Shen, KL; Liu, CY; Yang, WZ; Xu, WB				Mao, Naiying; Ji, Yixin; Xie, Zhengde; Wang, Huanhuan; Wang, Huiling; An, Junjing; Zhang, Xinxin; Zhang, Yan; Zhu, Zhen; Cui, Aili; Xu, Songtao; Shen, Kunling; Liu, Chunyan; Yang, Weizhong; Xu, Wenbo			Human Parainfluenza Virus-Associated Respiratory Tract Infection among Children and Genetic Analysis of HPIV-3 Strains in Beijing, China	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; REAL-TIME PCR; SYNCYTIAL-VIRUS; HEMAGGLUTININ-NEURAMINIDASE; YOUNG-CHILDREN; MOLECULAR EPIDEMIOLOGY; HUMAN METAPNEUMOVIRUS; PEDIATRIC-PATIENTS; TYPE-3; EVOLUTION	The relevance of human parainfluenza viruses (HPIVs) to the epidemiology of acute respiratory infections (ARI) in China is unclear. From May 2008 to September 2010, 443 nasopharyngeal aspirates (NPAs) from hospitalized pediatric patients (age from 1 to 93 months) in Beijing were collected and screened for HPIVs and other common respiratory viruses by real-time RT-PCR. Sixty-two of 443 samples were positive for HPIVs with 4 positive for HPIV-2 and 58 positive for HPIV-3, indicating that HPIV-3 was the predominant virus present during the study period. A phylogenetic tree based on all the available HN (hemagglutinin-neuraminidase) sequences of HPIV-3 indicated that three distinct clusters (A, B, and C) were circulating with some temporal and regional clustering. Cluster C was further divided into sub-clusters, C1, C2, C3 and C4. HPIV-3 from Beijing isolates belonged to sub-cluster C3, and were grouped with the isolates from two Provinces of China and the neighboring country of Japan. Genetic analysis based on entire HN gene revealed that the HPIV-3 isolates from Beijing were highly similar with 97.2%-100% identity at the nucleotide level and these could be divided into two closely related lineages, C3a and C3b. These findings suggested that there was co-circulation of multiple lineages of HPIV-3 in the Beijing region during the study period. This is the first study to describe the epidemiology and molecular characterization of HPIVs in China.	[Mao, Naiying; Ji, Yixin; Wang, Huanhuan; Wang, Huiling; An, Junjing; Zhang, Xinxin; Zhang, Yan; Zhu, Zhen; Cui, Aili; Xu, Songtao; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, World Hlth Org Reg Off, Western Pacific Reg Reference Measles Lab, Beijing, Peoples R China; [Mao, Naiying; Ji, Yixin; Wang, Huanhuan; Wang, Huiling; An, Junjing; Zhang, Xinxin; Zhang, Yan; Zhu, Zhen; Cui, Aili; Xu, Songtao; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China; [Xie, Zhengde; Wang, Huiling; Zhang, Xinxin; Shen, Kunling; Liu, Chunyan] Capital Med Univ, Beijing Childrens Hosp, Beijing, Peoples R China; [Wang, Huanhuan] Taishan Med Coll, Dept Neurobiol, Tai An, Shandong, Peoples R China; [Yang, Weizhong] Chinese Ctr Dis Control & Prevent, Off Dis Control & Emergency Response, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; World Health Organization; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Capital Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; Chinese Center for Disease Control & Prevention	Mao, NY (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, World Hlth Org Reg Off, Western Pacific Reg Reference Measles Lab, Beijing, Peoples R China.	Wenbo_xu1@yahoo.com.cn	Yang, Wei/HIA-0360-2022		Ministry of Science and Technology of the People's Republic of China [2009ZX1004-201, 2009ZX1004-202, 2007AA02Z463]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was supported by grants 2009ZX1004-201 and 2009ZX1004-202 from the National Infectious Disease Surveillance Program of the Ministry of Science and Technology of the People's Republic of China and grant 2007AA02Z463 from the Ministry of Science and Technology of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar JC, 2000, J CLIN MICROBIOL, V38, P1191, DOI 10.1128/JCM.38.3.1191-1195.2000; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Cilla G, 2008, J MED VIROL, V80, P1843, DOI 10.1002/jmv.21271; COELINGH KLV, 1988, VIROLOGY, V162, P137, DOI 10.1016/0042-6822(88)90402-3; COELINGH KLV, 1987, J VIROL, V61, P1473, DOI 10.1128/JVI.61.5.1473-1477.1987; COLLINS KR, 1995, EPIDEMIOL INFECT, V114, P493, DOI 10.1017/S0950268800052201; Cortez KJ, 2001, J INFECT DIS, V184, P1093, DOI 10.1086/322041; Counihan ME, 2001, PEDIATR INFECT DIS J, V20, P646, DOI 10.1097/00006454-200107000-00003; DENNY FW, 1986, J PEDIATR-US, V108, P635, DOI 10.1016/S0022-3476(86)81034-4; Downham M A, 1973, Arch Dis Child, V48, P824; DOWNHAM MAP, 1974, ARCH DIS CHILD, V49, P8, DOI 10.1136/adc.49.1.8; EASTON AJ, 1989, EPIDEMIOL INFECT, V102, P531, DOI 10.1017/S0950268800030247; Echevarria JE, 2000, J VIROL METHODS, V88, P105, DOI 10.1016/S0166-0934(00)00163-4; Fabbiani M, 2009, J MED VIROL, V81, P750, DOI 10.1002/jmv.21457; Gambarino S, 2009, MOL BIOTECHNOL, V42, P350, DOI 10.1007/s12033-009-9164-x; GLEZEN WP, 1984, J INFECT DIS, V150, P851, DOI 10.1093/infdis/150.6.851; Greensill J, 2003, EMERG INFECT DIS, V9, P372, DOI 10.3201/eid0903.020289; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Hayden FG, 2006, CURR OPIN INFECT DIS, V19, P169, DOI 10.1097/01.qco.0000216628.51563.b1; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; Henrickson KJ, 2003, CLIN MICROBIOL REV, V16, P242, DOI 10.1128/CMR.16.2.242-264.2003; HENRICKSON KJ, 1994, CLIN INFECT DIS, V18, P770, DOI 10.1093/clinids/18.5.770; HENRICKSON KJ, 1992, J INFECT DIS, V166, P995, DOI 10.1093/infdis/166.5.995; HETHERINGTON SV, 1994, J INFECT DIS, V169, P248, DOI 10.1093/infdis/169.2.248; Jalal H, 2007, J CLIN MICROBIOL, V45, P1690, DOI 10.1128/JCM.01912-06; Kim Sun Hyung, 2006, Korean J Lab Med, V26, P351, DOI 10.3343/kjlm.2006.26.5.351; KLIPPMARK E, 1990, J GEN VIROL, V71, P1577, DOI 10.1099/0022-1317-71-7-1577; KNOTT AM, 1994, PEDIATR INFECT DIS J, V13, P269, DOI 10.1097/00006454-199404000-00005; Lau SKP, 2009, J CLIN MICROBIOL, V47, P1549, DOI 10.1128/JCM.00047-09; Lu Rou-jian, 2008, Chinese Journal of Virology, V24, P305; Maertzdorf J, 2004, J CLIN MICROBIOL, V42, P981, DOI 10.1128/JCM.42.3.981-986.2004; Marx A, 1997, J INFECT DIS, V176, P1423, DOI 10.1086/514137; Moisiuk SE, 1998, PEDIATR INFECT DIS J, V17, P49, DOI 10.1097/00006454-199801000-00011; MONTO AS, 1986, AM J EPIDEMIOL, V124, P359, DOI 10.1093/oxfordjournals.aje.a114406; Fe MMM, 2008, BRAZ J INFECT DIS, V12, P192, DOI 10.1590/S1413-86702008000300006; Muraki Y, 1996, J GEN VIROL, V77, P673, DOI 10.1099/0022-1317-77-4-673; MURPHY B, 1980, MED J AUSTRALIA, V1, P22, DOI 10.5694/j.1326-5377.1980.tb134568.x; Niederman MS, 2004, AM J MED, V117, P51, DOI 10.1016/j.amjmed.2004.07.008; Palermo LM, 2009, J VIROL, V83, P6900, DOI 10.1128/JVI.00475-09; Papadopoulos NG, 2002, AM J RESP CRIT CARE, V165, P1285, DOI 10.1164/rccm.200112-118BC; Pierangeli A, 2007, J MED VIROL, V79, P463, DOI 10.1002/jmv.20832; PRINOSKI K, 1992, VIRUS RES, V22, P55, DOI 10.1016/0168-1702(92)90089-R; Reed G, 1997, J INFECT DIS, V175, P807, DOI 10.1086/513975; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; Ruth A, 2007, FIELDS VIROLOGY, P1498; Segal AO, 2005, PEDIATRICS, V116, P51, DOI 10.1542/peds.2004-1892; Semple MG, 2005, J INFECT DIS, V191, P382, DOI 10.1086/426457; Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004; VAINIONPAA R, 1994, CLIN MICROBIOL REV, V7, P265; van Elden LJR, 2003, J CLIN MICROBIOL, V41, P4378, DOI 10.1128/JCM.41.9.4378-4381.2003; Vijgen L, 2005, J CLIN MICROBIOL, V43, P5452, DOI 10.1128/JCM.43.11.5452-5456.2005; Watzinger F, 2004, J CLIN MICROBIOL, V42, P5189, DOI 10.1128/JCM.42.11.5189-5198.2004; Zambon M, 1998, J CLIN MICROBIOL, V36, P2289, DOI 10.1128/JCM.36.8.2289-2293.1998	53	34	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43893	10.1371/journal.pone.0043893	http://dx.doi.org/10.1371/journal.pone.0043893			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937119	gold, Green Submitted, Green Published			2022-12-25	WOS:000308213600055
J	Baca-Lopez, K; Mayorga, M; Hidalgo-Miranda, A; Gutierrez-Najera, N; Hernandez-Lemus, E				Baca-Lopez, Karol; Mayorga, Miguel; Hidalgo-Miranda, Alfredo; Gutierrez-Najera, Nora; Hernandez-Lemus, Enrique			The Role of Master Regulators in the Metabolic/Transcriptional Coupling in Breast Carcinomas	PLOS ONE			English	Article							HISTOLOGIC GRADE; CANCER PATIENTS; GENE; EXPRESSION; TRANSCRIPTION; SIGNATURE; DNA; IDENTIFICATION; HYBRIDIZATION; PREVENTION	Metabolic transformations have been reported as involved in neoplasms survival. This suggests a role of metabolic pathways as potential cancer pharmacological targets. Modulating tumor's energy production pathways may become a substantial research area for cancer treatment. The significant role of metabolic deregulation as inducing transcriptional instabilities and consequently whole-system failure, is thus of foremost importance. By using a data integration approach that combines experimental evidence for high-throughput genome wide gene expression, a non-equilibrium thermodynamics analysis, nonlinear correlation networks as well as database mining, we were able to outline the role that transcription factors MEF2C and MNDA may have as main master regulators in primary breast cancer phenomenology, as well as the possible interrelationship between malignancy and metabolic dysfunction. The present findings are supported by the analysis of 1191 whole genome gene expression experiments, as well as probabilistic inference of gene regulatory networks, and non-equilibrium thermodynamics of such data. Other evidence sources include pathway enrichment and gene set enrichment analyses, as well as motif comparison with a comprehensive gene regulatory network (of homologue genes) in Arabidopsis thaliana. Our key finding is that the non-equilibrium free energies provide a realistic description of transcription factor activation that when supplemented with gene regulatory networks made us able to find deregulated pathways. These analyses also suggest a novel potential role of transcription factor energetics at the onset of primary tumor development. Results are important in the molecular systems biology of cancer field, since deregulation and coupling mechanisms between metabolic activity and transcriptional regulation can be better understood by taking into account the way that master regulators respond to physicochemical constraints imposed by different phenotypic conditions.	[Baca-Lopez, Karol; Hernandez-Lemus, Enrique] Natl Inst Genom Med, Computat Genom Dept, Mexico City, DF, Mexico; [Baca-Lopez, Karol; Mayorga, Miguel] Autonomous Univ State Mexico, Sch Sci, Toluca, Mexico; [Hidalgo-Miranda, Alfredo] Natl Inst Genom Med, Canc Genom Lab, Mexico City, DF, Mexico; [Gutierrez-Najera, Nora] Natl Inst Genom Med, Prote Core Facil, Mexico City, DF, Mexico; [Hernandez-Lemus, Enrique] Univ Nacl Autonoma Mexico, Ctr Complex Sci, Mexico City 04510, DF, Mexico	Instituto Nacional de Medicina Genomica; Universidad Autonoma del Estado de Mexico; Instituto Nacional de Medicina Genomica; Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico	Baca-Lopez, K (corresponding author), Natl Inst Genom Med, Computat Genom Dept, Mexico City, DF, Mexico.	ehernandez@inmegen.gob.mx	Mayorga, Miguel/B-3458-2016; Hidalgo-Miranda, Alfredo/B-2123-2010	Mayorga, Miguel/0000-0001-7527-5197; Hidalgo-Miranda, Alfredo/0000-0003-2315-3977; Hernandez-Lemus, Enrique/0000-0002-1872-1397	El Instituto de Ciencia y Tecnologia del Distrito Federal (ICyT-DF) [PIUTE10-92, 281-2010]; National Institute of Genomic Medicine (Mexico)	El Instituto de Ciencia y Tecnologia del Distrito Federal (ICyT-DF); National Institute of Genomic Medicine (Mexico)	The authors gratefully acknowledge support by grant: PIUTE10-92 El Instituto de Ciencia y Tecnologia del Distrito Federal (ICyT-DF) [Contract 281-2010], as well as federal funding from the National Institute of Genomic Medicine (Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla ER, 2000, P NATL ACAD SCI USA, V97, P5328, DOI 10.1073/pnas.97.10.5328; [Anonymous], REV ONCOLOGIA; Baca-Lopez K, 2009, REV MEX FIS, V55, P456; Beger M, 2001, J MOL MED, V79, P314, DOI 10.1007/s001090100211; Bhardwaj V, 2010, ANTICANCER RES, V30, P743; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BURRUS GR, 1992, J CELL BIOCHEM, V48, P190, DOI 10.1002/jcb.240480210; Carlon E, 2006, PHYSICA A, V362, P433, DOI 10.1016/j.physa.2005.09.067; Chavez Montes RA, ARA BIDOPSIS THALIAN; CHEN M, 1993, J MATH PHYS, V34, P3012, DOI 10.1063/1.530060; Clendening JW, 2010, P NATL ACAD SCI USA, V107, P15051, DOI 10.1073/pnas.0910258107; Cotta-Ramusino C, 2011, SCIENCE, V332, P1313, DOI 10.1126/science.1203430; Dennison JB, 2009, BRIT J HAEMATOL, V147, P297, DOI 10.1111/j.1365-2141.2009.07850.x; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Duan H, 2008, ONCOGENE, V27, P6720, DOI 10.1038/onc.2008.286; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Galant NJ, 2009, J PHYS CHEM A, V113, P9138, DOI 10.1021/jp809116n; Geschwind Jean-Francois, 2004, Expert Rev Anticancer Ther, V4, P449, DOI 10.1586/14737140.4.3.449; Hekstra D, 2003, NUCLEIC ACIDS RES, V31, P1962, DOI 10.1093/nar/gkg283; Lemus EH, 2009, J NON-EQUIL THERMODY, V34, P371, DOI 10.1515/JNETDY.2009.019; Hernandez-Lemus E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021558; Hernandez-Lemus E, 2009, PHYSICA A, V388, P5057, DOI 10.1016/j.physa.2009.08.013; HERNANDEZLEMUS E, 2010, NEW TRENDS STAT PHYS; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; John S, 2009, ENDOCRINOLOGY, V150, P1766, DOI 10.1210/en.2008-0863; JOU D, 1985, PHYS REV A, V31, P2502, DOI 10.1103/PhysRevA.31.2502; Knight LA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-38; Komorowski M, 2010, BIOPHYS J, V98, P2759, DOI 10.1016/j.bpj.2010.03.032; Kong YCM, 2010, ANN NY ACAD SCI, V1183, P222, DOI 10.1111/j.1749-6632.2009.05138.x; Lee AW, 2011, MOL IMMUNOL, V48, P1160, DOI 10.1016/j.molimm.2011.02.010; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Lu ZJ, 2008, NUCLEIC ACIDS RES, V36, P640, DOI 10.1093/nar/gkm920; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Matsuura I, 2010, BIOCHEM J, V426, P327, DOI 10.1042/BJ20090990; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; Merry C, 2010, CELL CYCLE, V9, P279, DOI 10.4161/cc.9.2.10445; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Ni IBP, 2010, PATHOL RES PRACT, V206, P223, DOI 10.1016/j.prp.2009.11.006; Norris AJ, 2003, MOL ENDOCRINOL, V17, P193, DOI 10.1210/me.2002-0201; Ostrander JH, 2007, CANC RES, V67, P9; Ostrander JH, 2007, CANCER RES, V67, P4199, DOI 10.1158/0008-5472.CAN-06-3409; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Peasland A, 2011, BRIT J CANCER, V105, P372, DOI 10.1038/bjc.2011.243; Pedram A, 2009, MOL BIOL CELL, V20, P3374, DOI 10.1091/mbc.E09-01-0085; Petersen M, 2010, ONCOGENE, V29, P1351, DOI 10.1038/onc.2009.426; Pittman AM, 2008, HUM MOL GENET, V17, P3720, DOI 10.1093/hmg/ddn267; Reguera D, 2005, J PHYS CHEM B, V109, P21502, DOI 10.1021/jp052904i; Ressler S, 2011, EXPERT REV ANTICANC, V11, P333, DOI [10.1586/era.11.13, 10.1586/ERA.11.13]; Roy D, 2001, MOL CARCINOG, V31, P4; Salim NS, 2009, METHODS, V47; Schuetz CS, 2006, CANCER RES, V66, P5278, DOI 10.1158/0008-5472.CAN-05-4610; Schuetz CS, 2006, CANC RES, V66, P10; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Shen Q, 2003, J MAMMARY GLAND BIOL, V8, P45, DOI 10.1023/A:1025783221557; SMYTH GK, 2004, STAT APPL GENETICS M, V3; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan EY, 2007, CLIN CANCER RES, V13, P467, DOI 10.1158/1078-0432.CCR-06-1466; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; Tonon G, 2008, FUTURE ONCOL, V4, P569, DOI 10.2217/14796694.4.4.569; Tripathi A, 2008, INT J CANCER, V122, P1557, DOI 10.1002/ijc.23267; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Wang K, 2010, CANCER GENET CYTOGEN, V200, P40, DOI 10.1016/j.cancergencyto.2010.03.006; WHITE MRH, 1995, J CELL SCI, V108, P441; Xie J, 1998, J CELL BIOCHEM, V70; Yilmaz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022986; Yu J, 2006, AIDS RES HUM RETRO S, V311; Zhao C, 2008, ONCOGENE, V27, P63, DOI 10.1038/sj.onc.1210637	71	16	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e42678	10.1371/journal.pone.0042678	http://dx.doi.org/10.1371/journal.pone.0042678			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952604	gold, Green Submitted, Green Published			2022-12-25	WOS:000308044800009
J	Kitchen, JL; Allaby, RG				Kitchen, James L.; Allaby, Robin G.			The Limits of Mean-Field Heterozygosity Estimates under Spatial Extension in Simulated Plant Populations	PLOS ONE			English	Article							PREDATOR-PREY DYNAMICS; GENETIC DIVERSITY; DOMESTICATION; SPECIATION; EVOLUTION; SELECTION; DISTANCE; MODELS; DENSITY; MARKERS	Computational models of evolutionary processes are increasingly required to incorporate multiple and diverse sources of data. A popular feature to include in population genetics models is spatial extension, which reflects more accurately natural populations than does a mean field approach. However, such models necessarily violate the mean field assumptions of classical population genetics, as do natural populations in the real world. Recently, it has been questioned whether classical approaches are truly applicable to the real world. Individual based models (IBM) are a powerful and versatile approach to achieve integration in models. In this study an IBM was used to examine how populations of plants deviate from classical expectations under spatial extension. Populations of plants that used three different mating strategies were placed in a range of arena sizes giving crowded to sparse occupation densities. Using a measure of population density, the pollen communication distance (P-cd), the deviation exhibited by outbreeding populations differed from classical mean field expectations by less than 5% when P-cd was less than 1, and over this threshold value the deviation significantly increased. Populations with an intermediate mating strategy did not have such a threshold and deviated directly with increasing isolation between individuals. Populations with a selfing strategy were influenced more by the mating strategy than by increased isolation. In all cases pollen dispersal was more influential than seed dispersal. The IBM model showed that mean field calculations can be reasonably applied to natural outbreeding plant populations that occur at a density in which individuals are less than the average pollen dispersal distance from their neighbors.	[Kitchen, James L.; Allaby, Robin G.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Kitchen, JL (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	r.g.allaby@warwick.ac.uk			Leverhulme Trust [F/00 215/BC]	Leverhulme Trust(Leverhulme Trust)	This work is supported by the Leverhulme Trust F/00 215/BC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaby R, 2010, J EXP BOT, V61, P935, DOI 10.1093/jxb/erp382; Allaby RG, 2008, P NATL ACAD SCI USA, V105, P13982, DOI 10.1073/pnas.0803780105; Allaby RG, 2010, VEG HIST ARCHAEOBOT, V19, P151, DOI 10.1007/s00334-009-0232-8; Allphin L, 1998, AM J BOT, V85, P1251, DOI 10.2307/2446635; BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Barrett MD, 2012, AM J BOT, V99, pE14, DOI 10.3732/ajb.1100357; Beckie HJ, 2008, PLANT SCI, V175, P615, DOI 10.1016/j.plantsci.2008.05.021; Bomblies K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000890; Cuddington KM, 2000, THEOR POPUL BIOL, V58, P259, DOI 10.1006/tpbi.2000.1493; Dering M, 2012, SCAND J FOREST RES, V27, P2, DOI 10.1080/02827581.2011.631934; DEROOS AM, 1991, P ROY SOC B-BIOL SCI, V246, P117, DOI 10.1098/rspb.1991.0132; Doligez A, 1998, GENETICS, V148, P905; Douaihy B, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr003; Durrett R, 2000, HEREDITY, V84, P9, DOI 10.1046/j.1365-2540.2000.00566.x; Finkel R. A., 1974, Acta Informatica, V4, P1, DOI 10.1007/BF00288933; Garroway CJ, 2011, MOL ECOL, V20, P3978, DOI 10.1111/j.1365-294X.2011.05243.x; Gavrilets S, 1998, P ROY SOC B-BIOL SCI, V265, P1483, DOI 10.1098/rspb.1998.0461; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; Hartl DL, 1997, PRINCIPLES POPULATIO, P141; Hartman PJ, 2012, THEOR ECOL-NETH, V5, P219, DOI 10.1007/s12080-011-0117-1; Jones KN, 2001, AM J BOT, V88, P447, DOI 10.2307/2657109; KARRON JD, 1995, HEREDITY, V75, P175, DOI 10.1038/hdy.1995.121; King TL, 2011, CONSERV GENET RESOUR, V4, P39; Kuparinen A, 2007, ECOL MODEL, V202, P476, DOI 10.1016/j.ecolmodel.2006.11.015; Landguth EL, 2010, MOL ECOL RESOUR, V10, P156, DOI 10.1111/j.1755-0998.2009.02719.x; LEVIN DA, 1973, EVOLUTION, V27, P144, DOI [10.2307/2407128, 10.1111/j.1558-5646.1973.tb05926.x]; MAYR E, 1978, SYST ZOOL, V27, P83, DOI 10.2307/2412818; MCCAULEY E, 1993, AM NAT, V142, P412, DOI 10.1086/285547; Millar MA, 2012, CONSERV GENET RESOUR, V4, P51, DOI 10.1007/s12686-011-9473-9; Muir K, 2007, SILVAE GENET, V56, P222, DOI 10.1515/sg-2007-0033; Olivier A, 1998, PLANT SYST EVOL, V209, P33, DOI 10.1007/BF00991522; Peleg Z, 2011, J EXP BOT, V62, P5051, DOI 10.1093/jxb/err206; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Pritchard JK, 2010, SCI AM, V303, P41, DOI 10.1038/scientificamerican1010-40; Rasic G, 2012, MOL ECOL, V21, P223, DOI 10.1111/j.1365-294X.2011.05280.x; Restoux G, 2008, WEB ECOL, V8, P94, DOI [DOI 10.5194/we-8-94-2008, 10.5194/WE--8--94-2008]; RICE WR, 1984, EVOLUTION, V38, P1251, DOI 10.1111/j.1558-5646.1984.tb05647.x; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sadedin S, 2009, MOL ECOL, V18, P4006, DOI 10.1111/j.1365-294X.2009.04320.x; Savill NJ, 1998, P ROY SOC B-BIOL SCI, V265, P25, DOI 10.1098/rspb.1998.0259; SMITH WG, 1979, BIOCHEM SYST ECOL, V7, P121, DOI 10.1016/0305-1978(79)90019-X; Spear SF, 2010, MOL ECOL, V19, P3576, DOI 10.1111/j.1365-294X.2010.04657.x; TEMPLETON AR, 1980, GENETICS, V94, P1011; Weis AE, 2004, AM J BOT, V91, P825, DOI 10.3732/ajb.91.6.825; WILSON WG, 1993, THEOR POPUL BIOL, V43, P91, DOI 10.1006/tpbi.1993.1005; WILSON WG, 1995, B MATH BIOL, V57, P507, DOI 10.1016/S0092-8240(05)80754-2; Wohrmann T, 2011, GENET RESOUR CROP EV, V58, P1157, DOI 10.1007/s10722-010-9648-3; Wright S, 1943, GENETICS, V28, P114	49	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43254	10.1371/journal.pone.0043254	http://dx.doi.org/10.1371/journal.pone.0043254			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952655	Green Published, gold, Green Submitted			2022-12-25	WOS:000308044800025
J	Campitelli, M; Jeannot, E; Peter, M; Lappartient, E; Saada, S; de la Rochefordiere, A; Fourchotte, V; Alran, S; Petrow, P; Cottu, P; Pierga, JY; Lantz, O; Couturier, J; Sastre-Garau, X				Campitelli, Maura; Jeannot, Emmanuelle; Peter, Martine; Lappartient, Emmanuelle; Saada, Stephanie; de la Rochefordiere, Anne; Fourchotte, Virginie; Alran, Severine; Petrow, Peter; Cottu, Paul; Pierga, Jean-Yves; Lantz, Olivier; Couturier, Jerome; Sastre-Garau, Xavier			Human Papillomavirus Mutational Insertion: Specific Marker of Circulating Tumor DNA in Cervical Cancer Patients	PLOS ONE			English	Article							CELLULAR FUSION TRANSCRIPTS; PLASMA; SEQUENCES; HPV16; PCR	Introduction: In most cases of cervical cancers, HPV DNA is integrated into the genome of carcinoma cells. This mutational insertion constitutes a highly specific molecular marker of tumor DNA for every patient. Circulating tumor DNA (ctDNA) is an emerging marker of tumor dynamics which detection requires specific molecular motif. To determine whether the sequence of the cell-viral junction could be used in clinical practice as a specific marker of ctDNA, we analyzed a series of cervical cancer patient serums. Methods and Findings: Serum specimens of 16 patients diagnosed with HPV16/18-associated cervical cancer, and for which the viral integration locus had been previously localized, were analyzed. Sequential serum specimens, taken at different times during the course of the disease, were also available for two of these cases. ctDNA was found in 11 out of 13 patients with tumor size greater than 20 mm at diagnosis, and analysis of sequential serum specimens showed that ctDNA concentration in patients serum was related to tumor dynamics. Conclusions: We report that HPV mutational insertion constitutes a highly specific molecular marker of ctDNA in HPV-associated tumor patients. Using this original approach, ctDNA was detected in most cervical cancer patients over stage I and ctDNA concentration was found to reflect tumor burden. In addition to its potential prognostic and predictive value, HPV mutation insertion is likely to constitute a new molecular surrogate of minimal residual disease and of subclinical relapse in HPV-associated tumor. This is of major importance in the perspective of specific anti-HPV therapy.	[Campitelli, Maura; de la Rochefordiere, Anne] Hosp Paris, Inst Curie, Dept Radiat Oncol, Paris, France; [Jeannot, Emmanuelle; Peter, Martine; Lappartient, Emmanuelle; Saada, Stephanie; Lantz, Olivier; Couturier, Jerome; Sastre-Garau, Xavier] Hosp Paris, Inst Curie, Dept Biopathol, Paris, France; [Fourchotte, Virginie; Alran, Severine] Hosp Paris, Inst Curie, Dept Surg Oncol, Paris, France; [Petrow, Peter] Hosp Paris, Inst Curie, Dept Radiol, Paris, France; [Cottu, Paul; Pierga, Jean-Yves] Hosp Paris, Inst Curie, Dept Med Oncol, Paris, France	Hopital Universitaire Sainte-Perine - APHP; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Hopital Universitaire Sainte-Perine - APHP; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Hopital Universitaire Sainte-Perine - APHP; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Hopital Universitaire Sainte-Perine - APHP; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Hopital Universitaire Sainte-Perine - APHP; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Campitelli, M (corresponding author), Hosp Paris, Inst Curie, Dept Radiat Oncol, Paris, France.	xavier.sastre@curie.net	Lantz, Olivier J/J-4960-2012; Cottu, Paul/ABC-8595-2020	Lantz, Olivier J/0000-0003-3161-7719; Sastre-Garau, Xavier/0000-0001-5992-2083	La Maison Goyard	La Maison Goyard	This work was supported in part by a partnership with La Maison Goyard and by a generous gift from Ms. A. Mauresmo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker M, 2012, NAT METHODS, V9, P541, DOI 10.1038/nmeth.2027; CULLEN AP, 1991, J VIROL, V65, P606, DOI 10.1128/JVI.65.2.606-612.1991; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Dong SM, 2002, CANCER EPIDEM BIOMAR, V11, P3; Gadducci A, 2008, CRIT REV ONCOL HEMAT, V66, P10, DOI 10.1016/j.critrevonc.2007.09.002; Hopman AHN, 2004, J PATHOL, V202, P23, DOI 10.1002/path.1490; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Kraus I, 2008, CANCER RES, V68, P2514, DOI 10.1158/0008-5472.CAN-07-2776; Liu VWS, 2001, GYNECOL ONCOL, V82, P269, DOI 10.1006/gyno.2001.6289; Luft F, 2001, INT J CANCER, V92, P9, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1144>3.0.CO;2-L; Peter M, 2010, J PATHOL, V221, P320, DOI 10.1002/path.2713; Pornthanakasem W, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-2; Rago C, 2007, CANCER RES, V67, P9364, DOI 10.1158/0008-5472.CAN-07-0605; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Shimada T, 2010, JPN J CLIN ONCOL, V40, P420, DOI 10.1093/jjco/hyp193; Sung WK., 2012, NAT GENET       0527; Tseng CJ, 1999, J CLIN ONCOL, V17, P1391, DOI 10.1200/JCO.1999.17.5.1391; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wentzensen N, 2002, ONCOGENE, V21, P419, DOI 10.1038/sj.onc.1205104; Yang HJ, 2004, INT J GYNECOL CANCER, V14, P903, DOI 10.1111/j.1048-891X.2004.014528.x	20	57	61	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43393	10.1371/journal.pone.0043393	http://dx.doi.org/10.1371/journal.pone.0043393			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937045	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500047
J	Pfurtscheller, G; Daly, I; Bauernfeind, G; Muller-Putz, GR				Pfurtscheller, Gert; Daly, Ian; Bauernfeind, Guenther; Mueller-Putz, Gernot R.			Coupling between Intrinsic Prefrontal HbO2 and Central EEG Beta Power Oscillations in the Resting Brain	PLOS ONE			English	Article							BLOOD-PRESSURE FLUCTUATIONS; HEART-RATE-VARIABILITY; CARDIOVASCULAR-SYSTEM; CONSCIOUS INTENTION; TIME; RHYTHMS; MODEL; STATE; DESYNCHRONIZATION; EXCITABILITY	There is increasing interest in the intrinsic activity in the resting brain, especially that of ultraslow and slow oscillations. Using near-infrared spectroscopy (NIRS), electroencephalography (EEG), blood pressure (BP), respiration and heart rate recordings during 5 minutes of rest, combined with cross spectral and sliding cross correlation calculations, we identified a short-lasting coupling (duration approximate to 100 s) between prefrontal oxyhemoglobin (HbO2) in the frequency band between 0.07 and 0.13 Hz and central EEG alpha and/or beta power oscillations in 8 of the 9 subjects investigated. The HbO2 peaks preceded the EEG band power peaks by 3.7 s in 6 subjects, with moderate or no coupling between BP and HbO2 oscillations. HbO2 and EEG band power oscillations were approximately in phase with BP oscillations in the 2 subjects with an extremely high coupling (squared coherence >0.8) between BP and HbO2 oscillation. No coupling was identified in one subject. These results indicate that slow precentral (de) oxyhemoglobin concentration oscillations during awake rest can be temporarily coupled with EEG fluctuations in sensorimotor areas and modulate the excitability level in the brains' motor areas, respectively. Therefore, this provides support for the idea that resting state networks fluctuate with frequencies of between 0.01 and 0.1 Hz (Mantini et. al. PNAS 2007).	[Pfurtscheller, Gert; Daly, Ian; Bauernfeind, Guenther; Mueller-Putz, Gernot R.] Graz Univ Technol, Lab Brain Comp Interfaces, Inst Knowledge Discovery, A-8010 Graz, Austria	Graz University of Technology	Pfurtscheller, G (corresponding author), Graz Univ Technol, Lab Brain Comp Interfaces, Inst Knowledge Discovery, A-8010 Graz, Austria.	pfurtscheller@tugraz.at	Daly, Ian/Q-7322-2017	Daly, Ian/0000-0001-5489-0393; Muller-Putz, Gernot/0000-0002-0087-3720; Bauernfeind, Gunther/0000-0002-5205-8920	European ICT Programme Project [FP7-224631]; Land Steiermark [A3-22N-13/2009-8]; Neuro Center Styria; Allgemeine Unfallversicherungsanstalt in Austria	European ICT Programme Project; Land Steiermark; Neuro Center Styria; Allgemeine Unfallversicherungsanstalt in Austria	This work is supported by the European ICT Programme Project FP7-224631, Land Steiermark (project A3-22N-13/2009-8), the Neuro Center Styria and the Allgemeine Unfallversicherungsanstalt in Austria. This paper only reflects the authors' views and funding agencies are not liable for any use that may be made of the information contained herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett AG, 2005, IEEE T SIGNAL PROCES, V53, P26, DOI 10.1109/TSP.2004.838942; Bauernfeind G, 2008, BIOMED TECH, V53, P36, DOI 10.1515/BMT.2008.005; Chen R, 1998, ANN NEUROL, V44, P317, DOI 10.1002/ana.410440306; Chen R, 1999, EXP BRAIN RES, V128, P539, DOI 10.1007/s002210050878; Claus S, 2012, EPILEPSY RE IN PRESS; Daly I, 2012, PATTERN RECOGN, V45, P2123, DOI 10.1016/j.patcog.2011.04.034; DAMEN EJP, 1987, PSYCHOPHYSIOLOGY, V24, P700, DOI 10.1111/j.1469-8986.1987.tb00353.x; Darwin C., 1999, EXPRESSION EMOTIONS; DASILVA FL, 1991, ELECTROEN CLIN NEURO, V79, P81, DOI 10.1016/0013-4694(91)90044-5; de Munck JC, 2008, NEUROIMAGE, V42, P112, DOI 10.1016/j.neuroimage.2008.04.244; DEBOER RW, 1985, MED BIOL ENG COMPUT, V23, P352, DOI 10.1007/BF02441589; DEBOER RW, 1985, MED BIOL ENG COMPUT, V23, P359, DOI 10.1007/BF02441590; DEECKE L, 1976, BIOL CYBERN, V23, P99, DOI 10.1007/BF00336013; Florian G, 1998, INT J PSYCHOPHYSIOL, V28, P273, DOI 10.1016/S0167-8760(97)00075-5; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Haggard P, 2005, TRENDS COGN SCI, V9, P290, DOI 10.1016/j.tics.2005.04.012; Hummel F, 2004, NEUROIMAGE, V23, P1391, DOI 10.1016/j.neuroimage.2004.07.070; Hummel F, 2002, BRAIN, V125, P404, DOI 10.1093/brain/awf030; Julien C, 2006, CARDIOVASC RES, V70, P12, DOI 10.1016/j.cardiores.2005.11.008; Lambertz M, 1998, J AUTONOM NERV SYST, V68, P58, DOI 10.1016/S0165-1838(97)00126-4; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Montano N, 1996, J AUTONOM NERV SYST, V57, P116, DOI 10.1016/0165-1838(95)00113-1; Monto S, 2008, J NEUROSCI, V28, P8268, DOI 10.1523/JNEUROSCI.1910-08.2008; Neuper C, 2001, INT J PSYCHOPHYSIOL, V43, P41, DOI 10.1016/S0167-8760(01)00178-7; Papakostopoulos D., 1990, J PSYCHOPHYSIOL, V4, P163; Perlitz V, 2004, PFLUG ARCH EUR J PHY, V448, P579, DOI 10.1007/s00424-004-1291-4; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pfurtscheller G, 2012, NEUROSCI LETT, V508, P89, DOI 10.1016/j.neulet.2011.12.025; Pfurtscheller G, 2011, IEEE T BIO-MED ENG, V58, P2064, DOI 10.1109/TBME.2011.2134851; Pfurtscheller K, 2008, NEUROSCI LETT, V437, P103, DOI 10.1016/j.neulet.2008.03.079; PIJN JP, 1991, ELECTROEN CLIN NEURO, V79, P371, DOI 10.1016/0013-4694(91)90202-F; Politis D. N., 1992, EXPLORING LIMITS BOO, V2635270; PREISS G, 1974, AM J PHYSIOL, V226, P724, DOI 10.1152/ajplegacy.1974.226.3.724; Roche-Labarbe N, 2007, NEUROIMAGE, V36, P718, DOI 10.1016/j.neuroimage.2007.04.002; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; Sasai S, 2011, NEUROIMAGE, V56, P252, DOI 10.1016/j.neuroimage.2010.12.075; Schomer L., 2011, NIEDERMEYERS ELECTRO; Seidel H, 1998, PHYSICA D, V115, P145, DOI 10.1016/S0167-2789(97)00229-7; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Stancak A, 1996, COGNITIVE BRAIN RES, V4, P171, DOI 10.1016/S0926-6410(96)00031-6; Steriade M, 1999, TRENDS NEUROSCI, V22, P337, DOI 10.1016/S0166-2236(99)01407-1; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Van Roon AM, 2004, PSYCHOPHYSIOLOGY, V41, P961, DOI 10.1111/j.1469-8986.2004.00251.x; Vanhatalo S, 2004, P NATL ACAD SCI USA, V101, P5053, DOI 10.1073/pnas.0305375101; Vanhatalo S., 2011, NIEDERMEYRS ELECTROE, P741; Vogel RM, 1996, WATER RESOUR RES, V32, P1875, DOI 10.1029/96WR00928; Wagner CD, 1998, CARDIOVASC RES, V40, P257, DOI 10.1016/S0008-6363(98)00251-X; Witte H, 2004, CLIN NEUROPHYSIOL, V115, P2308, DOI 10.1016/j.clinph.2004.05.014; Wolf M, 2002, NEUROIMAGE, V16, P704, DOI 10.1006/nimg.2002.1128; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233; Zheng F, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3483466	51	43	44	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43640	10.1371/journal.pone.0043640	http://dx.doi.org/10.1371/journal.pone.0043640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937070	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000308225500071
J	Reddi, D; Belibasakis, GN				Reddi, Durga; Belibasakis, Georgios N.			Transcriptional Profiling of Bone Marrow Stromal Cells in Response to Porphyromonas gingivalis Secreted Products	PLOS ONE			English	Article							NF-KAPPA-B; MONOCYTE CHEMOATTRACTANT PROTEIN-1; PERIODONTAL-LIGAMENT CELLS; HUMAN ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; MATRIX METALLOPROTEINASES; ANTIMICROBIAL PEPTIDES; SIGNALING PATHWAYS; RECEPTOR ACTIVATOR; CREVICULAR FLUID	Periodontitis is an infectious inflammatory disease that destroys the tooth-supporting (periodontal) tissues. Porphyromonas gingivalis is an oral pathogen highly implicated in the pathogenesis of this disease. It can exert its effects to a number of cells, including osteogenic bone marrow stromal cells which are important for homeostastic capacity of the tissues. By employing gene microarray technology, this study aimed to describe the overall transcriptional events (>2-fold regulation) elicited by P. gingivalis secreted products in bone marrow stromal cells, and to dissect further the categories of genes involved in bone metabolism, inflammatory and immune responses. After 6 h of challenge with P. gingivalis, 271 genes were up-regulated whereas 209 genes were down-regulated, whereas after 24 h, these numbers were 259 and 109, respectively. The early (6 h) response was characterised by regulation of genes associated with inhibition of cell cycle, induction of apoptosis and loss of structural integrity, whereas the late (24 h) response was characterised by induction of chemokines, cytokines and their associated intracellular pathways (such as NF-kappa B), mediators of connective tissue and bone destruction, and suppression of regulators of osteogenic differentiation. The most strongly up-regulated genes were lipocalin 2 (LCN2) and serum amyloid A3 (SAA3), both encoding for proteins of the acute phase inflammatory response. Collectively, these transcriptional changes elicited by P. gingivalis denote that the fundamental cellular functions are hindered, and that the cells acquire a phenotype commensurate with propagated innate immune response and inflammatory-mediated tissue destruction. In conclusion, the global transcriptional profile of bone marrow stromal cells in response to P. gingivalis is marked by deregulated homeostatic functions, with implications in the pathogenesis of periodontitis.	[Reddi, Durga; Belibasakis, Georgios N.] Queen Mary Univ London, Barts & London Inst Dent, Ctr Adult Oral Hlth, London, England; [Belibasakis, Georgios N.] Univ Zurich, Ctr Dent Med, Inst Oral Biol, Zurich, Switzerland	University of London; Queen Mary University London; University of Zurich	Reddi, D (corresponding author), Queen Mary Univ London, Barts & London Inst Dent, Ctr Adult Oral Hlth, London, England.	george.belibasakis@zzm.uzh.ch	Belibasakis, Georgios/AAL-3159-2020	Belibasakis, Georgios/0000-0002-8164-0653	Barts and the London Dental Institute; Research Advisory Board of Barts; London Charitable Foundation [453/592]; University of London Central Research Fund (AR/CRF/B)	Barts and the London Dental Institute; Research Advisory Board of Barts; London Charitable Foundation; University of London Central Research Fund (AR/CRF/B)	This study was supported by Barts and the London Dental Institute (Support for Oral Science Bursary), Research Advisory Board of Barts and the London Charitable Foundation (start-up grant 453/592) and University of London Central Research Fund (AR/CRF/B). Publication costs were covered by the Institute of Oral Biology, University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman H, 2006, J ANTIMICROB CHEMOTH, V58, P198, DOI 10.1093/jac/dkl181; Arabaci Taner, 2010, Eur J Dent, V4, P454; ARMITAGE GC, 1994, J PERIODONTOL, V65, P120, DOI 10.1902/jop.1994.65.2.120; Asai Y, 2001, INFECT IMMUN, V69, P7387, DOI 10.1128/IAI.69.12.7387-7395.2001; Bachrach G, 2008, ANTIMICROB AGENTS CH, V52, P638, DOI 10.1128/AAC.01271-07; Bals R, 2003, CELL MOL LIFE SCI, V60, P711, DOI 10.1007/s00018-003-2186-9; Belibasakis GN, 2007, MICROB PATHOGENESIS, V43, P46, DOI 10.1016/j.micpath.2007.03.001; Belibasakis GN, 2011, INFLAMMATION, V34, P133, DOI 10.1007/s10753-010-9216-1; Bishop KA, 2009, MOL ENDOCRINOL, V23, P2095, DOI 10.1210/me.2009-0209; Bostanci N, 2007, ORAL MICROBIOL IMMUN, V22, P52; Bostanci N, 2009, ORAL MICROBIOL IMMUN, V24, P146, DOI 10.1111/j.1399-302X.2008.00488.x; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; BRAMANTI TE, 1991, J BACTERIOL, V173, P7330, DOI 10.1128/jb.173.22.7330-7339.1991; Brozovic S, 2006, MICROBIOL-SGM, V152, P797, DOI 10.1099/mic.0.28472-0; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; Cengiz M Inanc, 2010, J Med Case Rep, V4, P200, DOI 10.1186/1752-1947-4-200; Chang YC, 2002, J ENDODONT, V28, P90, DOI 10.1097/00004770-200202000-00010; Choi BK, 2005, J PERIODONTOL, V76, P813, DOI 10.1902/jop.2005.76.5.813; Choi EK, 2005, FEMS IMMUNOL MED MIC, V44, P51, DOI 10.1016/j.femsim.2004.12.003; Dickinson DP, 2002, CRIT REV ORAL BIOL M, V13, P238, DOI 10.1177/154411130201300304; Ebersole JL, 1997, CLIN EXP IMMUNOL, V107, P347, DOI 10.1111/j.1365-2249.1997.270-ce1162.x; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Fujita Y, 2011, ODONTOLOGY, V1- 7; Gao JL, 2010, J BIOL CHEM, V285, P40028, DOI 10.1074/jbc.M110.163535; Garlet GP, 2003, J PERIODONTAL RES, V38, P210, DOI 10.1034/j.1600-0765.2003.02012.x; Glurich I, 2002, CLIN DIAGN LAB IMMUN, V9, P425, DOI 10.1128/CDLI.9.2.425-432.2002; Grenier D, 2003, INFECT IMMUN, V71, P4742, DOI 10.1128/IAI.71.8.4742-4748.2003; Grenier D, 2001, FEMS MICROBIOL LETT, V203, P161, DOI 10.1016/S0378-1097(01)00351-2; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Hajishengallis G, 2006, CELL MICROBIOL, V8, P1557, DOI 10.1111/j.1462-5822.2006.00730.x; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hajishengallis G, 2012, ADV EXP MED BIOL, V946, P69, DOI 10.1007/978-1-4614-0106-3_5; Hajishengallis G, 2009, MICROBES INFECT, V11, P637, DOI 10.1016/j.micinf.2009.03.009; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hernandez M, 2007, J CLIN PERIODONTOL, V34, P729, DOI 10.1111/j.1600-051X.2007.01107.x; Hernandez M, 2006, J PERIODONTOL, V77, P1863, DOI 10.1902/jop.2006.050461; Imatani T, 2004, EUR J MED RES, V9, P528; Inaba H, 2009, CELL MICROBIOL, V11, P1517, DOI 10.1111/j.1462-5822.2009.01344.x; Into T, 2006, CLIN EXP IMMUNOL, V145, P545, DOI 10.1111/j.1365-2249.2006.03156.x; Jiang YL, 1999, J PERIODONTOL, V70, P1472, DOI 10.1902/jop.1999.70.12.1472; JIN LJ, 1995, EUR J ORAL SCI, V103, P84, DOI 10.1111/j.1600-0722.1995.tb00121.x; Johnson RB, 1999, J PERIODONTOL, V70, P848, DOI 10.1902/jop.1999.70.8.848; Kang IC, 2002, FEMS IMMUNOL MED MIC, V34, P311; Katagiri T, 2002, ORAL DIS, V8, P147, DOI 10.1034/j.1601-0825.2002.01829.x; Kato T, 2008, ORAL MICROBIOL IMMUN, V23, P158, DOI 10.1111/j.1399-302X.2007.00405.x; Kawai T, 2006, AM J PATHOL, V169, P987, DOI 10.2353/ajpath.2006.060180; Khoury S, 2004, J AM DENT ASSOC, V135, P617, DOI 10.14219/jada.archive.2004.0250; KLUVEBECKERMAN B, 1991, DNA CELL BIOL, V10, P651, DOI 10.1089/dna.1991.10.651; Krasnodembskaya A, 2010, STEM CELLS, V28, P2229, DOI 10.1002/stem.544; Krauss JL, 2010, PERIODONTOL 2000, V52, P141, DOI 10.1111/j.1600-0757.2009.00324.x; Kretschmar S, 2012, J PERIODONTAL RES, V47, P228, DOI 10.1111/j.1600-0765.2011.01425.x; Lachmann HJ, 2007, NEW ENGL J MED, V356, P2361, DOI 10.1056/NEJMoa070265; Laflamme C, 2009, PORPHYROMONAS GINIGI, P141; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Laugisch O, 2012, MOL ORAL MICROBIOL, V27, P45, DOI 10.1111/j.2041-1014.2011.00631.x; Leto G, 2011, CLIN REV BONE MINER, V9, P107, DOI 10.1007/s12018-011-9100-z; Liang SA, 2011, J IMMUNOL, V186, P869, DOI 10.4049/jimmunol.1003252; Liu YCG, 2010, PERIODONTOL 2000, V52, P163, DOI 10.1111/j.1600-0757.2009.00321.x; Mao S, 2007, CELL MICROBIOL, V9, P1997, DOI 10.1111/j.1462-5822.2007.00931.x; Mori T, 2011, INT IMMUNOL, V23, P701, DOI 10.1093/intimm/dxr077; Nakata K, 2000, J ENDODONT, V26, P410, DOI 10.1097/00004770-200007000-00008; Nemoto E, 2006, J DENT RES, V85, P733, DOI 10.1177/154405910608500809; Ng PKS, 2010, J CELL BIOCHEM, V110, P438, DOI 10.1002/jcb.22556; Nociti FH, 2004, J DENT RES, V83, P602, DOI 10.1177/154405910408300804; Noguchi K, 2007, PERIODONTOL 2000, V43, P85, DOI 10.1111/j.1600-0757.2006.00170.x; O'Brien CA, 1999, J BIOL CHEM, V274, P19301, DOI 10.1074/jbc.274.27.19301; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Offenbacher S, 1996, Ann Periodontol, V1, P821, DOI 10.1902/annals.1996.1.1.821; Ohno T, 2008, ORAL MICROBIOL IMMUN, V23, P96, DOI 10.1111/j.1399-302X.2007.00393.x; Ohno T, 2006, MICROBES INFECT, V8, P1025, DOI 10.1016/j.micinf.2005.10.021; Okahashi N, 2004, INFECT IMMUN, V72, P1706, DOI 10.1128/IAI.72.3.1706-1714.2004; Olczak T, 2005, FEMS MICROBIOL REV, V29, P119, DOI 10.1016/j.femsre.2004.09.001; Ortega-Hernandez OD, 2009, SEMIN ARTHRITIS RHEU, V39, P38, DOI 10.1016/j.semarthrit.2008.03.006; Oyarzun A, 2010, ORAL DIS, V16, P388, DOI 10.1111/j.1601-0825.2009.01651.x; PALCANIS KG, 1992, J PERIODONTOL, V63, P237, DOI 10.1902/jop.1992.63.4.237; Pattamapun K, 2003, J PERIODONTAL RES, V38, P115, DOI 10.1034/j.1600-0765.2003.01650.x; Popadiak K, 2007, J IMMUNOL, V178, P7242, DOI 10.4049/jimmunol.178.11.7242; Potempa J, 2000, PERIODONTOL 2000, V24, P153, DOI 10.1034/j.1600-0757.2000.2240108.x; Pradeep AR, 2011, J PERIODONTOL, V82, P734, DOI 10.1902/jop.2010.100526; Prapulla DV, 2007, J PERIODONTOL, V78, P1783, DOI 10.1902/jop.2007.070009; Rai B, 2010, SAUDI DENT J, V22, P129, DOI 10.1016/j.sdentj.2010.04.006; Rai Balwant, 2008, J Oral Sci, V50, P53, DOI 10.2334/josnusd.50.53; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Reddi D, 2011, MICROB PATHOGENESIS, V51, P415, DOI 10.1016/j.micpath.2011.09.001; Reddi D, 2008, MICROBES INFECT, V10, P1459, DOI 10.1016/j.micinf.2008.08.007; Reife RA, 2006, CELL MICROBIOL, V8, P857, DOI 10.1111/j.1462-5822.2005.00672.x; Reigstad CS, 2010, GUT MICROBES, V1, P55, DOI 10.4161/gmic.1.1.10514; Roth GA, 2007, FEMS MICROBIOL LETT, V272, P106, DOI 10.1111/j.1574-6968.2007.00736.x; Sawada N, 2007, CLIN EXP IMMUNOL, V148, P529, DOI 10.1111/j.1365-2249.2007.03346.x; Silva N, 2008, J CLIN PERIODONTOL, V35, P206, DOI 10.1111/j.1600-051X.2007.01190.x; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Sroka A, 2001, J BACTERIOL, V183, P5609, DOI 10.1128/JB.183.19.5609-5616.2001; Stathopoulou PG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-107; STETLER G, 1986, NUCLEIC ACIDS RES, V14, P7883, DOI 10.1093/nar/14.20.7883; Sun ZW, 2002, SHOCK, V18, P99, DOI 10.1097/00024382-200208000-00001; Suthin K, 2003, J PERIODONTAL RES, V38, P90, DOI 10.1034/j.1600-0765.2003.01646.x; THIES RS, 1992, ENDOCRINOLOGY, V130, P1318, DOI 10.1210/en.130.3.1318; Tolosano E, 2002, BLOOD, V100, P4201, DOI 10.1182/blood-2002-04-1270; van Winkelhoff AJ, 2002, J CLIN PERIODONTOL, V29, P1023, DOI 10.1034/j.1600-051X.2002.291107.x; Walter C, 2004, INFECT IMMUN, V72, P5910, DOI 10.1128/IAI.72.10.5910-5918.2004; Wang M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000697; WINGROVE JA, 1992, J BIOL CHEM, V267, P18902; Wojaczynski J, 2011, BIOCHEM BIOPH RES CO, V411, P299, DOI 10.1016/j.bbrc.2011.06.129; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Xing QA, 2010, J CELL PHYSIOL, V225, P106, DOI 10.1002/jcp.22201; Yang HW, 2004, J PERIODONTOL, V75, P1077, DOI 10.1902/jop.2004.75.8.1077; Yanti, 2009, BIOL PHARM BULL, V32, P1770, DOI 10.1248/bpb.32.1770; Zamurovic N, 2004, J BIOL CHEM, V279, P37704, DOI 10.1074/jbc.M403813200; Zanotti S, 2009, J ENDOCRINOL, V201, P263, DOI 10.1677/JOE-08-0514; Zhang D, 2011, J PERIODONTAL RES, V46, P31, DOI 10.1111/j.1600-0765.2010.01305.x; Zhou J, 2006, J PERIODONTAL RES, V41, P47, DOI 10.1111/j.1600.0765.2005.00835.x; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005; Zhou QD, 2006, INFECT IMMUN, V74, P1204, DOI 10.1128/IAI.74.2.1204-1214.2006; Zhou QD, 2007, J IMMUNOL, V179, P7777, DOI 10.4049/jimmunol.179.11.7777	114	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43899	10.1371/journal.pone.0043899	http://dx.doi.org/10.1371/journal.pone.0043899			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937121	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000308225500121
J	Zhu, HL; Zhao, JF; Wang, RJ; Zhang, LX				Zhu, Huili; Zhao, Jinfeng; Wang, Rongjun; Zhang, Longxian			Molecular Identification of a Rare Subtype of Cryptosporidium hominis in Infants in China	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; CHILDREN; HUMANS; SPP.; RUMINANTS; DIARRHEA	Two Cryptosporidium isolates from separate infants suffering from diarrhea were obtained from a hospital in Zhengzhou, China and were genotyped by PCR amplification and sequence analysis of the small-subunit ribosomal RNA (rRNA) (SSU rRNA), 70-kDa heat shock protein (HSP70), and actin genes. Further subtyping was performed by PCR amplification and sequence analysis of the 60-kDa glycoprotein (gp60) gene. Both the isolates were identified as Cryptosporidium hominis subtype IdA21, a rare subtype previously found only in a human immunodeficiency virus-infected child in South Africa and another child in Jordan.	[Zhu, Huili; Zhao, Jinfeng; Wang, Rongjun; Zhang, Longxian] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China; [Zhu, Huili; Wang, Rongjun; Zhang, Longxian] Int Joint Res Lab Zoonot Dis Henan, Zhengzhou, Peoples R China	Henan Agricultural University	Zhu, HL (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China.	zhanglx8999@yahoo.com.cn	Zhang, Longxian/R-7799-2019; Zhang, Longxian/HGE-1918-2022; Zhang, Longxian/I-9223-2019	Zhang, Longxian/0000-0002-5706-131X	Key National Science and Technology Specific Projects [2012ZX10004220-001]; National Natural Science Foundation of China [31172311]; Program for Innovative Research Team (in Science and Technology) in University of Henan Province [012IRTSTHN005]	Key National Science and Technology Specific Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team (in Science and Technology) in University of Henan Province	This study was supported in part by funds for the Key National Science and Technology Specific Projects (no. 2012ZX10004220-001, http://www.nmp.gov.cn/zxjs/crb/201012/t20101208_2127.htm), the National Natural Science Foundation of China (no. 31172311, http://www.nsfc.gov.cn/Portal0/default152.htm), and the Program for Innovative Research Team (in Science and Technology) in University of Henan Province (012IRTSTHN005, http://est.haedu.gov.cn/Article/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves M, 2003, J CLIN MICROBIOL, V41, P2744, DOI 10.1128/JCM.41.6.2744-2747.2003; Alves M, 2006, PARASITOL RES, V99, P287, DOI 10.1007/s00436-006-0164-5; Cama VA, 2008, EMERG INFECT DIS, V14, P1567, DOI 10.3201/eid1410.071273; Chen XW, 2004, HUMAN PARASITOLOGY, P269; CHEN YG, 1992, J CLIN MICROBIOL, V30, P492, DOI 10.1128/JCM.30.2.492-494.1992; Das P, 2006, J CLIN MICROBIOL, V44, P4246, DOI 10.1128/JCM.00091-06; Feltus DC, 2006, J CLIN MICROBIOL, V44, P4303, DOI 10.1128/JCM.01067-06; Feng YY, 2012, EMERG INFECT DIS, V18, P312, DOI 10.3201/eid1802.110666; Hijjawi N, 2010, EXP PARASITOL, V125, P161, DOI 10.1016/j.exppara.2010.01.011; Leav BA, 2002, INFECT IMMUN, V70, P3881, DOI 10.1128/IAI.70.7.3881-3890.2002; Leoni F, 2006, J MED MICROBIOL, V55, P703, DOI 10.1099/jmm.0.46251-0; Morse TD, 2007, EPIDEMIOL INFECT, V135, P1307, DOI 10.1017/S0950268806007758; Peng MM, 2003, J EUKARYOT MICROBIOL, V50, P557, DOI 10.1111/j.1550-7408.2003.tb00628.x; Peng MM, 2001, J EUKARYOT MICROBIOL, p28S; Ren XP, 2012, EXP PARASITOL, V130, P274, DOI 10.1016/j.exppara.2011.07.012; Robinson G, 2008, EMERG INFECT DIS, V14, P1800, DOI 10.3201/eid1411.080239; Wang KX, 2002, WORLD J GASTROENTERO, V8, P371; Wang RJ, 2008, PARASITOL RES, V102, P915, DOI 10.1007/s00436-007-0851-x; Wang RJ, 2011, EXP PARASITOL, V127, P42, DOI 10.1016/j.exppara.2010.06.034; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P1578; Xiao LH, 2004, CLIN MICROBIOL REV, V17, P72, DOI 10.1128/CMR.17.1.72-97.2004; Xiao Lihua, 2007, P119; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018	23	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43682	10.1371/journal.pone.0043682	http://dx.doi.org/10.1371/journal.pone.0043682			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937078	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500080
J	Wen, J; Shi, YK; Li, YP; Yuan, P; Wang, F				Wen, Jin; Shi, Ying-kang; Li, You-ping; Yuan, Ping; Wang, Fang			Quality of Life, Physical Diseases, and Psychological Impairment among Survivors 3 Years after Wenchuan Earthquake: A Population Based Survey	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; PTSD CHECKLIST; FEMALE VETERANS; RISK-FACTORS; PREVALENCE; RELIABILITY; DEPRESSION; VALIDITY; SICHUAN	Background: Few research studies have addressed the long-term effects caused by catastrophes, and no study has ever explored the life quality, physical diseases, and psychological impairment of earthquake survivors at the same time. This study seeks to reveal survivors' quality of life, physical diseases, and mental health. Methods: A cross-sectional survey was conducted through multi-stage sampling approach three years after the Wenchuan earthquake. Results: A total of 2525 subjects were interviewed. Symptoms of PTSD were reported by 8.8% of the respondents from the seriously affected areas and 0.5%, the less hit areas. Prevalence of chronic diseases was 39.2% and 22.1% respectively, and two-week prevalence rate, 24.9% and 12.7% respectively. In the multivariate analysis, two-week prevalence, displacement, no regular income, receiving mental health support after the disaster, family members died or missing, injured due to the quake, and person who witnessed someone being killed or injured were independently associated with higher prevalence for symptoms of PTSD. Most subscales of SF-12 negatively correlated with age, chronic diseases, two-week prevalence, injured due to the disaster, home or property loss, and score of the 3-year PTSD symptoms, but positively correlated with higher education and higher household income. Conclusions: The rates of physical diseases and symptoms of PTSD were relatively high, and the quality of life was poor among victims in the hard-hit areas 3 years after the earthquake. Physical impairment correlated with symptom of PTSD, and both were negatively associated with quality of life.	[Wen, Jin; Shi, Ying-kang] Sichuan Univ, W China Hosp, Dept Hosp Management & Hlth Policy, Chengdu 610064, Peoples R China; [Li, You-ping] Sichuan Univ, W China Hosp, Chinese Evidence Based Med Ctr, Chengdu 610064, Peoples R China; [Li, You-ping] Sichuan Univ, W China Hosp, Dept Clin Epidemiol, Chengdu 610064, Peoples R China; [Yuan, Ping; Wang, Fang] Sichuan Univ, W China Sch Publ Hlth, Dept Epidemiol & Biostat, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University	Wen, J (corresponding author), Sichuan Univ, W China Hosp, Dept Hosp Management & Hlth Policy, Chengdu 610064, Peoples R China.	huaxiwenjin@163.com			National Natural Science Foundation of China [81072376, 71131006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China (Grant No. 81072376 and 71131006; and funder's website: http://www.nsfc.gov.cn/Portal0/default152.htm) financially supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bland SH, 1996, PSYCHOSOM MED, V58, P18, DOI 10.1097/00006842-199601000-00004; Chou FHC, 2004, AUST NZ J PSYCHIAT, V38, P358, DOI 10.1111/j.1440-1614.2004.01364.x; Dobie DJ, 2002, GEN HOSP PSYCHIAT, V24, P367, DOI 10.1016/S0163-8343(02)00207-4; Ehring T, 2011, PSYCHIAT RES, V185, P161, DOI 10.1016/j.psychres.2009.10.018; Fan F, 2011, J TRAUMA STRESS, V24, P44, DOI 10.1002/jts.20599; Jia ZB, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-172; Ke X, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-573; Kun P, 2009, PUBLIC HEALTH, V123, P703, DOI 10.1016/j.puhe.2009.09.017; Lang AJ, 2003, J TRAUMA STRESS, V16, P257, DOI 10.1023/A:1023796007788; Luo XM, 2003, SPINE, V28, P1739, DOI 10.1097/00007632-200308010-00020; Nunnally J., 1978, PSYCHOMETRIC THEORY; Peng K., 2010, CHINESE HLTH EC, V29, P33; Ren ZJ, 2011, PSYCHIATRY, V74, P87, DOI 10.1521/psyc.2011.74.1.87; Salcioglu E, 2007, DISASTERS, V31, P115, DOI 10.1111/j.1467-7717.2007.01000.x; Terhakopian A, 2008, J TRAUMA STRESS, V21, P290, DOI 10.1002/jts.20341; van Griensven F, 2006, JAMA-J AM MED ASSOC, V296, P537, DOI 10.1001/jama.296.5.537; Varela E, 2008, DISASTERS, V32, P280, DOI 10.1111/j.1467-7717.2008.01039.x; Wang XD, 2000, PSYCHIAT CLIN NEUROS, V54, P427, DOI 10.1046/j.1440-1819.2000.00732.x; [王相兰 WANG Xianglan], 2008, [中山大学学报. 医学科学版, Journal of Sun Yat-sen University. Medical Sciences], V29, P367; Ware J. E., 2005, SCORE VERSION 2 SF 1; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; [肖至兰 XIAO Zhilan], 2011, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V11, P483; Xu JP, 2011, COMPR PSYCHIAT, V52, P431, DOI 10.1016/j.comppsych.2010.08.002; Zhang Y, 2011, PLOS ONE, V6, P223; Zhang Z, 2011, PUBLIC HEALTH, V125, P293, DOI 10.1016/j.puhe.2010.12.008	27	62	65	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43081	10.1371/journal.pone.0043081	http://dx.doi.org/10.1371/journal.pone.0043081			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	992PA	22937014	gold, Green Published, Green Submitted			2022-12-25	WOS:000307789700021
J	Hu, ZX; Perumal, SK; Yue, HJ; Benkovic, SJ				Hu, Zhenxin; Perumal, Senthil K.; Yue, Hongjun; Benkovic, Stephen J.			The Human Lagging Strand DNA Polymerase delta Holoenzyme Is Distributive	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; REPLICATION FACTOR-C; ATP BINDING; EPSILON; MECHANISM; FORK; COMPLEX; PROCESSIVITY; ELONGATION; MOVEMENT	Polymerase delta is widely accepted as the lagging strand replicative DNA polymerase in eukaryotic cells. It forms a replication complex in the presence of replication factor C and proliferating cell nuclear antigen to perform efficient DNA synthesis in vivo. In this study, the human lagging strand holoenzyme was reconstituted in vitro. The rate of DNA synthesis of this holoenzyme, measured with a singly primed ssM13 DNA substrate, is 4.0 +/- 0.4 nucleotides. Results from adenosine 5'-(3-thiotriphosphate) tetralithium salt (ATP gamma S) inhibition experiments revealed the nonprocessive characteristic of the human DNA polymerase (Pol delta) holoenzyme (150 bp for one binding event), consistent with data from chase experiments with catalytically inactive mutant Pol delta(AA.) The ATPase activity of replication factor C was characterized and found to be stimulated similar to 10-fold in the presence of both proliferating cell nuclear antigen and DNA, but the activity was not shut down by Pol delta in accord with rapid association/dissociation of the holoenzyme to/from DNA. It is noted that high concentrations of ATP inhibit the holoenzyme DNA synthesis activity, most likely due to its inhibition of the clamp loading process.	[Benkovic, Stephen J.] Penn State Univ, Dept Chem, Wartik Lab 414, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Benkovic, SJ (corresponding author), Penn State Univ, Dept Chem, Wartik Lab 414, University Pk, PA 16802 USA.	sjb1@psu.edu		Hu, Zhenxin/0000-0003-4410-4189	National Institutes of Health [RO1 GM13307]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM013306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM13307 (to S. J. B.).	Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; Berdis AJ, 1997, BIOCHEMISTRY-US, V36, P2733, DOI 10.1021/bi962139l; Bermudez VP, 2011, J BIOL CHEM, V286, P28963, DOI 10.1074/jbc.M111.256289; BREWER BJ, 1980, P NATL ACAD SCI-BIOL, V77, P6739, DOI 10.1073/pnas.77.11.6739; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Chilkova O, 2007, NUCLEIC ACIDS RES, V35, P6588, DOI 10.1093/nar/gkm741; Conti C, 2007, MOL BIOL CELL, V18, P3059, DOI 10.1091/mbc.E06-08-0689; Courbet S, 2008, NATURE, V455, P557, DOI 10.1038/nature07233; Elvers I, 2011, NUCLEIC ACIDS RES, V39, P7049, DOI 10.1093/nar/gkr420; FANGMAN WL, 1991, ANNU REV CELL BIOL, V7, P375, DOI 10.1146/annurev.cb.07.110191.002111; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Gomes XV, 2001, J BIOL CHEM, V276, P34776, DOI 10.1074/jbc.M011743200; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Johansson E, 2010, TRENDS BIOCHEM SCI, V35, P339, DOI 10.1016/j.tibs.2010.01.004; Kadyrov FA, 2009, P NATL ACAD SCI USA, V106, P8495, DOI 10.1073/pnas.0903654106; Kao HI, 2003, CRIT REV BIOCHEM MOL, V38, P433, DOI 10.1080/10409230390259382; Langston LD, 2008, J BIOL CHEM, V283, P29522, DOI 10.1074/jbc.M804488200; Liu L, 2000, J BIOL CHEM, V275, P18739, DOI 10.1074/jbc.M001217200; MAGA G, 1995, BIOCHEMISTRY-US, V34, P891, DOI 10.1021/bi00003a023; Masuda Y, 2007, NUCLEIC ACIDS RES, V35, P6904, DOI 10.1093/nar/gkm822; Meng X, 2010, BIOCHEMISTRY-US, V49, P3545, DOI 10.1021/bi100042b; Pietroni P, 2008, J BIOL CHEM, V283, P28338, DOI 10.1074/jbc.M804371200; PODUST VN, 1995, BIOCHEMISTRY-US, V34, P5003, DOI 10.1021/bi00015a011; PODUST VN, 1992, NUCLEIC ACIDS RES, V20, P4159, DOI 10.1093/nar/20.16.4159; PODUST VN, 1993, NUCLEIC ACIDS RES, V21, P841, DOI 10.1093/nar/21.4.841; Poli J, 2012, EMBO J, V31, P883, DOI 10.1038/emboj.2011.470; Pomerantz RT, 2007, TRENDS MICROBIOL, V15, P156, DOI 10.1016/j.tim.2007.02.007; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; Sexton DJ, 1998, BIOCHEMISTRY-US, V37, P7749, DOI 10.1021/bi980088h; Smith DJ, 2012, NATURE, V483, P434, DOI 10.1038/nature10895; TURCHI JJ, 1994, P NATL ACAD SCI USA, V91, P9803, DOI 10.1073/pnas.91.21.9803; Yang JS, 2004, P NATL ACAD SCI USA, V101, P8289, DOI 10.1073/pnas.0402625101; Yao NY, 2006, J BIOL CHEM, V281, P17528, DOI 10.1074/jbc.M601273200; Zhuang ZH, 2008, P NATL ACAD SCI USA, V105, P5361, DOI 10.1073/pnas.0801310105	35	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38442	38448		10.1074/jbc.M112.404319	http://dx.doi.org/10.1074/jbc.M112.404319			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22942285	hybrid, Green Published			2022-12-25	WOS:000310982800004
J	Thakur, P; Dadsetan, S; Fomina, AF				Thakur, Pratima; Dadsetan, Sepehr; Fomina, Alla F.			Bidirectional Coupling between Ryanodine Receptors and Ca2+ Release-activated Ca2+ (CRAC) Channel Machinery Sustains Store-operated Ca2+ Entry in Human T Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN DENDRITIC CELLS; HUMAN B-LYMPHOCYTES; CYCLIC ADP-RIBOSE; PLASMA-MEMBRANE; SKELETAL-MUSCLE; MONOCLONAL-ANTIBODIES; INTRACELLULAR CALCIUM; MOLECULAR-BASIS; FEEDER CELLS; EXPRESSION	The expression and functional significance of ryanodine receptors (RyR) were investigated in resting and activated primary human T cells. RyR1, RyR2, and RyR3 transcripts were detected in human T cells. RyR1/2 transcript levels increased, whereas those of RyR3 decreased after T cell activation. RyR1/2 protein immunoreactivity was detected in activated but not in resting T cells. The RyR agonist caffeine evoked Ca2+ release from the intracellular store in activated T cells but not in resting T cells, indicating that RyR are functionally up-regulated in activated T cells compared with resting T cells. In the presence of store-operated Ca2+ entry (SOCE) via plasmalemmal Ca2+ release-activated Ca2+ (CRAC) channels, RyR blockers reduced the Ca2+ leak from the endoplasmic reticulum (ER) and the magnitude of SOCE, suggesting that a positive feedback relationship exists between RyR and CRAC channels. Overexpression of fluorescently tagged RyR2 and stromal interaction molecule 1 (STIM1), an ER Ca2+ sensor gating CRAC channels, in HEK293 cells revealed that RyR are co-localized with STIM1 in the puncta formed after store depletion. These data indicate that in primary human T cells, the RyR are coupled to CRAC channel machinery such that SOCE activates RyR via a Ca2+ induced Ca2+ release mechanism, which in turn reduces the Ca2+ concentration within the ER lumen in the vicinity of STIM1, thus facilitating SOCE by reducing store-dependent CRAC channel inactivation. Treatment with RyR blockers suppressed activated T cell expansion, demonstrating the functional importance of RyR in T cells.	[Thakur, Pratima; Dadsetan, Sepehr; Fomina, Alla F.] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Fomina, AF (corresponding author), Univ Calif Davis, Dept Physiol & Membrane Biol, 1 Shields Ave, Davis, CA 95616 USA.	affomina@ucdavis.edu						AIREY JA, 1993, BIOCHEMISTRY-US, V32, P5739, DOI 10.1021/bi00073a003; AIREY JA, 1990, J BIOL CHEM, V265, P14187; Berg I, 2000, J CELL BIOL, V150, P581, DOI 10.1083/jcb.150.3.581; Bergling S, 1998, CELL CALCIUM, V23, P251, DOI 10.1016/S0143-4160(98)90123-3; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bracci L, 2007, J CELL SCI, V120, P2232, DOI 10.1242/jcs.007203; Burdakov D, 2005, CELL CALCIUM, V38, P303, DOI 10.1016/j.ceca.2005.06.010; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Clark JH, 2010, J BIOL CHEM, V285, P13542, DOI 10.1074/jbc.M110.101485; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; Dadsetan S, 2008, J BIOL CHEM, V283, P12512, DOI 10.1074/jbc.M709330200; Dammermann W, 2005, J BIOL CHEM, V280, P21394, DOI 10.1074/jbc.M413085200; Dammermann W, 2009, P NATL ACAD SCI USA, V106, P10678, DOI 10.1073/pnas.0809997106; Datta S, 2009, TRENDS IMMUNOL, V30, P430, DOI 10.1016/j.it.2009.06.002; Dolganov GM, 2001, GENOME RES, V11, P1473, DOI 10.1101/gr.191301; Du GG, 1998, J BIOL CHEM, V273, P33259, DOI 10.1074/jbc.273.50.33259; Dustin ML, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002311; Fanger CM, 2000, J IMMUNOL, V164, P1153, DOI 10.4049/jimmunol.164.3.1153; Feske S, 2011, ANN NY ACAD SCI, V1238, P74, DOI 10.1111/j.1749-6632.2011.06240.x; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Fomina AF, 2000, J CELL BIOL, V150, P1435, DOI 10.1083/jcb.150.6.1435; Gasser A, 2006, J BIOL CHEM, V281, P2489, DOI 10.1074/jbc.M506525200; GEPPERT TD, 1988, J CLIN INVEST, V81, P1497, DOI 10.1172/JCI113481; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Guse AH, 1999, NATURE, V398, P70, DOI 10.1038/18024; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hosoi E, 2001, J IMMUNOL, V167, P4887, DOI 10.4049/jimmunol.167.9.4887; JENKINS MK, 1990, J IMMUNOL, V144, P16; Kalamasz D, 2004, J IMMUNOTHER, V27, P405, DOI 10.1097/00002371-200409000-00010; Karamitros D, 2011, CRIT REV IMMUNOL, V31, P209, DOI 10.1615/CritRevImmunol.v31.i3.30; Kruisbeek A. M., 2004, CURR PROTOC IMMUNOL; Krummel MF, 2010, J CLIN IMMUNOL, V30, P364, DOI 10.1007/s10875-010-9393-6; Kunerth S, 2004, J CELL SCI, V117, P2141, DOI 10.1242/jcs.01063; Langhorst MF, 2004, CELL SIGNAL, V16, P1283, DOI 10.1016/j.cellsig.2004.03.013; Levine BL, 1997, J IMMUNOL, V159, P5921; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Li P, 2001, J GEN PHYSIOL, V118, P33, DOI 10.1085/jgp.118.1.33; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Liu Z, 2010, J CELL SCI, V123, P1775, DOI 10.1242/jcs.064071; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Manjarres IM, 2010, CELL CALCIUM, V47, P412, DOI 10.1016/j.ceca.2010.03.001; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Metcalfe J C, 1980, Biochem Soc Symp, V45, P1; Nagaleekar VK, 2008, J IMMUNOL, V181, P8315, DOI 10.4049/jimmunol.181.12.8315; NEGULESCU PA, 1994, P NATL ACAD SCI USA, V91, P2873, DOI 10.1073/pnas.91.7.2873; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Nori A, 1996, CELL CALCIUM, V19, P375, DOI 10.1016/S0143-4160(96)90110-4; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Petersen OH, 2007, CELL CALCIUM, V42, P373, DOI 10.1016/j.ceca.2007.05.012; RAO A, 1994, IMMUNOL TODAY, V15, P274, DOI 10.1016/0167-5699(94)90007-8; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwarzmann N, 2002, J BIOL CHEM, V277, P50636, DOI 10.1074/jbc.M209061200; Sei Y, 1999, J BIOL CHEM, V274, P5995, DOI 10.1074/jbc.274.9.5995; Sei Y, 2001, CELL CALCIUM, V29, P149, DOI 10.1054/ceca.2000.0175; Smyth JT, 2008, J CELL SCI, V121, P762, DOI 10.1242/jcs.023903; SunderPlassmann R, 1996, BLOOD, V87, P5179, DOI 10.1182/blood.V87.12.5179.bloodjournal87125179; Swain SL, 1999, CURR OPIN IMMUNOL, V11, P180, DOI 10.1016/S0952-7915(99)80030-2; Sweeney ZK, 2009, CHEMMEDCHEM, V4, P707, DOI 10.1002/cmdc.200800452; Alonso MT, 2012, MOL CELL ENDOCRINOL, V353, P37, DOI 10.1016/j.mce.2011.08.021; Uemura Y, 2007, BIOCHEM BIOPH RES CO, V362, P510, DOI 10.1016/j.bbrc.2007.08.024; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Vukcevic M, 2008, J BIOL CHEM, V283, P34913, DOI 10.1074/jbc.M804472200; Wang RW, 2007, J BIOL CHEM, V282, P17785, DOI 10.1074/jbc.M700660200; Wenning AS, 2011, BBA-MOL CELL RES, V1813, P412, DOI 10.1016/j.bbamcr.2010.12.022; Wu MM, 2007, CELL CALCIUM, V42, P163, DOI 10.1016/j.ceca.2007.03.003; Wulff H, 2003, CURR OPIN DRUG DI DE, V6, P640; Zalk R, 2007, ANNU REV BIOCHEM, V76, P367, DOI 10.1146/annurev.biochem.76.053105.094237; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813; Zucchi R, 1997, PHARMACOL REV, V49, P1; ZWEIFACH A, 1995, J BIOL CHEM, V270, P14445, DOI 10.1074/jbc.270.24.14445	77	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37233	37244		10.1074/jbc.M112.398974	http://dx.doi.org/10.1074/jbc.M112.398974			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22948152	Green Published, hybrid			2022-12-25	WOS:000310588500056
J	Maki, BA; Aman, TK; Amico-Ruvio, SA; Kussius, CL; Popescu, GK				Maki, Bruce A.; Aman, Teresa K.; Amico-Ruvio, Stacy A.; Kussius, Cassandra L.; Popescu, Gabriela K.			C-terminal Domains of N-Methyl-D-aspartic Acid Receptor Modulate Unitary Channel Conductance and Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROMERIC NMDA RECEPTORS; PROTEIN-KINASE-A; SYNAPTIC-TRANSMISSION; ALPHA-ACTININ; TIME COURSE; RAT-BRAIN; SUBUNIT; ZINC; CALMODULIN; GLUTAMATE	NMDA receptors (NRs) are glutamate-gated calcium-permeable channels that are essential for normal synaptic transmssion and contribute to neurodegeneration. Tetrameric proteins consist of two obligatory GluN1 (N1) and two GluN2 (N2) subunits, of which GluN2A (2A) and GluN2B (2B) are prevalent in adult brain. The intracellularly located C-terminal domains (CTDs) make a significant portion of mass of the receptors and are essential for plasticity and excitotoxicity, but their functions are incompletely defined. Recent evidence shows that truncation of the N2 CTD alters channel kinetics; however, the mechanism by which this occurs is unclear. Here we recorded activity from individual NRs lacking the CTDs of N1, 2A, or 2B and determined the gating mechanisms of these receptors. Receptors lacking the N1 CTDs had larger unitary conductance and faster deactivation kinetics, receptors lacking the 2A or 2B CTDs had longer openings and longer desensitized intervals, and the first 100 amino acids of the N2 CTD were essential for these changes. In addition, receptors lacking the CTDs of either 2A or 2B maintained isoform-specific kinetic differences and swapping CTDs between 2A and 2B had no effect on single-channel properties. Based on these results, we suggest that perturbations in the CTD can modify the NR-mediated signal in a subunit-dependent manner, in 2A these effects are most likely mediated by membrane-proximal residues, and the isoform-specific biophysical properties conferred by 2A and 2B are CTD-independent. The kinetic mechanisms we developed afford a quantitative approach to understanding how the intracellular domains of NR subunits can modulate the responses of the receptor.	[Aman, Teresa K.; Amico-Ruvio, Stacy A.; Kussius, Cassandra L.; Popescu, Gabriela K.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA; [Maki, Bruce A.; Popescu, Gabriela K.] SUNY Buffalo, Neurosci Program, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Popescu, GK (corresponding author), SUNY Buffalo, Dept Biochem, 636 Biomed Res Bldg,3435 Main St, Buffalo, NY 14214 USA.	popescu@buffalo.edu	popescu, gabriela k/AAB-6155-2022	popescu, gabriela k/0000-0003-4658-2002; Maki, Bruce/0000-0002-6760-375X	National Institutes of Health through the NINDS [052669]; SUNY REACH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052669] Funding Source: NIH RePORTER	National Institutes of Health through the NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); SUNY REACH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 052669 through the NINDS. This work was also supported by SUNY REACH.	Amico-Ruvio SA, 2011, BIOPHYS J, V100, P1910, DOI 10.1016/j.bpj.2011.02.042; Amico-Ruvio SA, 2010, BIOPHYS J, V98, P1160, DOI 10.1016/j.bpj.2009.12.4276; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; Banke TG, 2005, J NEUROSCI, V25, P42, DOI 10.1523/JNEUROSCI.3154-04.2005; Banke TG, 2003, NAT NEUROSCI, V6, P144, DOI 10.1038/nn1000; BEHE P, 1995, P ROY SOC B-BIOL SCI, V262, P205, DOI 10.1098/rspb.1995.0197; Borschel WF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1512; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; Choi UB, 2011, J BIOL CHEM, V286, P29904, DOI 10.1074/jbc.M111.258897; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; COLLINGRIDGE G, 1987, NATURE, V330, P604, DOI 10.1038/330604a0; Dravid SM, 2008, J PHYSIOL-LONDON, V586, P4425, DOI 10.1113/jphysiol.2008.158634; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; FORSYTHE ID, 1988, J NEUROSCI, V8, P3733; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Groschner K, 1996, BIOCHEM J, V318, P513, DOI 10.1042/bj3180513; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; HOLLMANN M, 1993, NEURON, V10, P943, DOI 10.1016/0896-6273(93)90209-A; ISHII T, 1993, J BIOL CHEM, V268, P2836; Kohr G, 2003, J NEUROSCI, V23, P10791; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Krupp JJ, 2002, NEUROPHARMACOLOGY, V42, P593, DOI 10.1016/S0028-3908(02)00031-X; Kussius CL, 2009, NAT NEUROSCI, V12, P1114, DOI 10.1038/nn.2361; Kussius CL, 2009, J NEUROSCI, V29, P6819, DOI 10.1523/JNEUROSCI.0281-09.2009; Laube B, 1998, J NEUROSCI, V18, P2954; LAURIE DJ, 1994, J NEUROSCI, V14, P3180; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; Lin Y, 2004, J NEUROSCI, V24, P10138, DOI 10.1523/JNEUROSCI.3159-04.2004; MAGLEBY KL, 1983, J PHYSIOL-LONDON, V344, P605, DOI 10.1113/jphysiol.1983.sp014958; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Mohrmann R, 2002, J NEUROSCI RES, V68, P265, DOI 10.1002/jnr.10219; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Mullner C, 2003, BIOPHYS J, V84, P1399, DOI 10.1016/S0006-3495(03)74954-6; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Paoletti P, 1997, J NEUROSCI, V17, P5711; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; Popescu G, 2004, NATURE, V430, P790, DOI 10.1038/nature02775; Popescu G, 2003, NAT NEUROSCI, V6, P476, DOI 10.1038/nn1044; Popescu GK, 2012, J PHYSIOL-LONDON, V590, P73, DOI 10.1113/jphysiol.2011.223750; Punnakkal P, 2012, NEUROPHARMACOLOGY, V62, P1985, DOI 10.1016/j.neuropharm.2011.12.018; Qin F, 2000, BIOPHYS J, V79, P1915, DOI 10.1016/S0006-3495(00)76441-1; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Retchless BS, 2012, NAT NEUROSCI, V15, P406, DOI 10.1038/nn.3025; Rossi P, 2002, J NEUROSCI, V22, P9687; Ryan TJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-6; Rycroft BK, 2004, J PHYSIOL-LONDON, V557, P795, DOI 10.1113/jphysiol.2003.059212; Rycroft BK, 2002, J NEUROSCI, V22, P8860; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Singer-Lahat D, 1999, PFLUG ARCH EUR J PHY, V439, P18, DOI 10.1007/s004240051123; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Zhang S, 1998, NEURON, V21, P443, DOI 10.1016/S0896-6273(00)80553-X	65	36	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36071	36080		10.1074/jbc.M112.390013	http://dx.doi.org/10.1074/jbc.M112.390013			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948148	Green Published, hybrid			2022-12-25	WOS:000310364000029
J	Chueh, TH; Lu, HHS				Chueh, Tung-Hung; Lu, Henry Horng-Shing			Inference of Biological Pathway from Gene Expression Profiles by Time Delay Boolean Networks	PLOS ONE			English	Article							REGULATORY NETWORKS; BAYESIAN NETWORKS; LARGE-SCALE; COEXPRESSION; IDENTIFICATION; KNOWLEDGE; MODELS	One great challenge of genomic research is to efficiently and accurately identify complex gene regulatory networks. The development of high-throughput technologies provides numerous experimental data such as DNA sequences, protein sequence, and RNA expression profiles makes it possible to study interactions and regulations among genes or other substance in an organism. However, it is crucial to make inference of genetic regulatory networks from gene expression profiles and protein interaction data for systems biology. This study will develop a new approach to reconstruct time delay Boolean networks as a tool for exploring biological pathways. In the inference strategy, we will compare all pairs of input genes in those basic relationships by their corresponding p-scores for every output gene. Then, we will combine those consistent relationships to reveal the most probable relationship and reconstruct the genetic network. Specifically, we will prove that O(log n) state transition pairs are sufficient and necessary to reconstruct the time delay Boolean network of n nodes with high accuracy if the number of input genes to each gene is bounded. We also have implemented this method on simulated and empirical yeast gene expression data sets. The test results show that this proposed method is extensible for realistic networks.	[Chueh, Tung-Hung] Ind Technol Res Inst, Green Energy & Environm Res Labs, Hsinchu, Taiwan; [Lu, Henry Horng-Shing] Natl Chiao Tung Univ, Inst Stat, Hsinchu, Taiwan	Industrial Technology Research Institute - Taiwan; National Yang Ming Chiao Tung University	Chueh, TH (corresponding author), Ind Technol Res Inst, Green Energy & Environm Res Labs, Hsinchu, Taiwan.	hslu@stat.nctu.edu.tw			National Science Council; National Center for Theoretical Sciences; Shing-Tung Yau Center; Center of Mathematical Modeling and Scientic Computing at the National Chiao Tung University in Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Center for Theoretical Sciences; Shing-Tung Yau Center; Center of Mathematical Modeling and Scientic Computing at the National Chiao Tung University in Taiwan	The authors acknowledge support from the National Science Council, National Center for Theoretical Sciences, Shing-Tung Yau Center, and Center of Mathematical Modeling and Scientic Computing at the National Chiao Tung University in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu T, 1999, Pac Symp Biocomput, P17; Akutsu T, 2003, THEOR COMPUT SCI, V298, P235, DOI 10.1016/S0304-3975(02)00425-5; Akutsu T., 1998, P 9 ANN ACM SIAM S D, P695; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Balakrishnan S, 2006, BAYESIAN ANAL, V1, P345, DOI 10.1214/06-BA112; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; Bosl WJ, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-13; Dealy S, 2005, COMPLEXITY, V11, P52, DOI 10.1002/cplx.20100; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Friedman N, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P206; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Huang S, 1999, J MOL MED-JMM, V77, P469, DOI 10.1007/s001099900023; Ideker T. E., 2000, PAC S BIOC, V5, P302; Imoto Seiya, 2004, J Bioinform Comput Biol, V2, P77, DOI 10.1142/S021972000400048X; Jensen FV, 2007, BAYESIAN NETWORKS DE; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kim H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-37; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Li LM, 2005, J COMPUT BIOL, V12, P170, DOI 10.1089/cmb.2005.12.170; Liu TF, 2006, INT J ARTIF INTELL T, V15, P353, DOI 10.1142/S0218213006002710; Moler EJ, 2000, PHYSIOL GENOMICS, V4, P127, DOI 10.1152/physiolgenomics.2000.4.2.127; Needham CJ, 2007, PLOS COMPUT BIOL, V3, P1409, DOI 10.1371/journal.pcbi.0030129; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Pearl J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Rawool SB, 2007, BIOSYSTEMS, V90, P636, DOI 10.1016/j.biosystems.2007.02.003; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; Sahoo D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r157; Scharfe C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000374; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Shmulevich I, 2003, COMP FUNCT GENOM, V4, P601, DOI 10.1002/cfg.342; Socolar JES, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.068702; Somogyi R, 1996, COMPLEXITY, V1, P45, DOI DOI 10.1002/CPLX.6130010612; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tzeng J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-179; Veliz-Cuba A, 2011, J COMPUT BIOL, V18, P783, DOI 10.1089/cmb.2011.0031; Wang HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020074; Zhang R, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.045202	41	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e42095	10.1371/journal.pone.0042095	http://dx.doi.org/10.1371/journal.pone.0042095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952589	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300005
J	Provost, V; Langlois, A; Chouinard, F; Rola-Pleszczynski, M; Chakir, J; Flamand, N; Laviolette, M				Provost, Veronique; Langlois, Anick; Chouinard, Francois; Rola-Pleszczynski, Marek; Chakir, Jamila; Flamand, Nicolas; Laviolette, Michel			Leukotriene D-4 and Interleukin-13 Cooperate to Increase the Release of Eotaxin-3 by Airway Epithelial Cells	PLOS ONE			English	Article							GENE-EXPRESSION; UP-REGULATION; FUNCTIONAL-CHARACTERIZATION; EOSINOPHIL TRANSMIGRATION; CYSTEINYL LEUKOTRIENES; ALLERGEN CHALLENGE; MESSENGER-RNA; HUMAN LUNG; TGF-BETA; KAPPA-B	Introduction: Airway epithelial cells play a central role in the physiopathology of asthma. They release eotaxins when treated with T(H)2 cytokines such as interleukin (IL)-4 or IL-13, and these chemokines attract eosinophils and potentiate the biosynthesis of cysteinyl leukotrienes (cysLTs), which in turn induce bronchoconstriction and mucus secretion. These effects of cysLTs mainly mediated by CysLT(1) and CysLT(2) receptors on epithelial cell functions remain largely undefined. Because the release of inflammatory cytokines, eotaxins, and cysLTs occur relatively at the same time and location in the lung tissue, we hypothesized that they regulate inflammation cooperatively rather than redundantly. We therefore investigated whether cysLTs and the T(H)2 cytokines would act in concert to augment the release of eotaxins by airway epithelial cells. Methods: A549 cells or human primary bronchial epithelial cells were incubated with or without IL-4, IL-13, and/or LTD4. The release of eotaxin-3 and the expression of cysLT receptors were assessed by ELISA, RT-PCR, and flow cytometry, respectively. Results: IL-4 and IL-13 induced the release of eotaxin-3 by airway epithelial cells. LTD4 weakly induced the release of eotaxin-3 but clearly potentiated the IL-13-induced eotaxin-3 release. LTD4 had no effect on IL-4-stimulated cells. Epithelial cells expressed CysLT(1) but not CysLT(2). CysLT(1) expression was increased by IL-13 but not by IL-4 and/or LTD4. Importantly, the upregulation of CysLT(1) by IL-13 preceded eotaxin-3 release. Conclusions: These results demonstrate a stepwise cooperation between IL-13 and LTD4. IL-13 upregulates CysLT(1) expression and consequently the response to cysLTs This results in an increased release of eotaxin-3 by epithelial cells which at its turn increases the recruitment of leukocytes and their biosynthesis of cysLTs. This positive amplification loop involving epithelial cells and leukocytes could be implicated in the recruitment of eosinophils observed in asthmatics.	[Provost, Veronique; Langlois, Anick; Chouinard, Francois; Chakir, Jamila; Flamand, Nicolas; Laviolette, Michel] Univ Laval, Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Rola-Pleszczynski, Marek] Univ Sherbrooke, Fac Med, Immunol Unit, Sherbrooke, PQ, Canada	Laval University; University of Sherbrooke	Provost, V (corresponding author), Univ Laval, Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.	Nicolas.Flamand@criucpq.ulaval.ca; Michel.Laviolette@med.ulaval.ca	Flamand, Nicolas/H-5823-2019	Flamand, Nicolas/0000-0001-5944-7200	Canadian Institutes of Health Research (CIHR); Respiratory Health Network of the Fonds de la recherche en sante du Quebec (FRSQ); CIHR; FRSQ	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Respiratory Health Network of the Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); CIHR(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant to ML from the Canadian Institutes of Health Research (CIHR), a doctoral studentships to VP from the Respiratory Health Network of the Fonds de la recherche en sante du Quebec (FRSQ) and to FC from the CIHR and a Scholarship to NF from the FRSQ. CIHR and FRSQ had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abonyo BO, 2006, CYTOKINE, V36, P237, DOI 10.1016/j.cyto.2007.01.001; Akaiwa M, 2001, CYTOKINE, V13, P75, DOI 10.1006/cyto.2000.0814; Asakura T, 2004, J ALLERGY CLIN IMMUN, V114, P310, DOI 10.1016/j.jaci.2004.04.037; Bandeira-Melo C, 2001, AM J RESP CELL MOL, V24, P653, DOI 10.1165/ajrcmb.24.6.f209; Banwell ME, 2002, CYTOKINE, V17, P317, DOI 10.1006/cyto.2002.1021; Berkman N, 2001, AM J RESP CELL MOL, V24, P682, DOI 10.1165/ajrcmb.24.6.4301; Blanchard C, 2005, INT J BIOCHEM CELL B, V37, P2559, DOI 10.1016/j.biocel.2005.06.010; Bosse Y, 2008, CLIN EXP ALLERGY, V38, P113, DOI 10.1111/j.1365-2222.2007.02873.x; Bosse Y, 2008, INT ARCH ALLERGY IMM, V146, P138, DOI 10.1159/000113517; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Chakir J, 2001, J ALLERGY CLIN IMMUN, V107, P36, DOI 10.1067/mai.2001.111929; Chatila TA, 2004, TRENDS MOL MED, V10, P493, DOI 10.1016/j.molmed.2004.08.004; Chibana K, 2003, J IMMUNOL, V170, P4290, DOI 10.4049/jimmunol.170.8.4290; Chouinard F, 2011, J IMMUNOL, V186, P3188, DOI 10.4049/jimmunol.1002853; DAHLEN SE, 1980, NATURE, V288, P484, DOI 10.1038/288484a0; Early SB, 2007, AM J RESP CELL MOL, V36, P715, DOI 10.1165/rcmb.2006-0252OC; Espinosa K, 2003, J ALLERGY CLIN IMMUN, V111, P1032, DOI 10.1067/mai.2003.1451; Ferland C, 2001, J LEUKOCYTE BIOL, V69, P772; Figueroa DJ, 2001, AM J RESP CRIT CARE, V163, P226, DOI 10.1164/ajrccm.163.1.2003101; Flamand N, 2007, CELL MOL LIFE SCI, V64, P2657, DOI 10.1007/s00018-007-7228-2; Guilbert M, 1999, AM J RESP CELL MOL, V21, P97, DOI 10.1165/ajrcmb.21.1.3517; Hebenstreit D, 2005, MOL IMMUNOL, V42, P295, DOI 10.1016/j.molimm.2004.09.004; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Hoeck J, 2001, J IMMUNOL, V167, P3216, DOI 10.4049/jimmunol.167.6.3216; Kagami S, 2005, CLIN EXP IMMUNOL, V141, P459, DOI 10.1111/j.1365-2249.2005.02875.x; Kawano T, 2003, J ALLERGY CLIN IMMUN, V112, P369, DOI 10.1067/mai.2003.1636; Komiya A, 2003, CELL IMMUNOL, V225, P91, DOI 10.1016/j.cellimm.2003.10.001; Langlois A, 2006, J ALLERGY CLIN IMMUN, V118, P113, DOI 10.1016/j.jaci.2006.03.010; Lee KS, 2007, J ALLERGY CLIN IMMUN, V119, P141, DOI 10.1016/j.jaci.2006.09.001; Lordan JL, 2002, J IMMUNOL, V169, P407, DOI 10.4049/jimmunol.169.1.407; Lynch KR, 1999, NATURE, V399, P789; Matsukura S, 2001, AM J RESP CELL MOL, V24, P755, DOI 10.1165/ajrcmb.24.6.4351; Matsukura S, 1999, J IMMUNOL, V163, P6876; Mattoli S, 1997, BIOCHEM BIOPH RES CO, V236, P299, DOI 10.1006/bbrc.1997.6958; Mellor EA, 2002, J EXP MED, V195, P583, DOI 10.1084/jem.20020044; Menard G, 2000, AM J RESP CELL MOL, V23, P572, DOI 10.1165/ajrcmb.23.4.4152; Milano S, 1996, PARASITOLOGY, V112, P13, DOI 10.1017/S0031182000065033; Mita H, 2001, CLIN EXP ALLERGY, V31, P1714, DOI 10.1046/j.1365-2222.2001.01184.x; Nicosia S, 2001, PULM PHARMACOL THER, V14, P3, DOI 10.1006/pupt.2000.0262; Oh CK, 2010, EUR RESPIR REV, V19, P46, DOI 10.1183/09059180.00007609; Pease James E., 2001, Current Opinion in Pharmacology, V1, P248, DOI 10.1016/S1471-4892(01)00044-3; Perng DW, 2006, AM J RESP CELL MOL, V34, P101, DOI 10.1165/rcmb.2005-0068OC; Ravensberg AJ, 2005, J ALLERGY CLIN IMMUN, V115, P779, DOI 10.1016/j.jaci.2004.11.045; Rola-Pleszczynski M, 2007, THESCIENTIFICWORLDJO, V7, P1348, DOI 10.1100/tsw.2007.183; Saito M, 2005, INT J CANCER, V116, P1, DOI 10.1002/ijc.20995; Serezani CH, 2011, J CLIN INVEST, V121, P671, DOI 10.1172/JCI43302; STANKOVA J, 1993, J IMMUNOL, V150, P4041; Suzuki S, 2008, PHARMACOLOGY, V81, P221, DOI 10.1159/000112866; Wong GW, 2002, J BIOL CHEM, V277, P41906, DOI 10.1074/jbc.M205868200; Woszczek G, 2005, J IMMUNOL, V175, P5152, DOI 10.4049/jimmunol.175.8.5152; YAMAOKA KA, 1993, EUR J IMMUNOL, V23, P2392, DOI 10.1002/eji.1830231003; Yasunaga S, 2003, CYTOKINE, V24, P293, DOI 10.1016/j.cyto.2003.08.006; Ying S, 1997, EUR J IMMUNOL, V27, P3507, DOI 10.1002/eji.1830271252; Zhou L, 2012, BIOORGAN MED CHEM, V20, P750, DOI 10.1016/j.bmc.2011.12.006; Zhu L, 2005, AM J RESP CELL MOL, V33, P531, DOI 10.1165/rcmb.2005-0124OC	55	17	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43544	10.1371/journal.pone.0043544	http://dx.doi.org/10.1371/journal.pone.0043544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952702	gold, Green Published, Green Submitted			2022-12-25	WOS:000308221300018
J	Bojunga, J; Dauth, N; Berner, C; Meyer, G; Holzer, K; Voelkl, L; Herrmann, E; Schroeter, H; Zeuzem, S; Friedrich-Rust, M				Bojunga, Joerg; Dauth, Nina; Berner, Christian; Meyer, Gesine; Holzer, Katharina; Voelkl, Lisa; Herrmann, Eva; Schroeter, Hartmut; Zeuzem, Stefan; Friedrich-Rust, Mireen			Acoustic Radiation Force Impulse Imaging for Differentiation of Thyroid Nodules	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; IN-VIVO; ELASTOGRAPHY; DIAGNOSIS; BENIGN; ELASTICITY; US; PERFORMANCE; MALIGNANCY; MANAGEMENT	Background: Acoustic Radiation Force Impulse (ARFI)-Imaging is an ultrasound-based elastography method enabling quantitative measurement of tissue stiffness. The aim of the present study was to evaluate sensitivity and specificity of ARFI-imaging for differentiation of thyroid nodules and to compare it to the well evaluated qualitative real-time elastography (RTE). Methods: ARFI-imaging involves the mechanical excitation of tissue using acoustic pulses to generate localized displacements resulting in shear-wave propagation which is tracked using correlation-based methods and recorded in m/s. Inclusion criteria were: nodules >= 5 mm, and cytological/histological assessment. All patients received conventional ultrasound, real-time elastography (RTE) and ARFI-imaging. Results: One-hundred-fifty-eight nodules in 138 patients were available for analysis. One-hundred-thirty-seven nodules were benign on cytology/histology, and twenty-one nodules were malignant. The median velocity of ARFI-imaging in the healthy thyroid tissue, as well as in benign and malignant thyroid nodules was 1.76 m/s, 1.90 m/s, and 2.69 m/s, respectively. While no significant difference in median velocity was found between healthy thyroid tissue and benign thyroid nodules, a significant difference was found between malignant thyroid nodules on the one hand and healthy thyroid tissue (p = 0.0019) or benign thyroid nodules (p = 0.0039) on the other hand. No significant difference of diagnostic accuracy for the diagnosis of malignant thyroid nodules was found between RTE and ARFI-imaging (0.74 vs. 0.69, p = 0.54). The combination of RTE with ARFI did not improve diagnostic accuracy. Conclusions: ARFI can be used as an additional tool in the diagnostic work up of thyroid nodules with high negative predictive value and comparable results to RTE.	[Bojunga, Joerg; Dauth, Nina; Berner, Christian; Meyer, Gesine; Zeuzem, Stefan; Friedrich-Rust, Mireen] JW Goethe Univ Hosp, Dept Internal Med 1, Frankfurt, Germany; [Holzer, Katharina] JW Goethe Univ Hosp, Dept Gen & Visceral Surg, Frankfurt, Germany; [Voelkl, Lisa] JW Goethe Univ Hosp, Inst Pathol, Frankfurt, Germany; [Herrmann, Eva] Goethe Univ Frankfurt, Fac Med, Inst Biostat & Math Modelling, Frankfurt, Germany; [Schroeter, Hartmut] Praxis Klin Diagnost PKD Staedel, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt	Bojunga, J (corresponding author), JW Goethe Univ Hosp, Dept Internal Med 1, Frankfurt, Germany.	Mireen.Friedrich-Rust@kgu.de	Zeuzem, Stefan/AAE-7435-2019; Meyer, Gesine/ABD-7219-2021		Siemens	Siemens(Siemens AG)	MFR received lecture fees from Siemens. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. All other authors have declared that no competing interests exist.	Arda K, 2011, AM J ROENTGENOL, V197, P532, DOI 10.2214/AJR.10.5449; Asteria C, 2008, THYROID, V18, P523, DOI 10.1089/thy.2007.0323; Bojunga J, 2010, THYROID, V20, P1145, DOI 10.1089/thy.2010.0079; Dietlein M, 2003, EUR J ENDOCRINOL, V148, P377, DOI 10.1530/eje.0.1480377; Ding JR, 2011, J ULTRAS MED, V30, P1259, DOI 10.7863/jum.2011.30.9.1259; Frey H, 2003, RADIOLOGE, V43, P850, DOI 10.1007/s00117-003-0943-2; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Friedrich-Rust M, 2012, ULTRASONICS, V52, P69, DOI 10.1016/j.ultras.2011.06.012; Gharib H, 2010, J ENDOCRINOL INVEST, V33, P1, DOI 10.4158/10024.GL; Goertz RS, 2011, EUR J RADIOL, V80, pE226, DOI 10.1016/j.ejrad.2010.09.025; Hegedus L, 2004, NEW ENGL J MED, V351, P1764, DOI 10.1056/NEJMcp031436; Iannuccilli JD, 2004, J ULTRAS MED, V23, P1455, DOI 10.7863/jum.2004.23.11.1455; Ivanac G, 2007, ULTRASCHALL MED, V28, P502, DOI 10.1055/s-2007-963023; KASAI C, 1985, IEEE T SON ULTRASON, V32, P458, DOI 10.1109/T-SU.1985.31615; LAROSA GL, 1991, CANCER, V67, P2137, DOI 10.1002/1097-0142(19910415)67:8<2137::AID-CNCR2820670822>3.0.CO;2-Y; Lippolis PV, 2011, J CLIN ENDOCR METAB, V96, pE1826, DOI 10.1210/jc.2011-1021; Moon HJ, 2012, RADIOLOGY, V262, P1002, DOI 10.1148/radiol.11110839; Nightingale K, 2003, ULTRASOUND MED BIOL, V29, P1715, DOI 10.1016/j.ultrasmedbio.2003.08.008; Nightingale K, 2002, ULTRASOUND MED BIOL, V28, P227, DOI 10.1016/S0301-5629(01)00499-9; Nightingale KR, 2006, ULTRASON, P1156; Ning CP, 2012, EUR J RADIOL, V81, P286, DOI 10.1016/j.ejrad.2010.12.010; Oertel YC, 2007, THYROID, V17, P1061, DOI 10.1089/thy.2007.0159; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; Peng Y, 2008, DIAGN CYTOPATHOL, V36, P916, DOI 10.1002/dc.20943; Reiners C, 2004, THYROID, V14, P926, DOI 10.1089/thy.2004.14.926; Rubaltelli L, 2009, ULTRASCHALL MED, V30, P175, DOI 10.1055/s-2008-1027442; Sarvazyan AP, 1998, ULTRASOUND MED BIOL, V24, P1419, DOI 10.1016/S0301-5629(98)00110-0; Sebag F, 2010, J CLIN ENDOCR METAB, V95, P5281, DOI 10.1210/jc.2010-0766; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Suen KC, 1996, MODERN PATHOL, V9, P710; Tee YY, 2007, ANN SURG, V246, P714, DOI 10.1097/SLA.0b013e3180f61adc; Vorlander C, 2010, LANGENBECK ARCH SURG, V395, P865, DOI 10.1007/s00423-010-0685-3; Wang Y, 2010, J INT MED RES, V38, P466, DOI 10.1177/147323001003800210; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	35	84	98	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e42735	10.1371/journal.pone.0042735	http://dx.doi.org/10.1371/journal.pone.0042735			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952609	Green Submitted, gold, Green Published			2022-12-25	WOS:000308206000011
J	Backlund, L; Lavebratt, C; Frisen, L; Nikamo, P; Sudic, DH; Traskman-Bendz, L; Landen, M; Edman, G; Vawter, MP; Osby, U; Schalling, M				Backlund, Lena; Lavebratt, Catharina; Frisen, Louise; Nikamo, Pernilla; Sudic, Dzana Hukic; Traskman-Bendz, Lil; Landen, Mikael; Edman, Gunnar; Vawter, Marquis P.; Osby, Urban; Schalling, Martin			P2RX7: Expression Responds to Sleep Deprivation and Associates with Rapid Cycling in Bipolar Disorder Type 1	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; NEUROTROPHIC FACTOR BDNF; SYNTHASE KINASE-3; P2X(7) RECEPTORS; PHASE-SHIFTS; MOOD; GENE; LITHIUM; ANTIDEPRESSANTS; GLUTAMATE	Context: Rapid cycling is a severe form of bipolar disorder with an increased rate of episodes that is particularly treatment-responsive to chronotherapy and stable sleep-wake cycles. We hypothesized that the P2RX7 gene would be affected by sleep deprivation and be implicated in rapid cycling. Objectives: To assess whether P2RX7 expression is affected by total sleep deprivation and if variation in P2RX7 is associated with rapid cycling in bipolar patients. Design: Gene expression analysis in peripheral blood mononuclear cells (PBMCs) from healthy volunteers and case-case and case-control SNP/haplotype association analyses in patients. Participants: Healthy volunteers at the sleep research center, University of California, Irvine Medical Center (UCIMC), USA (n = 8) and Swedish outpatients recruited from specialized psychiatric clinics for bipolar disorder, diagnosed with bipolar disorder type 1 (n = 569; rapid cycling: n = 121) and anonymous blood donor controls (n = 1,044). Results: P2RX7 RNA levels were significantly increased during sleep deprivation in PBMCs from healthy volunteers (p = 2.3*10(-9)). The P2RX7 rs2230912_A allele was more common (OR = 2.2, p = 0.002) and the ACGTTT haplotype in P2RX7 (rs1718119 to rs1621388) containing the protective rs2230912_G allele (OR = 0.45-0.49, p = 0.003-0.005) was less common, among rapid cycling cases compared to non-rapid cycling bipolar patients and blood donor controls. Conclusions: Sleep deprivation increased P2RX7 expression in healthy persons and the putatively low-activity P2RX7 rs2230912 allele A variant was associated with rapid cycling in bipolar disorder. This supports earlier findings of P2RX7 associations to affective disorder and is in agreement with that particularly rapid cycling patients have a more vulnerable diurnal system.	[Backlund, Lena; Frisen, Louise; Landen, Mikael] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Lavebratt, Catharina; Frisen, Louise; Nikamo, Pernilla; Sudic, Dzana Hukic; Edman, Gunnar; Osby, Urban; Schalling, Martin] Karolinska Inst, Neurogenet Unit, Dept Mol Med & Surg, Stockholm, Sweden; [Lavebratt, Catharina; Frisen, Louise; Nikamo, Pernilla; Sudic, Dzana Hukic; Edman, Gunnar; Osby, Urban; Schalling, Martin] Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden; [Traskman-Bendz, Lil] Univ Lund Hosp, Dept Clin Sci, S-22185 Lund, Sweden; [Landen, Mikael] Gothenburg Univ, Inst Neurosci & Physiol, Sahlgrenska Acad, S-41124 Gothenburg, Sweden; [Vawter, Marquis P.] Univ Calif Irvine, Dept Psychiat & Human Behav, Funct Genom Lab, Sch Med, Irvine, CA 92717 USA; [Edman, Gunnar; Osby, Urban] Tiohundra AB, Dept Psychiat, Norrtalje, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Lund University; Skane University Hospital; University of Gothenburg; University of California System; University of California Irvine	Backlund, L (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	lena.backlund@sll.se	Landen, Mikael/AAD-7917-2020; Schalling, Martin/F-1518-2015	Schalling, Martin/0000-0001-5011-2922; Backlund, Lena/0000-0001-9399-5024; Lavebratt, Catharina/0000-0003-4987-2718	Karolinska Institutet; Swedish Research Council; Soderstrom-Konigska Foundation; Royal Physiographic Society in Lund; Fredrik and Ingrid Thuring Foundation; Psychiatry Southwest, Stockholm; Stockholm County Council; National Institute of Mental Health (NIMH) [R01MH085801]; Bristol-Myers Squibb; Janssen-Cilag; AstraZeneca; Eli Lilly; Pfizer; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085801] Funding Source: NIH RePORTER	Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Soderstrom-Konigska Foundation; Royal Physiographic Society in Lund; Fredrik and Ingrid Thuring Foundation; Psychiatry Southwest, Stockholm; Stockholm County Council(Stockholm County Council); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Bristol-Myers Squibb(Bristol-Myers Squibb); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); AstraZeneca(AstraZeneca); Eli Lilly(Eli Lilly); Pfizer(Pfizer); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project was supported by grants from Karolinska Institutet, the Swedish Research Council, The Soderstrom-Konigska Foundation, The Royal Physiographic Society in Lund, the Fredrik and Ingrid Thuring Foundation and Psychiatry Southwest, Stockholm. Financial support was also provided through the regional agreement on medical training and clinical research (ALF) between the Stockholm County Council and Karolinska Institutet. The research was further supported by the William Lion Penzner Foundation (Department of Psychiatry and Human Behavior, University of California, Irvine), and National Institute of Mental Health (NIMH) grant R01MH085801 (MPV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: LB has received consultancy fees from Bristol-Myers Squibb and has been reimbursed by Eli Lilly and Bristol-Myers Squibb for attending conferences and presenting lectures. UO has received grant/research support from Bristol-Myers Squibb and Janssen-Cilag and has been a consultant for or received fees for speaking and attending conferences from AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Pfizer. GE has been a consultant for AstraZeneca and Janssen-Cilag and his wife is a shareholder of AstraZeneca. ML has been reimbursed by Eli Lilly, AstraZeneca and Wyeth for lectures, serves on advisory boards for AstraZeneca and Lundbeck, and has received research grants from AstraZeneca. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Angst J, 2000, BIOL PSYCHIAT, V48, P445, DOI 10.1016/S0006-3223(00)00909-4; Armstrong JN, 2002, J NEUROSCI, V22, P5938; Ashman SB, 1999, PSYCHIAT RES, V86, P1, DOI 10.1016/S0165-1781(99)00019-0; Avasthi A, 1999, J AFFECT DISORDERS, V54, P67, DOI 10.1016/S0165-0327(98)00135-9; Azorin JM, 2008, CNS SPECTRUMS, V13, P780, DOI 10.1017/S1092852900013900; Backlund L, 2011, BIPOLAR DISORD, V13, P500, DOI 10.1111/j.1399-5618.2011.00952.x; Barden N, 2006, AM J MED GENET B, V141B, P374, DOI 10.1002/ajmg.b.30303; Bauer M, 2008, BIPOLAR DISORD, V10, P153, DOI 10.1111/j.1399-5618.2007.00560.x; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Cirelli C, 2000, BRAIN RES, V885, P303, DOI 10.1016/S0006-8993(00)03008-0; Coryell W, 2003, ARCH GEN PSYCHIAT, V60, P914, DOI 10.1001/archpsyc.60.9.914; Csolle C, 2012, INT J NEUROPSYCHOPH, V16, P1; Cusin C, 2001, J PSYCHIAT RES, V35, P217, DOI 10.1016/S0022-3956(01)00026-7; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; Denlinger LC, 2006, CLIN CHEM, V52, P995, DOI 10.1373/clinchem.2005.065425; Duan SM, 2003, J NEUROSCI, V23, P1320, DOI 10.1523/JNEUROSCI.23-04-01320.2003; Dubovsky S L, 2001, Curr Psychiatry Rep, V3, P451, DOI 10.1007/s11920-001-0038-6; Erhardt A, 2007, J AFFECT DISORDERS, V101, P159, DOI 10.1016/j.jad.2006.11.016; FeldmanNaim S, 1997, J CLIN PSYCHIAT, V58, P79, DOI 10.4088/JCP.v58n0205; Fuller SJ, 2009, PURINERG SIGNAL, V5, P257, DOI 10.1007/s11302-009-9136-4; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gould TD, 2005, NEUROPSYCHOPHARMACOL, V30, P1223, DOI 10.1038/sj.npp.1300731; Green EK, 2006, BRIT J PSYCHIAT, V188, P21, DOI 10.1192/bjp.bp.105.009969; Green EK, 2009, AM J MED GENET B, V150B, P1063, DOI 10.1002/ajmg.b.30931; Grunze H, 2002, NEUROPSYCHOBIOLOGY, V45, P20, DOI 10.1159/000049257; Hamshere ML, 2009, BIPOLAR DISORD, V11, P610, DOI 10.1111/j.1399-5618.2009.00736.x; Hashimoto K, 2007, BIOL PSYCHIAT, V62, P1310, DOI 10.1016/j.biopsych.2007.03.017; Hejjas K, 2009, AM J MED GENET B, V150B, P295, DOI 10.1002/ajmg.b.30799; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johansson AS, 2011, J BIOL RHYTHM, V26, P541, DOI 10.1177/0748730411419775; Khakh BS, 2001, NAT REV NEUROSCI, V2, P165, DOI 10.1038/35058521; Kim DY, 2005, EUR J NEUROSCI, V21, P1215, DOI 10.1111/j.1460-9568.2005.03950.x; Kirov G, 1998, MOL PSYCHIATR, V3, P342, DOI 10.1038/sj.mp.4000385; Kupka RW, 2005, AM J PSYCHIAT, V162, P1273, DOI 10.1176/appi.ajp.162.7.1273; Kupka RW, 2003, J CLIN PSYCHIAT, V64, P1483, DOI 10.4088/JCP.v64n1213; KURIAN SM, 2009, MOL PSYCHIAT; Lappalainen T, 2009, ANN HUM GENET, V73, P61, DOI 10.1111/j.1469-1809.2008.00487.x; Lavebratt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009407; Leibenluft E, 1996, PSYCHIAT RES, V63, P161, DOI 10.1016/0165-1781(96)02854-5; Licht RW, 2008, ACTA PSYCHIAT SCAND, V118, P337, DOI 10.1111/j.1600-0447.2008.01237.x; Liu YD, 2007, J BIOL CHEM, V282, P8594, DOI 10.1074/jbc.M610230200; Lucae S, 2006, HUM MOL GENET, V15, P2438, DOI 10.1093/hmg/ddl166; McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003; McGuffin P, 2003, ARCH GEN PSYCHIAT, V60, P497, DOI 10.1001/archpsyc.60.5.497; McQuillin A, 2009, MOL PSYCHIATR, V14, P614, DOI 10.1038/mp.2008.6; Muller DJ, 2006, BRIT J PSYCHIAT, V189, P317, DOI 10.1192/bjp.bp.105.010587; Murray G, 2010, BIPOLAR DISORD, V12, P459, DOI 10.1111/j.1399-5618.2010.00843.x; Niculescu AB, 2010, AM J MED GENET B, V153B, P847, DOI 10.1002/ajmg.b.31076; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ogden CA, 2004, MOL PSYCHIATR, V9, P1007, DOI 10.1038/sj.mp.4001547; Perlis RH, 2009, AM J PSYCHIAT, V166, P718, DOI 10.1176/appi.ajp.2009.08111633; Rosa AR, 2010, J CLIN PSYCHIAT, V71, P1000, DOI 10.4088/JCP.09m05026gre; Rousseva A, 2003, PHARMACOGENOMICS J, V3, P101, DOI 10.1038/sj.tpj.6500156; Ryden E, 2009, ACTA PSYCHIAT SCAND, V120, P239, DOI 10.1111/j.1600-0447.2009.01399.x; Schneck CD, 2004, AM J PSYCHIAT, V161, P1902, DOI 10.1176/appi.ajp.161.10.1902; Schulze TG, 2005, AM J PSYCHIAT, V162, P2101, DOI 10.1176/appi.ajp.162.11.2101; Shink E, 2005, MOL PSYCHIATR, V10, P545, DOI 10.1038/sj.mp.4001601; Sjoholm LK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012632; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Tamaru T, 2000, J NEUROSCI, V20, P7525; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; Witting A, 2004, P NATL ACAD SCI USA, V101, P3214, DOI 10.1073/pnas.0306707101; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Young A, 2009, EVID-BASED MENT HEAL, V12, P49, DOI 10.1136/ebmh.12.2.49	68	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43057	10.1371/journal.pone.0043057	http://dx.doi.org/10.1371/journal.pone.0043057			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952630	Green Published, gold			2022-12-25	WOS:000308213600013
J	Hart, AB; Engelhardt, BE; Wardle, MC; Sokoloff, G; Stephens, M; de Wit, H; Palmer, AA				Hart, Amy B.; Engelhardt, Barbara E.; Wardle, Margaret C.; Sokoloff, Greta; Stephens, Matthew; de Wit, Harriet; Palmer, Abraham A.			Genome-Wide Association Study of d-Amphetamine Response in Healthy Volunteers Identifies Putative Associations, Including Cadherin 13 (CDH13)	PLOS ONE			English	Article							SMOKING-CESSATION SUCCESS; MOLECULAR-GENETICS; SUBJECTIVE RESPONSE; NICOTINE DEPENDENCE; ALCOHOL; BRAIN; STIMULANT; VARIANTS; GENOTYPE; HUMANS	Both the subjective response to d-amphetamine and the risk for amphetamine addiction are known to be heritable traits. Because subjective responses to drugs may predict drug addiction, identifying alleles that influence acute response may also provide insight into the genetic risk factors for drug abuse. We performed a Genome Wide Association Study (GWAS) for the subjective responses to amphetamine in 381 non-drug abusing healthy volunteers. Responses to amphetamine were measured using a double-blind, placebo-controlled, within-subjects design. We used sparse factor analysis to reduce the dimensionality of the data to ten factors. We identified several putative associations; the strongest was between a positive subjective drug-response factor and a SNP (rs3784943) in the 8th intron of cadherin 13 (CDH13; P = 4.58 x 10(-8)), a gene previously associated with a number of psychiatric traits including methamphetamine dependence. Additionally, we observed a putative association between a factor representing the degree of positive affect at baseline and a SNP (rs472402) in the 1st intron of steroid-5-alpha-reductase-alpha-polypeptide-1 (SRD5A1; P = 2.53 x 10(-7)), a gene whose protein product catalyzes the rate-limiting step in synthesis of the neurosteroid allopregnanolone. This SNP belongs to an LD-block that has been previously associated with the expression of SRD5A1 and differences in SRD5A1 enzymatic activity. The purpose of this study was to begin to explore the genetic basis of subjective responses to stimulant drugs using a GWAS approach in a modestly sized sample. Our approach provides a case study for analysis of high-dimensional intermediate pharmacogenomic phenotypes, which may be more tractable than clinical diagnoses.	[Hart, Amy B.; Engelhardt, Barbara E.; Sokoloff, Greta; Stephens, Matthew; Palmer, Abraham A.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Engelhardt, Barbara E.] Univ Chicago, Dept Comp Sci, Chicago, IL 60637 USA; [Wardle, Margaret C.; de Wit, Harriet; Palmer, Abraham A.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Hart, AB (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	aap@uchicago.edu	Palmer, Abraham/L-2158-2014; Wardle, Margaret/M-5157-2016	Palmer, Abraham/0000-0003-3634-0747; Wardle, Margaret/0000-0001-6071-6105; de Wit, Harriet/0000-0002-7211-8994; Engelhardt, Barbara/0000-0002-6139-7334; Sokoloff, Greta/0000-0003-3651-1980	NIH [DA007255, HG006265, HG002585, DA02812, DA021336, DA024845]; Bioinformatics Research Development Fund; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002585, R00HG006265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021336, R01DA002812, R21DA024845, T32DA007255] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bioinformatics Research Development Fund; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants, DA007255 (ABH and MCW), HG006265 (to BEE), HG002585 (to MS), DA02812 (to HdW), and DA021336 and DA024845 (to AAP). BEE was also funded through the Bioinformatics Research Development Fund, supported by Kathryn and George Gould. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins DE, 2011, MOL PSYCHIATR, V16, P321, DOI 10.1038/mp.2010.14; Agis-Balboa RC, 2006, P NATL ACAD SCI USA, V103, P14602, DOI 10.1073/pnas.0606544103; Alliey-Rodriguez N, 2011, PSYCHIAT GENET, V21, P190, DOI 10.1097/YPG.0b013e3283457a31; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arias-Vasquez A, 2011, GENES BRAIN BEHAV; Best T, 2011, NAT MED, V17, P941, DOI 10.1038/nm.2407; Brot MD, 1997, EUR J PHARMACOL, V325, P1, DOI 10.1016/S0014-2999(97)00096-4; Carvalho B, 2007, BIOSTATISTICS, V8, P485, DOI 10.1093/biostatistics/kxl042; CHAIT LD, 1985, DRUG ALCOHOL DEPEN, V15, P229, DOI 10.1016/0376-8716(85)90002-X; Chen XG, 2003, NICOTINE TOB RES, V5, P455, DOI 10.1080/14622200307239; Childs E, 2010, EXP CLIN PSYCHOPHARM, V18, P78, DOI 10.1037/a0018060; Cooper GM, 2008, BLOOD, V112, P1022, DOI 10.1182/blood-2008-01-134247; CRABBE JC, 1983, ACTA GENET MED GEMEL, V32, P139, DOI 10.1017/S0001566000006425; Daly AK, 2010, NAT REV GENET, V11, P241, DOI 10.1038/nrg2751; de Moor MHM, 2010, MOL PSYCHIAT; de Wit H, 2004, NEBR SYM MOTIV, V50, P19; de Wit H, 2001, PSYCHONEUROENDOCRINO, V26, P697, DOI 10.1016/S0306-4530(01)00024-5; DiFranza JR, 2004, ADDICT BEHAV, V29, P261, DOI 10.1016/j.addbeh.2003.08.002; Dlugos A, 2007, BIOL PSYCHIAT, V61, P1296, DOI 10.1016/j.biopsych.2006.09.031; Dlugos AM, 2010, NEUROPSYCHOPHARMACOL, V35, P613, DOI 10.1038/npp.2009.166; Dlugos AM, 2009, PSYCHOPHARMACOLOGY, V206, P501, DOI 10.1007/s00213-009-1628-y; Drgon T, 2009, MOL MED, V15, P21, DOI 10.2119/molmed.2008.00096; Edwards AC, 2012, PSYCHIAT GENET, V22, P31, DOI 10.1097/YPG.0b013e32834acd07; Ellis JA, 2005, J HUM GENET, V50, P534, DOI 10.1007/s10038-005-0289-x; Engelhardt BE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001117; Fergusson DM, 2003, ARCH GEN PSYCHIAT, V60, P1033, DOI 10.1001/archpsyc.60.10.1033; Flanagin BA, 2006, AM J MED GENET B, V141B, P576, DOI 10.1002/ajmg.b.30327; FOLTIN RW, 1991, DRUG ALCOHOL DEPEN, V28, P3, DOI 10.1016/0376-8716(91)90052-Z; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gamazon ER, 2013, MOL PSYCHIATR, V18, P340, DOI 10.1038/mp.2011.174; Goldman David, 2007, ScientificWorldJournal, V7, P124; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Hamidovic A, 2010, PSYCHIAT GENET, V20, P85, DOI 10.1097/YPG.0b013e32833a1f3c; Hamidovic A, 2009, EXP CLIN PSYCHOPHARM, V17, P374, DOI 10.1037/a0017840; Hamidovic A, 2010, BEHAV GENET, V40, P255, DOI 10.1007/s10519-009-9331-7; Hart AB, 2012, BHEAV NEUROGENETICS; Hodgkinson CA, 2010, P NATL ACAD SCI USA, V107, P8695, DOI 10.1073/pnas.0908134107; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang RS, 2007, AM J HUM GENET, V81, P427, DOI 10.1086/519850; Jee SH, 2010, AM J HUM GENET, V87, P545, DOI 10.1016/j.ajhg.2010.09.004; JOHANSON CE, 1980, PSYCHOPHARMACOLOGY, V71, P269, DOI 10.1007/BF00433061; Johnson C, 2006, AM J MED GENET B, V141B, P844, DOI 10.1002/ajmg.b.30346; Johnson CL, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016491, 10.1371/journal.pone.0021046, 10.1371/journal.pone.0019210]; King AC, 2011, ARCH GEN PSYCHIAT, V68, P389, DOI 10.1001/archgenpsychiatry.2011.26; Kirisci L, 2007, PSYCHOL ADDICT BEHAV, V21, P287, DOI 10.1037/0893-164X.21.3.287; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lasky-Su J, 2008, AM J MED GENET B, V147B, P1345, DOI 10.1002/ajmg.b.30867; Le Strat Y, 2009, ADDICTION, V104, P1710, DOI 10.1111/j.1360-0443.2009.02680.x; Lesch KP, 2008, J NEURAL TRANSM, V115, P1573, DOI 10.1007/s00702-008-0119-3; Liu QR, 2006, AM J MED GENET B, V141B, P918, DOI 10.1002/ajmg.b.30436; Lott DC, 2006, AM J ADDICTION, V15, P327, DOI 10.1080/10550490600859868; Lott DC, 2005, NEUROPSYCHOPHARMACOL, V30, P602, DOI 10.1038/sj.npp.1300637; Lynskey MT, 2007, DRUG ALCOHOL DEPEN, V86, P147, DOI 10.1016/j.drugalcdep.2006.05.023; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Mellon SH, 2001, BRAIN RES REV, V37, P3, DOI 10.1016/S0165-0173(01)00109-6; Milivojevic V, 2011, ALCOHOL CLIN EXP RES, V35, P946, DOI 10.1111/j.1530-0277.2010.01425.x; Neale BM, 2010, J AM ACAD CHILD PSY, V49, P906, DOI 10.1016/j.jaac.2010.06.007; NURNBERGER JI, 1982, PSYCHONEUROENDOCRINO, V7, P163, DOI 10.1016/0306-4530(82)90009-9; Palmer AA, 2012, HUM GENET, V131, P931, DOI 10.1007/s00439-011-1123-5; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; R Core Development Team, 2009, R LANG ENV STAT COMP; Rivero O, 2013, EUR NEUROPSYCHOPHARM, V23, P492, DOI 10.1016/j.euroneuro.2012.06.009; Roweis S, 1998, ADV NEUR IN, V10, P626; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Soderpalm AHV, 2004, PSYCHONEUROENDOCRINO, V29, P339, DOI 10.1016/S0306-4530(03)00033-7; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Takeuchi T, 2000, J NEUROCHEM, V74, P1489, DOI 10.1046/j.1471-4159.2000.0741489.x; Tanaka Y, 2011, HUMAN MOL GENETICS; Terracciano A, 2010, MOL PSYCHIATR, V15, P647, DOI 10.1038/mp.2008.113; Terracciano A, 2010, BIOL PSYCHIAT, V68, P811, DOI 10.1016/j.biopsych.2010.06.030; THIGPEN AE, 1993, J CLIN INVEST, V92, P903, DOI 10.1172/JCI116665; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Treutlein J, 2009, ARCH GEN PSYCHIAT, V66, P773, DOI 10.1001/archgenpsychiatry.2009.83; Uher R, 2010, AM J PSYCHIAT, V167, P555, DOI 10.1176/appi.ajp.2009.09070932; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P345, DOI 10.1001/archpsyc.65.3.345; Uhl GR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-10; Uhl GR, 2010, PHARMACOGENOMICS, V11, P357, DOI [10.2217/pgs.09.156, 10.2217/PGS.09.156]; Veenstra-VanderWeele J, 2006, NEUROPSYCHOPHARMACOL, V31, P1056, DOI 10.1038/sj.npp.1300936; Verbeek J, 2002, IAS UVA; Weber F, 2011, PHARMACOGENOMICS J; West M, 2003, BAYESIAN STATISTICS 7, P733; Wu Y, 2010, HUM MOL GENET, V19, P4955, DOI 10.1093/hmg/ddq423; Yang B-Z, 2011, NEUROPSYCHOPHARMACOL; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhou KX, 2008, AM J MED GENET B, V147B, P1392, DOI 10.1002/ajmg.b.30878	87	56	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e42646	10.1371/journal.pone.0042646	http://dx.doi.org/10.1371/journal.pone.0042646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952603	Green Published, gold, Green Submitted			2022-12-25	WOS:000308213600007
J	Janes, H; Frahm, N; DeCamp, A; Rolland, M; Gabriel, E; Wolfson, J; Hertz, T; Kallas, E; Goepfert, P; Friedrich, DP; Corey, L; Mullins, JI; McElrath, MJ; Gilbert, P				Janes, Holly; Frahm, Nicole; DeCamp, Allan; Rolland, Morgane; Gabriel, Erin; Wolfson, Julian; Hertz, Tomer; Kallas, Esper; Goepfert, Paul; Friedrich, David P.; Corey, Lawrence; Mullins, James I.; McElrath, M. Juliana; Gilbert, Peter			MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load	PLOS ONE			English	Article							FALSE DISCOVERY RATE; MEDIATED-IMMUNITY; STEP; GAG; EPITOPES; ESCAPE; CTL	Background: The sieve analysis for the Step trial found evidence that breakthrough HIV-1 sequences for MRKAd5/HIV-1 Gag/Pol/Nef vaccine recipients were more divergent from the vaccine insert than placebo sequences in regions with predicted epitopes. We linked the viral sequence data with immune response and acute viral load data to explore mechanisms for and consequences of the observed sieve effect. Methods: Ninety-one male participants (37 placebo and 54 vaccine recipients) were included; viral sequences were obtained at the time of HIV-1 diagnosis. T-cell responses were measured 4 weeks post-second vaccination and at the first or second week post-diagnosis. Acute viral load was obtained at RNA-positive and antibody-negative visits. Findings: Vaccine recipients had a greater magnitude of post-infection CD8+ T cell response than placebo recipients (median 1.68% vs 1.18%; p = 0.04) and greater breadth of post-infection response (median 4.5 vs 2; p = 0.06). Viral sequences for vaccine recipients were marginally more divergent from the insert than placebo sequences in regions of Nef targeted by pre-infection immune responses (p = 0.04; Pol p = 0.13; Gag p = 0.89). Magnitude and breadth of pre-infection responses did not correlate with distance of the viral sequence to the insert (p. 0.50). Acute log viral load trended lower in vaccine versus placebo recipients (estimated mean 4.7 vs 5.1) but the difference was not significant (p = 0.27). Neither was acute viral load associated with distance of the viral sequence to the insert (p>0.30). Interpretation: Despite evidence of anamnestic responses, the sieve effect was not well explained by available measures of T-cell immunogenicity. Sequence divergence from the vaccine was not significantly associated with acute viral load. While point estimates suggested weak vaccine suppression of viral load, the result was not significant and more viral load data would be needed to detect suppression.	[Janes, Holly; Frahm, Nicole; DeCamp, Allan; Hertz, Tomer; Friedrich, David P.; Corey, Lawrence; McElrath, M. Juliana; Gilbert, Peter] Fred Hutchinson Canc Res Ctr, Div Vaccines & Infect Dis, Seattle, WA 98104 USA; [Janes, Holly; Gabriel, Erin; Gilbert, Peter] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Frahm, Nicole] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Rolland, Morgane] US Mil HIV Res Program MHRP, Rockville, MD USA; [Wolfson, Julian] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Kallas, Esper] Univ Sao Paulo, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Goepfert, Paul] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Corey, Lawrence; McElrath, M. Juliana] Univ Washington, Dept Med, Seattle, WA USA; [Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Walter Reed Army Institute of Research (WRAIR); University of Minnesota System; University of Minnesota Twin Cities; Universidade de Sao Paulo; University of Alabama System; University of Alabama Birmingham; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Janes, H (corresponding author), Fred Hutchinson Canc Res Ctr, Div Vaccines & Infect Dis, 1124 Columbia St, Seattle, WA 98104 USA.	hjanes@fhcrc.org	Corey, Lawrence/AAE-1796-2020; Hertz, Tomer/S-5744-2016; Wolfson, Julian/G-6332-2011	Corey, Lawrence/0000-0002-2179-2436; Hertz, Tomer/0000-0002-0561-1578; Wolfson, Julian/0000-0002-2032-0875; Gabriel, Erin/0000-0002-0504-8404; Kallas, Esper/0000-0003-2026-6925	National Institute of Allergy and Infectious Diseases [R37AI054165-08, UM1AI068635, UM1AI068618]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068635, U01AI068635, UM1AI068614, U01AI068614, UM1AI068618, R37AI054165, U01AI068618, K25AI087397] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants R37AI054165-08, UM1AI068635, and UM1AI068618 from the National Institute of Allergy and Infectious Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Buus S, 2003, TISSUE ANTIGENS, V62, P378, DOI 10.1034/j.1399-0039.2003.00112.x; Fitzgerald DW, 2011, J INFECT DIS, V203, P765, DOI 10.1093/infdis/jiq114; Frahm N, 2012, J CLIN INVE IN PRESS; Harrer T, 1998, J IMMUNOL, V161, P4875; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Heckerman D, 2007, J COMPUT BIOL, V14, P736, DOI 10.1089/cmb.2007.R013; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; JOHNSON RP, 1991, J IMMUNOL, V147, P1512; Li FS, 2006, VACCINE, V24, P6893, DOI 10.1016/j.vaccine.2006.06.009; Lichterfeld M, 2004, AIDS, V18, P1383, DOI 10.1097/01.aids.0000131329.51633.a3; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Nickle DC, 2007, PLOS COMPUT BIOL, V3, P754, DOI 10.1371/journal.pcbi.0030075; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Rubin DB, 2004, MULTIPLE IMPUTATION; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Troyer RM, 2009, PLOS PATHOG IN PRESS	22	26	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43396	10.1371/journal.pone.0043396	http://dx.doi.org/10.1371/journal.pone.0043396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952672	Green Published, Green Submitted, gold			2022-12-25	WOS:000308044800029
J	Tietjen, I; Hovingh, GK; Singaraja, RR; Radomski, C; Barhdadi, A; McEwen, J; Chan, E; Mattice, M; Legendre, A; Franchini, PL; Dube, MP; Kastelein, JJP; Hayden, MR				Tietjen, Ian; Hovingh, G. Kees; Singaraja, Roshni R.; Radomski, Chris; Barhdadi, Amina; McEwen, Jason; Chan, Elden; Mattice, Maryanne; Legendre, Annick; Franchini, Patrick L.; Dube, Marie-Pierre; Kastelein, John J. P.; Hayden, Michael R.			Segregation of LIPG, CETP, and GALNT2 Mutations in Caucasian Families with Extremely High HDL Cholesterol	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; ESTER TRANSFER PROTEIN; CORONARY-ARTERY-DISEASE; ENDOTHELIAL LIPASE; COMMON DISEASES; TANGIER-DISEASE; HIGH-RISK; DEFICIENCY; IDENTIFICATION; ANACETRAPIB	To date, few mutations are described to underlie highly-elevated HDLc levels in families. Here we sequenced the coding regions and adjacent sequence of the LIPG, CETP, and GALNT2 genes in 171 unrelated Dutch Caucasian probands with HDLc >= 90th percentile and analyzed segregation of mutations with lipid phenotypes in family members. In these probands, mutations were most frequent in LIPG (12.9%) followed by GALNT2 (2.3%) and CETP (0.6%). A total of 6 of 10 mutations in these three genes were novel (60.0%), and mutations segregated with elevated HDLc in families. Interestingly, the LIPG mutations N396S and R476W, which usually result in elevated HDLc, were unexpectedly found in 6 probands with low HDLc (i.e., <= 10th percentile). However, 5 of these probands also carried mutations in ABCA1, LCAT, or LPL. Finally, no CETP and GALNT2 mutations were found in 136 unrelated probands with low HDLc. Taken together, we show that rare coding and splicing mutations in LIPG, CETP, and GALNT2 are enriched in persons with hyperalphalipoproteinemia and segregate with elevated HDLc in families. Moreover, LIPG mutations do not overcome low HDLc in individuals with ABCA1 and possibly LCAT and LPL mutations, indicating that LIPG affects HDLc levels downstream of these proteins.	[Tietjen, Ian; Singaraja, Roshni R.; Radomski, Chris; McEwen, Jason; Chan, Elden; Mattice, Maryanne; Legendre, Annick; Franchini, Patrick L.] Xenon Pharmaceut Inc, Burnaby, BC, Canada; [Hovingh, G. Kees; Kastelein, John J. P.] Univ Amsterdam, Dept Vasc Med, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands; [Singaraja, Roshni R.; Hayden, Michael R.] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Barhdadi, Amina; Dube, Marie-Pierre] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada	Xenon Pharmaceuticals Inc.; University of Amsterdam; Academic Medical Center Amsterdam; University of British Columbia; Universite de Montreal	Tietjen, I (corresponding author), Xenon Pharmaceut Inc, Burnaby, BC, Canada.	mrh@cmmt.ubc.ca	Hayden, Michael R/D-8581-2011; Kastelein, John/AAF-7950-2020; Dubé, Marie-Pierre/B-9364-2008	Hayden, Michael R/0000-0001-5159-1419; Dubé, Marie-Pierre/0000-0001-8442-4393; Singaraja, Roshni/0000-0002-3418-3867; Tietjen, Ian/0000-0002-8991-6490	Xenon Pharmaceuticals Inc.	Xenon Pharmaceuticals Inc.	The funders, Xenon Pharmaceuticals Inc., did have a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript, since some of the authors are employees of this company.	Ali M, 2009, WORLD HLTH STAT 2009; Barter Philip J, 2007, Curr Cardiol Rep, V9, P493, DOI 10.1007/BF02938394; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Bauer RC, 2011, CURR OPIN LIPIDOL, V22, P123, DOI 10.1097/MOL.0b013e32834469b3; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; BROWN ML, 1989, NATURE, V342, P448, DOI 10.1038/342448a0; Cannon CP, 2010, NEW ENGL J MED, V363, P2406, DOI 10.1056/NEJMoa1009744; Clee SM, 2000, J CLIN INVEST, V106, P1263, DOI 10.1172/JCI10727; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; deLemos AS, 2002, CIRCULATION, V106, P1321, DOI 10.1161/01.CIR.0000028423.07623.6A; Edmondson AC, 2009, J CLIN INVEST, V119, P1042, DOI 10.1172/JCI37176; FUNKE H, 1991, P NATL ACAD SCI USA, V88, P4855, DOI 10.1073/pnas.88.11.4855; Gauthier A, 2005, ARTERIOSCL THROM VAS, V25, P2177, DOI 10.1161/01.ATV.0000183613.13929.13; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; HEISS G, 1980, CIRCULATION, V62, P116; Holleboom AG, 2011, CELL METAB, V14, P811, DOI 10.1016/j.cmet.2011.11.005; Hovingh GK, 2004, J AM COLL CARDIOL, V44, P1429, DOI 10.1016/j.jacc.2004.06.070; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; Ishida T, 2003, J CLIN INVEST, V111, P347, DOI [10.1172/JCI200316306, 10.1172/JCI16306]; Jin WJ, 2003, J CLIN INVEST, V111, P357, DOI [10.1172/JCI16146, 10.1172/JCI200316146]; Khetarpal SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002393; Khovidhunkit W, 2012, AM J CARDIOL, V110, P62, DOI 10.1016/j.amjcard.2012.02.052; Klos KLE, 2007, CURR OPIN CARDIOL, V22, P344, DOI 10.1097/HCO.0b013e3281a8acad; KOIZUMI J, 1985, ATHEROSCLEROSIS, V58, P175, DOI 10.1016/0021-9150(85)90064-4; Krishna R, 2009, BRIT J CLIN PHARMACO, V68, P535, DOI 10.1111/j.1365-2125.2009.03465.x; Ku CS, 2011, HUM GENET, V129, P351, DOI 10.1007/s00439-011-0964-2; Kuivenhoven JA, 1997, J LIPID RES, V38, P191; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Marcil M, 1999, LANCET, V354, P1341, DOI 10.1016/S0140-6736(99)07026-9; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Muntner P, 2011, AM J MED SCI, V341, P173, DOI 10.1097/MAJ.0b013e3181f97e4a; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Plump AS, 2009, J AM COLL CARDIOL, V53, P1089, DOI 10.1016/j.jacc.2008.11.050; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; REYMER PWA, 1995, NAT GENET, V10, P28, DOI 10.1038/ng0595-28; ROGLER G, 1995, ARTERIOSCL THROM VAS, V15, P683, DOI 10.1161/01.ATV.15.5.683; Rogozin IB, 1997, J MOL EVOL, V45, P50, DOI 10.1007/PL00006200; Strauss JG, 2001, J BIOL CHEM, V276, P36083, DOI 10.1074/jbc.M104430200; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tietjen I, 2012, BBA-MOL CELL BIOL L, V1821, P416, DOI 10.1016/j.bbalip.2011.08.006; van der Steeg WA, 2007, J LIPID RES, V48, P674, DOI 10.1194/jlr.M600405-JLR200; von Eckardstein A, 2005, CURR OPIN CLIN NUTR, V8, P147, DOI 10.1097/00075197-200503000-00007; VONECKARDSTEIN A, 1991, J CLIN INVEST, V87, P1724, DOI 10.1172/JCI115190; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; Weissglas-Volkov D, 2010, J LIPID RES, V51, P2032, DOI 10.1194/jlr.R004739	48	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e37437	10.1371/journal.pone.0037437	http://dx.doi.org/10.1371/journal.pone.0037437			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952570	Green Published, gold, Green Submitted			2022-12-25	WOS:000308044800001
J	Duguez, S; Duddy, WJ; Gnocchi, V; Bowe, J; Dadgar, S; Partridge, TA				Duguez, Stephanie; Duddy, William J.; Gnocchi, Viola; Bowe, James; Dadgar, Sherry; Partridge, Terence A.			Atmospheric Oxygen Tension Slows Myoblast Proliferation via Mitochondrial Activation	PLOS ONE			English	Article							MUSCLE SATELLITE CELLS; PROTEIN-SYNTHESIS; DIFFERENTIATION; BIOGENESIS; MYOGENESIS; ENVIRONMENT; DERIVATION; CULTURE; GROWTH; RAPTOR	Background: Mitochondrial activity inhibits proliferation and is required for differentiation of myoblasts. Myoblast proliferation is also inhibited by the similar to 20% oxygen level used in standard tissue culture. We hypothesize that mitochondrial activity would be greater at hyperoxia (20% O-2) relative to more physiological oxygen (5% O-2). Methodology/Principal Findings: Murine primary myoblasts from isolated myofibres and conditionally immortalized H-2K myoblasts were cultured at 5% and 20% oxygen. Proliferation, assayed by cell counts, EdU labeling, and CFSE dilution, was slower at 20% oxygen. Expression of MyoD in primary myoblasts was delayed at 20% oxygen, but myogenicity, as measured by fusion index, was slightly higher. FACS-based measurement of mitochondrial activity indicators and luminometric measurement of ATP levels revealed that mitochondria exhibited greater membrane potential and higher levels of Reactive Oxygen Species (ROS) at 20% oxygen with concomitant elevation of intracellular ATP. Mitochondrial mass was unaffected. Low concentrations of CCCP, a respiratory chain uncoupler, and Oligomycin A, an ATP synthase inhibitor, each increased the rate of myoblast proliferation. ROS were investigated as a potential mechanism of mitochondrial retrograde signaling, but scavenging of ROS levels by N-acetyl-cysteine (NAC) or alpha-Phenyl-N-tert-butylnitrone (PBN) did not rescue the suppressed rate of cell division in hyperoxic conditions, suggesting other pathways. Primary myoblasts from older mice showed a slower proliferation than those from younger adult mice at 20% oxygen but no difference at 5% oxygen. Conclusions/Significance: These results implicate mitochondrial regulation as a mechanistic explanation for myoblast response to oxygen tension. The rescue of proliferation rate in myoblasts of aged mice by 5% oxygen suggests a major artefactual component to age-related decline of satellite cell proliferation in standard tissue culture at 20% oxygen. It lends weight to the idea that these age-related changes result at least in part from environmental factors rather than characteristics intrinsic to the satellite cell.	[Duguez, Stephanie; Duddy, William J.; Gnocchi, Viola; Bowe, James; Dadgar, Sherry; Partridge, Terence A.] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Duguez, Stephanie; Duddy, William J.] Univ Paris 06, INSERM, CNRS, Inst Myol,UMR S 974,UMR 7215,U974, Paris, France	Children's National Health System; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Duguez, S (corresponding author), Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA.	william.duddy@upmc.fr	Duddy, William/S-9773-2019; Duguez, Stephanie/J-1904-2016	Duddy, William/0000-0003-2239-9094; Duguez, Stephanie/0000-0001-6510-5426	Wellstone Muscular Dystrophy Center [U54HD053177]; Department of Defense United States Army Medical Research Acquisition Activity [W81XWH-09-1-0599, W81XWH-09-1-021]; Foundation to Eradicate Duchenne; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD053177] Funding Source: NIH RePORTER	Wellstone Muscular Dystrophy Center; Department of Defense United States Army Medical Research Acquisition Activity(United States Department of Defense); Foundation to Eradicate Duchenne; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a Wellstone Muscular Dystrophy Center grant U54HD053177, Department of Defense United States Army Medical Research Acquisition Activity grants W81XWH-09-1-0599 and W81XWH-09-1-021 and by The Foundation to Eradicate Duchenne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; Barani AE, 2003, J APPL PHYSIOL, V95, P2089, DOI 10.1152/japplphysiol.00437.2003; Barani AE, 2003, EXP CELL RES, V283, P196, DOI 10.1016/S0014-4827(02)00030-7; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Bockhold KJ, 1998, MUSCLE NERVE, V21, P173, DOI 10.1002/(SICI)1097-4598(199802)21:2<173::AID-MUS4>3.0.CO;2-8; Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Csete M, 2001, J CELL PHYSIOL, V189, P189, DOI 10.1002/jcp.10016; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Duguez S, 2004, EXP CELL RES, V299, P27, DOI 10.1016/j.yexcr.2004.05.017; Finley LWS, 2009, AGEING RES REV, V8, P173, DOI 10.1016/j.arr.2009.03.003; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hamai N, 1997, CELL STRUCT FUNCT, V22, P421, DOI 10.1247/csf.22.421; Hansen JM, 2007, CELL BIOL INT, V31, P546, DOI 10.1016/j.cellbi.2006.11.027; HERZBERG NH, 1993, BIOCHIM BIOPHYS ACTA, V1181, P63, DOI 10.1016/0925-4439(93)90091-E; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jahnke VE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008637; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; JOHNSON LV, 1981, J CELL BIOL, V88, P526, DOI 10.1083/jcb.88.3.526; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; KOROHODA W, 1993, FOLIA HISTOCHEM CYTO, V31, P9; Kraft CS, 2006, AM J PHYSIOL-CELL PH, V290, pC1119, DOI 10.1152/ajpcell.00463.2005; Leary SC, 1998, BBA-BIOENERGETICS, V1365, P522, DOI 10.1016/S0005-2728(98)00105-4; Lees SJ, 2008, CELL PROLIFERAT, V41, P193, DOI 10.1111/j.1365-2184.2008.00512.x; LI K, 1995, AM J PHYSIOL-CELL PH, V269, pC1265, DOI 10.1152/ajpcell.1995.269.5.C1265; Luo Y, 1997, P NATL ACAD SCI USA, V94, P9705, DOI 10.1073/pnas.94.18.9705; Martin SD, 2009, CYTOTECHNOLOGY, V61, P93, DOI 10.1007/s10616-009-9247-3; Mellstrom B, 2008, PHYSIOL REV, V88, P421, DOI 10.1152/physrev.00041.2005; MORGAN JE, 1994, DEV BIOL, V162, P486, DOI 10.1006/dbio.1994.1103; Moyes CD, 1997, AM J PHYSIOL-CELL PH, V272, pC1345, DOI 10.1152/ajpcell.1997.272.4.C1345; Passarino G, 2010, BIOGERONTOLOGY, V11, P575, DOI 10.1007/s10522-010-9294-3; Rehman J, 2010, J MOL MED, V88, P981, DOI 10.1007/s00109-010-0678-2; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Sarsour EH, 2009, ANTIOXID REDOX SIGN, V11, P2985, DOI [10.1089/ars.2009.2513, 10.1089/ARS.2009.2513]; Shavlakadze T, 2010, BIOGERONTOLOGY, V11, P363, DOI 10.1007/s10522-009-9260-0; Shibata M, 2006, EUR J APPL PHYSIOL, V97, P327, DOI 10.1007/s00421-006-0200-2; Starkey JD, 2011, J HISTOCHEM CYTOCHEM, V59, P33, DOI 10.1369/jhc.2010.956995; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	40	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43853	10.1371/journal.pone.0043853	http://dx.doi.org/10.1371/journal.pone.0043853			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937109	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500111
J	Qiao, L; Li, YH; Xiong, G; Liu, XF; He, SZ; Tong, XL; Wu, SY; Hu, H; Wang, RX; Hu, HW; Chen, LS; Zhang, L; Wu, J; Dai, FY; Lu, C; Xiang, ZH				Qiao, Liang; Li, Yuanhao; Xiong, Gao; Liu, Xiaofan; He, Songzhen; Tong, Xiaoling; Wu, Songyuan; Hu, Hai; Wang, Rixin; Hu, Hongwei; Chen, Lushi; Zhang, Li; Wu, Jie; Dai, Fangyin; Lu, Cheng; Xiang, Zhonghuai			Effects of Altered Catecholamine Metabolism on Pigmentation and Physical Properties of Sclerotized Regions in the Silkworm Melanism Mutant	PLOS ONE			English	Article							MEDITERRANEAN FRUIT-FLY; BLATTELLA-GERMANICA L; BETA-ALANINE; WILD-TYPE; TRIBOLIUM-CASTANEUM; CUTICULAR SCLEROTIZATION; N-ACETYLTRANSFERASE; INSECT PIGMENTATION; COLOR PATTERNS; CUTICLE	Catecholamine metabolism plays an important role in the determination of insect body color and cuticle sclerotization. To date, limited research has focused on these processes in silkworm. In the current study, we analyzed the interactions between catecholamines and melanin genes and their effects on the pigmentation patterns and physical properties of sclerotized regions in silkworm, using the melanic mutant melanism (mln) silkworm strain as a model. Injection of beta-alanine into mln mutant silkworm induced a change in catecholamine metabolism and turned its body color yellow. Further investigation of the catecholamine content and expression levels of the corresponding melanin genes from different developmental stages of Dazao-mln (mutant) and Dazao (wild-type) silkworm revealed that at the larval and adult stages, the expression patterns of melanin genes precipitated dopamine accumulation corresponding to functional loss of Bm-iAANAT, a repressive effect of excess NBAD on ebony, and upregulation of tan in the Dazao-mln strain. During the early pupal stage, dopamine did not accumulate in Dazao-mln, since upregulation of ebony and black genes led to conversion of high amounts of dopamine into NBAD, resulting in deep yellow cuticles. Scanning electron microscope analysis of a cross-section of adult dorsal plates from both wild-type and mutant silkworm disclosed the formation of different layers in Dazaomln owing to lack of NADA, compared to even and dense layers in Dazao. Analysis of the mechanical properties of the anterior wings revealed higher storage modulus and lower loss tangent in Dazao-mln, which was closely associated with the altered catecholamine metabolism in the mutant strain. Based on these findings, we conclude that catecholamine metabolism is crucial for the color pattern and physical properties of cuticles in silkworm. Our results should provide a significant contribution to Lepidoptera cuticle tanning research.	[Qiao, Liang; Li, Yuanhao; Xiong, Gao; Liu, Xiaofan; He, Songzhen; Tong, Xiaoling; Wu, Songyuan; Hu, Hai; Wang, Rixin; Chen, Lushi; Zhang, Li; Wu, Jie; Dai, Fangyin; Lu, Cheng; Xiang, Zhonghuai] Southwest Univ, State Key Lab Silkworm Genome Biol, Inst Sericulture & Syst Biol, Chongqing, Peoples R China; [Tong, Xiaoling] Chongqing Univ, Inst Agr & Life Sci, Chongqing 630044, Peoples R China; [Hu, Hongwei; Dai, Fangyin] Southwest Univ, Coll Biotechnol, Chongqing, Peoples R China	Southwest University - China; Chongqing University; Southwest University - China	Qiao, L (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Inst Sericulture & Syst Biol, Chongqing, Peoples R China.	fydai@swu.edu.cn; lucheng@swu.edu.cn		Qiao, Liang/0000-0002-4638-3225; Tong, Xiaoling/0000-0002-2649-899X	National Basic Research 973 Program of China [2012CB114600]; National Natural Science Foundation of China [31072088, 30901053]; Fundamental Research Funds for the Central Universities in China [XDJK2009C192]	National Basic Research 973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities in China	This work was supported by National Basic Research 973 Program of China Grant (No. 2012CB114600) (http://www.973.gov.cn/Default_3.aspx), the National Natural Science Foundation of China (No. 31072088, No. 30901053) (http://www.nsfc.gov.cn/Portal0/default152.htm), and Fundamental Research Funds for the Central Universities in China (No. XDJK2009C192) (http://www.moe.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SO, 1996, COMP BIOCHEM PHYS B, V113, P689, DOI 10.1016/0305-0491(95)02089-6; Andersen SO, 2007, INSECT BIOCHEM MOLEC, V37, P969, DOI 10.1016/j.ibmb.2007.05.002; Andersen SO, 2007, INSECT BIOCHEM MOLEC, V37, P223, DOI 10.1016/j.ibmb.2006.11.006; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; Arakane Y, 2005, P NATL ACAD SCI USA, V102, P11337, DOI 10.1073/pnas.0504982102; Arakane Y, 2009, J BIOL CHEM, V284, P16584, DOI 10.1074/jbc.M901629200; Bear A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011563; CZAPLA TH, 1989, ARCH INSECT BIOCHEM, V12, P145, DOI 10.1002/arch.940120303; CZAPLA TH, 1990, J INSECT PHYSIOL, V36, P647, DOI 10.1016/0022-1910(90)90069-R; CZAPLA TH, 1990, J COMP PHYSIOL B, V160, P175, DOI 10.1007/BF00300950; Dai FY, 2010, J BIOL CHEM, V285, P19553, DOI 10.1074/jbc.M109.096743; Dittmer NT, 2009, INSECT BIOCHEM MOLEC, V39, P596, DOI 10.1016/j.ibmb.2009.06.006; Engel MS, 2004, NATURE, V427, P627, DOI 10.1038/nature02291; Ferguson LC, 2011, DEV GENES EVOL, V221, P297, DOI 10.1007/s00427-011-0380-6; Futahashi R, 2005, DEV GENES EVOL, V215, P519, DOI 10.1007/s00427-005-0014-y; Futahashi R, 2011, INSECT BIOCHEM MOLEC, V41, P191, DOI 10.1016/j.ibmb.2010.12.003; Futahashi R, 2010, EVOL DEV, V12, P157, DOI 10.1111/j.1525-142X.2010.00401.x; Futahashi R, 2008, GENETICS, V180, P1995, DOI 10.1534/genetics.108.096388; Gorman MJ, 2010, INSECT BIOCHEM MOLEC, V40, P267, DOI 10.1016/j.ibmb.2010.01.004; Hassan EB, 2009, J APPL POLYM SCI, V112, P1436, DOI 10.1002/app.29521; Hiruma K, 2009, INSECT BIOCHEM MOLEC, V39, P245, DOI 10.1016/j.ibmb.2009.01.008; HOPKINS TL, 1984, INSECT BIOCHEM, V14, P533, DOI 10.1016/0020-1790(84)90008-8; Hu F, 2009, MICRON, V40, P320, DOI 10.1016/j.micron.2008.11.001; Ito K, 2010, J BIOL CHEM, V285, P5624, DOI 10.1074/jbc.M109.035741; Joron M, 2011, NATURE, V477, P203, DOI 10.1038/nature10341; Koch PB, 2000, PIGM CELL RES, V13, P54, DOI 10.1111/j.0893-5785.2000.130811.x; KRAMER KJ, 1984, INSECT BIOCHEM, V14, P293, DOI 10.1016/0020-1790(84)90063-5; Liu C, 2010, P NATL ACAD SCI USA, V107, P12980, DOI 10.1073/pnas.1001725107; Liu T, 2008, J NEUROSCI, V28, P5539, DOI 10.1523/JNEUROSCI.5290-07.2008; Liu T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004574; Lomakin J, 2011, BIOMACROMOLECULES, V12, P321, DOI 10.1021/bm1009156; Lomakin J, 2010, J INSECT PHYSIOL, V56, P1901, DOI 10.1016/j.jinsphys.2010.08.012; Ma ZY, 2011, P NATL ACAD SCI USA, V108, P3882, DOI 10.1073/pnas.1015098108; Menard K.P., 1999, DYNAMIC MECH ANAL PR; MORGAN TD, 1987, INSECT BIOCHEM, V17, P255, DOI 10.1016/0020-1790(87)90066-7; Moussian B, 2010, INSECT BIOCHEM MOLEC, V40, P363, DOI 10.1016/j.ibmb.2010.03.003; Murayama T., 1978, DYNAMIC MECH ANAL PO; Pendleton RG, 2005, PHARMACOL BIOCHEM BE, V81, P849, DOI 10.1016/j.pbb.2005.06.008; ROSELAND CR, 1987, INSECT BIOCHEM, V17, P21, DOI 10.1016/0020-1790(87)90139-9; Scherfer C, 2008, DEV BIOL, V323, P189, DOI 10.1016/j.ydbio.2008.08.030; Shirataki H, 2010, EVOL DEV, V12, P305, DOI 10.1111/j.1525-142X.2010.00416.x; Sugumaran M, 1998, ADV INSECT PHYSIOL, V27, P229, DOI 10.1016/S0065-2806(08)60014-4; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; TURI EA, 1997, THERMAL CHARACTERIZA; van't Hof AE, 2011, SCIENCE, V332, P958, DOI 10.1126/science.1203043; Walter MF, 1996, ARCH INSECT BIOCHEM, V31, P219, DOI 10.1002/(SICI)1520-6327(1996)31:2&lt;219::AID-ARCH9&gt;3.0.CO;2-U; WAPPNER P, 1995, INSECT BIOCHEM MOLEC, V25, P365, DOI 10.1016/0965-1748(94)00078-V; Wappner P, 1996, INSECT BIOCHEM MOLEC, V26, P585, DOI 10.1016/S0965-1748(96)00012-4; Wappner P, 1996, J INSECT PHYSIOL, V42, P455, DOI 10.1016/0022-1910(95)00131-X; Wicker-Thomas C, 2008, J INSECT PHYSIOL, V54, P1423, DOI 10.1016/j.jinsphys.2008.08.005; Wittkopp PJ, 2009, SCIENCE, V326, P540, DOI 10.1126/science.1176980; Wittkopp PJ, 2009, SEMIN CELL DEV BIOL, V20, P65, DOI 10.1016/j.semcdb.2008.10.002; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Zhan SA, 2010, DEVELOPMENT, V137, P4083, DOI 10.1242/dev.053678	54	17	19	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42968	10.1371/journal.pone.0042968	http://dx.doi.org/10.1371/journal.pone.0042968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937004	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500023
J	Eckford, PDW; Li, CH; Ramjeesingh, M; Bear, CE				Eckford, Paul D. W.; Li, Canhui; Ramjeesingh, Mohabir; Bear, Christine E.			Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Potentiator VX-770 (Ivacaftor) Opens the Defective Channel Gate of Mutant CFTR in a Phosphorylation-dependent but ATP-independent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAIN; SMALL-MOLECULE MODULATOR; CL-CHANNEL; CHLORIDE CHANNEL; FUNCTIONAL RECONSTITUTION; IN-VITRO; RESCUE; G551D; PURIFICATION; DIMERIZATION	The cystic fibrosis transmembrane conductance regulator (CFTR) acts as a channel on the apical membrane of epithelia. Disease-causing mutations in the cystic fibrosis gene can lead to CFTR protein misfolding as in the case of the F508del mutation and/or channel dysfunction. Recently, a small molecule, VX-770 (ivacaftor), has shown efficacy in restoring lung function in patients bearing the G551D mutation, and this has been linked to repair of its channel gating defect. However, these studies did not reveal the mechanism of action of VX-770 in detail. Normally, CFTR channel activity is regulated by phosphorylation, ATP binding, and hydrolysis. Hence, it has been hypothesized that VX-770 modifies one or more of these metabolic events. In this study, we examined VX-770 activity using a reconstitution system for purified CFTR protein, a system that enables control of known regulatory factors. We studied the consequences of VX-770 interaction with CFTR incorporated in planar lipid bilayers and in proteoliposomes, using a novel flux-based assay. We found that purified and phosphorylated CFTR was potentiated in the presence of Mg-ATP, suggesting that VX-770 bound directly to the CFTR protein, rather than associated kinases or phosphatases. Interestingly, we also found that VX-770 enhanced the channel activity of purified and mutant CFTR in the nominal absence of Mg-ATP. These findings suggest that VX-770 can cause CFTR channel opening through a nonconventional ATP-independent mechanism. This work sets the stage for future studies of the structural properties that mediate CFTR gating using VX-770 as a probe.	[Eckford, Paul D. W.; Li, Canhui; Ramjeesingh, Mohabir; Bear, Christine E.] Hosp Sick Children, Res Inst, Programme Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Eckford, Paul D. W.; Bear, Christine E.] Univ Toronto, Fac Med, Dept Biochem, Toronto, ON M5G 1X8, Canada; [Bear, Christine E.] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Bear, CE (corresponding author), Hosp Sick Children, Res Inst, Programme Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	bear@sickkids.ca	Eckford, Paul/ABE-9189-2021		Cystic Fibrosis Canada; Canadian Institutes of Health Research (supporting studies of channel function of purified and reconstituted WT-CFTR) [F508del-CFTR, G551D-CFTR]; Vertex Pharmaceuticals; Canadian Institutes of Health Research and Cystic Fibrosis Canada	Cystic Fibrosis Canada; Canadian Institutes of Health Research (supporting studies of channel function of purified and reconstituted WT-CFTR)(Canadian Institutes of Health Research (CIHR)); Vertex Pharmaceuticals(Vertex Pharmaceuticals); Canadian Institutes of Health Research and Cystic Fibrosis Canada(Canadian Institutes of Health Research (CIHR))	This work was supported in part by operating grants (to C. E. B.) by Cystic Fibrosis Canada and the Canadian Institutes of Health Research (supporting studies of channel function of purified and reconstituted WT-CFTR, F508del-CFTR, and G551D-CFTR). Vertex Pharmaceuticals supported the ATPase studies in Fig. 6D with a sponsored research agreement.; Supported by postdoctoral fellowships from Canadian Institutes of Health Research and Cystic Fibrosis Canada.; Studies of the effect of VX-770 on the ATPase activity of G551D-CFTR were supported by a sponsored research agreement from Vertex Pharmaceuticals (Fig. 6D). Vertex Pharmaceuticals provided VX-770 and its inactive analog for this study. We also thank Ling Jun Huan, Steven Molinski, and Stan Pasyk for their assistance with ATPase studies and discussions regarding interpretation. Stan Pasyk also assisted in the single channel analyses. We acknowledge the Cystic Fibrosis Foundation Therapeutics (CFFT) and Dr. Robert Bridges, Rosalind Franklin University, for providing CFTR<INF>inh</INF>-172 and other CFTR modulator compounds.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Alkhouri B, 2011, J MED CHEM, V54, P8693, DOI 10.1021/jm201335c; ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; Artigas P, 2006, MOL PHARMACOL, V70, P2015, DOI 10.1124/mol.106.026070; BAUKROWITZ T, 1994, NEURON, V12, P473, DOI 10.1016/0896-6273(94)90206-2; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; BEAR CE, 1991, J BIOL CHEM, V266, P19142; Bear CE, 1997, J BIOENERG BIOMEMBR, V29, P465, DOI 10.1023/A:1022435007193; Bernard K, 2009, J BIOL CHEM, V284, P30754, DOI 10.1074/jbc.M109.056010; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Cai ZW, 2006, J BIOL CHEM, V281, P1970, DOI 10.1074/jbc.M510576200; CHANG XB, 1993, J BIOL CHEM, V268, P11304; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Chiaw PK, 2010, MOL PHARMACOL, V78, P411, DOI 10.1124/mol.110.065862; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; Gadsby DC, 1999, ADV SEC MESS PHOSPH, V33, P79; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Jih KY, 2011, J PHYSIOL-LONDON, V589, P2719, DOI 10.1113/jphysiol.2010.202861; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; Kirk KL, 2011, J BIOL CHEM, V286, P12813, DOI 10.1074/jbc.R111.219634; Kogan Ilana, 2002, Methods Mol Med, V70, P143; Kogan Ilana, 2004, J Cyst Fibros, V3 Suppl 2, P133, DOI 10.1016/j.jcf.2004.05.028; Lee SY, 2009, J MOL BIOL, V387, P1055, DOI 10.1016/j.jmb.2009.02.034; LI CH, 1993, NAT GENET, V3, P311, DOI 10.1038/ng0493-311; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Lundbaek JA, 2010, P NATL ACAD SCI USA, V107, P15427, DOI 10.1073/pnas.1007455107; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Pasyk S, 2009, BIOCHEM J, V418, P185, DOI 10.1042/BJ20081424; Proesmans M, 2008, EUR J PEDIATR, V167, P839, DOI 10.1007/s00431-008-0693-2; Ramjeesingh M, 1997, BIOCHEM J, V327, P17, DOI 10.1042/bj3270017; Ramjeesingh M, 1999, BIOCHEMISTRY-US, V38, P1463, DOI 10.1021/bi982243y; Ramjeesingh M, 2001, BIOCHEMISTRY-US, V40, P10700, DOI 10.1021/bi0108195; Ramjeesingh M, 1999, Methods Enzymol, V294, P227; Ramjeesingh M., 2010, RELIABLE LAB SOLUTIO, P337; Ramjeesingh M, 2008, BIOCHEM J, V412, P315, DOI 10.1042/BJ20071719; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Roxo-Rosa M, 2006, P NATL ACAD SCI USA, V103, P17891, DOI 10.1073/pnas.0608312103; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Walden M, 2007, J GEN PHYSIOL, V129, P317, DOI 10.1085/jgp.200709756; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; Wang W, 2010, P NATL ACAD SCI USA, V107, P3888, DOI 10.1073/pnas.0913001107; Wellhauser L, 2009, MOL PHARMACOL, V75, P1430, DOI 10.1124/mol.109.055608	49	190	203	1	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36639	36649		10.1074/jbc.M112.393637	http://dx.doi.org/10.1074/jbc.M112.393637			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22942289	hybrid, Green Published			2022-12-25	WOS:000310588500002
J	Lian, N; Lin, TH; Liu, WG; Wang, WG; Li, LZ; Sun, S; Nyman, JS; Yang, XL				Lian, Na; Lin, Tonghui; Liu, Wenguang; Wang, Weiguang; Li, Lingzhen; Sun, Stephanie; Nyman, Jeffry S.; Yang, Xiangli			Transforming Growth Factor beta Suppresses Osteoblast Differentiation via the Vimentin Activating Transcription Factor 4 (ATF4) Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE LACKING VIMENTIN; MESENCHYMAL STEM-CELLS; TGF-BETA; INTERMEDIATE FILAMENT; GENE-EXPRESSION; PHOSPHATIDYLINOSITOL 3-KINASE; CLEIDOCRANIAL DYSPLASIA; CHEMOTACTIC RESPONSE; TARGETED DISRUPTION; SIGNAL-TRANSDUCTION	ATF4 is an osteoblast-enriched transcription factor of the leucine zipper family. We recently identified that vimentin, a leucine zipper-containing intermediate filament protein, suppresses ATF4-dependent osteocalcin (Ocn) transcription and osteoblast differentiation. Here we show that TGF beta inhibits ATF4-dependent activation of Ocn by up-regulation of vimentin expression. Osteoblasts lacking Atf4 (Atf4(-/-)) were less sensitive than wild-type (WT) cells to the inhibition by TGF beta on alkaline phosphatase activity, Ocn transcription and mineralization. Importantly, the anabolic effect of a monoclonal antibody neutralizing active TGF beta ligands on bone in WT mice was blunted in Atf4(-/-) mice. These data establish that ATF4 is required for TGF beta-related suppression of Ocn transcription and osteoblast differentiation in vitro and in vivo. Interestingly, TGF beta did not directly regulate the expression of ATF4; instead, it enhanced the expression of vimentin, a negative regulator of ATF4, at the post-transcriptional level. Accordingly, knockdown of endogenous vimentin in 2T3 osteoblasts abolished the inhibition of Ocn transcription by TGF beta, confirming an indirect mechanism by which TGF beta acts through vimentin to suppress ATF4-dependent Ocn activation. Furthermore, inhibition of PI3K/Akt/mTOR signaling, but not canonical Smad signaling, downstream of TGF beta, blocked TGF beta-induced synthesis of vimentin, and inhibited ATF4-dependent Ocn transcription in osteoblasts. Thus, our study identifies that TGF beta stimulates vimentin production via PI3K-Akt-mTOR signaling, which leads to suppression of ATF4-dependent Ocn transcription and osteoblast differentiation.	[Lian, Na; Lin, Tonghui; Liu, Wenguang; Wang, Weiguang; Li, Lingzhen; Sun, Stephanie; Nyman, Jeffry S.; Yang, Xiangli] Vanderbilt Univ Sch Med, Vanderbilt Ctr Bone Biol, Nashville, TN 37232 USA; [Lin, Tonghui; Liu, Wenguang; Li, Lingzhen; Sun, Stephanie; Yang, Xiangli] Vanderbilt Univ Sch Med, Dept Med, Nashville, TN 37232 USA; [Wang, Weiguang; Yang, Xiangli] Vanderbilt Univ Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; [Nyman, Jeffry S.] Vanderbilt Univ Sch Med, Dept Orthoped & Rehabil, Nashville, TN 37232 USA; [Nyman, Jeffry S.] Tennessee Valley Hlth Care Syst, Dept Vet Affairs, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Yang, XL (corresponding author), 2215B Garland Ave,1225F MRB 4, Nashville, TN 37232 USA.	xiangli.yang@vanderbilt.edu	Lin, Tonghui/L-7592-2016; Nyman, Jeffry/L-5736-2013	Lin, Tonghui/0000-0003-3512-9624; Nyman, Jeffry/0000-0001-7403-7605	Vanderbilt University; Dept. of Veterans Affairs, Biomedical Laboratory Research and Development; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE017111] Funding Source: NIH RePORTER	Vanderbilt University; Dept. of Veterans Affairs, Biomedical Laboratory Research and Development; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Vanderbilt University career developmental funds (to X. Y.) and the Dept. of Veterans Affairs, Biomedical Laboratory Research and Development (to J. S. N.).	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Bae SC, 2001, J BONE JOINT SURG AM, V83A, pS48; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; BREEN EC, 1994, J CELL PHYSIOL, V160, P323, DOI 10.1002/jcp.1041600214; Byfield SD, 2004, MOL PHARMACOL, V65, P744, DOI 10.1124/mol.65.3.744; CAPETANAKI Y, 1989, J CELL BIOL, V109, P1653, DOI 10.1083/jcb.109.4.1653; CAPETANAKI YG, 1984, P NATL ACAD SCI-BIOL, V81, P6909, DOI 10.1073/pnas.81.22.6909; CENTRELLA M, 1994, ENDOCR REV, V15, P27, DOI 10.1210/er.15.1.27; Colucci-Guyon E, 1999, GLIA, V25, P33, DOI 10.1002/(SICI)1098-1136(19990101)25:1<33::AID-GLIA4>3.0.CO;2-J; DASCH JR, 1989, J IMMUNOL, V142, P1536; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; ECAROTCHARRIER B, 1983, J CELL BIOL, V96, P639, DOI 10.1083/jcb.96.3.639; Eckes B, 2000, J CELL SCI, V113, P2455; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Edwards JR, 2010, J BONE MINER RES, V25, P2419, DOI 10.1002/jbmr.139; Erlebacher A, 1998, MOL BIOL CELL, V9, P1903, DOI 10.1091/mbc.9.7.1903; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Frey RS, 1997, CANCER RES, V57, P628; HAUSCHKA PV, 1986, HAEMOSTASIS, V16, P258; Henrion D, 1997, J CLIN INVEST, V100, P2909, DOI 10.1172/JCI119840; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Lee KW, 2010, STEM CELLS DEV, V19, P557, DOI 10.1089/scd.2009.0147; Lian N, 2009, J BIOL CHEM, V284, P30518, DOI 10.1074/jbc.M109.052373; LOMRI A, 1990, BONE MINER, V10, P1, DOI 10.1016/0169-6009(90)90045-H; LUCAS PA, 1989, BONE, V10, P459, DOI 10.1016/8756-3282(89)90079-3; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Masuoka HC, 2002, BLOOD, V99, P736, DOI 10.1182/blood.V99.3.736; MULDER KM, 1992, J BIOL CHEM, V267, P5029; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; MUNDY GR, 1991, CIBA F SYMP, V157, P137; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; OLSON EN, 1989, ONCOGENE, V4, P907; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; PFEILSCHIFTER J, 1990, J BONE MINER RES, V5, P825; Pinkas J, 2006, BIOCHEM PHARMACOL, V72, P523, DOI 10.1016/j.bcp.2006.03.004; Qiu T, 2010, NAT CELL BIOL, V12, P224, DOI 10.1038/ncb2022; ROBEY PG, 1987, J CELL BIOL, V105, P457, DOI 10.1083/jcb.105.1.457; Schinke T, 1999, J BIOL CHEM, V274, P30182, DOI 10.1074/jbc.274.42.30182; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Singha UK, 2008, J CELL BIOCHEM, V103, P434, DOI 10.1002/jcb.21411; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; TAPSCOTT SJ, 1981, DEV BIOL, V86, P40, DOI 10.1016/0012-1606(81)90313-4; Terzi F, 1997, J CLIN INVEST, V100, P1520, DOI 10.1172/JCI119675; Wang WG, 2009, DEVELOPMENT, V136, P4143, DOI 10.1242/dev.043281; Wilkes MC, 2005, CANCER RES, V65, P10431, DOI 10.1158/0008-5472.CAN-05-1522; Wu YZ, 2007, BBA-MOL CELL RES, V1773, P427, DOI 10.1016/j.bbamcr.2006.11.017; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; YAN ZF, 1994, J BIOL CHEM, V269, P13231; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Yang XL, 2000, J BIOL CHEM, V275, P1065, DOI 10.1074/jbc.275.2.1065; Yu SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007583; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	65	51	52	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35975	35984		10.1074/jbc.M112.372458	http://dx.doi.org/10.1074/jbc.M112.372458			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22952236	Green Published, hybrid			2022-12-25	WOS:000310364000019
J	West, JM; Zvonok, N; Whitten, KM; Vadivel, SK; Bowman, AL; Makriyannis, A				West, Jay M.; Zvonok, Nikolai; Whitten, Kyle M.; Vadivel, Subramanian K.; Bowman, Anna L.; Makriyannis, Alexandros			Biochemical and Mass Spectrometric Characterization of Human N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition	PLOS ONE			English	Article							HUMAN MONOACYLGLYCEROL LIPASE; PROTEOLYTIC ACTIVATION; CANNABINOID RECEPTOR; BETA-LACTONE; ACTIVE-SITE; HYDROLASE; CERAMIDASE; PALMITOYLETHANOLAMIDE; PURIFICATION; CYSTEINE	The mechanism of inactivation of human enzyme N-acylethanolamine-hydrolyzing acid amidase (hNAAA), with selected inhibitors identified in a novel fluorescent based assay developed for characterization of both reversible and irreversible inhibitors, was investigated kinetically and using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). 1-Isothiocyanatopentadecane (AM9023) was found to be a potent, selective and reversible hNAAA inhibitor, while two others, 5-((biphenyl-4-yl)methyl)-N,N-dimethyl-2H-tetrazole-2-carboxamide (AM6701) and N-Benzyloxycarbonyl-L-serine beta-lactone (N-Cbz-serine beta-lactone), inhibited hNAAA in a covalent and irreversible manner. MS analysis of the hNAAA/covalent inhibitor complexes identified modification only of the N-terminal cysteine (Cys126) of the beta-subunit, confirming a suggested mechanism of hNAAA inactivation by the beta-lactone containing inhibitors. These experiments provide direct evidence of the key role of Cys126 in hNAAA inactivation by different classes of covalent inhibitors, confirming the essential role of cysteine for catalysis and inhibition in this cysteine N-terminal nucleophile hydrolase enzyme. They also provide a methodology for the rapid screening and characterization of large libraries of compounds as potential inhibitors of NAAA, and subsequent characterization or their mechanism through MALDI-TOF MS based bottom up-proteomics.	[West, Jay M.; Zvonok, Nikolai; Whitten, Kyle M.; Vadivel, Subramanian K.; Bowman, Anna L.; Makriyannis, Alexandros] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA	Northeastern University	West, JM (corresponding author), Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA.	a.makriyannis@neu.edu	Makriyannis, Alexandros/GRF-1518-2022; Bowman, Anna/B-3771-2010	Makriyannis, Alexandros/0000-0003-3272-3687; Bowman, Anna/0000-0002-3287-1949	National Institutes of Health/National Institute on Drug Abuse [DA003801, DA007312, DA009158]; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA009158, R37DA003801, R01DA003801, T32DA007312] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants DA003801, DA007312, and DA009158 from the National Institutes of Health/National Institute on Drug Abuse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Alvarez-Jaimes LJ, CURR PHARM BIOTECHNO; Armirotti A, 2012, ACS MED CHEM LETT; BERNARDO K, 1995, J BIOL CHEM, V270, P11098, DOI 10.1074/jbc.270.19.11098; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Godlewski G, 2009, PROSTAG OTH LIPID M, V89, P105, DOI 10.1016/j.prostaglandins.2009.07.001; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Karageorgos I, 2010, MOL BIOSYST, V6, P1381, DOI 10.1039/c004515b; KITZ R, 1962, J BIOL CHEM, V237, P3245; Labar G, 2007, CHEM BIODIVERS, V4, P1882, DOI 10.1002/cbdv.200790157; Lall MS, 1999, ORG LETT, V1, P803, DOI 10.1021/ol990148r; Li C, 2005, J MED CHEM, V48, P6423, DOI 10.1021/jm050272i; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Lodola A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032397; Mileni M, 2008, P NATL ACAD SCI USA, V105, P12820, DOI 10.1073/pnas.0806121105; MORSE KL, 1995, LIFE SCI, V56, P1957, DOI 10.1016/0024-3205(95)00176-7; Naidoo V., 2012, NEUROTHERAPEUTICS; O'Sullivan SE, 2007, BRIT J PHARMACOL, V152, P576, DOI 10.1038/sj.bjp.0707423; Oinonen C, 2000, PROTEIN SCI, V9, P2329, DOI 10.1110/ps.9.12.2329; Picone RP, 2005, MOL PHARMACOL, V68, P1623, DOI 10.1124/mol.105.014407; Ramarao MK, 2005, ANAL BIOCHEM, V343, P143, DOI 10.1016/j.ab.2005.04.032; Rossocha M, 2005, BIOCHEMISTRY-US, V44, P5739, DOI 10.1021/bi0473206; Saario SM, 2007, BASIC CLIN PHARMACOL, V101, P287, DOI 10.1111/j.1742-7843.2007.00130.x; Saario SM, 2007, CHEM BIODIVERS, V4, P1903, DOI 10.1002/cbdv.200790158; Saturnino C, 2010, BIOORG MED CHEM LETT, V20, P1210, DOI 10.1016/j.bmcl.2009.11.134; Shtraizent N, 2008, J BIOL CHEM, V283, P11253, DOI 10.1074/jbc.M709166200; Solorzano C, 2010, J MED CHEM, V53, P5770, DOI 10.1021/jm100582w; Solorzano C, 2009, P NATL ACAD SCI USA, V106, P20966, DOI 10.1073/pnas.0907417106; Tsuboi K, 2005, J BIOL CHEM, V280, P11082, DOI 10.1074/jbc.M413473200; Tsuboi K, 2007, CHEM BIODIVERS, V4, P1914, DOI 10.1002/cbdv.200790159; Wang J, 2008, BBA-MOL CELL BIOL L, V1781, P710, DOI 10.1016/j.bbalip.2008.08.004; West JM, 2012, J PROTEOME RES, V11, P972, DOI 10.1021/pr200735a; West JM, 2011, MASS SPECTROMETRIC C, pP3; Yin J, 2005, J MOL BIOL, V354, P854, DOI 10.1016/j.jmb.2005.09.074; Zhao LY, 2007, BBA-MOL CELL BIOL L, V1771, P1397, DOI 10.1016/j.bbalip.2007.10.002; Zvonok N, 2008, CHEM BIOL, V15, P854, DOI 10.1016/j.chembiol.2008.06.008; Zvonok N, 2008, J PROTEOME RES, V7, P2158, DOI 10.1021/pr700839z	37	32	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43877	10.1371/journal.pone.0043877	http://dx.doi.org/10.1371/journal.pone.0043877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952796	Green Submitted, Green Published, gold			2022-12-25	WOS:000308221300030
J	Ballantyne, G; Willmer, P				Ballantyne, Gavin; Willmer, Pat			Nectar Theft and Floral Ant-Repellence: A Link between Nectar Volume and Ant-Repellent Traits?	PLOS ONE			English	Article							PLANT-POLLINATOR INTERACTIONS; EXTRAFLORAL NECTARIES; REABSORPTION; VISITATION; PATTERNS; COSTS; CONSEQUENCES; MUTUALISM; FLOWERS; POLLEN	As flower visitors, ants rarely benefit a plant. They are poor pollinators, and can also disrupt pollination by deterring other flower visitors, or by stealing nectar. Some plant species therefore possess floral ant-repelling traits. But why do particular species have such traits when others do not? In a dry forest in Costa Rica, of 49 plant species around a third were ant-repellent at very close proximity to a common generalist ant species, usually via repellent pollen. Repellence was positively correlated with the presence of large nectar volumes. Repellent traits affected ant species differently, some influencing the behaviour of just a few species and others producing more generalised ant-repellence. Our results suggest that ant-repellent floral traits may often not be pleiotropic, but instead could have been selected for as a defence against ant thieves in plant species that invest in large volumes of nectar. This conclusion highlights to the importance of research into the cost of nectar production in future studies into ant-flower interactions.	[Ballantyne, Gavin; Willmer, Pat] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland	University of St Andrews	Ballantyne, G (corresponding author), Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland.	gab32@st-andrews.ac.uk		Ballantyne, Gavin/0000-0001-7494-0642	Sir Harold Mitchell Scholarship Fund; University of St Andrews Russell Trust Award	Sir Harold Mitchell Scholarship Fund; University of St Andrews Russell Trust Award	This work was supported by Sir Harold Mitchell Scholarship Fund and University of St Andrews Russell Trust Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal VM, 2008, ECOL ENTOMOL, V33, P59, DOI 10.1111/j.1365-2311.2007.00938.x; Altshuler DL, 1999, OECOLOGIA, V119, P600, DOI 10.1007/s004420050825; Apple JL, 2001, OECOLOGIA, V127, P409, DOI 10.1007/s004420000605; Armbruster S., 2000, SCANDINAVIAN ASS POL, V39, P179; BEATTIE AJ, 1985, AM J BOT, V72, P606, DOI 10.2307/2443594; Blancafort X, 2005, ACTA OECOL, V28, P49, DOI 10.1016/j.actao.2005.02.004; Bluthgen N, 2000, OECOLOGIA, V125, P229, DOI 10.1007/s004420000449; Davidson DW, 1997, BIOL J LINN SOC, V61, P153, DOI 10.1006/bijl.1996.0128; de Vega C, 2009, ANN BOT-LONDON, V103, P1065, DOI 10.1093/aob/mcp049; Dukas R, 2003, OIKOS, V101, P157, DOI 10.1034/j.1600-0706.2003.12143.x; Dworschak K, 2010, ECOL ENTOMOL, V35, P216, DOI 10.1111/j.1365-2311.2010.01174.x; Galen C, 2003, OIKOS, V101, P521, DOI 10.1034/j.1600-0706.2003.12144.x; Galen C, 2011, AM NAT, V177, P258, DOI 10.1086/657993; Ghazoul J, 2001, ECOL LETT, V4, P295, DOI 10.1046/j.1461-0248.2001.00229.x; Golubov J, 2004, PLANT ECOL, V170, P267, DOI 10.1023/B:VEGE.0000021698.74964.a3; GUERRANT EO, 1981, BIOTROPICA, V13, P25, DOI 10.2307/2388067; Hansen DM, 2009, BIOTROPICA, V41, P202, DOI 10.1111/j.1744-7429.2008.00473.x; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Hodson AK, 2006, BIOTROPICA, V38, P127; Irwin RE, 2001, OECOLOGIA, V129, P161, DOI 10.1007/s004420100739; JANZEN DH, 1966, EVOLUTION, V20, P249, DOI 10.1111/j.1558-5646.1966.tb03364.x; Junker R, 2007, ECOL RES, V22, P665, DOI 10.1007/s11284-006-0306-3; Junker RR, 2008, EVOL ECOL RES, V10, P295; Junker RR, 2011, ECOL MONOGR, V81, P295, DOI 10.1890/10-1367.1; Junker RR, 2010, ANN BOT-LONDON, V105, P777, DOI 10.1093/aob/mcq045; Koopowitz H, 1998, AM J BOT, V85, P508, DOI 10.2307/2446434; Lach L, 2008, ECOL ENTOMOL, V33, P155, DOI 10.1111/j.1365-2311.2007.00969.x; Lach L, 2008, DIVERS DISTRIB, V14, P281, DOI 10.1111/j.1472-4642.2007.00410.x; Leiss KA, 2004, HEREDITY, V92, P446, DOI 10.1038/sj.hdy.6800439; Lennartsson T, 2002, ECOLOGY, V83, P3060; Luyt R, 2002, BIOTROPICA, V34, P442, DOI 10.1111/j.1744-7429.2002.tb00558.x; Maloof JE, 2000, ECOLOGY, V81, P2651, DOI 10.1890/0012-9658(2000)081[2651:ANRCOM]2.0.CO;2; Nepi M, 2007, PLANT BIOLOGY, V9, P93, DOI 10.1055/s-2006-924287; Ness JH, 2006, OIKOS, V113, P506, DOI 10.1111/j.2006.0030-1299.14143.x; Nicklen EF, 2006, OECOLOGIA, V148, P81, DOI 10.1007/s00442-006-0359-6; NICOLSON SW, 1995, FUNCT ECOL, V9, P584, DOI 10.2307/2390148; Oliver TH, 2007, POPUL ECOL, V49, P265, DOI 10.1007/s10144-007-0044-6; Ollerton J, 2007, TAXON, V56, P717, DOI 10.2307/25065856; Opler PA, 1983, BIOL NECTARIES; Ordano M, 2005, J TROP ECOL, V21, P541, DOI 10.1017/S026646740500266X; PYKE GH, 1991, NATURE, V350, P58, DOI 10.1038/350058a0; Raguso RA, 2004, ECOLOGY, V85, P1486, DOI 10.1890/03-0410; Raine NE, 2007, ARTHROPOD-PLANT INTE, V1, P101, DOI 10.1007/s11829-007-9010-7; Sagers CL, 2000, OECOLOGIA, V123, P582, DOI 10.1007/PL00008863; Schatz B, 1999, J INSECT BEHAV, V12, P641, DOI 10.1023/A:1020927703689; SCHEMSKE DW, 1980, J ECOL, V68, P959, DOI 10.2307/2259468; SOUTHWICK EE, 1984, ECOLOGY, V65, P1775, DOI 10.2307/1937773; Stanton ML, 2002, ECOL MONOGR, V72, P347, DOI 10.1890/0012-9615(2002)072[0347:CCTOIA]2.0.CO;2; Styrsky JD, 2007, P ROY SOC B-BIOL SCI, V274, P151, DOI 10.1098/rspb.2006.3701; Suarez AV, 1998, BIOTROPICA, V30, P480, DOI 10.1111/j.1744-7429.1998.tb00083.x; Tillberg CV, 2004, OECOLOGIA, V140, P506, DOI 10.1007/s00442-004-1601-8; Willmer P., 2011, POLLINATION FLORAL E; Willmer PG, 2009, FUNCT ECOL, V23, P888, DOI 10.1111/j.1365-2435.2009.01632.x; Willmer PG, 1997, NATURE, V388, P165, DOI 10.1038/40610; WILLMER PG, 1986, J ANIM ECOL, V55, P941, DOI 10.2307/4426; Zhang SC, 2012, P ROY SOC B-BIOL SCI, V279, P1824, DOI 10.1098/rspb.2011.2193	56	26	30	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43869	10.1371/journal.pone.0043869	http://dx.doi.org/10.1371/journal.pone.0043869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952793	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206000056
J	Ku, MJ; Dossin, FD; Hansen, MAE; Genovesio, A; Ayong, L; Freitas-Junior, LH				Ku, Min-Je; Dossin, Fernando de M.; Hansen, Michael A. E.; Genovesio, Auguste; Ayong, Lawrence; Freitas-Junior, Lucio H.			An Image-Based Drug Susceptibility Assay Targeting the Placental Sequestration of Plasmodium falciparum-Infected Erythrocytes	PLOS ONE			English	Article							CHONDROITIN-SULFATE-A; CELL-LINE; ADHESION; MALARIA; CYTOADHERENCE; BINDING; PARASITES; RECEPTOR; PROTEIN; CD36	Placental malaria is a significant cause of all malaria-related deaths globally for which no drugs have been developed to specifically disrupt its pathogenesis. To facilitate the discovery of antimalarial drugs targeting the cytoadherence process of Plasmodium-infected erythrocytes in the placenta microvasculature, we have developed an automated image-based assay for high-throughput screening for potent cytoadherence inhibitors in vitro. Parasitized erythrocytes were drug-treated for 24 h and then allowed to adhere on a monolayer of placental BeWo cells prior to red blood cell staining with glycophorin A antibodies. Upon image-acquisition, drug effects were quantified as the proportion of treated parasitized erythrocytes to BeWo cells compared to the binding of untreated iRBCs. We confirmed the reliability of this new assay by comparing the binding ratios of CSA- and CD36-panned parasites on the placental BeWo cells, and by quantifying the effects of chondroitin sulfate A, brefeldin A, and artemisinin on the binding. By simultaneously examining the drug effects on parasite viability, we could discriminate between cytoadherence-specific inhibitors and other schizonticidal compounds. Taken together, our data establish that the developed assay is highly suitable for drug studies targeting placental malaria, and will facilitate the discovery and rapid development of new therapies against malaria.	[Ku, Min-Je; Dossin, Fernando de M.; Ayong, Lawrence; Freitas-Junior, Lucio H.] Inst Pasteur Korea, Ctr Neglected Dis Drug Discovery CND3, Songnam, Gyeonggi Do, South Korea; [Hansen, Michael A. E.; Genovesio, Auguste] Inst Pasteur Korea, Ctr Core Technol Image Min, Songnam, Gyeonggi Do, South Korea	Institut Pasteur Korea; Institut Pasteur Korea	Ku, MJ (corresponding author), Inst Pasteur Korea, Ctr Neglected Dis Drug Discovery CND3, Songnam, Gyeonggi Do, South Korea.	freitasjunior@ip-korea.org	GENOVESIO, Auguste/I-1656-2017; Freitas-Junior, Lucio H/C-8677-2011; Hansen, Michael Adsetts Edberg/C-9028-2011	Freitas-Junior, Lucio H/0000-0002-8904-7897; Hansen, Michael Adsetts Edberg/0000-0001-7879-2106; Genovesio, Auguste/0000-0003-1877-5595	National Research Foundation of Korea (NRF); Korea government (MEST), Gyeonggi-do [2012-00011]; KISTI	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST), Gyeonggi-do; KISTI(Korea Institute of Science & Technology Information (KISTI))	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST)(No. 2012-00011), Gyeonggi-do and KISTI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APLIN JD, 1992, J CELL SCI, V103, P435; Chaisavaneeyakorn S, 2004, AM J TROP MED HYG, V70, P149, DOI 10.4269/ajtmh.2004.70.149; Chen QJ, 2000, CLIN MICROBIOL REV, V13, P439, DOI 10.1128/CMR.13.3.439-450.2000; Cohen J, 2002, APPL MULTIPLE REGRES; Cojean S, 2008, PARASITE, V15, P163, DOI 10.1051/parasite/2008152163; Cortina JM, 1997, PSYCHOL METHODS, V2, P161, DOI 10.1037/1082-989X.2.2.161; Costa FTM, 2006, BRAZ J MED BIOL RES, V39, P1525, DOI 10.1590/S0100-879X2006001200003; Crabb BS, 2010, INT J PARASITOL, V40, P509, DOI 10.1016/j.ijpara.2010.02.002; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Fernandez P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012558; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 2006, EXP PARASITOL, V113, P36, DOI 10.1016/j.exppara.2005.12.003; Haase RN, 2006, INFECT IMMUN, V74, P3035, DOI 10.1128/IAI.74.5.3035-3038.2006; HANDUNNETTI SM, 1992, BLOOD, V80, P2097; Hughes KR, 2010, MOL BIOCHEM PARASIT, V169, P71, DOI 10.1016/j.molbiopara.2009.09.007; Janes JH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002032; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Moon H, 2008, 2008 9TH IEEE/ACM INTERNATIONAL CONFERENCE ON GRID COMPUTING, P334, DOI 10.1109/GRID.2008.4662818; Rafael G., 2007, DIGITAL IMAGE PROCES, V2nd; Scherf A, 2001, CELL MICROBIOL, V3, P125, DOI 10.1046/j.1462-5822.2001.00109.x; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.1631315; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; van der Heyde HC, 2006, INFECT IMMUN, V74, P2717, DOI 10.1128/IAI.74.5.2717-2725.2006; Viebig NK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000910; Viebig NK, 2006, EXP PARASITOL, V112, P121, DOI 10.1016/j.exppara.2005.09.007; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636; Xu LL, 2006, MOL BIOCHEM PARASIT, V146, P142, DOI 10.1016/j.molbiopara.2005.11.005; Yosaatmadja F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-51; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	30	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e41765	10.1371/journal.pone.0041765	http://dx.doi.org/10.1371/journal.pone.0041765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952585	gold, Green Published, Green Submitted			2022-12-25	WOS:000308206000005
J	Soler-Cantero, A; Jove, M; Cacabelos, D; Boada, J; Naudi, A; Romero, MP; Cassanye, A; Serrano, JCE; Arola, L; Valls, J; Bellmunt, MJ; Prat, J; Pamplona, R; Portero-Otin, M; Motilva, MJ				Soler-Cantero, Arantza; Jove, Mariona; Cacabelos, Daniel; Boada, Jordi; Naudi, Alba; Romero, Maria-Paz; Cassanye, Anna; Serrano, Jose C. E.; Arola, Lluis; Valls, Josep; Josep Bellmunt, Maria; Prat, Joan; Pamplona, Reinald; Portero-Otin, Manuel; Motilva, Maria-Jose			Plant-Derived Phenolics Inhibit the Accrual of Structurally Characterised Protein and Lipid Oxidative Modifications	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; HEPATOMA HEPG2 CELLS; OLIVE OIL PHENOLS; ANTIOXIDANT ACTIVITY; GALLIC ACID; ALPHA-TOCOPHEROL; RED WINE; LDL; PEROXIDATION; SUPPLEMENTATION	Epidemiological data suggest that plant-derived phenolics beneficial effects include an inhibition of LDL oxidation. After applying a screening method based on 2,4-dinitrophenyl hydrazine-protein carbonyl reaction to 21 different plant-derived phenolic acids, we selected the most antioxidant ones. Their effect was assessed in 5 different oxidation systems, as well as in other model proteins. Mass-spectrometry was then used, evidencing a heterogeneous effect on the accumulation of the structurally characterized protein carbonyl glutamic and aminoadipic semialdehydes as well as for malondialdehyde-lysine in LDL apoprotein. After TOF based lipidomics, we identified the most abundant differential lipids in Cu++-incubated LDL as 1-palmitoyllysophosphatidylcholine and 1-stearoyl-sn-glycero-3-phosphocholine. Most of selected phenolic compounds prevented the accumulation of those phospholipids and the cellular impairment induced by oxidized LDL. Finally, to validate these effects in vivo, we evaluated the effect of the intake of a phenolic-enriched extract in plasma protein and lipid modifications in a well-established model of atherosclerosis (diet-induced hypercholesterolemia in hamsters). This showed that a dietary supplement with a phenolic-enriched extract diminished plasma protein oxidative and lipid damage. Globally, these data show structural basis of antioxidant properties of plant-derived phenolic acids in protein oxidation that may be relevant for the health-promoting effects of its dietary intake.	[Soler-Cantero, Arantza; Romero, Maria-Paz; Motilva, Maria-Jose] Univ Lleida, Escola Tecn Super Engn Agraria, Dept Food Technol, CeRTA TPV, Lleida, Spain; [Jove, Mariona; Cacabelos, Daniel; Boada, Jordi; Naudi, Alba; Cassanye, Anna; Serrano, Jose C. E.; Josep Bellmunt, Maria; Prat, Joan; Pamplona, Reinald; Portero-Otin, Manuel] Lleida Univ, Lleida IRBLLEIDA, Dept Expt Med, NUTREN Nutrigen Ctr, Lleida, Spain; [Arola, Lluis] Univ Rovira & Virgili, Nutrigen Res Grp, Dept Biochem & Biotechnol, Tarragona, Spain; [Valls, Josep] Shirota Funct Foods, SL, Reus, Spain	Universitat de Lleida; Universitat de Lleida; Universitat Rovira i Virgili	Soler-Cantero, A (corresponding author), Univ Lleida, Escola Tecn Super Engn Agraria, Dept Food Technol, CeRTA TPV, Lleida, Spain.	manuel.portero@mex.udl.cat; motilva@tecal.udl.cat	Motilva, María/U-1506-2019; Fonayet, Josep Valls/AAB-3378-2020; Pamplona, Reinald/A-7359-2010; Portero-Otin, Manuel/B-7122-2009; Arola, Lluís/C-6074-2011; Motilva, Maria-Jose/B-4223-2011; Boada, Jordi/AAG-3075-2019; Prat Sala, Joan/HCI-3331-2022; Naudí, Alba/B-5594-2009; Curcó, Maria Josep Bellmunt/C-3784-2011; Serrano, Jose C. E./C-6557-2011; Romero, Maria-Paz/H-3431-2011; Jové, Mariona/M-9104-2016; Boada, Jordi/B-5586-2009	Fonayet, Josep Valls/0000-0002-1359-4114; Pamplona, Reinald/0000-0003-4337-6107; Portero-Otin, Manuel/0000-0002-1823-0299; Arola, Lluís/0000-0003-2767-1974; Motilva, Maria-Jose/0000-0003-3823-3953; Boada, Jordi/0000-0001-5109-4244; Naudí, Alba/0000-0003-0699-1004; Curcó, Maria Josep Bellmunt/0000-0002-3187-1576; Serrano, Jose C. E./0000-0001-6714-6061; Romero, Maria-Paz/0000-0001-9892-4874; Jové, Mariona/0000-0001-5577-6162; Boada, Jordi/0000-0001-5109-4244; Casane, Anna/0000-0003-3157-7403; Motilva, Maria Jose/0000-0001-8985-7737	Spanish Ministry of Education and Science [BFU2006-14495/BFI, AGL2005-07881-C02-01, AGL2006-12433]; Generalitat of Catalunya [2005SGR00101]; Spanish Ministry of Health [FIS 04-0355, 05-2214, 05-2241]; COST B-35 Action; CENIT program from the Spanish Minister of Industry; La Morella Nuts S.A. (Reus, Catalonia, Spain); Shirota Functional Foods, S. L.; KRAFT; BTSA, Biotecnologias Aplicadas, S. L.; Seleccion Batalle, S. A.; Industrial Tecnica Pecuaria, S. A.; Neuron BioPharma, S. A.; Grupo Leche Pascual, S. A. U.; Innaves, S. A.	Spanish Ministry of Education and Science(Spanish Government); Generalitat of Catalunya(Generalitat de Catalunya); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); COST B-35 Action; CENIT program from the Spanish Minister of Industry; La Morella Nuts S.A. (Reus, Catalonia, Spain); Shirota Functional Foods, S. L.; KRAFT; BTSA, Biotecnologias Aplicadas, S. L.; Seleccion Batalle, S. A.; Industrial Tecnica Pecuaria, S. A.; Neuron BioPharma, S. A.; Grupo Leche Pascual, S. A. U.; Innaves, S. A.	This study was supported in part by Research and Development grants from the Spanish Ministry of Education and Science (BFU2006-14495/BFI) and the Generalitat of Catalunya (2005SGR00101) to RP; the Spanish Ministry of Health (FIS 04-0355, 05-2214 and 05-2241) to MPO, Spanish Ministry of Education and Science (AGL2005-07881-C02-01 and AGL2006-12433) to MJM and MPO. Supported partially by the COST B-35 Action. The present work was supported by the CENIT program from the Spanish Minister of Industry and by a consortium of companies led by La Morella Nuts S.A. (Reus, Catalonia, Spain) with the following companies: Shirota Functional Foods, S. L.; KRAFT; BTSA, Biotecnologias Aplicadas, S. L.; Seleccion Batalle, S. A.; Industrial Tecnica Pecuaria, S. A.; Neuron BioPharma, S. A.; Grupo Leche Pascual, S. A. U.; Innaves, S. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBEY M, 1993, AM J CLIN NUTR, V58, P525, DOI 10.1093/ajcn/58.4.525; Agarwal C, 2006, MOL CANCER THER, V5, P3294, DOI 10.1158/1535-7163.MCT-06-0483; Artajo LS, 2006, J AGR FOOD CHEM, V54, P6079, DOI 10.1021/jf060874q; Auger C, 2004, J AGR FOOD CHEM, V52, P5297, DOI 10.1021/jf040125d; BALLA G, 1991, ARTERIOSCLER THROMB, V11, P1700, DOI 10.1161/01.ATV.11.6.1700; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6; BORS W, 1990, METHOD ENZYMOL, V186, P343; Bouguerne B, 2011, ANTIOXID REDOX SIGN, V14, P2093, DOI 10.1089/ars.2010.3321; Brenes M, 1999, J AGR FOOD CHEM, V47, P3535, DOI 10.1021/jf990009o; Briante R, 2004, CHEM BIODIVERS, V1, P1716, DOI 10.1002/cbdv.200490130; Brown JE, 1998, BIOCHEM J, V330, P1173; Carluccio MA, 2003, ARTERIOSCL THROM VAS, V23, P622, DOI 10.1161/01.ATV.0000062884.69432.A0; Chen CC, 1999, PLANTA MED, V65, P709, DOI 10.1055/s-1999-14093; Chen CY, 2007, J NUTR BIOCHEM, V18, P785, DOI 10.1016/j.jnutbio.2006.12.015; Covas MI, 2007, PHARMACOL RES, V55, P175, DOI 10.1016/j.phrs.2007.01.010; Covas MI, 2003, DRUG EXP CLIN RES, V29, P203; Di Benedetto R, 2007, NUTR METAB CARDIOVAS, V17, P535, DOI 10.1016/j.numecd.2006.03.005; ESTERBAUER H, 1992, FREE RADICAL BIO MED, V13, P341, DOI 10.1016/0891-5849(92)90181-F; Fukuzawa K, 1997, FREE RADICAL BIO MED, V22, P923, DOI 10.1016/S0891-5849(96)00485-6; GOLDSTEIN JL, 1977, ANNU REV BIOCHEM, V46, P897, DOI 10.1146/annurev.bi.46.070177.004341; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Goya L, 2007, MOL NUTR FOOD RES, V51, P536, DOI 10.1002/mnfr.200600228; Goya L, 2007, EUR J NUTR, V46, P70, DOI 10.1007/s00394-006-0633-8; Grassi D, 2008, J NUTR, V138, P1554; Hamdi HK, 2005, BIOCHEM BIOPH RES CO, V334, P769, DOI 10.1016/j.bbrc.2005.06.161; Hayek T, 1997, ARTERIOSCL THROM VAS, V17, P2744, DOI 10.1161/01.ATV.17.11.2744; HAZELL LJ, 1993, BIOCHEM J, V290, P165, DOI 10.1042/bj2900165; Hazell LJ, 1996, J CLIN INVEST, V97, P1535, DOI 10.1172/JCI118576; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Hou LF, 2004, CHEM PHYS LIPIDS, V129, P209, DOI 10.1016/j.chemphyslip.2004.02.001; Hou Z, 2005, CANCER RES, V65, P8049, DOI 10.1158/0008-5472.CAN-05-0480; Hseu YC, 2008, FOOD CHEM TOXICOL, V46, P105, DOI 10.1016/j.fct.2007.07.003; Hsieh CL, 2005, J AGR FOOD CHEM, V53, P6151, DOI 10.1021/jf050707a; Hsu CL, 2007, J AGR FOOD CHEM, V55, P7359, DOI 10.1021/jf071223c; Jeong YJ, 2007, BRIT J NUTR, V97, P447, DOI 10.1017/S0007114507657894; JIALAL I, 1993, CIRCULATION, V88, P2780, DOI 10.1161/01.CIR.88.6.2780; Kamiyama M, 2009, J NUTR SCI VITAMINOL, V55, P471, DOI 10.3177/jnsv.55.471; Kostyuk VA, 2003, FEBS LETT, V537, P146, DOI 10.1016/S0014-5793(03)00113-3; LARANJINHA JAN, 1994, BIOCHEM PHARMACOL, V48, P487, DOI 10.1016/0006-2952(94)90278-X; Leenen R, 2002, J AGR FOOD CHEM, V50, P1290, DOI 10.1021/jf010968u; Leeuwenburgh C, 1997, J BIOL CHEM, V272, P1433, DOI 10.1074/jbc.272.3.1433; Locatelli C, 2008, BIOORGAN MED CHEM, V16, P3791, DOI 10.1016/j.bmc.2008.01.049; Long LH, 2000, BIOCHEM BIOPH RES CO, V273, P50, DOI 10.1006/bbrc.2000.2895; Mazziotti A, 2006, J AGR FOOD CHEM, V54, P7444, DOI 10.1021/jf060982c; Menendez JA, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-80; Nakagawa K, 1999, J AGR FOOD CHEM, V47, P3967, DOI 10.1021/jf981195l; Natella F, 2007, AM J CLIN NUTR, V86, P604, DOI 10.1093/ajcn/86.3.604; Ness AR, 1997, INT J EPIDEMIOL, V26, P1, DOI 10.1093/ije/26.1.1; Oorni K, 1997, J BIOL CHEM, V272, P21303, DOI 10.1074/jbc.272.34.21303; Pamplona R, 2005, J BIOL CHEM, V280, P21522, DOI 10.1074/jbc.M502255200; Pannala A, 1997, BIOCHEM BIOPH RES CO, V232, P164, DOI 10.1006/bbrc.1997.6254; Pulido R, 2000, J AGR FOOD CHEM, V48, P3396, DOI 10.1021/jf9913458; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Stupans I, 2002, J AGR FOOD CHEM, V50, P2464, DOI 10.1021/jf0112320; SUARNA C, 1993, BIOCHIM BIOPHYS ACTA, V1166, P163, DOI 10.1016/0005-2760(93)90092-N; Terra X, 2011, J NUTR BIOCHEM, V22, P380, DOI 10.1016/j.jnutbio.2010.03.006; Vieira O, 1998, BRIT J PHARMACOL, V123, P565, DOI 10.1038/sj.bjp.0701624; Vissers MN, 2004, EUR J CLIN NUTR, V58, P955, DOI 10.1038/sj.ejcn.1601917; Vuorela S, 2005, J AGR FOOD CHEM, V53, P5922, DOI 10.1021/jf050554r; Wagner P, 1997, ARTERIOSCL THROM VAS, V17, P3338, DOI 10.1161/01.ATV.17.11.3338; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Wikoff WR, 2007, CLIN CHEM, V53, P2169, DOI 10.1373/clinchem.2007.089011; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yan LJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P165, DOI 10.1006/abbi.1996.9867	67	8	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43308	10.1371/journal.pone.0043308	http://dx.doi.org/10.1371/journal.pone.0043308			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952663	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206000031
J	Koita, K; Rao, CV				Koita, Khushnuma; Rao, Christopher V.			Identification and Analysis of the Putative Pentose Sugar Efflux Transporters in Escherichia coli	PLOS ONE			English	Article							BETA-D-THIOGALACTOPYRANOSIDE; L-ARABINOSE; RESISTANCE; ENCODES; GENES; K-12; PROTEIN; METHYLGLYOXAL; ACCUMULATION; METABOLITES	Escherichia coli possesses a number of proteins that transport sugars out of the cell. We identified 31 candidate sugar efflux transporters based on their similarity to known sugar efflux transporters. We then tested whether these transporters affect arabinose and xylose metabolism. We identified 13 transporters - setC, cmr, ynfM, mdtD, yfcJ, yhhS, emrD, ydhC, ydeA, ybdA, ydeE, mhpT, and kgtP - that appeared to increase or decrease intracellular arabinose concentrations when respectively deleted or over- expressed. None of the candidate transporters affected xylose concentrations. These results indicate that E. coli possesses multiple arabinose efflux transporters. They also provide a novel target for future metabolic engineering.	[Koita, Khushnuma; Rao, Christopher V.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Koita, K (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.	chris@scs.uiuc.edu			Energy Biosciences Institute	Energy Biosciences Institute	This work was funded by the Energy Biosciences Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN RS, 1974, J BACTERIOL, V119, P357, DOI 10.1128/JB.119.2.357-362.1974; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Bohn C, 1998, J BACTERIOL, V180, P6072, DOI 10.1128/JB.180.22.6072-6075.1998; Bost S, 1999, J BACTERIOL, V181, P2185, DOI 10.1128/JB.181.7.2185-2191.1999; Carole S, 1999, J BACTERIOL, V181, P5123; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Chubiz LM, 2010, J BACTERIOL, V192, P4786, DOI 10.1128/JB.00371-10; Danchin A, 2009, BIOESSAYS, V31, P769, DOI 10.1002/bies.200900024; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Desai TA, 2010, APPL ENVIRON MICROB, V76, P1524, DOI 10.1128/AEM.01970-09; Edgar R, 1997, J BACTERIOL, V179, P2274, DOI 10.1128/jb.179.7.2274-2280.1997; ENGLESBERG E, 1962, J BACTERIOL, V84, P137, DOI 10.1128/JB.84.1.137-146.1962; Ferguson GP, 1998, ARCH MICROBIOL, V170, P209, DOI 10.1007/s002030050635; Furrer JL, 2002, MOL MICROBIOL, V44, P1225, DOI 10.1046/j.1365-2958.2002.02885.x; Han XL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-35; Hayashi M, 2010, FEMS MICROBIOL LETT, V304, P12, DOI 10.1111/j.1574-6968.2009.01879.x; LINDSAY SE, 1995, APPL MICROBIOL BIOT, V43, P70, DOI [10.1007/s002530050372, 10.1007/BF00170625]; Liu JY, 1999, MOL MICROBIOL, V31, P1845, DOI 10.1046/j.1365-2958.1999.01321.x; Liu JY, 1999, J BIOL CHEM, V274, P22977, DOI 10.1074/jbc.274.33.22977; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; NARODITSKAYA V, 1993, BIOCHEM BIOPH RES CO, V196, P803, DOI 10.1006/bbrc.1993.2320; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Rosner JL, 2009, J BACTERIOL, V191, P5283, DOI 10.1128/JB.00507-09; Schleif R, 2000, TRENDS GENET, V16, P559, DOI 10.1016/S0168-9525(00)02153-3; SEOL W, 1991, P NATL ACAD SCI USA, V88, P3802, DOI 10.1073/pnas.88.9.3802; Song SG, 1997, J BACTERIOL, V179, P7025, DOI 10.1128/jb.179.22.7025-7032.1997; Staub JM, 2012, J IND MICROBIOL BIOT, V39, P641, DOI 10.1007/s10295-011-1057-x; Sun Y, 2011, J BACTERIOL, V193, P143, DOI 10.1128/JB.01008-10; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Zgurskaya HI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00189	33	37	42	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43700	10.1371/journal.pone.0043700	http://dx.doi.org/10.1371/journal.pone.0043700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952739	Green Published, gold, Green Submitted			2022-12-25	WOS:000308213600037
J	Lyimo, MA; Mosi, MN; Housman, ML; Zain-Ul-Abideen, M; Lee, FV; Howell, AL; Connor, RI				Lyimo, Magdalena A.; Mosi, Matilda Ngarina; Housman, Molly L.; Zain-Ul-Abideen, Muhammad; Lee, Frederick V.; Howell, Alexandra L.; Connor, Ruth I.			Breast Milk from Tanzanian Women Has Divergent Effects on Cell-Free and Cell-Associated HIV-1 Infection In Vitro	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TO-CHILD TRANSMISSION; ACTIVE ANTIRETROVIRAL THERAPY; SUBCLINICAL MASTITIS; VIROLOGICAL SYNAPSES; RISK; PREVENTION; PREGNANCY; GLYCOSAMINOGLYCANS; GLYCOPROTEIN	Transmission of HIV-1 during breastfeeding is a significant source of new pediatric infections in sub-Saharan Africa. Breast milk from HIV-positive mothers contains both cell-free and cell-associated virus; however, the impact of breast milk on HIV-1 infectivity remains poorly understood. In the present study, breast milk was collected from HIV-positive and HIV-negative Tanzanian women attending antenatal clinics in Dar es Salaam. Milk was analyzed for activity in vitro against both cell-free and cell-associated HIV-1. Potent inhibition of cell-free R5 and X4 HIV-1 occurred in the presence of milk from all donors regardless of HIV-1 serostatus. Inhibition of cell-free HIV-1 infection positively correlated with milk levels of sialyl-Lewis(X) from HIV-positive donors. In contrast, milk from 8 of 16 subjects enhanced infection with cell-associated HIV-1 regardless of donor serostatus. Milk from two of these subjects contained high levels of multiple pro-inflammatory cytokines including TNF alpha, IL-1 beta, IL-6, IL-8, MIP-1 alpha, MIP-1 beta, MCP-1 and IP-10, and enhanced cell-associated HIV-1 infection at dilutions as high as 1:500. These findings indicate that breast milk contains innate factors with divergent activity against cell-free and cell-associated HIV-1 in vitro. Enhancement of cell-associated HIV-1 infection by breast milk may be associated with inflammatory conditions in the mother and may contribute to infant infection during breastfeeding.	[Lyimo, Magdalena A.] Geisel Sch Med Dartmouth, Dept Physiol, Lebanon, NH USA; [Lyimo, Magdalena A.] Geisel Sch Med Dartmouth, Program Expt & Mol Med, Lebanon, NH USA; [Housman, Molly L.; Zain-Ul-Abideen, Muhammad; Lee, Frederick V.; Howell, Alexandra L.; Connor, Ruth I.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH USA; [Lyimo, Magdalena A.; Mosi, Matilda Ngarina] Muhimbili Natl Hosp, Dar Es Salaam, Tanzania; [Lyimo, Magdalena A.] Muhimbili Univ Hlth & Allied Sci, Dept Hematol, Dar Es Salaam, Tanzania; [Howell, Alexandra L.] Vet Affairs Med Ctr, White River Jct, VT USA	Dartmouth College; Dartmouth College; Dartmouth College; Muhimbili University of Health & Allied Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Lyimo, MA (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Hematol, Dar Es Salaam, Tanzania.	Ruth.I.Connor@Dartmouth.edu			National Institutes of Health (NIH) AIDS International Training and Research Program/Fogarty International Center at The Geisel School of Medicine at Dartmouth; Howard Hughes Medical Institute Undergraduate Research Award; Veterans Affairs Merit Review Award	National Institutes of Health (NIH) AIDS International Training and Research Program/Fogarty International Center at The Geisel School of Medicine at Dartmouth(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Undergraduate Research Award(Howard Hughes Medical Institute); Veterans Affairs Merit Review Award(US Department of Veterans Affairs)	This study was supported by the National Institutes of Health (NIH) AIDS International Training and Research Program/Fogarty International Center at The Geisel School of Medicine at Dartmouth, Howard Hughes Medical Institute Undergraduate Research Award, and a Veterans Affairs Merit Review Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrovandi GM, 2010, J INFECT DIS, V202, pS366, DOI 10.1086/655972; Alfano M, 2005, MOL IMMUNOL, V42, P161, DOI 10.1016/j.molimm.2004.06.016; Alfsen A, 2005, MOL BIOL CELL, V16, P4267, DOI 10.1091/mbc.E05-03-0192; Arsenault JE, 2010, J INFECT DIS, V202, P370, DOI 10.1086/653706; Becquart P, 2006, AIDS, V20, P1453, DOI 10.1097/01.aids.0000233581.64467.55; Chama CM, 2010, J OBSTET GYNAECOL, V30, P362, DOI 10.3109/01443611003672104; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; Groot F, 2008, BLOOD, V111, P4660, DOI 10.1182/blood-2007-12-130070; Habte HH, 2008, NEONATOLOGY, V93, P162, DOI 10.1159/000108414; Habte HH, 2007, NEONATOLOGY, V92, P96, DOI 10.1159/000100808; Jolly C, 2007, J VIROL, V81, P13916, DOI 10.1128/JVI.01585-07; Kantarci S, 2007, JAIDS-J ACQ IMM DEF, V46, P651, DOI 10.1097/QAI.0b013e31815b2db2; Kilewo C, 2009, JAIDS-J ACQ IMM DEF, V52, P406, DOI 10.1097/QAI.0b013e3181b323ff; Lehman DA, 2008, AIDS, V22, P1475, DOI 10.1097/QAD.0b013e328302cc11; Lunney KM, 2010, CLIN INFECT DIS, V50, P762, DOI 10.1086/650535; Lyimo MA, 2009, JAIDS-J ACQ IMM DEF, V51, P117, DOI 10.1097/QAI.0b013e3181a3908d; Means RE, 2000, J VIROL, V74, P11181, DOI 10.1128/JVI.74.23.11181-11190.2000; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Naarding MA, 2005, J CLIN INVEST, V115, P3256, DOI 10.1172/JCI25105; Newburg DS, 2009, J ANIM SCI, V87, P26, DOI 10.2527/jas.2008-1347; NEWBURG DS, 1995, J NUTR, V125, P419; PearcePratt R, 1996, BIOL REPROD, V54, P173, DOI 10.1095/biolreprod54.1.173; Petitjean G, 2007, J CLIN VIROL, V39, P1, DOI 10.1016/j.jcv.2007.02.004; Puigdomenech I, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-32; Rousseau CM, 2003, J INFECT DIS, V187, P741, DOI 10.1086/374273; Rousseau CM, 2004, J INFECT DIS, V190, P1880, DOI 10.1086/425076; Saeland E, 2009, MOL IMMUNOL, V46, P2309, DOI 10.1016/j.molimm.2009.03.025; Semba RD, 2000, ANN NY ACAD SCI, V918, P156; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Shapiro RL, 2005, J INFECT DIS, V192, P713, DOI 10.1086/432489; Slyker JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029777; Southern S O, 1998, J Hum Virol, V1, P328; Sun JF, 2001, VIROLOGY, V284, P26, DOI 10.1006/viro.2001.0889; Valea D, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-34; Vasiliver-Shamis G, 2010, VIRUSES-BASEL, V2, P1239, DOI 10.3390/v2051239; Vet JAM, 1999, P NATL ACAD SCI USA, V96, P6394, DOI 10.1073/pnas.96.11.6394; Villamor E, 2007, AM J CLIN NUTR, V86, P682, DOI 10.1093/ajcn/86.3.682; Viveros-Rogel M, 2004, ADV EXP MED BIOL, V554, P481; Walter J, 2009, J INFECT DIS, V200, P1498, DOI 10.1086/644603; Willumsen JF, 2000, ADV EXP MED BIOL, V478, P211	41	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43815	10.1371/journal.pone.0043815	http://dx.doi.org/10.1371/journal.pone.0043815			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952771	Green Published, gold, Green Submitted			2022-12-25	WOS:000308213600046
J	Price, NN; Martz, TR; Brainard, RE; Smith, JE				Price, Nichole N.; Martz, Todd R.; Brainard, Russell E.; Smith, Jennifer E.			Diel Variability in Seawater pH Relates to Calcification and Benthic Community Structure on Coral Reefs	PLOS ONE			English	Article							CARBON-DIOXIDE FLUX; OCEAN ACIDIFICATION; CLIMATE-CHANGE; FLUCTUATIONS; TEMPERATURE; METABOLISM; RESPONSES; PATTERNS; SYSTEM; IMPACT	Community structure and assembly are determined in part by environmental heterogeneity. While reef-building corals respond negatively to warming (i.e. bleaching events) and ocean acidification (OA), the extent of present-day natural variability in pH on shallow reefs and ecological consequences for benthic assemblages is unknown. We documented high resolution temporal patterns in temperature and pH from three reefs in the central Pacific and examined how these data relate to community development and net accretion rates of early successional benthic organisms. These reefs experienced substantial diel fluctuations in temperature (0.78 degrees C) and pH (>0.2) similar to the magnitude of 'warming' and 'acidification' expected over the next century. Where daily pH within the benthic boundary layer failed to exceed pelagic climatological seasonal lows, net accretion was slower and fleshy, non-calcifying benthic organisms dominated space. Thus, key aspects of coral reef ecosystem structure and function are presently related to natural diurnal variability in pH.	[Price, Nichole N.; Martz, Todd R.; Smith, Jennifer E.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Brainard, Russell E.] Natl Ocean & Atmospher Adm, Pacific Isl Fisheries Sci Ctr, Coral Reef Ecosyst Div, Honolulu, HI USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; National Oceanic Atmospheric Admin (NOAA) - USA	Price, NN (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	nprice@ucsd.edu; smithj@ucsd.edu	Smith, Jennifer/E-5207-2013	Martz, Todd/0000-0002-1996-7145; Price, Nichole/0000-0001-6773-3215	Gordon and Betty Moore Foundation; Coral Reef Conservation Program (NOAA); Nature Conservancy; WWW Foundation; Scripps Institution of Oceanography Development Office	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Coral Reef Conservation Program (NOAA); Nature Conservancy; WWW Foundation; Scripps Institution of Oceanography Development Office	This research was supported by grants from the Gordon and Betty Moore Foundation, the Coral Reef Conservation Program (NOAA), the Nature Conservancy, the WWW Foundation, the Scripps Institution of Oceanography Development Office and by generous donations from Scott and Karin Wilson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agegian CR, 1985, BIOGEOCHEMICAL ECOLO; Albright R, 2011, GLOBAL CHANGE BIOL, V17, P2478, DOI 10.1111/j.1365-2486.2011.02404.x; Albright R, 2010, P NATL ACAD SCI USA, V107, P20400, DOI 10.1073/pnas.1007273107; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andersson AJ, 2009, BIOGEOSCIENCES, V6, P1811, DOI 10.5194/bg-6-1811-2009; Arp G, 2003, J SEDIMENT RES, V73, P105, DOI 10.1306/071002730105; Bates NR, 2010, BIOGEOSCIENCES, V7, P2509, DOI 10.5194/bg-7-2509-2010; Bates NR, 2002, LIMNOL OCEANOGR, V47, P43, DOI 10.4319/lo.2002.47.1.0043; Buckley BA, 2001, J EXP BIOL, V204, P3571; Clarke KR, 2006, MAR ECOL PROG SER, V320, P11, DOI 10.3354/meps320011; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cobb K, 2002, CORAL RECORDS EL NIN; Cooley SR, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024007; de Putron SJ, 2011, CORAL REEFS, V30, P321, DOI 10.1007/s00338-010-0697-z; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Diaz-Pulido G, 2011, ECOL LETT, V14, P156, DOI 10.1111/j.1461-0248.2010.01565.x; Dickson A. G., 2007, PICES SPECIAL PUBLIC, DOI DOI 10.1159/000331784; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fussel HM, 2009, CLIMATIC CHANGE, V97, P469, DOI 10.1007/s10584-009-9648-5; Gattuso J.-P., 1996, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V14, P39; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hurd CL, 2011, GLOBAL CHANGE BIOL, V17, P3254, DOI 10.1111/j.1365-2486.2011.02473.x; Jiang LQ, 2010, LIMNOL OCEANOGR, V55, P2424, DOI 10.4319/lo.2010.55.6.2424; Key R. M., 2004, GLOBAL BIOGEOCHEMICA, V18; Kinsey D. W., 1979, BIOGEOCHEMICAL CYCLI, P131; Kinsey D.W., 1977, P 3 INT COR REEF S; Kinsey D. W, 1979, CARBON TURNOVER ACCU; Kleypas JA, 2011, GLOBAL CHANGE BIOL, V17, P3667, DOI 10.1111/j.1365-2486.2011.02530.x; Kleypas JA, 2009, OCEANOGRAPHY, V22, P108, DOI 10.5670/oceanog.2009.101; Kroeker KJ, 2011, P NATL ACAD SCI USA, V108, P14515, DOI 10.1073/pnas.1107789108; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Lee K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027207; Leichter JJ, 2003, LIMNOL OCEANOGR, V48, P1394, DOI 10.4319/lo.2003.48.4.1394; Lombardi C, 2010, MARINE ECOLOGY; Mallela J, 2007, CORAL REEFS, V26, P775, DOI 10.1007/s00338-007-0260-8; Martz TR, 2010, LIMNOL OCEANOGR-METH, V8, P172, DOI 10.4319/lom.2010.8.172; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Mintenbeck K., 2022, CLIMATE CHANGE 2022; Morse JW, 2007, CHEM REV, V107, P342, DOI 10.1021/cr050358j; Ohde S, 1999, B MAR SCI, V65, P559; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pierrot D.E., 2006, ORNLCDIAC105A DEP EN; Putnam HM, 2011, J EXP MAR BIOL ECOL, V396, P216, DOI 10.1016/j.jembe.2010.10.026; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Santos IR, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046053; Selig ER, 2010, GLOBAL ECOL BIOGEOGR, V19, P397, DOI 10.1111/j.1466-8238.2009.00522.x; Shamberger KEF, 2011, MARINE CHEM; Silverman J, 2007, BIOGEOCHEMISTRY, V84, P67, DOI 10.1007/s10533-007-9075-5; Silverman J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036282; SMITH SV, 1977, SCIENCE, V197, P556, DOI 10.1126/science.197.4303.556-a; SMITH SV, 1974, PAC SCI, V28, P225; SMITH SV, 1978, ATOLL RES B, V221, P15; Takahashi T, 2009, DEEP-SEA RES PT II, V56, P554, DOI 10.1016/j.dsr2.2008.12.009; Tremolada F, 2004, MAR MICROPALEONTOL, V52, P107, DOI 10.1016/j.marmicro.2004.04.002; Webb MD, 1979, PATHWAYS CO2 O2 CO2; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105; Yates KK, 2006, BIOGEOSCIENCES, V3, P357, DOI 10.5194/bg-3-357-2006; Yates KK, 2003, CORAL REEFS, V22, P247, DOI 10.1007/s00338-003-0314-5; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004; Zeebe RE, 1999, MAR CHEM, V65, P135, DOI 10.1016/S0304-4203(98)00092-9	67	115	115	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43843	10.1371/journal.pone.0043843	http://dx.doi.org/10.1371/journal.pone.0043843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952785	gold, Green Published			2022-12-25	WOS:000308213600051
J	Ramella, NA; Schinella, GR; Ferreira, ST; Prieto, ED; Vela, ME; Rios, JL; Tricerri, MA; Rimoldi, OJ				Ramella, Nahuel A.; Schinella, Guillermo R.; Ferreira, Sergio T.; Prieto, Eduardo D.; Vela, Maria E.; Luis Rios, Jose; Alejandra Tricerri, M.; Rimoldi, Omar J.			Human Apolipoprotein A-I Natural Variants: Molecular Mechanisms Underlying Amyloidogenic Propensity	PLOS ONE			English	Article							SYSTEMIC AMYLOIDOSIS; HEREDITARY AMYLOIDOSIS; HYDROSTATIC-PRESSURE; ALZHEIMERS-DISEASE; CHOLESTEROL EFFLUX; BUNDLE PROTEIN; HUMAN LYSOZYME; MUTATION; BETA; FLUORESCENCE	Human apolipoprotein A-I (apoA-I)-derived amyloidosis can present with either wild-type (Wt) protein deposits in atherosclerotic plaques or as a hereditary form in which apoA-I variants deposit causing multiple organ failure. More than 15 single amino acid replacement amyloidogenic apoA-I variants have been described, but the molecular mechanisms involved in amyloid-associated pathology remain largely unknown. Here, we have investigated by fluorescence and biochemical approaches the stabilities and propensities to aggregate of two disease-associated apoA-I variants, apoA-IGly26Arg, associated with polyneuropathy and kidney dysfunction, and apoA-ILys107-0, implicated in amyloidosis in severe atherosclerosis. Results showed that both variants share common structural properties including decreased stability compared to Wt apoA-I and a more flexible structure that gives rise to formation of partially folded states. Interestingly, however, distinct features appear to determine their pathogenic mechanisms. ApoA-ILys107-0 has an increased propensity to aggregate at physiological pH and in a pro-inflammatory microenvironment than Wt apoA-I, whereas apoA-IGly26Arg elicited macrophage activation, thus stimulating local chronic inflammation. Our results strongly suggest that some natural mutations in apoA-I variants elicit protein tendency to aggregate, but in addition the specific interaction of different variants with macrophages may contribute to cellular stress and toxicity in hereditary amyloidosis.	[Ramella, Nahuel A.; Prieto, Eduardo D.; Alejandra Tricerri, M.; Rimoldi, Omar J.] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim La Plata INIBIOLP, La Plata, Buenos Aires, Argentina; [Schinella, Guillermo R.] Univ Nacl La Plata, Fac Ciencias Med, Catedra Farmacol Basica, La Plata, Buenos Aires, Argentina; [Schinella, Guillermo R.] Pcia Buenos Aires, Comis Invest Cient, La Plata, Buenos Aires, Argentina; [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, Program Biochem & Cellular Biophys, Rio De Janeiro, Brazil; [Vela, Maria E.] Univ Nacl La Plata, CONICET, Inst Invest Fis Quim Teor & Aplicadas INIFTA, La Plata, Buenos Aires, Argentina; [Luis Rios, Jose] Univ Valencia, Fac Farm, Dept Farmacol, E-46010 Valencia, Spain	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Comision de Investigaciones Cientificas; Universidade Federal do Rio de Janeiro; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; INIFTA; University of Valencia	Ramella, NA (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim La Plata INIBIOLP, La Plata, Buenos Aires, Argentina.	aletricerri@yahoo.com	Schinella, Guillermo/V-9937-2018; Ferreira, Sergio/AAZ-1576-2020; Neurociencia, Inct/I-1011-2013	Schinella, Guillermo/0000-0001-9541-9688; Ferreira, Sergio/0000-0001-7160-9866; Ramella, Nahuel/0000-0002-6275-3193; Vela, Maria Elena/0000-0003-4502-5618	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina [2106-2008, 26228]; Universidad Nacional de La Plata [M158]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 112-200801-00953]; Spanish government (MICIIN) [SAF2009-10059-C03-01]; National Institute of Translational Neuroscience (Brazil); Conselho Nacional de Pesquisas (CNPq/Brazil); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ/Brazil); Spanish government (FEDER) [SAF2009-10059-C03-01]	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); Universidad Nacional de La Plata(National University of La Plata); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Spanish government (MICIIN); National Institute of Translational Neuroscience (Brazil); Conselho Nacional de Pesquisas (CNPq/Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ/Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Spanish government (FEDER)(European Commission)	The work presented here was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina, grants Numbers 2106-2008 to MAT, and Number 26228 to Horacio Garda; Universidad Nacional de La Plata (grant Number M158 to MAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 112-200801-00953 to MAT and HG); and grant SAF2009-10059-C03-01 from the Spanish government (MICIIN and FEDER) to JLR. STF is supported by grants from National Institute of Translational Neuroscience (Brazil), Conselho Nacional de Pesquisas (CNPq/Brazil) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ/Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarzguioui M, 1998, BIOCHEM BIOPH RES CO, V242, P534, DOI 10.1006/bbrc.1997.8005; ARAKI K, 1994, BBA-LIPID LIPID MET, V1214, P272; Booth DR, 1996, J CLIN INVEST, V97, P2714, DOI 10.1172/JCI118725; Botelho MG, 2003, J BIOL CHEM, V278, P34259, DOI 10.1074/jbc.M303189200; Canet D, 1999, BIOCHEMISTRY-US, V38, P6419, DOI 10.1021/bi983037t; Chapeaurouge A, 2002, J BIOL CHEM, V277, P16478, DOI 10.1074/jbc.M105232200; Chapeaurouge A, 2001, J BIOL CHEM, V276, P14861, DOI 10.1074/jbc.M009622200; Curtiss LK, 2006, ARTERIOSCL THROM VAS, V26, P12, DOI 10.1161/01.ATV.0000194291.94269.5a; Davidson WS, 1999, BIOCHEMISTRY-US, V38, P14387, DOI 10.1021/bi991428h; De Felice FG, 2004, FASEB J, V18, P1099, DOI 10.1096/fj.03-1072fje; De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje; Eriksson M, 2009, J MOL DIAGN, V11, P257, DOI 10.2353/jmoldx.2009.080161; Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882; Ferreira ST, 2006, CELL BIOCHEM BIOPHYS, V44, P539, DOI 10.1385/CBB:44:3:539; Gonzalez MC, 2008, ARCH BIOCHEM BIOPHYS, V473, P34, DOI 10.1016/j.abb.2008.02.021; Gregorini G, 2005, J AM SOC NEPHROL, V16, P3680, DOI 10.1681/ASN.2005040382; Gursky O, 1996, P NATL ACAD SCI USA, V93, P2991, DOI 10.1073/pnas.93.7.2991; Gursky O, 2012, BIOCHEMISTRY-US, V51, P10, DOI 10.1021/bi2017014; Hamidi Asl K, 1999, BIOCHEM BIOPH RES CO, V257, P584, DOI DOI 10.1006/BBRC.1999.0518; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Jaureguiberry MS, 2010, J MEMBRANE BIOL, V234, P183, DOI 10.1007/s00232-010-9245-6; Kazama JJ, 2001, NEPHROL DIAL TRANSPL, V16, P31, DOI 10.1093/ndt/16.suppl_4.31; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; Lachmann HJ, 2002, NEW ENGL J MED, V346, P1786, DOI 10.1056/NEJMoa013354; Lagerstedt JO, 2007, BIOCHEMISTRY-US, V46, P9693, DOI 10.1021/bi7005493; Lakowicz J.R., 2013, PRINCIPLES FLUORESCE; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Lindstedt L, 1999, J BIOL CHEM, V274, P22627, DOI 10.1074/jbc.274.32.22627; Martins SM, 2003, J BIOL CHEM, V278, P50449, DOI 10.1074/jbc.M307354200; Martins SM, 2002, EUR J BIOCHEM, V269, P5484, DOI 10.1046/j.1432-1033.2002.03248.x; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Miettinen HE, 1997, ARTERIOSCL THROM VAS, V17, P3021, DOI 10.1161/01.ATV.17.11.3021; Mucchiano GI, 2001, J PATHOL, V193, P270, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH753>3.0.CO;2-S; Munishkina LA, 2007, BBA-BIOMEMBRANES, V1768, P1862, DOI 10.1016/j.bbamem.2007.03.015; NICHOLS WC, 1988, BIOCHEM BIOPH RES CO, V156, P762, DOI 10.1016/S0006-291X(88)80909-4; NICHOLS WC, 1990, GENOMICS, V8, P318, DOI 10.1016/0888-7543(90)90288-6; Obici L, 1999, AM J PATHOL, V155, P695, DOI 10.1016/S0002-9440(10)65167-X; Obici L, 2006, AMYLOID, V13, P191, DOI 10.1080/13506120600960288; Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003; Petrlova J, 2012, J LIPID RES, V53, P390, DOI 10.1194/jlr.M020883; RADER DJ, 1992, J LIPID RES, V33, P755; Ramella NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022532; Ryan RO, 2003, PROTEIN EXPRES PURIF, V27, P98, DOI 10.1016/S1046-5928(02)00568-5; Saraiva MJM, 2001, FEBS LETT, V498, P201, DOI 10.1016/S0014-5793(01)02480-2; Smoot AL, 2001, BIOCHEMISTRY-US, V40, P4484, DOI 10.1021/bi001822b; SOUTAR AK, 1992, P NATL ACAD SCI USA, V89, P7389, DOI 10.1073/pnas.89.16.7389; TAKADA Y, 1990, BIOCHIM BIOPHYS ACTA, V1043, P169, DOI 10.1016/0005-2760(90)90292-6; Testro AG, 2007, LIVER TRANSPLANT, V13, P1028, DOI 10.1002/lt.21176; TillyKiesi M, 1997, ARTERIOSCL THROM VAS, V17, P873, DOI 10.1161/01.ATV.17.5.873; Tricerri MA, 2000, BIOCHEMISTRY-US, V39, P14682, DOI 10.1021/bi0014251; Tricerri MA, 2001, BIOCHEMISTRY-US, V40, P5065, DOI 10.1021/bi002815q; VANALLEN MW, 1969, NEUROLOGY, V19, P10, DOI 10.1212/WNL.19.1.10; Vieira MNN, 2007, J NEUROCHEM, V103, P736, DOI 10.1111/j.1471-4159.2007.04809.x; VIGUSHIN DM, 1994, Q J MED, V87, P149; VOLLMER E, 1991, VIRCHOWS ARCH A, V419, P79, DOI 10.1007/BF01600220; Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	58	30	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43755	10.1371/journal.pone.0043755	http://dx.doi.org/10.1371/journal.pone.0043755			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952757	Green Submitted, Green Published, gold			2022-12-25	WOS:000308213600040
J	Shukla, NM; Salunke, DB; Balakrishna, R; Mutz, CA; Malladi, SS; David, SA				Shukla, Nikunj M.; Salunke, Deepak B.; Balakrishna, Rajalakshmi; Mutz, Cole A.; Malladi, Subbalakshmi S.; David, Sunil A.			Potent Adjuvanticity of a Pure TLR7-Agonistic Imidazoquinoline Dendrimer	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; THIOCYANATE ELUTION; STRUCTURAL BIOLOGY; PROTEIN ANTIGENS; CELL-ACTIVATION; PREDICTION; ANTIBODY; PEPTIDE; AGONISTS; INNATE	Engagement of toll-like receptors (TLRs) serve to link innate immune responses with adaptive immunity and can be exploited as powerful vaccine adjuvants for eliciting both primary and anamnestic immune responses. TLR7 agonists are highly immunostimulatory without inducing dominant proinflammatory cytokine responses. We synthesized a dendrimeric molecule bearing six units of a potent TLR7/TLR8 dual-agonistic imidazoquinoline to explore if multimerization of TLR7/8 would result in altered activity profiles. A complete loss of TLR8-stimulatory activity with selective retention of the TLR7-agonistic activity was observed in the dendrimer. This was reflected by a complete absence of TLR8-driven proinflammatory cytokine and interferon (IFN)-gamma induction in human PBMCs, with preservation of TLR7-driven IFN-alpha induction. The dendrimer was found to be superior to the imidazoquinoline monomer in inducing high titers of high-affinity antibodies to bovine alpha-lactalbumin. Additionally, epitope mapping experiments showed that the dendrimer induced immunoreactivity to more contiguous peptide epitopes along the amino acid sequence of the model antigen.	[Shukla, Nikunj M.; Salunke, Deepak B.; Balakrishna, Rajalakshmi; Mutz, Cole A.; Malladi, Subbalakshmi S.; David, Sunil A.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA	University of Kansas	Shukla, NM (corresponding author), Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA.	sdavid@ku.edu		Salunke, Deepak/0000-0002-1241-9146	National Institutes of Health/National Institute of Allergy and Infectious Diseases [HHSN272200900033C]	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases contract HHSN272200900033C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S., 1902, ADV IMMUNOL, V78, P1; Botos I, 2011, STRUCTURE, V19, P447, DOI 10.1016/j.str.2011.02.004; BUTTKE TM, 1993, J IMMUNOL METHODS, V157, P233, DOI 10.1016/0022-1759(93)90092-L; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Cottalorda A, 2006, EUR J IMMUNOL, V36, P1684, DOI 10.1002/eji.200636181; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Gorski KS, 2006, INT IMMUNOL, V18, P1115, DOI 10.1093/intimm/dxl046; Hood J.D., 2010, HUM VACCINES, V6, P1; Kaisho T, 2002, BBA-MOL CELL RES, V1589, P1, DOI 10.1016/S0167-4889(01)00182-3; Kandimalla ER, 2011, CELL IMMUNOL, V270, P126, DOI 10.1016/j.cellimm.2011.03.027; Kang JY, 2011, ANNU REV BIOCHEM, V80, P917, DOI 10.1146/annurev-biochem-052909-141507; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Kumagai Yutaro, 2008, Journal of Infection and Chemotherapy, V14, P86, DOI 10.1007/s10156-008-0596-1; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; MACDONALD RA, 1988, J IMMUNOL METHODS, V106, P191, DOI 10.1016/0022-1759(88)90196-2; Nguyen TB, 2008, MOL PHARMACEUT, V5, P1131, DOI 10.1021/mp8001123; Nociari MM, 1998, J IMMUNOL METHODS, V213, P157, DOI 10.1016/S0022-1759(98)00028-3; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; Ponomarenko JV, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-64; PULLEN GR, 1986, J IMMUNOL METHODS, V86, P83, DOI 10.1016/0022-1759(86)90268-1; Shukla NM, 2012, J MED CHEM, V55, P1106, DOI 10.1021/jm2010207; Shukla NM, 2011, BIOORG MED CHEM LETT, V21, P3232, DOI 10.1016/j.bmcl.2011.04.050; Shukla NM, 2010, BIOORG MED CHEM LETT, V20, P6384, DOI 10.1016/j.bmcl.2010.09.093; Shukla NM, 2010, J MED CHEM, V53, P4450, DOI 10.1021/jm100358c; Shukla NM, 2009, BIOORG MED CHEM LETT, V19, P2211, DOI 10.1016/j.bmcl.2009.02.100; Sil D, 2007, ANTIMICROB AGENTS CH, V51, P2811, DOI 10.1128/AAC.00200-07; Warshakoon HJ, 2009, HUM VACCINES, V5, P381, DOI 10.4161/hv.5.6.8175	31	62	63	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43612	10.1371/journal.pone.0043612	http://dx.doi.org/10.1371/journal.pone.0043612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952720	gold, Green Published, Green Submitted			2022-12-25	WOS:000308213600034
J	Ravimohan, S; Gama, L; Engle, EL; Zink, MC; Clements, JE				Ravimohan, Shruthi; Gama, Lucio; Engle, Elizabeth L.; Zink, M. Christine; Clements, Janice E.			Early Emergence and Selection of a SIV-LTR C/EBP Site Variant in SIV-Infected Macaques That Increases Virus Infectivity	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; LONG TERMINAL REPEAT; CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTIONAL INHIBITORY PROTEIN; CD4(+) T-CELLS; BINDING-PROTEIN; HIV-1 REPLICATION; IMMUNE-RESPONSES; COGNITIVE IMPAIRMENT; GENE-EXPRESSION	CCAAT/enhancer binding protein (C/EBP)beta, and C/EBP binding sites in the HIV/SIV-long terminal repeat (LTR) are crucial for regulating transcription and for IFN beta-mediated suppression of virus replication in macrophages, the predominant source of productive virus replication in the brain. We investigated sequence variation within the SIV-LTR C/EBP sites that may be under selective pressure in vivo and therefore associated with disease progression. Using the SIV-macaque model, we examined viral LTR sequences derived from the spleen, a site of macrophage and lymphocyte infection, and the brain from macaques euthanized at 10, 21, 42, 48 and 84 days postinoculation (p.i.). A dominant variant, DS1C/A, containing an adenine-to-guanine substitution and a linked cytosine-to-adenine substitution in the downstream (DS1) C/EBP site, was detected in the spleen at 10 days p.i. The DS1C/A genotype was not detected in the brain until 42 days p.i., after which it was the predominant replicating genotype in both brain and spleen. Functional characterization of the DS1C/A containing SIV showed increased infectivity with or without IFN beta treatment over the wild-type virus, SIV/17E-Fr. The DS1C/A C/EBP site had higher affinity for both protein isoforms of C/EBP beta compared to the wild-type DS1 C/EBP site. Cytokine expression in spleen compared to brain implicated IFN beta and IL-6 responses as part of the selective pressures contributing to emergence of the DS1C/A genotype in vivo. These studies demonstrate selective replication of virus containing the DS1C/A genotype that either emerges very early in spleen and spreads to the brain, or evolves independently in the brain when IFN beta and IL-6 levels are similar to that found in spleen earlier in infection.	[Ravimohan, Shruthi] Univ Penn, Div Infect Dis, Perelman Sch Med, Philadelphia, PA 19104 USA; [Gama, Lucio; Engle, Elizabeth L.; Zink, M. Christine; Clements, Janice E.] Johns Hopkins Univ, Dept Mol & Comparat Pathobiol, Sch Med, Baltimore, MD USA; [Clements, Janice E.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Zink, M. Christine; Clements, Janice E.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Ravimohan, S (corresponding author), Univ Penn, Div Infect Dis, Perelman Sch Med, Philadelphia, PA 19104 USA.	shruthiravimohan@gmail.com		Gama, Lucio/0000-0001-9511-012X	NIH [R01NS047984, R01NS055648, P01MH070306, AI076113]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH070306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047984, R01NS055648] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants: R01NS047984, R01NS055648, P01MH070306, AI076113 (JEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2005, J NEUROIMMUNOL, V160, P219, DOI 10.1016/j.jneuroim.2004.11.009; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Ambrosino C, 1997, J BIOL CHEM, V272, P14883, DOI 10.1074/jbc.272.23.14883; AMEDEE AM, 1995, J VIROL, V69, P7982, DOI 10.1128/JVI.69.12.7982-7990.1995; An SF, 1999, J NEUROPATH EXP NEUR, V58, P1156, DOI 10.1097/00005072-199911000-00005; ANDERSON MG, 1992, VIROLOGY, V191, P559, DOI 10.1016/0042-6822(92)90231-D; ANDERSON MG, 1991, J VIROL, V65, P51, DOI 10.1128/JVI.65.1.51-60.1991; Babas T, 2006, AIDS, V20, P197, DOI 10.1097/01.aids.0000198078.24584.21; Babas T, 2003, J VIROL, V77, P208, DOI 10.1128/JVI.77.1.208-216.2003; Babas T, 2001, VIROLOGY, V287, P371, DOI 10.1006/viro.2001.1043; Barber SA, 2006, J INFECT DIS, V193, P963, DOI 10.1086/500983; Barber SA, 2004, J NEUROVIROL, V10, P15, DOI 10.1080/13550280490268179; Boutwell CL, 2010, J INFECT DIS, V202, pS309, DOI 10.1086/655653; Burdo TH, 2004, DNA CELL BIOL, V23, P261, DOI 10.1089/104454904773819842; Clements JE, 2008, J NEUROVIROL, V14, P309, DOI 10.1080/13550280802132832; Clements JE, 2002, J INFECT DIS, V186, P905, DOI 10.1086/343768; Cysique LA, 2009, NEUROPSYCHOL REV, V19, P169, DOI 10.1007/s11065-009-9092-3; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Dudaronek JM, 2007, J IMMUNOL, V179, P7262, DOI 10.4049/jimmunol.179.11.7262; Dumais N, 2002, J IMMUNOL, V168, P274, DOI 10.4049/jimmunol.168.1.274; Ellis Ronald J, 2007, PLoS Clin Trials, V2, pe15, DOI 10.1371/journal.pctr.0020015; FALK S, 1990, RES VIROLOGY, V141, P161, DOI 10.1016/0923-2516(90)90018-E; Flaherty MT, 1997, J VIROL, V71, P5790, DOI 10.1128/JVI.71.8.5790-5798.1997; GARTNER S, 1990, AIDS RES HUM RETROV, V6, P1017, DOI 10.1089/aid.1990.6.1017; Gartner S, 2000, SCIENCE, V287, P602, DOI 10.1126/science.287.5453.602; GARTNER S, 1986, JAMA-J AM MED ASSOC, V256, P2365, DOI 10.1001/jama.256.17.2365; Griffin DE, 2003, NAT REV IMMUNOL, V3, P493, DOI 10.1038/nri1105; Henderson AJ, 1997, P NATL ACAD SCI USA, V94, P8714, DOI 10.1073/pnas.94.16.8714; HENDERSON AJ, 1995, J VIROL, V69, P5337, DOI 10.1128/JVI.69.9.5337-5344.1995; Henderson AJ, 1996, IMMUNITY, V5, P91, DOI 10.1016/S1074-7613(00)80313-1; Hogan TH, 2003, J NEUROVIROL, V9, P55, DOI 10.1080/13550280390173292; Honda Y, 1998, J EXP MED, V188, P1255, DOI 10.1084/jem.188.7.1255; Hungness ES, 2002, J CELL PHYSIOL, V192, P64, DOI 10.1002/jcp.10116; Igarashi T, 2001, P NATL ACAD SCI USA, V98, P658, DOI 10.1073/pnas.021551798; KOOP BF, 1993, BIOTECHNIQUES, V14, P442; KORNBLUTH RS, 1994, RES IMMUNOL, V145, P664, DOI 10.1016/S0923-2494(05)80051-3; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; Mameli G, 2007, J GEN VIROL, V88, P631, DOI 10.1099/vir.0.82487-0; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; McIlroy D, 1996, RES VIROLOGY, V147, P115, DOI 10.1016/0923-2516(96)80225-1; McMichael AJ, 1997, ANNU REV IMMUNOL, V15, P271, DOI 10.1146/annurev.immunol.15.1.271; MUESING MA, 1987, CELL, V48, P691, DOI 10.1016/0092-8674(87)90247-9; MURPHEYCORB M, 1991, AIDS, V5, P655, DOI 10.1097/00002030-199106000-00003; Niehof M, 2001, J BIOL CHEM, V276, P9016, DOI 10.1074/jbc.M009284200; Nonnemacher MR, 2003, BIOMED PHARMACOTHER, V57, P34, DOI 10.1016/S0753-3322(02)00334-7; POLI G, 1990, J EXP MED, V172, P151, DOI 10.1084/jem.172.1.151; POLI V, 1990, CELL, V63, P643, DOI 10.1016/0092-8674(90)90459-R; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Price R W, 1988, Ann N Y Acad Sci, V540, P162, DOI 10.1111/j.1749-6632.1988.tb27059.x; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; Ravimohan S, 2010, J BIOL CHEM, V285, P2268, DOI 10.1074/jbc.M109.075929; Roos JW, 2000, VIROLOGY, V273, P307, DOI 10.1006/viro.2000.0431; Ross HL, 2001, J NEUROVIROL, V7, P235; Sacktor N, 2002, J NEUROVIROL, V8, P136, DOI 10.1080/13550280290049615; Smith DB, 1997, J GEN VIROL, V78, P1511, DOI 10.1099/0022-1317-78-7-1511; Spooner CJ, 2007, MOL IMMUNOL, V44, P1384, DOI 10.1016/j.molimm.2006.05.004; SPOUGE JL, 1992, P NATL ACAD SCI USA, V89, P7581, DOI 10.1073/pnas.89.16.7581; Steiniger B, 2005, SPLEEN ENCY LIFE SCI; Szeto GLBA, 2009, J INFECT DIS; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Weiden M, 2000, J IMMUNOL, V165, P2028, DOI 10.4049/jimmunol.165.4.2028; Williams KC, 2001, J EXP MED, V193, P905, DOI 10.1084/jem.193.8.905; Witwer KW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008129; Wright EK, 2008, GENES IMMUN, V9, P419, DOI 10.1038/gene.2008.33; ZHANG JY, 1988, J INFECT DIS, V158, P1277, DOI 10.1093/infdis/158.6.1277; Zink MC, 1998, J NEUROVIROL, V4, P249, DOI 10.3109/13550289809114526; Zink MC, 1999, J VIROL, V73, P10480, DOI 10.1128/JVI.73.12.10480-10488.1999; Zink MC, 2002, J NEUROVIROL, V8, P42, DOI 10.1080/13550280290101076; Zink MC, 2005, JAMA-J AM MED ASSOC, V293, P2003, DOI 10.1001/jama.293.16.2003; Zink MC, 1997, AM J PATHOL, V151, P793	73	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e42801	10.1371/journal.pone.0042801	http://dx.doi.org/10.1371/journal.pone.0042801			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952612	Green Published, Green Submitted, gold			2022-12-25	WOS:000308044800013
J	Vieira, FG; Foret, S; He, XL; Rozas, J; Field, LM; Zhou, JJ				Vieira, Filipe G.; Foret, Sylvain; He, Xiaoli; Rozas, Julio; Field, Linda M.; Zhou, Jing-Jiang			Unique Features of Odorant-Binding Proteins of the Parasitoid Wasp Nasonia vitripennis Revealed by Genome Annotation and Comparative Analyses	PLOS ONE			English	Article							MOSQUITO AEDES-AEGYPTI; PHEROMONE-BINDING; ANOPHELES-GAMBIAE; BOMBYX-MORI; HYMENOPTERA-PTEROMALIDAE; DROSOPHILA-MELANOGASTER; PHYLOGENETIC INFERENCE; CHEMOSENSORY PROTEINS; MAXIMUM-LIKELIHOOD; SEXUAL ATTRACTION	Insects are the most diverse group of animals on the planet, comprising over 90% of all metazoan life forms, and have adapted to a wide diversity of ecosystems in nearly all environments. They have evolved highly sensitive chemical senses that are central to their interaction with their environment and to communication between individuals. Understanding the molecular bases of insect olfaction is therefore of great importance from both a basic and applied perspective. Odorant binding proteins (OBPs) are some of most abundant proteins found in insect olfactory organs, where they are the first component of the olfactory transduction cascade, carrying odorant molecules to the olfactory receptors. We carried out a search for OBPs in the genome of the parasitoid wasp Nasonia vitripennis and identified 90 sequences encoding putative OBPs. This is the largest OBP family so far reported in insects. We report unique features of the N. vitripennis OBPs, including the presence and evolutionary origin of a new subfamily of double-domain OBPs (consisting of two concatenated OBP domains), the loss of conserved cysteine residues and the expression of pseudogenes. This study also demonstrates the extremely dynamic evolution of the insect OBP family: (i) the number of different OBPs can vary greatly between species; (ii) the sequences are highly diverse, sometimes as a result of positive selection pressure with even the canonical cysteines being lost; (iii) new lineage specific domain arrangements can arise, such as the double domain OBP subfamily of wasps and mosquitoes.	[Vieira, Filipe G.; Rozas, Julio] Univ Barcelona, Dept Genet, Barcelona, Spain; [Vieira, Filipe G.; Rozas, Julio] Univ Barcelona, Inst Recerca Biodiversitat IRBio, Barcelona, Spain; [Foret, Sylvain] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Foret, Sylvain] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [He, Xiaoli; Field, Linda M.; Zhou, Jing-Jiang] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden, Herts, England	University of Barcelona; University of Barcelona; James Cook University; Australian National University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Vieira, FG (corresponding author), Univ Calif Berkeley, Ctr Theoret Evolutionary Genom, Berkeley, CA 94720 USA.	jing-jiang.zhou@rothamsted.ac.uk	Rozas, Julio/A-1733-2009; Garrett Vieira, Filipe/B-9464-2015; FORET, Sylvain/B-9207-2012	Rozas, Julio/0000-0002-6839-9148; Garrett Vieira, Filipe/0000-0002-8464-7770; Field, Linda/0000-0002-3328-2513	BBSRC of the UK; 'Fundacao para a Ciencia e a Tecnologia' (Portugal) [SFRH/BD/22360/2005]; 'Direccion General de Investigacion Cientifica y Tecnica' (Spain) [BFU2007-62927, BFU2010-15484]; ICREA Academia (Generalitat de Catalunya); BBSRC [BBS/E/C/00004947] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004947] Funding Source: researchfish	BBSRC of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); 'Fundacao para a Ciencia e a Tecnologia' (Portugal)(Portuguese Foundation for Science and Technology); 'Direccion General de Investigacion Cientifica y Tecnica' (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ICREA Academia (Generalitat de Catalunya)(ICREAGeneralitat de Catalunya); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives grant-aided support from the BBSRC of the UK. The authors thank Prof. David M. Shuker, University of Edinburgh, UK, who provided us with N. vitripennis. FGV was supported by a predoctoral fellowship SFRH/BD/22360/2005 from the 'Fundacao para a Ciencia e a Tecnologia' (Portugal). This work was funded by grants BFU2007-62927 and BFU2010-15484 from the 'Direccion General de Investigacion Cientifica y Tecnica' (Spain) to JR. JR was partially supported by ICREA Academia (Generalitat de Catalunya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andronopoulou E, 2006, INSECT MOL BIOL, V15, P797, DOI 10.1111/j.1365-2583.2006.00685.x; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Foret S, 2007, INSECT BIOCHEM MOLEC, V37, P19, DOI 10.1016/j.ibmb.2006.09.009; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Forstner Maike, 2009, Int J Biol Sci, V5, P745; Gotzek D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016289; Gotzek D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007713; Gu SH, 2011, ARCH INSECT BIOCHEM, V77, P81, DOI 10.1002/arch.20427; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Junier T, 2000, BIOINFORMATICS, V16, P178, DOI 10.1093/bioinformatics/16.2.178; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KING BH, 1991, ANIM BEHAV, V42, P23, DOI 10.1016/S0003-3472(05)80602-5; KING PE, 1970, J EXP BIOL, V53, P245; Lagarde A, 2011, J MOL BIOL, V414, P401, DOI 10.1016/j.jmb.2011.10.005; Lagarde A, 2011, BIOCHEM J, V437, P423, DOI 10.1042/BJ20110522; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 1999, FEBS LETT, V464, P85, DOI 10.1016/S0014-5793(99)01683-X; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lewis S.E., 2003, GENOME BIOL, V3, P1, DOI [10.1186/gb-2002-3-12-research0082, DOI 10.1186/GB-2002-3-12-RESEARCH0082]; Li S, 2008, BIOCHEM BIOPH RES CO, V372, P464, DOI 10.1016/j.bbrc.2008.05.064; Pelletier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006237; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Qiao HL, 2011, CELL MOL LIFE SCI, V68, P1799, DOI 10.1007/s00018-010-0539-8; Robertson HM, 2010, INSECT MOL BIOL, V19, P121, DOI 10.1111/j.1365-2583.2009.00979.x; Ruther J, 2008, J CHEM ECOL, V34, P99, DOI 10.1007/s10886-007-9411-1; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; Sanchez-Gracia A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-323; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Scaloni A, 1999, BIOCHEM BIOPH RES CO, V266, P386, DOI 10.1006/bbrc.1999.1791; Schurmann D, 2009, NATURWISSENSCHAFTEN, V96, P383, DOI 10.1007/s00114-008-0490-9; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Steiner S, 2006, J CHEM ECOL, V32, P1687, DOI 10.1007/s10886-006-9102-3; Swarup S, 2011, GENES BRAIN BEHAV, V10, P648, DOI 10.1111/j.1601-183X.2011.00704.x; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; Turlings Ted C. J., 1993, P51; VANDENBERG MJ, 1991, J INSECT PHYSIOL, V37, P79, DOI 10.1016/0022-1910(91)90022-R; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108; WYLIE HG, 1979, CAN ENTOMOL, V111, P105, DOI 10.4039/Ent111105-1; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9; Zhou JJ, 2009, J MOL BIOL, V389, P529, DOI 10.1016/j.jmb.2009.04.015; Zhou JJ, 2004, GENE, V327, P117, DOI 10.1016/j.gene.2003.11.007	52	45	48	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43034	10.1371/journal.pone.0043034	http://dx.doi.org/10.1371/journal.pone.0043034			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952629	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000308044800018
J	Berry, M; Wirtz, AL; Janayeva, A; Ragoza, V; Terlikbayeva, A; Amirov, B; Baral, S; Beyrer, C				Berry, Mark; Wirtz, Andrea L.; Janayeva, Assel; Ragoza, Valentina; Terlikbayeva, Assel; Amirov, Bauyrzhan; Baral, Stefan; Beyrer, Chris			Risk Factors for HIV and Unprotected Anal Intercourse among Men Who Have Sex with Men (MSM) in Almaty, Kazakhstan	PLOS ONE			English	Article							DRIVEN SAMPLING METHODOLOGY; MIDDLE-INCOME COUNTRIES; BEHAVIORAL SURVEILLANCE; INTERNATIONAL SETTINGS; EASTERN-EUROPE; EPIDEMIC	Introduction: Men who have sex with men (MSM) are at high risk for HIV infection. MSM in Central Asia, however, are not adequately studied to assess their risk of HIV transmission. Methods: This study used respondent driven sampling methods to recruit 400 MSM in Almaty, the largest city in Kazakhstan, into a cross-sectional study. Participation involved a one-time interviewer-administered questionnaire and rapid HIV screening test. Prevalence data were adjusted for respondent network size and recruitment patterns. Multivariate logistic regression was used to investigate the association between HIV and selected risk factors, and unprotected anal intercourse (UAI) and selected risk factors. Results: After respondent driven sampling (RDS) weighted analysis, 20.2% of MSM were HIV-positive, and 69.0% had unprotected sex with at least one male partner in the last 12 months. Regression analysis showed that HIV infection was associated with unprotected receptive anal sex (AOR: 2.00; 95% CI: 1.04-3.84). Having unprotected anal intercourse with male partners, a measure of HIV risk behaviors, was associated with being single (AOR: 0.38; 95% CI: 0.23-0.64); very difficult access to lubricants (AOR: 11.08; 95% CI: 4.93-24.91); STI symptoms (AOR: 3.45; 95% CI: 1.42-8.40); transactional sex (AOR: 3.21; 95% CI: 1.66-6.22); and non-injection drug use (AOR: 3.10; 95% CI: 1.51-6.36). Conclusions: This study found a high HIV prevalence among MSM in Almaty, and a population of MSM engaging in multiple high-risk behavior in Almaty. Greater access to HIV education and prevention interventions is needed to limit the HIV epidemic among MSM in Almaty.	[Berry, Mark; Wirtz, Andrea L.; Baral, Stefan; Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Janayeva, Assel; Ragoza, Valentina] Amulet Publ Org, Alma Ata, Kazakhstan; [Terlikbayeva, Assel; Amirov, Bauyrzhan] Global Hlth Res Ctr Cent Asia, Alma Ata, Kazakhstan	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Berry, M (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	mberry@jhsph.edu	Baral, Stefan/AAG-4818-2020; Baral, Stefan/D-2930-2013	Baral, Stefan/0000-0002-5482-2419; Terlikbayeva, Assel/0000-0002-4067-1998	Open Society Foundations (OSF)	Open Society Foundations (OSF)	The study in this manuscript was funded by the Open Society Foundations (OSF) (URL: www.soros.org). OSF had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Belguzhanova AKK, 2007, RESULTS SENTINEL SUR; Caceres C, 2006, SEX TRANSM INFECT, V82, pIII3, DOI 10.1136/sti.2005.019489; Caceres CF, 2008, SEX TRANSM INFECT, V84, pI49, DOI 10.1136/sti.2008.030569; Cambiano V, 2011, CURR OPIN INFECT DIS, V24, P19, DOI 10.1097/QCO.0b013e3283422c8c; Colfax G, 2005, J URBAN HEALTH, V82, pI62, DOI 10.1093/jurban/jti025; EuroHIV, 2007, HIV AIDS SURV EUR; Fay H, 2011, AIDS BEHAV, V15, P1088, DOI 10.1007/s10461-010-9861-2; Gelman A, 2007, STAT SCI, V22, P153, DOI 10.1214/088342306000000691; Goodreau SM, 2007, SEX TRANSM INFECT, V83, P458, DOI 10.1136/sti.2007.025627; Hamers FF, 2003, LANCET, V361, P1035, DOI 10.1016/S0140-6736(03)12831-0; Johnston LG, 2008, AIDS BEHAV, V12, pS131, DOI 10.1007/s10461-008-9413-1; Kelly JA, 2003, INT J STD AIDS, V14, P361, DOI 10.1258/095646203765371231; Lane T, 2011, AIDS BEHAV, V15, P626, DOI 10.1007/s10461-009-9598-y; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; Salganik MJ, 2006, J URBAN HEALTH, V83, pI98, DOI 10.1007/s11524-006-9106-x; Thorne C, 2010, LANCET INFECT DIS, V10, P479, DOI 10.1016/S1473-3099(10)70118-3; World Health Organization, 2008, 2008 REP GLOB AIDS E	18	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43071	10.1371/journal.pone.0043071	http://dx.doi.org/10.1371/journal.pone.0043071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937013	Green Submitted, Green Published, gold			2022-12-25	WOS:000308225500029
J	Brockerhoff, EG; Suckling, DM; Kimberley, M; Richardson, B; Coker, G; Gous, S; Kerr, JL; Cowan, DM; Lance, DR; Strand, T; Zhang, AJ				Brockerhoff, Eckehard G.; Suckling, David M.; Kimberley, Mark; Richardson, Brian; Coker, Graham; Gous, Stefan; Kerr, Jessica L.; Cowan, David M.; Lance, David R.; Strand, Tara; Zhang, Aijun			Aerial Application of Pheromones for Mating Disruption of an Invasive Moth as a Potential Eradication Tool	PLOS ONE			English	Article							LIGHTBROWN APPLE MOTH; EPIPHYAS-POSTVITTANA LEPIDOPTERA; SEX-PHEROMONE; NEW-ZEALAND; TORTRICIDAE; FOREST; MANAGEMENT; DISCRIMINATION; POPULATIONS; ORCHARDS	Biological invasions can cause major ecological and economic impacts. During the early stages of invasions, eradication is desirable but tactics are lacking that are both effective and have minimal non-target effects. Mating disruption, which may meet these criteria, was initially chosen to respond to the incursion of light brown apple moth, Epiphyas postvittana (LBAM; Lepidoptera: Tortricidae), in California. The large size and limited accessibility of the infested area favored aerial application. Moth sex pheromone formulations for potential use in California or elsewhere were tested in a pine forest in New Zealand where LBAM is abundant. Formulations were applied by helicopter at a target rate of 40 g pheromone per ha. Trap catch before and after application was used to assess the efficacy and longevity of formulations, in comparison with plots treated with ground-applied pheromone dispensers and untreated control plots. Traps placed at different heights showed LBAM was abundant in the upper canopy of tall trees, which complicates control attempts. A wax formulation and polyethylene dispensers were most effective and provided trap shut-down near ground level for 10 weeks. Only the wax formulation was effective in the upper canopy. As the pheromone blend contained a behavioral antagonist for LBAM, 'false trail following' could be ruled out as a mechanism explaining trap shutdown. Therefore, 'sensory impairment' and 'masking of females' are the main modes of operation. Mating disruption enhances Allee effects which contribute to negative growth of small populations and, therefore, it is highly suitable for area-wide control and eradication of biological invaders.	[Brockerhoff, Eckehard G.; Coker, Graham; Kerr, Jessica L.] Scion, New Zealand Forest Res Inst, Christchurch, New Zealand; [Suckling, David M.] New Zealand Inst Plant & Food Res Ltd, Lincoln, New Zealand; [Kimberley, Mark; Richardson, Brian; Gous, Stefan; Strand, Tara] Scion, New Zealand Forest Res Inst, Rotorua, New Zealand; [Cowan, David M.; Lance, David R.] Anim & Plant Hlth Inspect Serv, USDA, Buzzards Bay, MA USA; [Strand, Tara] US Forest Serv, Pacific Wildland Fire Sci Lab, USDA, Seattle, WA USA; [Zhang, Aijun] ARS, Invas Insect Biocontrol & Behav Lab, USDA, Beltsville Agr Res Ctr W, Beltsville, MD USA	Scion; New Zealand Institute for Plant & Food Research Ltd; Scion; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA)	Brockerhoff, EG (corresponding author), Scion, New Zealand Forest Res Inst, Christchurch, New Zealand.	eckehard.brockerhoff@scionresearch.com	Brockerhoff, Eckehard Gustav/C-1528-2009; Suckling, David M/F-7005-2010; Suckling, David Maxwell/M-7730-2019; Richardson, Brian/B-9822-2013	Brockerhoff, Eckehard Gustav/0000-0002-5962-3208; Suckling, David M/0000-0001-7216-9348; Suckling, David Maxwell/0000-0001-7216-9348; 	United States Department of Agriculture (USDA); New Zealand government (NZ Foundation for Research, Science and Technology)	United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); New Zealand government (NZ Foundation for Research, Science and Technology)	E.G.B. and D.M.S. declare having received research funds for this project from the United States Department of Agriculture (USDA) and the New Zealand government (NZ Foundation for Research, Science and Technology). The funders (in particular, USDA scientists who are listed as co-authors) contributed to the study design, aspects of the data collection, and the preparation of the manuscript. The funders had no role in the data analysis or the decision to publish.	Aukema JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024587; Aukema JE, 2010, BIOSCIENCE, V60, P886, DOI 10.1525/bio.2010.60.11.5; BARINAGA M, 1991, SCIENCE, V253, P1351, DOI 10.1126/science.1896843; BARTELL RJ, 1973, J INSECT PHYSIOL, V19, P845, DOI 10.1016/0022-1910(73)90156-X; BRADLEY SJ, 1995, J CHEM ECOL, V21, P745, DOI 10.1007/BF02033458; BRASIER CM, 1991, MYCOPATHOLOGIA, V115, P151, DOI 10.1007/BF00462219; Brockerhoff Eckehard G., 2010, New Zealand Journal of Forestry Science, V40, pS117; Brockerhoff EG, 2002, N Z PLANT PROTECT-SE, V55, P85, DOI 10.30843/nzpp.2002.55.3924; Carde R. T., 2007, P122, DOI 10.1017/CBO9780511752353.006; CARDE RT, 1995, ANNU REV ENTOMOL, V40, P559, DOI 10.1146/annurev.en.40.010195.003015; Carey JR, 2008, INVASION BIOL LIGHT; Clout M., 2002, TURNING TIDE ERADICA; El-Sayed AM, 2011, J CHEM ECOL, V37, P640, DOI 10.1007/s10886-011-9964-x; Fowler G., 2009, EC ANAL RISK US APPL; Holmes TP, 2009, ANN NY ACAD SCI, V1162, P18, DOI 10.1111/j.1749-6632.2009.04446.x; Liebhold A. M., 1995, FOREST SCI MONOGR, V30, P1; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Miller JR, 2010, P NATL ACAD SCI USA, V107, P22, DOI 10.1073/pnas.0908453107; Mo JH, 2006, J ECON ENTOMOL, V99, P421, DOI 10.1603/0022-0493-99.2.421; Myers JH, 1998, ANNU REV ENTOMOL, V43, P471, DOI 10.1146/annurev.ento.43.1.471; Poland TM, 2006, J FOREST, V104, P118; Richardson B, 2006, T ASABE, V49, P15, DOI 10.13031/2013.20230; ROELOFS WL, 1979, ESTABLISHING EFFICAC; Rogers DJ, 2003, N Z PLANT PROTECT-SE, V56, P168, DOI 10.30843/nzpp.2003.56.6037; RUMBO ER, 1993, J CHEM ECOL, V19, P953, DOI 10.1007/BF00992530; Sharov AA, 2002, J ECON ENTOMOL, V95, P1205, DOI 10.1603/0022-0493-95.6.1205; Simberloff D, 2003, WEED SCI, V51, P247, DOI 10.1614/0043-1745(2003)051[0247:EPIATO]2.0.CO;2; Stephens AEA, 2008, ENTOMOL EXP APPL, V127, P176, DOI 10.1111/j.1570-7458.2008.00694.x; Strand T, 2009, ECOL MODEL, V220, P640, DOI 10.1016/j.ecolmodel.2008.11.018; Suckling DM, 2010, ANNU REV ENTOMOL, V55, P285, DOI 10.1146/annurev-ento-112408-085311; SUCKLING DM, 1992, ENVIRON ENTOMOL, V21, P949, DOI 10.1093/ee/21.5.949; Suckling DM, 1999, J CHEM ECOL, V25, P117, DOI 10.1023/A:1020893201446; Suckling DM, 1999, J CHEM ECOL, V25, P2011, DOI 10.1023/A:1021028621262; Suckling DM, 1996, ENVIRON ENTOMOL, V25, P101, DOI 10.1093/ee/25.1.101; SUCKLING DM, 1995, NEW ZEAL J CROP HORT, V23, P127, DOI 10.1080/01140671.1995.9513879; Suckling DM, 2012, J EC ENTOMO IN PRESS; Thistle HW, 2004, FOREST SCI, V50, P610; Varela LG, 2010, CALIF AGR, V64, P6, DOI 10.3733/ca.v064n01p6; Walters ML, 2000, JOINT P INT C AR WID, P201; Yamanaka T, 2009, POPUL ECOL, V51, P427, DOI 10.1007/s10144-009-0155-3	41	32	31	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43767	10.1371/journal.pone.0043767	http://dx.doi.org/10.1371/journal.pone.0043767			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937092	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500094
J	Liu, SH; Bin Wang, K; Lan, KH; Lee, WJ; Pan, HC; Wu, SM; Peng, YC; Chen, YC; Shen, CC; Cheng, HC; Liao, KK; Sheu, ML				Liu, Shing Hwa; Bin Wang, Keh; Lan, Keng Hsin; Lee, Wen Jane; Pan, Hung Chuan; Wu, Sheng Mao; Peng, Yen Chun; Chen, Yi Ching; Shen, Chin Chang; Cheng, Hsu Chen; Liao, Ko Kaung; Sheu, Meei Ling			Calpain/SHP-1 Interaction by Honokiol Dampening Peritoneal Dissemination of Gastric Cancer in nu/nu Mice	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; ENDOTHELIAL GROWTH-FACTOR; WEIGHT NATURAL-PRODUCT; SIGNAL TRANSDUCER; TUMOR PROGRESSION; SMALL-MOLECULE; IN-VITRO; CELLS; ACTIVATION; INHIBITION	Background: Honokiol, a small-molecular weight natural product, has previously been reported to activate apoptosis and inhibit gastric tumorigenesis. Whether honokiol inhibits the angiogenesis and metastasis of gastric cancer cells remains unknown. Methodology/Principal Findings: We tested the effects of honokiol on angiogenic activity and peritoneal dissemination using in vivo, ex vivo and in vitro assay systems. The signaling responses in human gastric cancer cells, human umbilical vascular endothelial cells (HUVECs), and isolated tumors were detected and analyzed. In a xenograft gastric tumor mouse model, honokiol significantly inhibited the peritoneal dissemination detected by PET/CT technique. Honokiol also effectively attenuated the angiogenesis detected by chick chorioallantoic membrane assay, mouse matrigel plug assay, rat aortic ring endothelial cell sprouting assay, and endothelial cell tube formation assay. Furthermore, honokiol effectively enhanced signal transducer and activator of transcription (STAT-3) dephosphorylation and inhibited STAT-3 DNA binding activity in human gastric cancer cells and HUVECs, which was correlated with the up-regulation of the activity and protein expression of Src homology 2 (SH2)-containing tyrosine phosphatase-1 (SHP-1). Calpain-II inhibitor and siRNA transfection significantly reversed the honokiol-induced SHP-1 activity. The decreased STAT-3 phosphorylation and increased SHP-1 expression were also shown in isolated peritoneal metastatic tumors. Honokiol was also capable of inhibiting VEGF generation, which could be reversed by SHP-1 siRNA transfection. Conclusions/Significance: Honokiol increases expression and activity of SPH-1 that further deactivates STAT3 pathway. These findings also suggest that honokiol is a novel and potent inhibitor of angiogenesis and peritoneal dissemination of gastric cancer cells, providing support for the application potential of honokiol in gastric cancer therapy.	[Liu, Shing Hwa] Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei 10764, Taiwan; [Bin Wang, Keh] Kuang Tien Gen Hosp, Dept Nucl Med, Taichung, Taiwan; [Lan, Keng Hsin] Taipei Vet Gen Hosp, Div Gastroenterol, Dept Med, Taipei, Taiwan; [Lee, Wen Jane; Pan, Hung Chuan; Sheu, Meei Ling] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan; [Peng, Yen Chun] Taichung Vet Gen Hosp, Dept Internal Med, Div Gastroenterol, Taichung, Taiwan; [Shen, Chin Chang] Natl Taiwan Univ, Dept Chem, Taipei 10764, Taiwan; [Shen, Chin Chang] Atom Energy Council, Inst Nucl Energy Res, Tao Yuan, Taiwan; [Liao, Ko Kaung] Chung Shan Med Univ, Dept Anat, Taichung, Taiwan; [Bin Wang, Keh; Pan, Hung Chuan; Wu, Sheng Mao; Chen, Yi Ching; Sheu, Meei Ling] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Cheng, Hsu Chen] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan	National Taiwan University; Taipei Veterans General Hospital; Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Taiwan University; Institute of Nuclear Energy Research - Taiwan; Chung Shan Medical University; National Chung Hsing University; National Chung Hsing University	Liu, SH (corresponding author), Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei 10764, Taiwan.	mlsheu@nchu.edu.tw	Shen, Chin Chang/GXH-0183-2022; Sheu, Meei-Ling/AAT-3401-2020	Shen, Chin Chang/0000-0002-8508-8560; Sheu, Meei-Ling/0000-0002-0431-1282; Cheng, Hsu-Chen/0000-0002-6586-6425; LIU, SHING-HWA/0000-0002-9976-1197; Wu, Sheng-Mao/0000-0002-8569-5280	Taichung Veterans General Hospital, Taiwan [TCVGH-997314C, TCVGH-1007313C]; National Science Council of Taiwan [NSC99-2320-B-005-003-MY3]	Taichung Veterans General Hospital, Taiwan; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by research grants from Taichung Veterans General Hospital, Taiwan (TCVGH-997314C, TCVGH-1007313C) and the National Science Council of Taiwan (NSC99-2320-B-005-003-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abcouwer SF, 2002, INVEST OPHTH VIS SCI, V43, P2791; Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Bai XH, 2003, J BIOL CHEM, V278, P35501, DOI 10.1074/jbc.M302967200; Banerjee A, 2011, J BIOL CHEM, V286, P29127, DOI 10.1074/jbc.M110.169771; Chiang CK, 2006, KIDNEY INT, V70, P682, DOI 10.1038/sj.ki.5001617; Coggeshall KM, 2002, MOL IMMUNOL, V39, P521, DOI 10.1016/S0161-5890(02)00209-2; Falet H, 1998, BIOCHEM BIOPH RES CO, V252, P51, DOI 10.1006/bbrc.1998.9593; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Fried LE, 2009, ANTIOXID REDOX SIGN, V11, P1139, DOI 10.1089/ARS.2009.2440; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gong WD, 2005, CLIN CANCER RES, V11, P1386, DOI 10.1158/1078-0432.CCR-04-0487; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Kim KA, 2010, PARASITE IMMUNOL, V32, P176, DOI 10.1111/j.1365-3024.2009.01175.x; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; Koyama Y, 2008, INVEST OPHTH VIS SCI, V49, P2376, DOI 10.1167/iovs.07-1067; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li WC, 2006, CLIN CANCER RES, V12, P7140, DOI 10.1158/1078-0432.CCR-06-0484; Lin L, 2010, NEOPLASIA, V12, P39, DOI 10.1593/neo.91196; Liu SH, 2010, BRIT J PHARMACOL, V160, P1963, DOI 10.1111/j.1476-5381.2010.00804.x; Liu SH, 2010, CELL MOL LIFE SCI, V67, P1465, DOI 10.1007/s00018-009-0255-4; Min JK, 2004, CANCER RES, V64, P644, DOI 10.1158/0008-5472.CAN-03-3250; Munroe ME, 2007, J IMMUNOL, V179, P753, DOI 10.4049/jimmunol.179.2.753; Munroe ME, 2010, J IMMUNOL, V185, P5586, DOI 10.4049/jimmunol.1000630; Nystrom A, 2009, BLOOD, V114, P4897, DOI 10.1182/blood-2009-02-207134; Ohtsu A, 2006, J CLIN ONCOL, V24, P2188, DOI 10.1200/JCO.2006.05.9758; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Pain S, 1999, FEBS LETT, V453, P119, DOI 10.1016/S0014-5793(99)00698-5; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Redell MS, 2011, BLOOD, V117, P5701, DOI 10.1182/blood-2010-04-280123; Saif MW, 2010, EJSO-EUR J SURG ONC, V36, P709, DOI 10.1016/j.ejso.2010.05.023; Sako A, 2004, CANCER RES, V64, P3624, DOI 10.1158/0008-5472.CAN-04-0304; Sheu ML, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001096; Sheu ML, 2008, FREE RADICAL BIO MED, V44, P2043, DOI 10.1016/j.freeradbiomed.2008.03.014; Storr SJ, 2011, NAT REV CANCER, V11, P364, DOI 10.1038/nrc3050; Takahashi Y, 1996, CLIN CANCER RES, V2, P1679; Tallquist MD, 1999, ONCOGENE, V18, P7917, DOI 10.1038/sj.onc.1203216; Tsui FWL, 2006, IMMUNOL RES, V35, P127, DOI 10.1385/IR:35:1:127; Vaid M, 2010, CARCINOGENESIS, V31, P2004, DOI 10.1093/carcin/bgq186; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wu CY, 2003, GENE, V306, P1, DOI 10.1016/S0378-1119(03)00400-1; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhai H, 2003, EUR J PHARMACOL, V474, P199, DOI 10.1016/S0014-2999(03)02075-2	44	33	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43711	10.1371/journal.pone.0043711	http://dx.doi.org/10.1371/journal.pone.0043711			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937084	gold, Green Published, Green Submitted			2022-12-25	WOS:000308225500086
J	Saunders, SE; Bartelt-Hunt, SL; Bartz, JC				Saunders, Samuel E.; Bartelt-Hunt, Shannon L.; Bartz, Jason C.			Resistance of Soil-Bound Prions to Rumen Digestion	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; IN-VITRO DIGESTION; ORAL-TRANSMISSION; INOCULUM SOURCE; SHEEP SCRAPIE; PROTEIN PRPSC; DEER; STRAIN; TRANSPORTATION; DEGRADATION	Before prion uptake and infection can occur in the lower gastrointestinal system, ingested prions are subjected to anaerobic digestion in the rumen of cervids and bovids. The susceptibility of soil-bound prions to rumen digestion has not been evaluated previously. In this study, prions from infectious brain homogenates as well as prions bound to a range of soils and soil minerals were subjected to in vitro rumen digestion, and changes in PrP levels were measured via western blot. Binding to clay appeared to protect noninfectious hamster PrPc from complete digestion, while both unbound and soil-bound infectious PrPSc proved highly resistant to rumen digestion. In addition, no change in intracerebral incubation period was observed following active rumen digestion of unbound hamster HY TME prions and HY TME prions bound to a silty clay loam soil. These results demonstrate that both unbound and soil-bound prions readily survive rumen digestion without a reduction in infectivity, further supporting the potential for soil-mediated transmission of chronic wasting disease (CWD) and scrapie in the environment.	[Saunders, Samuel E.; Bartelt-Hunt, Shannon L.] Univ Nebraska Lincoln, Peter Kiewit Inst, Dept Civil Engn, Omaha, NE USA; [Bartz, Jason C.] Creighton Univ, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA	University of Nebraska System; University of Nebraska Lincoln; Creighton University	Saunders, SE (corresponding author), Stanford Law Sch, Stanford, CA USA.	sbartelt2@unl.edu		Bartz, Jason/0000-0003-4081-7886	National Science Foundation [CBET-1149242]; National Center for Research Resources [P20 RR0115635-6, C06 RR17417-01, G200RR024001]; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR024001, C06RR017417] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Science Foundation (CBET-1149242) and the National Center for Research Resources (P20 RR0115635-6, C06 RR17417-01 and G200RR024001). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ammar H, 2008, ANIM FEED SCI TECH, V147, P90, DOI 10.1016/j.anifeedsci.2007.09.011; Balachandran A, 2010, CAN VET J, V51, P169; Bartz JC, 2007, J VIROL, V81, P689, DOI 10.1128/JVI.01751-06; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Bueno ICS, 2005, ANIM FEED SCI TECH, V123, P95, DOI 10.1016/j.anifeedsci.2005.05.003; Cone JW, 2002, ANIM FEED SCI TECH, V99, P221, DOI 10.1016/S0377-8401(02)00073-1; Dagleish MP, 2010, J GEN VIROL, V91, P3116, DOI 10.1099/vir.0.025049-0; Detwiler LA, 2003, REV SCI TECH OIE, V22, P121, DOI 10.20506/rst.22.1.1386; FREUDENBERGER DO, 1994, BRIT J NUTR, V71, P489, DOI 10.1079/BJN19940157; Gordon IJ, 2002, CAN J ZOOL, V80, P1930, DOI 10.1139/Z02-179; Gough KC, 2010, PRION, V4, P275, DOI 10.4161/pri.4.4.13678; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007990; Hamir AN, 2005, J VET DIAGN INVEST, V17, P3, DOI 10.1177/104063870501700103; Hervas G, 2005, J SCI FOOD AGR, V85, P2495, DOI 10.1002/jsfa.2292; Jeffrey M, 2006, J PATHOL, V209, P4, DOI 10.1002/path.1962; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Kincaid AE, 2007, J VIROL, V81, P4482, DOI 10.1128/JVI.02649-06; Langeveld JPM, 2003, J INFECT DIS, V188, P1782, DOI 10.1086/379664; de Motes CM, 2008, VET MICROBIOL, V131, P205, DOI 10.1016/j.vetmic.2008.02.014; Mould FL, 2005, ANIM FEED SCI TECH, V123, P155, DOI 10.1016/j.anifeedsci.2005.05.002; Mould FL, 2005, ANIM FEED SCI TECH, V123, P31, DOI 10.1016/j.anifeedsci.2005.04.028; Nicholson EM, 2007, LETT APPL MICROBIOL, V44, P631, DOI 10.1111/j.1472-765X.2007.02124.x; Prusiner Stanley B., 2004, PRION BIOL DIS, P1; Pulford B, 2012, J WILDLIFE DIS, V48, P425, DOI 10.7589/0090-3558-48.2.425; Race B, 2009, J VIROL, V83, P9608, DOI 10.1128/JVI.01127-09; RUSELERVANEMBDEN JGH, 1985, FEMS MICROBIOL LETT, V28, P341, DOI 10.1016/0378-1097(85)90107-7; Rymer C, 2005, ANIM FEED SCI TECH, V123, P9, DOI 10.1016/j.anifeedsci.2005.04.055; Safar JG, 2008, J INFECT DIS, V198, P81, DOI 10.1086/588193; Saunders SE, 2008, ENVIRON SCI TECHNOL, V42, P6573, DOI 10.1021/es800590k; Saunders SE, 2012, CHEMOSPHERE, V87, P661, DOI 10.1016/j.chemosphere.2011.12.076; Saunders SE, 2012, EMERG INFECT DIS, V18, P369, DOI 10.3201/eid1803.110685; Saunders SE, 2011, APPL ENVIRON MICROB, V77, P4313, DOI 10.1128/AEM.00421-11; Saunders SE, 2011, J VIROL, V85, P5476, DOI 10.1128/JVI.00282-11; Saunders SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018752; Saunders SE, 2010, ENVIRON SCI TECHNOL, V44, P4129, DOI 10.1021/es903520d; Saunders SE, 2009, ENVIRON SCI TECHNOL, V43, P7728, DOI 10.1021/es901385t; Saunders SE, 2009, ENVIRON SCI TECHNOL, V43, P5242, DOI 10.1021/es900502f; Scherbel C, 2007, ZOONOSES PUBLIC HLTH, V54, P185, DOI 10.1111/j.1863-2378.2007.01040.x; Scherbel C, 2006, VET RES, V37, P695, DOI 10.1051/vetres:2006024; Sigurdson CJ, 1999, J GEN VIROL, V80, P2757, DOI 10.1099/0022-1317-80-10-2757; Tamguney G, 2009, NATURE, V461, P529, DOI 10.1038/nature08289; van Keulen LJM, 2008, VET RES, V39, DOI 10.1051/vetres:2007061; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748	44	11	11	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e44051	10.1371/journal.pone.0044051	http://dx.doi.org/10.1371/journal.pone.0044051			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937149	gold, Green Published			2022-12-25	WOS:000308225500136
J	Passalacqua, KD; Varadarajan, A; Weist, C; Ondov, BD; Byrd, B; Read, TD; Bergman, NH				Passalacqua, Karla D.; Varadarajan, Anjana; Weist, Charlotte; Ondov, Brian D.; Byrd, Benjamin; Read, Timothy D.; Bergman, Nicholas H.			Strand-Specific RNA-Seq Reveals Ordered Patterns of Sense and Antisense Transcription in Bacillus anthracis	PLOS ONE			English	Article							GENE-EXPRESSION; ESCHERICHIA-COLI; GENOME SEQUENCE; STERNE 34F(2); ORGANIZATION; SUBTILIS; GROWTH; ESSENTIALITY; REPLICATION; INHIBITION	Background: Although genome-wide transcriptional analysis has been used for many years to study bacterial gene expression, many aspects of the bacterial transcriptome remain undefined. One example is antisense transcription, which has been observed in a number of bacteria, though the function of antisense transcripts, and their distribution across the bacterial genome, is still unclear. Methodology/Principal Findings: Single-stranded RNA-seq results revealed a widespread and non-random pattern of antisense transcription covering more than two thirds of the B. anthracis genome. Our analysis revealed a variety of antisense structural patterns, suggesting multiple mechanisms of antisense transcription. The data revealed several instances of sense and antisense expression changes in different growth conditions, suggesting that antisense transcription may play a role in the ways in which B. anthracis responds to its environment. Significantly, genome-wide antisense expression occurred at consistently higher levels on the lagging strand, while the leading strand showed very little antisense activity. Intrasample gene expression comparisons revealed a gene dosage effect in all growth conditions, where genes farthest from the origin showed the lowest overall range of expression for both sense and antisense directed transcription. Additionally, transcription from both strands was verified using a novel strand-specific assay. The variety of structural patterns we observed in antisense transcription suggests multiple mechanisms for this phenomenon, suggesting that some antisense transcription may play a role in regulating the expression of key genes, while some may be due to chromosome replication dynamics and transcriptional noise. Conclusions/Significance: Although the variety of structural patterns we observed in antisense transcription suggest multiple mechanisms for antisense expression, our data also clearly indicate that antisense transcription may play a genome-wide role in regulating the expression of key genes in Bacillus species. This study illustrates the surprising complexity of prokaryotic RNA abundance for both strands of a bacterial chromosome.	[Passalacqua, Karla D.; Varadarajan, Anjana; Weist, Charlotte; Ondov, Brian D.; Byrd, Benjamin; Bergman, Nicholas H.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Ondov, Brian D.; Bergman, Nicholas H.] Natl Biodef Anal & Countermeasures Ctr, Frederick, MD USA; [Passalacqua, Karla D.; Read, Timothy D.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Passalacqua, Karla D.; Read, Timothy D.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA USA	University System of Georgia; Georgia Institute of Technology; Emory University; Emory University	Passalacqua, KD (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	bergmann@nbacc.net	Passalacqua, Karla/AAU-8156-2021	Read, Timothy/0000-0001-8966-9680; Passalacqua, Karla/0000-0002-2672-3261	Georgia Institute of Technology	Georgia Institute of Technology	This work was supported by internal funding from the Georgia Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman NH, 2007, INFECT IMMUN, V75, P3434, DOI 10.1128/IAI.01345-06; Bergman NH, 2006, J BACTERIOL, V188, P6092, DOI 10.1128/JB.00723-06; Beyer W, 2009, MOL ASPECTS MED, V30, P481, DOI 10.1016/j.mam.2009.08.004; BREWER BJ, 1988, CELL, V53, P679, DOI 10.1016/0092-8674(88)90086-4; Budde I, 2006, MICROBIOL-SGM, V152, P831, DOI 10.1099/mic.0.28530-0; Carlson PE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006988; Carninci P, 2010, DNA RES, V17, P51, DOI 10.1093/dnares/dsq006; Cendrowski S, 2004, MOL MICROBIOL, V51, P407, DOI 10.1046/j.1365-2958.2003.03861.x; Chatterjee A, 2011, P NATL ACAD SCI US; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Dawid A, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025007; Dornenburg JE, 2010, MBIO, V1, DOI 10.1128/mBio.00024-10; Figueroa-Bossi N, 2009, GENE DEV, V23, P2004, DOI 10.1101/gad.541609; Filiatrault MJ, 2010, J BACTERIOL, V192, P2359, DOI 10.1128/JB.01445-09; Fortina P, 2008, NAT BIOTECHNOL, V26, P293, DOI 10.1038/nbt0308-293; Francis AW, 2005, BBA-PROTEINS PROTEOM, V1748, P191, DOI 10.1016/j.bbapap.2005.01.007; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Gut IM, 2008, ANTIMICROB AGENTS CH, V52, P4281, DOI 10.1128/AAC.00625-08; Hahne H, 2010, J BACTERIOL, V192, P870, DOI 10.1128/JB.01106-09; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; Jeong KS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r86; Kim J, 2009, CELL MOL LIFE SCI, V66, P3127, DOI 10.1007/s00018-009-0067-6; Koehler TM, 2009, MOL ASPECTS MED, V30, P386, DOI 10.1016/j.mam.2009.07.004; Lei JZ, 2009, J THEOR BIOL, V256, P485, DOI 10.1016/j.jtbi.2008.10.028; Lindberg J, 2010, GENOMICS, V95, P1, DOI 10.1016/j.ygeno.2009.08.010; LIU B, 1995, SCIENCE, V267, P1131, DOI 10.1126/science.7855590; Martin J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S3-S10; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ondov BD, 2008, BIOINFORMATICS, V24, P2776, DOI 10.1093/bioinformatics/btn512; Passalacqua KD, 2007, J BACTERIOL, V189, P3996, DOI 10.1128/JB.00185-07; Passalacqua KD, 2006, J BACTERIOL, V188, P3837, DOI 10.1128/JB.00239-06; Passalacqua KD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004904; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Price CW, 2001, MOL MICROBIOL, V41, P757, DOI 10.1046/j.1365-2958.2001.02534.x; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Ravel J, 2009, J BACTERIOL, V191, P445, DOI 10.1128/JB.01347-08; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Rocha EPC, 2008, ANNU REV GENET, V42, P211, DOI 10.1146/annurev.genet.42.110807.091653; Rocha EPC, 2004, CURR OPIN MICROBIOL, V7, P519, DOI 10.1016/j.mib.2004.08.006; Rocha EPC, 2003, NUCLEIC ACIDS RES, V31, P6570, DOI 10.1093/nar/gkg859; Rocha EPC, 2003, NAT GENET, V34, P377, DOI 10.1038/ng1209; RONG JC, 1994, J BACTERIOL, V176, P5218, DOI 10.1128/JB.176.17.5218-5224.1994; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Steil L, 2003, J BACTERIOL, V185, P6358, DOI 10.1128/JB.185.21.6358-6370.2003; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tang MX, 2008, J THEOR BIOL, V253, P271, DOI 10.1016/j.jtbi.2008.03.023; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; WAGNER EGH, 1994, ANNU REV MICROBIOL, V48, P713, DOI 10.1146/annurev.mi.48.100194.003433; WAGNER RW, 1994, NATURE, V372, P333, DOI 10.1038/372333a0; Wolf JBW, 2010, MOL ECOL, V19, P162, DOI 10.1111/j.1365-294X.2009.04471.x	54	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43350	10.1371/journal.pone.0043350	http://dx.doi.org/10.1371/journal.pone.0043350			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937038	Green Submitted, Green Published, gold			2022-12-25	WOS:000308286300045
J	Sriram, K; Rodriguez-Fernandez, M; Doyle, FJ				Sriram, K.; Rodriguez-Fernandez, Maria; Doyle, Francis J., III			A Detailed Modular Analysis of Heat-Shock Protein Dynamics under Acute and Chronic Stress and Its Implication in Anxiety Disorders	PLOS ONE			English	Article							TRANSCRIPTION FACTOR HSF1; STIRRED-TANK REACTOR; MULTISITE PHOSPHORYLATION; DUAL PHOSPHORYLATION; MOLECULAR CHAPERONE; REGULATORY NETWORKS; SYSTEMS BIOLOGY; GENE-EXPRESSION; HSP90; ACTIVATION	Physiological and psychological stresses cause anxiety disorders such as depression and post-traumatic stress disorder (PTSD) and induce drastic changes at a molecular level in the brain. To counteract this stress, the heat-shock protein (HSP) network plays a vital role in restoring the homeostasis of the system. To study the stress-induced dynamics of heat-shock network, we analyzed three modules of the HSP90 network-namely trimerization reactions, phosphorylation-dephosphorylation reactions, and the conversion of HSP90 from an open to a closed conformation-and constructed a corresponding nonlinear differential equation model based on mass action kinetics laws. The kinetic parameters of the model were obtained through global optimization, and sensitivity analyses revealed that the most sensitive parameters are the kinase and phosphatase that drive the phosphorylation-dephosphorylation reactions. Bifurcation analysis carried out with the estimated kinetic parameters of the model with stress as bifurcation parameter revealed the occurrence of "mushroom", a type of complex dynamics in which S-shaped and Z-shaped hysteretic bistable forms are present together. We mapped the molecular events responsible for generating the mushroom dynamics under stress and interpreted the occurrence of the S-shaped hysteresis to a normal level of stress, and the Z-shaped hysteresis to the HSP90 variations under acute and chronic stress in the fear conditioned system, and further, we hypothesized that this can be extended to stress-related disorders such as depression and PTSD in humans. Finally, we studied the effect of parameter variations on the mushroom dynamics to get insight about the role of phosphorylation-dephosphorylation parameters in HSP90 network in bringing about complex dynamics such as isolas, where the stable steady states in a bistable system are isolated and separated from each other and not connected by an unstable steady state.	[Sriram, K.; Rodriguez-Fernandez, Maria; Doyle, Francis J., III] Univ Calif Santa Barbara, Inst Collaborat Biotechnol, Santa Barbara, CA 93106 USA; [Sriram, K.; Rodriguez-Fernandez, Maria; Doyle, Francis J., III] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; [Sriram, K.] IIIT, Delhi, India	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Indraprastha Institute of Information Technology Delhi	Sriram, K (corresponding author), Univ Calif Santa Barbara, Inst Collaborat Biotechnol, Santa Barbara, CA 93106 USA.	doyle@engineering.ucsb.edu	Rodriguez-Fernandez, Maria/I-7193-2016; Rodriguez-Fernandez, Maria/AAF-7049-2021	Rodriguez-Fernandez, Maria/0000-0003-1966-2920; Rodriguez-Fernandez, Maria/0000-0003-1966-2920	Institute for Collaborative Biotechnologies through the U.S. Army Research Office [W911NF-10-2-0111, W911NF-09-D-0001]	Institute for Collaborative Biotechnologies through the U.S. Army Research Office	The authors gratefully acknowledge the financial support from the Institute for Collaborative Biotechnologies through the U.S. Army Research Office (Grants W911NF-10-2-0111 and W911NF-09-D-0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abravaya K, 1991, GENE DEV, V5, P2177; Association AP, 2000, DIAGNOSTIC STAT MANU, V4; BALAKOTAIAH V, 1987, P ROY SOC LOND A MAT, V411, P193, DOI 10.1098/rspa.1987.0061; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Banga JR, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-47; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Burack WR, 1997, BIOCHEMISTRY-US, V36, P5929, DOI 10.1021/bi970535d; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Conde R, 2005, J BIOL CHEM, V280, P28989, DOI 10.1074/jbc.M503594200; DANNA A, 1986, P ROY SOC LOND A MAT, V403, P341, DOI 10.1098/rspa.1986.0015; Davies TH, 2002, J BIOL CHEM, V277, P4597, DOI 10.1074/jbc.C100531200; Egea JA, 2007, J GLOBAL OPTIM, V37, P481, DOI 10.1007/s10898-006-9075-3; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Ferrell JE, 1997, J BIOL CHEM, V272, P19008, DOI 10.1074/jbc.272.30.19008; GASS P, 1994, NEUROSCI LETT, V182, P188, DOI 10.1016/0304-3940(94)90794-3; Gerges NZ, 2004, J NEUROSCI, V24, P4758, DOI 10.1523/JNEUROSCI.0594-04.2004; GRAY P, 1983, CHEM ENG SCI, V38, P29, DOI 10.1016/0009-2509(83)80132-8; Gupta S, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-8; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; JACQUEZ JA, 1985, MATH BIOSCI, V77, P201, DOI 10.1016/0025-5564(85)90098-7; Kapuy O, 2009, PROG BIOPHYS MOL BIO, V100, P47, DOI 10.1016/j.pbiomolbio.2009.06.004; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kline MP, 1997, MOL CELL BIOL, V17, P2107, DOI 10.1128/MCB.17.4.2107; Liberzon I., 2009, POSTTRAUMATIC STRESS, P219; MAGER WH, 1995, MICROBIOL REV, V59, P506, DOI 10.1128/MMBR.59.3.506-531.1995; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Mayer MP, 2009, NAT STRUCT MOL BIOL, V16, P2, DOI 10.1038/nsmb0109-2; Mei B, 2005, BRAIN RES BULL, V67, P1, DOI 10.1016/j.brainresbull.2005.03.023; Mitsushima D, 2011, P NATL ACAD SCI USA, V108, P12503, DOI 10.1073/pnas.1104558108; Mizera A, 2010, J THEOR BIOL, V265, P455, DOI 10.1016/j.jtbi.2010.04.029; MOSSER DD, 1988, MOL CELL BIOL, V8, P4736, DOI 10.1128/MCB.8.11.4736; Murray J.D., 2007, INTERDISCIPLINARY AP, V2, P1; Neckers L, 2009, NAT STRUCT MOL BIOL, V16, P235, DOI 10.1038/nsmb0309-235; Peper A, 1998, INT J HYPERTHER, V14, P97, DOI 10.3109/02656739809018218; Peters A, 2007, AM J PHYSIOL-REG I, V293, pR83, DOI 10.1152/ajpregu.00907.2006; Rieger TR, 2006, BIOPHYS J, V90, P886, DOI 10.1529/biophysj.105.066662; Rieger TR, 2005, BIOPHYS J, V88, P1646, DOI 10.1529/biophysj.104.055301; Rodriguez-Fernandez M, 2010, BIOINFORMATICS, V26, P1675, DOI 10.1093/bioinformatics/btq242; Roy A, 2010, NEUROPSYCHOPHARMACOL, V35, P1674, DOI 10.1038/npp.2009.236; Sirri A, 2010, BRAIN RES, V1308, P14, DOI 10.1016/j.brainres.2009.10.049; Song H, 2006, BIOPHYS J, V90, P2309, DOI 10.1529/biophysj.105.074500; Sriram K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002379; Szymanska Z, 2009, J THEOR BIOL, V259, P562, DOI 10.1016/j.jtbi.2009.03.021; Thomas R, 1998, INT J DEV BIOL, V42, P479; Thomas R, 1981, SPRINGER SERIES SYNE, V9, P180; Thomson M, 2009, NATURE, V460, P274, DOI 10.1038/nature08102; Xia WL, 1997, J BIOL CHEM, V272, P4094, DOI 10.1074/jbc.272.7.4094; Yehuda R, 2005, HANDB EXP PHARM, V169, P371; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941; Yehuda R, 2004, BIOL PSYCHIAT, V55, P1110, DOI 10.1016/j.biopsych.2004.02.010; Yehuda R, 2004, AM J PSYCHIAT, V161, P1397, DOI 10.1176/appi.ajp.161.8.1397; YEHUDA R, 1991, BIOL PSYCHIAT, V30, P1031, DOI 10.1016/0006-3223(91)90123-4; Yehuda R, 1996, BIOL PSYCHIAT, V40, P79, DOI 10.1016/0006-3223(95)00451-3; YEHUDA R, 1995, ARCH GEN PSYCHIAT, V52, P583; YEHUDA R, 1993, AM J PSYCHIAT, V150, P83; Yehuda R, 2001, J CLIN PSYCHIAT, V62, P41; Yehuda R, 2009, BIOL PSYCHIAT, V66, P708, DOI 10.1016/j.biopsych.2009.02.034; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zak DE, 2003, GENOME RES, V13, P2396, DOI 10.1101/gr.1198103; Zhang L, 2010, HEAT SHOCK PROTEINS, V5, P179, DOI 10.1007/978-90-481-3381-9_11; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3; Zumsande M, 2010, J THEOR BIOL, V265, P481, DOI 10.1016/j.jtbi.2010.04.025	64	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42958	10.1371/journal.pone.0042958	http://dx.doi.org/10.1371/journal.pone.0042958			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937003	Green Submitted, Green Published, gold			2022-12-25	WOS:000308286300031
J	Chiu, CH; Chou, CW; Takada, S; Liu, YW				Chiu, Chih-Hao; Chou, Chih-Wei; Takada, Shinji; Liu, Yi-Wen			Development and Fibronectin Signaling Requirements of the Zebrafish Interrenal Vessel	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FETAL ADRENAL-GLAND; EXTRACELLULAR-MATRIX COMPONENTS; BASEMENT-MEMBRANE; CELL BEHAVIOR; COLLAGEN-IV; EXPRESSION; IDENTIFICATION; LAMININ; SITE	Background: The early morphogenetic steps of zebrafish interrenal tissue, the teleostean counterpart of the mammalian adrenal gland, are modulated by the peri-interrenal angioblasts and blood vessels. While an organized distribution of intra-adrenal vessels and extracellular matrix is essential for the fetal adrenal cortex remodeling, whether and how an intra-interrenal buildup of vasculature and extracellular matrix forms and functions during interrenal organogenesis in teleosts remains unclear. Methodology and Principal Findings: We characterized the process of interrenal gland vascularization by identifying the interrenal vessel (IRV); which develops from the axial artery through angiogenesis and is associated with highly enriched Fibronectin (Fn) accumulation at its microenvironment. The loss of Fn1 by either antisense morpholino (MO) knockdown or genetic mutation inhibited endothelial invasion and migration of the steroidogenic tissue. The accumulation of peri-IRV Fn requires Integrin alpha 5 (Itga5), with its knockdown leading to interrenal and IRV morphologies phenocopying those in the fn1 morphant and mutant. fn1b, another known fn gene in zebrafish, is however not involved in the IRV formation. The distribution pattern of peri-IRV Fn could be modulated by the blood flow, while a lack of which altered angiogenic direction of the IRV as well as its ability to integrate with the steroidogenic tissue. The administration of Fn antagonist through microangiography exerted reducing effects on both interrenal vessel angiogenesis and steroidogenic cell migration. Conclusions and Significance: This work is the first to identify the zebrafish IRV and to characterize how its integration into the developing interrenal gland requires the Fn-enriched microenvironment, which leads to the possibility of using the IRV formation as a platform for exploring organ-specific angiogenesis. In the context of other developmental endocrinology studies, our results indicate a highly dynamic interrenal-vessel interaction immediately before the onset of stress response in the zebrafish embryo.	[Chiu, Chih-Hao; Chou, Chih-Wei; Liu, Yi-Wen] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Takada, Shinji] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Takada, Shinji] Grad Univ Adv Studies SOKENDAI, Dept Basic Biol, Okazaki, Aichi, Japan	Tunghai University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB)	Chiu, CH (corresponding author), Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan.	dlslys@thu.edu.tw		Liu, Yi-Wen/0000-0003-0455-1013; Takada, Shinji/0000-0003-4125-6056	National Science Council (R.O.C) [96-2628-B-029-002-MY3, 99-2311-B-029-001, 99-2632-B-029-001-MY3, 100-2313-B-029-001, 100-2321-B-400-003]; Grants-in-Aid for Scientific Research [24111002, 23370094] Funding Source: KAKEN	National Science Council (R.O.C); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by National Science Council (R.O.C) grants (96-2628-B-029-002-MY3, 99-2311-B-029-001, 99-2632-B-029-001-MY3, 100-2313-B-029-001 and 100-2321-B-400-003). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop D, 2008, AM J PHYSIOL-REG I, V294, pR711, DOI 10.1152/ajpregu.00671.2007; Alvarez Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-114; BRESLOW MJ, 1992, AM J PHYSIOL, V262, pH1317, DOI 10.1152/ajpheart.1992.262.5.H1317; Chai C, 2003, DEV BIOL, V260, P226, DOI 10.1016/S0012-1606(03)00219-7; Chamoux E, 2005, BRAZ J MED BIOL RES, V38, P1495, DOI 10.1590/S0100-879X2005001000006; Chamoux E, 2002, ENDOCR RES, V28, P637, DOI 10.1081/ERC-120016978; Chamoux E, 2002, J CLIN ENDOCR METAB, V87, P1819, DOI 10.1210/jc.87.4.1819; Chamoux E, 2001, J CLIN ENDOCR METAB, V86, P2090, DOI 10.1210/jc.86.5.2090; Chou CW, 2010, DEV DYNAM, V239, P1995, DOI 10.1002/dvdy.22335; Ehrhart-Bornstein M, 1998, ENDOCR REV, V19, P101, DOI 10.1210/er.19.2.101; Farhadian F, 1996, CARDIOVASC RES, V32, P433, DOI 10.1016/S0008-6363(96)00119-8; Garavito-Aguilar ZV, 2010, DEVELOPMENT, V137, P3215, DOI 10.1242/dev.052225; George EL, 1997, BLOOD, V90, P3073, DOI 10.1182/blood.V90.8.3073; Heikkila P, 2000, ENDOCR RES, V26, P867, DOI 10.3109/07435800009048610; Hsu HJ, 2003, DEVELOPMENT, V130, P2107, DOI 10.1242/dev.00427; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ishimoto H, 2006, J CLIN ENDOCR METAB, V91, P1909, DOI 10.1210/jc.2005-2252; Ishimoto H, 2008, J CLIN ENDOCR METAB, V93, P2402, DOI 10.1210/jc.2007-2509; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Julich D, 2009, DEVELOPMENT, V136, P2913, DOI 10.1242/dev.038935; Julich D, 2005, DEV CELL, V8, P575, DOI 10.1016/j.devcel.2005.01.016; Kim AC, 2009, ENDOCR REV, V30, P241, DOI 10.1210/er.2008-0039; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koshida S, 2005, DEV CELL, V8, P587, DOI 10.1016/j.devcel.2005.03.006; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; LINASK KK, 1986, DEV BIOL, V114, P87, DOI 10.1016/0012-1606(86)90385-4; Liu YW, 2006, DEV BIOL, V297, P44, DOI 10.1016/j.ydbio.2006.04.464; Liu Yi-Wen, 2007, Organogenesis, V3, P44; Liu YW, 2002, DIFFERENTIATION, V70, P36, DOI 10.1046/j.1432-0436.2002.700104.x; Milano EG, 1997, GEN COMP ENDOCR, V108, P483, DOI 10.1006/gcen.1997.7005; Miralem T, 2001, ONCOGENE, V20, P5511, DOI 10.1038/sj.onc.1204753; MORLA A, 1992, J CELL BIOL, V118, P421, DOI 10.1083/jcb.118.2.421; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Nikolova G, 2007, TRENDS CELL BIOL, V17, P19, DOI 10.1016/j.tcb.2006.11.005; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Otis M, 2007, J ENDOCRINOL, V193, P331, DOI 10.1677/JOE-07-0055; Parsons MJ, 2002, DEVELOPMENT, V129, P3137; Pitynski K, 1996, ANN ANAT, V178, P215, DOI 10.1016/S0940-9602(96)80050-1; Pollard SM, 2006, DEV BIOL, V289, P64, DOI 10.1016/j.ydbio.2005.10.006; Red-Horse K, 2007, DEV CELL, V12, P181, DOI 10.1016/j.devcel.2007.01.013; Santoro MM, 2009, MECH DEVELOP, V126, P638, DOI 10.1016/j.mod.2009.06.1080; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Shifren JL, 1998, J CLIN ENDOCR METAB, V83, P1342, DOI 10.1210/jc.83.4.1342; Snow CJ, 2008, DEV DYNAM, V237, P2542, DOI 10.1002/dvdy.21670; Sumanas S, 2005, BLOOD, V106, P534, DOI 10.1182/blood-2004-12-4653; To TT, 2007, MOL ENDOCRINOL, V21, P472, DOI 10.1210/me.2006-0216; Trinh LA, 2004, DEV CELL, V6, P371; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Wijelath ES, 2004, J VASC SURG, V39, P655, DOI 10.1016/j.jvs.2003.10.042; Wijelath ES, 2002, CIRC RES, V91, P25, DOI 10.1161/01.RES.0000026420.22406.79; Yin CY, 2010, DEV CELL, V18, P973, DOI 10.1016/j.devcel.2010.05.009; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	54	17	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43040	10.1371/journal.pone.0043040	http://dx.doi.org/10.1371/journal.pone.0043040			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22937010	Green Submitted, Green Published, gold			2022-12-25	WOS:000307789700020
J	Jones, RM; Mortusewicz, O; Afzal, I; Lorvellec, M; Garcia, P; Helleday, T; Petermann, E				Jones, R. M.; Mortusewicz, O.; Afzal, I.; Lorvellec, M.; Garcia, P.; Helleday, T.; Petermann, E.			Increased replication initiation and conflicts with transcription underlie Cyclin E-induced replication stress	ONCOGENE			English	Article						Cyclin E; replication fork; origin firing; DNA damage; homologous recombination	DNA-DAMAGE RESPONSE; ONCOGENE-INDUCED SENESCENCE; GENOMIC INSTABILITY; HUMAN-CELLS; S-PHASE; FORK PROGRESSION; MAMMALIAN-CELLS; ANTICANCER BARRIER; CANCER DEVELOPMENT; TUMOR SUPPRESSION	It has become increasingly clear that oncogenes not only provide aberrant growth signals to cells but also cause DNA damage at replication forks (replication stress), which activate the ataxia telangiectasia mutated (ATM)/p53-dependent tumor barrier. Here we studied underlying mechanisms of oncogene-induced replication stress in cells overexpressing the oncogene Cyclin E. Cyclin E overexpression is associated with increased firing of replication origins, impaired replication fork progression and DNA damage that activates RAD51-mediated recombination. By inhibiting replication initiation factors, we show that Cyclin E-induced replication slowing and DNA damage is a consequence of excessive origin firing. A significant amount of Cyclin E-induced replication slowing is due to interference between replication and transcription, which also underlies the activation of homologous recombination. Our data suggest that Cyclin E-induced replication stress is caused by deregulation of replication initiation and increased interference between replication and transcription, which results in impaired replication fork progression and DNA damage triggering the tumor barrier or cancer-promoting mutations.	[Jones, R. M.; Afzal, I.; Petermann, E.] Univ Birmingham, Inst Biomed Res, Coll Med & Dent Sci, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England; [Mortusewicz, O.] Univ Oxford, Dept Oncol, Gray Inst Radiat Oncol & Biol, Oxford, England; [Lorvellec, M.; Garcia, P.] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Birmingham B15 2TT, W Midlands, England; [Helleday, T.] Karolinska Inst, Dept Med Biochem & Biophys, Sci Life Lab, Div Translat Med & Chem Biol, S-17121 Stockholm, Sweden	University of Birmingham; University of Oxford; University of Birmingham; Karolinska Institutet	Helleday, T (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Sci Life Lab, Div Translat Med & Chem Biol, S-17121 Stockholm, Sweden.	thomas.helleday@scilifelab.se; e.petermann@bham.ac.uk	Petermann, Eva/AAR-3368-2021; Garcia, Paloma/AFO-2595-2022	Petermann, Eva/0000-0002-5746-213X; Helleday, Thomas/0000-0002-7384-092X; Jones, Rebecca M/0000-0002-5310-8475; Garcia, Paloma/0000-0001-5582-8575; Lorvellec, Maelle/0000-0002-7566-1415	EMBO; Cancer Research UK	EMBO(European Molecular Biology Organization (EMBO)); Cancer Research UK(Cancer Research UK)	OM is supported by an EMBO Long-Term Fellowship. We thank Cancer Research UK for supporting this work financially, Dr Anastasia Zlatanou for cells and materials and Dr Agnieszka Gambus for helpful discussions.	Akli S, 2007, CANCER RES, V67, P7212, DOI 10.1158/0008-5472.CAN-07-0599; Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; Bartek J, 2007, CELL CYCLE, V6, P2344, DOI 10.4161/cc.6.19.4754; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Dereli-Oz A, 2011, MOL ONCOL, V5, P308, DOI 10.1016/j.molonc.2011.05.002; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Fang Y, 2004, EMBO J, V23, P3164, DOI 10.1038/sj.emboj.7600315; Gan WJ, 2011, GENE DEV, V25, P2041, DOI 10.1101/gad.17010011; Garcia P, 2000, ONCOGENE, V19, P1820, DOI 10.1038/sj.onc.1203494; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Geng Y, 2007, MOL CELL, V25, P127, DOI 10.1016/j.molcel.2006.11.029; Gilbert DM, 2007, CHROMOSOMA, V116, P341, DOI 10.1007/s00412-007-0105-9; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gottipati P, 2008, MOL CELL BIOL, V28, P154, DOI 10.1128/MCB.00816-07; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Helmrich A, 2011, MOL CELL, V44, P966, DOI 10.1016/j.molcel.2011.10.013; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; JACKSON DA, 1995, EXP CELL RES, V220, P62, DOI 10.1006/excr.1995.1292; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Kawabata T, 2011, MOL CELL, V41, P543, DOI 10.1016/j.molcel.2011.02.006; KEYOMARSI K, 1993, P NATL ACAD SCI USA, V90, P1112, DOI 10.1073/pnas.90.3.1112; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Lorvellec M, 2010, STEM CELLS, V28, P1751, DOI 10.1002/stem.496; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Lundin C, 2002, MOL CELL BIOL, V22, P5869, DOI 10.1128/MCB.22.16.5869-5878.2002; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Mechali M, 2010, NAT REV MOL CELL BIO, V11, P728, DOI 10.1038/nrm2976; Montagnoli A, 2008, NAT CHEM BIOL, V4, P357, DOI 10.1038/nchembio.90; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Petermann E, 2006, MOL CELL BIOL, V26, P3319, DOI 10.1128/MCB.26.8.3319-3326.2006; Petermann E, 2010, P NATL ACAD SCI USA, V107, P16090, DOI 10.1073/pnas.1005031107; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Santoni-Rugiu E, 2000, MOL CELL BIOL, V20, P3497, DOI 10.1128/MCB.20.10.3497-3509.2000; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Sorensen CS, 2004, CELL CYCLE, V3, P941; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Thomson AM, 2010, J CELL BIOL, V188, P209, DOI 10.1083/jcb.200911037; Tuduri S, 2010, CELL CYCLE, V9, P1886, DOI 10.4161/cc.9.10.11539; Tuduri S, 2009, NAT CELL BIOL, V11, P1315, DOI 10.1038/ncb1984; Woo RA, 2003, CELL CYCLE, V2, P316, DOI 10.4161/cc.2.4.468; Zlatanou A, 2011, MOL CELL, V43, P649, DOI 10.1016/j.molcel.2011.06.023	50	156	156	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG 8	2013	32	32					3744	3753		10.1038/onc.2012.387	http://dx.doi.org/10.1038/onc.2012.387			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	198EH	22945645				2022-12-25	WOS:000322904400009
J	Burns, KE; McAllister, FE; Schwerdtfeger, C; Mintseris, J; Cerda-Maira, F; Noens, EE; Wilmanns, M; Hubbard, SR; Melandri, F; Ovaa, H; Gygi, SP; Darwin, KH				Burns, Kristin E.; McAllister, Fiona E.; Schwerdtfeger, Carsten; Mintseris, Julian; Cerda-Maira, Francisca; Noens, Elke E.; Wilmanns, Matthias; Hubbard, Stevan R.; Melandri, Francesco; Ovaa, Huib; Gygi, Steven P.; Darwin, K. Heran			Mycobacterium tuberculosis Prokaryotic Ubiquitin-like Protein-deconjugating Enzyme Is an Unusual Aspartate Amidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOMAL ATPASE MPA; ANHYDRIDE INTERMEDIATE; CATALYZED-HYDROLYSIS; CARBOXYPEPTIDASE-A; PUPYLATION; PUP; MECHANISMS; PATHWAY; DOP; HYDROXYLAMINE	Deamidase of Pup (Dop), the prokaryotic ubiquitin-like protein (Pup)-deconjugating enzyme, is critical for the full virulence of Mycobacterium tuberculosis and is unique to bacteria, providing an ideal target for the development of selective chemotherapies. We used a combination of genetics and chemical biology to characterize the mechanism of depupylation. We identified an aspartate as a potential nucleophile in the active site of Dop, suggesting a novel protease activity to target for inhibitor development.	[Burns, Kristin E.; Cerda-Maira, Francisca; Darwin, K. Heran] NYU, Dept Microbiol, New York, NY 10016 USA; [Hubbard, Stevan R.] NYU, Skirball Inst, New York, NY 10016 USA; [Hubbard, Stevan R.] NYU, Dept Pharmacol, New York, NY 10016 USA; [McAllister, Fiona E.; Mintseris, Julian; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Schwerdtfeger, Carsten; Melandri, Francesco] Boston Biochem, Cambridge, MA 02139 USA; [Noens, Elke E.; Wilmanns, Matthias] European Mol Biol Lab, D-22603 Hamburg, Germany; [Ovaa, Huib] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands	New York University; New York University; New York University; Harvard University; Harvard Medical School; European Molecular Biology Laboratory (EMBL); Netherlands Cancer Institute	Darwin, KH (corresponding author), NYU, Dept Microbiol, 550 1st Ave,MSB 236, New York, NY 10016 USA.	heran.darwin@med.nyu.edu	Noens, Elke/A-6742-2015; ovaa, huib/M-2334-2016	Hubbard, Stevan/0000-0002-2707-9383; ovaa, huib/0000-0002-0068-054X; Darwin, K Heran/0000-0002-5043-7548; Wilmanns, Matthias/0000-0002-4643-5435	National Institutes of Health [1R01AI088075, GM67945]; Irma T. Hirschl Trust; Investigators in the Pathogenesis of Infectious Disease award from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirschl Trust; Investigators in the Pathogenesis of Infectious Disease award from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01AI088075 (to K. H. D) and GM67945 (to S. P. G.).; Supported by the Irma T. Hirschl Trust and an Investigators in the Pathogenesis of Infectious Disease award from the Burroughs Wellcome Fund. To whom correspondence should be addressed: Dept. of Microbiology, New York University, 550 First Ave., MSB 236, New York, NY 10016. Tel.: 212-263-2624; E-mail: heran.darwin@med.nyu.edu.	Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; BRESLOW R, 1983, P NATL ACAD SCI USA, V80, P4585, DOI 10.1073/pnas.80.14.4585; BRESLOW R, 1977, P NATL ACAD SCI USA, V74, P1303, DOI 10.1073/pnas.74.4.1303; Burns KE, 2010, MOL CELL, V39, P821, DOI 10.1016/j.molcel.2010.07.019; Burns KE, 2010, CELL MICROBIOL, V12, P424, DOI 10.1111/j.1462-5822.2010.01447.x; Burns KE, 2009, J BIOL CHEM, V284, P3069, DOI 10.1074/jbc.M808032200; Cerda-Maira FA, 2010, MOL MICROBIOL, V77, P1123, DOI 10.1111/j.1365-2958.2010.07276.x; CROOKS GP, 1995, J AM CHEM SOC, V117, P10791, DOI 10.1021/ja00149a001; Darwin KH, 2009, NAT REV MICROBIOL, V7, P485, DOI 10.1038/nrmicro2148; Delley CL, 2012, J BIOL CHEM, V287, P7907, DOI 10.1074/jbc.M111.331124; DION HW, 1956, J AM CHEM SOC, V78, P3075, DOI 10.1021/ja01594a036; Guth E, 2011, J BIOL CHEM, V286, P4412, DOI 10.1074/jbc.M110.189282; Hatfull GF, 2000, MOL GENETICS MYCOBAC; Hu GQ, 2006, MOL MICROBIOL, V59, P1417, DOI 10.1111/j.1365-2958.2005.05036.x; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Imkamp F, 2010, EMBO REP, V11, P791, DOI 10.1038/embor.2010.119; Imkamp F, 2010, MOL MICROBIOL, V75, P744, DOI 10.1111/j.1365-2958.2009.07013.x; Iyer LM, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-45; JENCKS WP, 1958, J AM CHEM SOC, V80, P4581, DOI 10.1021/ja01550a040; KAARTINEN V, 1991, J BIOL CHEM, V266, P5860; KAISER BL, 1969, P NATL ACAD SCI USA, V64, P36, DOI 10.1073/pnas.64.1.36; KUO LC, 1983, J MOL BIOL, V163, P63, DOI 10.1016/0022-2836(83)90030-X; Lee HC, 1998, BIOORG MED CHEM LETT, V8, P3379, DOI 10.1016/S0960-894X(98)00624-6; Lehmann C, 2004, PROTEINS, V56, P376, DOI 10.1002/prot.20103; Li J, 2000, J MOL BIOL, V299, P641, DOI 10.1006/jmbi.2000.3800; LIPMANN F, 1945, J BIOL CHEM, V161, P415; Liu JQ, 1997, J BIOL CHEM, V272, P3363, DOI 10.1074/jbc.272.6.3363; Merkx R, 2012, CHEMBIOCHEM, V13, P2056, DOI 10.1002/cbic.201200460; Noens EE, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-27; Ortlund E, 2000, BIOCHEMISTRY-US, V39, P1199, DOI 10.1021/bi991797d; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; SANDER ME, 1985, BIOCHEM BIOPH RES CO, V132, P681, DOI 10.1016/0006-291X(85)91186-6; Shapir N, 2005, J BACTERIOL, V187, P3731, DOI 10.1128/JB.187.11.3731-3738.2005; STELTE B, 1986, EUR J BIOCHEM, V155, P121, DOI 10.1111/j.1432-1033.1986.tb09466.x; Striebel F, 2010, EMBO J, V29, P1262, DOI 10.1038/emboj.2010.23; Striebel F, 2009, NAT STRUCT MOL BIOL, V16, P647, DOI 10.1038/nsmb.1597; Wang T, 2009, STRUCTURE, V17, P1377, DOI 10.1016/j.str.2009.08.010; Wilkinson KD, 2005, METHOD ENZYMOL, V399, P37, DOI 10.1016/S0076-6879(05)99003-4; Zhang MM, 2010, PROTEIN SCI, V19, P974, DOI 10.1002/pro.375	41	15	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37522	37529		10.1074/jbc.M112.384784	http://dx.doi.org/10.1074/jbc.M112.384784			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22942282	hybrid, Green Published			2022-12-25	WOS:000310588500080
J	Ekeruche-Makinde, J; Clement, M; Cole, DK; Edwards, ESJ; Ladell, K; Miles, JJ; Matthews, KK; Fuller, A; Lloyd, KA; Madura, F; Dolton, GM; Pentier, J; Lissina, A; Gostick, E; Baxter, TK; Baker, BM; Rizkallah, PJ; Price, DA; Wooldridge, L; Sewell, AK				Ekeruche-Makinde, Julia; Clement, Mathew; Cole, David K.; Edwards, Emily S. J.; Ladell, Kristin; Miles, John J.; Matthews, Katherine K.; Fuller, Anna; Lloyd, Katy A.; Madura, Florian; Dolton, Garry M.; Pentier, Johanne; Lissina, Anna; Gostick, Emma; Baxter, Tiffany K.; Baker, Brian M.; Rizkallah, Pierre J.; Price, David A.; Wooldridge, Linda; Sewell, Andrew K.			T-cell Receptor-optimized Peptide Skewing of the T-cell Repertoire Can Enhance Antigen Targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX CLASS-I; CARCINOEMBRYONIC ANTIGEN; TUMOR REACTIVITY; MOLECULAR-BASIS; CD8 CORECEPTOR; IMMUNE ESCAPE; SELF-ANTIGEN; TCR-BINDING; LYMPHOCYTES; VACCINATION	Altered peptide antigens that enhance T-cell immunogenicity have been used to improve peptide-based vaccination for a range of diseases. Although this strategy can prime T-cell responses of greater magnitude, the efficacy of constituent T-cell clonotypes within the primed population can be poor. To overcome this limitation, we isolated a CD8(+) T-cell clone (MEL5) with an enhanced ability to recognize the HLA A*0201-Melan A(27-35) (HLA A*0201-AAGIGILTV) antigen expressed on the surface of malignant melanoma cells. We used combinatorial peptide library screening to design an optimal peptide sequence that enhanced functional activation of the MEL5 clone, but not other CD8(+) T-cell clones that recognized HLA A*0201-AAGIGILTV poorly. Structural analysis revealed the potential for new contacts between the MEL5 T-cell receptor and the optimized peptide. Furthermore, the optimized peptide was able to prime CD8(+) T-cell populations in peripheral blood mononuclear cell isolates from multiple HLAA*0201(+) individuals that were capable of efficient HLA A*0201(+) melanoma cell destruction. This proof-of-concept study demonstrates that it is possible to design altered peptide antigens for the selection of superior T-cell clonotypes with enhanced antigen recognition properties.	[Ekeruche-Makinde, Julia; Clement, Mathew; Cole, David K.; Edwards, Emily S. J.; Ladell, Kristin; Miles, John J.; Matthews, Katherine K.; Fuller, Anna; Lloyd, Katy A.; Madura, Florian; Dolton, Garry M.; Pentier, Johanne; Lissina, Anna; Gostick, Emma; Rizkallah, Pierre J.; Price, David A.; Wooldridge, Linda; Sewell, Andrew K.] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales; [Miles, John J.] Queensland Inst Med Res, Australian Ctr Vaccine Dev, Human Immun Lab, Brisbane, Qld 4029, Australia; [Baxter, Tiffany K.; Baker, Brian M.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	Cardiff University; QIMR Berghofer Medical Research Institute; University of Notre Dame	Sewell, AK (corresponding author), Cardiff Univ, Sch Med, Inst Infect & Immun, Henry Wellcome Bldg,Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	SewellAK@cardiff.ac.uk	Sewell, Andrew/GPT-4220-2022; Ladell, Kristin/C-8301-2013; Miles, John J/ABC-1105-2020; Rizkallah, Pierre J/A-5367-2012; Price, David A/C-7876-2013; Ladell, Kristin/K-2475-2013; Edwards, Emily SJ/C-3219-2013; Edwards, Emily S.J./AAI-6037-2020	Sewell, Andrew/0000-0003-3194-3135; Ladell, Kristin/0000-0002-9856-2938; Miles, John J/0000-0001-5506-6304; Rizkallah, Pierre J/0000-0002-9290-0369; Price, David A/0000-0001-9416-2737; Edwards, Emily S.J./0000-0002-0240-4370; Cole, David/0000-0003-0028-9396; Wooldridge, Linda/0000-0002-6213-347X; Makinde, Julia/0000-0002-9906-7437; Fuller, Anna/0000-0002-8655-6741; Matthews, Katherine/0000-0002-4402-451X	Biotechnology and Biological Sciences Research Council [BB/H001085/1]; Wellcome Trust [WT086716, WT095767, WT079848MA]; National Institutes of Health Grant [GM067079]; Research Councils UK; Wales Office of Research and Development; The Medical Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067079] Funding Source: NIH RePORTER; Tenovus Cancer Care [PhD2009/L20] Funding Source: researchfish; BBSRC [BB/H001085/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Councils UK(UK Research & Innovation (UKRI)); Wales Office of Research and Development; The Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Tenovus Cancer Care; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (Grant BB/H001085/1), Wellcome Trust Grants WT086716 (to A. K. S.), WT095767 (to D. K. C.), and WT079848MA (to L. W.), and National Institutes of Health Grant GM067079 (to B. M. B.). Fellowship support was received from the Research Councils UK (to P. J. R.), Wales Office of Research and Development (to J. J. M.), and The Medical Research Council (to D. A. P.).	AlexanderMiller MA, 1996, P NATL ACAD SCI USA, V93, P4102, DOI 10.1073/pnas.93.9.4102; Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Ayyoub M, 2003, CLIN CANCER RES, V9, P669; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bangham CRM, 2009, EUR J IMMUNOL, V39, P1700, DOI 10.1002/eji.200939451; Bins A, 2007, J IMMUNOTHER, V30, P234, DOI 10.1097/01.cji.0000211333.06762.47; Borbulevych OY, 2007, J MOL BIOL, V372, P1123, DOI 10.1016/j.jmb.2007.07.025; Borbulevych OY, 2010, MOL IMMUNOL, V47, P2519, DOI 10.1016/j.molimm.2010.06.005; Bridgeman JS, 2012, IMMUNOLOGY, V135, P9, DOI 10.1111/j.1365-2567.2011.03515.x; CASANOVA JL, 1993, IMMUNOL TODAY, V14, P391, DOI 10.1016/0167-5699(93)90140-G; Chen Qiyuan, 2005, Cancer Immun, V5, P5; Cole DK, 2008, MOL IMMUNOL, V45, P2700, DOI 10.1016/j.molimm.2007.12.009; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Cole DK, 2007, PROTEINS, V67, P65, DOI 10.1002/prot.21176; Cole DK, 2010, J IMMUNOL, V185, P2600, DOI 10.4049/jimmunol.1000629; Cole DK, 2009, J BIOL CHEM, V284, P27281, DOI 10.1074/jbc.M109.022509; Cole DJ, 1997, CANCER RES, V57, P5320; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Derre L, 2007, J IMMUNOL, V179, P7635, DOI 10.4049/jimmunol.179.11.7635; Dietrich PY, 2003, J IMMUNOL, V170, P5103, DOI 10.4049/jimmunol.170.10.5103; Dutoit V, 2002, J EXP MED, V196, P207, DOI 10.1084/jem.20020242; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Hou YF, 2008, J IMMUNOL, V180, P1526, DOI 10.4049/jimmunol.180.3.1526; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; Jager E, 2002, INT J CANCER, V98, P376, DOI 10.1002/ijc.10165; Johnson LA, 2006, J IMMUNOL, V177, P6548, DOI 10.4049/jimmunol.177.9.6548; Kan-Mitchell J, 2006, J IMMUNOL, V176, P6690, DOI 10.4049/jimmunol.176.11.6690; KAWAKAMI Y, 1994, J EXP MED, V180, P347, DOI 10.1084/jem.180.1.347; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P3515, DOI 10.1073/pnas.91.9.3515; Khan AR, 2000, J IMMUNOL, V164, P6398, DOI 10.4049/jimmunol.164.12.6398; Laugel B, 2007, J BIOL CHEM, V282, P23799, DOI 10.1074/jbc.M700976200; Leslie A., 1992, 4 COLL COMP PROJ; Liddy N, 2012, NAT MED, V18, P980, DOI 10.1038/nm.2764; Linnemann T, 2001, EUR J IMMUNOL, V31, P156, DOI 10.1002/1521-4141(200101)31:1<156::AID-IMMU156>3.0.CO;2-P; Maryanski JL, 1999, MOL IMMUNOL, V36, P745, DOI 10.1016/S0161-5890(99)00088-7; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miles KM, 2011, MOL IMMUNOL, V48, P728, DOI 10.1016/j.molimm.2010.11.004; MURARO R, 1985, CANCER RES, V45, P5769; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PARKER KC, 1992, J IMMUNOL, V149, P3580; Pittet MJ, 2006, J IMMUNOL, V176, P2330, DOI 10.4049/jimmunol.176.4.2330; Price DA, 2005, J EXP MED, V202, P1349, DOI 10.1084/jem.20051357; Price DA, 2004, IMMUNITY, V21, P793, DOI 10.1016/j.immuni.2004.10.010; Price DA, 2009, J EXP MED, V206, P923, DOI 10.1084/jem.20081127; Rivoltini L, 1999, CANCER RES, V59, P301; Romero P, 1997, J IMMUNOL, V159, P2366; Rosenberg SA, 1998, NAT MED, V4, P321, DOI 10.1038/nm0398-321; Schaubert KL, 2010, EUR J IMMUNOL, V40, P1950, DOI 10.1002/eji.200940079; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Skipper JCA, 1999, INT J CANCER, V82, P669, DOI 10.1002/(SICI)1097-0215(19990827)82:5<669::AID-IJC9>3.0.CO;2-#; Speiser DE, 2008, P NATL ACAD SCI USA, V105, P3849, DOI 10.1073/pnas.0800080105; Speiser DE, 2002, EUR J IMMUNOL, V32, P731, DOI 10.1002/1521-4141(200203)32:3<731::AID-IMMU731>3.0.CO;2-H; STEWARD AM, 1974, CANCER-AM CANCER SOC, V33, P1246, DOI 10.1002/1097-0142(197405)33:5<1246::AID-CNCR2820330509>3.0.CO;2-O; TOPALIAN SL, 1989, J IMMUNOL, V142, P3714; Tumenjargal S, 2003, EUR J IMMUNOL, V33, P3175, DOI 10.1002/eji.200324244; Valmori D, 2000, J IMMUNOL, V165, P533, DOI 10.4049/jimmunol.165.1.533; Valmori D, 1998, J IMMUNOL, V161, P6956; Valmori D, 1998, J IMMUNOL, V160, P1750; Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779; Venturi V, 2008, NAT REV IMMUNOL, V8, P231, DOI 10.1038/nri2260; VINCENT RG, 1978, J THORAC CARDIOV SUR, V75, P734; Wieckowski S, 2009, J IMMUNOL, V183, P5397, DOI 10.4049/jimmunol.0901460; Wilson DB, 2004, MOL IMMUNOL, V40, P1047, DOI 10.1016/j.molimm.2003.11.022; Wooldridge L, 2005, J BIOL CHEM, V280, P27491, DOI 10.1074/jbc.M500555200; Wooldridge L, 2007, EUR J IMMUNOL, V37, P1323, DOI 10.1002/eji.200636765; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Wooldridge L, 2010, J IMMUNOL, V185, P4625, DOI 10.4049/jimmunol.1001480; Zaremba S, 1997, CANCER RES, V57, P4570; Zippelius A, 2002, J EXP MED, V195, P485, DOI 10.1084/jem.20011658	76	33	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37269	37281		10.1074/jbc.M112.386409	http://dx.doi.org/10.1074/jbc.M112.386409			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22952231	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000310588500059
J	Jia, M; Li, JC; Zhu, JW; Wen, WY; Zhang, MJ; Wang, WN				Jia, Min; Li, Jianchao; Zhu, Jinwei; Wen, Wenyu; Zhang, Mingjie; Wang, Wenning			Crystal Structures of the Scaffolding Protein LGN Reveal the General Mechanism by Which GoLoco Binding Motifs Inhibit the Release of GDP from G alpha(i)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASYMMETRIC CELL-DIVISION; REGULATES SPINDLE ORIENTATION; PINS; NUMA; POLARITY; ACTIVATION; COMPLEX; EXCHANGE; PARTNER; DOMAINS	GoLoco (GL) motif-containing proteins regulate G protein signaling by binding to G alpha subunit and acting as guanine nucleotide dissociation inhibitors. GLs of LGN are also known to bind the GDP form of G alpha(i/o) during asymmetric cell division. Here, we show that the C-terminal GL domain of LGN binds four molecules of G alpha(i).GDP. The crystal structures of G alpha(i).GDPin complex with LGN GL3 and GL4, respectively, reveal distinct GL/G alpha(i) interaction features when compared with the only high resolution structure known with GL/G alpha i interaction between RGS14 and G alpha(11). Only a few residues C-terminal to the conserved GL sequence are required for LGN GLs to bind to G alpha(i).GDP. A highly conserved "double Arg finger" sequence (R Psi(D/E)(D/E)QR) is responsible for LGN GL to bind to GDP bound to G alpha(i). Together with the sequence alignment, we suggest that the LGN GL/G alpha(i) interaction represents a general binding mode between GL motifs and G alpha(i). We also show that LGN GLs are potent guanine nucleotide dissociation inhibitors.	[Li, Jianchao; Zhu, Jinwei; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Zhang, Mingjie] Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, Kowloon, Hong Kong, Peoples R China; [Jia, Min; Zhu, Jinwei; Wen, Wenyu; Wang, Wenning] Fudan Univ, Dept Chem, Shanghai Key Lab Mol Catalysis & Innovat Mat, Shanghai 200433, Peoples R China; [Jia, Min; Zhu, Jinwei; Wen, Wenyu; Wang, Wenning] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Jia, Min] Fudan Univ, Dept Pharm, Shanghai 200433, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Fudan University; Fudan University; Fudan University	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk; wnwang@fudan.edu.cn	LI, Jianchao/J-2053-2017; LI, Jianchao/J-2053-2017	LI, Jianchao/0000-0002-8921-1626; LI, Jianchao/0000-0003-1012-0076; Zhang, Mingjie/0000-0001-9404-0190	National Major Basic Research Program of China [2009CB918600, 2011CB808505]; National Science Foundation of China [20973040, 31070642]; Science & Technology Commission of Shanghai Municipality Grant [08DZ2270500]; Research Grants Council of Hong Kong [663808, 664009, 660709, 663610, 663811, HKUST6/CRF/10, SEG_H-KUST06]	National Major Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Commission of Shanghai Municipality Grant(Science & Technology Commission of Shanghai Municipality (STCSM)); Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by National Major Basic Research Program of China Grants 2009CB918600 and 2011CB808505, National Science Foundation of China Grants 20973040 and 31070642, Science & Technology Commission of Shanghai Municipality Grant 08DZ2270500), and by Grants 663808, 664009, 660709, 663610, 663811, HKUST6/CRF/10, and SEG_H-KUST06 from the Research Grants Council of Hong Kong to MZ.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adhikari A, 2003, J BIOL CHEM, V278, P51825, DOI 10.1074/jbc.M306300200; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Bosch DE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002553; Bosch DE, 2011, J BIOL CHEM, V286, P3351, DOI 10.1074/jbc.M110.190496; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2002, CURR BIOL, V12, P1928, DOI 10.1016/S0960-9822(02)01298-8; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Granderath S, 1999, DEVELOPMENT, V126, P1781; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Kaushik R, 2003, MOL BIOL CELL, V14, P3144, DOI 10.1091/mbc.E03-04-0212; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Kopein D, 2009, MOL BIOL CELL, V20, P3865, DOI 10.1091/mbc.E09-01-0021; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Malbon CC, 2005, NAT REV MOL CELL BIO, V6, P689, DOI 10.1038/nrm1716; McCudden CR, 2005, BBA-MOL CELL RES, V1745, P254, DOI 10.1016/j.bbamcr.2005.05.002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Natochin M, 2001, BIOCHEMISTRY-US, V40, P5322, DOI 10.1021/bi015505w; Nipper RW, 2007, P NATL ACAD SCI USA, V104, P14306, DOI 10.1073/pnas.0701812104; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ponting CP, 1999, J MOL MED, V77, P695, DOI 10.1007/s001099900054; Sammond DW, 2007, J MOL BIOL, V371, P1392, DOI 10.1016/j.jmb.2007.05.096; Sammond DW, 2011, J AM CHEM SOC, V133, P4190, DOI 10.1021/ja110296z; Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; Smith NR, 2011, MOL CELL, V43, P540, DOI 10.1016/j.molcel.2011.06.030; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Yoshiura S, 2012, DEV CELL, V22, P79, DOI 10.1016/j.devcel.2011.10.027; Yu FW, 2006, NEURON, V51, P13, DOI 10.1016/j.neuron.2006.06.016; Zhu JW, 2011, EMBO J, V30, P4986, DOI 10.1038/emboj.2011.428; Zhu JW, 2011, MOL CELL, V43, P418, DOI 10.1016/j.molcel.2011.07.011	45	19	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36766	36776		10.1074/jbc.M112.391607	http://dx.doi.org/10.1074/jbc.M112.391607			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22952234	hybrid, Green Published			2022-12-25	WOS:000310588500014
J	Newington, JT; Rappon, T; Albers, S; Wong, DY; Rylett, RJ; Cumming, RC				Newington, Jordan T.; Rappon, Tim; Albers, Shawn; Wong, Daisy Y.; Rylett, R. Jane; Cumming, Robert C.			Overexpression of Pyruvate Dehydrogenase Kinase 1 and Lactate Dehydrogenase A in Nerve Cells Confers Resistance to Amyloid beta and Other Toxins by Decreasing Mitochondrial Respiration and Reactive Oxygen Species Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; ALZHEIMERS-DISEASE; A-BETA; AEROBIC GLYCOLYSIS; SUPEROXIDE-DISMUTASE; BINDING-SITES; PROTEIN; CANCER; STAUROSPORINE; METABOLISM	We previously demonstrated that nerve cell lines selected for resistance to amyloid beta (A beta) peptide exhibit elevated aerobic glycolysis in part due to increased expression of pyruvate dehydrogenase kinase 1 (PDK1) and lactate dehydrogenase A (LDHA). Here, we show that overexpression of either PDK1 or LDHA in a rat CNS cell line (B12) confers resistance to A beta and other neurotoxins. Treatment of A beta-sensitive cells with various toxins resulted in mitochondrial hyperpolarization, immediately followed by rapid depolarization and cell death, events accompanied by increased production of cellular reactive oxygen species (ROS). In contrast, cells expressing either PDK1 or LDHA maintained a lower mitochondrial membrane potential and decreased ROS production with or without exposure to toxins. Additionally, PDK1- and LDHA-overexpressing cells exhibited decreased oxygen consumption but maintained levels of ATP under both normal culture conditions and following A beta treatment. Interestingly, immunoblot analysis of wild type mouse primary cortical neurons treated with A beta or cortical tissue extracts from 12-month-old APPswe/PS1dE9 transgenic mice showed decreased expression of LDHA and PDK1 when compared with controls. Additionally, post-mortem brain extracts from patients with Alzheimer disease exhibited a decrease in PDK1 expression compared with nondemented patients. Collectively, these findings indicate that key Warburg effect enzymes play a central role in mediating neuronal resistance to A beta or other neurotoxins by decreasing mitochondrial activity and subsequent ROS production. Maintenance of PDK1 or LDHA expression in certain regions of the brain may explain why some individuals tolerate high levels of A beta deposition without developing Alzheimer disease.	[Newington, Jordan T.; Rappon, Tim; Cumming, Robert C.] Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada; [Albers, Shawn; Wong, Daisy Y.; Rylett, R. Jane] Robarts Res Inst, Dept Physiol & Pharmacol, London, ON N6A 5K8, Canada; [Albers, Shawn; Wong, Daisy Y.; Rylett, R. Jane] Robarts Res Inst, Mol Brain Res Grp, London, ON N6A 5K8, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Cumming, RC (corresponding author), Univ Western Ontario, Dept Biol, 1151 Richmond St N, London, ON N6A 5B7, Canada.	rcummin5@uwo.ca	Cumming, Robert/G-2185-2010; Rylett, Rebecca Jane/K-3597-2013	Rylett, Rebecca Jane/0000-0002-9158-9599	Natural Sciences and Engineering Research Council of Canada Grant [355803-2008]; Scottish Rite Charitable Foundation Grant [11103]; Canada Foundation for Innovation Grant [22167]; Canadian Institutes of Health Research Grant [115135]; Alzheimer Society of London; Alzheimer Society of Middlesex; Ontario Graduate Scholarships in Science and Technology	Natural Sciences and Engineering Research Council of Canada Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Scottish Rite Charitable Foundation Grant; Canada Foundation for Innovation Grant(Canada Foundation for Innovation); Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Alzheimer Society of London; Alzheimer Society of Middlesex; Ontario Graduate Scholarships in Science and Technology	This work was supported in part by Natural Sciences and Engineering Research Council of Canada Grant 355803-2008 (to R. C. C.), Scottish Rite Charitable Foundation Grant 11103 (to R. C. C.), Canada Foundation for Innovation Grant 22167 (to R. C. C.), and Canadian Institutes of Health Research Grant 115135 (to R. J. R.).; Supported by the Alzheimer Society of London and Middlesex and Ontario Graduate Scholarships in Science and Technology.	Aubert A, 2005, P NATL ACAD SCI USA, V102, P16448, DOI 10.1073/pnas.0505427102; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; BOURAS C, 1994, CEREB CORTEX, V4, P138, DOI 10.1093/cercor/4.2.138; Butterfield DA, 2007, FREE RADICAL BIO MED, V43, P658, DOI 10.1016/j.freeradbiomed.2007.05.037; Cardoso SM, 2001, FASEB J, V15, P1439, DOI 10.1096/fj.00-0561fje; Cardoso SM, 2002, BRAIN RES, V931, P117, DOI 10.1016/S0006-8993(02)02256-4; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Choi K, 2009, CURR NEUROVASC RES, V6, P213, DOI 10.2174/156720209789630375; Cumming RC, 2007, J BIOL CHEM, V282, P30523, DOI 10.1074/jbc.M700869200; Cunnane S, 2011, NUTRITION, V27, P3, DOI 10.1016/j.nut.2010.07.021; Dargusch R, 2002, J NEUROCHEM, V81, P1394, DOI 10.1046/j.1471-4159.2002.00950.x; Dineley KT, 2002, J BIOL CHEM, V277, P22768, DOI 10.1074/jbc.M200164200; Dumont M, 2009, FASEB J, V23, P2459, DOI 10.1096/fj.09-132928; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Fernandez-Vizarra P, 2004, HISTOL HISTOPATHOL, V19, P823, DOI 10.14670/HH-19.823; GolshaniHebroni SG, 1997, J BIOENERG BIOMEMBR, V29, P331, DOI 10.1023/A:1022442629543; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V171, P189, DOI 10.1016/0006-291X(90)91375-3; Hynes J, 2012, METHODS MOL BIOL, V810, P59, DOI 10.1007/978-1-61779-382-0_4; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kruman I, 1998, J NEUROSCI RES, V51, P293, DOI 10.1002/(SICI)1097-4547(19980201)51:3<293::AID-JNR3>3.0.CO;2-B; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Leuner K, 2012, ANTIOXID REDOX SIGN, V16, P1421, DOI 10.1089/ars.2011.4173; Lu HS, 2005, J BIOL CHEM, V280, P41928, DOI 10.1074/jbc.M508718200; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; McFate T, 2008, J BIOL CHEM, V283, P22700, DOI 10.1074/jbc.M801765200; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; Miwa S, 2003, BIOCHEM SOC T, V31, P1300; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; Newington JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019191; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Poisnel G, 2012, NEUROBIOL AGING, V33, P1995, DOI 10.1016/j.neurobiolaging.2011.09.026; Pong K, 2001, EXP NEUROL, V171, P84, DOI 10.1006/exnr.2001.7747; Powers WJ, 1998, J CEREBR BLOOD F MET, V18, P632, DOI 10.1097/00004647-199806000-00005; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Ribeiro FM, 2005, J NEUROCHEM, V94, P86, DOI 10.1111/j.1471-4159.2005.03171.x; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Sagara Y, 1996, J NEUROSCI, V16, P497; SCHUBERT D, 1974, NATURE, V249, P224, DOI 10.1038/249224a0; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Selkoe DJ, 2004, ANN INTERN MED, V140, P627, DOI 10.7326/0003-4819-140-8-200404200-00047; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Soucek T, 2003, NEURON, V39, P43, DOI 10.1016/S0896-6273(03)00367-2; Tillement L, 2011, MITOCHONDRION, V11, P13, DOI 10.1016/j.mito.2010.08.009; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; Vlassenko AG, 2010, P NATL ACAD SCI USA, V107, P17763, DOI 10.1073/pnas.1010461107; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Zhou M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-33	58	69	76	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37245	37258		10.1074/jbc.M112.366195	http://dx.doi.org/10.1074/jbc.M112.366195			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22948140	hybrid, Green Published			2022-12-25	WOS:000310588500057
J	Deng, JY; Sun, D; Pan, Y; Zhang, L; Zhang, RP; Wang, DC; Hao, XS; Liang, H				Deng, Jingyu; Sun, Dan; Pan, Yuan; Zhang, Li; Zhang, Rupeng; Wang, Dianchang; Hao, Xishan; Liang, Han			Ratio between Negative and Positive Lymph Nodes Is Suitable for Evaluation the Prognosis of Gastric Cancer Patients with Positive Node Metastasis	PLOS ONE			English	Article							AMERICAN-JOINT-COMMITTEE; CANCER/INTERNATIONAL-UNION; STAGE MIGRATION; N-RATIO; SURVIVAL; CLASSIFICATION; LYMPHADENECTOMY; CARCINOMA; NUMBER; IMPACT	Objective: To date, there is no consensus to evaluate the most appropriate category of the nodal metastasis for precise predication the prognosis of gastric cancer patients with positive node metastasis after curative surgery. Methods: We retrospectively analyzed the clinicopathologic characteristics and overall survival (OS) of 299 gastric cancer patients with positive node metastasis after curative surgery for evaluation the optimal category of the nodal metastasis. Results: With the univariate and multivariate survival analyses, the depth of primary tumor invasion was identified as the independent predicators with the OS of 299 gastric cancer patients with nodal metastasis postoperatively, as were the number of positive lymph nodes (PLNs), the number of negative lymph nodes (NLNs), and the ratio between negative and positive lymph nodes (RNPL). The RNPL was identified to be more suitable for predication the OS of gastric cancer patients with positive node metastasis than the ratio between positive and dissected lymph nodes (RPDL) by using the stratum procedure of survival analysis. Besides, we found both PLNs and NLNs were independently correlated with OS of gastric cancer patients with nodal metastasis when RNPL, instead of RPDL, was controlled in the partial correlation model. Conclusions: RNPL, a new category of the nodal metastasis, was suitable for predication the OS of gastric cancer patients with nodal metastasis after curative resection, as were the PLNs, and NLNs.	[Deng, Jingyu; Pan, Yuan; Zhang, Li; Zhang, Rupeng; Hao, Xishan; Liang, Han] Tianjin Med Univ, Canc Inst & Hosp, Key Lab Canc Prevent & Therapy, Gastr Canc Surg Div, Tianjin, Peoples R China; [Sun, Dan] Tianjin Med Univ, Gen Hosp, Inst Lung Canc, Tianjin, Peoples R China; [Wang, Dianchang] Tianjin Med Univ, Canc Inst & Hosp, Key Lab Canc Prevent & Therapy, Hepatobilliary Canc Surg Div, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Deng, JY (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Key Lab Canc Prevent & Therapy, Gastr Canc Surg Div, Tianjin, Peoples R China.	tjlianghan@sohu.com			National Basic Research Program of China (973 Program) [2010CB529301]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was supported by a grant from the National Basic Research Program of China (973 Program) 2010CB529301. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2010, CANCER-AM CANCER SOC, V116, P5592, DOI 10.1002/cncr.25550; Aurello P, 2007, AM SURGEON, V73, P359; Bilici A, 2010, MED ONCOL, V27, P975, DOI 10.1007/s12032-009-9319-4; Bilici A, 2010, ONKOLOGIE, V33, P101, DOI 10.1159/000277927; Bonenkamp JJ, 1999, NEW ENGL J MED, V340, P908, DOI 10.1056/NEJM199903253401202; Bouvier AM, 2002, CANCER, V94, P2862, DOI 10.1002/cncr.10550; BUNT AMG, 1995, J CLIN ONCOL, V13, P19, DOI 10.1200/JCO.1995.13.1.19; Cuschieri A, 1999, BRIT J CANCER, V79, P1522, DOI 10.1038/sj.bjc.6690243; Deng JY, 2008, J SURG ONCOL, V98, P343, DOI 10.1002/jso.21119; Deng JY, 2011, LANGENBECK ARCH SURG, V396, P615, DOI 10.1007/s00423-011-0753-3; Deng JY, 2010, ANN SURG ONCOL, V17, P1259, DOI 10.1245/s10434-010-0939-x; Deng JY, 2010, ANN SURG ONCOL, V17, P1043, DOI 10.1245/s10434-009-0863-0; FEINSTEIN AR, 1985, NEW ENGL J MED, V312, P1604, DOI 10.1056/NEJM198506203122504; Fukuda N, 2009, WORLD J SURG, V33, P2378, DOI 10.1007/s00268-009-0205-1; Funada T, 2011, HEPATO-GASTROENTEROL, V58, P642; HERMANEK P, 1994, SEMIN SURG ONCOL, V10, P12, DOI 10.1002/ssu.2980100105; Hohenberger P, 2003, LANCET, V362, P305, DOI 10.1016/S0140-6736(03)13975-X; Huang CM, 2008, WORLD J GASTROENTERO, V14, P4383, DOI 10.3748/wjg.14.4383; Huang CM, 2010, WORLD J GASTROENTERO, V16, P2055, DOI 10.3748/wjg.v16.i16.2055; Ichikura T, 1999, CANCER-AM CANCER SOC, V86, P553, DOI 10.1002/(SICI)1097-0142(19990815)86:4<553::AID-CNCR2>3.0.CO;2-D; JAEHNE J, 1992, ARCH SURG-CHICAGO, V127, P290; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/S101209800016; Katai H, 2000, CANCER-AM CANCER SOC, V88, P1796, DOI 10.1002/(SICI)1097-0142(20000415)88:8<1796::AID-CNCR6>3.3.CO;2-U; Kulig J, 2009, BRIT J SURG, V96, P910, DOI 10.1002/bjs.6653; Kunisaki C, 2004, ANN SURG ONCOL, V11, P203, DOI 10.1245/ASO.2004.06.012; Lee SY, 2010, INT J ONCOL, V36, P1461, DOI 10.3892/ijo_00000632; Maduekwe UN, 2010, ANN SURG ONCOL, V17, P1267, DOI 10.1245/s10434-010-0914-6; Marchet A, 2008, EJSO-EUR J SURG ONC, V34, P159, DOI 10.1016/j.ejso.2007.04.018; Marchet A, 2007, ANN SURG, V245, P543, DOI 10.1097/01.sla.0000250423.43436.e1; Nakajima Toshifusa, 2002, Gastric Cancer, V5, P1, DOI 10.1007/s101200200000; Sasako M, 2007, DIGEST SURG, V24, P101, DOI 10.1159/000101896; Sianesi M, 2010, J GASTROINTEST SURG, V14, P614, DOI 10.1007/s11605-009-1142-x; Smith DD, 2005, J CLIN ONCOL, V23, P7114, DOI 10.1200/JCO.2005.14.621; Sobin L, 1997, INT UNION CANC UICC; Tokunaga M, 2010, ANN SURG ONCOL, V17, P2031, DOI 10.1245/s10434-010-0969-4; Wang W, 2011, ANN SURG ONCOL, V18, P1060, DOI 10.1245/s10434-010-1424-2; Wu CW, 2004, BRIT J SURG, V91, P283, DOI 10.1002/bjs.4433	37	21	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43925	10.1371/journal.pone.0043925	http://dx.doi.org/10.1371/journal.pone.0043925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952812	Green Published, gold, Green Submitted			2022-12-25	WOS:000308221300035
J	McCracken, GF; Westbrook, JK; Brown, VA; Eldridge, M; Federico, P; Kunz, TH				McCracken, Gary F.; Westbrook, John K.; Brown, Veronica A.; Eldridge, Melanie; Federico, Paula; Kunz, Thomas H.			Bats Track and Exploit Changes in Insect Pest Populations	PLOS ONE			English	Article							FREE-TAILED BATS; TADARIDA-BRASILIENSIS-MEXICANA; DIETARY VARIATION; ARTHROPOD PREY; CORN-EARWORM; DNA; PCR; LEPIDOPTERA; MOLOSSIDAE; EMERGENCE	The role of bats or any generalist predator in suppressing prey populations depends on the predator's ability to track and exploit available prey. Using a qPCR fecal DNA assay, we document significant association between numbers of Brazilian free-tailed bats (Tadarida brasiliensis) consuming corn earworm (CEW) moths (Helicoverpa zea) and seasonal fluctuations in CEW populations. This result is consistent with earlier research linking the bats' diet to patterns of migration, abundance, and crop infestation by important insect pests. Here we confirm opportunistic feeding on one of the world's most destructive insects and support model estimates of the bats' ecosystem services. Regression analysis of CEW consumption versus the moth's abundance at four insect trapping sites further indicates that bats track local abundance of CEW within the regional landscape. Estimates of CEW gene copies in the feces of bats are not associated with seasonal or local patterns of CEW abundance, and results of captive feeding experiments indicate that our qPCR assay does not provide a direct measure of numbers or biomass of prey consumed. Our results support growing evidence for the role of generalist predators, and bats specifically, as agents for biological control and speak to the value of conserving indigenous generalist predators.	[McCracken, Gary F.; Brown, Veronica A.; Eldridge, Melanie; Federico, Paula] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Westbrook, John K.] ARS, Areawide Pest Management Res Unit, USDA, College Stn, TX USA; [Eldridge, Melanie] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Federico, Paula] Capital Univ, Dept Math Comp Sci & Phys, Columbus, OH USA; [Kunz, Thomas H.] Boston Univ, Dept Biol, Ctr Ecol & Conservat Biol, Boston, MA 02215 USA	University of Tennessee System; University of Tennessee Knoxville; United States Department of Agriculture (USDA); University of Tennessee System; University of Tennessee Knoxville; Capital University; Boston University	McCracken, GF (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	gmccrack@utk.edu		McCracken, Gary/0000-0002-2493-8103	NSF [EIA-0326483]; Bat Conservation International; University of Tennessee, Knoxville	NSF(National Science Foundation (NSF)); Bat Conservation International; University of Tennessee, Knoxville	This work was supported by NSF Grant EIA-0326483 (TH Kunz, PI, M Betke, GF McCracken, P Morton, and JK Westbrook, CoPI's); Bat Conservation International; and The University of Tennessee, Knoxville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEERWINKLE KR, 1994, ENVIRON ENTOMOL, V23, P676, DOI 10.1093/ee/23.3.676; Bohmann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021441; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Chang Gary C., 1999, P103, DOI 10.1017/CBO9780511542077.009; Clare EL, 2011, MOL ECOL, V20, P1772, DOI 10.1111/j.1365-294X.2011.05040.x; Clare EL, 2009, MOL ECOL, V18, P2532, DOI 10.1111/j.1365-294X.2009.04184.x; Cleveland CJ, 2006, FRONT ECOL ENVIRON, V4, P238, DOI 10.1890/1540-9295(2006)004[0238:EVOTPC]2.0.CO;2; Deagle BE, 2005, MOL ECOL, V14, P1831, DOI 10.1111/j.1365-294X.2005.02531.x; Ehler LE, 1998, BIOL CONTROL, V13, P127, DOI 10.1006/bcon.1998.0649; Federico P, 2008, ECOL APPL, V18, P826, DOI 10.1890/07-0556.1; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Gould F, 2002, P NATL ACAD SCI USA, V99, P16581, DOI 10.1073/pnas.242382499; Keeley B. W., 1999, 3 INT C WILDL EC TRA; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; Kohn MH, 1997, TRENDS ECOL EVOL, V12, P223, DOI 10.1016/S0169-5347(97)01050-1; KUNZ TH, 1995, OECOLOGIA, V101, P407, DOI 10.1007/BF00329419; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Lee YF, 2005, J MAMMAL, V86, P67, DOI 10.1644/1545-1542(2005)086&lt;0067:DVOBFB&gt;2.0.CO;2; Lee YF, 2002, ECOSCIENCE, V9, P306, DOI 10.1080/11956860.2002.11682717; Lee YF, 2001, ZOOL STUD, V40, P309; LINGREN PD, 1993, J ECON ENTOMOL, V86, P1429, DOI 10.1093/jee/86.5.1429; Liu H, 1992, MOL PHYLOGENET EVOL, V1, P41, DOI 10.1016/1055-7903(92)90034-E; McCracken GF, 2008, INTEGR COMP BIOL, V48, P107, DOI 10.1093/icb/icn033; Puechmaille SJ, 2007, ACTA CHIROPTEROL, V9, P269, DOI 10.3161/1733-5329(2007)9[269:GDFBD]2.0.CO;2; Reichard JD, 2009, J MAMMAL, V90, P1478, DOI 10.1644/08-MAMM-A-266R1.1; Rinta-Kanto JM, 2005, ENVIRON SCI TECHNOL, V39, P4198, DOI 10.1021/es048249u; Rozen S, 2000, Methods Mol Biol, V132, P365; Russell A.L., 2006, FUNCTIONAL EVOLUTION, P227; Sansone C, 2002, PUBLICATION TEXAS B; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; WESTBROOK JK, 1995, AGR FOREST METEOROL, V73, P67, DOI 10.1016/0168-1923(94)02171-F; Whitaker JO, 1996, J MAMMAL, V77, P716, DOI 10.2307/1382676; Whitaker Jr JO, 2009, ECOLOGICAL BEHAV MET, P569; WOLF WW, 1990, PHILOS T R SOC B, V328, P619, DOI 10.1098/rstb.1990.0132; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x	37	111	119	3	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43839	10.1371/journal.pone.0043839	http://dx.doi.org/10.1371/journal.pone.0043839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952782	Green Published, gold			2022-12-25	WOS:000308221300029
J	Yan, C; Bi, Y; Yin, D; Zhao, ZY				Yan, Cheung; Bi, Yu; Yin, Da; Zhao, Zhongying			A Method for Rapid and Simultaneous Mapping of Genetic Loci and Introgression Sizes in Nematode Species	PLOS ONE			English	Article							CAENORHABDITIS-BRIGGSAE; REPRODUCTIVE ISOLATION; REGULATORY ELEMENTS; ELEGANS; DROSOPHILA; EVOLUTION; CELL; TRANSCRIPTION; SPECIATION; PATTERNS	Caenorhabditis briggsae is emerging as an attractive model organism not only in studying comparative biology against C. elegans, but also in developing novel experimentation avenues. In particular, recent identification of a new Caenorhabditis species, C. sp.9 with which it can mate and produce viable progeny provides an opportunity for studying the genetics of hybrid incompatibilities (HI) between the two. Mapping of a specific HI locus demands repeated backcrossing to get hold of the specific genomic region underlying an observed phenotype. To facilitate mapping of HI loci between C. briggsae and C. sp.9, an efficient mapping method and a genetic map ideally consisting of dominant markers are required for systematic introgression of genomic fragments between the two species. We developed a fast and cost-effective method for high throughput mapping of dominant loci with resolution up to 1 million bps in C. briggsae. The method takes advantage of the introgression between C. briggsae and C. sp.9 followed by PCR genotyping using C. briggsae specific primers. Importantly, the mapping results can not only serve as an effective way for estimating the chromosomal position of a genetic locus in C. briggsae, but also provides size information for the introgression fragment in an otherwise C. sp.9 background. In addition, it also helps generate introgression line as a side-product that is invaluable for the subsequent mapping of HI loci. The method will greatly facilitate the construction of a genetic map consisting of dominant markers and pave the way for systematic isolation of HI loci between C. briggsae and C. sp.9 which has so far not been attempted between nematode species. The method is designed for mapping of a dominant allele, but can be easily adapted for mapping of any other type of alleles in any other species if introgression between a sister species pair is feasible.	[Yan, Cheung; Bi, Yu; Yin, Da; Zhao, Zhongying] Hong Kong Baptist Univ, Dept Biol, Fac Sci, Hong Kong, Hong Kong, Peoples R China	Hong Kong Baptist University	Yan, C (corresponding author), Hong Kong Baptist Univ, Dept Biol, Fac Sci, Hong Kong, Hong Kong, Peoples R China.	zyzhao@hkbu.edu.hk	Zhao, Zhongying/C-3261-2015; Yin, Da/AAM-1339-2021; Zhao, Zhongying/ABF-9458-2021	Yin, Da/0000-0002-5336-2772; Zhao, Zhongying/0000-0003-2743-9008; Yu, Bi/0000-0003-2154-400X	Hong Kong Baptist University Faculty Research Grant Category II [FRG2/11-12/058, FRG2/10-11/065]; Hong Kong Baptist University Faculty Start-up Fund	Hong Kong Baptist University Faculty Research Grant Category II; Hong Kong Baptist University Faculty Start-up Fund	The work was supported by Hong Kong Baptist University Faculty Research Grant Category II (FRG2/11-12/058, FRG2/10-11/065), Hong Kong Baptist University Faculty Start-up Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboobaker AA, 2003, CURR BIOL, V13, P37, DOI 10.1016/S0960-9822(02)01399-4; Baird SE, 2000, EVOL DEV, V2, P9, DOI 10.1046/j.1525-142x.2000.00031.x; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Coghlan A, 2002, GENOME RES, V12, P857, DOI 10.1101/gr.172702; Cutter AD, 2006, GENETICS, V173, P2021, DOI 10.1534/genetics.106.058651; Cutter AD, 2010, MOL ECOL, V19, P798, DOI 10.1111/j.1365-294X.2009.04491.x; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Etges WJ, 2007, EVOLUTION, V61, P1106, DOI 10.1111/j.1558-5646.2007.00104.x; GuhaThakurta D, 2004, GENOME RES, V14, P2457, DOI 10.1101/gr.2961104; Hillier LW, 2007, PLOS BIOL, V5, P1603, DOI 10.1371/journal.pbio.0050167; Hoyos E, 2011, CURR BIOL, V21, P527, DOI 10.1016/j.cub.2011.02.040; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kao KC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001038; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; Koboldt DC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-236; Kozlowska JL, 2012, EVOLUTION, V66, P1180, DOI 10.1111/j.1558-5646.2011.01514.x; Maheshwari S, 2010, ANN REV GENET; Masly JP, 2007, PLOS BIOL, V5, P1890, DOI 10.1371/journal.pbio.0050243; Matute DR, 2010, SCIENCE, V329, P1518, DOI 10.1126/science.1193440; Penigault JB, 2011, DEV BIOL, V357, P419, DOI 10.1016/j.ydbio.2011.05.675; Praitis V, 2001, GENETICS, V157, P1217; Ross JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002174; Rozen S, 2000, Methods Mol Biol, V132, P365; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Seidel HS, 2008, SCIENCE, V319, P589, DOI 10.1126/science.1151107; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Uyar B, 2012, GENOME RES; Vergara IA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-516; Wolf JBW, 2010, PHILOS T R SOC B, V365, P1717, DOI 10.1098/rstb.2010.0023; Woodruff GC, 2010, GENETICS, V186, P997, DOI 10.1534/genetics.110.120550; Zhao ZY, 2008, DEV BIOL, V314, P93, DOI 10.1016/j.ydbio.2007.11.015; Zhao ZY, 2010, GENETICS, V184, P853, DOI 10.1534/genetics.109.110270; Zhao ZY, 2005, J BIOL CHEM, V280, P38787, DOI 10.1074/jbc.M505701200; Zhao ZY, 2004, BIOCHEM BIOPH RES CO, V323, P104, DOI 10.1016/j.bbrc.2004.08.068	35	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43770	10.1371/journal.pone.0043770	http://dx.doi.org/10.1371/journal.pone.0043770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952761	gold, Green Published, Green Submitted			2022-12-25	WOS:000308221300027
J	Calero, O; Bullido, MJ; Clarimon, J; Frank-Garcia, A; Martinez-Martin, P; Lleo, A; Rey, MJ; Sastre, I; Rabano, A; de Pedro-Cuesta, J; Ferrer, I; Calero, M				Calero, Olga; Bullido, Maria J.; Clarimon, Jordi; Frank-Garcia, Ana; Martinez-Martin, Pablo; Lleo, Alberto; Jesus Rey, Maria; Sastre, Isabel; Rabano, Alberto; de Pedro-Cuesta, Jesus; Ferrer, Isidro; Calero, Miguel			A Common BACE1 Polymorphism Is a Risk Factor for Sporadic Creutzfeldt-Jakob Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; CELLULAR PRION PROTEIN; MILD COGNITIVE IMPAIRMENT; BETA-SECRETASE CLEAVAGE; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; SENILE PLAQUES; ASSOCIATION; GENE; ALLELE	The beta site APP cleaving enzyme 1 (BACE1) is the rate-limiting beta-secretase enzyme in the amyloidogenic processing of APP and A beta formation, and therefore it has a prominent role in Alzheimer's disease (AD) pathology. Recent evidence suggests that the prion protein (PrP) interacts directly with BACE1 regulating its beta-secretase activity. Moreover, PrP has been proposed as the cellular receptor involved in the impairment of synaptic plasticity and toxicity caused by Ab oligomers. Provided that common pathophysiologic mechanisms are shared by Alzheimer's and Creutzfeldt-Jakob (CJD) diseases, we investigated for the first time to the best of our knowledge a possible association of a common synonymous BACE1 polymorphism (rs638405) with sporadic CJD (sCJD). Our results indicate that BACE1 C-allele is associated with an increased risk for developing sCJD, mainly in PRNP M129M homozygous subjects with early onset. These results extend the very short list of genes (other than PRNP) involved in the development of human prion diseases; and support the notion that similar to AD, in sCJD several loci may contribute with modest overall effects to disease risk. These findings underscore the interplay in both pathologies of APP, A beta oligomers, ApoE, PrP and BACE1, and suggest that aging and perhaps vascular risk factors may modulate disease pathologies in part through these key players.	[Calero, Olga; Bullido, Maria J.; Clarimon, Jordi; Frank-Garcia, Ana; Martinez-Martin, Pablo; Lleo, Alberto; Sastre, Isabel; de Pedro-Cuesta, Jesus; Ferrer, Isidro; Calero, Miguel] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Calero, Olga; Calero, Miguel] CNM ISCIII, Unidad Encefalopatias Espongiformes, Madrid, Spain; [Bullido, Maria J.; Sastre, Isabel] Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain; [Bullido, Maria J.; Frank-Garcia, Ana; Sastre, Isabel] Inst Sanitary Res Hosp la Paz IdIPaz, Madrid, Spain; [Clarimon, Jordi; Lleo, Alberto] Univ Autonoma Barcelona, Hosp Santa Creu & Sant Pau, Dept Neurol, E-08193 Barcelona, Spain; [Frank-Garcia, Ana] Hosp Univ La Paz UAM, Neurol Serv, Madrid, Spain; [Martinez-Martin, Pablo] Alzheimer Ctr Reina Sofia Fdn, Carlos III Inst Hlth, Alzheimer Dis Res Unit, CIEN Fdn, Madrid, Spain; [Jesus Rey, Maria] Univ Barcelona Hosp Clin, Banco Tejidos Neurol, Barcelona, Spain; [Rabano, Alberto] Alzheimer Ctr Reina Sofia Fdn, Carlos III Inst Hlth, CIEN Fdn, Banco Tejidos Fdn CIEN, Madrid, Spain; [de Pedro-Cuesta, Jesus] Ctr Nacl Epidemiol Inst Salud Carlos III CNM ISC, Area Epidemiol Aplicada, Madrid, Spain; [Ferrer, Isidro] Univ Barcelona, Hospitalet LLobregat, IDIBELL Hosp Univ Bellvitge, Inst Neuropathol INP, Barcelona, Spain	CIBERNED; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Hospital Universitario La Paz; Instituto de Salud Carlos III; University of Barcelona; Hospital Clinic de Barcelona; Instituto de Salud Carlos III; Instituto de Salud Carlos III; Centro Nacional de Epidemiologia (CNE); CIBERNED; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Calero, O (corresponding author), Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.	mcalero@isciii.es	Martinez-Martin, Pablo/N-9909-2019; Lleó, Alberto/K-5783-2019; Calero, Miguel/H-5691-2015; García, Ana Frank/I-5159-2015; Bullido, maria j/C-8509-2014; Martinez-Martin, Pablo/E-1329-2013	Martinez-Martin, Pablo/0000-0003-0837-5280; Calero, Miguel/0000-0001-5366-3324; García, Ana Frank/0000-0003-3858-9116; Bullido, maria j/0000-0002-6477-1117; Clarimon, Jordi/0000-0002-6824-6942	Ministerio de Ciencia e Innovacion, DGSP from Ministerio de Sanidad, Politica Social e Igualdad [FIS 05/0912]; DGSP of the Spanish National Health Ministry; Spanish CIBERNED (Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas) network	Ministerio de Ciencia e Innovacion, DGSP from Ministerio de Sanidad, Politica Social e Igualdad; DGSP of the Spanish National Health Ministry; Spanish CIBERNED (Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas) network	This work was supported by grants FIS 05/0912 from the Ministerio de Ciencia e Innovacion, DGSP from Ministerio de Sanidad, Politica Social e Igualdad (MC), the DGSP of the Spanish National Health Ministry (MC), and the Spanish CIBERNED (Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas) network (AL, JdPC, IF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2003, SCIENCE, V302, P814, DOI 10.1126/science.1087348; Altmeppen HC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-36; Armstrong RA, 2005, NEUROPATHOLOGY, V25, P111, DOI 10.1111/j.1440-1789.2005.00605.x; Barnham KJ, 2006, TRENDS BIOCHEM SCI, V31, P465, DOI 10.1016/j.tibs.2006.06.006; Beck JA, 2008, J MED GENET, V45, P813, DOI 10.1136/jmg.2008.061804; Brown DR, 2001, TRENDS NEUROSCI, V24, P85, DOI 10.1016/S0166-2236(00)01689-1; Calero O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022090; Calero O, 2009, PRION, V3, P146, DOI 10.4161/pri.3.3.9339; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Checler F, 1999, IUBMB LIFE, V48, P33, DOI 10.1080/152165499307396; Checler F, 2002, TRENDS NEUROSCI, V25, P616, DOI 10.1016/S0166-2236(02)02263-4; CHECLER F, 1995, J NEUROCHEM, V65, P1431; Chiesa R, 2001, NEUROBIOL DIS, V8, P743, DOI 10.1006/nbdi.2001.0433; Clarimon J, 2012, PRION IN PRESS; Cole SL, 2009, NEUROBIOL AGING, V30, P1535, DOI 10.1016/j.neurobiolaging.2007.12.012; Combarros O, 2009, NEUROBIOL AGING, V30, P1333, DOI 10.1016/j.neurobiolaging.2007.11.027; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cortina-Borja Mario, 2009, BMC Res Notes, V2, P105, DOI 10.1186/1756-0500-2-105; de Pedro-Cuesta J, 2011, J NEUROL NEUROSUR PS, V82, P204, DOI 10.1136/jnnp.2009.188425; Debatin L, 2008, NEURODEGENER DIS, V5, P347, DOI 10.1159/000121389; Eisenberg DTA, 2010, AM J PHYS ANTHROPOL, V143, P100, DOI 10.1002/ajpa.21298; Endres K, 2009, NEUROBIOL DIS, V36, P233, DOI 10.1016/j.nbd.2009.07.015; Ewers M, 2008, BRAIN, V131, P1252, DOI 10.1093/brain/awn034; Ewers M, 2011, J ALZHEIMERS DIS, V25, P373, DOI 10.3233/JAD-2011-091153; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Ferrer I, 2001, ACTA NEUROPATHOL, V101, P49; Ferrer I, 2004, NEUROPATH APPL NEURO, V30, P329, DOI 10.1111/j.1365-2990.2003.00534.x; Ferrer I, 2000, NEUROSCIENCE, V97, P715, DOI 10.1016/S0306-4522(00)00045-2; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Gambetti P, 1998, NEPHROL DIAL TRANSPL, V13, P33, DOI 10.1093/ndt/13.suppl_7.33; Ge B, 2005, GENOME RES, V15, P1584, DOI 10.1101/gr.4023805; Ghetti B, 1996, BRAIN PATHOL, V6, P127, DOI 10.1111/j.1750-3639.1996.tb00796.x; Glatzel M, 2001, BRAIN RES REV, V36, P241, DOI 10.1016/S0165-0173(01)00100-X; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Griffiths HH, 2011, J BIOL CHEM, V286, P33489, DOI 10.1074/jbc.M111.278556; Hampel H, 2010, EXP NEUROL, V223, P334, DOI 10.1016/j.expneurol.2009.09.024; Holsinger RMD, 2006, NEUROLOGY, V67, P1105; Holsinger RMD, 2004, ANN NEUROL, V55, P898, DOI 10.1002/ana.20144; Hooper NM, 2008, TRENDS BIOCHEM SCI, V33, P151, DOI 10.1016/j.tibs.2008.01.004; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Kapaki E, 2001, J NEUROL NEUROSUR PS, V71, P401, DOI 10.1136/jnnp.71.3.401; Kellett KAB, 2009, PRION, V3, P190, DOI 10.4161/pri.3.4.9980; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lewis V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031754; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Lloyd S, 2011, TOP CURR CHEM, V305, P1, DOI 10.1007/128_2011_157; Lloyd SE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000383; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; Mead S, 2011, HUM MOL GENET; Mead S, 2009, LANCET NEUROL, V8, P57, DOI 10.1016/S1474-4422(08)70265-5; Mowrer KR, 2009, J NEUROCHEM, V109, P1008, DOI 10.1111/j.1471-4159.2009.06026.x; Mulder SD, 2010, J ALZHEIMERS DIS, V20, P253, DOI 10.3233/JAD-2010-1367; Nygaard HB, 2009, ARCH NEUROL-CHICAGO, V66, P1325, DOI 10.1001/archneurol.2009.223; Otto M, 2000, NEUROLOGY, V54, P1099, DOI 10.1212/WNL.54.5.1099; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; PRICE DL, 1993, P NATL ACAD SCI USA, V90, P6381, DOI 10.1073/pnas.90.14.6381; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1996, TRENDS BIOCHEM SCI, V21, P482, DOI 10.1016/S0968-0004(96)10063-3; Rushworth JV, 2011, INT J ALZHEIMERS DIS, V2011, DOI [10.4061/2011/603052, DOI 10.4061/2011/603052]; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Soldevila M, 2006, GENOME RES, V16, P231, DOI 10.1101/gr.4345506; Taylor DR, 2009, J BIOL CHEM, V284, P22590, DOI 10.1074/jbc.M109.032599; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Zetterberg H, 2008, ARCH NEUROL-CHICAGO, V65, P1102, DOI 10.1001/archneur.65.8.1102; Zhong ZY, 2007, ARCH GEN PSYCHIAT, V64, P718, DOI 10.1001/archpsyc.64.6.718	72	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43926	10.1371/journal.pone.0043926	http://dx.doi.org/10.1371/journal.pone.0043926			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952813	Green Published, gold			2022-12-25	WOS:000308206500029
J	Rautava, J; Willberg, J; Louvanto, K; Wideman, L; Syrjanen, K; Grenman, S; Syrjanen, S				Rautava, Jaana; Willberg, Jaana; Louvanto, Karolina; Wideman, Lilli; Syrjanen, Kari; Grenman, Seija; Syrjanen, Stina			Prevalence, Genotype Distribution and Persistence of Human Papillomavirus in Oral Mucosa of Women: A Six-Year Follow-Up Study	PLOS ONE			English	Article							NATURAL-HISTORY; HPV INFECTIONS; CANCER; TRANSMISSION; CARCINOMAS; CAVITY; ADULTS; HEAD; DNA; PCR	Background: Human papillomavirus (HPV) infections have been linked to a subset of oral and oropharyngeal cancers. However, little is known on the natural history of oral HPV infections. We designed the prospective Finnish HPV Family Study to assess the dynamics of HPV infections in parents and their infants. This study reports HPV genotype distribution and virus persistence in oral mucosa of the mothers. Materials and Methods: Totally, 324 pregnant women were enrolled at the 3rd trimester of pregnancy and followed-up for 6 years. Oral scrapings taken with a brush were collected and HPV-genotyping was performed with nested PCR and Multimetrix (R) test (Progen, Heidelberg, Germany). The predictors of persistent oral HPV species 7/9 infections were analyzed using generalized estimating equation models. Results: The point prevalence of oral HPV varied from 15% to 24% during the 6-year follow-up. Altogether, 18 HPV genotypes were identified either as single or multiple-type oral infections. HPV16 was the most prevalent type at 9.7%-18.4%, followed by HPV18, HPV6, and multiple infections. Altogether, 74 women had persistent oral HPV infection determined as at least two consecutive samples positive with the same HPV genotype. HPV16 and HPV6 were the two most frequent types to persist (76% and 9%) for a mean of 18.6 and 20.2 months, respectively, followed by multiple infections (8%) for 18.3 months. An increased risk for persistent oral HPV infection with species 7/9 was associated with being seropositive for low-risk (LR)-HPV-types at baseline, whereas the use of oral contraceptives and a second pregnancy during follow-up were protective. Clinical oral lesions were detected in 17% of these women, one-third of whom had persistent oral HPV-infections. Conclusion: HPV16 and HPV6 were the most common genotypes in oral HPV-infections and were also most likely to persist. Use of oral contraceptives and a second pregnancy protected against oral HPV persistence.	[Rautava, Jaana; Willberg, Jaana; Louvanto, Karolina; Wideman, Lilli; Syrjanen, Stina] Univ Turku, Inst Dent, Dept Oral Pathol, Fac Med, Turku, Finland; [Rautava, Jaana; Willberg, Jaana; Louvanto, Karolina; Wideman, Lilli; Syrjanen, Stina] Univ Turku, Fac Med, Medicity Res Lab, Turku, Finland; [Syrjanen, Kari] Turku Univ Hosp, Dept Radiotherapy & Oncol, FIN-20520 Turku, Finland; [Grenman, Seija] Turku Univ Hosp, Dept Obstet & Gynecol, FIN-20520 Turku, Finland	University of Turku; University of Turku; University of Turku; University of Turku	Rautava, J (corresponding author), Univ Turku, Inst Dent, Dept Oral Pathol, Fac Med, Turku, Finland.	stina.syrjanen@utu.fi	Louvanto, Karolina/GXG-3296-2022	Louvanto, Karolina/0000-0002-1172-363X; Syrjanen, Kari/0000-0001-7180-7491; Syrjanen, Stina/0000-0003-0738-5698	Academy of Finland [116438/2006, 130204/2008]; Finnish Cancer Foundation; Sohlberg Foundation; Finnish Dental Society; Government Special Foundation (EVO)	Academy of Finland(Academy of Finland); Finnish Cancer Foundation; Sohlberg Foundation; Finnish Dental Society; Government Special Foundation (EVO)	This study was supported by the Academy of Finland (#116438/2006, #130204/2008), Finnish Cancer Foundation, Sohlberg Foundation, Finnish Dental Society, the Government Special Foundation (EVO) to Turku University Hospital. The funders had no role in the study design and data analysis, decision to publish, or preparation of the manuscript.	Anttila M, 1999, GYNECOL ONCOL, V72, P337, DOI 10.1006/gyno.1998.5264; Castellsague X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-74; D'Souza G, 2007, INT J CANCER, V121, P143, DOI 10.1002/ijc.22667; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; D'Souza G, 2009, J INFECT DIS, V199, P1263, DOI 10.1086/597755; Diggle PJ, 2002, ANAL LONGITUDINAL DA; Esquenazi D, 2010, BRAZ J OTORHINOLAR, V76, P78, DOI 10.1590/S1808-86942010000100013; Hardin J., 2003, GEN ESTIMATING EQUAT; KELLOKOSKI J, 1992, ORAL MICROBIOL IMMUN, V7, P19, DOI 10.1111/j.1399-302X.1992.tb00014.x; Kreimer AR, 2010, SEX TRANSM DIS, V37, P386, DOI 10.1097/OLQ.0b013e3181c94a3b; Kreimer AR, 2004, J INFECT DIS, V189, P686, DOI 10.1086/381504; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Kurose K, 2004, ORAL SURG ORAL MED O, V98, P91, DOI 10.1016/j.tripleo.2003.12.029; Louvanto K, 2010, J INFECT DIS, V202, P436, DOI 10.1086/653826; Miller CS, 1996, ORAL SURG ORAL MED O, V82, P57, DOI 10.1016/S1079-2104(96)80378-7; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Rintala MAM, 2005, J CLIN MICROBIOL, V43, P376, DOI 10.1128/JCM.43.1.376-381.2005; Sanchez-Vargas L, 2010, INFECT AGENTS CANCER, V5, P25, DOI DOI 10.1186/1750-9378-5-25; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Smith E M, 2004, Infect Dis Obstet Gynecol, V12, P45; SNIJDERS PJF, 1990, J GEN VIROL, V71, P173, DOI 10.1099/0022-1317-71-1-173; Syrjanen S, 2007, NEW ENGL J MED, V356, P1993, DOI 10.1056/NEJMe078004; SYRJANEN K, 2000, PAPILLOMAVIRUS INFEC, P1; Syrjanen S, 2003, MED MICROBIOL IMMUN, V192, P123, DOI 10.1007/s00430-002-0173-7; Syrjanen S, 2011, ORAL DIS, V17, P58, DOI 10.1111/j.1601-0825.2011.01792.x; Terai M, 1999, ORAL MICROBIOL IMMUN, V14, P201, DOI 10.1034/j.1399-302X.1999.140401.x	27	55	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e42171	10.1371/journal.pone.0042171	http://dx.doi.org/10.1371/journal.pone.0042171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952591	Green Submitted, gold, Green Published			2022-12-25	WOS:000308206500004
J	Civiero, L; Vancraenenbroeck, R; Belluzzi, E; Beilina, A; Lobbestael, E; Reyniers, L; Gao, FY; Micetic, I; De Maeyer, M; Bubacco, L; Baekelandt, V; Cookson, MR; Greggio, E; Taymans, JM				Civiero, Laura; Vancraenenbroeck, Renee; Belluzzi, Elisa; Beilina, Alexandra; Lobbestael, Evy; Reyniers, Lauran; Gao, Fangye; Micetic, Ivan; De Maeyer, Marc; Bubacco, Luigi; Baekelandt, Veerle; Cookson, Mark R.; Greggio, Elisa; Taymans, Jean-Marc			Biochemical Characterization of Highly Purified Leucine-Rich Repeat Kinases 1 and 2 Demonstrates Formation of Homodimers	PLOS ONE			English	Article							DISEASE-ASSOCIATED MUTATIONS; PARKINSONS-DISEASE; GTP-BINDING; ROC DOMAIN; DOMINANT PARKINSONISM; ALPHA-SYNUCLEIN; LRRK2; GENE; LEUCINE-RICH-REPEAT-KINASE-2; PROTEINS	Leucine-rich repeat kinase 1 and 2 (LRRK1 and LRRK2) are large multidomain proteins containing kinase, GTPase and multiple protein-protein interaction domains, but only mutations in LRRK2 are linked to familial Parkinson's disease (PD). Independent studies suggest that LRRK2 exists in the cell as a complex compatible with the size of a dimer. However, whether this complex is truly a homodimer or a heterologous complex formed by monomeric LRRK2 with other proteins has not been definitively proven due to the limitations in obtaining highly pure proteins suitable for structural characterization. Here, we used stable expression of LRRK1 and LRRK2 in HEK293T cell lines to produce recombinant LRRK1 and LRRK2 proteins of greater than 90% purity. Both purified LRRKs are folded, with a predominantly alpha-helical secondary structure and are capable of binding GTP with similar affinity. Furthermore, recombinant LRRK2 exhibits robust autophosphorylation activity, phosphorylation of model peptides in vitro and ATP binding. In contrast, LRRK1 does not display significant autophosphorylation activity and fails to phosphorylate LRRK2 model substrates, although it does bind ATP. Using these biochemically validated proteins, we show that LRRK1 and LRRK2 are capable of forming homodimers as shown by single-particle transmission electron microscopy and immunogold labeling. These LRRK dimers display an elongated conformation with a mean particle size of 145 angstrom and 175 angstrom respectively, which is disrupted by addition of 6M guanidinium chloride. Immunogold staining revealed double-labeled particles also in the pathological LRRK2 mutant G2019S and artificial mutants disrupting GTPase and kinase activities, suggesting that point mutations do not hinder the dimeric conformation. Overall, our findings indicate for the first time that purified and active LRRK1 and LRRK2 can form dimers in their full-length conformation.	[Civiero, Laura; Belluzzi, Elisa; Micetic, Ivan; Bubacco, Luigi; Greggio, Elisa] Univ Padua, Dept Biol, Padua, Italy; [Vancraenenbroeck, Renee; Lobbestael, Evy; Reyniers, Lauran; Gao, Fangye; Baekelandt, Veerle; Taymans, Jean-Marc] Katholieke Univ Leuven, Lab Neurobiol & Gene Therapy, Louvain, Belgium; [Vancraenenbroeck, Renee; De Maeyer, Marc] Katholieke Univ Leuven, Lab Biomol Modelling, B-3001 Heverlee, Belgium; [Beilina, Alexandra; Cookson, Mark R.] NIA, Cell Biol & Gene Express Unit, Neurogenet Lab, Bethesda, MD 20892 USA	University of Padua; KU Leuven; KU Leuven; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Civiero, L (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	elisa.greggio@unipd.it; jean-marc.taymans@med.kuleuven.be	Taymans, Jean-Marc/M-9175-2018; Belluzzi, Elisa/K-4622-2016; Civiero, Laura/GXG-2968-2022; Civiero, Laura/K-7665-2016; Mičetić, Ivan/A-7146-2015; Cookson, Mark/AAW-2516-2021; Greggio, Elisa/H-6119-2013; Bubacco, Luigi/B-5602-2012; Lobbestael, Evy/H-7537-2018; Baekelandt, Veerle/ABB-9736-2020	Taymans, Jean-Marc/0000-0001-5503-5524; Belluzzi, Elisa/0000-0003-1129-2574; Civiero, Laura/0000-0002-5334-155X; Mičetić, Ivan/0000-0003-1691-8425; Cookson, Mark/0000-0002-1058-3831; Greggio, Elisa/0000-0002-8172-3598; Bubacco, Luigi/0000-0001-7927-9208; Lobbestael, Evy/0000-0002-6417-4670; Baekelandt, Veerle/0000-0001-8966-2921; Vancraenenbroeck, Renee/0000-0003-2685-2749	Michael J Fox Foundation; Rientro dei Cervelli Program (lncentivazione alla mobilita di studiosi stranieri e italiani residenti all'estero) from the Italian Ministry of Education, University and Research; PRIN2008 [55YP79]; Intramural Research Program of the National Institutes of Health, National Institute on Aging; Research Foundation - Flanders Fonds Wetenschappelijk Onderzoek (FWO) [G.0666.09]; project Neuro-TARGET [IWT SBO/80020]; KULeuven [OT/08/052A, IOF-KP/07/001]	Michael J Fox Foundation; Rientro dei Cervelli Program (lncentivazione alla mobilita di studiosi stranieri e italiani residenti all'estero) from the Italian Ministry of Education, University and Research; PRIN2008; Intramural Research Program of the National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Research Foundation - Flanders Fonds Wetenschappelijk Onderzoek (FWO)(FWO); project Neuro-TARGET; KULeuven(KU Leuven)	Funding provided by the Michael J Fox Foundation; the Rientro dei Cervelli Program (lncentivazione alla mobilita di studiosi stranieri e italiani residenti all'estero) from the Italian Ministry of Education, University and Research (EG); PRIN2008 (55YP79) (LB); the Intramural Research Program of the National Institutes of Health, National Institute on Aging; the Research Foundation - Flanders Fonds Wetenschappelijk Onderzoek (FWO project G.0666.09, PhD fellowships to RVC, EL and senior researcher fellowship to J-MT); the IWT SBO/80020 project Neuro-TARGET; the KULeuven (OT/08/052A and IOF-KP/07/001); and the Fund Druwe-Eerdekens managed by the King Baudouin Foundation (J-MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand VS, 2009, FEBS J, V276, P466, DOI 10.1111/j.1742-4658.2008.06789.x; Baekelandt V, 2002, HUM GENE THER, V13, P841, DOI 10.1089/10430340252899019; Berger Z, 2010, BIOCHEMISTRY-US, V49, P5511, DOI 10.1021/bi100157u; Bosgraaf L, 2003, BBA-MOL CELL RES, V1643, P5, DOI 10.1016/j.bbamcr.2003.08.008; Brehme M, 2009, P NATL ACAD SCI USA, V106, P7414, DOI 10.1073/pnas.0900653106; Carlessi R, 2011, EMBO REP, V12, P917, DOI 10.1038/embor.2011.126; Covy JP, 2010, J NEUROCHEM, V115, P36, DOI 10.1111/j.1471-4159.2010.06894.x; Daniels V, 2011, J NEUROCHEM, V116, P304, DOI 10.1111/j.1471-4159.2010.07105.x; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gandhi PN, 2008, J NEUROSCI RES, V86, P1711, DOI 10.1002/jnr.21622; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Geraerts M, 2005, J GENE MED, V7, P1299, DOI 10.1002/jgm.778; Gillardon F, 2009, NEUROSCIENCE, V163, P533, DOI 10.1016/j.neuroscience.2009.06.051; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Gotthardt K, 2008, EMBO J, V27, P2352, DOI 10.1038/emboj.2008.167; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2007, J NEUROCHEM, V102, P93, DOI 10.1111/j.1471-4159.2007.04523.x; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Hanafusa H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1161; Haugarvoll K, 2007, NEUROSCI LETT, V416, P299, DOI 10.1016/j.neulet.2007.02.020; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Ito G, 2012, BIOCHEM J, V441, P987, DOI 10.1042/BJ20111215; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Jorgensen ND, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008463; Klein CL, 2009, J NEUROCHEM, V111, P703, DOI 10.1111/j.1471-4159.2009.06358.x; Korr D, 2006, CELL SIGNAL, V18, P910, DOI 10.1016/j.cellsig.2005.08.015; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Lewis PA, 2009, BIOL CELL, V101, P183, DOI 10.1042/BC20080053; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Li XT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017153; Liu M, 2011, BIOCHEMISTRY-US, V50, P9399, DOI 10.1021/bi201173d; Lu B, 2010, BBA-PROTEINS PROTEOM, V1804, P1780, DOI 10.1016/j.bbapap.2010.05.004; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luzon-Toro B, 2007, HUM MOL GENET, V16, P2031, DOI 10.1093/hmg/ddm151; Marin I, 2008, FASEB J, V22, P3103, DOI 10.1096/fj.08-111310; Marin I, 2008, J MOL EVOL, V67, P41, DOI 10.1007/s00239-008-9122-4; Marin I, 2006, MOL BIOL EVOL, V23, P2423, DOI 10.1093/molbev/msl114; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Nichols RJ, 2009, BIOCHEM J, V424, P47, DOI 10.1042/BJ20091035; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Piccoli G, 2011, J NEUROSCI, V31, P2225, DOI 10.1523/JNEUROSCI.3730-10.2011; Rudenko IN, 2012, BIOCH J; Sen S, 2009, ANTIOXID REDOX SIGN, V11, P2167, DOI [10.1089/ars.2009.2430, 10.1089/ARS.2009.2430]; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Taylor JP, 2007, NEUROGENETICS, V8, P95, DOI 10.1007/s10048-006-0075-8; Taymans JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023207; Taymans JM, 2010, BIOESSAYS, V32, P227, DOI 10.1002/bies.200900163; Titz B, 2010, ONCOGENE, V29, P5895, DOI 10.1038/onc.2010.331; Vancraenenbroeck R, 2011, CNS NEUROL DISORD-DR, V10, P724, DOI 10.2174/187152711797247858; Wang LZ, 2008, J NEUROSCI, V28, P3384, DOI 10.1523/JNEUROSCI.0185-08.2008; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Zhang JW, 2012, BIOORG MED CHEM LETT, V22, P1864, DOI 10.1016/j.bmcl.2012.01.084; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	63	76	79	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43472	10.1371/journal.pone.0043472	http://dx.doi.org/10.1371/journal.pone.0043472			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952686	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000308206000037
J	Shaw, LH; Lin, LC; Tsai, TH				Shaw, Lee-Hsin; Lin, Lie-Chwen; Tsai, Tung-Hu			HPLC-MS/MS Analysis of a Traditional Chinese Medical Formulation of Bu-Yang-Huan-Wu-Tang and Its Pharmacokinetics after Oral Administration to Rats	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; RADIX-SCUTELLARIAE EXTRACT; GASTRIC PH; DECOCTION; METABOLISM; CONSTITUENTS; ASTRAGALI; PLASMA; IDENTIFICATION; LIGUSTILIDE	Bu-yang-huan-wu-tang (BYHWT) is one of the most popular formulated traditional Chinese medicine prescriptions, and is widely for prevention of ischemic cardio-cerebral vascular diseases and stroke-induced disability. A specific high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) has been developed and validated for simultaneous quantification of the nine main bioactive components, i.e., astragaloside I, astragaloside II, astragaloside IV, formononetin, ononin, calycosin, calycosin-7-O-beta-d-glucoside, ligustilide and paeoniflorin in rat plasma after oral administration of BYHWT extract. This method was applied to investigate the pharmacokinetics in conscious and freely moving rats. No significant matrix effects were observed. The overall analytical procedure was rapid and reproducible, which makes it suitable for quantitative analysis of a large number of samples. Among them, three astragalosides and four isoflavones in A. membranaceus, ligustilide in Radix Angelicae Sinensis and Rhizoma Ligustici Chuanxiong and paeoniflorin in Radix Paeoniae Rubra were identified. This developed method was then successfully applied to pharmacokinetic studies of the nine bioactive constituents after oral administration of BYHWT extracts in rats. The pharmacokinetic data demonstrated that astragaloside I, astragaloside II, astragaloside IV and ligustilide presented the phenomenon of double peaks. The other herbal ingredients of formononetin, ononin, calycosin, calycosin-7-O-beta-d-glucoside and paeoniflorin appeared together in a single and plateau absorption phase. These phenomenona suggest that these components may have multiple absorption sites, regulation of enterohepatic circulation or the gastric emptying rate, or there is ingredient-ingredient interaction. These pharmacokinetic results provide a constructive contribution to better understand the absorption mechanism of BYHWT and to support additional clinical evaluation.	[Shaw, Lee-Hsin; Lin, Lie-Chwen; Tsai, Tung-Hu] Natl Yang Ming Univ, Inst Tradit Med, Taipei 112, Taiwan; [Lin, Lie-Chwen] Natl Res Inst Chinese Med, Taipei, Taiwan; [Tsai, Tung-Hu] China Med Univ, Grad Inst Acupuncture Sci, Taichung, Taiwan; [Tsai, Tung-Hu] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Research Institute of Chinese Medicine; China Medical University Taiwan; Taipei City Hospital	Shaw, LH (corresponding author), Natl Yang Ming Univ, Inst Tradit Med, Taipei 112, Taiwan.	thtsai@ym.edu.tw	Tsai, Tung-Hu/AAG-4558-2021	Tsai, Tung-Hu/0000-0002-9007-2547	National Science Council, Taiwan [NSC99-2113-M-010-001-MY3, NSC99-2628-B-010-008-MY3]; Committee on Chinese Medicine and Pharmacy, Department of Health, Taiwan [CCMP99 -RD-024]; Taipei City Hospital, Taipei, Taiwan [10001-62-007];  [TCH 96001-62-014]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Committee on Chinese Medicine and Pharmacy, Department of Health, Taiwan; Taipei City Hospital, Taipei, Taiwan; 	Funding for this study was provided in part by research grants from the National Science Council (NSC99-2113-M-010-001-MY3, NSC99-2628-B-010-008-MY3) Taiwan; Committee on Chinese Medicine and Pharmacy, Department of Health (CCMP99 -RD-024) Taiwan and TCH 96001-62-014; 10001-62-007 from Taipei City Hospital, Taipei, Taiwan.	Chen YJ, 2008, INT J PHARMACEUT, V350, P230, DOI 10.1016/j.ijpharm.2007.08.052; Hsieh YJ, 2006, J CHROMATOGR B, V844, P1, DOI 10.1016/j.jchromb.2006.06.024; Huang Y, 2007, BIOPHARM DRUG DISPOS, V28, P361, DOI 10.1002/bdd.556; Ji Bo, 2006, Zhong Xi Yi Jie He Xue Bao, V4, P30; Li P, 2007, ANAL BIOANAL CHEM, V389, P2259, DOI 10.1007/s00216-007-1612-5; Lin LC, 2008, J PHARMACEUT BIOMED, V48, P909, DOI 10.1016/j.jpba.2008.07.013; Liu EH, 2010, BIOMED CHROMATOGR, V24, P125, DOI 10.1002/bmc.1269; Liu EH, 2009, BIOMED CHROMATOGR, V23, P828, DOI 10.1002/bmc.1193; Lu Q, 2006, EUR J PHARMACOL, V542, P136, DOI 10.1016/j.ejphar.2006.04.023; Lu T, 2007, J ETHNOPHARMACOL, V110, P412, DOI 10.1016/j.jep.2006.09.036; Ma XF, 2004, J CHROMATOGR A, V1023, P311, DOI 10.1016/j.chroma.2003.10.014; Mostafavi SA, 2003, INT J PHARMACEUT, V255, P81, DOI 10.1016/S0378-5173(03)00037-1; MUMMANENI V, 1995, PHARM RES-DORDR, V12, P780, DOI 10.1023/A:1016284214708; Qi LW, 2008, J SEP SCI, V31, P97, DOI 10.1002/jssc.200700286; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Tong L, 2010, BIOMED CHROMATOGR, V24, P1324, DOI 10.1002/bmc.1443; Tsai PL, 2002, ANAL LETT, V35, P2459, DOI 10.1081/AL-120016537; Tsai TH, 2005, PLANTA MED, V71, P640, DOI 10.1055/s-2005-871270; Wang D, 2006, J SEP SCI, V29, P2012, DOI 10.1002/jssc.200500486; Wang HW, 2011, J ETHNOPHARMACOL, V138, P22, DOI 10.1016/j.jep.2011.06.033; Wang WR, 2011, J ETHNOPHARMACOL, V137, P214, DOI 10.1016/j.jep.2011.05.008; Wen XD, 2009, J PHARMACEUT BIOMED, V50, P100, DOI 10.1016/j.jpba.2009.03.038; Wu YT, 2011, J TRADITION COMPLEME, V2, P30; Wu YT, 2010, J AGR FOOD CHEM, V58, P108, DOI 10.1021/jf902872j; Xiao HB, 2004, J CHROMATOGR A, V1032, P117, DOI 10.1016/j.chroma.2003.09.032; Yan R, 2008, DRUG METAB DISPOS, V36, P400, DOI 10.1124/dmd.107.017707; Yesilada E, 2005, J ETHNOPHARMACOL, V96, P71, DOI 10.1016/j.jep.2004.08.036; Yin OQP, 2003, CLIN PHARMACOKINET, V42, P179, DOI 10.2165/00003088-200342020-00005; Zhang Dongqing, 2011, Zhongguo Zhong Yao Za Zhi, V36, P3502; Zhang H, 2010, J ETHNOPHARMACOL, V130, P98, DOI 10.1016/j.jep.2010.04.017; Zhang JY, 2011, BIOMED CHROMATOGR, V25, P450, DOI 10.1002/bmc.1466; Zhao LD, 2012, J ETHNOPHARMACOL, V140, P339, DOI 10.1016/j.jep.2012.01.026; Zhou SF, 2004, LIFE SCI, V74, P935, DOI 10.1016/j.lfs.2003.09.035; Zhu ZY, 2010, J CHROMATOGR B, V878, P2184, DOI 10.1016/j.jchromb.2010.06.021; Zu YG, 2009, J SEP SCI, V32, P517, DOI 10.1002/jssc.200800499	35	66	74	3	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43848	10.1371/journal.pone.0043848	http://dx.doi.org/10.1371/journal.pone.0043848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952787	Green Published, Green Submitted, gold			2022-12-25	WOS:000308206000055
J	Sulistyoningrum, DC; Green, TJ; Lear, SA; Devlin, AM				Sulistyoningrum, Dian C.; Green, Timothy J.; Lear, Scott A.; Devlin, Angela M.			Ethnic-Specific Differences in Vitamin D Status Is Associated with Adiposity	PLOS ONE			English	Article							SERUM 25(OH)D CONCENTRATIONS; 1,25-DIHYDROXYVITAMIN D-3; RISK-FACTORS; HEALTH; TISSUE; BONE; METABOLISM; CALCIUM; DISEASE	Background: Low circulating 25 hydroxyvitamin D [25(OH) D] concentrations are common in obesity (BMI >= 30 kg/m(2)) and a negative relationship with body fat distribution has recently been reported. Ethnic-specific differences in body fat distribution have been described with South Asians are reported to have greater visceral adipose tissue (VAT), which could influence circulating 25(OH) D concentrations. The objective of this study is to investigate the relationship between plasma 25(OH) D, adiposity, and body fat distribution in Europeans and South Asians. Methods/Principal Findings: 187 Europeans and 192 South Asians were assessed for demographics, anthropometrics, and plasma 25(OH) D concentrations. Subcutaneous adipose tissue (SAT) and VAT were quantified by CT scan, and percent body fat by DEXA. Data were assessed by general linear models. South Asians had lower (P<0.001) plasma 25(OH) D concentrations and higher VAT (P = 0.04) than Europeans. Plasma 25(OH) D concentrations were negatively (P<0.05) associated with BMI, waist circumference, percent body fat, total adipose tissue, VAT, and SAT in unadjusted models and negatively (P<0.05) associated with VAT, SAT, and percent body fat after adjusting for BMI, ethnicity, age, and season of blood collection in males and females. When percent body fat, VAT, and SAT were included in the same model, only VAT remained negatively (P<0.05) associated with plasma 25(OH) D concentrations. Ethnicity remained significant in all models (P<0.001). Conclusion: Compared to other adipose tissue compartments, VAT may have a distinct role in determining plasma 25(OH) D concentrations, which may account for the lower levels in South Asians.	[Sulistyoningrum, Dian C.; Devlin, Angela M.] Univ British Columbia, Dept Pathol, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada; [Sulistyoningrum, Dian C.; Devlin, Angela M.] Univ British Columbia, Child & Family Res Inst, Lab Med, Vancouver, BC V5Z 1M9, Canada; [Green, Timothy J.] Univ British Columbia, Child & Family Res Inst, Dept Food Nutr & Hlth, Vancouver, BC V5Z 1M9, Canada; [Lear, Scott A.] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada; [Lear, Scott A.] Providence Hlth Care, Div Cardiol, Vancouver, BC, Canada; [Devlin, Angela M.] Univ British Columbia, Dept Pediat, Child & Family Res Inst, Vancouver, BC V6T 1W5, Canada	Child & Family Research Institute; University of British Columbia; Child & Family Research Institute; University of British Columbia; Child & Family Research Institute; University of British Columbia; Simon Fraser University; Child & Family Research Institute; University of British Columbia	Sulistyoningrum, DC (corresponding author), Univ British Columbia, Dept Pathol, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada.	adevlin@cfri.ubc.ca	Green, Tim/AAA-8601-2019	Green, Tim/0000-0002-0667-4300; Devlin, Angela/0000-0002-1390-6587	Canadian Institutes of Health Research, Institute of Circulatory and Respiratory Health; Child and Family Research Institute; Heart and Stroke Foundation of Canada	Canadian Institutes of Health Research, Institute of Circulatory and Respiratory Health(Canadian Institutes of Health Research (CIHR)); Child and Family Research Institute; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by a grant from the Canadian Institutes of Health Research, Institute of Circulatory and Respiratory Health to AM Devlin. DC Sulistyoningrum was supported by a graduate studentship from the Child and Family Research Institute. SA Lear is a Pfizer/Heart and Stroke Foundation of Canada Chair in Cardiovascular Disease Prevention Research and a Canadian Institutes of Health Research New Investigator. AM Devlin was supported by a New Investigator award from the Heart and Stroke Foundation of Canada and an Investigatorship from the Child and Family Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awumey EMK, 1998, J CLIN ENDOCR METAB, V83, P169, DOI 10.1210/jc.83.1.169; Caron-Jobin M, 2011, OBESITY, V19, P1335, DOI 10.1038/oby.2011.90; Cheng S, 2010, DIABETES, V59, P242, DOI 10.2337/db09-1011; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; Delvin EE, 2010, J NUTR, V140, P987, DOI 10.3945/jn.109.112250; Ersfeld DL, 2004, CLIN BIOCHEM, V37, P867, DOI 10.1016/j.clinbiochem.2004.06.006; Farrar MD, 2011, AM J CLIN NUTR BETHE, P1224; Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288; Freedman BI, 2010, J CLIN ENDOCR METAB, V95, P1076, DOI 10.1210/jc.2009-1797; Gozdzik A, 2011, J STEROID BIOCHEM, V127, P405, DOI 10.1016/j.jsbmb.2011.05.009; Gutin B, 2007, OBESITY, V15, P1029, DOI 10.1038/oby.2007.602; Hamson C, 2003, POSTGRAD MED J, V79, P279, DOI 10.1136/pmj.79.931.279; Heaney RP, 2011, J CLIN ENDOCR METAB, V96, pE447, DOI 10.1210/jc.2010-2230; IOM, 2011, DIET REF INT CALC VI; KVIST H, 1986, INT J OBESITY, V10, P53; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; Lear SA, 2007, STROKE, V38, P2422, DOI 10.1161/STROKEAHA.107.484113; Lee J, 2001, INT J EPIDEMIOL, V30, P983, DOI 10.1093/ije/30.5.983; LIEL Y, 1988, CALCIFIED TISSUE INT, V43, P199, DOI 10.1007/BF02555135; Liu Richard, 2010, Open Med, V4, pe143; Mason RS, 2011, CLIMACTERIC, V14, P197, DOI 10.3109/13697137.2010.514366; MATSUOKA LY, 1987, J CLIN ENDOCR METAB, V64, P1165, DOI 10.1210/jcem-64-6-1165; MATSUOKA LY, 1992, J CLIN ENDOCR METAB, V75, P1099, DOI 10.1210/jc.75.4.1099; McGill AT, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-4; Narvaez CJ, 2009, ENDOCRINOLOGY, V150, P651, DOI 10.1210/en.2008-1118; Raiten DJ, 2004, AM J CLIN NUTR, V80, p1673S, DOI 10.1093/ajcn/80.6.1673S; Rosenblum JL, 2012, AM J CLIN NUTR, V95, P101, DOI 10.3945/ajcn.111.019489; Roy DK, 2007, BONE, V40, P200, DOI 10.1016/j.bone.2006.07.004; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Young KA, 2009, J CLIN ENDOCR METAB, V94, P3306, DOI 10.1210/jc.2009-0079; Zehnder D, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133621	34	45	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43159	10.1371/journal.pone.0043159	http://dx.doi.org/10.1371/journal.pone.0043159			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952641	gold, Green Published, Green Submitted			2022-12-25	WOS:000308206000019
J	Flanagan, JU; Yosaatmadja, Y; Teague, RM; Chai, MZL; Turnbull, AP; Squire, CJ				Flanagan, Jack U.; Yosaatmadja, Yuliana; Teague, Rebecca M.; Chai, Matilda Z. L.; Turnbull, Andrew P.; Squire, Christopher J.			Crystal Structures of Three Classes of Non-Steroidal Anti-Inflammatory Drugs in Complex with Aldo-Keto Reductase 1C3	PLOS ONE			English	Article							PROSTAGLANDIN-F-SYNTHASE; PRE-RECEPTOR REGULATION; CANCER CELL-MIGRATION; PROSTATE-CANCER; 5 17-BETA-HYDROXYSTEROID-DEHYDROGENASE; 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); MACROMOLECULAR CRYSTALLOGRAPHY; CYCLOOXYGENASE INHIBITION; POTENT INHIBITOR	Aldo-keto reductase 1C3 (AKR1C3) catalyses the NADPH dependent reduction of carbonyl groups in a number of important steroid and prostanoid molecules. The enzyme is also over-expressed in prostate and breast cancer and its expression is correlated with the aggressiveness of the disease. The steroid products of AKR1C3 catalysis are important in proliferative signalling of hormone-responsive cells, while the prostanoid products promote prostaglandin-dependent proliferative pathways. In these ways, AKR1C3 contributes to tumour development and maintenance, and suggest that inhibition of AKR1C3 activity is an attractive target for the development of new anti-cancer therapies. Non-steroidal anti-inflammatory drugs (NSAIDs) are one well-known class of compounds that inhibits AKR1C3, yet crystal structures have only been determined for this enzyme with flufenamic acid, indomethacin, and closely related analogues bound. While the flufenamic acid and indomethacin structures have been used to design novel inhibitors, they provide only limited coverage of the NSAIDs that inhibit AKR1C3 and that may be used for the development of new AKR1C3 targeted drugs. To understand how other NSAIDs bind to AKR1C3, we have determined ten crystal structures of AKR1C3 complexes that cover three different classes of NSAID, N-phenylanthranilic acids (meclofenamic acid, mefenamic acid), arylpropionic acids (flurbiprofen, ibuprofen, naproxen), and indomethacin analogues (indomethacin, sulindac, zomepirac). The N-phenylanthranilic and arylpropionic acids bind to common sites including the enzyme catalytic centre and a constitutive active site pocket, with the arylpropionic acids probing the constitutive pocket more effectively. By contrast, indomethacin and the indomethacin analogues sulindac and zomepirac, display three distinctly different binding modes that explain their relative inhibition of the AKR1C family members. This new data from ten crystal structures greatly broadens the base of structures available for future structure-guided drug discovery efforts.	[Flanagan, Jack U.] Univ Auckland, Auckland Canc Soc, Res Ctr, Auckland 1, New Zealand; [Flanagan, Jack U.; Squire, Christopher J.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1, New Zealand; [Yosaatmadja, Yuliana; Teague, Rebecca M.; Chai, Matilda Z. L.; Squire, Christopher J.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Turnbull, Andrew P.] Wolfson Inst Biomed Res, Canc Res Technol Discovery Labs, London, England	University of Auckland; University of Auckland; University of Auckland; University of London; University College London	Flanagan, JU (corresponding author), Univ Auckland, Auckland Canc Soc, Res Ctr, Auckland 1, New Zealand.	c.squire@auckland.ac.nz		Squire, Christopher/0000-0001-9212-0461; Yosaatmadja, Yuliana/0000-0003-2875-5993	Lottery Health Research [265027]; Auckland Medical Research Foundation [1110004, 1109008]; National eScience Infrastructure; Maurice Wilkins Centre for Molecular Biodiscovery Flexible Research Seeding Programme; Maurice Wilkins Centre for Molecular Biodiscovery; Faculty of Science, University of Auckland	Lottery Health Research; Auckland Medical Research Foundation; National eScience Infrastructure; Maurice Wilkins Centre for Molecular Biodiscovery Flexible Research Seeding Programme; Maurice Wilkins Centre for Molecular Biodiscovery; Faculty of Science, University of Auckland	This work was funded by Lottery Health Research (CJS; grant number 265027), the Auckland Medical Research Foundation (JUF and CJS; grant number 1110004. JUF; grant number 1109008), the National eScience Infrastructure (JUF), and the Maurice Wilkins Centre for Molecular Biodiscovery Flexible Research Seeding Programme (JUF and CJS). We further acknowledge salary support from the Maurice Wilkins Centre for Molecular Biodiscovery (CJS, JUF) and Summer Studentship funding from the Faculty of Science, University of Auckland (CJS, RMT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeniji AO, 2012, J MED CHEM, V55, P2311, DOI 10.1021/jm201547v; Adeniji AO, 2011, BIOORG MED CHEM LETT, V21, P1464, DOI 10.1016/j.bmcl.2011.01.010; Andrews P, 2008, CANCER CHEMOTH PHARM, V61, P203, DOI 10.1007/s00280-007-0462-3; Bishay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010628; Blobaum AL, 2007, J MED CHEM, V50, P1425, DOI 10.1021/jm0613166; Butler R, 2000, CELL GROWTH DIFFER, V11, P49; Byrns MC, 2008, BIOCHEM PHARMACOL, V75, P484, DOI 10.1016/j.bcp.2007.09.008; Byrns MC, 2011, J STEROID BIOCHEM, V125, P95, DOI 10.1016/j.jsbmb.2010.11.004; Byrns MC, 2010, J STEROID BIOCHEM, V118, P177, DOI 10.1016/j.jsbmb.2009.12.009; Byrns MC, 2009, CHEM-BIOL INTERACT, V178, P221, DOI 10.1016/j.cbi.2008.10.024; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Diers AR, 2010, BIOCHEM J, V430, P69, DOI 10.1042/BJ20091193; Dufort I, 1999, ENDOCRINOLOGY, V140, P568, DOI 10.1210/en.140.2.568; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Duggan KC, 2010, J BIOL CHEM, V285, P34950, DOI 10.1074/jbc.M110.162982; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Guise CP, 2010, CANCER RES, V70, P1573, DOI 10.1158/0008-5472.CAN-09-3237; Hofland J, 2010, CANCER RES, V70, P1256, DOI 10.1158/0008-5472.CAN-09-2092; Jabbour HN, 2005, ENDOCRINOLOGY, V146, P4657, DOI 10.1210/en.2005-0804; Jackson VJ, 2012, ACTA CRYSTALLOGR F, V68, P409, DOI 10.1107/S1744309112009049; Jansson AK, 2006, CANCER RES, V66, P11471, DOI 10.1158/0008-5472.CAN-06-1448; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khan MNA, 2011, MED RES REV, V31, P161, DOI 10.1002/med.20182; Khanim FL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008147; Koda N, 2004, ARCH BIOCHEM BIOPHYS, V424, P128, DOI 10.1016/j.abb.2004.02.009; Komoto J, 2006, BIOCHEMISTRY-US, V45, P1987, DOI 10.1021/bi051861t; Komoto J, 2004, BIOCHEMISTRY-US, V43, P2188, DOI 10.1021/bi036046x; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Lin HK, 2004, STEROIDS, V69, P795, DOI 10.1016/j.steroids.2004.09.014; Lovering AL, 2004, CANCER RES, V64, P1802, DOI 10.1158/0008-5472.CAN-03-2847; Matsuura K, 1998, J BIOCHEM-TOKYO, V124, P940, DOI 10.1093/oxfordjournals.jbchem.a022211; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Mostaghel EA, 2007, CANCER RES, V67, P5033, DOI 10.1158/0008-5472.CAN-06-3332; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakamura Y, 2005, ENDOCR-RELAT CANCER, V12, P101, DOI 10.1677/erc.1.00914; Nakata S, 2006, MOL CANCER THER, V5, P1827, DOI 10.1158/1535-7163.MCT-06-0023; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; PENNING TM, 1984, BIOCHEM J, V222, P601, DOI 10.1042/bj2220601; Penning TM, 2008, MOL CELL ENDOCRINOL, V281, P1, DOI 10.1016/j.mce.2007.10.008; Qiu W, 2004, MOL ENDOCRINOL, V18, P1798, DOI 10.1210/me.2004-0032; Qiu W, 2007, J BIOL CHEM, V282, P8368, DOI 10.1074/jbc.M606784200; Rainsford K. D., 2007, V42, P3; Ray DM, 2006, J IMMUNOL, V177, P5068, DOI 10.4049/jimmunol.177.8.5068; Scher JU, 2009, J INVEST MED, V57, P703, DOI 10.2310/JIM.0b013e31819aaa76; Schlegel BP, 1998, BIOCHEMISTRY-US, V37, P3538, DOI 10.1021/bi9723055; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sharma KK, 2006, MOL CELL ENDOCRINOL, V248, P79, DOI 10.1016/j.mce.2005.10.024; Smuc T, 2009, MOL CELL ENDOCRINOL, V301, P74, DOI 10.1016/j.mce.2008.09.019; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Suzuki-Yamamoto T, 1999, FEBS LETT, V462, P335, DOI 10.1016/S0014-5793(99)01551-3; Verdonk ML, 2011, J MED CHEM, V54, P5422, DOI 10.1021/jm200558u; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407; Wynne S, 2010, MOL CANCER RES, V8, P1656, DOI 10.1158/1541-7786.MCR-10-0342	56	45	48	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43965	10.1371/journal.pone.0043965	http://dx.doi.org/10.1371/journal.pone.0043965			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937138	Green Published, gold			2022-12-25	WOS:000308213600066
J	Krishnamachary, B; Penet, MF; Nimmagadda, S; Mironchik, Y; Raman, V; Solaiyappan, M; Semenza, GL; Pomper, MG; Bhujwalla, ZM				Krishnamachary, Balaji; Penet, Marie-France; Nimmagadda, Sridhar; Mironchik, Yelena; Raman, Venu; Solaiyappan, Meiyappan; Semenza, Gregg L.; Pomper, Martin G.; Bhujwalla, Zaver M.			Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1 alpha in Triple Negative Breast Cancer	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; STEM-CELLS; EXPRESSION; PROTEIN; METASTASIS; RESISTANCE; IDENTIFICATION; CHEMOTHERAPY; HYALURONAN; POPULATION	Background: The CD44 transmembrane glycoproteins play multifaceted roles in tumor progression and metastasis. CD44 expression has also been associated with stem-like breast cancer cells. Hypoxia commonly occurs in tumors and is a major cause of radiation and chemo-resistance. Hypoxia is known to inhibit differentiation and facilitates invasion and metastasis. Here we have investigated the effect of hypoxia on CD44 and two of its isoforms in MDA-MB-231 and SUM-149 triple negative human breast cancer cells and MDA-MB-231 tumors using imaging and molecular characterization. Methods and Findings: The roles of hypoxia and hypoxia inducible factor (HIF) in regulating the expression of CD44 and its variant isoforms (CD44v6, CD44v7/8) were investigated in human breast cancer cells, by quantitative real-time polymerase chain reaction (qRT-PCR) to determine mRNA levels, and fluorescence associated cell sorting (FACS) to determine cell surface expression of CD44, under normoxic and hypoxic conditions. In vivo imaging studies with tumor xenografts derived from MDA-MD-231 cells engineered to express tdTomato red fluorescence protein under regulation of hypoxia response elements identified co-localization between hypoxic fluorescent regions and increased concentration of I-125-radiolabeled CD44 antibody. Conclusions: Our data identified HIF-1 alpha as a regulator of CD44 that increased the number of CD44 molecules and the percentage of CD44 positive cells expressing variant exons v6 and v7/8 in breast cancer cells under hypoxic conditions. Data from these cell studies were further supported by in vivo observations that hypoxic tumor regions contained cells with a higher concentration of CD44 expression.	[Krishnamachary, Balaji; Penet, Marie-France; Nimmagadda, Sridhar; Mironchik, Yelena; Raman, Venu; Solaiyappan, Meiyappan; Pomper, Martin G.; Bhujwalla, Zaver M.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, JHU ICMIC Program,Div Canc Imaging Res, Baltimore, MD 21218 USA; [Raman, Venu; Semenza, Gregg L.; Pomper, Martin G.; Bhujwalla, Zaver M.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Krishnamachary, B (corresponding author), Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, JHU ICMIC Program,Div Canc Imaging Res, Baltimore, MD 21218 USA.	bkrishn1@jhu.edu; zaver@mri.jhu.edu	Nimmagadda, Sridhar/D-6135-2011; Penet, Marie-France/AGZ-6991-2022	Nimmagadda, Sridhar/0000-0002-6413-7191; 	National Institutes of Health [R01 CA136576]; NATIONAL CANCER INSTITUTE [R01CA136576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health R01 CA136576. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611; Berner HS, 2003, HISTOPATHOLOGY, V42, P546, DOI 10.1046/j.1365-2559.2003.01622.x; Bourguignon LYW, 2010, J BIOL CHEM, V285, P36721, DOI 10.1074/jbc.M110.162305; Ceradini DJ, 2005, TRENDS CARDIOVAS MED, V15, P57, DOI 10.1016/j.tcm.2005.02.002; Das B, 2008, STEM CELLS, V26, P1818, DOI 10.1634/stemcells.2007-0724; Diaz LK, 2005, CLIN CANCER RES, V11, P3309, DOI 10.1158/1078-0432.CCR-04-2184; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; FUKAZAWA H, 1993, THYROID, V3, P285, DOI 10.1089/thy.1993.3.285; Gao F, 2005, ADV EXP MED BIOL, V566, P249; Giatromanolaki A, 2011, MED ONCOL, V28, P745, DOI 10.1007/s12032-010-9530-3; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; Hoffmeyer MR, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-11; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Jothy S, 2003, CLIN EXP METASTAS, V20, P195, DOI 10.1023/A:1022931016285; Jubb AM, 2010, J CELL MOL MED, V14, P18, DOI 10.1111/j.1582-4934.2009.00944.x; Jung T, 2009, NEOPLASIA, V11, P1093, DOI 10.1593/neo.09822; Khan SA, 2005, CLIN EXP METASTAS, V22, P663, DOI 10.1007/s10585-006-9007-0; Klingbeil P, 2009, MOL CANCER RES, V7, P168, DOI 10.1158/1541-7786.MCR-08-0207; Kopp R, 2009, INT J MOL MED, V24, P677, DOI 10.3892/ijmm_00000279; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Krishnamachary B, 2003, CANCER RES, V63, P1138; Krishnamachary B, 2009, CANCER RES, V69, P3464, DOI 10.1158/0008-5472.CAN-08-4120; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Louie E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2773; Moeller B, 2006, BRIT J CANCER, V95, P1, DOI 10.1038/sj.bjc.6603201; Nervi B, 2006, J CELL BIOCHEM, V99, P690, DOI 10.1002/jcb.21043; Panchision DM, 2009, J CELL PHYSIOL, V220, P562, DOI 10.1002/jcp.21812; Peng ST, 2007, INT J ONCOL, V31, P1119; Raman V, 2006, CANCER RES, V66, P9929, DOI 10.1158/0008-5472.CAN-06-0886; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Turcotte S, 2004, AM J PHYSIOL-RENAL, V286, pF338, DOI 10.1152/ajprenal.00254.2003; van Golen KL, 1999, CLIN CANCER RES, V5, P2511; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Zhong H, 1999, CANCER RES, V59, P5830	40	94	97	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44078	10.1371/journal.pone.0044078	http://dx.doi.org/10.1371/journal.pone.0044078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937154	Green Published, gold, Green Submitted			2022-12-25	WOS:000308213600074
J	Rabna, P; Andersen, A; Wejse, C; Oliveira, I; Gomes, VF; Haaland, MB; Aaby, P; Eugen-Olsen, J				Rabna, Paulo; Andersen, Andreas; Wejse, Christian; Oliveira, Ines; Gomes, Victor Francisco; Haaland, Maya Bonde; Aaby, Peter; Eugen-Olsen, Jesper			Utility of the Plasma Level of suPAR in Monitoring Risk of Mortality during TB Treatment	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; SOLUBLE UROKINASE RECEPTOR; TUBERCULOSIS PATIENTS; BORRELIA-BURGDORFERI; PREDICTS MORTALITY; UP-REGULATION; SERUM LEVEL; EXPRESSION; RELEASE; BLOOD	Objective: To investigate whether changes in the plasma level of soluble urokinase plasminogen activator receptor (suPAR) can be used to monitor tuberculosis (TB) treatment efficacy. Design: This prospective cohort study included 278 patients diagnosed with active pulmonary TB and followed throughout the 8-month treatment period. Results: Mortality during treatment was higher in the highest inclusion quartile of suPAR (23%) compared to the lowest three quartiles (7%), the risk ratio being 3.1 (95% CI 1.65-6.07). No association between early smear conversion and subsequent mortality or inclusion suPAR was observed. After 1 and 2 months of treatment, an increase in suPAR compared to at diagnosis was associated with a Mortality Rate Ratio (MRR) of 4.5 (95% CI: 1.45-14.1) and 2.1 (95% CI 0.62-6.82), respectively, for the remaining treatment period. Conclusions: The present study confirmed that elevated suPAR level at time of initiation of TB treatment is associated with increased risk of mortality. Furthermore, increased suPAR levels after one month of treatment was associated with increased risk of mortality during the remaining 7-month treatment period.	[Rabna, Paulo; Andersen, Andreas; Wejse, Christian; Gomes, Victor Francisco; Aaby, Peter; Eugen-Olsen, Jesper] Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau; [Wejse, Christian] Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus, Denmark; [Wejse, Christian; Haaland, Maya Bonde] Aarhus Univ, Sch Publ Hlth, Ctr Global Hlth, Aarhus, Denmark; [Oliveira, Ines] Univ Copenhagen, Hvidovre Hosp, Clin Res Ctr, DK-2650 Hvidovre, Denmark; [Aaby, Peter] Statens Serum Inst, Bandim Hlth Project, DK-2300 Copenhagen, Denmark	Aarhus University; Aarhus University; University of Copenhagen; Statens Serum Institut	Rabna, P (corresponding author), Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau.	jespereugenolsen@gmail.com	Wejse, Christian/C-8468-2014; Oliveira Souto, Ines/L-2947-2017	Wejse, Christian/0000-0002-2534-2942; Eugen-Olsen, Jesper/0000-0002-4630-4275; Oliveira Souto, Ines/0000-0001-6018-5797; Bonde, Maya/0000-0001-9353-4789; Aaby, Peter/0000-0001-8331-1389	EU [LSSP-CT-2005-012173]	EU(European Commission)	This study was funded by the EU FP6 project number LSSP-CT-2005-012173. The funding institution had no role in study design, data collection, analysis, interpretation, preparation of the manuscript, or decision to publish.	Alfano M, 2003, J LEUKOCYTE BIOL, V74, P750, DOI 10.1189/jlb.0403176; Coleman JL, 2003, INFECT IMMUN, V71, P5556, DOI 10.1128/IAI.71.10.5556-5564.2003; Coleman JL, 2001, J IMMUNOL, V166, P473, DOI 10.4049/jimmunol.166.1.473; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; de Bock CE, 2004, MED RES REV, V24, P13, DOI 10.1002/med.10054; Dekkers PEP, 2000, INFECT IMMUN, V68, P2156, DOI 10.1128/IAI.68.4.2156-2160.2000; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Eugen-Olsen J, 2010, J INTERN MED, V268, P296, DOI 10.1111/j.1365-2796.2010.02252.x; Eugen-Olsen J, 2002, INT J TUBERC LUNG D, V6, P686; Florquin S, 2001, KIDNEY INT, V59, P2054, DOI 10.1046/j.1523-1755.2001.00719.x; Gustafson P, 2004, INT J EPIDEMIOL, V33, P163, DOI 10.1093/ije/dyh026; Haupt TH, 2012, CRIT CARE, V16, DOI 10.1186/cc11434; Huttunen R, 2011, J INTERN MED, V270, P32, DOI 10.1111/j.1365-2796.2011.02363.x; Juffermans NP, 2001, INFECT IMMUN, V69, P5182, DOI 10.1128/IAI.69.8.5182-5185.2001; KIRCHHEIMER JC, 1988, J IMMUNOL, V141, P4229; Koch A, 2011, CRIT CARE, V15, DOI 10.1186/cc10037; Lawn SD, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-41; NYKJAER A, 1994, J IMMUNOL, V152, P505; Ostrowski SR, 2005, SCAND J IMMUNOL, V61, P347, DOI 10.1111/j.1365-3083.2005.01582.x; Ostrowski SR, 2005, J INFECT DIS, V191, P1331, DOI 10.1086/428854; Perch M, 2004, PARASITE IMMUNOL, V26, P207, DOI 10.1111/j.0141-9838.2004.00695.x; PLESNER T, 1994, AM J CLIN PATHOL, V102, P835, DOI 10.1093/ajcp/102.6.835; Plesner T, 1997, STEM CELLS, V15, P398, DOI 10.1002/stem.150398; Ploug M, 2003, CURR PHARM DESIGN, V9, P1499, DOI 10.2174/1381612033454630; Rabna P, 2009, TROP MED INT HEALTH, V14, P986, DOI 10.1111/j.1365-3156.2009.02328.x; Siawaya JFD, 2008, J INFECTION, V56, P340, DOI 10.1016/j.jinf.2008.02.007; Sidenius N, 2000, BLOOD, V96, P4091; SITRIN RG, 1994, BLOOD, V84, P1268; Slot O, 1999, ANN RHEUM DIS, V58, P488, DOI 10.1136/ard.58.8.488; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Wejse C, 2008, SCAND J INFECT DIS, V40, P111, DOI 10.1080/00365540701558698; Wittenhagen P, 2004, CLIN MICROBIOL INFEC, V10, P409, DOI 10.1111/j.1469-0691.2004.00850.x; World Health Organization, 2004, GUID DRINK WAT QUAL, P1, DOI DOI 10.1037/E333612004-001	33	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43933	10.1371/journal.pone.0043933	http://dx.doi.org/10.1371/journal.pone.0043933			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937128	Green Published, gold, Green Submitted			2022-12-25	WOS:000308213600060
J	Kulkarni, S; Augoff, K; Rivera, L; McCue, B; Khoury, T; Groman, A; Zhang, L; Tian, LL; Sossey-Alaoui, K				Kulkarni, Swati; Augoff, Katarzyna; Rivera, Louis; McCue, Brian; Khoury, Thaer; Groman, Adrienne; Zhang, Li; Tian, Lili; Sossey-Alaoui, Khalid			Increased Expression Levels of WAVE3 Are Associated with the Progression and Metastasis of Triple Negative Breast Cancer	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; PERIPHERAL-BLOOD; LAMELLIPODIA FORMATION; PROGNOSTIC-FACTORS; GENE; MICRORNA; INVASION; PATTERNS; THERAPY	Background: Breast Cancer (BC) is a heterogeneous disease comprised of at least five genetically distinct subtypes, which together form the second leading cause of cancer death in women in the United States. Within BC subtypes, those classified as Triple Negative BCs (TNBCs) exhibit dismal survival rates due to their propensity to develop distant metastases. We have identified the WAVE3 protein, which is a critical regulator of actin cytoskeleton dynamics that are required for the motility and invasion of cancer cells through its activation of the Arp2/3 complex, as a key regulator of the different steps of the invasion-metastasis cascade in BC, especially in the more aggressive TNBCs. Our published studies have also shown that elevated expression levels of WAVE3 in the TNBC cell lines directly contribute to their increased invasion and metastasis potentials both in vitro and in vivo in murine models of BC metastasis. Methodology/Principal Findings: Herein, we utilized both immunohistochemistry (IHC) of primary human BC tumors as well as quantitative real-time RT-PCR of WAVE3 in the peripheral blood of BC patients to clearly establish that WAVE3 is a predictive marker of overall BC patients' survival. High levels of WAVE3 were predictive for reduced distant recurrence-free survival as well as for decreased disease-specific mortality. Our analysis of WAVE3 expression levels in the peripheral blood of BC patients showed that WAVE3 is highly expressed in the blood of patients who developed metastatic breast cancer compared to those who did not. WAVE3 expression was also highly upregulated in the blood of BC patients with the more aggressive TNBC subtype. Conclusions: Together, these findings establish WAVE3 as a novel marker for increased risk of breast-cancer-specific mortality and for the metastatic potential of the TNBCs, and also identify WAVE3 as an attractive therapeutic target for the treatment of metastatic BC.	[Kulkarni, Swati] Univ Chicago, Med Ctr, Dept Surg, Chicago, IL 60637 USA; [Augoff, Katarzyna; McCue, Brian; Sossey-Alaoui, Khalid] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44106 USA; [Rivera, Louis] USN, Dept Surg, San Diego Med Ctr, San Diego, CA 92152 USA; [Khoury, Thaer] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Groman, Adrienne] Roswell Pk Canc Inst, Dept Biostat, Buffalo, NY 14263 USA; [Zhang, Li] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Tian, Lili] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA	University of Chicago; University of Chicago Medical Center; Cleveland Clinic Foundation; United States Department of Defense; United States Navy; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Cleveland Clinic Foundation; Roswell Park Cancer Institute	Kulkarni, S (corresponding author), Univ Chicago, Med Ctr, Dept Surg, Chicago, IL 60637 USA.	skulkarni@surgery.bsd.uchicago.edu; sosseyk@ccf.org		Augoff, Katarzyna/0000-0002-6133-3621	Cleveland Clinic Foundation, U.S. Department of Defense [W81XWH-08-1-0236]; National Institutes of Health [P01HL073311, P50HL077107]; Case Comprehensive Cancer Center [P30 CA043703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL077107, P01HL073311] Funding Source: NIH RePORTER	Cleveland Clinic Foundation, U.S. Department of Defense; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by Cleveland Clinic Foundation, U.S. Department of Defense grant number W81XWH-08-1-0236 to KSA, by National Institutes of Health grants P01HL073311 and P50HL077107, and by pilot funding from the Case Comprehensive Cancer Center (P30 CA043703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred DC, 1998, MODERN PATHOL, V11, P155; Anders C, 2008, ONCOLOGY-NY, V22, P1233; Anders CK, 2009, CLIN BREAST CANCER, V9, pS73, DOI 10.3816/CBC.2009.s.008; Apostolaki S, 2007, ANN ONCOL, V18, P851, DOI 10.1093/annonc/mdl502; Berx G, 2007, CLIN EXP METASTAS, V24, P587, DOI 10.1007/s10585-007-9114-6; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Bray I, 2011, CANCER LETT, V303, P56, DOI 10.1016/j.canlet.2011.01.016; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Cicatiello L, 2010, AM J PATHOL, V176, P2113, DOI 10.2353/ajpath.2010.090837; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Cristofanilli M, 2007, CLIN BREAST CANCER, V7, P471, DOI 10.3816/CBC.2007.n.004; Elston C W, 2002, Histopathology, V41, P154; Feng L, 2012, MED ONCOL, V29, P856, DOI 10.1007/s12032-011-9823-1; Finnegan Timothy J, 2007, Future Oncol, V3, P55, DOI 10.2217/14796694.3.1.55; Fitzgibbons PL, 2000, ARCH PATHOL LAB MED, V124, P966; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hayes DF, 2006, CLIN CANCER RES, V12, P4218, DOI 10.1158/1078-0432.CCR-05-2821; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang Z, 2011, CELL CYCLE, V10, P1563, DOI 10.4161/cc.10.10.15703; Lee KH, 2009, PANCREATOLOGY, V9, P293, DOI 10.1159/000186051; Lin SL, 2010, CANCER RES, V70, P9473, DOI 10.1158/0008-5472.CAN-10-2746; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobodasch K, 2007, BREAST, V16, P211, DOI 10.1016/j.breast.2006.12.005; May CD, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2789; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Oda A, 2005, BLOOD, V105, P3141, DOI 10.1182/blood-2003-04-1319; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rakha EA, 2009, CLIN CANCER RES, V15, P2302, DOI 10.1158/1078-0432.CCR-08-2132; Riethdorf S, 2007, CLIN CANCER RES, V13, P920, DOI 10.1158/1078-0432.CCR-06-1695; Ring A, 2004, LANCET ONCOL, V5, P79, DOI 10.1016/S1470-2045(04)01381-6; Ring AE, 2005, BRIT J CANCER, V92, P906, DOI 10.1038/sj.bjc.6602418; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider BP, 2008, CLIN CANCER RES, V14, P8010, DOI 10.1158/1078-0432.CCR-08-1208; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sossey-Alaoui K, 2005, EXP CELL RES, V308, P135, DOI 10.1016/j.yexcr.2005.04.011; Sossey-Alaoui K, 2005, J BIOL CHEM, V280, P21748, DOI 10.1074/jbc.M500503200; Sossey-Alaoui K, 2002, ONCOGENE, V21, P5967, DOI 10.1038/sj.onc.1205734; Sossey-Alaoui K, 2007, J BIOL CHEM, V282, P26257, DOI 10.1074/jbc.M701484200; Sossey-Alaoui K, 2007, AM J PATHOL, V170, P2112, DOI 10.2353/ajpath.2007.060975; Sossey-Alaoui K, 2011, INT J CANCER, V129, P1331, DOI 10.1002/ijc.25793; Sossey-Alaoui K, 2009, J BIOL CHEM, V284, P33019, DOI 10.1074/jbc.M109.034553; Spaderna S, 2007, Verh Dtsch Ges Pathol, V91, P21; Stathopoulou A, 2002, J CLIN ONCOL, V20, P3404, DOI 10.1200/JCO.2002.08.135; Taylor MA, 2010, J MAMMARY GLAND BIOL, V15, P169, DOI 10.1007/s10911-010-9181-1; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	53	42	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e42895	10.1371/journal.pone.0042895	http://dx.doi.org/10.1371/journal.pone.0042895			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952619	Green Published, Green Submitted, gold			2022-12-25	WOS:000308044800016
J	Qin, XJ; Chen, HM; Guo, L; Guo, YY				Qin, Xue-jiao; Chen, Hong-mei; Guo, Liang; Guo, Yong-yuan			Low-Dose Strontium-90 Irradiation Is Effective in Preventing the Recurrence of Pterygia: A Ten-Year Study	PLOS ONE			English	Article							BETA-IRRADIATION; POSTOPERATIVE IRRADIATION; COMPLICATIONS; RADIATION; SURGERY; REMOVAL	Background: To study the long-term effects of low-dosage strontium-90 (Sr90) irradiation on the recurrence of pterygium. Methodology/Principal Findings: One hundred twenty eyes from 104 patients with primary or recurrent pterygia were treated with surgery followed by Sr90 irradiation. In brief, starting on the sixth day after surgery, patients were treated with irradiation three times every other day at a total combined dosage of 2000 cGy to 3000 cGy. Corneal topography was used to evaluate ocular surface regularity before and after treatment. Patient follow-up was performed 2 days, 5 days, 2 weeks, 1 month, 3 months, 1 year, 5 years, and 10 years after surgery. Recurrence of pterygium was not observed in any of the patients in this study. Obvious cataract progression was observed in 6 eyes, which may be due to aging. During follow-up studies, only one eye was reported with dryness and foreign-body sensation. Significant pterygium-induced astigmatism was observed in corneal topography, which decreased after surgery. Conclusions/Significance: Sr90 irradiation is effective in preventing the recurrence of primary and recurrent pterygia. We recommend delivering a total combined dosage of 2000 cGy to 3000 cGy of Sr90 irradiation administered in three batches every other day starting from the sixth day after surgery. Surgery is important in the rapid recovery of the cornea from pterygium-induced astigmatism.	[Qin, Xue-jiao; Chen, Hong-mei; Guo, Liang; Guo, Yong-yuan] Shandong Univ, Qilu Hosp, Dept Ophthalmol, Jinan 250100, Peoples R China	Shandong University	Qin, XJ (corresponding author), Shandong Univ, Qilu Hosp, Dept Ophthalmol, Jinan 250100, Peoples R China.	qinxuejiao@hotmail.com			Scientific Research Foundation for the Returned Overseas Chinese Scholars, the State Education Ministry; Natural Science Foundation of Shandong Province [ZR2012HM024]; Independent Innovation Foundation to Universities and Colleges by Jinan Science and Technology Bureau [201202036]; Independent Innovation Foundation of Shandong University [2010JQ009]	Scientific Research Foundation for the Returned Overseas Chinese Scholars, the State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Independent Innovation Foundation to Universities and Colleges by Jinan Science and Technology Bureau; Independent Innovation Foundation of Shandong University	The Project was sponsored partly by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, the State Education Ministry (2005), the Natural Science Foundation of Shandong Province (ZR2012HM024), the Independent Innovation Foundation to Universities and Colleges by Jinan Science and Technology Bureau (201202036); and the Independent Innovation Foundation of Shandong University (2010JQ009). The funders were not involved in the study design, data collection and analysis, publishing decisions, or preparation of the manuscript.	ALANIZCAMINO F, 1982, OPHTHALMIC SURG LAS, V13, P1022; Ali AM, 2011, CANCER RADIOTHER, V15, P140, DOI 10.1016/j.canrad.2010.03.020; Ang LPK, 2007, CURR OPIN OPHTHALMOL, V18, P308, DOI 10.1097/ICU.0b013e3281a7ecbb; Aswad M, 1987, Trans Am Ophthalmol Soc, V85, P273; Avisar R, 2001, ISRAEL MED ASSOC J, V3, P836; BARENDSEN GW, 1982, INT J RADIAT ONCOL, V8, P1981, DOI 10.1016/0360-3016(82)90459-X; BERNSTEIN M, 1960, AM J OPHTHALMOL, V49, P1024, DOI 10.1016/0002-9394(60)91828-6; COOPER JS, 1980, RADIOLOGY, V135, P743, DOI 10.1148/radiology.135.3.7384465; Hoffman RS, 1999, INT OPHTHALMOL CLIN, V39, P15, DOI 10.1097/00004397-199903910-00004; Isohashi F, 2006, STRAHLENTHER ONKOL, V182, P437, DOI 10.1007/s00066-006-1484-1; JAROS PA, 1988, SURV OPHTHALMOL, V33, P41, DOI 10.1016/0039-6257(88)90071-9; Jurgenliemk-Schulz IM, 2004, INT J RADIAT ONCOL, V59, P1138, DOI 10.1016/j.ijrobp.2003.12.021; Kirwan JF, 2003, EYE, V17, P207, DOI 10.1038/sj.eye.6700306; LEVINE DJ, 1994, ARCH OPHTHALMOL-CHIC, V112, P1016, DOI 10.1001/archopht.1994.01090200018003; MAHAR PS, 1993, BRIT J OPHTHALMOL, V77, P433, DOI 10.1136/bjo.77.7.433; Monteiro-Grillo I, 2000, INT J RADIAT ONCOL, V48, P865, DOI 10.1016/S0360-3016(00)00701-X; MORIARTY AP, 1992, BRIT J OPHTHALMOL, V76, P766, DOI 10.1136/bjo.76.12.766; Nishimura Y, 2000, INT J RADIAT ONCOL, V46, P137, DOI 10.1016/S0360-3016(99)00419-8; Pajic B, 2005, RADIOTHER ONCOL, V74, P25, DOI 10.1016/j.radonc.2004.08.022; PAVILACK MA, 1995, J REFRACT SURG, V11, P92; ROWEN G E, 1968, Rocky Mountain Medical Journal, V65, P47; Smith R A, 2001, J Miss State Med Assoc, V42, P167; Solomon A, 2001, OPHTHALMOLOGY, V108, P449, DOI 10.1016/S0161-6420(00)00567-4; Solomon AS, 2006, BRIT J OPHTHALMOL, V90, P665, DOI 10.1136/bjo.2006.091413; Song C, 1994, ATLAS SURG VOLUME OP, P276; Tafti MRF, 2011, CORNEA, V30, P127, DOI 10.1097/ICO.0b013e3181e16d67; TARR KH, 1980, BRIT J OPHTHALMOL, V64, P496, DOI 10.1136/bjo.64.7.496; Viani Gustavo Arruda, 2012, Int J Radiat Oncol Biol Phys, V82, pe181, DOI 10.1016/j.ijrobp.2010.11.017; WILDER RB, 1992, INT J RADIAT ONCOL, V23, P533, DOI 10.1016/0360-3016(92)90008-6	29	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43500	10.1371/journal.pone.0043500	http://dx.doi.org/10.1371/journal.pone.0043500			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952695	Green Submitted, Green Published, gold			2022-12-25	WOS:000308044800034
J	Rodrigues, R; Shet, A; Antony, J; Sidney, K; Arumugam, K; Krishnamurthy, S; D'Souza, G; DeCosta, A				Rodrigues, Rashmi; Shet, Anita; Antony, Jimmy; Sidney, Kristi; Arumugam, Karthika; Krishnamurthy, Shubha; D'Souza, George; DeCosta, Ayesha			Supporting Adherence to Antiretroviral Therapy with Mobile Phone Reminders: Results from a Cohort in South India	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RANDOMIZED CONTROLLED-TRIAL; MEDICATION ADHERENCE; IMPROVING ADHERENCE; CELLULAR PHONES; CLINICAL-TRIALS; SYSTEM; CARE	Background: Adherence is central to the success of antiretroviral therapy. Supporting adherence has gained importance in HIV care in many national treatment programs. The ubiquity of mobile phones, even in resource-constrained settings, has provided an opportunity to utilize an inexpensive, contextually feasible technology for adherence support in HIV in these settings. We aimed to assess the influence of mobile phone reminders on adherence to antiretroviral therapy in South India. Participant experiences with the intervention were also studied. This is the first report of such an intervention for antiretroviral adherence from India, a country with over 800 million mobile connections. Methods: Study design: Quasi-experimental cohort study involving 150 HIV-infected individuals from Bangalore, India, who were on antiretroviral therapy between April and July 2010. The intervention: All participants received two types of adherence reminders on their mobile phones, (i) an automated interactive voice response (IVR) call and (ii) A non-interactive neutral picture short messaging service (SMS), once a week for 6 months. Adherence measured by pill count, was assessed at study recruitment and at months one, three, six, nine and twelve. Participant experiences were assessed at the end of the intervention period. Results: The mean age of the participants was 38 years, 27% were female and 90% urban. Overall, 3,895 IVRs and 3,073 SMSs were sent to the participants over 6 months. Complete case analysis revealed that the proportion of participants with optimal adherence increased from 85% to 91% patients during the intervention period, an effect that was maintained 6 months after the intervention was discontinued (p = 0.016). Both, IVR calls and SMS reminders were considered non-intrusive and not a threat to privacy. A significantly higher proportion agreed that the IVR was helpful compared to the SMS (p < 0.001). Conclusion: Mobile phone reminders may improve medication adherence in HIV infected individuals in this setting, the effect of which was found to persist for at least 6 months after cessation of the intervention.	[Rodrigues, Rashmi; Shet, Anita; Sidney, Kristi; DeCosta, Ayesha] Karolinska Inst, Div Global Hlth, Stockholm, Sweden; [Rodrigues, Rashmi] St Johns Natl Acad Hlth Sci, Dept Community Hlth, Bangalore, Karnataka, India; [Antony, Jimmy; Arumugam, Karthika; Krishnamurthy, Shubha] St Johns Natl Acad Hlth Sci, HIVIND Project, Bangalore, Karnataka, India; [D'Souza, George] St Johns Natl Acad Hlth Sci, Div Chest Dis, Bangalore, Karnataka, India; [Shet, Anita] St Johns Natl Acad Hlth Sci, Dept Pediat, Bangalore, Karnataka, India	Karolinska Institutet; St. John's National Academy of Health Sciences; St. John's National Academy of Health Sciences; St. John's National Academy of Health Sciences; St. John's National Academy of Health Sciences	Rodrigues, R (corresponding author), Karolinska Inst, Div Global Hlth, Stockholm, Sweden.	rashmijr@gmail.com	Rodrigues, Rashmi J/H-1901-2012; Annerstedt, Kristi/AAJ-8678-2020	Rodrigues, Rashmi J/0000-0002-0656-0178; Annerstedt, Kristi/0000-0002-8798-4027; Shet, Anita/0000-0002-7204-8164	National AIDS Control Organisation; European Commission	National AIDS Control Organisation; European Commission(European CommissionEuropean Commission Joint Research Centre)	Authors would like to thank Ravience Digital, Mumbai, India for technical assistance with the intervention, the National AIDS Control Organisation for their support, the staff at the Infectious Disease Clinic, St. John's National Academy of Health Sciences, Bangalore, India; Mr. As Mohammad, Swaroop N, Ashwini GS and Navya CJ from the department of Community Medicine, St. John's Medical College, for their assistance with the study data.; This work was funded by a European Commission FP7 grant for the HIVIND project. [URL: http://cordis.europa.eu/fetch?CALLER=FP7_PROJ_EN&ACTION=D&DOC=1&CAT=PROJ&QUERY=0132a68e52ee:51ac:213dc128&RCN=90123]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altice FL, 2010, ARCH INTERN MED, V170, P109, DOI 10.1001/archinternmed.2009.459; Armstrong AW, 2009, ARCH DERMATOL, V145, P1230, DOI 10.1001/archdermatol.2009.269; Bartlett JA, 2002, J ACQ IMMUN DEF SYND, V29, pS2, DOI 10.1097/00126334-200202011-00002; Bastard M, 2011, JAIDS-J ACQ IMM DEF, V57, P55, DOI 10.1097/QAI.0b013e318211b43b; Bhat VG, 2010, EUR J CLIN MICROBIOL, V29, P947, DOI 10.1007/s10096-010-0949-4; Boyer EW, 2010, J MED TOXICOL, V6, P212, DOI 10.1007/s13181-010-0080-z; Cauldbeck M., 2009, AIDS RES THERAPY; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Chung MH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000422; Cote JK, 2005, INT J STD AIDS, V16, P335, DOI 10.1258/0956462053888934; Crankshaw T, 2010, AIDS PATIENT CARE ST, V24, P729, DOI 10.1089/apc.2010.0146; De Costa A, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-25; El-Khatib Z, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-88; Freedberg KA, 2007, AIDS, V21, pS117, DOI 10.1097/01.aids.0000279714.60935.a2; Granger BB, 2011, CURR OPIN CARDIOL, V26, P279, DOI 10.1097/HCO.0b013e328347c150; Hardy H, 2011, AIDS PATIENT CARE ST, V25, P153, DOI 10.1089/apc.2010.0006; Harris AD, 2004, CLIN INFECT DIS, V38, P1586, DOI 10.1086/420936; Ickovics JR, 1997, J CLIN EPIDEMIOL, V50, P385, DOI 10.1016/S0895-4356(97)00041-3; Kalichman SC, 2011, AIDS PATIENT CARE ST, V25, P303, DOI 10.1089/apc.2010.0367; Kaplan WA, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-9; Kunutsor S, 2010, AIDS RES TREAT, V2010, DOI 10.1155/2010/872396; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Lyon ME, 2003, AIDS PATIENT CARE ST, V17, P299, DOI 10.1089/108729103322108175; Mbuagbaw L, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-5; Milam J, 2005, JAIDS-J ACQ IMM DEF, V40, P356, DOI 10.1097/01.qai.0000159710.98960.81; Nachega JB, 2011, AIDS S4, V24, P1273; *NACO, 2007, ANT THER GUID HIV IN; NACO, 2011, NAT AIDS CONTR ORG A; NIAID Adult AIDS Clinical Trials Group, 2003, Q10777 NIAID AD AIDS; Nyanzi-Wakholi B, 2012, AIDS CARE, V24, P137, DOI 10.1080/09540121.2011.596518; Perrine R, 2011, JAIDS-J ACQ IMM DEF, V57, pS40, DOI 10.1097/QAI.0b013e318222b5c2; Person AK, 2011, TELEMED E-HEALTH, V17, P189, DOI 10.1089/tmj.2010.0164; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Puccio JA, 2006, AIDS PATIENT CARE ST, V20, P438, DOI 10.1089/apc.2006.20.438; Read T, 2003, INTERN MED J, V33, P254, DOI 10.1046/j.1445-5994.2003.00333.x; Reidel K, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-46; Reynolds NR, 2008, JAIDS-J ACQ IMM DEF, V47, P62, DOI 10.1097/QAI.0b013e3181582d54; Rigsby MO, 2000, J GEN INTERN MED, V15, P841, DOI 10.1046/j.1525-1497.2000.00127.x; Roberts KJ, 2000, AIDS PATIENT CARE ST, V14, P155, DOI 10.1089/108729100317948; RUDD P, 1989, CLIN PHARMACOL THER, V46, P169, DOI 10.1038/clpt.1989.122; Safren SA, 2003, AIDS CARE, V15, P787, DOI 10.1080/09540120310001618630; Shet A, 2010, AIDS BEHAV, V14, P716, DOI 10.1007/s10461-009-9658-3; Sidney K, 2012, AIDS CARE, V24, P612, DOI 10.1080/09540121.2011.630357; Simoni Jane M, 2008, Curr Infect Dis Rep, V10, P515, DOI 10.1007/s11908-008-0083-y; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Tesoriero J, 2003, JAIDS-J ACQ IMM DEF, V33, P484, DOI 10.1097/00126334-200308010-00009; TRAI, 2011, IND TEL SERV PERF IN; Uzma Qudsia, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P373, DOI 10.1177/1545109710383175; Vital Wave Consulting, 2009, MHEALTH DEV OPP MOB; Woods SP, 2008, ARCH CLIN NEUROPSYCH, V23, P257, DOI 10.1016/j.acn.2007.12.006	50	77	79	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e40723	10.1371/journal.pone.0040723	http://dx.doi.org/10.1371/journal.pone.0040723			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	995WH	22952574	Green Submitted, Green Published, gold			2022-12-25	WOS:000308044800003
J	Serang, O				Serang, Oliver			Conic Sampling: An Efficient Method for Solving Linear and Quadratic Programming by Randomly Linking Constraints within the Interior	PLOS ONE			English	Article							MASS-SPECTROMETRY; ALGORITHM	Linear programming (LP) problems are commonly used in analysis and resource allocation, frequently surfacing as approximations to more difficult problems. Existing approaches to LP have been dominated by a small group of methods, and randomized algorithms have not enjoyed popularity in practice. This paper introduces a novel randomized method of solving LP problems by moving along the facets and within the interior of the polytope along rays randomly sampled from the polyhedral cones defined by the bounding constraints. This conic sampling method is then applied to randomly sampled LPs, and its runtime performance is shown to compare favorably to the simplex and primal affine-scaling algorithms, especially on polytopes with certain characteristics. The conic sampling method is then adapted and applied to solve a certain quadratic program, which compute a projection onto a polytope; the proposed method is shown to outperform the proprietary software Mathematica on large, sparse QP problems constructed from mass spectometry-based proteomics.	[Serang, Oliver] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Serang, Oliver] Boston Childrens Hosp, Dept Pathol, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Serang, O (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	Oliver.Serang@Childrens.Harvard.edu						BARNES ER, 1986, MATH PROGRAM, V36, P174, DOI 10.1007/BF02592024; Bland R. G., 1977, Mathematics of Operations Research, V2, P103, DOI 10.1287/moor.2.2.103; Dantzig GB, 1947, LINEAR PROGRAMMING E; Forrest J. J. H., 1972, MATH PROGRAM, V2, P263; Glocker B, 2008, MED IMAGE ANAL, V12, P731, DOI 10.1016/j.media.2008.03.006; Hauskrecht M, 2004, NIPS; Kalai G, 1985, SOME COMPUTATIONAL E, P85; Kalai G, 1991, SUBEXPONENTIAL UNPUB; KARMARKAR N, 1984, COMBINATORICA, V4, P373, DOI 10.1007/BF02579150; Khachiyan LG, 1979, SOV MATH DOKL, V20, P191; Klee V, 1972, INEQUALITIES, P159; Murty KG, 1988, LINEAR COMPLEMENTARI; REID JK, 1982, MATH PROGRAM, V24, P55, DOI 10.1007/BF01585094; Sanghavi S, 2008, NIPS, P1273; Serang O, 2012, STAT INTERFACE, V5, P3; Serang O, 2010, J PROTEOME RES, V9, P5346, DOI 10.1021/pr100594k; Tsuda K, 2004, IMAGE RECONSTRUCTION; VANDERBEI R. J, 1996, LINEAR PROGRAMMING F; Vanderbei RJ, 1986, ALGORITHMICA, V1, P395, DOI 10.1007/BF01840454; Wright SJ, 1997, INTERIOR POINT METHO; Y RS, 1991, SMALL DIMENSIONAL LI; Yanover C, 2006, J MACH LEARN RES, V7, P1887; Zhang B, 2007, J PROTEOME RES, V6, P3549, DOI 10.1021/pr070230d	24	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43706	10.1371/journal.pone.0043706	http://dx.doi.org/10.1371/journal.pone.0043706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952741	Green Published, gold, Green Submitted			2022-12-25	WOS:000308044800052
J	Zhang, W; Shi, Q; Xu, XT; Chen, H; Lin, W; Zhang, FC; Zeng, XF; Zhang, X; Ba, DN; He, W				Zhang, Wen; Shi, Qun; Xu, Xiaotian; Chen, Hua; Lin, Wei; Zhang, Fengchun; Zeng, Xiaofeng; Zhang, Xuan; Ba, Denian; He, Wei			Aberrant CD40-Induced NF-kappa B Activation in Human Lupus B Lymphocytes	PLOS ONE			English	Article							SOLUBLE CD40 LIGAND; LIPID RAFTS; ERYTHEMATOSUS; EXPRESSION; CELLS; TRAF2; CD154; GLOMERULONEPHRITIS; UBIQUITINATION; TRANSLOCATION	Auto-reactive B lymphocytes and its abnormal CD40 signaling play important roles in the pathogenesis of systemic lupus erythematosus (SLE). In this study, we analyzed CD40 expression and CD40/CD154 induced activation of NF-kappa B signaling pathway in B cells from SLE patients. B cells from healthy volunteers and tonsilar B cells from chronic tonsillitis were used as negative and positive controls. Results showed CD40-induced NF-kappa B signaling was constitutively activated in B cells from active lupus patients, including decreased CD40 in raft portion, increased phosphorylation and degradation of I kappa B alpha, phosphorylation of P65, as well as increased nuclear translocation of P65, P50, c-Rel, which could be blocked by anti-CD154. CD154 stimulation could induce further phosphorylation and degradation of I kappa B alpha, as well as phosphorylation of P65 and nuclear translocation of P65. In addition, CD40-induced kinase activities in B cells from lupus patients mimicked that of tonsil B cells, in that IKK alpha/beta were more activated compared to normal B cells. CD40-induced NF-kappa B activity was blocked by both I kappa B phosphorylation and proteosome degradation inhibitors in both lupus and normal B cells. All together, our findings revealed that canonical NF-kappa B signaling is constitutively activated in active lupus and is mediated by CD154/CD40. CD40 induced NF-kappa B activation is different in human lupus B lymphocytes compared with normal B cells.	[Zhang, Wen; Shi, Qun; Xu, Xiaotian; Chen, Hua; Lin, Wei; Zhang, Fengchun; Zeng, Xiaofeng; Zhang, Xuan] Peking Union Med Coll, Dept Rheumatol, Peking Union Med Coll Hosp, Beijing 100021, Peoples R China; [Ba, Denian; He, Wei] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Ba, Denian; He, Wei] Peking Union Med Coll, Dept Immunol, Sch Basic Med, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhang, W (corresponding author), Peking Union Med Coll, Dept Rheumatol, Peking Union Med Coll Hosp, Beijing 100021, Peoples R China.	zxpumch2003@yahoo.com.cn	zhang, xu/GRX-9733-2022; zhang, xuan/GQO-8953-2022; zhang, xuan/AAN-9914-2020	zhang, xuan/0000-0001-8775-1699; zhang, xuan/0000-0001-8775-1699	National Natural Science Foundation of China [81172858, 30972731]; National High Technology Research and Development Project of China (973 Project) [2007CB512405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Project of China (973 Project)(National Basic Research Program of ChinaNational High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China (81172858, 30972731), National High Technology Research and Development Project of China (973 Project) (2007CB512405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardila-Osorio H, 2005, INT J CANCER, V113, P267, DOI 10.1002/ijc.20503; Bishop GA, 2003, CYTOKINE GROWTH F R, V14, P297, DOI 10.1016/S1359-6101(03)00024-8; Blossom S, 1997, J IMMUNOL, V159, P4580; Boumpas DT, 2003, ARTHRITIS RHEUM-US, V48, P719, DOI 10.1002/art.10856; Caproni M, 2007, J RHEUMATOL, V34, P2412; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Cherukuri Anu, 2004, Methods Mol Biol, V271, P213; Crow MK, 2001, CURR OPIN RHEUMATOL, V13, P361, DOI 10.1097/00002281-200109000-00004; de Sanctis JB, 2009, AUTOIMMUNITY, V42, P263, DOI 10.1080/08916930902827942; Dejica D I, 2006, Roum Arch Microbiol Immunol, V65, P66; Dykstra ML, 2001, IMMUNITY, V14, P57, DOI 10.1016/S1074-7613(01)00089-9; Gladman DD, 2002, J RHEUMATOL, V29, P288; Grammer AC, 1999, J IMMUNOL, V163, P4150; Grammer AC, 2003, ARTHRITIS RES THER, V5, pS22, DOI 10.1186/ar1009; Grammer AC, 2003, J CLIN INVEST, V112, P1506, DOI 10.1172/JCI200319301; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Harigai M, 1999, LUPUS, V8, P227, DOI 10.1191/096120399678847678; Hillion S, 2007, J IMMUNOL, V179, P6790, DOI 10.4049/jimmunol.179.10.6790; Homig-Holzel C, 2008, J EXP MED, V205, P1317, DOI 10.1084/jem.20080238; Hostager BS, 2007, IMMUNOL RES, V39, P105, DOI 10.1007/s12026-007-0082-3; Jabara HH, 2009, INT IMMUNOL, V21, P477, DOI 10.1093/intimm/dxp013; Jabara HH, 2002, IMMUNITY, V17, P265, DOI 10.1016/S1074-7613(02)00394-1; Kato K, 1999, J CLIN INVEST, V104, P947, DOI 10.1172/JCI7014; Koshy M, 1996, J CLIN INVEST, V98, P826, DOI 10.1172/JCI118855; Liu Z, 2011, EUR J IMMUNOL, V41, P588, DOI 10.1002/eji.201041354; Loh C, 2011, EUR J IMMUNOL, V41, P527, DOI 10.1002/eji.201040983; Mehta J, 2010, ARTHRITIS RHEUM-US, V62, P2499, DOI 10.1002/art.27554; Vakkalanka RK, 1999, ARTHRITIS RHEUM, V42, P871, DOI 10.1002/1529-0131(199905)42:5<871::AID-ANR5>3.0.CO;2-J; Withers DR, 2007, BLOOD, V109, P4856, DOI 10.1182/blood-2006-08-043414; Wu CJ, 2005, EMBO J, V24, P1886, DOI 10.1038/sj.emboj.7600649; XIA ZP, 2005, SCI STKE, pE7; Yellin MJ, 1997, ARTHRITIS RHEUM, V40, P124, DOI 10.1002/art.1780400117	32	24	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e41644	10.1371/journal.pone.0041644	http://dx.doi.org/10.1371/journal.pone.0041644			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952582	Green Published, Green Submitted, gold			2022-12-25	WOS:000308044800005
J	Agudelo, D; Bourassa, P; Bruneau, J; Berube, G; Asselin, E; Tajmir-Riahi, HA				Agudelo, Daniel; Bourassa, Philippe; Bruneau, Julie; Berube, Gervais; Asselin, Eric; Tajmir-Riahi, Heidar-Ali			Probing the Binding Sites of Antibiotic Drugs Doxorubicin and N-(trifluoroacetyl) Doxorubicin with Human and Bovine Serum Albumins	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTRA; SECONDARY STRUCTURE; CHITOSAN NANOPARTICLES; DELIVERY-SYSTEMS; SWISS-MODEL; SPECTROSCOPY; DENDRIMERS; ACID	We located the binding sites of doxorubicin (DOX) and N-(trifluoroacetyl) doxorubicin (FDOX) with bovine serum albumin (BSA) and human serum albumins (HSA) at physiological conditions, using constant protein concentration and various drug contents. FTIR, CD and fluorescence spectroscopic methods as well as molecular modeling were used to analyse drug binding sites, the binding constant and the effect of drug complexation on BSA and HSA stability and conformations. Structural analysis showed that doxorubicin and N-(trifluoroacetyl) doxorubicin bind strongly to BSA and HSA via hydrophilic and hydrophobic contacts with overall binding constants of KDOX-BSA = 7.8 (+/- 0.7) x10(3) M-1, KFDOX-BSA = 4.8 (+/- 0.5) x10(3) M-1 and KDOX-HSA = 1.1 (+/- 0.3) x10(4) M-1, KFDOX-HSA = 8.3 (+/- 0.6) x10(3) M-1. The number of bound drug molecules per protein is 1.5 (DOX-BSA), 1.3 (FDOX-BSA) 1.5 (DOX-HSA), 0.9 (FDOX-HSA) in these drug-protein complexes. Docking studies showed the participation of several amino acids in drug-protein complexation, which stabilized by H-bonding systems. The order of drug-protein binding is DOX-HSA. FDOX-HSA. DOX-BSA. FDOX. BSA. Drug complexation alters protein conformation by a major reduction of a-helix from 63% (free BSA) to 47-44% (drug-complex) and 57% (free HSA) to 51-40% (drug-complex) inducing a partial protein destabilization. Doxorubicin and its derivative can be transported by BSA and HSA in vitro.	[Agudelo, Daniel; Bourassa, Philippe; Bruneau, Julie; Berube, Gervais; Asselin, Eric; Tajmir-Riahi, Heidar-Ali] Univ Quebec Trois Rivieres, Dept Chim Biol, Trois Rivieres, PQ GA9 5H7, Canada	University of Quebec; University of Quebec Trois Rivieres	Agudelo, D (corresponding author), Univ Quebec Trois Rivieres, Dept Chim Biol, CP 500, Trois Rivieres, PQ GA9 5H7, Canada.	tajmirri@uqtr.ca	Bérubé, Gervais/GQI-4209-2022	Berube, Gervais/0000-0001-8001-0150; Bourassa, Philippe/0000-0003-2662-2118; Agudelo Pinto, Daniel Steven/0000-0002-8794-4279	NSERC Canada (Natural Science and Engineering Research Council of Canada)	NSERC Canada (Natural Science and Engineering Research Council of Canada)	NSERC Canada (Natural Science and Engineering Research Council of Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACTON EM, 1981, J MED CHEM, V24, P669, DOI 10.1021/jm00138a005; AHMED A, 1995, FEBS LETT, V363, P65, DOI 10.1016/0014-5793(95)00282-E; Ahmed-Ouameur A, 2006, CELL BIOCHEM BIOPHYS, V45, P203, DOI 10.1385/CBB:45:2:203; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beauchemin R, 2007, BIOMACROMOLECULES, V8, P3177, DOI 10.1021/bm700697a; Belatik A, 2012, EUR J MED CHEM, V48, P114, DOI 10.1016/j.ejmech.2011.12.002; Belatik A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036723; BERUBE G, 1991, SYNTHETIC COMMUN, V21, P931, DOI 10.1080/00397919108019778; Bi SY, 2004, J MOL STRUCT, V703, P37, DOI 10.1016/j.molstruc.2004.05.026; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; Carvalho C, 2009, CURR MED CHEM, V16, P3267, DOI 10.2174/092986709788803312; Charbonneau D, 2009, J PHYS CHEM B, V113, P1777, DOI 10.1021/jp8092012; Choi KC, 2009, J PHARM SCI-US, V98, P2104, DOI 10.1002/jps.21588; DOUSSEAU F, 1989, APPL SPECTROSC, V43, P538, DOI 10.1366/0003702894202814; Dubeau S, 2010, BIOMACROMOLECULES, V11, P1507, DOI 10.1021/bm100144v; Dufour C, 2005, BBA-GEN SUBJECTS, V1721, P164, DOI 10.1016/j.bbagen.2004.10.013; Froehlich E, 2009, J PHYS CHEM B, V113, P6986, DOI 10.1021/jp9011119; Grdadolnik J, 2003, ACTA CHIM SLOV, V50, P777; He WY, 2005, BIOORGAN MED CHEM, V13, P1837, DOI 10.1016/j.bmc.2004.11.038; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Janes KA, 2001, J CONTROL RELEASE, V73, P255, DOI 10.1016/S0168-3659(01)00294-2; Jiang M, 2004, J MOL STRUCT, V692, P71, DOI 10.1016/j.molstruc.2004.01.003; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; KRAGHHANSEN U, 1990, DAN MED BULL, V37, P57; Kratochwil NA, 2002, BIOCHEM PHARMACOL, V64, P1355, DOI 10.1016/S0006-2952(02)01074-2; Kratz F, 2007, EXPERT OPIN INV DRUG, V16, P855, DOI 10.1517/13543784.16.6.855; Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Li C, 2008, ADV DRUG DELIVER REV, V60, P886, DOI 10.1016/j.addr.2007.11.009; Mandeville JS, 2010, BIOMACROMOLECULES, V11, P465, DOI 10.1021/bm9011979; Mandeville JS, 2009, J PHARMACEUT BIOMED, V49, P468, DOI 10.1016/j.jpba.2008.11.035; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Mitra S, 2001, J CONTROL RELEASE, V74, P317, DOI 10.1016/S0168-3659(01)00342-X; Painter L, 1998, J CHEM SOC PERK T 1, P3041, DOI 10.1039/a803429j; PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0; Peters T., 1996, ALL ALBUMIN BIOCH GE; Qi JN, 2010, INT J PHARMACEUT, V393, P176, DOI 10.1016/j.ijpharm.2010.03.063; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Son YJ, 2003, J CONTROL RELEASE, V91, P135, DOI 10.1016/S0168-3659(03)00231-1; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Tan ML, 2009, J PHARM PHARMACOL, V61, P131, DOI 10.1211/jpp/61.02.0001; Tayeh N, 2009, J PHARMACEUT BIOMED, V50, P107, DOI 10.1016/j.jpba.2009.03.015; Tian J., 2005, ARTIC AM J IMMUNOL, V1, P21, DOI [DOI 10.3844/AJISP.2005.21.23, DOI 10.3844/ajisp.2005.21.23]; Yokoe JI, 2008, INT J PHARMACEUT, V353, P28, DOI 10.1016/j.ijpharm.2007.11.008; Zhang GW, 2008, J MOL STRUCT, V881, P132, DOI 10.1016/j.molstruc.2007.09.002	49	154	160	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43814	10.1371/journal.pone.0043814	http://dx.doi.org/10.1371/journal.pone.0043814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937101	gold, Green Submitted, Green Published			2022-12-25	WOS:000308225500103
J	Chao, PK; Lu, KT; Lee, YL; Chen, JC; Wang, HL; Yang, YL; Cheng, MY; Liao, MF; Ro, LS				Chao, Po-Kuan; Lu, Kwok-Tung; Lee, Yun-Lin; Chen, Jin-Chung; Wang, Hung-Li; Yang, Yi-Ling; Cheng, Mei-Yun; Liao, Ming-Feng; Ro, Long-Sun			Early Systemic Granulocyte-Colony Stimulating Factor Treatment Attenuates Neuropathic Pain after Peripheral Nerve Injury	PLOS ONE			English	Article							CONTAINING POLYMORPHONUCLEAR CELLS; BONE CANCER PAIN; INFLAMMATORY PAIN; G-CSF; BETA-ENDORPHIN; NEUTROPHIL PRODUCTION; RECEPTOR EXPRESSION; OPIOID-PEPTIDES; IMMUNE CELLS; SPINAL-CORD	Recent studies have shown that opioid treatment can reduce pro-inflammatory cytokine production and counteract various neuropathic pain syndromes. Granulocyte colony-stimulating factor (G-CSF) can promote immune cell differentiation by increasing leukocytes (mainly opioid-containing polymorphonuclear (PMN) cells), suggesting a potential beneficial role in treating chronic pain. This study shows the effectiveness of exogenous G-CSF treatment (200 mg/kg) for alleviating thermal hyperalgesia and mechanical allodynia in rats with chronic constriction injury (CCI), during post-operative days 1-25, compared to that of vehicle treatment. G-CSF also increases the recruitment of opioid-containing PMN cells into the injured nerve. After CCI, single administration of G-CSF on days 0, 1, and 2, but not on day 3, relieved thermal hyperalgesia, which indicated that its effect on neuropathic pain had a therapeutic window of 0-48 h after nerve injury. CCI led to an increase in the levels of interleukin-6 (IL-6) mRNA and tumor necrosis factor-alpha (TNF-alpha) protein in the dorsal root ganglia (DRG). These high levels of IL-6 mRNA and TNF-alpha were suppressed by a single administration of G-CSF 48-144 h and 72-144 h after CCI, respectively. Furthermore, G-CSF administered 72-144 h after CCI suppressed the CCI-induced upregulation of microglial activation in the ipsilateral spinal dorsal horn, which is essential for sensing neuropathic pain. Moreover, the opioid receptor antagonist naloxone methiodide (NLXM) reversed G-CSF-induced antinociception 3 days after CCI, suggesting that G-CSF alleviates hyperalgesia via opioid/opioid receptor interactions. These results suggest that an early single systemic injection of G-CSF alleviates neuropathic pain via activation of PMN cell-derived endogenous opioid secretion to activate opioid receptors in the injured nerve, downregulate IL-6 and TNF-alpha inflammatory cytokines, and attenuate microglial activation in the spinal dorsal horn. This indicates that G-CSF treatment can suppress early inflammation and prevent the subsequent development of neuropathic pain.	[Chao, Po-Kuan; Lu, Kwok-Tung] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Lee, Yun-Lin; Cheng, Mei-Yun; Liao, Ming-Feng; Ro, Long-Sun] Chang Gung Univ, Chang Gung Mem Hosp & Univ, Dept Neurol, Div Neuromuscular Disorders, Tao Yuan, Taiwan; [Chen, Jin-Chung] Chang Gung Univ, Dept Pharmacol, Tao Yuan, Taiwan; [Wang, Hung-Li] Chang Gung Univ, Dept Physiol, Tao Yuan, Taiwan; [Yang, Yi-Ling] Natl Chia Yi Univ, Inst Biotechnol, Chiayi, Taiwan	National Taiwan Normal University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; National Chiayi University	Chao, PK (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	cgrols@adm.cgmh.org.tw		Chen, Jin-Chung/0000-0003-2996-5781	Chang Gung Medical Research Program [CMRP 351021-3]; National Science Council, Taiwan, ROC [NSC 96-2314-B-182A-111, 97-2314-B-182A-046, 98-2314-B-182A-076-MY3]	Chang Gung Medical Research Program; National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the Chang Gung Medical Research Program (CMRP 351021-3) and a grant from the National Science Council (NSC 96-2314-B-182A-111, 97-2314-B-182A-046, 98-2314-B-182A-076-MY3), Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker P S, 1997, Biol Blood Marrow Transplant, V3, P45; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Berrios I, 2008, P R HEALTH SCI J, V27, P119; Binder W, 2004, EUR J NEUROSCI, V20, P92, DOI 10.1111/j.1460-9568.2004.03459.x; Brack A, 2004, PAIN, V108, P67, DOI 10.1016/j.pain.2003.12.008; Brack A, 2004, ANESTHESIOLOGY, V100, P149, DOI 10.1097/00000542-200401000-00024; Brack A, 2004, PAIN, V112, P229, DOI 10.1016/j.pain.2004.08.029; Brack Alexander, 2004, Curr Opin Anaesthesiol, V17, P461, DOI 10.1097/00001503-200410000-00018; Busch-Dienstfertig M, 2010, BRAIN BEHAV IMMUN, V24, P683, DOI 10.1016/j.bbi.2009.10.013; Cabot PJ, 1997, J CLIN INVEST, V100, P142, DOI 10.1172/JCI119506; Cabot PJ, 2001, CLIN EXP PHARMACOL P, V28, P230, DOI 10.1046/j.1440-1681.2001.03425.x; Cabot PJ, 2001, PAIN, V93, P207, DOI 10.1016/S0304-3959(01)00322-0; Dale CS, 2005, MEM I OSWALDO CRUZ, V100, P105, DOI 10.1590/S0074-02762005000900017; Eyles JL, 2008, BLOOD, V112, P5193, DOI 10.1182/blood-2008-02-139535; Fecho K, 2007, BRAIN BEHAV IMMUN, V21, P68, DOI 10.1016/j.bbi.2006.02.003; Finley MJ, 2008, CELL IMMUNOL, V252, P146, DOI 10.1016/j.cellimm.2007.09.008; Hagiwara S, 2008, ANESTH ANALG, V107, P1058, DOI 10.1213/ane.0b013e31817ee43e; Hathway GJ, 2009, PAIN, V144, P110, DOI 10.1016/j.pain.2009.03.022; Hoggatt J, 2011, CURR OPIN HEMATOL, V18, P231, DOI 10.1097/MOH.0b013e3283477962; Iwasaka H, 2001, CAN J ANAESTH, V48, P81, DOI 10.1007/BF03019820; Kapitzke Daniel, 2005, Ther Clin Risk Manag, V1, P279; Labuz D, 2010, BRAIN BEHAV IMMUN, V24, P1045, DOI 10.1016/j.bbi.2010.04.001; Labuz D, 2009, J CLIN INVEST, V119, P278, DOI [10.1172/JCI36246, 10.1172/JCI36246C1]; Lazarini F, 2003, GLIA, V42, P139, DOI 10.1002/glia.10139; Leanez S, 2009, EUR J PHARMACOL, V602, P41, DOI 10.1016/j.ejphar.2008.11.019; Liou JT, 2011, J NEUROIMMUNOL, V232, P83, DOI 10.1016/j.jneuroim.2010.10.014; Lloyd CM, 2008, J IMMUNOL METHODS, V334, P70, DOI 10.1016/j.jim.2008.02.005; Machelska H, 2003, NAT MED, V9, P1353, DOI 10.1038/nm1103-1353; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; Mousa SA, 2002, J NEUROIMMUNOL, V126, P5, DOI 10.1016/S0165-5728(02)00049-8; Mousa SA, 2004, ENDOCRINOLOGY, V145, P1331, DOI 10.1210/en.2003-1287; Mousa SA, 2007, NEUROPSYCHOPHARMACOL, V32, P2530, DOI 10.1038/sj.npp.1301393; Nguyen HX, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-26; Nilsson A, 2005, MOL BRAIN RES, V136, P65, DOI 10.1016/j.molbrainres.2005.01.008; Poisbeau P, 2005, J NEUROSCI, V25, P11768, DOI 10.1523/JNEUROSCI.3841-05.2005; Pollari E, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-74; Rittner HL, 2008, NEUROSCI LETT, V437, P203, DOI 10.1016/j.neulet.2008.02.071; Rittner HL, 2006, FASEB J, V20, P2627, DOI 10.1096/fj.06-6077fje; Rittner HL, 2006, J LEUKOCYTE BIOL, V79, P1022, DOI 10.1189/jlb.0805452; Rittner HL, 2001, ANESTHESIOLOGY, V95, P500, DOI 10.1097/00000542-200108000-00036; Roberts AW, 2005, GROWTH FACTORS, V23, P33, DOI 10.1080/08977190500055836; Rutella S, 2007, TRANSPLANTATION, V84, pS26, DOI 10.1097/01.tp.0000269611.66517.bf; Schweizerhof M, 2009, NAT MED, V15, P802, DOI 10.1038/nm.1976; Semerad CL, 1999, IMMUNITY, V11, P153, DOI 10.1016/S1074-7613(00)80090-4; Solaroglu I, 2007, FRONT BIOSCI-LANDMRK, V12, P712, DOI 10.2741/2095; STEIN C, 1990, P NATL ACAD SCI USA, V87, P5935, DOI 10.1073/pnas.87.15.5935; Stein C, 2003, NAT MED, V9, P1003, DOI 10.1038/nm908; Takemoto Y, 2000, DRUG EXP CLIN RES, V26, P1; Touw IP, 2007, FRONT BIOSCI-LANDMRK, V12, P800, DOI 10.2741/2103; Tsai RK, 2008, EXP EYE RES, V87, P242, DOI 10.1016/j.exer.2008.06.004; Ugolini G, 2007, P NATL ACAD SCI USA, V104, P2985, DOI 10.1073/pnas.0611253104; Wang FZ, 2010, PAIN, V148, P275, DOI 10.1016/j.pain.2009.11.011; White FA, 2007, P NATL ACAD SCI USA, V104, P20151, DOI 10.1073/pnas.0709250104; Zhang RX, 2005, PAIN, V118, P125, DOI 10.1016/j.pain.2005.08.001; Zhang YQ, 2009, PAIN, V146, P130, DOI 10.1016/j.pain.2009.07.011	55	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43680	10.1371/journal.pone.0043680	http://dx.doi.org/10.1371/journal.pone.0043680			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937076	gold, Green Published, Green Submitted			2022-12-25	WOS:000308225500078
J	Harand, C; Bertran, F; La Joie, R; Landeau, B; Mezenge, F; Desgranges, B; Peigneux, P; Eustache, F; Rauchs, G				Harand, Caroline; Bertran, Francoise; La Joie, Renaud; Landeau, Brigitte; Mezenge, Florence; Desgranges, Beatrice; Peigneux, Philippe; Eustache, Francis; Rauchs, Geraldine			The Hippocampus Remains Activated over the Long Term for the Retrieval of Truly Episodic Memories	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; AUTOBIOGRAPHICAL MEMORIES; RETROGRADE-AMNESIA; RECOGNITION MEMORY; EMOTIONAL MEMORY; PARIETAL CORTEX; CONSOLIDATION; RECOLLECTION; FAMILIARITY; AMYGDALA	The role of the hippocampus in declarative memory consolidation is a matter of intense debate. We investigated the neural substrates of memory retrieval for recent and remote information using functional magnetic resonance imaging (fMRI). 18 young, healthy participants learned a series of pictures. Then, during two fMRI recognition sessions, 3 days and 3 months later, they had to determine whether they recognized or not each picture using the "Remember/Know" procedure. Presentation of the same learned images at both delays allowed us to track the evolution of memories and distinguish consistently episodic memories from those that were initially episodic and then became familiar or semantic over time and were retrieved without any contextual detail. Hippocampal activation decreased over time for initially episodic, later semantic memories, but remained stable for consistently episodic ones, at least in its posterior part. For both types of memories, neocortical activations were observed at both delays, notably in the ventromedial prefrontal and anterior cingulate cortices. These activations may reflect a gradual reorganization of memory traces within neural networks. Our data indicate maintenance and strengthening of hippocampal and cortico-cortical connections in the consolidation and retrieval of episodic memories over time, in line with the Multiple Trace theory (Nadel and Moscovitch, 1997). At variance, memories becoming semantic over time consolidate through strengthening of cortico-cortical connections and progressive disengagement of the hippocampus.	[Harand, Caroline; Bertran, Francoise; La Joie, Renaud; Landeau, Brigitte; Mezenge, Florence; Desgranges, Beatrice; Eustache, Francis; Rauchs, Geraldine] INSERM, U1077, Caen, France; [Harand, Caroline; Bertran, Francoise; La Joie, Renaud; Landeau, Brigitte; Mezenge, Florence; Desgranges, Beatrice; Eustache, Francis; Rauchs, Geraldine] Univ Caen Basse Normandie, UMR S1077, Caen, France; [Harand, Caroline; Bertran, Francoise; La Joie, Renaud; Landeau, Brigitte; Mezenge, Florence; Desgranges, Beatrice; Eustache, Francis; Rauchs, Geraldine] Ecole Prat Hautes Etud, UMR S1077, Caen, France; [Harand, Caroline; La Joie, Renaud; Landeau, Brigitte; Mezenge, Florence; Desgranges, Beatrice; Eustache, Francis; Rauchs, Geraldine] Ctr Hosp Univ, U1077, Caen, France; [Bertran, Francoise] CHU Caen, Serv Explorat Fonct Neurol, F-14000 Caen, France; [Peigneux, Philippe] Univ Libre Brussels, UR2NF, Brussels, Belgium	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; CHU de Caen NORMANDIE; CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite Libre de Bruxelles	Harand, C (corresponding author), INSERM, U1077, Caen, France.	geraldine.rauchs@inserm.fr	RAUCHS, Géraldine/L-7921-2015; DESGRANGES, BEATRICE/AAK-4756-2021; Desgranges, Béatrice/L-7739-2015; Eustache, Francis/J-9465-2015; La Joie, Renaud/AAC-8569-2021	RAUCHS, Géraldine/0000-0001-7128-2189; DESGRANGES, BEATRICE/0000-0002-3657-9996; Eustache, Francis/0000-0003-4460-8686; La Joie, Renaud/0000-0003-2581-8100; Peigneux, Philippe/0000-0003-4745-1434	Institut National de la Sante et de la Recherche Medicale (INSERM); French "Ministere de la Recherche"	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); French "Ministere de la Recherche"(Ministry of Research, France)	The study was funded by Institut National de la Sante et de la Recherche Medicale (INSERM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CH was supported by the French "Ministere de la Recherche". We thank Dr Dayan, Dr Schupp, and Cyceron neuroimaging staff for their help with data acquisition. We also thank Dr B. Bontempi for insightful comments on earlier versions of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bosshardt S, 2005, CORTEX, V41, P486, DOI 10.1016/S0010-9452(08)70189-8; Burianova H, 2010, NEUROIMAGE, V49, P865, DOI 10.1016/j.neuroimage.2009.08.066; Butters N., 1986, AUTOBIOGRAPHICAL MEM, P253, DOI DOI 10.1017/CBO9780511558313.021; Cabeza R, 2002, NEUROIMAGE, V16, P317, DOI 10.1006/nimg.2002.1063; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; CERMAK LS, 1983, NEUROPSYCHOLOGIA, V21, P213, DOI 10.1016/0028-3932(83)90039-8; Ciaramelli E, 2008, NEUROPSYCHOLOGIA, V46, P1828, DOI 10.1016/j.neuropsychologia.2008.03.022; Cipolotti L, 2001, NEUROPSYCHOLOGIA, V39, P151, DOI 10.1016/S0028-3932(00)00103-2; Daselaar SM, 2006, J NEUROPHYSIOL, V96, P1902, DOI 10.1152/jn.01029.2005; Dolcos F, 2005, P NATL ACAD SCI USA, V102, P2626, DOI 10.1073/pnas.0409848102; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Eustache F, 2004, BRAIN, V127, P1549, DOI 10.1093/brain/awh166; Eustache F, 2008, NEUROPSYCHOL REV, V18, P53, DOI 10.1007/s11065-008-9052-3; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; FLETCHER PC, 1995, NEUROIMAGE, V2, P195, DOI 10.1006/nimg.1995.1025; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Friston K. J., 2003, HUMAN BRAIN FUNCTION, P599; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; Gardiner JM, 1998, CONSCIOUS COGN, V7, P1, DOI 10.1006/ccog.1997.0321; Gilboa A, 2004, CEREB CORTEX, V14, P1214, DOI 10.1093/cercor/bhh082; La Joie R, 2010, NEUROIMAGE, V53, P506, DOI 10.1016/j.neuroimage.2010.06.024; Lang P. J., 1999, INT AFFECTIVE PICTUR; Lepage M, 1998, HIPPOCAMPUS, V8, P313, DOI 10.1002/(SICI)1098-1063(1998)8:4<313::AID-HIPO1>3.0.CO;2-I; Maguire EA, 2003, J NEUROSCI, V23, P5302; Malykhin NV, 2007, PSYCHIAT RES-NEUROIM, V155, P155, DOI 10.1016/j.pscychresns.2006.11.011; Mangels JA, 1996, NEUROPSYCHOLOGY, V10, P32, DOI 10.1037/0894-4105.10.1.32; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Montaldi D, 2006, HIPPOCAMPUS, V16, P504, DOI 10.1002/hipo.20178; MOSCOVITCH M, 1992, J COGNITIVE NEUROSCI, V4, P257, DOI 10.1162/jocn.1992.4.3.257; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nieuwenhuis ILC, 2011, BEHAV BRAIN RES, V218, P325, DOI 10.1016/j.bbr.2010.12.009; PENNY WD, 2003, HUMAN BRAIN FUNCTION, P843; Petrides M, 2002, NEUROBIOL LEARN MEM, V78, P528, DOI 10.1006/nlme.2002.4107; Piolino P, 2004, NEUROIMAGE, V22, P1371, DOI 10.1016/j.neuroimage.2004.02.025; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Rekkas PV, 2005, J COGNITIVE NEUROSCI, V17, P1950, DOI 10.1162/089892905775008652; Ryan L, 2001, HIPPOCAMPUS, V11, P707, DOI 10.1002/hipo.1086; Shtyrov Y, 2010, J NEUROSCI, V30, P16864, DOI 10.1523/JNEUROSCI.1376-10.2010; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Soderlund H, 2012, HIPPOCAMPUS, V22, P670, DOI 10.1002/hipo.20927; Spaniol J, 2009, NEUROPSYCHOLOGIA, V47, P1765, DOI 10.1016/j.neuropsychologia.2009.02.028; Squire L. R., 2000, MEMORY MIND MOL; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Sterpenich V, 2007, PLOS BIOL, V5, P2709, DOI 10.1371/journal.pbio.0050282; Sterpenich V, 2009, J NEUROSCI, V29, P5143, DOI 10.1523/JNEUROSCI.0561-09.2009; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Tse D, 2011, SCIENCE, V333, P891, DOI 10.1126/science.1205274; TULVING E, 1985, AM PSYCHOL, V40, P385, DOI 10.1037/0003-066x.40.4.385; Viard A, 2007, CEREB CORTEX, V17, P2453, DOI 10.1093/cercor/bhl153; Villain N, 2010, J NEUROIMAGING, V20, P324, DOI 10.1111/j.1552-6569.2010.00470.x; Viskontas IV, 2009, HIPPOCAMPUS, V19, P265, DOI 10.1002/hipo.20503; Viskontas IV, 2000, J NEUROSCI, V20, P5853, DOI 10.1523/JNEUROSCI.20-15-05853.2000; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Wais PE, 2008, J COGNITIVE NEUROSCI, V20, P400, DOI 10.1162/jocn.2008.20041; Wheeler ME, 2004, NEUROIMAGE, V21, P1337, DOI 10.1016/j.neuroimage.2003.11.001; Winocur G., 2011, J INT NEUROPSYCH SOC, V17, P1, DOI DOI 10.1017/; Winocur G, 2010, NEUROPSYCHOLOGIA, V48, P2339, DOI 10.1016/j.neuropsychologia.2010.04.016; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005	63	36	37	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43495	10.1371/journal.pone.0043495	http://dx.doi.org/10.1371/journal.pone.0043495			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998GM	22937055	Green Published, gold			2022-12-25	WOS:000308225500056
J	Lamana, A; Balsa, A; Rueda, B; Ortiz, AM; Nuno, L; Miranda-Carus, ME; Gonzalez-Escribano, MF; Lopez-Nevot, MA; Pascual-Salcedo, D; Martin, J; Gonzalez-Alvaro, I				Lamana, Amalia; Balsa, Alejandro; Rueda, Blanca; Ortiz, Ana M.; Nuno, Laura; Eugenia Miranda-Carus, Maria; Gonzalez-Escribano, Maria F.; Lopez-Nevot, Miguel A.; Pascual-Salcedo, Dora; Martin, Javier; Gonzalez-Alvaro, Isidoro			The TT Genotype of the STAT4 rs7574865 Polymorphism Is Associated with High Disease Activity and Disability in Patients with Early Arthritis	PLOS ONE			English	Article							EARLY RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASE; HLA-DRB1; PTPN22; PROGRESSION; GENETICS	Background: The number of copies of the HLA-DRB1 shared epitope, and the minor alleles of the STAT4 rs7574865 and the PTPN22 rs2476601 polymorphisms have all been linked with an increased risk of developing rheumatoid arthritis. In the present study, we investigated the effects of these genetic variants on disease activity and disability in patients with early arthritis. Methodology and Results: We studied 640 patients with early arthritis (76% women; median age, 52 years), recording disease-related variables every 6 months during a 2-year follow-up. HLA-DRB1 alleles were determined by PCR-SSO, while rs7574865 and rs2476601 were genotyped with the Taqman 5' allelic discrimination assay. Multivariate analysis was performed using generalized estimating equations for repeated measures. After adjusting for confounding variables such as gender, age and ACPA, the TT genotype of rs7574865 in STAT4 was associated with increased disease activity (DAS28) as compared with the GG genotype (beta coefficient [95% confidence interval] = 0.42 [0.01-0.83], p = 0.044). Conversely, the presence of the T allele of rs2476601 in PTPN22 was associated with diminished disease activity during follow-up in a dose-dependent manner (CT genotype = 20.27 [-0.56- -0.01], p = 0.042; TT genotype = -0.68 [-1.64- -0.27], p = 0.162). After adjustment for gender, age and disease activity, homozygosity for the T allele of rs7574865 in STAT4 was associated with greater disability as compared with the GG genotype. Conclusions: Our data suggest that patients with early arthritis who are homozygous for the T allele of rs7574865 in STAT4 may develop a more severe form of the disease with increased disease activity and disability.	[Lamana, Amalia; Ortiz, Ana M.; Gonzalez-Alvaro, Isidoro] Hosp Univ La Princesa, Rheumatol Serv, Inst Invest Sanitaria Princesa, Madrid, Spain; [Balsa, Alejandro; Nuno, Laura; Eugenia Miranda-Carus, Maria] Hosp Univ La Paz, Rheumatol Serv, Inst Invest Sanitaria La Paz, Madrid, Spain; [Rueda, Blanca] Univ Granada, Fac Ciencias Salud, Dept Enfermeria, Granada, Spain; [Gonzalez-Escribano, Maria F.] Hosp Univ Virgen del Rocio, Serv Immunol, Seville, Spain; [Lopez-Nevot, Miguel A.] Hosp Univ Virgen de las Nieves, Serv Immunol, Granada, Spain; [Pascual-Salcedo, Dora] Hosp Univ La Paz, Serv Immunol, IdiPaz, Inst Invest Sanitaria La Paz, Madrid, Spain; [Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain	Hospital Universitario La Paz; University of Granada; Virgen del Rocio University Hospital; Hospital Universitario Virgen de las Nieves; Hospital Universitario La Paz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Lamana, A (corresponding author), Hosp Univ La Princesa, Rheumatol Serv, Inst Invest Sanitaria Princesa, Madrid, Spain.	isidoro.ga@ser.es	Martín, Javier/AAV-5209-2021; Martin, Javier/B-8141-2008; Rueda-Medina, Blanca/F-3156-2019; Martín, María/HDL-9512-2022; González-Escribano, María Francisca/X-5554-2019; Miranda-Carus, Maria-Eugenia/S-7403-2019; LAMANA, AMALIA/I-6971-2017; Balsa, Alejandro/ABF-6456-2020	Martin, Javier/0000-0002-2202-0622; Rueda-Medina, Blanca/0000-0002-0263-7000; LAMANA, AMALIA/0000-0001-8779-5034; Lopez Nevot, Miguel Angel/0000-0002-3465-6062	RETICS (Redes Tematicas de Investigacion Cooperativa, Cooperative Research Thematic Networks) [RD08/0075 (RIER)]; FIS (Fondo de Investigacion en Salud) Health Research Fund from Instituto de Salud Carlos III (ISCIII) [FIS 08/0754]; European Innovative Medicines Initiative; BTCure Program; National Health Care System (Instituto Carlos III), Madrid, Spain; Roche; UCB; Bristol-Myers Squibb; Abbott Laboratories	RETICS (Redes Tematicas de Investigacion Cooperativa, Cooperative Research Thematic Networks); FIS (Fondo de Investigacion en Salud) Health Research Fund from Instituto de Salud Carlos III (ISCIII); European Innovative Medicines Initiative; BTCure Program; National Health Care System (Instituto Carlos III), Madrid, Spain(Instituto de Salud Carlos III); Roche(Roche Holding); UCB(UCB Pharma SA); Bristol-Myers Squibb(Bristol-Myers Squibb); Abbott Laboratories(Abbott Laboratories)	This work was partially supported by the RETICS (Redes Tematicas de Investigacion Cooperativa, Cooperative Research Thematic Networks) Program, RD08/0075 (RIER) and FIS (Fondo de Investigacion en Salud) Health Research Fund grant FIS 08/0754 to IG-A from Instituto de Salud Carlos III (ISCIII; www.isciii.es) and by grants from the European Innovative Medicines Initiative and BTCure Program (http://www.life-sciences-europe.com/organisation/btcure-project-imiefpia-201103-innovative-medicines-initiative-2001-28657.html). The work of IG-A was in part supported by a Research Intensification Grant from the National Health Care System (Instituto Carlos III; www.isciii.es), Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and some authors have the following conflicts: Unrestricted research grants have been provided by Roche, UCB and Bristol-Myers Squibb to IG-A; and by Abbott Laboratories and Roche to LN. All these research projects have no relation with the present study. AB holds an advisory board membership with Pfizer and UCB. The following authors hold Honoraria for speaking: IG-A (Spanish Society of Rheumatology (SER), Rheumatology Society of Madrid (SORCOM), Roche, Abbott Laboratories and Bristol-Myers Squibb); AB (Roche, Schering-Plough, Wyeth, Abbott, BMS, Janssen and UCB); AMO (Spanish Society of Rheumatology (SER), Laboratorios Esteve, Abbott Laboratories and MSD); JM (Spanish Society of Rheumatology (SER)); and LN (Abbott Laboratories). The remaining authors have declared that no competing interests exist. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online on the guide for authors.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Burn GL, 2011, FEBS LETT, V585, P3689, DOI 10.1016/j.febslet.2011.04.032; de Vries-Bouwstra JK, 2008, ARTHRITIS RHEUM-US, V58, P1293, DOI 10.1002/art.23439; ESTEVEVIVES J, 1993, J RHEUMATOL, V20, P2116; Gonzalez-Gay MA, 2007, ARTHRIT RHEUM-ARTHR, V57, P125, DOI 10.1002/art.22482; Goronzy JJ, 2004, ARTHRITIS RHEUM-US, V50, P43, DOI 10.1002/art.11445; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; Kariuki SN, 2009, J IMMUNOL, V182, P34, DOI 10.4049/jimmunol.182.1.34; Korman BD, 2008, CURR ALLERGY ASTHM R, V8, P398, DOI 10.1007/s11882-008-0077-8; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Marinou I, 2010, ANN RHEUM DIS, V69, P476, DOI 10.1136/ard.2009.117721; Morgan AW, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2969; Orozco G, 2005, ARTHRITIS RHEUM-US, V52, P219, DOI 10.1002/art.20771; Orozco G, 2006, BIOMED PHARMACOTHER, V60, P656, DOI 10.1016/j.biopha.2006.09.003; Orozco G, 2008, ARTHRITIS RHEUM-US, V58, P1974, DOI 10.1002/art.23549; Pan W, 2001, BIOMETRICS, V57, P529, DOI 10.1111/j.0006-341X.2001.00529.x; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Scott DL, 1996, BRIT J RHEUMATOL, V35, P14; Taylor KE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000084; WEYAND CM, 1992, J CLIN INVEST, V89, P2033, DOI 10.1172/JCI115814	20	13	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43661	10.1371/journal.pone.0043661	http://dx.doi.org/10.1371/journal.pone.0043661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937072	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500074
J	Lin, XM; Ding, K; Liu, Y; Yan, XH; Song, SJ; Jiang, TZ				Lin, Xiaoming; Ding, Kun; Liu, Yong; Yan, Xiaohe; Song, Shaojie; Jiang, Tianzi			Altered Spontaneous Activity in Anisometropic Amblyopia Subjects: Revealed by Resting-State fMRI	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; DIFFUSION TENSOR TRACTOGRAPHY; POSITRON-EMISSION-TOMOGRAPHY; REGIONAL HOMOGENEITY CHANGES; LATERAL GENICULATE-NUCLEUS; VERGENCE EYE-MOVEMENTS; ABNORMAL VISUAL-CORTEX; FUNCTIONAL CONNECTIVITY; EARLY BLINDNESS; BRAIN ACTIVITY	Amblyopia, also known as lazy eye, usually occurs during early childhood and results in poor or blurred vision. Recent neuroimaging studies have found cortical structural/functional abnormalities in amblyopia. However, until now, it was still not known whether the spontaneous activity of the brain changes in amblyopia subjects. In the present study, regional homogeneity (ReHo), a measure of the homogeneity of functional magnetic resonance imaging signals, was used for the first time to investigate changes in resting-state local spontaneous brain activity in individuals with anisometropic amblyopia. Compared with age-and gender-matched subjects with normal vision, the anisometropic amblyopia subjects showed decreased ReHo of spontaneous brain activity in the right precuneus, the left medial prefrontal cortex, the left inferior frontal gyrus, and the left cerebellum, and increased ReHo of spontaneous brain activity was found in the bilateral conjunction area of the postcentral and precentral gyri, the left paracentral lobule, the left superior temporal gyrus, the left fusiform gyrus, the conjunction area of the right insula, putamen and the right middle occipital gyrus. The observed decreases in ReHo may reflect decreased visuo-motor processing ability, and the increases in ReHo in the somatosensory cortices, the motor areas and the auditory area may indicate compensatory plasticity in amblyopia.	[Lin, Xiaoming; Ding, Kun; Yan, Xiaohe; Song, Shaojie] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Yong; Jiang, Tianzi] Chinese Acad Sci, Inst Automat, LIAMA Ctr Computat Med, Natl Lab Pattern Recognit, Beijing, Peoples R China; [Jiang, Tianzi] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Peoples R China; [Jiang, Tianzi] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	Sun Yat Sen University; Chinese Academy of Sciences; Institute of Automation, CAS; University of Electronic Science & Technology of China; University of Queensland	Lin, XM (corresponding author), Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China.	linxiaom@mail.sysu.edu.cn; yliu@nlpr.ia.ac.cn; jiangtz@nlpr.ia.ac.cn	Liu, Yong/F-2682-2011; Jiang, Tianzi/I-4256-2012	Liu, Yong/0000-0002-1862-3121; Jiang, Tianzi/0000-0001-9531-291X; lin, xiao ming/0000-0001-7161-1085	Natural Science Foundation of China [30900476, 30870694, 60831004]; Research Foundation of Science and Technology Plan Project, Guangdong, China [2008B060600031, 2011B061300067]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation of Science and Technology Plan Project, Guangdong, China	This work was supported by the Natural Science Foundation of China (Grant Numbers. 30900476, 30870694 and 60831004), and the Research Foundation of Science and Technology Plan Project, Guangdong, China (Grant Numbers: 2008B060600031, 2011B061300067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Anderson SJ, 2006, STRABISMUS, V14, P21, DOI 10.1080/09273970500538082; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Avillac M, 2005, NAT NEUROSCI, V8, P941, DOI 10.1038/nn1480; Barnes GR, 2010, INVEST OPHTH VIS SCI, V51, P1432, DOI 10.1167/iovs.09-3931; Barnes GR, 2001, J PHYSIOL-LONDON, V533, P281, DOI 10.1111/j.1469-7793.2001.0281b.x; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Burton H, 2004, HUM BRAIN MAPP, V23, P210, DOI 10.1002/hbm.20064; Chen SHA, 2005, NEUROIMAGE, V24, P332, DOI 10.1016/j.neuroimage.2004.08.032; Choi MY, 2002, J PEDIAT OPHTH STRAB, V39, P11, DOI 10.3928/0191-3913-20020101-05; Conner IP, 2007, J PHYSIOL-LONDON, V583, P159, DOI 10.1113/jphysiol.2007.136242; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; Demer J L, 1997, J AAPOS, V1, P158, DOI 10.1016/S1091-8531(97)90059-8; Fadiga L, 2006, CORTEX, V42, P486, DOI 10.1016/S0010-9452(08)70383-6; Fiehler K, 2010, RESTOR NEUROL NEUROS, V28, P193, DOI 10.3233/RNN-2010-0500; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gamlin PDR, 1996, EYE, V10, P167, DOI 10.1038/eye.1996.42; Goodyear BG, 2000, J NEUROPHYSIOL, V84, P1907, DOI 10.1152/jn.2000.84.4.1907; Grant S, 2007, INVEST OPHTH VIS SCI, V48, P1139, DOI 10.1167/iovs.06-0976; Hadjidimitrakis K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023335; HASHIMOTO M, 1995, BRAIN, V118, P1185, DOI 10.1093/brain/118.5.1185; Hayakawa Y, 2002, OPHTHALMOLOGICA, V216, P399, DOI 10.1159/000067551; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hess RF, 2010, HUM BRAIN MAPP, V31, P1233, DOI 10.1002/hbm.20931; Hess RF, 2009, EUR J NEUROSCI, V29, P1064, DOI 10.1111/j.1460-9568.2009.06650.x; Holmes JM, 2006, LANCET, V367, P1343, DOI 10.1016/S0140-6736(06)68581-4; Information from your family doctor, 2007, AM FAMILY PHYS, V75, P368; Jiang TZ, 2008, BRAIN IMAGING BEHAV, V2, P249, DOI 10.1007/s11682-008-9038-z; JUNCK L, 1988, J CEREBR BLOOD F MET, V8, P774, DOI 10.1038/jcbfm.1988.132; Kanonidou Evgenia, 2011, International Ophthalmology, V31, P249, DOI 10.1007/s10792-011-9434-z; Kelly RM, 2003, J NEUROSCI, V23, P8432; Kiviniemi V, 2008, HUM BRAIN MAPP, V29, P810, DOI 10.1002/hbm.20582; Krauzlis RJ, 2005, NEUROSCIENTIST, V11, P124, DOI 10.1177/1073858404271196; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Liang PP, 2011, CLIN NEUROPHYSIOL, V122, P121, DOI 10.1016/j.clinph.2010.05.026; Liu C, 2011, NEUROREPORT, V22, P190, DOI 10.1097/WNR.0b013e3283447c09; Liu Y, 2008, NEUROPSYCHOLOGIA, V46, P1648, DOI 10.1016/j.neuropsychologia.2008.01.027; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Liu Y, 2007, BRAIN, V130, P2085, DOI 10.1093/brain/awm121; Lv B, 2008, NEUROSCI LETT, V437, P5, DOI 10.1016/j.neulet.2008.03.071; Mankinen K, 2011, BRAIN RES, V1373, P221, DOI 10.1016/j.brainres.2010.12.004; MARPLEHORVAT DE, 1990, J PHYSIOL-LONDON, V428, P595, DOI 10.1113/jphysiol.1990.sp018230; McKee SP, 2003, J VISION, V3, P380, DOI 10.1167/3.5.5; Mendola JD, 2005, HUM BRAIN MAPP, V25, P222, DOI 10.1002/hbm.20109; Middleton FA, 2001, J NEUROSCI, V21, P700, DOI 10.1523/JNEUROSCI.21-02-00700.2001; Miki A, 2003, OPHTHALMOLOGICA, V217, P365, DOI 10.1159/000071353; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; Monti MM, 2007, NEUROIMAGE, V37, P1005, DOI 10.1016/j.neuroimage.2007.04.069; Mutschler I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000259; Negyessy L, 2006, EUR J NEUROSCI, V23, P1919, DOI 10.1111/j.1460-9568.2006.04678.x; Niechwiej-Szwedo E, 2011, INVEST OPHTH VIS SCI, V52, P5853, DOI 10.1167/iovs.11-7314; Nitta T, 2008, CEREB CORTEX, V18, P1042, DOI 10.1093/cercor/bhm143; Ohtsuka K, 1998, BRAIN, V121, P429, DOI 10.1093/brain/121.3.429; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; Sathian K, 2001, OPTOMETRY VISION SCI, V78, P276, DOI 10.1097/00006324-200105000-00010; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; Schmahmann JD, 2010, NEUROPSYCHOL REV, V20, P236, DOI 10.1007/s11065-010-9142-x; Sereno MI, 2006, NAT NEUROSCI, V9, P1337, DOI 10.1038/nn1777; Shu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007228; Shukla DK, 2010, NEUROSCI LETT, V476, P46, DOI 10.1016/j.neulet.2010.03.080; Simmers AJ, 2006, VISION RES, V46, P2571, DOI 10.1016/j.visres.2006.01.009; Simmers AJ, 2005, VISION RES, V45, P449, DOI 10.1016/j.visres.2004.08.026; Simmers AJ, 2003, VISION RES, V43, P729, DOI 10.1016/S0042-6989(02)00684-3; Straube A, 1997, ANN NEUROL, V42, P891, DOI 10.1002/ana.410420611; Suttle CM, 2011, INVEST OPHTH VIS SCI, V52, P1851, DOI 10.1167/iovs.10-6341; Takagi M, 1998, J NEUROPHYSIOL, V80, P1911, DOI 10.1152/jn.1998.80.4.1911; Thach WT, 1998, TRENDS COGN SCI, V2, P331, DOI 10.1016/S1364-6613(98)01223-6; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wang LQ, 2011, NEUROSCI LETT, V488, P275, DOI 10.1016/j.neulet.2010.11.046; Winstein CJ, 1997, J NEUROPHYSIOL, V77, P1581, DOI 10.1152/jn.1997.77.3.1581; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Xiao JX, 2007, AM J OPHTHALMOL, V143, P489, DOI 10.1016/j.ajo.2006.11.039; Yang T, 2010, NEUROREPORT, V21, P786, DOI 10.1097/WNR.0b013e32833cadf0; Yu CS, 2008, HUM BRAIN MAPP, V29, P533, DOI 10.1002/hbm.20420; Yu CS, 2007, NEUROIMAGE, V36, P411, DOI 10.1016/j.neuroimage.2007.03.003; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang ZQ, 2012, NEUROIMAGE, V59, P1429, DOI 10.1016/j.neuroimage.2011.08.049	78	37	37	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43373	10.1371/journal.pone.0043373	http://dx.doi.org/10.1371/journal.pone.0043373			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937041	Green Submitted, Green Published, gold			2022-12-25	WOS:000308225500045
J	Monestier, O; Brun, C; Cocquempot, O; Petit, D; Blanquet, V				Monestier, Olivier; Brun, Caroline; Cocquempot, Olivier; Petit, Daniel; Blanquet, Veronique			GASP/WFIKKN Proteins: Evolutionary Aspects of Their Functions	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; PROTEASE INHIBITOR; BETA SUPERFAMILY; GENOME EVOLUTION; MULTIPLE TYPES; EXPRESSION; GROWTH; GENES; WFIKKN1; DOMAIN	Growth and differentiation factor Associated Serum Protein (GASP) 1 and 2 are proteins known to be involved in the control of myostatin activity at least in vitro. Most deuterostome GASPs share a modular organization including WAP, follistatin/kazal, IGc2, two kunitz, and NTR domains. Based on an exon shuffling model, we performed independent phylogenetic analyses on these modules and assessed that papilin is probably a sister sequence to GASP with a divergence date estimated from the last common ancestor to bilateria. The final organization was acquired by the addition of the FS domain in early deuterostomes. Our study revealed that Gasp genes diverged during the first round of genome duplication in early vertebrates. By evaluating the substitution rate at different sites on the proteins, we showed a better conservation of the follistatin/kazal domain of GASP1 than GASP2 in mammals, suggesting a stronger interaction with myostatin. We also observed a progressive increase in the conservation of follistatin and kunitz domains from the ancestor of Ciona to early vertebrates. In situ hybridization performed on mouse embryos showed a weak Gasp1 expression in the formed somites at 10.5 dpc and in limb buds from embryonic E10.0 to E12.5. Similar results were obtained for zebrafish embryos. We propose a synthetic view showing possible interactions between GASP1 and myostatin and highlighting the role of the second kunitz domain in preventing myostatin proteolysis.	[Monestier, Olivier; Brun, Caroline; Cocquempot, Olivier; Petit, Daniel; Blanquet, Veronique] INRA, UMR1061, Unite Genet Mol Anim, Limoges, France; [Monestier, Olivier; Brun, Caroline; Cocquempot, Olivier; Petit, Daniel; Blanquet, Veronique] Univ Limoges, Limoges, France	INRAE; Universite de Limoges	Monestier, O (corresponding author), INRA, UMR1061, Unite Genet Mol Anim, Limoges, France.	veronique.blanquet@unilim.fr	Monestier, Olivier/AAB-2220-2020; Monestier, Olivier/E-2926-2013	Monestier, Olivier/0000-0002-3236-0807; Monestier, Olivier/0000-0002-3236-0807; Brun, Caroline/0000-0003-2824-5221	French National Institute for Agriculture Research; Limousin Regional Council	French National Institute for Agriculture Research; Limousin Regional Council	This work was supported by the French National Institute for Agriculture Research and the Limousin Regional Council (http://www.inra.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Fessler JH, 2004, INT J BIOCHEM CELL B, V36, P1079, DOI 10.1016/j.biocel.2003.12.010; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Haidet AM, 2008, P NATL ACAD SCI USA, V105, P4318, DOI 10.1073/pnas.0709144105; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; Hill JJ, 2003, MOL ENDOCRINOL, V17, P1144, DOI 10.1210/me.2002-0366; Kawaguchi M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-260; Kondas K, 2008, J BIOL CHEM, V283, P23677, DOI 10.1074/jbc.M803025200; Kondas K, 2011, BIOCHEM SOC T, V39, P1416, DOI 10.1042/BST0391416; Kramerova IA, 2000, DEVELOPMENT, V127, P5475; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Liu MY, 2004, TRENDS GENET, V20, P399, DOI 10.1016/j.tig.2004.06.013; Martin Renaud, 2009, Recent Pat DNA Gene Seq, V3, P63; Matise MP, 1997, J NEUROSCI, V17, P7805; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; Nagy A, 2003, EUR J BIOCHEM, V270, P2101, DOI 10.1046/j.1432-1033.2003.03593.x; Nakashima M, 1999, MECH DEVELOP, V80, P185, DOI 10.1016/S0925-4773(98)00205-6; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; Patthy L, 1999, GENE, V238, P103, DOI 10.1016/S0378-1119(99)00228-0; Petit D, 2006, J MOL EVOL, V63, P353, DOI 10.1007/s00239-005-0189-x; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Szlama G, 2010, FEBS J, V277, P5040, DOI 10.1111/j.1742-4658.2010.07909.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trexler M, 2002, BIOL CHEM, V383, P223, DOI 10.1515/BC.2002.023; Trexler M, 2001, P NATL ACAD SCI USA, V98, P3705, DOI 10.1073/pnas.061028398; Van Vactor D, 2006, CURR OPIN NEUROBIOL, V16, P40, DOI 10.1016/j.conb.2006.01.011; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100	40	8	8	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43710	10.1371/journal.pone.0043710	http://dx.doi.org/10.1371/journal.pone.0043710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937083	Green Published, gold			2022-12-25	WOS:000308225500085
J	Pamenter, ME; Ryu, J; Hua, ST; Perkins, GA; Mendiola, VL; Gu, XQ; Ellisman, MH; Haddad, GG				Pamenter, Matthew E.; Ryu, Julie; Hua, Serena T.; Perkins, Guy A.; Mendiola, Vincent L.; Gu, Xiang Q.; Ellisman, Mark H.; Haddad, Gabriel G.			DIDS Prevents Ischemic Membrane Degradation in Cultured Hippocampal Neurons by Inhibiting Matrix Metalloproteinase Release	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; BLOOD-BRAIN-BARRIER; CELL-DEATH; SIGNALING PATHWAY; ARTERY OCCLUSION; RAT; INFLAMMATION; STROKE; REPERFUSION; DISRUPTION	During stroke, cells in the infarct core exhibit rapid failure of their permeability barriers, which releases ions and inflammatory molecules that are deleterious to nearby tissue (the penumbra). Plasma membrane degradation is key to penumbral spread and is mediated by matrix metalloproteinases (MMPs), which are released via vesicular exocytosis into the extracellular fluid in response to stress. DIDS (4,4'-diisothiocyanatostilbene-2,2'-disulphonic acid) preserves membrane integrity in neurons challenged with an in vitro ischemic penumbral mimic (ischemic solution: IS) and we asked whether this action was mediated via inhibition of MMP activity. In cultured murine hippocampal neurons challenged with IS, intracellular proMMP-2 and -9 expression increased 4-10 fold and extracellular latent and active MMP isoform expression increased 2-22 fold. MMP-mediated extracellular gelatinolytic activity increased similar to 20-50 fold, causing detachment of 32.1+/-4.5% of cells from the matrix and extensive plasma membrane degradation (>60% of cells took up vital dyes and >60% of plasma membranes were fragmented or blebbed). DIDS abolished cellular detachment and membrane degradation in neurons and the pathology-induced extracellular expression of latent and active MMPs. DIDS similarly inhibited extracellular MMP expression and cellular detachment induced by the pro-apoptotic agent staurosporine or the general proteinase agonist 4-aminophenylmercuric acetate (APMA). Conversely, DIDS-treatment did not impair stress-induced intracellular proMMP production, nor the intracellular cleavage of proMMP-2 to the active form, suggesting DIDS interferes with the vesicular extrusion of MMPs rather than directly inhibiting proteinase expression or activation. In support of this hypothesis, an antagonist of the V-type vesicular ATPase also inhibited extracellular MMP expression to a similar degree as DIDS. In addition, in a proteinase-independent model of vesicular exocytosis, DIDS prevented stimulus-evoked release of von Willebrand Factor from human umbilical vein endothelial cells. We conclude that DIDS inhibits MMP exocytosis and through this mechanism preserves neuronal membrane integrity during pathological stress.	[Pamenter, Matthew E.; Ryu, Julie; Hua, Serena T.; Gu, Xiang Q.; Haddad, Gabriel G.] Univ Calif San Diego, Dept Pediat, Div Resp Med, La Jolla, CA 92093 USA; [Perkins, Guy A.; Mendiola, Vincent L.; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Perkins, Guy A.; Mendiola, Vincent L.; Ellisman, Mark H.] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Ellisman, Mark H.; Haddad, Gabriel G.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Haddad, Gabriel G.] Rady Childrens Hosp San Diego, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Pamenter, ME (corresponding author), Univ Calif San Diego, Dept Pediat, Div Resp Med, La Jolla, CA 92093 USA.	mpamenter@ucsd.edu	Pamenter, Matt/R-9216-2019	Pamenter, Matt/0000-0003-4035-9555; Mendiola, Vincent Louie/0000-0001-5287-0743; Perkins, Guy/0000-0002-1834-6646	NIH [5P01HD032573, P41-RR004050, P30-CA23100, P30 NS047101]; Natural Science and Engineering Research Council of Canada PDF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD032573] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science and Engineering Research Council of Canada PDF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants 5P01HD032573 to GGH, P41-RR004050 and P30-CA23100 to MHE, and P30 NS047101 to the UCSD Neurosciences Microscopy Shared Facility; and a Natural Science and Engineering Research Council of Canada PDF to MEP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Amantea D, 2008, NEUROSCIENCE, V152, P8, DOI 10.1016/j.neuroscience.2007.12.030; Amantea D, 2007, INT REV NEUROBIOL, V82, P149, DOI 10.1016/S0074-7742(07)82008-3; Anderson RE, 1999, STROKE, V30, P160, DOI 10.1161/01.STR.30.1.160; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Benchoua A, 2001, J NEUROSCI, V21, P7127, DOI 10.1523/JNEUROSCI.21-18-07127.2001; BRANSTON NM, 1974, EXP NEUROL, V45, P195, DOI 10.1016/0014-4886(74)90112-5; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Cavelier P, 2005, J PHYSIOL-LONDON, V564, P397, DOI 10.1113/jphysiol.2004.082131; del Zoppo GJ, 2010, ANN NY ACAD SCI, V1207, P46, DOI 10.1111/j.1749-6632.2010.05760.x; Delcarlo M, 2006, AM J PHYSIOL-CELL PH, V290, pC802, DOI 10.1152/ajpcell.00214.2005; Dong WP, 2008, J VASC SURG, V48, P709, DOI 10.1016/j.jvs.2008.04.007; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fujimoto M, 2008, J CEREBR BLOOD F MET, V28, P1674, DOI 10.1038/jcbfm.2008.59; Fukuda S, 2004, STROKE, V35, P998, DOI 10.1161/01.STR.0000119383.76447.05; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Gao DK, 2006, LIFE SCI, V78, P2564, DOI 10.1016/j.lfs.2005.10.030; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Gursoy-Ozdemir Y, 2004, J CLIN INVEST, V113, P1447, DOI 10.1172/JCI200421227; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Ju WK, 2009, MOL VIS, V15, P120; Kulisz A, 2002, AM J PHYSIOL-LUNG C, V282, pL1324, DOI 10.1152/ajplung.00326.2001; Lee SR, 2004, J NEUROSCI, V24, P671, DOI 10.1523/JNEUROSCI.4243-03.2004; Leppert D, 2001, BRAIN RES REV, V36, P249, DOI 10.1016/S0165-0173(01)00101-1; Liu AH, 2008, CELL PHYSIOL BIOCHEM, V22, P177, DOI 10.1159/000149795; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; McColl BW, 2008, J NEUROSCI, V28, P9451, DOI 10.1523/JNEUROSCI.2674-08.2008; MORIMOTO BH, 1990, NEURON, V5, P875, DOI 10.1016/0896-6273(90)90347-I; Mun-Bryce S, 1998, AM J PHYSIOL-REG I, V274, pR1203, DOI 10.1152/ajpregu.1998.274.5.R1203; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; OLSEN TS, 1983, STROKE, V14, P332, DOI 10.1161/01.STR.14.3.332; Pamenter ME, 2012, BRAIN RES, V1452, P165, DOI 10.1016/j.brainres.2012.03.004; Pan XY, 2006, BRIT J HAEMATOL, V134, P491, DOI 10.1111/j.1365-2141.2006.06224.x; Ramasamy R, 2001, CARDIOVASC RES, V51, P275, DOI 10.1016/S0008-6363(01)00301-7; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; SPORN LA, 1986, CELL, V46, P185, DOI 10.1016/0092-8674(86)90735-X; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Wang XM, 2005, CELL PHYSIOL BIOCHEM, V16, P147, DOI 10.1159/000089840; Xia ZL, 2003, NEUROSCI LETT, V340, P53, DOI 10.1016/S0304-3940(03)00075-2; Xue J, 2008, AM J PHYSIOL-REG I, V294, pR451, DOI 10.1152/ajpregu.00528.2007; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yao H, 2008, J NEUROCHEM; Yao H, 2007, J NEUROCHEM, V100, P1224, DOI 10.1111/j.1471-4159.2006.04299.x; Yao H, 2009, J NEUROCHEM, V108, P835, DOI 10.1111/j.1471-4159.2008.05838.x; Zalk R, 2006, FEBS LETT, V580, P5894, DOI 10.1016/j.febslet.2006.09.055; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003	49	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43995	10.1371/journal.pone.0043995	http://dx.doi.org/10.1371/journal.pone.0043995			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937143	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500134
J	Tsou, WL; Sheedlo, MJ; Morrow, ME; Blount, JR; McGregor, KM; Das, C; Todi, SV				Tsou, Wei-Ling; Sheedlo, Michael J.; Morrow, Marie E.; Blount, Jessica R.; McGregor, Kelly M.; Das, Chittaranjan; Todi, Sokol V.			Systematic Analysis of the Physiological Importance of Deubiquitinating Enzymes	PLOS ONE			English	Article							NF-KAPPA-B; UBIQUITIN-SPECIFIC PROTEASE; NONMUSCLE MYOSIN-II; VIRUS TYPE-1 TAX; DROSOPHILA OOGENESIS; EMERGING ROLES; ATAXIA MICE; FAT-FACETS; CELL-DEATH; GENE	Deubiquitinating enzymes (DUBs) are proteases that control the post-translational modification of proteins by ubiquitin and in turn regulate diverse cellular pathways. Despite a growing understanding of DUB biology at the structural and molecular level, little is known about the physiological importance of most DUBs. Here, we systematically identify DUBs encoded by the genome of Drosophila melanogaster and examine their physiological importance in vivo. Through domain analyses we uncovered 41 Drosophila DUBs, most of which have human orthologues. Systematic knockdown of the vast majority of DUBs throughout the fly or in specific cell types had dramatic consequences for Drosophila development, adult motility or longevity. Specific DUB subclasses proved to be particularly necessary during development, while others were important in adults. Several DUBs were indispensable in neurons or glial cells during developmental stages; knockdown of others perturbed the homeostasis of ubiquitinated proteins in adult flies, or had adverse effects on wing positioning as a result of neuronal requirements. We demonstrate the physiological significance of the DUB family of enzymes in intact animals, find that there is little functional redundancy among members of this family of proteases, and provide insight for future investigations to understand DUB biology at the molecular, cellular and organismal levels.	[Tsou, Wei-Ling; Blount, Jessica R.; McGregor, Kelly M.; Todi, Sokol V.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Tsou, Wei-Ling; Blount, Jessica R.; Todi, Sokol V.] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; [Sheedlo, Michael J.; Morrow, Marie E.; Das, Chittaranjan] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Wayne State University; Wayne State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Tsou, WL (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA.	stodi@med.wayne.edu	Das, Chittaranjan/AAM-1686-2020; Tsou, Wei-Ling/AAI-2655-2021	Tsou, Wei-Ling/0000-0001-9136-2581	National Institutes of Health [R00NS064097, 1R01RR026273]; National Ataxia Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR026273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS064097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Ataxia Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant R00NS064097 to SVT, 1R01RR026273 to CD and a Young Investigator Award to SVT from the National Ataxia Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAND AH, 1993, DEVELOPMENT, V118, P401; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chen PC, 2009, J NEUROSCI, V29, P10909, DOI 10.1523/JNEUROSCI.2635-09.2009; Clague MJ, 2012, J CELL SCI, V125, P277, DOI 10.1242/jcs.090985; Crimmins S, 2006, J NEUROSCI, V26, P11423, DOI 10.1523/JNEUROSCI.3600-06.2006; Fischer JA, 2002, BIOESSAYS, V24, P13, DOI 10.1002/bies.10030; FISCHERVIZE JA, 1992, DEVELOPMENT, V116, P985; Franke JD, 2005, CURR BIOL, V15, P2208, DOI 10.1016/j.cub.2005.11.064; Franke JD, 2010, DEV BIOL, V345, P117, DOI 10.1016/j.ydbio.2010.06.028; Goodrich JS, 2004, DEVELOPMENT, V131, P1949, DOI 10.1242/dev.01078; KING RC, 1988, BIOESSAYS, V8, P18, DOI 10.1002/bies.950080106; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Krzystanek K, 2012, HEART RHYTHM, V9, P440, DOI 10.1016/j.hrthm.2011.10.026; Lappe-Siefke C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000631; Lavorgna A, 2012, J VIROL, V86, P3357, DOI 10.1128/JVI.06456-11; Liu S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001237; Lui TTH, 2011, MOL CELL BIOL, V31, P2053, DOI 10.1128/MCB.01094-10; Luna-Vargas MPA, 2011, EMBO REP, V12, P365, DOI 10.1038/embor.2011.33; Mahul-Mellier AL, 2012, CELL DEATH DIFFER, V19, P891, DOI 10.1038/cdd.2011.185; Metzig M, 2011, INT J CANCER, V129, P607, DOI 10.1002/ijc.26124; Moffat J, 2006, NAT REV MOL CELL BIO, V7, P177, DOI 10.1038/nrm1860; Mukai A, 2010, EMBO J, V29, P2114, DOI 10.1038/emboj.2010.100; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Nongthomba U, 1999, GENETICS, V153, P261; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; Scaglione KM, 2011, MOL CELL, V43, P599, DOI 10.1016/j.molcel.2011.05.036; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Skaug B, 2011, MOL CELL, V44, P559, DOI 10.1016/j.molcel.2011.09.015; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; STEINHAUER WR, 1989, MOL CELL BIOL, V9, P5726, DOI 10.1128/MCB.9.12.5726; Sun XX, 2012, EMBO J, V31, P576, DOI 10.1038/emboj.2011.434; Thevenon D, 2009, CELL HOST MICROBE, V6, P309, DOI 10.1016/j.chom.2009.09.007; Todi SV, 2011, TRENDS NEUROSCI, V34, P370, DOI 10.1016/j.tins.2011.05.004; Todi SV, 2009, EMBO J, V28, P372, DOI 10.1038/emboj.2008.289; Todi SV, 2005, CURR BIOL, V15, P862, DOI 10.1016/j.cub.2005.03.050; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wilson SM, 2002, NAT GENET, V32, P420, DOI 10.1038/ng1006; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200; Xue L, 2007, DEV CELL, V13, P446, DOI 10.1016/j.devcel.2007.07.012; Yasunaga J, 2011, J VIROL, V85, P6212, DOI 10.1128/JVI.00079-11; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4	45	51	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43112	10.1371/journal.pone.0043112	http://dx.doi.org/10.1371/journal.pone.0043112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937016	gold, Green Published			2022-12-25	WOS:000308225500030
J	Venet, S; Ravn, U; Buatois, V; Gueneau, F; Calloud, S; Kosco-Vilbois, M; Fischer, N				Venet, Sophie; Ravn, Ulla; Buatois, Vanessa; Gueneau, Franck; Calloud, Sebastien; Kosco-Vilbois, Marie; Fischer, Nicolas			Transferring the Characteristics of Naturally Occurring and Biased Antibody Repertoires to Human Antibody Libraries by Trapping CDRH3 Sequences	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; PHAGE DISPLAY APPROACH; V-GENE LIBRARIES; COMBINATORIAL LIBRARIES; CRYSTAL-STRUCTURE; IMMUNE-RESPONSE; SELECTION; CONSTRUCTION; REGIONS; LENGTH	Antibody repertoires are characterized by diversity as they vary not only amongst individuals and post antigen exposure but also differ significantly between vertebrate species. Such plasticity can be exploited to generate human antibody libraries featuring hallmarks of these diverse repertoires. In this study, the focus was to capture CDRH3 sequences, as this region generally accounts for most of the interaction energy with antigen. Sequences from human as well as non-human sources were successfully integrated into human antibody libraries. Next generation sequencing of these libraries proved that the CDRH3 lengths and amino acid composition corresponded to the species of origin. Specific CDRH3 sequences, biased towards the recognition of a model antigen either by immunizing mice or by selecting with phage display, were then integrated into another set of libraries. From these antigen biased libraries, highly potent antibodies were more frequently isolated, indicating that the characteristics of an immune repertoire is transferrable via CDRH3 sequences into a human antibody library. Taken together, these data demonstrate that the properties of naturally or experimentally biased repertoires can be effectively harnessed for the generation of targeted human antibody libraries, substantially increasing the probability of isolating antibodies suitable for therapeutic and diagnostic applications.	[Venet, Sophie; Ravn, Ulla; Buatois, Vanessa; Gueneau, Franck; Calloud, Sebastien; Kosco-Vilbois, Marie; Fischer, Nicolas] NovImmune SA, Geneva, Switzerland	NovImmune SA	Venet, S (corresponding author), NovImmune SA, Geneva, Switzerland.	nfischer@novimmune.com						Ackerman ME, 2011, PROTEIN ENG DES SEL, V24, P845, DOI 10.1093/protein/gzr046; Amersdorfer P, 1997, INFECT IMMUN, V65, P3743, DOI 10.1128/IAI.65.9.3743-3752.1997; Amersdorfer P, 2002, VACCINE, V20, P1640, DOI 10.1016/S0264-410X(01)00482-0; BARBAS CF, 1995, NAT MED, V1, P837, DOI 10.1038/nm0895-837; BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P4457, DOI 10.1073/pnas.89.10.4457; BARBAS CF, 1991, P NATL ACAD SCI USA, V88, P7978, DOI 10.1073/pnas.88.18.7978; Barrios Y, JMR, V17, P332; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; Chassagne S, 2004, MOL IMMUNOL, V41, P539, DOI 10.1016/j.molimm.2004.03.040; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; DEKRUIF J, 1995, J MOL BIOL, V248, P97, DOI 10.1006/jmbi.1995.0204; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Fisch I, 1996, P NATL ACAD SCI USA, V93, P7761, DOI 10.1073/pnas.93.15.7761; Georgiou G, 1997, NAT BIOTECHNOL, V15, P29, DOI 10.1038/nbt0197-29; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Lee HW, 2006, BIOCHEM BIOPH RES CO, V346, P896, DOI 10.1016/j.bbrc.2006.05.202; Lloyd C, 2009, PROTEIN ENG DES SEL, V22, P159, DOI 10.1093/protein/gzn058; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Pelat T, 2009, MABS-AUSTIN, V1, P377, DOI 10.4161/mabs.1.4.8635; PERELSON AS, 1979, J THEOR BIOL, V81, P645, DOI 10.1016/0022-5193(79)90275-3; Persson H, 2006, J MOL BIOL, V357, P607, DOI 10.1016/j.jmb.2006.01.004; Popkov M, 2003, J MOL BIOL, V325, P325, DOI 10.1016/S0022-2836(02)01232-9; Rader C, 2000, J BIOL CHEM, V275, P13668, DOI 10.1074/jbc.275.18.13668; Rader C, 1998, P NATL ACAD SCI USA, V95, P8910, DOI 10.1073/pnas.95.15.8910; Ravn U, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq789; Reddy ST, 2010, NAT BIOTECHNOL, V28, P965, DOI 10.1038/nbt.1673; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Sheets MD, 1998, P NATL ACAD SCI USA, V95, P6157, DOI 10.1073/pnas.95.11.6157; SMITH GP, 1993, METHOD ENZYMOL, V217, P228; Stanfield RL, 2004, SCIENCE, V305, P1770, DOI 10.1126/science.1101148; Steinberger P, 2000, J BIOL CHEM, V275, P36073, DOI 10.1074/jbc.M002765200; Thie H, 2008, CURRENT PHARM BIOTEC, V9, P8; Throsby M, 2006, J VIROL, V80, P6982, DOI 10.1128/JVI.00551-06; Vaughan TJ, 1996, NAT BIOTECHNOL, V14, P309, DOI 10.1038/nbt0396-309; Wu BP, 2001, WORLD J GASTROENTERO, V7, P811, DOI 10.3748/wjg.v7.i6.811; WU TT, 1993, PROTEINS, V16, P1, DOI 10.1002/prot.340160102; Yin CC, 2008, J BIOCHEM, V144, P591, DOI 10.1093/jb/mvn103; Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007	42	18	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43471	10.1371/journal.pone.0043471	http://dx.doi.org/10.1371/journal.pone.0043471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937053	Green Submitted, Green Published, gold			2022-12-25	WOS:000308225500054
J	Yang, RF; Sun, CL; Bai, JJ; Luo, ZX; Shi, BA; Zhang, JM; Yan, WG; Piao, ZZ				Yang, Ruifang; Sun, Chunlong; Bai, Jianjiang; Luo, Zhixiang; Shi, Biao; Zhang, Jianming; Yan, Wengui; Piao, Zhongze			A Putative Gene sbe3-rs for Resistant Starch Mutated from SBE3 for Starch Branching Enzyme in Rice (Oryza sativa L.)	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; PROLINE RESIDUES; FOOD; CLASSIFICATION; DIGESTIBILITY; CARBOHYDRATE; CONSUMPTION; INDEXES; HEALTH	Foods high in resistant starch (RS) are beneficial to prevent various diseases including diabetes, colon cancers, diarrhea and chronic renal or hepatic diseases. Elevated RS in rice is important for public health since rice is a staple food for half of the world population. A japonica mutant 'Jiangtangdao 1' (RS = 11.67%) was crossed with an indica cultivar 'Miyang 23' (RS = 0.41%). The mutant sbe3-rs that explained 60.4% of RS variation was mapped between RM6611 and RM13366 on chromosome 2 (LOD = 36) using 178 F-2 plants genotyped with 106 genome-wide polymorphic SSR markers. Using 656 plants from four F-3:4 families, sbe3-rs was fine mapped to a 573.3 Kb region between InDel 2 and InDel 6 using one STS, five SSRs and seven InDel markers. SBE3 which codes for starch branching enzyme was identified as a candidate gene within the putative region. Nine pairs of primers covering 22 exons were designed to sequence genomic DNA of the wild type for SBE3 and the mutant for sbe3-rs comparatively. Sequence analysis identified a missense mutation site where Leu-599 of the wild was changed to Pro-599 of the mutant in the SBE3 coding region. Because the point mutation resulted in the loss of a restriction enzyme site, sbe3-rs was not digested by a CAPS marker for SpeI site while SBE3 was. Co-segregation of the digestion pattern with RS content among 178 F2 plants further supported sbe3-rs responsible for RS in rice. As a result, the CAPS marker could be used in marker-assisted breeding to develop rice cultivars with elevated RS which is otherwise difficult to accurately assess in crops. Transgenic technology should be employed for a definitive conclusion of the sbe3-rs.	[Yang, Ruifang; Sun, Chunlong; Bai, Jianjiang; Shi, Biao; Zhang, Jianming; Piao, Zhongze] Shanghai Acad Agr Sci, Crop Breeding & Cultivat Res Inst, Shanghai, Peoples R China; [Luo, Zhixiang] Anhui Acad Agr Sci, Rice Res Inst, Hefei, Anhui, Peoples R China; [Yan, Wengui] ARS, USDA, Dale Bumpers Natl Rice Res Ctr, Stuttgart, AR USA; [Sun, Chunlong] Jilin Univ, Coll Plant Sci, Changchu, Peoples R China	Shanghai Academy of Agricultural Sciences; Anhui Academy of Agricultural Sciences; United States Department of Agriculture (USDA); Jilin University	Yang, RF (corresponding author), Shanghai Acad Agr Sci, Crop Breeding & Cultivat Res Inst, Shanghai, Peoples R China.	Wengui.Yan@ars.usda.gov; zzpiao@163.com			973 Program of China [2011CB111506]; 863 Program of China [2012AA101103]; Key Basic Research Project in Shanghai [10JC1413900]; Foundation of Shanghai Academy of Agricultural Sciences [2012 yf01]	973 Program of China(National Basic Research Program of China); 863 Program of China(National High Technology Research and Development Program of China); Key Basic Research Project in Shanghai; Foundation of Shanghai Academy of Agricultural Sciences	This study was partially supported by the 973 Program of China (2011CB111506), 863 Program of China (2012AA101103), Key Basic Research Project in Shanghai (10JC1413900) and Foundation of Shanghai Academy of Agricultural Sciences (2012 yf01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEMANNO L, 1994, PLANT CELL REP, V13, P432, DOI 10.1007/BF00231961; Asp N. G., 1992, Trends in Food Science & Technology, V3, P111, DOI 10.1016/0924-2244(92)90153-N; ASP NG, 1994, AM J CLIN NUTR, V59, p679S, DOI 10.1093/ajcn/59.3.679Sa; Bird AR, 2004, J NUTR, V134, P831, DOI 10.1093/jn/134.4.831; Birkett AM, 1997, EUR J CLIN NUTR, V51, P625, DOI 10.1038/sj.ejcn.1600456; BrõndÚn CI., 1991, INTRO PROTEIN STRUCT; Brown IL, 2004, J AOAC INT, V87, P727; Champ M, 2003, NUTR RES REV, V16, P143, DOI 10.1079/NRR200364; Creste S, 2001, PLANT MOL BIOL REP, V19, P299, DOI 10.1007/BF02772828; Danjo K, 2003, J NUTR, V133, P2218, DOI 10.1093/jn/133.7.2218; ENGLYST HN, 1992, EUR J CLIN NUTR, V46, pS33; Escarpa A, 1997, FOOD CHEM, V60, P527, DOI 10.1016/S0308-8146(97)00025-3; Frei M, 2003, FOOD CHEM, V83, P395, DOI 10.1016/S0308-8146(03)00101-8; Govers MJAP, 1999, GUT, V45, P840, DOI 10.1136/gut.45.6.840; Harrington SE, 1997, THEOR APPL GENET, V94, P564, DOI 10.1007/s001220050452; Higgins JA, 1996, J NUTR, V126, P596, DOI 10.1093/jn/126.3.596; Hu PS, 2004, J CEREAL SCI, V40, P231, DOI 10.1016/j.jcs.2004.06.001; Jacobasch G, 1999, INT J COLORECTAL DIS, V14, P201, DOI 10.1007/s003840050212; Jia LiMeng, 2007, The Open Agriculture Journal, V1, P5, DOI 10.2174/1874331500701010005; Jobling S, 2004, CURR OPIN PLANT BIOL, V7, P210, DOI 10.1016/j.pbi.2003.12.001; JULIANO BO, 1971, CEREAL SCI TODAY, V16, P334; Kim JH, 2006, FOOD CHEM, V99, P718, DOI 10.1016/j.foodchem.2005.08.054; Li HuiHui, 2010, Acta Agronomica Sinica, V36, P918, DOI 10.3724/SP.J.1006.2010.00918; Li Min, 2008, Acta Nutrimenta Sinica, V30, P588; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Madrid J., 2000, P NUTR SOC AUST, V24, P208; McCleary BV, 2002, J AOAC INT, V85, P1103; McCouch SR, 1997, RICE GENET NEWSLETT, V14, P11, DOI [DOI 10.1007/S10142-013-0328-1, DOI 10.1007/S10681-005-0449-2]; MIZUNO K, 1993, J BIOL CHEM, V268, P19084; [牟方贵 Mou Fanggui], 2008, [分子植物育种, Molecular Plant Breeding], V6, P432; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nishi A, 2001, PLANT PHYSIOL, V127, P459, DOI [10.1104/pp.010127, 10.1104/pp.127.2.459]; Rahman S, 2007, J CEREAL SCI, V46, P251, DOI 10.1016/j.jcs.2007.05.001; Regina A, 2006, P NATL ACAD SCI USA, V103, P3546, DOI 10.1073/pnas.0510737103; Sajilata MG, 2006, COMPR REV FOOD SCI F, V5, P1, DOI 10.1111/j.1541-4337.2006.tb00076.x; Sluaghter S, 2001, BIOCH BIOPHY ACTA, V1525, P29; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Van Ooijen J., 2006, SOFTWARE CALCULATION; Wang Lin, 2009, Journal of Triticeae Crops, V29, P390; Wei CX, 2010, J AGR FOOD CHEM, V58, P1224, DOI 10.1021/jf9031316; WOOLFSON DN, 1990, FEBS LETT, V277, P185, DOI 10.1016/0014-5793(90)80839-B; Yang CZ, 2006, J AGR FOOD CHEM, V54, P523, DOI 10.1021/jf0524123; Yao Y, 2004, PLANT PHYSIOL, V136, P3515, DOI 10.1104/pp.104.043315; Younes H, 1997, AM J PHYSIOL-GASTR L, V272, pG515, DOI 10.1152/ajpgi.1997.272.3.G515; Zhu HM., 2010, CHIN AGR SCI B, V26, P108	45	40	52	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43026	10.1371/journal.pone.0043026	http://dx.doi.org/10.1371/journal.pone.0043026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937009	Green Submitted, Green Published, gold			2022-12-25	WOS:000308225500027
J	Sewell, D; Guillera-Arroita, G; Griffiths, RA; Beebee, TJC				Sewell, David; Guillera-Arroita, Gurutzeta; Griffiths, Richard A.; Beebee, Trevor J. C.			When Is a Species Declining? Optimizing Survey Effort to Detect Population Changes in Reptiles	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; DETECTION PROBABILITIES; DESIGNING OCCUPANCY; IMPERFECT DETECTION; AMPHIBIAN DECLINES; CITIZEN SCIENCE; EXTINCTION; ABSENCE; MODELS	Biodiversity monitoring programs need to be designed so that population changes can be detected reliably. This can be problematical for species that are cryptic and have imperfect detection. We used occupancy modeling and power analysis to optimize the survey design for reptile monitoring programs in the UK. Surveys were carried out six times a year in 20092010 at multiple sites. Four out of the six species - grass snake, adder, common lizard, slow-worm -were encountered during every survey from March-September. The exceptions were the two rarest species - sand lizard and smooth snake - which were not encountered in July 2009 and March 2010 respectively. The most frequently encountered and most easily detected species was the slow-worm. For the four widespread reptile species in the UK, three to four survey visits that used a combination of directed transect walks and artificial cover objects resulted in 95% certainty that a species would be detected if present. Using artificial cover objects was an effective detection method for most species, considerably increased the detection rate of some, and reduced misidentifications. To achieve an 85% power to detect a decline in any of the four widespread species when the true decline is 15%, three surveys at a total of 886 sampling sites, or four surveys at a total of 688 sites would be required. The sampling effort needed reduces to 212 sites surveyed three times, or 167 sites surveyed four times, if the target is to detect a true decline of 30% with the same power. The results obtained can be used to refine reptile survey protocols in the UK and elsewhere. On a wider scale, the occupancy study design approach can be used to optimize survey effort and help set targets for conservation outcomes for regional or national biodiversity assessments.	[Sewell, David; Griffiths, Richard A.] Univ Kent, Durrell Inst Conservat & Ecol, Sch Anthropol & Conservat, Canterbury, Kent, England; [Sewell, David; Beebee, Trevor J. C.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England; [Guillera-Arroita, Gurutzeta] Univ Kent, Natl Ctr Stat Ecol, Sch Math Stat & Actuarial Sci, Canterbury, Kent, England	University of Kent; University of Sussex; University of Kent	Sewell, D (corresponding author), Univ Kent, Durrell Inst Conservat & Ecol, Sch Anthropol & Conservat, Canterbury, Kent, England.	R.A.Griffiths@kent.ac.uk	Guillera-Arroita, Gurutzeta/F-7461-2015	Guillera-Arroita, Gurutzeta/0000-0002-8387-5739	Esmee Fairburn Foundation; EPSRC/NCSE (Engineering and Physical Sciences Research Council/National Centre for Statistical Ecology); Engineering and Physical Sciences Research Council [EP/I000917/1] Funding Source: researchfish; Natural Environment Research Council [NE/I008403/1] Funding Source: researchfish; EPSRC [EP/I000917/1] Funding Source: UKRI; NERC [NE/I008403/1] Funding Source: UKRI	Esmee Fairburn Foundation; EPSRC/NCSE (Engineering and Physical Sciences Research Council/National Centre for Statistical Ecology); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors thank the Esmee Fairburn Foundation (http://www.esmeefairbairn.org.uk/) for financial support. The work of G.G.-A. was supported by an EPSRC/NCSE (Engineering and Physical Sciences Research Council/National Centre for Statistical Ecology; http://gow.epsrc.ac.uk/) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D.R., 2008, MODEL BASED INFERENC; Bailey LL, 2007, ECOL APPL, V17, P281, DOI 10.1890/1051-0761(2007)017[0281:SDTIOS]2.0.CO;2; Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; Beebee TJC, 2000, AMPHIBIANS REPTILES, P166; Beebee Trevor J.C., 2009, Diversity, V1, P67; BRAITHWAITE AC, 1989, HERPETOL J, V1, P370; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Collins JP, 2003, DIVERS DISTRIB, V9, P89, DOI 10.1046/j.1472-4642.2003.00012.x; Deming WE, 1941, J AM STAT ASSOC, V36, P45, DOI 10.2307/2278811; Dorazio RM, 2007, ECOLOGY, V88, P2773, DOI 10.1890/07-0006.1; Engel Sarah R., 2002, American Entomologist, V48, P164; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Green DM, 2003, BIOL CONSERV, V111, P331, DOI 10.1016/S0006-3207(02)00302-6; Green DM, 1997, HERPETOLOGICAL CONSE, V1, P291; Griffiths RA, 2010, BIOL CONSERV, V143, P485, DOI 10.1016/j.biocon.2009.11.017; Guillera-Arroita G, METHODS ECO IN PRESS; Guillera-Arroita G, 2010, METHODS ECOL EVOL, V1, P131, DOI 10.1111/j.2041-210X.2010.00017.x; Harshbarger JC, 2000, MAR ENVIRON RES, V50, P247, DOI 10.1016/S0141-1136(00)00055-6; Hoffmann M, 2011, PHILOS T R SOC B, V366, P2598, DOI 10.1098/rstb.2011.0116; Holck MH, 2008, BIODIVERS CONSERV, V17, P2023, DOI 10.1007/s10531-007-9273-4; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Jiguet F, 2010, GLOBAL CHANGE BIOL, V16, P497, DOI 10.1111/j.1365-2486.2009.01963.x; Jones T, 2010, J ANIM ECOL, V79, P98, DOI 10.1111/j.1365-2656.2009.01610.x; Joppa LN, 2010, HERPETOL CONSERV BIO, V5, P143; Kery M, 2002, J WILDLIFE MANAGE, V66, P330, DOI 10.2307/3803165; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kery M, 2009, J APPL ECOL, V46, P1163, DOI 10.1111/j.1365-2664.2009.01724.x; King DI, 2008, BIODIVERS CONSERV, V17, P2691, DOI 10.1007/s10531-007-9244-9; Kostadinova I, 2011, CURR SCI INDIA, V100, P973; Light T, 2007, CONSERV BIOL, V21, P434, DOI 10.1111/j.1523-1739.2006.00643.x; Lotz A, 2007, J WILDLIFE MANAGE, V71, P675, DOI 10.2193/2005-759; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MCARDLE BH, 1990, OIKOS, V57, P276, DOI 10.2307/3565950; Morgan BJT, 2008, APPL STOCH MODEL BUS, P101; Pellet J, 2005, BIOL CONSERV, V123, P27, DOI 10.1016/j.biocon.2004.10.005; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Reading CJ, 2007, OECOLOGIA, V151, P125, DOI 10.1007/s00442-006-0558-1; Reading CJ, 2010, BIOL LETTERS, V6, P777, DOI 10.1098/rsbl.2010.0373; Reading CJ, 1997, J APPL ECOL, V34, P1057, DOI 10.2307/2405294; Reed JM, 1996, CONSERV BIOL, V10, P1283, DOI 10.1046/j.1523-1739.1996.10041283.x; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Schmeller DS, 2009, CONSERV BIOL, V23, P307, DOI 10.1111/j.1523-1739.2008.01125.x; Tanadini LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028244; WAKE DB, 1991, SCIENCE, V253, P860, DOI 10.1126/science.253.5022.860; Wee YC, 2011, RAFFLES B ZOOL, P23; Wintle BA, 2012, DIVERS DISTRIB, V18, P417, DOI 10.1111/j.1472-4642.2011.00874.x	48	49	53	5	147	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43387	10.1371/journal.pone.0043387	http://dx.doi.org/10.1371/journal.pone.0043387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937044	Green Published, gold			2022-12-25	WOS:000308286300048
J	Foley, JP; Lam, D; Jiang, HM; Liao, J; Cheong, N; McDevitt, TM; Zaman, A; Wright, JR; Savani, RC				Foley, Joseph P.; Lam, David; Jiang, Hongmei; Liao, Jie; Cheong, Naeun; McDevitt, Theresa M.; Zaman, Aisha; Wright, Jo Rae; Savani, Rashmin C.			Toll-like Receptor 2 (TLR2), Transforming Growth Factor-beta, Hyaluronan (HA), and Receptor for HA-mediated Motility (RHAMM) Are Required for Surfactant Protein A-stimulated Macrophage Chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULMONARY SURFACTANT; INNATE IMMUNITY; CELLULAR-RESPONSE; ALPHA SECRETION; CD44; BINDING; INFLAMMATION; COLLECTINS; CELLS; RECOGNITION	The innate immune system protects the host from bacterial and viral invasion. Surfactant protein A (SPA), a lung-specific collectin, stimulates macrophage chemotaxis. However, the mechanisms regulating this function are unknown. Hyaluronan (HA) and its receptors RHAMM (receptor for HA-mediated motility, CD168) and CD44 also regulate cell migration and inflammation. Wetherefore examined the role of HA, RHAMM, and CD44 in SPA-stimulated macrophage chemotaxis. Using antibody blockade and murine macrophages, SPA-stimulated macrophage chemotaxis was dependent on TLR2 but not the other SPA receptors examined. Anti-TLR2 blocked SPA-induced production of TGF beta. In turn, TGF beta 1-stimulated chemotaxis was inhibited by HA-binding peptide and anti-RHAMM antibody but not anti-TLR2 antibody. Macrophages from TLR2(-/-) mice failed to migrate in response to SPA but responded normally to TGF beta 1 and HA, effects that were blocked by anti-RHAMM antibody. Macrophages from WT and CD44(-/-) mice had similar responses to SPA, whereas those from RHAMM(-/-) mice had decreased chemotaxis to SPA, TGF beta 1, and HA. In primary macrophages, SPA-stimulated TGF beta production was dependent on TLR2, JNK, and ERK but notp38.Pam3Cys,a specific TLR2agonist, stimulated phosphorylation of JNK, ERK, and p38, but only JNK and ERK inhibition blocked Pam3Cys-stimulated chemotaxis. We have uncovered a novel pathway for SPA-stimulated macrophage chemotaxis where SPA stimulation via TLR2 drives JNK- and ERK-dependent TGF beta production. TGF beta 1, in turn, stimulates macrophage chemotaxis in a RHAMM and HA-dependent manner. These findings are highly relevant to the regulation of innate immune responses by SPA with key roles for specific components of the extracellular matrix.	[Lam, David; Jiang, Hongmei; Liao, Jie; Cheong, Naeun; Savani, Rashmin C.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Div Pulm & Vasc Biol, Dallas, TX 75390 USA; [Foley, Joseph P.; Savani, Rashmin C.] Univ Sci Philadelphia, Dept Pharmaceut Sci, Div Pharmacol & Toxicol, Philadelphia, PA 19104 USA; [Foley, Joseph P.; McDevitt, Theresa M.; Zaman, Aisha; Savani, Rashmin C.] Univ Penn, Sch Med, Childrens Hosp Philadelphia, Dept Pediat,Div Neonatol, Philadelphia, PA 19104 USA; [Lam, David; Jiang, Hongmei; Liao, Jie; Cheong, Naeun; Savani, Rashmin C.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Div Neonatal Perinatal Med, Dallas, TX 75390 USA; [Wright, Jo Rae] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Texas System; University of Texas Southwestern Medical Center Dallas; Duke University	Savani, RC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Div Pulm & Vasc Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	rashmin.savani@utsouthwestern.edu	Lam, David/AAI-3657-2020; Rashmin C. Savani, MBChB/AAG-2041-2021	Rashmin C. Savani, MBChB/0000-0002-9533-5422	National Institutes of Health [HL62472, HL073896, HL068072]; Seikagaku Corp., Japan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068072, R01HL062472, R01HL073896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Seikagaku Corp., Japan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL62472 and HL073896 (to R. C. S.) and HL068072 (to J. R. W.). This work was also supported by a Sponsored Research Agreement from Seikagaku Corp., Japan (to R. C. S.).	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Abreu MT, 2004, J PEDIATR-US, V144, P421, DOI 10.1016/j.jpeds.2004.01.057; ADAMS DH, 1991, J IMMUNOL, V147, P609; Adhikary G, 2008, J LEUKOCYTE BIOL, V83, P991, DOI 10.1189/jlb.1107783; Akira S, 2000, BIOCHEM SOC T, V28, P551, DOI 10.1042/bst0280551; Amara FM, 1996, J BIOL CHEM, V271, P15279, DOI 10.1074/jbc.271.25.15279; Borron P, 2000, AM J PHYSIOL-LUNG C, V278, pL840, DOI 10.1152/ajplung.2000.278.4.L840; Chroneos Z, 1995, AM J PHYSIOL-LUNG C, V269, pL721, DOI 10.1152/ajplung.1995.269.6.L721; Chroneos ZC, 1996, J BIOL CHEM, V271, P16375, DOI 10.1074/jbc.271.27.16375; Chroneos ZC, 2010, CELL PHYSIOL BIOCHEM, V25, P13, DOI 10.1159/000272047; Crouch E, 2001, ANNU REV PHYSIOL, V63, P521, DOI 10.1146/annurev.physiol.63.1.521; Crouch E, 2000, IMMUNOL REV, V173, P52, DOI 10.1034/j.1600-065X.2000.917311.x; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; DELPECH B, 1985, ANAL BIOCHEM, V149, P555, DOI 10.1016/0003-2697(85)90613-X; ENTWISTLE J, 1995, GENE, V163, P233, DOI 10.1016/0378-1119(95)00398-P; Fieber C, 1999, GENE, V226, P41, DOI 10.1016/S0378-1119(98)00566-6; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; GEERTSMA MF, 1994, AM J PHYSIOL-LUNG C, V267, pL578, DOI 10.1152/ajplung.1994.267.5.L578; HALL CL, 1994, J CELL BIOL, V126, P575, DOI 10.1083/jcb.126.2.575; Hall CL, 1996, ONCOGENE, V13, P2213; HELDIN P, 1989, BIOCHEM J, V258, P919, DOI 10.1042/bj2580919; Huang SP, 2012, CELL SIGNAL, V24, P569, DOI 10.1016/j.cellsig.2011.10.011; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Katoh S, 2003, J CLIN INVEST, V111, P1563, DOI 10.1172/JCI200316583; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Kramer BW, 2001, AM J RESP CRIT CARE, V163, P158, DOI 10.1164/ajrccm.163.1.2005084; Kuroki Y, 2007, CELL MICROBIOL, V9, P1871, DOI 10.1111/j.1462-5822.2007.00953.x; McCormack FX, 2002, J CLIN INVEST, V109, P707, DOI 10.1172/JCI200215293; McIntosh JC, 1996, AM J RESP CELL MOL, V15, P509, DOI 10.1165/ajrcmb.15.4.8879185; Murakami S, 2002, J BIOL CHEM, V277, P6830, DOI 10.1074/jbc.M106671200; Nedvetzki S, 1999, J AUTOIMMUN, V13, P39, DOI 10.1006/jaut.1999.0294; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; PURE E, 1995, J EXP MED, V181, P55, DOI 10.1084/jem.181.1.55; Reidy MF, 2003, AM J PHYSIOL-LUNG C, V285, pL854, DOI 10.1152/ajplung.00439.2002; ROBERTS AB, 1990, ANN NY ACAD SCI, V580, P225, DOI 10.1111/j.1749-6632.1990.tb17931.x; SAMUEL SK, 1993, J CELL BIOL, V123, P749, DOI 10.1083/jcb.123.3.749; Sano H, 1999, J IMMUNOL, V163, P387; Sato M, 2003, J IMMUNOL, V171, P417, DOI 10.4049/jimmunol.171.1.417; Savani RC, 2000, AM J RESP CELL MOL, V23, P475, DOI 10.1165/ajrcmb.23.4.3944; SAVANI RC, 1995, J CLIN INVEST, V95, P1158, DOI 10.1172/JCI117764; SAVANI RC, 1995, P W PHARMACOL SOC, V38, P131; SAVANI RC, 2003, LUNG BIOL HEALTH DIS, V168, P73; Savanti R, 2000, BAS CLIN DERMATOL, P115; SHI YF, 1993, J IMMUNOL METHODS, V164, P149, DOI 10.1016/0022-1759(93)90307-S; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; TEDER P, 1995, AM J RESP CELL MOL, V12, P181, DOI 10.1165/ajrcmb.12.2.7532420; Tino MJ, 1999, AM J RESP CELL MOL, V20, P759, DOI 10.1165/ajrcmb.20.4.3439; Tino MJ, 1999, AM J PHYSIOL-LUNG C, V276, pL164, DOI 10.1152/ajplung.1999.276.1.L164; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788; Waters P, 2009, ADV EXP MED BIOL, V653, P74; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; WRIGHT JR, 1993, AM J PHYSIOL, V264, pL338, DOI 10.1152/ajplung.1993.264.4.L338; Yamada C, 2006, J BIOL CHEM, V281, P21771, DOI 10.1074/jbc.M513041200; Yamasaki K, 2009, J BIOL CHEM, V284, P12762, DOI 10.1074/jbc.M806084200; YANG BH, 1994, EMBO J, V13, P286, DOI 10.1002/j.1460-2075.1994.tb06261.x; Zaman A, 2005, AM J RESP CELL MOL, V33, P447, DOI 10.1165/rcmb.2004-0333OC; Zhang SW, 1998, J BIOL CHEM, V273, P11342, DOI 10.1074/jbc.273.18.11342; ZIGMOND SH, 1973, J EXP MED, V137, P387, DOI 10.1084/jem.137.2.387	63	40	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37406	37419		10.1074/jbc.M112.360982	http://dx.doi.org/10.1074/jbc.M112.360982			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22948158	Green Published, hybrid			2022-12-25	WOS:000310588500071
J	Sapparapu, G; Planque, S; Mitsuda, Y; McLean, G; Nishiyama, Y; Paul, S				Sapparapu, Gopal; Planque, Stephanie; Mitsuda, Yukie; McLean, Gary; Nishiyama, Yasuhiro; Paul, Sudhir			Constant Domain-regulated Antibody Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; MYELIN BASIC-PROTEIN; BENCE-JONES PROTEINS; AMYLOID-BETA PEPTIDE; B-CELL; WALDENSTROMS MACROGLOBULINEMIA; IMMUNOGLOBULIN CONSTANT; PROTEOLYTIC ANTIBODIES; RHEUMATOID-ARTHRITIS; CHEMICAL-REACTIVITY	Some antibodies contain variable (V) domain catalytic sites. We report the superior amide and peptide bond-hydrolyzing activity of the same heavy and light chain V domains expressed in the IgM constant domain scaffold compared with the IgG scaffold. The superior catalytic activity of recombinant IgM was evident using two substrates, a small model peptide that is hydrolyzed without involvement of high affinity epitope binding, and HIV gp120, which is recognized specifically by noncovalent means prior to the hydrolytic reaction. The catalytic activity was inhibited by an electrophilic phosphonate diester, consistent with a nucleophilic catalytic mechanism. All 13 monoclonal IgMs tested displayed robust hydrolytic activities varying over a 91-fold range, consistent with expression of the catalytic functions at distinct levels by different V domains. The catalytic activity of polyclonal IgM was superior to polyclonal IgG from the same sera, indicating that on average IgMs express the catalytic function at levels greater than IgGs. The findings indicate a favorable effect of the remote IgM constant domain scaffold on the integrity of the V-domain catalytic site and provide a structural basis for conceiving antibody catalysis as a first line immune function expressed at high levels prior to development of mature IgG class antibodies.	[Sapparapu, Gopal; Planque, Stephanie; Mitsuda, Yukie; McLean, Gary; Nishiyama, Yasuhiro; Paul, Sudhir] Univ Texas Houston, Houston Med Sch, Chem Immunol Res Ctr, Dept Pathol & Lab Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Paul, S (corresponding author), Univ Texas Houston, Houston Med Sch, Chem Immunol Res Ctr, Dept Pathol & Lab Med, 6431 Fannin, Houston, TX 77030 USA.	sudhir.paul@uth.tmc.edu	Mclean, Gary/AAW-9525-2020	Sapparapu, Gopal/0000-0001-9670-1757	National Institutes of Health [AI071951, AI058865, AI067020, AI087527, AI093261]; Richard J. Massey Foundation for Arts and Sciences; Covalent Bioscience Inc; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067020, R41AI087527, R41AI093261, R21AI071951, R01AI058865] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard J. Massey Foundation for Arts and Sciences; Covalent Bioscience Inc; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI071951, AI058865, AI067020, AI087527, and AI093261. This work was also supported by The Richard J. Massey Foundation for Arts and Sciences and Covalent Bioscience Inc. Stephanie Planque, Yasuhiro Nishiyama, and Sudhir Paul have a financial interest in patents covering the catalytic antibody area. These individuals are also advisors for Covalent Bioscience Inc. and have a financial interest in the company.	Alvarez-Twose I, 2012, ALLERGY, V67, P813, DOI 10.1111/j.1398-9995.2012.02812.x; Auclair SM, 2012, PROTEIN SCI, V21, P13, DOI 10.1002/pro.757; BERBERIAN L, 1993, SCIENCE, V261, P1588, DOI 10.1126/science.7690497; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Bose B, 2005, IMMUNOLOGY, V116, P172, DOI 10.1111/j.1365-2567.2005.02208.x; Brown EL, 2012, J BIOL CHEM, V287, P9940, DOI 10.1074/jbc.M111.330043; CHEN TY, 1993, AM J HEMATOL, V44, P276, DOI 10.1002/ajh.2830440411; GAO QS, 1995, J MOL BIOL, V253, P658, DOI 10.1006/jmbi.1995.0580; Gololobov G, 1999, MOL IMMUNOL, V36, P1215, DOI 10.1016/S0161-5890(99)00141-8; Haury M, 1997, EUR J IMMUNOL, V27, P1557, DOI 10.1002/eji.1830270635; Hifumi E, 2008, J BIOL CHEM, V283, P899, DOI 10.1074/jbc.M705674200; Hifumi E, 2012, FASEB J, V26, P1607, DOI 10.1096/fj.11-195339; Janda A, 2010, MOL IMMUNOL, V47, P1421, DOI 10.1016/j.molimm.2010.02.018; KALAGA R, 1995, J IMMUNOL, V155, P2695; Kamalanathan AS, 2010, J MOL RECOGNIT, V23, P577, DOI 10.1002/jmr.1035; Karle S, 2004, AIDS, V18, P329, DOI 10.1097/00002030-200401230-00026; Karle S, 2003, VACCINE, V21, P1213, DOI 10.1016/S0264-410X(02)00504-2; Kriangkum J, 2007, CLIN CANCER RES, V13, P2005, DOI 10.1158/1078-0432.CCR-06-2788; Lacroix-Desmazes S, 2005, P NATL ACAD SCI USA, V102, P4109, DOI 10.1073/pnas.0500586102; Le Minoux D, 2012, MOL IMMUNOL, V50, P160, DOI 10.1016/j.molimm.2012.01.004; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MATSUURA K, 1994, BIOCHEM BIOPH RES CO, V204, P57, DOI 10.1006/bbrc.1994.2425; McLean GR, 2000, MOL IMMUNOL, V37, P837, DOI 10.1016/S0161-5890(00)00101-2; Mitsuda Y, 2007, MOL BIOTECHNOL, V36, P113, DOI 10.1007/s12033-007-0003-7; Murre C, 2007, CURR OPIN GENET DEV, V17, P415, DOI 10.1016/j.gde.2007.08.006; Nishiyama Y, 2005, J MOL RECOGNIT, V18, P295, DOI 10.1002/jmr.734; Nishiyama Y, 2004, J BIOL CHEM, V279, P7877, DOI 10.1074/jbc.M310950200; Nishiyama Y, 2002, ARCH BIOCHEM BIOPHYS, V402, P281, DOI 10.1016/S0003-9861(02)00087-5; Odintsova ES, 2012, J MOL RECOGNIT, V25, P193, DOI 10.1002/jmr.2159; OLEKSYSZYN J, 1994, METHOD ENZYMOL, V244, P423; Paul S, 1997, J IMMUNOL, V159, P1530; Paul S, 2004, J BIOL CHEM, V279, P39611, DOI 10.1074/jbc.M406719200; PAUL S, 1995, J BIOL CHEM, V270, P15257, DOI 10.1074/jbc.270.25.15257; Paul S, 2003, J BIOL CHEM, V278, P20429, DOI 10.1074/jbc.M300870200; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; Paul S, 2001, J BIOL CHEM, V276, P28314, DOI 10.1074/jbc.M102530200; Paul S, 1996, MOL BIOTECHNOL, V5, P197, DOI 10.1007/BF02900358; Planque S, 2004, J BIOL CHEM, V279, P14024, DOI 10.1074/jbc.M312152200; Planque S, 2003, J BIOL CHEM, V278, P20436, DOI 10.1074/jbc.M301468200; Planque S, 2007, AIDS RES HUM RETROV, V23, P1541, DOI 10.1089/aid.2007.0081; Polosukhina DI, 2004, J CELL MOL MED, V8, P359, DOI 10.1111/j.1582-4934.2004.tb00325.x; Ponomarenko NA, 2006, P NATL ACAD SCI USA, V103, P281, DOI 10.1073/pnas.0509849103; Radisky ES, 2006, P NATL ACAD SCI USA, V103, P6835, DOI 10.1073/pnas.0601910103; Raghavan M, 1996, ANNU REV CELL DEV BI, V12, P181, DOI 10.1146/annurev.cellbio.12.1.181; Ramsland PA, 1999, IMMUNOTECHNOLOGY, V4, P217, DOI 10.1016/S1380-2933(98)00025-6; Ramsland PA, 2006, BIOCHEM J, V395, P473, DOI 10.1042/BJ20051739; Rollett RA, 2006, CLIN LYMPHOMA MYELOM, V7, P70, DOI 10.3816/CLM.2006.n.042; Roux KH, 1998, J IMMUNOL, V161, P4083; Sahota SS, 2002, BLOOD, V100, P1505, DOI 10.1182/blood.V100.4.1505.h81602001505_1505_1507; Sapparapu G, 2009, J BIOL CHEM, V284, P24622, DOI 10.1074/jbc.M109.011858; Sharma V, 2009, J BIOL CHEM, V284, P33079, DOI 10.1074/jbc.M109.036087; SHUSTER AM, 1992, SCIENCE, V256, P665, DOI 10.1126/science.1585181; Smirnov I, 2011, P NATL ACAD SCI USA, V108, P15954, DOI 10.1073/pnas.1108460108; Taguchi H, 2008, J BIOL CHEM, V283, P4714, DOI 10.1074/jbc.M707983200; Taguchi H, 2008, J BIOL CHEM, V283, P36724, DOI 10.1074/jbc.M806766200; Torres M, 2005, J IMMUNOL, V174, P2132, DOI 10.4049/jimmunol.174.4.2132; Torres M, 2008, TRENDS IMMUNOL, V29, P91, DOI 10.1016/j.it.2007.11.004; Walsh SH, 2005, LEUKEMIA RES, V29, P729, DOI 10.1016/j.leukres.2004.12.008; Wootla B, 2008, J IMMUNOL, V180, P8455, DOI 10.4049/jimmunol.180.12.8455; Wootla B, 2011, J AUTOIMMUN, V37, P144, DOI 10.1016/j.jaut.2011.05.007; Wootla B, 2011, BLOOD, V117, P2257, DOI 10.1182/blood-2010-07-296103; Yang YH, 2010, RHEUMATOLOGY, V49, P34, DOI 10.1093/rheumatology/kep328	62	12	12	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36096	36104		10.1074/jbc.M112.401075	http://dx.doi.org/10.1074/jbc.M112.401075			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948159	Green Published, hybrid			2022-12-25	WOS:000310364000031
J	Hoek, W; Schuurmans, J; Koot, HM; Cuijpers, P				Hoek, Willemijn; Schuurmans, Josien; Koot, Hans M.; Cuijpers, Pim			Effects of Internet-Based Guided Self-Help Problem-Solving Therapy for Adolescents with Depression and Anxiety: A Randomized Controlled Trial	PLOS ONE			English	Article							HOSPITAL ANXIETY; DISC-IV; SYMPTOMS; SCALE; VALIDATION; PREVENTION; DISORDERS; VERSIONS; CHILDREN; EFFICACY	Background: Symptoms of depression and anxiety are highly prevalent in adolescence and they are the cause of considerable suffering. Even so, adolescents are not inclined to seek professional help for emotional problems. Internet-based preventive interventions have been suggested as a feasible method of providing appropriate care to adolescents with internalizing symptoms. The objective of this study was to evaluate the effects of preventive Internet-based (guided) self-help problem-solving therapy (PST) for adolescents reporting mild to moderate symptoms of depression and/or anxiety as compared to a waiting list control group (WL). Methodology/Principal Findings: A total of 45 participants were randomized to the 2 conditions. PST consisted of 5 weekly lessons. Participants were supported by e-mail. Self-report measures of depression and anxiety were filled in at baseline and after 3 weeks, 5 weeks, and 4 months. Of the 45 participants, 28 (62.2%) completed questionnaires after 3 weeks, 28 (62.2%) after 5 weeks, and 27 (60%) after 4 months. Hierarchical linear modeling analyses revealed overall improvement over time for both groups on depressive and anxiety symptoms. However, no significant group x time interactions were found. No differences were found between completers and non-completers. Conclusions/Significance: Results show that depressive and anxiety symptoms declined in both groups. No support was found, however, for the assumption that Internet-based PST was efficacious in reducing depression and anxiety in comparison to the waiting list control group. This finding could represent lack of power.	[Hoek, Willemijn; Schuurmans, Josien; Cuijpers, Pim] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Hoek, Willemijn; Koot, Hans M.] EMGO Inst, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Hoek, W (corresponding author), Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.	n.w.hoek@vu.nl	Cuijpers, Pim/G-1703-2013	Koot, Hans/0000-0002-9643-2363; Cuijpers, Pim/0000-0001-5497-2743; Schuurmans, Josien/0000-0003-4029-1810	ZonMw - the Netherlands organisation for Health Research and Development [120610006]	ZonMw - the Netherlands organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	This study is funded by ZonMw - the Netherlands organisation for Health Research and Development, grant number 120610006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles P, 2009, BEHAV COGN PSYCHOTH, V37, P151, DOI 10.1017/S1352465808005067; Andersson G, 2005, BRIT J PSYCHIAT, V187, P456, DOI 10.1192/bjp.187.5.456; Beck A.T., 1996, PSYCHOL ASSESS, DOI DOI 10.1037/T00742-000; Calear AL, 2009, J CONSULT CLIN PSYCH, V77, P1021, DOI 10.1037/a0017391; Christensen H, 2002, MED J AUSTRALIA, V177, pS122; Christensen H, 2004, BRIT MED J, V328, P265, DOI 10.1136/bmj.37945.566632.EE; Cole DA, 1998, J CONSULT CLIN PSYCH, V66, P451, DOI 10.1037/0022-006X.66.3.451; Cuijpers P, 1997, J BEHAV THER EXP PSY, V28, P139, DOI 10.1016/S0005-7916(97)00005-0; Cuijpers P, 2008, EUR CHILD ADOLES PSY, V17, P32, DOI 10.1007/s00787-007-0631-2; Cuijpers P, 2007, EUR PSYCHIAT, V22, P9, DOI 10.1016/j.eurpsy.2006.11.001; Cunningham MJ, 2009, EUR CHILD ADOLES PSY, V18, P125, DOI 10.1007/s00787-008-0703-y; Eysenbach G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e11; GARRISON CZ, 1991, J AM ACAD CHILD PSY, V30, P636, DOI 10.1097/00004583-199107000-00017; Hankin BL, 1998, J ABNORM PSYCHOL, V107, P128, DOI 10.1037/0021-843X.107.1.128; Hoek W, 2012, EUR CHILD A IN PRESS; Hoek W, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-93; Malouff JM, 2007, CLIN PSYCHOL REV, V27, P46, DOI 10.1016/j.cpr.2005.12.005; Nguyen T D, 1983, Eval Program Plann, V6, P299, DOI 10.1016/0149-7189(83)90010-1; O'Kearney Richard, 2006, Cognitive Behaviour Therapy, V35, P43, DOI 10.1080/16506070500303456; O'Kearney R, 2009, DEPRESS ANXIETY, V26, P65, DOI 10.1002/da.20507; Olsson I, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-46; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Sawyer MG, 2009, J AFFECT DISORDERS, V117, P48, DOI 10.1016/j.jad.2008.12.013; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Spence SH, 2006, J CONSULT CLIN PSYCH, V74, P614, DOI 10.1037/0022-006X.74.3.614; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Tillett J, 2005, J PERINAT NEONAT NUR, V19, P112, DOI 10.1097/00005237-200504000-00007; van der Zanden R, 2012, J MED INTERNET RES, V14, P274, DOI 10.2196/jmir.2033; van Lang NDJ, 2006, BEHAV RES THER, V44, P849, DOI 10.1016/j.brat.2005.06.004; Warmerdam L, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.954; Wasserman GA, 2002, J AM ACAD CHILD PSY, V41, P314, DOI 10.1097/00004583-200203000-00011; WELLS KB, 1988, J PSYCHIAT RES, V22, P207, DOI 10.1016/0022-3956(88)90006-4; White D, 1999, BRIT J PSYCHIAT, V175, P452, DOI 10.1192/bjp.175.5.452; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	34	49	51	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43485	10.1371/journal.pone.0043485	http://dx.doi.org/10.1371/journal.pone.0043485			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998EY	22952691	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300016
J	Sakamoto, K; Schmidt, JW; Wagner, KU				Sakamoto, Kazuhito; Schmidt, Jeffrey W.; Wagner, Kay-Uwe			Generation of a Novel MMTV-tTA Transgenic Mouse Strain for the Targeted Expression of Genes in the Embryonic and Postnatal Mammary Gland	PLOS ONE			English	Article							EPITHELIAL-CELLS; STEM-CELLS; IN-VIVO; MICE; NEU; TUMORIGENESIS; ACTIVATION; ONCOGENE; TISSUES; SYSTEM	We have generated a new and improved transgenic mouse strain that permits a temporally controlled expression of transgenes throughout mammary gland development. High expression of the tetracycline-regulatible transactivator (tTA) under control of the mouse mammary tumor virus long terminal repeat (MMTV-LTR) is restricted to mammary epithelial cells and the salivary gland. The novel MMTV-tTA mouse strain induces a sustained transactivation of responder transgenes, which can be swiftly suppressed through administration of doxycycline (Dox). An important characteristic of this strain is its expression in early progenitor cells of mammary gland anlagen beginning at day 13.5 of embryonic development. We show here that the MMTV-tTA can be used in combination with GFP reporter strains to visualize CK8/CK14-dual positive progenitors in newborn females and their derived basal and luminal epithelial cell lineages in adult females. Our observations suggest that the novel MMTV-tTA can be utilized to express exogenous proteins in multipotent mammary progenitors during the earliest stages of mammary gland development to assess their biological significance throughout mammogenesis. Moreover, we demonstrate that the expression of the MMTV-tTA is sustained during mammary gland tumorigenesis in female mice expressing wildtype ErbB2. This makes this strain particular valuable to target the expression of exogenous proteins into developing mammary tumors to assess their significance in biological processes, such as tumor cell growth and survival, metabolism, and metastasis.	[Sakamoto, Kazuhito; Schmidt, Jeffrey W.; Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA; [Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Sakamoto, K (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	ksakamoto@unmc.edu; kuwagner@unmc.edu	Wagner, Kay-Uwe/B-6044-2009	Wagner, Kay-Uwe/0000-0002-5081-0226	Public Health Service grants [CA93797, CA117930]; National Cancer Institute; Nebraska Cancer and Smoking Disease Research Program [NE DHHS LB506 2012-44]; Susan G. Komen Breast Cancer Foundation [PDF0600835]; UNMC Cancer Research Training Program [CA009476]; Program of Excellence Graduate Assistantship from the UNMC Graduate Studies Office; Department of Defense Congressionally Directed Medical Research Program [BC100147]; NATIONAL CANCER INSTITUTE [R01CA093797, T32CA009476, R01CA117930] Funding Source: NIH RePORTER	Public Health Service grants(United States Department of Health & Human ServicesUnited States Public Health Service); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Nebraska Cancer and Smoking Disease Research Program; Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); UNMC Cancer Research Training Program; Program of Excellence Graduate Assistantship from the UNMC Graduate Studies Office; Department of Defense Congressionally Directed Medical Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by the Public Health Service grants CA93797 and CA117930 and (to KUW) from the National Cancer Institute. Additional financial support provided to KUW by the Nebraska Cancer and Smoking Disease Research Program (NE DHHS LB506 2012-44) was imperative to finance the maintenance of the mouse models. KS received a postdoctoral fellowship from the Susan G. Komen Breast Cancer Foundation (PDF0600835). JWS received a graduate fellowship through the UNMC Cancer Research Training Program (CA009476), a Program of Excellence Graduate Assistantship from the UNMC Graduate Studies Office as well as a Breast Cancer Predoctoral Traineeship Award from the Department of Defense Congressionally Directed Medical Research Program (BC100147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boxer RB, 2004, CANCER CELL, V6, P577, DOI 10.1016/j.ccr.2004.10.013; Challen GA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002357; Creamer BA, 2010, MOL CELL BIOL, V30, P2957, DOI 10.1128/MCB.00851-09; Creamer BA, 2009, GENESIS, V47, P234, DOI 10.1002/dvg.20480; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Gunther EJ, 2003, GENE DEV, V17, P488, DOI 10.1101/gad.1051603; Gunther EJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0551com; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hennighausen L, 1995, J CELL BIOCHEM, V59, P463, DOI 10.1002/jcb.240590407; Henry MD, 2004, ONCOGENE, V23, P6980, DOI 10.1038/sj.onc.1207827; Iavnilovitch E, 2004, INT J CANCER, V112, P607, DOI 10.1002/ijc.20484; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Matulka LA, 2007, DEV BIOL, V303, P29, DOI 10.1016/j.ydbio.2006.12.017; Moody SE, 2002, CANCER CELL, V2, P451, DOI 10.1016/S1535-6108(02)00212-X; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Parmar H, 2004, ENDOCR-RELAT CANCER, V11, P437, DOI 10.1677/erc.1.00659; Robinson GW, 2007, NAT REV GENET, V8, P963, DOI 10.1038/nrg2227; Rose-Hellekant TA, 2003, ONCOGENE, V22, P4664, DOI 10.1038/sj.onc.1206619; SAKAKURA T, 1979, J NATL CANCER I, V63, P733, DOI 10.1093/jnci/63.3.733; Spike BT, 2012, CELL STEM CELL, V10, P183, DOI 10.1016/j.stem.2011.12.018; Triplett AA, 2008, NEOPLASIA, V10, P1325, DOI 10.1593/neo.08524; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Wagner Kay-Uwe, 1997, Genes and Function, V1, P233; Zeng X, 2010, ONCOGENE, V29, P5103, DOI 10.1038/onc.2010.253; Zhang Q, 2010, TRANSGENIC RES, V19, P499, DOI 10.1007/s11248-009-9329-1	27	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43778	10.1371/journal.pone.0043778	http://dx.doi.org/10.1371/journal.pone.0043778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952764	Green Submitted, Green Published, gold			2022-12-25	WOS:000308221300028
J	Pei, LM; Wang, JM; Li, KP; Li, YJ; Li, B; Gao, F; Yang, AF				Pei, Laming; Wang, Jiemin; Li, Kunpeng; Li, Yongjun; Li, Bei; Gao, Feng; Yang, Aifang			Overexpression of Thellungiella halophila H+-pyrophosphatase Gene Improves Low Phosphate Tolerance in Maize	PLOS ONE			English	Article							HETEROLOGOUS EXPRESSION; SALT TOLERANCE; PPASE GENE; PHOSPHORUS; GROWTH; PHOTOSYNTHESIS; RHIZOSPHERE; TRANSPORT; DROUGHT; ROOTS	Low phosphate availability is a major constraint on plant growth and agricultural productivity. Engineering a crop with enhanced low phosphate tolerance by transgenic technique could be one way of alleviating agricultural losses due to phosphate deficiency. In this study, we reported that transgenic maize plants that overexpressed the Thellungiella halophila vacuolar H+-pyrophosphatase gene (TsVP) were more tolerant to phosphate deficit stress than the wild type. Under phosphate sufficient conditions, transgenic plants showed more vigorous root growth than the wild type. When phosphate deficit stress was imposed, they also developed more robust root systems than the wild type, this advantage facilitated phosphate uptake, which meant that transgenic plants accumulated more phosphorus. So the growth and development in the transgenic maize plants were not damaged as much as in the wild type plants under phosphate limitation. Overexpression of TsVP increased the expression of genes involved in auxin transport, which indicated that the development of larger root systems in transgenic plants might be due in part to enhanced auxin transport which controls developmental events in plants. Moreover, transgenic plants showed less reproductive development retardation and a higher grain yield per plant than the wild type plants when grown in a low phosphate soil. The phenotypes of transgenic maize plants suggested that the overexpression of TsVP led to larger root systems that allowed transgenic maize plants to take up more phosphate, which led to less injury and better performance than the wild type under phosphate deficiency conditions. This study describes a feasible strategy for improving low phosphate tolerance in maize and reducing agricultural losses caused by phosphate deficit stress.	[Pei, Laming; Wang, Jiemin; Li, Kunpeng; Li, Yongjun; Li, Bei; Gao, Feng; Yang, Aifang] Shandong Univ, Sch Life Sci, Jinan 250100, Shandong, Peoples R China	Shandong University	Pei, LM (corresponding author), Shandong Univ, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	aifangyang@sdu.edu.cn		Li, Kunpeng/0000-0003-1807-4545	Transgenic New Crops Variety Breeding Major Project of China's Ministry of Agriculture [2011ZX08003-005]	Transgenic New Crops Variety Breeding Major Project of China's Ministry of Agriculture	This work was funded by the Transgenic New Crops Variety Breeding Major Project of China's Ministry of Agriculture (2011ZX08003-005). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CLAASSEN N, 1974, PLANT PHYSIOL, V54, P564, DOI 10.1104/pp.54.4.564; Corrales I, 2007, J PLANT NUTR, V30, P887, DOI 10.1080/15226510701375085; DEMICHELIS MI, 1986, PLANT PHYSIOL, V81, P542, DOI 10.1104/pp.81.2.542; Dietz KJ, 1997, BOOKS SOIL PLANT ENV, P951; DREW MC, 1978, J EXP BOT, V29, P435, DOI 10.1093/jxb/29.2.435; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Gao F, 2006, J EXP BOT, V57, P3259, DOI 10.1093/jxb/erl090; George TS, 2002, SOIL BIOL BIOCHEM, V34, P1487, DOI 10.1016/S0038-0717(02)00093-7; Hinsinger P, 2001, PLANT SOIL, V237, P173, DOI 10.1023/A:1013351617532; JACOB J, 1991, J EXP BOT, V42, P1003, DOI 10.1093/jxb/42.8.1003; Lai F, 2007, PLANT J, V50, P545, DOI 10.1111/j.1365-313X.2007.03070.x; Leakey ADB, 2006, PLANT PHYSIOL, V140, P779, DOI 10.1104/pp.105.073957; Li B, 2008, PLANT BIOTECHNOL J, V6, P146, DOI 10.1111/j.1467-7652.2007.00301.x; Li JS, 2005, SCIENCE, V310, P121, DOI 10.1126/science.1115711; Li KP, 2007, PLANT SCI, V172, P255, DOI 10.1016/j.plantsci.2006.09.004; LIN TI, 1977, ANAL BIOCHEM, V77, P10, DOI 10.1016/0003-2697(77)90284-6; Liu Y, 2004, PLANT SCI, V167, P217, DOI 10.1016/j.plantsci.2004.02.026; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv S, 2008, PLANT CELL PHYSIOL, V49, P1150, DOI 10.1093/pcp/pcn090; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; MUSICK G. J., 1965, CROP SCI, V5, P601, DOI 10.2135/cropsci1965.0011183X000500060040x; NATR L, 1992, PHOTOSYNTHETICA, V27, P271; Park S, 2005, P NATL ACAD SCI USA, V102, P18830, DOI 10.1073/pnas.0509512102; Pasapula V, 2011, PLANT BIOTECHNOL J, V9, P88, DOI 10.1111/j.1467-7652.2010.00535.x; Plenet D, 2000, PLANT SOIL, V223, P119, DOI 10.1023/A:1004877111238; Schachtman DP, 1998, PLANT PHYSIOL, V116, P447, DOI 10.1104/pp.116.2.447; Smart LB, 1998, PLANT PHYSIOL, V116, P1539, DOI 10.1104/pp.116.4.1539; Smith FW, 2000, BBA-BIOMEMBRANES, V1465, P236, DOI 10.1016/S0005-2736(00)00141-3; Smith FW, 2003, PLANT SOIL, V248, P71, DOI 10.1023/A:1022376332180; Smith FW, 2001, PLANT SOIL, V232, P109, DOI 10.1023/A:1010390120820; TADANO T, 1991, SOIL SCI PLANT NUTR, V37, P129, DOI 10.1080/00380768.1991.10415018; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Yang H, 2007, PLANT BIOTECHNOL J, V5, P735, DOI 10.1111/j.1467-7652.2007.00281.x	34	52	57	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43501	10.1371/journal.pone.0043501	http://dx.doi.org/10.1371/journal.pone.0043501			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952696	Green Published, Green Submitted, gold			2022-12-25	WOS:000308206500012
J	Abdo, DA; Bellchambers, LM; Evans, SN				Abdo, David A.; Bellchambers, Lynda M.; Evans, Scott N.			Turning up the Heat: Increasing Temperature and Coral Bleaching at the High Latitude Coral Reefs of the Houtman Abrolhos Islands	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CLIMATE-CHANGE; RANGE SHIFTS; WESTERN; IMPACTS; THRESHOLDS; MORTALITY; REPRODUCTION; COMMUNITIES; DIVERSITY	Background: Coral reefs face increasing pressures particularly when on the edge of their distributions. The Houtman Abrolhos Islands (Abrolhos) are the southernmost coral reef system in the Indian Ocean, and one of the highest latitude reefs in the world. These reefs have a unique mix of tropical and temperate marine fauna and flora and support 184 species of coral, dominated by Acropora species. A significant La Nina event during 2011 produced anomalous conditions of increased temperature along the whole Western Australian coastline, producing the first-recorded widespread bleaching of corals at the Abrolhos. Methodology/Principal Findings: We examined long term trends in the marine climate at the Abrolhos using historical sea surface temperature data (HadISST data set) from 1900-2011. In addition in situ water temperature data for the Abrolhos (from data loggers installed in 2008, across four island groups) were used to determine temperature exposure profiles. Coupled with the results of coral cover surveys conducted annually since 2007; we calculated bleaching thresholds for monitoring sites across the four Abrolhos groups. Conclusions/Significance: In situ temperature data revealed maximum daily water temperatures reached 29.54 degrees C in March 2011 which is 4.2 degrees C above mean maximum daily temperatures (2008-2010). The level of bleaching varied across sites with an average of similar to 12% of corals bleached. Mortality was high, with a mean similar to 50% following the 2011 bleaching event. Prior to 2011, summer temperatures reached a mean (across all monitoring sites) of 25.1 degrees C for 2.5 days. However, in 2011 temperatures reached a mean of 28.1 degrees C for 3.3 days. Longer term trends (1900-2011) showed mean annual sea surface temperatures increase by 0.01 degrees C per annum. Long-term temperature data along with short-term peaks in 2011, outline the potential for corals to be exposed to more frequent bleaching risk with consequences for this high latitude coral reef system at the edge of its distribution.	[Abdo, David A.; Bellchambers, Lynda M.; Evans, Scott N.] Govt Western Australia, Dept Fisheries, Biodivers & Biosecur Branch, Marine Ecol & Monitoring Sect, Hillarys, WA, Australia		Abdo, DA (corresponding author), Govt Western Australia, Dept Fisheries, Biodivers & Biosecur Branch, Marine Ecol & Monitoring Sect, Hillarys, WA, Australia.	dave.abdo@fish.wa.gov.au	Abdo, David/F-5480-2010		Department of Fisheries, Government of Western Australia	Department of Fisheries, Government of Western Australia	Funding was provided by the Department of Fisheries, Government of Western Australia (www.fish.wa.gov.au). The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Addessi L, 2001, CORAL REEFS, V19, P220, DOI 10.1007/PL00006957; Anthony KRN, 2007, LIMNOL OCEANOGR, V52, P716, DOI 10.4319/lo.2007.52.2.0716; Anthony KRN, 2011, AUSTR CORAL REEFS CH; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Berkelmans R, 2002, MAR ECOL PROG SER, V229, P73, DOI 10.3354/meps229073; Berkelmans R., 2009, V205, P103; Berkelmans R, 1999, CORAL REEFS, V18, P219, DOI 10.1007/s003380050186; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Brandt ME, 2009, ECOLOGY, V90, P2859, DOI 10.1890/08-0445.1; Caputi N, 2009, MAR FRESHWATER RES, V60, P129, DOI 10.1071/MF08199; Carilli J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034418; Celliers L, 2002, MAR POLLUT BULL, V44, P1380, DOI 10.1016/S0025-326X(02)00302-8; Cooper TF, 2012, SCIENCE, V335, P593, DOI 10.1126/science.1214570; CRESSWELL GR, 1980, DEEP-SEA RES, V27, P449, DOI 10.1016/0198-0149(80)90055-2; CROSSLAND CJ, 1984, MAR ECOL PROG SER, V15, P135, DOI 10.3354/meps015135; Department of Fisheries, 2011, 2011 DEP FISH; Department of Fisheries, 2007, MAN HOUTM ABR SYST D; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; English S., 1997, SURVEY MANUAL TROPIC; Evans SN, 2010, MAR FRESHWATER RES, V61, P1327, DOI 10.1071/MF10007; Figueira WF, 2010, GLOBAL CHANGE BIOL, V16, P506, DOI 10.1111/j.1365-2486.2009.01934.x; Fromont J, 1999, CORAL REEFS, V18, P340, DOI 10.1007/s003380050209; Greenstein BJ, 2008, GLOBAL CHANGE BIOL, V14, P513, DOI 10.1111/j.1365-2486.2007.01506.x; Harriott VJ, 2002, CORAL REEFS, V21, P83, DOI 10.1007/s00338-001-0201-x; Harrison PL, 2011, CORAL REEFS, V30, P775, DOI 10.1007/s00338-011-0778-7; Heyward AJ, 2010, CORAL REEFS, V29, P631, DOI 10.1007/s00338-009-0578-5; Hill JJ, 2004, METHODS ECOLOGICAL M; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoegh-Guldberg O, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P391, DOI 10.1007/978-94-007-0114-4_22; Hoey AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025824; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUTCHINS JB, 1994, B MAR SCI, V54, P245; JOHANNES RE, 1983, MAR ECOL PROG SER, V11, P105, DOI 10.3354/meps011105; Kleypas JA, 1999, AM ZOOLOGIST, P39; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Leggat W, 2006, CORAL REEFS, V25, P452, DOI 10.1007/s00338-006-0128-3; Leujak W, 2007, J EXP MAR BIOL ECOL, V351, P168, DOI 10.1016/j.jembe.2007.06.028; Logan M, 2020, BIOSTATISTICAL DESIG, DOI DOI 10.1002/9781444319620; Lough J., 2008, GEOPHYS RES LETT, V35; Manzello DP, 2007, MAR POLLUT BULL, V54, P1923, DOI 10.1016/j.marpolbul.2007.08.009; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Maynard JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032175; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; McClanahan TR, 2011, GLOBAL CHANGE BIOL, V17, P2023, DOI 10.1111/j.1365-2486.2011.02395.x; McWilliams JP, 2005, ECOLOGY, V86, P2055, DOI 10.1890/04-1657; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Noreen AME, 2009, P ROY SOC B-BIOL SCI, V276, P3927, DOI 10.1098/rspb.2009.1050; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pearce A., 2011, MARINE HEAT WAVE W A; Pearce A, 2007, MAR FRESHWATER RES, V58, P914, DOI 10.1071/MF07082; Precht WF, 2004, FRONT ECOL ENVIRON, V2, P307; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Silverstein RN, 2011, MAR ECOL PROG SER, V422, P63, DOI 10.3354/meps08934; Smale DA, 2012, CORAL REEFS, V31, P441, DOI 10.1007/s00338-012-0873-4; Sun C, 2012, CLIMATE CHA IN PRESS; Thomson DP, 2010, CORAL REEFS, V29, P923, DOI 10.1007/s00338-010-0650-1; Trewin B.C., 2007, ROLE CLIMATOLOGICAL; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Veron J.E.N., 1988, HERMATYPIC CORALS W; VERON JEN, 1995, CORALS SPACE TIME BI; Webster F, 2002, ASSESSMENT NATURAL H; Wells FE, 1994, INTRO MARINE ENV HOU; Whitaker K, 2006, MAR ECOL PROG SER, V306, P115, DOI 10.3354/meps306115; WILKINSON C, 2002, STATUS CORAL REEFS W; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474	70	51	51	4	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43878	10.1371/journal.pone.0043878	http://dx.doi.org/10.1371/journal.pone.0043878			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952797	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206000057
J	Cheung, T; Oberoi, S				Cheung, Tracy; Oberoi, Snehlata			Three Dimensional Assessment of the Pharyngeal Airway in Individuals with Non-Syndromic Cleft Lip and Palate	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; NASAL AIRWAY; NASOPHARYNGEAL CHARACTERISTICS; CHILDREN; AGE	Introduction: Children with cleft lip and palate (CLP) are known to have airway problems. Previous studies have shown that individuals with CLP have a 30% reduction in nasal airway size compared to non-cleft controls. No reports have been found on cross-sectional area and volume of the pharyngeal airway in clefts. Introduction of Cone-Beam CT (CBCT) and imaging software has facilitated generation of 3D images for assessment of the cross-sectional area and volume of the airway. Objective: To assess the pharyngeal airway in individuals with CLP using CBCT by measuring volume and smallest cross-sectional areas and compare with 19 age-and sex-matched non-cleft controls. Methods: Retrospective study of CBCT data of pre-adolescent individuals (N = 19, Mean age = 10.6, 7 females, 12 males, UCLP = 6, BCLP = 3) from the Center for Craniofacial Anomalies. Volumetric analysis was performed using image segmentation features in CB Works 3.0. Volume and smallest cross-sectional were studied in both groups. Seven measurements were repeated to verify reliability using Pearson correlation coefficient. Volume and cross-sectional area differences were analyzed using paired t-tests. Results: The method was found to be reliable. Individuals with CLP did not exhibit smaller total airway volume and cross sectional area than non-CLP controls. Conclusion: 3D imaging using CBCT and CB Works is reliable for assessing airway volume. Previous studies have shown that the nasal airway is restricted in individuals with CLP. In our study, we found that the pharyngeal airway is not compromised in these individuals.	[Cheung, Tracy] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Oberoi, Snehlata] Univ Calif San Francisco, Sch Dent, Dept Orofacial Sci, Div Orthodont, San Francisco, CA USA	University of California System; University of California Los Angeles; University of California System; University of California San Francisco	Cheung, T (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.	sneha.oberoi@ucsf.edu						Aboudara C, 2009, AM J ORTHOD DENTOFAC, V135, P468, DOI 10.1016/j.ajodo.2007.04.043; Abramson Z, 2009, J CRANIOFAC SURG, V20, P657, DOI 10.1097/SCS.0b013e318193d521; ADUSS H, 1967, ARCHIV OTOLARYNGOL, V85, P53; Canfield MA, 2006, BIRTH DEFECTS RES A, V76, P747, DOI 10.1002/bdra.20294; Desalu I, 2010, Ghana Med J, V44, P16; DRAKE AF, 1993, LARYNGOSCOPE, V103, P915; DRETTNER B, 1960, Acta Otolaryngol, V52, P131; Enciso R, 2010, ORAL SURG ORAL MED O, V109, P285, DOI 10.1016/j.tripleo.2009.09.033; Fukushiro AP, 2005, CLEFT PALATE-CRAN J, V42, P396, DOI 10.1597/03-081.1; Gubisch W, 1995, Facial Plast Surg, V11, P159, DOI 10.1055/s-2008-1064531; HAIRFIELD WM, 1988, CLEFT PALATE J, V25, P135; Honein MA, 1999, TERATOLOGY, V60, P356, DOI 10.1002/(SICI)1096-9926(199912)60:6<356::AID-TERA8>3.0.CO;2-B; Imamura N, 2002, AM J ORTHOD DENTOFAC, V122, P189, DOI 10.1067/mod.2002.125234; ISONO S, 1993, J APPL PHYSIOL, V75, P148, DOI 10.1152/jappl.1993.75.1.148; Iwasaki T, 2009, AM J ORTHOD DENTOFAC, V136; Iwasaki T, 2009, AM J ORTHOD DENTOFAC, V136, DOI 10.1016/j.ajodo.2009.04.010; Kim YJ, 2010, AM J ORTHOD DENTOFAC, V137, DOI 10.1016/j.ajodo.2009.10.025; Ludlow JB, 2006, DENTOMAXILLOFAC RAD, V35, P219, DOI 10.1259/dmfr/14340323; Oberoi S, 2011, ORAL SURG ORAL MED O; Oberoi S, 2010, CLEFT PALATE-CRAN J, V47, P507, DOI 10.1597/08-171; Oberoi S, 2009, CLEFT PALATE-CRAN J, V46, P503, DOI 10.1597/08-153.1; Olszewska E, 2009, EUR ARCH OTO-RHINO-L, V266, P535, DOI 10.1007/s00405-008-0826-2; Ronen O, 2007, PEDIATRICS, V120, pE1028, DOI 10.1542/peds.2006-3433; Scarfe WC, 2006, J CAN DENT ASSOC, V72, P75; Schendel SA, 2010, J ORAL MAXIL SURG, V68, P696, DOI 10.1016/j.joms.2009.07.040; SMAHEL Z, 1991, J CRAN GENET DEV BIO, V11, P24; SMAHEL Z, 1992, CLEFT PALATE-CRAN J, V29, P282, DOI 10.1597/1545-1569(1992)029<0282:NCICWC>2.3.CO;2; TRINDADE IEK, 1992, CLEFT PALATE-CRAN J, V29, P429, DOI 10.1597/1545-1569(1992)029<0429:PFOIWC>2.3.CO;2; WAITZMAN AA, 1992, CLEFT PALATE-CRAN J, V29, P112, DOI 10.1597/1545-1569(1992)029<0112:CSMBOC>2.3.CO;2; Warren D W, 1969, Cleft Palate J, V6, P134; WARREN DW, 1992, CLEFT PALATE-CRAN J, V29, P511, DOI 10.1597/1545-1569(1992)029<0511:NAIBAS>2.3.CO;2; WETMORE RF, 1992, CLEFT PALATE-CRAN J, V29, P498, DOI 10.1597/1545-1569(1992)029<0498:IOMNNF>2.3.CO;2	32	37	38	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43405	10.1371/journal.pone.0043405	http://dx.doi.org/10.1371/journal.pone.0043405			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952677	Green Published, Green Submitted, gold			2022-12-25	WOS:000308206000034
J	Wang, YJ; Zheng, Z; Wang, YC; Liu, JQ; Li, N; Hu, XL; Han, F; Liu, Y; Hu, DH				Wang, Yaojun; Zheng, Zhao; Wang, Yunchuan; Liu, Jiaqi; Li, Na; Hu, Xiaolong; Han, Fu; Liu, Yang; Hu, Dahai			Role of Donor-Specific Regulatory T Cells in Long-Term Acceptance of Rat Hind Limb Allograft	PLOS ONE			English	Article							COMPOSITE TISSUE ALLOTRANSPLANTATION; DOUBLE-HAND TRANSPLANTATION; IMMUNOSUPPRESSIVE DRUGS; HEMATOPOIETIC-CELLS; TOLERANCE; CHIMERISM; INDUCTION; REJECTION; SURVIVAL; THERAPY	Background: Vascularized bone marrow transplantation (VBMT) is widely accepted as an efficient means of establishing chimerism and inducing tolerance. However, the mechanism underlying is poorly understood. Recently, regulatory T cells (Tregs) have been shown to play an important role in regulating immune responses to allogeneic antigens. In this study, we explored the role of Tregs in the induction of tolerance in an allogeneic hind limb transplantation model. Methodology/Principal Findings: Forty-eight Lewis rats were divided into 6 groups. They received isografts and allografts from Brown-Norway hind limbs. Recipients in groups 1 and 2 received isografts and those in the other groups received allografts. The bone components of donor limbs were kept intact in groups 1, 3, and 5 but removed before transplantation into groups 2, 4, and 6. Tapered cyclosporin A (CsA) was administered to recipients in groups 5 and 6 after transplantation. During the 100-day observation period, all isografts survived, but the allografts in groups 3 and 4 were rejected within 8 to 12 days. CsA-treated intact allografts survived rejection-free for more than 100 days, and CsA-treated allografts lacking bone elements were rejected within 2 months. Stable peripheral chimerism and myeloid chimerism were observed in group 5. Declining peripheral chimerism and a lack of myeloid chimerism were observed in group 6. Donor-specific Tregs were exclusively detected in both peripheral blood and in the spleens of long-term recipient rats in group 5, with an increased FoxP3 mRNA expression in the allografts. This was further demonstrated to be responsible for donor-specific hyporeactivity by in vitro one-way mixed lymphocyte reaction (MLR). Conclusion/Significance: Bone components in the allogeneic hind limbs can induce myeloid chimerism and donor-specific Tregs may be essential to tolerance induction. The bone-removal hind limb model may be a suitable counterpart to the induction of tolerance in the study of limb transplantation.	[Wang, Yaojun; Zheng, Zhao; Wang, Yunchuan; Liu, Jiaqi; Li, Na; Hu, Xiaolong; Han, Fu; Liu, Yang; Hu, Dahai] Fourth Mil Med Univ, Xijing Hosp, Dept Burns & Cutaneous Surg, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University	Wang, YJ (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Burns & Cutaneous Surg, Xian 710032, Shaanxi Provinc, Peoples R China.	burns@fmmu.edu.cn		Hu, Dahai/0000-0001-5543-092X	Academic Support Program Funds of Xijing Hospital, Fourth Military Medical University	Academic Support Program Funds of Xijing Hospital, Fourth Military Medical University	Research described in this article was supported by the Academic Support Program Funds of Xijing Hospital, Fourth Military Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsian E, 2007, MICROSURG, V27, P190; Bonde S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003212; Bozulic LD, 2011, TRANSPLANTATION, V91, P908, DOI 10.1097/TP.0b013e31820fafb4; Brandt C, 2009, ALLERGY, V64, P1588, DOI 10.1111/j.1398-9995.2009.02054.x; Brouha PCR, 2001, TRANSPLANTATION, V72, pS36; Cendales LC, 2006, TRANSPLANTATION, V81, P418, DOI 10.1097/01.tp.0000185304.49987.d8; Demirkiran A, 2008, TRANSPLANTATION, V85, P783, DOI 10.1097/TP.0b013e318166910b; Denecke C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009232; DOI K, 1979, PLAST RECONSTR SURG, V64, P613, DOI 10.1097/00006534-197964050-00003; Dubernard JM, 2003, ANN SURG, V238, P128, DOI 10.1097/01.SLA.0000078945.70869.82; Eljaafari A, 2006, TRANSPLANTATION, V82, P1764, DOI 10.1097/01.tp.0000250937.46187.ca; Foster RD, 2003, TRANSPLANTATION, V76, P988, DOI 10.1097/01.TP.0000079827.91675.A3; Hettiaratchy S, 2004, BRIT J PLAST SURG, V57, P381, DOI 10.1016/j.bjps.2004.02.012; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kreisel D, 2002, TRANSPLANTATION, V73, P1501, DOI 10.1097/00007890-200205150-00022; Kulahci Y, 2010, TRANSPLANTATION, V90, P843, DOI 10.1097/TP.0b013e3181f28bb0; Lanzetta M, 2005, TRANSPLANTATION, V79, P1210, DOI 10.1097/01.TP.0000157118.28394.FA; Levine E, 2005, ANN PLAS SURG, V54, P502, DOI 10.1097/01.sap.0000155282.48465.94; Piza-Katzer H, 2002, J HAND SURG-BRIT EUR, V27B, P385, DOI 10.1054/jhsb.2002.0759; Ravindra KV, 2008, TRANSPL P, V40, P1237, DOI 10.1016/j.transproceed.2008.04.003; Rifle G, 2003, TRANSPLANTATION, V75, p3S, DOI 10.1097/01.TP.0000067943.90241.73; Robinson E, 1996, BRIT J PLAST SURG, V49, P281, DOI 10.1016/S0007-1226(96)90156-3; Rossini AA, 1999, PHYSIOL REV, V79, P99, DOI 10.1152/physrev.1999.79.1.99; Santiago SF, 1999, MICROSURG, V19, P330; Siemionow M, 2002, J HAND SURG-AM, V27A, P1095, DOI 10.1053/jhsu.2002.36524; Starzl TE, 1998, NEW ENGL J MED, V339, P1905, DOI 10.1056/NEJM199812243392607; STEVENS HPJD, 1991, TRANSPLANT P, V23, P623; Tai CY, 2003, TRANSPLANTATION, V75, P1591, DOI 10.1097/01.TP.0000061490.85273.29; Tang QZ, 2012, J MOL CELL BIOL, V4, P11, DOI 10.1093/jmcb/mjr047; Ye EM, 1998, BURNS, V24, P646, DOI 10.1016/S0305-4179(98)00081-3; Ziegler-Graham K, 2008, ARCH PHYS MED REHAB, V89, P422, DOI 10.1016/j.apmr.2007.11.005	31	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43825	10.1371/journal.pone.0043825	http://dx.doi.org/10.1371/journal.pone.0043825			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952774	Green Published, Green Submitted, gold			2022-12-25	WOS:000308206000052
J	Fenoy, IM; Chiurazzi, R; Sanchez, VR; Argenziano, MA; Soto, A; Picchio, MS; Martin, V; Goldman, A				Fenoy, Ignacio M.; Chiurazzi, Romina; Sanchez, Vanesa R.; Argenziano, Mariana A.; Soto, Ariadna; Picchio, Mariano S.; Martin, Valentina; Goldman, Alejandra			Toxoplasma gondii Infection Induces Suppression in a Mouse Model of Allergic Airway Inflammation	PLOS ONE			English	Article							REGULATORY T-CELLS; GROWTH-FACTOR-BETA; HELMINTH INFECTION; IMMUNE-RESPONSES; MURINE MODEL; ASTHMA; IMMUNOSUPPRESSION; CYTOKINES; IL-10; MICE	Allergic asthma is an inflammatory disorder characterized by infiltration of the airway wall with inflammatory cells driven mostly by activation of Th2-lymphocytes, eosinophils and mast cells. There is a link between increased allergy and a reduction of some infections in Western countries. Epidemiological data also show that respiratory allergy is less frequent in people exposed to orofecal and foodborne microbes such as Toxoplasma gondii. We previously showed that both acute and chronic parasite T. gondii infection substantially blocked development of airway inflammation in adult BALB/c mice. Based on the high levels of IFN-gamma along with the reduction of Th2 phenotype, we hypothesized that the protective effect might be related to the strong Th1 immune response elicited against the parasite. However, other mechanisms could also be implicated. The possibility that regulatory T cells inhibit allergic diseases has received growing support from both animal and human studies. Here we investigated the cellular mechanisms involved in T. gondii induced protection against allergy. Our results show for the first time that thoracic lymph node cells from mice sensitized during chronic T. gondii infection have suppressor activity. Suppression was detected both in vitro, on allergen specific T cell proliferation and in vivo, on allergic lung inflammation after adoptive transference from infected/sensitized mice to previously sensitized animals. This ability was found to be contact-independent and correlated with high levels of TGF-beta and CD4(+) FoxP3(+) cells.	[Fenoy, Ignacio M.; Chiurazzi, Romina; Sanchez, Vanesa R.; Argenziano, Mariana A.; Soto, Ariadna; Picchio, Mariano S.; Martin, Valentina; Goldman, Alejandra] Univ Nacl San Martin, CESyMA, Escuela Ciencia & Tecnol, Buenos Aires, DF, Argentina		Fenoy, IM (corresponding author), Univ Nacl San Martin, CESyMA, Escuela Ciencia & Tecnol, Buenos Aires, DF, Argentina.	agoldman@unsam.edu.ar	Argenziano, Mariana/J-9692-2019; Picchio, Mariano/AAE-1114-2019; Argenziano, Mariana/J-5382-2019	Argenziano, Mariana/0000-0002-2825-581X; Argenziano, Mariana/0000-0002-2825-581X; Soto, Ariadna/0000-0002-7265-0956	National Agency for Scientific and Technological Promotion (ANPCyT, Argentina) [PICT 0562/08]; National Research Council (CONICET, Argentina) [PIP 0168]; UNSAM [SJ10/55]	National Agency for Scientific and Technological Promotion (ANPCyT, Argentina)(ANPCyT); National Research Council (CONICET, Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UNSAM	This work was supported by PICT 0562/08 of the National Agency for Scientific and Technological Promotion (ANPCyT, Argentina), by PIP 0168 of the National Research Council (CONICET, Argentina) and by SJ10/55 of the UNSAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSOHN IA, 1995, J IMMUNOL, V155, P3955; Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Arnold IC, 2011, J CLIN INVEST, V121, P3088, DOI 10.1172/JCI45041; Auffermann-Gratzinger S, 2001, BLOOD, V97, P3171, DOI 10.1182/blood.V97.10.3171; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Cambos M, 2008, INT J PARASITOL, V38, P229, DOI 10.1016/j.ijpara.2007.07.006; Chang YJ, 2011, J CLIN INVEST, V121, P57, DOI 10.1172/JCI44845; Couper KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000004; Doetze A, 2000, INT IMMUNOL, V12, P623, DOI 10.1093/intimm/12.5.623; Erb KJ, 1998, J EXP MED, V187, P561, DOI 10.1084/jem.187.4.561; Fenoy I, 2009, CLIN EXP IMMUNOL, V155, P275, DOI 10.1111/j.1365-2249.2008.03813.x; Fernandes JFC, 2010, CLIN IMMUNOL, V136, P148, DOI 10.1016/j.clim.2010.02.019; Fonseca DM, 2012, CLIN EXP ALLERGY, V42, P131, DOI 10.1111/j.1365-2222.2011.03845.x; Gazzinelli RT, 1996, CURR TOP MICROBIOL, V219, P127; GAZZINELLI RT, 1991, J IMMUNOL, V146, P286; GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533; Goni O, 2002, INT IMMUNOL, V14, P1125, DOI 10.1093/intimm/dxf076; Gredmark S, 2003, J VIROL, V77, P10943, DOI 10.1128/JVI.77.20.10943-10956.2003; Guilliams M, 2007, J IMMUNOL, V179, P2748, DOI 10.4049/jimmunol.179.5.2748; Hall BM, 2011, CURR OPIN IMMUNOL, V23, P641, DOI 10.1016/j.coi.2011.07.012; Hansen G, 2000, J CLIN INVEST, V105, P61, DOI 10.1172/JCI7589; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; Jutel M, 2003, EUR J IMMUNOL, V33, P1205, DOI 10.1002/eji.200322919; Kasper L, 2004, INT J PARASITOL, V34, P401, DOI 10.1016/j.ijpara.2003.11.023; KHAN IA, 1995, PARASITE IMMUNOL, V17, P185, DOI 10.1111/j.1365-3024.1995.tb00888.x; Kitagaki K, 2006, J IMMUNOL, V177, P1628, DOI 10.4049/jimmunol.177.3.1628; Kline JN, 2002, AM J PHYSIOL-LUNG C, V283, pL170, DOI 10.1152/ajplung.00402.2001; KuoLee R, 2008, CLIN EXP ALLERGY, V38, P1003, DOI 10.1111/j.1365-2222.2008.02956.x; Langermans JAM, 2001, PARASITE IMMUNOL, V23, P169, DOI 10.1046/j.1365-3024.2001.00371.x; Lloyd CM, 2009, IMMUNITY, V31, P438, DOI 10.1016/j.immuni.2009.08.007; Matricardi PM, 2000, BMJ-BRIT MED J, V320, P412, DOI 10.1136/bmj.320.7232.412; Matricardi PM, 2003, ALLERGY, V58, P461, DOI 10.1034/j.1398-9995.2003.00175.x; McGuirk P, 1998, EUR J IMMUNOL, V28, P153, DOI 10.1002/(SICI)1521-4141(199801)28:01<153::AID-IMMU153>3.3.CO;2-R; McSorley HJ, 2008, J IMMUNOL, V181, P6456, DOI 10.4049/jimmunol.181.9.6456; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Morampudi V, 2011, MICROBES INFECT, V13, P394, DOI 10.1016/j.micinf.2011.01.006; Nakao A, 2000, J EXP MED, V192, P151, DOI 10.1084/jem.192.2.151; Navarro S, 2011, MUCOSAL IMMUNOL, V4, P53, DOI 10.1038/mi.2010.51; Nie CQ, 2007, INFECT IMMUN, V75, P2275, DOI 10.1128/IAI.01783-06; Ozdemir C, 2009, CLIN EXP ALLERGY, V39, P626, DOI 10.1111/j.1365-2222.2009.03242.x; Tenorio EP, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/786078; Provoost S, 2009, ALLERGY, V64, P1539, DOI 10.1111/j.1398-9995.2009.02056.x; Qiu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022004; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Ring J, 2001, CURR OPIN IMMUNOL, V13, P701, DOI 10.1016/S0952-7915(01)00282-5; Robinson DS, 2010, J ALLERGY CLIN IMMUN, V126, P1081, DOI 10.1016/j.jaci.2010.06.025; Romagnani S, 2006, ALLERGY, V61, P3, DOI 10.1111/j.1398-9995.2006.01005; Romagnani S, 2004, J ALLERGY CLIN IMMUN, V113, P395, DOI 10.1016/j.jaci.2003.11.025; Sayers I, 2004, J ALLERGY CLIN IMMUN, V114, P302, DOI 10.1016/j.jaci.2004.03.057; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Smit JJ, 2003, EUR J PHARMACOL, V470, P193, DOI 10.1016/S0014-2999(03)01794-1; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Vigario AM, 2007, INT J PARASITOL, V37, P963, DOI 10.1016/j.ijpara.2007.01.004; Wagner A, 2009, INT J PARASITOL, V39, P465, DOI 10.1016/j.ijpara.2008.09.003; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572; Wohlleben G, 2004, INT IMMUNOL, V16, P585, DOI 10.1093/intimm/dxh062; Wohlleben G, 2003, J IMMUNOL, V170, P4601, DOI 10.4049/jimmunol.170.9.4601; Zuany-Amorim C, 2002, NAT MED, V8, P625, DOI 10.1038/nm0602-625	61	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43420	10.1371/journal.pone.0043420	http://dx.doi.org/10.1371/journal.pone.0043420			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952678	Green Published, gold, Green Submitted			2022-12-25	WOS:000308213600023
J	Park, CS; Cha, H; Kwon, EJ; Jeong, D; Hajjar, RJ; Kranias, EG; Cho, C; Park, WJ; Kim, DH				Park, Chang Sik; Cha, Hyeseon; Kwon, Eun Jeong; Jeong, Dongtak; Hajjar, Roger J.; Kranias, Evangelia G.; Cho, Chunghee; Park, Woo Jin; Kim, Do Han			AAV-Mediated Knock-Down of HRC Exacerbates Transverse Aorta Constriction-Induced Heart Failure	PLOS ONE			English	Article							CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; INDUCED CARDIAC-HYPERTROPHY; CHANNEL RYANODINE RECEPTOR; CA-BINDING-PROTEIN; RICH CA2+-BINDING PROTEIN; HISTIDINE-RICH; SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; DILATED CARDIOMYOPATHY; II PHOSPHORYLATION	Background: Histidine-rich calcium binding protein (HRC) is located in the lumen of sarcoplasmic reticulum (SR) that binds to both triadin (TRN) and SERCA affecting Ca2+ cycling in the SR. Chronic overexpression of HRC that may disrupt intracellular Ca2+ homeostasis is implicated in pathogenesis of cardiac hypertrophy. Ablation of HRC showed relatively normal phenotypes under basal condition, but exhibited a significantly increased susceptibility to isoproterenol-induced cardiac hypertrophy. In the present study, we characterized the functions of HRC related to Ca2+ cycling and pathogenesis of cardiac hypertrophy using the in vitro siRNA-and the in vivo adeno-associated virus (AAV)-mediated HRC knock-down (KD) systems, respectively. Methodology/Principal Findings: AAV-mediated HRC-KD system was used with or without C57BL/6 mouse model of transverse aortic constriction-induced failing heart (TAC-FH) to examine whether HRC-KD could enhance cardiac function in failing heart (FH). Initially we expected that HRC-KD could elicit cardiac functional recovery in failing heart (FH), since predesigned siRNA-mediated HRC-KD enhanced Ca2+ cycling and increased activities of RyR2 and SERCA2 without change in SR Ca2+ load in neonatal rat ventricular cells (NRVCs) and HL-1 cells. However, AAV9-mediated HRC-KD in TAC-FH was associated with decreased fractional shortening and increased cardiac fibrosis compared with control. We found that phospho-RyR2, phospho-CaMKII, phospho-p38 MAPK, and phospho-PLB were significantly upregulated by HRC-KD in TAC-FH. A significantly increased level of cleaved caspase-3, a cardiac cell death marker was also found, consistent with the result of TUNEL assay. Conclusions/Significance: Increased Ca2+ leak and cytosolic Ca2+ concentration due to a partial KD of HRC could enhance activity of CaMKII and phosphorylation of p38 MAPK, causing the mitochondrial death pathway observed in TAC-FH. Our results present evidence that down-regulation of HRC could deteriorate cardiac function in TAC-FH through perturbed SR-mediated Ca2+ cycling.	[Park, Chang Sik; Cha, Hyeseon; Kwon, Eun Jeong; Cho, Chunghee; Park, Woo Jin; Kim, Do Han] Gwangju Inst Sci & Technol, Coll Life Sci, Kwangju, South Korea; [Park, Chang Sik; Cha, Hyeseon; Kwon, Eun Jeong; Cho, Chunghee; Park, Woo Jin; Kim, Do Han] Gwangju Inst Sci & Technol, Syst Biol Res Ctr, Kwangju, South Korea; [Jeong, Dongtak; Hajjar, Roger J.] Mt Sinai Sch Med, Cardiovasc Res Ctr, New York, NY USA; [Kranias, Evangelia G.] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Icahn School of Medicine at Mount Sinai; University System of Ohio; University of Cincinnati	Park, CS (corresponding author), Gwangju Inst Sci & Technol, Coll Life Sci, Kwangju, South Korea.	dhkim@gist.ac.kr	Jeong, Dongtak/AAK-4194-2020; Jeong, Dongtak/ABA-7745-2020; Dongtak, Jeong/AGZ-5435-2022	Jeong, Dongtak/0000-0003-4153-3498; 	National Research Foundation (NRF) for the Ministry of Education, Science and Technology (MEST) [2011-0002144]; Gwangju Institute of Science and Technology.(GIST) [2011]	National Research Foundation (NRF) for the Ministry of Education, Science and Technology (MEST); Gwangju Institute of Science and Technology.(GIST)	This project was supported by: National Research Foundation (NRF) for the Ministry of Education, Science and Technology (MEST) grant (2011-0002144). Gwangju Institute of Science and Technology.(GIST) Systems Biology Infrastructure Establishment Grant (2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; Arvanitis DA, 2008, EUR HEART J, V29, P2514, DOI 10.1093/eurheartj/ehn328; Arvanitis DA, 2007, AM J PHYSIOL-HEART C, V293, pH1581, DOI 10.1152/ajpheart.00278.2007; Babu GJ, 2006, J BIOL CHEM, V281, P3972, DOI 10.1074/jbc.M508998200; Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Cha H, 2010, EXP MOL MED, V42, P61, DOI 10.3858/emm.2010.42.1.006; CHEN SRW, 1993, BIOCHEMISTRY-US, V32, P3743, DOI 10.1021/bi00065a029; Chopra N, 2009, P NATL ACAD SCI USA, V106, P7636, DOI 10.1073/pnas.0902919106; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Diez J, 1998, CURR OPIN CARDIOL, V13, P317, DOI 10.1097/00001573-199809000-00005; Du GG, 2001, P NATL ACAD SCI USA, V98, P13625, DOI 10.1073/pnas.241516898; Fan GC, 2004, AM J PHYSIOL-HEART C, V287, pH1705, DOI 10.1152/ajpheart.01211.2003; Gregory KN, 2006, J MOL CELL CARDIOL, V40, P653, DOI 10.1016/j.yjmcc.2006.02.003; Guo T, 2006, CIRC RES, V99, P398, DOI 10.1161/01.RES.0000236756.06252.13; GUO W, 1995, J BIOL CHEM, V270, P9027, DOI 10.1074/jbc.270.16.9027; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; Han PD, 2011, AM J PHYSIOL-HEART C, V301, pH1588, DOI 10.1152/ajpheart.01153.2010; Hang T, 2006, ANN CLIN LAB SCI, V36, P88; Hoch B, 1999, CIRC RES, V84, P713, DOI 10.1161/01.RES.84.6.713; HOFMANN SL, 1989, J BIOL CHEM, V264, P18083; Jaehnig EJ, 2006, MOL CELL BIOL, V26, P9315, DOI 10.1128/MCB.00482-06; Jeong D, 2006, CIRC RES, V99, P307, DOI 10.1161/01.RES.0000234780.06115.2c; Jiang DW, 2002, CIRC RES, V91, P218, DOI 10.1161/01.RES.0000028455.36940.5E; KIM DH, 1994, J MOL CELL CARDIOL, V26, P1505, DOI 10.1006/jmcc.1994.1169; Kim E, 2003, BIOCHEM BIOPH RES CO, V300, P192, DOI 10.1016/S0006-291X(02)02829-2; Kobayashi YM, 2000, J BIOL CHEM, V275, P17639, DOI 10.1074/jbc.M002091200; Lee HG, 2001, J BIOL CHEM, V276, P39533, DOI 10.1074/jbc.M010664200; Lee JM, 2004, J BIOL CHEM, V279, P6994, DOI 10.1074/jbc.M312446200; Lee SH, 2012, J MOL CELL CARDIOL, V52, P718, DOI 10.1016/j.yjmcc.2011.12.002; Linden RM, 2002, NAT BIOTECHNOL, V20, P987, DOI 10.1038/nbt1002-987; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Nguyen A, 2004, FEBS LETT, V572, P307, DOI 10.1016/j.febslet.2004.06.061; Palomeque J, 2009, CIRC RES, V105, P1204, DOI 10.1161/CIRCRESAHA.109.204172; PICELLO E, 1992, BIOCHEM BIOPH RES CO, V186, P659, DOI 10.1016/0006-291X(92)90797-O; Sahoo SK, 2009, J BIOL CHEM, V284, P31109, DOI 10.1074/jbc.M109.031989; Seo IR, 2006, BIOCHEM J, V399, P325, DOI 10.1042/BJ20060701; Suckau L, 2009, CIRCULATION, V119, P1241, DOI 10.1161/CIRCULATIONAHA.108.783852; Suk JY, 1999, BIOCHEM BIOPH RES CO, V263, P667, DOI 10.1006/bbrc.1999.1432; Terentyev D, 2005, CIRC RES, V96, P651, DOI 10.1161/01.RES.0000160609.98948.25; Ward P, 2003, J VIROL, V77, P11480, DOI 10.1128/JVI.77.21.11480-11490.2003; Ward P, 2000, J VIROL, V74, P744, DOI 10.1128/JVI.74.2.744-754.2000; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; Yoon PO, 2010, J MOL CELL CARDIOL, V49, P294, DOI 10.1016/j.yjmcc.2010.04.010; Zhang T, 2004, CARDIOVASC RES, V63, P476, DOI 10.1016/j.cardiores.2004.04.026; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5; Zhang T, 2002, J BIOL CHEM, V277, P1261, DOI 10.1074/jbc.M108525200; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200; Zhao XL, 2010, BIOPHYS J, V99, P1556, DOI 10.1016/j.bpj.2010.06.050; Zhou XY, 2007, CARDIOVASC RES, V75, P487, DOI 10.1016/j.cardiores.2007.04.005; Zhu WZ, 2007, J BIOL CHEM, V282, P10833, DOI 10.1074/jbc.M611507200	50	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43282	10.1371/journal.pone.0043282	http://dx.doi.org/10.1371/journal.pone.0043282			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952658	Green Submitted, gold, Green Published			2022-12-25	WOS:000308213600019
J	Yamaguchi, A; Tanaka, S; Yamaguchi, S; Kuwahara, H; Takamura, C; Imajoh-Ohmi, S; Horikawa, DD; Toyoda, A; Katayama, T; Arakawa, K; Fujiyama, A; Kubo, T; Kunieda, T				Yamaguchi, Ayami; Tanaka, Sae; Yamaguchi, Shiho; Kuwahara, Hirokazu; Takamura, Chizuko; Imajoh-Ohmi, Shinobu; Horikawa, Daiki D.; Toyoda, Atsushi; Katayama, Toshiaki; Arakawa, Kazuharu; Fujiyama, Asao; Kubo, Takeo; Kunieda, Takekazu			Two Novel Heat-Soluble Protein Families Abundantly Expressed in an Anhydrobiotic Tardigrade	PLOS ONE			English	Article							LIFE-TARSE MISSION; TREHALOSE; SPACE; DESICCATION; SEQUENCE; MECHANISMS; RESISTANCE; TOLERANCE	Tardigrades are able to tolerate almost complete dehydration by reversibly switching to an ametabolic state. This ability is called anhydrobiosis. In the anhydrobiotic state, tardigrades can withstand various extreme environments including space, but their molecular basis remains largely unknown. Late embryogenesis abundant (LEA) proteins are heat-soluble proteins and can prevent protein-aggregation in dehydrated conditions in other anhydrobiotic organisms, but their relevance to tardigrade anhydrobiosis is not clarified. In this study, we focused on the heat-soluble property characteristic of LEA proteins and conducted heat-soluble proteomics using an anhydrobiotic tardigrade. Our heat-soluble proteomics identified five abundant heat-soluble proteins. All of them showed no sequence similarity with LEA proteins and formed two novel protein families with distinct subcellular localizations. We named them Cytoplasmic Abundant Heat Soluble (CAHS) and Secretory Abundant Heat Soluble (SAHS) protein families, according to their localization. Both protein families were conserved among tardigrades, but not found in other phyla. Although CAHS protein was intrinsically unstructured and SAHS protein was rich in beta-structure in the hydrated condition, proteins in both families changed their conformation to an alpha-helical structure in water-deficient conditions as LEA proteins do. Two conserved repeats of 19-mer motifs in CAHS proteins were capable to form amphiphilic stripes in alpha-helices, suggesting their roles as molecular shield in water-deficient condition, though charge distribution pattern in alpha-helices were different between CAHS and LEA proteins. Tardigrades might have evolved novel protein families with a heat-soluble property and this study revealed a novel repertoire of major heat-soluble proteins in these anhydrobiotic animals.	[Yamaguchi, Ayami; Tanaka, Sae; Yamaguchi, Shiho; Kuwahara, Hirokazu; Horikawa, Daiki D.; Kubo, Takeo; Kunieda, Takekazu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; [Takamura, Chizuko; Imajoh-Ohmi, Shinobu] Univ Tokyo, Inst Med Sci, Tokyo 113, Japan; [Toyoda, Atsushi; Fujiyama, Asao] Natl Inst Genet, Ctr Genet Resource Informat, Mishima, Shizuoka 411, Japan; [Katayama, Toshiaki] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo 113, Japan; [Arakawa, Kazuharu] Keio Univ, Inst Adv Biosci, Fujisawa, Kanagawa, Japan; [Fujiyama, Asao] Natl Inst Informat, Principles Informat Res Div, Tokyo, Japan	University of Tokyo; University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Tokyo; Keio University; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan	Yamaguchi, A (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan.	kunieda@biol.s.u-tokyo.ac.jp	KUBO, TAKEO/G-4951-2014; Kunieda, Takekazu/G-4946-2014	Arakawa, Kazuharu/0000-0002-2893-4919; Kunieda, Takekazu/0000-0002-6256-1335; Kubo, Takeo/0000-0002-5914-5269; Tanaka, Sae/0000-0002-3460-2777	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [21710223, 20017010]; Grants-in-Aid for Scientific Research [21200043] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Young Scientists (B) 21710223, and a Grant-in-Aid for Scientific Research on Priority Areas, Comparative Genomics 20017010 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browne JA, 2004, EUKARYOT CELL, V3, P966, DOI 10.1128/EC.3.4.966-975.2004; Chakrabortee S, 2007, P NATL ACAD SCI USA, V104, P18073, DOI 10.1073/pnas.0706964104; CLEGG JS, 1965, COMP BIOCHEM PHYSIOL, V14, P135, DOI 10.1016/0010-406X(65)90014-9; Dure L, 2001, PROTEIN PEPTIDE LETT, V8, P115, DOI 10.2174/0929866013409643; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Forster F, 2012, BIOINFORM BIOL INSIG, V6, P69, DOI 10.4137/BBI.S9150; Forster F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-469; Goyal K, 2003, J BIOL CHEM, V278, P12977, DOI 10.1074/jbc.M212007200; Hengherr S, 2008, FEBS J, V275, P281, DOI 10.1111/j.1742-4658.2007.06198.x; Horikawa DD, 2008, ASTROBIOLOGY, V8, P549, DOI 10.1089/ast.2007.0139; Jones BL, 2012, COMP BIOCHEM PHYS A, V162, P193, DOI 10.1016/j.cbpa.2012.02.020; Jonsson I., 2014, OPEN ZOOL J, V3, P1, DOI [10.2174/1874336601003010001, DOI 10.2174/1874336601003010001]; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Kikawada T, 2006, BIOCHEM BIOPH RES CO, V348, P56, DOI 10.1016/j.bbrc.2006.07.003; MADIN KAC, 1975, J EXP ZOOL, V193, P335, DOI 10.1002/jez.1401930309; Mali B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-168; Mobjerg N, 2011, ACTA PHYSIOL, V202, P409, DOI 10.1111/j.1748-1716.2011.02252.x; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Persson D, 2011, J ZOOL SYST EVOL RES, V49, P90, DOI 10.1111/j.1439-0469.2010.00605.x; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Rebecchi L, 2011, J ZOOL SYST EVOL RES, V49, P98, DOI 10.1111/j.1439-0469.2010.00606.x; Rebecchi L, 2009, ASTROBIOLOGY, V9, P581, DOI 10.1089/ast.2008.0305; SCHIEVANO E, 1994, BIOPOLYMERS, V34, P879, DOI 10.1002/bip.360340707; Schill RO, 2010, TOPICS CURRENT GENET, P133; Schokraie E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009502; Shimizu T, 2010, BIOCHEMISTRY-US, V49, P1093, DOI 10.1021/bi901745f; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Tolleter D, 2007, PLANT CELL, V19, P1580, DOI 10.1105/tpc.107.050104; Tunnacliffe A, 2005, HYDROBIOLOGIA, V546, P315, DOI 10.1007/s10750-005-4239-6; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Watanabe M, 2003, J EXP BIOL, V206, P2281, DOI 10.1242/jeb.00418; WESTH P, 1991, J EXP ZOOL, V258, P303, DOI 10.1002/jez.1402580305	32	68	76	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44209	10.1371/journal.pone.0044209	http://dx.doi.org/10.1371/journal.pone.0044209			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937162	Green Submitted, Green Published, gold			2022-12-25	WOS:000308213600091
J	Yin, D; Yang, WRG; Weissberg, J; Goff, CB; Chen, WK; Kuwayama, Y; Leiter, A; Xing, HT; Meixel, A; Gaut, D; Kirkbir, F; Sawcer, D; Vernier, PT; Said, JW; Gundersen, MA; Koeffler, HP				Yin, Dong; Yang, Wangrong G.; Weissberg, Jack; Goff, Catherine B.; Chen, Weikai; Kuwayama, Yoshio; Leiter, Amanda; Xing, Hongtao; Meixel, Antonie; Gaut, Daria; Kirkbir, Fikret; Sawcer, David; Vernier, P. Thomas; Said, Jonathan W.; Gundersen, Martin A.; Koeffler, H. Phillip			Cutaneous Papilloma and Squamous Cell Carcinoma Therapy Utilizing Nanosecond Pulsed Electric Fields (nsPEF)	PLOS ONE			English	Article							SKIN TUMORIGENESIS; SELF-DESTRUCT; MELANOMAS; SENCAR; MICE; CONVERSION; TUMORS; CD-1	Nanosecond pulsed electric fields (nsPEF) induce apoptotic pathways in human cancer cells. The potential therapeutic effective of nsPEF has been reported in cell lines and in xenograft animal tumor model. The present study investigated the ability of nsPEF to cause cancer cell death in vivo using carcinogen-induced animal tumor model, and the pulse duration of nsPEF was only 7 and 14 nano second (ns). An nsPEF generator as a prototype medical device was used in our studies, which is capable of delivering 7-30 nanosecond pulses at various programmable amplitudes and frequencies. Seven cutaneous squamous cell carcinoma cell lines and five other types of cancer cell lines were used to detect the effect of nsPEF in vitro. Rate of cell death in these 12 different cancer cell lines was dependent on nsPEF voltage and pulse number. To examine the effect of nsPEF in vivo, carcinogen-induced cutaneous papillomas and squamous cell carcinomas in mice were exposed to nsPEF with three pulse numbers (50, 200, and 400 pulses), two nominal electric fields (40 KV/cm and 31 KV/cm), and two pulse durations (7 ns and 14 ns). Carcinogen-induced cutaneous papillomas and squamous carcinomas were eliminated efficiently using one treatment of nsPEF with 14 ns duration pulses (33/39 = 85%), and all remaining lesions were eliminated after a 2nd treatment (6/39 = 15%). 13.5% of carcinogen-induced tumors (5 of 37) were eliminated using 7 ns duration pulses after one treatment of nsPEF. Associated with tumor lysis, expression of the anti-apoptotic proteins Bcl-xl and Bcl-2 were markedly reduced and apoptosis increased (TUNEL assay) after nsPEF treatment. nsPEF efficiently causes cell death in vitro and removes papillomas and squamous cell carcinoma in vivo from skin of mice. nsPEF has the therapeutic potential to remove human squamous carcinoma.	[Yin, Dong; Goff, Catherine B.; Chen, Weikai; Kuwayama, Yoshio; Leiter, Amanda; Xing, Hongtao; Meixel, Antonie; Gaut, Daria; Koeffler, H. Phillip] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Div Hematol Oncol, Los Angeles, CA 90048 USA; [Yang, Wangrong G.; Weissberg, Jack; Kirkbir, Fikret] Univ So Calif, Alfred E Mann Inst Biomed Engn, Los Angeles, CA USA; [Sawcer, David] Univ So Calif, Keck Sch Med, Dept Dermatol, Los Angeles, CA 90033 USA; [Vernier, P. Thomas; Gundersen, Martin A.] Univ So Calif, Ming Hsieh Dept Elect Engn, Viterbi Sch Engn, Los Angeles, CA USA; [Said, Jonathan W.] Univ Calif Los Angeles, Sch Med, Dept Pathol, Los Angeles, CA 90024 USA; [Koeffler, H. Phillip] Natl Univ Hlth Syst, Natl Univ Canc Inst Singapore, Dept Haematol Oncol, Singapore, Singapore; [Koeffler, H. Phillip] Natl Univ Singapore, Canc Sci Inst, Singapore 117548, Singapore	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California; University of Southern California; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National University of Singapore; National University of Singapore	Yin, D (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Div Hematol Oncol, Los Angeles, CA 90048 USA.	yin_dong@yahoo.com	Vernier, P. Thomas/D-7926-2016	Vernier, P. Thomas/0000-0003-2335-1500	Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California; National Institutes of Health [1U54CA143930-02, 5R01CA026038-32]; Tom Collier Foundation; Parker Hughes Trust; A*STAR grant; NATIONAL CANCER INSTITUTE [R01CA026038, U54CA143930] Funding Source: NIH RePORTER	Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tom Collier Foundation; Parker Hughes Trust; A*STAR grant(Agency for Science Technology & Research (A*STAR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Work was supported in part by the Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California, and with grants from the National Institutes of Health 1U54CA143930-02 and 5R01CA026038-32, Tom Collier Foundation, Parker Hughes Trust, A*STAR grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beebe SJ, 2005, J BIOMED BIOTECHNOL, P297, DOI 10.1155/JBB.2005.297; Beebe SJ, 2003, DNA CELL BIOL, V22, P785, DOI 10.1089/104454903322624993; Chen XH, 2009, MELANOMA RES, V19, P361, DOI 10.1097/CMR.0b013e32832f1558; Garon EB, 2007, INT J CANCER, V121, P675, DOI 10.1002/ijc.22723; Hall EH, 2005, DNA CELL BIOL, V24, P283, DOI 10.1089/dna.2005.24.283; Hall EH, 2007, APOPTOSIS, V12, P1721, DOI 10.1007/s10495-007-0083-7; HENNINGS H, 1986, ENVIRON HEALTH PERSP, V68, P69, DOI 10.2307/3430250; HENNINGS H, 1985, CARCINOGENESIS, V6, P1607, DOI 10.1093/carcin/6.11.1607; MCCORMICK DL, 1986, CANCER LETT, V31, P133, DOI 10.1016/0304-3835(86)90003-0; Nuccitelli R, 2006, BIOCHEM BIOPH RES CO, V343, P351, DOI 10.1016/j.bbrc.2006.02.181; Nuccitelli R, 2010, INT J CANCER, V127, P1727, DOI 10.1002/ijc.25364; Nuccitelli R, 2009, INT J CANCER, V125, P438, DOI 10.1002/ijc.24345; Simicevic N, 2005, PHYS MED BIOL, V50, P347, DOI 10.1088/0031-9155/50/2/012; SLAGA TJ, 1986, ENVIRON HEALTH PERSP, V68, P27, DOI 10.2307/3430244; Sylvester PW, 2005, CELL PROLIFERAT, V38, P153, DOI 10.1111/j.1365-2184.2005.00340.x; Vernier PT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-37; Vernier PT, 2004, BIOPHYS J, V86, P4040, DOI 10.1529/biophysj.103.037945; Vernier PT, 2003, BIOCHEM BIOPH RES CO, V310, P286, DOI 10.1016/j.bbrc.2003.08.140; Yang W, 2011, TECHNOL CANCER RES T, V10, P281, DOI 10.7785/tcrt.2012.500204	19	28	32	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43891	10.1371/journal.pone.0043891	http://dx.doi.org/10.1371/journal.pone.0043891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937117	Green Published, Green Submitted, gold			2022-12-25	WOS:000308213600054
J	Kong, SL; Liu, XY; Fu, LW; Yu, XC; An, CC				Kong, Shuanglei; Liu, Xinyao; Fu, Liwen; Yu, Xiangchun; An, Chengcai			I-PfoP3I: A Novel Nicking HNH Homing Endonuclease Encoded in the Group I Intron of the DNA Polymerase Gene in Phormidium foveolarum Phage Pf-WMP3	PLOS ONE			English	Article							COXIELLA-BURNETII; RNA; SEQUENCE; REGION; PSBA	Homing endonucleases encoded in a group I self-splicing intron in a protein-coding gene in cyanophage genomes have not been reported, apart from some free-standing homing edonucleases. In this study, a nicking DNA endonuclease, I-PfoP3I, encoded in a group IA2 intron in the DNA polymerase gene of a T7-like cyanophage Pf-WMP3, which infects the freshwater cyanobacterium Phormidium foveolarum is described. The Pf-WMP3 intron splices efficiently in vivo and self-splices in vitro simultaneously during transcription. I-PfoP3I belongs to the HNH family with an unconventional C-terminal HNH motif. I-PfoP3I nicks the intron-minus Pf-WMP3 DNA polymerase gene more efficiently than the Pf-WMP4 DNA polymerase gene that lacks any intervening sequence in vitro, indicating the variable capacity of I-PfoP3I. I-PfoP3I cleaves 4 nt upstream of the intron insertion site on the coding strand of EXON 1 on both intron-minus Pf-WMP3 and Pf-WMP4 DNA polymerase genes. Using an in vitro cleavage assay and scanning deletion mutants of the intronless target site, the minimal recognition site was determined to be a 14 bp region downstream of the cut site. I-PfoP3I requires Mg2+, Ca2+ or Mn2+ for nicking activity. Phylogenetic analysis suggests that the intron and homing endonuclease gene elements might be inserted in Pf-WMP3 genome individually after differentiation from Pf-WMP4. To our knowledge, this is the first report of the presence of a group I self-splicing intron encoding a functional homing endonuclease in a protein-coding gene in a cyanophage genome.	[Kong, Shuanglei; Liu, Xinyao; Fu, Liwen; Yu, Xiangchun; An, Chengcai] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China	Peking University	Kong, SL (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	chcaian@pku.edu.cn			National High Technology Research and Development Program of China [2006AA06Z341, 2004AA214072]; Beijing Natural Science Foundation [5062020]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the National High Technology Research and Development Program of China [2006AA06Z341, 2004AA214072] (http://www.863.gov.cn/default.htm); and the Beijing Natural Science Foundation [5062020] (http://www.bjnsf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016825; BELFORT M, 1985, CELL, V41, P375, DOI 10.1016/S0092-8674(85)80010-6; BINISZKIEWICZ D, 1994, EMBO J, V13, P4629, DOI 10.1002/j.1460-2075.1994.tb06785.x; Bonocora RP, 2009, CURR BIOL, V19, P223, DOI 10.1016/j.cub.2009.01.033; Bonocora RP, 2004, J BACTERIOL, V186, P8153, DOI 10.1128/JB.186.23.8153-8155.2004; Bonocora RP, 2001, MOL MICROBIOL, V39, P1299, DOI 10.1111/j.1365-2958.2001.02318.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CECH TR, 1994, NAT STRUCT BIOL, V1, P273, DOI 10.1038/nsb0594-273; COLLEAUX L, 1986, CELL, V44, P521, DOI 10.1016/0092-8674(86)90262-X; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Edgell DR, 2000, J BACTERIOL, V182, P5281, DOI 10.1128/JB.182.19.5281-5289.2000; GoodrichBlair H, 1996, CELL, V84, P211, DOI 10.1016/S0092-8674(00)80976-9; Haugen P, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-159; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Johnson RM, 2009, CLIN CHIM ACTA, V400, P74, DOI 10.1016/j.cca.2008.10.006; Ko M, 2002, J BACTERIOL, V184, P3917, DOI 10.1128/JB.184.14.3917-3922.2002; Landthaler M, 2004, J BACTERIOL, V186, P4307, DOI 10.1128/JB.186.13.4307-4314.2004; Landthaler M, 2003, NUCLEIC ACIDS RES, V31, P3071, DOI 10.1093/nar/gkg433; Landthaler M, 2002, NUCLEIC ACIDS RES, V30, P1935, DOI 10.1093/nar/30.9.1935; Landthaler M, 2006, J MOL BIOL, V358, P1137, DOI 10.1016/J.JMB.2006.02.054; Lee CN, 2009, APPL ENVIRON MICROB, V75, P7828, DOI 10.1128/AEM.01214-09; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Liu XY, 2008, MICROB ECOL, V56, P671, DOI 10.1007/s00248-008-9386-7; Liu XY, 2007, VIROLOGY, V366, P28, DOI 10.1016/j.virol.2007.04.019; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Mehta P, 2004, PROTEIN SCI, V13, P295, DOI 10.1110/ps.03115604; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Millard A, 2004, P NATL ACAD SCI USA, V101, P11007, DOI 10.1073/pnas.0401478101; Millard AD, 2010, ISME J, V4, P1121, DOI 10.1038/ismej.2010.43; Nikolcheva T, 1997, RNA, V3, P1016; Nord D, 2007, J BACTERIOL, V189, P5293, DOI 10.1128/JB.00234-07; Paques F, 2007, CURR GENE THER, V7, P49, DOI 10.2174/156652307779940216; Raghavan R, 2008, J BACTERIOL, V190, P5934, DOI 10.1128/JB.00602-08; Raghavan R, 2007, J BACTERIOL, V189, P6572, DOI 10.1128/JB.00812-07; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Rohwer F, 2000, LIMNOL OCEANOGR, V45, P408, DOI 10.4319/lo.2000.45.2.0408; Shen BW, 2004, J MOL BIOL, V342, P43, DOI 10.1016/j.jmb.2004.07.032; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; WILSON WH, 1993, APPL ENVIRON MICROB, V59, P3736, DOI 10.1128/AEM.59.11.3736-3743.1993; Zeng QL, 2009, CURR BIOL, V19, P218, DOI 10.1016/j.cub.2008.11.069; Zhao L, 2007, EMBO J, V26, P2432, DOI 10.1038/sj.emboj.7601672; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	43	2	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43738	10.1371/journal.pone.0043738	http://dx.doi.org/10.1371/journal.pone.0043738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952751	Green Submitted, gold, Green Published			2022-12-25	WOS:000308044800056
J	Pascalis, H; Temmam, S; Wilkinson, DA; Dsouli, N; Turpin, M; de Lamballerie, X; Dellagi, K				Pascalis, Herve; Temmam, Sarah; Wilkinson, David A.; Dsouli, Najla; Turpin, Magali; de lamballerie, Xavier; Dellagi, Koussay			Molecular Evolutionary Analysis of pH1N1 2009 Influenza Virus in Reunion Island, South West Indian Ocean Region: A Cohort Study	PLOS ONE			English	Article							A H1N1 VIRUS; PANDEMIC INFLUENZA; HEMAGGLUTININ; A(H1N1); TRANSMISSION; EMERGENCE; ORIGIN; INDIVIDUALS; INFECTION; SEVERITY	Background/Objectives: Molecular epidemiology is a powerful tool to decipher the dynamics of viral transmission, quasispecies temporal evolution and origins. Little is known about the pH1N1 molecular dynamics in general population. A prospective study (CoPanFlu-RUN) was carried out in Reunion Island to characterize pH1N1 genetic variability and molecular evolution occurring in population during the pH1N1 Influenza pandemic in 2009. Methodology: We directly amplified pH1N1 genomes from 28 different nasal swabs (26 individuals from 21 households). Fifteen strains were fully sequenced and 13 partially. This includes pairs of sequences from different members of 5 separate households; and two pairs from individuals, collected at different times. We assessed the molecular evolution of pH1N1 by genetic variability and phylogenetic analyses. Principal Findings: We found that i) Reunion pH1N1 sequences stemmed from global "clade 7'' but shaped two phylogenetic sub-clades; ii) D239E mutation was identified in the hemagglutinin protein of all Reunion sequences, a mutation which has been associated elsewhere with mild-, upper-respiratory tract pH1N1 infecting strains; iii) Date estimates from molecular phylogenies predicted clade emergence some time before the first detection of pH1N1 by the epidemiological surveillance system; iv) Phylogenetic relatedness was observed between Reunion pH1N1 viruses and those from other countries in South-western Indian Ocean area; v) Quasispecies populations were observed within households and individuals of the cohort-study. Conclusions: Surveillance and/or prevention systems presently based on Influenza virus sequence variation should take into account that the majority of studies of pH1N1 Influenza generate genetic data for the HA/NA viral segments obtained from hospitalized-patients, which is potentially non-representative of the overall viral diversity within whole populations. Our observations highlight the importance of collecting unbiased data at the community level and conducting whole genome analysis to accurately understand viral dynamics.	[Pascalis, Herve; Temmam, Sarah; Wilkinson, David A.; Dsouli, Najla; Turpin, Magali; Dellagi, Koussay] GIS CRVOI, Ctr Rech & Veille Malad Emergentes Ocean Indien, Plateforme Technol CYROI, St Denis, Reunion, France; [Temmam, Sarah] Univ Lyon, CNRS, Ecol Microbienne UMR 5557, Lyon, France; [Wilkinson, David A.] Univ Reunion, St Denis, Reunion, France; [de lamballerie, Xavier] Univ Mediterranee, IRD, Unite Virus Emergents UMR S 190, Marseille, France	Centre National de la Recherche Scientifique (CNRS); University of La Reunion; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Pascalis, H (corresponding author), GIS CRVOI, Ctr Rech & Veille Malad Emergentes Ocean Indien, Plateforme Technol CYROI, St Denis, Reunion, France.	herve.pascalis@ird.fr	TEMMAM, Sarah/AAX-3717-2021; Pascalis, Herve/M-9410-2019; Pascalis, Herve/F-5726-2014	TEMMAM, Sarah/0000-0003-3655-9220; Pascalis, Herve/0000-0002-6822-7311; Abid, sayda/0000-0003-2488-1431; Wilkinson, David/0000-0002-9986-6212	CPER-ERDF (Contrat Programme Etat/Region and European Regional Development Fund); INSERM/IMMI; CRVOI; RUN-Emerge: European; European Commission under FP7 program; CPER-ERDF (Contrat Programme Etat/Region and European Regional Development Fund); INSERM/IMMI; CRVOI; RUN-Emerge: European; European Commission under FP7 program	CPER-ERDF (Contrat Programme Etat/Region and European Regional Development Fund); INSERM/IMMI(Institut National de la Sante et de la Recherche Medicale (Inserm)); CRVOI; RUN-Emerge: European; European Commission under FP7 program; CPER-ERDF (Contrat Programme Etat/Region and European Regional Development Fund); INSERM/IMMI(Institut National de la Sante et de la Recherche Medicale (Inserm)); CRVOI; RUN-Emerge: European; European Commission under FP7 program	This study was supported by funds from CPER-ERDF (Contrat Programme Etat/Region and European Regional Development Fund), INSERM/IMMI and CRVOI. D.A. Wilkinson post-doctoral fellowships were funded by RUN-Emerge: European project funded by European Commission under FP7 program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Barrero PR, 2011, J VIROL, V85, P1058, DOI 10.1128/JVI.00936-10; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Boelle PY, 2011, INFLUENZA OTHER RESP, V5, P306, DOI 10.1111/j.1750-2659.2011.00234.x; Brownstein JS, 2006, PLOS MED, V3, P1826, DOI 10.1371/journal.pmed.0030401; Chan KH, 2011, CLIN VACCINE IMMUNOL, V18, P867, DOI 10.1128/CVI.00555-10; Chao DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014555; Chen HL, 2010, J INFECT DIS, V201, P1517, DOI 10.1086/652661; D'Ortenzio E, 2010, CLIN MICROBIOL INFEC, V16, P309, DOI 10.1111/j.1469-0691.2010.03171.x; Dellagi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025738; Drummond AJ, 2010, GENEIOUS V5 3; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Ferraris O, 2008, J CLIN VIROL, V41, P13, DOI 10.1016/j.jcv.2007.10.020; Filleul L, 2010, LANCET INFECT DIS, V10, P294, DOI 10.1016/S1473-3099(10)70076-1; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Furuse Y, 2010, BIOINFORMATION, V5, P7, DOI 10.6026/97320630005007; Furuse Y, 2010, INFECT GENET EVOL, V10, P569, DOI 10.1016/j.meegid.2010.01.010; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ghedin E, 2011, J INFECT DIS, V203, P168, DOI 10.1093/infdis/jiq040; Giria MT, 2011, J CLIN VIROLOGY OFFI; Glinsky GV, 2010, CELL CYCLE, V9, P958, DOI 10.4161/cc.9.5.10913; Goni N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-215; Graham M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016087; Greninger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013381; Gubareva LV, 2002, J INFECT DIS, V186, P1575, DOI 10.1086/345372; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Ilyicheva T, 2011, INFECT GENET EVOL; Kelly HA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011341; Koita OA, 2011, SEROEPIDEMIOLOGICAL; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Nelson M., 2009, PLOS CURR, V1, DOI [DOI 10.1371/CURRENTS.RRN1126, 10.1371/currents.RRN1126]; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Ninove L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016142; Ninove L, 2010, VECTOR-BORNE ZOONOT, V10, P237, DOI 10.1089/vbz.2009.0110; Pariani E, 2011, J Prev Med Hyg, V52, P17; Parks D, 2009, PLOS CURRENTS, V1; Poon LLM, 2011, J CLIN VIROL, V52, P146, DOI 10.1016/j.jcv.2011.06.022; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Potdar VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009693; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shiino T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011057; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tse H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022534; Tse H, 2011, EXP BIOL MED, V236, P915, DOI 10.1258/ebm.2011.010264; Zhang AJX, 2011, CLIN VACCINE IMMUNOL, V18, P1918, DOI 10.1128/CVI.05357-11; Zhirnov OP, 2009, J CLIN VIROL, V45, P322, DOI 10.1016/j.jcv.2009.05.030	49	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43742	10.1371/journal.pone.0043742	http://dx.doi.org/10.1371/journal.pone.0043742			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952752	Green Published, gold			2022-12-25	WOS:000308044800057
J	Potashkin, JA; Santiago, JA; Ravina, BM; Watts, A; Leontovich, AA				Potashkin, Judith A.; Santiago, Jose A.; Ravina, Bernard M.; Watts, Arthur; Leontovich, Alexey A.			Biosignatures for Parkinson's Disease and Atypical Parkinsonian Disorders Patients	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; PERIPHERAL-BLOOD LYMPHOCYTES; MITOCHONDRIAL COMPLEX-I; DIFFERENTIAL EXPRESSION; DOPAMINE-RECEPTOR; OXIDATIVE STRESS; GENE-EXPRESSION; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; IMMUNE CELLS	Diagnosis of Parkinson' disease (PD) carries a high misdiagnosis rate due to failure to recognize atypical parkinsonian disorders (APD). Usually by the time of diagnosis greater than 60% of the neurons in the substantia nigra are dead. Therefore, early detection would be beneficial so that therapeutic intervention may be initiated early in the disease process. We used splice variant-specific microarrays to identify mRNAs whose expression is altered in peripheral blood of early-stage PD patients compared to healthy and neurodegenerative disease controls. Quantitative polymerase chain reaction assays were used to validate splice variant transcripts in independent sample sets. Here we report a PD signature used to classify blinded samples with 90% sensitivity and 94% specificity and an APD signature that resulted in a diagnosis with 95% sensitivity and 94% specificity. This study provides the first discriminant functions with coherent diagnostic signatures for PD and APD. Analysis of the PD biomarkers identified a regulatory network with nodes centered on the transcription factors HNF4A and TNF, which have been implicated in insulin regulation.	[Potashkin, Judith A.; Santiago, Jose A.] Rosalind Franklin Univ Med & Sci, Cellular & Mol Pharmacol Dept, Chicago Med Sch, N Chicago, IL USA; [Ravina, Bernard M.] Univ Rochester, Dept Neurol, Sch Med, Rochester, NY USA; [Ravina, Bernard M.] Biogen Idec Inc, Cambridge, MA USA; [Watts, Arthur] Univ Rochester, Sch Med, Dept Biostat, Rochester, NY USA; [Leontovich, Alexey A.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA	Chicago Medical School; Rosalind Franklin University Medical & Science; University of Rochester; Biogen; University of Rochester; Mayo Clinic	Potashkin, JA (corresponding author), Rosalind Franklin Univ Med & Sci, Cellular & Mol Pharmacol Dept, Chicago Med Sch, N Chicago, IL USA.	judy.potashkin@rosalindfranklin.edu	Santiago, Jose A./CAJ-2999-2022	Santiago, Jose A./0000-0002-1431-5789	U.S. Army Medical Research and Materiel Command [W81XWH-09-0708, W23RRYX7022N606]	U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was supported by the U.S. Army Medical Research and Materiel Command under awards number W81XWH-09-0708 to JAP and W23RRYX7022N606 to BMR [https://mrmc.amedd.army.mil/]. Opinions, conclusions, interpretations and recommendations are those of the authors and are not necessarily endorsed by the U.S. Army. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Barbanti P, 1999, MOVEMENT DISORD, V14, P764, DOI 10.1002/1531-8257(199909)14:5<764::AID-MDS1008>3.0.CO;2-W; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Ben-Shaul Y, 2006, EUR J NEUROSCI, V23, P2915, DOI 10.1111/j.1460-9568.2006.04812.x; Beyer K, 2008, NEUROGENETICS, V9, P163, DOI 10.1007/s10048-008-0124-6; Bieler S, 2012, J PROTEOME RES; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Cantuti-Castelvetri I, 2007, NEUROBIOL DIS, V26, P606, DOI 10.1016/j.nbd.2007.02.009; Caronti B, 1999, NEUROREPORT, V10, P2907, DOI 10.1097/00001756-199909290-00006; Caronti B, 2001, J NEURAL TRANSM, V108, P803, DOI 10.1007/s007020170030; Chen HJ, 2006, GENE DEV, V20, P1933, DOI 10.1101/gad.1411206; Choi WS, 2011, J CELL BIOL, V192, P873, DOI 10.1083/jcb.201009132; Cox LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009872; D'Amelio M, 2009, PARKINSONISM RELAT D, V15, P660, DOI 10.1016/j.parkreldis.2009.02.013; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; Fehlbaum-Beurdeley P, 2010, ALZHEIMERS DEMENT, V6, P25, DOI 10.1016/j.jalz.2009.07.001; Foti R, 2010, J BIOL CHEM, V285, P18565, DOI 10.1074/jbc.M109.088294; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Gordon J, 2003, TRENDS IMMUNOL, V24, P438, DOI 10.1016/S1471-4906(03)00176-5; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ilani T, 2004, FASEB J, V18, DOI 10.1096/fj.04-1652fje; Kipnis J, 2004, J NEUROSCI, V24, P6133, DOI 10.1523/JNEUROSCI.0600-04.2004; Lines MA, 2012, AM J HUMAN GENETICS; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Maestro MA, 2007, ENDOCR DEV, V12, P33, DOI 10.1159/000109603; Maracchioni A, 2007, J NEUROCHEM, V100, P142, DOI 10.1111/j.1471-4159.2006.04204.x; McKenna F, 2002, J NEUROIMMUNOL, V132, P34, DOI 10.1016/S0165-5728(02)00280-1; Meredith EJ, 2005, IMMUNOLOGY, V115, P289, DOI 10.1111/j.1365-2567.2005.02166.x; Mill J, 2002, AM J MED GENET, V114, P975, DOI 10.1002/ajmg.b.10948; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Molochnikov L, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-26; Moran LB, 2006, NEUROGENETICS, V7, P1, DOI 10.1007/s10048-005-0020-2; Nagai Y, 1996, NEUROLOGY, V46, P791, DOI 10.1212/WNL.46.3.791; Nieto-Vazquez Iria, 2008, Archives of Physiology and Biochemistry, V114, P183, DOI [10.1080/13813450802181047, 10.1080/13813450802181047 ]; Novikova SI, 2005, NEUROTOXICOL TERATOL, V27, P3, DOI 10.1016/j.ntt.2004.08.004; Petrozzi L, 2001, NEUROL SCI, V22, P83, DOI 10.1007/s100720170058; Poewe W, 2002, EUR J NEUROL, V9, P23, DOI 10.1046/j.1468-1331.9.s3.3.x; Potashkin JA, 2007, BRAIN RES, V1182, P1, DOI 10.1016/j.brainres.2007.08.080; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Rasche A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-310; Ravina B, 2009, MOVEMENT DISORD, V24, P2081, DOI 10.1002/mds.22690; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Sandyk R, 1993, Int J Neurosci, V69, P125; Saris CGJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-405; Savaskan NE, 2004, EUR J NEUROSCI, V19, P212, DOI 10.1046/j.1460-9568.2003.03078.x; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Scherzer CR, 2009, NEUROBIOL DIS, V35, P148, DOI 10.1016/j.nbd.2009.02.016; SCHULZ JB, 1994, CURR OPIN NEUROL, V7, P333, DOI 10.1097/00019052-199408000-00010; Shehadeh LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009104; Soreq L, 2011, NEURODEGENERATIVE DI; Soreq L, 2008, J NEUROIMMUNOL, V201, P227, DOI 10.1016/j.jneuroim.2008.06.019; Spoden GA, 2009, EXP CELL RES, V315, P2765, DOI 10.1016/j.yexcr.2009.06.024; Stetak A, 2007, CANCER RES, V67, P1602, DOI 10.1158/0008-5472.CAN-06-2870; Sunada Y, 1998, NEUROSCI LETT, V254, P180, DOI 10.1016/S0304-3940(98)00697-1; Taccioli C, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar007; Takeo K, 2009, AM J PHYSIOL-CELL PH, V297, pC330, DOI 10.1152/ajpcell.00009.2009; Tan EK, 2005, NEUROGENETICS, V6, P179, DOI 10.1007/s10048-005-0001-5; Testa D, 2001, NEUROL SCI, V22, P247, DOI 10.1007/s100720100021; Turner L, 2011, METHODS MOL BIOL, V724, P269, DOI 10.1007/978-1-61779-055-3_17; ULITSKY I, 2010, PLOS ONE, V0005; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang X, 2007, BRAIN RES, V1132, P1, DOI 10.1016/j.brainres.2006.11.032; Xu Q, 2011, DIABETES CARE, V34, P910, DOI 10.2337/dc10-1922; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; YOSHINO H, 1992, J NEURAL TRANSM-PARK, V4, P27, DOI 10.1007/BF02257619; Zhang YL, 2005, AM J MED GENET B, V137B, P5, DOI 10.1002/ajmg.b.30195; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200	71	45	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43595	10.1371/journal.pone.0043595	http://dx.doi.org/10.1371/journal.pone.0043595			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952715	Green Published, Green Submitted, gold			2022-12-25	WOS:000308044800042
J	Taniwaki, MH; Pitt, JI; Iamanaka, BT; Sartori, D; Copetti, MV; Balajee, A; Fungaro, MHP; Frisvad, JC				Taniwaki, Marta H.; Pitt, John I.; Iamanaka, Beatriz T.; Sartori, Daniele; Copetti, Marina V.; Balajee, Arun; Fungaro, Maria Helena P.; Frisvad, Jens C.			Aspergillus bertholletius sp. nov. from Brazil Nuts	PLOS ONE			English	Article							MYCOTOXINS	During a study on the mycobiota of brazil nuts (Bertholletia excelsa) in Brazil, a new Aspergillus species, A. bertholletius, was found, and is described here. A polyphasic approach was applied using morphological characters, extrolite data as well as partial beta-tubulin, calmodulin and ITS sequences to characterize this taxon. A. bertholletius is represented by nineteen isolates from samples of brazil nuts at various stages of production and soil close to Bertholletia excelsa trees. The following extrolites were produced by this species: aflavinin, cyclopiazonic acid, kojic acid, tenuazonic acid and ustilaginoidin C. Phylogenetic analysis using partial beta-tubulin and camodulin gene sequences showed that A. bertholletius represents a new phylogenetic clade in Aspergillus section Flavi. The type strain of A. bertholletius is CCT 7615 (=ITAL 270/06 = IBT 29228).	[Taniwaki, Marta H.; Iamanaka, Beatriz T.] Inst Tecnol Alimentos, Ctr Ciencia & Qualidade Alimentos, Sao Paulo, Brazil; [Pitt, John I.] CSIRO Anim Food & Hlth Sci, Sydney, NSW, Australia; [Sartori, Daniele; Fungaro, Maria Helena P.] Univ Estadual Londrina, Ctr Ciencias Biol, Londrina, Parana, Brazil; [Copetti, Marina V.] Univ Fed Santa Maria, Dept Tecnol & Ciencia Alimentos, BR-97119900 Santa Maria, RS, Brazil; [Balajee, Arun] Ctr Dis Control & Prevent, Mycot Dis Branch, Atlanta, GA USA; [Frisvad, Jens C.] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Universidade Estadual de Londrina; Universidade Federal de Santa Maria (UFSM); Centers for Disease Control & Prevention - USA; Technical University of Denmark	Taniwaki, MH (corresponding author), Inst Tecnol Alimentos, Ctr Ciencia & Qualidade Alimentos, Sao Paulo, Brazil.	marta@ital.sp.gov.br	Frisvad, Jens C/K-2818-2017; Fapesp, Biota/F-8655-2017; Fungaro, Maria Helena P/H-7369-2014; Taniwaki, Marta/ABF-9849-2021; Copetti, Marina/ABG-3490-2020	Frisvad, Jens C/0000-0002-0573-4340; Fapesp, Biota/0000-0002-9887-8449; Fungaro, Maria Helena P/0000-0002-6199-7030; Taniwaki, Marta/0000-0002-1676-2101; Copetti, Marina/0000-0002-1419-9159	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Ministerio da Agricultura, Pecuaria e Abastecimento, (MAPA) Brazil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministerio da Agricultura, Pecuaria e Abastecimento, (MAPA) Brazil	This research was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Ministerio da Agricultura, Pecuaria e Abastecimento, (MAPA) Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo A. C. S., 2000, Scientia Agricola, V57, P729, DOI 10.1590/S0103-90162000000400021; Bayman P, 2002, MYCOPATHOLOGIA, V155, P161, DOI 10.1023/A:1020419226146; Freire FDO, 2000, MYCOPATHOLOGIA, V149, P13, DOI 10.1023/A:1007241827937; FRISVAD JC, 1987, J CHROMATOGR, V404, P195, DOI 10.1016/S0021-9673(01)86850-3; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Goncalves JS, 2012, WORLD J MICROB BIOT, V28, P1817, DOI 10.1007/s11274-011-0956-3; Hong SB, 2006, INT J SYST EVOL MICR, V56, P477, DOI 10.1099/ijs.0.63980-0; Houbraken J, 2012, ANTON LEEUW INT J G, V101, P403, DOI 10.1007/s10482-011-9647-1; Kornerup A., 1978, METHUEN HDB COLOUR; Olsen M, 2008, WORLD MYCOTOXIN J, V1, P123, DOI 10.3920/WMJ2008.1032; Pitt J. I., 2009, FUNGI FOOD SPOILAGE, DOI DOI 10.3114/sim.2007.59.13; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Varga J, 2011, STUD MYCOL, P57, DOI 10.3114/sim.2011.69.05; Wadt LHO, 2005, FOREST ECOL MANAG, V211, P371, DOI 10.1016/j.foreco.2005.02.061; White T., 1990, PCR PROTOCOLS GUIDE, P315	17	20	22	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e42480	10.1371/journal.pone.0042480	http://dx.doi.org/10.1371/journal.pone.0042480			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952594	Green Submitted, Green Published, gold			2022-12-25	WOS:000308044800008
J	Chen, X; Liu, MX; Cui, QH; Yan, GY				Chen, Xing; Liu, Ming-Xi; Cui, Qing-Hua; Yan, Gui-Ying			Prediction of Disease-Related Interactions between MicroRNAs and Environmental Factors Based on a Semi-Supervised Classifier	PLOS ONE			English	Article							EXPRESSION; CELLS; LIVER; PRIORITIZATION; PATHOGENESIS; MECHANISM; GENOMICS	Accumulated evidence has shown that microRNAs (miRNAs) can functionally interact with a number of environmental factors (EFs) and their interactions critically affect phenotypes and diseases. Therefore, in-silico inference of disease-related miRNA-EF interactions is becoming crucial not only for the understanding of the mechanisms by which miRNAs and EFs contribute to disease, but also for disease diagnosis, treatment, and prognosis. In this paper, we analyzed the human miRNA-EF interaction data and revealed that miRNAs (EFs) with similar functions tend to interact with similar EFs (miRNAs) in the context of a given disease, which suggests a potential way to expand the current relation space of miRNAs, EFs, and diseases. Based on this observation, we further proposed a semi-supervised classifier based method (miREFScan) to predict novel disease-related interactions between miRNAs and EFs. As a result, the leave-one-out cross validation has shown that miREFScan obtained an AUC of 0.9564, indicating that miREFScan has a reliable performance. Moreover, we applied miREFScan to predict acute promyelocytic leukemia-related miRNA-EF interactions. The result shows that forty-nine of the top 1% predictions have been confirmed by experimental literature. In addition, using miREFScan we predicted and publicly released novel miRNA-EF interactions for 97 human diseases. Finally, we believe that miREFScan would be a useful bioinformatic resource for the research about the relationships among miRNAs, EFs, and human diseases.	[Chen, Xing; Yan, Gui-Ying] Chinese Acad Sci, Natl Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China; [Chen, Xing; Liu, Ming-Xi; Yan, Gui-Ying] Chinese Acad Sci, Acad Math & Syst Sci, Beijing, Peoples R China; [Liu, Ming-Xi] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Cui, Qing-Hua] Peking Univ, Dept Biomed Informat, Sch Basic Med Sci, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University	Chen, X (corresponding author), Chinese Acad Sci, Natl Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China.	cuiqinghua@hsc.pku.edu.cn; yangy@amss.ac.cn	Chen, Xing/G-6844-2016	Chen, Xing/0000-0001-9028-5342	National Natural Science of Foundation of China [10531070, 10721101]; NCMIS;  [KJCX-YW-S7]	National Natural Science of Foundation of China(National Natural Science Foundation of China (NSFC)); NCMIS; 	This work was supported by the National Natural Science of Foundation of China under Grant Nos. 10531070, 10721101, KJCX-YW-S7 and NCMIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Alisi A, 2011, LAB INVEST, V91, P283, DOI 10.1038/labinvest.2010.166; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Belkin M, 2006, J MACH LEARN RES, V7, P2399; Bolton EE, 2008, ANN REP COMPUT CHEM, P217; Boren T, 2009, GYNECOL ONCOL, V113, P249, DOI 10.1016/j.ygyno.2009.01.014; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Catania AS, 2009, ARQ BRAS ENDOCRINOL, V53, P550, DOI 10.1590/S0004-27302009000500008; Chen X, 2012, MOL BIOSYST, V8, P1970, DOI 10.1039/c2mb00002d; Chen X, 2010, OMICS, V14, P337, DOI 10.1089/omi.2009.0143; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Das UN, 2010, NUTRITION, V26, P459, DOI 10.1016/j.nut.2009.09.020; Davis CD, 2008, NUTR REV, V66, P477, DOI 10.1111/j.1753-4887.2008.00080.x; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Dudley JT, 2011, BRIEF BIOINFORM, V12, P303, DOI 10.1093/bib/bbr013; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Frantz S, 2005, NATURE, V437, P942, DOI 10.1038/437942a; Gao SM, 2010, BIOCHEM BIOPH RES CO, V403, P203, DOI 10.1016/j.bbrc.2010.10.137; Ghaffari SH, 2012, TUMOR BIOL, V33, P157, DOI 10.1007/s13277-011-0259-1; Gidron Y, 2010, MOL MED REP, V3, P455, DOI 10.3892/mmr_00000279; Gu JY, 2011, MED ONCOL, V28, P211, DOI 10.1007/s12032-009-9413-7; Hattori M, 2003, J AM CHEM SOC, V125, P11853, DOI 10.1021/ja036030u; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Izzotti A, 2010, CARCINOGENESIS, V31, P894, DOI 10.1093/carcin/bgq037; Jafarifar F, 2011, EMBO J, V30, P1324, DOI 10.1038/emboj.2011.38; Jardim MJ, 2011, MUTAT RES-FUND MOL M, V717, P38, DOI 10.1016/j.mrfmmm.2011.03.014; Jiang JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023271; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Landry Y, 2008, FUND CLIN PHARMACOL, V22, P1, DOI 10.1111/j.1472-8206.2007.00548.x; Latronico MVG, 2007, CIRC RES, V101, P1225, DOI 10.1161/CIRCRESAHA.107.163147; Li YM, 2010, HEMATOLOGY, V15, P215, DOI 10.1179/102453310X12647083620840; Lima RT, 2011, EUR J CANCER, V47, P163, DOI 10.1016/j.ejca.2010.11.005; Lin Z, 2011, CANCER LETT, V305, P186, DOI 10.1016/j.canlet.2010.08.018; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Niemoeller OM, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-29; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pandolfi PP, 2007, ACUTE PROMYELOCYTIC; Qiu CX, 2012, SCI REP-UK, V2, DOI 10.1038/srep00318; Soto AM, 2010, NAT REV ENDOCRINOL, V6, P364, DOI 10.1038/nrendo.2010.87; Tang YM, 2008, ALCOHOL CLIN EXP RES, V32, P355, DOI 10.1111/j.1530-0277.2007.00584.x; van Laarhoven T, 2011, BIOINFORMATICS, V27, P3036, DOI 10.1093/bioinformatics/btr500; Wang D, 2010, BIOINFORMATICS, V26, P1644, DOI 10.1093/bioinformatics/btq241; Xi SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013764; Xia Z, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S6; Yang QQ, 2011, BIOINFORMATICS, V27, P3329, DOI 10.1093/bioinformatics/btr556; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338	52	54	55	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43425	10.1371/journal.pone.0043425	http://dx.doi.org/10.1371/journal.pone.0043425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937049	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500050
J	Takenaka, A; Nakamura, S; Mitsunaga, F; Inoue-Murayama, M; Udono, T; Suryobroto, B				Takenaka, Akiko; Nakamura, Shin; Mitsunaga, Fusako; Inoue-Murayama, Miho; Udono, Toshifumi; Suryobroto, Bambang			Human-Specific SNP in Obesity Genes, Adrenergic Receptor Beta2 (ADRB2), Beta3 (ADRB3), and PPAR gamma 2 (PPARG), during Primate Evolution	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; BETA(3)-ADRENERGIC RECEPTOR; INSULIN-RESISTANCE; DIABETES-MELLITUS; BETA-3-ADRENERGIC RECEPTOR; BETA(2)-ADRENOCEPTOR GENE; TRP64ARG POLYMORPHISM; 3-ADRENERGIC RECEPTOR; JAPANESE MONKEYS; SEASONAL-CHANGES	Adrenergic-receptor beta2 (ADRB2) and beta3 (ADRB3) are obesity genes that play a key role in the regulation of energy balance by increasing lipolysis and thermogenesis. The Glu27 allele in ADRB2 and the Arg64 allele in ADRB3 are associated with abdominal obesity and early onset of non-insulin-dependent diabetes mellitus (NIDDM) in many ethnic groups. Peroxisome proliferator-activated receptor gamma (PPARG) is required for adipocyte differentiation. Pro12Ala mutation decreases PPARG activity and resistance to NIDDM. In humans, energy-expense alleles, Gln27 in ADRB2 and Trp64 in ADRB3, are at higher frequencies than Glu27 and Arg64, respectively, but Ala12 in PPARG is at lower frequency than Pro12. Adaptation of humans for lipolysis, thermogenesis, and reduction of fat accumulation could be considered by examining which alleles in these genes are dominant in non-human primates (NHP). All NHP (P. troglodytes, G. gorilla, P. pygmaeus, H. agilis and macaques) had energy-thrifty alleles, Gly16 and Glu27 in ADRB2, and Arg64 in ADRB3, but did not have energy-expense alleles, Arg16, Gln27 and Trp64 alleles. In PPARG gene, all NHP had large adipocyte accumulating type, the Pro12 allele. Conclusions: These results indicate that a tendency to produce much more heat through the energy-expense alleles developed only in humans, who left tropical rainforests for savanna and developed new features in their heat-regulation systems, such as reduction of body hair and increased evaporation of water, and might have helped the protection of entrails from cold at night, especially in glacial periods.	[Takenaka, Akiko] Nagoya Bunri Univ, Fac Hlth & Human Life, Dept Hlth & Nutr, Inazawa, Aichi, Japan; [Nakamura, Shin; Mitsunaga, Fusako] Kyoto Univ, Primate Res Inst, Dept Cellular & Mol Biol, Inuyama, Aichi 484, Japan; [Inoue-Murayama, Miho] Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan; [Udono, Toshifumi] Kyoto Univ, Kumamoto Sanctuary, Uki, Kumamoto, Japan; [Suryobroto, Bambang] Bogor Agr Univ, Fac Math & Nat Sci, Dept Biol, Bogor, Indonesia	Kyoto University; Kyoto University; Kyoto University; Bogor Agricultural University	Takenaka, A (corresponding author), Nagoya Bunri Univ, Fac Hlth & Human Life, Dept Hlth & Nutr, Inazawa, Aichi, Japan.	take105orc@oboe.ocn.ne.jp		Takenaka, Akiko/0000-0002-8517-5664; Suryobroto, Bambang/0000-0002-9393-4085	Cooperation Research Program of Primate Research Institute, Kyoto University	Cooperation Research Program of Primate Research Institute, Kyoto University	This study was financially supported by the Cooperation Research Program of Primate Research Institute, Kyoto University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agetsuma N, 1998, PRIMATES, V39, P275, DOI 10.1007/BF02573077; Aiello LC, 2002, ANNU REV ANTHROPOL, V31, P323, DOI 10.1146/annurev.anthro.31.040402.085403; Anton SC, 2003, YEARB PHYS ANTHROPOL, V46, P126, DOI 10.1002/ajpa.10399; Barbe P, 1996, BRIT J PHARMACOL, V117, P907, DOI 10.1111/j.1476-5381.1996.tb15279.x; Biery AJ, 1997, INT J OBESITY, V21, P1176, DOI 10.1038/sj.ijo.0800532; Buettner R, 1998, J CLIN ENDOCR METAB, V83, P2892, DOI 10.1210/jc.83.8.2892; BUNN HT, 1981, NATURE, V291, P574, DOI 10.1038/291574a0; Cagliani R, 2009, AM J HUM GENET, V85, P64, DOI 10.1016/j.ajhg.2009.06.005; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CLEMENT K, 1995, NEW ENGL J MED, V333, P352, DOI 10.1056/NEJM199508103330605; Corella D, 2001, J INTERN MED, V250, P348, DOI 10.1046/j.1365-2796.2001.00894.x; Dansgaard W, 2004, FROZEN ANN GREENL IC; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Ellsworth DL, 2002, INT J OBESITY, V26, P928, DOI 10.1038/sj.ijo.0802020; FOLK GE, 1991, INT J BIOMETEOROL, V35, P180, DOI 10.1007/BF01049065; Gabunia L, 2001, EVOL ANTHROPOL, V10, P158, DOI 10.1002/evan.1030; GIRARDIER L, 1981, DIABETOLOGIA, V20, P362, DOI 10.1007/BF00254504; Sanchez JLG, 2003, CLIN ENDOCRINOL, V59, P476, DOI 10.1046/j.1365-2265.2003.01871.x; Green SA, 1995, PULM PHARMACOL, V8, P1, DOI 10.1006/pulp.1995.1001; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; Haile-Selassie Y, 2004, SCIENCE, V303, P1503, DOI 10.1126/science.1092978; Hara K, 2000, BIOCHEM BIOPH RES CO, V271, P212, DOI 10.1006/bbrc.2000.2605; Harcourt-Smith WEH, 2004, J ANAT, V204, P403, DOI 10.1111/j.0021-8782.2004.00296.x; HARRISON MJS, 1985, INT J PRIMATOL, V6, P351, DOI 10.1007/BF02736383; Hashimoto C, 2003, PRIMATES, V44, P77, DOI 10.1007/s10329-002-0026-4; Hayama S, 1994, AFRICA RES, V44, P97; Hayama S, 1993, CONSTATIONS CLONICOP; HEATON JM, 1972, J ANAT, V112, P35; Hellstrom L, 1999, J INTERN MED, V245, P253, DOI 10.1046/j.1365-2796.1999.0437e.x; HILEY PG, 1976, J PHYSIOL-LONDON, V254, P657, DOI 10.1113/jphysiol.1976.sp011251; Hirai H, 2003, CHROMOSOME RES, V11, P37, DOI 10.1023/A:1022006015379; Hong KW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022144; Ishiyama-Shigemoto S, 1999, DIABETOLOGIA, V42, P98, DOI 10.1007/s001250051120; JOUZEL J, 1987, NATURE, V329, P403, DOI 10.1038/329403a0; KADOWAKI H, 1995, BIOCHEM BIOPH RES CO, V215, P555, DOI 10.1006/bbrc.1995.2500; Kadowaki T, 2000, J CLIN INVEST, V106, P459, DOI 10.1172/JCI10830; Kimbel WH, 1997, AM J PHYS ANTHROPOL, V103, P235, DOI 10.1002/(SICI)1096-8644(199706)103:2<235::AID-AJPA8>3.3.CO;2-V; KimMotoyama H, 1997, DIABETOLOGIA, V40, P469, DOI 10.1007/s001250050702; Kimura K, 2000, HORM METAB RES, V32, P91, DOI 10.1055/s-2007-978597; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Large V, 1997, J CLIN INVEST, V100, P3005, DOI 10.1172/JCI119854; LEAKEY MD, 1979, NATURE, V278, P317, DOI 10.1038/278317a0; LEAKEY MD, 1976, HUMAN ORIGINS L LEAK, P431; Lepre CJ, 2011, NATURE, V477, P82, DOI 10.1038/nature10372; Levin NE, 2004, EARTH PLANET SC LETT, V219, P93, DOI 10.1016/S0012-821X(03)00707-6; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Macho-Azcarate T, 2003, J NUTR BIOCHEM, V14, P275, DOI 10.1016/S0955-2863(03)00035-4; Macho-Azcarate T, 2002, INT J OBESITY, V26, P1434, DOI 10.1038/sj.ijo.0802129; Masuo K, 2006, AM J HYPERTENS, V19, P1084, DOI 10.1016/j.amjhyper.2006.02.015; McHenry HM, 1998, J HUM EVOL, V35, P1, DOI 10.1006/jhev.1997.0197; MCHENRY HM, 1994, P NATL ACAD SCI USA, V91, P6780, DOI 10.1073/pnas.91.15.6780; McHenry HM, 2000, ANNU REV ANTHROPOL, V29, P125, DOI 10.1146/annurev.anthro.29.1.125; Muroyama Y, 2006, PRIMATES, V47, P355, DOI 10.1007/s10329-006-0184-x; Nakagawa N, 1997, AM J PRIMATOL, V41, P267, DOI 10.1002/(SICI)1098-2345(1997)41:4<267::AID-AJP1>3.3.CO;2-E; Nakagawa N, 2000, AM J PRIMATOL, V52, P169, DOI 10.1002/1098-2345(200012)52:4<169::AID-AJP2>3.0.CO;2-B; NEEL JV, 1962, AM J HUM GENET, V14, P353; PietriRouxel F, 1997, EUR J BIOCHEM, V247, P1174, DOI 10.1111/j.1432-1033.1997.01174.x; Robertshaw D., 1975, HDB PHYSIOLOGY, P591; Ruff Christopher B., 1993, P234; Sakane N, 1997, DIABETOLOGIA, V40, P200, DOI 10.1007/s001250050663; SCHWARTZ GG, 1981, AM J PHYS ANTHROPOL, V55, P9, DOI 10.1002/ajpa.1330550103; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; SHACKLETON NJ, 1984, NATURE, V307, P620, DOI 10.1038/307620a0; Silver K, 1997, HUM GENET, V101, P306, DOI 10.1007/s004390050633; Silver K, 1996, J CLIN ENDOCR METAB, V81, P4155, DOI 10.1210/jc.81.11.4155; Sun L, 2000, Zhonghua Yi Xue Za Zhi, V80, P107; SUSMAN RL, 1982, SCIENCE, V217, P931, DOI 10.1126/science.217.4563.931; SWISHER CC, 1994, SCIENCE, V263, P1118, DOI 10.1126/science.8108729; SYMINGTON MM, 1990, INT J PRIMATOL, V11, P47, DOI 10.1007/BF02193695; Takemoto H, 2004, AM J PHYS ANTHROPOL, V124, P81, DOI 10.1002/ajpa.10342; TAKENAKA A, 1993, PRIMATES, V34, P55, DOI 10.1007/BF02381280; Tappy L, 1996, REPROD NUTR DEV, V36, P391, DOI 10.1051/rnd:19960405; Thompson LG, 2002, SCIENCE, V298, P589, DOI 10.1126/science.1073198; Thompson ME, 2008, HORM BEHAV, V53, P526, DOI 10.1016/j.yhbeh.2007.12.005; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Trauth MH, 2007, J HUM EVOL, V53, P475, DOI 10.1016/j.jhevol.2006.12.009; Tutin CEG, 1997, AM J PRIMATOL, V42, P1, DOI 10.1002/(SICI)1098-2345(1997)42:1<1::AID-AJP1>3.0.CO;2-0; UEHARA S, 1987, AM J PHYS ANTHROPOL, V72, P315, DOI 10.1002/ajpa.1330720305; Umekawa T, 1999, DIABETES, V48, P117, DOI 10.2337/diabetes.48.1.117; WALSTON J, 1995, NEW ENGL J MED, V333, P343, DOI 10.1056/NEJM199508103330603; Walston J, 1997, GENE, V188, P207, DOI 10.1016/S0378-1119(96)00796-2; WHEELER PE, 1992, J HUM EVOL, V23, P379, DOI 10.1016/0047-2484(92)90086-O; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; WIDEN E, 1995, NEW ENGL J MED, V333, P348, DOI 10.1056/NEJM199508103330604; Wilson RH, 2010, AM J HUM GENET, V86, P490, DOI 10.1016/j.ajhg.2010.01.031; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; Wrangham R., 2009, COOKING MADE US HUMA; Wynn JG, 2004, AM J PHYS ANTHROPOL, V123, P106, DOI 10.1002/ajpa.10317; Yamagiwa J, 2006, PRIMATES, V47, P74, DOI 10.1007/s10329-005-0147-7; Yen CJ, 1997, BIOCHEM BIOPH RES CO, V241, P270, DOI 10.1006/bbrc.1997.7798; YOSHIDA T, 1995, LANCET, V346, P1433, DOI 10.1016/S0140-6736(95)92452-3	93	24	26	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43461	10.1371/journal.pone.0043461	http://dx.doi.org/10.1371/journal.pone.0043461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937051	Green Submitted, Green Published, gold			2022-12-25	WOS:000308225500052
J	Weng, K; Hu, HY; Xu, AG; Khaitovich, P; Somel, M				Weng, Kai; Hu, Haiyang; Xu, Augix Guohua; Khaitovich, Philipp; Somel, Mehmet			Mechanisms of Dietary Response in Mice and Primates: A Role for EGR1 in Regulating the Reaction to Human-Specific Nutritional Content	PLOS ONE			English	Article							GENE-EXPRESSION; POSITIVE SELECTION; HUMAN GENOME; EVOLUTION; CELLS; MOUSE; ACTIVATION; INHIBITION; GROWTH; TRANSFORMATION	Background: Humans have a widely different diet from other primate species, and are dependent on its high nutritional content. The molecular mechanisms responsible for adaptation to the human diet are currently unknown. Here, we addressed this question by investigating whether the gene expression response observed in mice fed human and chimpanzee diets involves the same regulatory mechanisms as expression differences between humans and chimpanzees. Results: Using mouse and primate transcriptomic data, we identified the transcription factor EGR1 (early growth response 1) as a putative regulator of diet-related differential gene expression between human and chimpanzee livers. Specifically, we predict that EGR1 regulates the response to the high caloric content of human diets. However, we also show that close to 90% of the dietary response to the primate diet found in mice, is not observed in primates. This might be explained by changes in tissue-specific gene expression between taxa. Conclusion: Our results suggest that the gene expression response to the nutritionally rich human diet is partially mediated by the transcription factor EGR1. While this EGR1-driven response is conserved between mice and primates, the bulk of the mouse response to human and chimpanzee dietary differences is not observed in primates. This result highlights the rapid evolution of diet-related expression regulation and underscores potential limitations of mouse models in dietary studies.	[Weng, Kai; Hu, Haiyang; Xu, Augix Guohua; Khaitovich, Philipp; Somel, Mehmet] Chinese Acad Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai, Peoples R China; [Xu, Augix Guohua; Khaitovich, Philipp; Somel, Mehmet] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Somel, Mehmet] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Max Planck Society; University of California System; University of California Berkeley	Weng, K (corresponding author), Chinese Acad Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai, Peoples R China.	khaitovich@eva.mpg.de; somel.mehmet@gmail.com	Somel, Mehmet/B-1471-2016; Khaitovich, Philipp/HGC-8520-2022; Hu, Haiyang/AAA-6929-2022; Hu, Haiyang/F-7544-2016; hu, hai yang/F-7544-2016	Hu, Haiyang/0000-0002-5348-5641; Hu, Haiyang/0000-0002-5348-5641; Xu, Augix Guohua/0000-0002-8509-1137; Somel, Mehmet/0000-0002-3138-1307; hu, hai yang/0000-0003-1657-4765	Ministry of Science and Technology of the People's Republic of China [2007CB947004]; Chinese Academy of Sciences [KSCX2-YW-R-094, KSCX2-YW-R-251, 2009Y2BS12]; Shanghai Institutes for Biological Sciences [2008KIT104]; National Science Foundation of China [31010022, 31050110128]; Max Planck-Society; Bundesministerum fuer Bildung und Forschung; European Molecular Biology Organization [EMBO ALTF 1475-2010]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Max Planck-Society(Max Planck SocietyFoundation CELLEX); Bundesministerum fuer Bildung und Forschung; European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	The study was funded by the Ministry of Science and Technology of the People's Republic of China (grant no. 2007CB947004), Chinese Academy of Sciences (grant nos. KSCX2-YW-R-094 and KSCX2-YW-R-251), the Shanghai Institutes for Biological Sciences (grant no. 2008KIT104), National Science Foundation of China research grant (grant nos. 31010022 and 31050110128), the Max Planck-Society, and the Bundesministerum fuer Bildung und Forschung. MS was supported by fellowships from the Chinese Academy of Sciences (2009Y2BS12) and European Molecular Biology Organization (EMBO ALTF 1475-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agner F, 2011, BIASEDURN BIASED URN; Aiello LC, 1995, CURR ANTHR, V36; Aljada A, 2004, AM J CLIN NUTR, V80, P51; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babbitt CC, 2011, P ROY SOC B-BIOL SCI, V278, P961, DOI 10.1098/rspb.2010.2433; Bae SH, 2007, BIOINFORMATICS, V23, P2619, DOI 10.1093/bioinformatics/btm288; Baron V, 2003, ONCOGENE, V22, P4194, DOI 10.1038/sj.onc.1206560; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Cain CE, 2011, GENETICS, V187, P1225, DOI 10.1534/genetics.110.126177; Carlson M, 2007, GO DB SET ANNOTATION; Carmody RN, 2009, COLD SH Q B, V74, P427, DOI 10.1101/sqb.2009.74.019; Chan MY, 2008, OBESITY, V16, P972, DOI 10.1038/oby.2008.32; Chateauvieux S, 2011, BIOCHEM PHARMACOL, V81, P498, DOI 10.1016/j.bcp.2010.11.011; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Davis S, 2003, BEHAV BRAIN RES, V142, P17, DOI 10.1016/S0166-4328(02)00421-7; DeLigio JT, 2009, CANCER BIOL THER, V8, P1889, DOI 10.4161/cbt.8.20.9804; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Francescatto M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S11-A8; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gibson G, 2008, NAT REV GENET, V9, P575, DOI 10.1038/nrg2383; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; Gokey NG, 2011, J BIOL CHEM, V286, P29501, DOI 10.1074/jbc.M111.263509; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Haygood R, 2007, NAT GENET, V39, P1140, DOI 10.1038/ng2104; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Hohmann G, 2006, FEEDING ECOLOGY APEA, pxvi; Hu HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002327; Huang RP, 1997, INT J CANCER, V72, P102, DOI 10.1002/(SICI)1097-0215(19970703)72:1<102::AID-IJC15>3.0.CO;2-L; Ingram CJE, 2009, HUM GENET, V124, P579, DOI 10.1007/s00439-008-0593-6; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; Jiang MH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-192; Kadowaki T, 2000, J CLIN INVEST, V106, P459, DOI 10.1172/JCI10830; Keeton AB, 2003, ENDOCRINOLOGY, V144, P5402, DOI 10.1210/en.2003-0592; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Khaitovich P, 2004, PLOS BIOL, V2, P682, DOI 10.1371/journal.pbio.0020132; Khaitovich P, 2006, CURR BIOL, V16, pR356, DOI 10.1016/j.cub.2006.03.082; Kloting N, 2005, DIABETES-METAB RES, V21, P281, DOI 10.1002/dmrr.526; Koebnick C, 1999, ANN NUTR METAB, V43, P69, DOI 10.1159/000012770; Kubosaki A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r41; Levitsky VG, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-481; Liu CT, 1996, P NATL ACAD SCI USA, V93, P11831, DOI 10.1073/pnas.93.21.11831; Luca F, 2010, ANNU REV NUTR, V30, P291, DOI 10.1146/annurev-nutr-080508-141048; MCCRACKEN RD, 1971, CURR ANTHROPOL, V12, P479, DOI 10.1086/201234; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Navarrete A, 2011, NATURE, V480, P91, DOI 10.1038/nature10629; NEEL JV, 1962, AM J HUM GENET, V14, P353; Organ C, 2011, P NATL ACAD SCI USA, V108, P14555, DOI 10.1073/pnas.1107806108; Pai AA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001316; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Roche HM, 2005, P NUTR SOC, V64, P371, DOI 10.1079/PNS2005445; Seo HY, 2010, ENDOCRINOLOGY, V151, P561, DOI 10.1210/en.2009-0641; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Somel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001504; Somel M, 2010, GENOME RES, V20, P1207, DOI 10.1101/gr.106849.110; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Swallow DM, 2003, ANNU REV GENET, V37, P197, DOI 10.1146/annurev.genet.37.110801.143820; Tang C, 2010, ELECTROPHORESIS, V31, P2936, DOI 10.1002/elps.201000094; Teaford MF, 2000, P NATL ACAD SCI USA, V97, P13506, DOI 10.1073/pnas.260368897; Team R, 2010, R LANGUAGE ENV STAT; Ungar PS, 2004, EVOL ANTHROPOL, V13, P45, DOI 10.1002/evan.10126; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Wrangham R, 2003, COMP BIOCHEM PHYS A, V136, P35, DOI 10.1016/S1095-6433(03)00020-5	70	1	1	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43915	10.1371/journal.pone.0043915	http://dx.doi.org/10.1371/journal.pone.0043915			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937124	Green Submitted, Green Published, gold			2022-12-25	WOS:000308225500123
J	Hoffman, KB; Kraus, C; Dimbil, M; Golomb, BA				Hoffman, Keith B.; Kraus, Christina; Dimbil, Mo; Golomb, Beatrice A.			A Survey of the FDA's AERS Database Regarding Muscle and Tendon Adverse Events Linked to the Statin Drug Class	PLOS ONE			English	Article							POSTMARKETING SURVEILLANCE; ROSUVASTATIN; METAANALYSIS; SAFETY; SIMVASTATIN; EFFICACY; THERAPY; DISEASE; TRIALS; RISK	Background: Cholesterol management drugs known as statins are widely used and often well tolerated; however, a variety of muscle-related side effects can arise. These adverse events (AEs) can have serious impact, and form a significant barrier to therapy adherence. Surveillance of post-marketing AEs is of vital importance to understand real-world AEs and reporting differences between individual statin drugs. We conducted a review of post-approval muscle and tendon AE reports in association with statin use, to assess differences within the drug class. Methods: We analyzed all case reports from the FDA AE Reporting System (AERS) database linking muscle-related AEs to statin use (07/01/2005-03/31/2011). Drugs examined were: atorvastatin, simvastatin, lovastatin, pravastatin, rosuvastatin, and fluvastatin. Results: Relative risk rates for rosuvastatin were consistently higher than other statins. Atorvastatin and simvastatin showed intermediate risks, while pravastatin and lovastatin appeared to have the lowest risk rates. Relative risk of muscle-related AEs, therefore, approximately tracked with per milligram LDL-lowering potency, with fluvastatin an apparent exception. Incorporating all muscle categories, rates for atorvastatin, simvastatin, pravastatin, and lovastatin were, respectively, 55%, 26%, 17%, and 7.5% as high, as rosuvastatin, approximately tracking per milligram potency (Rosuvastatin > Atorvastatin > Simvastatin > Pravastatin approximate to Lovastatin) and comporting with findings of other studies. Relative potency, therefore, appears to be a fundamental predictor of muscle-related AE risk, with fluvastatin, the least potent statin, an apparent exception (risk 74% vs rosuvastatin). Interpretation: AE reporting rates differed strikingly for drugs within the statin class, with relative reporting aligning substantially with potency. The data presented in this report offer important reference points for the selection of statins for cholesterol management in general and, especially, for the rechallenge of patients who have experienced muscle-related AEs (for whom agents of lower expected potency should be preferred). Interpretation: AE reporting rates differed strikingly for drugs within the statin class, with relative reporting aligning substantially with potency. The data presented in this report offer important reference points for the selection of statins for cholesterol management in general and, especially, for the rechallenge of patients who have experienced muscle-related AEs (for whom agents of lower expected potency should be preferred).	[Hoffman, Keith B.; Kraus, Christina; Dimbil, Mo] AdverseEvents Inc, Healdsburg, CA USA; [Golomb, Beatrice A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Golomb, Beatrice A.] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Hoffman, KB (corresponding author), AdverseEvents Inc, Healdsburg, CA USA.	bgolomb@ucsd.edu						Afilalo J, 2007, HEART, V93, P914, DOI 10.1136/hrt.2006.112508; Alsheikh-Ali AA, 2005, CIRCULATION, V111, P3051, DOI 10.1161/CIRCULATIONAHA.105.555482; Anderson E, 2002, JAIDS-J ACQ IMM DEF, V31, pS43, DOI 10.1097/00126334-200210012-00004; Arnaiz JA, 2001, EUR J CLIN PHARMACOL, V57, P89, DOI 10.1007/s002280100265; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bruckert E, 1999, J CLIN EPIDEMIOL, V52, P589, DOI 10.1016/S0895-4356(99)00019-0; Cham S, 2010, PHARMACOTHERAPY, V30, P541, DOI 10.1592/phco.30.6.541; Collins R, 2003, LANCET, V361, P2005; Egan A, 2011, NEW ENGL J MED, V365, P285, DOI 10.1056/NEJMp1106689; Fontanarosa PB, 2004, JAMA-J AM MED ASSOC, V292, P2647, DOI 10.1001/jama.292.21.2647; GOLOMB BA, 2009, RISK, V25, P66; Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004; IMS Health, 2004, LIP LEADS WAY 2003; IMS Health website, 2010, IMS HLTH REP US PRES; *IMS HLTH, 2006, COMM REQ THER CLASS; *IMS HLTH, 2007, IMS GLOB INS IMS RET; Kones R, 2010, DRUG DES DEV THER, V4, P383, DOI 10.2147/DDDT.S10812; Kostapanos MS, 2010, AM J CARDIOVASC DRUG, V10, P11, DOI 10.2165/13168600-000000000-00000; McKenney JM, 2003, CLIN CARDIOL, V26, P32, DOI 10.1002/clc.4960261507; McNeil JJ, 1999, MED J AUSTRALIA, V170, P270, DOI 10.5694/j.1326-5377.1999.tb127751.x; McTaggart F, 2003, ATHEROSCLEROSIS SUPP, V4, P9, DOI 10.1016/S1567-5688(03)00004-7; Olsson GO, 2004, LANCET, V364, P135, DOI 10.1016/S0140-6736(04)16616-6; Paraskevas KI, 2010, NEW DEV STATIN TREAT; Psaty BM, 2004, JAMA-J AM MED ASSOC, V292, P2622, DOI 10.1001/jama.292.21.2622; Rallidis LS, 2011, INT J CARDIOL; Roberts WC, 1997, AM J CARDIOL, V80, P106, DOI 10.1016/S0002-9149(97)00298-1; Sakaeda T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028124; Silva M, 2007, CLIN THER, V29, P253, DOI 10.1016/j.clinthera.2007.02.008; Wolfe SM, 2004, LANCET, V363, P2189, DOI 10.1016/S0140-6736(04)16513-6; Zipes Douglas P, 2006, MedGenMed, V8, P73	30	70	75	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42866	10.1371/journal.pone.0042866	http://dx.doi.org/10.1371/journal.pone.0042866			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22936996	Green Published, gold			2022-12-25	WOS:000308286300028
J	Alijevic, O; Kellenberger, S				Alijevic, Omar; Kellenberger, Stephan			Subtype-specific Modulation of Acid-sensing Ion Channel (ASIC) Function by 2-Guanidine-4-methylquinazoline	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARADOXICAL STIMULATION; DOMAIN; DESENSITIZATION; ION-CHANNEL-1; CONTRIBUTES; CURRENTS; FAMILY; SENSOR; RANGE; ALTER	Acid-sensing ion channels (ASICs) are neuronal Na+-selective channels that are transiently activated by extracellular acidification. ASICs are involved in fear and anxiety, learning, neurodegeneration after ischemic stroke, and pain sensation. The small molecule 2-guanidine-4-methylquinazoline (GMQ) was recently shown to open ASIC3 at physiological pH. We have investigated the mechanisms underlying this effect and the possibility that GMQ may alter the function of other ASICs besides ASIC3. GMQ shifts the pH dependence of activation to more acidic pH in ASIC1a and ASIC1b, whereas in ASIC3 this shift goes in the opposite direction and is accompanied by a decrease in its steepness. GMQ also induces an acidic shift of the pH dependence of inactivation of ASIC1a, -1b, -2a, and -3. As a consequence, the activation and inactivation curves of ASIC3 but not other ASICs overlap in the presence of GMQ at pH 7.4, thereby creating a window current. At concentrations >1 mM, GMQ decreases maximal peak currents by reducing the unitary current amplitude. Mutation of residue Glu-79 in the palm domain of ASIC3, previously shown to be critical for channel opening by GMQ, disrupted the GMQ effects on inactivation but not activation. This suggests that this residue is involved in the consequences of GMQ binding rather than in the binding interaction itself. This study describes the mechanisms underlying the effects of a novel class of ligands that modulate the function of all ASICs as well as activate ASIC3 at physiological pH.	[Alijevic, Omar; Kellenberger, Stephan] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland	University of Lausanne	Kellenberger, S (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Rue Bugnon 27, CH-1005 Lausanne, Switzerland.	Stephan.Kellenberger@unil.ch		Kellenberger, Stephan/0000-0003-1755-6198	Swiss National Science Foundation [310030-135542]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant 310030-135542 (to S. K.).	Adams CM, 1999, J BIOL CHEM, V274, P15500, DOI 10.1074/jbc.274.22.15500; Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Blanchard MG, 2011, PFLUG ARCH EUR J PHY, V461, P123, DOI 10.1007/s00424-010-0884-3; Champigny G, 1998, J BIOL CHEM, V273, P15418, DOI 10.1074/jbc.273.25.15418; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Donier E, 2008, EUR J NEUROSCI, V28, P74, DOI 10.1111/j.1460-9568.2008.06282.x; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Horisberger JD., 2004, NEPHRON PHYSIOL, V96, P37, DOI [10.1159/000076406, DOI 10.1159/000076406]; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Li TB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1409; Li WG, 2011, J BIOL CHEM, V286, P42635, DOI 10.1074/jbc.M111.289058; Li WG, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-88; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Lu M, 2008, J BIOL CHEM, V283, P11981, DOI 10.1074/jbc.M708001200; Lu YJ, 2009, NEURON, V64, P885, DOI 10.1016/j.neuron.2009.11.007; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Poirot O, 2006, J PHYSIOL-LONDON, V576, P215, DOI 10.1113/jphysiol.2006.113035; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Salinas M, 2009, J BIOL CHEM, V284, P31851, DOI 10.1074/jbc.M109.043984; Sherwood TW, 2008, J BIOL CHEM, V283, P1818, DOI 10.1074/jbc.M705118200; Springauf A, 2011, J BIOL CHEM, V286, P24374, DOI 10.1074/jbc.M111.230797; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c; Yu Y, 2011, J BIOL CHEM, V286, P24996, DOI 10.1074/jbc.M111.239558; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001; Zhang P, 2006, J GEN PHYSIOL, V127, P109, DOI 10.1085/jgp.200509396; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	40	50	51	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36059	36070		10.1074/jbc.M112.360487	http://dx.doi.org/10.1074/jbc.M112.360487			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948146	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000310364000028
J	Horakova, O; Medrikova, D; van Schothorst, EM; Bunschoten, A; Flachs, P; Kus, V; Kuda, O; Bardova, K; Janovska, P; Hensler, M; Rossmeisl, M; Wang-Sattler, R; Prehn, C; Adamski, J; Illig, T; Keijer, J; Kopecky, J				Horakova, Olga; Medrikova, Dasa; van Schothorst, Evert M.; Bunschoten, Annelies; Flachs, Pavel; Kus, Vladimir; Kuda, Ondrej; Bardova, Kristina; Janovska, Petra; Hensler, Michal; Rossmeisl, Martin; Wang-Sattler, Rui; Prehn, Cornelia; Adamski, Jerzy; Illig, Thomas; Keijer, Jaap; Kopecky, Jan			Preservation of Metabolic Flexibility in Skeletal Muscle by a Combined Use of n-3 PUFA and Rosiglitazone in Dietary Obese Mice	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; ACTIVATED-RECEPTOR-ALPHA; FISH-OIL; INSULIN SENSITIVITY; WEIGHT-LOSS; MARINE ORIGIN; EICOSAPENTAENOIC ACID; GLYCOGEN-SYNTHESIS; MALONYL-COA; FIBER TYPES	Insulin resistance, the key defect in type 2 diabetes (T2D), is associated with a low capacity to adapt fuel oxidation to fuel availability, i.e., metabolic inflexibility. This, in turn, contributes to a further damage of insulin signaling. Effectiveness of T2D treatment depends in large part on the improvement of insulin sensitivity and metabolic adaptability of the muscle, the main site of whole-body glucose utilization. We have shown previously in mice fed an obesogenic high-fat diet that a combined use of n-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFA) and thiazolidinediones (TZDs), anti-diabetic drugs, preserved metabolic health and synergistically improved muscle insulin sensitivity. We investigated here whether n-3 LC-PUFA could elicit additive beneficial effects on metabolic flexibility when combined with a TZD drug rosiglitazone. Adult male C57BL/6N mice were fed an obesogenic corn oil-based high-fat diet (cHF) for 8 weeks, or randomly assigned to various interventions: cHF with n-3 LC-PUFA concentrate replacing 15% of dietary lipids (cHF+F), cHF with 10 mg rosiglitazone/kg diet (cHF+ROSI), cHF+F+ROSI, or chow-fed. Indirect calorimetry demonstrated superior preservation of metabolic flexibility to carbohydrates in response to the combined intervention. Metabolomic and gene expression analyses in the muscle suggested distinct and complementary effects of the interventions, with n-3 LC-PUFA supporting complete oxidation of fatty acids in mitochondria and the combination with n-3 LC-PUFA and rosiglitazone augmenting insulin sensitivity by the modulation of branched-chain amino acid metabolism. These beneficial metabolic effects were associated with the activation of the switch between glycolytic and oxidative muscle fibers, especially in the cHF+F+ROSI mice. Our results further support the idea that the combined use of n-3 LC-PUFA and TZDs could improve the efficacy of the therapy of obese and diabetic patients.	[Horakova, Olga; Medrikova, Dasa; Flachs, Pavel; Kus, Vladimir; Kuda, Ondrej; Bardova, Kristina; Janovska, Petra; Hensler, Michal; Rossmeisl, Martin; Kopecky, Jan] Acad Sci Czech Republ Vvi, Inst Physiol, Dept Adipose Tissue Biol, Prague, Czech Republic; [van Schothorst, Evert M.; Bunschoten, Annelies; Keijer, Jaap] Wageningen Univ, Dept Human & Anim Physiol, Wageningen, Netherlands; [Wang-Sattler, Rui; Illig, Thomas] Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Prehn, Cornelia; Adamski, Jerzy] Helmholtz Zentrum Munchen, Genome Anal Ctr, Inst Expt Genet, Neuherberg, Germany	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Wageningen University & Research; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Horakova, O (corresponding author), Acad Sci Czech Republ Vvi, Inst Physiol, Dept Adipose Tissue Biol, Prague, Czech Republic.	kopecky@biomed.cas.cz	Janovska, Petra/E-7160-2013; Rossmeisl, Martin/C-1892-2012; Rossmeisl, Martin/CAF-0060-2022; Hensler, Michal/C-7986-2012; Flachs, Pavel/A-5341-2012; Horakova, Olga/C-8001-2012; Kopecky, Jan/B-8244-2012; Wang-Sattler, Rui/B-5354-2014; Kuda, Ondrej/B-7990-2012; Bardova, Kristina/C-3493-2015; Keijer, Jaap/J-8089-2013	Janovska, Petra/0000-0002-6154-2175; Rossmeisl, Martin/0000-0001-8534-4002; Rossmeisl, Martin/0000-0001-8534-4002; Horakova, Olga/0000-0003-0933-4616; Kopecky, Jan/0000-0001-8072-2035; Wang-Sattler, Rui/0000-0002-8794-8229; Kuda, Ondrej/0000-0001-7034-4536; Bardova, Kristina/0000-0002-2297-5066; Adamski, Jerzy/0000-0001-9259-0199; van Schothorst, Evert/0000-0002-3036-5903; Keijer, Jaap/0000-0002-9720-7491; Prehn, Cornelia/0000-0002-1274-4715	Czech Science Foundation [303/08/0664, RVO: 67985823]; EPAX AS (Norway); European Union's Seventh Framework Programme [244995]; EFSD New Horizons research grant; German Federal Ministry of Education and Research (BMBF)	Czech Science Foundation(Grant Agency of the Czech Republic); EPAX AS (Norway); European Union's Seventh Framework Programme; EFSD New Horizons research grant; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The research leading to these results has received funding from the Czech Science Foundation (303/08/0664), RVO: 67985823, EPAX AS (Norway), the European Union's Seventh Framework Programme FP7 2007-2013 under grant agreement no 244995 (BIOCLAIMS), and the EFSD New Horizons research grant. This project has been also in part supported by a Grant from the German Federal Ministry of Education and Research (BMBF) to the German Center Diabetes Research (DZD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 2011, ADV NUTR, V2, P445, DOI 10.3945/an.111.000737; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Arnold C, 2010, PHARMACOL REP, V62, P536, DOI 10.1016/S1734-1140(10)70311-X; Asterholm IW, 2010, AM J PATHOL, V176, P1364, DOI 10.2353/ajpath.2010.090647; Baranowski M, 2007, PROSTAG OTH LIPID M, V83, P99, DOI 10.1016/j.prostaglandins.2006.10.004; Bays HE, 2010, CURR MED RES OPIN, V26, P907, DOI 10.1185/03007991003645318; BELZUNG F, 1993, AM J PHYSIOL, V264, pR1111, DOI 10.1152/ajpregu.1993.264.6.R1111; Blachnio-Zabielska A, 2011, LIPIDS, V46, P229, DOI 10.1007/s11745-010-3515-z; Coen PM, 2010, DIABETES, V59, P80, DOI 10.2337/db09-0988; Corpeleijn E, 2008, OBESITY, V16, P1025, DOI 10.1038/oby.2008.24; Couet C, 1997, INT J OBESITY, V21, P637, DOI 10.1038/sj.ijo.0800451; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; ESSEN B, 1975, ACTA PHYSIOL SCAND, V95, P153, DOI 10.1111/j.1748-1716.1975.tb10038.x; FASCHING P, 1991, DIABETES, V40, P583, DOI 10.2337/diabetes.40.5.583; Flachs P, 2005, DIABETOLOGIA, V48, P2365, DOI 10.1007/s00125-005-1944-7; Flachs P, 2011, DIABETOLOGIA, V54, P2626, DOI 10.1007/s00125-011-2233-2; Flachs P, 2009, CLIN SCI, V116, P1, DOI 10.1042/CS20070456; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Han MS, 2011, J LIPID RES, V52, P1234, DOI 10.1194/jlr.M014787; Hensler M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-128; HILL JO, 1993, INT J OBESITY, V17, P223; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Hsiao G, 2011, AM J PHYSIOL-ENDOC M, V300, pE164, DOI 10.1152/ajpendo.00219.2010; Hunt MC, 2006, FASEB J, V20, P1855, DOI 10.1096/fj.06-6042com; Ikemoto S, 1996, METABOLISM, V45, P1539, DOI 10.1016/S0026-0495(96)90185-7; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; Jelenik T, 2010, DIABETES, V59, P2737, DOI 10.2337/db09-1716; Jucker BM, 1999, DIABETES, V48, P134, DOI 10.2337/diabetes.48.1.134; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Kim HG, 2008, TOXICOLOGY, V246, P166, DOI 10.1016/j.tox.2008.01.003; Kischel P, 2001, J APPL PHYSIOL, V90, P1095, DOI 10.1152/jappl.2001.90.3.1095; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Krebs JD, 2006, INT J OBESITY, V30, P1535, DOI 10.1038/sj.ijo.0803309; Kromhout D, 2011, DIABETES CARE, V34, P2515, DOI 10.2337/dc11-0896; Kuda O, 2009, DIABETOLOGIA, V52, P941, DOI 10.1007/s00125-009-1305-z; Kunesova M, 2006, PHYSIOL RES, V55, P63, DOI 10.33549/physiolres.930770; Kus V, 2008, AM J PHYSIOL-ENDOC M, V295, pE356, DOI 10.1152/ajpendo.90256.2008; Kus V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027126; Kwon HS, 2004, ADV ENZYME REGUL, V44, P109, DOI 10.1016/j.advenzreg.2003.11.020; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; MacLean CH, 2004, AHRQ PUBLICATION, V04-E012-2; MCGARRY JD, 1983, BIOCHEM J, V214, P21, DOI 10.1042/bj2140021; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Mori TA, 1999, AM J CLIN NUTR, V70, P817; Munro IA, 2012, BR J NUTR, P1; Nathan DM, 2008, DIABETOLOGIA, V51, P8, DOI 10.1007/s00125-007-0873-z; Neschen S, 2007, DIABETES, V56, P1034, DOI 10.2337/db06-1206; Nettleton JA, 2005, J AM DIET ASSOC, V105, P428, DOI 10.1016/j.jada.2004.11.029; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; PELIKANOVA T, 1993, ANN NY ACAD SCI, V683, P272; Punthakee Z, 2012, DIABETOLOGIA, V55, P36, DOI 10.1007/s00125-011-2357-4; Raclot T, 1997, J LIPID RES, V38, P1963; Reyes-Soffer G, 2011, EXPERT OPIN PHARMACO, V12, P1429, DOI 10.1517/14656566.2011.563506; Romisch-Margl W, 2012, METABOLOMICS, V8, P133, DOI 10.1007/s11306-011-0293-4; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; RUSTAN AC, 1993, J LIPID RES, V34, P1299; Ruxton CH, 2007, J HUM NUTR DIET, V17, P449; Ruzickova J, 2004, LIPIDS, V39, P1177, DOI 10.1007/s11745-004-1345-9; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sato A, 2010, DIABETES, V59, P2495, DOI 10.2337/db09-1554; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; Schmitz-Peiffer C, 2008, DIABETES, V57, P1774, DOI 10.2337/db07-1769; STORLIEN LH, 1987, SCIENCE, V237, P885, DOI 10.1126/science.3303333; Szendroedi J, 2008, DIABETOLOGIA, V51, P2155, DOI 10.1007/s00125-008-1153-2; Thorsdottir I, 2007, INT J OBESITY, V31, P1560, DOI 10.1038/sj.ijo.0803643; Tillmann H, 2000, GENE, V247, P241, DOI 10.1016/S0378-1119(00)00079-2; Todd MK, 2007, AM J PHYSIOL-ENDOC M, V292, pE485, DOI 10.1152/ajpendo.00080.2006; van Helden YGJ, 2010, CARCINOGENESIS, V31, P1329, DOI 10.1093/carcin/bgq083; van Schothorst EM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-110; Varma V, 2009, AM J PHYSIOL-ENDOC M, V296, pE1300, DOI 10.1152/ajpendo.90885.2008; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Zhou GD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026589	76	50	50	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43764	10.1371/journal.pone.0043764	http://dx.doi.org/10.1371/journal.pone.0043764			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952760	Green Published, gold			2022-12-25	WOS:000308221300026
J	Olsen, HH; Grunewald, J; Tornling, G; Skold, CM; Eklund, A				Olsen, Helga H.; Grunewald, Johan; Tornling, Goran; Skold, C. Magnus; Eklund, Anders			Bronchoalveolar Lavage Results Are Independent of Season, Age, Gender and Collection Site	PLOS ONE			English	Article							NORMAL VOLUNTEER SUBJECT; BRONCHIAL BIOPSIES; CELL COUNTS; FLUID; COPD	Background: Clinical interpretation of bronchoalveolar lavage fluid results is dependent on the availability of reference values for healthy individuals. Only a few studies have published such reference values and the applicability of results is restricted by small sample sizes and the limited representativeness of the study population. We aim to investigate the influence of age, gender, collection site and season on bronchoalveolar lavage fluid results and to establish reference values for use in clinical practice. Methodology/Principal Findings: Bronchoalveolar lavage fluid data from 295 healthy never-smoking volunteers, investigated during 1990-2009, were analyzed retrospectively. 47 volunteers had 2-5 repeat lavages during the course of several years. Fluid recovery, total number of cells, cell concentration, and differential cell counts on cytospin prepared slides were recorded. Reference values, as represented by the 5th to the 95th percentile, were 72-96% for macrophages, 2-26% for lymphocytes, 0-4% for neutrophils and 0-1% for eosinophils. Basophils and mast cells were rare. When repeat lavages were performed, there was a relatively large intra-individual variability, mainly for macrophages and lymphocytes. An age dependent decrease of lavage fluid return was present, but there was no age dependent correlation with any of the other BALF parameters. The BALF cell parameters were independent of gender, season and site (lingula vs. middle lobe). Conclusions/Significance: Our data show that bronchoalveolar lavage fluid cell differential count is independent of age, gender, season and collection site (RML or lingua). It therefore seems acceptable to use the same reference values for all never-smoking individuals.	[Olsen, Helga H.; Grunewald, Johan; Tornling, Goran; Skold, C. Magnus; Eklund, Anders] Karolinska Univ Hosp, Div Resp Med, Dept Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Olsen, HH (corresponding author), Karolinska Univ Hosp, Div Resp Med, Dept Med, Stockholm, Sweden.	helga.haugomolsen@mpa.se	Grunewald, Johan/GQZ-8122-2022	Grunewald, Johan/0000-0003-0473-3984	AstraZeneca; Swedish Heart and Lung Foundation; Swedish Medical Research Council; Stockholm County Council	AstraZeneca(AstraZeneca); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Stockholm County Council(Stockholm County Council)	JG and AE received financial support from AstraZeneca to be able to pay a statistician and a BMA for a shorter time helping in putting data together. Funding was also received from The Swedish Heart and Lung Foundation, The Swedish Medical Research Council and Stockholm County Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balbi B, 2007, EUR RESPIR J, V30, P769, DOI 10.1183/09031936.00112306; BANKS DE, 1990, AM J MED SCI, V300, P275, DOI 10.1097/00000441-199011000-00001; BARBERS RG, 1987, AM REV RESPIR DIS, V135, P1271; Behndig AF, 2006, EUR RESPIR J, V27, P359, DOI 10.1183/09031936.06.00136904; DAVIS GS, 1982, AM REV RESPIR DIS, V126, P611; DRENT M, 1993, THORAX, V48, P835, DOI 10.1136/thx.48.8.835; Ekberg-Jansson A, 2000, RESP MED, V94, P264, DOI 10.1053/rmed.1999.0735; EKLUND A, 1986, THORAX, V41, P629, DOI 10.1136/thx.41.8.629; ETTENSOHN DB, 1988, CHEST, V94, P275, DOI 10.1378/chest.94.2.275; ETTENSOHN DB, 1988, CHEST, V94, P281, DOI 10.1378/chest.94.2.281; EVERSON RB, 1994, AM J RESP CRIT CARE, V149, P899, DOI 10.1164/ajrccm.149.4.8143053; Friend JAR, 2001, THORAX, V56, P1, DOI 10.1136/thorax.56.1.1; Hardie JA, 2002, EUR RESPIR J, V20, P1117, DOI 10.1183/09031936.02.00023202; Haslam PL, 1999, EUR RESPIR REV, V9, P25; Karimi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034232; Larsson BM, 2007, EUR RESPIR J, V29, P699, DOI 10.1183/09031936.00035706; Larsson K, 1998, EUR RESPIR J, V12, P825, DOI 10.1183/09031936.98.12040825; LAVIOLETTE M, 1988, AM REV RESPIR DIS, V138, P451, DOI 10.1164/ajrccm/138.2.451; LAVIOLETTE M, 1985, THORAX, V40, P651, DOI 10.1136/thx.40.9.651; Lofdahl JM, 2005, EUR RESPIR J, V25, P275, DOI 10.1183/09031936.05.00033504; Medbo A, 2007, RESP MED, V101, P1097, DOI [10.1016/j.rmed.2006.11.019, 10.1016/j.rmed.2007.07.018]; MERCHANT RK, 1992, AM REV RESPIR DIS, V146, P448, DOI 10.1164/ajrccm/146.2.448; Meyer K, 2007, CLIN PULM MED, V141, P148; Meyer KC, 1999, THORAX, V54, P697, DOI 10.1136/thx.54.8.697; Meyer KC, 1996, AM J RESP CRIT CARE, V153, P1072, DOI 10.1164/ajrccm.153.3.8630547; Meyer KC, 2012, AM J RESP CRIT CARE, V185, P1004, DOI 10.1164/rccm.201202-0320ST; Ouellette DR, 2006, CHEST, V130, P1185, DOI 10.1378/chest.130.4.1185; Sehlstedt M, 2010, INHAL TOXICOL, V22, P1144, DOI 10.3109/08958378.2010.529181; SUTINEN S, 1995, RESP MED, V89, P85, DOI 10.1016/0954-6111(95)90189-2; The BAL Cooperative Group Steering Committee, 1990, AM REV RESPIR DIS, V141, pS169; Turcotte H, 2003, LUNG, V181, P9, DOI 10.1007/s00408-002-0110-y; Warr GA, 1978, AM REV RESPIR DIS, V113, P96	32	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43644	10.1371/journal.pone.0043644	http://dx.doi.org/10.1371/journal.pone.0043644			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952729	gold, Green Published, Green Submitted			2022-12-25	WOS:000308221300020
J	Gavvovidis, I; Rost, I; Trimborn, M; Kaiser, FJ; Purps, J; Wiek, C; Hanenberg, H; Neitzel, H; Schindler, D				Gavvovidis, Ioannis; Rost, Isabell; Trimborn, Marc; Kaiser, Frank J.; Purps, Josephine; Wiek, Constanze; Hanenberg, Helmut; Neitzel, Heidemarie; Schindler, Detlev			A Novel MCPH1 Isoform Complements the Defective Chromosome Condensation of Human MCPH1-Deficient Cells	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION SIGNALS; RECESSIVE MICROCEPHALY MAPS; DNA-DAMAGE RESPONSE; CENTROSOMAL PROTEIN; MENTAL-RETARDATION; MITOTIC ENTRY; MUTATIONS; LOCUS; BRAIN; CHECKPOINT	Biallelic mutations in MCPH1 cause primary microcephaly (MCPH) with the cellular phenotype of defective chromosome condensation. MCPH1 encodes a multifunctional protein that notably is involved in brain development, regulation of chromosome condensation, and DNA damage response. In the present studies, we detected that MCPH1 encodes several distinct transcripts, including two major forms: full-length MCPH1 (MCPH1-FL) and a second transcript lacking the six 3' exons (MCPH1 Delta e9-14). Both variants show comparable tissue-specific expression patterns, demonstrate nuclear localization that is mediated independently via separate NLS motifs, and are more abundant in certain fetal than adult organs. In addition, the expression of either isoform complements the chromosome condensation defect found in genetically MCPH1-deficient or MCPH1 siRNA-depleted cells, demonstrating a redundancy of both MCPH1 isoforms for the regulation of chromosome condensation. Strikingly however, both transcripts are regulated antagonistically during cell-cycle progression and there are functional differences between the isoforms with regard to the DNA damage response; MCPH1-FL localizes to phosphorylated H2AX repair foci following ionizing irradiation, while MCPH1 Delta e9-14 was evenly distributed in the nucleus. In summary, our results demonstrate here that MCPH1 encodes different isoforms that are differentially regulated at the transcript level and have different functions at the protein level.	[Gavvovidis, Ioannis; Rost, Isabell; Schindler, Detlev] Univ Wurzburg, Dept Human Genet, D-8700 Wurzburg, Germany; [Gavvovidis, Ioannis] Max Delbruck Ctr Mol Med, Berlin, Germany; [Trimborn, Marc] Charite, Dept Med Genet, D-13353 Berlin, Germany; [Kaiser, Frank J.] Univ Lubeck, Inst Humangenet, Lubeck, Germany; [Purps, Josephine; Neitzel, Heidemarie] Charite, Dept Human Genet, D-13353 Berlin, Germany; [Wiek, Constanze; Hanenberg, Helmut] Univ Dusseldorf, Sch Med, Dept Otorhinolaryngol & Head & Neck Surg, D-40225 Dusseldorf, Germany; [Hanenberg, Helmut] Indiana Univ, Riley Hosp Children, Sch Med, Dept Pediat, Indianapolis, IN 46204 USA; [Hanenberg, Helmut] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	University of Wurzburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Lubeck; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Heinrich Heine University Dusseldorf; Indiana University System; Indiana University-Purdue University Indianapolis; James Whitcomb Riley Hospital Children; Indiana University System; Indiana University-Purdue University Indianapolis	Gavvovidis, I (corresponding author), Univ Wurzburg, Dept Human Genet, D-8700 Wurzburg, Germany.	ioannis.gavvovidis@mdc-berlin.de		Wiek, Constanze/0000-0003-2214-8148; Gavvovidis, Ioannis/0000-0001-5644-9788	Hofmann La Roche; Deutsche Forschungsgemeinschaft (DFG) [NE531/5-3]; University of Wuerzburg; BMBF network of 'Inherited bone marrow failure syndromes'; BMBF network of 'Foamyvirus-mediated genetic therapy for FNACA (FoneFA)'; National Institutes of Health [R01s CA138237-01, CA155294-01]; NATIONAL CANCER INSTITUTE [R01CA155294, R01CA138237] Funding Source: NIH RePORTER	Hofmann La Roche; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Wuerzburg; BMBF network of 'Inherited bone marrow failure syndromes'; BMBF network of 'Foamyvirus-mediated genetic therapy for FNACA (FoneFA)'; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by a grant from Hofmann La Roche to DS and, in part, by a grant of the Deutsche Forschungsgemeinschaft (DFG) (NE531/5-3) to HN. This publication was funded by the DFG and the University of Wuerzburg in the funding program Open Access Publishing to DS. This work was suppored by the BMBF networks of 'Inherited bone marrow failure syndromes' and 'Foamyvirus-mediated genetic therapy for FNACA (FoneFA)' and the National Institutes of Health R01s CA138237-01 and CA155294-01 to HH. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Marchal JA, 2011, CELL CYCLE, V10, P2967, DOI 10.4161/cc.10.17.16871; Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Boue S, 2002, BIOINFORMATICS, V18, pS65, DOI 10.1093/bioinformatics/18.suppl_2.S65; Brunk K, 2007, J CELL SCI, V120, P3578, DOI 10.1242/jcs.014290; Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006; Desir J, 2008, AM J MED GENET A, V146A, P1439, DOI 10.1002/ajmg.a.32312; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; DWORETZKY SI, 1988, J CELL BIOL, V107, P1279, DOI 10.1083/jcb.107.4.1279; Garshasbi M, 2006, HUM GENET, V118, P708, DOI 10.1007/s00439-005-0104-y; Gavvovidis I, 2010, CELL CYCLE, V9, P4893, DOI 10.4161/cc.9.24.14157; Guernsey DL, 2010, AM J HUM GENET, V87, P40, DOI 10.1016/j.ajhg.2010.06.003; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jackson AP, 1998, AM J HUM GENET, V63, P541, DOI 10.1086/301966; Jamieson CR, 2000, AM J HUM GENET, V67, P1575, DOI 10.1086/316909; Jamieson CR, 1999, AM J HUM GENET, V65, P1465, DOI 10.1086/302640; Jeffers LJ, 2008, ONCOGENE, V27, P139, DOI 10.1038/sj.onc.1210595; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Le Texier V, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-169; Leal GF, 2003, J MED GENET, V40, P540, DOI 10.1136/jmg.40.7.540; Lee JY, 2007, NUCLEIC ACIDS RES, V35, pD165, DOI 10.1093/nar/gkl870; Liang YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000826; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Moynihan L, 2000, AM J HUM GENET, V66, P724, DOI 10.1086/302777; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Neitzel H, 2002, AM J HUM GENET, V70, P1015, DOI 10.1086/339518; Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682; Pattison L, 2000, AM J HUM GENET, V67, P1578, DOI 10.1086/316910; Pietschmann T, 1999, J VIROL, V73, P2613, DOI 10.1128/JVI.73.4.2613-2621.1999; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Regad T, 2009, NAT NEUROSCI, V12, P132, DOI 10.1038/nn.2251; Richards MW, 2010, J MOL BIOL, V395, P908, DOI 10.1016/j.jmb.2009.11.029; Rickmyre JL, 2007, J CELL SCI, V120, P3565, DOI 10.1242/jcs.016626; Roberts E, 1999, EUR J HUM GENET, V7, P815, DOI 10.1038/sj.ejhg.5200385; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Sudbeck P, 1997, J BIOL CHEM, V272, P27848, DOI 10.1074/jbc.272.44.27848; Tibelius A, 2009, J CELL BIOL, V185, P1149, DOI 10.1083/jcb.200810159; Trimborn M, 2006, CELL CYCLE, V5, P322, DOI 10.4161/cc.5.3.2412; Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855; Trimborn Marc, 2005, Hum Mutat, V26, P496, DOI 10.1002/humu.9382; Trimborn M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009242; VANDROMME M, 1995, P NATL ACAD SCI USA, V92, P4646, DOI 10.1073/pnas.92.10.4646; Wilson KA, 2008, CELL CYCLE, V7, P3584, DOI 10.4161/cc.7.22.7102; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wood JL, 2008, J BIOL CHEM, V283, P29586, DOI 10.1074/jbc.M804080200; Wood JL, 2007, J BIOL CHEM, V282, P35416, DOI 10.1074/jbc.M705245200; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Yamashita D, 2011, J CELL BIOL, V194, P841, DOI 10.1083/jcb.201106141; Yang SZ, 2008, EMBO REP, V9, P907, DOI 10.1038/embor.2008.128; Yu TW, 2010, NAT GENET, V42, P1015, DOI 10.1038/ng.683; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zhang XY, 2004, J VIROL, V78, P1219, DOI 10.1128/JVI.78.3.1219-1229.2004	60	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e40387	10.1371/journal.pone.0040387	http://dx.doi.org/10.1371/journal.pone.0040387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952573	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000308206500001
J	Langer, M; Pacureanu, A; Suhonen, H; Grimal, Q; Cloetens, P; Peyrin, F				Langer, Max; Pacureanu, Alexandra; Suhonen, Heikki; Grimal, Quentin; Cloetens, Peter; Peyrin, Francoise			X-Ray Phase Nanotomography Resolves the 3D Human Bone Ultrastructure	PLOS ONE			English	Article							SYNCHROTRON-RADIATION; TRABECULAR BONE; COMPACT-BONE; SECONDARY OSTEONS; CORTICAL BONE; CEMENT LINE; COLLAGEN; DENSITY; MINERALIZATION; ORIENTATION	Bone strength and failure are increasingly thought to be due to ultrastructural properties, such as the morphology of the lacuno-canalicular network, the collagen fiber orientation and the mineralization on the nanoscale. However, these properties have not been studied in 3D so far. Here we report the investigation of the human bone ultrastructure with X-ray phase nanotomography, which now provides the required sensitivity, spatial resolution and field of view. The 3D organization of the lacuno-canalicular network is studied in detail over several cells in osteonal and interstitial tissue. Nanoscale density variations are revealed and show that the cement line separating these tissues is hypermineralized. Finally, we show that the collagen fibers are organized as a twisted plywood structure in 3D.	[Langer, Max; Pacureanu, Alexandra; Peyrin, Francoise] Univ Lyon 1, CNRS, UMR5220, Inserm,U1044, F-69365 Lyon, France; [Langer, Max; Pacureanu, Alexandra; Suhonen, Heikki; Cloetens, Peter; Peyrin, Francoise] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Pacureanu, Alexandra] Politeh Univ Bucharest, LAPI, Bucharest, Romania; [Grimal, Quentin] UPMC Univ Paris 06, CNRS, UMR7623, LIP, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; European Synchrotron Radiation Facility (ESRF); Polytechnic University of Bucharest; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Langer, M (corresponding author), Univ Lyon 1, CNRS, UMR5220, Inserm,U1044, F-69365 Lyon, France.	max.langer@esrf.fr	Cloetens, Peter/AAJ-6131-2020; Suhonen, Heikki/B-7851-2012; Peyrin, Francoise/G-2823-2013; Langer, Max/E-1408-2013; grimal, quentin/P-4758-2014	Cloetens, Peter/0000-0002-4129-9091; Suhonen, Heikki/0000-0002-0337-6308; Peyrin, Francoise/0000-0002-1988-3435; Langer, Max/0000-0002-5821-9617; grimal, quentin/0000-0001-9041-8176; Pacureanu, Alexandra/0000-0003-2306-7040	French Medical Research Foundation (FRM - Fondation pour la recherche medicale)	French Medical Research Foundation (FRM - Fondation pour la recherche medicale)	This work was funded by the French Medical Research Foundation (FRM - Fondation pour la recherche medicale, www.frm.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JC, 2010, MICROSC MICROANAL, V16, P327, DOI 10.1017/S1431927610000231; Barth HD, 2011, BIOMATERIALS, V32, P8892, DOI 10.1016/j.biomaterials.2011.08.013; Bleuet P, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3117489; Bousson V, 2004, J BONE MINER RES, V19, P794, DOI 10.1359/JBMR.040124; Bromage Timothy G., 2003, Anatomical Record, V274B, P157, DOI 10.1002/ar.b.10031; BURR DB, 1988, J BIOMECH, V21, P939, DOI 10.1016/0021-9290(88)90132-7; Cloetens P, 1999, APPL PHYS LETT, V75, P2912, DOI 10.1063/1.125225; Davies JE, 2007, BIOMATERIALS, V28, P5058, DOI 10.1016/j.biomaterials.2007.07.049; Dierolf M, 2010, NATURE, V467, P436, DOI 10.1038/nature09419; Giraud-Guille MM, 2003, J BIOMECH, V36, P1571, DOI 10.1016/S0021-9290(03)00134-9; GIRAUDGUILLE MM, 1988, CALCIFIED TISSUE INT, V42, P167, DOI 10.1007/BF02556330; Guinier A., 1994, XRAY DIFFRACTION CRY; Hassenkam T, 2004, BONE, V35, P4, DOI 10.1016/j.bone.2004.02.024; Hignette O, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1928191; HOSHEN J, 1976, PHYS REV B, V14, P3438, DOI 10.1103/PhysRevB.14.3438; Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116; Kazanci M, 2006, J STRUCT BIOL, V156, P489, DOI 10.1016/j.jsb.2006.06.011; Kerschnitzki M, 2011, J STRUCT BIOL, V173, P303, DOI 10.1016/j.jsb.2010.11.014; Kingsmill VJ, 1998, J ANAT, V192, P245, DOI 10.1046/j.1469-7580.1998.19220245.x; KIRKPATRICK P, 1948, J OPT SOC AM, V38, P766, DOI 10.1364/JOSA.38.000766; Lane NE, 2006, J BONE MINER RES, V21, P466, DOI 10.1359/JBMR.051103; MAROTTI G, 1995, BONE, V16, P125, DOI 10.1016/S8756-3282(94)00019-0; Martin T, 2009, IEEE T NUCL SCI, V56, P1412, DOI 10.1109/TNS.2009.2015878; Mokso R, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2719653; Muller R, 2009, NAT REV RHEUMATOL, V5, P373, DOI 10.1038/nrrheum.2009.107; Nuzzo S, 2002, J BONE MINER RES, V17, P1372, DOI 10.1359/jbmr.2002.17.8.1372; O'Brien FJ, 2003, J BIOMECH, V36, P973, DOI 10.1016/S0021-9290(03)00066-6; PANNARALE L, 1994, ACTA ANAT, V151, P36; Sato Y, 1998, Med Image Anal, V2, P143, DOI 10.1016/S1361-8415(98)80009-1; SCHAFFLER MB, 1987, ANAT REC, V217, P223, DOI 10.1002/ar.1092170302; Schneider P, 2011, BONE, V49, P304, DOI 10.1016/j.bone.2011.04.005; Schneider P, 2010, BONE, V47, P848, DOI 10.1016/j.bone.2010.07.026; Skedros JG, 2005, ANAT REC PART A, V286A, P781, DOI 10.1002/ar.a.20214; Sugawara Y, 2005, BONE, V36, P877, DOI 10.1016/j.bone.2004.10.008; Taylor D, 2007, NAT MATER, V6, P263, DOI 10.1038/nmat1866; Teti A, 2009, BONE, V44, P11, DOI 10.1016/j.bone.2008.09.017; van Hove RP, 2009, BONE, V45, P321, DOI 10.1016/j.bone.2009.04.238	37	121	122	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e35691	10.1371/journal.pone.0035691	http://dx.doi.org/10.1371/journal.pone.0035691			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952569	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206000001
J	Buscariollo, DL; Davidson, MA; Black, M; Russell, WE; Rothman, RL; Moore, DJ				Buscariollo, Daniela L.; Davidson, Mario A.; Black, Margo; Russell, William E.; Rothman, Russell L.; Moore, Daniel J.			Factors That Influence Parental Attitudes toward Enrollment in Type 1 Diabetes Trials	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; RECRUITMENT; PERCEPTIONS	Aims: To assess parental attitudes towards type 1 diabetes clinical trials (T1DCTs) and factors that impact willingness to enroll their children with and without diabetes. Methods: A cross-sectional survey of parents of children with type 1 diabetes was administered at an academic clinic and a diabetes educational event. Results: Survey response rate was 36%. Of 166 participating parents, 76% were aware of T1DCTs. More parents reported willingness to enroll children with diabetes (47%) than unaffected children (36%). Only 18% recalled being asked to enroll their children, and of these, 60% agreed to enroll at least some of those times. Less than 30% were comfortable with placebos. Factors predicting willingness to enroll children with diabetes included healthcare provider trust, comfort with consent by proxy, low fear of child being a "guinea pig," and comfort with placebo. Factors predicting willingness to enroll unaffected children were provider trust, comfort with consent by proxy, comfort with placebo, and perceived ease of understanding T1DCT information. Conclusions: Parents report moderate willingness to enroll children in T1DCTs. Willingness is diminished by common trial methodologies. Although most parents recalled receiving trial-related information, significantly fewer recalled being asked to participate. Efforts to optimize effective communication around identified areas of parental concern may increase T1DCT participation.	[Buscariollo, Daniela L.; Black, Margo; Russell, William E.; Moore, Daniel J.] Vanderbilt Univ, Med Ctr, Dept Pediat, Ian Burr Div Endocrinol & Diabet, Nashville, TN 37232 USA; [Davidson, Mario A.] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN 37232 USA; [Rothman, Russell L.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Buscariollo, DL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Ian Burr Div Endocrinol & Diabet, Nashville, TN 37232 USA.	daniel.moore@vanderbilt.edu	Davidson, Mario/AAX-1102-2021; Moore, Daniel/V-6145-2019; Moore, Daniel J/A-4924-2008	Moore, Daniel/0000-0002-6889-9345; Moore, Daniel J/0000-0002-6889-9345; Rothman, Russsell/0000-0002-1506-3990	United States National Institutes of Health [F32DK083161]; Vanderbilt Physician Scientist Development Program; Type 1 Diabetes TrialNet Clinical Center Award;  [U01DK085465]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085465, F32DK083161, P30DK092986] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Physician Scientist Development Program; Type 1 Diabetes TrialNet Clinical Center Award; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	DJM was supported by United States National Institutes of Health F32DK083161 and the Vanderbilt Physician Scientist Development Program. WER was supported by U01DK085465, Type 1 Diabetes TrialNet Clinical Center Award to Vanderbilt University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caldwell PHY, 2004, LANCET, V364, P803, DOI 10.1016/S0140-6736(04)16942-0; Caldwell PHY, 2003, J PEDIATR-US, V142, P554, DOI 10.1067/mpd.2003.192; Caldwell PHY, 2002, J PEDIATR-US, V141, P798, DOI 10.1067/mpd.2002.129173; Harrell FE, 2001, REGRESSION MODELING; Harth SC, 1995, SOC SCI MED, V41, P1647, DOI 10.1016/0277-9536(95)00058-F; Liese AD, 2006, PEDIATRICS, V118, P1510, DOI 10.1542/peds.2006-0690; Ludvigsson J, 2011, DIABETOLOGIA, V54, P634, DOI 10.1007/s00125-010-1988-1; McGuinness Claire, 2007, Paediatr Nurs, V19, P37; Poland GA, 2011, NEW ENGL J MED, V364, P97, DOI 10.1056/NEJMp1010594; Smyth RL, 2001, BRIT MED J, V322, P1377, DOI 10.1136/bmj.322.7299.1377; Snowdon C, 1997, SOC SCI MED, V45, P1337, DOI 10.1016/S0277-9536(97)00063-4; Stolt UG, 2005, EUR J HUM GENET, V13, P376, DOI 10.1038/sj.ejhg.5201336; Tait AR, 2003, ANESTHESIOLOGY, V99, P819, DOI 10.1097/00000542-200310000-00012; Tait AR, 2003, ANESTHESIOLOGY, V98; Tercyak KP, 1998, DIABETES CARE, V21, P213, DOI 10.2337/diacare.21.2.213; Walson PD, 1999, PEDIATRICS, V104, P619; Welton AJ, 1999, BRIT MED J, V318, P1114, DOI 10.1136/bmj.318.7191.1114; Wiley FM, 1999, CANCER PRACT, V7, P248, DOI 10.1046/j.1523-5394.1999.75010.x; Zupancic JAF, 1997, PEDIATRICS, V99, pE61	19	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44341	10.1371/journal.pone.0044341	http://dx.doi.org/10.1371/journal.pone.0044341			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998CA	22937171	Green Published, gold, Green Submitted			2022-12-25	WOS:000308213600102
J	Guo, WT; Hao, HH; Dai, MH; Wang, YL; Huang, LL; Peng, DP; Wang, X; Wang, HL; Yao, M; Sun, YW; Liu, ZL; Yuan, ZH				Guo, Wentao; Hao, Haihong; Dai, Menghong; Wang, Yulian; Huang, Lingli; Peng, Dapeng; Wang, Xu; Wang, Hailan; Yao, Min; Sun, Yawei; Liu, Zhenli; Yuan, Zonghui			Development of Quinoxaline 1, 4-Dioxides Resistance in Escherichia coli and Molecular Change under Resistance Selection	PLOS ONE			English	Article							TO-FINISH FARMS; CENTRAL CARBON METABOLISM; INDUCED OXIDATIVE STRESS; ELONGATION-FACTOR G; LIPOIC ACID; ANTIMICROBIAL RESISTANCE; CONFERRING RESISTANCE; SUBSTRATE-SPECIFICITY; SODIUM-SALICYLATE; BRITISH-COLUMBIA	Quinoxaline 1, 4-dioxides (QdNOs) has been used in animals as antimicrobial agents and growth promoters for decades. However, the resistance to QdNOs in pathogenic bacteria raises worldwide concern but it is barely known. To explore the molecular mechanism involved in development of QdNOs resistance in Escherichia coli, 6 strains selected by QdNOs in vitro and 21 strains isolated from QdNOs-used swine farm were subjected to MIC determination and PCR amplification of oqxA gene. A conjugative transfer was carried out to evaluate the transfer risk of QdNOs resistant determinant. Furthermore, the transcriptional profile of a QdNOs-resistant E. coli (79O4-2) selected in vitro with its parent strain 79-161 was assayed with a prokaryotic suppression subtractive hybridization (SSH) PCR cDNA subtraction. The result showed that more than 95% (20/21) clinical isolates were oqxA positive, while all the 6 induced QdNOs-resistant strains carried no oqxA gene and exhibited low frequency of conjugation. 44 fragments were identified by SSH PCR subtraction in the QdNOs-resistant strain 79O4-2. 18 cDNAs were involved in biosynthesis of Fe-S cluster (narH), protein (rpoA, trmD, truA, glyS, ileS, rplFCX, rpsH, fusA), lipoate (lipA), lipid A (lpxC), trehalose (otsA), CTP(pyrG) and others molecular. The 11 cDNAs were related to metabolism or degradation of glycolysis (gpmA and pgi) and proteins (clpX, clpA, pepN and fkpB). The atpADG and ubiB genes were associated with ATP biosynthesis and electron transport chain. The pathway of the functional genes revealed that E. coli may adapt the stress generated by QdNOs or develop specific QdNOs-resistance by activation of antioxidative agents biosynthesis (lipoate and trehalose), protein biosynthesis, glycolysis and oxidative phosphorylation. This study initially reveals the possible molecular mechanism involved in the development of QdNOs-resistance in E. coli, providing with novel insights in prediction and assessment of the emergency and horizontal transfer of QdNOs-resistance in E. coli.	[Guo, Wentao; Hao, Haihong; Dai, Menghong; Wang, Yulian; Huang, Lingli; Peng, Dapeng; Wang, Xu; Wang, Hailan; Yao, Min; Sun, Yawei; Liu, Zhenli; Yuan, Zonghui] Huazhong Agr Univ, Natl Reference Lab Vet Drug Residues, MOA Key Lab Detect Vet Drug Residues, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	Guo, WT (corresponding author), Huazhong Agr Univ, Natl Reference Lab Vet Drug Residues, MOA Key Lab Detect Vet Drug Residues, Wuhan, Hubei, Peoples R China.	yuan5802@mail.hzau.edu.cn	DAI, M/GPS-8291-2022; yuan, zonghui/A-1158-2017; Hao, Haihong/E-2789-2019	Hao, Haihong/0000-0003-0199-5700	National Natural Science Foundation of China [31101856]; Fundamental Research Funds for the Central Universities [2011QC005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This article is supported by National Natural Science Foundation of China (31101856) and the Fundamental Research Funds for the Central Universities (2011QC005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akwar HT, 2008, CAN J VET RES, V72, P202; Akwar HT, 2008, CAN J VET RES, V72, P195; Anderson JK, 2010, TRENDS MICROBIOL, V18, P30, DOI 10.1016/j.tim.2009.11.001; Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200; BEUTIN L, 1981, ANTIMICROB AGENTS CH, V20, P336, DOI 10.1128/AAC.20.3.336; Blasco F, 2001, CELL MOL LIFE SCI, V58, P179, DOI 10.1007/PL00000846; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Carta A, 2005, CURR MED CHEM, V12, P2259, DOI 10.2174/0929867054864831; Chandu D, 2003, MICROBIOL-SGM, V149, P3437, DOI 10.1099/mic.0.26518-0; Cicchillo RM, 2005, J AM CHEM SOC, V127, P2860, DOI 10.1021/ja042428u; Cronan JE, 2005, ADV MICROB PHYSIOL, V50, P103, DOI 10.1016/S0065-2911(05)50003-1; DAMERAU K, 1993, J BACTERIOL, V175, P53, DOI 10.1128/JB.175.1.53-63.1993; De Long SK, 2008, APPL ENVIRON MICROB, V74, P225, DOI 10.1128/AEM.01647-07; Ding MX, 2006, J ANIM SCI, V84, P2367, DOI 10.2527/jas.2005-564; Ding X, 2006, J ANIM PHYSIOL AN N, V90, P238, DOI 10.1111/j.1439-0396.2005.00593.x; Drago L, 2005, J CHEMOTHERAPY, V17, P161, DOI 10.1179/joc.2005.17.2.161; Dunlop RH, 1998, PREV VET MED, V34, P283, DOI 10.1016/S0167-5877(97)00095-0; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Fang GJ, 2006, FOOD CHEM TOXICOL, V44, P36, DOI 10.1016/j.fct.2005.06.003; Ganley B, 2001, BIOORGAN MED CHEM, V9, P2395, DOI 10.1016/S0968-0896(01)00163-8; Goraca A, 2008, J PHYSIOL PHARMACOL, V59, P379; Goraca A, 2009, J PHYSIOL PHARMACOL, V60, P61; Hansen LH, 2007, J ANTIMICROB CHEMOTH, V60, P145, DOI 10.1093/jac/dkm167; Hansen LH, 2004, ANTIMICROB AGENTS CH, V48, P3332, DOI 10.1128/AAC.48.9.3332-3337.2004; He QH, 2006, PHOTODERMATOL PHOTO, V22, P100, DOI 10.1111/j.1600-0781.2006.00199.x; HEDGES AJ, 1988, J APPL BACTERIOL, V64, P429, DOI 10.1111/j.1365-2672.1988.tb05100.x; Huang LL, 2008, J CHROMATOGR B, V874, P7, DOI 10.1016/j.jchromb.2008.08.013; KAASEN I, 1994, GENE, V145, P9, DOI 10.1016/0378-1119(94)90316-6; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Katunin VI, 2002, BIOCHEMISTRY-US, V41, P12806, DOI 10.1021/bi0264871; Kim YR, 2008, J MICROBIOL BIOTECHN, V18, P1146; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Krehenbrink M, 2011, MOL MICROBIOL, V82, P164, DOI 10.1111/j.1365-2958.2011.07803.x; Kumar A, 2007, BIOCHEM BIOPH RES CO, V353, P706, DOI 10.1016/j.bbrc.2006.12.073; Laskowska E, 1996, MOL MICROBIOL, V22, P555, DOI 10.1046/j.1365-2958.1996.1231493.x; Lee C, 2008, APPL MICROBIOL BIOT, V78, P371, DOI 10.1007/s00253-007-1300-6; Liang XF, 2011, BIOORGAN MED CHEM, V19, P852, DOI 10.1016/j.bmc.2010.12.017; LINTON AH, 1988, J APPL BACTERIOL, V64, P311, DOI 10.1111/j.1365-2672.1988.tb01876.x; Martinez JL, 2011, CURR OPIN PHARMACOL, V11, P439, DOI 10.1016/j.coph.2011.07.005; Lushchak VI, 2001, BIOCHEMISTRY-MOSCOW+, V66, P476, DOI 10.1023/A:1010294415625; Maciag M, 2012, MUTAT RES-FUND MOL M, V731, P99, DOI 10.1016/j.mrfmmm.2011.12.005; Maciag M, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-19; MAURIZI MR, 1992, EXPERIENTIA, V48, P178, DOI 10.1007/BF01923511; Moreira PI, 2007, J ALZHEIMERS DIS, V12, P195, DOI 10.3233/jad-2007-12210; Narita S, 2003, MOL MICROBIOL, V49, P167, DOI 10.1046/j.1365-2958.2003.03569.x; Narita S, 2002, J BACTERIOL, V184, P1417, DOI 10.1128/JB.184.5.1417-1422.2002; OHMAE K, 1981, ANTIMICROB AGENTS CH, V19, P86, DOI 10.1128/AAC.19.1.86; Ollagnier-de Choudens S, 1999, FEBS LETT, V453, P25, DOI 10.1016/S0014-5793(99)00694-8; Peed L, 2010, J BACTERIOL, V192, P4643, DOI 10.1128/JB.00317-10; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Rothery RA, 2001, BIOCHEMISTRY-US, V40, P5260, DOI 10.1021/bi002393k; Rudd KE, 2000, NUCLEIC ACIDS RES, V28, P60, DOI 10.1093/nar/28.1.60; Schweder T, 1996, J BACTERIOL, V178, P470, DOI 10.1128/jb.178.2.470-476.1996; Segers K, 2011, CHEM BIOL, V18, P685, DOI 10.1016/j.chembiol.2011.04.007; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Sorensen AH, 2003, ANTIMICROB AGENTS CH, V47, P798, DOI 10.1128/AAC.47.2.798-799.2003; STROM AR, 1993, MOL MICROBIOL, V8, P205, DOI 10.1111/j.1365-2958.1993.tb01564.x; STYRVOLD OB, 1991, J BACTERIOL, V173, P1187, DOI 10.1128/jb.173.3.1187-1192.1991; Coelho MLV, 2009, J MICROBIOL, V47, P327, DOI 10.1007/s12275-009-0044-7; Vaughan S, 2010, CURR OPIN MICROBIOL, V13, P453, DOI 10.1016/j.mib.2010.05.006; Gomis-Ruth FX, 2006, CURR OPIN STRUC BIOL, V16, P744, DOI 10.1016/j.sbi.2006.10.004; Yakushi T, 2000, NAT CELL BIOL, V2, P212, DOI 10.1038/35008635; Yuan YM, 2007, ARCH MICROBIOL, V187, P425, DOI 10.1007/s00203-006-0206-5; ZENGEL JM, 1994, PROG NUCLEIC ACID RE, V47, P331, DOI 10.1016/S0079-6603(08)60256-1; Zhou YN, 1998, J BACTERIOL, V180, P1154, DOI 10.1128/JB.180.5.1154-1158.1998; Zou JJ, 2009, MUTAT RES-GEN TOX EN, V676, P27, DOI 10.1016/j.mrgentox.2009.03.001	68	48	50	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43322	10.1371/journal.pone.0043322	http://dx.doi.org/10.1371/journal.pone.0043322			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952665	Green Published, gold, Green Submitted			2022-12-25	WOS:000308213600021
J	Hu, SH; Whitten, AE; King, GJ; Jones, A; Rowland, AF; James, DE; Martin, JL				Hu, Shu-Hong; Whitten, Andrew E.; King, Gordon J.; Jones, Alun; Rowland, Alexander F.; James, David E.; Martin, Jennifer L.			The Weak Complex between RhoGAP Protein ARHGAP22 and Signal Regulatory Protein 14-3-3 Has 1:2 Stoichiometry and a Single Peptide Binding Mode	PLOS ONE			English	Article							STRUCTURAL BASIS; WIDE PREDICTION; PHOSPHORYLATION; IDENTIFICATION; RAC; AKT	ARHGAP22 is a RhoGAP protein comprising an N-terminal PH domain, a RhoGAP domain and a C-terminal coiled-coil domain. It has recently been identified as an Akt substrate that binds 14-3-3 proteins in response to treatment with growth factors involved in cell migration. We used a range of biophysical techniques to investigate the weak interaction between 14-3-3 and a truncated form of ARHGAP22 lacking the coiled-coil domain. This weak interaction could be stabilized by chemical cross-linking which we used to show that: a monomer of ARHGAP22 binds a dimer of 14-3-3; the ARHGAP22 PH domain is required for the 14-3-3 interaction; the RhoGAP domain is unlikely to participate in the interaction; Ser16 is the more important of two predicted 14-3-3 binding sites; and, phosphorylation of Ser16 may not be necessary for 14-3-3 interaction under the conditions we used. Small angle X-ray scattering and cross-link information were used to generate solution structures of the isolated proteins and of the cross-linked ARHGAP22: 14-3-3 complex, showing that no major rearrangement occurs in either protein upon binding, and supporting a role for the PH domain and N-terminal peptide of ARHGAP22 in the 14-3-3 interaction. Small-angle X-ray scattering measurements of mixtures of ARHGAP22 and 14-3-3 were used to establish that the affinity of the interaction is similar to 30 mu M.	[Hu, Shu-Hong; Whitten, Andrew E.; King, Gordon J.; Jones, Alun; Martin, Jennifer L.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld, Australia; [Rowland, Alexander F.; James, David E.] Garvan Inst Med Res, Sydney, NSW, Australia	University of Queensland; Garvan Institute of Medical Research	Hu, SH (corresponding author), Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld, Australia.	j.martin@imb.uq.edu.au	King, Gordon/J-8718-2014; Martin, Jennifer L./A-6039-2010	Whitten, Andrew/0000-0001-8856-3120; Martin, Jennifer L./0000-0002-9225-8863; James, David/0000-0001-5946-5257	Australian National Health and Medical Research Council (NHMRC) [535921]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian National Health and Medical Research Council (NHMRC) program grant 535921. The contents of this paper are solely the responsibility of the University of Queensland, the Garvan Institute and the individual authors and do not reflect the views of the National Health and Medical Research Council (NHMRC). AEW is an NHMRC Peter Doherty Fellow (569864); DEJ is an NHMRC Senior Principal Research Fellow (1019680); JLM is an ARC Australian Laureate Fellow (FL0992138) and honorary NHMRC Fellow (455829). The authors also acknowledge access to the SAXS/WAXS beam-line at the Australian Synchrotron (AS111/SAXS3171). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Cookson D. J., 2007, SAXS15ID SOFTWARE AC; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Geraghty KM, 2007, BIOCHEM J, V407, P231, DOI 10.1042/BJ20070649; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Larance M, 2010, MOL CELL PROTEOMICS, V9, P682, DOI 10.1074/mcp.M900435-MCP200; Menetrey J, 2007, EMBO J, V26, P1953, DOI 10.1038/sj.emboj.7601634; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Nishi H, 2011, STRUCTURE, V19, P1807, DOI 10.1016/j.str.2011.09.021; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Ottmann C, 2007, EMBO J, V26, P902, DOI 10.1038/sj.emboj.7601530; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/NMETH.1192, 10.1038/nmeth.1192]; Rowland AF, 2011, MOL CELL BIOL, V31, P4789, DOI 10.1128/MCB.05583-11; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wurtele M, 2001, NAT STRUCT BIOL, V8, P23; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Zhai JB, 2001, J BIOL CHEM, V276, P41318, DOI 10.1074/jbc.M107709200; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	33	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e41731	10.1371/journal.pone.0041731	http://dx.doi.org/10.1371/journal.pone.0041731			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952583	gold, Green Published, Green Submitted			2022-12-25	WOS:000308213600003
J	Kanzaki, N; Giblin-Davis, RM; Scheffrahn, RH; Taki, H; Esquivel, A; Davies, KA; Herre, EA				Kanzaki, Natsumi; Giblin-Davis, Robin M.; Scheffrahn, Rudolf H.; Taki, Hisatomo; Esquivel, Alejandro; Davies, Kerrie A.; Allen Herre, E.			Reverse Taxonomy for Elucidating Diversity of Insect-Associated Nematodes: A Case Study with Termites	PLOS ONE			English	Article							N. SP; ENVIRONMENTAL DNA; APHELENCHOIDIDAE; DIPLOGASTRIDAE; BIODIVERSITY; MORPHOLOGY; PHYLOGENY; PRIMERS	Background: The molecular operational taxonomic unit (MOTU) has recently been applied to microbial and microscopic animal biodiversity surveys. However, in many cases, some of the MOTUs cannot be definitively tied to any of the taxonomic groups in current databases. To surmount these limitations, the concept of "reverse taxonomy" has been proposed, i.e. to primarily list the MOTUs with morphological information, and then identify and/ordescribe them at genus/species level using subsamples or by re-isolating the target organisms. Nevertheless, the application of "reverse taxonomy" has not been sufficiently evaluated. Therefore, the practical applicability of "reverse taxonomy" is tested using termite-associated nematodes as a model system for phoretic/parasitic organisms which have high habitat specificity and a potential handle (their termite host species) for re-isolation attempts. Methodology: Forty-eight species (from 298 colonies) of termites collected from the American tropics and subtropics were examined for their nematode associates using the reverse taxonomy method and culturing attempts (morphological identification and further sequencing efforts). The survey yielded 51 sequence types (= MOTUs) belonging to 19 tentatively identified genera. Within these, four were identified based on molecular data with preliminary morphological observation, and an additional seven were identified or characterized from successful culturing, leaving eight genera unidentified. Conclusions: That 1/3 of the genera were not successfully identified suggests deficiencies in the depth of available sequences in the database and biological characters, i.e. usually isolated as phoretic/parasitic stages which are not available for morphological identification, and too many undiscovered lineages of nematodes. Although there still is the issue of culturability of nematodes, culturing attempts could help to make reverse taxonomy methods more effective. However, expansion of the database, i.e., production of more DNA barcodes tied to biological information by finding and characterizing additional new and known lineages, is necessary for analyzing functional diversity.	[Kanzaki, Natsumi; Giblin-Davis, Robin M.; Scheffrahn, Rudolf H.] Univ Florida IFAS, Ft Lauderdale Res & Educ Ctr, Davie, FL USA; [Kanzaki, Natsumi; Taki, Hisatomo] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 305, Japan; [Esquivel, Alejandro] Univ Nacl, Escuela Ciencias Agr, Lab Nematol, Heredia, Costa Rica; [Davies, Kerrie A.] Univ Adelaide, Sch Agr Food & Wine, Ctr Evolutionary Biol & Biodivers, Glen Osmond, SA, Australia; [Allen Herre, E.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama	State University System of Florida; University of Florida; Forestry & Forest Products Research Institute - Japan; Universidad Nacional Costa Rica; University of Adelaide; Smithsonian Institution; Smithsonian Tropical Research Institute	Kanzaki, N (corresponding author), Univ Florida IFAS, Ft Lauderdale Res & Educ Ctr, Davie, FL USA.	nkanzaki@affrc.go.jp		Giblin-Davis, Robin/0000-0002-8861-8678	National Science Foundation [DEB-0450537]; Ministry of Education, Culture, Sports, Science and Technology, Japan [21770094]	National Science Foundation(National Science Foundation (NSF)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partially supported by the National Science Foundation (DEB-0450537) - Biodiversity Surveys and Inventories, and a Grant-in-Aid for Young Scientists (B) (#21770094) from The Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRASSY I, 1984, KLASSE NEMATODA ORDN; Blaxter M, 2003, NATURE, V421, P122, DOI 10.1038/421122a; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Borneman J, 1997, APPL ENVIRON MICROB, V63, P2647, DOI 10.1128/AEM.63.7.2647-2653.1997; Carta LK, 2005, NEMATOLOGY, V7, P863, DOI 10.1163/156854105776186299; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Davies K, 2010, NEMATOLOGY, V12, P935, DOI 10.1163/138855410X498932; De Ley P, 2005, PHILOS T R SOC B, V360, P1945, DOI 10.1098/rstb.2005.1726; Derycke S, 2010, ZOOL SCR, V39, P276, DOI 10.1111/j.1463-6409.2009.00420.x; DeSantis TZ, 2005, FEMS MICROBIOL LETT, V245, P271, DOI 10.1016/j.femsle.2005.03.016; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Floyd RM, 2005, MOL ECOL NOTES, V5, P611, DOI 10.1111/j.1471-8286.2005.01009.x; Hazir C, 2010, NEMATOLOGY, V12, P65, DOI 10.1163/156854109X448348; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunt D. J., 2007, Journal of Nematode Morphology and Systematics, V10, P99; Hunt DJ, 1993, APHELENCHIDA LONGIDO; Kanzaki N., 2008, PINE WILT DISEASE, P44; Kanzaki N, 2011, ENVIRON ENTOMOL, V40, P281, DOI 10.1603/EN10182; Kanzaki N, 2010, NEMATOLOGY, V12, P803, DOI 10.1163/138855410X499067; Kanzaki N, 2009, NEMATOLOGY, V11, P171, DOI 10.1163/156854109X429510; Kanzaki N, 2009, NEMATOLOGY, V11, P203, DOI 10.1163/156854109X429547; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Lambshead PJD, 2003, J BIOGEOGR, V30, P475, DOI 10.1046/j.1365-2699.2003.00843.x; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Markmann M, 2005, PHILOS T R SOC B, V360, P1917, DOI 10.1098/rstb.2005.1723; Mayer WE, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-212; Moser JC, 2005, AGR FOREST ENTOMOL, V7, P169, DOI 10.1111/j.1461-9555.2005.00261.x; Padial JM, 2007, ZOOTAXA, P67, DOI 10.11646/zootaxa.1586.1.7; Poinar GO., 1975, ENTOMOGENOUS NEMATOD; Porazinska DL, 2010, ZOOTAXA, P55, DOI 10.11646/zootaxa.2427.1.6; Porazinska DL, 2010, MOL ECOL, V19, P5521, DOI 10.1111/j.1365-294X.2010.04891.x; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Powers TO, 2009, MOL ECOL, V18, P985, DOI 10.1111/j.1365-294X.2008.04075.x; Robeson Michael S. II, 2009, BMC Ecology, V9, P25, DOI 10.1186/1472-6785-9-25; Siddall ME, 2012, J PARASITOL IN PRESS, P98; Steel H, 2011, NEMATOLOGY, V13, P347, DOI 10.1163/138855410X523023; Sudhaus W., 2003, Journal of Nematode Morphology and Systematics, V6, P43; Sudhaus W, 2001, J NEMATOL, V33, P1; van Megen H, 2009, NEMATOLOGY, V11, P927, DOI 10.1163/156854109X456862; Von Lieven AF, 2003, NEMATOLOGY, V5, P583, DOI 10.1163/156854103322683300; von Lieven AF, 2000, J ZOOL SYST EVOL RES, V38, P37, DOI 10.1046/j.1439-0469.2000.381125.x; VONLIEVEN AF, 2001, THESIS FREIE U BERLI; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; WILLIAMS BD, 1992, GENETICS, V131, P609; Ye WM, 2007, MOL PHYLOGENET EVOL, V43, P1185, DOI 10.1016/j.ympev.2007.02.006	49	29	29	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43865	10.1371/journal.pone.0043865	http://dx.doi.org/10.1371/journal.pone.0043865			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952792	gold, Green Published, Green Submitted			2022-12-25	WOS:000308213600052
J	Pallu, S; Rochefort, GY; Jaffre, C; Refregiers, M; Maurel, DB; Benaitreau, D; Lespessailles, E; Jamme, F; Chappard, C; Benhamou, CL				Pallu, Stephane; Rochefort, Gael Y.; Jaffre, Christelle; Refregiers, Matthieu; Maurel, Delphine B.; Benaitreau, Delphine; Lespessailles, Eric; Jamme, Frederic; Chappard, Christine; Benhamou, Claude-Laurent			Synchrotron Ultraviolet Microspectroscopy on Rat Cortical Bone: Involvement of Tyrosine and Tryptophan in the Osteocyte and Its Environment	PLOS ONE			English	Article							MASS-SPECTROMETRY; ALCOHOL; GROWTH; PHOSPHATASE; ACTIVATION; LOCALIZATION; SPECTROSCOPY; OSTEOSTATIN; METABOLISM; DEPENDENCE	Alcohol induced osteoporosis is characterized by a bone mass decrease and microarchitecture alterations. Having observed an excess in osteocyte apoptosis, we aimed to assess the bone tissue biochemistry, particularly in the osteocyte and its environment. For this purpose, we used a model of alcohol induced osteoporosis in rats. Bone sections of cortical bone were investigated using synchrotron UV-microspectrofluorescence at subcellular resolution. We show that bone present three fluorescence peaks at 305, 333 and 385 nm, respectively corresponding to tyrosine, tryptophan and collagen. We have determined that tyrosine/collagen and tryptophan/collagen ratios were higher in the strong alcohol consumption group. Tryptophan is related to the serotonin metabolism involved in bone formation, while tyrosine is involved in the activity of tyrosine kinases and phosphatases in osteocytes. Our experiment represents the first combined synchrotron UV microspectroscopy analysis of bone tissue with a quantitative biochemical characterization in the osteocyte and surrounding matrix performed separately.	[Pallu, Stephane; Rochefort, Gael Y.; Jaffre, Christelle; Maurel, Delphine B.; Benaitreau, Delphine; Lespessailles, Eric; Benhamou, Claude-Laurent] Univ Orleans, INSERM, U658, Orleans, France; [Refregiers, Matthieu; Jamme, Frederic] Synchrotron SOLEIL, DISCO Beamline, Gif Sur Yvette, France; [Jamme, Frederic] INRA, Unite Caracterisat & Elaborat Prod Iss Agr U1008, CEPIA, Nantes, France; [Chappard, Christine] CNRS, Unite Mixte Rech Biomecan & Biomat Osteo Articula, UMR 7052 B2OA, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Orleans; SOLEIL Synchrotron; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite	Pallu, S (corresponding author), Univ Orleans, INSERM, U658, Orleans, France.	stephane.pallu@univ-orleans.fr	Rochefort, Gaël Y./H-3359-2019; Chappard, Christine/AAB-2613-2022; Réfrégiers, Matthieu/A-4249-2011; LESPESSAILLES, Eric/AAA-2946-2022; Réfrégiers, Matthieu/AAE-2075-2022; Soleil, SMIS/I-3166-2014; JAMME, Frederic/E-2170-2011	Rochefort, Gaël Y./0000-0001-6428-3570; Réfrégiers, Matthieu/0000-0002-3281-2308; JAMME, Frederic/0000-0002-7398-7868	SOLEIL Synchrotron [20090113]; FEDER; Region Centre grant "IBIFOS"	SOLEIL Synchrotron; FEDER(European Commission); Region Centre grant "IBIFOS"(Region Centre-Val de Loire)	This work was supported by beam time allocations at SOLEIL Synchrotron (proposal 20090113) and by the FEDER and Region Centre grant "IBIFOS". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso V, 2008, J CELL PHYSIOL, V217, P717, DOI 10.1002/jcp.21547; Asikainen AJ, 2006, J R SOC INTERFACE, V3, P629, DOI 10.1098/rsif.2006.0119; Badawy AAB, 2002, NUTR RES REV, V15, P123, DOI 10.1079/NRR200133; BALLENGER JC, 1979, ARCH GEN PSYCHIAT, V36, P224; Batard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019440; Billiard J, 2005, MOL ENDOCRINOL, V19, P90, DOI 10.1210/me.2004-0153; Bliziotes M, 2006, BONE, V39, P1313, DOI 10.1016/j.bone.2006.06.009; Bodine PVN, 2009, BONE, V44, P1063, DOI 10.1016/j.bone.2009.02.013; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bonnet N, 2006, J PHARMACOL EXP THER, V318, P1118, DOI 10.1124/jpet.106.105437; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chengalvala MV, 2001, BIOCHEMISTRY-US, V40, P814, DOI 10.1021/bi0019996; Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094; Dumas P, 2007, TRENDS BIOTECHNOL, V25, P40, DOI 10.1016/j.tibtech.2006.11.002; Giuliani A, 2009, J SYNCHROTRON RADIAT, V16, P835, DOI 10.1107/S0909049509034049; Haorah J, 2008, GLIA, V56, P78, DOI 10.1002/glia.20596; Hu XZ, 2005, ALCOHOL CLIN EXP RES, V29, P8, DOI 10.1097/01.ALC.0000150008.68473.62; Jamme F, 2010, MICROSC MICROANAL, V16, P507, DOI 10.1017/S1431927610093852; Lemonnier J, 2000, EXP CELL RES, V256, P158, DOI 10.1006/excr.2000.4820; Lotinun S, 2004, J BONE MINER RES, V19, P1165, DOI 10.1359/JBMR.040404; Lozano D, 2010, ACTA BIOMATER, V6, P797, DOI 10.1016/j.actbio.2009.08.033; Maddalozzo GF, 2009, OSTEOPOROSIS INT, V20, P1529, DOI 10.1007/s00198-009-0836-y; Maurel DB, 2011, BONE, V49, P543, DOI 10.1016/j.bone.2011.06.001; Maurel DB, 2011, JOINT BONE SPINE; McLaughlin F, 2002, BONE, V30, P924, DOI 10.1016/S8756-3282(02)00737-8; Miao DS, 2008, P NATL ACAD SCI USA, V105, P20309, DOI 10.1073/pnas.0805690105; Nesic J, 2008, ALCOHOL ALCOHOLISM, V43, P151, DOI 10.1093/alcalc/agm179; Nguyen TM, 2002, J BONE MINER RES, V17, P1728, DOI 10.1359/jbmr.2002.17.9.1728; Pallu S, 2003, PEPTIDES, V24, P1349, DOI 10.1016/j.peptides.2003.09.003; Pastor IJ, 2009, EUR PSYCHIAT, V24, P191, DOI 10.1016/j.eurpsy.2008.08.007; Petit VW, 2010, ANAL CHEM, V82, P3963, DOI 10.1021/ac100581y; RihaniBasharat S, 1997, CALCIFIED TISSUE INT, V61, P426, DOI 10.1007/s002239900359; Rochefort GY, 2010, OSTEOPOROSIS INT, V21, P1457, DOI 10.1007/s00198-010-1194-5; Schiller KR, 2005, J CELL BIOCHEM, V96, P262, DOI 10.1002/jcb.20515; Schinke T, 2008, BONE, V42, P524, DOI 10.1016/j.bone.2007.11.009; Schumann G, 2003, BIOL PSYCHIAT, V54, P1422, DOI 10.1016/S0006-3223(03)00635-8; Smirnov V. Yu., 2003, Ukrainskii Biokhimicheskii Zhurnal, V75, P101; Takai E., 2006, Molecular & Cellular Biomechanics, V3, P1; Vatsa A, 2008, BIOCHEM BIOPH RES CO, V377, P1019, DOI 10.1016/j.bbrc.2007.12.174; Voicescu M, 2009, J FLUORESC, V19, P257, DOI 10.1007/s10895-008-0411-5; Wagnieres GA, 1998, PHOTOCHEM PHOTOBIOL, V68, P603; Wei JW, 2010, ARCH BIOCHEM BIOPHYS, V503, P35, DOI 10.1016/j.abb.2010.05.021; Yadav VK, 2010, NAT MED, V16, P308, DOI 10.1038/nm.2098; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0; Zeskind BJ, 2007, NAT METHODS, V4, P567, DOI 10.1038/NMETH1053; Zhang ZY, 2003, J IMMUNOL, V171, P3620, DOI 10.4049/jimmunol.171.7.3620; ZHENG MH, 1994, J CELL BIOCHEM, V54, P145, DOI 10.1002/jcb.240540203; Zimmerman TA, 2008, METHOD CELL BIOL, V89, P361, DOI 10.1016/S0091-679X(08)00613-4	48	18	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43930	10.1371/journal.pone.0043930	http://dx.doi.org/10.1371/journal.pone.0043930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937127	Green Published, gold, Green Submitted			2022-12-25	WOS:000308213600059
J	Nazer, E; Verdun, RE; Sanchez, DO				Nazer, Ezequiel; Verdun, Ramiro E.; Sanchez, Daniel O.			Severe Heat Shock Induces Nucleolar Accumulation of mRNAs in Trypanosoma cruzi	PLOS ONE			English	Article							TUBULIN GENE-EXPRESSION; POSTTRANSCRIPTIONAL CONTROL; ARABIDOPSIS NUCLEOLUS; PROTEOMIC ANALYSIS; STRESS GRANULES; NUCLEAR EXPORT; PROTEINS; BODIES; REGION; INTERFERENCE	Several lines of evidence have shown that, besides its traditional function in ribosome biogenesis, the nucleolus is also involved in regulating other cellular processes such as mRNA metabolism, and that it also plays an important role as a sensor and coordinator of the stress response. We have recently shown that a subset of RNA Binding Proteins and the poly(A)+ RNA are accumulated into the Trypanosoma cruzi nucleolus after inducing transcription inhibition with Actinomycin D. In this study, we investigated the behaviour of the T. cruzi mRNA population in parasites subjected to severe heat shock, an environmental stress that also decreases the rate of RNA synthesis. We found that the bulk of poly(A)+ RNA is reversibly accumulated into the nucleolus when exposing T. cruzi epimastigote forms to severe heat shock. However, the Hsp70 mRNA was able to bypass such nucleolar accumulation. Together, these data reinforce the idea about the involvement of the T. cruzi nucleolus in mRNA metabolism during an environmental stress response. Interestingly, T. brucei procyclic forms did not induce nucleolar accumulation of poly(A)+ RNA under such stress condition, suggesting that different trypanosomatids have adopted different responses to deal with the same stress conditions.	[Nazer, Ezequiel; Sanchez, Daniel O.] UNSAM, CONICET, Inst Invest Biotecnol, San Martin, Buenos Aires, Argentina; [Verdun, Ramiro E.] Univ Miami, Leonard M Miller Sch Med, Miami, FL USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Miami	Nazer, E (corresponding author), UNSAM, CONICET, Inst Invest Biotecnol, San Martin, Buenos Aires, Argentina.	dsanchez@unsam.edu.ar		sanchez, daniel/0000-0002-5427-7764	National Agency for Promotion of Science and Technology, (ANPCyT, Argentina [PICT 2007-00624]	National Agency for Promotion of Science and Technology, (ANPCyT, Argentina(ANPCyT)	This work was funded by the National Agency for Promotion of Science and Technology, (ANPCyT, Argentina. PICT 2007-00624 to DOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Bartholomeu DC, 2002, EXP PARASITOL, V102, P123, DOI 10.1016/S0014-4894(03)00034-1; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Boyne JR, 2006, P NATL ACAD SCI USA, V103, P15190, DOI 10.1073/pnas.0604890103; Cassola A, 2007, MOL MICROBIOL, V65, P655, DOI 10.1111/j.1365-2958.2007.05833.x; Cassola A, 2009, J BIOL CHEM, V284, P35015, DOI 10.1074/jbc.M109.031633; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Cuevas IC, 2005, MOL BIOCHEM PARASIT, V139, P15, DOI 10.1016/j.molbiopara.2004.11.002; DaRocha WD, 2004, MOL BIOCHEM PARASIT, V133, P175, DOI 10.1016/j.molbiopara.2003.10.005; Di Noia JM, 2000, J BIOL CHEM, V275, P10218, DOI 10.1074/jbc.275.14.10218; Fang YD, 2007, CURR BIOL, V17, P818, DOI 10.1016/j.cub.2007.04.005; Hiscox JA, 2007, NAT REV MICROBIOL, V5, P119, DOI 10.1038/nrmicro1597; Holetz FB, 2007, BIOCHEM BIOPH RES CO, V356, P1062, DOI 10.1016/j.bbrc.2007.03.104; Ideue T, 2004, J CELL SCI, V117, P2887, DOI 10.1242/jcs.01155; Jager AV, 2007, P NATL ACAD SCI USA, V104, P2035, DOI 10.1073/pnas.0611125104; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kim SH, 2009, PLANT CELL, V21, P2045, DOI 10.1105/tpc.109.067736; Koroleva OA, 2009, PLANT CELL, V21, P1592, DOI 10.1105/tpc.108.060434; Kramer S, 2012, J CELL SCI; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Lee MGS, 1998, NUCLEIC ACIDS RES, V26, P4025, DOI 10.1093/nar/26.17.4025; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Martinez-Calvillo S, 2003, MOL CELL, V11, P1291, DOI 10.1016/S1097-2765(03)00143-6; Michienzi A, 2000, P NATL ACAD SCI USA, V97, P8955, DOI 10.1073/pnas.97.16.8955; Nazer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024184; Nazer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019920; Okura M, 2005, J BIOL CHEM, V280, P16235, DOI 10.1074/jbc.M414535200; Olson Mark O J, 2004, Sci STKE, V2004, ppe10; Pendle AF, 2005, MOL BIOL CELL, V16, P260, DOI 10.1091/mbc.E04-09-0791; REQUENA JM, 1992, MOL BIOCHEM PARASIT, V53, P201, DOI 10.1016/0166-6851(92)90022-C; Rodrigues DC, 2010, EXP PARASITOL, V126, P245, DOI 10.1016/j.exppara.2010.05.009; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Saavedra C, 1996, GENE DEV, V10, P1608, DOI 10.1101/gad.10.13.1608; SUTTON RE, 1986, CELL, V47, P527, DOI 10.1016/0092-8674(86)90617-3; TANI T, 1995, MOL BIOL CELL, V6, P1515, DOI 10.1091/mbc.6.11.1515; Ullu E, 2004, CELL MICROBIOL, V6, P509, DOI 10.1111/j.1462-5822.2004.00399.x; Urban I, 2011, BIOCHEM J, V438, P303, DOI 10.1042/BJ20110683; URMENYI TP, 1992, DNA CELL BIOL, V11, P101, DOI 10.1089/dna.1992.11.101	42	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43715	10.1371/journal.pone.0043715	http://dx.doi.org/10.1371/journal.pone.0043715			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952745	Green Published, gold, Green Submitted			2022-12-25	WOS:000308044800053
J	Carnegie, NB; Morris, M				Carnegie, Nicole Bohme; Morris, Martina			Size Matters: Concurrency and the Epidemic Potential of HIV in Small Networks	PLOS ONE			English	Article							TRANSMITTED-DISEASE TRANSMISSION; UNITED-STATES; PREVALENCE; PARTNERSHIPS; DYNAMICS; SPREAD; SYPHILIS; AFRICA	Background: Generalized heterosexual epidemics are responsible for the largest share of the global burden of HIV. These occur in populations that do not have high rates of partner acquisition, and research suggests that a pattern of fewer, but concurrent, partnerships may be the mechanism that provides the connectivity necessary for sustained transmission. We examine how network size affects the impact of concurrency on network connectivity. Methodology/Principal Findings: We use a stochastic network model to generate a sample of networks, varying the size of the network and the level of concurrency, and compare the largest components for each scenario to the asymptotic expected values. While the threshold for the growth of a giant component does not change, the transition is more gradual in the smaller networks. As a result, low levels of concurrency generate more connectivity in small networks. Conclusions/Significance: Generalized HIV epidemics are by definition those that spread to a larger fraction of the population, but the mechanism may rely in part on the dynamics of transmission in a set of linked small networks. Examples include rural populations in sub-Saharan Africa and segregated minority populations in the US, where the effective size of the sexual network may well be in the hundreds, rather than thousands. Connectivity emerges at lower levels of concurrency in smaller networks, but these networks can still be disconnected with small changes in behavior. Concurrency remains a strategic target for HIV combination prevention programs in this context.	[Carnegie, Nicole Bohme] NYU, Dept Humanities & Social Sci Profess, New York, NY 10012 USA; [Morris, Martina] Univ Washington, Dept Stat, Seattle, WA 98195 USA; [Morris, Martina] Univ Washington, Dept Sociol, Seattle, WA 98195 USA	New York University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Carnegie, NB (corresponding author), NYU, Dept Humanities & Social Sci Profess, New York, NY 10012 USA.	morrism@u.washington.edu	Morris, Martina/I-7510-2012	Carnegie, Nicole/0000-0001-7664-6682	National Institutes of Health [HDR24 056799, HDR24 042828l]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042828] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041877, R24HD056799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012831] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work was supported by National Institutes of Health grants HDR24 056799 and HDR24 042828l. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2008, AIDS, V22, P1055, DOI 10.1097/QAD.0b013e3282f8af84; Acevedo-Garcia D, 2000, SOC SCI MED, V51, P1143, DOI 10.1016/S0277-9536(00)00016-2; Admiraal R., 2008, J STAT SOFTW, DOI [DOI 10.18637/JSS.V024.I08, 10.18637/jss.v024.i08]; [Anonymous], 1998, AM APARTHEID SEGREGA; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bauch C, 2000, P ROY SOC B-BIOL SCI, V267, P2019, DOI 10.1098/rspb.2000.1244; Butts C. T., 2008, J STAT SOFTW, V24, P1, DOI [10.18637/jss.v024.i06, DOI 10.18637/JSS.V024.I06, 10.18637/jss.v024.i02]; Campsmith M. L., 2008, Morbidity and Mortality Weekly Report, V57, P1073; Ferguson NM, 2000, SEX TRANSM DIS, V27, P600, DOI 10.1097/00007435-200011000-00008; Goodreau SM, 2012, AIDS BEHAV, V16, P312, DOI 10.1007/s10461-010-9858-x; Hallett T B, 2006, Sex Transm Infect, V82 Suppl 1, pi1; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Hethcote H, 1984, GENORRHEA TRANSMISSI; HUDSON CP, 1993, INT J STD AIDS, V4, P249, DOI 10.1177/095646249300400501; Hudson CP, 1996, INT J STD AIDS, V7, P236, DOI 10.1258/0956462961917906; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Kenya National Bureau of Statistics ICF Macro, 2010, 2008 09 KEN DEM HLTH; Kenyon C, 2009, AJAR-AFR J AIDS RES, V8, P243, DOI 10.2989/AJAR.2009.8.3.1.922; Koumans EH, 2001, SEX TRANSM DIS, V28, P497, DOI 10.1097/00007435-200109000-00004; Laumann EO, 1999, SEX TRANSM DIS, V26, P250, DOI 10.1097/00007435-199905000-00003; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Morris M, 2001, SEX TRANSM DIS, V28, P504, DOI 10.1097/00007435-200109000-00005; Morris M, 1996, AIDS, V10, P1265, DOI 10.1097/00002030-199609000-00013; Morris M, 2006, AM J PUBLIC HEALTH, V96, P1091, DOI 10.2105/AJPH.2004.054759; Morris M, 2009, AM J PUBLIC HEALTH, V99, P1023, DOI 10.2105/AJPH.2008.147835; National Bureau of Statistics (NBS) [Tanzania] Macro International Inc, 2009, TANZ HIV AIDS MAL IN; Newman MEJ, 2007, PHYS REV E, V76; Potterat JJ, 1999, AM J EPIDEMIOL, V150, P1331, DOI 10.1093/oxfordjournals.aje.a009965; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Tanser F, 2011, LANCET, V378, P247, DOI 10.1016/S0140-6736(11)60779-4; UNAIDS Reference Grp Estimates Mod, 2010, LANCET, V375, P621, DOI 10.1016/S0140-6736(09)62040-7; WATTS CH, 1992, MATH BIOSCI, V108, P89, DOI 10.1016/0025-5564(92)90006-I; Watts D.J., 1999, SMALL WORLDS DYNAMIC; Wilson WJ., 1990, TRULY DISADVANTAGED	35	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43048	10.1371/journal.pone.0043048	http://dx.doi.org/10.1371/journal.pone.0043048			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998GM	22937011	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500028
J	Guo, JY; Dong, SZ; Yang, XL; Cheng, L; Wan, FH; Liu, SS; Zhou, XP; Ye, GY				Guo, Jian-Yang; Dong, Sheng-Zhang; Yang, Xiu-ling; Cheng, Lu; Wan, Fang-Hao; Liu, Shu-Sheng; Zhou, Xue-ping; Ye, Gong-Yin			Enhanced Vitellogenesis in a Whitefly via Feeding on a Begomovirus-Infected Plant	PLOS ONE			English	Article							BEMISIA-TABACI; GENE-EXPRESSION; BIOCHEMICAL-CHARACTERIZATION; PTEROMALUS-PUPARUM; MOLECULAR-CLONING; YOLK PROTEINS; SWEET-POTATO; B-BIOTYPE; VIRUS; HYMENOPTERA	Background: The MEAM1 (B biotype) Bemisia tabaci (Gennadius) is one of the most widespread and damaging whitefly cryptic species. Our previous studies discovered that the MEAM1 whitefly indirectly benefits from interactions with the tomato yellow leaf curl China virus (TYLCCNV) via accelerated ovarian development and increased fecundity. However, the physiological mechanism of begomoviruse-infected plants acting on the reproduction of the insect vector was unknown. Methodology/Principal Findings: Biochemical and molecular properties of vitellogenin (Vg) and vitellin (Vt) were characterized in the MEAM1 whitefly. In addition, kinetics of Vt levels in ovary and Vg levels in hemolymph in different stages were detected using a sandwich ELISA. The level of hemolymph Vg increased rapidly after eclosion. A significantly higher level of hemolymph Vg and ovary Vt were observed in whiteflies feeding on virus-infected tobacco plants than those feeding on uninfected plants. In order to detect the levels of Vg mRNA transcription, complete vitellogenin (Vg) mRNA transcripts of 6474 bp were sequenced. Vg mRNA level in whiteflies feeding on virus-infected plants was higher than those feeding on uninfected plants. However, virus-infection of the whiteflies per se, as demonstrated using an artificial diet system, did not produce significant changes in Vg mRNA level. Conclusions/Significance: In MEAM1 whitefly, increased levels of both vitellin and vitellogenin as well as increased transcription of Vg mRNA are associated with feeding on begomovirus-infected plants, thus providing a mechanism for accelerated vitellogenesis. We conclude that MEAM1 whitefly profits from feeding on begomovirus-infected plants for yolk protein synthesis and uptake, and thereby increases its fecundity. These results not only provide insights into the molecular and physiological mechanisms underlying the elevated reproduction of a whitefly species through its association with a begomovirus-infected plant, but also provide a better understanding of the molecular mechanisms related to whitefly reproduction.	[Guo, Jian-Yang; Cheng, Lu; Liu, Shu-Sheng; Ye, Gong-Yin] Zhejiang Univ, Inst Insect Sci, Minist Agr, Key Lab Agr Entomol, Hangzhou 310003, Zhejiang, Peoples R China; [Dong, Sheng-Zhang] China Jiliang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Yang, Xiu-ling; Zhou, Xue-ping] Zhejiang Univ, Inst Biotechnol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Wan, Fang-Hao] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University; China Jiliang University; Zhejiang University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Guo, JY (corresponding author), Zhejiang Univ, Inst Insect Sci, Minist Agr, Key Lab Agr Entomol, Hangzhou 310003, Zhejiang, Peoples R China.	chu@zju.edu.cn	Liu, Shu-Sheng/D-2300-2013	Dong, Shengzhang/0000-0002-8218-4688; Yang, Xiuling/0000-0002-7355-5643	China National Science Fund for Distinguished Young Scholars [31025021]; China National Science Fund for Innovative Research Groups of Biological Control [31021003]; National Nature Science Foundation of China [30730061]; National Basic Research Programme of China [2009CB119203]	China National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); China National Science Fund for Innovative Research Groups of Biological Control(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Programme of China(National Basic Research Program of China)	This work was supported by grants from China National Science Fund for Distinguished Young Scholars (Grant no. 31025021), China National Science Fund for Innovative Research Groups of Biological Control (Grant no. 31021003), the National Nature Science Foundation of China (30730061)(http://www.nsfc.gov.cn/Portal0/default124.htm) and the National Basic Research Programme of China (2009CB119203) (http://www.most.gov.cn/) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013; Bosque-Perez NA, 2011, VIRUS RES, V159, P201, DOI 10.1016/j.virusres.2011.04.020; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Brumin M, 2011, INSECT SCI, V18, P57, DOI 10.1111/j.1744-7917.2010.01396.x; Crowder DW, 2010, J ANIM ECOL, V79, P563, DOI 10.1111/j.1365-2656.2010.01666.x; Cui XF, 2004, J VIROL, V78, P13966, DOI 10.1128/JVI.78.24.13966-13974.2004; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Dong SZ, 2007, J INSECT PHYSIOL, V53, P468, DOI 10.1016/j.jinsphys.2007.01.008; Dong SZ, 2009, GEN COMP ENDOCR, V160, P102, DOI 10.1016/j.ygcen.2008.11.007; Dong Shengzhang, 2008, Acta Phytophylacica Sinica, V35, P193; GAMEEL O I, 1974, Revue de Zoologie Africaine, V88, P784; Ghanim M, 2001, J MORPHOL, V248, P22, DOI 10.1002/jmor.1018; Gildow FE, 1993, J PHYTOPATHOL, V83, P270; Gray S, 2003, ANNU REV PHYTOPATHOL, V41, P539, DOI 10.1146/annurev.phyto.41.012203.105815; Guo JY, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.9001; Guo JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011713; Hagedorn HH, 1998, ADV INSECT PHYSIOL, V27, P335, DOI 10.1016/S0065-2806(08)60015-6; Harmel N, 2008, INSECT MOL BIOL, V17, P165, DOI 10.1111/j.1365-2583.2008.00790.x; Hirai M, 1998, INSECT BIOCHEM MOLEC, V28, P537, DOI 10.1016/S0965-1748(98)00052-6; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Jimenez-Martinez ES, 2004, ENVIRON ENTOMOL, V33, P1207, DOI 10.1603/0046-225X-33.5.1207; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; KAGEYAMA Y, 1994, INSECT BIOCHEM MOLEC, V24, P599, DOI 10.1016/0965-1748(94)90096-5; Leshkowitz D, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-79; Li ZH, 2005, PHYTOPATHOLOGY, V95, P902, DOI 10.1094/PHYTO-95-0902; Liu J, 2009, ANN APPL BIOL, V155, P439, DOI 10.1111/j.1744-7348.2009.00366.x; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan JB, 2011, J VIROL, V85, P3330, DOI 10.1128/JVI.02507-10; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Nose Y, 1997, INSECT BIOCHEM MOLEC, V27, P1047, DOI 10.1016/S0965-1748(97)00091-X; PERRING TM, 1993, SCIENCE, V259, P74, DOI 10.1126/science.8418497; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raikhel Alexander S., 2005, P329; RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245; Sappington TW, 1998, INSECT BIOCHEM MOLEC, V28, P277, DOI 10.1016/S0965-1748(97)00110-0; Shen HH, 2009, J MED MICROBIOL, V58, P531, DOI 10.1099/jmm.0.002246-0; Shu YH, 2009, J INSECT PHYSIOL, V55, P608, DOI 10.1016/j.jinsphys.2009.03.005; Tang Q., 2007, DPS DATA PROCESSING; Tu ZJ, 1997, ARCH INSECT BIOCHEM, V34, P223, DOI 10.1002/(SICI)1520-6327(1997)34:2<223::AID-ARCH7>3.3.CO;2-Z; Tufail M, 2005, INSECT MOL BIOL, V14, P389, DOI 10.1111/j.1365-2583.2005.00570.x; Tufail M, 2010, INSECT MOL BIOL, V19, P787, DOI 10.1111/j.1365-2583.2010.01035.x; Tufail M, 2009, J INSECT PHYSIOL, V55, P87, DOI 10.1016/j.jinsphys.2008.11.007; Wang J, 2012, ENTOMOL EXP APPL, V144, P191, DOI 10.1111/j.1570-7458.2012.01278.x; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; WU SJ, 1986, INSECT BIOCHEM, V16, P789, DOI 10.1016/0020-1790(86)90115-0; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; Zang LS, 2006, ENTOMOL EXP APPL, V121, P221, DOI 10.1111/j.1570-8703.2006.00482.x; Zang Lian-Sheng, 2005, Acta Entomologica Sinica, V48, P742; Zhang T, 2012, MOL ECOL, V21, P1294, DOI 10.1111/j.1365-294X.2012.05457.x; Zhou XP, 2003, J GEN VIROL, V84, P237, DOI 10.1099/vir.0.18608-0	51	33	43	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43567	10.1371/journal.pone.0043567	http://dx.doi.org/10.1371/journal.pone.0043567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937062	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500063
J	Kaushal, M; Mishra, AK; Sharma, J; Zomawia, E; Kataki, A; Kapur, S; Saxena, S				Kaushal, Mishi; Mishra, Ashwani K.; Sharma, Jagannath; Zomawia, Eric; Kataki, Amal; Kapur, Sujala; Saxena, Sunita			Genomic Alterations in Breast Cancer Patients in Betel Quid and Non Betel Quid Chewers	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; COPY NUMBER ALTERATIONS; GENE-EXPRESSION; CHROMOSOMAL-ABERRATIONS; THERAPEUTIC TARGET; COLORECTAL-CANCER; CIGARETTE-SMOKING; FRAGILE SITES; LUNG-CANCER; BONE-MARROW	Betel Quid (BQ) chewing independently contributes to oral, hepatic and esophageal carcinomas. Strong association of breast cancer risk with BQ chewing in Northeast Indian population has been reported where this habit is prodigal. We investigated genomic alterations in breast cancer patients with and without BQ chewing exposure. Twenty six BQ chewers (BQC) and 17 non BQ chewer (NBQC) breast cancer patients from Northeast India were analyzed for genomic alterations and pathway networks using SNP array and IPA. BQC tumors showed significantly (P<0.01) higher total number of alterations, as compared with NBQC tumors, 48 +/- 17% versus 32 +/- 25 respectively. Incidence of gain in fragile sites in BQC tumors were significantly (P<0.001) higher as compared with NBQC tumors, 34 versus 23% respectively. Two chromosomal regions (7q33 and 21q22.13) were significantly (p<0.05) associated with BQC tumors while two regions (19p13.3-19p12 and 20q11.22) were significantly associated with NBQC tumors. GO terms oxidoreductase and aldo-keto reductase activity in BQC tumors in contrast to G-protein coupled receptor protein signaling pathway and cell surface receptor linked signal transduction in NBQC tumors were enriched in DAVID. One network "Drug Metabolism, Molecular Transport, Nucleic Acid Metabolism" including genes AKR1B1, AKR1B10, ETS2 etc in BQC and two networks "Molecular Transport, Nucleic Acid Metabolism, Small Molecule Biochemistry" and "Cellular Development, Embryonic Development, Organismal Development" including genes RPN2, EMR3, VAV1, NNAT and MUC16 etc were seen in NBQC. Common alterations (>30%) were seen in 27 regions. Three networks were significant in common regions with key roles of PTK2, RPN2, EMR3, VAV1, NNAT, MUC16, MYC and YWHAZ genes. These data show that breast cancer arising by environmental carcinogens exemplifies genetic alterations differing from those observed in the non exposed ones. A number of genetic changes are shared in both tumor groups considered as crucial in breast cancer progression.	[Kaushal, Mishi; Mishra, Ashwani K.; Kapur, Sujala; Saxena, Sunita] ICMR, Natl Inst Pathol, New Delhi, India; [Sharma, Jagannath; Kataki, Amal] Dr B Borrooah Canc Inst, Gauhati, India; [Zomawia, Eric] Civil Hosp, Aizwal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Pathology (IOP); Tata Memorial Centre (TMC); Dr. Bhubaneswar Borooah Cancer Institute	Kaushal, M (corresponding author), ICMR, Natl Inst Pathol, Safdarjung Hosp Campus, New Delhi, India.	sunita_saxena@yahoo.com	Mishra, Ashwani Kumar/AAA-3998-2020	Mishra, Ashwani Kumar/0000-0002-8872-1886; Wasson, Mishi/0000-0003-4347-417X	Indian Council of Medical Research (ICMR), New Delhi, India [123/4/RMRC/NE/2005-NCD-II/III, 3/2/2/183/2009/NCD-III]	Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR))	This study was supported by grants from Indian Council of Medical Research (ICMR), New Delhi, India(Ref no, 123/4/RMRC/NE/2005-NCD-II/III. Mishi Kaushal is a recipient of a Senior Research Fellowship of Indian Council of Medical Research (ICMR), New Delhi, India (Ref. No. 3/2/2/183/2009/NCD-III). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambatipudi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017250; BAN S, 1995, MUTAT RES-ENVIR MUTA, V334, P197, DOI 10.1016/0165-1161(95)90011-X; Baras A, 2009, ONCOGENE, V28, P2919, DOI 10.1038/onc.2009.150; Barski OA, 2008, DRUG METAB REV, V40, P553, DOI [10.1080/03602530802431439, 10.1080/03602530802431439 ]; Beaber EF, 2008, CANCER EPIDEM BIOMAR, V17, P3427, DOI 10.1158/1055-9965.EPI-08-0641; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bergamaschi A, 2012, ONCOGENE, V31, P39, DOI 10.1038/onc.2011.223; Chatterjee A, 1999, CANCER LETT, V139, P23, DOI 10.1016/S0304-3835(98)00364-4; Chiang WF, 2011, ORAL DIS, V17, P53, DOI 10.1111/j.1601-0825.2010.01702.x; Dal Maso L, 2008, INT J CANCER, V123, P2188, DOI 10.1002/ijc.23747; Das A. J., 2012, International Food Research Journal, V19, P377; Diez-Dacal B, 2011, CANCER RES, V71, P4161, DOI 10.1158/0008-5472.CAN-10-3816; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fang M, 2011, CANCER-AM CANCER SOC, V117, P2024, DOI 10.1002/cncr.25770; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Ferroni P, 2004, INT J CANCER, V111, P404, DOI 10.1002/ijc.20189; George RE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000255; Ghayad SE, 2009, J MOL ENDOCRINOL, V42, P87, DOI 10.1677/JME-08-0076; Gu J, 2008, CANCER EPIDEM BIOMAR, V17, P2445, DOI 10.1158/1055-9965.EPI-07-2890; Herzog CR, 2006, BIOCHEM BIOPH RES CO, V341, P856, DOI 10.1016/j.bbrc.2006.01.043; Hodgson JG, 2003, BREAST CANCER RES TR, V78, P337, DOI 10.1023/A:1023085825042; Honma K, 2008, NAT MED, V14, P939, DOI 10.1038/nm.1858; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang KT, 2008, INT J CANCER, V123, P1807, DOI 10.1002/ijc.23672; Jonsson G, 2005, CANCER RES, V65, P7612, DOI 10.1158/0008-5472.CAN-05-0570; Kane AJ, 2010, NEUROREPORT, V21, P1018, DOI 10.1097/WNR.0b013e32833f19f2; KAOSHAN CS, 1987, CANCER RES, V47, P6278; Kaushal M, 2010, MUTAT RES-GEN TOX EN, V703, P143, DOI 10.1016/j.mrgentox.2010.08.011; Korenaga Y, 2005, CANCER GENET CYTOGEN, V163, P7, DOI 10.1016/j.cancergencyto.2005.03.015; Lakshmanan I, 2012, ONCOGENE, V31, P805, DOI 10.1038/onc.2011.297; Lazer G, 2009, J PATHOL, V219, P25, DOI 10.1002/path.2579; Liao DJ, 2000, ENDOCR-RELAT CANCER, V7, P143, DOI 10.1677/erc.0.0070143; Lin CF, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-271; Lin MT, 2009, INT J CANCER, V125, P603, DOI 10.1002/ijc.24346; Liu JH, 2009, RECENT PAT ANTI-CANC, V4, P246, DOI 10.2174/157489209789206931; Liu SY, 2007, ORAL ONCOL, V43, P1026, DOI 10.1016/j.oraloncology.2006.11.018; Loo LWM, 2004, CANCER RES, V64, P8541, DOI 10.1158/0008-5472.CAN-04-1992; Luo LZ, 2004, MUTAT RES-FUND MOL M, V554, P375, DOI 10.1016/j.mrfmmm.2004.06.031; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Muenphon K, 2006, WORLD J GASTROENTERO, V12, P4143, DOI 10.3748/wjg.v12.i26.4143; Nair U, 2004, MUTAGENESIS, V19, P251, DOI 10.1093/mutage/geh036; Nakao K, 2004, CARCINOGENESIS, V25, P1345, DOI 10.1093/carcin/bgh134; Narayan S, 2004, ONCOGENE, V23, P5880, DOI 10.1038/sj.onc.1207792; Neal CL, 2010, EXPERT OPIN THER TAR, V14, P1343, DOI 10.1517/14728222.2010.531011; Nowak NJ, 2005, CANCER GENET CYTOGEN, V161, P36, DOI 10.1016/j.cancergencyto.2005.01.009; Ouellet V, 2011, AM J PATHOL, V178, P2377, DOI 10.1016/j.ajpath.2011.01.033; Pang H, 2011, EUR J HUM GENET, V19, P704, DOI 10.1038/ejhg.2011.3; Purdie KJ, 2007, GENE CHROMOSOME CANC, V46, P661, DOI 10.1002/gcc.20447; Reinartz S, 2012, EUR J CANCER, V48, P1558, DOI 10.1016/j.ejca.2011.07.004; Saama PM, 2006, PHYSIOL GENOMICS, V28, P62, DOI 10.1152/physiolgenomics.00108.2006; Sakamuro D, 1999, ONCOGENE, V18, P2942, DOI 10.1038/sj.onc.1202725; Sangrajrang S, 2009, INT J CANCER, V125, P837, DOI 10.1002/ijc.24434; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Singh B, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-22; Tchatchou S, 2008, CYTOGENET GENOME RES, V123, P183, DOI 10.1159/000184707; Terry PD, 2002, CANCER EPIDEM BIOMAR, V11, P953; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Tzeng HE, 2011, J CELL PHYSIOL, V226, P3181, DOI 10.1002/jcp.22672; Uchihara T, 2007, J THORAC ONCOL, V2, P796, DOI 10.1097/JTO.0b013e318145af5e; Vasudev NS, 2011, ARCH GYNECOL OBSTET, V284, P221, DOI 10.1007/s00404-010-1655-2; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Xu DK, 2008, J BIOL CHEM, V283, P23567, DOI 10.1074/jbc.M800790200; Yeh PY, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-53; Zabuawala T, 2010, CANCER RES, V70, P1323, DOI 10.1158/0008-5472.CAN-09-1474; Zhou Y, 2005, ENDOCR-RELAT CANCER, V12, pS37, DOI 10.1677/erc.1.00977	66	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43789	10.1371/journal.pone.0043789	http://dx.doi.org/10.1371/journal.pone.0043789			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937096	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500098
J	Liu, L; Beck, H; Wang, XL; Hsieh, HP; Mason, RP; Liu, XL				Liu, Li; Beck, Haley; Wang, Xiaolei; Hsieh, Hsing-Pang; Mason, Ralph P.; Liu, Xinli			Tubulin-Destabilizing Agent BPR0L075 Induces Vascular-Disruption in Human Breast Cancer Mammary Fat Pad Xenografts	PLOS ONE			English	Article							COMBRETASTATIN A4 PHOSPHATE; ASSESSING TUMOR BURDEN; ACTIVITY IN-VIVO; THERAPEUTIC STRATEGY; TARGETING AGENTS; HIGH-THROUGHPUT; BLOOD-VESSELS; ANGIOGENESIS; VITRO; COMBINATION	BPR0L075, 6-methoxy-3-(39,49,59-trimethoxy-benzoyl)-1H-indole, is a tubulin-binding agent that inhibits tubulin polymerization by binding to the colchicine-binding site. BPR0L075 has shown antimitotic and antiangiogenic activity in vitro. The current study evaluated the vascular-disrupting activity of BPR0L075 in human breast cancer mammary fat pad xenografts using dynamic bioluminescence imaging. A single dose of BPR0L075 (50 mg/kg, intraperitoneally (i.p.)) induced rapid, temporary tumor vascular shutdown (at 2, 4, and 6 hours); evidenced by rapid and reproducible decrease of light emission from luciferase-expressing orthotopic MCF7 and MDA-MB-231 breast tumors after administration of luciferin substrate. A time-dependent reduction of tumor perfusion after BPR0L075 treatment was confirmed by immunohistological staining of the perfusion marker Hoechst 33342 and tumor vasculature marker CD31. The vasculature showed distinct recovery within 24 hours post therapy. A single i.p. injection of 50 mg/kg of BPR0L075 initially produced plasma concentrations in the micromolar range within 6 hours, but subsequent drug distribution and elimination caused BPR0L075 plasma levels to drop rapidly into the nanomolar range within 24 h. Tests with human umbilical vein endothelial (HUVEC) cells and tumor cells in culture showed that BPR0L075 was cytotoxic to both tumor cells and proliferating endothelial cells, and disrupted preestablished vessels in vitro and ex vivo. In conclusion, BPR0L075 caused rapid, albeit, temporary tumor vascular shutdown and led to reduction of tumor perfusion in orthotopic human breast cancer xenografts, suggesting that this antimitotic agent may be useful as a vascular-disrupting cancer therapy.	[Liu, Li; Beck, Haley; Mason, Ralph P.] Univ Texas SW Med Ctr Dallas, Dept Radiol, Canc Imaging Program, Dallas, TX 75390 USA; [Hsieh, Hsing-Pang] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Taipei, Taiwan; [Wang, Xiaolei; Liu, Xinli] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; National Health Research Institutes - Taiwan; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Liu, L (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Radiol, Canc Imaging Program, Dallas, TX 75390 USA.	ralph.mason@utsouthwestern.edu; xinli.liu@ttuhsc.edu	Liu, LI/B-6912-2013; Mason, Ralph/C-8472-2012; Hsieh, Hsing-Pang/B-2649-2010	Liu, LI/0000-0002-9731-6145; Mason, Ralph/0000-0001-7517-3721; Hsieh, Hsing-Pang/0000-0002-1332-005X	Texas Tech University Health Sciences Center (TTUHSC) School of Pharmacy; National Cancer Institute [NCI U24 CA126608]; Harold C. Simmons Cancer Center through an NCI Cancer Center Support Grant [1P30 CA142543]; Department of Radiology; National Institutes of Health, NIH [1S10RR024757]; National Health Research Institutes; National Science Council (Taiwan, ROC) [NSC 100-2325-B-400-003]; NATIONAL CANCER INSTITUTE [U24CA126608, P30CA142543] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024757] Funding Source: NIH RePORTER	Texas Tech University Health Sciences Center (TTUHSC) School of Pharmacy; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Harold C. Simmons Cancer Center through an NCI Cancer Center Support Grant; Department of Radiology; National Institutes of Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health Research Institutes(National Health Research Institutes, Japan); National Science Council (Taiwan, ROC)(Ministry of Science and Technology, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded by funds from Texas Tech University Health Sciences Center (TTUHSC) School of Pharmacy (to XL). The authors would also like to acknowledge the assistance of the Southwestern Small Animal Imaging Resource (SW-SAIRP), which is supported in part by the National Cancer Institute, NCI U24 CA126608, the Harold C. Simmons Cancer Center through an NCI Cancer Center Support Grant, 1P30 CA142543 and the Department of Radiology, and in particular a supplement under the American Recovery and Reinvestment Act (ARRA) 3 U24 CA126608-02S1 (to HB, RPM). The Caliper IVIS Spectrum was purchased under a Shared Instrumentation grant from the National Institutes of Health, NIH 1S10RR024757. The support from National Health Research Institutes and National Science Council (NSC 100-2325-B-400-003, Taiwan, ROC) is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blakey DC, 2002, INT J RADIAT ONCOL, V54, P1497, DOI 10.1016/S0360-3016(02)03922-6; Brown KJ, 1996, LAB INVEST, V75, P539; Cai WB, 2008, METHOD ENZYMOL, V445, P141, DOI 10.1016/S0076-6879(08)03007-3; Chaplin DJ, 1999, BRIT J CANCER, V80, P57; Chen CP, 2010, ANTICANCER RES, V30, P2813; Contero A, 2009, METHODS MOL BIOL, V574, P37, DOI 10.1007/978-1-60327-321-3_4; Davis PD, 2002, CANCER RES, V62, P7247; DENEKAMP J, 1990, CANCER METAST REV, V9, P267, DOI 10.1007/BF00046365; DENEKAMP J, 1982, BRIT J CANCER, V46, P711, DOI 10.1038/bjc.1982.263; DENEKAMP J, 1984, ACTA RADIOL ONCOL, V23, P217, DOI 10.3109/02841868409136015; Galbraith SM, 2001, ANTICANCER RES, V21, P93; Heath VL, 2009, NAT REV CLIN ONCOL, V6, P395, DOI 10.1038/nrclinonc.2009.52; Helmlinger G, 2000, NATURE, V405, P139, DOI 10.1038/35012132; Horsman MR, 2006, CANCER RES, V66, P11520, DOI 10.1158/0008-5472.CAN-06-2848; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kuo CC, 2004, CANCER RES, V64, P4621, DOI 10.1158/0008-5472.CAN-03-3474; Liou JP, 2002, J MED CHEM, V45, P2556, DOI 10.1021/jm010365+; Liu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012024; Mason RP, 2011, INTEGR BIOL-UK, V3, P375, DOI 10.1039/c0ib00135j; Masunaga S, 2007, J CANCER RES CLIN, V133, P47, DOI 10.1007/s00432-006-0145-1; Maye P, 2011, GENESIS, V49, P410, DOI 10.1002/dvg.20733; McKeage MJ, 2010, CANCER-AM CANCER SOC, V116, P1859, DOI 10.1002/cncr.24975; Nicholson B, 2006, ANTI-CANCER DRUG, V17, P25, DOI 10.1097/01.cad.0000182745.01612.8a; Nicosia RF, 1997, AM J PATHOL, V151, P1379; Paroo Z, 2004, MOL IMAGING, V3, P117, DOI 10.1162/1535350041464865; Schwartz EL, 2009, CLIN CANCER RES, V15, P2594, DOI 10.1158/1078-0432.CCR-08-2710; Siemann DW, 2011, CANCER TREAT REV, V37, P63, DOI 10.1016/j.ctrv.2010.05.001; Siemann DW, 2009, CELL TISSUE RES, V335, P241, DOI 10.1007/s00441-008-0646-0; Siemann DW, 2010, CANC TREAT REV; Sun A, NEUROSURGERY, V66, P751; Tozer GM, 2008, BRIT J RADIOL, V81, pS12, DOI 10.1259/bjr/36205483; Tozer GM, 2002, INT J EXP PATHOL, V83, P21, DOI 10.1046/j.1365-2613.2002.00211.x; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Zhao DW, 2008, FASEB J, V22, P2445, DOI 10.1096/fj.07-103713; Zhao DW, 2005, INT J RADIAT ONCOL, V62, P872, DOI 10.1016/j.ijrobp.2005.03.009	36	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43314	10.1371/journal.pone.0043314	http://dx.doi.org/10.1371/journal.pone.0043314			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937031	gold, Green Published, Green Submitted			2022-12-25	WOS:000308225500038
J	Llaurado, G; Gonzalez-Clemente, JM; Maymo-Masip, E; Subias, D; Vendrell, J; Chacon, MR				Llaurado, Gemma; Gonzalez-Clemente, Jose-Miguel; Maymo-Masip, Elsa; Subias, David; Vendrell, Joan; Chacon, Matilde R.			Serum Levels of TWEAK and Scavenger Receptor CD163 in Type 1 Diabetes Mellitus: Relationship with Cardiovascular Risk Factors. A Case-Control Study	PLOS ONE			English	Article							SOLUBLE TWEAK; ARTERIAL STIFFNESS; IDENTIFICATION; MORTALITY; DISEASE; STWEAK; COMPLICATIONS; INFLAMMATION; MACROPHAGES; PREDICTION	Objective: To test the usefulness of serum concentrations of tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and soluble scavenger receptor CD163 (sCD163) as markers of subtle inflammation in patients with type 1 diabetes mellitus (T1DM) without clinical cardiovascular (CV) disease and to evaluate their relationship with arterial stiffness (AS). Methods: Sixty-eight patients with T1DM and 68 age and sex-matched, healthy subjects were evaluated. Anthropometrical variables and CV risk factors were recorded. Serum concentrations of sTWEAK and sCD163 were measured. AS was assessed by aortic pulse wave velocity (aPWV). All statistical analyses were stratified by gender. Results: T1DM patients showed lower serum concentrations of sTWEAK (Men: 1636.5 (1146.3-3754.8) pg/mL vs. 765.9 (650.4-1097.1) pg/mL; p < 0.001. Women: 1401.0 (788.0-2422.2) pg/mL vs. 830.1 (562.6-1175.9) pg/mL; p = 0.011) compared with their respective controls. Additionally, T1DM men had higher serum concentrations of sCD163 (285.0 (247.7-357.1) ng/mL vs. 224.8 (193.3-296.5) ng/mL; p = 0.012) compared with their respective controls. sTWEAK correlated negatively with aPWV in men (r = -0.443; p < 0.001). However, this association disappeared after adjusting for potential confounders. In men, the best multiple linear regression model showed that the independent predictors of sTWEAK were T1DM and WHR (R-2 = 0.640; p < 0.001). In women, T1DM and SBP were the independent predictors for sTWEAK (R-2 = 0.231; p = 0.001). Conclusion: sTWEAK is decreased in T1DM patients compared with age and sex-matched healthy subjects after adjusting for classic CV risk factors, although sTWEAK levels may be partially influenced by some of them. Additionally, T1DM men have higher serum concentrations of sCD163. These results point out an association between the inflammatory system and CV risk in T1DM.	[Llaurado, Gemma; Gonzalez-Clemente, Jose-Miguel; Subias, David] Univ Autonoma Barcelona, Hosp Sabadell, Dept Diabet Endocrinol & Nutr, Corp Sanitaria Univ, Sabadell, Spain; [Maymo-Masip, Elsa; Vendrell, Joan; Chacon, Matilde R.] Univ Rovira & Virgili, Insitut Pere Virgili, Hosp Univ Joan XXIII Tarragona, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Tarragona, Spain	Autonomous University of Barcelona; Parc Tauli Hospital Universitari; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universitat Rovira i Virgili	Llaurado, G (corresponding author), Univ Autonoma Barcelona, Hosp Sabadell, Dept Diabet Endocrinol & Nutr, Corp Sanitaria Univ, Univ Parc Tauli, Sabadell, Spain.	gllauradoc@gmail.com; mrodriguez.hj23.ics@gencat.cat	Llauradó, Gemma/AAB-9839-2020; Maymó Masip, Elsa/T-1828-2017; Vendrell, Joan j/V-4034-2018; Chacón, Matilde R./E-5574-2019	Maymó Masip, Elsa/0000-0002-9133-3120; Vendrell, Joan j/0000-0002-6994-6115; Chacón, Matilde R./0000-0003-1531-2165; Subias, David/0000-0003-3589-7842	Fundacio la Marato de TV3-2008 [081410]; Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain [FIS PS09/01360, PI08/0733, PI11/00049]; Fondo de Investigacion Sanitaria (FIS) [CP06/00119]; European Regional Development Fund (ERDF) [PI08/0733, PI11/00049, CP06/00119]	Fundacio la Marato de TV3-2008; Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain(Instituto de Salud Carlos III); Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); European Regional Development Fund (ERDF)(European Commission)	Financial support was provided by: 1) Fundacio la Marato de TV3-2008 (Project No 081410); 2) FIS PS09/01360 (Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain); 3) PI08/0733 (Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain); 4) PI11/00049 (Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain); and 5) Matilde R. Chacon is supported by a fellowship from the Fondo de Investigacion Sanitaria (FIS) CP06/00119. CP06/00119 PI08/0733 and PI11/00049 are co-financed by the European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aristoteli LP, 2006, ATHEROSCLEROSIS, V184, P342, DOI 10.1016/j.atherosclerosis.2005.05.004; Axelsson J, 2006, AM J KIDNEY DIS, V48, P916, DOI 10.1053/j.ajkd.2006.08.022; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Blanco-Colio LM, 2007, ARTERIOSCL THROM VAS, V27, P916, DOI 10.1161/01.ATV.0000258972.10109.ff; Bover LC, 2007, J IMMUNOL, V178, P8183, DOI 10.4049/jimmunol.178.12.8183; Carrero JJ, 2009, CLIN J AM SOC NEPHRO, V4, P110, DOI 10.2215/CJN.02790608; Cavalcante JL, 2011, J AM COLL CARDIOL, V57, P1511, DOI 10.1016/j.jacc.2010.12.017; Chorianopoulos E, 2010, ATHEROSCLEROSIS, V211, P322, DOI 10.1016/j.atherosclerosis.2010.02.016; Gonzalez-Clemente JM, 2005, EUR J ENDOCRINOL, V153, P687, DOI 10.1530/eje.1.02016; Guetta J, 2007, ATHEROSCLEROSIS, V191, P48, DOI 10.1016/j.atherosclerosis.2006.04.032; Jelic-Ivanovic Z, 2009, CLIN BIOCHEM, V42, P1381, DOI 10.1016/j.clinbiochem.2009.06.001; Koivistoinen T, 2011, ATHEROSCLER IN PRESS; Kralisch S, 2008, ATHEROSCLEROSIS, V199, P440, DOI 10.1016/j.atherosclerosis.2007.10.022; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Levy AP, 2007, CIRC RES, V101, P106, DOI 10.1161/CIRCRESAHA.107.149435; Libby P, 2005, CIRCULATION, V111, P3489, DOI 10.1161/CIRCULATIONAHA.104.529651; Llaurado G, 2012, DIABETES CARE, V35, P1083, DOI 10.2337/dc11-1475; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022; Moller HJ, 2002, BLOOD, V99, P378, DOI 10.1182/blood.V99.1.378; Moller HJ, 2011, CLIN CHEM, V57, P291, DOI 10.1373/clinchem.2010.154724; Moreno JA, 2010, ARTERIOSCL THROM VAS, V30, P1253, DOI 10.1161/ATVBAHA.110.203364; Moreno JA, 2009, ATHEROSCLEROSIS, V207, P103, DOI 10.1016/j.atherosclerosis.2009.04.033; Richter B, 2010, ATHEROSCLEROSIS, V213, P545, DOI 10.1016/j.atherosclerosis.2010.08.061; Schram MT, 2005, DIABETOLOGIA, V48, P370, DOI 10.1007/s00125-004-1628-8; Sowers JR, 2001, HYPERTENSION, V37, P1053, DOI 10.1161/01.HYP.37.4.1053; Urbonaviciene G, 2011, ATHEROSCLEROSIS, V219, P892, DOI 10.1016/j.atherosclerosis.2011.09.016; Vlachopoulos C, 2010, EUR HEART J, V31, P1865, DOI 10.1093/eurheartj/ehq024; Wiley SR, 2003, CYTOKINE GROWTH F R, V14, P241, DOI 10.1016/S1359-6101(03)00019-4; Williams KV, 2000, DIABETES, V49, P626, DOI 10.2337/diabetes.49.4.626; Yilmaz MI, 2010, CLIN J AM SOC NEPHRO, V5, P1174, DOI 10.2215/CJN.01110210	32	42	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43919	10.1371/journal.pone.0043919	http://dx.doi.org/10.1371/journal.pone.0043919			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937125	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500124
J	Tan, S; Lam, WP; Wai, MSM; Yu, WHA; Yew, DT				Tan, Sijie; Lam, Wai Ping; Wai, Maria S. M.; Yu, Wan-Hua Amy; Yew, David T.			Chronic Ketamine Administration Modulates Midbrain Dopamine System in Mice	PLOS ONE			English	Article							NMDA RECEPTOR BLOCKADE; EMERGENCY-DEPARTMENT; INDUCED APOPTOSIS; ACTIVATION; TRANSCRIPTION; SEROTONIN; RELEASE; SIGNALS; ABUSERS; MODELS	Ketamine is an anesthetic and a popular abusive drug. As an anesthetic, effects of ketamine on glutamate and GABA transmission have been well documented but little is known about its long-term effects on the dopamine system. In the present study, the effects of ketamine on dopamine were studied in vitro and in vivo. In pheochromocytoma (PC 12) cells and NGF differentiated-PC 12 cells, ketamine decreased the cell viability while increasing dopamine (DA) concentrations in a dose-related manner. However, ketamine did not affect the expression of genes involved in DA synthesis. In the long-term (3 months) ketamine treated mice, significant increases of DA contents were found in the midbrain. Increased DA concentrations were further supported by up-regulation of tyrosine hydroxylase (TH), the rate limiting enzyme in catecholamine synthesis. Activation of midbrain dopaminergic neurons could be related to ketamine modulated cortical-subcortical glutamate connections. Using western blotting, significant increases in BDNF protein levels were found in the midbrain, suggesting that perhaps BDNF pathways in the cortical-subcortical connections might contribute to the long-term ketamine induced TH upregulation. These data suggest that long-term ketamine abuse caused a delayed and persistent upregulation of subcortical DA systems, which may contribute to the altered mental status in ketamine abusers.	[Tan, Sijie; Lam, Wai Ping; Wai, Maria S. M.; Yew, David T.] Chinese Univ Hong Kong, Fac Med, Brain Res Inst, Shatin, Hong Kong, Peoples R China; [Yu, Wan-Hua Amy] CUNY, Sch Med, Dept Cell Biol & Anat Sci, Sophie Davis Sch Biomed Educ, New York, NY 10031 USA	Chinese University of Hong Kong; City University of New York (CUNY) System; Sophie Davis School of Biomedical Education	Tan, S (corresponding author), Chinese Univ Hong Kong, Fac Med, Brain Res Inst, Shatin, Hong Kong, Peoples R China.	david-yew@cuhk.edu.hk		tan, Sijie/0000-0002-8389-7372	Beat Drugs Fund Association, Hong Kong Government [100052]	Beat Drugs Fund Association, Hong Kong Government	This work was supported by the Beat Drugs Fund Association (100052), Hong Kong Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman S A, 1999, Anesth Prog, V46, P10; Boundy VA, 1998, J NEUROSCI, V18, P9989; CRDA and drug statistics, CRDA DRUG STAT; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; du Bois TM, 2008, NEUROCHEM RES, V33, P1224, DOI 10.1007/s11064-007-9571-y; Flatmark T, 1999, CHEM REV, V99, P2137, DOI 10.1021/cr980450y; Fukuchi M, 2010, BRAIN RES, V1366, P18, DOI 10.1016/j.brainres.2010.10.034; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hayashi T, 1999, NATURE, V397, P72, DOI 10.1038/16269; Hevers W, 2008, J NEUROSCI, V28, P5383, DOI 10.1523/JNEUROSCI.5443-07.2008; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Irifune M, 2000, ANESTH ANALG, V91, P230, DOI 10.1097/00000539-200007000-00043; Jones DC, 2000, J NEUROCHEM, V74, P2296, DOI 10.1046/j.1471-4159.2000.0742296.x; Kapur S, 2002, MOL PSYCHIATR, V7, P837, DOI 10.1038/sj.mp.4001093; Kegeles LS, 2000, BIOL PSYCHIAT, V48, P627, DOI 10.1016/S0006-3223(00)00976-8; Kobori N, 2004, J BIOL CHEM, V279, P2182, DOI 10.1074/jbc.M310734200; Lee ST, 2009, BRIT J ANAESTH, V102, P80, DOI 10.1093/bja/aen322; Lindefors N, 1997, BRAIN RES, V759, P205, DOI 10.1016/S0006-8993(97)00255-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mak YT, 2010, MICROSC RES TECHNIQ, V73, P195, DOI 10.1002/jemt.20774; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Morgan CJA, 2012, ADDICTION, V107, P27, DOI 10.1111/j.1360-0443.2011.03576.x; Morgan CJA, 2009, ADDICTION, V104, P77, DOI 10.1111/j.1360-0443.2008.02394.x; Ng S. H., 2010, Hong Kong Medical Journal, V16, P6; Okamoto T, 1996, Masui, V45, P1083; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Rodvelt KR, 2008, NEUROSCI LETT, V440, P319, DOI 10.1016/j.neulet.2008.05.106; ROTHMAN DL, 1985, P NATL ACAD SCI USA, V82, P1633, DOI 10.1073/pnas.82.6.1633; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Tan SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021328; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Wang C, 2006, TOXICOL SCI, V91, P192, DOI 10.1093/toxsci/kfj144; Wang C, 2005, NEUROSCIENCE, V132, P967, DOI 10.1016/j.neuroscience.2005.01.053; Weiner AL, 2000, J EMERG MED, V18, P447, DOI 10.1016/S0736-4679(00)00162-1; Yeung LY, 2010, TOXICOL LETT, V193, P189, DOI 10.1016/j.toxlet.2010.01.008	35	47	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43947	10.1371/journal.pone.0043947	http://dx.doi.org/10.1371/journal.pone.0043947			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937133	gold, Green Published			2022-12-25	WOS:000308225500128
J	Lange, R; Gerlach, T; Beninde, J; Werminghausen, J; Reichel, V; Anthes, N				Lange, Rolanda; Gerlach, Tobias; Beninde, Joscha; Werminghausen, Johanna; Reichel, Verena; Anthes, Nils			Female Fitness Optimum at Intermediate Mating Rates under Traumatic Mating	PLOS ONE			English	Article							BATEMAN GRADIENTS; SEXUAL SELECTION; SPERM TRANSFER; INSEMINATION; ALLOCATION; CONFLICT; SIZE; COPULATION; EVOLUTION; COSTS	Traumatic mating behaviors often bear signatures of sexual conflict and are then typically considered a male strategy to circumvent female choice mechanisms. In an extravagant mating ritual, the hermaphroditic sea slug Siphopteron quadrispinosum pierces the integument of their mating partners with a syringe-like penile stylet that injects prostate fluids. Traumatic injection is followed by the insertion of a spiny penis into the partner's gonopore to transfer sperm. Despite traumatic mating, field mating rates exceed those required for female fertilization insurance, possibly because costs imposed on females are balanced by direct or indirect benefits of multiple sperm receipt. To test this idea, we exposed animals to a relevant range of mating opportunity regimes and assessed the effects on mating behavior and proxies of female fitness. We find penis intromission duration to decrease with mating rates, and a female fecundity maximum at intermediate mating rates. The latter finding indicates that benefits beyond fertilization insurance can make higher mating rates also beneficial from a female perspective in this traumatically mating species.	[Lange, Rolanda; Gerlach, Tobias; Werminghausen, Johanna; Reichel, Verena; Anthes, Nils] Univ Tubingen, Fac Sci, Anim Evolutionary Ecol Grp, Tubingen, Germany; [Beninde, Joscha] Univ Trier, Dept Biogeog, Trier, Germany	Eberhard Karls University of Tubingen; Universitat Trier	Lange, R (corresponding author), Univ Tubingen, Fac Sci, Anim Evolutionary Ecol Grp, Tubingen, Germany.	rolanda.lange@uni-tuebingen.de	Anthes, Nils/A-2434-2009	Anthes, Nils/0000-0003-4189-7849	German Science Foundation [An549/2-1]	German Science Foundation(German Research Foundation (DFG))	The German Science Foundation (grant An549/2-1) provided funds for field work and during manuscript preparation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JK, 2011, P ROY SOC B-BIOL SCI, V278, P161, DOI 10.1098/rspb.2010.1401; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Anthes N, 2006, BEHAV ECOL SOCIOBIOL, V60, P359, DOI 10.1007/s00265-006-0173-5; Anthes N, 2007, INVERTEBR BIOL, V126, P335, DOI 10.1111/j.1744-7410.2007.00096.x; Anthes N, 2007, BIOL LETTERS, V3, P121, DOI 10.1098/rsbl.2006.0596; Anthes N, 2010, AM NAT, V176, P249, DOI 10.1086/655218; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist Goran, 2005, pUnpaginated; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Bedhomme S, 2009, BIOL LETTERS, V5, P717, DOI 10.1098/rsbl.2009.0401; Blanckenhorn WU, 2002, BEHAV ECOL, V13, P353, DOI 10.1093/beheco/13.3.353; Brauer VS, 2007, EVOLUTION, V61, P216, DOI 10.1111/j.1558-5646.2007.00018.x; Cayetano L, 2011, EVOLUTION, V65, P2171, DOI 10.1111/j.1558-5646.2011.01309.x; CHARNOV E L, 1982; Crudgington HS, 2000, NATURE, V407, P855, DOI 10.1038/35038154; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Engqvist L, 2005, ANIM BEHAV, V70, P967, DOI 10.1016/j.anbehav.2005.01.016; Engqvist L, 2003, J EVOLUTION BIOL, V16, P1196, DOI 10.1046/j.1420-9101.2003.00613.x; GOSLINER TM, 1989, VELIGER, V32, P333; Koene JM, 2005, INVERTEBR REPROD DEV, V48, P101, DOI 10.1080/07924259.2005.9652176; Koene JM, 2001, J COMP PHYSIOL A, V187, P323, DOI 10.1007/s003590100214; Koene JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010117; Lange R, 2012, ANIM BEHAV, V83, P469, DOI 10.1016/j.anbehav.2011.11.021; Michiels NK, 1998, SPERM COMPETITION SE, P219; Morrow EH, 2003, P ROY SOC B-BIOL SCI, V270, P2377, DOI 10.1098/rspb.2003.2514; Parker G.A., 1979, P123; Pelissie B, 2012, EVOLUTION, V66, P66, DOI 10.1111/j.1558-5646.2011.01442.x; Pizzari T, 2003, NATURE, V426, P70, DOI 10.1038/nature02004; Puurtinen M, 2009, AM NAT, V174, P741, DOI 10.1086/606024; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ram KR, 2007, INTEGR COMP BIOL, V47, P427, DOI 10.1093/icb/icm046; Reinhardt K, 2003, P ROY SOC B-BIOL SCI, V270, P2371, DOI 10.1098/rspb.2003.2515; Rezac M, 2009, P ROY SOC B-BIOL SCI, V276, P2697, DOI 10.1098/rspb.2009.0104; Ronn J, 2006, ANIM BEHAV, V72, P335, DOI 10.1016/j.anbehav.2005.10.024; Sato T, 2005, MAR ECOL PROG SER, V296, P251, DOI 10.3354/meps296251; Scharer L, 2011, P NATL ACAD SCI USA, V108, P1490, DOI 10.1073/pnas.1013892108; Scharer L, 2009, EVOLUTION, V63, P1377, DOI 10.1111/j.1558-5646.2009.00669.x; Scharer L, 2005, J EVOLUTION BIOL, V18, P396, DOI 10.1111/j.1420-9101.2004.00827.x; Simmons LW, 2011, J EVOLUTION BIOL, V24, P132, DOI 10.1111/j.1420-9101.2010.02158.x; Siva-Jothy MT, 2006, PHILOS T ROY SOC B, V361, P269, DOI 10.1098/rstb.2005.1789; Smolensky N, 2009, BIOL BULL-US, V216, P188; Sprenger D, 2008, J ANIM ECOL, V77, P696, DOI 10.1111/j.1365-2656.2008.01376.x; Sprenger D, 2008, MAR BIOL, V153, P891, DOI 10.1007/s00227-007-0861-3; Sprenger D, 2010, EVOL ECOL, V24, P185, DOI 10.1007/s10682-009-9300-x; Stutt AD, 2001, P NATL ACAD SCI USA, V98, P5683, DOI 10.1073/pnas.101440698; Tatarnic NJ, 2010, J EVOLUTION BIOL, V23, P1321, DOI 10.1111/j.1420-9101.2010.01991.x; Wang Q, 2008, J INSECT BEHAV, V21, P89, DOI 10.1007/s10905-007-9110-3; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Zeh JA, 2003, ETHOLOGY, V109, P929, DOI 10.1046/j.1439-0310.2003.00945.x	49	16	16	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43234	10.1371/journal.pone.0043234	http://dx.doi.org/10.1371/journal.pone.0043234			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937024	Green Submitted, Green Published, gold			2022-12-25	WOS:000308286300036
J	Bartholomeeusen, K; Xiang, YH; Fujinaga, K; Peterlin, BM				Bartholomeeusen, Koen; Xiang, Yanhui; Fujinaga, Koh; Peterlin, B. Matija			Bromodomain and Extra-terminal (BET) Bromodomain Inhibition Activate Transcription via Transient Release of Positive Transcription Elongation Factor b (P-TEFb) from 7SK Small Nuclear Ribonucleoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST CELL-GROWTH; GENE-EXPRESSION; RNA; HIV; COMPLEX; HEXIM1; TAT; REPLICATION; RECRUITMENT; CHROMATIN	By phosphorylating elongation factors and the C-terminal domain of RNA polymerase II, the positive transcription elongation factor b (P-TEFb) is the critical kinase for transcription elongation and co-transcriptional processing of eukaryotic genes. It exists in inactive small nuclear ribonucleoprotein (7SK snRNP) and active (free P-TEFb) complexes in cells. The P-TEFb equilibrium determines the state of cellular activation, proliferation, and differentiation. Free P-TEFb, which is required for growth, can be recruited to RNA polymerase II via transcription factors, BRD4, or the super elongation complex (SEC). UV light, various signaling cascades, transcriptional blockade, or compounds such as hexamethylene bisacetamide (HMBA), suberoylanilide hydroxamic acid (SAHA), and other histone deacetylase inhibitors lead to a rapid release of free P-TEFb, followed by its reassembly into the 7SK snRNP. As a consequence, transcription of HEXIM1, a critical 7SK snRNP subunit, and HIV is induced. In this study, we found that a bromodomain and extra-terminal (BET) bromodomain inhibitor, JQ1, which inhibits BRD4 by blocking its association with chromatin, also leads to the rapid release of free P-TEFb from the 7SK snRNP. Indeed, JQ1 transiently increased levels of free P-TEFb and BRD4.P-TEFb and SEC.P-TEFb complexes in cells. As a consequence, the levels of HEXIM1 and HIV proteins rose. Importantly, the knockdown of ELL2, a subunit of the SEC, blocked the ability of JQ1 to increase HIV transcription. Finally, the effects of JQ1 and HMBA or SAHA on the P-TEFb equilibrium were cooperative. We conclude that HMBA, SAHA, and JQ1 affect transcription elongation by a similar and convergent mechanism.	[Peterlin, B. Matija] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Peterlin, BM (corresponding author), Univ Calif San Francisco, Dept Med, Rm U432,533 Parnassus Ave, San Francisco, CA 94143 USA.	matija.peterlin@ucsf.edu	bartholomeeusen, koen/J-1843-2015	bartholomeeusen, koen/0000-0001-9576-2400	National Institutes of Health CARE Center [U19 AI076113]; University of California San Francisco Center for AIDS Research; amfAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, R01AI049104, U19AI096113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250] Funding Source: NIH RePORTER	National Institutes of Health CARE Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco Center for AIDS Research(University of California System); amfAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health CARE Center Grant U19 AI076113. This work was also supported by grants from the University of California San Francisco Center for AIDS Research (to K. B.) and amfAR (to K. F.).	Ai NP, 2011, NUCLEIC ACIDS RES, V39, P9592, DOI 10.1093/nar/gkr698; ANTONI BA, 1994, VIROLOGY, V202, P684, DOI 10.1006/viro.1994.1390; Banerjee C., 2012, J LEUKOCYTE BIOL, V92, P1; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Biglione S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-47; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Chiang K, 2012, J VIROL, V86, P3244, DOI 10.1128/JVI.05065-11; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Czudnochowski N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1846; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; He NH, 2006, MOL CELL BIOL, V26, P7068, DOI 10.1128/MCB.00778-06; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Krueger BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012335; Lenasi T, 2008, CELL HOST MICROBE, V4, P123, DOI 10.1016/j.chom.2008.05.016; Li J, 2011, CURR OPIN GENET DEV, V21, P231, DOI 10.1016/j.gde.2011.01.010; Luo ZJ, 2012, MOL CELL BIOL, V32, P2608, DOI 10.1128/MCB.00182-12; Martincic K, 2009, NAT IMMUNOL, V10, P1102, DOI 10.1038/ni.1786; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Mueller D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000249; Nechaev S, 2011, BBA-GENE REGUL MECH, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Peterlin BM, 2012, WIRES RNA, V3, P92, DOI 10.1002/wrna.106; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schroder S, 2012, J BIOL CHEM, V287, P1090, DOI 10.1074/jbc.M111.282855; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Sung TL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000263; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Wittmann BM, 2005, ONCOGENE, V24, P5576, DOI 10.1038/sj.onc.1208728; Wittmann BM, 2003, CANCER RES, V63, P5151; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Zhao R, 2011, NAT CELL BIOL, V13, P1295, DOI 10.1038/ncb2341; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	40	150	176	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36609	36616		10.1074/jbc.M112.410746	http://dx.doi.org/10.1074/jbc.M112.410746			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22952229	Green Published, hybrid			2022-12-25	WOS:000310364000080
J	Landau, G; Ran, A; Bercovich, Z; Feldmesser, E; Horn-Saban, S; Korkotian, E; Jacob-Hirsh, J; Rechavi, G; Ron, D; Kahana, C				Landau, Guy; Ran, Avichai; Bercovich, Zippi; Feldmesser, Ester; Horn-Saban, Shirley; Korkotian, Eduard; Jacob-Hirsh, Jasmine; Rechavi, Gideon; Ron, David; Kahana, Chaim			Expression Profiling and Biochemical Analysis Suggest Stress Response as a Potential Mechanism Inhibiting Proliferation of Polyamine-depleted Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; TRANSCRIPTION FACTOR; ORNITHINE-DECARBOXYLASE; GENE-EXPRESSION; OXIDATIVE STRESS; TRANSLATION INITIATION; MESSENGER-RNA; CYCLE; APOPTOSIS	Polyamines are small organic polycations that are absolutely required for cell growth and proliferation; yet the basis for this requirement is mostly unknown. Here, we combined a genome-wide expression profiling with biochemical analysis to reveal the molecular basis for inhibited proliferation of polyamine-depleted cells. Transcriptional responses accompanying growth arrest establishment in polyamine-depleted cells or growth resumption following polyamine replenishment were monitored and compared. Changes in the expression of genes related to various fundamental cellular processes were established. Analysis of mirror-symmetric expression patterns around the G(1)-arrest point identified a set of genes representing a stress-response signature. Indeed, complementary biochemical analysis demonstrated activation of the PKR-like endoplasmic reticulum kinase arm of the unfolded protein response and of the stress-induced p38 MAPK. These changes were accompanied by induction of key growth-inhibitory factors such as p21 and Gadd45a and reduced expression of various cyclins, most profoundly cyclin D1, setting the basis for the halted proliferation. However, although the induced stress response could arrest growth, polyamine depletion also inhibited proliferation of PKR-like endoplasmic reticulum kinase and p38 alpha-deficient cells and of cells harboring a nonphosphorylatable mutant eIF2 alpha (S51A), suggesting that additional yet unidentified mechanisms might inhibit proliferation of polyamine-depleted cells. Despite lengthy persistence of the stress and activation of apoptotic signaling, polyamine-depleted cells remained viable, apparently due to induced expression of protective genes and development of autophagy.	[Landau, Guy; Ran, Avichai; Bercovich, Zippi; Kahana, Chaim] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Feldmesser, Ester; Horn-Saban, Shirley] Weizmann Inst Sci, Dept Biol Serv, IL-76100 Rehovot, Israel; [Korkotian, Eduard] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Jacob-Hirsh, Jasmine; Rechavi, Gideon] Chaim Sheba Med Ctr, Sheba Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Rechavi, Gideon] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Ron, David] Univ Cambridge, Addenbrookes Hosp, Metab Res Lab, Cambridge CB2 0QQ, England; [Ron, David] Univ Cambridge, Addenbrookes Hosp, NIHR Cambridge Biomed Res Ctr, Cambridge CB2 0QQ, England	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Kahana, C (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	chaim.kahana@weizmann.ac.il	Korkotian, Eduard/K-1744-2012; Korkotian, Eduard/P-4559-2019	Korkotian, Eduard/0000-0001-5515-3387; Ron, David/0000-0002-3014-5636	Israel Academy of Science and Humanities; M. D. Moross Institute for Cancer Research; Kahn Family Research Center for Systems Biology of the Human Cell at the Weizmann Institute	Israel Academy of Science and Humanities; M. D. Moross Institute for Cancer Research; Kahn Family Research Center for Systems Biology of the Human Cell at the Weizmann Institute	This work was supported by grants from the Israel Academy of Science and Humanities, the M. D. Moross Institute for Cancer Research, and the Kahn Family Research Center for Systems Biology of the Human Cell at the Weizmann Institute.	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; Bevilacqua E, 2010, J BIOL CHEM, V285, P17098, DOI 10.1074/jbc.M110.109439; Bhattacharya A, 2003, CANCER RES, V63, P8167; Biswas M, 2011, J BIOL CHEM, V286, P39282, DOI 10.1074/jbc.M111.253807; Brewer JW, 1999, P NATL ACAD SCI USA, V96, P8505, DOI 10.1073/pnas.96.15.8505; Clement A, 2001, AM J RESP CRIT CARE, V164, pS81, DOI 10.1164/ajrccm.164.supplement_2.2106069; CLIFFORD A, 1995, CANCER RES, V55, P1680; d'Azzo A, 2006, CELL DEATH DIFFER, V13, P404, DOI 10.1038/sj.cdd.4401834; Dalton TP, 2002, CHEM-BIOL INTERACT, V141, P77, DOI 10.1016/S0009-2797(02)00067-4; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Fasanaro P, 2006, FASEB J, V20, P1242, DOI 10.1096/fj.05-4695fje; Ferreiro I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-144; GILLE H, 1995, CURR BIOL, V5, P1191, DOI 10.1016/S0960-9822(95)00235-1; Grinstein E, 2002, ONCOGENE, V21, P1485, DOI 10.1038/sj.onc.1205211; Gurtner A, 2010, CANCER RES, V70, P9711, DOI 10.1158/0008-5472.CAN-10-0721; Harding HP, 2005, CELL METAB, V2, P361, DOI 10.1016/j.cmet.2005.11.005; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hsieh WC, 2010, MOL CELLS, V30, P311, DOI 10.1007/s10059-010-0120-1; Hu X, 2005, CANCER RES, V65, P11026, DOI 10.1158/0008-5472.CAN-05-1339; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hyvonen MT, 2007, BIOCHEM SOC T, V35, P326, DOI 10.1042/BST0350326; Igarashi K, 2010, PLANT PHYSIOL BIOCH, V48, P506, DOI 10.1016/j.plaphy.2010.01.017; KAGEYAMA R, 1989, J BIOL CHEM, V264, P15508; Kaneto H, 1999, DIABETOLOGIA, V42, P1093, DOI 10.1007/s001250051276; Kawata H, 2003, BIOCHEM J, V373, P747, DOI 10.1042/BJ20030171; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Landau G, 2010, J BIOL CHEM, V285, P12474, DOI 10.1074/jbc.M110.106419; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee GH, 2011, J BIOL CHEM, V286, P24743, DOI 10.1074/jbc.M110.167734; Leung-Pineda V, 2004, BIOCHEM J, V379, P79, DOI 10.1042/BJ20031383; Li L, 1999, AM J PHYSIOL-CELL PH, V276, pC946, DOI 10.1152/ajpcell.1999.276.4.C946; Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15; Liu Y, 2010, NEOPLASIA, V12, P61, DOI 10.1593/neo.91354; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; MAMONT PS, 1978, BIOCHEM BIOPH RES CO, V81, P58, DOI 10.1016/0006-291X(78)91630-3; Manni A, 2004, CLIN EXP METASTAS, V21, P461, DOI 10.1007/s10585-004-2724-3; Masamha CP, 2009, CANCER RES, V69, P6565, DOI 10.1158/0008-5472.CAN-09-0913; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; NISHIKAWA Y, 1980, BIOCHEM BIOPH RES CO, V97, P1296, DOI 10.1016/S0006-291X(80)80007-6; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Oku M, 2011, CELL STRUCT FUNCT, V36, P1, DOI 10.1247/csf.10014; Parkkinen JJ, 1997, J CELL BIOCHEM, V66, P165, DOI 10.1002/(SICI)1097-4644(19970801)66:2<165::AID-JCB4>3.3.CO;2-D; PEGG AE, 1988, CANCER RES, V48, P759; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Qin XQ, 1997, ONCOGENE, V14, P53, DOI 10.1038/sj.onc.1200809; Raven JF, 2008, J BIOL CHEM, V283, P3097, DOI 10.1074/jbc.M709677200; Ray RM, 1999, AM J PHYSIOL-CELL PH, V276, pC684, DOI 10.1152/ajpcell.1999.276.3.C684; Rzymski T, 2010, ONCOGENE, V29, P4424, DOI 10.1038/onc.2010.191; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Sharan R, 2003, BIOINFORMATICS, V19, P1787, DOI 10.1093/bioinformatics/btg232; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Tessitore A, 2004, MOL CELL, V15, P753, DOI 10.1016/j.molcel.2004.08.029; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; Tuli R, 2002, ANN NY ACAD SCI, V961, P172, DOI 10.1111/j.1749-6632.2002.tb03077.x; Ulitsky I, 2010, NAT PROTOC, V5, P303, DOI 10.1038/nprot.2009.230; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Zellmer S, 2010, HEPATOLOGY, V52, P2127, DOI 10.1002/hep.23930; Zeng YX, 1997, NAT GENET, V15, P78, DOI 10.1038/ng0197-78; Zhang X, 2009, NUCLEIC ACIDS RES, V37, P7623, DOI 10.1093/nar/gkp755; Zou TT, 2004, AM J PHYSIOL-CELL PH, V286, pC1009, DOI 10.1152/ajpcell.00480.2003	70	30	30	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35825	35837		10.1074/jbc.M112.381335	http://dx.doi.org/10.1074/jbc.M112.381335			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22942278	hybrid, Green Published			2022-12-25	WOS:000310364000006
J	Schmitt, C; Schultheis, C; Husson, SJ; Liewald, JF; Gottschalk, A				Schmitt, Cornelia; Schultheis, Christian; Husson, Steven J.; Liewald, Jana F.; Gottschalk, Alexander			Specific Expression of Channelrhodopsin-2 in Single Neurons of Caenorhabditis elegans	PLOS ONE			English	Article							TRANSMEMBRANE PROTEIN TOPOLOGY; MULTIPLE SEQUENCE ALIGNMENT; GREEN FLUORESCENT PROTEIN; C-ELEGANS; NERVOUS-SYSTEM; CELLULAR CAMP; SPATIOTEMPORAL CONTROL; OPTOGENETIC ANALYSIS; GLUTAMATE-RECEPTOR; MAMMALIAN-CELLS	Optogenetic approaches using light-activated proteins like Channelrhodopsin-2 (ChR2) enable investigating the function of populations of neurons in live Caenorhabditis elegans (and other) animals, as ChR2 expression can be targeted to these cells using specific promoters. Sub-populations of these neurons, or even single cells, can be further addressed by restricting the illumination to the cell of interest. However, this is technically demanding, particularly in free moving animals. Thus, it would be helpful if expression of ChR2 could be restricted to single neurons or neuron pairs, as even wide-field illumination would photostimulate only this particular cell. To this end we adopted the use of Cre or FLP recombinases and conditional ChR2 expression at the intersection of two promoter expression domains, i.e. in the cell of interest only. Success of this method depends on precise knowledge of the individual promoters' expression patterns and on relative expression levels of recombinase and ChR2. A bicistronic expression cassette with GFP helps to identify the correct expression pattern. Here we show specific expression in the AVA reverse command neurons and the aversive polymodal sensory ASH neurons. This approach shall enable to generate strains for optogenetic manipulation of each of the 302 C. elegans neurons. This may eventually allow to model the C. elegans nervous system in its entirety, based on functional data for each neuron.	[Schmitt, Cornelia; Schultheis, Christian; Husson, Steven J.; Liewald, Jana F.; Gottschalk, Alexander] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, Frankfurt, Germany; [Schmitt, Cornelia; Schultheis, Christian; Husson, Steven J.; Liewald, Jana F.; Gottschalk, Alexander] Goethe Univ Frankfurt, Inst Biochem, Frankfurt, Germany; [Husson, Steven J.] Katholieke Univ Leuven, Louvain, Belgium	Goethe University Frankfurt; Goethe University Frankfurt; KU Leuven	Schmitt, C (corresponding author), Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, Frankfurt, Germany.	a.gottschalk@em.uni-frankfurt.de	Gottschalk, Alexander/D-3155-2011; Pokala, Navin/AAH-5719-2019	Gottschalk, Alexander/0000-0002-1197-6119; Pokala, Navin/0000-0003-2323-6190	Schram Foundation [T287/18545/2008]; Deutsche Forschungsgemeinschaft [EXC114, SFB807-P11, GO1011/3-1]; Human Frontier Science Program Organization Long Term Fellowship LTF [548/2009-L]	Schram Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Human Frontier Science Program Organization Long Term Fellowship LTF	This study was supported by Schram Foundation grant T287/18545/2008, Deutsche Forschungsgemeinschaft grants EXC114, SFB807-P11, GO1011/3-1, and Human Frontier Science Program Organization Long Term Fellowship LTF 548/2009-L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreas S, 2002, NUCLEIC ACIDS RES, V30, P2299, DOI 10.1093/nar/30.11.2299; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chao MY, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-45; Chelur DS, 2007, P NATL ACAD SCI USA, V104, P2283, DOI 10.1073/pnas.0610877104; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Davis MW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000028; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Ezcurra M, 2011, EMBO J, V30, P1110, DOI 10.1038/emboj.2011.22; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Gerdes HH, 1996, FEBS LETT, V389, P44, DOI 10.1016/0014-5793(96)00586-8; Ghosh K, 2002, METHODS, V28, P374, DOI 10.1016/S1046-2023(02)00244-X; Hart AC, 1999, J NEUROSCI, V19, P1952; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; HOESS R, 1984, COLD SPRING HARB SYM, V49, P761, DOI 10.1101/SQB.1984.049.01.086; Husson SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040937; Husson SJ, 2012, CURR BIOL, V22, P743, DOI 10.1016/j.cub.2012.02.066; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Liewald JF, 2008, NAT METHODS, V5, P895, DOI 10.1038/NMETH.1252; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Marti T, 1998, J BIOL CHEM, V273, P9312, DOI 10.1074/jbc.273.15.9312; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miyabayashi T, 1999, DEV BIOL, V215, P314, DOI 10.1006/dbio.1999.9470; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OGAWA H, 1995, P NATL ACAD SCI USA, V92, P11899, DOI 10.1073/pnas.92.25.11899; Piggott BJ, 2011, CELL, V147, P922, DOI 10.1016/j.cell.2011.08.053; PINES J, 1995, TRENDS GENET, V11, P326, DOI 10.1016/S0168-9525(00)89092-7; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rogers C, 2003, NAT NEUROSCI, V6, P1178, DOI 10.1038/nn1140; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; SCHERTLER GFX, 1993, J MOL BIOL, V234, P156, DOI 10.1006/jmbi.1993.1570; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Schultheis C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018766; Schwarz V, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-13; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Stirman JN, 2012, NAT PROTOC, V7, P207, DOI 10.1038/nprot.2011.433; Stirman JN, 2011, NAT METHODS, V8, P153, DOI 10.1038/NMETH.1555; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Treinin M, 1998, P NATL ACAD SCI USA, V95, P15492, DOI 10.1073/pnas.95.26.15492; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; Weissenberger S, 2011, J NEUROCHEM, V116, P616, DOI 10.1111/j.1471-4159.2010.07148.x; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang SF, 2004, CELL, V119, P137, DOI 10.1016/j.cell.2004.09.012; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	66	44	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43164	10.1371/journal.pone.0043164	http://dx.doi.org/10.1371/journal.pone.0043164			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952643	Green Submitted, Green Published, gold			2022-12-25	WOS:000308206500009
J	Gray, KS; Collins, CM; Speck, SH				Gray, Kathleen S.; Collins, Christopher M.; Speck, Samuel H.			Characterization of Omental Immune Aggregates during Establishment of a Latent Gammaherpesvirus Infection	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTORS; B-CELLS; MILKY SPOTS; MURINE GAMMAHERPESVIRUS-68; PERITONEAL-CAVITY; UP-REGULATION; IN-VIVO; MACROPHAGES; MIGRATION; LESSONS	Herpesviruses are characterized by their ability to establish lifelong latent infection. The gammaherpesvirus subfamily is distinguished by lymphotropism, establishing and maintaining latent infection predominantly in B lymphocytes. Consequently, gammaherpesvirus pathogenesis is closely linked to normal B cell physiology. Murine gammaherpesvirus 68 (MHV68) pathogenesis in laboratory mice has been extensively studied as a model system to gain insights into the nature of gammaherpesvirus infection in B cells and their associated lymphoid compartments. In addition to B cells, MHV68 infection of macrophages contributes significantly to the frequency of viral genome-positive cells in the peritoneal cavity throughout latency. The omentum, a sheet of richly-vascularized adipose tissue, resides in the peritoneal cavity and contains clusters of immune cell aggregates termed milky spots. Although the value of the omentum in surgical wound-healing has long been appreciated, the unique properties of this tissue and its contribution to both innate and adaptive immunity have only recently been recognized. To determine whether the omentum plays a role in gammaherpesvirus pathogenesis we examined this site during early MHV68 infection and long-term latency. Following intraperitoneal infection, immune aggregates within the omentum expanded in size and number and contained virus-infected cells. Notably, a germinal-center B cell population appeared in the omentum of infected animals with earlier kinetics and greater magnitude than that observed in the spleen. Furthermore, the omentum harbored a stable frequency of viral genome-positive cells through early and into long-term latency, while removal of the omentum prior to infection resulted in a slight decrease in the establishment of splenic latency following intraperitoneal infection. These data provide the first evidence that the omentum is a site of chronic MHV68 infection that may contribute to the maintenance of chronic infection.	[Gray, Kathleen S.] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Emory University; Emory University	Gray, KS (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	sspeck@emory.edu	Speck, Samuel/L-5893-2019		NIH [CA052004, CA095318]; NATIONAL CANCER INSTITUTE [R01CA052004, R01CA095318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058057] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIH R01 grants CA052004 and CA095318 to SHS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; Barton E, 2011, ANNU REV IMMUNOL, V29, P351, DOI 10.1146/annurev-immunol-072710-081639; Berberich S, 2008, J IMMUNOL, V180, P2196, DOI 10.4049/jimmunol.180.4.2196; Berberich S, 2007, BLOOD, V109, P4627, DOI 10.1182/blood-2006-12-064345; Cai QI, 2006, J VIROL, V80, P7965, DOI 10.1128/JVI.00689-06; Coleman CB, 2010, J VIROL, V84, P13045, DOI 10.1128/JVI.01455-10; Collins CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033230; Collins CM, 2009, J VIROL, V83, P6484, DOI 10.1128/JVI.00297-09; Fang HY, 2009, BLOOD, V114, P844, DOI 10.1182/blood-2008-12-195941; Gerber SA, 2006, AM J PATHOL, V169, P1739, DOI 10.2353/ajpath.2006.051222; Gill MB, 2009, J GEN VIROL, V90, P1461, DOI 10.1099/vir.0.010603-0; Gray KS, 2009, J VIROL, V83, P314, DOI 10.1128/JVI.01444-08; Hwang S, 2008, J VIROL, V82, P12498, DOI 10.1128/JVI.01152-08; Imtiyaz HZ, 2010, CURR TOP MICROBIOL, V345, P105, DOI 10.1007/82_2010_74; Kearney J F, 1992, Int Rev Immunol, V8, P247, DOI 10.3109/08830189209055577; Krug LT, 2009, J VIROL, V83, P4732, DOI 10.1128/JVI.00111-09; Lee BJ, 2000, J VIROL, V74, P2786, DOI 10.1128/JVI.74.6.2786-2792.2000; Mebius RE, 2009, IMMUNITY, V30, P670, DOI 10.1016/j.immuni.2009.04.005; Moon H, 2012, J KOREAN MED SCI, V27, P27, DOI 10.3346/jkms.2012.27.1.27; Moser JA, 2006, J VIROL, V80, P1592, DOI 10.1128/JVI.80.3.1592-1598.2006; Peacock JW, 2000, J GEN VIROL, V81, P421, DOI 10.1099/0022-1317-81-2-421; Polcicova K, 2008, VIRUS RES, V132, P257, DOI 10.1016/j.virusres.2007.12.004; Rangel-Moreno J, 2009, IMMUNITY, V30, P731, DOI 10.1016/j.immuni.2009.03.014; SOLVASON N, 1992, J EXP MED, V175, P397, DOI 10.1084/jem.175.2.397; SOLVASON N, 1992, ANN NY ACAD SCI, V651, P10; SORENSEN EW, 2009, IMMUNOL RES; Speck SH, 2010, CELL HOST MICROBE, V8, P100, DOI 10.1016/j.chom.2010.06.014; Weck KE, 1996, J VIROL, V70, P6775, DOI 10.1128/JVI.70.10.6775-6780.1996; Weck KE, 1999, J VIROL, V73, P4651, DOI 10.1128/JVI.73.6.4651-4661.1999; Weck KE, 1999, J VIROL, V73, P3273, DOI 10.1128/JVI.73.4.3273-3283.1999; Willer DO, 2003, J VIROL, V77, P8310, DOI 10.1128/JVI.77.15.8310-8321.2003	31	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43196	10.1371/journal.pone.0043196	http://dx.doi.org/10.1371/journal.pone.0043196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952645	Green Submitted, Green Published, gold			2022-12-25	WOS:000308206000022
J	Perumal, D; Singh, S; Yoder, SJ; Bloom, GC; Chellappan, SP				Perumal, Deepak; Singh, Sandeep; Yoder, Sean J.; Bloom, Gregory C.; Chellappan, Srikumar P.			A Novel Five Gene Signature Derived from Stem-Like Side Population Cells Predicts Overall and Recurrence-Free Survival in NSCLC	PLOS ONE			English	Article							TOPOISOMERASE-II-ALPHA; LUNG ADENOCARCINOMA; EXPRESSION DATA; TUMOR; PATHWAY; MODELS; DEATH; MICROARRAYS; CARCINOMAS; PROFILES	Gene expression profiling has been used to characterize prognosis in various cancers. Earlier studies had shown that side population cells isolated from Non-Small Cell Lung Cancer (NSCLC) cell lines exhibit cancer stem cell properties. In this study we apply a systems biology approach to gene expression profiling data from cancer stem like cells isolated from lung cancer cell lines to identify novel gene signatures that could predict prognosis. Microarray data from side population (SP) and main population (MP) cells isolated from 4 NSCLC lines (A549, H1650, H460, H1975) were used to examine gene expression profiles associated with stem like properties. Differentially expressed genes that were over or under-expressed at least two fold commonly in all 4 cell lines were identified. We found 354 were upregulated and 126 were downregulated in SP cells compared to MP cells; of these, 89 up and 62 downregulated genes (average 2 fold changes) were used for Principle Component Analysis (PCA) and MetaCore (TM) pathway analysis. The pathway analysis demonstrated representation of 4 up regulated genes (TOP2A, AURKB, BRRN1, CDK1) in chromosome condensation pathway and 1 down regulated gene FUS in chromosomal translocation. Microarray data was validated using qRT-PCR on the 5 selected genes and all showed robust correlation between microarray and qRT-PCR. Further, we analyzed two independent gene expression datasets that included 360 lung adenocarcinoma patients from NCI Director's Challenge Set for overall survival and 63 samples from Sungkyunkwan University (SKKU) for recurrence free survival. Kaplan-Meier and log-rank test analysis predicted poor survival of patients in both data sets. Our results suggest that genes involved in chromosome condensation are likely related with stem-like properties and might predict survival in lung adenocarcinoma. Our findings highlight a gene signature for effective identification of lung adenocarcinoma patients with poor prognosis and designing more aggressive therapies for such patients.	[Perumal, Deepak; Singh, Sandeep; Chellappan, Srikumar P.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL 33612 USA; [Yoder, Sean J.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Mol Genom Core Facil, Tampa, FL 33612 USA; [Bloom, Gregory C.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Biomed Informat, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Chellappan, SP (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL 33612 USA.	Srikumar.Chellappan@moffitt.org			NCI [CA127725]; Lung Cancer SPORE; National Functional Genomics Center at Moffitt Cancer Center; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA127725] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lung Cancer SPORE; National Functional Genomics Center at Moffitt Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported by grant CA127725 from the NCI. Support of the Lung Cancer SPORE as well as the National Functional Genomics Center at Moffitt Cancer Center is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SG, 2002, BMC MED RES METHODOL, V2; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Chekerov R, 2006, NEOPLASIA, V8, P38, DOI 10.1593/neo.05580; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Chikaish Y, 2011, ANTICANCER RES, V31, P4451; Dalton WS, 2006, SCIENCE, V312, P1165, DOI 10.1126/science.1125948; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Endoh H, 2004, J CLIN ONCOL, V22, P811, DOI 10.1200/JCO.2004.04.109; Fatoba ST, 2011, CELL CYCLE, V10, P2317, DOI 10.4161/cc.10.14.15913; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Guo NL, 2008, CLIN CANCER RES, V14, P8213, DOI 10.1158/1078-0432.CCR-08-0095; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Hoheisel JD, 2006, NAT REV GENET, V7, P200, DOI 10.1038/nrg1809; Huang E, 2003, NAT GENET, V34, P226, DOI 10.1038/ng1167; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kanta SY, 2006, HUM PATHOL, V37, P1333, DOI 10.1016/j.humpath.2006.05.008; Koren R, 2004, ONCOL REP, V12, P915; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Lafferty-Whyte K, 2009, BBA-MOL BASIS DIS, V1792, P341, DOI 10.1016/j.bbadis.2009.02.003; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Navab R, 2011, P NATL ACAD SCI; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; R Development Core Team, 2008, LANG ENV STAT COMP; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Reimers M, 2006, METHOD ENZYMOL, V411, P119, DOI 10.1016/S0076-6879(06)11008-3; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shuda K, 2009, MOL REPROD DEV, V76, P1094, DOI 10.1002/mrd.21075; Stevens JB, 2007, CANCER RES, V67, P7686, DOI 10.1158/0008-5472.CAN-07-0472; Stevens JB, 2010, MOL CYTOGENET, V3, DOI 10.1186/1755-8166-3-20; Subramanian J, 2010, JNCI-J NATL CANCER I, V102, P464, DOI 10.1093/jnci/djq025; Tanaka T, 2004, INT J CANCER, V111, P617, DOI 10.1002/ijc.20289; Tinker AV, 2006, CANCER CELL, V9, P333, DOI 10.1016/j.ccr.2006.05.001; Varis A, 2004, INT J CANCER, V109, P548, DOI 10.1002/ijc.20001; Wechsler T, 2011, NATURE, V471, P642, DOI 10.1038/nature09790; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Xu K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013696; Yang P, 2004, LUNG CANCER, V46, P215, DOI 10.1016/j.lungcan.2004.03.012; Yi JM, 2011, CLIN CANCER RES, V17, P1535, DOI 10.1158/1078-0432.CCR-10-2509; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	54	23	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43589	10.1371/journal.pone.0043589	http://dx.doi.org/10.1371/journal.pone.0043589			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952714	gold, Green Published, Green Submitted			2022-12-25	WOS:000308206000043
J	Ross, A; Koepfli, C; Li, XH; Schoepflin, S; Siba, P; Mueller, I; Felger, I; Smith, T				Ross, Amanda; Koepfli, Cristian; Li, Xiaohong; Schoepflin, Sonja; Siba, Peter; Mueller, Ivo; Felger, Ingrid; Smith, Thomas			Estimating the Numbers of Malaria Infections in Blood Samples Using High-Resolution Genotyping Data	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; ANTIMALARIAL EFFICACY; TRIALS; VIVAX; DIVERSITY; IMPACT	People living in endemic areas often habour several malaria infections at once. High-resolution genotyping can distinguish between infections by detecting the presence of different alleles at a polymorphic locus. However the number of infections may not be accurately counted since parasites from multiple infections may carry the same allele. We use simulation to determine the circumstances under which the number of observed genotypes are likely to be substantially less than the number of infections present and investigate the performance of two methods for estimating the numbers of infections from high-resolution genotyping data. The simulations suggest that the problem is not substantial in most datasets: the disparity between the mean numbers of infections and of observed genotypes was small when there was 20 or more alleles, 20 or more blood samples, a mean number of infections of 6 or less and where the frequency of the most common allele was no greater than 20%. The issue of multiple infections carrying the same allele is unlikely to be a major component of the errors in PCR-based genotyping. Simulations also showed that, with heterogeneity in allele frequencies, the observed frequencies are not a good approximation of the true allele frequencies. The first method that we proposed to estimate the numbers of infections assumes that they are a good approximation and hence did poorly in the presence of heterogeneity. In contrast, the second method by Li et al estimates both the numbers of infections and the true allele frequencies simultaneously and produced accurate estimates of the mean number of infections.	[Ross, Amanda; Koepfli, Cristian; Schoepflin, Sonja; Felger, Ingrid; Smith, Thomas] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Ross, Amanda; Koepfli, Cristian; Schoepflin, Sonja; Felger, Ingrid; Smith, Thomas] Univ Basel, Basel, Switzerland; [Koepfli, Cristian; Mueller, Ivo] Walter & Eliza Hall Inst Med Res, Infect & Immun Div, Parkville, Vic, Australia; [Li, Xiaohong] BG Med Inc, Waltham, MA USA; [Siba, Peter; Mueller, Ivo] Papua New Guinea Inst Med Res, Goroka, Eastern Highlan, Papua N Guinea; [Mueller, Ivo] Barcelona Ctr Int Hlth Res, Barcelona, Spain	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Walter & Eliza Hall Institute; PNG Institute Of Medical Research; ISGlobal; CRESIB	Ross, A (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	amanda.ross@unibas.ch	Koepfli, Cristian/H-8772-2019; Smith, Thomas/B-5569-2015; Mueller, Ivo/C-7251-2013	Koepfli, Cristian/0000-0002-9354-0414; Smith, Thomas/0000-0002-3650-9381; Mueller, Ivo/0000-0001-6554-6889; Ross, Amanda/0000-0001-6027-5645; Felger, Ingrid/0000-0003-1255-2606	Swiss National Science Foundation [320030-125316, 31003A-112196]; National Institutes of Health [AI063135, AI46919, TW007872]; Australian Agency for International Development; Victorian State Government OIS grant; National Health and Medical Research Council (NHMRC) IRIISS grant; FOGARTY INTERNATIONAL CENTER [R01TW007872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI063135, R01AI046919] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Agency for International Development; Victorian State Government OIS grant; National Health and Medical Research Council (NHMRC) IRIISS grant(National Health and Medical Research Council (NHMRC) of Australia); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Swiss National Science Foundation project number 320030-125316. The data used was additionally supported by the Swiss National Science Foundation project number 31003A-112196, the National Institutes of Health (AI063135, AI46919 and TW007872) and the Australian Agency for International Development. Infrastructure was supported by the Victorian State Government OIS and National Health and Medical Research Council (NHMRC) IRIISS grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, METHODS TECHNIQUES C; Antao T, 2011, P ROY SOC B-BIOL SCI, V278, P1705, DOI 10.1098/rspb.2010.1907; Bejon P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021711; Bretscher MT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-234; Bruce MC, 2000, PARASITOLOGY, V121, P257, DOI 10.1017/S0031182099006356; CARTER R, 1973, T ROY SOC TROP MED H, V67, P830, DOI 10.1016/0035-9203(73)90011-4; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Farnert A, 2001, T ROY SOC TROP MED H, V95, P225, DOI 10.1016/S0035-9203(01)90175-0; Gatton ML, 2008, TRENDS PARASITOL, V24, P68, DOI 10.1016/j.pt.2007.11.003; Greenhouse B, 2007, ANTIMICROB AGENTS CH, V51, P3096, DOI 10.1128/AAC.00159-07; Gupta V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-19; Hastings IM, 2010, AM J TROP MED HYG, V83, P489, DOI 10.4269/ajtmh.2010.10-0072; Hastings IM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-130; Hill WG, 1995, P ROY SOC B-BIOL SCI, V262, P249, DOI 10.1098/rspb.1995.0203; Juliano JJ, 2010, TRENDS PARASITOL, V26, P119, DOI 10.1016/j.pt.2009.12.007; Juliano JJ, 2009, J INFECT DIS, V200, P5, DOI 10.1086/599379; Koepfli C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001424; Koepfli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019010; Kwiek JJ, 2007, ANTIMICROB AGENTS CH, V51, P521, DOI 10.1128/AAC.00902-06; Li X, 2009, J R STAT SOC C-APPL, V58, P663, DOI 10.1111/j.1467-9876.2009.00673.x; Li XH, 2007, STAT APPL GENET MOL, V6; Lin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009047; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; McNamara DT, 2006, AM J TROP MED HYG, V74, P413, DOI 10.4269/ajtmh.2006.74.413; Schoepflin S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-250; Slater M, 2005, AM J TROP MED HYG, V73, P256, DOI 10.4269/ajtmh.2005.73.256; Stepniewska K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-127; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	28	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e42496	10.1371/journal.pone.0042496	http://dx.doi.org/10.1371/journal.pone.0042496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952595	Green Published, gold, Green Accepted			2022-12-25	WOS:000308206000007
J	Walter, J; Hartung, HP; Dihne, M				Walter, Janine; Hartung, Hans-Peter; Dihne, Marcel			Interferon Gamma and Sonic Hedgehog Signaling Are Required to Dysregulate Murine Neural Stem/Precursor Cells	PLOS ONE			English	Article							TRANSCRIPTIONAL CONTROL; NEURITE OUTGROWTH; IFN-GAMMA; DIFFERENTIATION; NEUROGENESIS; EXPRESSION; CYTOKINES; IMPACT; BRAIN; STATS	Background: The pro-inflammatory cytokine interferon gamma (IFN gamma), a key player in various neurological diseases, was recently shown to induce a dysregulated phenotype in neural stem/precursor cells (NSPCs) that is characterized by the simultaneous expression of glial and neuronal markers and irregular electrophysiological properties. Thus far, the mechanisms of this phenomenon have remained unclear. Methodology/Principal Findings: To determine if binding of the signal transducers and activators of transcription (Stat 1) to the sonic hedgehog (SHH) promoter is important for this phenomenon to occur, chromatin immunoprecipitation and pharmacological inhibition studies were performed. We report here that the activation of both the Stat 1 and SHH pathways is necessary to elicit the dysregulated phenotype. Conclusions/Significance: Thus, blocking these pathways might preserve functional differentiation of NSPCs under inflammatory conditions leading to more effective regeneration.	[Walter, Janine; Hartung, Hans-Peter; Dihne, Marcel] Univ Dusseldorf, Dept Neurol, D-40225 Dusseldorf, N Rhine Westpha, Germany; [Walter, Janine; Dihne, Marcel] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, Tubingen, Baden Wurttembe, Germany	Heinrich Heine University Dusseldorf; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Walter, J (corresponding author), Univ Dusseldorf, Dept Neurol, D-40225 Dusseldorf, N Rhine Westpha, Germany.	Janine.Walter@googlemail.com						Baron R, 2008, FASEB J, V22, P2843, DOI 10.1096/fj.08-105866; Ben-Hur T, 2003, MOL CELL NEUROSCI, V24, P623, DOI 10.1016/S1044-7431(03)00218-5; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Darnell JE, 2007, CURR TOP MICROBIOL, V316, P155; De Simone R, 1998, CYTOKINE, V10, P418, DOI 10.1006/cyto.1997.0314; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Griffin DE, 1997, J CLIN INVEST, V100, P2948, DOI 10.1172/JCI119847; Kim IJ, 2002, J NEUROSCI, V22, P4530, DOI 10.1523/JNEUROSCI.22-11-04530.2002; Kim SJ, 2007, NEUROCHEM RES, V32, P1399, DOI 10.1007/s11064-007-9323-z; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lin WS, 2004, J NEUROSCI, V24, P10074, DOI 10.1523/JNEUROSCI.2604-04.2004; Makela J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011091; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; RADY PL, 1995, CYTOKINE, V7, P793, DOI 10.1006/cyto.1995.0095; Rottenberg M, 2002, VIRAL IMMUNOL, V15, P247, DOI 10.1089/08828240260066206; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Song JH, 2005, J BIOL CHEM, V280, P12896, DOI 10.1074/jbc.M412139200; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sun L, 2010, BRAIN BEHAV IMMUN, V24, P220, DOI 10.1016/j.bbi.2009.09.016; Sweeten TL, 2004, BIOL PSYCHIAT, V55, P434, DOI 10.1016/j.biopsych.2003.09.001; Todoric J, 2011, DIABETES, V60, P1668, DOI 10.2337/db10-1628; Walter J, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-18; Wang HP, 2004, MOL CELL NEUROSCI, V27, P489, DOI 10.1016/j.mcn.2004.08.004; Wang Y, 2008, ANN NEUROL, V64, P417, DOI 10.1002/ana.21457; Wei YP, 2000, J INTERF CYTOK RES, V20, P403, DOI 10.1089/107999000312342; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Wong G, 2004, EXP NEUROL, V187, P171, DOI 10.1016/j.expneurol.2004.01.009; YONG VW, 1992, GLIA, V6, P269, DOI 10.1002/glia.440060405; Zahir T, 2009, STEM CELLS DEV, V18, P1423, DOI 10.1089/scd.2008.0412	30	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43338	10.1371/journal.pone.0043338	http://dx.doi.org/10.1371/journal.pone.0043338			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952668	Green Published, Green Submitted, gold			2022-12-25	WOS:000308206000032
J	Arunkumar, KP; Sahu, AK; Mohanty, AR; Awasthi, AK; Pradeep, AR; Urs, SR; Nagaraju, J				Arunkumar, Kallare P.; Sahu, Anup Kumar; Mohanty, Atish Ranjan; Awasthi, Arvind K.; Pradeep, Appukuttannair R.; Urs, S. Raje; Nagaraju, Javaregowda			Genetic Diversity and Population Structure of Indian Golden Silkmoth (Antheraea assama)	PLOS ONE			English	Article							MITOCHONDRIAL-DNA VARIATION; LEPIDOPTERA; SOFTWARE; MARKERS; COMPLEX	Background: The Indian golden saturniid silkmoth (Antheraea assama), popularly known as muga silkmoth, is a semi-domesticated silk producing insect confined to a narrow habitat range of the northeastern region of India. Owing to the prevailing socio-political problems, the muga silkworm habitats in the northeastern region have not been accessible hampering the phylogeography studies of this rare silkmoth. Recently, we have been successful in our attempt to collect muga cocoon samples, although to a limited extent, from their natural habitats. Out of 87 microsatellite markers developed previously for A. assama, 13 informative markers were employed to genotype 97 individuals from six populations and analyzed their population structure and genetic variation. Methodology/Principal Findings: We observed highly significant genetic diversity in one of the populations (WWS-1, a population derived from West Garo Hills region of Meghalaya state). Further analysis with and without WWS-1 population revealed that dramatic genetic differentiation (global F-ST = 0.301) was due to high genetic diversity contributed by WWS-1 population. Analysis of the remaining five populations (excluding WWS-1) showed a marked reduction in the number of alleles at all the employed loci. Structure analysis showed the presence of only two clusters: one formed by WWS-1 population and the other included the remaining five populations, inferring that there is no significant genetic diversity within and between these five populations, and suggesting that these five populations are probably derived from a single population. Patterns of recent population bottlenecks were not evident in any of the six populations studied. Conclusions/Significance: A. assama inhabiting the WWS-1 region revealed very high genetic diversity, and was genetically divergent from the five populations studied. The efforts should be continued to identify and study such populations from this region as well as other muga silkworm habitats. The information generated will be very useful in conservation of dwindling muga culture in Northeast India.	[Arunkumar, Kallare P.; Nagaraju, Javaregowda] Ctr DNA Fingerprinting & Diagnost, Mol Genet Lab, Ctr Excellence Genet & Genom Silkmoths, Hyderabad, Andhra Pradesh, India; [Sahu, Anup Kumar] Cent Muga Eri Res & Training Inst, Reg Muga Res Stn, Boko, India; [Mohanty, Atish Ranjan; Awasthi, Arvind K.; Pradeep, Appukuttannair R.; Urs, S. Raje] Cent Silk Board, Seribiotech Res Lab, Bangalore, Karnataka, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Arunkumar, KP (corresponding author), Ctr DNA Fingerprinting & Diagnost, Mol Genet Lab, Ctr Excellence Genet & Genom Silkmoths, Hyderabad, Andhra Pradesh, India.	jnagaraju@cdfd.org.in			Centre of Excellence from the Department of Biotechnology, Government of India; Council of Scientific and Industrial Research (CSIR), India	Centre of Excellence from the Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	JN acknowledges Centre of Excellence grant from the Department of Biotechnology, Government of India. AKP is recipient of the fellowship from Council of Scientific and Industrial Research (CSIR), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arunkumar KP, 2009, MOL ECOL RESOUR, V9, P268, DOI 10.1111/j.1755-0998.2008.02414.x; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Coates Brad Steven, 2011, Frontiers in Genetics, V2, P38, DOI 10.3389/fgene.2011.00038; Cornuet JM, 1996, GENETICS, V144, P2001; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Endler J.A., 1986, Monographs in Population Biology, pviii; ERSTS PJ, GEOGRAPHIC DISTANCE; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fuentes-Contreras E, 2008, J ECON ENTOMOL, V101, P190, DOI 10.1603/0022-0493(2008)101[190:PGSOCM]2.0.CO;2; Goel RK, 2004, OAK TASAR CULTURE AB; HALE LR, 1991, GENETICS, V129, P103; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jolly MS, 1981, FAO AGR SERVICES B N; Lewis PO, 2001, GENETIC DATA ANAL GD; Llewellyn KS, 2003, MOL ECOL, V12, P21, DOI 10.1046/j.1365-294X.2003.01703.x; MANTEL N, 1967, CANCER RES, V27, P209; Meglecz E, 1997, GENETICA, V101, P59, DOI 10.1023/A:1018368622549; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nei M., 1987, MOL EVOLUTIONARY GEN; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Prasad MD, 2003, J BIOSCIENCES, V28, P443, DOI 10.1007/BF02705119; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Salvato P, 2002, MOL ECOL, V11, P2435, DOI 10.1046/j.1365-294X.2002.01631.x; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; Slatkin M, 1994, GENE FLOW POPULATION; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vila M, 2011, J ZOOL SYST EVOL RES, V49, P119, DOI 10.1111/j.1439-0469.2010.00587.x; YOON CK, 1994, J HERED, V85, P421, DOI 10.1093/oxfordjournals.jhered.a111495	34	13	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43716	10.1371/journal.pone.0043716	http://dx.doi.org/10.1371/journal.pone.0043716			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952746	Green Published, Green Submitted, gold			2022-12-25	WOS:000308213600039
J	Chiem, JC; Macq, J; Speybroeck, N				Chiem, Jean-Christophe; Macq, Jean; Speybroeck, Niko			Rule-Based Modeling of Chronic Disease Epidemiology: Elderly Depression as an Illustration	PLOS ONE			English	Article							SOCIAL SUPPORT; LIFE EVENTS; OLD-AGE; PREVALENCE; PREDICTORS; SIMULATION; COMMUNITY; NETWORKS; ANXIETY	Background: Rule-based Modeling (RBM) is a computer simulation modeling methodology already used to model infectious diseases. Extending this technique to the assessment of chronic diseases, mixing quantitative and qualitative data appear to be a promising alternative to classical methods. Elderly depression reveals an important source of comorbidities. Yet, the intertwined relationship between late-life events and the social support of the elderly person remains difficult to capture. We illustrate the usefulness of RBM in modeling chronic diseases using the example of elderly depression in Belgium. Methods: We defined a conceptual framework of interactions between late-life events and social support impacting elderly depression. This conceptual framework was underpinned by experts' opinions elicited through a questionnaire. Several scenarios were implemented successively to better mimic the real population, and to explore a treatment effect and a socioeconomic distinction. The simulated patterns of depression by age were compared with empirical patterns retrieved from the Belgian Health Interview Survey. Results: Simulations were run using different groupings of experts' opinions on the parameters. The results indicate that the conceptual framework can reflect a realistic evolution of the prevalence of depression. Indeed, simulations combining the opinions of well-selected experts and a treatment effect showed no significant difference with the empirical pattern. Conclusions: Our conceptual framework together with a quantification of parameters through elicited expert opinions improves the insights into possible dynamics driving elderly depression. While RBM does not require high-level skill in mathematics or computer programming, the whole implementation process provides a powerful tool to learn about complex chronic diseases, combining advantages of both quantitative and qualitative approaches.	[Chiem, Jean-Christophe; Macq, Jean; Speybroeck, Niko] Catholic Univ Louvain, Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium	Universite Catholique Louvain	Chiem, JC (corresponding author), Catholic Univ Louvain, Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium.	jean-christophe.chiem@uclouvain.be		Speybroeck, Niko/0000-0003-3322-3502	Universite Catholique de Louvain (UCL)	Universite Catholique de Louvain (UCL)	One Phd student working on this study was paid under a Phd Scholarship granted by Universite Catholique de Louvain (UCL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrino-Silva C, 2011, CLINICS, V66, P233, DOI 10.1590/S1807-59322011000200009; Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2; Axelrod R., 1997, COMPLEXITY, V3, P16, DOI DOI 10.1002/(ISSN)1099-0526; Belgian Federal Government, 2009, TABL MORT; Berk L.E., 2009, DEV LIFESPAN, V5th; Beswick AD, 2008, LANCET, V371, P725, DOI 10.1016/S0140-6736(08)60342-6; Blazer DG, 2005, PSYCHOL MED, V35, P1241, DOI 10.1017/S0033291705004411; Boisson M, 2010, SANTE MENTALE AFFAIR; COLLOPY F, 1992, MANAGE SCI, V38, P1394, DOI 10.1287/mnsc.38.10.1394; Dalgard OS, 2009, SOCIAL SUPPORT DEFIN; DeBeauvoir S., 1970, COMING AGE; Demarest S DS, 1997, HLTH INTERVIEW SURVE; Djernes JK, 2006, ACTA PSYCHIAT SCAND, V113, P372, DOI 10.1111/j.1600-0447.2006.00770.x; Edmonds B, 2005, J MATH SOCIOL, V29, P209, DOI 10.1080/00222500590921283; Edmonds B, 2001, LECT NOTES ARTIF INT, V1979, P15; Edmonds B, 2010, J ARTIFICIAL SOC SOC, V13; Epstein JM, 2009, NATURE, V460, P687, DOI 10.1038/460687a; Epstein JM, 2008, JASSS-J ARTIF SOC S, V11; Evans M., 2000, ADV PSYCHIAT TREAT, V6, P49, DOI [DOI 10.1192/APT.6.1.49, 10.1192/apt.6.1.49]; Galea S, 2009, INT J DRUG POLICY, V20, P209, DOI 10.1016/j.drugpo.2008.08.005; Gerstorf D, 2009, PSYCHOL AGING, V24, P296, DOI 10.1037/a0015069; Gisle L, 2008, SANTE MENTALE ENQUET; Golden J, 2009, INT J GERIATR PSYCH, V24, P694, DOI 10.1002/gps.2181; Green Carla A, 2004, Evid Based Ment Health, V7, P58; Guilbaut C, 2007, GERONTOLOGIE SOC, V121, P163; Hammond RA, 2009, PREV CHRONIC DIS, V6; Haworth JE, 2005, EUR J HEART FAIL, V7, P803, DOI 10.1016/j.ejheart.2005.03.001; Hollingworth SA, 2010, AUST NZ J PSYCHIAT, V44, P513, DOI 10.3109/00048670903555138; Holroyd S, 2000, MEDSCAPE GEN MED, V2; Hoppmann C, 2009, GERONTOLOGY, V55, P449, DOI 10.1159/000211948; HUNT SM, 1985, J ROY COLL GEN PRACT, V35, P185; Jones AP, 2006, AM J PUBLIC HEALTH, V96, P488, DOI 10.2105/AJPH.2005.063529; Kelley-Moore JA, 2006, J HEALTH SOC BEHAV, V47, P126, DOI 10.1177/002214650604700203; Kim D, 2008, EPIDEMIOL REV, V30, P101, DOI 10.1093/epirev/mxn009; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Lorant V, 2007, BRIT J PSYCHIAT, V190, P293, DOI 10.1192/bjp.bp.105.020040; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; Mcdowell I., 2006, MEASURING HLTH GUIDE, V3, P37, DOI [DOI 10.1093/ACPROF:OSO/9780195165678.001.0001, 10.1093/acprof:oso/9780195165678.001.0001]; Moss S, 2005, AM J SOCIOL, V110, P1095, DOI 10.1086/427320; O'Malley AJ, 2011, STAT MED, V30, P950, DOI 10.1002/sim.4190; Population Reference Bureau, 2008, TOD RES AG, V11; Population Reference Bureau, 2009, TOD RES AG, V17; Reker GT, 1997, GERONTOLOGIST, V37, P709, DOI 10.1093/geront/37.6.709; Rosenquist JN, 2011, MOL PSYCHIATR, V16, P273, DOI 10.1038/mp.2010.13; Smith JP, 2004, POPUL DEV REV, V30, P108; Subramanian SV, 2008, SOC SCI MED, V66, P873, DOI 10.1016/j.socscimed.2007.11.029; van Iersel MB, 2006, J AM GERIATR SOC, V54, P728, DOI 10.1111/j.1532-5415.2006.00668_14.x; Waite A, 2004, BRIT J CLIN PSYCHOL, V43, P313, DOI 10.1348/0144665031753005; WENGER GC, 1995, AGEING SOC, V15, P59, DOI 10.1017/S0144686X00002129; Wilson K, 2007, INT J GERIATR PSYCH, V22, P974, DOI 10.1002/gps.1773; Yang Y, 2007, J HEALTH SOC BEHAV, V48, P16, DOI 10.1177/002214650704800102; ZISOOK S, 1991, AM J PSYCHIAT, V148, P1346	53	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e41452	10.1371/journal.pone.0041452	http://dx.doi.org/10.1371/journal.pone.0041452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998CA	22952581	Green Published, gold, Green Submitted			2022-12-25	WOS:000308213600002
J	Costa, GMJ; Avelar, GF; Rezende-Neto, JV; Campos, PHA; Lacerda, SMSN; Andrade, BSC; Thome, RG; Hofmann, MC; Franca, LR				Costa, Guilherme M. J.; Avelar, Gleide F.; Rezende-Neto, Jose V.; Campos-Junior, Paulo Henrique A.; Lacerda, Samyra M. S. N.; Andrade, Bruno S. C.; Thome, Ralph Gruppi; Hofmann, Marie-Claude; Franca, Luiz R.			Spermatogonial Stem Cell Markers and Niche in Equids	PLOS ONE			English	Article							DAILY SPERM PRODUCTION; SEMINIFEROUS TUBULES; NEUROTROPHIC FACTOR; GERM-CELLS; ADULT; MOUSE; SPERMATOGENESIS; TESTIS; GDNF; EXPRESSION	Spermatogonial stem cells (SSCs) are the foundation of spermatogenesis and are located in a highly dynamic microenvironment called "niche" that influences all aspects of stem cell function, including homing, self-renewal and differentiation. Several studies have recently identified specific proteins that regulate the fate of SSCs. These studies also aimed at identifying surface markers that would facilitate the isolation of these cells in different vertebrate species. The present study is the first to investigate SSC physiology and niche in stallions and to offer a comparative evaluation of undifferentiated type A spermatogonia (Aund) markers (GFRA1, PLZF and CSF1R) in three different domestic equid species (stallions, donkeys, and mules). Aund were first characterized according to their morphology and expression of the GFRA1 receptor. Our findings strongly suggest that in stallions these cells were preferentially located in the areas facing the interstitium, particularly those nearby blood vessels. This distribution is similar to what has been observed in other vertebrate species. In addition, all three Aund markers were expressed in the equid species evaluated in this study. These markers have been well characterized in other mammalian species, which suggests that the molecular mechanisms that maintain the niche and Aund/SSCs physiology are conserved among mammals. We hope that our findings will help future studies needing isolation and cryopreservation of equids SSCs. In addition, our data will be very useful for studies that aim at preserving the germplasm of valuable animals, and involve germ cell transplantation or xenografts of equids testis fragments/germ cells suspensions.	[Costa, Guilherme M. J.; Avelar, Gleide F.; Rezende-Neto, Jose V.; Campos-Junior, Paulo Henrique A.; Lacerda, Samyra M. S. N.; Andrade, Bruno S. C.; Thome, Ralph Gruppi; Franca, Luiz R.] Univ Fed Minas Gerais, Lab Cellular Biol, Dept Morphol, Belo Horizonte, MG, Brazil; [Hofmann, Marie-Claude] Univ Texas MD Anderson Canc Ctr, Unit 1105, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA	Universidade Federal de Minas Gerais; University of Texas System; UTMD Anderson Cancer Center	Franca, LR (corresponding author), Univ Fed Minas Gerais, Lab Cellular Biol, Dept Morphol, Belo Horizonte, MG, Brazil.	lrfranca@icb.ufmg.br	Campos-Junior, Paulo HA/H-5751-2015; Mattos Jardim Costa, Guilherme/A-7369-2016; Lacerda, Samyra/AAG-8948-2021; Lacerda, Samyra/A-7756-2016; Thomé, Ralph G/M-7997-2018; Nassif, Samyra/AAR-5947-2020; DE FRANCA, LUIZ/AAA-6923-2021	Campos-Junior, Paulo HA/0000-0003-2400-2548; Mattos Jardim Costa, Guilherme/0000-0002-2907-7760; Lacerda, Samyra/0000-0003-4577-6243; Lacerda, Samyra/0000-0003-4577-6243; Hofmann, Marie-Claude/0000-0002-4899-8039	CNPq; FAPEMIG; Experimental Farm of Pedro Leopoldo - UFMG; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K02HD054607, R01HD044543] Funding Source: NIH RePORTER	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Experimental Farm of Pedro Leopoldo - UFMG; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by CNPq and FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Technical help from Mara Livia Santos as well as the support provided by the Experimental Farm of Pedro Leopoldo - UFMG, are highly appreciated.	Aeckerle N, 2012, MOL HUM REP IN PRESS; Albert S, 2012, CELLS TISSU IN PRESS; Auharek SA, 2010, J ANAT, V216, P577, DOI 10.1111/j.1469-7580.2010.01219.x; Avarbock MR, 1996, NAT MED, V2, P693, DOI 10.1038/nm0696-693; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; BERNDTSON WE, 1983, THERIOGENOLOGY, V20, P449, DOI 10.1016/0093-691X(83)90204-2; Borjigin U, 2010, REPROD FERT DEVELOP, V22, P733, DOI 10.1071/RD09237; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Caires K, 2010, J ENDOCRINOL, V205, P133, DOI 10.1677/JOE-09-0275; Campos PHA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095430; Chiarini-Garcia H, 2003, REPRODUCTION, V126, P669, DOI 10.1530/reprod/126.5.669; Chiarini-Garcia H, 2001, BIOL REPROD, V65, P1179, DOI 10.1095/biolreprod65.4.1179; Chiarini-Garcia H, 2009, ANIM REPROD SCI, V116, P139, DOI 10.1016/j.anireprosci.2008.12.019; Costa GMJ, 2008, THERIOGENOLOGY, V70, P1136, DOI 10.1016/j.theriogenology.2008.06.035; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; De Rooij DG, 2000, J ANDROL, V21, P776; De Rooij DG, 2009, MICROSC RES TECHNIQ, V72, P580, DOI 10.1002/jemt.20699; Dettin L, 2003, BIOL REPROD, V69, P1565, DOI 10.1095/biolreprod.103.016394; do Nascimento HF, 2009, INT J ANDROL, V32, P486, DOI 10.1111/j.1365-2605.2008.00884.x; Ehmcke J, 2006, REPRODUCTION, V132, P673, DOI 10.1530/rep.1.01081; Filipponi D, 2007, MOL CELL BIOL, V27, P6770, DOI 10.1128/MCB.00479-07; Franca LR, 1998, MALE REPROD MULTIDIS, V197, P219; Gassei K, 2010, J MED PRIMATOL, V39, P83, DOI 10.1111/j.1600-0684.2009.00397.x; Grasso M, 2012, REPRODUCTION, V143, P325, DOI 10.1530/REP-11-0385; Grisanti L, 2009, STEM CELLS, V27, P3043, DOI 10.1002/stem.206; Ha Tae-young, 2003, J Vet Sci, V4, P21; He ZP, 2012, METHODS MOL BIOL, V825, P45, DOI 10.1007/978-1-61779-436-0_4; Hermann BP, 2007, STEM CELLS, V25, P2330, DOI 10.1634/stemcells.2007-0143; Hermann BP, 2010, REPRODUCTION, V139, P479, DOI 10.1530/REP-09-0255; Hermann BP, 2009, HUM REPROD, V24, P1704, DOI 10.1093/humrep/dep073; Hess R. A., 2007, MOL MECH SPERMATOGEN, P1; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; Hofmann MC, 2005, DEV BIOL, V279, P114, DOI 10.1016/j.ydbio.2004.12.006; Honaramooz A, 2011, Vet Med Int, V2011, P915031, DOI 10.4061/2011/915031; Honaramooz A, 2011, VET MED INT, V4; HUCKINS C, 1971, ANAT REC, V169, P533, DOI 10.1002/ar.1091690306; HUCKINS C, 1978, ANAT REC, V192, P519, DOI 10.1002/ar.1091920406; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; JOHNSON L, 1987, J REPROD FERTIL, V81, P227, DOI 10.1530/jrf.0.0810227; JOHNSON L, 1985, BIOL REPROD, V32, P1181, DOI 10.1095/biolreprod32.5.1181; JOHNSON L, 1990, ANAT RECORD, V227, P167, DOI 10.1002/ar.1092270205; JOHNSON L, 1990, J REPROD FERTIL, V89, P689, DOI 10.1530/jrf.0.0890689; JOHNSON L, 1991, BIOL REPROD, V44, P284, DOI 10.1095/biolreprod44.2.284; Johnston DS, 2011, BIOL REPROD, V85, P763, DOI 10.1095/biolreprod.110.087676; Klisch K, 2011, REPRODUCTION, V142, P667, DOI 10.1530/REP-11-0007; Kokkinaki M, 2009, BIOL REPROD, V80, P707, DOI 10.1095/biolreprod.108.073809; Kolasa A, 2012, REPROD BIOL, V12, P5, DOI 10.1016/S1642-431X(12)60074-6; Kuijk EW, 2009, REPRODUCTION, V138, P721, DOI 10.1530/REP-09-0138; Maki CB, 2009, HUM REPROD, V24, P1480, DOI 10.1093/humrep/dep033; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Neves ES, 2002, BIOL REPROD, V67, P247, DOI 10.1095/biolreprod67.1.247; OAKBERG EF, 1971, ANAT REC, V169, P515, DOI 10.1002/ar.1091690305; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Oatley JM, 2009, DEVELOPMENT, V136, P1191, DOI 10.1242/dev.032243; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; Powell RH, 2012, REPROD FERT DEVELOP, V24, P221, DOI 10.1071/RDv24n1Ab219; Robertson K, 1997, TRENDS GENET, V13, P1, DOI 10.1016/S0168-9525(96)30113-3; Russell LD, 2002, BIOL REPROD, V66, P950, DOI 10.1095/biolreprod66.4.950; Silva RC, 2012, J ANDROL, V33, P264, DOI 10.2164/jandrol.110.012898; Simon L, 2007, EXP CELL RES, V313, P3090, DOI 10.1016/j.yexcr.2007.05.002; Simon L, 2009, STEM CELLS, V27, P1666, DOI 10.1002/stem.93; Spinnler K, 2010, HUM REPROD, V25, P2181, DOI 10.1093/humrep/deq170; SWIERSTRA EE, 1974, J REPROD FERTIL, V40, P113, DOI 10.1530/jrf.0.0400113; TEGELENBOSCH RAJ, 1993, MUTAT RES, V290, P193; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Verini-Supplizi A, 2000, RES VET SCI, V69, P113, DOI 10.1053/rvsc.2000.0398; von Schonfeldt V, 2004, CYTOGENET GENOME RES, V105, P235, DOI 10.1159/000078194; Worby CA, 1996, J BIOL CHEM, V271, P23619, DOI 10.1074/jbc.271.39.23619; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885	70	48	49	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44091	10.1371/journal.pone.0044091	http://dx.doi.org/10.1371/journal.pone.0044091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937157	Green Submitted, gold, Green Published			2022-12-25	WOS:000308213600077
J	McLain, AT; Meyer, TJ; Faulk, C; Herke, SW; Oldenburg, JM; Bourgeois, MG; Abshire, CF; Roos, C; Batzer, MA				McLain, Adam T.; Meyer, Thomas J.; Faulk, Christopher; Herke, Scott W.; Oldenburg, J. Michael; Bourgeois, Matthew G.; Abshire, Camille F.; Roos, Christian; Batzer, Mark A.			An Alu-Based Phylogeny of Lemurs (Infraorder: Lemuriformes)	PLOS ONE			English	Article							PRIMED REVERSE TRANSCRIPTION; EVOLUTIONARY HISTORY; PRIMATE PHYLOGENY; MOLECULAR SYSTEMATICS; MALAGASY PRIMATES; MADAGASCAR LEMURS; SINE INSERTIONS; SINGLE ORIGIN; DNA; EULEMUR	Lemurs (infraorder: Lemuriformes) are a radiation of strepsirrhine primates endemic to the island of Madagascar. As of 2012, 101 lemur species, divided among five families, have been described. Genetic and morphological evidence indicates all species are descended from a common ancestor that arrived in Madagascar similar to 55-60 million years ago (mya). Phylogenetic relationships in this species-rich infraorder have been the subject of debate. Here we use Alu elements, a family of primate-specific Short INterspersed Elements (SINEs), to construct a phylogeny of infraorder Lemuriformes. Alu elements are particularly useful SINEs for the purpose of phylogeny reconstruction because they are identical by descent and confounding events between loci are easily resolved by sequencing. The genome of the grey mouse lemur (Microcebus murinus) was computationally assayed for synapomorphic Alu elements. Those that were identified as Lemuriformes-specific were analyzed against other available primate genomes for orthologous sequence in which to design primers for PCR (polymerase chain reaction) verification. A primate phylogenetic panel of 24 species, including 22 lemur species from all five families, was examined for the presence/absence of 138 Alu elements via PCR to establish relationships among species. Of these, 111 were phylogenetically informative. A phylogenetic tree was generated based on the results of this analysis. We demonstrate strong support for the monophyly of Lemuriformes to the exclusion of other primates, with Daubentoniidae, the aye-aye, as the basal lineage within the infraorder. Our results also suggest Lepilemuridae as a sister lineage to Cheirogaleidae, and Indriidae as sister to Lemuridae. Among the Cheirogaleidae, we show strong support for Microcebus and Mirza as sister genera, with Cheirogaleus the sister lineage to both. Our results also support the monophyly of the Lemuridae. Within Lemuridae we place Lemur and Hapalemur together to the exclusion of Eulemur and Varecia, with Varecia the sister lineage to the other three genera.	[McLain, Adam T.; Meyer, Thomas J.; Faulk, Christopher; Herke, Scott W.; Oldenburg, J. Michael; Bourgeois, Matthew G.; Abshire, Camille F.; Batzer, Mark A.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Meyer, Thomas J.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Faulk, Christopher] Univ Michigan, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [Abshire, Camille F.] Louisiana State Univ, Hlth Sci Ctr, Dept Mol & Cellular Physiol, Shreveport, LA 71105 USA; [Roos, Christian] German Primate Ctr, Primates & Primate Genet Lab, Gene Bank, Gottingen, Germany	Louisiana State University System; Louisiana State University; Oregon Health & Science University; University of Michigan System; University of Michigan; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Deutsches Primatenzentrum (DPZ)	McLain, AT (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	mbatzer@lsu.edu		Faulk, Christopher/0000-0002-9749-9658	National Institutes of Health [R01 GM59290]; National Science Foundation [CNS-1126739]; Louisiana Board of Regents Governor's Biotechnology Initiative [GBI 2002-005]; Louisiana Board of Regents; Louisiana Biomedical Research Network (LBRN); National Center for Research Resources [P20RR016456]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Louisiana Board of Regents Governor's Biotechnology Initiative; Louisiana Board of Regents; Louisiana Biomedical Research Network (LBRN); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by National Institutes of Health R01 GM59290 (M. A. B.), National Science Foundation CNS-1126739 (M. A. B.), and Louisiana Board of Regents Governor's Biotechnology Initiative GBI 2002-005 (M. A. B.). A. T. McLain was supported in part by the Louisiana Board of Regents Fellowship. C. F. Abshire was supported in part by the Louisiana Biomedical Research Network (LBRN) with funding from the National Center for Research Resources (Grant Number P20RR016456) and by the Louisiana Board of Regents Support Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; BATZER MA, 1991, GENOMICS, V9, P481, DOI 10.1016/0888-7543(91)90414-A; BATZER MA, 1994, P NATL ACAD SCI USA, V91, P12288, DOI 10.1073/pnas.91.25.12288; Bochkov AV, 2011, ZOOL J LINN SOC-LOND, V162, P1, DOI 10.1111/j.1096-3642.2010.00666.x; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Churakov G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-376; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cost GJ, 2002, EMBO J, V21, P5899, DOI 10.1093/emboj/cdf592; Delpero M, 2001, ZOOL J LINN SOC-LOND, V133, P83, DOI 10.1111/j.1096-3642.2001.tb00624.x; Djlelati R, 1997, AM J PRIMATOL, V42, P235; EAGLEN RH, 1983, INT J PRIMATOL, V4, P249, DOI 10.1007/BF02735549; Eckhardt RB, 1970, AM J PHYS ANTHROPOL, V31, P85; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; GROVES CP, 1988, J HUM EVOL, V17, P513, DOI 10.1016/0047-2484(88)90040-1; Groves CP, 2001, PRIMATE TAXONOMY; Herke SW, 2007, GENE, V390, P39, DOI 10.1016/j.gene.2006.08.015; Horvath JE, 2008, GENOME RES, V18, P489, DOI 10.1101/gr.7265208; ISHAK B, 1988, AM J PRIMATOL, V15, P275, DOI 10.1002/ajp.1350150309; Karanth KP, 2005, P NATL ACAD SCI USA, V102, P5090, DOI 10.1073/pnas.0408354102; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Konkel MK, 2010, EVOL ANTHROPOL, V19, P236, DOI 10.1002/evan.20283; Kriegs JO, 2007, TRENDS GENET, V23, P158, DOI 10.1016/j.tig.2007.02.002; Lebrun R, 2010, J ANAT, V216, P368, DOI 10.1111/j.1469-7580.2009.01177.x; Li J, 2009, GENE, V448, P242, DOI 10.1016/j.gene.2009.05.013; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Liu GE, 2009, GENOME RES, V19, P876, DOI 10.1101/gr.083972.108; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; LUAN DD, 1995, MOL CELL BIOL, V15, P3882; Maddison WP, 2011, MESQUITE MODULAR SYS; Masters JC, 2006, FOLIA PRIMATOL, V77, P399, DOI 10.1159/000095388; Meyer TJ, 2012, MOL BIOL EV IN PRESS; Mittermeier RA, 2010, CONSERVATION INT TRO; Mittermeier R, 2008, INT J PRIMATOL, V29, P1607, DOI 10.1007/s10764-008-9317-y; MURATA S, 1993, P NATL ACAD SCI USA, V90, P6995, DOI 10.1073/pnas.90.15.6995; Okada N, 2004, METH MOL B, V260, P189, DOI 10.1385/1-59259-755-6:189; Orlando L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-121; Osterholz M, 2009, MOL PHYLOGENET EVOL, V50, P507, DOI 10.1016/j.ympev.2008.12.014; Pastorini J, 2000, MOL PHYLOGENET EVOL, V16, P418, DOI 10.1006/mpev.2000.0796; Pastorini J, 2003, P NATL ACAD SCI USA, V100, P5879, DOI 10.1073/pnas.1031673100; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Poux C, 2004, AM J PHYS ANTHROPOL, V124, P1, DOI 10.1002/ajpa.10322; RABARIVOLA C, 1991, PRIMATES, V32, P269, DOI 10.1007/BF02381186; Ray DA, 2005, MOL PHYLOGENET EVOL, V35, P117, DOI 10.1016/j.ympev.2004.10.023; Ray DA, 2006, SYSTEMATIC BIOL, V55, P928, DOI 10.1080/10635150600865419; Ray DA, 2007, MOL ECOL, V16, P19, DOI 10.1111/j.1365-294X.2006.03104.x; Roos C, 2004, P NATL ACAD SCI USA, V101, P10650, DOI 10.1073/pnas.0403852101; Roos C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-77; RUMPLER Y, 1985, FOLIA PRIMATOL, V44, P108, DOI 10.1159/000156202; Rumpler Y, 2004, EVOL ANTHROPOL, V13, P67, DOI 10.1002/evan.20010; Salem AH, 2003, P NATL ACAD SCI USA, V100, P12787, DOI 10.1073/pnas.2133766100; Sanger F, 1992, Biotechnology, V24, P104; Schmitz J, 2005, CYTOGENET GENOME RES, V108, P26, DOI 10.1159/000080799; Schmitz J, 2001, GENETICS, V157, P777; Shapiro LJ, 2005, AM J PHYS ANTHROPOL, V128, P823, DOI 10.1002/ajpa.20122; Shedlock AM, 2000, BIOESSAYS, V22, P148, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;148::AID-BIES6&gt;3.0.CO;2-Z; Shedlock AM, 2004, TRENDS ECOL EVOL, V19, P545, DOI 10.1016/j.tree.2004.08.002; SIMONS EL, 1988, CR ACAD SCI III-VIE, V307, P547; Smit A, 1996, REPEATMASKER OPEN 30; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; TATTERSALL I, 1991, ANTHROPOL PAP AM MUS, V69, P1; Tattersall I, 2007, LEMURS ECOLOGY ADAPT, P3; Tattersall I, 2007, EVOL ANTHROPOL, V16, P12, DOI 10.1002/evan.20126; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Waddell P J, 2001, Genome Inform, V12, P141; Wells N, 2003, NATURAL HIST MADAGAS, P16; Wyner Y, 2000, MOL PHYLOGENET EVOL, V15, P124, DOI 10.1006/mpev.1999.0723; Xing J, 2005, MOL PHYLOGENET EVOL, V37, P872, DOI 10.1016/j.ympev.2005.04.015; Yoder AD, 2004, MOL ECOL, V13, P757, DOI 10.1046/j.1365-294X.2004.02106.x; Yoder AD, 1997, EVOL ANTHROPOL, V6, P11, DOI 10.1002/(SICI)1520-6505(1997)6:1<11::AID-EVAN6>3.0.CO;2-Z; YODER AD, 1994, AM J PHYS ANTHROPOL, V94, P25, DOI 10.1002/ajpa.1330940104; Yoder AD, 1996, P NATL ACAD SCI USA, V93, P5122, DOI 10.1073/pnas.93.10.5122; Yoder Anne D., 1999, Lemur News, V4, P31	72	18	18	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44035	10.1371/journal.pone.0044035	http://dx.doi.org/10.1371/journal.pone.0044035			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937148	Green Published, Green Submitted, gold			2022-12-25	WOS:000308213600071
J	Guo, SC; Liu, ML; Godwin, AK				Guo, Shanchun; Liu, Mingli; Godwin, Andrew K.			Transcriptional Regulation of hTREX84 in Human Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; MESSENGER-RNA EXPORT; HUMAN BREAST-CANCER; SYNUCLEIN-GAMMA-GENE; DOMAIN PROTEIN P84N5; CHROMATIN IMMUNOPRECIPITATION; SACCHAROMYCES-CEREVISIAE; OVARIAN-CARCINOMA; AP-1 ACTIVITY; TREX COMPLEX	TREX (transcription/export) is a multiprotein complex that plays a key role in the transcriptional elongation and transport of mRNA from the nucleus to the cytoplasm. We previously reported the purification of the human TREX protein and found that expression of a member of this complex, p84N5 (referred to as hTREX84 or hHPR1), a RB binding protein, correlated with breast tumor size and metastasis. Here we examine the mechanisms of aberrant expression of hTREX84 in breast and ovarian cancer cells and evaluate its role in tumorigenesis. We show that ovarian tumor cells over-express hTREX84 4-fold and 10-fold compared to immortal, non-tumorigenic and primary ovarian surface epithelial cells, respectively. Reduction of hTREX84 levels by small interfering RNA result in inhibition of cellular proliferation and G(2/M) arrest. Even though we observed that hTREX84 expression was induced by treatment with a demethylation agent, 5-aza-2'-deoxycytidine (5-aza-dC), sodium bisulfite DNA sequencing and methylation specific PCR found no evidence of changes in DNA methylation in the CpG islands in the regulator region of hTREX84. We subsequently identify several transcriptional factors, including NF-kappa B binding sites in the hTREX84 gene promoter and demonstrate by chromatin immunoprecipation (ChIP) and site directed mutagenesis that RelA/p65 binds the NF-kB binding sites and induces hTREX84 expression. Finally, we show by immunohistochemistry (IHC) that RelA/p65 is abundantly expressed in malignant cells that aberrantly express hTREX84 indicating that RelA/p65 might play a pivotal role in regulating hTREX84 expression in cancer. Our results indicate that overexpression of hTREX84 is associated with cancer cell transformation, proliferation and may be regulated by RelA/p65.	[Guo, Shanchun; Godwin, Andrew K.] Fox Chase Canc Ctr, Div Med Sci, Philadelphia, PA 19111 USA; [Guo, Shanchun; Liu, Mingli] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA; [Godwin, Andrew K.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA	Fox Chase Cancer Center; Morehouse School of Medicine; University of Kansas; University of Kansas Medical Center	Guo, SC (corresponding author), Fox Chase Canc Ctr, Div Med Sci, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	sguo@msm.edu; AGodwin@kumc.edu			National Institutes of Health [R01 CA140323, 5U01CA113916]; Department of Defense Breast Cancer Research Program of the US Army Medical Research [DAMD17-03-1-0312]; Ovarian Cancer Research Fund; Kansas Bioscience Authority Eminent Scholar Program; Chancellors Distinguished Chair in Biomedical Sciences endowment; NATIONAL CANCER INSTITUTE [U54CA118638, U01CA113916, R01CA140323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program of the US Army Medical Research; Ovarian Cancer Research Fund; Kansas Bioscience Authority Eminent Scholar Program; Chancellors Distinguished Chair in Biomedical Sciences endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health, R01 CA140323 and 5U01CA113916, the Department of Defense Breast Cancer Research Program of the US Army Medical Research, DAMD17-03-1-0312, and the Ovarian Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the support of the Biosample Repository, Cell Imaging, DNA Sequencing, Flow Cytometry and Cell Sorting, and Histopathology facilities at FCCC. We would like to thank Dr. Paul Cairns for helpful advice regarding DNA methylation methods. The authors would also like to acknowledge support from the Kansas Bioscience Authority Eminent Scholar Program and the Chancellors Distinguished Chair in Biomedical Sciences endowment.	AUERSPERG N, 1994, LAB INVEST, V71, P510; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Biswas DK, 2000, P NATL ACAD SCI USA, V97, P8542, DOI 10.1073/pnas.97.15.8542; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Boyd KE, 1999, MOL CELL BIOL, V19, P8393; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; CHEN CC, 1995, AGENT ACTION SUPPL, V47, P135; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Daschner PJ, 1999, BREAST CANCER RES TR, V53, P229, DOI 10.1023/A:1006138803392; Dobrovic A, 1997, CANCER RES, V57, P3347; Doostzadeh-Cizeron J, 2000, J BIOL CHEM, V275, P25336, DOI 10.1074/jbc.M000793200; DURFEE T, 1994, J CELL BIOL, V127, P609, DOI 10.1083/jcb.127.3.609; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; Fischer T, 2002, EMBO J, V21, P5843, DOI 10.1093/emboj/cdf590; Garg A, 2002, LEUKEMIA, V16, P1053, DOI 10.1038/sj.leu.2402482; Gasparri F, 2004, FEBS LETT, V574, P13, DOI 10.1016/j.febslet.2004.07.074; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Gozuacik D, 2001, ONCOGENE, V20, P6233, DOI 10.1038/sj.onc.1204835; GRAFF JR, 1995, CANCER RES, V55, P5195; Guo S, 2003, P AM ASSOC CANC RES, P548; Guo SC, 2005, CANCER RES, V65, P3011, DOI 10.1158/0008-5472.CAN-04-3624; Gupta A, 2003, CANCER RES, V63, P664; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; HAAF T, 1995, PHARMACOL THERAPEUT, V65, P19, DOI 10.1016/0163-7258(94)00053-6; HAMILTON TC, 1983, CANCER RES, V43, P5379; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hurt E, 2004, P NATL ACAD SCI USA, V101, P1858, DOI 10.1073/pnas.0308663100; Jackson K, 2004, CANCER BIOL THER, V3, P1225, DOI 10.4161/cbt.3.12.1222; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jimeno S, 2002, EMBO J, V21, P3526, DOI 10.1093/emboj/cdf335; Johnston SRD, 1999, CLIN CANCER RES, V5, P251; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kwon Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018872; LANGDON SP, 1988, CANCER RES, V48, P6166; Li YP, 2005, MOL CELL BIOL, V25, P4023, DOI 10.1128/MCB.25.10.4023-4033.2005; Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002; LINARDOPOULOS S, 1990, ANTICANCER RES, V10, P1711; Liu HY, 2005, CANCER RES, V65, P7635, DOI 10.1158/0008-5472.CAN-05-1089; Magdinier F, 2001, P NATL ACAD SCI USA, V98, P4990, DOI 10.1073/pnas.101617298; Masuda S, 2005, GENE DEV, V19, P1512, DOI 10.1101/gad.1302205; MICHALOWSKY LA, 1989, MOL CELL BIOL, V9, P885, DOI 10.1128/MCB.9.3.885; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pakneshan P, 2004, J BIOL CHEM, V279, P31735, DOI 10.1074/jbc.M401669200; Paredes J, 2005, CLIN CANCER RES, V11, P5869, DOI 10.1158/1078-0432.CCR-05-0059; Piruat JI, 1998, EMBO J, V17, P4859, DOI 10.1093/emboj/17.16.4859; Reed R, 2005, CURR OPIN CELL BIOL, V17, P269, DOI 10.1016/j.ceb.2005.04.011; Rehwinkel J, 2004, NAT STRUCT MOL BIOL, V11, P558, DOI 10.1038/nsmb759; Rondon AG, 2003, J BIOL CHEM, V278, P39037, DOI 10.1074/jbc.M305718200; Sato N, 2004, ONCOGENE, V23, P1531, DOI 10.1038/sj.onc.1207269; SOULE HD, 1990, CANCER RES, V50, P6075; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; TAIT L, 1990, CANCER RES, V50, P6087; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Widschwendter M, 2002, ONCOGENE, V21, P5462, DOI 10.1038/sj.onc.1205606; Yang J, 2008, ANN CLIN LAB SCI, V38, P105; ZABEL U, 1993, EMBO J, V12, P201, DOI 10.1002/j.1460-2075.1993.tb05646.x	71	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43610	10.1371/journal.pone.0043610	http://dx.doi.org/10.1371/journal.pone.0043610			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952718	gold, Green Published, Green Submitted			2022-12-25	WOS:000308044800043
J	Lowe, CB; Haussler, D				Lowe, Craig B.; Haussler, David			29 Mammalian Genomes Reveal Novel Exaptations of Mobile Elements for Likely Regulatory Functions in the Human Genome	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; ULTRACONSERVED ELEMENTS; PARALLEL EVOLUTION; SUBSTITUTION RATES; BINDING SITES; NONCODING DNA; VERTEBRATE; ENHANCER; IDENTIFICATION; DATABASE	Recent research supports the view that changes in gene regulation, as opposed to changes in the genes themselves, play a significant role in morphological evolution. Gene regulation is largely dependent on transcription factor binding sites. Researchers are now able to use the available 29 mammalian genomes to measure selective constraint at the level of binding sites. This detailed map of constraint suggests that mammalian genomes co-opt fragments of mobile elements to act as gene regulatory sequence on a large scale. In the human genome we detect over 280,000 putative regulatory elements, totaling approximately 7 Mb of sequence, that originated as mobile element insertions. These putative regulatory regions are conserved non-exonic elements (CNEEs), which show considerable cross-species constraint and signatures of continued negative selection in humans, yet do not appear in a known mature transcript. These putative regulatory elements were co-opted from SINE, LINE, LTR and DNA transposon insertions. We demonstrate that at least 11%, and an estimated 20%, of gene regulatory sequence in the human genome showing cross-species conservation was co-opted from mobile elements. The location in the genome of CNEEs co-opted from mobile elements closely resembles that of CNEEs in general, except in the centers of the largest gene deserts where recognizable co-option events are relatively rare. We find that regions of certain mobile element insertions are more likely to be held under purifying selection than others. In particular, we show 6 examples where paralogous instances of an often co-opted mobile element region define a sequence motif that closely matches a transcription factor's binding profile.	[Lowe, Craig B.; Haussler, David] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Haussler, David] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz	Lowe, CB (corresponding author), Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA.	haussler@soe.ucsc.edu			Howard Hughes Medical Institute; National Institutes of Health [5U01 HG004695-03]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004695] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by the Howard Hughes Medical Institute and the National Institutes of Health (5U01 HG004695-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseyev MA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r117; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baertsch R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-466; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bi S, 1997, J BIOL CHEM, V272, P30583, DOI 10.1074/jbc.272.48.30583; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Bourque G, 2009, CURR OPIN GENET DEV, V19, P607, DOI 10.1016/j.gde.2009.10.013; BRITTEN RJ, 1971, Q REV BIOL, V46, P111, DOI 10.1086/406830; Britten RJ, 1997, GENE, V205, P177, DOI 10.1016/S0378-1119(97)00399-5; Brosius J, 1999, GENE, V238, P115, DOI 10.1016/S0378-1119(99)00227-9; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Chiaromonte F, 2003, COLD SPRING HARB SYM, V68, P245, DOI 10.1101/sqb.2003.68.245; Chung DJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002111; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; de la Calle-Mustienes E, 2005, GENOME RES; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Franchini LF, 2011, P NATL ACAD SCI USA, V108, P15270, DOI 10.1073/pnas.1104997108; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Giordano J, 2007, PLOS COMPUT BIOL, V3, P1321, DOI 10.1371/journal.pcbi.0030137; Glazko GV, 2003, TRENDS GENET, V19, P119, DOI 10.1016/S0168-9525(03)00016-7; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Haussler, 2004, P 8 ANN INT C RES CO, P177, DOI DOI 10.1145/974614.974638; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Imamura H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-89; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Jurka J, 1996, COMPUT CHEM, V20, P119, DOI 10.1016/S0097-8485(96)80013-1; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Karro JE, 2007, NUCLEIC ACIDS RES, V35, pD55, DOI 10.1093/nar/gkl851; Katzman S, 2007, SCIENCE, V317, P915, DOI 10.1126/science.1142430; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lenasi T, 2006, RNA, V12, P498, DOI 10.1261/rna.7261206; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Lowe CB, 2011, SCIENCE, V333, P1019, DOI 10.1126/science.1202702; Lowe CB, 2010, J HERED, V101, P437, DOI 10.1093/jhered/esq016; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; MCCLINTOCK B, 1956, COLD SPRING HARB SYM, V21, P197, DOI 10.1101/SQB.1956.021.01.017; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Meader S, 2010, GENOME RES, V20, P1335, DOI 10.1101/gr.108795.110; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Nishihara H, 2006, GENOME RES, V16, P864, DOI 10.1101/gr.5255506; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Parker SCJ, 2009, SCIENCE, V324, P389, DOI 10.1126/science.1169050; Polavarapu N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-226; Ponting CP, 2011, GENOME RES, V21, P1769, DOI 10.1101/gr.116814.110; Poulin F, 2005, GENOMICS, V85, P774, DOI 10.1016/j.ygeno.2005.03.003; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Rebeiz M, 2009, SCIENCE, V326, P1663, DOI 10.1126/science.1178357; Santangelo AM, 2007, PLOS GENET, V3, P1813, DOI 10.1371/journal.pgen.0030166; Sasaki T, 2008, P NATL ACAD SCI USA, V105, P4220, DOI 10.1073/pnas.0709398105; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Siepel A, 2004, MOL BIOL EVOL, V21, P468, DOI 10.1093/molbev/msh039; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Smith AM, 2008, GENOME RES, V18, P1422, DOI 10.1101/gr.077008.108; Smith NGC, 2004, GENOMICS, V84, P806, DOI 10.1016/j.ygeno.2004.07.012; SVED J, 1990, P NATL ACAD SCI USA, V87, P4692, DOI 10.1073/pnas.87.12.4692; Taher L, 2009, BIOINFORMATICS, V25, P578, DOI 10.1093/bioinformatics/btp043; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weber MJ, 2005, FEBS J, V272, P59, DOI 10.1111/j.1432-1033.2004.04389.x; Wilming LG, 2008, NUCLEIC ACIDS RES, V36, pD753, DOI 10.1093/nar/gkm987; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Zemojtel T, 2009, TRENDS GENET, V25, P63, DOI 10.1016/j.tig.2008.11.005; Zhu JC, 2007, PLOS COMPUT BIOL, V3, P2498, DOI 10.1371/journal.pcbi.0030247	84	55	60	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43128	10.1371/journal.pone.0043128	http://dx.doi.org/10.1371/journal.pone.0043128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952639	Green Published, gold, Green Submitted			2022-12-25	WOS:000308044800020
J	Pastorino, L; Pollio, A; Pellacani, G; Guarneri, C; Ghiorzo, P; Longo, C; Bruno, W; Giusti, F; Bassoli, S; Bianchi-Scarra, G; Ruini, C; Seidenari, S; Tomasi, A; Ponti, G				Pastorino, Lorenza; Pollio, Annamaria; Pellacani, Giovanni; Guarneri, Carmelo; Ghiorzo, Paola; Longo, Caterina; Bruno, William; Giusti, Francesca; Bassoli, Sara; Bianchi-Scarra, Giovanna; Ruini, Cristel; Seidenari, Stefania; Tomasi, Aldo; Ponti, Giovanni			Novel PTCH1 Mutations in Patients with Keratocystic Odontogenic Tumors Screened for Nevoid Basal Cell Carcinoma (NBCC) Syndrome	PLOS ONE			English	Article							PROTEINS; DEFECTS; GENE	Keratocystic odontogenic tumors (KCOTs) are cystic tumors that arise sporadically or associated with nevoid basal cell carcinoma syndrome (NBCCS). NBCCS is a rare autosomal dominantly inherited disease mainly characterized by multiple basal cell carcinomas, KCOTs of the jaws and a variety of other tumors. PTCH1 mutation can be found both in sporadic or NBCCS associated KCOTs. The aim of the current study was to assess whether a combined clinical and bio-molecular approach could be suitable for the detection of NBCCS among patients with a diagnosis of keratocystic odontogenic tumors (KCOTs). The authors collected keratocystic odontogenic tumors recorded in the database of the Pathology Department of the University of Modena and Reggio Emilia during the period 1991-2011. Through interviews and examinations, family pedigrees were drawn for all patients affected by these odontogenic lesions. We found out that 18 of the 70 patients with KCOTs and/or multiple basal cell carcinomas actually met the clinical criteria for the diagnosis of NBCCS. A wide inter- and intra-familial phenotypic variability was evident in the families. Ameloblastomas (AMLs) were reported in two probands that are also carriers of the PCTH1 germline mutations. Nine germline mutations in the PTCH1 gene, 5 of them novel, were evident in 14 tested probands. The clinical evaluation of the keratocystic odontogenic tumors can be used as screening for the detection of families at risk of NBCCS. Keratocystic odontogenic lesions are uncommon, and their discovery deserves the search for associated cutaneous basal cell carcinomas and other benign and malignant tumors related to NBCCS.	[Pastorino, Lorenza; Ghiorzo, Paola; Bruno, William; Bianchi-Scarra, Giovanna] Univ Genoa, Dept Internal Med & Med Specialties DiMI, Genoa, Italy; [Pollio, Annamaria] Univ Naples Federico II, Sch Med & Surg, Dept Odontostomatol & Maxillofacial Sci, Oral Med Unit, Naples, Italy; [Pellacani, Giovanni; Guarneri, Carmelo; Giusti, Francesca; Bassoli, Sara; Ruini, Cristel; Seidenari, Stefania] Univ Modena & Reggio Emilia, Div Dermatol, Dept Head & Neck Surg, Modena, Italy; [Longo, Caterina] Arcispedale Santa Maria Nuova, Dept Med 1, Dermatol Unit, Reggio Emilia, Italy; [Ghiorzo, Paola; Bianchi-Scarra, Giovanna] IRCCS AOU San Martino IST, Lab Genet Rare Hereditary Canc, Genoa, Italy; [Tomasi, Aldo; Ponti, Giovanni] Univ Modena & Reggio Emilia, Univ Hosp Modena & Reggio Emilia, Dept Clin & Diagnost Med & Publ Hlth, Modena, Italy	University of Genoa; University of Naples Federico II; Universita di Modena e Reggio Emilia; IRCCS Arcispedale S. Maria Nuova; University of Genoa; IRCCS AOU San Martino IST; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital	Pastorino, L (corresponding author), Univ Genoa, Dept Internal Med & Med Specialties DiMI, Genoa, Italy.	giovanni.ponti@unimore.it	pellacani, giovanni/E-8573-2011; Ruini, Cristel/ABB-6493-2020; Bruno, William/N-7477-2013; Ghiorzo, Paola/CAG-0673-2022; Pastorino, Lorenza/E-6084-2018; Ponti, Giovanni/A-5565-2012; Tomasi, Aldo/F-8513-2017; Longo, Caterina/A-8046-2012; Scarrà, Giovanna Bianchi/G-8933-2014	pellacani, giovanni/0000-0002-7222-2951; Ruini, Cristel/0000-0002-9860-1095; Bruno, William/0000-0002-0337-0168; Ghiorzo, Paola/0000-0002-3651-8173; Pastorino, Lorenza/0000-0002-2575-8331; Ponti, Giovanni/0000-0002-1971-7306; Tomasi, Aldo/0000-0002-1356-3430; Longo, Caterina/0000-0002-8218-3896; Scarrà, Giovanna Bianchi/0000-0002-6127-1192; Guarneri, Claudio/0000-0002-5892-0120				Altamura D, 2010, J AM ACAD DERMATOL, V62, P67, DOI 10.1016/j.jaad.2009.05.035; August M, 2000, J ORAL MAXIL SURG, V58, P935, DOI 10.1053/joms.2000.8731; Bale AE, 1997, CANCER INVEST, V15, P180, DOI 10.3109/07357909709115772; BROWNE RM, 1971, BRIT DENT J, V131, P249, DOI 10.1038/sj.bdj.4802732; Chow HT, 1998, ORAL SURG ORAL MED O, V86, P573; CROWLEY TE, 1992, J ORAL MAXIL SURG, V50, P22, DOI 10.1016/0278-2391(92)90187-5; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Endo M, 2012, AM J MED GENET A, V158A, P351, DOI 10.1002/ajmg.a.34421; Eslami B, 2008, ORAL SURG ORAL MED O, V105, pE10, DOI 10.1016/j.tripleo.2008.01.034; Evans DG, 2010, AM J MED GENET A, V152A, P327, DOI 10.1002/ajmg.a.33139; Go JW, 2011, ANN DERMATOL, V23, pS36, DOI 10.5021/ad.2011.23.S1.S36; GORLIN RJ, 1987, MEDICINE, V66, P98, DOI 10.1097/00005792-198703000-00002; Hardcastle Z, 1998, DEVELOPMENT, V125, P2803; Kakarantza-Angelopoulou E, 1990, J ORAL MAXILLOFAC SU, V48, P599; KAKARANTZAANGELOPOULOU E, 1990, J ORAL MAXIL SURG, V48, P593, DOI 10.1016/S0278-2391(10)80472-0; Kimonis VE, 1997, AM J MED GENET, V69, P299, DOI 10.1002/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.0.CO;2-M; Lam KY, 2000, LARYNGOSCOPE, V110, P1328, DOI 10.1097/00005537-200008000-00020; Levanat S, 1996, NAT GENET, V12, P85, DOI 10.1038/ng0196-85; LI TJ, 1994, J ORAL PATHOL MED, V23, P184, DOI 10.1111/j.1600-0714.1994.tb01110.x; Lo Muzio L, 1999, J AM DENT ASSOC, V130, P669; Lo Muzio L, 2011, EUR J HUM G IN PRESS; Lo Muziol L, 1999, J DENT RES, V78, P1345, DOI 10.1177/00220345990780070901; MATTHEWS JB, 1988, J PATHOL, V156, P283, DOI 10.1002/path.1711560403; Pastorino L, 2005, CHILD CARE HLTH DEV, V31, P351, DOI 10.1111/j.1365-2214.2005.00514.x; Philipsen HP, 2006, J ORAL PATHOL MED, V35, P525; Ponti G, 2012, CANC GENETI IN PRESS; Ponti G, 2012, ONCOLOGY LE IN PRESS; SHULER CF, 1987, ORAL SURG ORAL MED O, V64, P439, DOI 10.1016/0030-4220(87)90149-6; Sidransky D, 1996, NAT GENET, V14, P7, DOI 10.1038/ng0996-7; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Tom WL, 2011, AM J MED GENET A, V155A, P2098, DOI 10.1002/ajmg.a.34127; Wicking C, 1997, AM J MED GENET, V73, P304	32	18	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43827	10.1371/journal.pone.0043827	http://dx.doi.org/10.1371/journal.pone.0043827			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952776	Green Submitted, Green Published, gold			2022-12-25	WOS:000308044800062
J	De Pisapia, N; Sandrini, M; Braver, TS; Cattaneo, L				De Pisapia, Nicola; Sandrini, Marco; Braver, Todd S.; Cattaneo, Luigi			Integration in Working Memory: A Magnetic Stimulation Study on the Role of Left Anterior Prefrontal Cortex	PLOS ONE			English	Article							INVOLVEMENT; FACILITATION; INFORMATION; RETENTION; RETRIEVAL; LANGUAGE; ACCESS; MODEL; EYE	Integration is a fundamental working memory operation, requiring the insertion of information from one task into the execution of another concurrent task. Previous neuroimaging studies have suggested the involvement of left anterior prefrontal cortex (L-aPFC) in relation to working memory integration demands, increasing during presentation of information to be integrated (loading), throughout its maintenance during a secondary task, up to the integration step, and then decreasing afterward (unloading). Here we used short bursts of 5 Hz repetitive Transcranic Magnetic Stimulation (rTMS) to modulate L-aPFC activity and to assess its causal role in integration. During experimental blocks, rTMS was applied (N = 10) over L-aPFC or vertex (control site) at different time-points of a task involving integration of a preloaded digit into a sequence of arithmetical steps, and contrasted with a closely matched task without integration demand (segregation). When rTMS was applied during the loading phase, reaction times during secondary task were faster, without significant changes in error rates. RTMS instead worsened performance when applied during information unloading. In contrast, no effects were observed when rTMS was applied during the other phases of integration, or during the segregation condition. These results confirm the hypothesis that L-aPFC is causally and selectively involved in the integration of information in working memory. They additionally suggest that pre-integration loading and post-integration unloading of information involving this area may be active and resource-consuming processes.	[De Pisapia, Nicola; Sandrini, Marco; Cattaneo, Luigi] Univ Trento, CIMeC Ctr Mind Brain Sci, Rovereto, TN, Italy; [De Pisapia, Nicola] Univ Trento, DiSCoF Dept Cognit Sci & Educ, Rovereto, TN, Italy; [Sandrini, Marco] Uniformed Serv Univ Hlth Sci, Henry M Jackson Fdn, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Sandrini, Marco] NINDS, Human Cort Physiol & Stroke Neuro Rehabil Sect, NIH, Bethesda, MD USA; [Braver, Todd S.] Washington Univ, Dept Psychol, Cognit Control & Psychopathol CCP Lab, St Louis, MO 63130 USA	University of Trento; University of Trento; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Washington University (WUSTL)	De Pisapia, N (corresponding author), Univ Trento, CIMeC Ctr Mind Brain Sci, Rovereto, TN, Italy.	nicola.depisapia@unitn.it	De Pisapia, Nicola/AHE-1410-2022; Sandrini, Marco/J-2276-2014	Sandrini, Marco/0000-0002-1664-5722; Braver, Todd/0000-0002-2631-3393; Cattaneo, Luigi/0000-0001-8905-7529; De Pisapia, Nicola/0000-0002-1089-8841	Societa Scienze Mente Cervello (SMC)/Fondazione Cassa di Risparmio di Trento e Rovereto; Provincia Autonoma di Trento	Societa Scienze Mente Cervello (SMC)/Fondazione Cassa di Risparmio di Trento e Rovereto; Provincia Autonoma di Trento(Autonomous Province of Trento)	Study supported by the Societa Scienze Mente Cervello (SMC)/Fondazione Cassa di Risparmio di Trento e Rovereto and by the Provincia Autonoma di Trento. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JR, 1996, COGNITIVE PSYCHOL, V30, P221, DOI 10.1006/cogp.1996.0007; Aramideh M, 2002, MUSCLE NERVE, V26, P14, DOI 10.1002/mus.10120; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Bour LJ, 2000, J NEUROPHYSIOL, V83, P166, DOI 10.1152/jn.2000.83.1.166; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; Bunge SA, 2005, CEREB CORTEX, V15, P239, DOI 10.1093/cercor/bhh126; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Cattaneo L, 2005, CLIN NEUROPHYSIOL, V116, P2348, DOI 10.1016/j.clinph.2005.06.018; Christoff K, 2001, NEUROIMAGE, V14, P1136, DOI 10.1006/nimg.2001.0922; Cohen J, 2002, CURR OPIN NEUROBIOL, V12, P223, DOI 10.1016/S0959-4388(02)00314-8; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; De Pisapia N, 2008, NEUROREPORT, V19, P15, DOI 10.1097/WNR.0b013e3282f31530; De Pisapia N, 2007, CEREB CORTEX, V17, P993, DOI 10.1093/cercor/bhl010; Edin F, 2009, P NATL ACAD SCI USA, V106, P6802, DOI 10.1073/pnas.0901894106; Fangmeier T, 2006, J COGNITIVE NEUROSCI, V18, P320, DOI 10.1162/jocn.2006.18.3.320; Fedorenko E, 2007, J MEM LANG, V56, P246, DOI 10.1016/j.jml.2006.06.007; Grosbras MH, 2003, EUR J NEUROSCI, V18, P3121, DOI 10.1111/j.1460-9568.2003.03055.x; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Kroger JK, 2002, CEREB CORTEX, V12, P477, DOI 10.1093/cercor/12.5.477; Luber B, 2007, BRAIN RES, V1128, P120, DOI 10.1016/j.brainres.2006.10.011; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Monti MM, 2009, P NATL ACAD SCI USA, V106, P12554, DOI 10.1073/pnas.0902422106; Mottaghy FM, 2006, NEUROSCIENCE, V139, P85, DOI 10.1016/j.neuroscience.2005.05.037; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; Oberauer K, 2001, MEM COGNITION, V29, P18, DOI 10.3758/BF03195737; Oliveri M, 2001, CEREB CORTEX, V11, P606, DOI 10.1093/cercor/11.7.606; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Postle BR, 2006, J COGNITIVE NEUROSCI, V18, P1712, DOI 10.1162/jocn.2006.18.10.1712; Postle BR, 2010, CORTEX, V46, P121, DOI 10.1016/j.cortex.2008.12.008; Prabhakaran V, 2000, NAT NEUROSCI, V3, P85, DOI 10.1038/71156; Pulvermuller F, 2005, EUR J NEUROSCI, V21, P793, DOI 10.1111/j.1460-9568.2005.03900.x; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Reynolds JR, 2006, CEREB CORTEX, V16, P519, DOI 10.1093/cercor/bhi131; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Sandrini M, 2011, NEUROSCI BIOBEHAV R, V35, P516, DOI 10.1016/j.neubiorev.2010.06.005; Silvanto J, 2008, TRENDS COGN SCI, V12, P447, DOI 10.1016/j.tics.2008.09.004; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Stoeckel C, 2009, CORTEX, V45, P1091, DOI 10.1016/j.cortex.2008.12.004; Topper R, 1998, EXP BRAIN RES, V121, P371, DOI 10.1007/s002210050471; Walsh V, 1999, NEUROPSYCHOLOGIA, V37, P125	43	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43731	10.1371/journal.pone.0043731	http://dx.doi.org/10.1371/journal.pone.0043731			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937085	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500087
J	Gupta, S; Saxena, M; Saini, N; Mahmooduzzafar; Kumar, R; Kumar, A				Gupta, Saurabh; Saxena, Mritunjay; Saini, Neeru; Mahmooduzzafar; Kumar, Rita; Kumar, Anil			An Effective Strategy for a Whole-Cell Biosensor Based on Putative Effector Interaction Site of the Regulatory DmpR Protein	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATOR; PHENOLS; BINDING; BIODEGRADATION; TYROSINASE; STRAIN; MODEL	Introduction and Rationale: The detection of bioavailable phenol is a very important issue in environmental and human hazard assessment. Despite modest developments recently, there is a stern need for development of novel biosensors with high sensitivity for priority phenol pollutants. DmpR (Dimethyl phenol regulatory protein), an NtrC-like regulatory protein for the phenol degradation of Pseudomonas sp. strain CF600, represents an attractive biosensor regimen. Thus, we sought to design a novel biosensor by modifying the phenol detection capacity of DmpR by using mutagenic PCR. Methods: Binding sites of 'A' domain of DmpR were predicted by LIGSITE, and molecular docking was performed by using GOLD to identify the regions where phenol may interact with DmpR. Total five point mutations, one single at position 42 (Phe-to-Leu), two double at 140 (Asp-to-Glu) and 143 (Gln-to-Leu), and two double at L113M (Leu-to-Met) and D116A (Asp-to- Ala) were created in DmpR by site-directed mutagenesis to construct the reporter plasmids pRLuc42R, pRLuc140p143R, and pRLuc113p116R, respectively. Luciferase assays were performed to measure the activity of luc gene in the presence of phenol and its derivatives, while RT-PCR was used to check the expression of luc gene in the presence of phenol. Results: Only pRLuc42R and pRLuc113p116R showed positive responses to phenolic effectors. The lowest detectable concentration of phenol was 0.5 mu M (0.047 mg/L), 0.1 mu M for 2, 4-dimethylphenol and 2-nitrophenol, 10 mu M for 2, 4, 6-trichlorophenol and 2-chlorophenol, 100 mu M for 2, 4-dichlorophenol, 0.01 mu M for 4-nitrophenol, and 1 mu M for o-cresol. These concentrations were measured by modified luciferase assay within 3 hrs compared to 6-7 hrs in previous studies. Importantly, increased expression of luciferase gene of pRLuc42R was observed by RT-PCR. Conclusions: The present study offers an effective strategy to design a quick and sensitive biosensor for phenol by constructing recombinant bacteria having DmpR gene.	[Gupta, Saurabh; Saxena, Mritunjay; Saini, Neeru; Kumar, Rita] Inst Genom & Integrat Biol, Delhi, India; [Kumar, Anil] Natl Inst Immunol, New Delhi 110067, India; [Gupta, Saurabh; Mahmooduzzafar] Jamia Hamdard, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Jamia Hamdard University	Gupta, S (corresponding author), Inst Genom & Integrat Biol, Mall Rd, Delhi, India.	rita@igib.res.in; anilk@nii.ac.in	Kumar, Anil/L-3294-2016; Kumar, Anil/AAT-4547-2020	Kumar, Anil/0000-0002-8785-6033; Kumar, Anil/0000-0002-8785-6033	Council for Scientific and Industrial Research (CSIR), India	Council for Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	We would like to thank the Council for Scientific and Industrial Research (CSIR), India for providing necessary facilities and funding to accomplish this work.	Abdullah J, 2006, TALANTA, V70, P527, DOI 10.1016/j.talanta.2005.12.061; Altschmied J, 1997, BIOTECHNIQUES, V23, P436, DOI 10.2144/97233bm19; Association AWW, 1998, STAND METH EST WAT W; Cabrera C, J STRUCTURAL BIOL, P371; Ceto X, 2012, ANALYST, V137, P349, DOI 10.1039/c1an15456g; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Devos D, 2002, ENVIRON MICROBIOL, V4, P29, DOI 10.1046/j.1462-2920.2002.00265.x; Escher BI, 1997, ENVIRON TOXICOL CHEM, V16, P405, DOI 10.1002/etc.5620160303; Escher BI, 1996, ENVIRON SCI TECHNOL, V30, P3071, DOI 10.1021/es960153f; Hakkila K, 2002, ANAL BIOCHEM, V301, P235, DOI 10.1006/abio.2001.5517; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; Herchi W, 2011, FOOD CHEM, V129, P437, DOI 10.1016/j.foodchem.2011.04.096; Jiang HL, 2002, LETT APPL MICROBIOL, V35, P439, DOI 10.1046/j.1472-765X.2002.01217.x; Johansson LUM, 2008, MOL MICROBIOL, V70, P709, DOI 10.1111/j.1365-2958.2008.06440.x; Kelsey JW, 1997, ENVIRON SCI TECHNOL, V31, P214, DOI 10.1021/es960354j; Kohler S, 2000, FRESEN J ANAL CHEM, V366, P769, DOI 10.1007/s002160051571; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; Leedjarv A, 2006, CHEMOSPHERE, V64, P1910, DOI 10.1016/j.chemosphere.2006.01.026; Lei Y, 2006, ANAL CHIM ACTA, V568, P200, DOI 10.1016/j.aca.2005.11.065; Liu C, 2011, TALANTA, V84, P766, DOI 10.1016/j.talanta.2011.02.006; Liu XM, 2010, SENSORS-BASEL, V10, P1377, DOI 10.3390/s100201377; Michalowicz J, 2007, POL J ENVIRON STUD, V16, P347; Mulchandani B, 1998, ENZYME MICROBIAL BIO; O'Neill E, 1998, MOL MICROBIOL, V28, P131, DOI 10.1046/j.1365-2958.1998.00780.x; Park SM, 2003, J BIOTECHNOL, V103, P227, DOI 10.1016/S0168-1656(03)00122-6; Peng ZX, 2010, BIOTECHNOL LETT, V32, P1265, DOI 10.1007/s10529-010-0317-6; Sambrook J, 2001, MOL CLONING LAB MANU; Sarand I, 2001, APPL ENVIRON MICROB, V67, P162, DOI 10.1128/AEM.67.1.162-171.2001; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; SHINGLER V, 1989, J GEN MICROBIOL, V135, P1083; SHINGLER V, 1994, J BACTERIOL, V176, P1555, DOI 10.1128/jb.176.6.1555-1560.1994; SHINGLER V, 1993, J BACTERIOL, V175, P1596, DOI 10.1128/JB.175.6.1596-1604.1993; SHINGLER V, 1995, MOL MICROBIOL, V17, P505, DOI 10.1111/j.1365-2958.1995.mmi_17030505.x; Silva LMC, 2011, ENVIRON TECHNOL, V32, P493, DOI 10.1080/09593330.2010.504234; Suresh Panneer Selvam, 2010, In Silico Biology, V10, P223, DOI 10.3233/ISB-2010-0434; Vogne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016539; Willardson BM, 1998, APPL ENVIRON MICROB, V64, P1006; Wise AA, 2000, APPL ENVIRON MICROB, V66, P163, DOI 10.1128/AEM.66.1.163-169.2000; Wise AA, 2007, USA Patent, Patent No. [7,303,894, 7303894]; Yagi K, 2007, APPL MICROBIOL BIOT, V73, P1251, DOI 10.1007/s00253-006-0718-6; Yildiz HB, 2007, MICROCHIM ACTA, V159, P27, DOI 10.1007/s00604-007-0768-1	43	25	25	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43527	10.1371/journal.pone.0043527	http://dx.doi.org/10.1371/journal.pone.0043527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937060	Green Submitted, gold, Green Published			2022-12-25	WOS:000308225500061
J	Huang, KP; Liu, WH; Lan, T; Xie, X; Peng, J; Huang, J; Wang, SG; Shen, XY; Liu, PQ; Huang, HQ				Huang, Kaipeng; Liu, Weihua; Lan, Tian; Xie, Xi; Peng, Jing; Huang, Juan; Wang, Shaogui; Shen, Xiaoyan; Liu, Peiqing; Huang, Heqing			Berberine Reduces Fibronectin Expression by Suppressing the S1P-S1P2 Receptor Pathway in Experimental Diabetic Nephropathy Models	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; MESANGIAL CELLS; SPHINGOSINE 1-PHOSPHATE; PATHOGENETIC MECHANISMS; MATRIX ACCUMULATION; KINASE; SPHINGOSINE-1-PHOSPHATE; MICE; SPHINGOLIPIDS; SURVIVAL	The accumulation of glomerular extracellular matrix (ECM) is one of the critical pathological characteristics of diabetic renal fibrosis. Fibronectin (FN) is an important constituent of ECM. Our previous studies indicate that the activation of the sphingosine kinase 1 (SphK1)-sphingosine 1- phosphate (S1P) signaling pathway plays a key regulatory role in FN production in glomerular mesangial cells (GMCs) under diabetic condition. Among the five S1P receptors, the activation of S1P2 receptor is the most abundant. Berberine (BBR) treatment also effectively inhibits SphK1 activity and S1P production in the kidneys of diabetic models, thus improving renal injury. Based on these data, we further explored whether BBR could prevent FN production in GMCs under diabetic condition via the S1P2 receptor. Here, we showed that BBR significantly down-regulated the expression of S1P2 receptor in diabetic rat kidneys and GMCs exposed to high glucose (HG) and simultaneously inhibited S1P2 receptor-mediated FN overproduction. Further, BBR also obviously suppressed the activation of NF-kappa B induced by HG, which was accompanied by reduced S1P2 receptor and FN expression. Taken together, our findings suggest that BBR reduces FN expression by acting on the S1P2 receptor in the mesangium under diabetic condition. The role of BBR in S1P2 receptor expression regulation could closely associate with its inhibitory effect on NF-kappa B activation.	[Huang, Kaipeng; Xie, Xi; Peng, Jing; Huang, Juan; Wang, Shaogui; Shen, Xiaoyan; Liu, Peiqing; Huang, Heqing] Sun Yat Sen Univ, Lab Pharmacol & Toxicol, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Weihua] GuangZhou Med Univ, Guangzhou Inst Cardiovasc Dis, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China; [Lan, Tian] Guangdong Pharmaceut Univ, Vasc Biol Res Inst, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou Medical University; Guangdong Pharmaceutical University	Huang, KP (corresponding author), Sun Yat Sen Univ, Lab Pharmacol & Toxicol, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China.	huangheq@mail.sysu.edu.cn			National Natural Science Foundation of China [81170676]; critical Project of Guangdong Science and Technology, People's Republic of China [2011A080502004]; Guangzhou Science and Technology Project [10A32060084]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); critical Project of Guangdong Science and Technology, People's Republic of China; Guangzhou Science and Technology Project	This work was supported by research grants from the National Natural Science Foundation of China (No. 81170676), the critical Project of Guangdong Science and Technology, People's Republic of China (No. 2011A080502004) and Guangzhou Science and Technology Project (No. 10A32060084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarthi JJ, 2011, J DENT RES, V90, P841, DOI 10.1177/0022034510389178; Alvarez SE, 2007, TRENDS ENDOCRIN MET, V18, P300, DOI 10.1016/j.tem.2007.07.005; Amasheh M, 2010, J CELL SCI, V123, P4145, DOI 10.1242/jcs.070896; English D, 2001, CARDIOVASC RES, V49, P588, DOI 10.1016/S0008-6363(00)00230-3; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Giunti S, 2006, Minerva Med, V97, P241; Hanafusa N, 2002, NEPHROL DIAL TRANSPL, V17, P580, DOI 10.1093/ndt/17.4.580; Imasawa T, 2010, EXP TOXICOL PATHOL, V62, P53, DOI 10.1016/j.etp.2009.02.068; Jia HJ, 2009, REGUL PEPTIDES, V154, P69, DOI 10.1016/j.regpep.2008.12.004; Jiang Q, 2011, MOL CELL ENDOCRINOL, V331, P34, DOI 10.1016/j.mce.2010.07.023; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Katsuma S, 2005, FEBS LETT, V579, P2576, DOI 10.1016/j.febslet.2005.03.073; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Lan T, 2011, MOL ENDOCRINOL, V25, P2094, DOI 10.1210/me.2011-0095; Lan TA, 2010, ARCH BIOCHEM BIOPHYS, V502, P112, DOI 10.1016/j.abb.2010.07.012; Liu WH, 2008, ARCH BIOCHEM BIOPHYS, V475, P128, DOI 10.1016/j.abb.2008.04.022; Liu WH, 2012, EXP CELL RES, V318, P936, DOI 10.1016/j.yexcr.2012.02.020; Liu WH, 2010, EUR J PHARMACOL, V638, P150, DOI 10.1016/j.ejphar.2010.04.033; Liu WH, 2009, MOL CELL BIOCHEM, V325, P99, DOI 10.1007/s11010-008-0024-y; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Olivera A, 2003, J BIOL CHEM, V278, P46452, DOI 10.1074/jbc.M308749200; Randriamboavonjy V, 2009, BASIC RES CARDIOL, V104, P333, DOI 10.1007/s00395-008-0769-1; Schena FP, 2005, J AM SOC NEPHROL, V16, pS30, DOI 10.1681/ASN.2004110970; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Wahab N, 2007, BIOCHEM J, V406, P131, DOI 10.1042/BJ20061817; Wang F, 2010, J CLIN INVEST, V120, P3979, DOI 10.1172/JCI42315; Whetzel AM, 2006, CIRC RES, V99, P731, DOI 10.1161/01.RES.0000244088.33375.52; Xia XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016556; Yatomi Y, 2006, CURR PHARM DESIGN, V12, P575, DOI 10.2174/138161206775474404	31	49	54	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43874	10.1371/journal.pone.0043874	http://dx.doi.org/10.1371/journal.pone.0043874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937115	gold, Green Submitted, Green Published			2022-12-25	WOS:000308225500117
J	Le, TMV; Ngo, NQM; Thuong, TC; Khuong, HD; Tran, VTN; Thompson, C; Campbell, JI; de Jong, M; Farrar, JJ; Schultsz, C; van Doorn, HR; Baker, S				Le Thi Minh Vien; Ngo Ngoc Quang Minh; Tang Chi Thuong; Huynh Duy Khuong; Tran Vu Thieu Nga; Thompson, Corinne; Campbell, James I.; de Jong, Menno; Farrar, Jeremy J.; Schultsz, Constance; van Doorn, H. Rogier; Baker, Stephen			The Co-Selection of Fluoroquinolone Resistance Genes in the Gut Flora of Vietnamese Children	PLOS ONE			English	Article							MEDIATED QUINOLONE RESISTANCE; COMPLETE NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; BETA-LACTAMASE; STREPTOCOCCUS-PNEUMONIAE; KLEBSIELLA-PNEUMONIAE; DETERMINANTS QNR; RAPID DETECTION; HIGH PREVALENCE; ANTIBIOTIC USE	Antimicrobial consumption is one of the major contributing factors facilitating the development and maintenance of bacteria exhibiting antimicrobial resistance. Plasmid-mediated quinolone resistance (PMQR) genes, such as the qnr family, can be horizontally transferred and contribute to reduced susceptibility to fluoroquinolones. We performed an observational study, investigating the copy number of PMQR after antimicrobial therapy. We enrolled 300 children resident in Ho Chi Minh City receiving antimicrobial therapy for acute respiratory tract infections (ARIs). Rectal swabs were taken on enrollment and seven days subsequently, counts for Enterobacteriaceae were performed and qnrA, qnrB and qnrS were quantified by using real-time PCR on metagenomic stool DNA. On enrollment, we found no association between age, gender or location of the participants and the prevalence of qnrA, qnrB or qnrS. Yet, all three loci demonstrated a proportional increase in the number of samples testing positive between day 0 and day 7. Furthermore, qnrB demonstrated ;a significant increase in copy number between paired samples (p<0.001; Wilcoxon rank-sum), associated with non-fluoroquinolone combination antimicrobial therapy. To our knowledge, this is the first study describing an association between the use of non-fluoroquinolone antimicrobials and the increasing relative prevalence and quantity of qnr genes. Our work outlines a potential mechanism for the selection and maintenance of PMQR genes and predicts a strong effect of co-selection of these resistance determinants through the use of unrelated and potentially unnecessary antimicrobial regimes.	[Le Thi Minh Vien; Ngo Ngoc Quang Minh; Huynh Duy Khuong; Tran Vu Thieu Nga; Thompson, Corinne; Campbell, James I.; de Jong, Menno; Farrar, Jeremy J.; Schultsz, Constance; van Doorn, H. Rogier; Baker, Stephen] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam; [Farrar, Jeremy J.; van Doorn, H. Rogier; Baker, Stephen] Univ Oxford, Ctr Trop Dis, Oxford, England; [Ngo Ngoc Quang Minh; Tang Chi Thuong] Childrens Hosp, Ho Chi Minh City, Vietnam; [de Jong, Menno; Schultsz, Constance] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Schultsz, Constance] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands	University of Oxford; University of Oxford; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Le, TMV (corresponding author), Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam.	sbaker@oucru.org	van Doorn, H. Rogier/H-3080-2019; Farrar, Jeremy J./HGA-7610-2022	van Doorn, H. Rogier/0000-0002-9807-1821; Farrar, Jeremy/0000-0002-2700-623X	Wellcome Trust of Great Britain; OAK Foundation through Oxford University, United Kingdom	Wellcome Trust of Great Britain(Wellcome Trust); OAK Foundation through Oxford University, United Kingdom	This work was supported by The Wellcome Trust of Great Britain. Stephen Baker is funded by an OAK Foundation through Oxford University, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alali WQ, 2009, FOODBORNE PATHOG DIS, V6, P917, DOI 10.1089/fpd.2009.0271; Bailey JK, 2010, J MED MICROBIOL, V59, P1331, DOI 10.1099/jmm.0.022475-0; Bell JM, 2010, ANTIMICROB AGENTS CH, V54, P1378, DOI 10.1128/AAC.01476-09; Bergman M, 2009, ANTIMICROB AGENTS CH, V53, P912, DOI 10.1128/AAC.00856-08; BLOOD RM, 1995, INT J FOOD MICROBIOL, V26, P93, DOI 10.1016/0168-1605(94)00040-D; Brink AJ, 2004, SAMJ S AFR MED J, V94, P475; Cattoir V, 2007, J ANTIMICROB CHEMOTH, V59, P751, DOI 10.1093/jac/dkl547; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Chmelnitsky I, 2008, ANTIMICROB AGENTS CH, V52, P2962, DOI 10.1128/AAC.01341-07; CLARKE JS, 1974, WESTERN J MED, V121, P390; Garcia-Fulgueiras V, 2011, J ANTIMICROB CHEMOTH, V66, P1725, DOI 10.1093/jac/dkr222; Garnier F, 2006, ANTIMICROB AGENTS CH, V50, P3200, DOI 10.1128/AAC.00293-06; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Guillard T, 2011, DIAGN MICR INFEC DIS, V70, P253, DOI 10.1016/j.diagmicrobio.2011.01.004; Guillard T, 2010, J CLIN MICROBIOL, V48, P286, DOI 10.1128/JCM.01498-09; Hidalgo-Grass C, 2010, ANTIMICROB AGENTS CH, V54, P3509, DOI 10.1128/AAC.00485-10; Hu FP, 2008, ACTA PHARMACOL SIN, V29, P320, DOI 10.1111/j.1745-7254.2008.00757.x; Huang SY, 2009, FOODBORNE PATHOG DIS, V6, P1203, DOI 10.1089/fpd.2009.0348; Jacoby G, 2008, ANTIMICROB AGENTS CH, V52, P2297, DOI 10.1128/AAC.00147-08; Jiang Y, 2008, J ANTIMICROB CHEMOTH, V61, P1003, DOI 10.1093/jac/dkn063; Kehrenberg C, 2007, J ANTIMICROB CHEMOTH, V60, P903, DOI 10.1093/jac/dkm283; Kirjavainen PV, 1999, ANN MED, V31, P288, DOI 10.3109/07853899908995892; Lautenbach E, 2005, CLIN INFECT DIS, V41, P923, DOI 10.1086/432940; Le TMV, 2011, ANTIMICROB AGENTS CH, V55, P1798, DOI 10.1128/AAC.01200-10; Le TMV, 2009, J MED MICROBIOL, V58, P1585, DOI 10.1099/jmm.0.010033-0; Levy J, 2000, AM J GASTROENTEROL, V95, pS8, DOI 10.1016/S0002-9270(99)00808-4; Luo YP, 2011, INT J ANTIMICROB AG, V37, P352, DOI 10.1016/j.ijantimicag.2010.12.018; Ma JY, 2009, ANTIMICROB AGENTS CH, V53, P519, DOI 10.1128/AAC.00886-08; Madigan M.T., 2006, BROCK BIOL MICROORGA; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; MOORE WEC, 1974, APPL MICROBIOL, V27, P961, DOI 10.1128/AEM.27.5.961-979.1974; Nguyen TKN, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000702; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; Poirel L, 2006, CLIN MICROBIOL INFEC, V12, P1021, DOI 10.1111/j.1469-0691.2006.01531.x; Poirel L, 2007, ANTIMICROB AGENTS CH, V51, P631, DOI 10.1128/AAC.01082-06; Pomba C, 2009, ANTIMICROB AGENTS CH, V53, P327, DOI 10.1128/AAC.00896-08; Quagliarello AB, 2003, J HEALTH POPUL NUTR, V21, P316; Rasmussen R, 2000, RAPID CYCLE REAL TIM; Robicsek A, 2005, ANTIMICROB AGENTS CH, V49, P3001, DOI 10.1128/AAC.49.7.3001-3003.2005; Saito R, 2007, INT J ANTIMICROB AG, V29, P600, DOI 10.1016/j.ijantimicag.2006.11.016; Schultsz C, 2007, T ROY SOC TROP MED H, V101, P484, DOI 10.1016/j.trstmh.2006.08.010; Shen P, 2008, J ANTIMICROB CHEMOTH, V62, P1252, DOI 10.1093/jac/dkn397; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Travers K, 2002, CLIN INFECT DIS, V34, pS131, DOI 10.1086/340251; van der Veen EL, 2009, J ANTIMICROB CHEMOTH, V63, P1011, DOI 10.1093/jac/dkp050; van Doornum GJJ, 2003, J CLIN MICROBIOL, V41, P576, DOI 10.1128/JCM.41.2.576-580.2003; Whichard JM, 2007, EMERG INFECT DIS, V13, P1681, DOI 10.3201/eid1311.061438; WHO, 2002, AC RESP INF; Yue L, 2008, VET MICROBIOL, V132, P414, DOI 10.1016/j.vetmic.2008.05.009; Zhang R, 2012, MICROBES ENVIRON, V27, P158, DOI 10.1264/jsme2.ME11308	50	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42919	10.1371/journal.pone.0042919	http://dx.doi.org/10.1371/journal.pone.0042919			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937000	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000308225500021
J	Pimenta, J; Domingos, A; Santos, P; Marques, CC; Cantante, C; Santos, A; Barbas, JP; Baptista, MC; Horta, AEM; Viegas, A; Mesquita, P; Goncalves, J; Fontes, CA; Prates, JAM; Pereira, RMLN				Pimenta, Jorge; Domingos, Ana; Santos, Pedro; Marques, Carla C.; Cantante, Catia; Santos, Ana; Barbas, Joao P.; Baptista, Maria C.; Horta, Antonio E. M.; Viegas, Aldino; Mesquita, Patricia; Goncalves, Joao; Fontes, Carlos A.; Prates, Jose A. M.; Pereira, Rosa M. L. N.			Is prnt a Pseudogene? Identification of Ram Prt in Testis and Ejaculated Spermatozoa	PLOS ONE			English	Article							PRION-LIKE PROTEIN; COMPLETE GENOMIC SEQUENCE; AGGREGATION-PRONE; MALE-INFERTILITY; DOPPEL GENE; I-TASSER; EXPRESSION; BOVINE; MICE; PREDICTION	A hallmark of prion diseases or transmissible spongiform encephalopaties is the conversion of the cellular prion protein (PrPC), expressed by the prion gene (prnp), into an abnormally folded isoform (PrPSc) with amyloid-like features that causes scrapie in sheep among other diseases. prnp together with prnd (which encodes a prion-like protein designated as Doppel), and prnt (that encodes the prion protein testis specific - Prt) with sprn (shadow of prion protein gene, that encodes Shadoo or Sho) genes, constitute the "prion gene complex". Whereas a role for prnd in the proper functioning of male reproductive system has been confirmed, the function of prnt, a recently discovered prion family gene, comprises a conundrum leading to the assumption that ruminant prnt is a pseudogene with no protein expression. The main objective of the present study was to identify Prt localization in the ram reproductive system and simultaneously to elucidate if ovine prnt gene is transcribed into protein-coding RNA. Moreover, as Prt is a prnp-related protein, the amyloid propensity was also tested for ovine and caprine Prt. Recombinant Prt was used to immunize BALB/c mice, and the anti-Prt polyclonal antibody (APPA) immune response was evaluated by ELISA and Western Blot. When tested by indirect immunofluorescence, APPA showed high avidity to the ram sperm head apical ridge subdomain, before and after induced capacitation, but did not show the same behavior against goat spermatozoa, suggesting high antibody specificity against ovine-Prt. Prt was also found in the testis when assayed by immunohistochemistry during ram spermatogenesis, where spermatogonia, spermatocytes, spermatids and spermatozoa, stained positive. These observations strongly suggest ovine prnt to be a translated protein-coding gene, pointing to a role for Prt protein in the ram reproductive physiology. Besides, caprine Prt appears to exhibit a higher amyloid propensity than ovine Prt, mostly associated with its phenylalanine residue.	[Pimenta, Jorge; Marques, Carla C.; Barbas, Joao P.; Baptista, Maria C.; Horta, Antonio E. M.; Mesquita, Patricia; Pereira, Rosa M. L. N.] Inst Nacl Recursos Biol INRB L INIA Santarem, Unidade Recursos Genet Reprod & Melhoramento Anim, Quinta Da Fonte Boa, Vale De Santare, Portugal; [Pimenta, Jorge; Fontes, Carlos A.; Prates, Jose A. M.] Univ Tecn Lisboa, CIISA, FMV, P-1100 Lisbon, Portugal; [Domingos, Ana] Ctr Malaria & Doencas Tropicais, IHMT CMDT Inst Higiene Med Trop, Lisbon, Portugal; [Santos, Pedro] Hosp Univ Coimbra, Coimbra, Portugal; [Cantante, Catia; Santos, Ana; Goncalves, Joao] Univ Lisbon, URIA, ADEIM Ctr Patogenese Mol, IMM,Fac Farm, P-1699 Lisbon, Portugal; [Viegas, Aldino] Univ Nova Lisboa, REQUIMTE CQFB Dept Quim, Fac Ciencias & Tecnol, Caparica, Portugal; [Pereira, Rosa M. L. N.] Escola Univ Vasco da Gama, Coimbra, Portugal	Universidade de Lisboa; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Lisboa; Universidade Nova de Lisboa	Pimenta, J (corresponding author), Inst Nacl Recursos Biol INRB L INIA Santarem, Unidade Recursos Genet Reprod & Melhoramento Anim, Quinta Da Fonte Boa, Vale De Santare, Portugal.	rosalnp@gmail.com	Pereira, Rosa MLN/I-4003-2012; Viegas, Aldino/A-1889-2011; Goncalves, Joao/B-2013-2008; iMed.ULisboa, M2B/B-5277-2014; Cunha-Santos, Catarina/ABA-7417-2020; Domingos, Ana G/I-8409-2012; Prates, José A M/K-9934-2013; Pimenta, Jorge/N-3132-2016; Pereira, Rosa Maria Rodrigues/C-5192-2012	Pereira, Rosa MLN/0000-0002-7514-6130; Viegas, Aldino/0000-0003-1733-136X; Goncalves, Joao/0000-0002-1245-3715; iMed.ULisboa, M2B/0000-0002-1245-3715; Domingos, Ana G/0000-0002-4570-2060; Prates, José A M/0000-0003-1032-5987; barbas, joao/0000-0001-8991-4009; Pimenta, Jorge/0000-0002-3796-0238; Pereira, Rosa Maria Rodrigues/0000-0002-3723-5028; marques, carla/0000-0002-8529-3812; Mesquita, Patricia/0000-0002-4766-9831; Fontes, Carlos/0000-0002-1219-9753; Cunha-Santos, Catarina/0000-0001-8789-1966	Portuguese Foundation for Science and Technology (FCT); Portuguese Ministry of Science and Technology [PTDC/CVT/98607/2008]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); Portuguese Ministry of Science and Technology	This research was funded by the Portuguese Foundation for Science and Technology (FCT), Portuguese Ministry of Science and Technology, under the project PTDC/CVT/98607/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azriel R, 2001, J BIOL CHEM, V276, P34156, DOI 10.1074/jbc.M102883200; Baptista MC, 2008, REPROD DOMEST ANIM, V43, P53; Behrens A, 2002, EMBO J, V21, P3652, DOI 10.1093/emboj/cdf386; Bryan Jr AW, 2011, PROTEINS; Calzolai L, 2005, P NATL ACAD SCI USA, V102, P651, DOI 10.1073/pnas.0408939102; Choi SH, 2006, GENOMICS, V87, P598, DOI 10.1016/j.ygeno.2005.12.012; Comincini S, 2001, MAMM GENOME, V12, P729, DOI 10.1007/s00335-001-2064-4; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; Dattena M, 2000, THERIOGENOLOGY, V53, P1511, DOI 10.1016/S0093-691X(00)00293-4; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Diaz-Espinoza R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031678; Espenes A, 2006, INT J ANDROL, V29, P400, DOI 10.1111/j.1365-2605.2005.00618.x; Essalmani R, 2002, GENE, V285, P287, DOI 10.1016/S0378-1119(02)00391-8; Franca LR, 1999, TISSUE CELL, V31, P274, DOI 10.1054/tice.1999.0044; Guan Feng, 2009, Sheng Wu Gong Cheng Xue Bao, V25, P170; Gupta SK, 2011, ASIAN J ANDROL, V13, P97, DOI 10.1038/aja.2010.72; Harrison PM, 2010, GENOMICS, V95, P268, DOI 10.1016/j.ygeno.2010.02.008; Hills D, 2001, ANIM GENET, V32, P231, DOI 10.1046/j.1365-2052.2001.0769a.x; Jiang B, 1998, BIOPOLYMERS, V45, P35, DOI 10.1002/(SICI)1097-0282(199801)45:1<35::AID-BIP4>3.0.CO;2-#; Kamaruddin M, 2004, ANDROLOGIA, V36, P327, DOI 10.1111/j.1439-0272.2004.00629.x; Kocer A, 2007, DEV DYNAM, V236, P836, DOI 10.1002/dvdy.21066; Kozak M, 1997, EMBO J, V16, P2482, DOI 10.1093/emboj/16.9.2482; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee IY, 1998, GENOME RES, V8, P1022, DOI 10.1101/gr.8.10.1022; Li G, 1997, BRAIN RES, V751, P265, DOI 10.1016/S0006-8993(96)01407-2; Makrinou E, 2002, MAMM GENOME, V13, P696, DOI 10.1007/s00335-002-3043-0; Mesquita P, 2010, ANIM GENET, V41, P311, DOI 10.1111/j.1365-2052.2009.01992.x; Moore RC, 1999, J MOL BIOL, V292, P797, DOI 10.1006/jmbi.1999.3108; Moretti S, 2007, NUCLEIC ACIDS RES, V35, pW645, DOI 10.1093/nar/gkm333; Paisley D, 2004, AM J PATHOL, V164, P2279, DOI 10.1016/S0002-9440(10)63784-4; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Peoc'h K, 2002, J BIOL CHEM, V277, P43071, DOI 10.1074/jbc.M206357200; Pereira RM, 2009, ANIM REPROD SCI, V114, P157, DOI 10.1016/j.anireprosci.2008.10.003; Pimenta J, 2012, REPROD DOMEST ANIM, V47, P196, DOI 10.1111/j.1439-0531.2011.01827.x; Pimenta J, 2012, HORIZONS NEUROSCIENC, P283; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Premzl M, 2003, GENE, V314, P89, DOI 10.1016/S0378-1119(03)00707-8; Premzl M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-1; Preuss S, 2004, GENE, V329, P197, DOI 10.1016/j.gene.2003.12.030; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rondena M, 2005, THERIOGENOLOGY, V63, P1195, DOI 10.1016/j.theriogenology.2004.06.009; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saiki M, 2012, BIOCHEMISTRY-US, V51, P1566, DOI 10.1021/bi201688r; Silverman GL, 2000, J BIOL CHEM, V275, P26834; SPARKES RS, 1986, P NATL ACAD SCI USA, V83, P7358, DOI 10.1073/pnas.83.19.7358; Staut J, 2009, CORRELACAO MORFOLOGI; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Tranulis MA, 2001, MAMM GENOME, V12, P376, DOI 10.1007/s003350010285; Whyte SM, 2003, BIOCHEM J, V373, P485, DOI 10.1042/BJ20021911; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004	51	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42957	10.1371/journal.pone.0042957	http://dx.doi.org/10.1371/journal.pone.0042957			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937002	Green Published, gold			2022-12-25	WOS:000308225500022
J	Zhao, J; Ramos, R; Demma, M				Zhao, J.; Ramos, R.; Demma, M.			CDK8 regulates E2F1 transcriptional activity through S375 phosphorylation	ONCOGENE			English	Article						CDK8; E2F1; tumor suppressor; phosphorylation; transcriptional regulation	POSITIVE REGULATOR; COLORECTAL-CANCER; CELL-CYCLE; BETA; MEDIATOR; SUPPRESSES; PROTEIN; KINASE; WNT; PRB	Activation of the Wnt/beta-catenin pathway is a critical step in the development of colorectal cancers. A key mediator of this activation is the recently described oncogene CDK8, which is amplified in a large number of colorectal tumors. CDK8 affects beta-catenin activation by interaction of the CDK8 submodule of the mediator complex with beta-catenin/TCF transcriptional complex, and by CDK8 interacting with and phosphorylating E2F1, which acts as a repressor of beta-catenin/TCF transcriptional activity. The amino-acid residue in E2F1 that CDK8 phosphorylates and how this phosphorylation impacts E2F1 activity in general is not known. Here, we describe that CDK8 phosphorylates serine 375 in E2F1 both in vitro and in cells, and that phosphorylation of this residue is required for E2F1 interaction with CDK8, and that the phosphorylation is dependent on CDK8 kinase activity. The phosphorylation of S375 by CDK8 regulates E2F1 ability to repress transcription of beta-catenin/TCF-dependent genes, as well as activation of E2F1-dependent genes. This regulation is due to inactivation of E2F1 transcriptional activation, and not to the interference of E2F1's ability to bind to E2F1-binding sites in various promoters or to interact with DP1.	[Zhao, J.] Dept Late Stage Analyt, Union, NJ USA; [Ramos, R.] Merck Res Labs, Dept Vitro Cell Pharmacol, Rahway, NJ USA; [Demma, M.] Merck Res Labs, Dept Oncol, Boston, MA 02115 USA	Merck & Company; Merck & Company	Demma, M (corresponding author), Merck Res Labs, Dept Oncol, BMB 9-107,33 Ave Louis Pasteur, Boston, MA 02115 USA.	Mark.Demma@merck.com						Agarwal A, 2005, ONCOGENE, V24, P1021, DOI 10.1038/sj.onc.1208296; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; BANDARA LR, 1993, EMBO J, V12, P4317, DOI 10.1002/j.1460-2075.1993.tb06116.x; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Firestein R, 2010, INT J CANCER, V126, P2863, DOI 10.1002/ijc.24908; Firestein R, 2009, CANCER RES, V69, P7899, DOI 10.1158/0008-5472.CAN-09-1704; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Galbraith MD, 2010, TRANSCR-AUSTIN, V1, P4, DOI 10.4161/trns.1.1.12373; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Graham TA, 2002, MOL CELL, V10, P563, DOI 10.1016/S1097-2765(02)00637-8; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; Hurford RK, 1997, GENE DEV, V11, P1447, DOI 10.1101/gad.11.11.1447; Ji JY, 2010, CONTEMP CANCER RES, P23, DOI 10.1007/978-1-4419-1770-6_2; Kapoor A, 2010, NATURE, V468, P1105, DOI 10.1038/nature09590; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Knuesel MT, 2009, MOL CELL BIOL, V29, P650, DOI 10.1128/MCB.00993-08; KREK W, 1994, CELL, V78, P161, DOI 10.1016/0092-8674(94)90582-7; Meyer KD, 2008, EMBO J, V27, P1447, DOI 10.1038/emboj.2008.78; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morris EJ, 2008, NATURE, V455, P552, DOI 10.1038/nature07310; Mundle SD, 2003, FASEB J, V17, P569, DOI 10.1096/fj.02-0431rev; Nair JS, 2009, MOL BIOL CELL, V20, P2218, DOI 10.1091/mbc.E08-08-0885; Ohantani K, 1994, MOL CELL BIOL, V14, P1603; PEEPER DS, 1995, ONCOGENE, V10, P39; Rickert P, 1999, ONCOGENE, V18, P1093, DOI 10.1038/sj.onc.1202399; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Tago K, 2000, GENE DEV, V14, P1741; Vandel L, 1999, EMBO J, V18, P4280, DOI 10.1093/emboj/18.15.4280; Verma UN, 2003, CLIN CANCER RES, V9, P1291; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3; Wu Z, 2011, ONCOGENE, V30, P3979, DOI 10.1038/onc.2011.129; XU M, 1994, MOL CELL BIOL, V14, P8420, DOI 10.1128/MCB.14.12.8420; Xu W, 2011, J GENET GENOMICS, V38, P439, DOI 10.1016/j.jgg.2011.09.002; Zhang J, 2010, J NEUROSCI, V30, P5219, DOI 10.1523/JNEUROSCI.5628-09.2010	42	42	45	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 25	2013	32	30					3520	3530		10.1038/onc.2012.364	http://dx.doi.org/10.1038/onc.2012.364			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	188UQ	22945643				2022-12-25	WOS:000322220800005
J	Lamanna, WC; Lawrence, R; Sarrazin, S; Lameda-Diaz, C; Gordts, PLSM; Moremen, KW; Esko, JD				Lamanna, William C.; Lawrence, Roger; Sarrazin, Stephane; Lameda-Diaz, Carlos; Gordts, Philip L. S. M.; Moremen, Kelley W.; Esko, Jeffrey D.			A Genetic Model of Substrate Reduction Therapy for Mucopolysaccharidosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME REPLACEMENT THERAPY; HEPARAN-SULFATE; MOUSE MODEL; GLYCOSAMINOGLYCAN SYNTHESIS; LYSOSOMAL STORAGE; DEPRIVATION THERAPY; RHODAMINE-B; GENISTEIN; DISEASE; PROTEOGLYCANS	Inherited defects in the ability to catabolize glycosaminoglycans result in lysosomal storage disorders known as mucopolysaccharidoses (MPS), causing severe pathology, particularly in the brain. Enzyme replacement therapy has been used to treat mucopolysaccharidoses; however, neuropathology has remained refractory to this approach. To test directly whether substrate reduction might be feasible for treating MPS disease, we developed a genetic model for substrate reduction therapy by crossing MPS IIIa mice with animals partially deficient in heparan sulfate biosynthesis due to heterozygosity in Ext1 and Ext2, genes that encode the copolymerase required for heparan sulfate chain assembly. Reduction of heparan sulfate by 30-50% using this genetic strategy ameliorated the amount of disease-specific biomarker and pathology in multiple tissues, including the brain. In addition, we were able to demonstrate that substrate reduction therapy can improve the efficacy of enzyme replacement therapy in cell culture and in mice. These results provide proof of principle that targeted inhibition of heparan sulfate biosynthetic enzymes together with enzyme replacement might prove beneficial for treating mucopolysaccharidoses.	[Lamanna, William C.; Lawrence, Roger; Sarrazin, Stephane; Lameda-Diaz, Carlos; Gordts, Philip L. S. M.; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Moremen, Kelley W.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University of California System; University of California San Diego; University System of Georgia; University of Georgia	Esko, JD (corresponding author), 9500 Gilman Dr,Rm 1055,CMM E, La Jolla, CA 92093 USA.	jesko@ucsd.edu	Moremen, Kelley/AAD-4661-2019	Gordts, Philip/0000-0001-7224-4328	National Institutes of Health through NIGMS [P41GM103390]; NHLBI [HL107150]; National Mucopolysaccharidosis Society; Kirschstein National Research Service Award [DK085905]; European Community [PIOF-GA-2010-273994]; National Center for Research Resources [P41RR005351]; National Institutes of Health [HL107150]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK085905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390] Funding Source: NIH RePORTER	National Institutes of Health through NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Mucopolysaccharidosis Society; Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community(European Commission); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health through NIGMS Grant P41GM103390 and NHLBI Grant HL107150 (to J. D. E). This work was also supported by a grant from the National Mucopolysaccharidosis Society, Kirschstein National Research Service Award DK085905 (to W. C. L.), European Community FP7 Award PIOF-GA-2010-273994 (to P. L. S. M. G.), and National Center for Research Resources Grant P41RR005351.; Histological staining was provided by Dr. Nissi Varki and her staff at the University of California San Diego Mouse Histopathology Core with support from National Institutes of Health program Project Grant HL107150 from the. We also thank Drs. Kazuhiro Ohmi and Elizabeth F. Neufeld for suggestions and analysis of phosphorylated Tau.	Banerjee S, 2008, CANCER LETT, V269, P226, DOI 10.1016/j.canlet.2008.03.052; Bhattacharyya R, 2001, GLYCOBIOLOGY, V11, P99, DOI 10.1093/glycob/11.1.99; Bhaumik M, 1999, GLYCOBIOLOGY, V9, P1389, DOI 10.1093/glycob/9.12.1389; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Blanch L, 1997, HUM MOL GENET, V6, P787, DOI 10.1093/hmg/6.5.787; Brady RO, 2006, ANNU REV MED, V57, P283, DOI 10.1146/annurev.med.57.110104.115650; Cox T, 2000, LANCET, V355, P1481, DOI 10.1016/S0140-6736(00)02161-9; Crawley AC, 2006, BRAIN RES, V1104, P1, DOI 10.1016/j.brainres.2006.05.079; de Ruijter J, 2012, ANN NEUROL, V71, P110, DOI 10.1002/ana.22643; Delgadillo V, 2011, J INHERIT METAB DIS, V34, P1039, DOI 10.1007/s10545-011-9342-4; Dickson PI, 2011, CURR PHARM BIOTECHNO, V12, P946, DOI 1389-2010/11 $58.00+.00; Dziedzic D, 2010, EUR J HUM GENET, V18, P200, DOI 10.1038/ejhg.2009.144; Esko J. D., 1993, CURRENT PROTOCOLS MO; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Friso A, 2010, BRIT J PHARMACOL, V159, P1082, DOI 10.1111/j.1476-5381.2009.00565.x; Jakobkiewicz-Banecka J, 2011, CURR PHARM BIOTECHNO, V12, P1860, DOI 10.2174/138920111798376932; Jakobkiewicz-Banecka J, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-26; Jeyakumar M, 1999, P NATL ACAD SCI USA, V96, P6388, DOI 10.1073/pnas.96.11.6388; Kaidonis X, 2010, EUR J HUM GENET, V18, P194, DOI 10.1038/ejhg.2009.143; Lachmann RH, 2001, EXPERT OPIN INV DRUG, V10, P455, DOI 10.1517/13543784.10.3.455; Lamanna WC, 2011, J BIOL CHEM, V286, P6955, DOI 10.1074/jbc.M110.192062; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Lawrence R, 2012, NAT CHEM BIOL, V8, P197, DOI 10.1038/nchembio.766; Li HH, 2002, J NEUROSCI RES, V69, P30, DOI 10.1002/jnr.10278; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Liu YJ, 1999, J CLIN INVEST, V103, P497, DOI 10.1172/JCI5542; Malinowska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014192; Malinowska M, 2009, MOL GENET METAB, V98, P235, DOI 10.1016/j.ymgme.2009.06.013; NEUFELD EF, 1975, ANNU REV BIOCHEM, V44, P357, DOI 10.1146/annurev.bi.44.070175.002041; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Ohmi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027461; Platt FM, 1997, SCIENCE, V276, P428, DOI 10.1126/science.276.5311.428; Platt FM, 2009, BBA-MOL CELL RES, V1793, P737, DOI 10.1016/j.bbamcr.2008.08.009; Polkowski K, 2000, Acta Pol Pharm, V57, P135; Roberts ALK, 2006, PEDIATR RES, V60, P309, DOI 10.1203/01.pdr.0000233037.00707.da; Savas PS, 2004, MOL GENET METAB, V82, P273, DOI 10.1016/j.ymgme.2004.05.005; Settembre C, 2008, AUTOPHAGY, V4, P113, DOI 10.4161/auto.5227; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; SHELLEY WB, 1969, HISTOCHEMISTRY, V20, P244, DOI 10.1007/BF00306012; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; WASTESON A, 1971, J CHROMATOGR, V59, P87, DOI 10.1016/S0021-9673(01)80009-1; Wegrzyn A, 2012, IUBMB LIFE, V64, P307, DOI 10.1002/iub.1007; Wraith JE, 2009, INT J CLIN PHARM TH, V47, pS63; YANAGISHITA M, 1984, J BIOL CHEM, V259, P270; Zak BM, 2011, BONE, V48, P979, DOI 10.1016/j.bone.2011.02.001	47	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36283	36290		10.1074/jbc.M112.403360	http://dx.doi.org/10.1074/jbc.M112.403360			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22952226	Green Published, hybrid			2022-12-25	WOS:000310364000049
J	Lindsey-Boltz, LA; Reardon, JT; Wold, MS; Sancar, A				Lindsey-Boltz, Laura A.; Reardon, Joyce T.; Wold, Marc S.; Sancar, Aziz			In Vitro Analysis of the Role of Replication Protein A (RPA) and RPA Phosphorylation in ATR-mediated Checkpoint Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE CHECKPOINT; ATAXIA-TELANGIECTASIA; EXCISION NUCLEASE; BINDING PROTEIN; BASIC CLEFT; REPAIR; KINASE; DOMAIN; RECONSTITUTION; ACTIVATION	Replication protein A (RPA) plays essential roles in DNA metabolism, including replication, checkpoint, and repair. Recently, wedescribed an in vitro system in which the phosphorylation of human Chk1 kinase by ATR (ataxia telangiectasia mutated and Rad3-related) is dependent on RPA bound to single-stranded DNA. Here, we report that phosphorylation of other ATR targets, p53 and Rad17, has the same requirements and that RPA is also phosphorylated in this system. At high p53 or Rad17 concentrations, RPAphosphorylation is inhibited and, in this system, RPA with phosphomimetic mutations cannot support ATR kinase function, whereas a non-phosphorylatable RPA mutant exhibits full activity. Phosphorylation of these ATR substrates depends on the recruitment of ATR and the substrates by RPA to the RPA-ssDNA complex. Finally, mutant RPAs lacking checkpoint function exhibit essentially normal activity in nucleotide excision repair, revealing RPA separation of function for checkpoint and excision repair.	[Lindsey-Boltz, Laura A.; Reardon, Joyce T.; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Wold, Marc S.] Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Iowa	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, CB 7260, Chapel Hill, NC 27599 USA.	Aziz_Sancar@med.unc.edu	Lindsey-Boltz, Laura/A-3121-2010	Lindsey-Boltz, Laura/0000-0001-6493-8194; Wold, Marc/0000-0002-4580-1624	National Institutes of Health [GM32833, GM44721]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044721, R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM32833 (to A.S.) and GM44721 (to M.S.W.).	Abramova NA, 1997, P NATL ACAD SCI USA, V94, P7186, DOI 10.1073/pnas.94.14.7186; Anantha RW, 2007, J BIOL CHEM, V282, P35910, DOI 10.1074/jbc.M704645200; Anantha RW, 2008, P NATL ACAD SCI USA, V105, P12903, DOI 10.1073/pnas.0803001105; Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Barr SM, 2003, CURR BIOL, V13, P1047, DOI 10.1016/S0960-9822(03)00376-2; Bessho T, 1997, J BIOL CHEM, V272, P3833, DOI 10.1074/jbc.272.6.3833; Binz SK, 2008, J BIOL CHEM, V283, P21559, DOI 10.1074/jbc.M802450200; Binz SK, 2003, J BIOL CHEM, V278, P35584, DOI 10.1074/jbc.M305388200; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; CARTY MP, 1994, EMBO J, V13, P2114, DOI 10.1002/j.1460-2075.1994.tb06487.x; Chang MS, 1999, J BIOL CHEM, V274, P36544, DOI 10.1074/jbc.274.51.36544; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Choi JH, 2009, METHODS, V48, P3, DOI 10.1016/j.ymeth.2009.02.006; Choi JH, 2009, NUCLEIC ACIDS RES, V37, P1501, DOI 10.1093/nar/gkn1075; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; de Laat WL, 1998, GENE DEV, V12, P2598, DOI 10.1101/gad.12.16.2598; DUTTA A, 1993, NATURE, V365, P79, DOI 10.1038/365079a0; DUTTA A, 1992, EMBO J, V11, P2189, DOI 10.1002/j.1460-2075.1992.tb05278.x; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Fisher LA, 2011, J MOL BIOL, V413, P337, DOI 10.1016/j.jmb.2011.08.034; FOTEDAR R, 1992, EMBO J, V11, P2177, DOI 10.1002/j.1460-2075.1992.tb05277.x; Furuya K, 2010, MOL CELL, V40, P606, DOI 10.1016/j.molcel.2010.10.026; Guo SL, 2006, J BIOL CHEM, V281, P21607, DOI 10.1074/jbc.M603504200; Haring SJ, 2008, J BIOL CHEM, V283, P19095, DOI 10.1074/jbc.M800881200; Hass CS, 2010, MOL CANCER RES, V8, P1017, DOI 10.1158/1541-7786.MCR-10-0161; HE ZG, 1995, NATURE, V374, P566, DOI 10.1038/374566a0; HE ZG, 1993, CELL, V73, P1223, DOI 10.1016/0092-8674(93)90650-F; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Jacobs DM, 1999, J BIOMOL NMR, V14, P321, DOI 10.1023/A:1008373009786; Kang TH, 2010, P NATL ACAD SCI USA, V107, P4890, DOI 10.1073/pnas.0915085107; Kim HS, 2001, MOL CELL BIOL, V21, P3725, DOI 10.1128/MCB.21.11.3725-3737.2001; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lindsey-Boltz LA, 2011, J BIOL CHEM, V286, P19229, DOI 10.1074/jbc.M111.237958; Lindsey-Boltz LA, 2009, J BIOL CHEM, V284, P33107, DOI 10.1074/jbc.M109.064485; Liu JS, 2006, DNA REPAIR, V5, P369, DOI 10.1016/j.dnarep.2005.11.007; LIU VF, 1993, MOL CELL BIOL, V13, P7222, DOI 10.1128/MCB.13.12.7222; Majka J, 2006, J BIOL CHEM, V281, P27855, DOI 10.1074/jbc.M605176200; Matsunaga T, 1996, J BIOL CHEM, V271, P11047, DOI 10.1074/jbc.271.19.11047; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Namiki Y, 2006, P NATL ACAD SCI USA, V103, P580, DOI 10.1073/pnas.0510223103; Oakley GG, 2003, BIOCHEMISTRY-US, V42, P3255, DOI 10.1021/bi026377u; Oakley GG, 2010, FRONT BIOSCI-LANDMRK, V15, P883, DOI 10.2741/3652; Oakley GG, 2009, BIOCHEMISTRY-US, V48, P7473, DOI 10.1021/bi900694p; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; PAN ZQ, 1995, P NATL ACAD SCI USA, V92, P4636, DOI 10.1073/pnas.92.10.4636; Patrick SM, 2005, BIOCHEMISTRY-US, V44, P8438, DOI 10.1021/bi048057b; Reardon JT, 2006, METHOD ENZYMOL, V408, P189, DOI 10.1016/S0076-6879(06)08012-8; SALAHUDDIN, 1990, GENE DEV, V4, P968, DOI 10.1101/gad.4.6.968; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Umezu K, 1998, GENETICS, V148, P989; Unsal-Kacmaz K, 2004, MOL CELL BIOL, V24, P1292, DOI 10.1128/MCB.24.3.1292-1300.2003; Vassin VM, 2009, J CELL SCI, V122, P4070, DOI 10.1242/jcs.053702; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; Wang YX, 2005, NAT GENET, V37, P750, DOI 10.1038/ng1587; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wu XM, 2005, ONCOGENE, V24, P4728, DOI 10.1038/sj.onc.1208674; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	62	19	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36123	36131		10.1074/jbc.M112.407825	http://dx.doi.org/10.1074/jbc.M112.407825			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948311	Green Published, hybrid			2022-12-25	WOS:000310364000034
J	Bouzat, S; Levi, V; Bruno, L				Bouzat, Sebastian; Levi, Valeria; Bruno, Luciana			Transport Properties of Melanosomes along Microtubules Interpreted by a Tug-of-War Model with Loose Mechanical Coupling	PLOS ONE			English	Article							MOLECULAR MOTORS; XENOPUS MELANOPHORES; CYTOPLASMIC DYNEIN; CARGO TRANSPORT; INTRACELLULAR-TRANSPORT; BIDIRECTIONAL TRANSPORT; ORGANELLE TRANSPORT; AXONAL-TRANSPORT; KINESIN MOTORS; IN-VITRO	In this work, we explored theoretically the transport of organelles driven along microtubules by molecular motors of opposed polarities using a stochastic model that considers a Langevin dynamics for the cargo, independent cargo-motor linkers and stepping motion for the motors. It has been recently proposed that the stiffness of the motor plays an important role when multiple motors collectively transport a cargo. Therefore, we considered in our model the recently reported values for the stiffness of the cargo-motor linker determined in living cells (similar to 0.01 pN/nm, [1]) which is significantly lower than the motor stiffness obtained in in vitro assays and used in previous studies. Our model could reproduce the multimodal velocity distributions and typical trajectory characteristics including the properties of the reversions in the overall direction of motion observed during melanosome transport along microtubules in Xenopus laevis melanophores. Moreover, we explored the contribution of the different motility states of the cargo-motor system to the different modes of the velocity distributions and could identify the microscopic mechanisms of transport leading to trajectories compatible with those observed in living cells. Finally, by changing the attachment and detachment rates, the model could reproduce the different velocity distributions observed during melanosome transport along microtubules in Xenopus laevis melanophores stimulated for aggregation and dispersion. Our analysis suggests that active tug-of-war processes with loose mechanical coupling can account for several aspects of cargo transport along microtubules in living cells.	[Bouzat, Sebastian] Comis Nacl Energia Atom, Ctr Atom Bariloche, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Levi, Valeria] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, Argentina; [Bruno, Luciana] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, RA-1428 Buenos Aires, Argentina	Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; University of Buenos Aires; University of Buenos Aires	Bouzat, S (corresponding author), Comis Nacl Energia Atom, Ctr Atom Bariloche, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina.	lbruno@df.uba.ar		Levi, Valeria/0000-0002-1666-4675	ANPCyT -Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2008-1104]; CONICET - Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 11220080100076]; CNEA -Comision Nacional de Energia Atomica	ANPCyT -Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); CONICET - Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CNEA -Comision Nacional de Energia Atomica	This research was supported by ANPCyT -Agencia Nacional de Promocion Cientifica y Tecnologica (under grant number PICT 2008-1104), CONICET - Consejo Nacional de Investigaciones Cientificas y Tecnicas (under grant number PIP 11220080100076) and CNEA -Comision Nacional de Energia Atomica, all Argentinean agencies. The authors are members of CONICET, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MY, 2011, P NATL ACAD SCI USA, V108, pE535, DOI 10.1073/pnas.1104298108; Bieling P, 2008, EMBO REP, V9, P1121, DOI 10.1038/embor.2008.169; Bouzat S, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/6/066010; Bouzat S, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/4/046009; Bruno L, 2008, CELL BIOCHEM BIOPHYS, V52, P191, DOI 10.1007/s12013-008-9034-3; Bruno L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018332; Coppin CM, 1997, P NATL ACAD SCI USA, V94, P8539, DOI 10.1073/pnas.94.16.8539; Courty S, 2006, NANO LETT, V6, P1491, DOI 10.1021/nl060921t; Driver JW, 2011, BIOPHYS J, V101, P386, DOI 10.1016/j.bpj.2011.05.067; Driver JW, PHYS CHEM CHEM PHYS, V12; Encalada SE, 2011, CELL, V144, P551, DOI 10.1016/j.cell.2011.01.021; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Gross SP, 2004, PHYS BIOL, V1, pR1, DOI 10.1088/1478-3967/1/2/R01; Gross SP, 2000, J CELL BIOL, V148, P945, DOI 10.1083/jcb.148.5.945; Gross SP, 2002, J CELL BIOL, V156, P855, DOI 10.1083/jcb.200105055; GUERIN T, 2010, THEORY CURRENT OPINI, V22, P14, DOI DOI 10.1016/J.CEB.2009.12.012; Guo SL, 2008, PHOTOCHEM PHOTOBIOL, V84, P671, DOI 10.1111/j.1751-1097.2008.00331.x; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Higuchi H, 1997, P NATL ACAD SCI USA, V94, P4395, DOI 10.1073/pnas.94.9.4395; Hollenbeck Peter J., 1996, Frontiers in Bioscience (online), V1, pD91; Jamison DK, 2010, BIOPHYS J, V99, P2967, DOI 10.1016/j.bpj.2010.08.025; Kojima H, 1997, BIOPHYS J, V73, P2012, DOI 10.1016/S0006-3495(97)78231-6; Kunwar A, 2008, CURR BIOL, V18, P1173, DOI 10.1016/j.cub.2008.07.027; Kunwar A, 2011, P NATL ACAD SCI USA, V108, P18960, DOI 10.1073/pnas.1107841108; Kunwar A, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016012; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Leduc C, 2007, P NATL ACAD SCI USA, V104, P10847, DOI 10.1073/pnas.0701B64104; Levi V, 2006, BIOPHYS J, V90, P318, DOI 10.1529/biophysj.105.067843; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Muller MJI, 2008, P NATL ACAD SCI USA, V105, P4609, DOI 10.1073/pnas.0706825105; Muller MJI, 2010, BIOPHYS J, V98, P2610, DOI 10.1016/j.bpj.2010.02.037; Nascimento AA, 2003, ANNU REV CELL DEV BI, V19, P469, DOI 10.1146/annurev.cellbio.19.111401.092937; Nilsson H, 1997, CELL MOTIL CYTOSKEL, V38, P397, DOI 10.1002/(SICI)1097-0169(1997)38:4<397::AID-CM9>3.3.CO;2-5; Rogers AR, 2009, PHYS CHEM CHEM PHYS, V11, P4882, DOI 10.1039/b900964g; ROZDZIAL MM, 1986, CELL, V47, P1061, DOI 10.1016/0092-8674(86)90821-4; SAMMAK PJ, 1992, J CELL BIOL, V117, P57, DOI 10.1083/jcb.117.1.57; Schnitzer MJ, 2000, NAT CELL BIOL, V2, P718, DOI 10.1038/35036345; Schroeder HW, 2010, CURR BIOL, V20, P687, DOI 10.1016/j.cub.2010.03.024; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Sims PA, 2009, CHEMPHYSCHEM, V10, P1511, DOI 10.1002/cphc.200900113; Smith GA, 2001, P NATL ACAD SCI USA, V98, P3466, DOI 10.1073/pnas.061029798; Soppina V, 2009, P NATL ACAD SCI USA, V106, P19381, DOI 10.1073/pnas.0906524106; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Tuma MC, 1998, J CELL BIOL, V143, P1547, DOI 10.1083/jcb.143.6.1547; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Vershinin M, 2008, TRAFFIC, V9, P882, DOI 10.1111/j.1600-0854.2008.00741.x; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Zhang YX, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.011909	48	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43599	10.1371/journal.pone.0043599	http://dx.doi.org/10.1371/journal.pone.0043599			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952716	Green Submitted, gold, Green Published			2022-12-25	WOS:000308206500014
J	Abeyasinghe, RR; Galappaththy, GNL; Gueye, CS; Kahn, JG; Feachem, RGA				Abeyasinghe, Rabindra R.; Galappaththy, Gawrie N. L.; Gueye, Cara Smith; Kahn, James G.; Feachem, Richard G. A.			Malaria Control and Elimination in Sri Lanka: Documenting Progress and Success Factors in a Conflict Setting	PLOS ONE			English	Article							PLASMODIUM-VIVAX; CULICIFACIES; TRANSMISSION; SUBPICTUS; SEEKING; COSTS	Background: Sri Lanka has a long history of malaria control, and over the past decade has had dramatic declines in cases amid a national conflict. A case study of Sri Lanka's malaria programme was conducted to characterize the programme and explain recent progress. Methods: The case study employed qualitative and quantitative methods. Data were collected from published and grey literature, district-level and national records, and thirty-three key informant interviews. Expenditures in two districts for two years - 2004 and 2009 - were compiled. Findings: Malaria incidence in Sri Lanka has declined by 99.9% since 1999. During this time, there were increases in the proportion of malaria infections due to Plasmodium vivax, and the proportion of infections occurring in adult males. Indoor residual spraying and distribution of long-lasting insecticide-treated nets have likely contributed to the low transmission. Entomological surveillance was maintained. A strong passive case detection system captures infections and active case detection was introduced. When comparing conflict and non-conflict districts, vector control and surveillance measures were maintained in conflict areas, often with higher coverage reported in conflict districts. One of two districts in the study reported a 48% decline in malaria programme expenditure per person at risk from 2004 to 2009. The other district had stable malaria spending. Conclusions/Significance: Malaria is now at low levels in Sri Lanka - 124 indigenous cases were found in 2011. The majority of infections occur in adult males and are due to P. vivax. Evidence-driven policy and an ability to adapt to new circumstances contributed to this decline. Malaria interventions were maintained in the conflict districts despite an ongoing war. Sri Lanka has set a goal of eliminating malaria by the end of 2014. Early identification and treatment of infections, especially imported ones, together with effective surveillance and response, will be critical to achieving this goal.	[Abeyasinghe, Rabindra R.] WHO, Country Off, Port Moresby, Natl Capital Di, Papua N Guinea; [Galappaththy, Gawrie N. L.] Minist Hlth, Colombo, Western Provinc, Sri Lanka; [Gueye, Cara Smith; Feachem, Richard G. A.] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Kahn, James G.] Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA USA	World Health Organization; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Abeyasinghe, RR (corresponding author), WHO, Country Off, Port Moresby, Natl Capital Di, Papua N Guinea.	smithc1@globalhealth.ucsf.edu			Bill & Melinda Gates Foundation; World Health Organization; ExxonMobil; Australian Agency for International Development (AusAID); Anti-Malaria Campaign, Ministry of Health, Sri Lanka	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); World Health Organization(World Health Organization); ExxonMobil(Exxon Mobil Corporation); Australian Agency for International Development (AusAID)(Australian Aid (AusAID)); Anti-Malaria Campaign, Ministry of Health, Sri Lanka	This case study was funded by a grant from the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: RRA is currently supported by the World Health Organization. During the period of case study data collection and write up, RRA was supported by the Anti-Malaria Campaign, Ministry of Health, Sri Lanka. GNLG is supported by the Anti-Malaria Campaign, Ministry of Health, Sri Lanka. GNLG represents Sri Lanka in the Asia Pacific Malaria Elimination Network (APMEN) and RRA chaired the APMEN Advisory Board. RRA is a member of the Malaria Elimination Group. RGAF is the Director of the UCSF Global Health Group, chair of the Malaria Elimination Group and is also the Network Chair of APMEN. CSG is Program Coordinator at the UCSF Global Health Group and provides assistance to the APMEN Joint-Secretariat. The Global Health Group provides support to eliminating countries, such as Sri Lanka, and is funded by the Bill & Melinda Gates Foundation. The Global Health Group also received funding from ExxonMobil during the period of this study. APMEN is funded through a grant from the Australian Agency for International Development (AusAID). JGK is a professor of health policy at UCSF. This case study is a component of a collaboration between the UCSF Global Health Group and the WHO Global Malaria Programme to document country experience with malaria elimination.	Abeyasinghe RR, 2010, MONITORING IN PRESS; Amerasinghe PH, 1999, MED VET ENTOMOL, V13, P124, DOI 10.1046/j.1365-2915.1999.00160.x; AMERASINGHE PH, 1992, J MED ENTOMOL, V29, P577, DOI 10.1093/jmedent/29.4.577; [Anonymous], 2009, WORLD MAL REP 2009; Barat LM, 2006, AM J TROP MED HYG, V74, P12, DOI 10.4269/ajtmh.2006.74.12; Barik TK, 2009, ACTA TROP, V109, P87, DOI 10.1016/j.actatropica.2008.09.017; Beier JC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S4; Bouffard S., 2006, J S ASIAN DEV, V1, P151; Briet OJT, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-8; Briet OJT, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-77; Briet OJT, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-42; Carrara VI, 2006, PLOS MED, V3, P856, DOI 10.1371/journal.pmed.0030183; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-213; COHN EJ, 1973, AM J PUBLIC HEALTH, V63, P1086, DOI 10.2105/AJPH.63.12.1086; Colombo Page News Desk, FERR SERV INT SRI LA; de Silva MWA, 2001, SOC SCI MED, V53, P1363, DOI 10.1016/S0277-9536(00)00425-1; Dunn CL, 1936, POSTGRAD MED J, V12, P483; Dutt AK, 2010, ADV ASIAN HUM-ENV RE, V1, P29, DOI 10.1007/978-90-481-3358-1_2; Feachem RGA, 2009, SHRINKING MALARIA MA; Feachem RGA, 2010, LANCET, V376, P1517, DOI 10.1016/S0140-6736(10)61500-0; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Fernando SD, 2008, T ROY SOC TROP MED H, V102, P1081, DOI 10.1016/j.trstmh.2008.06.007; Fernando SD, 2009, AM J TROP MED HYG, V81, P763, DOI 10.4269/ajtmh.2009.09-0042; Fernando V.N, 2020, INT J SCI RES, V9, P1310; Galappaththy GNL, 1999, J COLL COMMUNITY PHY, V4; Gill CA, 1936, ANN TROP MED PARASIT, V91, P428; GREEN CA, 1980, J TROP MED HYG, V83, P75; GUNARATNA L F, 1956, Bull World Health Organ, V15, P791; *IMF, WORLD EC OUTL DAT; IMF, 2009, IMF REPR EXCH RAT SE; International Crisis Group, 2011, 124 INT CRIS GROUP; Irin, SRI LANK OP TOUR BUS; KARUNARATNE W A, 1959, J Trop Med Hyg, V62, P79; Konradsen F, 1999, B WORLD HEALTH ORGAN, V77, P301; Konradsen F, 1997, T ROY SOC TROP MED H, V91, P127, DOI 10.1016/S0035-9203(97)90194-2; Martins JS, 2009, CONFLICT HLTH, V3, P1; Matthys B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-217; McCombie SC, 1996, SOC SCI MED, V43, P933, DOI 10.1016/0277-9536(95)00446-7; MENDIS C, 1990, AM J TROP MED HYG, V42, P298, DOI 10.4269/ajtmh.1990.42.298; Mills A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S11; Ministry of Health Anti-Malaria Campaign, 1998, CENTR BANK ANN REP; Najera J, 2010, MALARIA EPIDEMICS DE; Office of the Director General of Health Services, 2008, 01142008 OFF DIR GEN; Pinikahana Jayaratne, 1993, Indian Journal of Malariology, V30, P51; Rajakaruna RS, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-25; RAJENDRAM S, 1951, Indian J Malariol, V5, P1; Ramos WM, 2010, BRAZ J INFECT DIS, V14, P410, DOI 10.1590/S1413-86702010000400017; RBM-MERG, 2009, RBM TECHN PAP SER; Reilley B, 2002, TROP MED INT HEALTH, V7, P744, DOI 10.1046/j.1365-3156.2002.00919.x; Roberts DR, 2000, LANCET, V356, P330, DOI 10.1016/S0140-6736(00)02516-2; ROJAS W, 1992, PARASITOL TODAY, V8, P141, DOI 10.1016/0169-4758(92)90287-C; Ruberu PS, 1977, EC JUSTIFICATI UNPUB; Rutherford GW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-447; Sabot O, 2010, LANCET, V376, P1604, DOI 10.1016/S0140-6736(10)61355-4; Seo SNN, 2005, ENVIRON DEV ECON, V10, P581, DOI 10.1017/S1355770X05002044; Sri Lanka Ministry of Defense, SPAT TEMP DISTR TERR, P1; Sri Lanka Ministry of Health Anti-Malaria Campaign, 2002, ADM REP ANT CAMP 200; Sri Lanka Ministry of Health Anti-Malaria Campaign, 2008, STRAT PLAN PHAS EL M; Tatarsky A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023832; Tatem AJ, 2010, LANCET, V376, P1579, DOI 10.1016/S0140-6736(10)61301-3; The Global Health Group and the Malaria Atlas Project, 2011, ATL AS PAC MAL EL NE; The Henry J. Kaiser Family Foundation US Global Health Policy News, GLOB FUND CANC ROUND; The World Health Organization DoME, 1961, WHOMAL289 DOME, P289; van den Berg H, 2007, B WORLD HEALTH ORGAN, V85, P561, DOI 10.2471/BLT.06.035600; van der Hoek W, 2003, INT J EPIDEMIOL, V32, P280, DOI 10.1093/ije/dyg055; van der Hoek W, 1997, ANN TROP MED PARASIT, V91, P945, DOI 10.1080/00034989760347; VANDENBERGH H, 2006, EVALUATION INTEGRATE; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2004, WHOCDSCPEPVC200410; WHO, 2010, GUID TREATM MAL, V2nd; WHOLIS, GEN WHO LIB DAT; WIJESUNDERA MD, 1988, PARASITOL TODAY, V4, P147, DOI 10.1016/0169-4758(88)90193-7; World Bank, 2002, IMPL COMPL REP IDA 2; World Health Organization, 2007, MAL EL FIELD MAN LOW; World Health Organization, 1993, GLOB STRAT MAL CONTR; Yangzom T, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-9	78	88	90	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43162	10.1371/journal.pone.0043162	http://dx.doi.org/10.1371/journal.pone.0043162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952642	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206000020
J	Foote, AD; Thomsen, PF; Sveegaard, S; Wahlberg, M; Kielgast, J; Kyhn, LA; Salling, AB; Galatius, A; Orlando, L; Gilbert, MTP				Foote, Andrew D.; Thomsen, Philip Francis; Sveegaard, Signe; Wahlberg, Magnus; Kielgast, Jos; Kyhn, Line A.; Salling, Andreas B.; Galatius, Anders; Orlando, Ludovic; Gilbert, M. Thomas P.			Investigating the Potential Use of Environmental DNA (eDNA) for Genetic Monitoring of Marine Mammals	PLOS ONE			English	Article							ATLANTIC; OCEAN; ACID	The exploitation of non-invasive samples has been widely used in genetic monitoring of terrestrial species. In aquatic ecosystems, non-invasive samples such as feces, shed hair or skin, are less accessible. However, the use of environmental DNA (eDNA) has recently been shown to be an effective tool for genetic monitoring of species presence in freshwater ecosystems. Detecting species in the marine environment using eDNA potentially offers a greater challenge due to the greater dilution, amount of mixing and salinity compared with most freshwater ecosystems. To determine the potential use of eDNA for genetic monitoring we used specific primers that amplify short mitochondrial DNA sequences to detect the presence of a marine mammal, the harbor porpoise, Phocoena phocoena, in a controlled environment and in natural marine locations. The reliability of the genetic detections was investigated by comparing with detections of harbor porpoise echolocation clicks by static acoustic monitoring devices. While we were able to consistently genetically detect the target species under controlled conditions, the results from natural locations were less consistent and detection by eDNA was less successful than acoustic detections. However, at one site we detected long-finned pilot whale, Globicephala melas, a species rarely sighted in the Baltic. Therefore, with optimization aimed towards processing larger volumes of seawater this method has the potential to compliment current visual and acoustic methods of species detection of marine mammals.	[Foote, Andrew D.; Thomsen, Philip Francis; Kielgast, Jos; Salling, Andreas B.; Orlando, Ludovic; Gilbert, M. Thomas P.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Sveegaard, Signe; Kyhn, Line A.; Galatius, Anders] Aarhus Univ, Dept Biosci, Roskilde, Denmark; [Wahlberg, Magnus] Fjord&Baelt, Kerteminde, Denmark; [Wahlberg, Magnus] Univ So Denmark, Marine Biol Lab, Kerteminde, Denmark	University of Copenhagen; Aarhus University; University of Southern Denmark	Foote, AD (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark.	footead@gmail.com	sveegaard, signe/AAZ-7529-2021; Galatius, Anders/J-4755-2013; Thomsen, Philip Francis/AAE-9354-2019; Kyhn, Line Anker/AAY-9923-2021; Gilbert, Marcus TP/A-8936-2013; Galatius, Anders/AAM-9028-2020; Galatius, Anders/AGG-7831-2022; Sveegaard, Signe/K-2938-2013; Orlando, Ludovic/A-8932-2013	Thomsen, Philip Francis/0000-0002-9867-4366; Gilbert, Marcus TP/0000-0002-5805-7195; Galatius, Anders/0000-0003-1237-2066; Sveegaard, Signe/0000-0002-8893-9842; Orlando, Ludovic/0000-0003-3936-1850; Foote, Andrew/0000-0001-7384-1634; Kyhn, Line/0000-0002-0926-6812	Marie Curie Intra-European Fellowship [272385]; EU [293845]	Marie Curie Intra-European Fellowship(European Commission); EU(European Commission)	A.D.F. was funded by a Marie Curie Intra-European Fellowship no. 272385. L.O. was supported by a EU Marie Curie Career Integration Grant (293845). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen K, 2012, MOL ECOL, V21, P1966, DOI 10.1111/j.1365-294X.2011.05261.x; Arnason U, 2004, GENE, V333, P27, DOI 10.1016/j.gene.2004.02.010; Bailey H, 2010, AQUAT CONSERV, V20, P150, DOI 10.1002/aqc.1060; Carstensen J, 2006, MAR ECOL PROG SER, V321, P295, DOI 10.3354/meps321295; Corinaldesi C, 2005, APPL ENVIRON MICROB, V71, P46, DOI 10.1128/AEM.71.1.46-50.2005; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Dell'Anno A, 2004, APPL ENVIRON MICROB, V70, P4384, DOI 10.1128/AEM.70.7.4384-4386.2004; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Frere CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012299; Gillett RM, 2010, MAR MAMMAL SCI, V26, P917, DOI 10.1111/j.1748-7692.2010.00380.x; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Gross M, 2012, CURR BIOL, V22, pR73, DOI 10.1016/j.cub.2012.01.036; Haile J, 2009, P NATL ACAD SCI USA, V106, P22352, DOI 10.1073/pnas.0912510106; Hofreiter M, 2003, CURR BIOL, V13, pR693, DOI 10.1016/j.cub.2003.08.039; HOLMHANS.O, 1968, LIMNOL OCEANOGR, V13, P507; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kinze CC, 2003, BIOL WRITINGS FISHER; Kyhn LA, 2008, J MAR BIOL ASSOC UK, V88, P1085, DOI 10.1017/S0025315408000416; Parsons KM, 2003, MAR MAMMAL SCI, V19, P224, DOI 10.1111/j.1748-7692.2003.tb01104.x; Rolland Rosalind M., 2006, Journal of Cetacean Research and Management, V8, P121; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Scheidat M., 2008, Endangered Species Research, V5, P215, DOI 10.3354/esr00161; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Thomsen PF, 2012, PLOS ONE; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Verfuss UK, 2007, J MAR BIOL ASSOC UK, V87, P165, DOI 10.1017/S0025315407054938; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997	30	209	226	8	256	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e41781	10.1371/journal.pone.0041781	http://dx.doi.org/10.1371/journal.pone.0041781			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952587	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206000006
J	Marchewka, A; Jednorog, K; Falkiewicz, M; Szeszkowski, W; Grabowska, A; Szatkowska, I				Marchewka, Artur; Jednorog, Katarzyna; Falkiewicz, Marcel; Szeszkowski, Wojciech; Grabowska, Anna; Szatkowska, Iwona			Sex, Lies and fMRI-Gender Differences in Neural Basis of Deception	PLOS ONE			English	Article							PREFRONTAL CORTEX; WORKING-MEMORY; BRAIN ACTIVATION; INHIBITION; CEREBELLUM; CONFLICT; ROLES; TASK	Deception has always been a part of human communication as it helps to promote self-presentation. Although both men and women are equally prone to try to manage their appearance, their strategies, motivation and eagerness may be different. Here, we asked if lying could be influenced by gender on both the behavioral and neural levels. To test whether the hypothesized gender differences in brain activity related to deceptive responses were caused by differential socialization in men and women, we administrated the Gender Identify Inventory probing the participants' subjective social sex role. In an fMRI session, personal information. Only for personal information, we found differences in neural responses during instructed deception in men and women. The women vs. men direct contrast revealed no significant differences in areas of activation, but men showed higher BOLD signal compared to women in the left middle front gyrus (MFG). Moreover, this effect remained unchanged when self-reported psycholoigical gender was controlled for. Thus, ourstudy showed that gender differences in the neural processes engaged during falsifying personal information might be independent from socialization.	[Marchewka, Artur; Jednorog, Katarzyna; Falkiewicz, Marcel; Grabowska, Anna; Szatkowska, Iwona] M Nencki Inst Expt Biol, Dept Neurophysiol, PL-02093 Warsaw, Poland; [Marchewka, Artur] Univ Warsaw, Fac Psychol, Warsaw, Poland; [Szeszkowski, Wojciech] Warsan Med Univ, Dept Radiol, Warsaw, Poland; [Grabowska, Anna] Warsan Sch Social Sci & Humanities, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Warsaw	Marchewka, A (corresponding author), M Nencki Inst Expt Biol, Dept Neurophysiol, PL-02093 Warsaw, Poland.	i.szatkowska@nencki.gov.pl	Jednoróg, Katarzyna/AFO-8052-2022; Szatkowska, Iwona/R-4152-2016; Marchewka, Artur/ABF-5174-2021	Jednoróg, Katarzyna/0000-0003-3072-6956; Grabowska, Anna/0000-0003-2156-350X; Szatkowska, Iwona/0000-0002-3185-7336; Marchewka, Artur/0000-0002-1982-3299	Polish Ministry of Science and Higher Education [NN 106 042 034]; Polish National Science Center [2011/01/B/HS6/04611]; European Social Fund; Human Capital Operational Programme for the execution of the project "Support for bio tech med scientists in technology transfer" [UDA-POKL.08.01-14-041/09-00]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Polish National Science Center; European Social Fund(European Social Fund (ESF)); Human Capital Operational Programme for the execution of the project "Support for bio tech med scientists in technology transfer"	This study was supported by grants from the Polish Ministry of Science and Higher Education (grant number: NN 106 042 034) and from the Polish National Science Center (grant number 2011/01/B/HS6/04611). Marcel Falkiewicz has been supported with scholarship from the European Social Fund, Human Capital Operational Programme for the execution of the project "Support for bio tech med scientists in technology transfer" (UDA-POKL.08.01-14-041/09-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2006, CEREB CORTEX, V16, P192, DOI 10.1093/cercor/bhi097; Abe N, 2007, J COGNITIVE NEUROSCI, V19, P287, DOI 10.1162/jocn.2007.19.2.287; Abe N, 2011, NEUROSCIENTIST, V17, P560, DOI 10.1177/1073858410393359; Abe N, 2009, CURR OPIN NEUROL, V22, P594, DOI 10.1097/WCO.0b013e328332c3cf; Abe N, 2009, BRAIN, V132, P1386, DOI 10.1093/brain/awp052; Andreasen NC, 1999, HUM BRAIN MAPP, V8, P226, DOI 10.1002/(SICI)1097-0193(1999)8:4<226::AID-HBM6>3.3.CO;2-W; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bauer K, 2008, GENDER DIFFERENCES E; Bell EC, 2006, NEUROIMAGE, V30, P529, DOI 10.1016/j.neuroimage.2005.09.049; Bem S. L., 1981, J PERS SOC PSYCHOL; Bjorklund DF, 1996, PSYCHOL BULL, V120, P163, DOI 10.1037/0033-2909.120.2.163; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brett M, 2002, NEUROIMAGE, V16; Buchsbaum BR, 2005, HUM BRAIN MAPP, V25, P35, DOI 10.1002/hbm.20128; Christ SE, 2009, CEREB CORTEX, V19, P1557, DOI 10.1093/cercor/bhn189; D'Esposito M, 1999, P NATL ACAD SCI USA, V96, P7514, DOI 10.1073/pnas.96.13.7514; DePaulo B., 1993, LYING DECEPTION EVER, P126; DePaulo BM, 1996, J PERS SOC PSYCHOL, V70, P979, DOI 10.1037/0022-3514.70.5.979; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Dreber A, 2008, ECON LETT, V99, P197, DOI 10.1016/j.econlet.2007.06.027; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; Feldman RS, 2002, BASIC APPL SOC PSYCH, V24, P163, DOI 10.1207/S15324834BASP2402_8; Ganis G, 2003, CEREB CORTEX, V13, P830, DOI 10.1093/cercor/13.8.830; Ganis G, 2009, SOC NEUROSCI, V4, P465, DOI 10.1080/17470910802507660; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Greely HT, 2007, AM J LAW MED, V33, P377, DOI 10.1177/009885880703300211; Herman-Jeglinska A, 2002, ARCH SEX BEHAV, V31, P527, DOI 10.1023/A:1020611416035; Hines TM, 1996, ACTA NEUROBIOL EXP, V56, P263; HUSELID RF, 1992, J HEALTH SOC BEHAV, V33, P348, DOI 10.2307/2137313; Jonides J, 1998, P NATL ACAD SCI USA, V95, P8410, DOI 10.1073/pnas.95.14.8410; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; Karim AA, 2010, CEREB CORTEX, V20, P205, DOI 10.1093/cercor/bhp090; Kaylor-Hughes CJ, 2011, CRIM BEHAV MENT HEAL, V21, P8, DOI 10.1002/cbm.785; Kenner NM, 2010, J NEUROSCI, V30, P8512, DOI 10.1523/JNEUROSCI.1096-10.2010; Kuczynska A., 1992, INWENTARZ OCENY PLCI; Lee TMC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012291; Lee TMC, 2002, HUM BRAIN MAPP, V15, P157, DOI 10.1002/hbm.10020; Li CSR, 2006, NEUROIMAGE, V32, P1918, DOI 10.1016/j.neuroimage.2006.05.017; Marvel CL, 2010, NEUROPSYCHOL REV, V20, P271, DOI 10.1007/s11065-010-9137-7; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Nunez JM, 2005, NEUROIMAGE, V25, P267, DOI 10.1016/j.neuroimage.2004.10.041; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paulus MP, 2003, NEUROREPORT, V14, P1311, DOI 10.1097/01.wnr.0000078543.07662.02; Rosenblitt JC, 2001, HORM BEHAV, V40, P396, DOI 10.1006/hbeh.2001.1704; Ross M, 1990, SELF INFERENCE PROCE, V6, P135; Silverman IW, 2003, DEV REV, V23, P219, DOI 10.1016/S0273-2297(03)00012-1; Sip KE, 2008, TRENDS COGN SCI, V12, P48, DOI 10.1016/j.tics.2007.11.008; Sip KE, 2010, NEUROPSYCHOLOGIA, V48, P3619, DOI 10.1016/j.neuropsychologia.2010.08.013; Speck O, 2000, NEUROREPORT, V11, P2581, DOI 10.1097/00001756-200008030-00046; Spence SA, 2001, NEUROREPORT, V12, P2849, DOI 10.1097/00001756-200109170-00019; Staunton C, 2011, J CRIM PSYCHOL, V1, P1, DOI 10.1108/20093829201100001; Szatkowska I, 2008, NEUROBIOL LEARN MEM, V90, P475, DOI 10.1016/j.nlm.2008.06.001; Szatkowska I, 2011, NEUROBIOL LEARN MEM, V96, P385, DOI 10.1016/j.nlm.2011.06.014; THOMAS BS, 1995, J ADOLESCENT HEALTH, V17, P91, DOI 10.1016/1054-139X(94)00104-M; Thompson-Schill SL, 2002, COGN AFFECT BEHAV NE, V2, P109, DOI 10.3758/CABN.2.2.109; TOOKE W, 1991, ETHOL SOCIOBIOL, V12, P345, DOI 10.1016/0162-3095(91)90030-T; Tyler JM, 2004, J APPL SOC PSYCHOL, V34, P2602, DOI 10.1111/j.1559-1816.2004.tb01994.x; Whiteside SP, 2003, EXP CLIN PSYCHOPHARM, V11, P210, DOI 10.1037/1064-1297.11.3.210; Whitley BE, 1999, SEX ROLES, V41, P657, DOI 10.1023/A:1018863909149	60	34	35	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43076	10.1371/journal.pone.0043076	http://dx.doi.org/10.1371/journal.pone.0043076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952631	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206000017
J	Wang, TG; Lee, MH; Choi, E; Pardo-Villamizar, CA; Lee, SB; Yang, IH; Calabresi, PA; Nath, A				Wang, Tongguang; Lee, Myoung-Hwa; Choi, Elliot; Pardo-Villamizar, Carlos A.; Lee, Sung Bin; Yang, In Hong; Calabresi, Peter A.; Nath, Avindra			Granzyme B-Induced Neurotoxicity Is Mediated via Activation of PAR-1 Receptor and Kv1.3 Channel	PLOS ONE			English	Article							POTASSIUM CHANNELS; T-CELLS; NOTCH-1 ACTIVATION; THERAPEUTIC TARGET; ADENYLYL-CYCLASE; NEURONAL DAMAGE; OLFACTORY-BULB; LATE-PHASE; BRAIN; EXPRESSION	Increasing evidence supports a critical role of T cells in neurodegeneration associated with acute and subacute brain inflammatory disorders. Granzyme B (GrB), released by activated T cells, is a cytotoxic proteinase which may induce perforin-independent neurotoxicity. Here, we studied the mechanism of perforin-independent GrB toxicity by treating primary cultured human neuronal cells with recombinant GrB. GrBactivated the protease-activated receptor (PAR)-1 receptor on the neuronal cell surface leading to decreased intracellular cyclic AMP levels. This was followed by increased expression and translocation of the voltage gated potassium channel, Kv1.3 to the neuronal cell membrane. Similar expression of Kv1.3 was also seen in neurons of the cerebral cortex adjacent to active inflammatory lesions in patients with multiple sclerosis. Kv1.3 expression was followed by activation of Notch-1 resulting in neurotoxicity. Blocking PAR-1, Kv1.3 or Notch-1 activation using specific pharmacological inhibitors or siRNAs prevented GrB-induced neurotoxicity. Furthermore, clofazimine protected against GrB-induced neurotoxicity in rat hippocampus, in vivo. These observations indicate that GrB released from T cells induced neurotoxicity by interacting with the membrane bound Gi-coupled PAR-1 receptor and subsequently activated Kv1.3 and Notch-1. These pathways provide novel targets to treat T cell-mediated neuroinflammatory disorders. Kv1.3 is of particular interest since it is expressed on the cell surface, only under pathological circumstances, and early in the cascade of events making it an attractive therapeutic target.	[Wang, Tongguang; Lee, Myoung-Hwa; Choi, Elliot; Nath, Avindra] NINDS, Sect Infect Nervous Syst, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Pardo-Villamizar, Carlos A.; Calabresi, Peter A.; Nath, Avindra] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Lee, Sung Bin; Yang, In Hong] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Yang, In Hong] Natl Univ Singapore, Singapore Inst Nanotechnol, Singapore 117548, Singapore	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Johns Hopkins University; Johns Hopkins University; National University of Singapore	Wang, TG (corresponding author), NINDS, Sect Infect Nervous Syst, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	natha@ninds.nih.gov	Pardo, Carlos A./A-5192-2008; Yang, In Hong/F-9125-2015; Calabresi, Peter A./AAF-2288-2019	Pardo, Carlos A./0000-0002-4128-5335; Yang, In Hong/0000-0002-1020-0538	National Multiple Sclerosis Society; National Institutes of Health (NIH) [NS41435]; NIH intramural funds; Project Restore-Bart Mclean Fund for Neuroimmunology Research; Maryland Stem Cell Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041435, ZIANS003130, ZIANS003134] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH intramural funds(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Project Restore-Bart Mclean Fund for Neuroimmunology Research; Maryland Stem Cell Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by grants from the National Multiple Sclerosis Society, the National Institutes of Health (NIH) (NS41435, PAC), NIH intramural funds, Project Restore-Bart Mclean Fund for Neuroimmunology Research, and the Maryland Stem Cell Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Baliko F, 2007, AM J PATHOL, V170, P1686, DOI 10.2353/ajpath.2007.060971; Beeton C, 2001, J IMMUNOL, V166, P936, DOI 10.4049/jimmunol.166.2.936; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Biju KC, 2008, J COMP NEUROL, V506, P161, DOI 10.1002/cne.21540; Bock J, 2002, BIOCHEM BIOPH RES CO, V295, P526, DOI 10.1016/S0006-291X(02)00695-2; Chaitanya GV, 2009, NEUROPATHOLOGY, V29, P270, DOI 10.1111/j.1440-1789.2008.00980.x; Clayberger C, 2009, CURR OPIN ORGAN TRAN, V14, P30, DOI 10.1097/MOT.0b013e32831c8462; Colley B, 2004, RECEPTOR CHANNEL, V10, P25, DOI 10.1080/10606820490270870; Colley BS, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-8; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Doczi MA, 2008, AM J PHYSIOL-REG I, V295, pR733, DOI 10.1152/ajpregu.00077.2008; Fordyce CB, 2005, J NEUROSCI, V25, P7139, DOI 10.1523/JNEUROSCI.1251-05.2005; Ganor Y, 2007, J IMMUNOL, V178, P683, DOI 10.4049/jimmunol.178.2.683; Giuliani F, 2003, J IMMUNOL, V171, P368, DOI 10.4049/jimmunol.171.1.368; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Hamill CE, 2007, MOL PHARMACOL, V72, P653, DOI 10.1124/mol.107.038158; Hu DH, 2009, GLIA, V57, P1492, DOI 10.1002/glia.20865; Ishikura N, 2005, P NATL ACAD SCI USA, V102, P886, DOI 10.1073/pnas.0408612101; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Junge CE, 2003, P NATL ACAD SCI USA, V100, P13019, DOI 10.1073/pnas.2235594100; Jurynczyk M, 2010, J NEUROIMMUNOL, V218, P3, DOI 10.1016/j.jneuroim.2009.08.010; Kessler CB, 2007, ENDOCRINOLOGY, V148, P1666, DOI 10.1210/en.2006-0443; Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235; Kurschus FC, 2005, BLOOD, V105, P2049, DOI 10.1182/blood-2004-06-2180; Kurschus FC, 2008, P NATL ACAD SCI USA, V105, P13799, DOI 10.1073/pnas.0801724105; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Liu D, 2003, J NEUROCHEM, V86, P966, DOI 10.1046/j.1471-4159.2003.01913.x; Loeb CRK, 2006, J BIOL CHEM, V281, P28326, DOI 10.1074/jbc.M604544200; MAGNUSON DSK, 1995, ANN NEUROL, V37, P373, DOI 10.1002/ana.410370314; Marks DR, 2009, J NEUROSCI, V29, P6734, DOI 10.1523/JNEUROSCI.1350-09.2009; Mullen KM, 2006, ANN NEUROL, V60, P118, DOI 10.1002/ana.20884; Nagarsheth MH, 2006, J NEUROL SCI, V244, P111, DOI 10.1016/j.jns.2006.01.007; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; OhnoShosaku T, 1996, NEUROSCI LETT, V207, P195, DOI 10.1016/0304-3940(96)12518-0; Olianas MC, 2007, NEUROSCIENCE, V146, P1289, DOI 10.1016/j.neuroscience.2007.02.059; Olson EE, 2004, J CEREBR BLOOD F MET, V24, P964, DOI 10.1097/01.WCB.0000128266.87474.BF; Petito CK, 2006, J NEUROVIROL, V12, P272, DOI 10.1080/13550280600879204; Rangaraju S, 2009, EXPERT OPIN THER TAR, V13, P909, DOI 10.1517/14728220903018957; Ren YZR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004009; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schwab N, 2009, BRAIN, V132, P1236, DOI 10.1093/brain/awp003; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Soto I, 2006, J NEUROCHEM, V96, P82, DOI 10.1111/j.1471-4159.2005.03510.x; Spilman P, 2008, P NATL ACAD SCI USA, V105, P10595, DOI 10.1073/pnas.0803671105; Szabo I, 2005, J BIOL CHEM, V280, P12790, DOI 10.1074/jbc.M413548200; Taniguchi N, 2006, NEUROSCI LETT, V406, P38, DOI 10.1016/j.neulet.2006.06.071; Trapani JA, 2003, CURR OPIN IMMUNOL, V15, P533, DOI 10.1016/S0952-7915(03)00107-9; Trejo J, 2003, J PHARMACOL EXP THER, V307, P437, DOI 10.1124/jpet.103.052100; Turgeon VL, 1998, J NEUROSCI, V18, P6882; Wang H, 2003, BIOL CHEM, V384, P193, DOI 10.1515/BC.2003.021; Wang T, 2006, FASEB J, V20, P1209, DOI 10.1096/fj.05-5022fje; Wang TG, 2010, J NEUROSCI, V30, P5020, DOI 10.1523/JNEUROSCI.0311-10.2010; Warny M, 1999, AM J PHYSIOL-CELL PH, V276, pC717, DOI 10.1152/ajpcell.1999.276.3.C717; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Yu SP, 1999, J NEUROCHEM, V73, P933, DOI 10.1046/j.1471-4159.1999.0730933.x	56	29	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43950	10.1371/journal.pone.0043950	http://dx.doi.org/10.1371/journal.pone.0043950			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952817	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206000062
J	Maltha, J; Gamboa, D; Bendezu, J; Sanchez, L; Cnops, L; Gillet, P; Jacobs, J				Maltha, Jessica; Gamboa, Dionicia; Bendezu, Jorge; Sanchez, Luis; Cnops, Lieselotte; Gillet, Philippe; Jacobs, Jan			Rapid Diagnostic Tests for Malaria Diagnosis in the Peruvian Amazon: Impact of pfhrp2 Gene Deletions and Cross-Reactions	PLOS ONE			English	Article							PLASMODIUM-VIVAX; FALCIPARUM-MALARIA; PLDH; INSTRUCTIONS; PERFORMANCE; REGION; ASSAYS	Background: In the Peruvian Amazon, Plasmodium falciparum and Plasmodium vivax malaria are endemic in rural areas, where microscopy is not available. Malaria rapid diagnostic tests (RDTs) provide quick and accurate diagnosis. However, pfhrp2 gene deletions may limit the use of histidine-rich protein-2 (PfHRP2) detecting RDTs. Further, cross-reactions of P. falciparum with P. vivax-specific test lines and vice versa may impair diagnostic specificity. Methods: Thirteen RDT products were evaluated on 179 prospectively collected malaria positive samples. Species diagnosis was performed by microscopy and confirmed by PCR. Pfhrp2 gene deletions were assessed by PCR. Results: Sensitivity for P. falciparum diagnosis was lower for PfHRP2 compared to P. falciparum-specific Plasmodium lactate dehydrogenase (Pf-pLDH)-detecting RDTs (71.6% vs. 98.7%, p<0.001). Most (19/21) false negative PfHRP2 results were associated with pfhrp2 gene deletions (25.7% of 74 P. falciparum samples). Diagnostic sensitivity for P. vivax (101 samples) was excellent, except for two products. In 10/12 P. vivax-detecting RDT products, cross-reactions with the PfHRP2 or Pf-pLDH line occurred at a median frequency of 2.5% (range 0%-10.9%) of P. vivax samples assessed. In two RDT products, two and one P. falciparum samples respectively cross-reacted with the Pv-pLDH line. Two Pf-pLDH/pan-pLDH-detecting RDTs showed excellent sensitivity with few (1.0%) cross-reactions but showed faint Pf-pLDH lines in 24.7% and 38.9% of P. falciparum samples. Conclusion: PfHRP2-detecting RDTs are not suitable in the Peruvian Amazon due to pfhrp2 gene deletions. Two Pf-pLDH-detecting RDTs performed excellently and are promising RDTs for this region although faint test lines are of concern.	[Maltha, Jessica; Cnops, Lieselotte; Gillet, Philippe; Jacobs, Jan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Gamboa, Dionicia; Bendezu, Jorge; Sanchez, Luis] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Dept Ciencias Celulares & Mol, Fac Ciencias & Filosofia, Lima, Peru	Institute of Tropical Medicine (ITM); Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia	Maltha, J (corresponding author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.	jmaltha@itg.be	Gamboa, Dionicia/CAF-2097-2022; Jacobs, Jan/GRX-7316-2022; Bendezu, Jorge/L-6597-2019	Gamboa, Dionicia/0000-0002-1420-7729; Bendezu, Jorge/0000-0001-7102-3144; gillet, philippe/0000-0001-5878-6446; Cnops, Lieselotte/0000-0003-0658-1291	Steunfonds Marguerite-Marie Delacroix; National Institute of Health [U19 AI089681]; Directorate General for Development Cooperation (DGCD) of the Belgian Government [95502]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089681] Funding Source: NIH RePORTER	Steunfonds Marguerite-Marie Delacroix; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Directorate General for Development Cooperation (DGCD) of the Belgian Government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Part of the work performed by JM was funded by the "Steunfonds Marguerite-Marie Delacroix". Part of the work performed by DG and JB was funded by a National Institute of Health grant (U19 AI089681) and by Directorate General for Development Cooperation (DGCD) of the Belgian Government (framework agreement 3, project 95502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, MAL RAP DIAGN TEST P; [Anonymous], 2009, MAL RAP DIAGN TEST P; Arrospide N, 2006, REV PERU MED EXP SAL, P23; Baker J, 2005, J INFECT DIS, V192, P870, DOI 10.1086/432010; Baker J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022593; Bendezu J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-154; Cho D, 2001, PARASITOL RES, V87, P445, DOI 10.1007/s004360000360; Cnops L, 2010, CLIN MICROBIOL INFEC; Durand V Salomón, 2005, Rev. perú. med. exp. salud publica, V22, P47; Forney JR, 2003, J CLIN MICROBIOL, V41, P2358, DOI 10.1128/JCM.41.6.2358-2366.2003; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Gobierno regional de Loreto, 2011, AN SIT SAL REG LOR A; Harvey SA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-160; Houze S, 2011, J CLIN MICROBIOL, V49, P2694, DOI 10.1128/JCM.00281-11; Koita OA, 2012, AM J TROP MED HYG, V86, P194, DOI 10.4269/ajtmh.2012.10-0665; Maltha J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-7; Maltha J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-198; Mayxay M, 2004, TROP MED INT HEALTH, V9, P325, DOI 10.1111/j.1365-3156.2004.01199.x; Mayxay M, 2001, T ROY SOC TROP MED H, V95, P179, DOI 10.1016/S0035-9203(01)90156-7; Minesterio de Salud, 2011, BOL EP AN 2011; Piper RC, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-213; Rennie W, 2007, T ROY SOC TROP MED H, V101, P9, DOI 10.1016/j.trstmh.2006.03.011; Aguirre AMR, 2009, REV PANAM SALUD PUBL, V25, P377, DOI 10.1590/S1020-49892009000500001; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2010, BAS MAL MICR 1; WHO, 2010, GUID TREATM MAL, V2nd; World Health Organization, 2018, MAL RAP DIAGN TEST P	27	83	83	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43094	10.1371/journal.pone.0043094	http://dx.doi.org/10.1371/journal.pone.0043094			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952633	Green Published, Green Submitted, gold			2022-12-25	WOS:000308213600014
J	Li, ZY; Yi, YZ; Yin, XP; Zhang, Y; Liu, M; Liu, H; Li, XR; Li, YN; Zhang, ZF; Liu, JX				Li, Zhiyong; Yi, Yongzhu; Yin, Xiangping; Zhang, Yun; Liu, Ming; Liu, Hang; Li, Xuerui; Li, Yinu; Zhang, Zhifang; Liu, Jixing			Development of a Foot-and-Mouth Disease Virus Serotype A Empty Capsid Subunit Vaccine Using Silkworm (Bombyx mori) Pupae	PLOS ONE			English	Article							IMMUNE-RESPONSES; ANTIBODY-RESPONSE; FMDV; EXPRESSION; PROTECTION; SWINE; BACULOVIRUS; CHALLENGE; INDUCTION; SYSTEM	Foot-and-mouth disease (FMD) is a highly contagious disease of cloven-hoofed animals that inflicts severe economic losses in the livestock industry. In 2009, FMDV serotype A caused outbreaks of FMD in cattle in China. Although an inactivated virus vaccine has proven effective to control FMD, its use may lead to new disease outbreaks due to a possible incomplete inactivation of the virus during the manufacturing process. Here, we expressed the P1-2A and the 3C coding regions of a serotype A FMDV field isolate in silkworm pupae (Bombyx mori) and evaluated the immunogenicity of the expression products. Four of five cattle vaccinated with these proteins developed high titers of FMDV-specific antibody and were completely protected against virulent homologous virus challenge with 10,000 50% bovine infectious doses (BID50). Furthermore, the 50% bovine protective dose (PD50) test was performed to assess the bovine potency of the empty capsid subunit vaccine and was shown to achieve 4.33 PD50 per dose. These data provide evidence that silkworm pupae can be used to express immunogenic FMDV proteins. This strategy might be used to develop a new generation of empty capsid subunit vaccines against a variety of diseases.	[Li, Zhiyong; Yin, Xiangping; Zhang, Yun; Liu, Ming; Liu, Hang; Li, Xuerui; Liu, Jixing] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Grazing Anim Dis, State Key Lab Vet Etiol Biol,Minist Agr, Lanzhou, Gansu, Peoples R China; [Yi, Yongzhu; Li, Yinu; Zhang, Zhifang] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Li, ZY (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Grazing Anim Dis, State Key Lab Vet Etiol Biol,Minist Agr, Lanzhou, Gansu, Peoples R China.	zhifangzhang@yahoo.com; liujixing@hotmail.com		Li, Yinu/0000-0002-9310-8381	National 863 Project of China [2011AA10A211-3, 2006AA02Z440]; International Science & Technology Cooperation Program of China [2011DFA31830]; National Natural Science Foundation of China [3107139]; Chinese Funding for Social Public Interests [2005DIB4J041]	National 863 Project of China(National High Technology Research and Development Program of China); International Science & Technology Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Funding for Social Public Interests	This work was supported by grants from National 863 Project of China (Grant No. 2011AA10A211-3, 2006AA02Z440), International Science & Technology Cooperation Program of China (Grant No. 2011DFA31830), National Natural Science Foundation of China (Grant No. 3107139), and Chinese Funding for Social Public Interests (No. 2005DIB4J041). The funders had no role in the study design and conduct, data collection and analysis, decision to publish, or in the preparation of the manuscript.	Cao YM, 2009, VET MICROBIOL, V137, P10, DOI 10.1016/j.vetmic.2008.12.007; Chen WZ, 2004, J VIROL, V78, P6900, DOI 10.1128/JVI.78.13.6900-6907.2004; De Clercq K, 2008, TRANSBOUND EMERG DIS, V55, P46, DOI 10.1111/j.1865-1682.2007.01012.x; Doel TR, 2003, VIRUS RES, V91, P81, DOI 10.1016/S0168-1702(02)00261-7; Domingo E, 2003, VIRUS RES, V91, P47, DOI 10.1016/S0168-1702(02)00259-9; FERRIS NP, 1990, J VIROL METHODS, V29, P33, DOI 10.1016/0166-0934(90)90005-Z; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; HAMBLIN C, 1986, J IMMUNOL METHODS, V93, P115, DOI 10.1016/0022-1759(86)90441-2; Jin RZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003933; Kato T, 2010, APPL MICROBIOL BIOT, V85, P459, DOI 10.1007/s00253-009-2267-2; LEWIS SA, 1991, J VIROL, V65, P6572, DOI 10.1128/JVI.65.12.6572-6580.1991; Li XM, 2008, VACCINE, V26, P2714, DOI 10.1016/j.vaccine.2008.03.020; Li YM, 2006, VACCINE, V24, P4602, DOI 10.1016/j.vaccine.2005.08.032; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002273; Lin XA, 2006, Z NATURFORSCH C, V61, P595; Ma MX, 2008, VET IMMUNOL IMMUNOP, V121, P1, DOI 10.1016/j.vetimm.2007.06.029; Mayr GA, 2001, VACCINE, V19, P2152, DOI 10.1016/S0264-410X(00)00384-4; Moraes MP, 2003, VACCINE, V22, P268, DOI 10.1016/S0264-410X(03)00560-7; Moraes MP, 2002, VACCINE, V20, P1631, DOI 10.1016/S0264-410X(01)00483-2; Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7; Pacheco JM, 2005, VIROLOGY, V337, P205, DOI 10.1016/j.virol.2005.04.014; Rodriguez LL, 2009, VACCINE, V27, pD90, DOI 10.1016/j.vaccine.2009.08.039; Santos MJD, 2005, VACCINE, V23, P1838, DOI 10.1016/j.vaccine.2004.11.014; Su BW, 2008, VACCINE, V26, P5111, DOI 10.1016/j.vaccine.2008.03.089; Wang CY, 2001, BIOLOGICALS, V29, P221, DOI 10.1006/biol.2001.0302; Wang CY, 2002, VACCINE, V20, P2603, DOI 10.1016/S0264-410X(02)00148-2; Wang DM, 2008, TRANSGENIC RES, V17, P1163, DOI 10.1007/s11248-008-9188-1; Wang YZ, 2005, APPL MICROBIOL BIOT, V69, P385, DOI 10.1007/s00253-005-1998-y; Wu XF, 2001, GENE EXPRESSION TECH, P135	29	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43849	10.1371/journal.pone.0043849	http://dx.doi.org/10.1371/journal.pone.0043849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952788	Green Published, Green Submitted, gold			2022-12-25	WOS:000308044800066
J	Hedin, M; Starrett, J; Akhter, S; Schonhofer, AL; Shultz, JW				Hedin, Marshal; Starrett, James; Akhter, Sajia; Schoenhofer, Axel L.; Shultz, Jeffrey W.			Phylogenomic Resolution of Paleozoic Divergences in Harvestmen (Arachnida, Opiliones) via Analysis of Next-Generation Transcriptome Data	PLOS ONE			English	Article							FOSSIL CALIBRATIONS; BAYESIAN-ESTIMATION; VENOM GLAND; RNA-SEQ; GENES; INFORMATIVENESS; EVOLUTIONARY; SEQUENCES; TIMES; MULTILOCUS	Next-generation sequencing technologies are rapidly transforming molecular systematic studies of non-model animal taxa. The arachnid order Opiliones (commonly known as "harvestmen") includes more than 6,400 described species placed into four well-supported lineages (suborders). Fossil plus molecular clock evidence indicates that these lineages were diverging in the late Silurian to mid-Carboniferous, with some fossil harvestmen representing the earliest known land animals. Perhaps because of this ancient divergence, phylogenetic resolution of subordinal interrelationships within Opiliones has been difficult. We present the first phylogenomics analysis for harvestmen, derived from comparative RNA-Seq data for eight species representing all suborders. Over 30 gigabases of original Illumina short-read data were used in de novo assemblies, resulting in 50-80,000 transcripts per taxon. Transcripts were compared to published scorpion and tick genomics data, and a stringent filtering process was used to identify over 350 putatively single-copy, orthologous protein-coding genes shared among taxa. Phylogenetic analyses using various partitioning strategies, data coding schemes, and analytical methods overwhelmingly support the "classical" hypothesis of Opiliones relationships, including the higher-level clades Palpatores and Phalangida. Relaxed molecular clock analyses using multiple alternative fossil calibration strategies corroborate ancient divergences within Opiliones that are possibly deeper than the recorded fossil record indicates. The assembled data matrices, comprising genes that are conserved, highly expressed, and varying in length and phylogenetic informativeness, represent an important resource for future molecular systematic studies of Opiliones and other arachnid groups.	[Hedin, Marshal; Schoenhofer, Axel L.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Starrett, James] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Akhter, Sajia] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA; [Shultz, Jeffrey W.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	California State University System; San Diego State University; University of California System; University of California Riverside; California State University System; San Diego State University; University System of Maryland; University of Maryland College Park	Hedin, M (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	mhedin@sciences.sdsu.edu			National Science Foundation [0640179, 0640173]; California State University Program for Education and Research in Biotechnology (CSUPERB); Maryland Agricultural Experiment Station; Deutsche Forschungsgemeinschaft (DFG)	National Science Foundation(National Science Foundation (NSF)); California State University Program for Education and Research in Biotechnology (CSUPERB); Maryland Agricultural Experiment Station; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Research funding was provided by a collaborative National Science Foundation grant awarded to JWS (award no. 0640179) and MH (award no. 0640173), and a California State University Program for Education and Research in Biotechnology (CSUPERB) grant to MH. JWS was also supported by the Maryland Agricultural Experiment Station, and AS was supported by a postdoc grant from the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Andrews S, 2011, FASTQC QUALITY CONTR; Bellgard MI, 2012, INT J PARASITOL, V42, P161, DOI 10.1016/j.ijpara.2011.11.006; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Bybee SM, 2011, GENOME BIOL EVOL, V3, P1312, DOI 10.1093/gbe/evr106; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Drummond A., 2011, GENEIOUS V5 5; Dunlop J.A., 2007, HARVESTMEN BIOL OPIL, DOI [10.4159/9780674276833-007, DOI 10.4159/9780674276833-007]; Dunlop JA, 2004, T ROY SOC EDIN-EARTH, V94, P341, DOI 10.1017/S0263593300000730; Dunlop JA, 2003, NATURE, V425, P916, DOI 10.1038/425916a; Dunlop Jason A., 2007, P247; Dunlop JA, 2010, ARTHROPOD STRUCT DEV, V39, P124, DOI 10.1016/j.asd.2010.01.003; Dunlop JA, 2009, EXP APPL ACAROL, V48, P183, DOI 10.1007/s10493-009-9247-1; Fong JJ, 2011, MOL PHYLOGENET EVOL, V61, P300, DOI 10.1016/j.ympev.2011.06.016; Garwood RJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1458; Giribet G, 2005, P ROY SOC B-BIOL SCI, V272, P1007, DOI 10.1098/rspb.2005.3063; Giribet G, 1999, MOL PHYLOGENET EVOL, V11, P296, DOI 10.1006/mpev.1998.0583; Giribet G, 2001, NATURE, V413, P157, DOI 10.1038/35093097; Giribet G, 2002, CLADISTICS, V18, P5, DOI 10.1006/clad.2001.0185; Giribet Gonzalo, 2007, P62; Giribet G, 2012, BIOL J LINN SOC, V105, P92, DOI 10.1111/j.1095-8312.2011.01774.x; Giribet G, 2010, CLADISTICS, V26, P408, DOI 10.1111/j.1096-0031.2009.00296.x; Hansen H. J., 1904, 2 ORDERS ARACHNIDA O; Hartmann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029843; Harvey MS, 2002, J ARACHNOL, V30, P357, DOI 10.1636/0161-8202(2002)030[0357:TNCWDW]2.0.CO;2; Hedin M, 2010, J ARACHNOL, V38, P9, DOI 10.1636/HA09-49.1; Hittinger CT, 2010, P NATL ACAD SCI USA, V107, P1476, DOI 10.1073/pnas.0910449107; Huang DY, 2009, NATURWISSENSCHAFTEN, V96, P955, DOI 10.1007/s00114-009-0556-3; Inoue J, 2010, SYST BIOL, V59, P74, DOI 10.1093/sysbio/syp078; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382; Kury A.B., 2011, CLASSIFICATION OPILI; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2008, PHYLOBAYES 2 3 BAYES; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Lopez-Giraldez F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-152; Ma YB, 2010, PROTEOMICS, V10, P2471, DOI 10.1002/pmic.200900763; Machado Glauco, 2007, P1; Mardis ER, 2011, NATURE, V470, P198, DOI 10.1038/nature09796; Martens J., 1980, P355; Martens J., 1986, P289; MARTENS J, 1976, Entomologica Germanica, V3, P51; Masta SE, 2010, GENE, V449, P9, DOI 10.1016/j.gene.2009.09.009; Mattila TM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-70; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; McCormack JE, 2012, MOL PHYLO E IN PRESS; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Moeller AH, 2011, MOL PHYLOGENET EVOL, V60, P271, DOI 10.1016/j.ympev.2011.04.023; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Pick C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-167; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Prosdocimi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021634; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Rehm P, 2011, MOL PHYLOGENET EVOL, V61, P880, DOI 10.1016/j.ympev.2011.09.003; Sanders KL, 2010, SYST BIODIVERS, V8, P63, DOI 10.1080/14772000903562012; Sanderson MJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-155; Schaefer I, 2010, MOL PHYLOGENET EVOL, V57, P113, DOI 10.1016/j.ympev.2010.04.015; Schultz Jeffrey W., 2007, P14; Schwartz EF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-119; Sharma PP, 2011, INVERTEBR SYST, V25, P106, DOI 10.1071/IS11002; Shultz JW, 2007, ZOOL J LINN SOC-LOND, V150, P221, DOI 10.1111/j.1096-3642.2007.00284.x; Shultz JW, 1998, J ARACHNOL, V26, P257; SHULTZ JW, 1990, CLADISTICS, V6, P1, DOI 10.1111/j.1096-0031.1990.tb00523.x; Shultz JW, 2001, J ARACHNOL, V29, P189, DOI 10.1636/0161-8202(2001)029[0189:PAOPAO]2.0.CO;2; Shulz MH, 2012, BIOINFORMATICS; Stamatakis A., 2008, RAXML 7 0 4 MANUAL; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Townsend JP, 2008, J MOL EVOL, V67, P437, DOI 10.1007/s00239-008-9142-0; Townsend JP, 2007, SYSTEMATIC BIOL, V56, P222, DOI 10.1080/10635150701311362; Van Zee JP, 2007, INT J PARASITOL, V37, P1297, DOI 10.1016/j.ijpara.2007.05.011; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhao RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-452	79	52	52	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42888	10.1371/journal.pone.0042888	http://dx.doi.org/10.1371/journal.pone.0042888			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936998	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500019
J	Ledberg, A; Montagnini, A; Coppola, R; Bressler, SL				Ledberg, Anders; Montagnini, Anna; Coppola, Richard; Bressler, Steven L.			Reduced Variability of Ongoing and Evoked Cortical Activity Leads to Improved Behavioral Performance	PLOS ONE			English	Article							VISUAL-CORTEX V1; CEREBRAL-CORTEX; PSYCHOPHYSICS TOOLBOX; RESPONSE VARIABILITY; NEURAL ACTIVITY; STRIATE CORTEX; EYE-MOVEMENTS; REACTION-TIME; AREA V4; ATTENTION	Sensory responses of the brain are known to be highly variable, but the origin and functional relevance of this variability have long remained enigmatic. Using the variable foreperiod of a visual discrimination task to assess variability in the primate cerebral cortex, we report that visual evoked response variability is not only tied to variability in ongoing cortical activity, but also predicts mean response time. We used cortical local field potentials, simultaneously recorded from widespread cortical areas, to gauge both ongoing and visually evoked activity. Trial-to-trial variability of sensory evoked responses was strongly modulated by foreperiod duration and correlated both with the cortical variability before stimulus onset as well as with response times. In a separate set of experiments we probed the relation between small saccadic eye movements, foreperiod duration and manual response times. The rate of eye movements was modulated by foreperiod duration and eye position variability was positively correlated with response times. Our results indicate that when the time of a sensory stimulus is predictable, reduction in cortical variability before the stimulus can improve normal behavioral function that depends on the stimulus.	[Ledberg, Anders] Univ Pompeu Fabra, Ctr Brain & Cognit, Dept Informat & Commun Technol, Barcelona, Spain; [Montagnini, Anna] Ctr Natl Rech Sci, Inst Neurosci Timone, Marseille, France; [Montagnini, Anna] Aix Marseille Univ, Marseille, France; [Coppola, Richard] NIMH, Clin Brain Disorders Branch, Bethesda, MD 20892 USA; [Bressler, Steven L.] Florida Atlantic Univ, Ctr Complex Syst & Brain Sci, Dept Psychol, Boca Raton, FL 33431 USA	Pompeu Fabra University; University of Barcelona; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); State University System of Florida; Florida Atlantic University	Ledberg, A (corresponding author), Univ Pompeu Fabra, Ctr Brain & Cognit, Dept Informat & Commun Technol, Barcelona, Spain.	anders.ledberg@gmail.com		Coppola, Richard/0000-0003-0273-0675; Ledberg, Anders/0000-0003-3827-8721	European Union [269921]; Ramon y Cajal program from the Spanish government; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002890] Funding Source: NIH RePORTER	European Union(European Commission); Ramon y Cajal program from the Spanish government(Spanish Government); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 269921 (BrainScaleS). AL is supported by the Ramon y Cajal program from the Spanish government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; BERTELSON P, 1969, ACTA PSYCHOL, V30, P145, DOI 10.1016/0001-6918(69)90047-X; BERTELSON P, 1967, Q J EXP PSYCHOL, V19, P272, DOI 10.1080/14640746708400102; Bosman CA, 2009, J NEUROSCI, V29, P9471, DOI 10.1523/JNEUROSCI.1193-09.2009; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRESSLER SL, 1993, COMPUTATION AND NEURAL SYSTEMS, P515; Carpenter RHS, 2009, J PHYSIOL-LONDON, V587, P4051, DOI 10.1113/jphysiol.2009.173955; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Cover TM, 1991, ELEMENTS INFORM THEO; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Ergenoglu T, 2004, COGNITIVE BRAIN RES, V20, P376, DOI 10.1016/j.cogbrainres.2004.03.009; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; FUSTER JM, 1962, EXP NEUROL, V6, P384, DOI 10.1016/0014-4886(62)90020-1; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; GREEN DM, 1983, PERCEPT PSYCHOPHYS, V34, P195, DOI 10.3758/BF03202946; Gur M, 1997, J NEUROSCI, V17, P2914; Gur M, 2006, CEREB CORTEX, V16, P888, DOI 10.1093/cercor/bhj032; Hafed ZM, 2011, J NEUROSCI, V31, P15219, DOI 10.1523/JNEUROSCI.3106-11.2011; Jasper HH, 1954, BRAIN MECH CONCIOUSN; KRAUT MA, 1985, ELECTROEN CLIN NEURO, V62, P300, DOI 10.1016/0168-5597(85)90007-3; LANSING RW, 1959, J EXP PSYCHOL, V58, P1, DOI 10.1037/h0041016; Ledberg A, 2007, CEREB CORTEX, V17, P44, DOI 10.1093/cercor/bhj123; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; Luce R. D., 1986, RESPONSE TIMES; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90066-8; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PURPURA DP, 1959, INT REV NEUROBIOL, V1, P47, DOI 10.1016/S0074-7742(08)60314-1; Rajkai C, 2008, CEREB CORTEX, V18, P200, DOI 10.1093/cercor/bhm046; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Rieke F., 1997, SPIKES EXPLORING NEU; Rolfs M, 2008, J VISION, V8, DOI 10.1167/8.11.5; Roxin A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000046; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; SCHROEDER CE, 1991, VISION RES, V31, P1143, DOI 10.1016/0042-6989(91)90040-C; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; Steriade M, 1997, CEREB CORTEX, V7, P583, DOI 10.1093/cercor/7.6.583; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; VOGELS R, 1989, EXP BRAIN RES, V77, P432, DOI 10.1007/BF00275002; WERNER G, 1963, J NEUROPHYSIOL, V26, P958, DOI 10.1152/jn.1963.26.6.958; WHITSEL BL, 1977, J NEUROPHYSIOL, V40, P589, DOI 10.1152/jn.1977.40.3.589; WURTZ RH, 1969, J NEUROPHYSIOL, V32, P975, DOI 10.1152/jn.1969.32.6.975; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	53	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43166	10.1371/journal.pone.0043166	http://dx.doi.org/10.1371/journal.pone.0043166			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937021	gold, Green Submitted, Green Published			2022-12-25	WOS:000308225500033
J	Ye, L; Su, XM; Wu, ZC; Zheng, XR; Wang, J; Zi, C; Zhu, GQ; Wu, SL; Bao, WB				Ye, Lan; Su, Xianmin; Wu, Zhengchang; Zheng, Xianrui; Wang, Jin; Zi, Chen; Zhu, Guoqiang; Wu, Shenglong; Bao, Wenbin			Analysis of Differential miRNA Expression in the Duodenum of Escherichia coli F18-Sensitive and -Resistant Weaned Piglets	PLOS ONE			English	Article							CANCER; GENE; IDENTIFICATION; MICRORNAS; MECHANISM; DISEASE; GROWTH	Small RNA duodenal libraries were constructed for Escherichia coli F18-sensitive and -resistant weaned piglets in full-sib pair groups and sequenced using Illumina Solexa high-throughput sequencing technology. The identification of differentially expressed miRNAs provides the basis for improved database information on pig miRNAs, understanding the genetic basics of differences in resistance to E. coli F18 between local Chinese and exotic pig breeds, and finding new resistance markers for E. coli F18 infection. The duodenum of all individuals contained more than 90% of known swine miRNAs. A total of 58 differentially expressing miRNAs were identified, of which 46 were increased and 12 were decreased in E. coli F18-sensitive pigs. Of miRNAs with increased expression, ssc-miR-143 was most highly expressed, followed by ssc-let-7f, ssc-miR-192, and ssc-miR-21. We identified a total of 2036 intersection target genes by comparing TargetScan data and previous gene expression profile results. Gene ontology and pathway analysis of intersection genes showed that differentially expressed miRNAs were mainly involved in the immune response and transcriptional regulation. Combining information on differential miRNA expression and their regulatory relationships with transcription factors, identified 12 candidate miRNA disease markers, including 11 miRNAs with increased expression, ssc-miR-143, ssc-let-7f, ssc-miR-30e, ssc-miR-148a, ssc-miR-148b, ssc-miR-181a, ssc-miR-192, ssc-miR-27b, ssc-miR-15b, ssc-miR-21, and ssc-miR-215, and one with decreased expression, ssc-miR-152. Quantitative real-time PCR analysis of candidate miRNA expression in a larger cohort of E coli F18-sensitive and resistant animals confirmed the high-throughput sequencing results.	[Ye, Lan; Su, Xianmin; Wu, Zhengchang; Zheng, Xianrui; Wang, Jin; Zi, Chen; Wu, Shenglong; Bao, Wenbin] Yangzhou Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding Reprod & Mol Design J, Yangzhou, Jiangsu, Peoples R China; [Zhu, Guoqiang] Yangzhou Univ, Coll Vet Med, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University	Ye, L (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding Reprod & Mol Design J, Yangzhou, Jiangsu, Peoples R China.	slwu@yzu.edu.cn; wenbinbao74@yahoo.com			National Natural Science Funds [31140027, 31172183]; Science and Technology Supporting Project (agriculture) of Jiangsu Province [BE2009330-2, BE2010450]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Science and Technology Supporting Project (agriculture) of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by funding from the National Natural Science Funds (31140027, 31172183), Science and Technology Supporting Project (agriculture) of Jiangsu Province (BE2009330-2 and BE2010450) and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao N, 2004, DEV CELL, V7, P653, DOI 10.1016/j.devcel.2004.10.003; Bao WB, 2008, J ANIM BREED GENET, V125, P427, DOI 10.1111/j.1439-0388.2008.00722.x; Bao WB, 2012, ANIM GENET, V43, P525, DOI 10.1111/j.1365-2052.2011.02287.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen Y, 2010, J GASTROINTEST SURG, V14, P1170, DOI 10.1007/s11605-010-1202-2; Clape C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007542; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Kim J, 2008, MAMM GENOME, V19, P570, DOI 10.1007/s00335-008-9111-3; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Liao YL, 2009, FASEB J, V23; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Reiner G, 2011, BERL MUNCH TIERARZTL, V124, P102, DOI 10.2376/0005-9366-124-102; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015; Song B, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-96; Song YX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-1; Vogeli P, 1997, SCHWEIZ ARCH TIERH, V139, P479; Wang YF, 2009, J BIOL CHEM, V284, P23094, DOI 10.1074/jbc.M109.012617; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Xie SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016235; Ye L, 2010, CHINA ANIMAL HUSBAND, V37, P158; Zhou J, 2009, IMMUNITY, V30, P845, DOI 10.1016/j.immuni.2009.03.021	29	21	26	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43741	10.1371/journal.pone.0043741	http://dx.doi.org/10.1371/journal.pone.0043741			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937089	gold, Green Published			2022-12-25	WOS:000308225500091
J	Zhu, W; Miao, Q; Sun, D; Yang, GD; Wu, CG; Huang, JG; Zheng, CC				Zhu, Wei; Miao, Qing; Sun, Dan; Yang, Guodong; Wu, Changai; Huang, Jinguang; Zheng, Chengchao			The Mitochondrial Phosphate Transporters Modulate Plant Responses to Salt Stress via Affecting ATP and Gibberellin Metabolism in Arabidopsis thaliana	PLOS ONE			English	Editorial Material							MAIZE ROOT-TIPS; ABIOTIC STRESS; SACCHAROMYCES-CEREVISIAE; SOLUBLE SUGARS; ENERGY-CHARGE; COLD STRESSES; LIFE-CYCLE; CARRIER; TOLERANCE; EXPRESSION	The mitochondrial phosphate transporter (MPT) plays crucial roles in ATP production in plant cells. Three MPT genes have been identified in Arabidopsis thaliana. Here we report that the mRNA accumulations of AtMPTs were up-regulated by high salinity stress in A. thaliana seedlings. And the transgenic lines overexpressing AtMPTs displayed increased sensitivity to salt stress compared with the wild-type plants during seed germination and seedling establishment stages. ATP content and energy charge was higher in overexpressing plants than those in wild-type A. thaliana under salt stress. Accordingly, the salt-sensitive phenotype of overexpressing plants was recovered after the exogenous application of atractyloside due to the change of ATP content. Interestingly, Genevestigator survey and qRT-PCR analysis indicated a large number of genes, including those related to gibberellin synthesis could be regulated by the energy availability change under stress conditions in A. thaliana. Moreover, the exogenous application of uniconazole to overexpressing lines showed that gibberellin homeostasis was disturbed in the overexpressors. Our studies reveal a possible link between the ATP content mediated by AtMPTs and gibberellin metabolism in responses to high salinity stress in A. thaliana.	[Zhu, Wei; Miao, Qing; Sun, Dan; Yang, Guodong; Wu, Changai; Huang, Jinguang; Zheng, Chengchao] Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Zheng, CC (corresponding author), Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	cczheng@sdau.edu.cn	Wu, Changai/AFF-1493-2022	Wu, Changai/0000-0003-4053-8262				Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Alonso-Ramirez A, 2009, PLANT PHYSIOL, V150, P1335, DOI 10.1104/pp.109.139352; Baena-Gonzalez E, 2008, TRENDS PLANT SCI, V13, P474, DOI 10.1016/j.tplants.2008.06.006; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Bauwe H, 2010, TRENDS PLANT SCI, V15, P330, DOI 10.1016/j.tplants.2010.03.006; Claeys H, 2012, PLANT PHYSIOL, V159, P739, DOI 10.1104/pp.112.195032; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Croos JNA, 2004, J BIOENERG BIOMEMBR, V36, P229, DOI 10.1023/B:JOBB.0000031974.35812.c9; DOLCE V, 1994, J BIOL CHEM, V269, P10451; Dutilleul C, 2003, PLANT CELL, V15, P1212, DOI 10.1105/tpc.009464; Fiermonte G, 1998, J BIOL CHEM, V273, P22782, DOI 10.1074/jbc.273.35.22782; Groppa MD, 2008, AMINO ACIDS, V34, P35, DOI 10.1007/s00726-007-0501-8; Haferkamp I, 2007, FEBS LETT, V581, P2375, DOI 10.1016/j.febslet.2007.02.020; Hamel P, 2004, MOL MICROBIOL, V51, P307, DOI 10.1046/j.1365-2958.2003.03810.x; Hayashi M, 2005, P NATL ACAD SCI USA, V102, P7020, DOI 10.1073/pnas.0502556102; Hirano K, 2007, PLANT CELL, V19, P3058, DOI 10.1105/tpc.107.051524; Huang JG, 2009, PLANT CELL ENVIRON, V32, P1132, DOI 10.1111/j.1365-3040.2009.01995.x; Huang X, 2008, PLANTA, V228, P545, DOI 10.1007/s00425-008-0757-6; Jacoby RP, 2011, TRENDS PLANT SCI, V16, P614, DOI 10.1016/j.tplants.2011.08.002; Kasahara H, 2002, J BIOL CHEM, V277, P45188, DOI 10.1074/jbc.M208659200; Kiiskinen M, 1997, PLANT MOL BIOL, V35, P271, DOI 10.1023/A:1005868715571; Liu F, 2011, MOL PLANT, V4, P1105, DOI 10.1093/mp/ssr058; Magome H, 2008, PLANT J, V56, P613, DOI 10.1111/j.1365-313X.2008.03627.x; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788; Mayr JA, 2011, NEUROMUSCULAR DISORD, V21, P803, DOI 10.1016/j.nmd.2011.06.005; Millar AH, 2011, ANNU REV PLANT BIOL, V62, P79, DOI 10.1146/annurev-arplant-042110-103857; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mitchum MG, 2006, PLANT J, V45, P804, DOI 10.1111/j.1365-313X.2005.02642.x; Nakamori K, 2002, PLANT CELL PHYSIOL, V43, P1250, DOI 10.1093/pcp/pcf141; NAMBARA E, 1991, PLANT PHYSIOL, V97, P736, DOI 10.1104/pp.97.2.736; Nelson DC, 2009, PLANT PHYSIOL, V149, P863, DOI 10.1104/pp.108.131516; Noctor G, 2006, J EXP BOT, V57, P1603, DOI 10.1093/jxb/erj202; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Phelps A, 1996, BIOCHEMISTRY-US, V35, P10757, DOI 10.1021/bi961052x; Poirier Yves, 2002, Arabidopsis Book, V1, pe0024, DOI 10.1199/tab.0024; Rawyler A, 2002, ANN BOT-LONDON, V90, P499, DOI 10.1093/aob/mcf126; Ribeiro DM, 2012, J EXPT BOT; Rieu I, 2008, PLANT CELL, V20, P2420, DOI 10.1105/tpc.108.058818; Rieu I, 2008, PLANT J, V53, P488, DOI 10.1111/j.1365-313X.2007.03356.x; Robert-Seilaniantz A, 2007, CURR OPIN PLANT BIOL, V10, P372, DOI 10.1016/j.pbi.2007.06.003; Rustin P, 2009, PHYSIOL PLANTARUM, V137, P362, DOI 10.1111/j.1399-3054.2009.01249.x; SAGLIO PH, 1980, PLANT PHYSIOL, V66, P516, DOI 10.1104/pp.66.3.516; SAGLIO PH, 1980, PLANT PHYSIOL, V66, P1053, DOI 10.1104/pp.66.6.1053; Schomburg FM, 2003, PLANT CELL, V15, P151, DOI 10.1105/tpc.005975; Schroers A, 1998, J BIOL CHEM, V273, P14269, DOI 10.1074/jbc.273.23.14269; Shan DP, 2007, NEW PHYTOL, V176, P70, DOI 10.1111/j.1469-8137.2007.02160.x; Takabatake R, 2001, J BIOCHEM, V129, P827, DOI 10.1093/oxfordjournals.jbchem.a002926; Takabatake R, 1999, PLANT MOL BIOL, V40, P479, DOI 10.1023/A:1006285009435; TALON M, 1990, P NATL ACAD SCI USA, V87, P7983, DOI 10.1073/pnas.87.20.7983; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zhu JK, 2001, CURR OPIN PLANT BIOL, V4, P401, DOI 10.1016/S1369-5266(00)00192-8	53	70	83	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43530	10.1371/journal.pone.0043530	http://dx.doi.org/10.1371/journal.pone.0043530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937061	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500062
J	Gopisetty, G; Xu, J; Sampath, D; Colman, H; Puduvalli, VK				Gopisetty, G.; Xu, J.; Sampath, D.; Colman, H.; Puduvalli, V. K.			Epigenetic regulation of CD133/PROM1 expression in glioma stem cells by Sp1/myc and promoter methylation	ONCOGENE			English	Article						CD133; glioma Stem Cell; Sp1; Myc; promoter methylation; epigenetic regulation	DNA METHYLATION; CPG METHYLATION; HEMATOPOIETIC STEM; CHROMOSOMAL-PROTEIN; FUNCTIONAL-ANALYSIS; EPITHELIAL-CELLS; GENE-EXPRESSION; BINDING-SITES; C-MYC; TRANSCRIPTION	Tumor stem cells, postulated to be the source cells for malignancies, have been identified in several cancers using cell-surface expression of markers including CD133, a pentaspan membrane protein. CD133+ve cells form neurospheres, exhibit self-renewal and differentiation, and are tumorigenic. However, despite its association with stem cells, a causal relationship of CD133 to tumorigenesis remains to be defined. Hypothesizing that specific epigenetic and transcription factors implicated in driving the stem cell state may concurrently regulate CD133 expression in stem cells, we analyzed the structure and regulation of CD133 promoter in glioma stem cells and glioma cell lines. Initially, a minimal promoter region was identified by analyzing the activity of CD133 promoter-driven luciferase-expressing 5'-and 3'-deletion-constructs upstream of the transcription start site. This region contained a CpG island that was hypermethylated in CD133-ve glioma stem cells (GSC) and glioma cells but unmethylated in CD133+ve ones. Of several predicted TF-binding sites in this region, the role of tandem Sp1 (-242 and -221) and two Myc (-541 and -25)-binding sites were examined. Overexpression of Sp1 or Myc increased CD133 minimal promoter-driven luciferase activity and CD133 levels in GSC and in glioma cell line. Mithramycin, a Sp1 inhibitor, decreased minimal promoter activity and downregulated CD133 levels in GSC. Gel-shift assays demonstrated direct binding of Sp1 to their predicted sites that was competitively inhibited by oligonucleotide-binding-site sequences and supershifted by anti-Sp1 confirming the interaction. Sp1 and Myc-antibody chromatin immunoprecipitation (ChIP) analysis in GSC showed enrichment of regions with Sp1 and Myc-binding sites. In CD133-ve cells, ChIP analysis showed binding of the methyl-DNA-binding proteins, MBD1, MBD2 and MeCP2 to the methylated CpG island and repression of transcription. These results demonstrate that Sp1 and Myc regulate CD133 transcription in GSC and that promoter methylation and methyl-DNA-binding proteins cause repression of CD133 by excluding transcription-factor binding.	[Gopisetty, G.; Xu, J.; Colman, H.; Puduvalli, V. K.] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77035 USA; [Sampath, D.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77035 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Puduvalli, VK (corresponding author), Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd,Unit 431, Houston, TX 77035 USA.	vpuduval@mdanderson.org	Sampath, Deepa/T-5069-2019; Colman, Howard/L-5433-2019; Puduvalli, Vinay K/A-2411-2016; Sampath, Deepa/J-3298-2016; Gopisetty, Gopal/ABB-6470-2020	Sampath, Deepa/0000-0002-4366-8436	Gregory Jungeblut Brain Tumor Research Fund; Dr Marnie Rose Foundation; Chuoke Brain Tumor Fund; NATIONAL CANCER INSTITUTE [K24CA160777, P30CA016672] Funding Source: NIH RePORTER	Gregory Jungeblut Brain Tumor Research Fund; Dr Marnie Rose Foundation; Chuoke Brain Tumor Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge the Gregory Jungeblut Brain Tumor Research Fund, The Dr Marnie Rose Foundation and the Chuoke Brain Tumor Fund for providing funding support for this project.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; BEDNARIK DP, 1991, NEW BIOL, V3, P969; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; BOYES J, 1992, EMBO J, V11, P327, DOI 10.1002/j.1460-2075.1992.tb05055.x; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; CHEN HM, 1993, J BIOL CHEM, V268, P8230; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Cheng LP, 2004, FEBS LETT, V565, P195, DOI 10.1016/j.febslet.2004.03.097; Clouaire T, 2010, NUCLEIC ACIDS RES, V38, P4620, DOI 10.1093/nar/gkq228; COMB M, 1990, NUCLEIC ACIDS RES, V18, P3975, DOI 10.1093/nar/18.13.3975; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Cowling VH, 2006, SEMIN CANCER BIOL, V16, P242, DOI 10.1016/j.semcancer.2006.08.001; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Elsaba TMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010714; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Jiang H, 2007, J NATL CANCER I, V99, P1410, DOI 10.1093/jnci/djm102; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KADONAGA JT, 1988, SCIENCE, V242, P1566, DOI 10.1126/science.3059495; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; LopezRodriguez C, 1995, EUR J IMMUNOL, V25, P3496, DOI 10.1002/eji.1830251243; Mancini DN, 1999, ONCOGENE, V18, P4108, DOI 10.1038/sj.onc.1202764; Mancini DN, 1998, ONCOGENE, V16, P1161, DOI 10.1038/sj.onc.1201630; Marsden CG, 2009, METHODS MOL BIOL, V590, P363, DOI 10.1007/978-1-60327-378-7_23; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Neuzil J, 2007, BIOCHEM BIOPH RES CO, V355, P855, DOI 10.1016/j.bbrc.2007.01.159; Ng HH, 2000, MOL CELL BIOL, V20, P1394, DOI 10.1128/MCB.20.4.1394-1406.2000; OHTANIFUJITA N, 1993, ONCOGENE, V8, P1063; Parisi F, 2007, NUCLEIC ACIDS RES, V35, P1098, DOI 10.1093/nar/gkl1157; RAY BK, 1994, GENE, V147, P253, DOI 10.1016/0378-1119(94)90076-0; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Shmelkov SV, 2005, INT J BIOCHEM CELL B, V37, P715, DOI 10.1016/j.biocel.2004.08.010; Shmelkov SV, 2004, BLOOD, V103, P2055, DOI 10.1182/blood-2003-06-1881; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tabu K, 2008, CELL RES, V18, P1037, DOI 10.1038/cr.2008.270; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Wang JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003769; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Wu DY, 2006, CELL RES, V16, P319, DOI 10.1038/sj.cr.7310040; Yi JM, 2008, CANCER RES, V68, P8094, DOI 10.1158/0008-5472.CAN-07-6208; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zutter MM, 1997, BLOOD, V90, P678, DOI 10.1182/blood.V90.2.678.678_678_689	50	50	52	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 27	2013	32	26					3119	3129		10.1038/onc.2012.331	http://dx.doi.org/10.1038/onc.2012.331			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	172LL	22945648	Green Accepted			2022-12-25	WOS:000321004600002
J	Kopp, K; Buntru, A; Pils, S; Zimmermann, T; Frank, R; Zumbusch, A; Hauck, CR				Kopp, Kathrin; Buntru, Alexander; Pils, Stefan; Zimmermann, Timo; Frank, Ronald; Zumbusch, Andreas; Hauck, Christof R.			Grb14 Is a Negative Regulator of CEACAM3-mediated Phagocytosis of Pathogenic Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEISSERIA-GONORRHOEAE; INSULIN-RECEPTOR; PROTEINS; ANTIGEN; CEACAM3; KINASE; CELLS; FAMILY; DOMAIN; QUANTIFICATION	Carcinoembryonic antigen-related cell adhesion molecule 3 (CEACAM3) is a phagocytic receptor on human granulocytes, which mediates the opsonin-independent recognition and internalization of a restricted set of Gram-negative bacteria such as Neisseria gonorrhoeae. In an unbiased screen using a SH2 domain microarray we identified the SH2 domain of growth factor receptor-bound protein 14 (Grb14) as a novel binding partner of CEACAM3. Biochemical assays and microscopic studies demonstrated that the Grb14 SH2 domain promoted the rapid recruitment of this adaptor protein to the immunoreceptor-based activation motif (ITAM)-like sequence within the cytoplasmic domain of CEACAM3. Furthermore, FRET-FLIM analyses confirmed the direct association of Grb14 and CEACAM3 in intact cells at the sites of bacteria-host cell contact. Knockdown of endogenous Grb14 by RNA interference as well as Grb14 overexpression indicate an inhibitory role for this adapter protein in CEACAM3-mediated phagocytosis. Therefore, Grb14 is the first negative regulator of CEACAM3-initiated bacterial phagocytosis and might help to focus granulocyte responses to the subcellular sites of pathogen-host cell contact.	[Kopp, Kathrin; Buntru, Alexander; Pils, Stefan; Hauck, Christof R.] Univ Konstanz, Lehrstuhl Zellbiol, D-78457 Constance, Germany; [Buntru, Alexander; Zumbusch, Andreas; Hauck, Christof R.] Univ Konstanz, Konstanz Res Sch Chem Biol, D-78457 Constance, Germany; [Zimmermann, Timo] CRG, Adv Light Microscopy Unit, Barcelona 08003, Spain; [Frank, Ronald] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Zumbusch, Andreas] Univ Konstanz, Lehrstuhl Phys Chem, D-78457 Constance, Germany	University of Konstanz; University of Konstanz; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); University of Konstanz	Hauck, CR (corresponding author), Univ Konstanz, Lehrstuhl Zellbiol, Postfach X908, D-78457 Constance, Germany.	christof.hauck@uni-konstanz.de	Zimmermann, Timo/G-1681-2015	Zimmermann, Timo/0000-0001-7098-0700	Landesstiftung BW [LS-Prot-66]; Ministry of Science; Zukunftskolleg of the University of Konstanz; Research and the Arts of Baden-Wurttemberg [CAP17]	Landesstiftung BW; Ministry of Science(Ministry of Science, ICT & Future Planning, Republic of Korea); Zukunftskolleg of the University of Konstanz; Research and the Arts of Baden-Wurttemberg	This study was supported by funds from the Landesstiftung BW (LS-Prot-66) and by a grant from the Ministry of Science, Research and the Arts of Baden-Wurttemberg (CAP17) (to C.R.H.).; Recipient of a fellowship according to the LGFG, Baden-Wurttemberg and acknowledges support by the Zukunftskolleg of the University of Konstanz.	Bereziat V, 2002, J BIOL CHEM, V277, P4845, DOI 10.1074/jbc.M106574200; Buntru A, 2012, ARCH BIOCHEM BIOPHYS, V524, P77, DOI 10.1016/j.abb.2012.03.020; Buntru A, 2011, J BIOL CHEM, V286, P9555, DOI 10.1074/jbc.M110.216085; Buntru A, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-81; Chen T, 1996, P NATL ACAD SCI USA, V93, P14851, DOI 10.1073/pnas.93.25.14851; Cooney GJ, 2004, EMBO J, V23, P582, DOI 10.1038/sj.emboj.7600082; Daly RJ, 1996, J BIOL CHEM, V271, P12502, DOI 10.1074/jbc.271.21.12502; Depetris RS, 2005, MOL CELL, V20, P325, DOI 10.1016/j.molcel.2005.09.001; DVEKSLER GS, 1993, J VIROL, V67, P1; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Gratton E, 2003, J BIOMED OPT, V8, P381, DOI 10.1117/1.1586704; Han DC, 2001, ONCOGENE, V20, P6315, DOI 10.1038/sj.onc.1204775; Hauck CR, 1998, EMBO J, V17, P443, DOI 10.1093/emboj/17.2.443; Hauck CR, 2001, J BIOL CHEM, V276, P17653, DOI 10.1074/jbc.M009329200; Hemmila E, 2004, J VIROL, V78, P10156, DOI 10.1128/JVI.78.18.10156-10165.2004; Holt LJ, 2005, BIOCHEM J, V388, P393, DOI 10.1042/BJ20050216; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kammerer R, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-12; Kuespert K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014609; KUPSCH EM, 1993, EMBO J, V12, P641, DOI 10.1002/j.1460-2075.1993.tb05697.x; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; McCaw SE, 2003, MOL MICROBIOL, V49, P623, DOI 10.1046/j.1365-2958.2003.03591.x; Mehlitz A, 2010, J CELL BIOL, V190, P143, DOI 10.1083/jcb.200909095; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; Pils S, 2008, INT J MED MICROBIOL, V298, P553, DOI 10.1016/j.ijmm.2008.04.005; Pils S, 2006, J MICROBIOL METH, V65, P301, DOI 10.1016/j.mimet.2005.08.013; Pils S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032808; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; Schmitter T, 2004, J EXP MED, V199, P35, DOI 10.1084/jem.20030204; Schmitter T, 2007, INFECT IMMUN, V75, P4116, DOI 10.1128/IAI.01835-06; Schmitter T, 2007, J IMMUNOL, V178, P3797, DOI 10.4049/jimmunol.178.6.3797; Tramier M, 2002, BIOPHYS J, V83, P3570, DOI 10.1016/S0006-3495(02)75357-5; Voges M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-117; Wolf-Yadlin A, 2009, CURR OPIN CHEM BIOL, V13, P398, DOI 10.1016/j.cbpa.2009.06.027	37	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39158	39170		10.1074/jbc.M112.395228	http://dx.doi.org/10.1074/jbc.M112.395228			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22948154	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000310982800071
J	Ma, LQ; Zhang, XX; Zhou, M; Chen, HJ				Ma, Liqun; Zhang, Xuexin; Zhou, Min; Chen, Haijun			Acid-sensitive TWIK and TASK Two-pore Domain Potassium Channels Change Ion Selectivity and Become Permeable to Sodium in Extracellular Acidification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE INACTIVATION; K+ CHANNEL; ENDOPLASMIC-RETICULUM; PH-SENSITIVITY; N-TYPE; PORE; EXPRESSION; CURRENTS; HISTIDINE; FILTER	Two-pore domain K+ channels (K2P) mediate background K+ conductance and play a key role in a variety of cellular functions. Among the 15 mammalian K2P isoforms, TWIK-1, TASK-1, and TASK-3 K+ channels are sensitive to extracellular acidification. Lowered or acidic extracellular pH (pHo) strongly inhibits outward currents through these K2P channels. However, the mechanism of how low pHo affects these acid-sensitive K2P channels is not well understood. Here we show that in Na+ based bath solutions with physiological K+ gradients, lowered pHo largely shifts the reversal potential of TWIK-1, TASK-1, and TASK-3 K+ channels, which are heterologously expressed in Chinese hamster ovary cells, into the depolarizing direction and significantly increases their Na+ to K+ relative permeability. Low pHo-induced inhibitions in these acid-sensitive K2P channels are more profound in Na+-based bath solutions than in channel-impermeable N-methyl-D-glucamine-based bath solutions, consistent with increases in the Na+ to K+ relative permeability and decreases in electrochemical driving forces of outward K+ currents of the channels. These findings indicate that TWIK-1, TASK-1, and TASK-3 K+ channels change ion selectivity in response to lowered pHo, provide insights on the understanding of how extracellular acidification modulates acid-sensitive K2P channels, and imply that these acid-sensitive K2P channels may regulate cellular function with dynamic changes in their ion selectivity.	[Ma, Liqun; Zhang, Xuexin; Chen, Haijun] SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA; [Ma, Liqun; Zhang, Xuexin; Chen, Haijun] SUNY Albany, Neurosci Res Ctr, Albany, NY 12222 USA; [Zhou, Min] Ohio State Univ, Wexner Med Ctr, Dept Neurosci, Columbus, OH 43210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University System of Ohio; Ohio State University	Chen, HJ (corresponding author), SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA.	hchen01@albany.edu	Zhang, Xuexin/I-7600-2013; 张学新, XUEXIN ZHANG/AAD-7645-2019	张学新, XUEXIN ZHANG/0000-0001-8276-3885; Zhou, Min/0000-0001-6249-2977	National Institutes of Health through NIGMS [1R01GM102943-01A1]; American Heart Association [11GRNT7270014]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102943] Funding Source: NIH RePORTER	National Institutes of Health through NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01GM102943-01A1 (to H. C.) through the NIGMS. This work was also supported by American Heart Association (11GRNT7270014) (to H. C.).	Chatelain FC, 2012, P NATL ACAD SCI USA, V109, P5499, DOI 10.1073/pnas.1201132109; Clarke CE, 2008, J BIOL CHEM, V283, P16985, DOI 10.1074/jbc.M801368200; Claydon TW, 2002, AM J PHYSIOL-CELL PH, V283, pC1114, DOI 10.1152/ajpcell.00542.2001; Claydon TW, 2000, J PHYSIOL-LONDON, V526, P253, DOI 10.1111/j.1469-7793.2000.00253.x; Cohen A, 2009, EUR BIOPHYS J BIOPHY, V39, P61, DOI 10.1007/s00249-009-0457-6; Cohen A, 2008, J BIOL CHEM, V283, P19448, DOI 10.1074/jbc.M801273200; COULTER KL, 1995, NEURON, V15, P1157, DOI 10.1016/0896-6273(95)90103-5; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Feliciangeli S, 2010, J BIOL CHEM, V285, P4798, DOI 10.1074/jbc.M109.078535; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Goldstein SAN, 2005, PHARMACOL REV, V57, P527, DOI 10.1124/pr.57.4.12; Goldstein SAN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002225; HILLE B, 2001, ION CHANNELS EXCITAB, P469; Kang D, 2004, J BIOL CHEM, V279, P28063, DOI 10.1074/jbc.M402940200; Kehl SJ, 2002, J PHYSIOL-LONDON, V541, P9, DOI 10.1113/jphysiol.2001.014456; Keshavaprasad B, 2005, ANESTH ANALG, V101, P1042, DOI 10.1213/01.ane.0000168447.87557.5a; Kim Y, 1999, AM J PHYSIOL-HEART C, V277, pH1669, DOI 10.1152/ajpheart.1999.277.5.H1669; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; Kiss L, 1999, BIOPHYS J, V76, P253, DOI 10.1016/S0006-3495(99)77194-8; Lesage F, 1997, FEBS LETT, V402, P28, DOI 10.1016/S0014-5793(96)01491-3; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Lesage F, 2011, PHYSIOLOGY, V26, P424, DOI 10.1152/physiol.00029.2011; Li XY, 2003, AM J PHYSIOL-HEART C, V284, pH71, DOI 10.1152/ajpheart.00392.2002; Lopes CMB, 2001, J BIOL CHEM, V276, P24449, DOI 10.1074/jbc.C100184200; Lopes CMB, 2000, J BIOL CHEM, V275, P16969, DOI 10.1074/jbc.M001948200; Lotshaw DP, 2007, CELL BIOCHEM BIOPHYS, V47, P209, DOI 10.1007/s12013-007-0007-8; Ma LQ, 2012, BIOPHYS J, V102, pL34, DOI 10.1016/j.bpj.2012.03.011; Ma LQ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001726; Mathie A, 2010, J PHYSIOL-LONDON, V588, P3149, DOI 10.1113/jphysiol.2010.192344; Meadows HJ, 2001, NEUROPHARMACOLOGY, V40, P551, DOI 10.1016/S0028-3908(00)00189-1; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Nie X, 2005, PFLUG ARCH EUR J PHY, V451, P479, DOI 10.1007/s00424-005-1480-9; O'Connell AD, 2005, J PHYSIOL-LONDON, V562, P687, DOI 10.1113/jphysiol.2004.079020; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Ordog B, 2006, INT J CARDIOL, V111, P386, DOI 10.1016/j.ijcard.2005.07.063; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Rajan S, 2000, J BIOL CHEM, V275, P16650, DOI 10.1074/jbc.M000030200; Renigunta V, 2006, TRAFFIC, V7, P168, DOI 10.1111/j.1600-0854.2005.00375.x; Stansfeld PJ, 2008, BIOCHEMISTRY-US, V47, P7414, DOI 10.1021/bi800475j; Steidl JV, 1999, MOL PHARMACOL, V55, P812; Yuill K, 2004, PFLUG ARCH EUR J PHY, V448, P63, DOI 10.1007/s00424-003-1218-5; Zhou M, 2009, J NEUROSCI, V29, P8551, DOI 10.1523/JNEUROSCI.5784-08.2009; Zilberberg N, 2001, NEURON, V32, P635, DOI 10.1016/S0896-6273(01)00503-7	44	36	37	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37145	37153		10.1074/jbc.M112.398164	http://dx.doi.org/10.1074/jbc.M112.398164			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22948150	hybrid, Green Published			2022-12-25	WOS:000310588500048
J	Coster, G; Gold, A; Chen, D; Schatz, DG; Goldberg, M				Coster, Gideon; Gold, Ayala; Chen, Darlene; Schatz, David G.; Goldberg, Michal			A Dual Interaction between the DNA Damage Response Protein MDC1 and the RAG1 Subunit of the V(D)J Recombinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; B-CELL; GENOMIC INSTABILITY; ACTIVATING GENE; BRCT REPEATS; HISTONE H2AX; MRN COMPLEX; N-TERMINUS; REPAIR; NBS1	The first step in V(D)J recombination is the formation of specific DNA double-strand breaks (DSBs) by the RAG1 and RAG2 proteins, which form the RAG recombinase. DSBs activate a complex network of proteins termed the DNA damage response (DDR). A key early event in the DDR is the phosphorylation of histone H2AX around DSBs, which forms a binding site for the tandem BRCA1 C-terminal (tBRCT) domain of MDC1. This event is required for subsequent signal amplification and recruitment of additional DDR proteins to the break site. RAG1 bears a histone H2AX-like motif at its C terminus (R1Ct), making it a putative MDC1-binding protein. In this work we show that the tBRCT domain of MDC1 binds the R1Ct motif of RAG1. Surprisingly, we also observed a second binding interface between the two proteins that involves the Proline-Serine-Threonine rich (PST) repeats of MDC1 and the N-terminal non-core region of RAG1 (R1Nt). The repeats-R1Nt interaction is constitutive, whereas the tBRCT-R1Ct interaction likely requires phosphorylation of the R1Ct motif of RAG1. As the C terminus of RAG1 has been implicated in inhibition of RAG activity, we propose a model in which phosphorylation of the R1Ct motif of RAG1 functions as a self-initiated regulatory signal.	[Coster, Gideon; Gold, Ayala; Goldberg, Michal] Hebrew Univ Jerusalem, Dept Genet, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel; [Chen, Darlene; Schatz, David G.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06511 USA; [Schatz, David G.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06511 USA	Hebrew University of Jerusalem; Yale University; Howard Hughes Medical Institute; Yale University	Goldberg, M (corresponding author), Hebrew Univ Jerusalem, Dept Genet, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel.	goldbergm@vms.huji.ac.il	Coster, Gideon/L-6319-2019; Schatz, David/A-6748-2013; Coster, Gideon/B-2781-2009	Coster, Gideon/0000-0002-1449-6655; Schatz, David/0000-0002-5669-1176; Goldberg, Michal/0000-0001-9397-2383	United States-Israel Bi-National Science Foundation [2009286]; Abisch-Frenkel Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032524] Funding Source: NIH RePORTER	United States-Israel Bi-National Science Foundation(US-Israel Binational Science Foundation); Abisch-Frenkel Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by Grant 2009286 from the United States-Israel Bi-National Science Foundation (to D. G. S. and M. G.) and by the Abisch-Frenkel Foundation (to M. G.).	Akamatsu Y, 2003, P NATL ACAD SCI USA, V100, P1209, DOI 10.1073/pnas.0237043100; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; CORTES P, 1994, P NATL ACAD SCI USA, V91, P7633, DOI 10.1073/pnas.91.16.7633; Coster G, 2007, J BIOL CHEM, V282, P32053, DOI 10.1074/jbc.M705890200; Cui XP, 2007, P NATL ACAD SCI USA, V104, P17046, DOI 10.1073/pnas.0610928104; CUOMO CA, 1994, P NATL ACAD SCI USA, V91, P6156, DOI 10.1073/pnas.91.13.6156; Dudley DD, 2003, J EXP MED, V198, P1439, DOI 10.1084/jem.20030627; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Grundy GJ, 2010, P NATL ACAD SCI USA, V107, P22487, DOI 10.1073/pnas.1014958107; Helmink BA, 2011, NATURE, V469, P245, DOI 10.1038/nature09585; Helmink BA, 2009, J EXP MED, V206, P669, DOI 10.1084/jem.20081326; Jones JM, 2009, ARCH IMMUNOL THER EX, V57, P105, DOI 10.1007/s00005-009-0011-3; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kirch SA, 1996, EUR J IMMUNOL, V26, P886, DOI 10.1002/eji.1830260425; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lee GS, 2004, CELL, V117, P171, DOI 10.1016/S0092-8674(04)00301-0; Li G, 2008, MOL CELL, V31, P631, DOI 10.1016/j.molcel.2008.07.017; Liang HE, 2002, IMMUNITY, V17, P639, DOI 10.1016/S1074-7613(02)00448-X; Lloyd J, 2009, CELL, V139, P100, DOI 10.1016/j.cell.2009.07.043; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2004, J BIOL CHEM, V279, P46359, DOI 10.1074/jbc.C400375200; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Muljo SA, 2003, NAT IMMUNOL, V4, P31, DOI 10.1038/ni870; Noordzij JG, 2000, BLOOD, V96, P203, DOI 10.1182/blood.V96.1.203.013k33_203_209; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Petrini JHJ, 2003, TRENDS CELL BIOL, V13, P458, DOI 10.1016/S0962-8924(03)00170-3; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Roman CAJ, 1997, IMMUNITY, V7, P13, DOI 10.1016/S1074-7613(00)80506-3; Rval P, 2008, NUCLEIC ACIDS RES, V36, P2060, DOI 10.1093/nar/gkn049; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Santagata S, 2000, IMMUNOL REV, V178, P64, DOI 10.1034/j.1600-065X.2000.17818.x; Santagata S, 2000, P NATL ACAD SCI USA, V97, P14572, DOI 10.1073/pnas.97.26.14572; Schatz DG, 2011, NAT REV IMMUNOL, V11, P251, DOI 10.1038/nri2941; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Schwarz K, 1996, SCIENCE, V274, P97, DOI 10.1126/science.274.5284.97; Sikes ML, 2002, P NATL ACAD SCI USA, V99, P12309, DOI 10.1073/pnas.182166699; SILVER DP, 1993, P NATL ACAD SCI USA, V90, P6100, DOI 10.1073/pnas.90.13.6100; So SR, 2009, J CELL BIOL, V187, P977, DOI 10.1083/jcb.200906064; Sobacchi C, 2006, HUM MUTAT, V27, P1174, DOI 10.1002/humu.20408; Soulas-Sprauel P, 2007, ONCOGENE, V26, P7780, DOI 10.1038/sj.onc.1210875; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Swanson PC, 2004, IMMUNOL REV, V200, P90, DOI 10.1111/j.0105-2896.2004.00159.x; Talukder SR, 2004, NUCLEIC ACIDS RES, V32, P4539, DOI 10.1093/nar/gkh778; Tewari R, 2010, TRENDS CELL BIOL, V20, P470, DOI 10.1016/j.tcb.2010.05.003; Villa A, 1998, CELL, V93, P885, DOI 10.1016/S0092-8674(00)81448-8; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Wu LM, 2008, P NATL ACAD SCI USA, V105, P11200, DOI 10.1073/pnas.0802885105; Yin B, 2009, J EXP MED, V206, P2625, DOI 10.1084/jem.20091320; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zha S, 2011, NATURE, V469, P250, DOI 10.1038/nature09604	64	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36488	36498		10.1074/jbc.M112.402487	http://dx.doi.org/10.1074/jbc.M112.402487			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22942284	Green Published, hybrid			2022-12-25	WOS:000310364000068
J	Kazi, JU; Sun, JM; Phung, B; Zadjali, F; Flores-Morales, A; Ronnstrand, L				Kazi, Julhash U.; Sun, Jianmin; Phung, Bengt; Zadjali, Fahad; Flores-Morales, Amilcar; Ronnstrand, Lars			Suppressor of Cytokine Signaling 6 (SOCS6) Negatively Regulates Flt3 Signal Transduction through Direct Binding to Phosphorylated Tyrosines 591 and 919 of Flt3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC FAMILY KINASES; INSULIN-RECEPTOR; ACTIVATION; DOMAIN; JUXTAMEMBRANE; SPECIFICITY; INHIBITION; MUTATIONS; PROTEINS; SITES	The receptor tyrosine kinase Flt3 is an important growth factor receptor in hematopoiesis, and gain-of-function mutations of the receptor contribute to the transformation of acute myeloid leukemia. SOCS6 ( suppressor of cytokine signaling 6) is a member of the SOCS family of E3 ubiquitin ligases that can regulate receptor tyrosine kinase signal transduction. In this study, we analyzed the role of SOCS6 in Flt3 signal transduction. The results show that ligand stimulation of Flt3 can induce association of SOCS6 and Flt3 and tyrosine phosphorylation of SOCS6. Phosphopeptide fishing indicated that SOCS6 binds directly to phosphotyrosines 591 and 919 of Flt3. By using stably transfected Ba/F3 cells with Flt3 and/or SOCS6, we show that the presence of SOCS6 can enhance ubiquitination of Flt3, as well as internalization and degradation of the receptor. The presence of SOCS6 also induces weaker activation of Erk1/2, but not Akt, in transfected Ba/F3 and UT-7 cells and in OCI-AML-5 cells. The absence of SOCS6 promotes Ba/F3 and UT-7 cell proliferation induced by oncogenic internal tandem duplications of Flt3. Taken together, these results suggest that SOCS6 negatively regulates Flt3 activation, the downstream Erk signaling pathway, and cell proliferation.	[Kazi, Julhash U.; Sun, Jianmin; Phung, Bengt; Ronnstrand, Lars] Lund Univ, Dept Lab Med, Skane Univ Hosp, Wallenberg Lab, S-20502 Malmo, Sweden; [Zadjali, Fahad] Sultan Qaboos Univ, Dept Biochem, Coll Med & Hlth Sci, Muscat 123, Oman; [Flores-Morales, Amilcar] Univ Copenhagen, Novo Nordisk Fdn, Ctr Prot Res, Fac Hlth Sci, DK-2200 Copenhagen, Denmark	Lund University; Skane University Hospital; Sultan Qaboos University; Novo Nordisk Foundation; University of Copenhagen	Ronnstrand, L (corresponding author), Lund Univ, Dept Lab Med, Skane Univ Hosp, Wallenberg Lab, S-20502 Malmo, Sweden.	lars.ronnstrand@med.lu.se	Sun, Jianmin/AAX-5094-2021; ZADJALI, FAHAD/B-5091-2019; Kazi, Julhash U./D-9190-2011	Sun, Jianmin/0000-0003-2327-4285; ZADJALI, FAHAD/0000-0001-5891-4700; Kazi, Julhash U./0000-0002-0719-5336; Ronnstrand, Lars/0000-0003-1275-5809; Phung, Bengt/0000-0002-9923-0847	Swedish Cancer Society; Swedish Children's Cancer Organization; Swedish Research Council; Wenner-Gren Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Children's Cancer Organization; Swedish Research Council(Swedish Research CouncilEuropean Commission); Wenner-Gren Foundation	This work was supported in part by the Swedish Cancer Society, the Swedish Children's Cancer Organization, and the Swedish Research Council.; Supported by the Wenner-Gren Foundation.	Bayle J, 2004, J BIOL CHEM, V279, P12249, DOI 10.1074/jbc.M313381200; BLUMEJENSEN P, 1993, EMBO J, V12, P4199, DOI 10.1002/j.1460-2075.1993.tb06104.x; Choi YB, 2010, J BIOL CHEM, V285, P7271, DOI 10.1074/jbc.M109.073726; De Sepulveda P, 1999, EMBO J, V18, P904; Elliott J, 2008, BIOCHEM SOC T, V36, P464, DOI 10.1042/BST0360464; Gelderloos JA, 1998, J BIOL CHEM, V273, P5908, DOI 10.1074/jbc.273.10.5908; Heiss E, 2006, BLOOD, V108, P1542, DOI 10.1182/blood-2005-07-008896; Ishiko J, 2005, ONCOGENE, V24, P8144, DOI 10.1038/sj.onc.1208957; Krebs DL, 2002, MOL CELL BIOL, V22, P4567, DOI 10.1128/MCB.22.13.4567-4578.2002; Lai RH, 2010, CANCER LETT, V288, P75, DOI 10.1016/j.canlet.2009.06.025; Levis M, 2003, LEUKEMIA, V17, P1738, DOI 10.1038/sj.leu.2403099; Masson K, 2009, CELL SIGNAL, V21, P1717, DOI 10.1016/j.cellsig.2009.06.002; Masson K, 2009, BRIT J HAEMATOL, V146, P193, DOI 10.1111/j.1365-2141.2009.07725.x; Meshinchi S, 2006, BLOOD, V108, P3654, DOI 10.1182/blood-2006-03-009233; Mooney RA, 2001, J BIOL CHEM, V276, P25889, DOI 10.1074/jbc.M010579200; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Peschard P, 2003, CANCER CELL, V3, P519, DOI 10.1016/S1535-6108(03)00136-3; Price DJ, 1999, BIOCHEM BIOPH RES CO, V259, P611, DOI 10.1006/bbrc.1999.0840; Razumovskaya E, 2009, EXP HEMATOL, V37, P979, DOI 10.1016/j.exphem.2009.05.008; Reindl C, 2009, CLIN CANCER RES, V15, P2238, DOI 10.1158/1078-0432.CCR-08-1325; Sargin B, 2007, BLOOD, V110, P1004, DOI 10.1182/blood-2007-01-066076; Stirewalt DL, 2006, BLOOD, V107, P3724, DOI 10.1182/blood-2005-08-3453; Takahashi S, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-13; Valgeirsdottir S, 1998, ONCOGENE, V16, P505, DOI 10.1038/sj.onc.1201555; Voytyuk O, 2003, J BIOL CHEM, V278, P9159, DOI 10.1074/jbc.M211726200; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zadjali F, 2011, J BIOL CHEM, V286, P480, DOI 10.1074/jbc.M110.173526; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071	29	51	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36509	36517		10.1074/jbc.M112.376111	http://dx.doi.org/10.1074/jbc.M112.376111			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22952242	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000310364000070
J	Parthasarathy, G; Lun, SC; Guo, HD; Ammerman, NC; Geiman, DE; Bishai, WR				Parthasarathy, Geetha; Lun, Shichun; Guo, Haidan; Ammerman, Nicole C.; Geiman, Deborah E.; Bishai, William R.			Rv2190c, an NlpC/P60 Family Protein, Is Required for Full Virulence of Mycobacterium tuberculosis	PLOS ONE			English	Article							RESUSCITATION-PROMOTING FACTORS; GROWTH IN-VITRO; LISTERIA-MONOCYTOGENES; CELL-SEPARATION; BACILLUS-SUBTILIS; GENE; VIVO; P60; MUTAGENESIS; DIVISION	Mycobacterium tuberculosis, the etiologic agent of tuberculosis (TB) possesses at least five genes predicted to encode proteins with NlpC/P60 hydrolase domains, including the relatively uncharacterized Rv2190c. As NlpC/P60 domain-containingdomain-containing proteins are associated with diverse roles in bacterial physiology, our objective was to characterize Rv2190c in M. tuberculosis growth and virulence. Our data indicate that lack of Rv2190c is associated with impaired growth, both in vitro and during an in vivo mouse model of TB. These growth defects are associated with altered colony morphology and phthiocerol dimycocerosate levels, indicating that Rv2190c is involved in cell wall maintenance and composition. In addition, we have demonstrated that Rv2190c is expressed during active growth phase and that its protein product is immunogenic during infection. Our findings have significant implications, both for better understanding the role of Rv2190c in M. tuberculosis biology and also for translational developments.	[Parthasarathy, Geetha; Lun, Shichun; Guo, Haidan; Ammerman, Nicole C.; Geiman, Deborah E.; Bishai, William R.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA; [Bishai, William R.] Howard Hughes Med Inst, Chevy Chase, MD USA	Johns Hopkins University; Howard Hughes Medical Institute	Parthasarathy, G (corresponding author), Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA.	wbishai1@jhmi.edu		Ammerman, Nicole C./0000-0001-9359-9144	HHMI; NIH [AI36973, AI37856]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036973, R01AI037856, R29AI036973] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors gratefully acknowledge the support of HHMI and NIH grants AI36973 and AI37856. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Bauerl C, 2010, J MOL MICROB BIOTECH, V19, P231, DOI 10.1159/000322233; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Galagan JE, 2010, TUBERCULOSIS, V90, P225, DOI 10.1016/j.tube.2010.03.010; Gao LY, 2006, INFECT IMMUN, V74, P1757, DOI 10.1128/IAI.74.3.1757-1767.2006; Geiman DE, 2006, ANTIMICROB AGENTS CH, V50, P2836, DOI 10.1128/AAC.00295-06; HESS J, 1995, INFECT IMMUN, V63, P2047, DOI 10.1128/IAI.63.5.2047-2053.1995; Hett EC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000001; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; Hett EC, 2007, MOL MICROBIOL, V66, P658, DOI 10.1111/j.1365-2958.2007.05945.x; Hett EC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001020; Ishikawa S, 1998, J BACTERIOL, V180, P2549, DOI 10.1128/JB.180.9.2549-2555.1998; Kana BD, 2008, MOL MICROBIOL, V67, P672, DOI 10.1111/j.1365-2958.2007.06078.x; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Lee JH, 2008, J BACTERIOL, V190, P699, DOI 10.1128/JB.01273-07; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; Nedeltchev GG, 2009, INFECT IMMUN, V77, P598, DOI 10.1128/IAI.01132-08; Ohnishi R, 1999, J BACTERIOL, V181, P3178, DOI 10.1128/JB.181.10.3178-3184.1999; Pilgrim S, 2003, INFECT IMMUN, V71, P3473, DOI 10.1128/IAI.71.6.3473-3484.2003; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Thayil SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028076; Tsuge Y, 2008, J BACTERIOL, V190, P8204, DOI 10.1128/JB.00752-08; Tufariello JM, 2004, INFECT IMMUN, V72, P515, DOI 10.1128/IAI.72.1.515-526.2004; WHO, 2008, 2008 TUB FACTS; WHO, 2011, WHO GLOBAL TUBERCULO; WUENSCHER MD, 1993, J BACTERIOL, V175, P3491, DOI 10.1128/jb.175.11.3491-3501.1993	28	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43429	10.1371/journal.pone.0043429	http://dx.doi.org/10.1371/journal.pone.0043429			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952680	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300015
J	Wu, CC; D'Argenio, D; Asgharzadeh, S; Triche, T				Wu, Chia-Chin; D'Argenio, David; Asgharzadeh, Shahab; Triche, Timothy			TARGETgene: A Tool for Identification of Potential Therapeutic Targets in Cancer	PLOS ONE			English	Article							PHASE-II TRIAL; METASTATIC BREAST-CANCER; D-RECEPTOR VDR; VITAMIN-D; CELL-CYCLE; KINASE INHIBITORS; ARSENIC TRIOXIDE; NETWORK; PATHWAYS; TRASTUZUMAB	The vast array of in silico resources and data of high throughput profiling currently available in life sciences research offer the possibility of aiding cancer gene and drug discovery process. Here we propose to take advantage of these resources to develop a tool, TARGETgene, for efficiently identifying mutation drivers, possible therapeutic targets, and drug candidates in cancer. The simple graphical user interface enables rapid, intuitive mapping and analysis at the systems level. Users can find, select, and explore identified target genes and compounds of interest (e. g., novel cancer genes and their enriched biological processes), and validate predictions using user-defined benchmark genes (e. g., target genes detected in RNAi screens) and curated cancer genes via TARGETgene. The high-level capabilities of TARGETgene are also demonstrated through two applications in this paper. The predictions in these two applications were then satisfactorily validated by several ways, including known cancer genes, results of RNAi screens, gene function annotations, and target genes of drugs that have been used or in clinical trial in cancer treatments. TARGETgene is freely available from the Biomedical Simulations Resource web site (http://bmsr.usc.edu/Software/TARGET/TARGET.html).	[Wu, Chia-Chin] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [D'Argenio, David] Univ So Calif, Dept Biomed Engn & Biomed Simulat Resource, Los Angeles, CA USA; [Asgharzadeh, Shahab; Triche, Timothy] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Asgharzadeh, Shahab; Triche, Timothy] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA	University of Texas System; UTMD Anderson Cancer Center; University of Southern California; University of Southern California; Children's Hospital Los Angeles	Wu, CC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA.	perwu777@gmail.com	Wu, Chia-Chin/ABD-5516-2021	Wu, Chia-Chin/0000-0002-5208-6016; Asgharzadeh, Shahab/0000-0002-0510-3848; D'Argenio, David/0000-0003-3658-7088	National Institutes of Health (NIH) [P41-EB001978]; U.S. Department of Defence [W81XWH-07-1-0580]; NIH Child Health Research Career Development Award Program [K12-CA60104]; NATIONAL CANCER INSTITUTE [U01CA060104, R01CA060104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001978] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defence(United States Department of Defense); NIH Child Health Research Career Development Award Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health (NIH) grant P41-EB001978 (to DD), U.S. Department of Defence grant W81XWH-07-1-0580 (to TT), and NIH Child Health Research Career Development Award Program K12-CA60104 (to SA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Beliakoff J, 2004, ANTI-CANCER DRUG, V15, P651, DOI 10.1097/01.cad.0000136876.11928.be; BURAS RR, 1994, BREAST CANCER RES TR, V31, P191, DOI 10.1007/BF00666153; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Costa JL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-499; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Diesing D, 2006, ANTICANCER RES, V26, P2755; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Esteva FJ, 2010, NAT REV CLIN ONCOL, V7, P98, DOI 10.1038/nrclinonc.2009.216; Farina AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004797; Fornier MN, 2007, CLIN CANCER RES, V13, P5841, DOI 10.1158/1078-0432.CCR-07-1218; Fornier MN, 2011, ANN ONCOL, V22, P2575, DOI 10.1093/annonc/mdr018; Frampton JE, 2009, DRUGS, V69, P2125, DOI 10.2165/11203240-000000000-00000; Frank DA, 2009, IDRUGS, V12, P29; Friedrich M, 2002, HISTOCHEM J, V34, P35, DOI 10.1023/A:1021343825552; Fujii T, 2008, CURR MED CHEM, V15, P528, DOI 10.2174/092986708783769759; Gilsdorf M, 2010, NUCLEIC ACIDS RES, V38, pD448, DOI 10.1093/nar/gkp1038; Gligorov J, 2008, BREAST CANCER RES TR, V112, P53, DOI 10.1007/s10549-008-0232-x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hawkins W, 2005, CANCER BIOL THER, V4, P1275, DOI 10.4161/cbt.4.11.2286; Herold CI, 2011, CLIN CANCER RES, V17, P6061, DOI 10.1158/1078-0432.CCR-11-1071; Higgins ME, 2007, NUCLEIC ACIDS RES, V35, pD721, DOI 10.1093/nar/gkl811; Hodge AE, 2007, CLIN PHARMACOL THER, V81, P21, DOI 10.1038/sj.clpt.6100048; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Iorns E, 2007, NAT REV DRUG DISCOV, V6, P556, DOI 10.1038/nrd2355; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kaufman B, 2009, J CLIN ONCOL, V27, P5529, DOI 10.1200/JCO.2008.20.6847; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kostner K, 2009, ANTICANCER RES, V29, P3511; Kohfeld S, 2007, EUR J MED CHEM, V42, P1317, DOI 10.1016/j.ejmech.2007.02.007; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Lee SK, 2009, ADV DRUG DELIVER REV, V61, P650, DOI 10.1016/j.addr.2009.03.016; Li XQ, 2004, CANCER INVEST, V22, P389, DOI 10.1081/CNV-200029068; Liu HF, 2003, J BIOL CHEM, V278, P2541, DOI 10.1074/jbc.M210391200; Loging W, 2007, NAT REV DRUG DISCOV, V6, P220, DOI 10.1038/nrd2265; Luu TH, 2008, CLIN CANCER RES, V14, P7138, DOI 10.1158/1078-0432.CCR-08-0122; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Mills E, 2005, J PINEAL RES, V39, P360, DOI 10.1111/j.1600-079X.2005.00258.x; Navara KJ, 2007, J PINEAL RES, V43, P215, DOI 10.1111/j.1600-079X.2007.00473.x; Perotti C, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2193; Rabinovsky R, 2009, MOL CELL BIOL, V29, P5377, DOI 10.1128/MCB.01649-08; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Russ AP, 2005, DRUG DISCOV TODAY, V10, P1607, DOI 10.1016/S1359-6446(05)03666-4; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Shawver LK, 2002, CANCER CELL, V1, P117, DOI 10.1016/S1535-6108(02)00039-9; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Srougi MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017108; Stears RL, 2003, NAT MED, V9, P140, DOI 10.1038/nm0103-140; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Torkamani A, 2009, GENOME RES, V19, P1570, DOI 10.1101/gr.092833.109; Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang Q, 2002, CANCER LETT, V179, P71, DOI 10.1016/S0304-3835(01)00846-1; Wardley AM, 2010, J CLIN ONCOL, V28, P976, DOI 10.1200/JCO.2008.21.6531; Wesierska-Gqdek J, 2004, POL J PHARMACOL, V56, P635; Witters LM, 2004, ONCOL REP, V11, P693; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu CC, 2010, BIOINFORMATICS, V26, P807, DOI 10.1093/bioinformatics/btq044; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Ye JA, 2005, CLIN EXP PHARMACOL P, V32, P1042, DOI 10.1111/j.1440-1681.2005.04302.x; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zhu F, 2010, NUCLEIC ACIDS RES, V38, pD787, DOI 10.1093/nar/gkp1014	72	12	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43305	10.1371/journal.pone.0043305	http://dx.doi.org/10.1371/journal.pone.0043305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952662	Green Submitted, Green Published, gold			2022-12-25	WOS:000308221300011
J	Raafat, A; Strizzi, L; Lashin, K; Ginsburg, E; McCurdy, D; Salomon, D; Smith, GH; Medina, D; Callahan, R				Raafat, Ahmed; Strizzi, Luigi; Lashin, Karim; Ginsburg, Erika; McCurdy, David; Salomon, David; Smith, Gilbert H.; Medina, Daniel; Callahan, Robert			Effects of Age and Parity on Mammary Gland Lesions and Progenitor Cells in the FVB/N-RC Mice	PLOS ONE			English	Article							RECEPTOR-ALPHA EXPRESSION; BREAST-CANCER RISK; EPITHELIAL-CELLS; STEM-CELLS; MOUSE; GROWTH; HYPERPLASIA; PREGNANCY; HORMONE	The FVB/N mouse strain is extensively used in the development of animal models for breast cancer research. Recently it has been reported that the aging FVB/N mice develop spontaneous mammary lesions and tumors accompanied with abnormalities in the pituitary glands. These observations have a great impact on the mouse models of human breast cancer. We have developed a population of inbred FVB/N mice (designated FVB/N-RC) that have been genetically isolated for 20 years. To study the effects of age and parity on abnormalities of the mammary glands of FVB/N-RC mice, twenty-five nulliparous and multiparous (3-4 pregnancies) females were euthanized at 16-22 months of age. Examination of the mammary glands did not reveal macroscopic evidence of mammary gland tumors in either aged-nulliparous or multiparous FVB/N-RC mice (0/25). However, histological analysis of the mammary glands showed rare focal nodules of squamous changes in 2 of the aged multiparous mice. Mammary gland hyperplasia was detected in 8% and 71% of the aged-nulliparous and aged-multiparous mice, respectively. Epithelial contents and serum levels of triiodothyronine were significantly higher in the experimental groups than the 14-wk-old control mice. Immuno-histochemical staining of the pituitary gland pars distalis showed no difference in prolactin staining between the control and the aged mice. Tissue transplant and dilution studies showed no effect of age and/or parity on the ability of putative progenitor cells present among the injected mammary cells to repopulate a cleared fat pad and develop a full mammary gland outgrowth. This FVB/N-RC mouse substrain is suitable to develop mouse models for breast cancer.	[Raafat, Ahmed; Lashin, Karim; McCurdy, David; Smith, Gilbert H.; Callahan, Robert] NCI, Cell & Canc Biol Branch, NIH, Bethesda, MD 20892 USA; [Strizzi, Luigi] Northwestern Univ, Feinberg Sch Med, Childrens Mem Res Ctr, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA; [Ginsburg, Erika] NCI, Off Director, NIH, Bethesda, MD 20892 USA; [Salomon, David] NCI, Lab Canc Prevent, NIH, Bethesda, MD 20892 USA; [Medina, Daniel] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Baylor College of Medicine	Raafat, A (corresponding author), NCI, Cell & Canc Biol Branch, NIH, Bethesda, MD 20892 USA.	rc54d@nih.gov			NCI's Center for Cancer Research Intramural Research Program; NATIONAL CANCER INSTITUTE [ZIABC005148, ZIABC010021] Funding Source: NIH RePORTER	NCI's Center for Cancer Research Intramural Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The NCI's Center for Cancer Research Intramural Research Program funded this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel MH, 2003, REPRODUCTION, V125, P165, DOI 10.1530/reprod/125.2.165; Brisken C, 1998, P NATL ACAD SCI USA, V95, P5076, DOI 10.1073/pnas.95.9.5076; Britt KL, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2245; Bussard KM, 2010, CANCER RES, V70, P6336, DOI 10.1158/0008-5472.CAN-10-0591; Fendrick JL, 1998, J MAMMARY GLAND BIOL, V3, P7, DOI 10.1023/A:1018766000275; Frech MS, 2005, CANCER RES, V65, P681; Gonzalez-Sancho JM, 2002, MOL CARCINOGEN, V34, P25, DOI 10.1002/mc.10046; Hovey RC, 2002, J MAMMARY GLAND BIOL, V7, P17, DOI 10.1023/A:1015766322258; Khan SA, 1998, J NATL CANCER I, V90, P37, DOI 10.1093/jnci/90.1.37; Lawson JS, 1999, LANCET, V354, P1787, DOI 10.1016/S0140-6736(99)04936-3; Mahler JF, 1996, TOXICOL PATHOL, V24, P710, DOI 10.1177/019262339602400606; Neville M. C., 1987, MAMMARY GLAND DEV RE; Nieto AI, 2003, COMPARATIVE MED, V53, P433; Potter M, 1985, CURR TOP MICROBIOL, P234; Raafat A, 2004, ONCOGENE, V23, P9401, DOI 10.1038/sj.onc.1208187; Radaelli E, 2009, VET PATHOL, V46, P736, DOI 10.1354/vp.08-VP-0280-R-FL; Siwko SK, 2008, STEM CELLS, V26, P3205, DOI 10.1634/stemcells.2008-0103; SMITH GH, 1988, J CELL SCI, V90, P173; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; TANAKA T, 1980, J CLIN ENDOCR METAB, V51, P1058, DOI 10.1210/jcem-51-5-1058; Tosovic A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2587; Visvader JE, 2006, CANCER RES, V66, P9798, DOI 10.1158/0008-5472.CAN-06-2254; VONDERHAAR BK, 1982, CANCER RES, V42, P4553; Wagner KU, 2004, BREAST CANCER RES, V6, P31, DOI 10.1186/bcr723; Wakefield LM, 2003, COMPARATIVE MED, V53, P424; YOUNG LJT, 1971, EXP GERONTOL, V6, P49, DOI 10.1016/0531-5565(71)90048-9	26	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43624	10.1371/journal.pone.0043624	http://dx.doi.org/10.1371/journal.pone.0043624			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952723	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206500018
J	Ek, CJ; Habgood, MD; Dennis, R; Dziegielewska, KM; Mallard, C; Wheaton, B; Saunders, NR				Ek, C. Joakim; Habgood, Mark D.; Dennis, Ross; Dziegielewska, Katarzyna M.; Mallard, Carina; Wheaton, Benjamin; Saunders, Norman R.			Pathological Changes in the White Matter after Spinal Contusion Injury in the Rat	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CORD-INJURY; INFLAMMATORY RESPONSE; CHRONIC DEMYELINATION; AXONAL DAMAGE; SPARED AXONS; REGENERATION; MYELIN; IDENTIFICATION; REMYELINATION	It has been shown previously that after spinal cord injury, the loss of grey matter is relatively faster than loss of white matter suggesting interventions to save white matter tracts offer better therapeutic possibilities. Loss of white matter in and around the injury site is believed to be the main underlying cause for the subsequent loss of neurological functions. In this study we used a series of techniques, including estimations of the number of axons with pathology, immunohistochemistry and mapping of distribution of pathological axons, to better understand the temporal and spatial pathological events in white matter following contusion injury to the rat spinal cord. There was an initial rapid loss of axons with no detectable further loss beyond 1 week after injury. Immunoreactivity for CNPase indicated that changes to oligodendrocytes are rapid, extending to several millimetres away from injury site and preceding much of the axonal loss, giving early prediction of the final volume of white matter that survived. It seems that in juvenile rats the myelination of axons in white matter tracts continues for some time, which has an important bearing on interpretation of our, and previous, studies. The amount of myelin debris and axon pathology progressively decreased with time but could still be observed at 10 weeks after injury, especially at more distant rostral and caudal levels from the injury site. This study provides new methods to assess injuries to spinal cord and indicates that early interventions are needed for the successful sparing of white matter tracts following injury.	[Ek, C. Joakim; Habgood, Mark D.; Dennis, Ross; Dziegielewska, Katarzyna M.; Wheaton, Benjamin; Saunders, Norman R.] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia; [Ek, C. Joakim; Mallard, Carina] Univ Gothenburg, Sahlgrenska Acad, Dept Neurosci & Physiol, Gothenburg, Sweden	University of Melbourne; University of Gothenburg	Ek, CJ (corresponding author), Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia.	cjek@unimelb.edu.au	Wheaton, Ben/AAC-7037-2021	Saunders, Norman/0000-0001-6660-7639; Wheaton, Benjamin/0000-0003-0619-4777; Mallard, Carina/0000-0001-8953-919X	Victorian Neurotrauma Initiative [DP048]	Victorian Neurotrauma Initiative	This work was supported by the Victorian Neurotrauma Initiative (Grant #DP048). For more information about this research fund, go to http://www.vni.com.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MSR, 2008, TISSUE CELL, V40, P143, DOI 10.1016/j.tice.2007.11.002; BACKE HA, 1991, PARAPLEGIA, V29, P607, DOI 10.1038/sc.1991.89; BLIGHT AR, 1983, NEUROSCIENCE, V10, P521, DOI 10.1016/0306-4522(83)90150-1; BLIGHT AR, 1989, J NEUROL SCI, V91, P15, DOI 10.1016/0022-510X(89)90073-7; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; BRESNAHAN JC, 1978, J NEUROL SCI, V37, P59, DOI 10.1016/0022-510X(78)90228-9; Cheng S, 2012, J BIOMECH, V45, P1186, DOI 10.1016/j.jbiomech.2012.01.050; Domeniconi M, 2005, J NEUROL SCI, V233, P43, DOI 10.1016/j.jns.2005.03.023; Ek CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012021; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; Gomes-Leal W, 2005, BRAIN RES, V1066, P57, DOI 10.1016/j.brainres.2005.10.069; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; GRIFFITHS IR, 1983, J NEUROL SCI, V58, P335, DOI 10.1016/0022-510X(83)90093-X; Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628; HIRSCHBERG DL, 1994, J NEUROIMMUNOL, V50, P9, DOI 10.1016/0165-5728(94)90209-7; Illis LS, 2012, SPINAL CORD, V50, P259, DOI 10.1038/sc.2011.132; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Koopmans G.C., 2009, EXP NEUROL; LAMPERT P, 1967, J NEUROPATH EXP NEUR, V26, P156; Lasiene J, 2008, J NEUROSCI, V28, P3887, DOI 10.1523/JNEUROSCI.4756-07.2008; LOTAN M, 1994, EXP NEUROL, V126, P284, DOI 10.1006/exnr.1994.1066; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Mills LR, 2004, NEUROIMAGE, V21, P1069, DOI 10.1016/j.neuroimage.2003.10.041; Nashmi R, 2001, NEUROSCIENCE, V104, P235, DOI 10.1016/S0306-4522(01)00009-4; Olby NJ, 1996, J NEUROCYTOL, V25, P465, DOI 10.1007/BF02284816; Plemel JR, 2011, GLIA, V59, P1891, DOI 10.1002/glia.21232; Powers BE, 2012, J NEUROSCI, V32, P5120, DOI 10.1523/JNEUROSCI.0002-12.2012; Rabchevsky AG, 2007, GLIA, V55, P831, DOI 10.1002/glia.20508; Rosenberg LJ, 1997, J NEUROTRAUM, V14, P823, DOI 10.1089/neu.1997.14.823; Smith PM, 2006, BRAIN PATHOL, V16, P99, DOI 10.1111/j.1750-3639.2006.00001.x; Steward O, 2012, EXP NEUROL, V233, P597, DOI 10.1016/j.expneurol.2011.06.017; Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517; Wang L, 2009, NEUROPATHOLOGY, V29, P230, DOI 10.1111/j.1440-1789.2008.00969.x; Wu B, 2009, J NEUROTRAUM, V26, P1847, DOI 10.1089/neu.2008.0551	35	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43484	10.1371/journal.pone.0043484	http://dx.doi.org/10.1371/journal.pone.0043484			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952690	Green Published, gold			2022-12-25	WOS:000308206000039
J	Lu, L; Chesters, D; Zhang, W; Li, GC; Ma, Y; Ma, HL; Song, XP; Wu, HX; Meng, FX; Zhu, CD; Liu, QY				Lu, Liang; Chesters, Douglas; Zhang, Wen; Li, Guichang; Ma, Ying; Ma, Huailei; Song, Xiuping; Wu, Haixia; Meng, Fengxia; Zhu, Chaodong; Liu, Qiyong			Small Mammal Investigation in Spotted Fever Focus with DNA-Barcoding and Taxonomic Implications on Rodents Species from Hainan of China	PLOS ONE			English	Article							DELIMITATION; MITOCHONDRIAL; PHYLOGENY; EVOLUTION; IDENTIFICATION; DIVERGENCE; AUSTRALIA; MURIDAE; GENE	Although mammals are a well-studied group of animals, making accurate field identification of small mammals is still complex because of morphological variation across developmental stages, color variation of pelages, and often damaged osteological and dental characteristics. In 2008, small mammals were collected for an epidemiological study of a spotted fever outbreak in Hainan, China. Ten species of small mammals were identified by morphological characters in the field, most using pelage color characters only. The study is extended here, in order to assess whether DNA barcoding would be suitable as an identification tool in these small mammals. Barcode clusters showed some incongruence with morphospecies, especially for some species of Rattus and Niviventer, so molecular delineation was carried out with an expanded dataset of combined cytochrome b (Cyt-b) and cytochrome c oxidase subunit I (COI) sequences. COI sequences were successfully amplified from 83% of collected mammals, but failed in all specimens of Suncus murinus, which were thus excluded in DNA barcoding analysis. Of note, ten molecular taxonomic units were found from samples of nine morphologically identified species. Accordingly, 11 species of small mammals were present in the investigated areas, including four Rattus species, three Niviventer species, Callosciurus erythraeus, Neohylomys hainanensis, Tupaia belangeri, and Suncus murinus. Based on the results of the phylogenetic and molecular delineation analyses, the systematic status of some rodent species should be redefined. R. rattus hainanicus and R. rattus sladeni are synonyms of R. andamanensis. R. losea from China and Southeast Asia comprises two independent species: R. losea and R. sakeratensis. Finally, the taxonomic status of three putative species of Niviventer should be further confirmed according to morphological, molecular and ecological characters.	[Lu, Liang; Li, Guichang; Ma, Ying; Ma, Huailei; Song, Xiuping; Wu, Haixia; Meng, Fengxia; Liu, Qiyong] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Dept Vector Biol & Control, Beijing, Peoples R China; [Zhang, Wen] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Dept Bioinformat, Beijing, Peoples R China; [Lu, Liang; Zhang, Wen; Li, Guichang; Ma, Ying; Ma, Huailei; Song, Xiuping; Wu, Haixia; Meng, Fengxia; Liu, Qiyong] State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Chesters, Douglas; Zhu, Chaodong] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; [Ma, Ying] QingHai Inst Endem Dis Prevent & Control, Xining, Qinghai, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Academy of Sciences; Institute of Zoology, CAS	Lu, L (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Dept Vector Biol & Control, Beijing, Peoples R China.	liuqiyong@icdc.cn	Chesters, Douglas/AAF-7926-2019; ZHU, Chao-Dong/E-5961-2011	ZHU, Chao-Dong/0000-0002-9347-3178	Special Infectious Disease Program [2008ZX10004-010]; National Science and Technology Pillar Program of the Ministry of Science and Technology, China [2008BAI56B02]	Special Infectious Disease Program; National Science and Technology Pillar Program of the Ministry of Science and Technology, China	This work was supported by the Special Infectious Disease Program (Grant No. 2008ZX10004-010) and the National Science and Technology Pillar Program (2008BAI56B02) of the Ministry of Science and Technology, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin Ken P., 2003, ACIAR Monograph Series, V100, P1; Aplin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026357; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Balakirev A.E., 2010, MOSCOW U BIOL SCI B, V65, P171, DOI [10.3103/S0096392510040139, DOI 10.3103/S0096392510040139]; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Chen W, 2011, J ZOOL, V284, P215, DOI 10.1111/j.1469-7998.2011.00797.x; Chen WC, 2010, ZOOL SCI, V27, P487, DOI 10.2108/zsj.27.487; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Fontaneto D, 2008, J EVOLUTION BIOL, V21, P580, DOI 10.1111/j.1420-9101.2007.01472.x; GOLDMAN N, 1993, J MOL EVOL, V36, P182, DOI 10.1007/BF00166252; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huang WJ, 1995, GLIRES CHINA; Huelsenbeck JP, 1997, ANNU REV ECOL SYST, V28, P437, DOI 10.1146/annurev.ecolsys.28.1.437; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Jin Y, 2011, DIS SURVEIL, V26, P18; Jing MD, 2007, MOL PHYLOGENET EVOL, V44, P521, DOI 10.1016/j.ympev.2007.04.003; Lecompte E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-199; Li YC, 2008, ZOOL SCI, V25, P686, DOI 10.2108/zsj.25.686; Lorenz JG, 2005, PHILOS T R SOC B, V360, P1869, DOI 10.1098/rstb.2005.1718; Meerburg BG, 2009, CRIT REV MICROBIOL, V35, P221, DOI 10.1080/10408410902989837; Meredith RW, 2010, J MAMM EVOL, V17, P75, DOI 10.1007/s10914-010-9129-7; Meredith RW, 2009, MOL PHYLOGENET EVOL, V51, P554, DOI 10.1016/j.ympev.2009.02.009; Mills JN, 1998, EMERG INFECT DIS, V4, P529, DOI 10.3201/eid0404.980403; Monroe MC, 1999, EMERG INFECT DIS, V5, P75, DOI 10.3201/eid0501.990109; Montgelard C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-321; Musser G.G., 1973, American Museum Novitates, VNo. 2525, P1; Musser G. G., 1970, Am. Mus. Novit., VNo. 2406, P1; Musser G.G., 1981, B AM MUS NAT HIST, V168, P225; Musser Guy G., 1993, P501; Pages M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-184; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quicke DLJ, 2012, MOL ECOLOGY RESOURCE; Rambaut A., 2007, TRACER V1 4; Rivera PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022199; Robins JH, 2007, MOL ECOL NOTES, V7, P717, DOI 10.1111/j.1471-8286.2007.01752.x; Roe AD, 2007, MOL ECOL, V16, P3617, DOI 10.1111/j.1365-294X.2007.03412.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ross KG, 2010, SYST BIOL, V59, P162, DOI 10.1093/sysbio/syp089; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Siler CD, 2010, HERPETOL MONOGR, V24, P1, DOI 10.1655/HERPMONOGRAPHS-D-10-00003.1; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang Y. X., 2003, COMPLETE CHECKLIST M; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wilson D.E., 2005, MAMMAL SPECIES WORLD; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yu HT, 1996, ZOOL STUD, V35, P195; Zhang LJ, 2009, CLIN MICROBIOL INFEC, V15, P338, DOI 10.1111/j.1469-0691.2008.02266.x; ZWICKL D.J., 2006, THESIS U TEXAS AUSTI	57	15	20	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43479	10.1371/journal.pone.0043479	http://dx.doi.org/10.1371/journal.pone.0043479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952689	gold, Green Published, Green Submitted			2022-12-25	WOS:000308206000038
J	Rao, VG; Bhat, J; Yadav, R; Gopalan, GP; Nagamiah, S; Bhondeley, MK; Anjinappa, SM; Ramchandra, J; Chadha, VK; Wares, F				Rao, Vikas G.; Bhat, Jyothi; Yadav, Rajiv; Gopalan, Gopi Punnathanathu; Nagamiah, Selvakumar; Bhondeley, Manoj Kumar; Anjinappa, Sharada M.; Ramchandra, Jitendra; Chadha, Vineet K.; Wares, Fraser			Prevalence of Pulmonary Tuberculosis - A Baseline Survey In Central India	PLOS ONE			English	Article							TRIBAL POPULATION; MADHYA-PRADESH; IMPLEMENTATION	Background: The present study provides an estimate of the prevalence of bacteriologially positive pulmonary tuberculosis in Jabalpur, a district in central India. Methodology/Principal Findings: A community based cross-sectional survey was undertaken in Jabalpur District of the central Indian state of Madhya Pradesh. A stratified cluster sampling design was adopted to select the sample. All eligible individuals were questioned for pulmonary symptoms suggestive of TB disease. Two sputum samples were collected from all eligible individuals and were examined by Ziehl-Neelsen smear microscopy and solid media culture methods. Of the 99,918 individuals eligible for screening, 95,071 (95.1%) individuals were screened. Of these, 7,916 (8.3%) were found to have symptoms and sputum was collected from 7,533 (95.2%) individuals. Overall prevalence of bacteriologically positive PTB was found to be 255.3 per 100,000 population (95% C. I: 195.3-315.4). Prevalence was significantly higher (p < 0.001) amongst males (355.8; 95% C. I: 304.4-413.4) compared with females (109.0; 95% C. I: 81.2-143.3). Prevalence was also significantly higher in rural areas (348.9; 95% C. I: 292.6-412.8) as compared to the urban (153.9; 95% C. I: 123.2-190.1). Conclusions/Significance: The TB situation in Jabalpur district, central India, is observed to be comparable to the TB situation at the national level (255.3 versus 249). There is however, a need to maintain and further strengthen TB control measures on a sustained and long term basis in the area to have a significant impact on the disease prevalence in the community.	[Rao, Vikas G.; Bhat, Jyothi; Yadav, Rajiv; Bhondeley, Manoj Kumar] Indian Council Med Res, Reg Med Res Ctr Tribals, Jabalpur, Madhya Pradesh, India; [Gopalan, Gopi Punnathanathu; Nagamiah, Selvakumar] Indian Council Med Res, Natl Inst Res TB, Madras, Tamil Nadu, India; [Anjinappa, Sharada M.; Ramchandra, Jitendra; Chadha, Vineet K.] Natl TB Inst, Bangalore, Karnataka, India; [Wares, Fraser] WHO, Stop TB Dept, CH-1211 Geneva, Switzerland	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tribal Health (NIRTH); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); World Health Organization	Rao, VG (corresponding author), Indian Council Med Res, Reg Med Res Ctr Tribals, Jabalpur, Madhya Pradesh, India.	drvgrao@rediffmail.com		, Jyothi/0000-0001-8788-2250	WHO; United States Agency for International Development under WHO/TRC (NIRT) Collaborative Model DOTS Project; Indian Council of Medical Research, New Delhi	WHO(World Health Organization); United States Agency for International Development under WHO/TRC (NIRT) Collaborative Model DOTS Project(United States Agency for International Development (USAID)); Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	The study was supported in part by the WHO, with financial assistance provided by the United States Agency for International Development under the WHO/TRC (NIRT) Collaborative Model DOTS Project and the Indian Council of Medical Research, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1974, Bull World Health Organ, V51, P473; [Anonymous], 2001, REV NAT TUB CONTR PR; [Anonymous], 2011, REV NAT TUB CONTR PR; Bhat J, 2009, INT J EPIDEMIOL, V38, P1026, DOI 10.1093/ije/dyp222; Chakma T., 1996, Indian Journal of Tuberculosis, V43, P85; Datta M, 2001, INT J TUBERC LUNG D, V5, P240; Gopi P. G., 1997, Indian Journal of Tuberculosis, V44, P171; Gopi PG, 2006, INT J TUBERC LUNG D, V10, P343; GOTHI G. D., 1979, Indian Journal of Tuberculosis, V26, P121; GOTHI GD, 1976, INDIAN J MED RES, V64, P1150; Indian Council of Medical Research, 1959, IND COUNC MED RES SP; International Institute for Population Sciences (IIPS) and Macro International, 2007, INT I POP SCI IIPS M, VI; Manjula Datta, 2000, Indian Journal of Tuberculosis, V47, P147; MAYURNATH S, 1984, INDIAN J MED RES, V80, P129; Module for Laboratory technicians, 2005, REV NAT TUB CONTR PR; Murhekar MV, 2004, B WORLD HEALTH ORGAN, V82, P836; Narang P, 1999, INT J TUBERC LUNG D, V3, P478; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Pamra SP, 1973, INDIAN J TUBERC, P20; Rao VG, 2010, INT J TUBERC LUNG D, V14, P368; Rao VG, 2010, INT J INFECT DIS, V14, pE713, DOI 10.1016/j.ijid.2010.02.2243; Subramani R, 2008, INT J TUBERC LUNG D, V12, P916; Tupasi TE, 1999, INT J TUBERC LUNG D, V3, P471; World Health Organisation, 2011, WHOHTMTB201116; World Health Organization, 2010, WHOHTMTB20107; World Health Organization, 1994, WHOTB94179; Yadav R, 2010, Indian J Tuberc, V57, P114	27	28	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43225	10.1371/journal.pone.0043225	http://dx.doi.org/10.1371/journal.pone.0043225			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952651	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000308206000025
J	Hastie, KM; King, LB; Zandonatti, MA; Saphire, EO				Hastie, Kathryn M.; King, Liam B.; Zandonatti, Michelle A.; Saphire, Erica Ollmann			Structural Basis for the dsRNA Specificity of the Lassa Virus NP Exonuclease	PLOS ONE			English	Article							I KLENOW FRAGMENT; CRYSTAL-STRUCTURE; DNA SUBSTRATE; HUMAN TREX2; BINDING; MECHANISM; REVEALS; SITE; RNA	Lassa virus causes hemorrhagic fever characterized by immunosuppression. The nucleoprotein of Lassa virus, termed NP, binds the viral genome. It also has an additional enzymatic activity as an exonuclease that specifically digests double-stranded RNA (dsRNA). dsRNA is a strong signal to the innate immune system of viral infection. Digestion of dsRNA by the NP exonuclease activity appears to cause suppression of innate immune signaling in the infected cell. Although the fold of the NP enzyme is conserved and the active site completely conserved with other exonucleases in its DEDDh family, NP is atypical among exonucleases in its preference for dsRNA and its strict specificity for one substrate. Here, we present the crystal structure of Lassa virus NP in complex with dsRNA. We find that unlike the exonuclease in Klenow fragment, the double-stranded nucleic acid in complex with Lassa NP remains base-paired instead of splitting, and that binding of the paired complementary strand is achieved by "relocation" of a basic loop motif from its typical exonuclease position. Further, we find that just one single glycine that contacts the substrate strand and one single tyrosine that stacks with a base of the complementary, non-substrate strand are responsible for the unique substrate specificity. This work thus provides templates for development of antiviral drugs that would be specific for viral, rather than host exonucleases of similar fold and active site, and illustrates how a very few amino acid changes confer alternate specificity and biological phenotype to an enzyme.	[Hastie, Kathryn M.; King, Liam B.; Zandonatti, Michelle A.; Saphire, Erica Ollmann] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Saphire, Erica Ollmann] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Hastie, KM (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	erica@scripps.edu		Saphire, Erica Ollmann/0000-0002-1206-7451	NIAID [HHSN27220090049C]; Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease Award; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease Award(Burroughs Wellcome Fund); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by NIAID grant HHSN27220090049C and The Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease Award and the Skaggs Institute for Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; BRENOWITZ S, 1991, J BIOL CHEM, V266, P7888; Brucet M, 2007, J BIOL CHEM, V282, P14547, DOI 10.1074/jbc.M700236200; COWART M, 1989, BIOCHEMISTRY-US, V28, P1975, DOI 10.1021/bi00431a004; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; de Silva U, 2009, NUCLEIC ACIDS RES, V37, P2411, DOI 10.1093/nar/gkp025; Eckerle LD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000896; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FISHERHOCH SP, 1987, J INFECT DIS, V155, P465, DOI 10.1093/infdis/155.3.465; Hamdan S, 2002, STRUCTURE, V10, P535, DOI 10.1016/S0969-2126(02)00738-4; Hastie KM, 2011, P NATL ACAD SCI USA, V108, P2396, DOI 10.1073/pnas.1016404108; Horio T, 2004, FEBS LETT, V577, P111, DOI 10.1016/j.febslet.2004.09.074; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kukreti P, 2008, J BIOL CHEM, V283, P17979, DOI 10.1074/jbc.M801053200; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Martinez-Sobrido L, 2007, J VIROL, V81, P12696, DOI 10.1128/JVI.00882-07; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; Minskaia E, 2006, P NATL ACAD SCI USA, V103, P5108, DOI 10.1073/pnas.0508200103; Nguyen LH, 2001, BIOCHEMISTRY-US, V40, P7174, DOI 10.1021/bi010141t; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrino FW, 2005, J BIOL CHEM, V280, P15212, DOI 10.1074/jbc.M500108200; Qi XX, 2010, NATURE, V468, P779, DOI 10.1038/nature09605	23	38	39	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44211	10.1371/journal.pone.0044211	http://dx.doi.org/10.1371/journal.pone.0044211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937163	Green Published, Green Submitted, gold			2022-12-25	WOS:000308213600092
J	Huang, XL; Wang, L; Zhang, H; Wang, HB; Zhao, XP; Qian, GX; Hu, JF; Ge, SF; Fan, XQ				Huang, Xiaolin; Wang, Li; Zhang, He; Wang, Haibo; Zhao, Xiaoping; Qian, Guanxiang; Hu, Jifan; Ge, Shengfang; Fan, Xianqun			Therapeutic Efficacy by Targeting Correction of Notch1-Induced Aberrants in Uveal Tumors	PLOS ONE			English	Article							ONCOLYTIC ADENOVIRUS; GENE-THERAPY; MELANOMA-CELLS; BREAST-CANCER; NOTCH1; INHIBITION; EXPRESSION; GROWTH; P53; SUPPRESSION	There is a need for more effective treatments for uveal melanoma. The recombinant oncolytic adenovirus H101 replicates specifically in p53-depleted tumor cells, and has been approved for use by the Chinese State Food and Drug Administration. However, this treatment is associated with subsequent remission. Transfection of uveal melanoma cells with a small interfering RNA against Notch1 (siNotch1) effectively suppressed Notch1 expression, resulting in significant cell growth inhibition when combined with H101 treatment. Combined treatment with siNotch1 and H101 (H101-Notch1-siRNA) greatly enhanced apoptosis and cell cycle arrest in vitro as compared to treatment with H101 or siNotch1 alone. For in vivo treatments, the combined treatment of siNotch1 and H101 showed remarkable tumor growth inhibition and prolonged mouse survival in the OCM1 xenograft model. We predict that Notch pathway deregulation could be a feature of uveal melanoma, and could be a therapeutic target, especially if p53 is concurrently targeted.	[Huang, Xiaolin; Zhao, Xiaoping; Ge, Shengfang; Fan, Xianqun] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Zhang, He; Wang, Haibo; Hu, Jifan] Stanford Univ, Sch Med, Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Wang, Li; Zhang, He; Wang, Haibo; Zhao, Xiaoping; Qian, Guanxiang; Ge, Shengfang] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Biol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Shanghai Jiao Tong University	Fan, XQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Ophthalmol, Shanghai 200030, Peoples R China.	geshengfang@sjtu.edu.cn; fanxq@sh163.net	WANG, LI/K-2495-2014	WANG, LI/0000-0002-3784-8828	National Key Program for Basic Research of China [2010CB529902]; National Natural Science Foundation of China [10979034]; Shanghai Leading Academic Discipline Project [S30205]	National Key Program for Basic Research of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by a National Key Program for Basic Research of China grant (2010CB529902) to GXQ, a National Natural Science Foundation of China grant (10979034) to SFG, and a Shanghai Leading Academic Discipline Project grant (S30205) to XQF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT DM, 1984, INVEST OPHTH VIS SCI, V25, P1284; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Asnaghi L, 2012, CLIN CANCER RES, V18, P654, DOI 10.1158/1078-0432.CCR-11-1406; Aster JC, 2001, CURR OPIN HEMATOL, V8, P237, DOI 10.1097/00062752-200107000-00010; Bergelson JM, 1997, J INFECT DIS, V175, P697, DOI 10.1093/infdis/175.3.697; Bin Hafeez B, 2009, CLIN CANCER RES, V15, P452, DOI 10.1158/1078-0432.CCR-08-1631; Bischoff JR, 1996, SCIENCE, V274, P373, DOI 10.1126/science.274.5286.373; Brennan K, 2003, BREAST CANCER RES, V5, P69, DOI 10.1186/bcr559; Cherubini G, 2006, CELL CYCLE, V5, P2244, DOI 10.4161/cc.5.19.3263; Coyne CB, 2005, ADV DRUG DELIVER REV, V57, P869, DOI 10.1016/j.addr.2005.01.007; Cun BY, 2012, CANCER BIOL THER, V13, P77, DOI 10.4161/cbt.13.2.18436; Damato B, 2009, ARCH OPHTHALMOL-CHIC, V127, P113, DOI 10.1001/archophthalmol.2008.529; EGAN KM, 1988, SURV OPHTHALMOL, V32, P239, DOI 10.1016/0039-6257(88)90173-7; Fukazawa T, 2010, INT J MOL MED, V25, P3, DOI 10.3892/ijmm_00000306; Harper JA, 2003, CLIN GENET, V64, P461, DOI 10.1046/j.1399-0004.2003.00194.x; Hu Fang, 2006, Ai Zheng, V25, P919; Huang X, 2012, BR J OPHTHALMOL; Inskip PD, 2003, CANCER CAUSE CONTROL, V14, P251, DOI 10.1023/A:1023684502638; Jia RB, 2011, MOL MED REP, V4, P163, DOI 10.3892/mmr.2010.397; KANMITCHELL J, 1989, INVEST OPHTH VIS SCI, V30, P829; Kasuya H, 2007, CURR CANCER DRUG TAR, V7, P123, DOI 10.2174/156800907780058826; Kirschmann DA, 2002, CANCER RES, V62, P4478; Kujala E, 2009, ACTA OPHTHALMOL, V87, P149, DOI 10.1111/j.1755-3768.2008.01369.x; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lambertini C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010369; Laws AM, 2004, EUR J IMMUNOL, V34, P726, DOI 10.1002/eji.200324772; Leethanakul C, 2000, ONCOGENE, V19, P3220, DOI 10.1038/sj.onc.1203703; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Masuda S, 2005, CANCER SCI, V96, P274, DOI 10.1111/j.1349-7006.2005.00048.x; Moriyama M, 2006, J CELL BIOL, V173, P333, DOI 10.1083/jcb.200509084; Oh JY, 2010, INT J MOL MED, V25, P369, DOI 10.3892/ijmm_00000354; Qian CF, 2009, INT J MOL MED, V24, P445, DOI 10.3892/ijmm_00000251; Rae FK, 2000, INT J CANCER, V88, P726, DOI 10.1002/1097-0215(20001201)88:5<726::AID-IJC7>3.0.CO;2-H; Saxena MT, 2001, J BIOL CHEM, V276, P40268, DOI 10.1074/jbc.M107234200; Song X, 2010, INVEST OPHTH VIS SCI, V51, P2626, DOI 10.1167/iovs.09-3516; Sonoshita M, 2011, CANCER CELL, V19, P125, DOI 10.1016/j.ccr.2010.11.008; Suzuki T, 2000, INT J ONCOL, V17, P1131; Triozzi PL, 2008, CANCER TREAT REV, V34, P247, DOI 10.1016/j.ctrv.2007.12.002; Weijzen S, 2002, NAT MED, V8, P979, DOI 10.1038/nm754; Xu Rui-Hua, 2005, Ai Zheng, V24, P975; Yu H, 2007, INT J GYNECOL CANCER, V17, P511, DOI 10.1111/j.1525-1438.2007.00813.x; Yu W, 2007, CURR CANCER DRUG TAR, V7, P141, DOI 10.2174/156800907780058817; Yugawa T, 2007, MOL CELL BIOL, V27, P3732, DOI 10.1128/MCB.02119-06; ZAGOURAS P, 1995, P NATL ACAD SCI USA, V92, P6414, DOI 10.1073/pnas.92.14.6414; Zerp SF, 1999, BRIT J CANCER, V79, P921, DOI 10.1038/sj.bjc.6690147; Zhang H, 2009, MOL THER, V17, P57, DOI 10.1038/mt.2008.236; Zhou YX, 2010, PIGM CELL MELANOMA R, V23, P661, DOI 10.1111/j.1755-148X.2010.00729.x	47	21	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44301	10.1371/journal.pone.0044301	http://dx.doi.org/10.1371/journal.pone.0044301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937170	Green Published, gold, Green Submitted			2022-12-25	WOS:000308213600101
J	Bernard, B; Thorsson, V; Rovira, H; Shmulevich, I				Bernard, Brady; Thorsson, Vesteinn; Rovira, Hector; Shmulevich, Ilya			Increasing Coverage of Transcription Factor Position Weight Matrices through Domain-level Homology	PLOS ONE			English	Article							DNA-BINDING SITES; DATABASE; IDENTIFICATION; EXPRESSION; SMART	Transcription factor-DNA interactions, central to cellular regulation and control, are commonly described by position weight matrices (PWMs). These matrices are frequently used to predict transcription factor binding sites in regulatory regions of DNA to complement and guide further experimental investigation. The DNA sequence preferences of transcription factors, encoded in PWMs, are dictated primarily by select residues within the DNA binding domain(s) that interact directly with DNA. Therefore, the DNA binding properties of homologous transcription factors with identical DNA binding domains may be characterized by PWMs derived from different species. Accordingly, we have implemented a fully automated domain-level homology searching method for identical DNA binding sequences. By applying the domain-level homology search to transcription factors with existing PWMs in the JASPAR and TRANSFAC databases, we were able to significantly increase coverage in terms of the total number of PWMs associated with a given species, assign PWMs to transcription factors that did not previously have any associations, and increase the number of represented species with PWMs over an order of magnitude. Additionally, using protein binding microarray (PBM) data, we have validated the domain-level method by demonstrating that transcription factor pairs with matching DNA binding domains exhibit comparable DNA binding specificity predictions to transcription factor pairs with completely identical sequences. The increased coverage achieved herein demonstrates the potential for more thorough species-associated investigation of protein-DNA interactions using existing resources. The PWM scanning results highlight the challenging nature of transcription factors that contain multiple DNA binding domains, as well as the impact of motif discovery on the ability to predict DNA binding properties. The method is additionally suitable for identifying domain-level homology mappings to enable utilization of additional information sources in the study of transcription factors. The domain-level homology search method, resulting PWM mappings, web-based user interface, and web API are publicly available at http://dodoma.systemsbiology.netdodoma.systemsbiology.net.	[Bernard, Brady; Thorsson, Vesteinn; Rovira, Hector; Shmulevich, Ilya] Inst Syst Biol, Seattle, WA 98109 USA	Institute for Systems Biology (ISB)	Bernard, B (corresponding author), Inst Syst Biol, Seattle, WA 98109 USA.	ilya.shmulevich@systemsbiology.org			National Cancer Institute [U24CA143835]; NATIONAL CANCER INSTITUTE [U24CA143835] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute [U24CA143835]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alleyne TM, 2009, BIOINFORMATICS, V25, P1012, DOI 10.1093/bioinformatics/btn645; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Annala M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020059; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Chen XY, 2007, BIOINFORMATICS, V23, pI72, DOI 10.1093/bioinformatics/btm224; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Lahdesmaki H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001820; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Thijs G, 2002, BIOINFORMATICS, V18, P331, DOI 10.1093/bioinformatics/18.2.331; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wagner A, 1999, BIOINFORMATICS, V15, P776, DOI 10.1093/bioinformatics/15.10.776; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281	25	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e42779	10.1371/journal.pone.0042779	http://dx.doi.org/10.1371/journal.pone.0042779			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952610	Green Published, gold, Green Submitted			2022-12-25	WOS:000308044800012
J	Ponsuksili, S; Murani, E; Schwerin, M; Schellander, K; Tesfaye, D; Wimmers, K				Ponsuksili, Siriluck; Murani, Eduard; Schwerin, Manfred; Schellander, Karl; Tesfaye, Dawit; Wimmers, Klaus			Gene Expression and DNA-Methylation of Bovine Pretransfer Endometrium Depending on Its Receptivity after In Vitro-Produced Embryo Transfer	PLOS ONE			English	Article							ADHESION MOLECULES; GROWTH-FACTORS; ESTROUS-CYCLE; IMPLANTATION; P53; WOMEN; CYTOKINES; EZH2; REPRODUCTION; PROFILES	Embryonic implantation to establish a pregnancy is a complex process that requires appropriate communication between the embryo and the maternal endometrium. Inadequate uterine receptivity may contribute to the majority of implantation failures. To provide a comprehensive inventory of genes and functional networks that represent the maternal input of the embryo-maternal cross-talk, a longitudinal, holistic study of the endometrial transcriptome in relation to the days of estrous and to the receptivity of the endometrium was performed in bovine. At day 3 of estrous, genes related to cell communication and mitochondrial energy metabolism were differentially expressed among high-and low-receptive endometria (HR, LR); at day 7, transcripts functioning in immune and inflammatory pathways, oxidative stress, and angiogenesis had different abundances. Additionally, temporal transcriptional changes between days 3 and 7 differed considerably among HR and LR. Further, several transcription factors were predicted as relevant for receptivity because they were either differentially expressed among HR and LR animals or are known to be associated with genes we detected to have differential expression. Finally, global DNA methylation varied according to the interaction of receptivity group and day of estrous, and a divergent trend, which correlated with abundance of DNMT1 transcript, was observed in LR and HR along the estrous cycle days. The study revealed that, even in early estrous, transcripts related to cell communication and response to exogenous stimuli, vascularization, and energy supply show divergent expression and longitudinal temporal regulation in HR and LR. Key components of these molecular pathways are known to be dependent on ovarian hormones that promote uterine receptivity.	[Ponsuksili, Siriluck; Schwerin, Manfred] Leibniz Inst Farm Anim Biol, Res Grp Funct Genome Anal, Dummerstorf, Germany; [Murani, Eduard; Wimmers, Klaus] Leibniz Inst Farm Anim Biol, Res Unit Mol Biol, Dummerstorf, Germany; [Schellander, Karl; Tesfaye, Dawit] Univ Bonn, Inst Anim Sci, Anim Breeding & Husb Grp, Bonn, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); University of Bonn	Ponsuksili, S (corresponding author), Leibniz Inst Farm Anim Biol, Res Grp Funct Genome Anal, Dummerstorf, Germany.	wimmers@fbn-dummerstorf.de	Wimmers, Klaus/AAF-9434-2020	Wimmers, Klaus/0000-0002-9523-6790	German Research Foundation (Deutsche Forschungsgemeinschaft) [DFG PO753/6-1]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This research was supported by German Research Foundation (Deutsche Forschungsgemeinschaft, DFG PO753/6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004; Aplin JD, 2000, BEST PRACT RES CL OB, V14, P757, DOI 10.1053/beog.2000.0116; Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Bagot CN, 2001, DEV DYNAM, V222, P538, DOI 10.1002/dvdy.1209; Bauersachs S, 2005, J MOL ENDOCRINOL, V34, P889, DOI 10.1677/jme.1.01799; Bowen JA, 2000, P SOC EXP BIOL MED, V223, P331, DOI 10.1046/j.1525-1373.2000.22348.x; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Dimitriadis E, 2005, HUM REPROD UPDATE, V11, P613, DOI 10.1093/humupd/dmi023; Furst RW, 2012, MOL CELL ENDOCRINOL, V348, P67, DOI 10.1016/j.mce.2011.07.032; Hastings JM, 2006, BIOL REPROD, V75, P176, DOI 10.1095/biolreprod.106.052852; HINTERMAIR V, 2007, THESIS TU MUNICH; Horcajadas JA, 2007, HUM REPROD UPDATE, V13, P77, DOI 10.1093/humupd/dml046; Hu WW, 2008, CELL CYCLE, V7, P848, DOI 10.4161/cc.7.7.5658; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Hu WW, 2009, CELL CYCLE, V8, P3621, DOI 10.4161/cc.8.22.9938; Hung TH, 2011, TAIWAN J OBSTET GYNE, V45, P189; Jabbour HN, 2006, ENDOCR REV, V27, P17, DOI 10.1210/er.2004-0021; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Kammerer U, 2004, IMMUNOBIOLOGY, V209, P569, DOI 10.1016/j.imbio.2004.04.009; Kane MT, 1997, HUM REPROD UPDATE, V3, P137, DOI 10.1093/humupd/3.2.137; Kao LC, 2003, ENDOCRINOLOGY, V144, P2870, DOI 10.1210/en.2003-0043; King AE, 2010, J STEROID BIOCHEM, V120, P116, DOI 10.1016/j.jsbmb.2010.01.003; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Liu AX, 2011, J CLIN ENDOCR METAB, V96, pE493, DOI 10.1210/jc.2010-2192; Loset M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.043; Makker A, 2006, MED RES REV, V26, P699, DOI 10.1002/med.20061; Mansouri-Attia N, 2009, PHYSIOL GENOMICS, V39, P14, DOI 10.1152/physiolgenomics.90404.2008; Mansouri-Attia N, 2009, P NATL ACAD SCI USA, V106, P5687, DOI 10.1073/pnas.0812722106; Mattingly KA, 2008, MOL ENDOCRINOL, V22, P609, DOI 10.1210/me.2007-0029; Mitko K, 2008, REPRODUCTION, V135, P225, DOI 10.1530/REP-07-0415; Morsch DM, 2009, J MOL HISTOL, V40, P53, DOI 10.1007/s10735-009-9212-7; Nakamura H, 2004, AM J REPROD IMMUNOL, V51, P16, DOI 10.1046/j.8755-8920.2003.00116.x; Pafilis J, 2007, CELL TISSUE RES, V329, P1, DOI 10.1007/s00441-007-0406-6; Raaphorst FM, 2003, NEOPLASIA, V5, P481, DOI 10.1016/S1476-5586(03)80032-5; Revel A, 2005, FERTIL STERIL, V83, P580, DOI 10.1016/j.fertnstert.2004.11.008; Saino M, 2004, ONCOL REP, V12, P47; Salilew-Wondim D, 2010, PHYSIOL GENOMICS, V42, P201, DOI 10.1152/physiolgenomics.00047.2010; Simon C, 2000, BEST PRACT RES CL OB, V14, P815, DOI 10.1053/beog.2000.0121; Simon C, 1998, J REPROD IMMUNOL, V39, P117, DOI 10.1016/S0165-0378(98)00017-5; Sohr S, 2011, CELL CYCLE, V10, P3758, DOI 10.4161/cc.10.21.17946; Spell AR, 2001, THERIOGENOLOGY, V56, P287, DOI 10.1016/S0093-691X(01)00563-5; Stolk L, 2012, NAT GENET, V44, P260, DOI 10.1038/ng.1051; Sugino N, 2002, REPRODUCTION, V123, P379, DOI 10.1530/reprod/123.3.379; Szczepanska M, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-1; TABIBZADEH S, 1995, HUM REPROD, V10, P1579, DOI 10.1093/HUMREP/10.6.1579; Tan YF, 2003, REPRODUCTION, V126, P171, DOI 10.1530/rep.0.1260171; Taylor HS, 1998, J CLIN INVEST, V101, P1379, DOI 10.1172/JCI1057; Taylor HS, 2000, HUM REPROD UPDATE, V6, P75, DOI 10.1093/humupd/6.1.75; Thomas K, 2003, FERTIL STERIL, V80, P502, DOI 10.1016/S0015-0282(03)00792-1; van Kaam KJAF, 2011, FERTIL STERIL, V95, P1421, DOI 10.1016/j.fertnstert.2011.01.031; van Mourik MSM, 2009, J LEUKOCYTE BIOL, V85, P4, DOI 10.1189/jlb.0708395; Van Vaerenbergh I, 2010, FERTIL STERIL, V93, DOI 10.1016/j.fertnstert.2009.08.057; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Walker CG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-100; Wolf E, 2003, REPROD DOMEST ANIM, V38, P276, DOI 10.1046/j.1439-0531.2003.00435.x; Wu Y, 2007, FERTIL STERIL, V87, P24, DOI 10.1016/j.fertnstert.2006.05.077; Yamagata Y, 2009, HUM REPROD, V24, P1126, DOI 10.1093/humrep/dep015; Zanatta A, 2010, J ASSIST REPROD GEN, V27, P701, DOI 10.1007/s10815-010-9471-y; Zhai PY, 2000, AM J PHYSIOL-HEART C, V278, pH1640, DOI 10.1152/ajpheart.2000.278.5.H1640; Zhai PY, 2000, AM J PHYSIOL-HEART C, V279, pH2766, DOI 10.1152/ajpheart.2000.279.6.H2766	60	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e42402	10.1371/journal.pone.0042402	http://dx.doi.org/10.1371/journal.pone.0042402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952593	Green Submitted, gold, Green Published			2022-12-25	WOS:000308044800007
J	Escalante, AE; Inouye, S; Travisano, M				Escalante, Ana E.; Inouye, Sumiko; Travisano, Michael			A Spectrum of Pleiotropic Consequences in Development Due to Changes in a Regulatory Pathway	PLOS ONE			English	Article							BACTERIUM MYXOCOCCUS-XANTHUS; FRUITING BODY FORMATION; PROTEIN SER/THR KINASE; EVO-DEVO; DICTYOSTELIUM-DISCOIDEUM; EVOLUTIONARY SYNTHESIS; SALTATIONAL EVOLUTION; ADAPTIVE EVOLUTION; SOCIAL AMEBA; 6-PHOSPHOFRUCTOKINASE	Regulatory evolution has frequently been proposed as the primary mechanism driving morphological evolution. This is because regulatory changes may be less likely to cause deleterious pleiotropic effects than changes in protein structure, and consequently have a higher likelihood to be beneficial. We examined the potential for mutations in trans acting regulatory elements to drive phenotypic change, and the predictability of such change. We approach these questions by the study of the phenotypic scope and size of controlled alteration in the developmental network of the bacterium Myxococcus xanthus. We perturbed the expression of a key regulatory gene (fruA) by constructing independent in-frame deletions of four trans acting regulatory loci that modify its expression. While mutants retained developmental capability, the deletions caused changes in the expression of fruA and a dramatic shortening of time required for completion of development. We found phenotypic changes in the majority of traits measured, indicating pleiotropic effects of changes in regulation. The magnitude of the change for different traits was variable but the extent of differences between the mutants and parental type were consistent with changes in fruA expression. We conclude that changes in the expression of essential regulatory regions of developmental networks may simultaneously lead to modest as well as dramatic morphological changes upon which selection may subsequently act.	[Escalante, Ana E.; Travisano, Michael] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Escalante, Ana E.] Univ Nacl Autonoma Mexico, Dept Ecol Biodiversidad, Inst Ecol, Mexico City 04510, DF, Mexico; [Escalante, Ana E.; Travisano, Michael] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; [Inouye, Sumiko] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ USA	University of Minnesota System; University of Minnesota Twin Cities; Universidad Nacional Autonoma de Mexico; University of Minnesota System; University of Minnesota Twin Cities; Rutgers State University New Brunswick; Rutgers State University Medical Center	Escalante, AE (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	anaelena.escalante@gmail.com	Escalante, Ana/D-5479-2011; Travisano, Michael/AAI-4809-2020	Escalante, Ana/0000-0001-8147-4598; Travisano, Michael/0000-0001-8168-0842	University of Minnesota; CONACyT [126166]; Foundation of Medicine and Dentistry of New Jersey; US National Science Foundation [DEB-0918897, SES-0959134, MCB-1042335, DEB-1146463]	University of Minnesota(University of Minnesota System); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Foundation of Medicine and Dentistry of New Jersey; US National Science Foundation(National Science Foundation (NSF))	Ana E. Escalante was supported by University of Minnesota and CONACyT postdoctoral Fellowship 126166, Sumiko Inouye by the Foundation of Medicine and Dentistry of New Jersey, and Michael Travisano by the US National Science Foundation (DEB-0918897, SES-0959134, MCB-1042335, DEB-1146463). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Atallah J, 2009, INT REV CEL MOL BIO, V278, P119, DOI 10.1016/S1937-6448(09)78003-7; BARTON NH, 1984, ANNU REV ECOL SYST, V15, P133, DOI 10.1146/annurev.es.15.110184.001025; Canestro C, 2007, NAT REV GENET, V8, P932, DOI 10.1038/nrg2226; CARROLL SB, 2005, DNA DIVERSITY MOL GE; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; Davelos AL, 2004, APPL ENVIRON MICROB, V70, P1051, DOI 10.1128/AEM.70.2.1051-1058.2004; de Vries H, 1906, SPECIES VARIETIES TH; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; DYKHUIZEN DE, 1990, TRENDS ECOL EVOL, V5, P257, DOI 10.1016/0169-5347(90)90067-N; Fortunato A, 2003, MOL ECOL, V12, P1031, DOI 10.1046/j.1365-294X.2003.01792.x; Goldschmidt R., 1940, MAT BASIS EVOLUTION; Higgs PI, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P465; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Huntley S, 2011, MOL BIOL EVOL, V28, P1083, DOI 10.1093/molbev/msq292; Inouye S, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P191; Jenner RA, 2007, NAT REV GENET, V8, P311, DOI 10.1038/nrg2062; Kraemer SA, 2010, FEMS MICROBIOL ECOL, V73, P226, DOI 10.1111/j.1574-6941.2010.00888.x; KROOS L, 1987, GENE DEV, V1, P840, DOI 10.1101/gad.1.8.840; Lemons D, 2006, SCIENCE, V313, P1918, DOI 10.1126/science.1132040; Lewontin RC, 1974, GENETIC BASIS EVOLUT; Liao BY, 2010, P NATL ACAD SCI USA, V107, P7353, DOI 10.1073/pnas.0910339107; Minelli A, 2009, EVOL DEV, V11, P318, DOI 10.1111/j.1525-142X.2009.00334.x; MORRISON CE, 1979, J BACTERIOL, V140, P1036, DOI 10.1128/JB.140.3.1036-1042.1979; Muller GB, 2007, NAT REV GENET, V8, P943, DOI 10.1038/nrg2219; Nariya H, 2005, MOL MICROBIOL, V56, P1314, DOI 10.1111/j.1365-2958.2005.04619.x; Nariya H, 2003, MOL MICROBIOL, V49, P517, DOI 10.1046/j.1365-2958.2003.03572.x; Nariya H, 2002, MOL MICROBIOL, V46, P1353, DOI 10.1046/j.1365-2958.2002.03251.x; Nariya H, 2006, MOL MICROBIOL, V60, P1205, DOI 10.1111/j.1365-2958.2006.05178.x; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Pighucci M, 2009, ANN NY ACAD SCI, V1168, P218, DOI 10.1111/j.1749-6632.2009.04578.x; Pigliucci M, 2010, PHILOS T R SOC B, V365, P557, DOI 10.1098/rstb.2009.0241; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; Rice SH, 2008, ANN NY ACAD SCI, V1133, P67, DOI 10.1196/annals.1438.002; Rubinoff D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004035; Shimkets LJ, 1999, ANNU REV MICROBIOL, V53, P525, DOI 10.1146/annurev.micro.53.1.525; Stefanic P, 2009, J BACTERIOL, V191, P1756, DOI 10.1128/JB.01290-08; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Suzuki Y, 2008, J EVOLUTION BIOL, V21, P57, DOI 10.1111/j.1420-9101.2007.01464.x; Travisano M, 1996, GENETICS, V143, P15; Ueki T, 1996, GENE, V183, P153, DOI 10.1016/S0378-1119(96)00546-X; Ueki T, 2006, APPL MICROBIOL BIOT, V72, P21, DOI 10.1007/s00253-006-0455-x; Velicer GJ, 1998, P NATL ACAD SCI USA, V95, P12376, DOI 10.1073/pnas.95.21.12376; Velicer GJ, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P17; Vos M, 2008, CURR BIOL, V18, P386, DOI 10.1016/j.cub.2008.02.050; Whitlock M. C., 2009, ANAL BIOL DATA; Yu YTN, 2010, SCIENCE, V328, P993, DOI 10.1126/science.1187200; Zar JH, 1999, BIOSTATISTICAL ANAL; Zhang YQ, 2005, APPL ENVIRON MICROB, V71, P3331, DOI 10.1128/AEM.71.6.3331-3336.2005; Zusman DR, 2007, NAT REV MICROBIOL, V5, P862, DOI 10.1038/nrmicro1770	53	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43413	10.1371/journal.pone.0043413	http://dx.doi.org/10.1371/journal.pone.0043413			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937047	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500049
J	Hu, G; Wu, JG; Feeley, KJ; Xu, GF; Yu, MJ				Hu, Guang; Wu, Jianguo; Feeley, Kenneth J.; Xu, Gaofu; Yu, Mingjian			The Effects of Landscape Variables on the Species-Area Relationship during Late-Stage Habitat Fragmentation	PLOS ONE			English	Article							THREE-GORGES DAM; SPATIAL COMPONENT; LIFE-HISTORY; RICHNESS; ISLANDS; BIRDS; PATCH; IMMIGRATION; PATTERNS; SIZE	Few studies have focused explicitly on the later stages of the fragmentation process, or "late-stage fragmentation", during which habitat area and patch number decrease simultaneously. This lack of attention is despite the fact that many of the anthropogenically fragmented habitats around the world are, or soon will be, in late-stage fragmentation. Understanding the ecological processes and patterns that occur in late-stage fragmentation is critical to protect the species richness in these fragments. We investigated plant species composition on 152 islands in the Thousand Island Lake, China. A random sampling method was used to create simulated fragmented landscapes with different total habitat areas and numbers of patches mimicking the process of late-stage fragmentation. The response of the landscape-scale species-area relationship (LSAR) to fragmentation per se was investigated, and the contribution of inter-specific differences in the responses to late-stage fragmentation was tested. We found that the loss of species at small areas was compensated for by the effects of fragmentation per se, i.e., there were weak area effects on species richness in landscapes due to many patches with irregular shapes and high variation in size. The study also illustrated the importance of inter-specific differences for responses to fragmentation in that the LSARs of rare and common species were differently influenced by the effects of fragmentation per se. In conclusion, our analyses at the landscape scale demonstrate the significant influences of fragmentation per se on area effects and the importance of inter-specific differences for responses to fragmentation in late-stage fragmentation. These findings add to our understanding of the effects of habitat fragmentation on species diversity.	[Hu, Guang; Yu, Mingjian] Zhejiang Univ, Key Lab Conservat Biol Endangered Wildlife, Minist Educ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Jianguo] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Wu, Jianguo] Arizona State Univ, Global Inst Sustainabil, Tempe, AZ USA; [Wu, Jianguo] Inner Mongolia Univ, Sino US Ctr Conservat Energy & Sustainabil, Hohhot, Peoples R China; [Feeley, Kenneth J.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Feeley, Kenneth J.] Fairchild Trop Bot Garden, Ctr Trop Plant Conservat, Coral Gables, FL USA; [Xu, Gaofu] Xinan River Dev Corp, Chunan, South Korea	Zhejiang University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Inner Mongolia University; State University System of Florida; Florida International University	Hu, G (corresponding author), Zhejiang Univ, Key Lab Conservat Biol Endangered Wildlife, Minist Educ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	fishmj202@hotmail.com	Feeley, Kenneth James/A-7631-2009; Hu, Guang/AAF-1689-2020; Wu, Jianguo/G-6267-2010	Feeley, Kenneth James/0000-0002-3618-1144; Wu, Jianguo/0000-0002-1182-3024; Hu, Guang/0000-0002-4390-6166	Zhejiang Provincial Natural Science Foundation of China [Z5100053]; National Nature Science Foundation of China [30770371]; Fundamental Research Funds for the Central Universities; Graduate Innovation Program of Zhejiang Province; Florida International University; Fairchild Tropical Botanic Garden	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Graduate Innovation Program of Zhejiang Province; Florida International University; Fairchild Tropical Botanic Garden	Funding provided by Zhejiang Provincial Natural Science Foundation of China (No. Z5100053) (http://www.zjnsf.gov.cn), National Nature Science Foundation of China (No. 30770371) (http://www.nsfc.gov.cn), Fundamental Research Funds for the Central Universities (http://www.dost.moe.edu.cn), and the Graduate Innovation Program of Zhejiang Province (http://www.zjedu.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Our field work has obtained the permission from the responsible authority, Chun'an Forestry Bureau and Xin'an River Development Corporation of Chun'an County - we are grateful to them for support with field work. We thank the Florida International University and the Fairchild Tropical Botanic Garden for their support.	ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Banks-Leite C, 2010, OIKOS, V119, P918, DOI 10.1111/j.1600-0706.2009.18061.x; Bascompte J, 2001, ECOL LETT, V4, P417, DOI 10.1046/j.1461-0248.2001.00242.x; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borges PAV, 2009, ACTA OECOL, V35, P149, DOI 10.1016/j.actao.2008.09.003; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Caley MJ, 2001, ECOLOGY, V82, P3435, DOI 10.2307/2680163; Chalfoun AD, 2002, CONSERV BIOL, V16, P306, DOI 10.1046/j.1523-1739.2002.00308.x; Collins CD, 2009, ECOLOGY, V90, P2577, DOI 10.1890/08-1405.1; Conceicao KS, 2010, PHYSICA A, V389, P3496, DOI 10.1016/j.physa.2010.04.036; Davis JD, 2007, LANDSCAPE ECOL, V22, P1341, DOI 10.1007/s10980-007-9111-9; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; Debuse VJ, 2007, LANDSCAPE ECOL, V22, P731, DOI 10.1007/s10980-006-9068-0; Dengler J, 2009, J BIOGEOGR, V36, P728, DOI 10.1111/j.1365-2699.2008.02038.x; Diamond J, 2001, SCIENCE, V294, P1847, DOI 10.1126/science.1067012; Editorial Committee of Flora of Zhejiang, 1993, FLOR ZHEJ; ESRI, 2009, ARCGIS DESKT REL 9 3; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fletcher RJ, 2007, CAN J ZOOL, V85, P1017, DOI 10.1139/Z07-100; Gardner RH, 2008, PERSPECT PLANT ECOL, V9, P211, DOI 10.1016/j.ppees.2007.08.003; Gilbert B, 2006, AM NAT, V168, P304, DOI 10.1086/506969; GUSTAFSON EJ, 1992, LANDSCAPE ECOL, V7, P101, DOI 10.1007/BF02418941; Hamer TL, 2006, LANDSCAPE ECOL, V21, P569, DOI 10.1007/s10980-005-2167-5; He FL, 2005, ECOLOGY, V86, P360, DOI 10.1890/04-1449; He FL, 1996, AM NAT, V148, P719, DOI 10.1086/285950; He FL, 2002, ECOLOGY, V83, P1185, DOI 10.1890/0012-9658(2002)083[1185:SDPDFS]2.0.CO;2; Hill MF, 1999, ECOL LETT, V2, P121, DOI 10.1046/j.1461-0248.1999.22061.x; Holt RD, 1999, ECOLOGY, V80, P1495, DOI 10.2307/176542; Hortal J, 2009, AM NAT, V174, pE205, DOI 10.1086/645085; Hu G, 2011, LANDSCAPE ECOL, V26, P1405, DOI 10.1007/s10980-011-9662-7; Kim S, 2011, PPCOR PARTIAL SEMIPA; Kitamura K, 2005, PLANT SPEC BIOL, V20, P133, DOI 10.1111/j.1442-1984.2005.00132.x; Koper N, 2007, LANDSCAPE ECOL, V22, P811, DOI 10.1007/s10980-007-9083-9; Laurance WF, 2008, BIOL CONSERV, V141, P1731, DOI 10.1016/j.biocon.2008.05.011; Lees AC, 2009, OIKOS, V118, P280, DOI 10.1111/j.1600-0706.2008.16842.x; Levin S, 2009, PRINCETON GUIDE ECOL, P438; Magness DR, 2006, WILDLIFE SOC B, V34, P473, DOI 10.2193/0091-7648(2006)34[473:QRAGWO]2.0.CO;2; Marks B.J., 1995, 351 PNV US FOR SERV; May RM, 2000, SCIENCE, V290, P2084, DOI 10.1126/science.290.5499.2084; McGarigal K, 2002, ECOL APPL, V12, P335, DOI 10.1890/1051-0761(2002)012[0335:CEOEAT]2.0.CO;2; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; Meot A, 1998, ENVIRON ECOL STAT, V5, P1, DOI 10.1023/A:1009693501830; Murray BR, 2002, AUSTRAL ECOL, V27, P291, DOI 10.1046/j.1442-9993.2002.01181.x; Oksanen J, 2013, PACKAGE VEGAN COMMUN, P2; Panitsa M, 2006, J BIOGEOGR, V33, P1223, DOI 10.1111/j.1365-2699.2006.01481.x; Prevedello JA, 2010, BIODIVERS CONSERV, V19, P1205, DOI 10.1007/s10531-009-9750-z; Qie L, 2011, J BIOGEOGR, V38, P792, DOI 10.1111/j.1365-2699.2010.02439.x; R Development Core Team, 2009, R FDN STAT COMP; Rosenberg KV, 1999, CONSERV BIOL, V13, P568, DOI 10.1046/j.1523-1739.1999.98020.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Santos AMC, 2010, GLOBAL ECOL BIOGEOGR, V19, P527, DOI 10.1111/j.1466-8238.2010.00536.x; Scheiner SM, 2003, GLOBAL ECOL BIOGEOGR, V12, P441, DOI 10.1046/j.1466-822X.2003.00061.x; Sizling AL, 2009, AM NAT, V174, P82, DOI 10.1086/599305; Smith AC, 2009, LANDSCAPE ECOL, V24, P1271, DOI 10.1007/s10980-009-9383-3; Sonderegger D., 2011, SIZER SIGNIFICANT ZE; Sondgerath D, 2002, LANDSCAPE ECOL, V17, P57, DOI 10.1023/A:1015237002145; Terborgh JW, 2008, TROPICAL FOREST COMM; Thornton DH, 2011, LANDSCAPE ECOL, V26, P7, DOI 10.1007/s10980-010-9549-z; Toms JD, 2003, ECOLOGY, V84, P2034, DOI 10.1890/02-0472; Triantis KA, 2012, J BIOGEOGR, V39, P215, DOI 10.1111/j.1365-2699.2011.02652.x; Trzcinski MK, 1999, ECOL APPL, V9, P586, DOI 10.1890/1051-0761(1999)009[0586:IEOFCA]2.0.CO;2; Tscharntke T, 2002, ECOL APPL, V12, P354, DOI 10.1890/1051-0761(2002)012[0354:COSHFT]2.0.CO;2; Wang Y, 2009, ANIM CONSERV, V12, P329, DOI 10.1111/j.1469-1795.2009.00257.x; Wang YP, 2010, DIVERS DISTRIB, V16, P862, DOI 10.1111/j.1472-4642.2010.00682.x; Wilcove D.S., 1986, P237; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wright DH, 1998, OECOLOGIA, V113, P1, DOI 10.1007/s004420050348; Wu JG, 2004, FRONT ECOL ENVIRON, V2, P241, DOI 10.2307/3868264; Wu JG, 2003, SCIENCE, V300, P1239, DOI 10.1126/science.1083312; Yaacobi G, 2007, P ROY SOC B-BIOL SCI, V274, P2409, DOI 10.1098/rspb.2007.0674; Yu MJ, 2012, J BIOGEOGR, V39, P1124, DOI 10.1111/j.1365-2699.2011.02676.x; Zheng C., 2005, KEYS SEED PLANTS ZHE	73	19	24	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43894	10.1371/journal.pone.0043894	http://dx.doi.org/10.1371/journal.pone.0043894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937120	gold, Green Published, Green Submitted			2022-12-25	WOS:000308225500120
J	McWilliam, SJ; Antoine, DJ; Sabbisetti, V; Turner, MA; Farragher, T; Bonventre, JV; Park, BK; Smyth, RL; Pirmohamed, M				McWilliam, Stephen J.; Antoine, Daniel J.; Sabbisetti, Venkata; Turner, Mark A.; Farragher, Tracey; Bonventre, Joseph V.; Park, B. Kevin; Smyth, Rosalind L.; Pirmohamed, Munir			Mechanism-Based Urinary Biomarkers to Identify the Potential for Aminoglycoside-Induced Nephrotoxicity in Premature Neonates: A Proof-of-Concept Study	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; GELATINASE-ASSOCIATED LIPOCALIN; CRITICALLY-ILL CHILDREN; ACUTE-RENAL-FAILURE; MARKER; NGAL; APOPTOSIS; TOXICITY; VALUES	Premature infants are frequently exposed to aminoglycoside antibiotics. Novel urinary biomarkers may provide a non-invasive means for the early identification of aminoglycoside-related proximal tubule renal toxicity, to enable adjustment of treatment and identification of infants at risk of long-term renal impairment. In this proof-of-concept study, urine samples were collected from 41 premature neonates (<= 32 weeks gestation) at least once per week, and daily during courses of gentamicin, and for 3 days afterwards. Significant increases were observed in the three urinary biomarkers measured (Kidney Injury Molecule-1 (KIM-1), Neutrophil Gelatinase-associated Lipocalin (NGAL), and N-acetyl-beta-D-glucosaminidase (NAG)) during treatment with multiple courses of gentamicin. When adjusted for potential confounders, the treatment effect of gentamicin remained significant only for KIM-1 (mean difference from not treated, 1.35 ng/mg urinary creatinine; 95% CI 0.05-2.65). Our study shows that (a) it is possible to collect serial urine samples from premature neonates, and that (b) proximal tubule specific urinary biomarkers can act as indicators of aminoglycoside-associated nephrotoxicity in this age group. Further studies to investigate the clinical utility of novel urinary biomarkers in comparison to serum creatinine need to be undertaken.	[McWilliam, Stephen J.; Antoine, Daniel J.; Park, B. Kevin; Pirmohamed, Munir] Univ Liverpool, MRC Ctr Drug Safety Sci, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England; [Antoine, Daniel J.; Sabbisetti, Venkata; Bonventre, Joseph V.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Renal Div,Med Sch, Boston, MA 02115 USA; [Turner, Mark A.] Univ Liverpool, Dept Womens & Childrens Hlth, Neonatal Unit, Liverpool Womens Hosp, Liverpool L69 3BX, Merseyside, England; [Farragher, Tracey] Univ Leeds, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England; [Smyth, Rosalind L.] Univ Liverpool, Inst Child Hlth, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England	University of Liverpool; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Liverpool; University of Leeds; University of Liverpool	McWilliam, SJ (corresponding author), Univ Liverpool, MRC Ctr Drug Safety Sci, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England.	d.antoine@liv.ac.uk	Farragher, Tracey/P-5847-2019; McWilliam, Stephen/J-3811-2019; Pirmohamed, Munir/H-6004-2011	McWilliam, Stephen/0000-0002-0509-7425; Pirmohamed, Munir/0000-0002-7534-7266; Farragher, Tracey/0000-0002-1968-6378; Turner, Mark/0000-0002-5299-8656	Medical Research Council [G0700654, G1000417/94909]; Royal Society for an International Travelling Fellowship; US National Institutes of Health [DK39773, DK072381]; North West England Medical Research Council Fellowship Scheme in Clinical Pharmacology and Therapeutics; ICON; GlaxoSmithKline; AstraZeneca; Medical Evaluation Unit; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039773, R01DK039773, R01DK072381] Funding Source: NIH RePORTER; Medical Research Council [G0700654B, G1000417] Funding Source: researchfish; MRC [G1000417, G0700654] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society for an International Travelling Fellowship; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North West England Medical Research Council Fellowship Scheme in Clinical Pharmacology and Therapeutics(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ICON; GlaxoSmithKline(GlaxoSmithKline); AstraZeneca(AstraZeneca); Medical Evaluation Unit; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to acknowledge financial support from the Medical Research Council (grant number G0700654) and to the Royal Society for an International Travelling Fellowship awarded to DJA. JVB is supported by US National Institutes of Health grants DK39773 and DK072381. SMcW is an MRC Clinical Training Fellow supported by the North West England Medical Research Council Fellowship Scheme in Clinical Pharmacology and Therapeutics which is funded by the Medical Research Council (grant number G1000417/94909), ICON, GlaxoSmithKline, AstraZeneca and the Medical Evaluation Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoli SP, 2004, SEMIN PERINATOL, V28, P112, DOI 10.1053/j.semperi.2003.11.003; Askenazi DJ, 2011, J PEDIATR-US, V159, P907, DOI 10.1016/j.jpeds.2011.05.045; Askenazi DJ, 2011, PEDIATR RES, V70, P302, DOI 10.1203/PDR.0b013e3182275164; Askenazi DJ, 2009, PEDIATR NEPHROL, V24, P265, DOI 10.1007/s00467-008-1060-2; Coca SG, 2008, KIDNEY INT, V73, P1008, DOI 10.1038/sj.ki.5002729; Davidovic-Plavsic B, 2010, J MED BIOCHEM, V29, P44, DOI 10.2478/v10011-010-0002-2; Devarajan P, 2008, SCAND J CLIN LAB INV, V68, P89, DOI 10.1080/00365510802150158; Du Y, 2011, PEDIATR NEPHROL, V26, P267, DOI 10.1007/s00467-010-1673-0; Espandiari P, 2007, TOXICOL SCI, V99, P637, DOI 10.1093/toxsci/kfm184; Huynh TK, 2009, PEDIATR RES, V66, P528, DOI 10.1203/PDR.0b013e3181baa3dd; Jetton JG, 2012, CURR OPIN PEDIATR, V24, P191, DOI 10.1097/MOP.0b013e32834f62d5; Karlowicz MG, 1995, PEDIATR NEPHROL, V9, P718, DOI 10.1007/BF00868721; Koralkar R, 2011, PEDIATR RES, V69, P354, DOI 10.1203/PDR.0b013e31820b95ca; LANGHENDRIES JP, 1989, BIOL NEONATE, V56, P76; Lavery AP, 2008, PEDIATR RES, V64, P423, DOI 10.1203/PDR.0b013e318181b3b2; MATHEWS A, 1987, J CLIN PHARM THER, V12, P273, DOI 10.1111/j.1365-2710.1987.tb00539.x; Nestaas E, 2005, ARCH DIS CHILD-FETAL, V90, pF294, DOI 10.1136/adc.2004.056317; Parikh CR, 2011, J AM SOC NEPHROL, V22, P1737, DOI 10.1681/ASN.2010111163; Parravicini E, 2010, PEDIATR RES, V67, P636, DOI 10.1203/PDR.0b013e3181da75c1; Parravicini E, 2009, AM J PERINAT, V26, P437, DOI 10.1055/s-0029-1214242; Royston P, 2005, METHOD INFORM MED, V44, P561; Schmidt-Ott KM, 2007, J AM SOC NEPHROL, V18, P407, DOI 10.1681/ASN.2006080882; Schmidt-Ott KM, 2006, CURR OPIN NEPHROL HY, V15, P442, DOI 10.1097/01.mnh.0000232886.81142.58; Schmitz C, 2002, J BIOL CHEM, V277, P618, DOI 10.1074/jbc.M109959200; Servais H, 2008, APOPTOSIS, V13, P11, DOI 10.1007/s10495-007-0151-z; Servais H, 2005, TOXICOL APPL PHARM, V206, P321, DOI 10.1016/j.taap.2004.11.024; Slaughter RL, 1998, PHARMACOECONOMICS, V14, P385, DOI 10.2165/00019053-199814040-00005; Vaidya VS, 2009, KIDNEY INT, V76, P108, DOI 10.1038/ki.2009.96; Vaidya VS, 2008, CTS-CLIN TRANSL SCI, V1, P200, DOI 10.1111/j.1752-8062.2008.00053.x; Victor S, 2011, ARCH DIS CHILD-FETAL, V96, pF144, DOI 10.1136/adc.2008.152454; Waikar SS, 2010, KIDNEY INT, V78, P486, DOI 10.1038/ki.2010.165; Wasilewska A, 2011, PEDIATR NEPHROL, V26, P579, DOI 10.1007/s00467-011-1773-5; Wheeler DS, 2008, CRIT CARE MED, V36, P1297, DOI 10.1097/CCM.0b013e318169245a; Willis F, 1997, ARCH DIS CHILD-FETAL, V77, pF57, DOI 10.1136/fn.77.1.F57; Zappitelli M, 2007, CRIT CARE, V11, DOI 10.1186/cc6089	35	64	65	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43809	10.1371/journal.pone.0043809	http://dx.doi.org/10.1371/journal.pone.0043809			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937100	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500102
J	Kim, C; Choi, H; Jung, ES; Lee, W; Oh, S; Jeon, NL; Mook-Jung, I				Kim, Chaeyoung; Choi, Heesun; Jung, Eun Sun; Lee, Wonik; Oh, Soojung; Jeon, Noo Li; Mook-Jung, Inhee			HDAC6 Inhibitor Blocks Amyloid Beta-Induced Impairment of Mitochondrial Transport in Hippocampal Neurons	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; AXONAL-TRANSPORT; A-BETA; TUBULIN; DYSFUNCTION; INTERACTS; ABNORMALITIES; TRAFFICKING; DYNAMICS; DEFICITS	Even though the disruption of axonal transport is an important pathophysiological factor in neurodegenerative diseases including Alzheimer's disease (AD), the relationship between disruption of axonal transport and pathogenesis of AD is poorly understood. Considering that alpha-tubulin acetylation is an important factor in axonal transport and that A beta impairs mitochondrial axonal transport, we manipulated the level of alpha-tubulin acetylation in hippocampal neurons with A beta cultured in a microfluidic system and examined its effect on mitochondrial axonal transport. We found that inhibiting histone deacetylase 6 (HDAC6), which deacetylates alpha-tubulin, significantly restored the velocity and motility of the mitochondria in both anterograde and retrograde axonal transports, which would be otherwise compromised by A beta. The inhibition of HDAC6 also recovered the length of the mitochondria that had been shortened by A beta to a normal level. These results suggest that the inhibition of HDAC6 significantly rescues hippocampal neurons from A beta-induced impairment of mitochondrial axonal transport as well as mitochondrial length. The results presented in this paper identify HDAC6 as an important regulator of mitochondrial transport as well as elongation and, thus, a potential target whose pharmacological inhibition contributes to improving mitochondrial dynamics in Ab treated neurons.	[Kim, Chaeyoung; Choi, Heesun; Jung, Eun Sun; Lee, Wonik; Mook-Jung, Inhee] Seoul Natl Univ, Coll Med, Dept Biochem & Biomed Sci, Seoul, South Korea; [Oh, Soojung; Jeon, Noo Li] Seoul Natl Univ, Sch Mech & Aerosp Engn, Program Multiscale Design, WCU, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, C (corresponding author), Seoul Natl Univ, Coll Med, Dept Biochem & Biomed Sci, Seoul, South Korea.	inhee@snu.ac.kr	Kim, Chaeyoung/GPW-6531-2022; Mook, Inhee/J-2754-2012; JUNG, EUN SUN/C-2042-2018	JUNG, EUN SUN/0000-0002-3887-987X	21C Frontier Functional Proteomics Project [FPR08K1301-02210]; National Research Foundation [2009-0081673]; World Class University-Neurocytomics; Korean National Institute of Health R&D Program Project [2009-0443]; Basic Research Program [2008-05943]; MRC at SNU [2011-0030738]	21C Frontier Functional Proteomics Project(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation; World Class University-Neurocytomics; Korean National Institute of Health R&D Program Project; Basic Research Program; MRC at SNU	This work was supported by grants from the 21C Frontier Functional Proteomics Project (FPR08K1301-02210), National Research Foundation 2009-0081673, World Class University-Neurocytomics, and the Korean National Institute of Health R&D Program Project (2009-0443) and supported in part by the Basic Research Program (2008-05943) and MRC at SNU (2011-0030738). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anesti V, 2006, BBA-BIOENERGETICS, V1757, P692, DOI 10.1016/j.bbabio.2006.04.013; Boo JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004172; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Calkins MJ, 2011, BBA-MOL BASIS DIS, V1812, P507, DOI 10.1016/j.bbadis.2011.01.007; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Cha MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034929; Chang DTW, 2006, PROG NEUROBIOL, V80, P241, DOI 10.1016/j.pneurobio.2006.09.003; Chen SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010848; d'Ydewalle C, 2011, NAT MED, V17, P968, DOI 10.1038/nm.2396; Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Ding HP, 2008, J NEUROCHEM, V106, P2119, DOI 10.1111/j.1471-4159.2008.05564.x; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Frederick RL, 2007, TRAFFIC, V8, P1668, DOI 10.1111/j.1600-0854.2007.00644.x; Fukushima N, 2009, J NEUROCHEM, V109, P683, DOI 10.1111/j.1471-4159.2009.06013.x; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hempen B, 1996, J NEUROPATH EXP NEUR, V55, P964, DOI 10.1097/00005072-199609000-00003; Henriques AG, 2010, J NEUROCHEM, V113, P761, DOI 10.1111/j.1471-4159.2010.06643.x; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Janke C, 2010, TRENDS NEUROSCI, V33, P362, DOI 10.1016/j.tins.2010.05.001; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Lee JS, 2012, J CELL PHYSIOL, V227, P2856, DOI 10.1002/jcp.23027; Lei Peng, 2011, Int J Alzheimers Dis, V2011, P189246, DOI 10.4061/2011/189246; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; Reddy PH, 2007, ANTIOXID REDOX SIGN, V9, P1647, DOI 10.1089/ars.2007.1754; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rice SE, 2006, J CELL BIOL, V173, P459, DOI 10.1083/jcb.200604071; Rui YF, 2006, J NEUROSCI, V26, P10480, DOI 10.1523/JNEUROSCI.3231-06.2006; Sigala R, 2007, CURR BIOL, V17, pR18, DOI 10.1016/j.cub.2006.11.036; Silva DFF, 2011, J ALZHEIMERS DIS, V26, P565, DOI 10.3233/JAD-2011-110423; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Varadi A, 2004, J CELL SCI, V117, P4389, DOI 10.1242/jcs.01299; Wang XL, 2010, NEURODEGENER DIS, V7, P56, DOI 10.1159/000283484; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang Y, 2006, J BIOL CHEM, V281, P2401, DOI 10.1074/jbc.C500241200; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813	44	98	106	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42983	10.1371/journal.pone.0042983	http://dx.doi.org/10.1371/journal.pone.0042983			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937007	gold, Green Published, Green Submitted			2022-12-25	WOS:000308286300032
J	Yukich, J; Briet, O; Bretscher, MT; Bennett, A; Lemma, S; Berhane, Y; Eisele, TP; Keating, J; Smith, T				Yukich, Joshua; Briet, Olivier; Bretscher, Michael T.; Bennett, Adam; Lemma, Seblewengel; Berhane, Yemane; Eisele, Thomas P.; Keating, Joseph; Smith, Thomas			Estimating Plasmodium falciparum Transmission Rates in Low-Endemic Settings Using a Combination of Community Prevalence and Health Facility Data	PLOS ONE			English	Article							MALARIA TRANSMISSION; INOCULATION RATES; INFECTION; INTENSITY; INDICATOR; TANZANIA; VACCINE; TRIAL; PROSPECTS; EXPOSURE	As some malaria control programs shift focus from disease control to transmission reduction, there is a need for transmission data to monitor progress. At lower levels of transmission, it becomes increasingly more difficult to measure precisely, for example through entomological studies. Many programs conduct regular cross sectional parasite prevalence surveys, and have access to malaria treatment data routinely collected by ministries of health, often in health management information systems. However, by themselves, these data are poor measures of transmission. In this paper, we propose an approach for combining annual parasite incidence and treatment data with cross-sectional parasite prevalence and treatment seeking survey data to estimate the incidence of new infections in the human population, also known as the force of infection. The approach is based on extension of a reversible catalytic model. The accuracy of the estimates from this model appears to be highly dependent on levels of detectability and treatment in the community, indicating the importance of information on private sector treatment seeking and access to effective and appropriate treatment.	[Yukich, Joshua; Bennett, Adam; Eisele, Thomas P.; Keating, Joseph] Tulane Univ, Med Ctr, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA 70112 USA; [Briet, Olivier; Smith, Thomas] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Briet, Olivier; Smith, Thomas] Univ Basel, Basel, Switzerland; [Bretscher, Michael T.] London Sch Hyg & Trop Med, London WC1, England; [Lemma, Seblewengel; Berhane, Yemane] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia	Tulane University; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of London; London School of Hygiene & Tropical Medicine; Addis Continental Institute of Public Health	Yukich, J (corresponding author), Tulane Univ, Med Ctr, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA 70112 USA.	jyukich@tulane.edu	Smith, Thomas/B-5569-2015; Eisele, Thom/AAE-8958-2020; Berhane, Yemane/ABB-8154-2020; Briet, Olivier/K-1917-2015	Smith, Thomas/0000-0002-3650-9381; Briet, Olivier/0000-0003-1186-2688; Lemma, Seblewengel/0000-0001-5910-3723; Berhane, Yemane/0000-0002-2527-1339	Bill & Melinda Gates Foundation [0PP1032350]; United States Agency for International Development [663-A-00-09-00431-00]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); United States Agency for International Development(United States Agency for International Development (USAID))	This study was partly financially supported by the Bill & Melinda Gates Foundation (www.gatesfoundation.org/), Award number 0PP1032350 to Swiss Tropical and Public Health Institute (Swiss TPH). Collection of data in Ethiopia was funded by the United States Agency for International Development (www.usaid.gov/) (Associate Cooperative Agreement: No. 663-A-00-09-00431-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguas R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001767; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; ALONSO PL, 1994, LANCET, V344, P1175, DOI 10.1016/S0140-6736(94)90505-3; BEIER JC, 1994, AM J TROP MED HYG, V50, P529, DOI 10.4269/ajtmh.1994.50.529; BEKESSY A, 1976, B WORLD HEALTH ORGAN, V54, P685; Bodker R, 2003, J MED ENTOMOL, V40, P706, DOI 10.1603/0022-2585-40.5.706; Bousema T, 2010, EMERG INFECT DIS, V16, P392, DOI 10.3201/eid1603.090732; Bretscher MT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-234; BURATTINI MN, 1993, EPIDEMIOL INFECT, V111, P525, DOI 10.1017/S0950268800057253; Charlwood JD, 1998, AM J TROP MED HYG, V59, P243, DOI 10.4269/ajtmh.1998.59.243; Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Crowell VYJ, 2012, MEASURING BURDEN UNC; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Felger I, 2003, TRENDS PARASITOL, V19, P60, DOI 10.1016/S1471-4922(02)00066-1; Gething PW, 2007, COMPUT GEOSCI-UK, V33, P1337, DOI 10.1016/j.cageo.2007.05.006; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Jima D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-58; *MALERA CONS GROUP, 2011, PLOS MED, V0008; MSUYA FHM, 1991, ACTA TROP, V49, P165, DOI 10.1016/0001-706X(91)90035-I; Muench H., CATALYTIC MODELS EPI, P8928; O'Connell KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-326; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Owusu-Agyei S, 2001, AM J TROP MED HYG, V65, P197, DOI 10.4269/ajtmh.2001.65.197; PULL JH, 1974, B WORLD HEALTH ORGAN, V51, P507; Roca-Feltrer A, 2012, AM J TROP MED HYG, V86, P96, DOI 10.4269/ajtmh.2012.11-0397; Ross A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-132; Smith DL, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1107; Smith DM, 2005, J INFECT DIS, V192, P438, DOI 10.1086/431682; Smith T, 2006, AM J TROP MED HYG, V75, P11, DOI 10.4269/ajtmh.2006.75.2_suppl.0750011; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Yukich JK J, 2011, MALARIA EPIDEMIC DET	35	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42861	10.1371/journal.pone.0042861	http://dx.doi.org/10.1371/journal.pone.0042861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22936995	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000308286300027
J	da Silva-Diz, V; Sole-Sanchez, S; Valdes-Gutierrez, A; Urpi, M; Riba-Artes, D; Penin, RM; Pascual, G; Gonzalez-Suarez, E; Casanovas, O; Vinals, F; Paramio, JM; Batlle, E; Munoz, P				da Silva-Diz, V.; Sole-Sanchez, S.; Valdes-Gutierrez, A.; Urpi, M.; Riba-Artes, D.; Penin, R. M.; Pascual, G.; Gonzalez-Suarez, E.; Casanovas, O.; Vinals, F.; Paramio, J. M.; Batlle, E.; Munoz, P.			Progeny of Lgr5-expressing hair follicle stem cell contributes to papillomavirus-induced tumor development in epidermis	ONCOGENE			English	Article						cell lineage tracing; hair follicle stem cells; carcinogenesis mouse models; papillomavirus; squamous cell carcinoma	SQUAMOUS-CELL; BETA-CATENIN; TRANSGENIC MICE; SKIN TUMORS; CARCINOMA; CANCER; DIFFERENTIATION; CARCINOGENESIS; MORPHOGENESIS; EXPRESSION	Epidermal keratinocytes and hair follicle (HF) stem cells (SCs) expressing oncogenes are competent at developing squamous cell carcinomas (SCCs) in epidermis and HFs, respectively. To determine whether bulge and hair germ (HG) SCs from HF contribute to SCC generation at distant epidermis, the most frequent epidermal region where these lesions arise in human skin, we used a skin cancer mouse model expressing E6 and E7 oncoproteins from Human papillomavirus (HPV) 16 in SCs and basal keratinocytes. This previously described mouse model recapitulates the human skin papillomavirus-induced SCC pathology. We show that E6 and E7 expression promote the expansion of keratin 15 (K15)-expressing cells. These K15(+) aberrant cells exhibit some HGSC markers and diminished expression of Tcf3 and Sox9 hair SC specification genes, which are accumulated in HFs and mislocalized to interfollicular epidermis. Leucine-rich G-protein-coupled receptor 5 (Lgr5)-expressing SCs, localized in the bulge and HG, are the origin of the expanded K15(+) cell population. A large subset of the Lgr5(+) SC progeny, expressing K15 and P-cadherin, is aberrantly mobilized to the upper region of HFs and the epidermis, and accumulates at E6/E7-induced pre-neoplastic lesions and epidermal tumors. These findings indicate that aberrant accumulation of altered SCs in HFs and their subsequent migration to the epidermis contribute to HPV-induced tumor development.	[da Silva-Diz, V.; Sole-Sanchez, S.; Valdes-Gutierrez, A.; Urpi, M.; Riba-Artes, D.; Gonzalez-Suarez, E.; Munoz, P.] Bellvitge Biomed Res Inst IDIBELL, PEBC, Barcelona 08907, Spain; [Penin, R. M.] Hosp Univ Bellvitge IDIBELL, Pathol Serv, Barcelona, Spain; [Pascual, G.] CRG, Dept Cell Differentiat & Canc, Barcelona, Spain; [Casanovas, O.; Vinals, F.] Catalan Inst Oncol ICO IDIBELL, Translat Res Lab, Barcelona, Spain; [Vinals, F.] Univ Barcelona IDIBELL, Dept Ciencies Fisiol 2, Unitat Bioquim & Biol Mol, Barcelona, Spain; [Paramio, J. M.] Ctr Invstigac Energet Medioambientales & Tecnol, Mol Oncol Unit, Madrid, Spain; [Batlle, E.] IRB, Oncol Program, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Munoz, P (corresponding author), Bellvitge Biomed Res Inst IDIBELL, PEBC, Aging & Canc Grp, Av Gran Via LHospitalet 199-203, Barcelona 08907, Spain.	p.munoz@idibell.cat	Viñals, Francesc/F-5928-2016; Gonzalez-Suarez, Eva/L-6298-2014; Batlle, Eduard/K-8080-2014; Paramio, Jesus M/M-8482-2014; Vinals, Francesc/P-6278-2019; Angulo, Gloria Pascual/AAA-7668-2019; Casanovas, Oriol/L-5210-2014	Viñals, Francesc/0000-0002-9918-6751; Gonzalez-Suarez, Eva/0000-0003-0858-8171; Batlle, Eduard/0000-0003-2422-0326; Paramio, Jesus M/0000-0001-7520-3177; Angulo, Gloria Pascual/0000-0003-3810-6647; Valdes, Antonio/0000-0002-9119-3092; Casanovas, Oriol/0000-0002-4298-3995	Spanish Ministry of Science and Innovation [SAF2008-01173]; Spanish Ministry of Education; IDIBELL fellowship; Catalan Department of Health (Generalitat de Catalunya)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Education(Spanish Government); IDIBELL fellowship; Catalan Department of Health (Generalitat de Catalunya)	We thank D Hanahan and JM Arbeit (NCI MMHCC Repository) for the K14-HPV16 mice, A Villanueva for helpful advice, S Gonzalo for critical reading of the manuscript, R Alvarez, J Comas and E Castano (Universitat de Barcelona-SCT) for their technical support in flow cytometry and the IDIBELL animal facility service for mouse care. VdSD is funded by a Spanish Ministry of Science and Innovation fellowship, SSS is funded by a Spanish Ministry of Education fellowship and DRA and AVG received an IDIBELL fellowship. The research of PM's group is supported by the Spanish Ministry of Science and Innovation (SAF2008-01173) and by the Catalan Department of Health (Generalitat de Catalunya).	Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; ARBEIT JM, 1994, J VIROL, V68, P4358, DOI 10.1128/JVI.68.7.4358-4368.1994; ARBEIT JM, 1993, AM J PATHOL, V142, P1187; Arwert EN, 2010, P NATL ACAD SCI USA, V107, P19903, DOI 10.1073/pnas.1007404107; Blanco R, 2007, GENE DEV, V21, P206, DOI 10.1101/gad.406207; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Boccardo E, 2010, CARCINOGENESIS, V31, P1905, DOI 10.1093/carcin/bgq176; Boxman ILA, 1999, J CLIN MICROBIOL, V37, P2270, DOI 10.1128/JCM.37.7.2270-2273.1999; Bulut G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027243; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Coussens LM, 1996, AM J PATHOL, V149, P1899; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Ghittoni R, 2010, VIRUS GENES, V40, P1, DOI 10.1007/s11262-009-0412-8; Gormley RH, 2011, J AM ACAD DERMATOL, V64, P981, DOI 10.1016/j.jaad.2009.10.044; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Hama N, 2006, J DERMATOL, V33, P331, DOI 10.1111/j.1346-8138.2006.00078.x; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Karagas MR, 2006, J NATL CANCER I, V98, P389, DOI 10.1093/jnci/djj092; Kasper M, 2011, P NATL ACAD SCI USA, V108, P4099, DOI 10.1073/pnas.1014489108; Lapouge G, 2011, P NATL ACAD SCI USA, V108, P7431, DOI 10.1073/pnas.1012720108; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Lorz C, 2010, STEM CELL REV REP, V6, P162, DOI 10.1007/s12015-010-9139-0; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Martinez-Cruz AB, 2008, CANCER RES, V68, P683, DOI 10.1158/0008-5472.CAN-07-3049; McLaughlin-Drubin ME, 2009, VIRUS RES, V143, P195, DOI 10.1016/j.virusres.2009.06.008; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Muller-Rover S, 1999, EXP DERMATOL, V8, P237; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Petersson M, 2011, EMBO J, V30, P3004, DOI 10.1038/emboj.2011.199; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Rodriguez-Sastre MA, 2005, GYNECOL ONCOL, V97, P330, DOI 10.1016/j.ygyno.2004.12.062; Ruiz S, 2004, DEVELOPMENT, V131, P2737, DOI 10.1242/dev.01148; Schaper ID, 2005, CANCER RES, V65, P1394, DOI 10.1158/0008-5472.CAN-04-3263; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Shinohara A, 2001, GYNECOL ONCOL, V82, P450, DOI 10.1006/gyno.2001.6298; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Thomas M, 2008, ONCOGENE, V27, P7018, DOI 10.1038/onc.2008.351; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033; White AC, 2011, P NATL ACAD SCI USA, V108, P7425, DOI 10.1073/pnas.1012670108; Wong SY, 2011, P NATL ACAD SCI USA, V108, P4093, DOI 10.1073/pnas.1013098108; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	57	40	40	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG 8	2013	32	32					3732	3743		10.1038/onc.2012.375	http://dx.doi.org/10.1038/onc.2012.375			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	198EH	22945646				2022-12-25	WOS:000322904400008
J	Niederer, SA; Lamata, P; Plank, G; Chinchapatnam, P; Ginks, M; Rhode, K; Rinaldi, CA; Razavi, R; Smith, NP				Niederer, Steven Alexander; Lamata, Pablo; Plank, Gernot; Chinchapatnam, Phani; Ginks, Matt; Rhode, Kawal; Rinaldi, Christopher Aldo; Razavi, Reza; Smith, Nicolas Peter			Analyses of the Redistribution of Work following Cardiac Resynchronisation Therapy in a Patient Specific Model	PLOS ONE			English	Article							BUNDLE-BRANCH BLOCK; RESYNCHRONIZATION THERAPY; DILATED CARDIOMYOPATHY; OXYGEN-CONSUMPTION; BLOOD-FLOW; OXIDATIVE-METABOLISM; HEART; EFFICIENCY; PERFUSION; STRAIN	Regulation of regional work is essential for efficient cardiac function. In patients with heart failure and electrical dysfunction such as left branch bundle block regional work is often depressed in the septum. Following cardiac resynchronisation therapy (CRT) this heterogeneous distribution of work can be rebalanced by altering the pattern of electrical activation. To investigate the changes in regional work in these patients and the mechanisms underpinning the improved function following CRT we have developed a personalised computational model. Simulations of electromechanical cardiac function in the model estimate the regional stress, strain and work pre- and post-CRT. These simulations predict that the increase in observed work performed by the septum following CRT is not due to an increase in the volume of myocardial tissue recruited during contraction but rather that the volume of recruited myocardium remains the same and the average peak work rate per unit volume increases. These increases in the peak average rate of work is is attributed to slower and more effective contraction in the septum, as opposed to a change in active tension. Model results predict that this improved septal work rate following CRT is a result of resistance to septal contraction provided by the LV free wall. This resistance results in septal shortening over a longer period which, in turn, allows the septum to contract while generating higher levels of active tension to produce a higher work rate.	[Niederer, Steven Alexander; Chinchapatnam, Phani; Ginks, Matt; Rhode, Kawal; Rinaldi, Christopher Aldo; Razavi, Reza; Smith, Nicolas Peter] Kings Coll London, Imaging Sci & Biomed Engn Div, London WC2R 2LS, England; [Lamata, Pablo; Smith, Nicolas Peter] Univ Oxford, Comp Lab, Oxford OX1 3QD, England; [Plank, Gernot] Med Univ Graz, Inst Biophys, Graz, Austria; [Ginks, Matt; Rinaldi, Christopher Aldo; Razavi, Reza] St Thomas Hosp, Dept Cardiol, London, England	University of London; King's College London; University of Oxford; Medical University of Graz; Guy's & St Thomas' NHS Foundation Trust	Niederer, SA (corresponding author), Kings Coll London, Imaging Sci & Biomed Engn Div, London WC2R 2LS, England.	Nicolas.smith@kcl.ox.ac.uk	Plank, Gernot/C-9498-2011; Lamata, Pablo/E-3251-2010; Lamata, Pablo/AAE-7884-2020; Plank, Gernot/O-3791-2019; Rinaldi, Claudia/GSD-6821-2022	Plank, Gernot/0000-0002-7380-6908; Lamata, Pablo/0000-0002-3097-4928; Lamata, Pablo/0000-0002-3097-4928; Plank, Gernot/0000-0002-7380-6908; Rinaldi, christopher/0000-0002-3930-1957; Rhode, Kawal/0000-0002-4707-7318; Niederer, Steven/0000-0002-4612-6982; Razavi, Reza/0000-0003-1065-3008	U.K. Engineering and Physical Sciences Research Council; St Jude Medical educational grant; Austrian Science Fund (FWF) [F 3201] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H019898/1] Funding Source: researchfish; Medical Research Council [MR/J006742/1] Funding Source: researchfish	U.K. Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); St Jude Medical educational grant; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the U.K. Engineering and Physical Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Matthew Ginks receives a St Jude Medical educational grant and Christopher Rinaldi receives St Jude educational support and is on advisory boards for St Jude Medical and Medtronic. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bassingthwaighte JB, 1999, AM J CARDIOL, V83, P7; Bogaard MD, 2011, EUR J HEART FAIL, V13, P1126, DOI 10.1093/eurjhf/hfr094; DELHAAS T, 1994, J PHYSIOL-LONDON, V477, P481, DOI 10.1113/jphysiol.1994.sp020209; Deussen A, 1997, PFLUG ARCH EUR J PHY, V433, P488, DOI 10.1007/s004240050304; Dokos S, 2002, AM J PHYSIOL-HEART C, V283, pH2650, DOI 10.1152/ajpheart.00111.2002; Duckett SG, 2011, J AM COLL CARDIOL, V58, P1128, DOI 10.1016/j.jacc.2011.04.042; Durrer D, 1970, TOTAL EXCITATION ISO, P899; GROVER M, 1983, CIRC RES, V53, P72, DOI 10.1161/01.RES.53.1.72; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; HISANO R, 1987, CIRC RES, V61, P318, DOI 10.1161/01.RES.61.3.318; Kass DA, 1999, CIRCULATION, V99, P1567, DOI 10.1161/01.CIR.99.12.1567; Lindner O, 2005, EUR HEART J, V26, P70, DOI 10.1093/eurheartj/ehi046; Lindner O, 2006, J NUCL MED, V47, P378; Nelson GS, 2000, CIRCULATION, V102, P3053; Niederer SA, 2011, CARDIOVASC RES, V89, P336, DOI 10.1093/cvr/cvq318; Nowak B, 2003, J AM COLL CARDIOL, V41, P1523, DOI 10.1016/S0735-1097(03)00257-2; OPIE LH, 1965, J PHYSIOL-LONDON, V180, P529, DOI 10.1113/jphysiol.1965.sp007715; Prinzen FW, 1999, J AM COLL CARDIOL, V33, P1735, DOI 10.1016/S0735-1097(99)00068-6; Suga H, 1979, AM J PHYSIOL, P498; Sundell J, 2004, J AM COLL CARDIOL, V43, P1027, DOI 10.1016/j.jacc.2003.10.044; Ten Tusscher KHWJ, 2006, PROG BIOPHYS MOL BIO, V90, P326, DOI 10.1016/j.pbiomolbio.2005.05.015; Ukkonen H, 2003, CIRCULATION, V107, P28, DOI 10.1161/01.CIR.0000047068.02226.95	22	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43504	10.1371/journal.pone.0043504	http://dx.doi.org/10.1371/journal.pone.0043504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952697	Green Published, gold, Green Submitted			2022-12-25	WOS:000308213600029
J	Wang, JP; Rudzinski, JF; Gong, Q; Soh, HT; Atzberger, PJ				Wang, Jinpeng; Rudzinski, Joseph F.; Gong, Qiang; Soh, H. Tom; Atzberger, Paul J.			Influence of Target Concentration and Background Binding on In Vitro Selection of Affinity Reagents	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EXPONENTIAL ENRICHMENT; SYSTEMATIC EVOLUTION; MATHEMATICAL-ANALYSIS; RNA MOLECULES; LIGANDS; APTAMERS; SELEX	Nucleic acid-based aptamers possess many useful features that make them a promising alternative to antibodies and other affinity reagents, including well-established chemical synthesis, reversible folding, thermal stability and low cost. However, the selection process typically used to generate aptamers (SELEX) often requires significant resources and can fail to yield aptamers with sufficient affinity and specificity. A number of seminal theoretical models and numerical simulations have been reported in the literature offering insights into experimental factors that govern the effectiveness of the selection process. Though useful, these previous models have not considered the full spectrum of experimental factors or the potential impact of tuning these parameters at each round over the course of a multi-round selection process. We have developed an improved mathematical model to address this important question, and report that both target concentration and the degree of non-specific background binding are critical determinants of SELEX efficiency. Although smaller target concentrations should theoretically offer superior selection outcome, we show that the level of background binding dramatically affect the target concentration that will yield maximum enrichment at each round of selection. Thus, our model enables experimentalists to determine appropriate target concentrations as a means for protocol optimization. Finally, we perform a comparative analysis of two different selection methods over multiple rounds of selection, and show that methods with inherently lower background binding offer dramatic advantages in selection efficiency.	[Wang, Jinpeng; Gong, Qiang; Soh, H. Tom; Atzberger, Paul J.] Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA; [Rudzinski, Joseph F.; Atzberger, Paul J.] Univ Calif Santa Barbara, Dept Math, Santa Barbara, CA 93106 USA; [Gong, Qiang; Soh, H. Tom] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Wang, JP (corresponding author), Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA.	tsoh@engr.ucsb.edu; atzberg@math.ucsb.edu	Wang, Jinpeng/P-4015-2019; Gong, Qiang/H-3234-2014; Gong, Qiang/D-5337-2009; Wang, Jinpeng/H-6542-2014; Rudzinski, Joseph F./AAR-7971-2020; Atzberger, Paul/B-2799-2016	Wang, Jinpeng/0000-0002-3739-2015; Wang, Jinpeng/0000-0002-3739-2015; Rudzinski, Joseph F./0000-0003-3403-640X; Atzberger, Paul/0000-0001-6806-8069	National Science Foundation [0956210]; ARO Institute for Collaborative Biotechnologies; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099773] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); ARO Institute for Collaborative Biotechnologies; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study was funded by National Science Foundation CAREER Award 0956210, ARO Institute for Collaborative Biotechnologies, and the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027051; Bunka DHJ, 2006, NAT REV MICROBIOL, V4, P588, DOI 10.1038/nrmicro1458; Daniels DA, 2003, P NATL ACAD SCI USA, V100, P15416, DOI 10.1073/pnas.2136683100; Djordjevic M, 2006, PHYS BIOL, V3, P13, DOI 10.1088/1478-3975/3/1/002; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; GREEN LS, 1995, CHEM BIOL, V2, P683, DOI 10.1016/1074-5521(95)90032-2; Haller AA, 1997, P NATL ACAD SCI USA, V94, P8521, DOI 10.1073/pnas.94.16.8521; IRVINE D, 1991, J MOL BIOL, V222, P739, DOI 10.1016/0022-2836(91)90509-5; JELLINEK D, 1995, BIOCHEMISTRY-US, V34, P11363, DOI 10.1021/bi00036a009; Levine HA, 2007, COMPUT BIOL CHEM, V31, P11, DOI 10.1016/j.compbiolchem.2006.10.002; Lou XH, 2009, P NATL ACAD SCI USA, V106, P2989, DOI 10.1073/pnas.0813135106; Plaxco KW, 2011, TRENDS BIOTECHNOL, V29, P1, DOI 10.1016/j.tibtech.2010.10.005; Seo YJ, 2010, B MATH BIOL, V72, P1623, DOI 10.1007/s11538-009-9491-x; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Sun FZ, 1996, J MOL BIOL, V258, P650, DOI 10.1006/jmbi.1996.0276; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vant-Hull B, 1998, J MOL BIOL, V278, P579, DOI 10.1006/jmbi.1998.1727; Vant-Hull B., 2000, CURR PROTOC NUCL ACI; Willis MC, 1998, BIOCONJUGATE CHEM, V9, P573, DOI 10.1021/bc980002x; Zhao Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000590	20	44	46	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43940	10.1371/journal.pone.0043940	http://dx.doi.org/10.1371/journal.pone.0043940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952815	Green Published, gold			2022-12-25	WOS:000308213600061
J	Almon, R; Alvarez-Leon, EE; Serra-Majem, L				Almon, Ricardo; Elisa Alvarez-Leon, Eva; Serra-Majem, Lluis			Association of the European Lactase Persistence Variant (LCT-13910 C > T Polymorphism) with Obesity in the Canary Islands	PLOS ONE			English	Article							ADULT-TYPE HYPOLACTASIA; MENDELIAN RANDOMIZATION; LACTOSE-INTOLERANCE; PYROSEQUENCING(TM) TECHNOLOGY; GENETIC EPIDEMIOLOGY; DIETARY CALCIUM; HEIGHT GROWTH; MILK; POPULATIONS; CONSUMPTION	Background: European lactose tolerance genotype (LCT -13910 C>T, rs4988234) has been positively associated to body mass indexes (BMI) in a meta-analysis of 31,720 individuals of northern and central European descent. A strong association of lactase persistence (LP) with BMI and obesity has also been traced in a Spanish Mediterranean population. The aim of this study was to analyze a potential association of LP compared to lactase non-persistence (LNP) with BMI in inhabitants of the Canary Islands of Spain using Mendelian randomization. Methods: A representative, randomly sampled population of adults belonging to the Canary Islands Nutrition Survey (ENCA) in Spain, aged 18-75 years (n = 551), was genotyped for the LCT - 13910 C>T polymorphism. Milk consumption was assessed by a validated questionnaire. Anthropometric variables were directly measured. WHO classification of BMI was used. Results: LP individuals were significantly more obese than LNP subjects (chi(2) = 10.59; p < 0.005). LP showed in a multivariate linear regression analysis showed a positive association of LP with BMI compared to LNP, (beta = 0.96; 95% CI: 0.08-1.85, p = 0.033). In a multinomial logistic regression analysis normal range weight LP subjects showed an odds ratio for obesity of 2.41; 95% CI 1.39-418, (p = 0.002) compared to LNP. Conclusions: The T-13910 of the allele LCT-13910 C>T polymorphism is positively associated with BMI. LP increases significantly the risk to develop obesity in the studied population. The LCT-13910 C>T polymorphism stands proxy for the lifetime exposure pattern, milk intake, that may increase susceptibility to obesity and to obesity related pathologies.	[Almon, Ricardo] Univ Orebro, Sch Hlth & Med Sci, Family Med Res Ctr, Orebro, Sweden; [Elisa Alvarez-Leon, Eva; Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Fac Hlth Sci, Dept Clin Sci, Prevent Med Serv,Canary Hlth Serv, Las Palmas Gran Canaria, Canary Islands, Spain	Orebro University; Universidad de Las Palmas de Gran Canaria	Almon, R (corresponding author), Univ Orebro, Sch Hlth & Med Sci, Family Med Res Ctr, Orebro, Sweden.	ricardo.almon@orebroll.se	Serra-Majem, Lluis/I-6708-2019	Serra-Majem, Lluis/0000-0002-9658-9061	Spanish Canarian Health Service and Orebro County, Sweden	Spanish Canarian Health Service and Orebro County, Sweden	This project has been funded by the Spanish Canarian Health Service and Orebro County, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebamowo CA, 2008, J AM ACAD DERMATOL, V58, P787, DOI 10.1016/j.jaad.2007.08.049; Almon R, 2010, LACTASE PERSISTENCE; Almon R, 2011, FOOD NUTR RES, V55, DOI 10.3402/fnr.v55i0.7253; Almon R, 2010, FOOD NUTR RES, V54, DOI 10.3402/fnr.v54i0.5141; Almon R, 2010, EUR J NUTR, V49, P141, DOI 10.1007/s00394-009-0058-2; Aranceta J, 2005, LECHE LACTEOS SALUD, P31; Aranceta-Bartrina J, 2005, MED CLIN-BARCELONA, V125, P460, DOI 10.1157/13079612; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Berkey CS, 2009, CANCER EPIDEM BIOMAR, V18, P1881, DOI 10.1158/1055-9965.EPI-08-1163; Berkey CS, 2005, ARCH PEDIAT ADOL MED, V159, P543, DOI 10.1001/archpedi.159.6.543; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Corella D, 2011, CURR CARDIOVASC RISK; Corella D, 2010, OBESITY SILVER SPRIN; Corella D, 2009, CIRC-CARDIOVASC GENE, V2, P637, DOI 10.1161/CIRCGENETICS.109.891366; Ebrahim S, 2008, HUM GENET, V123, P15, DOI 10.1007/s00439-007-0448-6; Enattah N, 2004, CALCIFIED TISSUE INT, V75, P488, DOI 10.1007/s00223-004-0029-9; Enattah NS, 2008, AM J HUM GENET, V82, P57, DOI 10.1016/j.ajhg.2007.09.012; Enattah NS, 2007, AM J HUM GENET, V81, P615, DOI 10.1086/520705; Enattah NS, 2007, WORLD J GASTROENTERO, V13, P3508, DOI 10.3748/wjg.v13.i25.3508; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; FLATZ G, 1973, LANCET, V2, P76; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Heid IM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000694; Kettunen J, 2010, HUM MOL GENET, V19, P1129, DOI 10.1093/hmg/ddp561; Lehtimaki T, 2006, PEDIATRICS, V118, P1553, DOI 10.1542/peds.2006-0542; Lewis SJ, 2010, CIRC-CARDIOVASC GENE, V3, P109, DOI 10.1161/CIRCGENETICS.109.880955; Majem LS, 2000, ARCH LATINOAM NUTR, V50, P62; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Mueller-Nordhorn J, 2008, EUR HEART J, V29, P1316, DOI 10.1093/eurheartj/ehm604; Nilsson TK, 2004, SCAND J GASTROENTERO, V39, P287, DOI 10.1080/00365520310008304; Nilsson TK, 2008, CLIN CHEM LAB MED, V46, P80, DOI 10.1515/CCLM.2008.015; Obermayer-Pietsch BM, 2007, OSTEOPOROSIS INT, V18, P445, DOI 10.1007/s00198-006-0251-6; Pino-Yanes M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018389; Ramachandrappa S, 2011, J CLIN INVEST, V121, P2080, DOI 10.1172/JCI46044; Rasinpera H, 2004, GUT, V53, P1571, DOI 10.1136/gut.2004.040048; SAHI T, 1994, SCAND J GASTROENTERO, V29, P7, DOI 10.3109/00365529409091740; Sanchez PH, 2000, ARCH LATINOAM NUTR, V50, P43; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2005, BMJ-BRIT MED J, V330, P1076, DOI 10.1136/bmj.330.7499.1076; Soedamah-Muthu SS, 2011, AM J CLIN NUTR, V93, P158, DOI 10.3945/ajcn.2010.29866; Suarez FL, 1997, AM J CLIN NUTR, V65, P1502, DOI 10.1093/ajcn/65.5.1502; Suchy FJ, 2010, ANN INTERN MED, V152, P792, DOI 10.7326/0003-4819-152-12-201006150-00248; Swallow DM, 2003, ANNU REV GENET, V37, P197, DOI 10.1146/annurev.genet.37.110801.143820; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang RQ, 2011, BIOMED ENVIRON SCI, V24, P200, DOI 10.3967/0895-3988.2011.02.015; World Healths Organization, WHO GLOB DAT BOD MAS	47	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43978	10.1371/journal.pone.0043978	http://dx.doi.org/10.1371/journal.pone.0043978			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937140	Green Published, Green Submitted			2022-12-25	WOS:000308225500131
J	Gu, YR; Li, MZ; Wang, T; Liang, Y; Zhong, ZJ; Wang, XY; Zhou, Q; Chen, L; Lang, QL; He, ZP; Chen, XH; Gong, JJ; Gao, XL; Li, XW; Lv, XB				Gu, Yiren; Li, Mingzhou; Wang, Tao; Liang, Yan; Zhong, Zhijun; Wang, Xiaoyan; Zhou, Qi; Chen, Lei; Lang, Qiulei; He, Zhiping; Chen, Xiaohui; Gong, Jianjun; Gao, Xiaolian; Li, Xuewei; Lv, Xuebin			Lactation-Related MicroRNA Expression Profiles of Porcine Breast Milk Exosomes	PLOS ONE			English	Article							IMMUNE-SYSTEM; SIGNATURE; EVOLUTION; RECEPTOR; TARGET	Breast milk is the primary source of nutrition for newborns, and is rich in immunological components. MicroRNAs (miRNAs) are present in various body fluids and are selectively packaged inside the exosomes, a type of membrane vesicles, secreted by most cell types. These exosomal miRNAs could be actively delivered into recipient cells, and could regulate target gene expression and recipient cell function. Here, we analyzed the lactation-related miRNA expression profiles in porcine milk exosomes across the entire lactation period (newborn to 28 days after birth) by a deep sequencing. We found that immune-related miRNAs are present and enriched in breast milk exosomes (p<10(-16), chi(2) test) and are generally resistant to relatively harsh conditions. Notably, these exosomal miRNAs are present in higher numbers in the colostrums than in mature milk. It was higher in the serum of colostrum-only fed piglets compared with the mature milk-only fed piglets. These immune-related miRNA-loaded exosomes in breast milk may be transferred into the infant body via the digestive tract. These observations are a prelude to in-depth investigations of the essential roles of breast milk in the development of the infant's immune system.	[Gu, Yiren; Liang, Yan; Zhong, Zhijun; He, Zhiping; Chen, Xiaohui; Gong, Jianjun; Lv, Xuebin] Sichuan Anim Sci Acad, Chengdu, Sichuan, Peoples R China; [Li, Mingzhou; Wang, Tao; Zhong, Zhijun; Wang, Xiaoyan; Li, Xuewei] Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan, Sichuan, Peoples R China; [Li, Mingzhou] Peking Univ, Biodynam Opt Imaging Ctr, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Li, Mingzhou] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Zhou, Qi] Yaan Vocat Coll, Dept Nursing, Yaan, Sichuan, Peoples R China; [Chen, Lei] Chongqing Acad Anim Sci, Chongqing, Peoples R China; [Lang, Qiulei] LC Bio, Hangzhou, Zhejiang, Peoples R China; [Gao, Xiaolian] Univ Houston, Dept Biol & Biochem, Houston, TX USA	Sichuan Agricultural University; Peking University; Peking University; University of Houston System; University of Houston	Gu, YR (corresponding author), Sichuan Anim Sci Acad, Chengdu, Sichuan, Peoples R China.	xuewei.li@sicau.edu.cn; lvxuebin1965@gmail.com			Key Technology Research and Development Program of Sichuan [16]; Key Projects in the National Science & Technology Pillar Program [2011BAD28B01]; National Swine Industry Technology System Program [CARS-36]; National Natural Science Foundation of China [30901024]; International Science & Technology Cooperation Program of China [2011DFB30340]	Key Technology Research and Development Program of Sichuan; Key Projects in the National Science & Technology Pillar Program; National Swine Industry Technology System Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China	This work was supported by grants from the Key Technology Research and Development Program of Sichuan (Project-16), the Key Projects in the National Science & Technology Pillar Program (2011BAD28B01), the National Swine Industry Technology System Program (CARS-36), the National Natural Science Foundation of China (30901024) and the International Science & Technology Cooperation Program of China (2011DFB30340). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994; Brabletz T, 1999, INT IMMUNOL, V11, P1701, DOI 10.1093/intimm/11.10.1701; Chen X, 2010, CELL RES, V20, P1128, DOI 10.1038/cr.2010.80; Dawson HD, 2012, MINIPIG IN BIOMEDICAL RESEARCH, P323; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Elyakim E, 2010, CANCER RES, V70, P8077, DOI 10.1158/0008-5472.CAN-10-1313; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Goldman AS, 2007, BREASTFEED MED, V2, P195, DOI 10.1089/bfm.2007.0024; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Jennewein C, 2010, J BIOL CHEM, V285, P11846, DOI 10.1074/jbc.M109.066399; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Kuhn AR, 2010, AM J RESP CELL MOL, V42, P506, DOI 10.1165/rcmb.2009-0123OC; Lawrence Robert M, 2007, Curr Probl Pediatr Adolesc Health Care, V37, P7, DOI 10.1016/j.cppeds.2006.10.002; Lefevre CM, 2010, ANNU REV GENOM HUM G, V11, P219, DOI 10.1146/annurev-genom-082509-141806; Li MZ, 2011, INT J BIOL SCI, V7, P1045, DOI 10.7150/ijbs.7.1045; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Meng FY, 2007, J BIOL CHEM, V282, P8256, DOI 10.1074/jbc.M607712200; Meurens F, 2011, TRENDS MICROBIOLOGY; O'Hara AJ, 2008, BLOOD, V111, P2347, DOI 10.1182/blood-2007-08-104463; Palanisamy V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008577; Paramasivam K, 2006, INT J FERTIL WOMEN M, V51, P208; Petherick A, 2010, NATURE, V468, pS5, DOI 10.1038/468S5a; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Takagi S, 2008, J BIOL CHEM, V283, P9674, DOI 10.1074/jbc.M709382200; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zhang L, 2011, CELL RES; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118	38	156	177	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43691	10.1371/journal.pone.0043691	http://dx.doi.org/10.1371/journal.pone.0043691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937080	Green Published, gold			2022-12-25	WOS:000308225500082
J	Lin, ZS; Chu, HC; Yen, YC; Lewis, BC; Chen, YW				Lin, Ze-Shiang; Chu, Hsiao-Chien; Yen, Yi-Chen; Lewis, Brian C.; Chen, Ya-Wen			Kruppel-Like Factor 4, a Tumor Suppressor in Hepatocellular Carcinoma Cells Reverts Epithelial Mesenchymal Transition by Suppressing Slug Expression	PLOS ONE			English	Article							DOWN-REGULATION; LINE RKO; C-MYC; KLF4; GENE; METASTASIS; IDENTIFICATION; PROLIFERATION; INVASION; KRUPPEL-LIKE-FACTOR-4	Kruppel-like factor 4 (KLF4) is a zinc-finger transcription factor that plays an important role in differentiation and pathogenesis. KLF4 has been suggested to act as an oncogene or tumor suppressor in different tumor types. However, the role of KLF4 in hepatocellular carcinoma (HCC) remains unclear. Here, we demonstrate that forced expression of Klf4 in murine HCC cell lines reduced anchorage-independent growth in soft agar as well as cell migration and invasion activities in vitro. Ectopic Klf4 expression impaired subcutaneous tumor growth and lung colonization in vivo. By contrast, Klf4 knockdown enhanced HCC cell migration. Interestingly, ectopic expression of Klf4 changed the morphology of murine HCC cells to a more epithelial phenotype. Associated with this, we found that expression of Slug, a critical epithelial mesenchymal transition (EMT)-related transcription factor, was significantly down-regulated in Klf4-expressing cells. Chromatin immunoprecipitation (ChIP) and luciferase reporter assays showed that Klf4 is able to bind and repress the activity of the Slug promoter. Furthermore, ectopic Slug expression partially reverts the Klf4-mediated phenotypes. Consistent with a role as a tumor suppressor in HCC, analysis of the public microarray databases from Oncomine revealed reduced KLF4 expression in human HCC tissues in comparison with normal liver tissues in 3 out of 4 data sets. By quantitative reverse transcription-polymerase chain reaction (qRT-PCR), we found reduced KLF4 mRNA in 50% of HCC tissues. Importantly, an inverse correlation between the expression of KLF4 and SLUG was found in HCC tissues. Our data suggest that KLF4 acts as a tumor suppressor in HCC cells, in part by suppressing SLUG transcription.	[Lin, Ze-Shiang; Chu, Hsiao-Chien; Yen, Yi-Chen; Chen, Ya-Wen] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan; [Lewis, Brian C.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA USA; [Lewis, Brian C.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Lewis, Brian C.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA USA; [Lewis, Brian C.] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA USA	National Health Research Institutes - Taiwan; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Lin, ZS (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan.	ywc@nhri.org.tw	Chen, Ya-Wen/B-1100-2010; Chen, Ya-Wen/AAG-7549-2019	Chen, Ya-Wen/0000-0002-6080-8859	National Science Council [NSC 100-2320-B-400-008, NSC 94-3112-B-182-002, NSC 97-3112-B-182-004]; National Health Research Institutes [NHRI CA-100-PP-03]; Department of Health [DOH101-TD-C-111-004]; National Research Program for Genomic Medicine Grants of NSC [NSC 97-3112-B-001-016]; National Health Research Institutes, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan); Department of Health; National Research Program for Genomic Medicine Grants of NSC; National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This study was supported by NSC 100-2320-B-400-008 (National Science Council; web1.nsc.gov.tw), NHRI CA-100-PP-03 (National Health Research Institutes; www.nhri.org.tw) and DOH101-TD-C-111-004 (Department of Health; www.doh.org.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Zhi-Xiang Li and Ju-Ching Yu for assistance in construction of plasmids. We thank Dr. Cheng-Wen Wu for proving the SLUG-Luc plasmid, Dr. Jer-Wei Chang for technical support in ChIP experiments, Dr. Shih-Sheng Jiang for data mining in Oncomine and GEO, Dr. Jang-Yang Chang for HCC samples and Drs Shankuang Lin and Hui-Lin Wu for critical review of the manuscript. RNAi reagents were obtained from the National RNAi Core Facility located at the Institute of Molecular Biology/Genomic Research Center, Academia Sinica, supported by the National Research Program for Genomic Medicine Grants of NSC (NSC 97-3112-B-001-016). We would like to thank Taiwan Liver Cancer Network (TLCN) for providing the liver tumor tissue samples and related clinical data (all are anonymous) for our research work. TLCN is supported by grants from National Science Council (NSC 94-3112-B-182-002, NSC 97-3112-B-182-004) and National Health Research Institutes, Taiwan.	Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185; Chen XM, 2003, J MOL BIOL, V326, P665, DOI 10.1016/S0022-2836(02)01449-3; Chen YW, 2008, CANCER RES, V68, P476, DOI 10.1158/0008-5472.CAN-07-1960; Chen YW, 2007, CANCER RES, V67, P7589, DOI 10.1158/0008-5472.CAN-07-0381; Chen YW, 2009, NEOPLASIA, V11, P835, DOI 10.1593/neo.09476; Dang DT, 2003, ONCOGENE, V22, P3424, DOI 10.1038/sj.onc.1206413; Dang DT, 2001, ONCOGENE, V20, P4884, DOI 10.1038/sj.onc.1204645; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Flandez M, 2008, EXP CELL RES, V314, P3712, DOI 10.1016/j.yexcr.2008.10.004; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Foster KW, 2000, CANCER RES, V60, P6488; Ghaleb AM, 2008, MOL CANCER RES, V6, P1920, DOI 10.1158/1541-7786.MCR-08-0224; Hu WX, 2009, CLIN CANCER RES, V15, P5688, DOI 10.1158/1078-0432.CCR-09-0310; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kremer-Tal S, 2004, HEPATOLOGY, V40, P1047, DOI 10.1002/hep.20460; Kremer-Tal S, 2007, J HEPATOL, V46, P645, DOI 10.1016/j.jhep.2006.10.012; Liao YL, 2008, ONCOGENE, V27, P5578, DOI 10.1038/onc.2008.168; Liu YN, 2012, MOL CELL BIOL; Mas VR, 2009, MOL MED, V15, P85, DOI 10.2119/molmed.2008.00110; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; NAKABAYASHI H, 1984, GANN, V75, P151; Nakahara Y, 2010, NEOPLASIA, V12, P20, DOI 10.1593/neo.91122; NAMBU S, 1987, JPN J CANCER RES, V78, P695; Ohnishi S, 2003, BIOCHEM BIOPH RES CO, V308, P251, DOI 10.1016/S0006-291X(03)01356-1; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; ROBINSON WS, 1994, ANNU REV MED, V45, P297; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Roussos ET, 2010, CANCER RES, V70, P7360, DOI 10.1158/0008-5472.CAN-10-1208; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Wang J, 2004, CANCER RES, V70, P10182; Wei DY, 2005, CANCER RES, V65, P2746, DOI 10.1158/0008-5472.CAN-04-3619; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang MH, 2009, HEPATOLOGY, V50, P1464, DOI 10.1002/hep.23221; Yang YZ, 2005, CANCER BIOL THER, V4, P1216, DOI 10.4161/cbt.4.11.2090; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; Yuan F, 2012, MOL CELL BIOCHEM, V343, P155; Zammarchi F, 2011, AM J PATHOL, V178, P361, DOI 10.1016/j.ajpath.2010.11.021; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067	48	67	76	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43593	10.1371/journal.pone.0043593	http://dx.doi.org/10.1371/journal.pone.0043593			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937066	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500067
J	Zhang, N; Qiao, ZY; Liang, Z; Mei, B; Xu, ZK; Song, RT				Zhang, Nan; Qiao, Zhenyi; Liang, Zheng; Mei, Bing; Xu, Zhengkai; Song, Rentao			Zea mays Taxilin Protein Negatively Regulates Opaque-2 Transcriptional Activity by Causing a Change in Its Sub-Cellular Distribution	PLOS ONE			English	Article							MAIZE ENDOSPERM; LEUCINE-ZIPPER; BINDING PROTEIN; GENE-EXPRESSION; LOCUS OPAQUE-2; TARGET SITE; BONE MASS; ACTIVATOR; FIAT; MUTATIONS	Zea mays (maize) Opaque-2 (ZmO2) protein is an important bZIP transcription factor that regulates the expression of major storage proteins (22-kD zeins) and other important genes during maize seed development. ZmO2 is subject to functional regulation through protein-protein interactions. To unveil the potential regulatory network associated with ZmO2, a protein-protein interaction study was carried out using the truncated version of ZmO2 (O2-2) as bait in a yeast two-hybrid screen with a maize seed cDNA library. A protein with homology to Taxilin was found to have stable interaction with ZmO2 in yeast and was designated as ZmTaxilin. Sequence analysis indicated that ZmTaxilin has a long coiled-coil domain containing three conserved zipper motifs. Each of the three zipper motifs is individually able to interact with ZmO2 in yeast. A GST pull-down assay demonstrated the interaction between GST-fused ZmTaxilin and ZmO2 extracted from developing maize seeds. Using onion epidermal cells as in vivo assay system, we found that ZmTaxilin could change the sub-cellular distribution of ZmO2. We also demonstrated that this change significantly repressed the transcriptional activity of ZmO2 on the 22-kD zein promoter. Our study suggests that a Taxilin-mediated change in sub-cellular distribution of ZmO2 may have important functional consequences for ZmO2 activity.	[Zhang, Nan; Qiao, Zhenyi; Liang, Zheng; Mei, Bing; Xu, Zhengkai; Song, Rentao] Shanghai Univ, Shanghai Key Lab Bioenergy Crops, Sch Life Sci, Shanghai, Peoples R China	Shanghai University	Zhang, N (corresponding author), Shanghai Univ, Shanghai Key Lab Bioenergy Crops, Sch Life Sci, Shanghai, Peoples R China.	rentaosong@staff.shu.edu.cn	Song, Rentao/A-6544-2012; Song, Rentao/AAG-9107-2021	Song, Rentao/0000-0003-1810-9875; Song, Rentao/0000-0003-1810-9875; Zhang, Nan/0000-0002-8097-6876	Ministry of Science and Technology of China [2012AA10A305, 2009CB118400]; Natural Sciences Foundation of China [30671303]; Shanghai Science and Technology Committee [11DZ2272100]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This work was supported by the Ministry of Science and Technology of China (2012AA10A305, 2009CB118400; http://www.most.gov.cn/eng/index.htm), the Natural Sciences Foundation of China (30671303; http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm) and Shanghai Science and Technology Committee (11DZ2272100; http://www.stcsm.gov.cn/structure/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aukerman M J, 1994, Results Probl Cell Differ, V20, P209; Bhat RA, 2004, PLANT MOL BIOL, V55, P239, DOI 10.1007/s11103-004-0553-z; Brennecke K, 1996, PHYTOCHEMISTRY, V41, P707, DOI 10.1016/0031-9422(95)00634-6; Burnett RJ, 1999, MOL GEN GENET, V261, P908, DOI 10.1007/s004380051038; BURR FA, 1982, J CELL BIOL, V94, P201, DOI 10.1083/jcb.94.1.201; Ciceri P, 1997, PLANT CELL, V9, P97, DOI 10.1105/tpc.9.1.97; Ciceri P, 1999, PLANT PHYSIOL, V121, P1321, DOI 10.1104/pp.121.4.1321; DOLFINI SF, 1992, DEV GENET, V13, P264, DOI 10.1002/dvg.1020130404; Feng LN, 2009, PLANT MOL BIOL, V69, P649, DOI 10.1007/s11103-008-9444-z; GALLUSCI P, 1994, MOL GEN GENET, V244, P391, DOI 10.1007/BF00286691; Gavazzi F, 2007, PLANT PHYSIOL, V145, P933, DOI 10.1104/pp.107.103606; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; HARTINGS H, 1989, EMBO J, V8, P2795, DOI 10.1002/j.1460-2075.1989.tb08425.x; Hunter BG, 2002, PLANT CELL, V14, P2591, DOI 10.1105/tpc.003905; Kaffman A, 1999, ANNU REV CELL DEV BI, V15, P291, DOI 10.1146/annurev.cellbio.15.1.291; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Kemper EL, 1999, PLANT CELL, V11, P1981, DOI 10.1105/tpc.11.10.1981; KODRZYCKI R, 1989, PLANT CELL, V1, P105, DOI 10.1105/tpc.1.1.105; LI B, 1993, FASEB J, V7, P957, DOI 10.1096/fasebj.7.10.8344494; LOHMER S, 1991, EMBO J, V10, P617, DOI 10.1002/j.1460-2075.1991.tb07989.x; Maddaloni M, 1996, MOL GEN GENET, V250, P647, DOI 10.1007/s004380050117; Matsuo N, 2008, PLANT PHYSIOL BIOCH, V46, P1045, DOI 10.1016/j.plaphy.2008.07.007; Muth JR, 1996, MOL GEN GENET, V252, P723, DOI 10.1007/s004380050282; Nogami S, 2004, BIOCHEM BIOPH RES CO, V319, P936, DOI 10.1016/j.bbrc.2004.05.073; Nogami S, 2003, BIOCHEM BIOPH RES CO, V311, P797, DOI 10.1016/j.bbrc.2003.10.069; Nogami S, 2003, GENES CELLS, V8, P17, DOI 10.1046/j.1365-2443.2003.00612.x; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Prioul JL, 2008, CR BIOL, V331, P772, DOI 10.1016/j.crvi.2008.07.019; PYSH LD, 1993, PLANT CELL, V5, P227, DOI 10.1105/tpc.5.2.227; Sakakibara S, 2008, J COMP NEUROL, V511, P65, DOI 10.1002/cne.21817; SCHMIDT RJ, 1987, SCIENCE, V238, P960, DOI 10.1126/science.2823388; SCHMIDT RJ, 1990, P NATL ACAD SCI USA, V87, P46, DOI 10.1073/pnas.87.1.46; SCHMIDT RJ, 1992, PLANT CELL, V4, P689, DOI 10.1105/tpc.4.6.689; Schmitz D, 1997, NUCLEIC ACIDS RES, V25, P756, DOI 10.1093/nar/25.4.756; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; VicenteCarbajosa J, 1997, P NATL ACAD SCI USA, V94, P7685, DOI 10.1073/pnas.94.14.7685; Yoshida K, 2005, GENES CELLS, V10, P465, DOI 10.1111/j.1365-2443.2005.00848.x; Yu VWC, 2006, ANN NY ACAD SCI, V1068, P131, DOI 10.1196/annals.1346.027; Yu VWC, 2009, GENE EXPR PATTERNS, V9, P335, DOI 10.1016/j.gep.2009.02.002; Yu VWC, 2008, J CELL BIOCHEM, V105, P859, DOI 10.1002/jcb.21881; Yu VWC, 2009, J CELL BIOCHEM, V106, P186, DOI 10.1002/jcb.21995; Yu VWC, 2005, J CELL BIOL, V169, P591, DOI 10.1083/jcb.200412139	43	15	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43822	10.1371/journal.pone.0043822	http://dx.doi.org/10.1371/journal.pone.0043822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937104	Green Submitted, gold, Green Published			2022-12-25	WOS:000308225500106
J	Lew, QJ; Chia, YL; Chu, KL; Lam, YT; Gurumurthy, M; Xu, SL; Lam, KP; Cheong, N; Chao, SH				Lew, Qiao Jing; Chia, Yi Ling; Chu, Kai Ling; Lam, Yuen Ting; Gurumurthy, Meera; Xu, Shengli; Lam, Kong Peng; Cheong, Nge; Chao, Sheng-Hao			Identification of HEXIM1 as a Positive Regulator of p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; ELONGATION-FACTOR-B; DEPENDENT KINASE INHIBITORS; CDK9 PHOSPHORYLATES P53; PROLYL ISOMERASE PIN1; BREAST CELL-GROWTH; P-TEFB; TRANSCRIPTION ELONGATION; 7SK SNRNA; NUCLEAR ACCUMULATION	Hexamethylene bisacetamide-inducible protein 1 (HEXIM1) is best known as the inhibitor of positive transcription elongation factor b (P-TEFb), which regulates the transcription elongation of RNA polymerase II and controls 60-70% of mRNA synthesis. Our previous studies show that HEXIM1 interacts with two key p53 regulators, nucleophosmin and human double minute-2 protein (HDM2), implying a possible connection between HEXIM1 and the p53 signaling pathway. Here we report the interaction between p53 and HEXIM1 in breast cancer, acute myeloid leukemia, and colorectal carcinoma cells. The C-terminal regions of p53 and HEXIM1 are required for the protein-protein interaction. Overexpression of HEXIM1 prevents the ubiquitination of p53 by HDM2 and enhances the protein stability of p53, resulting in up-regulation of p53 target genes, such as Puma and p21. Induction of p53 can be achieved by several means, such as UV radiation and treatment with anticancer agents (including doxorubicin, etoposide, roscovitine, flavopiridol, and nutlin-3). Under all the conditions examined, elevated protein levels of p53 are found to associate with the increased p53-HEXIM1 interaction. In addition, knockdown of HEXIM1 significantly inhibits the induction of p53 and releases the cell cycle arrest caused by p53. Finally, the transcription of the p53 target genes is regulated by HEXIM1 in a p53-dependent fashion. Our results not only identify HEXIM1 as a positive regulator of p53, but also propose a novel molecular mechanism of p53 activation caused by the anti-cancer drugs and compounds.	[Cheong, Nge; Chao, Sheng-Hao] ASTAR, Bioproc Technol Inst, Express Engn, Singapore 138668, Singapore; [Xu, Shengli; Lam, Kong Peng] ASTAR, Bioproc Technol Inst, Immunol Grp, Singapore 138668, Singapore; [Xu, Shengli; Lam, Kong Peng] Natl Univ Singapore, Dept Physiol, Singapore 117597, Singapore; [Lam, Kong Peng; Chao, Sheng-Hao] Natl Univ Singapore, Dept Microbiol, Singapore 117597, Singapore; [Lam, Kong Peng] Natl Univ Singapore, Dept Paediat, Singapore 117597, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); National University of Singapore; National University of Singapore; National University of Singapore	Chao, SH (corresponding author), ASTAR, Bioproc Technol Inst, 20 Biopolis Way,06-01 Centros, Singapore 138668, Singapore.	jimmy_chao@bti.a-star.edu.sg		Lam, Kong-Peng/0000-0002-1316-4333	Agency for Science, Technology, and Research (A*STAR), Singapore	Agency for Science, Technology, and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work is supported by the Agency for Science, Technology, and Research (A*STAR), Singapore.	Barboric M, 2005, EMBO J, V24, P4291, DOI 10.1038/sj.emboj.7600883; Blaydes JP, 2001, J BIOL CHEM, V276, P4699, DOI 10.1074/jbc.M003485200; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Byers SA, 2005, J BIOL CHEM, V280, P16360, DOI 10.1074/jbc.M500424200; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Claudio PP, 2006, J CELL PHYSIOL, V208, P602, DOI 10.1002/jcp.20698; Czudnochowski N, 2010, J MOL BIOL, V395, P28, DOI 10.1016/j.jmb.2009.10.055; Demidenko ZN, 2004, CANCER RES, V64, P3653, DOI 10.1158/0008-5472.CAN-04-0204; Dey A, 2007, CELL CYCLE, V6, P1856, DOI 10.4161/cc.6.15.4556; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Fraldi A, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-42; FRITSCHE M, 1993, ONCOGENE, V8, P307; Galatioto J, 2010, J CELL SCI, V123, P3789, DOI 10.1242/jcs.073387; GRANA X, 1994, P NATL ACAD SCI USA, V91, P3834, DOI 10.1073/pnas.91.9.3834; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gurumurthy M, 2008, J MOL BIOL, V378, P302, DOI 10.1016/j.jmb.2008.02.055; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Ketchart W, 2011, ONCOGENE, V30, P3563, DOI 10.1038/onc.2011.76; Krystof V, 2010, CURR DRUG TARGETS, V11, P291, DOI 10.2174/138945010790711950; KWOK TT, 1994, CANCER RES, V54, P2834; Lau J, 2009, CELL CYCLE, V8, P2247, DOI 10.4161/cc.8.14.9015; Lew QJ, 2011, CELL CYCLE, V10, P1978, DOI 10.4161/cc.10.12.15859; Li QT, 2005, J BIOL CHEM, V280, P28819, DOI 10.1074/jbc.M502712200; Ljungman M, 1999, ONCOGENE, V18, P583, DOI 10.1038/sj.onc.1202356; Ljungman M, 2001, MOL PHARMACOL, V60, P785; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Napolitano G, 2007, CELL CYCLE, V6, P1126, DOI 10.4161/cc.6.9.4137; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Ouchida R, 2003, GENES CELLS, V8, P95, DOI 10.1046/j.1365-2443.2003.00618.x; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Poyurovsky MV, 2010, NAT STRUCT MOL BIOL, V17, P982, DOI 10.1038/nsmb.1872; Pumfery A, 2006, CURR PHARM DESIGN, V12, P1949, DOI 10.2174/138161206777442083; Radhakrishnan SK, 2006, CELL CYCLE, V5, P519, DOI 10.4161/cc.5.5.2514; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Sano M, 2002, NAT MED, V8, P1310, DOI 10.1038/nm778; Shen H, 2011, CURR PHARM DESIGN, V17, P560, DOI 10.2174/138161211795222603; Shimizu N, 2005, P NATL ACAD SCI USA, V102, P8555, DOI 10.1073/pnas.0409863102; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; STINSKI MF, 1976, J VIROL, V19, P594, DOI 10.1128/JVI.19.2.594-609.1976; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wittmann BM, 2005, ONCOGENE, V24, P5576, DOI 10.1038/sj.onc.1208728; Wittmann BM, 2003, CANCER RES, V63, P5151; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	59	21	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36443	36454		10.1074/jbc.M112.374157	http://dx.doi.org/10.1074/jbc.M112.374157			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948151	hybrid, Green Published			2022-12-25	WOS:000310364000064
J	Mora-Lee, S; Sirerol-Piquer, MS; Gutierrez-Perez, M; Gomez-Pinedo, U; Roobrouck, VD; Lopez, T; Casado-Nieto, M; Abizanda, G; Rabena, MT; Verfaille, C; Prosper, F; Garcia-Verdugo, JM				Mora-Lee, Silvia; Salome Sirerol-Piquer, Ma; Gutierrez-Perez, Maria; Gomez-Pinedo, Ulises; Roobrouck, Valerie D.; Lopez, Tania; Casado-Nieto, Mayte; Abizanda, Gloria; Teresa Rabena, Maria; Verfaille, Catherine; Prosper, Felipe; Manuel Garcia-Verdugo, Jose			Therapeutic Effects of hMAPC and hMSC Transplantation after Stroke in Mice	PLOS ONE			English	Article							MARROW STROMAL CELLS; MESENCHYMAL STEM-CELLS; ADULT PROGENITOR CELLS; ISCHEMIC RAT-BRAIN; BONE-MARROW; MYOCARDIAL-INFARCTION; ARTERIAL THROMBOSIS; FUNCTIONAL RECOVERY; FERRIC-CHLORIDE; FOLLOW-UP	Stroke represents an attractive target for stem cell therapy. Although different types of cells have been employed in animal models, a direct comparison between cell sources has not been performed. The aim of our study was to assess the effect of human multipotent adult progenitor cells (hMAPCs) and human mesenchymal stem cells (hMSCs) on endogenous neurogenesis, angiogenesis and inflammation following stroke. BALB/Ca-RAG 2(-/-) gamma C-/- mice subjected to FeCl3 thrombosis mediated stroke were intracranially injected with 2x10(5) hMAPCs or hMSCs 2 days after stroke and followed for up to 28 days. We could not detect long-term engraftment of either cell population. However, in comparison with PBS-treated animals, hMSC and hMAPC grafted animals demonstrated significantly decreased loss of brain tissue. This was associated with increased angiogenesis, diminished inflammation and a glial-scar inhibitory effect. Moreover, enhanced proliferation of cells in the subventricular zone (SVZ) and survival of newly generated neuroblasts was observed. Interestingly, these neuroprotective effects were more pronounced in the group of animals treated with hMAPCs in comparison with hMSCs. Our results establish cell therapy with hMAPCs and hMSCs as a promising strategy for the treatment of stroke.	[Mora-Lee, Silvia; Gutierrez-Perez, Maria; Lopez, Tania; Abizanda, Gloria; Prosper, Felipe] Univ Navarra, Ctr Appl Med Res, Univ Navarra Clin, Hematol & Cell Therapy Area, E-31080 Pamplona, Spain; [Mora-Lee, Silvia; Gutierrez-Perez, Maria; Lopez, Tania; Abizanda, Gloria; Prosper, Felipe] Univ Navarra, Ctr Appl Med Res, Div Canc, E-31080 Pamplona, Spain; [Salome Sirerol-Piquer, Ma; Casado-Nieto, Mayte; Manuel Garcia-Verdugo, Jose] Univ Valencia, Cavanilles Inst Biodivers & Evolut Biol, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Dept Comparat Neurobiol, Valencia, Spain; [Gomez-Pinedo, Ulises] Hosp Clin San Carlos, Lab Med Regenerat, Madrid, Spain; [Roobrouck, Valerie D.; Verfaille, Catherine] Katholieke Univ Leuven, Stem Cell Inst, Louvain, Belgium; [Teresa Rabena, Maria] Univ Valencia, Dept Stat, Valencia, Spain	University of Navarra; University of Navarra; CIBERNED; University of Valencia; Hospital Clinico San Carlos; KU Leuven; University of Valencia	Mora-Lee, S (corresponding author), Univ Navarra, Ctr Appl Med Res, Univ Navarra Clin, Hematol & Cell Therapy Area, E-31080 Pamplona, Spain.	fprosper@unav.es; J.Manuel.Garcia@uv.es	, ulises.gomez-pinedo/C-3414-2016; Prosper, Felipe/H-6859-2017; Sirerol, Salome/K-6141-2012; García-Verdugo, José Manuel/L-8421-2017; Verfaillie, Catherine/H-5148-2013	, ulises.gomez-pinedo/0000-0003-3097-5557; Prosper, Felipe/0000-0001-6115-8790; Sirerol, Salome/0000-0002-9678-4502; García-Verdugo, José Manuel/0000-0001-9872-6499; Verfaillie, Catherine/0000-0001-7564-4079; Abizanda, Gloria/0000-0002-2504-5163	Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion (ISCIII) [RD06/0014, RD06/0010]; "UTE project CIMA", Centro de Investigacion Biomedica en Red, Enfermedades Neurodegenerativas; Spanish Plan Nacional (Ministerio de Ciencia e Innovacion); Consejo Nacional de Ciencia y Tecnologia fellowship [205970]	Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion (ISCIII); "UTE project CIMA", Centro de Investigacion Biomedica en Red, Enfermedades Neurodegenerativas; Spanish Plan Nacional (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejo Nacional de Ciencia y Tecnologia fellowship	This work was supported by FP6 STREP Project (STROKEMAP), Comunidad de Trabajo de los Pirineos and FEDER Funds, Red de Terapia Celular TERCEL (RETICS) from Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion (ISCIII) RD06/0014 and RD06/0010, PSE SINBAD, and funds from the "UTE project CIMA", Centro de Investigacion Biomedica en Red, Enfermedades Neurodegenerativas, and Spanish Plan Nacional (Ministerio de Ciencia e Innovacion). SML is funded by a Consejo Nacional de Ciencia y Tecnologia fellowship (205970). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranguren XL, 2008, J CLIN INVEST, V118, P505, DOI [10.1172/JC131153, 10.1172/JCI31153]; Aranguren XL, 2007, BLOOD, V109, P2634, DOI 10.1182/blood-2006-06-030411; Aranguren XL, 2011, CELL TRANSPLANT, V20, P259, DOI 10.3727/096368910X516592; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bacigaluppi M, 2009, BRAIN, V132, P2239, DOI 10.1093/brain/awp174; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Bin Deng Y, 2010, NEUROL RES, V32, P148, DOI 10.1179/174313209X414434; Borlongan CV, 2009, STROKE, V40, pS146, DOI 10.1161/STROKEAHA.108.533091; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Chen JL, 2004, BRAIN RES, V1005, P21, DOI 10.1016/j.brainres.2003.11.080; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Eglitis MA, 1999, NEUROREPORT, V10, P1289, DOI 10.1097/00001756-199904260-00025; Fan YF, 2010, ANN NEUROL, V67, P488, DOI 10.1002/ana.21919; Gonzalez-Perez O, 2002, NEUROSCI LETT, V321, P100, DOI 10.1016/S0304-3940(02)00056-3; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Janssens S, 2010, ANNU REV MED, V61, P287, DOI 10.1146/annurev.med.051508.215152; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kim JM, 2007, BRAIN RES, V1183, P43, DOI 10.1016/j.brainres.2007.09.005; Kovacsovics-Bankowski M, 2009, CELL IMMUNOL, V255, P55, DOI 10.1016/j.cellimm.2008.10.004; Krupinski J, 2003, NEUROREPORT, V14, P1171, DOI 10.1097/00001756-200306110-00014; KURZ KD, 1990, THROMB RES, V60, P269, DOI 10.1016/0049-3848(90)90106-M; Lee JS, 2010, STEM CELLS, V28, P1099, DOI 10.1002/stem.430; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Li Y, 2001, CELL TRANSPLANT, V10, P31; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Marti-Fabregas J, 2010, NEUROLOGY, V74, P357, DOI 10.1212/WNL.0b013e3181cbccec; Mazo M, 2010, J CARDIOVASC TRANSL, V3, P79, DOI 10.1007/s12265-009-9159-9; Mora-Lee S, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-28; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pelacho B, 2007, J TISSUE ENG REGEN M, V1, P51, DOI 10.1002/term.7; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 2000, BIOCHEM SOC T, V28, P341, DOI 10.1042/0300-5127:0280341; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; Rodrigo R, 2010, GASTROENTEROLOGY, V139, P675, DOI 10.1053/j.gastro.2010.03.040; Roobrouck VD, 2011, STEM CELLS, V29, P871, DOI 10.1002/stem.633; Schwarting S, 2008, STROKE, V39, P2867, DOI 10.1161/STROKEAHA.108.513978; Senior K, 2001, LANCET, V358, P817, DOI 10.1016/S0140-6736(05)71790-6; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Shen LH, 2008, GLIA, V56, P1747, DOI 10.1002/glia.20722; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311; Suarez-Monteagudo C, 2009, RESTOR NEUROL NEUROS, V27, P151, DOI 10.3233/RNN-2009-0483; Walker PA, 2010, EXP NEUROL; Wang XK, 2005, THROMB RES, V115, P95, DOI 10.1016/j.thromres.2004.07.009; Yasuhara T, 2008, J CEREBR BLOOD F MET, V28, P1804, DOI 10.1038/jcbfm.2008.68; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Yu GL, 2009, RESTOR NEUROL NEUROS, V27, P41, DOI 10.3233/RNN-2009-0460; Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853	53	56	61	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43683	10.1371/journal.pone.0043683	http://dx.doi.org/10.1371/journal.pone.0043683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952736	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300021
J	Rocha-Rego, V; Pereira, MG; Oliveira, L; Mendlowicz, MV; Fiszman, A; Marques-Portella, C; Berger, W; Chu, C; Joffily, M; Moll, J; Mari, JJ; Figueira, I; Volchan, E				Rocha-Rego, Vanessa; Pereira, Mirtes G.; Oliveira, Leticia; Mendlowicz, Mauro V.; Fiszman, Adriana; Marques-Portella, Carla; Berger, William; Chu, Carlton; Joffily, Mateus; Moll, Jorge; Mari, Jair J.; Figueira, Ivan; Volchan, Eliane			Decreased Premotor Cortex Volume in Victims of Urban Violence with Posttraumatic Stress Disorder	PLOS ONE			English	Article							CHILDHOOD SEXUAL-ABUSE; STRUCTURAL BRAIN ABNORMALITIES; SELF-INDUCED SADNESS; GRAY-MATTER VOLUME; ANTERIOR CINGULATE; HIPPOCAMPAL VOLUME; PREFRONTAL CORTEX; PERSONAL-SPACE; PTSD; MRI	Background: Studies addressing posttraumatic stress disorder (PTSD) have demonstrated that PTSD patients exhibit structural abnormalities in brain regions that relate to stress regulation and fear responses, such as the hippocampus, amygdala, anterior cingulate cortex, and ventromedial prefrontal cortex. Premotor cortical areas are involved in preparing to respond to a threatening situation and in representing the peripersonal space. Urban violence is an important and pervasive cause of human suffering, especially in large urban centers in the developing world. Violent events, such as armed robbery, are very frequent in certain cities, and these episodes increase the risk of PTSD. Assaultive trauma is characterized by forceful invasion of the peripersonal space; therefore, could this traumatic event be associated with structural alteration of premotor areas in PTSD? Methodology/Principal Findings: Structural magnetic resonance imaging scans were acquired from a sample of individuals that had been exposed to urban violence. This sample consisted of 16 PTSD patients and 16 age-and gender-matched controls. Psychometric questionnaires differentiated PTSD patients from trauma-exposed controls with regard to PTSD symptoms, affective, and resilience predispositions. Voxel-based morphometric analysis revealed that, compared with controls, the PTSD patients presented significant reductions in gray matter volume in the ventral premotor cortex and in the pregenual anterior cingulate cortex. Conclusions: Volume reduction in the premotor cortex that is observed in victims of urban violence with PTSD may be associated with a disruption in the dynamical modulation of the safe space around the body. The finding that PTSD patients presented a smaller volume of pregenual anterior cingulate cortex is consistent with the results of other PTSD neuroimaging studies that investigated different types of traumatic events.	[Rocha-Rego, Vanessa; Joffily, Mateus; Volchan, Eliane] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Pereira, Mirtes G.; Oliveira, Leticia; Mendlowicz, Mauro V.; Berger, William] Univ Fed Fluminense, Niteroi, RJ, Brazil; [Fiszman, Adriana; Marques-Portella, Carla; Figueira, Ivan] Univ Fed Rio de Janeiro, Inst Psiquiatria, Rio De Janeiro, Brazil; [Chu, Carlton] UCL, London, England; [Moll, Jorge] DOr Inst Res & Educ, Rio De Janeiro, Brazil; [Mari, Jair J.] Univ Fed Sao Paulo, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal Fluminense; Universidade Federal do Rio de Janeiro; University of London; University College London; IDOR - Instituto D'Or de Ensino e Pesquisa; Universidade Federal de Sao Paulo (UNIFESP)	Rocha-Rego, V (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.	rochavr@biof.ufrj.br	Berger, William/K-3258-2012; Oliveira, Leticia/P-1159-2019; Neurociencia, Inct/I-1011-2013; Moll, Jorge/B-2654-2013; figueira, ivan/B-4577-2008; Joffily, Mateus/H-7457-2017; Volchan, Eliane/C-5792-2013; Pereira, Mirtes Garcia/J-6222-2016; de Jesus Mari, Jair/A-7309-2008; Moll, Jorge/AAF-8388-2021	Berger, William/0000-0001-7656-4548; Oliveira, Leticia/0000-0002-8450-2264; Joffily, Mateus/0000-0003-4073-4562; Pereira, Mirtes Garcia/0000-0003-4682-223X; de Jesus Mari, Jair/0000-0002-5403-0112; Moll, Jorge/0000-0002-4297-591X	National Council for Scientific and Technological Development (CNPq); Carlos Chagas Filho Foundation for Research Support in Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Foundation for Research Support in Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the National Council for Scientific and Technological Development (CNPq) and the Carlos Chagas Filho Foundation for Research Support in Rio de Janeiro (FAPERJ). Currently, Vanessa Rocha-Rego is funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Berger William, 2004, Rev. psiquiatr. Rio Gd. Sul, V26, P167, DOI 10.1590/S0101-81082004000200006; Block J, 1996, J PERS SOC PSYCHOL, V70, P349, DOI 10.1037/0022-3514.70.2.349; Bremner JD, 2003, AM J PSYCHIAT, V160, P924, DOI 10.1176/appi.ajp.160.5.924; Bremner JD, 1999, AM J PSYCHIAT, V156, P1787; Bremner JD, 2003, BIOL PSYCHIAT, V53, P879, DOI 10.1016/S0006-3223(02)01891-7; Bremner JD, 2001, HIPPOCAMPUS, V11, P75, DOI 10.1002/hipo.1023; Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Chen SL, 2006, PSYCHIAT RES-NEUROIM, V146, P65, DOI 10.1016/j.pscychresns.2005.09.006; Cohn MA, 2009, EMOTION, V9, P361, DOI 10.1037/a0015952; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; de Gelder B, 2004, P NATL ACAD SCI USA, V101, P16701, DOI 10.1073/pnas.0407042101; Del-Ben Cristina Marta, 2001, Revista Brasileira de Psiquiatria, V23, P156, DOI 10.1590/S1516-44462001000300008; Eckart C, 2011, J PSYCHIATR NEUROSCI, V36, P176, DOI 10.1503/jpn.100010; Falconer E, 2008, J PSYCHIATR NEUROSCI, V33, P413; Figueira I, 2007, J TRAUMA STRESS, V20, P89, DOI 10.1002/jts.20183; First M. B., 1997, STRUCTURED CLIN INTE; Francati V, 2007, DEPRESS ANXIETY, V24, P202, DOI 10.1002/da.20208; Friedman M.J., 2008, PSYCHOPHARMACOLOGY A, P245; George MS, 1996, BIOL PSYCHIAT, V40, P859, DOI 10.1016/0006-3223(95)00572-2; Geuze E, 2008, NEUROIMAGE, V41, P675, DOI 10.1016/j.neuroimage.2008.03.007; Ghashghaei H, 2007, NEUROIMAGE, V34, P905, DOI 10.1016/j.neuroimage.2006.09.046; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P2621, DOI 10.1016/j.neuropsychologia.2005.09.011; Grezes J, 2007, NEUROIMAGE, V35, P959, DOI 10.1016/j.neuroimage.2006.11.030; Hakamata Y, 2007, NEUROSCI RES, V59, P383, DOI 10.1016/j.neures.2007.08.012; Hall E.T., 1966, HIDDEN DIMENSION, V609; HAYDUK LA, 1978, PSYCHOL BULL, V85, P117, DOI 10.1037/0033-2909.85.1.117; Hidalgo RB, 2000, J CLIN PSYCHIAT, V61, P5; HOROWITZ MJ, 1964, ARCH GEN PSYCHIAT, V11, P651; Hughes KC, 2011, EXPERT REV NEUROTHER, V11, P275, DOI 10.1586/ERN.10.198; Hull AM, 2002, BRIT J PSYCHIAT, V181, P102; Jatzko A, 2006, J AFFECT DISORDERS, V94, P121, DOI 10.1016/j.jad.2006.03.010; Johansen-Berg H, 2008, CEREB CORTEX, V18, P1374, DOI 10.1093/cercor/bhm167; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; Kesler ML, 2001, COGNITIVE BRAIN RES, V11, P213, DOI 10.1016/S0926-6410(00)00073-2; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Killgore WDS, 2004, NEUROIMAGE, V21, P1215, DOI 10.1016/j.neuroimage.2003.12.033; Kitayama N, 2005, J AFFECT DISORDERS, V88, P79, DOI 10.1016/j.jad.2005.05.014; Kroes MCW, 2011, J PSYCHIATR NEUROSCI, V36, P256, DOI 10.1503/jpn.100077; Lane RD, 1997, AM J PSYCHIAT, V154, P926; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Litz BT, 2000, J ABNORM PSYCHOL, V109, P26, DOI 10.1037/0021-843X.109.1.26; Lloyd DM, 2009, NEUROSCI BIOBEHAV R, V33, P297, DOI 10.1016/j.neubiorev.2008.09.007; Lobo Isabela, 2011, Psychol. Neurosci., V4, P191, DOI 10.3922/j.psns.2011.2.004; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maren S, 2000, BEHAV BRAIN RES, V110, P97, DOI 10.1016/S0166-4328(99)00188-6; Mari JD, 2008, REV BRAS PSIQUIATR, V30, P183, DOI 10.1590/S1516-44462008000300002; Mitterschiffthaler MT, 2007, HUM BRAIN MAPP, V28, P1150, DOI 10.1002/hbm.20337; Pelletier M, 2003, NEUROREPORT, V14, P1111, DOI 10.1097/00001756-200306110-00003; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Phillips ML, 1998, PSYCHIAT RES-NEUROIM, V83, P127, DOI 10.1016/S0925-4927(98)00036-5; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Reichenheim ME, 2011, LANCET, V377, P1962, DOI 10.1016/S0140-6736(11)60053-6; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; Robinson BL, 2011, CURR OPIN PSYCHIATR, V24, P29, DOI 10.1097/YCO.0b013e3283413519; Sanders MJ, 2003, EUR J PHARMACOL, V463, P217, DOI 10.1016/S0014-2999(03)01283-4; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Shin LM, 2009, J TRAUMA STRESS, V22, P409, DOI 10.1002/jts.20442; Shin LM, 2004, HIPPOCAMPUS, V14, P292, DOI 10.1002/hipo.10183; Smith ME, 2005, HIPPOCAMPUS, V15, P798, DOI 10.1002/hipo.20102; Takahashi H, 2008, CEREB CORTEX, V18, P898, DOI 10.1093/cercor/bhm120; Thomaes K, 2010, J CLIN PSYCHIAT, V71, P1636, DOI 10.4088/JCP.08m04754blu; Vogt B. A., 2009, CINGULATE NEUROBIOLO; Volchan E, 2011, BIOL PSYCHOL, V88, P13, DOI 10.1016/j.biopsycho.2011.06.002; Vytal K, 2010, J COGNITIVE NEUROSCI, V22, P2864, DOI 10.1162/jocn.2009.21366; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Weathers F.W., 1994, PTSD CHECKLIST CIVIL; Wieser MJ, 2010, CYBERPSYCH BEH SOC N, V13, P547, DOI 10.1089/cyber.2009.0432; Woodward SH, 2006, BIOL PSYCHIAT, V59, P582, DOI 10.1016/j.biopsych.2005.07.033; Woon FL, 2009, J NEUROPSYCH CLIN N, V21, P5, DOI 10.1176/appi.neuropsych.21.1.5; Yamasue H, 2003, P NATL ACAD SCI USA, V100, P9039, DOI 10.1073/pnas.1530467100; Zhang J, 2011, PSYCHIAT RES-NEUROIM, V192, P84, DOI 10.1016/j.pscychresns.2010.09.001	76	36	36	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e42560	10.1371/journal.pone.0042560	http://dx.doi.org/10.1371/journal.pone.0042560			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998EY	22952599	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300007
J	Squirrell, JM; Fong, JJ; Ariza, CA; Mael, A; Meyer, K; Shevde, NK; Roopra, A; Lyons, GE; Kamp, TJ; Eliceiri, KW; Ogle, BM				Squirrell, Jayne M.; Fong, Jimmy J.; Ariza, Carlos A.; Mael, Amber; Meyer, Kassondra; Shevde, Nirupama K.; Roopra, Avtar; Lyons, Gary E.; Kamp, Timothy J.; Eliceiri, Kevin W.; Ogle, Brenda M.			Endogenous Fluorescence Signatures in Living Pluripotent Stem Cells Change with Loss of Potency	PLOS ONE			English	Article							IN-VITRO DIFFERENTIATION; OXIDATIVE-PHOSPHORYLATION; NEURAL DIFFERENTIATION; EMBRYOID BODIES; MICROSCOPY; MOUSE; NADH; ACTIVATION; DEPENDENCE; NAD(P)H	The therapeutic potential of stem cells is limited by the non-uniformity of their phenotypic state. Thus it would be advantageous to noninvasively monitor stem cell status. Driven by this challenge, we employed multidimensional multiphoton microscopy to quantify changes in endogenous fluorescence occurring with pluripotent stem cell differentiation. We found that global and cellular-scale fluorescence lifetime of human embryonic stem cells (hESC) and murine embryonic stem cells (mESC) consistently decreased with differentiation. Less consistent were trends in endogenous fluorescence intensity with differentiation, suggesting intensity is more readily impacted by nuances of species and scale of analysis. What emerges is a practical and accessible approach to evaluate, and ultimately enrich, living stem cell populations based on changes in metabolism that could be exploited for both research and clinical applications.	[Squirrell, Jayne M.; Fong, Jimmy J.; Lyons, Gary E.; Kamp, Timothy J.; Eliceiri, Kevin W.; Ogle, Brenda M.] Univ Wisconsin, Lab Opt & Computat Instrumentat, Madison, WI 53715 USA; [Mael, Amber; Shevde, Nirupama K.] WiCell Res Inst, Madison, WI USA; [Ogle, Brenda M.] Univ Wisconsin, Mat Sci Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; WiCell Research Institute; University of Wisconsin System; University of Wisconsin Madison	Squirrell, JM (corresponding author), Univ Wisconsin, Lab Opt & Computat Instrumentat, Madison, WI 53715 USA.	ogle@wisc.edu	Kamp, Timothy/ABD-1343-2020; Eliceiri, Kevin/ABD-4516-2020	Kamp, Timothy/0000-0003-2103-7876; Eliceiri, Kevin/0000-0001-8678-670X	National Institutes of Health [1K18HL092218, HL100014]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K18HL092218, RC1HL100014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by grants from National Institutes of Health (1K18HL092218), (HL100014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasthi S, 2012, J BIOPHOTONICS, V5, P57, DOI 10.1002/jbio.201100077; Becker W, 2004, MICROSC RES TECHNIQ, V63, P58, DOI 10.1002/jemt.10421; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Beres M, 2010, CULT HEALTH SEX, V12, P1, DOI 10.1080/13691050903075226; Bieberich E, 2004, J CELL BIOL, V167, P723, DOI 10.1083/jcb.200405144; Bird DK, 2004, APPL OPTICS, V43, P5173, DOI 10.1364/AO.43.005173; Bird DK, 2005, CANCER RES, V65, P8766, DOI 10.1158/0008-5472.CAN-04-3922; Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272; Buschke DG, 2011, MICROSC MICROANAL, V17, P540, DOI 10.1017/S1431927610000280; Centonze VE, 1998, BIOPHYS J, V75, P2015, DOI 10.1016/S0006-3495(98)77643-X; CHANCE B, 1958, J BIOL CHEM, V233, P736; Chen AA, 2010, INTEGR BIOL-UK, V2, P517, DOI 10.1039/c0ib00054j; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Conklin MW, 2009, CELL BIOCHEM BIOPHYS, V53, P145, DOI 10.1007/s12013-009-9046-7; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Feraud O, 2007, CELL DEATH DIFFER, V14, P385, DOI 10.1038/sj.cdd.4402041; Fernandez LA, 2005, TRANSPLANTATION, V80, P729, DOI 10.1097/01.tp.0000179105.95770.cd; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; GALLAS JM, 1987, PHOTOCHEM PHOTOBIOL, V45, P595, DOI 10.1111/j.1751-1097.1987.tb07385.x; Gaspers LD, 2008, METHODS, V46, P224, DOI 10.1016/j.ymeth.2008.09.012; Georgakoudi I, 2002, CANCER RES, V62, P682; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/NMETH.1403, 10.1038/nmeth.1403]; Hernandez-Garcia D, 2008, EXP CELL RES, V314, P2090, DOI 10.1016/j.yexcr.2008.03.005; Hronik-Tupaj M, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-9; Huang SH, 2002, BIOPHYS J, V82, P2811, DOI 10.1016/S0006-3495(02)75621-X; Iyer V, 2006, J NEUROPHYSIOL, V95, P535, DOI 10.1152/jn.00865.2005; King MA, 2000, J IMMUNOL METHODS, V243, P155, DOI 10.1016/S0022-1759(00)00232-5; Konig K, 2011, MICROSC RES TECHNIQ, V74, P9, DOI 10.1002/jemt.20866; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; KORETSKY AP, 1987, BIOCHIM BIOPHYS ACTA, V893, P398, DOI 10.1016/0005-2728(87)90092-2; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; Lakowicz JR, 1999, J BIOMOL SCREEN, V4, P355, DOI 10.1177/108705719900400610; LAKOWICZ JR, 1992, P NATL ACAD SCI USA, V89, P1271, DOI 10.1073/pnas.89.4.1271; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lee ER, 2006, J BIOL CHEM, V281, P21162, DOI 10.1074/jbc.M602734200; Levitt JM, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2401149; Liang J, 2007, SPECTROCHIM ACTA A, V67, P355, DOI 10.1016/j.saa.2006.07.035; Lim HJ, 2011, MOL CELLS, V31, P123, DOI 10.1007/s10059-011-0016-8; MALTSEV VA, 1993, MECH DEVELOP, V44, P41, DOI 10.1016/0925-4773(93)90015-P; Mathur A, 2000, CARDIOVASC RES, V46, P126, DOI 10.1016/S0008-6363(00)00002-X; Menter JM, 2006, PHOTOCH PHOTOBIO SCI, V5, P403, DOI 10.1039/b516429j; Mohr JC, 2010, BIOMATERIALS, V31, P1885, DOI 10.1016/j.biomaterials.2009.11.033; Nelson TJ, 2006, ANAT REC PART A, V288A, P1216, DOI 10.1002/ar.a.20388; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Pachernik J, 2002, REPROD NUTR DEV, V42, P317, DOI 10.1051/rnd:2002028; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Rice WL, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2823019; Rice WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010075; Skala MC, 2005, CANCER RES, V65, P1180, DOI 10.1158/0008-5472.CAN-04-3031; Skala MC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717503; Squirrell JM, 1999, NAT BIOTECHNOL, V17, P763, DOI 10.1038/11698; St John JC, 2005, CLONING STEM CELLS, V7, P141, DOI 10.1089/clo.2005.7.141; Stringari C, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.4.046012; Stringari C, 2011, P NATL ACAD SCI USA, V108, P13582, DOI 10.1073/pnas.1108161108; Tadrous PJ, 2003, J PATHOL, V199, P309, DOI 10.1002/path.1286; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Uchugonova A, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3002370; Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Vishwasrao HD, 2005, J BIOL CHEM, V280, P25119, DOI 10.1074/jbc.M502475200; Wang HW, 2009, ANTI-CANCER AGENT ME, V9, P1012, DOI 10.2174/187152009789377718; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Wu Tom Y H, 2006, Drug Discov Today Technol, V3, P255, DOI 10.1016/j.ddtec.2006.09.001; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang JC, 1997, LASER SURG MED, V20, P319, DOI 10.1002/(SICI)1096-9101(1997)20:3<319::AID-LSM11>3.0.CO;2-8; Zhang QH, 2002, SCIENCE, V295, P1895; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100	71	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43708	10.1371/journal.pone.0043708	http://dx.doi.org/10.1371/journal.pone.0043708			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952742	gold, Green Submitted, Green Published			2022-12-25	WOS:000308206000046
J	Kwok, YH; Hutchinson, MR; Gentgall, MG; Rolan, PE				Kwok, Yuen H.; Hutchinson, Mark R.; Gentgall, Melanie G.; Rolan, Paul E.			Increased Responsiveness of Peripheral Blood Mononuclear Cells to In Vitro TLR 2, 4 and 7 Ligand Stimulation in Chronic Pain Patients	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; NEUROPATHIC PAIN; RAT MODEL; ACTIVATION; IMMUNE; EXPRESSION; HYPERSENSITIVITY; MAINTENANCE; MACROPHAGES; TOLERANCE	Glial activation via Toll-like receptor (TLR) signaling has been shown in animals to play an important role in the initiation and establishment of chronic pain. However, our ability to assess this central immune reactivity in clinical pain populations is currently lacking. Peripheral blood mononuclear cells (PBMCs) are an accessible source of TLR expressing cells that may mirror similarities in TLR responsiveness of the central nervous system. The aim of this study was to characterize the IL-1 beta response to various TLR agonists in isolated PBMCs from chronic pain sufferers (on and not on opioids) and pain-free controls. Venous blood was collected from 11 chronic pain sufferers on opioids (>= 20 mg of morphine / day), 8 chronic pain sufferers not on opioids and 11 pain-free controls. PBMCs were isolated and stimulated in vitro with a TLR2 (Pam3CSK4), TLR4 (LPS) or TLR7 (imiquimod) agonist. IL-1 beta released into the supernatant was measured with ELISA. Significantly increased IL-1 beta expression was found in PBMCs from chronic pain sufferers (on and not on opioids) compared with pain-free controls for TLR2 (F ((6, 277)) = 15, P<0.0001), TLR4 (F ((8, 263)) = 3, P = 0.002) and TLR7 (F ((2,201)) = 5, P = 0.005) agonists. These data demonstrate that PBMCs from chronic pain sufferers were more responsive to TLR agonists compared with controls, suggesting peripheral cells may have the potential to become a source of biomarkers for chronic pain.	[Kwok, Yuen H.; Rolan, Paul E.] Univ Adelaide, Sch Med Sci, Discipline Pharmacol, Adelaide, SA, Australia; [Hutchinson, Mark R.] Univ Adelaide, Sch Med Sci, Discipline Physiol, Adelaide, SA, Australia; [Gentgall, Melanie G.; Rolan, Paul E.] Univ Adelaide, Pain & Anaesthesia Res Clin, Adelaide, SA, Australia; [Rolan, Paul E.] Royal Adelaide Hosp, Pain Management Unit, Adelaide, SA 5000, Australia	University of Adelaide; University of Adelaide; University of Adelaide; Royal Adelaide Hospital	Kwok, YH (corresponding author), Univ Adelaide, Sch Med Sci, Discipline Pharmacol, Adelaide, SA, Australia.	yuen.kwok@adelaide.edu.au	Hutchinson, Mark/N-1815-2019; Hutchinson, Mark R/G-4147-2014	Hutchinson, Mark/0000-0003-2154-5950; Hutchinson, Mark R/0000-0003-2154-5950; Kwok, Yuen/0000-0002-5336-9544	Pain and Anaesthesia Research Clinic, University of Adelaide; Australian Research Council (ARC) [DP110100297]	Pain and Anaesthesia Research Clinic, University of Adelaide; Australian Research Council (ARC)(Australian Research Council)	The study was funded by the Pain and Anaesthesia Research Clinic, University of Adelaide and was supported by Grant Number [DP110100297] from Australian Research Council (ARC). Its contents are solely the responsibility of the authors and the funders had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	2010 National Opioid Use Guideline Group, 2010, CANADIAN GUIDELINE S; Akira S, 2003, SCAND J INFECT DIS, V35, P555, DOI 10.1080/00365540310015683; Beg AA, 2002, TRENDS IMMUNOL, V23, P509, DOI 10.1016/S1471-4906(02)02317-7; Budd K, 2006, BIOMED PHARMACOTHER, V60, P310, DOI 10.1016/j.biopha.2006.06.015; CHAO CC, 1991, CYTOKINE, V3, P292, DOI 10.1016/1043-4666(91)90497-2; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Chu LF, 2006, J PAIN, V7, P43, DOI 10.1016/j.jpain.2005.08.001; Davis JM, 2010, J IMMUNOL, V184, P7297, DOI 10.4049/jimmunol.0904180; de Leo JA, 2006, PAIN, V122, P17, DOI 10.1016/j.pain.2006.02.034; DEFORGE LE, 1991, BIOCHEM BIOPH RES CO, V174, P18, DOI 10.1016/0006-291X(91)90478-P; Doverty M, 2001, PAIN, V90, P91, DOI 10.1016/S0304-3959(00)00391-2; Dunne DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011343; Grace PM, 2011, BRAIN BEHAV IMMUN, V25, P1322, DOI 10.1016/j.bbi.2011.04.003; Guo LH, 2007, CELL MOL LIFE SCI, V64, P1128, DOI 10.1007/s00018-007-6494-3; Hutchinson Mark R, 2007, ScientificWorldJournal, V7, P98; Hutchinson MR, 2008, EUR J NEUROSCI, V28, P20, DOI 10.1111/j.1460-9568.2008.06321.x; Hutchinson MR, 2010, BRAIN BEHAV IMMUN, V24, P83, DOI 10.1016/j.bbi.2009.08.004; Hutchinson MR, 2004, PAIN, V110, P751, DOI 10.1016/j.pain.2004.05.017; Hutchinson MR, 2008, BRAIN BEHAV IMMUN; Hutchinson MR, 2009, BRAIN BEHAV IMMUN; Jang Y, 2012, ANESTH ANALG; Kim D, 2007, J BIOL CHEM, V282, P14975, DOI 10.1074/jbc.M607277200; Kovarik JJ, 2011, EUR J CLIN INVEST, V41, P291, DOI 10.1111/j.1365-2362.2010.02407.x; Kowalski ML, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/132732; Ledeboer A, 2005, PAIN, V115, P71, DOI 10.1016/j.pain.2005.02.009; Mao TK, 2005, HEPATOLOGY, V42, P802, DOI 10.1002/hep.20859; McMahon SB, 2005, EXP NEUROL, V192, P444, DOI 10.1016/j.expneurol.2004.11.001; Menzebach A, 2004, ANASTH INTENSIV NOTF, V39, P204, DOI 10.1055/s-2004-814389; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Nicotra L, 2012, EXP NEUROL, V234, P316, DOI 10.1016/j.expneurol.2011.09.038; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; Raghavendra V, 2003, J PHARMACOL EXP THER, V306, P624, DOI 10.1124/jpet.103.052407; Raghavendra V, 2002, J NEUROSCI, V22, P9980, DOI 10.1523/jneurosci.22-22-09980.2002; Rajkowska G., 2007, CNS & Neurological Disorders-Drug Targets, V6, P219, DOI 10.2174/187152707780619326; Risdahl JM, 1998, J NEUROIMMUNOL, V83, P4, DOI 10.1016/S0165-5728(97)00216-6; Rossi S., 2011, AUSTR MED HDB 2011; Sacerdote P, 1997, BRIT J PHARMACOL, V121, P834, DOI 10.1038/sj.bjp.0701138; Shi XQ, 2011, GLIA, V59, P231, DOI 10.1002/glia.21093; Sutterwala FS, 2006, J ENDOTOXIN RES, V12, P251, DOI 10.1179/096805106X118771; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Tanga FY, 2004, NEUROCHEM INT, V45, P397, DOI 10.1016/j.neuint.2003.06.002; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Tsuda M, 2004, GLIA, V45, P89, DOI 10.1002/glia.10308; Tsujimoto H, 2006, CLIN IMMUNOL, V119, P180, DOI 10.1016/j.clim.2006.01.004; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Watkins LR, 2003, NAT REV DRUG DISCOV, V2, P973, DOI 10.1038/nrd1251	50	40	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44232	10.1371/journal.pone.0044232	http://dx.doi.org/10.1371/journal.pone.0044232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937165	Green Published, gold, Green Submitted			2022-12-25	WOS:000308213600095
J	Reperant, LA; Kuiken, T; Grenfell, BT; Osterhaus, ADME; Dobson, AP				Reperant, Leslie A.; Kuiken, Thijs; Grenfell, Bryan T.; Osterhaus, Albert D. M. E.; Dobson, Andrew P.			Linking Influenza Virus Tissue Tropism to Population-Level Reproductive Fitness	PLOS ONE			English	Article							ADAPTIVE IMMUNE-RESPONSE; RESPIRATORY-TRACT; WITHIN-HOST; METABOLIC PROPERTIES; TRANSMISSION; INFECTION; DYNAMICS; MODEL; EVOLUTION; CLEARANCE	Influenza virus tissue tropism defines the host cells and tissues that support viral replication and contributes to determining which regions of the respiratory tract are infected in humans. The location of influenza virus infection along the respiratory tract is a key determinant of virus pathogenicity and transmissibility, which are at the basis of influenza burdens in the human population. As the pathogenicity and transmissibility of influenza virus ultimately determine its reproductive fitness at the population level, strong selective pressures will shape influenza virus tissue tropisms that maximize fitness. At present, the relationships between influenza virus tissue tropism within hosts and reproductive fitness at the population level are poorly understood. The selective pressures and constraints that shape tissue tropism and thereby influence the location of influenza virus infection along the respiratory tract are not well characterized. We use mathematical models that link within-host infection dynamics in a spatially-structured human respiratory tract to between-host transmission dynamics, with the aim of characterizing the possible selective pressures on influenza virus tissue tropism. The results indicate that spatial heterogeneities in virus clearance, virus pathogenicity or both, resulting from the unique structure of the respiratory tract, may drive optimal receptor binding affinity-that maximizes influenza virus reproductive fitness at the population level-towards sialic acids with alpha 2,6 linkage to galactose. The expanding cell pool deeper down the respiratory tract, in association with lower clearance rates, may result in optimal infectivity rates-that likewise maximize influenza virus reproductive fitness at the population level-to exhibit a decreasing trend towards deeper regions of the respiratory tract. Lastly, pre-existing immunity may drive influenza virus tissue tropism towards upper regions of the respiratory tract. The proposed framework provides a new template for the cross-scale study of influenza virus evolutionary and epidemiological dynamics in humans.	[Reperant, Leslie A.; Kuiken, Thijs; Osterhaus, Albert D. M. E.] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Reperant, Leslie A.; Grenfell, Bryan T.; Dobson, Andrew P.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Erasmus University Rotterdam; Erasmus MC; Princeton University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Reperant, LA (corresponding author), Erasmus MC, Dept Virol, Rotterdam, Netherlands.	l.reperant@erasmusmc.nl		Osterhaus, Albert/0000-0002-6074-1172; Kuiken, Thijs/0000-0001-5501-9049; Reperant, Leslie/0000-0002-7212-1595	Dutch Ministry of Economic Affairs; VIRGO Consortium; Dutch government [BSIK03012]; European Commission [044490, 258084]; Science & Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; NSF [0742373]; NIH [R01 GM083983-01]; ERC [250136]; EU [223498]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083983] Funding Source: NIH RePORTER	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); VIRGO Consortium; Dutch government; European Commission(European CommissionEuropean Commission Joint Research Centre); Science & Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC(European Research Council (ERC)European Commission); EU(European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	LAR, ADMEO and TK were supported by the Dutch Ministry of Economic Affairs grant "Impuls Veterinair Influenza Onderzoek Nederland". ADMEO and TK were supported by the VIRGO Consortium, an innovative cluster approved by the Netherlands Genomics Initiative, and partially funded by the Dutch government (grant number BSIK03012); European Commission grant no. 044490 "New-FluBird", and European Commission grant no. 258084 "Flupig". BTG was supported by the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health, and by grants NSF 0742373, and NIH R01 GM083983-01. ADMEO was supported by the ERC advanced grant no. 250136 "FluPlan", and EU FP7 grant no. 223498 "Emperie". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2009, J EVOLUTION BIOL, V22, P245, DOI 10.1111/j.1420-9101.2008.01658.x; Almeida ARM, 2005, SEMIN IMMUNOL, V17, P239, DOI 10.1016/j.smim.2005.02.002; ANDERSON R M, 1991; [Anonymous], WKLY EPIDEMIOL REC; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Bajaria SH, 2002, J ACQ IMMUN DEF SYND, V30, P41, DOI 10.1097/00042560-200205010-00006; BARTH WF, 1964, J CLIN INVEST, V43, P1036, DOI 10.1172/JCI104987; Beauchemin C, 2005, J THEOR BIOL, V232, P223, DOI 10.1016/j.jtbi.2004.08.001; Beauchemin CAA, 2008, J THEOR BIOL, V254, P439, DOI 10.1016/j.jtbi.2008.05.031; Beauchemin CAA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S7; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; BOCHAROV GA, 1994, J THEOR BIOL, V167, P323, DOI 10.1006/jtbi.1994.1074; Bodewes R, 2011, CLIN VACCINE IMMUNOL, V18, P469, DOI 10.1128/CVI.00396-10; BROWN GC, 1973, J IMMUNOL, V110, P889; Brydon EWA, 2003, J GEN VIROL, V84, P2389, DOI 10.1099/vir.0.18913-0; Canini L, 2011, J VIROL, V85, P2764, DOI 10.1128/JVI.01318-10; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; Chowell G, 2008, EPIDEMIOL INFECT, V136, P852, DOI 10.1017/S0950268807009144; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; CRAPO JD, 1982, AM REV RESPIR DIS, V126, P332; Dahari H, 2005, J HEPATOL, V42, P491, DOI 10.1016/j.jhep.2004.12.017; Dobrovolny HM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013811; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Doherty PC, 2000, ANNU REV IMMUNOL, V18, P561, DOI 10.1146/annurev.immunol.18.1.561; ELVEBACK LR, 1976, AM J EPIDEMIOL, V103, P152, DOI 10.1093/oxfordjournals.aje.a112213; Falk R, 1997, EXP LUNG RES, V23, P495, DOI 10.3109/01902149709039240; Gambaryan A, 2005, VIROLOGY, V334, P276, DOI 10.1016/j.virol.2005.02.003; GREEN GM, 1973, ARCH INTERN MED, V131, P109, DOI 10.1001/archinte.131.1.109; Guarner J, 2000, AM J CLIN PATHOL, V114, P227, DOI 10.1309/HV74-N24T-2K2C-3E8Q; Guarner J, 2006, CLIN INFECT DIS, V43, P132, DOI 10.1086/505122; Hancioglu B, 2007, J THEOR BIOL, V246, P70, DOI 10.1016/j.jtbi.2006.12.015; Handel A, 2010, J R SOC INTERFACE, V7, P35, DOI 10.1098/rsif.2009.0067; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Ito R, 2003, VACCINE, V21, P2362, DOI 10.1016/S0264-410X(03)00078-1; Jackson C, 2010, AM J EPIDEMIOL, V171, P465, DOI 10.1093/aje/kwp394; Khurana S, 2012, J INFECT DIS, V205, P610, DOI 10.1093/infdis/jir791; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Kuiken T, 2008, VACCINE, V26, pD59, DOI 10.1016/j.vaccine.2008.07.025; Lee HY, 2009, J VIROL, V83, P7151, DOI 10.1128/JVI.00098-09; Memoli MJ, 2009, J INFECT DIS, V200, P1232, DOI 10.1086/605893; Miao HY, 2010, J VIROL, V84, P6687, DOI 10.1128/JVI.00266-10; Mideo N, 2008, TRENDS ECOL EVOL, V23, P511, DOI 10.1016/j.tree.2008.05.009; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Moller W, 2004, J APPL PHYSIOL, V97, P2200, DOI 10.1152/japplphysiol.00970.2003; MORELL A, 1973, CLIN EXP IMMUNOL, V13, P521; MORELL A, 1970, J CLIN INVEST, V49, P673, DOI 10.1172/JCI106279; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; Park AW, 2009, SCIENCE, V326, P726, DOI 10.1126/science.1175980; Pepin KM, 2010, J THEOR BIOL, V265, P501, DOI 10.1016/j.jtbi.2010.05.036; PLOPPER CG, 1989, AM J ANAT, V184, P31, DOI 10.1002/aja.1001840104; R Development Core Team, 2009, R FDN STAT COMP; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Renegar KB, 2004, J IMMUNOL, V173, P1978, DOI 10.4049/jimmunol.173.3.1978; REYNOLDS HY, 1991, PHYSIOL REV, V71, P1117, DOI 10.1152/physrev.1991.71.4.1117; Saenz RA, 2010, J VIROL; Shechter Y, 2001, P NATL ACAD SCI USA, V98, P1212, DOI 10.1073/pnas.98.3.1212; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; SIM GK, 1995, ADV IMMUNOL, V58, P297, DOI 10.1016/S0065-2776(08)60622-7; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; SMITH H, 1988, REV INFECT DIS, V10, P56; Sorrell EM, 2011, CURR OPIN VIROL, V1, P635, DOI 10.1016/j.coviro.2011.07.003; Stahlhofen W., 1989, J AEROSOL MED, V2, P285, DOI [10.1089/jam.1989.2.285, DOI 10.1089/JAM.1989.2.285]; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P1; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Turner D, 2011, J IMMUNOL; van den Brand JMA, PLOS ONE IN PRESS; van den Brand JMA, 2010, J INFECT DIS, V201, P993, DOI 10.1086/651132; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; van Riel D, 2010, AM J PATHOL, V176, P1614, DOI 10.2353/ajpath.2010.090949; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; Volkov I, 2010, J R SOC INTERFACE, V7, P1311, DOI 10.1098/rsif.2009.0560; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; WEIBEL ER, 1979, B EUR PHYSIOPATH RES, V15, P999; World Health Organization (WHO), 2011, CUM NUMB CONF HUM CA	86	29	29	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43115	10.1371/journal.pone.0043115	http://dx.doi.org/10.1371/journal.pone.0043115			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952637	Green Published, gold, Green Submitted			2022-12-25	WOS:000308213600016
J	Lee, WC; Kan, D; Chen, YY; Han, SK; Lu, KS; Chien, CL				Lee, Wen-Ching; Kan, Daphne; Chen, Yun-Yu; Han, Shan-Kuo; Lu, Kuo-Shyan; Chien, Chung-Liang			Suppression of Extensive Neurofilament Phosphorylation Rescues alpha-Internexin/Peripherin-Overexpressing PC12 Cells from Neuronal Cell Death	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; AMYOTROPHIC-LATERAL-SCLEROSIS; INTERMEDIATE-FILAMENT PROTEIN; GLYCOGEN-SYNTHASE KINASE-3; NF-H; INCLUSION DISEASE; MOTOR-NEURONS; NEURODEGENERATIVE DISEASES; TRIPLET PROTEINS; TAIL DOMAINS	Intermediate filament (IF) overproduction induces abnormal accumulation of neuronal IF, which is a pathological indicator of some neurodegenerative disorders. In our study, alpha-Internexin-and peripherin-overexpressing PC12 cells (pINT-EGFP and pEGFP-peripherin) were used as models to study neuropathological pathways responsible for neurodegenerative diseases. Microarray data revealed that Cdk5-related genes were downregulated and Cdk5 regulatory subunit-associated protein 3 (GSK-3 alpha and GSK-3 beta) were upregulated in pINT-EGFP cells. Increased expression of phosphorylated neurofilament and aberrant activation of Cdk5 and GSK-3 beta were detected in both pEGFP-peripherin and pINT-EGFP cells by Western blotting. In addition, pharmacological approaches to retaining viability of pINT-EGFP and pEGFP-peripherin cells were examined. Treatment with Cdk5 inhibitor and GSK-3 beta inhibitor significantly suppressed neuronal death. Dynamic changes of disaggregation of EGFP-peripherin and decrease in green fluorescence intensity were observed in pEGFP-peripherin and pINT-EGFP cells by confocal microscopy after GSK-3 beta inhibitor treatment. We conclude that inhibition of Cdk5 and GSK-3 beta suppresses neurofilament phosphorylation, slows down the accumulation of neuronal IF in the cytoplasm, and subsequently avoids damages to cell organelles. The results suggest that suppression of extensive neurofilament phosphorylation may be a potential strategy for ameliorating neuron death. The suppression of hyperphosphorylation of neuronal cytoskeletons with kinase inhibitors could be one of potential therapeutic treatments for neurodegenerative diseases.	[Lee, Wen-Ching; Chen, Yun-Yu; Han, Shan-Kuo; Lu, Kuo-Shyan; Chien, Chung-Liang] Natl Taiwan Univ, Coll Med, Dept Anat & Cell Biol, Taipei 10764, Taiwan; [Kan, Daphne; Chien, Chung-Liang] Natl Taiwan Univ, Coll Med, Ctr Genom Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Lee, WC (corresponding author), Natl Taiwan Univ, Coll Med, Dept Anat & Cell Biol, Taipei 10764, Taiwan.	chien@ntu.edu.tw		CHIEN, CHUNG-LIANG/0000-0001-9806-486X	National Science Council, Taiwan [NSC NSC-97-2628-B-002-043-MY3, NSC-98-3111-B-002-004]; Ministry of Education, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported by grants to C.-L. Chien (NSC NSC-97-2628-B-002-043-MY3 and NSC-98-3111-B-002-004) from the National Science Council, Taiwan. Facilities provided by grants from the Ministry of Education, Taiwan to the Center of Genomic Medicine in National Taiwan University are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; Bajaj NPS, 1999, PROG NEURO-PSYCHOPH, V23, P833, DOI 10.1016/S0278-5846(99)00044-5; Bajaj NPS, 2000, AMYOTROPH LATERAL SC, V1, P319, DOI 10.1080/146608200300079563; Bajaj NPS, 1997, J NEUROCHEM, V69, P737; Beaulieu JM, 1999, BIOCHEM CELL BIOL, V77, P41, DOI 10.1139/bcb-77-1-41; Beaulieu JM, 1999, J CELL BIOL, V147, P531, DOI 10.1083/jcb.147.3.531; Bhatta H, 2009, J MICROBIOL METH, V77, P77, DOI 10.1016/j.mimet.2009.01.011; Cairns NJ, 2004, ACTA NEUROPATHOL, V108, P213, DOI 10.1007/s00401-004-0882-7; Cairns NJ, 2004, AM J PATHOL, V164, P2153, DOI 10.1016/S0002-9440(10)63773-X; Cairns NJ, 2004, J PATHOL, V204, P438, DOI 10.1002/path.1650; Chen J, 2005, J HUAZHONG U SCI TEC, V25, P403; Chen Juan, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P375; Chien CL, 2005, J NEUROSCI RES, V80, P693, DOI 10.1002/jnr.20506; CHING GY, 1993, J CELL BIOL, V122, P1323, DOI 10.1083/jcb.122.6.1323; Ching GY, 1998, J CELL SCI, V111, P321; CORBO M, 1992, J NEUROPATH EXP NEUR, V51, P531, DOI 10.1097/00005072-199209000-00008; De Sarno P, 2002, NEUROPHARMACOLOGY, V43, P1158, DOI 10.1016/S0028-3908(02)00215-0; ESCURAT M, 1990, J NEUROSCI, V10, P764; FLIEGNER KH, 1994, J COMP NEUROL, V342, P161, DOI 10.1002/cne.903420202; FLIEGNER KH, 1991, INT REV CYTOL, V131, P109, DOI 10.1016/S0074-7696(08)62018-5; Grant P, 2000, J NEUROCYTOL, V29, P843, DOI 10.1023/A:1010999509251; GUAN RJ, 1991, J BIOL CHEM, V266, P8262; Guidato S, 1996, NEUROSCI LETT, V217, P157, DOI 10.1016/0304-3940(96)13098-6; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; He CZ, 2004, J NEUROL SCI, V217, P47, DOI 10.1016/j.jns.2003.08.016; Helfand BT, 2003, J CELL SCI, V116, P2345, DOI 10.1242/jcs.00526; KAPLAN MP, 1990, J NEUROSCI, V10, P2735; Kesavapany S, 2003, NEUROSIGNALS, V12, P252, DOI 10.1159/000074627; Lariviere RC, 2004, J NEUROBIOL, V58, P131, DOI 10.1002/neu.10270; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; LEE VMY, 1988, P NATL ACAD SCI USA, V85, P7384, DOI 10.1073/pnas.85.19.7384; Lee WC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-8; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liem RKH, 2009, J CLIN INVEST, V119, P1814, DOI 10.1172/JCI38003; Liu HL, 2003, J NEUROCHEM, V86, P1553, DOI 10.1046/j.1471-4159.2003.01978.x; Lobsiger CS, 2005, P NATL ACAD SCI USA, V102, P10351, DOI 10.1073/pnas.0503862102; Marszalek JR, 1996, J CELL BIOL, V135, P711, DOI 10.1083/jcb.135.3.711; MIGHELI A, 1993, LAB INVEST, V68, P185; Millecamps S, 2006, J NEUROCHEM, V98, P926, DOI 10.1111/j.1471-4159.2006.03932.x; Molina-Porcel L, 2008, ARCH NEUROL-CHICAGO, V65, P272, DOI 10.1001/archneurol.2007.37; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; Omary MB, 2009, J CLIN INVEST, V119, P1756, DOI 10.1172/JCI39894; PARYSEK LM, 1987, J NEUROSCI, V7, P781; PARYSEK LM, 1991, J NEUROSCI RES, V30, P80, DOI 10.1002/jnr.490300110; Portier Marie-Madeleine, 1993, Comptes Rendus de l'Academie des Sciences Serie III Sciences de la Vie, V316, P1124; PORTIER MM, 1984, DEV NEUROSCI-BASEL, V6, P335, DOI 10.1159/000112360; Robertson J, 2001, J CELL BIOL, V155, P217, DOI 10.1083/jcb.200107058; Rudrabhatla P, 2011, FASEB J, V25, P3896, DOI 10.1096/fj.11-181297; Sasaki T, 2002, J BIOL CHEM, V277, P36032, DOI 10.1074/jbc.M206674200; Sharma M, 1999, J NEUROCHEM, V73, P79, DOI 10.1046/j.1471-4159.1999.0730079.x; Sharma P, 1999, P NATL ACAD SCI USA, V96, P11156, DOI 10.1073/pnas.96.20.11156; Sun DM, 1996, J BIOL CHEM, V271, P14245, DOI 10.1074/jbc.271.24.14245; Tu PH, 1996, P NATL ACAD SCI USA, V93, P3155, DOI 10.1073/pnas.93.7.3155; Veeranna, 2008, J NEUROCHEM, V107, P35, DOI 10.1111/j.1471-4159.2008.05547.x; WONG PC, 1995, J CELL BIOL, V130, P1413, DOI 10.1083/jcb.130.6.1413; Yokota O, 2008, ACTA NEUROPATHOL, V115, P561, DOI 10.1007/s00401-007-0329-z; Yuan AD, 2006, J NEUROSCI, V26, P10006, DOI 10.1523/JNEUROSCI.2580-06.2006	57	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43883	10.1371/journal.pone.0043883	http://dx.doi.org/10.1371/journal.pone.0043883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952800	Green Published, gold, Green Submitted			2022-12-25	WOS:000308044800072
J	Lertpiriyapong, K; Gamazon, ER; Feng, Y; Park, DS; Pang, J; Botka, G; Graffam, ME; Ge, ZM; Fox, JG				Lertpiriyapong, Kvin; Gamazon, Eric R.; Feng, Yan; Park, Danny S.; Pang, Jassia; Botka, Georgina; Graffam, Michelle E.; Ge, Zhongming; Fox, James G.			Campylobacter jejuni Type VI Secretion System: Roles in Adaptation to Deoxycholic Acid, Host Cell Adherence, Invasion, and In Vivo Colonization	PLOS ONE			English	Article							CYTOLETHAL DISTENDING TOXIN; BILE-ACIDS; ESCHERICHIA-COLI; EPITHELIAL-CELLS; VIBRIO-CHOLERAE; GENE; IDENTIFICATION; GENOME; EXPRESSION; INFECTION	The recently identified type VI secretion system (T6SS) of proteobacteria has been shown to promote pathogenicity, competitive advantage over competing microorganisms, and adaptation to environmental perturbation. By detailed phenotypic characterization of loss-of-function mutants, in silico, in vitro and in vivo analyses, we provide evidence that the enteric pathogen, Campylobacter jejuni, possesses a functional T6SS and that the secretion system exerts pleiotropic effects on two crucial processes - survival in a bile salt, deoxycholic acid (DCA), and host cell adherence and invasion. The expression of T6SS during initial exposure to the upper range of physiological levels of DCA (0.075%-0.2%) was detrimental to C. jejuni proliferation, whereas down-regulation or inactivation of T6SS enabled C. jejuni to resist this effect. The C. jejuni multidrug efflux transporter gene, cmeA, was significantly up-regulated during the initial exposure to DCA in the wild type C. jejuni relative to the T6SS-deficient strains, suggesting that inhibition of proliferation is the consequence of T6SS-mediated DCA influx. A sequential modulation of the efflux transporter activity and the T6SS represents, in part, an adaptive mechanism for C. jejuni to overcome this inhibitory effect, thereby ensuring its survival. C. jejuni T6SS plays important roles in host cell adhesion and invasion as T6SS inactivation resulted in a reduction of adherence to and invasion of in vitro cell lines, while over-expression of a hemolysin co-regulated protein, which encodes a secreted T6SS component, greatly enhanced these processes. When inoculated into B6.129P2-IL-10(tm1Cgn) mice, the T6SS-deficient C. jejuni strains did not effectively establish persistent colonization, indicating that T6SS contributes to colonization in vivo. Taken together, our data demonstrate the importance of bacterial T6SS in host cell adhesion, invasion, colonization and, for the first time to our knowledge, adaptation to DCA, providing new insights into the role of T6SS in C. jejuni pathogenesis.	[Lertpiriyapong, Kvin; Feng, Yan; Pang, Jassia; Botka, Georgina; Graffam, Michelle E.; Ge, Zhongming; Fox, James G.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Gamazon, Eric R.] Univ Chicago, Dept Med, Med Genet Sect, Chicago, IL 60637 USA; [Park, Danny S.] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA	Massachusetts Institute of Technology (MIT); University of Chicago; Columbia University	Lertpiriyapong, K (corresponding author), MIT, Div Comparat Med, Cambridge, MA 02139 USA.	zge@mit.edu; jgfox@mit.edu	Gamazon, Eric/I-6873-2018	Gamazon, Eric/0000-0003-4204-8734; Ge, Zhongming/0000-0003-0924-7563	National Institutes of Health [R01CH067529, R01DK05413, T32RR007036, P30ES002109]; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR007036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants R01CH067529, R01DK05413, T32RR007036 and P30ES002109. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert DF, 2008, INFECT IMMUN, V76, P1979, DOI 10.1128/IAI.01338-07; Bidlack JE, 2004, J BACTERIOL, V186, P5202, DOI 10.1128/JB.186.16.5202-5209.2004; BJORKHEM I, 1989, J LIPID RES, V30, P1033; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Blondel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011724; Bodhidatta L, 2010, AM J TROP MED HYG, V83, P1106, DOI 10.4269/ajtmh.2010.10-0367; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; BRODEY PA, 1982, AM J ROENTGENOL, V139, P1199, DOI 10.2214/ajr.139.6.1199; Broms JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034639; Busscher HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002440; Chen ML, 2006, INFECT IMMUN, V74, P6581, DOI 10.1128/IAI.00958-06; Chow J, 2010, CELL HOST MICROBE, V7, P265, DOI 10.1016/j.chom.2010.03.004; Das S, 2002, BIOCHEM BIOPH RES CO, V295, P922, DOI 10.1016/S0006-291X(02)00782-9; de Pace F, 2011, MICROBIOL-SGM, V157, P2954, DOI 10.1099/mic.0.050005-0; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Ge ZM, 2005, INFECT IMMUN, V73, P3559, DOI 10.1128/IAI.73.6.3559-3567.2005; Gustafsson U, 2003, WORLD J GASTROENTERO, V9, P1576, DOI 10.3748/wjg.v9.i7.1576; Hamilton JP, 2007, AM J PHYSIOL-GASTR L, V293, pG256, DOI 10.1152/ajpgi.00027.2007; Hepworth PJ, 2011, ENVIRON MICROBIOL, V13, P1549, DOI 10.1111/j.1462-2920.2011.02461.x; Hofmann AF, 2006, P NATL ACAD SCI USA, V103, P4333, DOI 10.1073/pnas.0600780103; Ishikawa T, 2012, INFECT IMMUN, V80, P575, DOI 10.1128/IAI.05510-11; Jani AJ, 2010, CELL HOST MICROBE, V8, P2, DOI 10.1016/j.chom.2010.06.012; Janssen R, 2008, CLIN MICROBIOL REV, V21, P505, DOI 10.1128/CMR.00055-07; Kaakoush NO, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-15; Karlyshev AV, 2005, APPL ENVIRON MICROB, V71, P4004, DOI 10.1128/AEM.71.7.4004-4013.2005; LAMBERT ME, 1979, BRIT MED J, V1, P857, DOI 10.1136/bmj.1.6167.857; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Lin J, 2005, J BACTERIOL, V187, P7417, DOI 10.1128/JB.187.21.7417-7424.2005; Ludu JS, 2008, J BACTERIOL, V190, P4584, DOI 10.1128/JB.00198-08; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Malik-Kale P, 2008, J BACTERIOL, V190, P2286, DOI 10.1128/JB.01736-07; Mansfield LS, 2007, INFECT IMMUN, V75, P1099, DOI 10.1128/IAI.00833-06; NORTHFIE.TC, 1973, GUT, V14, P513, DOI 10.1136/gut.14.7.513; Poly F, 2004, J BACTERIOL, V186, P4781, DOI 10.1128/JB.186.14.4781-4795.2004; Poly F, 2008, INFECT IMMUN, V76, P5655, DOI 10.1128/IAI.00780-08; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Records AR, 2011, MOL PLANT MICROBE IN, V24, P751, DOI 10.1094/MPMI-11-10-0262; ROLLINS DM, 1983, APPL ENVIRON MICROB, V45, P284, DOI 10.1128/AEM.45.1.284-289.1983; Ruiz-Palacios GM, 2007, CLIN INFECT DIS, V44, P701, DOI 10.1086/509936; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Sana TG, 2012, J BIOL CHEM; Sarris PF, 2011, INFECT GENET EVOL, V11, P157, DOI 10.1016/j.meegid.2010.09.006; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; SHERIHA GM, 1968, LIPIDS, V3, P72, DOI 10.1007/BF02530972; Shrivastava S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002955; VANSPREEUWEL JP, 1985, GUT, V26, P945, DOI 10.1136/gut.26.9.945; Vertzoni M, 2008, J LIPID RES, V49, P2690, DOI 10.1194/jlr.D800039-JLR200; Weber B, 2009, ENVIRON MICROBIOL, V11, P3018, DOI 10.1111/j.1462-2920.2009.02005.x; Wilson DL, 2010, MICROBIOL-SGM, V156, P2046, DOI 10.1099/mic.0.035717-0; Zheng J, 2008, INFECT IMMUN, V76, P4498, DOI 10.1128/IAI.01317-07; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zheng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023876; Zhou Y, 2012, INFECT IMMUN, V80, P1243, DOI 10.1128/IAI.05994-11	55	90	93	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e42842	10.1371/journal.pone.0042842	http://dx.doi.org/10.1371/journal.pone.0042842			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952616	Green Published, gold, Green Submitted			2022-12-25	WOS:000308044800015
J	Zhao, TS; Gao, S; Wang, XC; Liu, JC; Duan, YT; Yuan, ZN; Sheng, J; Li, SS; Wang, F; Yu, M; Ren, H; Hao, JH				Zhao, Tiansuo; Gao, Song; Wang, Xiuchao; Liu, Jingcheng; Duan, Yitao; Yuan, Zhanna; Sheng, Jun; Li, Shasha; Wang, Feng; Yu, Ming; Ren, He; Hao, Jihui			Hypoxia-Inducible Factor-1 alpha Regulates Chemotactic Migration of Pancreatic Ductal Adenocarcinoma Cells through Directly Transactivating the CX3CR1 Gene	PLOS ONE			English	Article							NEUROPATHIC PAIN; RECEPTOR CX3CR1; CHEMOKINE; FRACTALKINE; EXPRESSION; CANCER; ADHESION; IDENTIFICATION	CX3CR1 is an important chemokine receptor and regulates the chemotactic migration of pancreatic ductal adenocarcinoma (PDAC) cells. Up to now, its regulatory mechanism remains largely undefined. Here, we report that hypoxia upregulates the expression of CX3CR1 in pancreatic cancer cells. When hypoxia-inducible factor (HIF)-1 alpha expression was knocked down in vitro and in vivo, the expression of CX3CR1 was significantly decreased. Chromatin immunoprecipitation assay demonstrated that HIF-1 alpha bound to the hypoxia-response element (HRE; 5'-A/GCGTG-3') of CX3CR1 promoter under normoxia, and this binding was significantly enhanced under hypoxia. Overexpression of HIF-1 alpha significantly upregulated the expression of luciferase reporter gene under the control of the CX3CR1 promoter in pancreatic cancer cells. Importantly, we demonstrated that HIF-1 alpha may regulate cancer cell migration through CX3CR1. The HIF-1 alpha/CX3CR1 pathway might represent a valuable therapeutic target to prevent invasion and distant metastasis in PDAC.	[Zhao, Tiansuo; Gao, Song; Wang, Xiuchao; Liu, Jingcheng; Yuan, Zhanna; Sheng, Jun; Li, Shasha; Yu, Ming; Ren, He; Hao, Jihui] Tianjin Med Univ Canc Inst & Hosp, Dept Pancreat Canc, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Duan, Yitao] Tianjin Univ, Sch Chem Engn & Technol, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China; [Wang, Feng] Tianjin Med Univ Nankai Hosp, Inst Chinese & Modern Med Acute Abdominal Dis, Tianjin, Peoples R China	Tianjin Medical University; Tianjin University; Tianjin Medical University	Zhao, TS (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Dept Pancreat Canc, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China.	herenrh@yahoo.com.cn; jihuihao@yahoo.com	wu, ping/AAP-9449-2020		National Natural Science Foundation of China [81172355 30973490, 30900596, 30901448]; New Century Excellent Talents Programme of the Ministry of Education [NCET-07-0614]; Natural Science Foundation of Tianjin [10JCZDJC20200]; China Postdoctoral Science Foundation [20090450773]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents Programme of the Ministry of Education(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (81172355 30973490, 30900596, 30901448), the New Century Excellent Talents Programme of the Ministry of Education (NCET-07-0614), the Natural Science Foundation of Tianjin (10JCZDJC20200) and the China Postdoctoral Science Foundation (20090450773). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2006, ANN ONCOL, V17, P945, DOI 10.1093/annonc/mdl053; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; ELSASSER HP, 1992, VIRCHOWS ARCH B, V61, P295, DOI 10.1007/BF02890431; Fraticelli P, 2001, J CLIN INVEST, V107, P1173, DOI 10.1172/JCI11517; Gao YJ, 2010, PHARMACOL THERAPEUT, V126, P56, DOI 10.1016/j.pharmthera.2010.01.002; Garin A, 2002, BIOCHEM J, V368, P753, DOI 10.1042/BJ20020951; Han ZB, 2008, CARCINOGENESIS, V29, P1853, DOI 10.1093/carcin/bgn066; Haskell CA, 2000, J BIOL CHEM, V275, P34183, DOI 10.1074/jbc.M005731200; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Hung SC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000416; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Liu M, 2010, J PATHOL, V221, P221, DOI 10.1002/path.2706; Marchesi F, 2008, CANCER RES, V68, P9060, DOI 10.1158/0008-5472.CAN-08-1810; Mimura L, 2011, J PHARMACOL SCI, V115, P453, DOI 10.1254/jphs.10R19FM; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; Pour PM, 2003, PANCREAS, V26, P322, DOI 10.1097/00006676-200305000-00002; Ryu J, 2008, CARDIOVASC RES, V78, P333, DOI 10.1093/cvr/cvm067; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Shulby SA, 2004, CANCER RES, V64, P4693, DOI 10.1158/0008-5472.CAN-03-3437; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Vaupel P, 2001, SEMIN ONCOL, V28, P29, DOI 10.1016/S0093-7754(01)90210-6; Verge GM, 2004, EUR J NEUROSCI, V20, P1150, DOI 10.1111/j.1460-9568.2004.03593.x	22	45	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43399	10.1371/journal.pone.0043399	http://dx.doi.org/10.1371/journal.pone.0043399			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952674	Green Submitted, Green Published, gold			2022-12-25	WOS:000308044800030
J	Dietmair, S; Hodson, MP; Quek, LE; Timmins, NE; Gray, P; Nielsen, LK				Dietmair, Stefanie; Hodson, Mark P.; Quek, Lake-Ee; Timmins, Nicholas E.; Gray, Peter; Nielsen, Lars K.			A Multi-Omics Analysis of Recombinant Protein Production in Hek293 Cells	PLOS ONE			English	Article							TRANSIENT GENE-EXPRESSION; HAMSTER OVARY CELLS; MAMMALIAN-CELLS; PYRUVATE-CARBOXYLASE; MOLECULE-BETA; CYTOSOLIC CHAPERONIN; EUKARYOTIC PREFOLDIN; MONOCLONAL-ANTIBODY; BINDING PROTEINS; GLUCOSE-UPTAKE	Hek293 cells are the predominant hosts for transient expression of recombinant proteins and are used for stable expression of proteins where post-translational modifications performed by CHO cells are inadequate. Nevertheless, there is little information available on the key cellular features underpinning recombinant protein production in Hek293 cells. To improve our understanding of recombinant protein production in Hek293 cells and identify targets for the engineering of an improved host cell line, we have compared a stable, recombinant protein producing Hek293 cell line and its parental cell line using a combination of transcriptomics, metabolomics and fluxomics. Producer cultures consumed less glucose than non-producer cultures while achieving the same growth rate, despite the additional burden of recombinant protein production. Surprisingly, there was no indication that producer cultures compensated for the reduction in glycolytic energy by increasing the efficiency of glucose utilization or increasing glutamine consumption. In contrast, glutamine consumption was lower and the majority of genes involved in oxidative phosphorylation were downregulated in producer cultures. We observed an overall downregulation of a large number of genes associated with broad cellular functions (e. g., cell growth and proliferation) in producer cultures, and therefore speculate that a broad adaptation of the cellular network freed up resources for recombinant protein production while maintaining the same growth rate. Increased abundance of genes associated with endoplasmic reticulum stress indicated a possible bottleneck at the point of protein folding and assembly.	[Dietmair, Stefanie; Hodson, Mark P.; Quek, Lake-Ee; Timmins, Nicholas E.; Gray, Peter; Nielsen, Lars K.] Univ Queensland, Australian Inst Bioengn & Nanotechnol AIBN, Brisbane, Qld, Australia	University of Queensland	Dietmair, S (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol AIBN, Brisbane, Qld, Australia.	stefanie.dietmair@googlemail.com	Hodson, Mark P/J-7609-2013; Nielsen, Lars K/A-5519-2011; Gray, Peter/AAC-3737-2019	Hodson, Mark P/0000-0002-5436-1886; Nielsen, Lars K/0000-0001-8191-3511; 				Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Backliwal G, 2008, BIOTECHNOL BIOENG, V101, P182, DOI 10.1002/bit.21882; Backliwal G, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn423; Baldi L, 2007, BIOTECHNOL LETT, V29, P677, DOI 10.1007/s10529-006-9297-y; Carlage T, 2009, ANAL CHEM, V81, P7357, DOI 10.1021/ac900792z; Clarke C, 2011, J BIOTECHNOL, V151, P159, DOI 10.1016/j.jbiotec.2010.11.016; Dietmair S, 2012, BIOTECHNOLOGY J; Dietmair S, 2012, BIOTECHNOL J, V7, P75, DOI 10.1002/biot.201100369; Dietmair S, 2010, ANAL BIOCHEM, V404, P155, DOI 10.1016/j.ab.2010.04.031; Dinnis DM, 2006, BIOTECHNOL BIOENG, V94, P830, DOI 10.1002/bit.20899; Doolan P, 2008, MOL BIOTECHNOL, V39, P187, DOI 10.1007/s12033-008-9039-6; Dorai H, 2007, BIOTECHNOL PROGR, V23, P911, DOI 10.1021/bp0700051; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Durocher Y, 2009, CURR OPIN BIOTECH, V20, P700, DOI 10.1016/j.copbio.2009.10.008; Europa AF, 2000, BIOTECHNOL BIOENG, V67, P25, DOI 10.1002/(SICI)1097-0290(20000105)67:1<25::AID-BIT4>3.0.CO;2-K; FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Geisse S, 2009, METHOD ENZYMOL, V463, P223, DOI 10.1016/S0076-6879(09)63015-9; Geisse S, 2009, PROTEIN EXPRES PURIF, V64, P99, DOI 10.1016/j.pep.2008.10.017; George A, 2010, BLOOD CELL MOL DIS, V45, P41, DOI 10.1016/j.bcmd.2010.02.006; Grabenhorst E, 1999, GLYCOCONJUGATE J, V16, P81, DOI 10.1023/A:1026466408042; Henry O, 2011, METAB ENG, V13, P499, DOI 10.1016/j.ymben.2011.05.004; Henry O, 2011, BIOPROC BIOSYST ENG, V34, P263, DOI 10.1007/s00449-010-0468-9; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Irani N, 2002, J BIOTECHNOL, V93, P269, DOI 10.1016/S0168-1656(01)00409-6; Irani N, 1999, BIOTECHNOL BIOENG, V66, P238, DOI 10.1002/(SICI)1097-0290(1999)66:4<238::AID-BIT5>3.0.CO;2-6; Jenkins N, 2007, CYTOTECHNOLOGY, V53, P121, DOI 10.1007/s10616-007-9075-2; Kalfa TA, 2006, BLOOD, V108, P3637, DOI 10.1182/blood-2006-03-005942; Kim SH, 2007, APPL MICROBIOL BIOT, V76, P659, DOI 10.1007/s00253-007-1041-6; Korke R, 2004, J BIOTECHNOL, V107, P1, DOI 10.1016/j.jbiotec.2003.09.007; Kushiyama A, 2005, J BIOL CHEM, V280, P42016, DOI 10.1074/jbc.M503065200; Kusudo T, 2011, GENES CELLS, V16, P681, DOI 10.1111/j.1365-2443.2011.01517.x; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; Luo J, 2012, BIOTECHNOL BIOENG, V109, P146, DOI 10.1002/bit.23291; Martin-Benito J, 2002, EMBO J, V21, P6377, DOI 10.1093/emboj/cdf640; Meissner P, 2001, BIOTECHNOL BIOENG, V75, P197, DOI 10.1002/bit.1179; Meleady P, 2008, PROTEOMICS, V8, P2611, DOI 10.1002/pmic.200700854; Mitchell T, 2008, AM J PHYSIOL-CELL PH, V295, pC1354, DOI 10.1152/ajpcell.00239.2008; Moon B, 2003, AM J PHYSIOL-ENDOC M, V285, pE106, DOI 10.1152/ajpendo.00457.2002; Neilson AP, 2011, CANCER EPIDEMIOL, V35, P485, DOI 10.1016/j.canep.2010.10.007; Norman JC, 1996, MOL BIOL CELL, V7, P1429, DOI 10.1091/mbc.7.9.1429; Paredes C, 1999, CYTOTECHNOLOGY, V30, P85, DOI 10.1023/A:1008012518961; Pham PL, 2005, BIOTECHNOL BIOENG, V90, P332, DOI 10.1002/bit.20428; Quek LE, 2010, METAB ENG, V12, P161, DOI 10.1016/j.ymben.2009.09.002; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rajala MW, 2003, J CLIN INVEST, V111, P225, DOI 10.1172/JCI200316521; Sangster T, 2006, ANALYST, V131, P1075, DOI 10.1039/b604498k; Schroder M, 2008, BIOTECHNOL LETT, V30, P187, DOI 10.1007/s10529-007-9524-1; Schwartz DR, 2011, TRENDS ENDOCRIN MET, V22, P259, DOI 10.1016/j.tem.2011.03.005; Seth G, 2007, BIOTECHNOL BIOENG, V97, P933, DOI 10.1002/bit.21234; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Simons CT, 2004, J BIOL CHEM, V279, P4196, DOI 10.1074/jbc.M306053200; Singh V, 1996, BIOTECHNOL BIOENG, V52, P443, DOI 10.1002/(SICI)1097-0290(19961105)52:3<443::AID-BIT12>3.0.CO;2-K; Song M, 2011, J CHEM TECHNOL BIOT, V86, P935, DOI 10.1002/jctb.2618; Stansfield SH, 2007, BIOTECHNOL BIOENG, V97, P410, DOI 10.1002/bit.21263; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Steppan CM, 2001, P NATL ACAD SCI USA, V98, P502, DOI 10.1073/pnas.98.2.502; Stewart JM, 2006, ENCY MOL CELL BIOL M; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tigges M, 2006, METAB ENG, V8, P264, DOI 10.1016/j.ymben.2006.01.006; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Walsh G, 2010, NAT BIOTECHNOL, V28, P917, DOI 10.1038/nbt0910-917; Wulhfard S, 2008, BIOTECHNOL PROGR, V24, P458, DOI 10.1021/bp070286c; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003; Zhang XW, 2010, BIOTECHNOL LETT, V32, P1587, DOI 10.1007/s10529-010-0331-8	68	81	81	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43394	10.1371/journal.pone.0043394	http://dx.doi.org/10.1371/journal.pone.0043394			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937046	gold, Green Submitted, Green Published			2022-12-25	WOS:000308225500048
J	Patterson, SK; Borewicz, K; Johnson, T; Xu, W; Isaacson, RE				Patterson, Sheila K.; Borewicz, Klaudyna; Johnson, Timothy; Xu, Wayne; Isaacson, Richard E.			Characterization and Differential Gene Expression between Two Phenotypic Phase Variants in Salmonella enterica Serovar Typhimurium	PLOS ONE			English	Article							PYELONEPHRITIS-ASSOCIATED PILI; ESCHERICHIA-COLI; IN-VIVO; TRANSCRIPTIONAL CONTROL; GENOMIC SEQUENCE; TYPE-1 FIMBRIAE; RNA GENES; SWINE; PATHOGENESIS; INFECTIONS	Salmonella enterica serovar Typhimurium strain 798 has previously been shown to undergo phenotypic phase variation. One of the phenotypes expresses virulence traits such as adhesion, while the other phenotype does not. Phenotypic phase variation appears to correlate with the ability of this strain to cause persistent, asymptomatic infections of swine. A new method to detect cells in either phenotypic phase was developed using Evans Blue-Uranine agar plates. Using this new assay, rates of phenotypic phase variation were obtained. The rate of phase variation from non-adhesive to adhesive phenotype was approximately 10(-4) per cell per generation while phase variation from the adhesive to the non-adhesive phenotype was approximately 10(-6) per cell per generation. Two highly virulent S. Typhimurium strains, SL1344 and ATCC 14028, were also shown to undergo phase variation. However, while the rate from adhesive to non-adhesive phenotype was approximately the same as for strain 798, the non-adhesive to adhesive phenotype shift was 37-fold higher. Differential gene expression was measured using RNA-Seq. Eighty-three genes were more highly expressed by 798 cells in the adhesive phenotype compared to the non-adhesive cells. Most of the up-regulated genes were in virulence genes and in particular all genes in the Salmonella pathogenicity island 1 were up-regulated. When compared to the virulent strain SL1344, expression of the virulence genes was approximately equal to those up-regulated in the adhesive phenotype of strain 798. A comparison of invasive ability demonstrated that strain SL1344 was the most invasive followed by the adhesive phenotype of strain 798, then the non-adhesive phenotype of strain 798. The least invasive strain was ATCC 14028. The genome of strain 798 was sequenced and compared to SL1344. Both strains had very similar genome sequences and gene deletions could not readily explain differences in the rates of phase variation from non-adhesive to the adhesive phenotype.	[Patterson, Sheila K.] Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA; [Borewicz, Klaudyna; Johnson, Timothy; Isaacson, Richard E.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Xu, Wayne] Univ Minnesota, Minnesota Supercomp Inst, St Paul, MN 55108 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Patterson, SK (corresponding author), Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA.	isaac015@umn.edu	xu, wayne/ABA-1961-2020	xu, wayne/0000-0003-0484-7340	United States Department of Agriculture, National Research Initiative; USDA [NRI: 2002-35201-12542]	United States Department of Agriculture, National Research Initiative(United States Department of Agriculture (USDA)); USDA(United States Department of Agriculture (USDA))	This work was supported by a grant from the United States Department of Agriculture, National Research Initiative. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Kevin Lange for assistance in preparing Table S3. This work was supported by a grant from the USDA, NRI: 2002-35201-12542.	Althouse C, 2003, INFECT IMMUN, V71, P6446, DOI 10.1128/IAI.71.11.6446-6452.2003; Andrews-Polymenis HL, 2010, INFECT IMMUN, V78, P2356, DOI 10.1128/IAI.00096-10; Austin JW, 1998, FEMS MICROBIOL LETT, V162, P295, DOI 10.1016/S0378-1097(98)00137-2; Bajaj V, 1996, MOL MICROBIOL, V22, P703, DOI 10.1046/j.1365-2958.1996.d01-1718.x; Batz M. B., 2011, RANKING RISKS 10 PAT, P1; BLYN LB, 1989, EMBO J, V8, P613, DOI 10.1002/j.1460-2075.1989.tb03416.x; BLYN LB, 1990, EMBO J, V9, P4045, DOI 10.1002/j.1460-2075.1990.tb07626.x; BRAATEN BA, 1994, CELL, V76, P577, DOI 10.1016/0092-8674(94)90120-1; Chaudhuri RR, 2008, NUCLEIC ACIDS RES, V36, pD543, DOI 10.1093/nar/gkm928; Chen CY, 1996, INFECT IMMUN, V64, P4739, DOI 10.1128/IAI.64.11.4739-4743.1996; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Darwin KH, 1999, CLIN MICROBIOL REV, V12, P405, DOI 10.1128/CMR.12.3.405; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; EISENSTEIN BI, 1981, SCIENCE, V214, P337, DOI 10.1126/science.6116279; FEDORKACRAY PJ, 1994, VET MICROBIOL, V41, P333, DOI 10.1016/0378-1135(94)90029-9; FINLAY BB, 1989, SCIENCE, V243, P940, DOI 10.1126/science.2919285; Friebel A, 2001, J BIOL CHEM, V276, P34035, DOI 10.1074/jbc.M100609200; GALAN JE, 1990, INFECT IMMUN, V58, P1879; Grassl GA, 2008, CURR OPIN GASTROEN, V24, P22, DOI 10.1097/MOG.0b013e3282f21388; Gray JT, 1996, AM J VET RES, V57, P313; Guerrant RL, 1999, ADV EXP MED BIOL, V473, P103; Guiney DG, 1997, J CLIN INVEST, V99, P565, DOI 10.1172/JCI119196; ISAACSON RE, 1983, INFECT IMMUN, V40, P633, DOI 10.1128/IAI.40.2.633-639.1983; Isaacson RE, 1999, AM J VET RES, V60, P1155; Isaacson RE, 1999, ADV EXP MED BIOL, V473, P281; ISAACSON RE, 1992, INFECT IMMUN, V60, P3193, DOI 10.1128/IAI.60.8.3193-3200.1992; KAMPELMACHER E H, 1969, Zentralblatt fuer Veterinaermedizin Reihe B, V16, P717; Kwan LY, 1998, INFECT IMMUN, V66, P5725, DOI 10.1128/IAI.66.12.5725-5730.1998; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Layton Abigail N., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000373; LEE CA, 1990, P NATL ACAD SCI USA, V87, P4304, DOI 10.1073/pnas.87.11.4304; Letellier A, 1999, VET MICROBIOL, V67, P299, DOI 10.1016/S0378-1135(99)00049-8; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lucas RL, 2000, MOL MICROBIOL, V36, P1024, DOI 10.1046/j.1365-2958.2000.01961.x; Maloy SR., 1996, GENETIC ANAL PATHOGE; Norris TL, 1998, MOL MICROBIOL, V29, P311, DOI 10.1046/j.1365-2958.1998.00934.x; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; SEIFERT HS, 1988, NATURE, V336, P392, DOI 10.1038/336392a0; Smith H, 1998, TRENDS MICROBIOL, V6, P239, DOI 10.1016/S0966-842X(98)01250-5; Song J, 2005, BIOINFORMATICS, V21, P2083, DOI 10.1093/bioinformatics/bti176; Stevens MP, 2009, PHILOS T R SOC B, V364, P2709, DOI 10.1098/rstb.2009.0094; Tettelin H, 1999, GENOMICS, V62, P500, DOI 10.1006/geno.1999.6048; Thiennimitr P, 2011, P NAT AC SCI; Torres-Cruz J, 2003, J BACTERIOL, V185, P6990, DOI 10.1128/JB.185.23.6990-6994.2003; WOOD RL, 1989, AM J VET RES, V50, P1015; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0	47	17	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43592	10.1371/journal.pone.0043592	http://dx.doi.org/10.1371/journal.pone.0043592			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937065	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500066
J	Purdue, MP; Hofmann, JN; Colt, JS; Hoxha, M; Ruterbusch, JJ; Davis, FG; Rothman, N; Wacholder, S; Schwartz, KL; Baccarelli, A; Chow, WH				Purdue, Mark P.; Hofmann, Jonathan N.; Colt, Joanne S.; Hoxha, Mirjam; Ruterbusch, Julie J.; Davis, Faith G.; Rothman, Nathaniel; Wacholder, Sholom; Schwartz, Kendra L.; Baccarelli, Andrea; Chow, Wong-Ho			A Case-Control Study of Peripheral Blood Mitochondrial DNA Copy Number and Risk of Renal Cell Carcinoma	PLOS ONE			English	Article							ACTIVATION; CANCER	Background: Low mitochondrial DNA (mtDNA) copy number is a common feature of renal cell carcinoma (RCC), and may influence tumor development. Results from a recent case-control study suggest that low mtDNA copy number in peripheral blood may be a marker for increased RCC risk. In an attempt to replicate that finding, we measured mtDNA copy number in peripheral blood DNA from a U. S. population-based case-control study of RCC. Methodology/Principal Findings: Relative mtDNA copy number was measured in triplicate by a quantitative real-time PCR assay using DNA extracted from peripheral whole blood. Cases (n = 603) had significantly lower mtDNA copy number than controls (n = 603; medians 0.85, 0.91 respectively; P = 0.0001). In multiple logistic regression analyses, the lowest quartile of mtDNA copy number was associated with a 60% increase in RCC risk relative to the highest quartile (OR = 1.6, 95% CI = 1.1-2.2; P-trend = 0.009). This association remained in analyses restricted to cases treated by surgery alone (OR (Q1) = 1.4, 95% CI = 1.0-2.1) and to localized tumors (2.0, 1.3-2.8). Conclusions/Significance: Our findings from this investigation, to our knowledge the largest of its kind, offer important confirmatory evidence that low mtDNA copy number is associated with increased RCC risk. Additional research is needed to assess whether the association is replicable in prospective studies.	[Purdue, Mark P.; Hofmann, Jonathan N.; Colt, Joanne S.; Rothman, Nathaniel; Wacholder, Sholom; Chow, Wong-Ho] NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Hoxha, Mirjam; Baccarelli, Andrea] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Ctr Mol & Genet Epidemiol, Dept Prevent Med, Milan, Italy; [Hoxha, Mirjam; Baccarelli, Andrea] Univ Milan, Dept Environm & Occupat Hlth, Milan, Italy; [Ruterbusch, Julie J.] Wayne State Univ, Sch Med, Dept Family Med & Publ Hlth Sci, Detroit, MI USA; [Ruterbusch, Julie J.] Wayne State Univ, Sch Med, Barbara Ann Karmanos Inst, Detroit, MI USA; [Davis, Faith G.; Schwartz, Kendra L.] Univ Illinois, Sch Publ Hlth, Dept Epidemiol, Chicago, IL USA; [Baccarelli, Andrea] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Purdue, MP (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	purduem@mail.nih.gov	Purdue, Mark P/C-9228-2016; Hofmann, Jonathan/I-4168-2017	Purdue, Mark P/0000-0003-1177-3108; Hofmann, Jonathan/0000-0002-1043-5812; Baccarelli, Andrea/0000-0002-3436-0640	Intramural Research Program of the National Institutes of Health; National Cancer Institute	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health and the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chandel NS, 1999, FEBS LETT, V454, P173, DOI 10.1016/S0014-5793(99)00783-8; Chatterjee A, 2011, CANCER PREV RES, V4, P638, DOI 10.1158/1940-6207.CAPR-10-0326; Colt JS, 2011, EPIDEMIOLOGY, V22, P797, DOI 10.1097/EDE.0b013e3182300720; Higuchi M, 1997, J CLIN INVEST, V99, P1751, DOI 10.1172/JCI119339; Hou LF, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-48; Lee HC, 2005, MITOCHONDRIAL GENOME; Liao LM, 2011, CANCER EPIDEM BIOMAR, V20, P1944, DOI 10.1158/1055-9965.EPI-11-0379; Lin Chen-Sung, 2008, Interact Cardiovasc Thorac Surg, V7, P954, DOI 10.1510/icvts.2008.177006; Meierhofer D, 2004, CARCINOGENESIS, V25, P1005, DOI 10.1093/carcin/bgh104; Selvanayagam P, 1996, LAB INVEST, V74, P592; Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213	14	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43149	10.1371/journal.pone.0043149	http://dx.doi.org/10.1371/journal.pone.0043149			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937019	Green Submitted, Green Published, gold			2022-12-25	WOS:000308225500032
J	Wang, TT; Lv, MM; Shen, SN; Zhou, S; Wang, P; Chen, YQ; Liu, BR; Yu, LK; Hou, YY				Wang, Tingting; Lv, Mingming; Shen, Sunan; Zhou, Sheng; Wang, Ping; Chen, Yueqiu; Liu, Baorui; Yu, Like; Hou, Yayi			Cell-Free MicroRNA Expression Profiles in Malignant Effusion Associated with Patient Survival in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							PLEURAL EFFUSION; MESSENGER-RNA; GENE; CARCINOMA; PROGNOSIS; ONCOGENES; DIAGNOSIS; LEUKEMIA; BIOLOGY; RELAPSE	Objective: MicroRNAs (miRNAs) expression is altered in cancer cells, and miRNAs could serve as diagnostic and prognostic biomarker for cancer patients. This study was designed to analyze circulating miRNAs expression in the malignant pleural effusion (MPE) and their association with patient survival in non-small cell lung cancer (NSCLC). Methods: Pleural effusion from 184 patients with NSCLC and MPE were collected. MiRNA microarray and bioinformatics interpretation were used to evaluate miRNA expression profiles in 10 NSCLC patients with different survival prognosis. Associations were validated in 184 patients (randomly classified into training and validation set with equal number in each group) using quantitative RT-PCR. Risk scores were formulated based on the expression signature of miRNAs. Clinical data, such as patient survival, were collected for correlation analysis. Results: Thirty-three miRNAs were found to be altered more than two-fold by microarray in malignant effusions between longer-survival and shorter-survival groups, and levels of five miRNAs (miRNA-93, miRNA-100, miRNA-134, miRNA-151 and miRNA-345) were significantly associated with overall survival. High expression of miR-100 and low expression of miRNA-93, miRNA-134, miRNA-151 and miRNA-345 were associated with poor survival in both the training and validation cohort. Patients with high risk scores had overall poor survival compared to the patients with low risk scores. Risk score was an independent predictor of patient survival. Conclusions: Expression patterns of miRNAs are systematically altered in MPE of patient with NSCLC. The five miRNA signature from the effusion may serve as a predictor for the overall survival of patients with lung cancers.	[Wang, Tingting; Lv, Mingming; Shen, Sunan; Zhou, Sheng; Wang, Ping; Chen, Yueqiu; Hou, Yayi] Nanjing Univ, Immunol & Reprod Biol Lab, Sch Med, Nanjing, Jiangsu, Peoples R China; [Wang, Tingting; Lv, Mingming; Shen, Sunan; Zhou, Sheng; Wang, Ping; Chen, Yueqiu; Hou, Yayi] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Wang, Tingting; Lv, Mingming; Shen, Sunan; Zhou, Sheng; Wang, Ping; Chen, Yueqiu; Hou, Yayi] Nanjing Univ, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China; [Wang, Tingting; Liu, Baorui] Nanjing Univ, Dept Oncol, Drum Tower Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China; [Wang, Tingting; Liu, Baorui] Nanjing Univ, Clin Canc Inst, Nanjing, Jiangsu, Peoples R China; [Yu, Like] Nanjing Chest Hosp, Dept Resp Med 1, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University; Nanjing University	Wang, TT (corresponding author), Nanjing Univ, Immunol & Reprod Biol Lab, Sch Med, Nanjing, Jiangsu, Peoples R China.	yayihou@nju.edu.cn	lv, mingming/C-2891-2013; zhou, sheng/GYJ-6012-2022; wang, tingting/AAK-2640-2020		National Natural Science Foundation of China [81101552]; Natural Science Foundation of Jiangsu Province [BK2011571]; Specialized Research Fund for the Doctoral Program of Higher Education [20100091120002]; Fundamental Research Funds for the Central Universities [1118021418, 1118021406]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (81101552), the Natural Science Foundation of Jiangsu Province (BK2011571), Specialized Research Fund for the Doctoral Program of Higher Education (20100091120002), and the Fundamental Research Funds for the Central Universities (1118021418 and 1118021406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bielsa S, 2008, EUR J INTERN MED, V19, P334, DOI 10.1016/j.ejim.2007.09.014; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Clarke R, 2008, NAT REV CANCER, V8, P37, DOI 10.1038/nrc2294; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Gallardo E, 2009, CARCINOGENESIS, V30, P1903, DOI 10.1093/carcin/bgp219; Guo LL, 2010, EUR J CANCER, V46, P1692, DOI 10.1016/j.ejca.2010.02.043; Hsu IL, 2009, LUNG CANCER, V65, P371, DOI 10.1016/j.lungcan.2008.12.007; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Joung JG, 2007, BIOINFORMATICS, V23, P1141, DOI 10.1093/bioinformatics/btm045; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; SIYAMEK NM, 2006, LUNG CANCER, V54, P1; Su WC, 2003, ONCOLOGY-BASEL, V64, P18, DOI 10.1159/000066516; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Wang TT, 2009, INT J CANCER, V125, P1921, DOI 10.1002/ijc.24516; Xie L, 2011, CLIN BIOCHEM, V44, P216, DOI 10.1016/j.clinbiochem.2010.11.002; Xie L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-591; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang CN, 2010, CLIN CHEM, V56, P1871, DOI 10.1373/clinchem.2010.147553; Zheng YS, 2012, ONCOGENE, V31, P80, DOI 10.1038/onc.2011.208	29	52	56	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43268	10.1371/journal.pone.0043268	http://dx.doi.org/10.1371/journal.pone.0043268			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937028	gold, Green Submitted, Green Published			2022-12-25	WOS:000308225500037
J	Conley, NJ; Pavlinac, PB; Guthrie, BL; Mackelprang, RD; Muiru, AN; Choi, RY; Bosire, R; Gatuguta, A; Farquhar, C				Conley, N. Jeanne; Pavlinac, Patricia B.; Guthrie, Brandon L.; Mackelprang, Romel D.; Muiru, Anthony N.; Choi, Robert Y.; Bosire, Rose; Gatuguta, Ann; Farquhar, Carey			Distance from Home to Study Clinic and Risk of Follow-Up Interruption in a Cohort of HIV-1-Discordant Couples in Nairobi, Kenya	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY PROGRAMS; HIV-INFECTED PATIENTS; SUB-SAHARAN AFRICA; WESTERN KENYA; PATIENTS LOST; MISSING DATA; SCALING-UP; RETENTION; HEALTH; TRIALS	Background: Longitudinal studies of HIV-1-infected individuals or those at risk of infection are subject to missed study visits that may have negative consequences on the care of participants and can jeopardize study validity due to bias and loss of statistical power. Distance between participant residence and study clinic, as well as other socioeconomic and demographic factors, may contribute to interruptions in patient follow-up. Methods: HIV-1-serodiscordant couples were enrolled between May 2007 and October 2009 and followed for two years in Nairobi, Kenya. At baseline, demographic and home location information was collected and linear distance from each participant's home to the study clinic was determined. Participants were asked to return to the study clinic for quarterly visits, with follow-up interruptions (FUI) defined as missing two consecutive visits. Cox proportional hazards regression was used to assess crude and adjusted associations between FUI and home-to-clinic distance, and other baseline characteristics. Results: Of 469 enrolled couples, 64% had a female HIV-1-infected partner. Overall incidence of FUI was 13.4 per 100 person-years (PY), with lower incidence of FUI in HIV-1-infected (10.8 per 100 PY) versus - uninfected individuals (16.1 per 100 PY) (hazard ratio [HR] = 0.66; 95% confidence interval [CI]: 0.50, 0.88). Among HIV-1-infected participants, those living between 5 and 10 kilometers (km) from the study clinic had a two-fold increased rate of FUI compared to those living < 5 km away (HR = 2.17; 95% CI: 1.09, 4.34). Other factors associated with FUI included paying higher rent (HR = 1.67; 95% CI: 1.05, 2.65), having at least primary school education (HR = 1.96; 95% CI: 1.02, 3.70), and increased HIV-1 viral load (HR = 1.23 per log(10) increase; 95% CI: 1.01, 1.51). Conclusions: Home-to-clinic distance, indicators of socioeconomic status, and markers of disease progression may affect compliance with study follow-up schedules. Retention strategies should focus on participants at greatest risk of FUI to ensure study validity.	[Conley, N. Jeanne; Pavlinac, Patricia B.; Guthrie, Brandon L.; Mackelprang, Romel D.; Farquhar, Carey] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Choi, Robert Y.; Farquhar, Carey] Univ Washington, Dept Med, Seattle, WA USA; [Guthrie, Brandon L.; Mackelprang, Romel D.; Farquhar, Carey] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Muiru, Anthony N.] Harvard Univ, Sch Med, Boston, MA USA; [Bosire, Rose] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Gatuguta, Ann] Kenyatta Univ, Dept Publ Hlth, Nairobi, Kenya	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Kenya Medical Research Institute; Kenyatta University	Conley, NJ (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	brguth@u.washington.edu	Fazli, Ghazal/AAE-8320-2022		U.S. NIH NIAID [R01 684316]; University of Washington Center for AIDS Research (CFAR); NIH-funded program [P30 A1027757]; NIAID; NCI; NIMH; NIDA; NICHD; NHLBI; NIA; NIH [K24 AI087399]; International Research Scientist Development Award [K01TW008406]; National Institutes of Health [R24 TW007988]; Fogarty International Center through Vanderbilt University; NIH FIC [D43 TW000007]; FOGARTY INTERNATIONAL CENTER [D43TW000007, R24TW007988, K01TW008406] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007140, K24AI087399] Funding Source: NIH RePORTER	U.S. NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Washington Center for AIDS Research (CFAR); NIH-funded program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Research Scientist Development Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center through Vanderbilt University(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH FIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the U.S. NIH NIAID R01 684316 and the University of Washington Center for AIDS Research (CFAR), an NIH-funded program (P30 A1027757) which is supported by the following NIH Institutes and Centers: NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, and NIA. CF received support from NIH grant K24 AI087399 and RC was supported by the International Research Scientist Development Award, K01TW008406. RC, AG and AM were supported by grant number R24 TW007988 from the National Institutes of Health, Fogarty International Center through Vanderbilt University and PP was supported by NIH FIC D43 TW000007. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health or Fogarty International Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; Andersen JW, 2007, CONTEMP CLIN TRIALS, V28, P583, DOI 10.1016/j.cct.2007.02.002; Baron G, 2008, ARTHRIT RHEUM-ARTHR, V59, P25, DOI 10.1002/art.23253; Bigogo G, 2010, INT J INFECT DIS, V14, pE967, DOI 10.1016/j.ijid.2010.05.016; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Buor D, 2003, INT J HEALTH PLAN M, V18, P293, DOI 10.1002/hpm.729; Davis LL, 2002, J NURS SCHOLARSHIP, V34, P47, DOI 10.1111/j.1547-5069.2002.00047.x; de Bruyn G, 2005, JAIDS-J ACQ IMM DEF, V39, P499, DOI 10.1097/01.qai.0000148532.12329.df; DeVita DA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-19; Ekouevi DK, 2010, TROP MED INT HEALTH, V15, P34, DOI 10.1111/j.1365-3156.2010.02505.x; Ezechi OC, 2009, ARCH GYNECOL OBSTET, V280, P745, DOI 10.1007/s00404-009-0956-9; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Getz KA, 2008, AM J THER, V15, P450, DOI 10.1097/MJT.0b013e31816b9027; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Hogan JW, 2004, STAT MED, V23, P1455, DOI 10.1002/sim.1728; Ioannidis JPA, 1997, J ACQ IMMUN DEF SYND, V16, P22, DOI 10.1097/00042560-199709010-00004; Kempf MC, 2008, JAIDS-J ACQ IMM DEF, V47, P116, DOI 10.1097/QAI.0b013e31815d2f3f; Lowrance DW, 2009, JAIDS-J ACQ IMM DEF, V52, P49, DOI 10.1097/QAI.0b013e3181b03316; Marcellus L, 2004, CJNR, V36, P16; Maru DSR, 2008, AIDS BEHAV, V12, P284, DOI 10.1007/s10461-007-9336-2; Maskew M, 2007, SAMJ S AFR MED J, V97, P853; Miller CM, 2010, TROP MED INT HEALTH, V15, P48, DOI 10.1111/j.1365-3156.2010.02514.x; Moisi JC, 2011, B WORLD HEALTH ORGAN, V89, P102, DOI 10.2471/BLT.10.080796; Muller I, 1998, INT J EPIDEMIOL, V27, P878, DOI 10.1093/ije/27.5.878; Ochieng-Ooko V, 2010, B WORLD HEALTH ORGAN, V88, P681, DOI 10.2471/BLT.09.064329; Otieno PA, 2010, AIDS CARE, V22, P729, DOI 10.1080/09540120903373565; Painter TM, 2004, BMJ-BRIT MED J, V329, P543, DOI 10.1136/bmj.329.7465.543; RAHAMAN MM, 1982, AM J PUBLIC HEALTH, V72, P1124, DOI 10.2105/AJPH.72.10.1124; Republic of Kenya Ministry of Transport, 2009, INT NAT TRANSP POL M; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Roura M, 2009, SEX TRANSM INFECT, V85, P308, DOI 10.1136/sti.2008.033183; Roura M, 2009, AIDS PATIENT CARE ST, V23, P203, DOI 10.1089/apc.2008.0129; Snow WM, 2007, CONTEMP CLIN TRIALS, V28, P25, DOI 10.1016/j.cct.2006.08.010; Touloumi G, 2002, EPIDEMIOLOGY, V13, P347, DOI 10.1097/00001648-200205000-00017; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; Vestbo J, 2011, CLIN RESPIR J, V5, P44, DOI 10.1111/j.1752-699X.2010.00198.x; Wasike WSK, 2001, ROAD INFRASTRUCTURE; Wood Angela M, 2004, Clin Trials, V1, P368; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea; Zachariah R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000121	42	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43138	10.1371/journal.pone.0043138	http://dx.doi.org/10.1371/journal.pone.0043138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	992PA	22937017	Green Published, gold, Green Submitted			2022-12-25	WOS:000307789700024
J	Scherf, DB; Sarkisyan, N; Jacobsson, H; Claus, R; Bermejo, JL; Peil, B; Gu, L; Muley, T; Meister, M; Dienemann, H; Plass, C; Risch, A				Scherf, D. B.; Sarkisyan, N.; Jacobsson, H.; Claus, R.; Bermejo, J. L.; Peil, B.; Gu, L.; Muley, T.; Meister, M.; Dienemann, H.; Plass, C.; Risch, A.			Epigenetic screen identifies genotype-specific promoter DNA methylation and oncogenic potential of CHRNB4	ONCOGENE			English	Article						DNA methylation; risk factors; non-small cell lung cancer (NSCLC); CHRNB4; TERT	CANCER SUSCEPTIBILITY LOCUS; LUNG-CANCER; MASS-SPECTROMETRY; NICOTINE; GENES; SEQUENCE; BINDING; RISK; POLYMORPHISMS; TRANSCRIPTION	Genome-wide association studies have highlighted three major lung cancer susceptibility regions at 15q25.1, 5p15.33 and 6p21.33. To gain insight into the possible mechanistic relevance of the genes in these regions, we investigated the regulation of candidate susceptibility gene expression by epigenetic alterations in healthy and lung tumor tissues. For genes up or downregulated in lung tumors, the influence of genetic variants on DNA methylation was investigated and in vitro studies were performed. We analyzed 394 CpG units within 19 CpG islands in the susceptibility regions in a screening set of 34 patients. Significant findings were validated in an independent patient set (n = 50) with available DNA and RNA. The most consistent overall DNA methylation difference between tumor and adjacent normal tissue on 15q25 was tumor hypomethylation in the promoter region of CHRNB4 with a median difference of 8% (P<0.001), which resulted in overexpression of the transcript in tumors (P<0.001). Confirming previous studies, we also found hypermethylation in CHRNA3 and telomerase reverse transcriptase (TERT) with significant expression changes. Decitabine treatment of H1299 cells resulted in reduced methylation levels in gene promoters, elevated transcript levels of CHRNB4 and CHRNA3, and a slight downregulation of TERT demonstrating epigenetic regulation of lung cancer cells. Single-nucleotide polymorphisms rs421629 on 5p15.33 and rs1948, rs660652, rs8040868 and rs2036527 on 15q25.1, previously identified as lung cancer risk or nicotine-addiction modifiers, were associated with tumor DNA methylation levels in the promoters of TERT and CHRNB4 (P < 0.001), respectively, in two independent sample sets (n = 82; n = 150). In addition, CHRNB4 knockdown in two different cell lines (A549 and H1299) resulted in reduced proliferation (P-A549 < 0.05; P-H1299 < 0.001) and propensity to form colonies in H1299 cells. These results suggest epigenetic deregulation of nicotinic acetylcholine receptor subunit (nAChR) genes which in the case of CHRNB4 is strongly associated with genetic lung cancer susceptibility variants and a functional impact on tumorigenic potential.	[Scherf, D. B.; Sarkisyan, N.; Jacobsson, H.; Claus, R.; Gu, L.; Plass, C.; Risch, A.] German Canc Res Ctr, Div Epigen & Canc Risk Factors C010, D-69120 Heidelberg, Germany; [Bermejo, J. L.; Peil, B.] Univ Heidelberg Hosp, German Canc Res Ctr, Div Mol Genet Epidemiol, Inst Med Biometry & Informat, Heidelberg, Germany; [Muley, T.; Meister, M.] Heidelberg Univ, Thoraxklin Heidelberg gGmbH, Translat Res Unit, D-69115 Heidelberg, Germany; [Dienemann, H.] Heidelberg Univ, Thoraxklin Heidelberg gGmbH, Dept Thorac Surg, D-69115 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Risch, A (corresponding author), German Canc Res Ctr, Div Epigen & Canc Risk Factors C010, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	a.risch@dkfz.de	Plass, Christoph/H-7192-2014; Claus, Rainer/AAZ-5606-2020; Risch, Angela/H-2669-2013	Claus, Rainer/0000-0003-2617-8766; Risch, Angela/0000-0002-8026-5505	Genetic Associations and Mechanisms in Oncology (GAME-ON): a NCI Cancer Post-GWAS Initiative; National Institute of Health (USA) [CA148127]; Deutsche Krebshilfe [70-2387]; Deutsche Forschungsgemeinschaft (DFG) [SFB/TRR77]; NATIONAL CANCER INSTITUTE [U19CA148127] Funding Source: NIH RePORTER	Genetic Associations and Mechanisms in Oncology (GAME-ON): a NCI Cancer Post-GWAS Initiative; National Institute of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Frau Heinzmann-Groth, Birgit Jager and all other members of the clinical and laboratory teams for help with sample and/or data collection and archiving for the Heidelberg lung study. We are grateful to all patients at the Thoraxklinik Heidelberg, who participated in the study. We thank Ruprecht Kuner for the cell lines, Oliver Mucke for competent technical assistance, Chris Amos for helpful comments on the manuscript and the members of the Plass Laboratory for thoughtful discussions. The scientific development and funding of this project were in part supported by the Genetic Associations and Mechanisms in Oncology (GAME-ON): a NCI Cancer Post-GWAS Initiative. This work was in part supported by the National Institute of Health (USA; grant number CA148127) and earlier sample collection by the Deutsche Krebshilfe (grant number 70-2387). JLB was in part supported by a grant of the Deutsche Forschungsgemeinschaft (DFG, SFB/TRR77, project Z2).	Allemand E, 2008, CURR OPIN GENET DEV, V18, P145, DOI 10.1016/j.gde.2008.01.006; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Amos CI, 2010, J NATL CANCER I, V102, P1199, DOI 10.1093/jnci/djq232; Belinsky SA, 2006, CANCER RES, V66, P3338, DOI 10.1158/0008-5472.CAN-05-3408; Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; Brena RM, 2007, PLOS MED, V4, P572, DOI 10.1371/journal.pmed.0040108; Brena RM, 2007, HUM MOL GENET, V16, pR96, DOI 10.1093/hmg/ddm073; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Dai ZY, 2001, NEOPLASIA, V3, P314, DOI 10.1038/sj.neo.7900162; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Erlich PM, 2010, HUM GENET, V128, P491, DOI 10.1007/s00439-010-0876-6; Esteller M, 1997, CARCINOGENESIS, V18, P2307, DOI 10.1093/carcin/18.12.2307; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Gebhard C, 2010, CANCER RES, V70, P1398, DOI 10.1158/0008-5472.CAN-09-3406; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Herceg Zdenko, 2009, Eur J Cancer, V45 Suppl 1, P442, DOI 10.1016/S0959-8049(09)70082-6; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hitchins MP, 2011, CANCER CELL, V20, P200, DOI 10.1016/j.ccr.2011.07.003; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Improgo MR, MOL CANC RES, V8, P194; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Joseph J, 2002, CANCER RES, V62, P6467; Kawai H, 2001, J NEUROCHEM, V78, P1367, DOI 10.1046/j.1471-4159.2001.00526.x; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Liu Y, 2009, CANCER RES, V69, P7844, DOI 10.1158/0008-5472.CAN-09-1833; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; McCabe MT, 2009, CANCER RES, V69, P282, DOI 10.1158/0008-5472.CAN-08-3274; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Oeth P, 2009, METHODS MOL BIOL, V578, P307, DOI 10.1007/978-1-60327-411-1_20; Paliwal A, 2010, CANCER RES, V70, P2779, DOI 10.1158/0008-5472.CAN-09-4550; Park JC, 2008, BIOCHEM BIOPH RES CO, V365, P221, DOI 10.1016/j.bbrc.2007.10.144; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P1245, DOI 10.1093/nar/gkl1125; Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014; Schlaelpfer IR, 2008, BIOL PSYCHIAT, V63, P1039, DOI 10.1016/j.biopsych.2007.10.024; Schuller HM, 2009, NAT REV CANCER, V9, P195, DOI 10.1038/nrc2590; Schuller HM, 1999, CANCER RES, V59, P4510; Shames DS, 2006, PLOS MED, V3, P2244, DOI 10.1371/journal.pmed.0030486; Shiraishi K, 2009, CARCINOGENESIS, V30, P65, DOI 10.1093/carcin/bgn257; Shivapurkar N, 2008, CANCER EPIDEM BIOMAR, V17, P995, DOI 10.1158/1055-9965.EPI-07-2808; Stephens SH, 2012, BEHAV GENET, V42, P402, DOI 10.1007/s10519-011-9514-x; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Van den Berg RM, 2010, INT J ONCOL, V37, P455, DOI 10.3892/ijo_00000694; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Zhang YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r138	49	29	31	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 11	2013	32	28					3329	3338		10.1038/onc.2012.344	http://dx.doi.org/10.1038/onc.2012.344			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	180TM	22945651	Green Accepted			2022-12-25	WOS:000321620200003
J	Isaac, NJB; Redding, DW; Meredith, HM; Safi, K				Isaac, Nick J. B.; Redding, David W.; Meredith, Helen M.; Safi, Kamran			Phylogenetically-Informed Priorities for Amphibian Conservation	PLOS ONE			English	Article							EVOLUTIONARY HISTORY; POPULATION DECLINES; SPECIES CATEGORIES; EXTINCTION RISK; PHYLOGENY; DIVERSITY; BIODIVERSITY; MODELS; FROGS; DIVERSIFICATION	The amphibian decline and extinction crisis demands urgent action to prevent further large numbers of species extinctions. Lists of priority species for conservation, based on a combination of species' threat status and unique contribution to phylogenetic diversity, are one tool for the direction and catalyzation of conservation action. We describe the construction of a near-complete species-level phylogeny of 5713 amphibian species, which we use to create a list of evolutionarily distinct and globally endangered species (EDGE list) for the entire class Amphibia. We present sensitivity analyses to test the robustness of our priority list to uncertainty in species' phylogenetic position and threat status. We find that both sources of uncertainty have only minor impacts on our 'top 100' list of priority species, indicating the robustness of the approach. By contrast, our analyses suggest that a large number of Data Deficient species are likely to be high priorities for conservation action from the perspective of their contribution to the evolutionary history.	[Isaac, Nick J. B.] Nat Environm Res Council Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Redding, David W.] UCL, London, England; [Meredith, Helen M.] Durrell Inst Conservat & Ecol, London, England; [Meredith, Helen M.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Safi, Kamran] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Safi, Kamran] Univ Konstanz, Dept Biol, Constance, Germany	UK Centre for Ecology & Hydrology (UKCEH); University of London; University College London; Zoological Society of London; Max Planck Society; University of Konstanz	Isaac, NJB (corresponding author), Nat Environm Res Council Ctr Ecol & Hydrol, Maclean Bldg, Wallingford, Oxon, England.	ksafi@orn.mpg.de	Isaac, Nick/C-2716-2011; Safi, Kamran/B-2079-2008; Redding, David/M-1766-2019	Isaac, Nick/0000-0002-4869-8052; Safi, Kamran/0000-0002-8418-6759; Redding, David/0000-0001-8615-1798	Natural Environment Research Council [CEH010021] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Adams MJ, 1999, J WILDLIFE MANAGE, V63, P1162, DOI 10.2307/3802834; Agapow PM, 2002, SYST BIOL, V51, P866, DOI 10.1080/10635150290155845; Alford RA, 2011, NATURE, V480, P461, DOI 10.1038/480461a; [Anonymous], 2008, EDG EX PROGR; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bininda-Emonds ORP, 2008, NATURE, V456, P274, DOI 10.1038/nature07347; Bininda-Emonds ORP, 1999, BIOL REV, V74, P143, DOI 10.1017/S0006323199005307; Bininda-Emonds ORP, 2002, ANNU REV ECOL SYST, V33, P265, DOI 10.1146/annurev.ecolsys.33.010802.150511; Blaustein AR, 2002, ECOL LETT, V5, P597, DOI 10.1046/j.1461-0248.2002.00352.x; Carpenter SR, 2000, ECOSYSTEMS, V3, P1, DOI 10.1007/s100210000001; Collen B, 2011, PHILOS T R SOC B, V366, P2611, DOI 10.1098/rstb.2011.0109; Collen B, 2011, PHILOS T R SOC B, V366, P2577, DOI 10.1098/rstb.2011.0015; Cooper N, 2008, GLOBAL ECOL BIOGEOGR, V17, P211, DOI 10.1111/j.1466-8238.2007.00355.x; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Diniz JAF, 2004, CONSERV BIOL, V18, P698; Emerson SB, 2000, MOL PHYLOGENET EVOL, V16, P131, DOI 10.1006/mpev.2000.0778; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Faith DP, 1996, CONSERV BIOL, V10, P1286, DOI 10.1046/j.1523-1739.1996.10041286.x; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Frost DR, 2007, AMPHIBIAN SPECIES WO; Gower DJ, 2005, CONSERV BIOL, V19, P45, DOI 10.1111/j.1523-1739.2005.00589.x; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Kuhn TS, 2011, METHODS ECOL EVOL, V2, P427, DOI 10.1111/j.2041-210X.2011.00103.x; MACE GM, 1991, CONSERV BIOL, V5, P148, DOI 10.1111/j.1523-1739.1991.tb00119.x; McCallum ML, 2007, J HERPETOL, V41, P483, DOI 10.1670/0022-1511(2007)41[483:ADOECD]2.0.CO;2; Mendelson II J, 2007, AMPHIBIAN CONSERVATI, P32; Mendelson JR, 2006, SCIENCE, V313, P48, DOI 10.1126/science.1128396; Mooers AO, 2003, ANIM CONSERV, V6, P183, DOI 10.1017/S1367943003003226; Mooers AO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003700; Myers N, 2001, P NATL ACAD SCI USA, V98, P5389, DOI 10.1073/pnas.091092498; Nee S, 2001, EVOLUTION, V55, P661, DOI 10.1554/0014-3820(2001)055[0661:ISRFP]2.0.CO;2; Orme C.D.L., 2011, CAPER COMP ANAL PHYL; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; POUNDS JA, 1994, CONSERV BIOL, V8, P72, DOI 10.1046/j.1523-1739.1994.08010072.x; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Safi K, 2010, GLOBAL ECOL BIOGEOGR, V19, P352, DOI 10.1111/j.1466-8238.2010.00523.x; Sechrest W, 2002, P NATL ACAD SCI USA, V99, P2067, DOI 10.1073/pnas.251680798; Sitas N, 2009, ANIM CONSERV, V12, P231, DOI 10.1111/j.1469-1795.2009.00244.x; Sodhi NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001636; Stuart BL, 2006, BIOL LETTERS, V2, P470, DOI 10.1098/rsbl.2006.0505; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Stuart SN, 2004, SCIENCE, V10, P1; Team R. D. C, 2011, R LANG ENV STAT COMP; Van Bocxlaer I, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000074; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Wake DB, 2012, SCIENCE, V335, P1052, DOI 10.1126/science.1218364; WITTING L, 1995, BIOL CONSERV, V71, P205, DOI 10.1016/0006-3207(94)00041-N; Zhang P, 2006, P NATL ACAD SCI USA, V103, P7360, DOI 10.1073/pnas.0602325103	57	101	106	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43912	10.1371/journal.pone.0043912	http://dx.doi.org/10.1371/journal.pone.0043912			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952807	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000308206500028
J	Nakayama, S; Johnstone, RA; Manica, A				Nakayama, Shinnosuke; Johnstone, Rufus A.; Manica, Andrea			Temperament and Hunger Interact to Determine the Emergence of Leaders in Pairs of Foraging Fish	PLOS ONE			English	Article							DECISION-MAKING; PERSONALITY-DIFFERENCES; INDIVIDUAL-DIFFERENCES; SOCIAL FACILITATION; BARNACLE GEESE; ZEBRA FINCHES; EVOLUTION; MOVEMENTS; BOLDNESS; DOMINANCE	Studies on leadership have focused either on physiological state as the key predictor (i.e. "leading according to need"), or else on temperamental asymmetries among group members (i.e. intrinsic leadership). In this paper, we explore how both factors interact in determining the emergence of leaders. We observed pairs of sticklebacks with varying degrees of temperamental difference, and recorded their movements back and forth between a safe covered area and a risky foraging area, both before and after satiating one of the two pair members (but not the other). Before satiation, when the fish had similar hunger levels, temperament was a good predictor of social roles, with the bolder member of a pair leading and the shyer member following. The effect of satiation depended on which fish received the additional food. When the shyer member of a pair was fed, and consequently became less active, the bolder fish did not change its behaviour but continued to lead. By contrast, when the bolder member of a pair was fed, and consequently initiated fewer trips out of cover, the shyer partner compensated by initiating trips more frequently itself. In pairs that differed only a little in temperament, feeding the bolder fish actually led to a role reversal, with the shyer fish emerging as a leader in the majority of joint trips out of cover. Our results show that leadership emerges as the consequence of multiple factors, and that their interaction can be complex.	[Nakayama, Shinnosuke; Johnstone, Rufus A.; Manica, Andrea] Univ Cambridge, Dept Zool, Cambridge, England	University of Cambridge	Nakayama, S (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	shinn407@gmail.com	Manica, Andrea/B-5497-2008; Manica, Andrea/N-9013-2019	Manica, Andrea/0000-0003-1895-450X; Manica, Andrea/0000-0003-1895-450X	Association for the Study of Animal Behaviour; Japan Society of the Promotion of Science	Association for the Study of Animal Behaviour; Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was funded by a grant from the Association for the Study of Animal Behaviour to AM and a fellowship from the Japan Society of the Promotion of Science to SN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Barelli C, 2008, BEHAVIOUR, V145, P965, DOI 10.1163/156853908784089243; Beauchamp G, 2000, BEHAVIOUR, V137, P301, DOI 10.1163/156853900502097; Borg B, 2004, BEHAVIOUR, V141, P1521, DOI 10.1163/1568539042948213; Conradt L, 2007, P ROY SOC B-BIOL SCI, V274, P2317, DOI 10.1098/rspb.2007.0186; Conradt L, 2009, AM NAT, V173, P304, DOI 10.1086/596532; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; Conradt L, 2009, PHILOS T R SOC B, V364, P807, DOI 10.1098/rstb.2008.0257; Dahlbom SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023565; Erhart EM, 1999, INT J PRIMATOL, V20, P927, DOI 10.1023/A:1020830703012; Fischhoff IR, 2007, ANIM BEHAV, V73, P825, DOI 10.1016/j.anbehav.2006.10.012; Flack A, 2012, ANIM BEHAV, V83, P703, DOI 10.1016/j.anbehav.2011.12.018; FOSSEY D, 1972, ANIM BEHAV, V20, P36, DOI 10.1016/S0003-3472(72)80171-4; Freeman R, 2011, BIOL LETTERS, V7, P63, DOI 10.1098/rsbl.2010.0627; Glickman SE, 1997, ANN NY ACAD SCI, V807, P175, DOI 10.1111/j.1749-6632.1997.tb51919.x; Harcourt JL, 2010, ETHOLOGY, V116, P440, DOI 10.1111/j.1439-0310.2010.01757.x; Harcourt JL, 2010, CURR BIOL, V20, P156, DOI 10.1016/j.cub.2009.11.045; Harcourt JL, 2009, ANIM BEHAV, V77, P1501, DOI 10.1016/j.anbehav.2009.03.004; Harcourt JL, 2009, CURR BIOL, V19, P248, DOI 10.1016/j.cub.2008.12.051; JAMES WT, 1953, J COMP PHYSIOL PSYCH, V46, P427, DOI 10.1037/h0056028; Johnstone RA, 2011, P NATL ACAD SCI USA, V108, P8373, DOI 10.1073/pnas.1102191108; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; KRAUSE J, 1992, BEHAV ECOL SOCIOBIOL, V30, P177, DOI 10.1007/BF00166700; Krause J, 2002, LIVING GROUPS; Kurvers RHJM, 2011, P ROY SOC B-BIOL SCI, V278, P2018, DOI 10.1098/rspb.2010.2266; Kurvers RHJM, 2010, P ROY SOC B-BIOL SCI, V277, P601, DOI 10.1098/rspb.2009.1474; Kurvers RHJM, 2009, ANIM BEHAV, V78, P447, DOI 10.1016/j.anbehav.2009.06.002; Laland KN, 2004, LEARN BEHAV, V32, P4; Leblond C, 2006, BEHAVIOUR, V143, P1263, DOI 10.1163/156853906778691603; McClure M, 2011, BEHAV ECOL SOCIOBIOL, V65, P1573, DOI 10.1007/s00265-011-1167-5; McNamara JM, 2009, P ROY SOC B-BIOL SCI, V276, P605, DOI 10.1098/rspb.2008.1182; Michelena P, 2010, P ROY SOC B-BIOL SCI, V277, P1093, DOI 10.1098/rspb.2009.1926; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Nakayama S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036606; Peterson RO, 2002, CAN J ZOOL, V80, P1405, DOI 10.1139/Z02-124; Pike TW, 2008, P ROY SOC B-BIOL SCI, V275, P2515, DOI 10.1098/rspb.2008.0744; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Scheid C, 2010, ANIM COGN, V13, P545, DOI 10.1007/s10071-009-0305-1; Schuett W, 2009, ANIM BEHAV, V77, P1041, DOI 10.1016/j.anbehav.2008.12.024; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sueur C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000917; Webster MM, 2011, BIOL REV, V86, P759, DOI 10.1111/j.1469-185X.2010.00169.x; Wolf M, 2008, P NATL ACAD SCI USA, V105, P15825, DOI 10.1073/pnas.0805473105; Wolf M, 2011, P ROY SOC B-BIOL SCI, V278, P440, DOI 10.1098/rspb.2010.1051	44	34	35	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43747	10.1371/journal.pone.0043747	http://dx.doi.org/10.1371/journal.pone.0043747			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952753	Green Published, Green Submitted, gold			2022-12-25	WOS:000308206000049
J	Behanzin, L; Diabate, S; Minani, I; Lowndes, CM; Boily, MC; Labbe, AC; Anagonou, S; Zannou, DM; Buve, A; Alary, M				Behanzin, Luc; Diabate, Souleymane; Minani, Isaac; Lowndes, Catherine M.; Boily, Marie-Claude; Labbe, Annie-Claude; Anagonou, Severin; Zannou, Djimon Marcel; Buve, Anne; Alary, Michel			Decline in HIV Prevalence among Young Men in the General Population of Cotonou, Benin, 1998-2008	PLOS ONE			English	Article							REDUCING HETEROSEXUAL TRANSMISSION; SIMPLEX-VIRUS TYPE-2; FEMALE SEX WORKERS; INFECTION; INTERVENTIONS; EPIDEMIC; CONDOMS; SEROPREVALENCE; PERFORMANCE; ANTIBODIES	Objective: To assess changes in the prevalence of HIV and other sexually transmitted infections, as well as in different proximal and distal factors related to HIV infection, in the general population of Cotonou between 1998 and 2008, while an intensive preventive intervention targeting the sex work milieu was ongoing. Methods: A two-stage cluster sampling procedure was used to select the participants in each study. Subjects aged 15-49 who agreed to participate were interviewed and tested for HIV, syphilis, HSV-2, gonorrhoea and chlamydia. We used the Roa-Scott Chi-square test (proportions) and the Student's t test (means) for bivariate comparisons, and adjusted logistic regression models taking into account the cluster effect for multivariate analyses. Results: HIV prevalence decreased significantly in men (3.4% in 1998 versus 2.0% in 2008, p = 0.048), especially in those aged 15-29 (3.0% to 0.5%, p = 0.002). Among men, the prevalence of gonorrhoea decreased significantly (1.1% to 0.3%, p = 0.046) while HSV-2 prevalence increased from 12.0% to 18.1% (p = 0.0003). The proportion of men who reported condom use at least once (29.3% to 61.0%, p<0.0001) and of those having attained a secondary educational level or more (17.1% to 61.3%, p<0.0001) also increased significantly. There was an overall decrease in the prevalence of syphilis (1.5% to 0.6%, p = 0.0003). Conclusion: This is the first population-based study reporting a significant decline in HIV prevalence among young men in an African setting where overall prevalence has never reached 5%. The decline occurred while preventive interventions targeting the sex work milieu were ongoing and the educational level was increasing.	[Behanzin, Luc; Diabate, Souleymane; Lowndes, Catherine M.; Boily, Marie-Claude; Alary, Michel] Univ Quebec, Ctr Rech FRSQ CHA, URESP, Quebec City, PQ, Canada; [Behanzin, Luc; Diabate, Souleymane; Alary, Michel] Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada; [Minani, Isaac] Dispensaire IST, Cotonou, Benin; [Lowndes, Catherine M.] Hlth Protect Agcy, London, England; [Boily, Marie-Claude] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Labbe, Annie-Claude] Hop Maison Neuve Rosemont, Dept Microbiol, Montreal, PQ, Canada; [Anagonou, Severin; Zannou, Djimon Marcel] Univ Abomey Calavi, Fac Sci Sante, Cotonou, Benin; [Anagonou, Severin; Zannou, Djimon Marcel] Ctr Natl Hosp Univ, Cotonou, Benin; [Buve, Anne] Inst Trop Med, Unit Epidemiol & Control HIV STD, B-2000 Antwerp, Belgium; [Alary, Michel] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada	Laval University; University of Quebec; Laval University; Health Protection Agency; Imperial College London; Universite de Montreal; University of Abomey Calavi; Institute of Tropical Medicine (ITM); Institut national de sante publique du Quebec (INSPQ)	Behanzin, L (corresponding author), Univ Quebec, Ctr Rech FRSQ CHA, URESP, Quebec City, PQ, Canada.	malary@uresp.ulaval.ca		Boily, Marie-Claude/0000-0003-3919-006X	Canadian Institutes of Health Research [HCB-82159]; UNAIDS; Canadian International Development Agency	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); UNAIDS; Canadian International Development Agency	Funding provided by Canadian Institutes of Health Research (grant no. HCB-82159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Canadian Institutes of Health Research (grant no. HCB-82159) for funding the 2008 survey, UNAIDS for funding the 1998 survey, the Canadian International Development Agency for funding the intervention in the sex work milieu, the Programme national de lutte contre le Sida et les IST and the Ministry of Health of Benin for their involvement at all levels. We also thank the participants as well as the personnel of Projet Sida 1/2/3 and of Dispensaire IST (Benin), the Institute of Tropical Medicine (Antwerp, Belgium) and the Centre hospitalier affilie universitaire de Quebec (Canada) for their contribution.	Alary M, 2002, AIDS, V16, P463, DOI 10.1097/00002030-200202150-00019; [Anonymous], PROGR REP 2011 GLOB; [Anonymous], 2006, RAPP DEUX ENQ SURV 2; Banandur P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S13; BENOIT SN, 1990, J ACQ IMMUN DEF SYND, V3, P1193; Biraro S, 2011, SEX TRANSM DIS, V38, P140, DOI 10.1097/OLQ.0b013e3181f0bafb; Boily MC, 2002, SEX TRANSM INFECT, V78, pI78, DOI 10.1136/sti.78.suppl_1.i78; Buve A, 2002, LANCET, V359, P2011, DOI 10.1016/S0140-6736(02)08823-2; Buve A, 2001, AIDS, V15, pS127, DOI 10.1097/00002030-200108004-00014; Buve A, 2001, AIDS, V15, pS117, DOI 10.1097/00002030-200108004-00013; Carael M, 2006, SEX TRANSM INFECT, V82, pIII26, DOI 10.1136/sti.2006.021196; Cayley WE, 2004, AM FAM PHYSICIAN, V70, P1268; [Cellule de Planification et de Statistique du Ministere de la Sante (CPS/MS) Direction Nationale de la Statistique et de l'Informatique Ministere du plan et de. l'amenagement du territoire (DNSI/MPAT) ORC Macro International Inc], 2006, ENQ DEM SANT EDSM 4; [Cellule de Planification et de Statistique du Ministere de la Sante (CPS/MS) Direction Nationale de la Statistique et de l'Informatique Ministere du plan et de. l'amenagement du territoire (DNSI/MPAT) ORC Macro International Inc], 2002, ENQ DEM SANT EDSM 3; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Davis KR, 1999, FAM PLANN PERSPECT, V31, P272, DOI 10.2307/2991537; Gaydos CA, 2010, J CLIN MICROBIOL, V48, P3236, DOI 10.1128/JCM.01019-10; Ghys PD, 2001, AIDS, V15, P1421, DOI 10.1097/00002030-200107270-00012; Ghys PD, 2010, SEX TRANSM INFECT, V86, pI1, DOI [10.1136/sti.2010.047852, 10.1136/sti.2010.044933]; Glynn JR, 2001, AIDS, V15, P1717, DOI 10.1097/00002030-200109070-00016; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Hankins CA, 2010, AIDS, V24, pS70, DOI 10.1097/01.aids.0000390709.04255.fd; Hargreaves JR, 2008, AIDS, V22, P403, DOI 10.1097/QAD.0b013e3282f2aac3; Institut National de la Statistique et de l'Analyse Economique (INSAE) du Benin, 2008, PROJ DEP POP 2002 20; Institut National de la Statistique et de l'Analyse Economique (INSAE) du Benin/Macro International Inc, 2007, ENQ DEM SANT EDSB 3; [Institut national de la statistique (INS) Ministere de la lutte contre le SIDA (MLS) ORC Macro], 2005, ENQ IND SIDA COT IV; [Institut national de la Statistique (INS) du Niger Macro International Inc], 2007, ENQ DEM SANT IND MUL; Joint United Nations Programme on HIV/AIDS, 1998, LOOK DEEP HIV EP QUE; Lagarde E, 2001, AIDS, V15, P1399, DOI 10.1097/00002030-200107270-00009; Lowndes CM, 2007, SEX TRANSM INFECT, V83, P577, DOI 10.1136/sti.2007.027441; Lowndes CM, 2002, SEX TRANSM INFECT, V78, pI69, DOI 10.1136/sti.78.suppl_1.i69; Lowndes CM, 2008, CHARACTERISATION HIV; Martin ET, 2009, ARCH INTERN MED, V169, P1233, DOI 10.1001/archinternmed.2009.177; [Ministere de la Sante Publique et de la lutte contre les Endemies du Niger CARESM Centre de la la Recherche Medicale et sanitaires du Niger], 2002, ENQ NAT SER INF VIH; MULDER D, 1995, BRIT MED J, V311, P833, DOI 10.1136/bmj.311.7009.833; Oelemann WMR, 2002, J CLIN MICROBIOL, V40, P881, DOI 10.1128/JCM.40.3.881-885.2002; Rehle TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011094; RENTON AM, 1994, SOC SCI MED, V38, P1153, DOI 10.1016/0277-9536(94)90230-5; Strick LB, 2006, CLIN INFECT DIS, V43, P347, DOI 10.1086/505496; Temmerman M, 1999, INT J STD AIDS, V10, P405, DOI 10.1258/0956462991914339; UNAIDS, 2010, REP GLOB AIDS EP; Van Dyck E, 2004, J CLIN MICROBIOL, V42, P2961, DOI 10.1128/JCM.42.7.2961-2965.2004; Ward H, 2010, CURR OPIN HIV AIDS, V5, P305, DOI 10.1097/COH.0b013e32833a8844; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; [World Health Organization (WHO) UNAIDS UNICEF], 2010, UN ACC SCAL PRIOR HI; [World Health Organization (WHO) USAID DELIVER], 2003, CAP HIV 1 HIV 2 RAPI; World Health Organization (WHO) UNAIDS/WHO, 1997, WKLY EPIDEMIOL REC, V12, P81; Zaba B, 2000, AIDS, V14, P1633, DOI 10.1097/00002030-200007280-00020	48	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43818	10.1371/journal.pone.0043818	http://dx.doi.org/10.1371/journal.pone.0043818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952773	gold, Green Published, Green Submitted			2022-12-25	WOS:000308213600047
J	Dumon, S; Walton, DS; Volpe, G; Wilson, N; Dasse, E; Del Pozzo, W; Landry, JR; Turner, B; O'Neill, LP; Gottgens, B; Frampton, J				Dumon, Stephanie; Walton, David S.; Volpe, Giacomo; Wilson, Nicola; Dasse, Emilie; Del Pozzo, Walter; Landry, Josette-Renee; Turner, Bryan; O'Neill, Laura P.; Goettgens, Berthold; Frampton, Jon			Itga2b Regulation at the Onset of Definitive Hematopoiesis and Commitment to Differentiation	PLOS ONE			English	Article							GENE-EXPRESSION; HISTONE ACETYLATION; CHROMATIN-STRUCTURE; DEMETHYLASE JMJD3; MPL RECEPTOR; STEM-CELLS; THROMBOPOIETIN; PROGENITORS; INHIBITION; TISSUE	Product of the Itga2b gene, CD41 contributes to hematopoietic stem cell (HSC) and megakaryocyte/platelet functions. CD41 expression marks the onset of definitive hematopoiesis in the embryo where it participates in regulating the numbers of multipotential progenitors. Key to platelet aggregation, CD41 expression also characterises their precursor, the megakaryocyte, and is specifically up regulated during megakaryopoiesis. Though phenotypically unique, megakaryocytes and HSC share numerous features, including key transcription factors, which could indicate common sub-regulatory networks. In these respects, Itga2b can serve as a paradigm to study features of both developmental-stage and HSC-versus megakaryocyte-specific regulations. By comparing different cellular contexts, we highlight a mechanism by which internal promoters participate in Itga2b regulation. A developmental process connects epigenetic regulation and promoter switching leading to CD41 expression in HSC. Interestingly, a similar process can be observed at the Mpl locus, which codes for another receptor that defines both HSC and megakaryocyte identities. Our study shows that Itga2b expression is controlled by lineage-specific networks and associates with H4K8ac in megakaryocyte or H3K27me3 in the multipotential hematopoietic cell line HPC7. Correlating with the decrease in H3K27me3 at the Itga2b Iocus, we find that following commitment to megakaryocyte differentiation, the H3K27 demethylase Jmjd3 up-regulation influences both Itga2b and Mpl expression.	[Dumon, Stephanie; Walton, David S.; Volpe, Giacomo; Dasse, Emilie; Turner, Bryan; O'Neill, Laura P.; Frampton, Jon] Univ Birmingham, Inst Biomed Res, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Wilson, Nicola; Goettgens, Berthold] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge, England; [Landry, Josette-Renee] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Del Pozzo, Walter] Nikhef, Amsterdam, Netherlands	University of Birmingham; University of Cambridge; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; FOM National Institute for Subatomic Physics	Dumon, S (corresponding author), Univ Birmingham, Inst Biomed Res, Coll Med & Dent Sci, Birmingham, W Midlands, England.	s.dumon@bham.ac.uk	Volpe, Giacomo/AAQ-5235-2021; Volpe, Giacomo/AAT-2783-2020; Volpe, Giacomo/GSI-6601-2022	Volpe, Giacomo/0000-0001-5000-6951; Del Pozzo, Walter/0000-0003-3978-2030; Gottgens, Berthold/0000-0001-6302-5705	Leukemia and Lymphoma Research [06062, 09022]; Wellcome Trust [08433/Z/07/Z]; Biotechnology and Biological Sciences Research Council [BB/I00050X/1] Funding Source: researchfish; Cancer Research UK [12765] Funding Source: researchfish; Medical Research Council [G0800784, G9818340B, G0900951, G0800784B] Funding Source: researchfish; National Centre for the Replacement [G0900729/1] Funding Source: researchfish; BBSRC [BB/I00050X/1] Funding Source: UKRI; MRC [G0800784, G0900951] Funding Source: UKRI	Leukemia and Lymphoma Research; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Leukemia and Lymphoma Research (grant number 06062 and 09022) http://leukaemialymphomaresearch.org.uk/ and the Wellcome Trust (grant number 08433/Z/07/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano Y, 2009, MOL CELL BIOL, V29, P1882, DOI 10.1128/MCB.01320-08; Baek D, 2007, GENOME RES, V17, P145, DOI 10.1101/gr.5872707; Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Burgold T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003034; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; do O PP, 2002, BLOOD, V99, P3939, DOI 10.1182/blood.V99.11.3939; Dumon S, 2006, EXP HEMATOL, V34, P654, DOI 10.1016/j.exphem.2006.01.014; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Emambokus NR, 2003, IMMUNITY, V19, P33, DOI 10.1016/S1074-7613(03)00173-0; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Fleury M, 2010, INT J DEV BIOL, V54, P1067, DOI 10.1387/ijdb.103104mf; Follows GA, 2006, GENOME RES, V16, P1310, DOI 10.1101/gr.5373606; Frith MC, 2001, BIOINFORMATICS, V17, P878, DOI 10.1093/bioinformatics/17.10.878; Garcia P, 1996, ONCOGENE, V13, P695; Hayakawa F, 2004, J LEUKOCYTE BIOL, V75, P529, DOI 10.1189/jlb.0603289; Hong W, 2002, MOL CELL BIOL, V22, P3729, DOI 10.1128/MCB.22.11.3729-3743.2002; Huang H, 2009, J CELL BIOCHEM, V107, P857, DOI 10.1002/jcb.22184; Jackers P, 2004, J BIOL CHEM, V279, P52183, DOI 10.1074/jbc.M407489200; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Letting DL, 2003, MOL CELL BIOL, V23, P1334, DOI 10.1128/MCB.23.4.1334-1340.2003; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Lorvellec M, 2010, STEM CELLS, V28, P1751, DOI 10.1002/stem.496; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Ninos JM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-9; Perlingeiro RCR, 2003, STEM CELLS, V21, P272, DOI 10.1634/stemcells.21-3-272; Petit-Cocault L, 2007, DEVELOPMENT, V134, P3031, DOI 10.1242/dev.001818; Pinto do O P, 1998, EMBO J, V17, P5744, DOI 10.1093/emboj/17.19.5744; Pozner A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213x-7-84; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Tober J, 2007, BLOOD, V109, P1433, DOI 10.1182/blood-2006-06-031898; Verdone Loredana, 2006, Briefings in Functional Genomics & Proteomics, V5, P209, DOI 10.1093/bfgp/ell028; Vincent A, 2009, DIFFERENTIATION, V78, P99, DOI 10.1016/j.diff.2009.07.002; White DA, 1999, METHODS, V19, P417, DOI 10.1006/meth.1999.0878; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316	44	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43300	10.1371/journal.pone.0043300	http://dx.doi.org/10.1371/journal.pone.0043300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952660	Green Submitted, Green Published, gold			2022-12-25	WOS:000308213600020
J	Leikoski, N; Fewer, DP; Jokela, J; Alakoski, P; Wahlsten, M; Sivonen, K				Leikoski, Niina; Fewer, David P.; Jokela, Jouni; Alakoski, Pirita; Wahlsten, Matti; Sivonen, Kaarina			Analysis of an Inactive Cyanobactin Biosynthetic Gene Cluster Leads to Discovery of New Natural Products from Strains of the Genus Microcystis	PLOS ONE			English	Article							FRESH-WATER CYANOBACTERIUM; LISSOCLINUM-PATELLA; CYCLIC-PEPTIDES; AERUGINOSA PCC-7806; MARINE TUNICATE; BLOOM; ULITHIACYCLAMIDE; UNDECAPEPTIDE; PRENYLATION; ANABAENA	Cyanobactins are cyclic peptides assembled through the cleavage and modification of short precursor proteins. An inactive cyanobactin gene cluster has been described from the genome Microcystis aeruginosa NIES843. Here we report the discovery of active counterparts in strains of the genus Microcystis guided by this silent cyanobactin gene cluster. The end products of the gene clusters were structurally diverse cyclic peptides, which we named piricyclamides. Some of the piricyclamides consisted solely of proteinogenic amino acids while others contained disulfide bridges and some were prenylated or geranylated. The piricyclamide gene clusters encoded between 1 and 4 precursor genes. They encoded highly diverse core peptides ranging in length from 7-17 amino acids with just a single conserved amino acid. Heterologous expression of the pir gene cluster from Microcystis aeruginosa PCC7005 in Escherichia coli confirmed that this gene cluster is responsible for the biosynthesis of piricyclamides. Chemical analysis demonstrated that Microcystis strains could produce an array of piricyclamides some of which are geranylated or prenylated. The genetic diversity of piricyclamides in a bloom sample was explored and 19 different piricyclamide precursor genes were found. This study provides evidence for a stunning array of piricyclamides in Microcystis, a worldwide occurring bloom forming cyanobacteria.	[Leikoski, Niina; Fewer, David P.; Jokela, Jouni; Alakoski, Pirita; Wahlsten, Matti; Sivonen, Kaarina] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland	University of Helsinki	Leikoski, N (corresponding author), Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland.	kaarina.sivonen@helsinki.fi	Fewer, David P/A-8704-2008	Fewer, David P/0000-0003-3978-4845; Sivonen, Kaarina/0000-0002-2904-0458; Jokela, Jouni/0000-0001-5096-3575; Wahlsten, Matti/0000-0002-4107-1695	Academy of Finland (Research Center of Excellence) [118637]	Academy of Finland (Research Center of Excellence)(Academy of FinlandFinnish Funding Agency for Technology & Innovation (TEKES))	This work was supported by the grant from the Academy of Finland to KS (Research Center of Excellence 118637). NL is a student at Viikki Doctoral Programme in Molecular Biosciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann HI, 2007, J NAT PROD, V70, P1611, DOI 10.1021/np0700873; Burja AM, 2001, TETRAHEDRON, V57, P9347, DOI 10.1016/S0040-4020(01)00931-0; Cascales L, 2010, ORG BIOMOL CHEM, V8, P5035, DOI 10.1039/c0ob00139b; Donia MS, 2008, NAT CHEM BIOL, V4, P341, DOI 10.1038/nchembio.84; Donia MS, 2006, NAT CHEM BIOL, V2, P729, DOI 10.1038/nchembio829; Donia MS, 2011, CHEM BIOL, V18, P508, DOI 10.1016/j.chembiol.2011.01.019; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fewer DP, 2011, ENV MICROBIOL REP, V3, P189, DOI 10.1111/j.1758-2229.2010.00207.x; Frangeul L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-274; Fu X, 1998, J NAT PROD, V61, P1547, DOI 10.1021/np9802872; Gelb MH, 1997, SCIENCE, V275, P1750, DOI 10.1126/science.275.5307.1750; IRELAND C, 1980, J AM CHEM SOC, V102, P5688, DOI 10.1021/ja00537a053; IRELAND CM, 1982, J ORG CHEM, V47, P1807, DOI 10.1021/jo00349a002; Ishida K, 1996, TETRAHEDRON, V52, P9025, DOI 10.1016/0040-4020(96)00452-8; Ishida K, 1997, J NAT PROD, V60, P724, DOI 10.1021/np970146k; Kaneko T, 2007, DNA RES, V14, P247, DOI 10.1093/dnares/dsm026; Kotai J, 1972, 1169 NORW I WAT RES; Lagerwerf FM, 1996, RAPID COMMUN MASS SP, V10, P1905, DOI 10.1002/(SICI)1097-0231(199612)10:15<1905::AID-RCM755>3.0.CO;2-9; Lee SW, 2008, P NATL ACAD SCI USA, V105, P5879, DOI 10.1073/pnas.0801338105; Leet JE, 2008, J NAT PROD, V71, P460, DOI 10.1021/np070523l; Leikoski N, 2010, APPL ENVIRON MICROB, V76, P701, DOI 10.1128/AEM.01061-09; Leikoski N, 2009, APPL ENVIRON MICROB, V75, P853, DOI 10.1128/AEM.02134-08; Lin S, 2011, GENE, V473, P139, DOI 10.1016/j.gene.2010.11.011; McIntosh JA, 2011, J AM CHEM SOC, V133, P13698, DOI 10.1021/ja205458h; McIntosh JA, 2010, J AM CHEM SOC, V132, P15499, DOI 10.1021/ja1067806; McIntosh JA, 2010, CHEMBIOCHEM, V11, P1413, DOI 10.1002/cbic.201000196; Neitz S, 2001, RAPID COMMUN MASS SP, V15, P1586, DOI 10.1002/rcm.413; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Portmann C, 2008, J NAT PROD, V71, P1891, DOI 10.1021/np800409z; Portmann C, 2008, J NAT PROD, V71, P1193, DOI 10.1021/np800118g; Raveh A, 2010, TETRAHEDRON, V66, P2705, DOI 10.1016/j.tet.2010.02.008; Schmidt EW, 2009, METHOD ENZYMOL, V458, P575, DOI 10.1016/S0076-6879(09)04823-X; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; Sivonen K, 2010, APPL MICROBIOL BIOT, V86, P1213, DOI 10.1007/s00253-010-2482-x; Sudek S, 2006, APPL ENVIRON MICROB, V72, P4382, DOI 10.1128/AEM.00380-06; Van Wagoner RM, 2007, ADV APPL MICROBIOL, V61, P89, DOI 10.1016/S0065-2164(06)61004-6; WILLIAMS DE, 1989, J NAT PROD, V52, P732, DOI 10.1021/np50064a011; Zafrir-Ilan E, 2010, TETRAHEDRON LETT, V51, P6602, DOI 10.1016/j.tetlet.2010.10.051; Ziemert N, 2008, APPL ENVIRON MICROB, V74, P1791, DOI 10.1128/AEM.02392-07	40	35	35	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43002	10.1371/journal.pone.0043002	http://dx.doi.org/10.1371/journal.pone.0043002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952627	Green Submitted, Green Published, gold			2022-12-25	WOS:000308044800017
J	Kumar, N; Cai, HY; von Mering, C; Baudis, M				Kumar, Nitin; Cai, Haoyang; von Mering, Christian; Baudis, Michael			Specific Genomic Regions Are Differentially Affected by Copy Number Alterations across Distinct Cancer Types, in Aggregated Cytogenetic Data	PLOS ONE			English	Article							HIGH-RESOLUTION ANALYSIS; ACUTE MYELOID-LEUKEMIA; GERM-CELL TUMORS; CGH DATA; MYELODYSPLASTIC SYNDROME; CHROMOSOMAL-ABERRATIONS; HYBRIDIZATION; LYMPHOMA; DNA; IMBALANCES	Background: Regional genomic copy number alterations (CNA) are observed in the vast majority of cancers. Besides specifically targeting well-known, canonical oncogenes, CNAs may also play more subtle roles in terms of modulating genetic potential and broad gene expression patterns of developing tumors. Any significant differences in the overall CNA patterns between different cancer types may thus point towards specific biological mechanisms acting in those cancers. In addition, differences among CNA profiles may prove valuable for cancer classifications beyond existing annotation systems. Principal Findings: We have analyzed molecular-cytogenetic data from 25579 tumors samples, which were classified into 160 cancer types according to the International Classification of Disease (ICD) coding system. When correcting for differences in the overall CNA frequencies between cancer types, related cancers were often found to cluster together according to similarities in their CNA profiles. Based on a randomization approach, distance measures from the cluster dendrograms were used to identify those specific genomic regions that contributed significantly to this signal. This approach identified 43 non-neutral genomic regions whose propensity for the occurrence of copy number alterations varied with the type of cancer at hand. Only a subset of these identified loci overlapped with previously implied, highly recurrent (hot-spot) cytogenetic imbalance regions. Conclusions: Thus, for many genomic regions, a simple null-hypothesis of independence between cancer type and relative copy number alteration frequency can be rejected. Since a subset of these regions display relatively low overall CNA frequencies, they may point towards second-tier genomic targets that are adaptively relevant but not necessarily essential for cancer development.	[Kumar, Nitin; Cai, Haoyang; von Mering, Christian; Baudis, Michael] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Kumar, Nitin; Cai, Haoyang; von Mering, Christian; Baudis, Michael] Swiss Inst Bioinformat, Lausanne, Switzerland	University of Zurich; Swiss Institute of Bioinformatics	Kumar, N (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	mering@imls.uzh.ch; mbaudis@imls.uzh.ch	von Mering, Christian/B-3300-2008; Baudis, Michael/J-4602-2012	von Mering, Christian/0000-0001-7734-9102; Baudis, Michael/0000-0002-9903-4248				Aktas D, 2006, CANCER GENET CYTOGEN, V171, P72, DOI 10.1016/j.cancergencyto.2006.06.010; Appelbaum FR, 2006, BLOOD, V107, P3481, DOI 10.1182/blood-2005-09-3724; Baudis M, 2001, BIOINFORMATICS, V17, P1228, DOI 10.1093/bioinformatics/17.12.1228; Baudis M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-226; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Cai HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036944; Cheung KJJ, 2010, GENE CHROMOSOME CANC, V49, P669, DOI 10.1002/gcc.20780; Cordoba I, 2012, CANCER-AM CANCER SOC, V118, P127, DOI 10.1002/cncr.26279; Ferreira BI, 2008, HAEMATOLOGICA, V93, P670, DOI 10.3324/haematol.12221; JOOS S, 1993, HUM GENET, V90, P584, DOI 10.1007/BF00202475; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kuhn MWM, 2012, BLOOD; Kumar N, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-21; Liu J, 2007, BIOINFORMATICS, V23, P450, DOI 10.1093/bioinformatics/btl624; Liu J, 2009, BIOINFORMATICS, V25, P2208, DOI 10.1093/bioinformatics/btp365; McIntyre A, 2007, BRIT J CANCER, V97, P1707, DOI 10.1038/sj.bjc.6604079; Myllykangas S, 2006, ONCOGENE, V25, P7324, DOI 10.1038/sj.onc.1209717; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Schwaenen C, 2009, GENE CHROMOSOME CANC, V48, P39, DOI 10.1002/gcc.20617; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Sun Ya-jing, 2010, Chinese Journal of Pathology, V39, P606, DOI 10.3760/cma.j.issn.0529-5807.2010.09.007; Takeuchi I, 2009, HAEMATOL-HEMATOL J, V94, P61, DOI 10.3324/haematol.12986; Tan P.-N., 2019, INTRO DATA MINING, V2nd ed.; Van Wieringen WN, 2008, BIOSTATISTICS, V9, P484, DOI 10.1093/biostatistics/kxm048; Veltman I, 2005, GENE CHROMOSOME CANC, V43, P367, DOI 10.1002/gcc.20208; Wong JCY, 2010, BLOOD, V115, P4524, DOI 10.1182/blood-2009-07-232504; Woo KS, 2009, CANCER GENET CYTOGEN, V194, P71, DOI 10.1016/j.cancergencyto.2009.04.017	28	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43689	10.1371/journal.pone.0043689	http://dx.doi.org/10.1371/journal.pone.0043689			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937079	Green Published, Green Accepted, gold			2022-12-25	WOS:000308225500081
J	Wang, QJ; Yang, LD; Alexander, C; Temple, S				Wang, Qingjie; Yang, Landi; Alexander, Caroline; Temple, Sally			The Niche Factor Syndecan-1 Regulates the Maintenance and Proliferation of Neural Progenitor Cells during Mammalian Cortical Development	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; NEURONS ARISE; BETA-CATENIN; N-SYNDECAN; EXPRESSION; LOCALIZATION; NEUROGENESIS; BINDING; STEM; MATURATION	Neural progenitor cells (NPCs) divide and differentiate in a precisely regulated manner over time to achieve the remarkable expansion and assembly of the layered mammalian cerebral cortex. Both intrinsic signaling pathways and environmental factors control the behavior of NPCs during cortical development. Heparan sulphate proteoglycans (HSPG) are critical environmental regulators that help modulate and integrate environmental cues and downstream intracellular signals. Syndecan-1 (Sdc1), a major transmembrane HSPG, is highly enriched in the early neural germinal zone, but its function in modulating NPC behavior and cortical development has not been explored. In this study we investigate the expression pattern and function of Sdc1 in the developing mouse cerebral cortex. We found that Sdc1 is highly expressed by cortical NPCs. Knockdown of Sdc1 in vivo by in utero electroporation reduces NPC proliferation and causes their premature differentiation, corroborated in isolated cells in vitro. We found that Sdc1 knockdown leads to reduced levels of beta-catenin, indicating reduced canonical Wnt signaling. Consistent with this, GSK3 beta inhibition helps rescue the Sdc1 knockdown phenotype, partially restoring NPC number and proliferation. Moreover, exogenous Wnt protein promotes cortical NPC proliferation, but this is prevented by Sdc1 knockdown. Thus, Sdc1 in the germinal niche is a key HSPG regulating the maintenance and proliferation of NPCs during cortical neurogenesis, in part by modulating the ability of NPCs to respond to Wnt ligands.	[Wang, Qingjie; Yang, Landi; Temple, Sally] Neural Stem Cell Inst, Rensselaer, NY USA; [Wang, Qingjie] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; [Alexander, Caroline] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA	Albany Medical College; University of Wisconsin System; University of Wisconsin Madison	Wang, QJ (corresponding author), Neural Stem Cell Inst, Rensselaer, NY USA.	sallytemple@nynsci.org			National Institutes of Health (NIH) [NS033529]; New York State Department of Health (NYSDOH) from the Empire State Stem Cell Fund [C024352]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033529, R37NS033529] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Department of Health (NYSDOH) from the Empire State Stem Cell Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The project was supported by Grant Number NS033529 from the National Institutes of Health (NIH) and by the New York State Department of Health (NYSDOH) Contract C024352 from the Empire State Stem Cell Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Buchman JJ, 2007, NAT REV NEUROSCI, V8, P89, DOI 10.1038/nrn2058; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Carey DJ, 1997, BIOCHEM J, V327, P1; Chen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004947; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Derksen PWB, 2002, BLOOD, V99, P1405, DOI 10.1182/blood.V99.4.1405; Ethell IM, 1999, J CELL BIOL, V144, P575, DOI 10.1083/jcb.144.3.575; Ford-Perriss M, 2003, DEV DYNAM, V227, P170, DOI 10.1002/dvdy.10298; Fuerer C, 2010, DEV DYNAM, V239, P184, DOI 10.1002/dvdy.22067; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Grove EA, 1998, DEVELOPMENT, V125, P2315; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hienola A, 2006, J CELL BIOL, V174, P569, DOI 10.1083/jcb.200602043; Hsueh YP, 1999, J NEUROSCI, V19, P7415, DOI 10.1523/JNEUROSCI.19-17-07415.1999; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105; Khotskaya YB, 2009, J BIOL CHEM, V284, P26085, DOI 10.1074/jbc.M109.018473; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Avalos AM, 2009, J CELL SCI, V122, P3462, DOI 10.1242/jcs.034827; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; McDermott SP, 2007, ONCOGENE, V26, P1407, DOI 10.1038/sj.onc.1209930; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Najm J, 2008, NAT GENET, V40, P1065, DOI 10.1038/ng.194; Nakanishi T, 1997, J BIOCHEM-TOKYO, V121, P197; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Olivares GH, 2009, DEV BIOL, V329, P338, DOI 10.1016/j.ydbio.2009.03.007; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Phoenix TN, 2010, GENE DEV, V24, P45, DOI 10.1101/gad.1839510; Pu P, 2009, CANCER GENE THER, V16, P351, DOI 10.1038/cgt.2008.78; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Skorupa A, 2012, J NEUROSCI, V32, P5024, DOI 10.1523/JNEUROSCI.6366-11.2012; Srinivasan K, 2008, DEVELOPMENT, V135, P1781, DOI 10.1242/dev.013847; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Toba Y, 2002, EUR J NEUROSCI, V15, P1461, DOI 10.1046/j.1460-9568.2002.01983.x; Vaccarino FM, 1999, NAT NEUROSCI, V2, P485, DOI 10.1038/8163; Watanabe A, 2006, J NEURO-ONCOL, V77, P25, DOI 10.1007/s11060-005-9010-3; Woodhead GJ, 2006, J NEUROSCI, V26, P12620, DOI 10.1523/JNEUROSCI.3180-06.2006; Zong F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007346	50	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42883	10.1371/journal.pone.0042883	http://dx.doi.org/10.1371/journal.pone.0042883			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936997	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500018
J	Wojtal, KA; Rogler, G; Scharl, M; Biedermann, L; Frei, P; Fried, M; Weber, A; Eloranta, JJ; Kullak-Ublick, GA; Vavricka, SR				Wojtal, Kacper A.; Rogler, Gerhard; Scharl, Michael; Biedermann, Luc; Frei, Pascal; Fried, Michael; Weber, Achim; Eloranta, Jyrki J.; Kullak-Ublick, Gerd A.; Vavricka, Stephan R.			Fc Gamma Receptor CD64 Modulates the Inhibitory Activity of Infliximab	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NECROSIS-FACTOR-ALPHA; TRANSMEMBRANE TNF-ALPHA; CELL-LINE THP-1; CROHNS-DISEASE; HUMAN CYTOMEGALOVIRUS; CROSS-LINKING; IN-VITRO; RHEUMATOID-ARTHRITIS; CERTOLIZUMAB PEGOL	Background: Tumor necrosis factor (TNF) is an important cytokine in the pathogenesis of inflammatory bowel disease (IBD). Anti-TNF antibodies have been successfully implemented in IBD therapy, however their efficacies differ among IBD patients. Here we investigate the influence of CD64 Fc receptor on the inhibitory activity of anti-TNFs in cells of intestinal wall. Methods: Intestinal cell lines, monocytes/macrophages and peripheral blood mononuclear cells (PBMCs) were used as models. The efficacies of adalimumab, infliximab and certolizumab-pegol were assessed by RT-PCR for target genes. Protein levels and localizations were examined by Western blotting and immunofluorescence. Antibody fragments were obtained by proteolytic digestion, immunoprecipitation and protein chip analysis. Knock-down of specific gene expression was performed using siRNAs. Results: Infliximab had limited efficacy towards soluble TNF in cell types expressing Fc gamma receptor CD64. Both adalimumab and infliximab had lower efficacies in PBMCs of IBD patients, which express elevated levels of CD64. Infliximab-TNF complexes were more potent in activating CD64 in THP-1 cells than adalimumab, which was accompanied by distinct phospho-tyrosine signals. Blocking Fc parts and isolation of Fab fragments of infliximab improved its efficacy. IFN-gamma-induced expression of CD64 correlated with a loss of efficacy of infliximab, whereas reduction of CD64 expression by either siRNA or PMA treatment improved inhibitory activity of this drug. Colonic mRNA expression levels of CD64 and other Fc gamma receptors were significantly increased in the inflamed tissues of infliximab non-responders. Conclusions: CD64 modulates the efficacy of infliximab both in vitro and ex vivo, whereas the presence of this receptor has no impact on the inhibitory activity of certolizumab-pegol, which lacks Fc fragment. These data could be helpful in both predicting and evaluating the outcome of anti-TNF therapy in IBD patients with elevated systemic and local levels of Fc receptors.	[Wojtal, Kacper A.; Rogler, Gerhard; Scharl, Michael; Biedermann, Luc; Frei, Pascal; Fried, Michael; Vavricka, Stephan R.] Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Rogler, Gerhard; Vavricka, Stephan R.] SwissIBD Cohort Study, Zurich, Switzerland; [Weber, Achim] Univ Zurich Hosp, Inst Surg Pathol, Dept Pathol, CH-8091 Zurich, Switzerland; [Eloranta, Jyrki J.; Kullak-Ublick, Gerd A.] Univ Zurich Hosp, Dept Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland; [Vavricka, Stephan R.] Hosp Triemli, Div Gastroenterol & Hepatol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Triemli Hospital	Wojtal, KA (corresponding author), Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland.	kacper.wojtal@usz.ch	Rogler, Gerhard/O-5308-2015; Biedermann, Luc/J-2654-2017	Rogler, Gerhard/0000-0002-1733-9188; Weber, Achim/0000-0003-0073-3637; Scharl, Michael/0000-0002-6729-1469	Swiss National Science Foundation (SNF) [320000-114009/3, 32473B_135694/1, 310030-120312, 320030_120463]; Swiss IBD Cohort [3347CO-108792]; Essex Chemie, Switzerland; European Crohn's and Colitis Organisation (ECCO); Swiss Philanthropy Foundation; Zurich Center for Integrative Human Physiology (ZIHP) of the University of Zurich; Essex; Abbot; UCB Pharma; Essex Chemie	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Swiss IBD Cohort; Essex Chemie, Switzerland; European Crohn's and Colitis Organisation (ECCO); Swiss Philanthropy Foundation; Zurich Center for Integrative Human Physiology (ZIHP) of the University of Zurich; Essex; Abbot; UCB Pharma(UCB Pharma SA); Essex Chemie	This research was supported by research grants from the Swiss National Science Foundation (SNF) to SRV (Grant No. 320000-114009/3 and 32473B_135694/1), to GR (Grant No. 310030-120312), and to GAKU and JJE (Grant No. 320030_120463), by the Swiss IBD Cohort (Grant No. 3347CO-108792), an educational grant from Essex Chemie, Switzerland, to MS, a research grant from the European Crohn's and Colitis Organisation (ECCO) to MS, a grant from the Swiss Philanthropy Foundation to MS and GR, by the Zurich Center for Integrative Human Physiology (ZIHP) of the University of Zurich, and by unrestricted research grants from Essex, Abbot, and UCB Pharma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests: this study was partly funded by Essex Chemie, Abbot, and UCB Pharma. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Alonso A, 2000, INT IMMUNOL, V12, P547, DOI 10.1093/intimm/12.4.547; An Z, 2009, GLYCOSYLATION THERAP, P73; Arora T, 2009, CYTOKINE, V45, P124, DOI 10.1016/j.cyto.2008.11.008; AUWERX J, 1992, LEUKEMIA RES, V16, P317, DOI 10.1016/0145-2126(92)90070-N; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; BOLTZNITULESCU G, 1995, J LEUKOCYTE BIOL, V58, P256, DOI 10.1002/jlb.58.2.256; Brenmoehl J, 2009, WORLD J GASTROENTERO, V15, P1431, DOI 10.3748/wjg.15.1431; Canete JD, 2009, ANN RHEUM DIS, V68, P1547, DOI 10.1136/ard.2008.096982; Chang JT, 2006, NAT CLIN PRACT GASTR, V3, P220, DOI 10.1038/ncpgasthep0447; Chen X, 2008, AM J PATHOL, V173, P1647, DOI 10.2353/ajpath.2008.080487; Davis PM, 2007, J RHEUMATOL, V34, P2204; Ericson SG, 1998, BLOOD, V91, P2099, DOI 10.1182/blood.V91.6.2099.2099_2099_2107; FLEIT HB, 1991, J LEUKOCYTE BIOL, V49, P556, DOI 10.1002/jlb.49.6.556; Fries Walter, 2008, Int J Med Sci, V5, P169; Grip O, 2007, INFLAMM BOWEL DIS, V13, P566, DOI 10.1002/ibd.20025; Habbal W, 2009, J MED MICROBIOL, V58, P878, DOI 10.1099/jmm.0.010587-0; Hanai H, 2008, AM J GASTROENTEROL, V103, P1210, DOI 10.1111/j.1572-0241.2007.01714.x; Hommes DW, 1996, GUT, V38, P564, DOI 10.1136/gut.38.4.564; Horiuchi T, 2010, RHEUMATOLOGY, V49, P1215, DOI 10.1093/rheumatology/keq031; Jiang XR, 2011, NAT REV DRUG DISCOV, V10, P101, DOI 10.1038/nrd3365; Kaymakcalan Z, 2009, CLIN IMMUNOL, V131, P308, DOI 10.1016/j.clim.2009.01.002; KELLER R, 1976, J IMMUNOL, V116, P772; Kobayashi R, 2007, CLIN IMMUNOL, V125, P149, DOI 10.1016/j.clim.2007.07.008; Koch S, 2010, CLIN EXP IMMUNOL, V161, P332, DOI 10.1111/j.1365-2249.2010.04177.x; KRUTMANN J, 1990, J IMMUNOL, V145, P1337; Kuwabara A, 2007, J GASTROENTEROL, V42, P823, DOI 10.1007/s00535-007-2103-3; Lawlor G, 2010, INFLAMM BOWEL DIS, V16, P1620, DOI 10.1002/ibd.21275; Leveque N, 2010, J MED VIROL, V82, P1694, DOI 10.1002/jmv.21877; Lloyd S, 2010, RHEUMATOLOGY, V49, P2313, DOI 10.1093/rheumatology/keq169; Louis E, 2004, ALIMENT PHARM THER, V19, P511, DOI 10.1111/j.1365-2036.2004.01871.x; Lugering A, 2001, GASTROENTEROLOGY, V121, P1145, DOI 10.1053/gast.2001.28702; LUND J, 1995, FASEB J, V9, P115, DOI 10.1096/fasebj.9.1.7821750; MARSH CB, 1995, J IMMUNOL, V155, P3161; Miller DM, 1998, J EXP MED, V187, P675, DOI 10.1084/jem.187.5.675; Mitoma H, 2005, GASTROENTEROLOGY, V128, P376, DOI 10.1053/j.gastro.2004.11.060; Mitoma H, 2008, ARTHRITIS RHEUM-US, V58, P1248, DOI 10.1002/art.23447; MURAYAMA T, 1986, J GEN VIROL, V67, P1475, DOI 10.1099/0022-1317-67-7-1475; Nesbitt A, 2007, INFLAMM BOWEL DIS, V13, P1323, DOI 10.1002/ibd.20225; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Okuyama A, 2011, ANN RHEUM DIS, V70, P299, DOI 10.1136/ard.2010.136283; PAN L, 1990, J IMMUNOL, V145, P267; RAHMAN AA, 1976, J IMMUNOL, V117, P253; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Roblin X, 2011, AM J GASTROENTEROL, V106, P2001, DOI 10.1038/ajg.2011.202; Rogler G, 1997, EUR J GASTROEN HEPAT, V9, P893, DOI 10.1097/00042737-199709000-00013; Rogler G, 1998, WORLD J SURG, V22, P382, DOI 10.1007/s002689900401; Ryan MH, 2008, MOL IMMUNOL, V45, P1837, DOI 10.1016/j.molimm.2007.10.043; Sandborn WJ, 2011, CLIN GASTROENTEROL H, V9, P670, DOI 10.1016/j.cgh.2011.04.031; Shen C, 2005, ALIMENT PHARM THER, V21, P251, DOI 10.1111/j.1365-2036.2005.02309.x; Siberil S, 2006, IMMUNOL LETT, V106, P111, DOI 10.1016/j.imlet.2006.05.009; Steel AW, 2011, ALIMENT PHARM THER, V33, P115, DOI 10.1111/j.1365-2036.2010.04499.x; Tanaka M, 2009, J IMMUNOL, V183, P2349, DOI 10.4049/jimmunol.0801683; Tillinger W, 2009, AM J GASTROENTEROL, V104, P102, DOI 10.1038/ajg.2008.6; Tomita K, 2010, HEPATO-GASTROENTEROL, V57, P535; van Vugt MJ, 1999, BLOOD, V94, P808, DOI 10.1182/blood.V94.2.808.414k31_808_817; Vos ACW, 2012, INFLAMM BOWEL DIS, V18, P401, DOI 10.1002/ibd.21818; Vos ACW, 2011, GASTROENTEROLOGY, V140, P221, DOI 10.1053/j.gastro.2010.10.008; Waetzig GH, 2002, J IMMUNOL, V168, P5342, DOI 10.4049/jimmunol.168.10.5342	58	38	39	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43361	10.1371/journal.pone.0043361	http://dx.doi.org/10.1371/journal.pone.0043361			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937039	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000308225500043
J	Kang, HE; Weng, CC; Saijo, E; Saylor, V; Bian, JF; Kim, S; Ramos, L; Angers, R; Langenfeld, K; Khaychuk, V; Calvi, C; Bartz, J; Hunter, N; Telling, GC				Kang, Hae-Eun; Weng, Chu Chun; Saijo, Eri; Saylor, Vicki; Bian, Jifeng; Kim, Sehun; Ramos, Laylaa; Angers, Rachel; Langenfeld, Katie; Khaychuk, Vadim; Calvi, Carla; Bartz, Jason; Hunter, Nora; Telling, Glenn C.			Characterization of Conformation-dependent Prion Protein Epitopes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CHRONIC WASTING DISEASE; MONOCLONAL-ANTIBODIES; NEUTRALIZING ANTIBODY; TRUNCATED FORMS; SHEEP SCRAPIE; PRP; BINDING; BRAIN; MICE	Whereas prion replication involves structural rearrangement of cellular prion protein (PrPC), the existence of conformational epitopes remains speculative and controversial, and PrP transformation is monitored by immunoblot detection of PrP(2730), a protease-resistant counterpart of the pathogenic scrapie form (PrPSc) of PrP. We now describe the involvement of specific amino acids in conformational determinants of novel monoclonal antibodies (mAbs) raised against randomly chimeric PrP. Epitope recognition of two mAbs depended on polymorphisms controlling disease susceptibility. Detection by one, referred to as PRC5, required alanine and asparagine at discontinuous mouse PrP residues 132 and 158, which acquire proximity when residues 126-218 form a structured globular domain. The discontinuous epitope of glycosylation-dependent mAb PRC7 also mapped within this domain at residues 154 and 185. In accordance with their conformational dependence, tertiary structure perturbations compromised recognition by PRC5, PRC7, as well as previously characterized mAbs whose epitopes also reside in the globular domain, whereas conformation-independent epitopes proximal or distal to this region were refractory to such destabilizing treatments. Our studies also address the paradox of how conformational epitopes remain functional following denaturing treatments and indicate that cellular PrP and PrP(27-30) both renature to a common structure that reconstitutes the globular domain.	[Kang, Hae-Eun; Saijo, Eri; Bian, Jifeng; Kim, Sehun; Ramos, Laylaa; Khaychuk, Vadim; Calvi, Carla; Telling, Glenn C.] Colorado State Univ, Prion Res Ctr, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Weng, Chu Chun; Saijo, Eri; Saylor, Vicki; Angers, Rachel; Telling, Glenn C.] Univ Kentucky, Integrated Biomed Sci Program, Dept Microbiol Immunol & Mol Genet, Dept Neurol,Med Ctr, Lexington, KY 40536 USA; [Weng, Chu Chun; Saijo, Eri; Saylor, Vicki; Angers, Rachel; Telling, Glenn C.] Univ Kentucky, Med Ctr, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Langenfeld, Katie; Bartz, Jason] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA; [Hunter, Nora] Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland	Colorado State University; University of Kentucky; University of Kentucky; Creighton University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Telling, GC (corresponding author), Colorado State Univ, Prion Res Ctr, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	glenn.telling@colostate.edu	Bian, Jifeng/AAE-6262-2019; Telling, Glenn C/G-1217-2019	Bian, Jifeng/0000-0001-6838-9938; Telling, Glenn C/0000-0002-6294-1805; Bartz, Jason/0000-0003-4081-7886	National Institutes of Health [RO1 NS040334, PO1 AI077774-015261, T32 DA022738]; BBSRC [BBS/E/D/05241340, BBS/E/D/20251967, BBS/E/D/20251968] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/05241340, BBS/E/D/20251967, BBS/E/D/20251968] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI077774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA022738] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 NS040334 and PO1 AI077774-015261 (to G. C. T.) and T32 DA022738 (to V. K., R. A., and G. C. T.).	Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; Antonyuk SV, 2009, P NATL ACAD SCI USA, V106, P2554, DOI 10.1073/pnas.0809170106; Apt D, 2006, VACCINE, V24, P335, DOI 10.1016/j.vaccine.2005.07.100; BARRY RA, 1986, J INFECT DIS, V153, P848, DOI 10.1093/infdis/153.5.848; BENDHEIM PE, 1984, NATURE, V310, P418, DOI 10.1038/310418a0; Bian JF, 2010, J VIROL, V84, P8322, DOI 10.1128/JVI.00633-10; Biasini E, 2008, J NEUROCHEM, V105, P2190, DOI 10.1111/j.1471-4159.2008.05306.x; Bilheude JM, 2007, J VIROL METHODS, V145, P169, DOI 10.1016/j.jviromet.2007.05.026; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Cordes H, 2008, J IMMUNOL METHODS, V337, P106, DOI 10.1016/j.jim.2008.07.004; Courageot MP, 2008, J GEN VIROL, V89, P341, DOI 10.1099/vir.0.83344-0; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; Du SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020927; Dupuy LC, 2009, VACCINE, V27, P4152, DOI 10.1016/j.vaccine.2009.04.049; Goldmann W, 2008, VET RES, V39, DOI 10.1051/vetres:2008010; Harmeyer S, 1998, J GEN VIROL, V79, P937, DOI 10.1099/0022-1317-79-4-937; Johnson C, 2003, J WILDLIFE DIS, V39, P576, DOI 10.7589/0090-3558-39.3.576; Jones M, 2009, HYBRIDOMA, V28, P13, DOI 10.1089/hyb.2008.0067; Kanyo ZF, 1999, J MOL BIOL, V293, P855, DOI 10.1006/jmbi.1999.3193; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Khalili-Shirazi A, 2005, J GEN VIROL, V86, P2635, DOI 10.1099/vir.0.80375-0; Khalili-Shirazi A, 2005, J IMMUNOL, V174, P3256, DOI 10.4049/jimmunol.174.6.3256; Khalill-Shirazi A, 2007, BBA-PROTEINS PROTEOM, V1774, P1438, DOI 10.1016/j.bbapap.2007.08.028; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Kurt TD, 2009, VIROLOGY, V387, P235, DOI 10.1016/j.virol.2009.02.025; LAVER WG, 1990, CELL, V61, P553, DOI 10.1016/0092-8674(90)90464-P; Li RL, 2000, J MOL BIOL, V301, P567, DOI 10.1006/jmbi.2000.3986; Morel N, 2004, J BIOL CHEM, V279, P30143, DOI 10.1074/jbc.M403896200; Moudjou M, 2004, J VIROL, V78, P9270, DOI 10.1128/JVI.78.17.9270-9276.2004; Nazor KE, 2005, EMBO J, V24, P2472, DOI 10.1038/sj.emboj.7600717; Petsch B, 2011, J VIROL, V85, P4538, DOI 10.1128/JVI.02467-10; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; PRIOLA SA, 1994, J VIROL, V68, P4873, DOI 10.1128/JVI.68.8.4873-4878.1994; Priola SA, 2001, J VIROL, V75, P4673, DOI 10.1128/JVI.75.10.4673-4680.2001; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; Raviprakash K, 2006, VIROLOGY, V353, P166, DOI 10.1016/j.virol.2006.05.005; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Safar JG, 2002, NAT BIOTECHNOL, V20, P1147, DOI 10.1038/nbt748; Sasamori E, 2010, ARCH BIOCHEM BIOPHYS, V501, P232, DOI 10.1016/j.abb.2010.06.025; SCOTT MR, 1992, PROTEIN SCI, V1, P986, DOI 10.1002/pro.5560010804; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Stack MJ, 2002, ACTA NEUROPATHOL, V104, P279, DOI 10.1007/s00401-002-0556-2; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Stanker LH, 2010, J IMMUNOL, V185, P729, DOI 10.4049/jimmunol.0902930; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; Thuring CMA, 2004, J CLIN MICROBIOL, V42, P972, DOI 10.1128/JCM.42.3.972-980.2004; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vorberg I, 1999, VIROLOGY, V255, P26, DOI 10.1006/viro.1998.9561; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Yadavalli R, 2004, J BIOL CHEM, V279, P21948, DOI 10.1074/jbc.M400793200; Yuan J, 2005, BIOCHEM BIOPH RES CO, V326, P652, DOI 10.1016/j.bbrc.2004.11.088; Zanusso G, 2004, J BIOL CHEM, V279, P38936, DOI 10.1074/jbc.M405468200; Zhou YH, 2007, IMMUNOL CELL BIOL, V85, P73, DOI 10.1038/sj.icb.7100004; Zou WQ, 2010, J BIOL CHEM, V285, P13874, DOI 10.1074/jbc.M109.088831	58	25	26	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37219	37232		10.1074/jbc.M112.395921	http://dx.doi.org/10.1074/jbc.M112.395921			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22948149	hybrid, Green Published			2022-12-25	WOS:000310588500055
J	Cande, J; Andolfatto, P; Prud'homme, B; Stern, DL; Gompel, N				Cande, Jessica; Andolfatto, Peter; Prud'homme, Benjamin; Stern, David L.; Gompel, Nicolas			Evolution of Multiple Additive Loci Caused Divergence between Drosophila yakuba and D-santomea in Wing Rowing during Male Courtship	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; MELANOGASTER SPECIES SUBGROUP; SEXUAL ISOLATION; MORPHOLOGICAL EVOLUTION; REPRODUCTIVE ISOLATION; GENUS DROSOPHILA; GENETIC-BASIS; BEHAVIOR; SONG; QTL	In Drosophila, male flies perform innate, stereotyped courtship behavior. This innate behavior evolves rapidly between fly species, and is likely to have contributed to reproductive isolation and species divergence. We currently understand little about the neurobiological and genetic mechanisms that contributed to the evolution of courtship behavior. Here we describe a novel behavioral difference between the two closely related species D. yakuba and D. santomea: the frequency of wing rowing during courtship. During courtship, D. santomea males repeatedly rotate their wing blades to face forward and then back (rowing), while D. yakuba males rarely row their wings. We found little intraspecific variation in the frequency of wing rowing for both species. We exploited multiplexed shotgun genotyping (MSG) to genotype two backcross populations with a single lane of Illumina sequencing. We performed quantitative trait locus (QTL) mapping using the ancestry information estimated by MSG and found that the species difference in wing rowing mapped to four or five genetically separable regions. We found no evidence that these loci display epistasis. The identified loci all act in the same direction and can account for most of the species difference.	[Cande, Jessica; Prud'homme, Benjamin; Gompel, Nicolas] Aix Marseille Univ, Inst Biol Dev Marseille Luminy, Marseille, France; [Andolfatto, Peter; Stern, David L.] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; [Andolfatto, Peter] Princeton Univ, Lewis Sigler Inst Integrat Biol, Princeton, NJ 08544 USA; [Stern, David L.] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA	UDICE-French Research Universities; Aix-Marseille Universite; Princeton University; Princeton University; Howard Hughes Medical Institute; Princeton University	Cande, J (corresponding author), Aix Marseille Univ, Inst Biol Dev Marseille Luminy, Marseille, France.	benjamin.prudhomme@univ-amu.fr; sternd@janelia.hhmi.org; nicolas.gompel@univ-amu.fr		Andolfatto, Peter/0000-0003-3393-4574; Stern, David/0000-0002-1847-6483; Gompel, Nicolas/0000-0003-3358-7963	Human Frontiers Long Term Fellowship [LT000708/2010-L]; EURYI award; Human Frontier Science Program Career and Development Award; ANR grant; Centre National de la Recherche Scientifique	Human Frontiers Long Term Fellowship; EURYI award(European Science Foundation (ESF)); Human Frontier Science Program Career and Development Award; ANR grant(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by a Human Frontiers Long Term Fellowship (LT000708/2010-L), a EURYI award, a Human Frontier Science Program Career and Development Award, an ANR grant, and the Centre National de la Recherche Scientifique. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Ashburner M., 1989, DROSOPHILA LAB HDB; Bachtrog D, 2006, EVOLUTION, V60, P292, DOI 10.1111/j.0014-3820.2006.tb01107.x; Beavis W.D., 1994, P 49 ANN CORN SORGH, P250; Blyth JE, 2008, ETHOLOGY, V114, P728, DOI 10.1111/j.1439-0310.2008.01519.x; Bock IR, 1972, U TEXAS PUBLS, V7, P1; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Carbone MA, 2005, GENETICS, V171, P211, DOI 10.1534/genetics.105.044412; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; COBB M, 1989, J INSECT BEHAV, V2, P63, DOI 10.1007/BF01053619; COBB M, 1985, BEHAVIOUR, V95, P203, DOI 10.1163/156853985X00136; COWLING DE, 1981, ANIM BEHAV, V29, P924, DOI 10.1016/S0003-3472(81)80030-9; Edwards AC, 2009, GENETICS, V182, P889, DOI 10.1534/genetics.109.101691; Ellison CK, 2011, J EVOLUTION BIOL, V24, P1110, DOI 10.1111/j.1420-9101.2011.02244.x; Feder JL, 2003, GENETICS, V163, P939; Gleason JM, 2009, HEREDITY, V103, P416, DOI 10.1038/hdy.2009.79; Gleason JM, 2002, HEREDITY, V89, P1, DOI 10.1038/sj.hdy.6800099; Gleason JM, 2004, GENETICS, V166, P1303, DOI 10.1534/genetics.166.3.1303; Gould F, 2010, P NATL ACAD SCI USA, V107, P8660, DOI 10.1073/pnas.0910945107; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Holtzman S, 2010, FLY, V4, P349, DOI 10.4161/fly.4.4.13304; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Kitano J, 2009, NATURE, V461, P1079, DOI 10.1038/nature08441; Kronforst MR, 2006, P NATL ACAD SCI USA, V103, P6575, DOI 10.1073/pnas.0509685103; Lachaise D, 2000, P ROY SOC B-BIOL SCI, V267, P1487, DOI 10.1098/rspb.2000.1169; Lagisz M, 2012, HEREDITY, V108, P602, DOI 10.1038/hdy.2011.129; Lasbleiz C, 2006, ANIM BEHAV, V72, P1001, DOI 10.1016/j.anbehav.2006.01.027; LEMEUNIER F, 1976, PROC R SOC SER B-BIO, V193, P275, DOI 10.1098/rspb.1976.0046; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Llopart A, 2002, EVOLUTION, V56, P2262; Lynch M., 1998, GENETICS ANAL QUANTI; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Martins E. P., 1996, PHYLOGENIES COMP MET; Mas F, 2005, J CHEM ECOL, V31, P2747, DOI 10.1007/s10886-005-7570-5; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Moehring AJ, 2006, GENETICS, V173, P225, DOI 10.1534/genetics.105.052985; Moehring AJ, 2004, GENETICS, V167, P1265, DOI 10.1534/genetics.103.024364; Moehring AJ, 2006, GENETICS, V173, P215, DOI 10.1534/genetics.105.052993; Noor MAF, 2001, GENETICS, V159, P581; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Orgogozo V, 2006, GENETICS, V173, P197, DOI 10.1534/genetics.105.054098; Orgogozo V, 2009, FLY, V3, P117, DOI 10.4161/fly.8836; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Rebeiz M, 2009, CELL, V139, P1189, DOI 10.1016/j.cell.2009.11.004; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Rueppell O, 2009, BEHAV GENET, V39, P541, DOI 10.1007/s10519-009-9278-8; Schafer MA, 2010, J EVOLUTION BIOL, V23, P518, DOI 10.1111/j.1420-9101.2009.01916.x; Shaw KL, 2009, P NATL ACAD SCI USA, V106, P9737, DOI 10.1073/pnas.0900229106; Shubin N, 2009, NATURE, V457, P818, DOI 10.1038/nature07891; Spieth H.T., 1952, B AM MUS NAT HIST, V99, P399; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; Williams MA, 2001, HEREDITY, V86, P68, DOI 10.1046/j.1365-2540.2001.00811.x; Williams TM, 2009, NAT REV GENET, V10, P797, DOI 10.1038/nrg2687; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483	55	27	27	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43888	10.1371/journal.pone.0043888	http://dx.doi.org/10.1371/journal.pone.0043888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952802	gold, Green Submitted, Green Published			2022-12-25	WOS:000308206500026
J	Castagneyrol, B; Lagache, L; Giffard, B; Kremer, A; Jactel, H				Castagneyrol, Bastien; Lagache, Lelia; Giffard, Brice; Kremer, Antoine; Jactel, Herve			Genetic Diversity Increases Insect Herbivory on Oak Saplings	PLOS ONE			English	Article							PLANT GENOTYPIC DIVERSITY; ARTHROPOD COMMUNITY; ASSOCIATIONAL SUSCEPTIBILITY; TREE; BIODIVERSITY; RESISTANCE; DAMAGE; METAANALYSIS; SELECTION; COMPLEMENTARITY	A growing body of evidence from community genetics studies suggests that ecosystem functions supported by plant species richness can also be provided by genetic diversity within plant species. This is not yet true for the diversity-resistance relationship as it is still unclear whether damage by insect herbivores responds to genetic diversity in host plant populations. We developed a manipulative field experiment based on a synthetic community approach, with 15 mixtures of one to four oak (Quercus robur) half-sib families. We quantified genetic diversity at the plot level by genotyping all oak saplings and assessed overall damage caused by ectophagous and endophagous herbivores along a gradient of increasing genetic diversity. Damage due to ectophagous herbivores increased with the genetic diversity in oak sapling populations as a result of higher levels of damage in mixtures than in monocultures for all families (complementarity effect) rather than because of the presence of more susceptible oak genotypes in mixtures (selection effect). Assemblages of different oak genotypes would benefit polyphagous herbivores via improved host patch location, spill over among neighbouring saplings and diet mixing. By contrast, genetic diversity was a poor predictor of the abundance of endophagous herbivores, which increased with individual sapling apparency. Plant genetic diversity may not provide sufficient functional contrast to prevent tree sapling colonization by specialist herbivores while enhancing the foraging of generalist herbivores. Long term studies are nevertheless required to test whether the effect of genetic diversity on herbivory change with the ontogeny of trees and local adaptation of specialist herbivores.	[Castagneyrol, Bastien; Lagache, Lelia; Giffard, Brice; Kremer, Antoine; Jactel, Herve] Univ Bordeaux, BIOGECO, UMR1202, Talence, France; [Castagneyrol, Bastien; Lagache, Lelia; Giffard, Brice; Kremer, Antoine; Jactel, Herve] INRA, BIOGECO, UMR1202, Cestas, France	UDICE-French Research Universities; Universite de Bordeaux; INRAE	Castagneyrol, B (corresponding author), Univ Bordeaux, BIOGECO, UMR1202, Talence, France.	bastien.castagneyrol@gmail.com	Kremer, Antoine/G-2272-2018	Kremer, Antoine/0000-0002-3372-3235; Giffard, Brice/0000-0003-4367-1245; Castagneyrol, Bastien/0000-0001-8795-7806	EVOLTREE Network of Excellence (EU) [016322]; European Commission [226299]; LinkTree project (ANR BIODIVERSA); EU Network of Excellence EvolTree	EVOLTREE Network of Excellence (EU)(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); LinkTree project (ANR BIODIVERSA)(French National Research Agency (ANR)); EU Network of Excellence EvolTree	This study was founded by the EVOLTREE Network of Excellence (EU FP7 project 016322). BC was funded by a grant for the BACCARA project, which received funding from the European Commission's Seventh Framework Programme (FP7/2007-2013), under grant agreement no. 226299. LL received funding from the LinkTree project (ANR BIODIVERSA) and the EU Network of Excellence EvolTree. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JG, 2012, TRENDS PLAN IN PRESS; ANDOW DA, 1991, ANNU REV ENTOMOL, V36, P561, DOI 10.1146/annurev.en.36.010191.003021; [Anonymous], 2010, R LANG ENV STAT COMP; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bangert RK, 2006, MOL ECOL, V15, P4215, DOI 10.1111/j.1365-294X.2006.03092.x; Barbosa P, 2009, ANNU REV ECOL EVOL S, V40, P1, DOI 10.1146/annurev.ecolsys.110308.120242; Barbour RC, 2009, ECOLOGY, V90, P1762, DOI 10.1890/08-0951.1; Bates D., 2011, PACKAGE LME4 LINEAR, V1; BERNAYS EA, 1994, ECOLOGY, V75, P1997, DOI 10.2307/1941604; Bertheau C, 2010, ECOL LETT, V13, P506, DOI 10.1111/j.1461-0248.2010.01445.x; Booth RE, 2003, J ECOL, V91, P721, DOI 10.1046/j.1365-2745.2003.00804.x; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Bruce TJA, 2011, PHYTOCHEMISTRY, V72, P1605, DOI 10.1016/j.phytochem.2011.04.011; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Castagneyrol B, 2012, ECOLOGY IN PRESS; Cook-Patton SC, 2011, ECOLOGY, V92, P915, DOI 10.1890/10-0999.1; Crawford KM, 2007, ECOLOGY, V88, P2114, DOI 10.1890/06-1441.1; Crutsinger GM, 2008, OECOLOGIA, V158, P65, DOI 10.1007/s00442-008-1130-y; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Dungey HS, 2000, EVOLUTION, V54, P1938, DOI 10.1111/j.0014-3820.2000.tb01238.x; Finch S, 2000, ENTOMOL EXP APPL, V96, P91, DOI 10.1023/A:1004058518179; Floater GJ, 2000, J APPL ECOL, V37, P87, DOI 10.1046/j.1365-2664.2000.00468.x; Gamfeldt L, 2007, OIKOS, V116, P700, DOI 10.1111/j.2007.0030-1299.15382.x; Genung MA, 2012, OECOLOGIA, V168, P167, DOI 10.1007/s00442-011-2080-3; Giffard B, 2012, OECOLOGIA, V168, P415, DOI 10.1007/s00442-011-2089-7; Glinwood R, 2009, ARTHROPOD-PLANT INTE, V3, P215, DOI 10.1007/s11829-009-9072-9; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Guichoux E, 2011, MOL ECOL RESOUR, V11, P578, DOI 10.1111/j.1755-0998.2011.02983.x; Hajjar R, 2008, AGR ECOSYST ENVIRON, V123, P261, DOI 10.1016/j.agee.2007.08.003; Hamback PA, 2000, ECOLOGY, V81, P1784, DOI 10.1890/0012-9658(2000)081[1784:ARIDTP]2.0.CO;2; Hersch-Green EI, 2011, PHILOS T R SOC B, V366, P1453, DOI 10.1098/rstb.2010.0331; Hochwender CG, 2004, OECOLOGIA, V138, P547, DOI 10.1007/s00442-003-1472-4; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Ito M, 2005, ACTA OECOL, V27, P17, DOI 10.1016/j.actao.2004.08.005; Jactel H, 2006, CAN J FOREST RES, V36, P314, DOI 10.1139/x05-251; Jactel H, 2007, ECOL LETT, V10, P835, DOI 10.1111/j.1461-0248.2007.01073.x; Jactel H, 2012, GLOBAL CHANGE BIOL, V18, P267, DOI 10.1111/j.1365-2486.2011.02512.x; Johnson MTJ, 2005, ECOLOGY, V86, P874, DOI 10.1890/04-1068; Johnson MTJ, 2006, ECOL LETT, V9, P24, DOI 10.1111/j.1461-0248.2005.00833.x; Kaplan I, 2007, ECOL LETT, V10, P977, DOI 10.1111/j.1461-0248.2007.01093.x; Karban R, 2010, ECOL ENTOMOL, V35, P92, DOI 10.1111/j.1365-2311.2009.01162.x; Kotowska AM, 2010, J ECOL, V98, P237, DOI 10.1111/j.1365-2745.2009.01606.x; Kramer M., 2005, R2 STAT MIXED MODELS; Letourneau DK, 2011, ECOL APPL, V21, P9, DOI 10.1890/09-2026.1; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Madritch MD, 2005, SOIL BIOL BIOCHEM, V37, P319, DOI 10.1016/j.soilbio.2004.08.002; Madritch MD, 2002, ECOLOGY, V83, P2084, DOI 10.1890/0012-9658(2002)083[2084:PDIEFI]2.0.CO;2; Milligan BG, 2003, GENETICS, V163, P1153; Mody K, 2007, ECOLOGY, V88, P1012, DOI 10.1890/06-1338; Otway SJ, 2005, J ANIM ECOL, V74, P234, DOI 10.1111/j.1365-2656.2005.00913.x; Peacock L, 2000, J APPL ECOL, V37, P821, DOI 10.1046/j.1365-2664.2000.00528.x; Peacock L, 2001, J APPL ECOL, V38, P1070, DOI 10.1046/j.1365-2664.2001.00655.x; Pinheiro J., 2011, NLME LINEAR NONLINEA; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Riihimaki J, 2005, OECOLOGIA, V142, P90, DOI 10.1007/s00442-004-1696-y; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Schuldt A, 2010, J ECOL, V98, P917, DOI 10.1111/j.1365-2745.2010.01659.x; Silfver T, 2009, FOREST ECOL MANAG, V257, P2145, DOI 10.1016/j.foreco.2009.02.020; Smith DS, 2011, J EVOLUTION BIOL, V24, P422, DOI 10.1111/j.1420-9101.2010.02178.x; Sobek S, 2009, OECOLOGIA, V160, P279, DOI 10.1007/s00442-009-1304-2; Tack AJM, 2012, OIKOS, V121, P481, DOI 10.1111/j.1600-0706.2011.19926.x; Tack AJM, 2011, ECOLOGY, V92, P1594, DOI 10.1890/10-2006.1; Tack AJM, 2010, ECOLOGY, V91, P2660, DOI 10.1890/09-1027.1; Tikkanen OP, 2003, FOREST ECOL MANAG, V177, P587, DOI 10.1016/S0378-1127(02)00330-4; TONHASCA A, 1994, ECOL ENTOMOL, V19, P239, DOI 10.1111/j.1365-2311.1994.tb00415.x; Unsicker SB, 2008, OECOLOGIA, V156, P313, DOI 10.1007/s00442-008-0973-6; Utsumi S, 2011, P ROYAL SOC B; Vehvilainen H, 2007, OECOLOGIA, V152, P287, DOI 10.1007/s00442-007-0673-7; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P121, DOI 10.1146/annurev.en.31.010186.001005; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; White JA, 2000, ECOLOGY, V81, P1795, DOI 10.1890/0012-9658(2000)081[1795:ASOCTA]2.0.CO;2; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Wimp GM, 2007, MOL ECOL, V16, P5057, DOI 10.1111/j.1365-294X.2007.03544.x	76	51	51	0	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44247	10.1371/journal.pone.0044247	http://dx.doi.org/10.1371/journal.pone.0044247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937168	Green Published, gold, Green Submitted			2022-12-25	WOS:000308213600098
J	Bratton, EW; El Husseini, N; Chastain, CA; Lee, MS; Poole, C; Sturmer, T; Juliano, JJ; Weber, DJ; Perfect, JR				Bratton, Emily W.; El Husseini, Nada; Chastain, Cody A.; Lee, Michael S.; Poole, Charles; Stuermer, Til; Juliano, Jonathan J.; Weber, David J.; Perfect, John R.			Comparison and Temporal Trends of Three Groups with Cryptococcosis: HIV-Infected, Solid Organ Transplant, and HIV-Negative/Non-Transplant	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; NERVOUS-SYSTEM CRYPTOCOCCOSIS; HIGH-DOSE FLUCONAZOLE; APPARENTLY IMMUNOCOMPETENT PATIENTS; ACTIVE ANTIRETROVIRAL THERAPY; CALCINEURIN-INHIBITOR AGENTS; LIPOSOMAL AMPHOTERICIN-B; RANDOMIZED-TRIAL; RISK-FACTORS; PRACTICE GUIDELINES	Background: The Infectious Disease Society of America (IDSA) 2010 Clinical Practice Guidelines for the management of cryptococcosis outlined three key populations at risk of disease: (1) HIV-infected, (2) transplant recipient, and (3) HIV-negative/non-transplant. However, direct comparisons of management, severity and outcomes of these groups have not been conducted. Methodology/Principal Findings: Annual changes in frequency of cryptococcosis diagnoses, cryptococcosis-attributable mortality and mortality were captured. Differences examined between severe and non-severe disease within the context of the three groups included: demographics, symptoms, microbiology, clinical management and treatment. An average of nearly 15 patients per year presented at Duke University Medical Center (DUMC) with cryptococcosis. Out of 207 study patients, 86 (42%) were HIV-positive, 42 (20%) were transplant recipients, and 79 (38%) were HIV-negative/non-transplant. HIV-infected individuals had profound CD4 lymphocytopenia and a majority had elevated intracranial pressure. Transplant recipients commonly (38%) had renal dysfunction. Nearly one-quarter (24%) had their immunosuppressive regimens stopped or changed. The HIV-negative/non-transplant population reported longer duration of symptoms than HIV-positive or transplant recipients and 28% (22/79) had liver insufficiency or underlying hematological malignancies. HIV-positive and HIV-negative/non-transplant patients accounted for 89% of severe disease cryptococcosis-attributable deaths and 86% of all-cause mortality. Conclusions/Significance: In this single-center study, the frequency of cryptococcosis did not change in the last two decades, although the underlying case mix shifted (fewer HIV-positive cases, stable transplant cases, more cases with neither). Cryptococcosis had a relatively uniform and informed treatment strategy, but disease-attributable mortality was still common.	[Bratton, Emily W.; Poole, Charles; Stuermer, Til; Weber, David J.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [El Husseini, Nada; Perfect, John R.] Duke Univ, Dept Med, Durham, NC USA; [Chastain, Cody A.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Lee, Michael S.; Juliano, Jonathan J.; Weber, David J.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Univ N Carolina, Dept Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University; Vanderbilt University; Harvard University; Brigham & Women's Hospital; University of North Carolina; University of North Carolina Chapel Hill	Bratton, EW (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA.	emily_bratton@unc.edu	Stürmer, Til/AAB-5459-2022		United States National Institutes of Health Public Health Service [AI73896]; Enzon; Pfizer; Merck; Astellas; Schering-Plough; UNC Center of Excellence in Pharmacoepidemiology and Public Health; UNC-DEcIDE center from the Agency for Healthcare Research and Quality; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073896] Funding Source: NIH RePORTER	United States National Institutes of Health Public Health Service; Enzon; Pfizer(Pfizer); Merck(Merck & Company); Astellas(Astellas Pharmaceuticals); Schering-Plough(Merck & CompanySchering Plough Corporation); UNC Center of Excellence in Pharmacoepidemiology and Public Health; UNC-DEcIDE center from the Agency for Healthcare Research and Quality; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by United States National Institutes of Health Public Health Service Grant [grant number AI73896]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; EWB, NEH, MSL, CAC, CP, JJJ and DJW have declared that they have no competing interests. The following authors have the following conflicts to declare: JRP has research grants, consulting and honorariums from Enzon, Pfizer, Merck, Astellas and Schering-Plough. TS does not accept personal compensation of any kind from any pharmaceutical company, though he receives salary support from the UNC Center of Excellence in Pharmacoepidemiology and Public Health and from unrestricted research grants from pharmaceutical companies to UNC. TS also receives research funding as Principal Investigator of the UNC-DEcIDE center from the Agency for Healthcare Research and Quality. However, this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	BENNETT JE, 1979, NEW ENGL J MED, V301, P126, DOI 10.1056/NEJM197907193010303; Bicanic T, 2008, CLIN INFECT DIS, V47, P123, DOI 10.1086/588792; Bicanic T, 2009, JAIDS-J ACQ IMM DEF, V51, P130, DOI 10.1097/QAI.0b013e3181a56f2e; Bicanic T, 2009, CLIN INFECT DIS, V49, P702, DOI 10.1086/604716; Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; Byrnes EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005851; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM, Vviii; Chen JH, 2008, EMERG INFECT DIS, V14, P755, DOI 10.3201/eid1405.071312; Del Poeta M, 2000, ANTIMICROB AGENTS CH, V44, P739, DOI 10.1128/AAC.44.3.739-746.2000; DISMUKES WE, 1987, NEW ENGL J MED, V317, P334, DOI 10.1056/NEJM198708063170602; Dromer F, 2004, AIDS, V18, P555, DOI 10.1097/00002030-200402200-00024; Dromer F, 1996, CLIN INFECT DIS, V22, pS154, DOI 10.1093/clinids/22.Supplement_2.S154; Dromer F, 2007, PLOS MED, V4, P297, DOI 10.1371/journal.pmed.0040021; Ecevit IZ, 2006, CLIN INFECT DIS, V42, P1443, DOI 10.1086/503570; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Galanis E, 2009, CAN J INFECT DIS MED, V20, P23, DOI 10.1155/2009/719659; Hajjeh RA, 1999, J INFECT DIS, V179, P449, DOI 10.1086/314606; Hamill RJ, 2010, CLIN INFECT DIS, V51, P225, DOI 10.1086/653606; Jarvis JN, 2008, CURR OPIN INFECT DIS, V21, P596, DOI 10.1097/QCO.0b013e3283177f6c; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; Kontoyiannis DP, 2008, ANTIMICROB AGENTS CH, V52, P735, DOI 10.1128/AAC.00990-07; Kontoyiannis DP, 2003, J ANTIMICROB CHEMOTH, V51, P313, DOI 10.1093/jac/dkg090; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2011, CURR OPIN INFECT DIS, V24, P34, DOI 10.1097/QCO.0b013e3283420f76; Leenders ACAP, 1997, AIDS, V11, P1463, DOI 10.1097/00002030-199712000-00010; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; Longley N, 2008, CLIN INFECT DIS, V47, P1556, DOI 10.1086/593194; Lortholary O, 2005, AIDS, V19, P1043, DOI 10.1097/01.aids.0000174450.70874.30; Lortholary O, 2006, AIDS, V20, P2183, DOI 10.1097/01.aids.0000252060.80704.68; Loyse A, 2012, CLIN INFECT DIS, V54, P121, DOI 10.1093/cid/cir745; Lui G, 2006, QJM-INT J MED, V99, P143, DOI 10.1093/qjmed/hcl014; MacDougall L, 2011, EMERG INFECT DIS, V17, P193, DOI 10.3201/eid1702.101020; Marchetti O, 2000, ANTIMICROB AGENTS CH, V44, P2373, DOI 10.1128/AAC.44.9.2373-2381.2000; Milefchik E, 2008, MED MYCOL, V46, P393, DOI 10.1080/13693780701851695; Mirza SA, 2003, CLIN INFECT DIS, V36, P789, DOI 10.1086/368091; Nguyen MH, 2010, J INFECTION, V61, P419, DOI 10.1016/j.jinf.2010.08.004; Nussbaum JC, 2010, CLIN INFECT DIS, V50, P338, DOI 10.1086/649861; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pappas PG, 2010, CLIN INFECT DIS, V50, P1101, DOI 10.1086/651262; Pappas PG, 2009, CLIN INFECT DIS, V48, P1775, DOI 10.1086/599112; Pappas PG, 2001, CLIN INFECT DIS, V33, P690, DOI 10.1086/322597; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Person AK, 2010, INFECT DIS CLIN N AM, V24, P439, DOI 10.1016/j.idc.2010.01.002; ROZENBAUM R, 1994, CLIN INFECT DIS, V18, P369, DOI 10.1093/clinids/18.3.369; Rust D M, 1998, Oncol Nurs Forum, V25, P35; Saag MS, 2000, CLIN INFECT DIS, V30, P710, DOI 10.1086/313757; Shelburne SA, 2005, AIDS, V19, P399, DOI 10.1097/01.aids.0000161769.06158.8a; Singh N, 2008, CLIN INFECT DIS, V47, P1321, DOI 10.1086/592690; Singh N, 2008, TRANSPLANTATION, V86, P647, DOI 10.1097/TP.0b013e3181814e76; Singh N, 2007, LANCET INFECT DIS, V7, P395, DOI 10.1016/S1473-3099(07)70085-3; Singh N, 2007, J INFECT DIS, V195, P756, DOI 10.1086/511438; Sun HY, 2009, CLIN INFECT DIS, V49, P1721, DOI 10.1086/647948; Sungkanuparph S, 2007, JAIDS-J ACQ IMM DEF, V45, P595, DOI 10.1097/QAI.0b013e318061b5eb; vanderHorst CM, 1997, NEW ENGL J MED, V337, P15, DOI 10.1056/NEJM199707033370103; Wu G, 2002, Transpl Infect Dis, V4, P183, DOI 10.1034/j.1399-3062.2002.t01-1-02005.x	56	123	123	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43582	10.1371/journal.pone.0043582	http://dx.doi.org/10.1371/journal.pone.0043582			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937064	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500065
J	Keswani, SG; Balaji, S; Le, L; Leung, A; Katz, AB; Lim, FY; Habli, M; Jones, HN; Wilson, JM; Crombleholme, TM				Keswani, Sundeep G.; Balaji, Swathi; Le, Louis; Leung, Alice; Katz, Anna B.; Lim, Foong-Yen; Habli, Mounira; Jones, Helen N.; Wilson, James M.; Crombleholme, Timothy M.			Pseudotyped AAV Vector-Mediated Gene Transfer in a Human Fetal Trachea Xenograft Model: Implications for In Utero Gene Therapy for Cystic Fibrosis	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS VECTORS; AIRWAY EPITHELIAL-CELLS; SUBMUCOSAL GLAND; RECOMBINANT ADENOVIRUS; APICAL SURFACES; RHESUS-MONKEYS; VIRAL VECTORS; RABBIT AIRWAY; PHASE-I; EXPRESSION	Background: Lung disease including airway infection and inflammation currently causes the majority of morbidities and mortalities associated with cystic fibrosis (CF), making the airway epithelium and the submucosal glands (SMG) novel target cells for gene therapy in CF. These target cells are relatively inaccessible to postnatal gene transfer limiting the success of gene therapy. Our previous work in a human-fetal trachea xenograft model suggests the potential benefit for treating CF in utero. In this study, we aim to validate adeno-associated virus serotype 2 (AAV2) gene transfer in a human fetal trachea xenograft model and to compare transduction efficiencies of pseudotyping AAV2 vectors in fetal xenografts and postnatal xenograft controls. Methodology/Principal Findings: Human fetal trachea or postnatal bronchus controls were xenografted onto immunocompromised SCID mice for a four-week engraftment period. After injection of AAV2/2, 2/1, 2/5, 2/7 or 2/8 with a LacZ reporter into both types of xenografts, we analyzed for transgene expression in the respiratory epithelium and SMGs. At 1 month, transduction by AAV2/2 and AAV2/8 in respiratory epithelium and SMG cells was significantly greater than that of AAV2/1, 2/5, and 2/7 in xenograft tracheas. Efficiency in SMG transduction was significantly greater in AAV2/8 than AAV2/2. At 3 months, AAV2/2 and AAV2/8 transgene expression was >99% of respiratory epithelium and SMG. At 1 month, transduction efficiency of AAV2/2 and AAV2/8 was significantly less in adult postnatal bronchial xenografts than in fetal tracheal xenografts. Conclusions/Significance: Based on the effectiveness of AAV vectors in SMG transduction, our findings suggest the potential utility of pseudotyped AAV vectors for treatment of cystic fibrosis. The human fetal trachea xenograft model may serve as an effective tool for further development of fetal gene therapy strategies for the in utero treatment of cystic fibrosis.	[Keswani, Sundeep G.; Balaji, Swathi; Le, Louis; Leung, Alice; Lim, Foong-Yen; Habli, Mounira; Jones, Helen N.; Crombleholme, Timothy M.] Cincinnati Childrens Hosp Med Ctr, Ctr Mol Fetal Therapy, Div Pediat Gen Thorac & Fetal Surg, Cincinnati, OH USA; [Keswani, Sundeep G.; Balaji, Swathi; Le, Louis; Leung, Alice; Lim, Foong-Yen; Habli, Mounira; Jones, Helen N.; Crombleholme, Timothy M.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Keswani, Sundeep G.; Katz, Anna B.; Lim, Foong-Yen; Crombleholme, Timothy M.] Childrens Hosp Philadelphia, Childrens Inst Surg Sci, Philadelphia, PA 19104 USA; [Wilson, James M.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Gene Therapy Program, Philadelphia, PA 19104 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Keswani, SG (corresponding author), Cincinnati Childrens Hosp Med Ctr, Ctr Mol Fetal Therapy, Div Pediat Gen Thorac & Fetal Surg, Cincinnati, OH USA.	sundeep.keswani@cchmc.org	Crombleholme, Timothy/Y-1477-2019; Wilson, James M/F-9220-2011	Wilson, James M/0000-0002-9630-3131	National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK074055, R01-DK072446, R01-DK59242]; Wound Healing Foundation 3 M Award; National Institute of General Medical Sciences [K08 GM098831-01]; affiliates of ReGenX Holdings; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425, UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072446, R01DK059242, R01DK074055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM098831] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wound Healing Foundation 3 M Award; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); affiliates of ReGenX Holdings; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK074055, R01-DK072446 and R01-DK59242) (TMC), Wound Healing Foundation 3 M Award, and National Institute of General Medical Sciences (K08 GM098831-01) (SGK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: JMW is a consultant to ReGenX Holdings, and is a founder of, holds equity in, and receives a grant from affiliates of ReGenX Holdings. In addition, he is an inventor on patents licensed to various biopharmaceutical companies, including affiliates of ReGenX Holdings. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. All other authors have declared that no competing interests exist.	Aitken ML, 2001, HUM GENE THER, V12, P1907, DOI 10.1089/104303401753153956; Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Arbetman AE, 2005, J VIROL, V79, P15238, DOI 10.1128/JVI.79.24.15238-15245.2005; Beck SE, 1999, J VIROL, V73, P9446, DOI 10.1128/JVI.73.11.9446-9455.1999; Bilbao R, 2005, HUM GENE THER, V16, P678, DOI 10.1089/hum.2005.16.678; Borthwick DW, 2001, AM J RESP CELL MOL, V24, P662, DOI 10.1165/ajrcmb.24.6.4217; Bouchard S, 2003, J GENE MED, V5, P941, DOI 10.1002/jgm.421; Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182; Carter BJ, 2005, HUM GENE THER, V16, P541, DOI 10.1089/hum.2005.16.541; Colletti E, 2008, EXP HEMATOL, V36, P816, DOI 10.1016/j.exphem.2008.02.007; Conese M, 2011, J CYST FIBROS, V10, pS114, DOI 10.1016/S1569-1993(11)60017-9; Davies JC, 2001, J GENE MED, V3, P409, DOI 10.1002/jgm.200; Ding W, 2003, J VIROL, V77, P7361, DOI 10.1128/JVI.77.13.7361-7366.2003; Driskell RA, 2003, ANNU REV PHYSIOL, V65, P585, DOI 10.1146/annurev.physiol.65.092101.142426; Duan DS, 2000, J CLIN INVEST, V105, P1573, DOI 10.1172/JCI8317; Duan DS, 1998, AM J RESP CELL MOL, V18, P750, DOI 10.1165/ajrcmb.18.6.2987; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; Flotte TR, 2010, MOL THER, V18, P594, DOI 10.1038/mt.2009.230; Flume PA, 2011, CURR OPIN PULM MED, V17, P220, DOI 10.1097/MCP.0b013e328345e1f8; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; GOLDMAN MJ, 1995, NAT GENET, V9, P126, DOI 10.1038/ng0295-126; Gray SJ, 2010, MOL THER, V18, P570, DOI 10.1038/mt.2009.292; Griesenbach Uta, 2009, Expert Rev Respir Med, V3, P363, DOI 10.1586/ers.09.25; GRUBB BR, 1994, NATURE, V371, P802, DOI 10.1038/371802a0; Halbert CL, 2002, NAT BIOTECHNOL, V20, P697, DOI 10.1038/nbt0702-697; Halbert CL, 1997, J VIROL, V71, P5932, DOI 10.1128/JVI.71.8.5932-5941.1997; Halbert CL, 2001, J VIROL, V75, P6615, DOI 10.1128/JVI.75.14.6615-6624.2001; Halbert CL, 2000, J VIROL, V74, P1524, DOI 10.1128/JVI.74.3.1524-1532.2000; Harvey BG, 1999, J CLIN INVEST, V104, P1245, DOI 10.1172/JCI7935; Hida K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019919; Hildinger M, 2001, J VIROL, V75, P6199, DOI 10.1128/JVI.75.13.6199-6203.2001; Jani JC, 2009, ULTRASOUND OBST GYN, V34, P304, DOI 10.1002/uog.6450; Jerebtsova M, 2002, PEDIATR RES, V52, P95, DOI 10.1203/00006450-200207000-00018; Keswani Sundeep G, 2004, Semin Pediatr Surg, V13, P44, DOI 10.1053/j.sempedsurg.2003.09.007; Keswani SG, 2012, WOUND REPAIR REGEN, V20, P592, DOI 10.1111/j.1524-475X.2012.00810.x; Keswani SG, 2011, J PEDIATR SURG, V46, P33, DOI 10.1016/j.jpedsurg.2010.09.064; Knight AK, 1999, SURG FORUM, P509; Li HJ, 2011, BLOOD, V117, P3311, DOI 10.1182/blood-2010-08-302729; Lim FY, 2003, J PEDIATR SURG, V38, P834, DOI 10.1016/S0022-3468(03)00106-4; Lim FY, 2002, J PEDIATR SURG, V37, P1051, DOI 10.1053/jpsu.2002.33843; Lu Y, 2004, STEM CELLS DEV, V13, P133, DOI 10.1089/154732804773099335; Michelfelder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023101; Nakai H, 2000, NAT BIOTECHNOL, V18, P527, DOI 10.1038/75390; Ostedgaard LS, 2005, P NATL ACAD SCI USA, V102, P2952, DOI 10.1073/pnas.0409845102; Ostedgaard LS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001868; PEAULT B, 1994, HUM GENE THER, V5, P1131, DOI 10.1089/hum.1994.5.9-1131; Pergolizzi RG, 2003, MOL THER, V8, P999, DOI 10.1016/j.ymthe.2003.08.022; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Stenbit AE, 2011, CURR OPIN PULM MED, V17, P442, DOI 10.1097/MCP.0b013e32834b8c04; Tarantal AF, 2010, HUM GENE THER, V21, P143, DOI 10.1089/hum.2009.126; THURLBECK WM, 1961, BRIT J DIS CHEST, V55, P54, DOI 10.1016/S0007-0971(61)80002-8; Wagner JA, 1998, HUM GENE THER, V9, P889, DOI 10.1089/hum.1998.9.6-889; Wang XR, 2001, AM J RESP CELL MOL, V24, P195, DOI 10.1165/ajrcmb.24.2.3918; Weiss Daniel J, 2004, Methods Mol Biol, V246, P53; Welsh Michael J, 2009, Trans Am Clin Climatol Assoc, V120, P149; White AF, 2008, HUM GENE THER, V19, P1407, DOI [10.1089/hum.2008.117, 10.1089/hgt.2008.117]; Xie W, 2011, J CLIN INVESTIGATION; Yan ZY, 2004, J VIROL, V78, P2863, DOI 10.1128/JVI.78.6.2863-2874.2004; Zabner J, 2000, J VIROL, V74, P3852, DOI 10.1128/JVI.74.8.3852-3858.2000; Zuckerman JB, 1999, HUM GENE THER, V10, P2973, DOI 10.1089/10430349950016384	60	15	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43633	10.1371/journal.pone.0043633	http://dx.doi.org/10.1371/journal.pone.0043633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937069	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500070
J	Xing, LY; Hoshijima, K; Grunwald, DJ; Fujimoto, E; Quist, TS; Sneddon, J; Chien, CB; Stevenson, TJ; Bonkowsky, JL				Xing, Lingyan; Hoshijima, Kazuyuki; Grunwald, David J.; Fujimoto, Esther; Quist, Tyler S.; Sneddon, Jacob; Chien, Chi-Bin; Stevenson, Tamara J.; Bonkowsky, Joshua L.			Zebrafish foxP2 Zinc Finger Nuclease Mutant Has Normal Axon Pathfinding	PLOS ONE			English	Article							LANGUAGE DISORDER; DEVELOPMENTAL EXPRESSION; BRAIN ABNORMALITIES; MOLECULAR-CLONING; INHERITED SPEECH; GENE-EXPRESSION; DYSPRAXIA; DEFICITS; CNTNAP2; PROTEIN	foxP2, a forkhead-domain transcription factor, is critical for speech and language development in humans, but its role in the establishment of CNS connectivity is unclear. While in vitro studies have identified axon guidance molecules as targets of foxP2 regulation, and cell culture assays suggest a role for foxP2 in neurite outgrowth, in vivo studies have been lacking regarding a role for foxP2 in axon pathfinding. We used a modified zinc finger nuclease methodology to generate mutations in the zebrafish foxP2 gene. Using PCR-based high resolution melt curve analysis (HRMA) of G0 founder animals, we screened and identified three mutants carrying nonsense mutations in the 2(nd) coding exon: a 17 base-pair (bp) deletion, an 8bp deletion, and a 4bp insertion. Sequence analysis of cDNA confirmed that these were frameshift mutations with predicted early protein truncations. Homozygous mutant fish were viable and fertile, with unchanged body morphology, and no apparent differences in CNS apoptosis, proliferation, or patterning at embryonic stages. There was a reduction in expression of the known foxP2 target gene cntnap2 that was rescued by injection of wild-type foxP2 transcript. When we examined axon pathfinding using a pan-axonal marker or transgenic lines, including a foxP2-neuron-specific enhancer, we did not observe any axon guidance errors. Our findings suggest that foxP2 is not necessary for axon pathfinding during development.	[Xing, Lingyan; Fujimoto, Esther; Quist, Tyler S.; Sneddon, Jacob; Stevenson, Tamara J.; Bonkowsky, Joshua L.] Univ Utah, Sch Med, Dept Pediat, Div Pediat Neurol, Salt Lake City, UT 84112 USA; [Xing, Lingyan; Chien, Chi-Bin; Bonkowsky, Joshua L.] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT USA; [Xing, Lingyan; Chien, Chi-Bin; Bonkowsky, Joshua L.] Univ Utah, Sch Med, Interdept Program Neurosci, Salt Lake City, UT USA; [Bonkowsky, Joshua L.] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT USA; [Hoshijima, Kazuyuki; Grunwald, David J.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Xing, LY (corresponding author), Univ Utah, Sch Med, Dept Pediat, Div Pediat Neurol, Salt Lake City, UT 84112 USA.	joshua.bonkowsky@hsc.utah.edu	Xing, Lingyan/GPS-6294-2022	Xing, Lingyan/0000-0002-7646-2522	Primary Children's Medical Center (PCMC) Foundation; National Institutes of Health (NIH) [K12 5HD001410, K08 DA024753, P01 HD048886]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001410] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD048886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K08DA024753] Funding Source: NIH RePORTER	Primary Children's Medical Center (PCMC) Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a Primary Children's Medical Center (PCMC) Foundation grant to JLB, National Institutes of Health (NIH) K12 5HD001410 and K08 DA024753 to JLB, and NIH P01 HD048886 to KH, DJG, and CBC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Belton E, 2003, HUM BRAIN MAPP, V18, P194, DOI 10.1002/hbm.10093; Bill BR, 2009, CURR OPIN GENET DEV, V19, P271, DOI 10.1016/j.gde.2009.04.004; Bonkowsky JL, 2005, DEV DYNAM, V234, P740, DOI 10.1002/dvdy.20504; Bonkowsky Joshua L, 2008, BMC Dev Biol, V8, P103, DOI 10.1186/1471-213X-8-103; Cheng L, 2007, DEV GENES EVOL, V217, P699, DOI 10.1007/s00427-007-0177-9; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Feuk L, 2006, AM J HUM GENET, V79, P965, DOI 10.1086/508902; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Fujimoto E, 2011, DEV BIOL, V352, P393, DOI 10.1016/j.ydbio.2011.01.023; Groszer M, 2008, CURR BIOL, V18, P354, DOI 10.1016/j.cub.2008.01.060; Gupta A, 2011, NUCLEIC ACIDS RES, V39, P381, DOI 10.1093/nar/gkq787; Gutnick A, 2011, DEV CELL, V21, P642, DOI 10.1016/j.devcel.2011.09.004; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hoshijima K, INDEX EXPT PROTOCOLS; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lennon PA, 2007, AM J MED GENET A, V143A, P791, DOI 10.1002/ajmg.a.31632; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Liegeois F, 2003, NAT NEUROSCI, V6, P1230, DOI 10.1038/nn1138; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Meyer MP, 2006, J NEUROSCI, V26, P3604, DOI 10.1523/JNEUROSCI.0223-06.2006; Parant JM, 2009, DEV DYNAM, V238, P3168, DOI 10.1002/dvdy.22143; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sanek NA, 2009, DEVELOPMENT, V136, P3791, DOI 10.1242/dev.037820; Schon C, 2006, DEV GENES EVOL, V216, P641, DOI 10.1007/s00427-006-0073-8; Scott-Van Zeeland AA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001344; Shriberg LD, 2006, J SPEECH LANG HEAR R, V49, P500, DOI 10.1044/1092-4388(2006/038); Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; Spiteri E, 2007, AM J HUM GENET, V81, P1144, DOI 10.1086/522237; Stevenson TJ, 2012, PLOS GENET, V8, P257, DOI 10.1371/journal.pgen.1002638; Suh Y, 2009, MOL CELL NEUROSCI, V42, P308, DOI 10.1016/j.mcn.2009.08.003; Takahashi K, 2003, J NEUROSCI RES, V73, P61, DOI 10.1002/jnr.10638; Vargha-Khadem F, 2005, NAT REV NEUROSCI, V6, P131, DOI 10.1038/nrn1605; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Vernes SC, 2007, AM J HUM GENET, V81, P1232, DOI 10.1086/522238; Vernes SC, 2006, HUM MOL GENET, V15, P3154, DOI 10.1093/hmg/ddl392; Vernes SC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002145; Watkins KE, 2002, BRAIN, V125, P452, DOI 10.1093/brain/awf058; Watkins KE, 2002, BRAIN, V125, P465, DOI 10.1093/brain/awf057; Williams CA, 2010, GENET MED, V12, P385, DOI 10.1097/GIM.0b013e3181def138; WILSON SW, 1990, DEVELOPMENT, V108, P121; Wittwer CT, 2009, HUM MUTAT, V30, P857, DOI 10.1002/humu.20951; Zeesman S, 2006, AM J MED GENET A, V140A, P509, DOI 10.1002/ajmg.a.31110	57	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43968	10.1371/journal.pone.0043968	http://dx.doi.org/10.1371/journal.pone.0043968			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937139	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500130
J	Musee, J; Marnett, LJ				Musee, Joel; Marnett, Lawrence J.			Prostaglandin H Synthase-2-catalyzed Oxygenation of 2-Arachidonoylglycerol Is More Sensitive to Peroxide Tone than Oxygenation of Arachidonic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOPORPHYRIN-IX; OXIDATIVE STRESS; MECHANISM; SYNTHASE; 2-ARACHIDONYLGLYCEROL; CYCLOOXYGENASE-2; HYDROPEROXIDES; BIOSYNTHESIS; PURIFICATION; RECEPTOR	The endocannabinoid, 2-arachidonoylglycerol (2-AG), is a selective substrate for the inducible isoform of prostaglandin H synthase (PGHS), PGHS-2. Its turnover leads to the formation of glyceryl esters of prostaglandins (PG-Gs), a subset of which elicits agonism at unique, as yet unidentified, receptors. The k(cat)/K-m values for oxygenation of arachidonic acid (AA) and 2-AG by PGHS-2 are very similar, but the sensitivities of the two substrates to peroxide-dependent activation have not been compared. 15-Hydroperoxy derivatives of AA and 2-AG were found to be comparable in their ability to serve as substrates for the peroxidase activities of PGHS-2, PGHS-1, and glutathione peroxidase (GPx). They also were comparable in the activation of AA oxygenation by cyanide-inhibited PGHS-2. However, oxygenation of 2-AG was significantly suppressed relative to AA by the presence of GPx and GSH. Furthermore, 2-AG oxygenation by peroxidase-deficient H388YmPGHS-2 was much less efficient than AA oxygenation. Wild-type rates of 2-AG oxygenation were restored by treatment of H388YmPGHS-2 with hydroperoxide derivatives of AA or 2-AG. RNAi silencing of phospholipid hydroperoxide-specific GPx (GPx4) in NIH/3T3 cells led to increases in cellular peroxidation and in the levels of the isoprostane product, 8-epi-PGF(2 alpha). GPx4 silencing led to 2-4-fold increases in PG-G formation but no change in PG formation. Thus, cellular peroxide tone may be an important determinant of the extent of endocannabinoid oxygenation by PGHS-2.	[Marnett, Lawrence J.] Vanderbilt Univ, Sch Med,Ctr Mol Toxicol, Dept Biochem,AB Hancock Jr Mem Lab Canc Res, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med,Ctr Mol Toxicol, AB Hancock Jr Mem Lab Canc Res, Vanderbilt Inst Chem Biol,Dept Chem & Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Marnett, LJ (corresponding author), Vanderbilt Univ, Sch Med,Ctr Mol Toxicol, Dept Biochem,AB Hancock Jr Mem Lab Canc Res, Vanderbilt Inst Chem Biol, 2200 Pierce Ave, Nashville, TN 37232 USA.	larry.marnett@vanderbilt.edu			National Institutes of Health Research Grant [GM15431]; Vanderbilt Medical-Scientist Training Program Grant [GM07347]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347, P01GM015431, P50GM015431] Funding Source: NIH RePORTER	National Institutes of Health Research Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Medical-Scientist Training Program Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grant GM15431. This work was also supported by Vanderbilt Medical-Scientist Training Program Grant GM07347.	DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; DIETZ R, 1988, EUR J BIOCHEM, V171, P321, DOI 10.1111/j.1432-1033.1988.tb13793.x; FUNK MO, 1976, LIPIDS, V11, P113, DOI 10.1007/BF02532660; Goodwin DC, 2000, BIOCHEMISTRY-US, V39, P5422, DOI 10.1021/bi992752f; HEMLER ME, 1980, J BIOL CHEM, V255, P6253; Hu SSJ, 2008, BRIT J PHARMACOL, V153, P1538, DOI 10.1038/bjp.2008.33; JIANG ZY, 1991, LIPIDS, V26, P853, DOI 10.1007/BF02536169; Kingsley PJ, 2005, ANAL BIOCHEM, V343, P203, DOI 10.1016/j.ab.2005.05.005; Kozak KR, 2002, J BIOL CHEM, V277, P44877, DOI 10.1074/jbc.M206788200; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kozak KR, 2002, J BIOL CHEM, V277, P23278, DOI 10.1074/jbc.M201084200; KULMACZ RJ, 1990, METHOD ENZYMOL, V186, P431; KULMACZ RJ, 1995, J BIOL CHEM, V270, P24019, DOI 10.1074/jbc.270.41.24019; Landino LM, 1996, P NATL ACAD SCI USA, V93, P15069, DOI 10.1073/pnas.93.26.15069; Malkowski MG, 2001, J BIOL CHEM, V276, P37547, DOI 10.1074/jbc.M105982200; MARNETT LJ, 1984, MOL PHARMACOL, V26, P328; Milne GL, 2007, NAT PROTOC, V2, P221, DOI 10.1038/nprot.2006.375; Rouzer CA, 2003, CHEM REV, V103, P2239, DOI 10.1021/cr000068x; Rouzer CA, 2008, J BIOL CHEM, V283, P8065, DOI 10.1074/jbc.R800005200; Rouzer CA, 2006, BIOCHEM J, V399, P91, DOI 10.1042/BJ20060615; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; Sakamoto H, 2000, J BIOL CHEM, V275, P40028, DOI 10.1074/jbc.M003191200; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; STRIEDER S, 1992, J BIOL CHEM, V267, P13870; Tsai AL, 1997, J BIOL CHEM, V272, P8885; VANDEROUDERAA FJ, 1977, BIOCHIM BIOPHYS ACTA, V487, P315, DOI 10.1016/0005-2760(77)90008-X; Vecchio AJ, 2011, J BIOL CHEM, V286, P20736, DOI 10.1074/jbc.M111.230367; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200	29	13	16	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37383	37394		10.1074/jbc.M112.381202	http://dx.doi.org/10.1074/jbc.M112.381202			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22942274	Green Published, hybrid			2022-12-25	WOS:000310588500069
J	Gohlke, H; Schlieper, D; Groth, G				Gohlke, Holger; Schlieper, Daniel; Groth, Georg			Resolving the Negative Potential Side (n-side) Water-accessible Proton Pathway of F-type ATP Synthase by Molecular Dynamics Simulations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESSENTIAL ARGININE RESIDUE; C-RING ROTATION; SUBUNIT-C; AQUEOUS ACCESS; ROTOR RING; ROTARY MOTOR; ALPHA; TRANSLOCATION; MEMBRANE; ARCHITECTURE	The rotation of F1Fo-ATP synthase is powered by the proton motive force across the energy-transducing membrane. The protein complex functions like a turbine; the proton flow drives the rotation of the c-ring of the transmembrane F-o domain, which is coupled to the ATP-producing F-1 domain. The hairpin-structured c-protomers transport the protons by reversible protonation/deprotonation of a conserved Asp/Glu at the outer transmembrane helix (TMH). An open question is the proton transfer pathway through the membrane at atomic resolution. The protons are thought to be transferred via two half-channels to and from the conserved cAsp/Glu in the middle of the membrane. By molecular dynamics simulations of c-ring structures in a lipid bilayer, we mapped a water channel as one of the half-channels. We also analyzed the suppressor mutant cP24D/E61G in which the functional carboxylate is shifted to the inner TMH of the c-protomers. Current models concentrating on the "locked" and "open" conformations of the conserved carboxylate side chain are unable to explain the molecular function of this mutant. Our molecular dynamics simulations revealed an extended water channel with additional water molecules bridging the distance of the outer to the inner TMH. We suggest that the geometry of the water channel is an important feature for the molecular function of the membrane part of F1Fo-ATP synthase. The inclination of the proton pathway isolates the two half-channels and may contribute to a favorable clockwise rotation in ATP synthesis mode.	[Schlieper, Daniel; Groth, Georg] Univ Dusseldorf, Inst Biochem Plant Physiol, D-40204 Dusseldorf, Germany; [Gohlke, Holger] Univ Dusseldorf, Inst Pharmaceut & Med Chem, D-40204 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Groth, G (corresponding author), Univ Dusseldorf, Inst Biochem Plant Physiol, D-40204 Dusseldorf, Germany.	georg.groth@hhu.de			Deutsche Forschungsgemeinschaft [GR 1616/5-3]; funds of the initiative "Fit for Excellence" at the Heinrich Heine University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); funds of the initiative "Fit for Excellence" at the Heinrich Heine University	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (GR 1616/5-3) (to G. G.) and by funds of the initiative "Fit for Excellence" at the Heinrich Heine University (to H. G.).	Anezo C, 2003, J PHYS CHEM B, V107, P9424, DOI 10.1021/jp0348981; Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Borsch M, 2002, FEBS LETT, V527, P147, DOI 10.1016/S0014-5793(02)03198-8; CAIN BD, 1989, J BIOL CHEM, V264, P3292; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dimroth P, 1999, P NATL ACAD SCI USA, V96, P4924, DOI 10.1073/pnas.96.9.4924; Dmitriev OY, 2008, BBA-BIOENERGETICS, V1777, P227, DOI 10.1016/j.bbabio.2007.11.011; Dong H, 2010, J BIOL CHEM, V285, P39811, DOI 10.1074/jbc.M110.175844; Duser MG, 2009, EMBO J, V28, P2689, DOI 10.1038/emboj.2009.213; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Groth G, 2002, P NATL ACAD SCI USA, V99, P3464, DOI 10.1073/pnas.052546099; Hakulinen JK, 2012, P NATL ACAD SCI USA, V109, pE2050, DOI 10.1073/pnas.1203971109; HATCH LP, 1995, J BIOL CHEM, V270, P29407, DOI 10.1074/jbc.270.49.29407; Ishmukhametov R, 2010, EMBO J, V29, P3911, DOI 10.1038/emboj.2010.259; Ishmukhametov RR, 2008, BBA-BIOENERGETICS, V1777, P32, DOI 10.1016/j.bbabio.2007.11.004; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Krah A, 2010, J MOL BIOL, V395, P20, DOI 10.1016/j.jmb.2009.10.059; Langemeyer L, 2007, BBA-BIOENERGETICS, V1767, P998, DOI 10.1016/j.bbabio.2007.05.007; Lau WCY, 2012, NATURE, V481, P214, DOI 10.1038/nature10699; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Long JC, 1998, J BIOL CHEM, V273, P16235, DOI 10.1074/jbc.273.26.16235; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2003, J MOL BIOL, V325, P389, DOI 10.1016/S0022-2836(02)01204-4; Meier T, 2001, FEBS LETT, V505, P353, DOI 10.1016/S0014-5793(01)02837-X; Meier T, 2007, MOL MICROBIOL, V65, P1181, DOI 10.1111/j.1365-2958.2007.05857.x; Meier T, 2006, J BACTERIOL, V188, P7759, DOI 10.1128/JB.00934-06; MILLER MJ, 1990, P NATL ACAD SCI USA, V87, P4900, DOI 10.1073/pnas.87.13.4900; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; Mitome N, 2010, BIOCHEM J, V430, P171, DOI 10.1042/BJ20100621; Moore KJ, 2008, J BIOL CHEM, V283, P13044, DOI 10.1074/jbc.M800900200; Pierson HE, 2011, J BIOL CHEM, V286, P38583, DOI 10.1074/jbc.M111.294868; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; Pogoryelov D, 2007, J BACTERIOL, V189, P5895, DOI 10.1128/JB.00581-07; Pogoryelov D, 2010, NAT CHEM BIOL, V6, P891, DOI 10.1038/NCHEMBIO.457; Pogoryelov D, 2009, NAT STRUCT MOL BIOL, V16, P1068, DOI 10.1038/nsmb.1678; Rosso L, 2008, J COMPUT CHEM, V29, P24, DOI 10.1002/jcc.20675; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; Seelert H, 2000, NATURE, V405, P418, DOI 10.1038/35013148; Simmerling C, 2002, J AM CHEM SOC, V124, P11258, DOI 10.1021/ja0273851; Stahlberg H, 2001, EMBO REP, V2, P229, DOI 10.1093/embo-reports/kve047; Steed PR, 2008, J BIOL CHEM, V283, P12365, DOI 10.1074/jbc.M800901200; Steed PR, 2009, J BIOL CHEM, V284, P23243, DOI 10.1074/jbc.M109.002501; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Symersky J, 2012, NAT STRUCT MOL BIOL, V19, P485, DOI 10.1038/nsmb.2284; Tieleman DP, 1997, BBA-REV BIOMEMBRANES, V1331, P235, DOI 10.1016/S0304-4157(97)00008-7; Valiyaveetil FI, 1997, J BIOL CHEM, V272, P32635, DOI 10.1074/jbc.272.51.32635; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; VIK SB, 1994, J BIOL CHEM, V269, P30364; Vik SB, 1998, J BIOL CHEM, V273, P16229, DOI 10.1074/jbc.273.26.16229; Vollmar M, 2009, J BIOL CHEM, V284, P18228, DOI 10.1074/jbc.M109.006916; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Zhang D, 2003, J BIOL CHEM, V278, P12319, DOI 10.1074/jbc.M212413200	67	14	14	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36536	36543		10.1074/jbc.M112.398396	http://dx.doi.org/10.1074/jbc.M112.398396			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22942277	Green Published, hybrid			2022-12-25	WOS:000310364000074
J	Redanz, S; Standar, K; Podbielski, A; Kreikemeyer, B				Redanz, Sylvio; Standar, Kerstin; Podbielski, Andreas; Kreikemeyer, Bernd			Heterologous Expression of sahH Reveals That Biofilm Formation Is Autoinducer-2-independent in Streptococcus sanguinis but Is Associated with an Intact Activated Methionine Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUORUM-SENSING SIGNAL; GROUP-A STREPTOCOCCI; ESCHERICHIA-COLI; VIBRIO-HARVEYI; SALMONELLA-TYPHIMURIUM; S-ADENOSYLHOMOCYSTEINE; INFECTIVE ENDOCARDITIS; FUNCTIONAL-ANALYSIS; LUXS; VIRULENCE	Numerous studies have claimed deleterious effects of LuxS mutation on many bacterial phenotypes, including bacterial biofilm formation. Genetic complementation mostly restored the observed mutant phenotypes to WT levels, leading to the postulation that quorum sensing via a family of molecules generically termed autoinducer-2 (AI-2) is essential for many phenotypes. Because LuxS mutation has dual effects, this hypothesis needs to be investigated into the details for each bacterial species. In this study we used S. sanguinis SK36 as a model biofilm bacterium and employed physiological characterization and transcriptome approaches on WT and luxS-deficient strains, in combination with chemical, luxS, and sahH complementation experiments. SahH enables a direct conversion of SAH to homocysteine and thereby restores the activated methionine cycle in a luxS-negative background without formation of the AI-2 precursor 4,5-dihydroxy-2,3-pentanedione. With this strategy we were able to dissect the individual contribution of LuxS and AI-2 activity in detail. Our data revealed that S. sanguinis biofilm formation is independent from AI-2 substance pools and is rather supported by an intact activated methyl cycle. Of 216 differentially transcribed genes in the luxS mutant, 209 were restored by complementation with a gene encoding the S-adenosylhomocysteine hydrolase. Only nine genes, mainly involved in natural competence, were directly affected by the AI-2 quorum-sensing substance pool. Cumulatively, this suggested that biofilm formation in S. sanguinis is not under control of AI-2. Our study suggests that previously evaluated LuxS mutants in other species need to be revisited to resolve the precise contribution of AI-2 substance pools and the methionine pathways.	[Redanz, Sylvio; Standar, Kerstin; Podbielski, Andreas; Kreikemeyer, Bernd] Rostock Univ Hosp, Inst Med Microbiol Virol & Hyg, D-18057 Rostock, Germany	University of Rostock	Kreikemeyer, B (corresponding author), Rostock Univ Hosp, Inst Med Microbiol Virol & Hyg, Schillingallee 70, D-18057 Rostock, Germany.	bernd.kreikemeyer@med.uni-rostock.de	Redanz, Sylvio/AAH-1369-2020	Redanz, Sylvio/0000-0003-1541-2545; Kreikemeyer, Bernd/0000-0001-9527-5098	PathoGenoMic Plus Program Grant [FKZ 0313801M]; ERANet PathoGenoMics I Program Grant [FKZ 0313936B]; German Federal Ministry of Education and Research	PathoGenoMic Plus Program Grant; ERANet PathoGenoMics I Program Grant; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by PathoGenoMic Plus Program Grant FKZ 0313801M and ERANet PathoGenoMics I Program Grant FKZ 0313936B from the German Federal Ministry of Education and Research.	Ahmed NAAM, 2008, ORAL MICROBIOL IMMUN, V23, P492, DOI 10.1111/j.1399-302X.2008.00460.x; Ahmed NAAM, 2007, J ANTIMICROB CHEMOTH, V60, P49, DOI 10.1093/jac/dkm124; Antunes LCM, 2010, MICROBIOL-SGM, V156, P2271, DOI 10.1099/mic.0.038794-0; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Biswas I, 2008, MICROBIOL-SGM, V154, P2275, DOI 10.1099/mic.0.2008/019265-0; Blehert DS, 2003, J BACTERIOL, V185, P4851, DOI 10.1128/JB.185.16.4851-4860.2003; Callahan JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026403; Cao M, 2011, J MICROBIOL, V49, P1000, DOI 10.1007/s12275-011-1523-1; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Christopher SA, 2002, MOL GENET METAB, V75, P335, DOI 10.1016/S1096-7192(02)00003-3; De Keersmaecker SCJ, 2005, J BIOL CHEM, V280, P19563, DOI 10.1074/jbc.M412660200; Dyson C, 1999, J INFECTION, V38, P87, DOI 10.1016/S0163-4453(99)90074-9; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; GREENBERG EP, 1979, ARCH MICROBIOL, V120, P87, DOI 10.1007/BF00409093; Grinwis ME, 2010, J CLIN MICROBIOL, V48, P395, DOI 10.1128/JCM.01807-09; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hardie KR, 2008, NAT REV MICROBIOL, V6, P635, DOI 10.1038/nrmicro1916; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Joyce EA, 2004, INFECT IMMUN, V72, P2964, DOI 10.1128/IAI.72.5.2964-2975.2004; Kajfasz JK, 2009, J BACTERIOL, V191, P2060, DOI 10.1128/JB.01609-08; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Kushner SR, 1978, GENET ENG N Y, P17; Kwon HY, 2003, INFECT IMMUN, V71, P3757, DOI 10.1128/IAI.71.7.3757-3765.2003; Lyon WR, 2001, MOL MICROBIOL, V42, P145, DOI 10.1046/j.1365-2958.2001.02616.x; Marouni MJ, 2003, INFECT IMMUN, V71, P5633, DOI 10.1128/IAI.71.10.5633-5639.2003; McNab R, 2003, J MED MICROBIOL, V52, P541, DOI 10.1099/jmm.0.05128-0; McNab R, 2003, J BACTERIOL, V185, P274, DOI 10.1128/JB.185.1.274-284.2003; Merritt J, 2005, MICROBIOL-SGM, V151, P157, DOI 10.1099/mic.0.27554-0; Merritt J, 2003, INFECT IMMUN, V71, P1972, DOI 10.1128/IAI.71.4.1972-1979.2003; Miller ST, 2004, MOL CELL, V15, P677, DOI 10.1016/j.molcel.2004.07.020; Mok KC, 2003, EMBO J, V22, P870, DOI 10.1093/emboj/cdg085; Moslehi-Jenabian S, 2009, INT J FOOD MICROBIOL, V135, P295, DOI 10.1016/j.ijfoodmicro.2009.08.011; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; Parveen N, 2011, MOL MICROBIOL, V79, P7, DOI 10.1111/j.1365-2958.2010.07455.x; Pecharki D, 2008, ORAL MICROBIOL IMMUN, V23, P79, DOI 10.1111/j.1399-302X.2007.00395.x; Petersen FC, 2006, ANTON LEEUW INT J G, V90, P109, DOI 10.1007/s10482-006-9065-y; Podbielski A, 1996, GENE, V177, P137, DOI 10.1016/0378-1119(96)84178-3; Redanz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027827; Rezzonico F, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-154; Rickard AH, 2006, MOL MICROBIOL, V60, P1446, DOI 10.1111/j.1365-2958.2006.05202.x; Rodriguez AM, 2011, MOL ORAL MICROBIOL, V26, P99, DOI 10.1111/j.2041-1014.2011.00606.x; Romao S, 2006, MICROBIOL-SGM, V152, P333, DOI 10.1099/mic.0.28406-0; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Shao H, 2007, INFECT IMMUN, V75, P4211, DOI 10.1128/IAI.00402-07; SHAW RG, 1993, ECOLOGY, V74, P1638, DOI 10.2307/1939922; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; Siller M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-188; Standar K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013135; Stroeher UH, 2003, INFECT IMMUN, V71, P3206, DOI 10.1128/IAI.71.6.3206-3212.2003; Sun JB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-36; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Sztajer H, 2008, J BACTERIOL, V190, P401, DOI 10.1128/JB.01086-07; Trappetti C, 2011, INFECT IMMUN, V79, P4550, DOI 10.1128/IAI.05644-11; TRIEUCUOT P, 1991, GENE, V102, P99, DOI 10.1016/0378-1119(91)90546-N; UELAND PM, 1982, PHARMACOL REV, V34, P223; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Vidal JE, 2011, INFECT IMMUN, V79, P4050, DOI 10.1128/IAI.05186-11; Walters M, 2006, J BACTERIOL, V188, P5668, DOI 10.1128/JB.00648-06; Wang Y, 2011, VET MICROBIOL, V152, P151, DOI 10.1016/j.vetmic.2011.04.029; Wen ZT, 2011, MOL ORAL MICROBIOL, V26, P2, DOI 10.1111/j.2041-1014.2010.00581.x; Wen ZT, 2004, J BACTERIOL, V186, P2682, DOI 10.1128/JB.186.9.2682-2691.2004; Winzer K, 2002, MICROBIOL-SGM, V148, P909, DOI 10.1099/00221287-148-4-909; Xavier KB, 2005, NATURE, V437, P750, DOI 10.1038/nature03960; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yoshida A, 2005, APPL ENVIRON MICROB, V71, P2372, DOI 10.1128/AEM.71.5.2372-2380.2005; Zhu L, 2011, MOL ORAL MICROBIOL, V26, P117, DOI 10.1111/j.2041-1014.2010.00602.x	71	20	30	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36111	36122		10.1074/jbc.M112.379230	http://dx.doi.org/10.1074/jbc.M112.379230			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22942290	hybrid, Green Published			2022-12-25	WOS:000310364000033
J	Andrabi, R; Bala, M; Kumar, R; Wig, N; Hazarika, A; Luthra, K				Andrabi, Raiees; Bala, Manju; Kumar, Rajesh; Wig, Naveet; Hazarika, Anjali; Luthra, Kalpana			Neutralization of Tier-2 Viruses and Epitope Profiling of Plasma Antibodies from Human Immunodeficiency Virus Type 1 Infected Donors from India	PLOS ONE			English	Article							PROXIMAL EXTERNAL REGION; HUMAN MONOCLONAL-ANTIBODIES; SUBTYPE-C INFECTION; VACCINE DESIGN; HIV VACCINES; TRANSMEMBRANE GLYCOPROTEIN; ENVELOPE GLYCOPROTEINS; GP120 GLYCOPROTEIN; CRYSTAL-STRUCTURE; GP41 ANTIBODIES	Broadly cross neutralizing antibodies (NAbs) are generated in a group of HIV-1 infected individuals during the natural infection, but little is known about their prevalence in patients infected with viral subtypes from different geographical regions. We tested here the neutralizing efficiency of plasma antibodies from 80 HIV-1 infected antiretroviral drug naive patients against a panel of subtype-B and C tier 2 viruses. We detected cross-neutralizing antibodies in approximately 19-27% of the plasma, however the subtype-C specific neutralization efficiency predominated (p = 0.004). The neutralizing activity was shown to be exclusively mediated by the immunoglobulin G (IgG) fraction in the representative plasma samples. Epitope mapping of three, the most cross-neutralizing plasma (CNP) AIIMS206, AIIMS239 and AIIMS249 with consensus-C overlapping envelope peptides revealed ten different binding specificities with only V3 and IDR being common. The V3 and IDR were highly antigenic regions but no correlation between their reciprocal Max50 binding titers and neutralization was observed. In addition, the neutralizing activity of CNP was not substantially reduced by V3 and gp41 peptides except a modest contribution of MPER peptide. The MPER was rarely recognized by plasma antibodies though antibody depletion and competition experiments demonstrated MPER dependent neutralization in two out of three CNP. Interestingly, the binding specificity of one of the CNP (AIIMS206) overlapped with broadly neutralizing mAb 2F5 epitope. Overall, the data suggest that, despite the low immunogenicity of HIV-1 MPER, the antibodies directed to this region may serve as crucial reagents for HIV-1 vaccine design.	[Andrabi, Raiees; Kumar, Rajesh; Luthra, Kalpana] All India Inst Med Sci, Dept Biochem, CN Ctr, New Delhi 110029, India; [Wig, Naveet] All India Inst Med Sci, Dept Med, CN Ctr, New Delhi 110029, India; [Hazarika, Anjali] All India Inst Med Sci, Blood Bank, CN Ctr, New Delhi, India; [Bala, Manju] Safdarjang Hosp, Reg STD Teaching Training & Res Ctr, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Vardhman Mahavir Medical College & Safdarjung Hospital	Andrabi, R (corresponding author), All India Inst Med Sci, Dept Biochem, CN Ctr, New Delhi 110029, India.	kalpanaluthra@gmail.com		Bala, Manju/0000-0002-1934-8272; Singh, Vikram/0000-0003-2737-8102	Department of Biotechnology India (DBT) [BT/PR 10511/MED/29/66/2008]; Indian Council of Medical Research (ICMR) [61/7/2008-BMS]; Indian Council of Medical Research (ICMR)	Department of Biotechnology India (DBT)(Department of Biotechnology (DBT) India); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR))	This work was funded by Department of Biotechnology India (DBT) (BT/PR 10511/MED/29/66/2008) and Indian Council of Medical Research (ICMR) (61/7/2008-BMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We profoundly thank all the study participants. We acknowledge Prof. Miroslaw K. Gorny for critically reviewing the manuscript and Prof. Susan Zolla Pazner for constant technical advice and support. The Fogarty AIDS International Training & Research Program (AITRP) fellowship (USA), RF/SRF fellowship provided by Indian Council of Medical Research (ICMR) to Raiees Andrabi is highly acknowledged.	Alam SM, 2008, J VIROL, V82, P115, DOI 10.1128/JVI.00927-07; Andrabi R, 2011, ARCH VIROL, V156, P1787, DOI 10.1007/s00705-011-1053-5; Balla-Jhagjhoorsingh SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025488; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Braibant M, 2006, AIDS, V20, P1923, DOI 10.1097/01.aids.0000247113.43714.5e; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Bures R, 2002, J VIROL, V76, P2233, DOI 10.1128/JVI.76.5.2233-2244.2002; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Changela A, 2011, J VIROL, V85, P2524, DOI 10.1128/JVI.02335-10; CHIODI F, 1987, J MED VIROL, V23, P1, DOI 10.1002/jmv.1890230102; Choudhary AK, 2012, J MICROBIOL, V50, P149, DOI 10.1007/s12275-012-1246-y; Cleveland SM, 2000, VIROLOGY, V266, P66, DOI 10.1006/viro.1999.0041; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Davis KL, 2009, VIROLOGY, V387, P414, DOI 10.1016/j.virol.2009.02.022; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Frey G, 2010, NAT STRUCT MOL BIOL, V17, P1486, DOI 10.1038/nsmb.1950; GABUZDA DH, 1992, J VIROL, V66, P3306, DOI 10.1128/JVI.66.6.3306-3315.1992; GNANN JW, 1987, J VIROL, V61, P2639, DOI 10.1128/JVI.61.8.2639-2641.1987; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Haynes BF, 2006, EXPERT REV VACCINES, V5, P347, DOI 10.1586/14760584.5.3.347; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254; Jere A, 2004, MICROBES INFECT, V6, P279, DOI 10.1016/j.micinf.2003.11.012; Kim JH, 2010, CURR OPIN HIV AIDS, V5, P428, DOI 10.1097/COH.0b013e32833d17ac; Koff WC, 2011, VACCINE; Krachmarov C, 2005, J VIROL, V79, P780, DOI 10.1128/JVI.79.2.780-790.2005; Kulkarni SS, 2009, VIROLOGY, V385, P505, DOI 10.1016/j.virol.2008.12.032; Lakhashe S, 2008, J BIOSCIENCES, V33, P515, DOI 10.1007/s12038-008-0070-3; Lakhashe SK, 2007, VIROLOGY, V359, P295, DOI 10.1016/j.virol.2006.09.019; Li B, 2006, J VIROL, V80, P5211, DOI 10.1128/JVI.00201-06; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Liu PH, 2011, J VIROL, V85, P11196, DOI 10.1128/JVI.05601-11; Louisirirotchanakul S, 1998, J ACQ IMMUN DEF SYND, V19, P315, DOI 10.1097/00042560-199812010-00001; Lynch RM, 2009, AIDS RES HUM RETROV, V25, P237, DOI 10.1089/aid.2008.0219; Lynch RM, 2012, J VIROLOGY; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 1996, AIDS RES HUM RETROV, V12, P1319, DOI 10.1089/aid.1996.12.1319; Mascola JR, 2002, J VIROL, V76, P4810, DOI 10.1128/JVI.76.10.4810-4821.2002; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; McMichael AJ, 2003, NAT MED, V9, P874, DOI 10.1038/nm0703-874; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; MOORE JP, 1994, J VIROL, V68, P5142, DOI 10.1128/JVI.68.8.5142-5155.1994; MOORE JP, 1993, J VIROL, V67, P863, DOI 10.1128/JVI.67.2.863-875.1993; Moore PL, 2008, J VIROL, V82, P1860, DOI 10.1128/JVI.02187-07; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nicely NI, 2010, NAT STRUCT MOL BIOL, V17, P1492, DOI 10.1038/nsmb.1944; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Parren PWHI, 1997, IMMUNOL LETT, V57, P105, DOI 10.1016/S0165-2478(97)00043-6; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; POUMBOURIOS P, 1992, AIDS RES HUM RETROV, V8, P2055, DOI 10.1089/aid.1992.8.2055; Rademeyer C, 2007, VIROLOGY, V368, P172, DOI 10.1016/j.virol.2007.06.013; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rong R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000594; Sather DN, 2010, VACCINE, V28, pB8, DOI 10.1016/j.vaccine.2009.07.085; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shankarappa R, 2001, J VIROL, V75, P10479, DOI 10.1128/JVI.75.21.10479-10487.2001; Shen XY, 2009, J VIROL, V83, P3617, DOI 10.1128/JVI.02631-08; Spenlehauer C, 1998, J VIROL, V72, P9855, DOI 10.1128/JVI.72.12.9855-9864.1998; Spurrier B, 2011, STRUCTURE, V19, P691, DOI 10.1016/j.str.2011.02.012; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2011, J VIROL, V85, P4578, DOI 10.1128/JVI.02585-10; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; XU JY, 1991, J VIROL, V65, P4832, DOI 10.1128/JVI.65.9.4832-4838.1991; Zolla-Pazner S, 2008, VIROLOGY, V372, P233, DOI 10.1016/j.virol.2007.09.024; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	85	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43704	10.1371/journal.pone.0043704	http://dx.doi.org/10.1371/journal.pone.0043704			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952740	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300024
J	Shi, DB; Guo, W; Chen, WB; Fu, LY; Wang, JS; Tian, Y; Xiao, XS; Kang, TB; Huang, WL; Deng, WG				Shi, Dingbo; Guo, Wei; Chen, Wangbin; Fu, Lingyi; Wang, Jingshu; Tian, Yung; Xiao, Xiangsheng; Kang, Tiebang; Huang, Wenlin; Deng, Wuguo			Nicotine Promotes Proliferation of Human Nasopharyngeal Carcinoma Cells by Regulating alpha 7AChR, ERK, HIF-1 alpha and VEGF/PEDF Signaling	PLOS ONE			English	Article							LUNG-CANCER CELLS; ACETYLCHOLINE-RECEPTORS; TUMOR-GROWTH; ANGIOGENESIS; HYPOXIA; EXPRESSION; PATHWAY; ACTIVATION; KINASE; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA	Nicotine, the major component in cigarette smoke, can promote tumor growth and angiogenesis, but the precise mechanisms involved remain largely unknown. Here, we investigated the mechanism of action of nicotine in human nasopharyngeal carcinoma (NPC) cells. Nicotine significantly promoted cell proliferation in a dose and time-dependent manner in human NPC cells. The mechanism studies showed that the observed stimulation of proliferation was accompanied by the nicotine-mediated simultaneous modulation of alpha 7AChR, HIF-1 alpha, ERK and VEGF/PEDF signaling. Treatment of NPC cells with nicotine markedly upregulated the expression of alpha 7AChR and HIF-1 alpha proteins. Transfection with a alpha 7AChR or HIF-1 alpha-specific siRNA or a alpha 7AChR-selective inhibitor significantly attenuated the nicotine-mediated promotion of NPC cell proliferation. Nicotine also promoted the phosphorylation of ERK1/2 but not JNK and p38 proteins, thereby induced the activation of ERK/MAPK signaling pathway. Pretreatment with an ERK-selective inhibitor effectively reduced the nicotine-induced proliferation of NPC cells. Moreover, nicotine upregulated the expression of VEGF but suppressed the expression of PEDF at mRNA and protein levels, leading to a significant increase of the ratio of VEGF/PEDF in NPC cells. Pretreatment with a alpha 7AChR or ERK-selective inhibitor or transfection with a HIF-1 alpha-specific siRNA in NPC cells significantly inhibited the nicotine-induced HIF-1 alpha expression and VEGF/PEDF ratio. These results therefore indicate that nicotine promotes proliferation of human NPC cells in vitro through simultaneous modulation of alpha 7AChR, HIF-1 alpha, ERK and VEGF/PEDF signaling and suggest that the related molecules such as HIF-1 alpha might be the potential therapeutic targets for tobacco-associated diseases such as nasopharyngeal carcinomas.	[Shi, Dingbo; Chen, Wangbin; Fu, Lingyi; Wang, Jingshu; Tian, Yung; Xiao, Xiangsheng; Kang, Tiebang; Huang, Wenlin; Deng, Wuguo] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Wenlin; Deng, Wuguo] State Key Lab Targeted Therapy Drug Guangdong, Guangzhou, Guangdong, Peoples R China; [Guo, Wei] Dalian Med Univ, Ctr Canc, Inst Canc Stem Cell, Dalian, Peoples R China	Sun Yat Sen University; Dalian Medical University	Shi, DB (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China.	dengwg@sysucc.org.cn	xiao, xiang/GWU-6035-2022		National Natural Science Foundation of China [81071687]; Ph.D. Programs Foundation of Ministry of Education of China; State Key Laboratory of Oncology in Southern China; "985 Program" of Sun Yat-Sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); State Key Laboratory of Oncology in Southern China; "985 Program" of Sun Yat-Sen University	This work was supported from the National Natural Science Foundation of China (No. 81071687), the Ph.D. Programs Foundation of Ministry of Education of China, the State Key Laboratory of Oncology in Southern China, and the "985 Program" of Sun Yat-Sen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio S, 2005, BIOCHEM BIOPH RES CO, V326, P387, DOI 10.1016/j.bbrc.2004.11.041; Arias HR, 2009, INT J BIOCHEM CELL B, V41, P1441, DOI 10.1016/j.biocel.2009.01.013; Bose C, 2005, AM J PHYSIOL-GASTR L, V289, pG926, DOI 10.1152/ajpgi.00138.2005; Cao Su-Mei, 2011, Chin J Cancer, V30, P114; Cardinale A, 2012, CRIT REV TOXICOL, V42, P68, DOI 10.3109/10408444.2011.623150; Carlisle DL, 2007, PULM PHARMACOL THER, V20, P629, DOI 10.1016/j.pupt.2006.07.001; Cheeseman MT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002336; Chowdhury P, 2007, CELL PROLIFERAT, V40, P125; Davis R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007524; Fan W, 2011, DIFFERENTIATION, V81, P181, DOI 10.1016/j.diff.2010.12.003; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Harada H, 2007, ONCOGENE, V26, P7508, DOI 10.1038/sj.onc.1210556; Jia WH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-446; Kaluz S, 2009, BBA-REV CANCER, V1795, P162, DOI 10.1016/j.bbcan.2009.01.001; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Lam DCL, 2007, CANCER RES, V67, P4638, DOI 10.1158/0008-5472.CAN-06-4628; Lane D, 2005, AM J REPROD IMMUNOL, V53, P153, DOI 10.1111/j.1600-0897.2005.00259.x; Li Q, 2011, CELL PHYSIOL BIOCHEM, V27, P605, DOI 10.1159/000329982; Li YM, 2005, CANCER RES, V65, P3257, DOI 10.1158/0008-5472.CAN-04-1284; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Lopez-Lazaro M, 2009, P NATL ACAD SCI USA, V106, pE26, DOI 10.1073/pnas.0813047106; Nishioka T, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3055; Oshima M, 2005, AUTOIMMUNITY, V38, P161, DOI 10.1080/08916930500050491; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rathinavelu A, 2011, J CELL MOL IN PRESS; Riljak V, 2011, NEUROENDOCRINOL LETT, V32, P816; Sang NL, 2003, J BIOL CHEM, V278, P14013, DOI 10.1074/jbc.M209702200; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Sebolt-Leopold Judith S., 2007, V172, P155; Shi D, 2012, J PINEAL RE IN PRESS; Shin VY, 2005, MOL CANCER RES, V3, P607, DOI 10.1158/1541-7786.MCR-05-0106; Shin VY, 2004, CARCINOGENESIS, V25, P2487, DOI 10.1093/carcin/bgh266; Shou Z, 2012, J CANCER RES CLIN, V138, P585, DOI 10.1007/s00432-011-1125-7; Tanaka H, 2006, CANCER RES, V66, P11263, DOI 10.1158/0008-5472.CAN-06-1699; Taslim N, 2011, ALCOHOL CLIN EXP RES, V35, P540, DOI 10.1111/j.1530-0277.2010.01371.x; Tsurutani J, 2005, CARCINOGENESIS, V26, P1182, DOI 10.1093/carcin/bgi072; Wan XB, 2012, CANC SCI IN PRESS; Wang JS, 2012, J PINEAL RES, V53, P77, DOI 10.1111/j.1600-079X.2012.00973.x; Xiao XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022934; Ye YN, 2004, J PHARMACOL EXP THER, V308, P66, DOI 10.1124/jpet.103.058321; Zheng Y, 2007, AM J RESP CELL MOL, V37, P681, DOI 10.1165/rcmb.2007-0051OC	41	54	61	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43898	10.1371/journal.pone.0043898	http://dx.doi.org/10.1371/journal.pone.0043898			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952803	gold, Green Published, Green Submitted			2022-12-25	WOS:000308221300031
J	Tang, YP; Wade, J				Tang, Yu Ping; Wade, Juli			17 beta-Estradiol Regulates the Sexually Dimorphic Expression of BDNF and TrkB Proteins in the Song System of Juvenile Zebra Finches	PLOS ONE			English	Article							FACTOR MESSENGER-RNA; NERVE GROWTH-FACTOR; ANDROGEN RECEPTOR PROTEIN; EARLY ESTROGEN-TREATMENT; NEUROTROPHIC FACTOR; SEX-DIFFERENCES; NEURONAL CONNECTIVITY; BRAIN; DIFFERENTIATION; SURVIVAL	Mature brain derived neurotrophic factor (BDNF) plays critical roles in development of brain structure and function, including neurogenesis, axon growth, cell survival and processes associated with learning. Expression of this peptide is regulated by estradiol (E2). The zebra finch song system is sexually dimorphic - only males sing and the brain regions controlling song are larger and have more cells in males compared to females. Masculinization of this system is partially mediated by E2, and earlier work suggests that BDNF with its high affinity receptor TrkB may also influence this development. The present study evaluated expression of multiple forms of both BDNF and TrkB in the developing song system in juvenile males and females treated with E2 or a vehicle control. Using immunohistochemistry and Western blot analysis, BDNF was detected across the song nuclei of 25-day-old birds. Westerns allowed the pro-and mature forms of BDNF to be individually identified, and proBDNF to be quantified. Several statistically significant effects of sex existed in both the estimated total number of BDNF+ cells and relative concentration of proBDNF, varying across the regions and methodologies. E2 modulated BDNF expression, although the specific nature of the regulation depended on brain region, sex and the technique used. Similarly, TrkB (both truncated and full-length isoforms) was detected by Western blot in the song system of juveniles of both sexes, and expression was regulated by E2. In the context of earlier research on these molecules in the developing song system, this work provides a critical step in describing specific forms of BDNF and TrkB, and how they can be mediated by sex and E2. As individual isoforms of each can have opposing effects on mechanisms, such as cell survival, it will now be important to investigate in depth their specific functions in song system maturation.	[Tang, Yu Ping] Michigan State Univ, Neurosci Program, Dept Psychol, E Lansing, MI 48824 USA; Michigan State Univ, Neurosci Program, Dept Zool, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Tang, YP (corresponding author), Michigan State Univ, Neurosci Program, Dept Psychol, E Lansing, MI 48824 USA.	tangyupi@msu.edu	wade, juli/F-4993-2012		NIH [RO1-MH55488]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH055488, R01MH096705] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH RO1-MH55488. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKINSREGAN E, 1990, HORM BEHAV, V24, P114, DOI 10.1016/0018-506X(90)90031-R; Agate RJ, 2003, P NATL ACAD SCI USA, V100, P4873, DOI 10.1073/pnas.0636925100; Aguirre CC, 2009, EUR J NEUROSCI, V29, P447, DOI 10.1111/j.1460-9568.2008.06591.x; Akutagawa E, 1998, P NATL ACAD SCI USA, V95, P11429, DOI 10.1073/pnas.95.19.11429; ARNOLD AP, 1975, J EXP ZOOL, V191, P309, DOI 10.1002/jez.1401910302; Arnold AP, 1997, J NEUROBIOL, V33, P572, DOI 10.1002/(SICI)1097-4695(19971105)33:5<572::AID-NEU6>3.3.CO;2-6; BALTHAZART J, 1995, BEHAVIOUR, V120, P225; Barker PA, 2009, NAT NEUROSCI, V12, P105, DOI 10.1038/nn0209-105; BOTTJER SW, 1985, J NEUROSCI, V5, P1556, DOI 10.1523/jneurosci.05-06-01556.1985; Cambiasso MJ, 2000, EUR J NEUROSCI, V12, P2291, DOI 10.1046/j.1460-9568.2000.00120.x; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Chen XQ, 2005, P NATL ACAD SCI USA, V102, P7730, DOI 10.1073/pnas.0408350102; CLAYTON NS, 1988, ANIM BEHAV, V36, P1016, DOI 10.1016/S0003-3472(88)80061-7; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; De Vries GJ, 2004, ENDOCRINOLOGY, V145, P1063, DOI 10.1210/en.2003-1504; Dittrich F, 1999, P NATL ACAD SCI USA, V96, P8241, DOI 10.1073/pnas.96.14.8241; Fenner BM, 2012, CYTOKINE GROWTH FACT; Gibbs RB, 1999, BRAIN RES, V844, P20, DOI 10.1016/S0006-8993(99)01880-6; GRISHAM W, 1995, J NEUROBIOL, V26, P163, DOI 10.1002/neu.480260202; GRISHAM W, 1994, J NEUROBIOL, V25, P185, DOI 10.1002/neu.480250209; Grisham W, 2007, NEUROSCI LETT, V418, P92, DOI 10.1016/j.neulet.2007.03.002; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Itoh Y, 2010, GENOME RES, V20, P512, DOI 10.1101/gr.102343.109; Johnson F, 1997, J NEUROSCI, V17, P2101; Johnson F, 2000, DEV BRAIN RES, V120, P113, DOI 10.1016/S0165-3806(00)00002-X; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; KIRN JR, 1989, J NEUROSCI, V9, P3176; Kittelberger JM, 2005, J NEUROBIOL, V62, P406, DOI 10.1002/neu.20109; KLEIN R, 1992, NEURON, V8, P947, DOI 10.1016/0896-6273(92)90209-V; Koshimizu H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-27; Lessmann V, 2009, NEUROSCI RES, V65, P11, DOI 10.1016/j.neures.2009.06.004; Li XC, 2000, P NATL ACAD SCI USA, V97, P8584, DOI 10.1073/pnas.140222497; MATHEWS GA, 1988, HORM BEHAV, V22, P540, DOI 10.1016/0018-506X(88)90057-8; MATHEWS GA, 1991, J NEUROBIOL, V22, P970, DOI 10.1002/neu.480220908; MATHEWS GA, 1990, GEN COMP ENDOCR, V80, P48, DOI 10.1016/0016-6480(90)90147-E; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; MIRANDA RC, 1993, MOL CELL NEUROSCI, V4, P510, DOI 10.1006/mcne.1993.1063; MIRANDA RC, 1993, P NATL ACAD SCI USA, V90, P6439, DOI 10.1073/pnas.90.14.6439; Nixdorf-Bergweiler BE, 2001, MICROSC RES TECHNIQ, V54, P335, DOI 10.1002/jemt.1147; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Qi LM, 2012, DEV NEUROBIOL, V72, P199, DOI 10.1002/dneu.20956; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; Rasika S, 1999, NEURON, V22, P53, DOI 10.1016/S0896-6273(00)80678-9; SIMPSON HB, 1991, J NEUROBIOL, V22, P755, DOI 10.1002/neu.480220710; SIMPSON HB, 1991, J NEUROBIOL, V22, P777, DOI 10.1002/neu.480220711; Sohrabji F, 2006, FRONT NEUROENDOCRIN, V27, P404, DOI 10.1016/j.yfrne.2006.09.003; Solum DT, 2002, J NEUROSCI, V22, P2650, DOI 10.1523/JNEUROSCI.22-07-02650.2002; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; Tang YP, 2011, J NEUROENDOCRINOL, V23, P584, DOI 10.1111/j.1365-2826.2011.02146.x; Tang YP, 2010, NEUROSCIENCE, V171, P1131, DOI 10.1016/j.neuroscience.2010.10.014; Tang YP, 2007, DEV NEUROBIOL, V67, P474, DOI 10.1002/dneu.20354; Tang YP, 2006, BRAIN RES, V1126, P102, DOI 10.1016/j.brainres.2006.08.002; Tang YP, 2009, DEV NEUROBIOL, V69, P462, DOI 10.1002/dneu.20721; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Tomaszycki ML, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-24; TORANALLERAND CD, 1992, P NATL ACAD SCI USA, V89, P4668, DOI 10.1073/pnas.89.10.4668; Wade J, 1999, HORM BEHAV, V36, P141, DOI 10.1006/hbeh.1999.1537; Wade J, 1996, P NATL ACAD SCI USA, V93, P5264, DOI 10.1073/pnas.93.11.5264; Wade J, 2000, J CHEM NEUROANAT, V19, P33, DOI 10.1016/S0891-0618(00)00051-X; WADE J, 1994, GEN COMP ENDOCR, V94, P53, DOI 10.1006/gcen.1994.1059; Wade J, 2004, ANN NY ACAD SCI, V1016, P540, DOI 10.1196/annals.1298.015; Wade J, 2001, MICROSC RES TECHNIQ, V54, P354, DOI 10.1002/jemt.1148; Wissman AM, 2009, J NEUROSCI, V29, P6461, DOI 10.1523/JNEUROSCI.0638-09.2009; Wu D, 2010, BRAIN RES, V1343, P104, DOI 10.1016/j.brainres.2010.04.084; Xu ZQ, 2011, EUR J NEUROSCI, V33, P1376, DOI 10.1111/j.1460-9568.2011.07635.x; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765	71	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43687	10.1371/journal.pone.0043687	http://dx.doi.org/10.1371/journal.pone.0043687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952738	gold, Green Published			2022-12-25	WOS:000308221300023
J	Pieramico, V; Esposito, R; Sensi, F; Cilli, F; Mantini, D; Mattei, PA; Frazzini, V; Ciavardelli, D; Gatta, V; Ferretti, A; Romani, GL; Sensi, SL				Pieramico, Valentina; Esposito, Roberto; Sensi, Francesca; Cilli, Franco; Mantini, Dante; Mattei, Peter A.; Frazzini, Valerio; Ciavardelli, Domenico; Gatta, Valentina; Ferretti, Antonio; Romani, Gian Luca; Sensi, Stefano L.			Combination Training in Aging Individuals Modifies Functional Connectivity and Cognition, and Is Potentially Affected by Dopamine-Related Genes	PLOS ONE			English	Article							RESTING-STATE NETWORKS; ALZHEIMERS-DISEASE; DEFAULT-MODE; RECEPTOR GENE; BRAIN; POLYMORPHISMS; ASSOCIATION; EXERCISE; HIPPOCAMPUS; DYSFUNCTION	Background: Aging is a major co-risk factor in many neurodegenerative diseases. Cognitive enrichment positively affects the structural plasticity of the aging brain. In this study, we evaluated effects of a set of structured multimodal activities (Combination Training; CT) on cognitive performances, functional connectivity, and cortical thickness of a group of healthy elderly individuals. CT lasted six months. Methodology: Neuropsychological and occupational performances were evaluated before and at the end of the training period. fMRI was used to assess effects of training on resting state network (RSN) functional connectivity using Independent Component Analysis (ICA). Effects on cortical thickness were also studied. Finally, we evaluated whether specific dopamine-related genes can affect the response to training. Principal Findings: Results of the study indicate that CT improves cognitive/occupational performances and reorganizes functional connectivity. Intriguingly, individuals responding to CT showed specific dopamine-related genotypes. Indeed, analysis of dopamine-related genes revealed that carriers of DRD3 ser9gly and COMT Val158Met polymorphisms had the greatest benefits from exposure to CT. Conclusions and Significance: Overall, our findings support the idea that exposure to a set of structured multimodal activities can be an effective strategy to counteract aging-related cognitive decline and also indicate that significant capability of functional and structural changes are maintained in the elderly.	[Pieramico, Valentina; Esposito, Roberto; Mantini, Dante; Mattei, Peter A.; Frazzini, Valerio; Ferretti, Antonio; Romani, Gian Luca; Sensi, Stefano L.] Univ G dAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Pieramico, Valentina; Sensi, Francesca; Cilli, Franco; Frazzini, Valerio; Ciavardelli, Domenico; Sensi, Stefano L.] Univ G dAnnunzio, Ctr Excellence Aging, Mol Neurol Unit, Chieti, Italy; [Mantini, Dante] Catholic Univ Louvain, Dept Neurosci, Lab Neuro & Psychophysiol, B-3000 Louvain, Belgium; [Ciavardelli, Domenico] Kore Univ Enna, Sch Motor Sci, Dept Biochem, Enna, Italy; [Gatta, Valentina] Univ G dAnnunzio, Dept Psychol Sci, Chieti, Italy; [Gatta, Valentina] Univ G dAnnunzio, Ctr Excellence Aging, Funct Genom Unit, Chieti, Italy; [Sensi, Stefano L.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Sensi, Stefano L.] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Universite Catholique Louvain; Universita Kore di ENNA; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of California System; University of California Irvine; University of California System; University of California Irvine	Pieramico, V (corresponding author), Univ G dAnnunzio, Dept Neurosci & Imaging, Chieti, Italy.	ssensi@uci.edu	Sensi, Stefano L./O-1335-2019; Mantini, Dante/D-6989-2014; Sensi, Stefano L./J-3164-2016; Mattei, Peter/J-6661-2012; Gatta, Valentina/G-5765-2014; Frazzini, Valerio/R-3643-2016	Sensi, Stefano L./0000-0002-0710-2574; Mantini, Dante/0000-0001-6485-5559; Sensi, Stefano L./0000-0002-0710-2574; Mattei, Peter A./0000-0002-7343-5625; FERRETTI, Antonio/0000-0002-8459-0129; Esposito, Roberto/0000-0003-4708-6860; Frazzini, Valerio/0000-0003-1187-3352; GATTA, Valentina/0000-0002-9999-5823	Italian Department of Education	Italian Department of Education	SLS is supported by funds from the Italian Department of Education [Fondo per gli Investimenti della Ricerca di Base (FIRB) 2003; programmi di ricerca di rilevante interesse nazionale (PRIN) 2008]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backman L, 2010, NEUROSCI BIOBEHAV R, V34, P670, DOI 10.1016/j.neubiorev.2009.12.008; BEISCHLAG TV, 1995, BIOCHEMISTRY-US, V34, P5960, DOI 10.1021/bi00017a025; Belleville S, 2011, BRAIN, V134, P1623, DOI 10.1093/brain/awr037; Bennett S, 2011, AUST OCCUP THER J, V58, P155, DOI 10.1111/j.1440-1630.2011.00930.x; Bertolino A, 2006, BIOL PSYCHIAT, V60, P1250, DOI 10.1016/j.biopsych.2006.03.078; Black KJ, 2002, P NATL ACAD SCI USA, V99, P17113, DOI 10.1073/pnas.012260599; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Daniels JK, 1996, AM J PSYCHIAT, V153, P268; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Deweerdt S, 2011, NATURE, V475, pS16, DOI 10.1038/475S16a; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Engvig A, 2010, NEUROIMAGE, V52, P1667, DOI 10.1016/j.neuroimage.2010.05.041; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Esposito F, 2005, NEUROIMAGE, V25, P193, DOI 10.1016/j.neuroimage.2004.10.042; Fabel K, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.002.2009; Fisher Anne G, 2007, Scand J Occup Ther, V14, P240, DOI 10.1080/11038120601182958; Fleisher AS, 2009, NEUROIMAGE, V47, P1678, DOI 10.1016/j.neuroimage.2009.06.021; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gill M, 1997, MOL PSYCHIATR, V2, P311, DOI 10.1038/sj.mp.4000290; Grady CL, 2010, CEREB CORTEX, V20, P1432, DOI 10.1093/cercor/bhp207; GRANDY DK, 1993, HUM MOL GENET, V2, P2197, DOI 10.1093/hmg/2.12.2197-a; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Ho AMC, 2008, ANN NY ACAD SCI, V1139, P20, DOI 10.1196/annals.1432.054; Horner Michael David, 2002, Appl Neuropsychol, V9, P114, DOI 10.1207/S15324826AN0902_7; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Izaki Y, 2008, EUR J NEUROSCI, V27, P3029, DOI 10.1111/j.1460-9568.2008.06284.x; Joyce JN, 2005, DRUG DISCOV TODAY, V10, P917, DOI 10.1016/S1359-6446(05)03491-4; Kelly AMC, 2005, CEREB CORTEX, V15, P1089, DOI 10.1093/cercor/bhi005; Kempermann G, 2008, TRENDS NEUROSCI, V31, P163, DOI 10.1016/j.tins.2008.01.002; Kempermann G, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00189; Kikuchi M, 2011, J NEUROSCI, V31, P11193, DOI 10.1523/JNEUROSCI.2535-11.2011; Koch W, 2010, NEUROIMAGE, V51, P280, DOI 10.1016/j.neuroimage.2009.12.008; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Lu Y, 2011, J NEUROSCI, V31, P11762, DOI 10.1523/JNEUROSCI.2707-11.2011; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mantini D, 2009, RADIOLOGY, V253, P797, DOI 10.1148/radiol.2533090602; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; McNab F, 2009, SCIENCE, V323, P800, DOI 10.1126/science.1166102; Mill J, 2004, AM J MED GENET B, V125B, P38, DOI 10.1002/ajmg.b.20127; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Retz W, 2003, J NEURAL TRANSM, V110, P561, DOI 10.1007/s00702-002-0805-5; Reuter-Lorenz PA, 2005, NEUROPSYCHOLOGIA, V43, P1307, DOI 10.1016/j.neuropsychologia.2004.12.007; Rocca MA, 2010, NEUROLOGY, V74, P1252, DOI 10.1212/WNL.0b013e3181d9ed91; ROSENZWEIG MR, 1978, BRAIN RES, V153, P563, DOI 10.1016/0006-8993(78)90340-2; ROSSINI ED, 1994, PERCEPT MOTOR SKILL, V78, P625, DOI 10.2466/pms.1994.78.2.625; Rybakowski JK, 2005, J NEURAL TRANSM, V112, P1575, DOI 10.1007/s00702-005-0292-6; Sambataro F, 2010, NEUROBIOL AGING, V31, P839, DOI 10.1016/j.neurobiolaging.2008.05.022; Scarmeas N, 2001, NEUROLOGY, V57, P2236, DOI 10.1212/WNL.57.12.2236; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Stokes PRA, 2011, NEUROPSYCHOPHARMACOL, V36, P763, DOI 10.1038/npp.2010.210; Swart M, 2011, NEUROIMAGE, V55, P338, DOI 10.1016/j.neuroimage.2010.12.017; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Ursini G, 2011, J NEUROSCI, V31, P6692, DOI 10.1523/JNEUROSCI.6631-10.2011; VALENSTEIN E, 1987, BRAIN, V110, P1631, DOI 10.1093/brain/110.6.1631; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Voss MW, 2011, J APPL PHYSIOL, V111, P1505, DOI 10.1152/japplphysiol.00210.2011; Voss MW, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00032; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wong AHC, 2000, EUR J PHARMACOL, V410, P183	70	51	55	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43901	10.1371/journal.pone.0043901	http://dx.doi.org/10.1371/journal.pone.0043901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937122	Green Published, gold			2022-12-25	WOS:000308213600056
J	Lechene, CP; Lee, GY; Poczatek, JC; Toner, M; Biggers, JD				Lechene, Claude P.; Lee, Gloria Y.; Poczatek, J. Collin; Toner, Mehmet; Biggers, John D.			3D Multi-isotope Imaging Mass Spectrometry Reveals Penetration of O-18-Trehalose in Mouse Sperm Nucleus	PLOS ONE			English	Article							SPERMATOZOA; PORE; CELLS	The prevalence of genetically engineered mice in medical research has led to ever increasing storage costs. Trehalose has a significant beneficial effect in preserving the developmental potential of mouse sperm following partial desiccation and storage at temperatures above freezing. Using multi-isotope imaging mass spectrometry, we are able to image and measure trehalose in individual spermatozoa. We provide the first evidence that trehalose penetrates the nucleus of a mammalian cell, permitting tolerance to desiccation. These results have broad implications for long-term storage of mammalian cells.	[Lechene, Claude P.; Poczatek, J. Collin] Harvard Univ, Sch Med, Div Genet, Brigham & Womens Hosp, Cambridge, MA 02138 USA; [Lee, Gloria Y.; Toner, Mehmet] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Biggers, John D.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lechene, CP (corresponding author), Harvard Univ, Sch Med, Div Genet, Brigham & Womens Hosp, Cambridge, MA 02138 USA.	cpl@harvard.edu			NIH/NIBIB [5P41 EB001974-10]; NIH/NIA [1R21AG034641-01]; NIH/NCRR [5 R24 RR018934]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR018934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG034641] Funding Source: NIH RePORTER	NIH/NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded through the following grants: NIH/NIBIB 5P41 EB001974-10, NIH/NIA 1R21AG034641-01 and NIH/NCRR 5 R24 RR018934. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MJ, 1996, MOL REPROD DEV, V45, P87, DOI 10.1002/(SICI)1098-2795(199609)45:1&lt;87::AID-MRD12&gt;3.0.CO;2-U; Bagchi B, 2005, CHEM REV, V105, P3197, DOI 10.1021/cr020661+; Cheng J, 2006, J PHYS CHEM B, V110, P8329, DOI 10.1021/jp0573341; Cheng J, 2005, ANAL CHEM, V77, P3651, DOI 10.1021/ac048131w; Crowe JH, 2001, CRYOBIOLOGY, V43, P89, DOI 10.1006/cryo.2001.2353; Elmoazzen HY, 2009, CRYOBIOLOGY, V59, P113, DOI 10.1016/j.cryobiol.2009.03.005; FAWCETT DW, 1965, AM J ANAT, V116, P567, DOI 10.1002/aja.1001160306; Ho HC, 2010, J ANAT, V216, P525, DOI 10.1111/j.1469-7580.2009.01204.x; Hochi S, 2011, J REPROD DEVELOP, V57, P557, DOI 10.1262/jrd.11-061O; Knight J, 2002, NATURE, V417, P785, DOI 10.1038/417785a; Kusakabe H, 2001, P NATL ACAD SCI USA, V98, P13501, DOI 10.1073/pnas.241517598; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Lechene CP, 2007, SCIENCE, V317, P1563, DOI 10.1126/science.1145557; Lelong G, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2753841; Li MW, 2007, REPRODUCTION, V133, P919, DOI 10.1530/REP-06-0096; Liu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029924; McGinnis LK, 2005, BIOL REPROD, V73, P627, DOI 10.1095/biolreprod.105.042291; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Russo MJ, 1997, NAT BIOTECHNOL, V15, P278, DOI 10.1038/nbt0397-278; Shaman JA, 2007, ARCH ANDROLOGY, V53, P135, DOI 10.1080/01485010701329378; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Steinhauser ML, 2012, NATURE, V481, P516, DOI 10.1038/nature10734; Zhang DS, 2012, NATURE, V481, P520, DOI 10.1038/nature10745	23	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e42267	10.1371/journal.pone.0042267	http://dx.doi.org/10.1371/journal.pone.0042267			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952592	Green Published, Green Submitted, gold			2022-12-25	WOS:000308044800006
J	Li, YF; Wang, DD; Zhao, BW; Wang, W; Yuan, SQ; Huang, CY; Chen, YM; Zheng, Y; Keshari, RP; Xia, JC; Zhou, ZW				Li, Yuan-fang; Wang, Dan-dan; Zhao, Bai-wei; Wang, Wei; Yuan, Shu-qiang; Huang, Chun-yu; Chen, Yong-ming; Zheng, Yan; Keshari, Rajiv Prasad; Xia, Jian-chuan; Zhou, Zhi-wei			Poor Prognosis of Gastric Adenocarcinoma with Decreased Expression of AHRR	PLOS ONE			English	Article							HYDROCARBON RECEPTOR REPRESSOR; GENE-EXPRESSION; CANCER; IDENTIFICATION; SURVIVAL; PROFILE	Background: The aryl hydrocarbon receptor (AHR) repressor (AHRR), a member of growing superfamily, is a basic-helix-loop-helix/Per-AHR nuclear translocator (ARNT)-Sim (bHLH-PAS) protein. Recently, AHRR has been proposed to function as a putative new tumor suppressor gene based on some relevant studies in multiple types of human cancers. This current study aims to investigate AHHR expression and its prognostic significance in primary gastric adenocarcinoma. Methodology/Principal Findings: The expression level of AHRR was analyzed using real-time quantitative PCR (RT-qPCR), western blotting, and immunohistochemical staining. It was clearly showed that the expression status of AHRR was reduced in tumor tissue samples compared with that in matched adjacent non-tumor tissue samples by RT-qPCR (P = 0.0423) and western blotting analysis (P = 0.004). Moreover, data revealed that AHRR without exon 8 (the active isoform) was the predominant form either in tumor tissues (66.7%, 8/12) or in matched adjacent non-tumor tissues (100.0%, 12/12), and the mRNA level of this isoform was significantly reduced in tumor tissues (P = 0.006). Immunohistochemistry analysis indicated that AHRR expression was significantly decreased in 175 of 410 (42.7%) gastric adenocarcinoma cases. Kaplan-Meier survival curves and Multivariate Cox analysis revealed that decreased expression of AHRR was significantly associated with poor prognosis in gastric adenocarcinoma patients. Conclusions/Significance: Our data suggests that, in primary gastric adenocarcinoma, AHRR may play as a suppressor gene and its expression status has the potential to be an independent prognostic factor.	[Li, Yuan-fang; Wang, Dan-dan; Zhao, Bai-wei; Wang, Wei; Yuan, Shu-qiang; Huang, Chun-yu; Chen, Yong-ming; Zheng, Yan; Keshari, Rajiv Prasad; Xia, Jian-chuan; Zhou, Zhi-wei] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Li, Yuan-fang; Wang, Dan-dan; Zhao, Bai-wei; Wang, Wei; Yuan, Shu-qiang; Huang, Chun-yu; Chen, Yong-ming; Zheng, Yan; Keshari, Rajiv Prasad; Xia, Jian-chuan; Zhou, Zhi-wei] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Li, Yuan-fang; Zhao, Bai-wei; Wang, Wei; Yuan, Shu-qiang; Huang, Chun-yu; Chen, Yong-ming; Zheng, Yan; Keshari, Rajiv Prasad; Zhou, Zhi-wei] Sun Yat Sen Univ, Ctr Canc, Dept Gastr & Pancreat Surg, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Li, YF (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China.	xiajch@sysucc.org.cn; zhouzhw@sysucc.org.cn	Li, Yuan/GXV-1310-2022; Chen, Yongming/E-3656-2015	Chen, Yongming/0000-0003-2843-5543	Guangdong Province Science and Technology Project [2009B080701006]	Guangdong Province Science and Technology Project	This work was supported by the Guangdong Province Science and Technology Project (2009B080701006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttila MA, 2000, BRIT J CANCER, V82, P1974; Cauchi S, 2003, PHARMACOGENETICS, V13, P339, DOI 10.1097/00008571-200306000-00005; Chen CN, 2005, J CLIN ONCOL, V23, P7286, DOI 10.1200/JCO.2004.00.2253; Currier N, 2005, TOXICOL PATHOL, V33, P726, DOI 10.1080/01926230500352226; Evans BR, 2005, ARCH BIOCHEM BIOPHYS, V441, P151, DOI 10.1016/j.abb.2005.07.008; Fujita H, 2002, TERATOLOGY, V65, P10, DOI 10.1002/tera.1093; Haarmann-Stemmann T, 2007, DRUG METAB DISPOS, V35, P2262, DOI 10.1124/dmd.107.016253; Haarmann-Stemmann T, 2006, BIOL CHEM, V387, P1195, DOI 10.1515/BC.2006.147; Hahn ME, 2009, BIOCHEM PHARMACOL, V77, P485, DOI 10.1016/j.bcp.2008.09.016; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hippo Y, 2002, CANCER RES, V62, P233; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Karchner SI, 2009, MOL CELL BIOL, V29, P3465, DOI 10.1128/MCB.00206-09; Lee HS, 2007, CLIN CANCER RES, V13, P4154, DOI 10.1158/1078-0432.CCR-07-0173; Lee JS, 2011, TOXICOL SCI, V119, P319, DOI 10.1093/toxsci/kfq336; Liang Y, 2012, INT J CANCER, V130, P1745, DOI 10.1002/ijc.26166; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Monick MM, 2012, AM J MED GENET B, V159B, P141, DOI 10.1002/ajmg.b.32021; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Oue N, 2004, CANCER RES, V64, P2397, DOI 10.1158/0008-5472.CAN-03-3514; Pellikainen J, 2002, CLIN CANCER RES, V8, P3487; Sanada N, 2009, J PHARMACOL SCI, V109, P380, DOI 10.1254/jphs.08328FP; STANBRIDGE EJ, 1990, SCIENCE, V247, P12, DOI 10.1126/science.2403692; Wang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024897; Yasui Wataru, 2005, Gastric Cancer, V8, P86, DOI 10.1007/s10120-005-0320-0; Zudaire E, 2008, J CLIN INVEST, V118, P640, DOI 10.1172/JCI30024	29	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43555	10.1371/journal.pone.0043555	http://dx.doi.org/10.1371/journal.pone.0043555			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952704	gold, Green Submitted, Green Published			2022-12-25	WOS:000308044800038
J	Aklilu, E; Zakaria, Z; Hassan, L; Cheng, CH				Aklilu, Erkihun; Zakaria, Zunita; Hassan, Latiffah; Cheng, Chen Hui			Molecular Relatedness of Methicillin-Resistant S. aureus Isolates from Staff, Environment and Pets at University Veterinary Hospital in Malaysia	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; STAPHYLOCOCCUS-AUREUS; OXACILLIN-RESISTANT; NASAL CARRIAGE; MRSA; PREVALENCE; PERSONNEL; SURVIVAL; ANIMALS; RISK	Methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a problem in veterinary medicine and is no longer considered as a mere nosocomial pathogen. We studied the occurrence of MRSA in veterinary personnel, cats and dogs and the environmental premises in University Veterinary Hospital (UVH). We found the prevalence of MRSA as follows: UVH 2/28 (7.1%) staff, 8/100 (8%) of the pets [5/50 (10%) of the dogs and 3/50 (6%) of the cats)], and 9/28 (4.5%) of the environmental samples. Antibiotic sensitivity tests (AST) show multi-resistance characteristics of the MRSA and the minimum inhibitory concentration (MIC) values for the isolates ranged from 1.5 mu g to >256 mu g/ml. Molecular typing by using multi-locus sequence typing (MLST), staphylococcal protein A typing (spa typing) and pulsed-field gel electrophoresis (PFGE) was conducted and the results from MLST indicated that an isolate from a veterinary personnel (PG21), typed as ST1241 belonged to the same clonal complex (CC) as the two isolates from two dogs (DG16 and DG20), both being typed as ST59. The PFGE results revealed that the two isolates from two veterinary personnel, PG21 and PG16 belonged to closely related MRSA strains with isolates from dog (DG36) and from environmental surface (EV100) respectively. The fact that PFGE revealed close similarity between isolates from humans, a dog and environmental surfaces indicates the possibility for either of them to be the source of MRSA and the potential routes and risks of spread.	[Aklilu, Erkihun; Zakaria, Zunita; Hassan, Latiffah; Cheng, Chen Hui] Univ Putra Malaysia, Fac Vet Med, Serdang, Malaysia; [Aklilu, Erkihun] Univ Malaysia Kelantan, Fac Vet Med, Pengkalan Chepa, Kota Bharu, Malaysia	Universiti Putra Malaysia; Universiti Malaysia Kelantan	Aklilu, E (corresponding author), Univ Putra Malaysia, Fac Vet Med, Serdang, Malaysia.	erkihun@umk.edu.my	Aklilu, Erkihun/L-8601-2015; Zakaria, Zunita/AAF-5110-2020; hassan, latiffah/H-4795-2019	Aklilu, Erkihun/0000-0003-1031-3935; hassan, latiffah/0000-0003-0731-9906; Chen, Hui Cheng/0000-0003-3717-0831	Ministry of Science Technology and Innovation MOSTI ScienceFund; Ministry of Science, Technology and Innovation (MOSTI)	Ministry of Science Technology and Innovation MOSTI ScienceFund; Ministry of Science, Technology and Innovation (MOSTI)(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This research was supported by the Ministry of Science Technology and Innovation MOSTI ScienceFund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the laboratory technicians and assistants at Bacteriology laboratory and staff at UVH, Faculty of Veterinary Medicine, Universiti Putra Malaysia for their kind cooperation over the course of this study. We also like to thank Ministry of Science, Technology and Innovation (MOSTI) for funding the research project.	Anderson MEC, 2008, VET MICROBIOL, V129, P410, DOI 10.1016/j.vetmic.2007.11.031; Baptiste KE, 2005, EMERG INFECT DIS, V11, P1942, DOI 10.3201/eid1112.050241; Boost MV, 2007, CLIN MICROBIOL INFEC, V13, P731, DOI 10.1111/j.1469-0691.2007.01737.x; Boyce JM, 1997, INFECT CONT HOSP EP, V18, P622; Clinical and Laboratory Standards Institute (CLSI), 2006, M100S16 CLSI NAT COM; de Boer HEL, 2006, INFECT CONT HOSP EP, V27, P1120, DOI 10.1086/507966; Deplano A, 2000, CLIN MICROBIOL INFEC, V6, P239, DOI 10.1046/j.1469-0691.2000.00064.x; Dietze B, 2001, J HOSP INFECT, V49, P255, DOI 10.1053/jhin.2001.1094; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2004, CURR OPIN MICROBIOL, V7, P308, DOI 10.1016/j.mib.2004.04.002; Ghaznavi-Rad E, 2010, J CLIN MICROBIOL, V48, P867, DOI 10.1128/JCM.01112-09; Hanselman BA, 2006, EMERG INFECT DIS, V12, P1933; Hardy KJ, 2006, INFECT CONT HOSP EP, V27, P127, DOI 10.1086/500622; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hawkey PM, 2008, BRIT J PHARMACOL, V153, pS406, DOI 10.1038/sj.bjp.0707632; Heller J, 2010, RISK ANAL, V30, P458, DOI 10.1111/j.1539-6924.2009.01342.x; Hoet AE, 2011, VECTOR-BORNE ZOONOT, V11, P609, DOI 10.1089/vbz.2010.0181; Ishihara K, 2010, APPL ENVIRON MICROB, V76, P5165, DOI 10.1128/AEM.02780-09; Jawad A, 1996, J CLIN MICROBIOL, V34, P2881, DOI 10.1128/JCM.34.12.2881-2887.1996; Jones RD, 2007, JAVMA-J AM VET MED A, V230, P221, DOI 10.2460/javma.230.2.221; Loeffler A, 2005, J ANTIMICROB CHEMOTH, V56, P692, DOI 10.1093/jac/dki312; Louie L, 2002, J CLIN MICROBIOL, V40, P2786, DOI 10.1128/JCM.40.8.2786-2790.2002; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Moodley A, 2008, SCAND J WORK ENV HEA, V34, P151, DOI 10.5271/sjweh.1219; Moodley A, 2006, J ANTIMICROB CHEMOTH, V58, P1118, DOI 10.1093/jac/dkl394; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; Neely AN, 2000, J CLIN MICROBIOL, V38, P724, DOI 10.1128/JCM.38.2.724-726.2000; Nulens E, 2008, J CLIN MICROBIOL, V46, P2438, DOI 10.1128/JCM.00808-08; O'Mahony R, 2005, VET MICROBIOL, V109, P285, DOI 10.1016/j.vetmic.2005.06.003; Rich M, 2004, VET REC, V154, P310; Safdar N, 2003, J CLIN MICROBIOL, V41, P3163, DOI 10.1128/JCM.41.7.3163-3166.2003; Stein RA, 2009, INT J INFECT DIS, V13, P299, DOI 10.1016/j.ijid.2008.09.008; Stranden A, 2003, J CLIN MICROBIOL, V41, P3181, DOI 10.1128/JCM.41.7.3181-3186.2003; STRUELENS MJ, 1992, J CLIN MICROBIOL, V30, P2599, DOI 10.1128/JCM.30.10.2599-2605.1992; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; van Duijkeren E, 2004, EMERG INFECT DIS, V10, P2235, DOI 10.3201/eid1012.040387; Vitale CB, 2006, EMERG INFECT DIS, V12, P1998; Walther B, 2008, VET MICROBIOL, V127, P171, DOI 10.1016/j.vetmic.2007.07.018; Weese JS, 2006, VET MICROBIOL, V115, P148, DOI 10.1016/j.vetmic.2006.01.004; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039; Weese JS, 2005, EMERG INFECT DIS, V11, P430, DOI 10.3201/eid1103.040481; Weese JS, 2004, J VET INTERN MED, V18, P468, DOI 10.1892/0891-6640(2004)18&lt;468:IOMSAF&gt;2.0.CO;2; Wulf M, 2006, EMERG INFECT DIS, V12, P1939	43	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43329	10.1371/journal.pone.0043329	http://dx.doi.org/10.1371/journal.pone.0043329			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937034	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000308225500041
J	Feikin, DR; Njenga, MK; Bigogo, G; Aura, B; Aol, G; Audi, A; Jagero, G; Muluare, PO; Gikunju, S; Nderitu, L; Balish, A; Winchell, J; Schneider, E; Erdman, D; Oberste, MS; Katz, MA; Breiman, RF				Feikin, Daniel R.; Njenga, M. Kariuki; Bigogo, Godfrey; Aura, Barrack; Aol, George; Audi, Allan; Jagero, Geoffrey; Muluare, Peter Ochieng; Gikunju, Stella; Nderitu, Leonard; Balish, Amanda; Winchell, Jonas; Schneider, Eileen; Erdman, Dean; Oberste, M. Steven; Katz, Mark A.; Breiman, Robert F.			Etiology and Incidence of Viral and Bacterial Acute Respiratory Illness among Older Children and Adults in Rural Western Kenya, 2007-2010	PLOS ONE			English	Article							HIV-INFECTED ADULTS; COMMUNITY-ACQUIRED PNEUMONIA; REAL-TIME PCR; HOSPITALIZED CHILDREN; SYNCYTIAL VIRUS; MYCOPLASMA-PNEUMONIAE; HUMAN BOCAVIRUS; UGANDAN ADULTS; MORTALITY; DIAGNOSIS	Background: Few comprehensive data exist on disease incidence for specific etiologies of acute respiratory illness (ARI) in older children and adults in Africa. Methodology/Principal Findings: From March 1, 2007, to February 28, 2010, among a surveillance population of 21,420 persons >5 years old in rural western Kenya, we collected blood for culture and malaria smears, nasopharyngeal and oropharyngeal swabs for quantitative real-time PCR for ten viruses and three atypical bacteria, and urine for pneumococcal antigen testing on outpatients and inpatients meeting a ARI case definition (cough or difficulty breathing or chest pain and temperature >38.0 degrees C or oxygen saturation <90% or hospitalization). We also collected swabs from asymptomatic controls, from which we calculated pathogen-attributable fractions, adjusting for age, season, and HIV-status, in logistic regression. We calculated incidence by pathogen, adjusting for health-seeking for ARI and pathogen-attributable fractions. Among 3,406 ARI patients >5 years old (adjusted annual incidence 12.0 per 100 person-years), influenza A virus was the most common virus (22% overall; 11% inpatients, 27% outpatients) and Streptococcus pneumoniae was the most common bacteria (16% overall; 23% inpatients, 14% outpatients), yielding annual incidences of 2.6 and 1.7 episodes per 100 person-years, respectively. Influenza A virus, influenza B virus, respiratory syncytial virus (RSV) and human metapneumovirus were more prevalent in swabs among cases (22%, 6%, 8% and 5%, respectively) than controls. Adenovirus, parainfluenza viruses, rhinovirus/enterovirus, parechovirus, and Mycoplasma pneumoniae were not more prevalent among cases than controls. Pneumococcus and non-typhi Salmonella were more prevalent among HIV-infected adults, but prevalence of viruses was similar among HIV-infected and HIV-negative individuals. ARI incidence was highest during peak malaria season. Conclusions/Signficance: Vaccination against influenza and pneumococcus (by potential herd immunity from childhood vaccination or of HIV-infected adults) might prevent much of the substantial ARI incidence among persons >5 years old in similar rural African settings.	[Feikin, Daniel R.; Njenga, M. Kariuki; Bigogo, Godfrey; Aura, Barrack; Aol, George; Audi, Allan; Jagero, Geoffrey; Muluare, Peter Ochieng; Gikunju, Stella; Nderitu, Leonard; Breiman, Robert F.] Ctr Dis Control & Prevent, Global Dis Detect Div, Int Emerging Infect Program, Kisumu, Kenya; [Feikin, Daniel R.; Njenga, M. Kariuki; Bigogo, Godfrey; Aura, Barrack; Aol, George; Audi, Allan; Jagero, Geoffrey; Muluare, Peter Ochieng; Gikunju, Stella; Nderitu, Leonard; Katz, Mark A.; Breiman, Robert F.] Ctr Dis Control & Prevent, Kenya Med Res Inst, Publ Hlth & Res Collaborat, Kisumu, Kenya; [Balish, Amanda; Winchell, Jonas; Schneider, Eileen; Erdman, Dean; Oberste, M. Steven; Katz, Mark A.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA	Feikin, DR (corresponding author), Ctr Dis Control & Prevent, Global Dis Detect Div, Int Emerging Infect Program, Kisumu, Kenya.	dfeikin@jhsph.edu	Jagero, Geofrey/AAE-6835-2021; Bigogo, Godfrey/W-3591-2019	Audi, Allan/0000-0003-1683-554X	Core Funding of the International Emerging Infections Program of CDC	Core Funding of the International Emerging Infections Program of CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The funding for this project is from Core Funding of the International Emerging Infections Program of CDC. The findings and conclusions are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; [Anonymous], 2011, WORLD HLTH STAT; Bassat Q, 2011, AM J TROP MED HYG, V85, P626, DOI 10.4269/ajtmh.2011.11-0223; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Bickel P.J., 2001, MATH STAT BASIC IDEA; Brittain-Long R, 2008, J CLIN VIROL, V41, P53, DOI 10.1016/j.jcv.2007.10.029; Burton DC, 2011, J HEALTH POPUL NUTR, V29, P61, DOI 10.3329/jhpn.v29i1.7567; Butler JC, 2003, J INFECT DIS, V187, P1416, DOI 10.1086/374623; CLSI, 2009, M100S19 CLSI; Cohen C, 2010, CLIN INFECT DIS, V51, P1362, DOI 10.1086/657314; Dalal W, J AIDS IN PRESS; DAVIDSON M, 1976, JAMA-J AM MED ASSOC, V235, P158, DOI 10.1001/jama.235.2.158; Dowell SF, 1996, J INFECT DIS, V174, P456, DOI 10.1093/infdis/174.3.456; FALSEY AR, 1995, J INFECT DIS, V172, P389, DOI 10.1093/infdis/172.2.389; Feikin DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016085; Feikin DR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-186; Flannery B, 2006, ANN INTERN MED, V144, P1, DOI 10.7326/0003-4819-144-1-200601030-00004; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; Fry AM, 2007, J INFECT DIS, V195, P1038, DOI 10.1086/512163; Fry AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017780; Gordon MA, 2002, AIDS, V16, P1633, DOI 10.1097/00002030-200208160-00009; Graham SM, 2000, PEDIATR INFECT DIS J, V19, P1189, DOI 10.1097/00006454-200012000-00016; Grant AD, 1998, INT J TUBERC LUNG D, V2, P926; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Hammitt LL, 2012, CLIN INFECT DIS, V54, pS190, DOI 10.1093/cid/cir1071; Hartung TK, 2011, AM J TROP MED HYG, V85, P105, DOI 10.4269/ajtmh.2011.10-0640; Hicks LA, 2006, J AM GERIATR SOC, V54, P284, DOI 10.1111/j.1532-5415.2005.00529.x; Ideh RC, 2011, INT J TUBERC LUNG D, V15, P729, DOI 10.5588/ijtld.10.0468; Imamura Tadatsugu, 2011, Morbidity and Mortality Weekly Report, V60, P1301; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; Jokinen J, 2010, EPIDEMIOLOGY, V21, P719, DOI 10.1097/EDE.0b013e3181e4c4d5; JOOSTING ACC, 1979, S AFR MED J, V55, P403; Karstaedt AS, 2009, SAMJ S AFR MED J, V99, P750; Katz MA, J INFECT DI IN PRESS; Kenya National Bureau of Statistics, 2010, 2009 KEN POP HOUS CE; Kim C, 2011, J IMMIGR MINOR HEALT; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES; Kodani M, 2011, J CLIN MICROBIOL, V49, P2175, DOI 10.1128/JCM.02270-10; Lockman S, 2003, INT J TUBERC LUNG D, V7, P714; Longtin J, 2008, EMERG INFECT DIS, V14, P217, DOI 10.3201/eid1402.070851; Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07; MAARTENS G, 1994, S AFR MED J, V84, P678; MACFARLANE JT, 1979, THORAX, V34, P713, DOI 10.1136/thx.34.6.713; Murdoch DR, 2009, J CLIN MICROBIOL, V47, P3405, DOI 10.1128/JCM.01685-09; Murdoch DR, 2001, J CLIN MICROBIOL, V39, P3495, DOI 10.1128/JCM.39.10.3495-3498.2001; Murray JF, 2005, INT J TUBERC LUNG D, V9, P826; Nix WA, 2008, J CLIN MICROBIOL, V46, P2519, DOI 10.1128/JCM.00277-08; Nkinin SW, 2009, ACTA TROP, V112, P219, DOI 10.1016/j.actatropica.2009.07.030; Nunes MC, 2011, AIDS, V25, P453, DOI 10.1097/QAD.0b013e328341b7f1; Olsen SJ, 2010, EPIDEMIOL INFECT, V138, P1811, DOI 10.1017/S0950268810000646; Ope MO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020111; Ortiz JR, 2009, EMERG INFECT DIS, V15, P1271, DOI 10.3201/eid1508.081422; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P38; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X; Scott JAG, 2000, LANCET, V355, P1225, DOI 10.1016/S0140-6736(00)02089-4; Singeton RJ, 2010, J MED VIROL, V82, P1282, DOI 10.1002/jmv.21790; Smith MD, 2009, J CLIN MICROBIOL, V47, P1046, DOI 10.1128/JCM.01480-08; Thurman KA, 2011, DIAGN MICR INFEC DIS, V70, P1, DOI 10.1016/j.diagmicrobio.2010.11.014; Tornheim JA, 2007, INT J INFECT DIS, V11, P536, DOI 10.1016/j.ijid.2007.03.006; van't Hoog AH, 2011, AM J RESP CRIT CARE, V183, P1245, DOI 10.1164/rccm.201008-1269OC; Vray M, 2008, AIDS, V22, P1323, DOI 10.1097/QAD.0b013e3282fdf8bf; Vuori-Holopainen E, 2001, CLIN INFECT DIS, V32, P715, DOI 10.1086/319213; World Health Organization, 2003, WHOCDSCSRRMD20036; Worodria W, 2003, INT J TUBERC LUNG D, V7, P117; Zaki ME, 2009, MICROBIOL IMMUNOL, V53, P603, DOI 10.1111/j.1348-0421.2009.00162.x	68	96	100	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43656	10.1371/journal.pone.0043656	http://dx.doi.org/10.1371/journal.pone.0043656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937071	gold, Green Published, Green Submitted			2022-12-25	WOS:000308225500073
J	Gu, T; Su, X; Zhou, QY; Li, XY; Yu, M; Ding, Y; Zhao, SH; Li, CC				Gu, Ting; Su, Xi; Zhou, Quanyong; Li, Xinyun; Yu, Mei; Ding, Yi; Zhao, Shuhong; Li, Changchun			Molecular Characterization of the Neuronatin Gene in the Porcine Placenta	PLOS ONE			English	Article							INSULIN-SECRETION; LARGE WHITE; EXPRESSION; GESTATION; MEISHAN; ROLES; CELLS; PIGS	Imprinted genes play important roles in placental and embryonic development. Neuronatin (NNAT), first identified as an imprinted gene in human and mouse brains, played important roles in neuronal differentiation in the brain and in glucose-mediated insulin secretion in pancreatic beta cells. In the pig, NNAT was reported to be imprinted in eleven tissues. Our previous microarray hybridization study showed that NNAT was differentially expressed in Yorkshire and Meishan pig placentas, but the imprinting status and function of NNAT in the placenta have not been investigated. We demonstrated for the first time that NNAT was monoallelically expressed in the placenta. Immunochemistry analysis showed that NNAT was located in the uterine luminal and glandular epithelium in placentas. We also confirmed the differential expression of NNAT in Meishan and Yorkshire pig placentas by qPCR. Using IPA software and the published literature, we created a model network of the possible relationships between NNAT and glucose transporter genes. A dual luciferase reporter assay demonstrated that the crucial promoter region of NNAT contained a CANNTG sequence in the +210 to +215 positions, which corresponded to the E-box. Our findings demonstrated important roles of NNAT in placenta function.	[Gu, Ting; Su, Xi; Li, Xinyun; Yu, Mei; Ding, Yi; Zhao, Shuhong; Li, Changchun] Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Peoples R China; [Gu, Ting; Su, Xi; Li, Xinyun; Yu, Mei; Ding, Yi; Zhao, Shuhong; Li, Changchun] Huazhong Agr Univ, Key Lab Swine Genet & Breeding, Minist Agr, Wuhan, Peoples R China; [Zhou, Quanyong] Jiangxi Acad Agr Sci, Inst Anim Husb & Vet, Nanchang, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Gu, T (corresponding author), Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Peoples R China.	lichangchun@mail.hzau.edu.cn		Gu, Ting/0000-0002-8732-7377	National Natural Science Foundation of China [30972082, 31060300]; key project of Transgenetics of the Ministry of Agriculture; Creative team project of the Ministry of Education [IRT-0831]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key project of Transgenetics of the Ministry of Agriculture; Creative team project of the Ministry of Education	This work was supported by National Natural Science Foundation of China (30972082 and 31060300), the key project of Transgenetics of the Ministry of Agriculture, and the Creative team project (IRT-0831) of the Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAZER FW, 1988, J REPROD FERTIL, V84, P37, DOI 10.1530/jrf.0.0840037; Burton GJ, 2007, PLACENTA, V28, pS64, DOI 10.1016/j.placenta.2007.01.007; Charalambous M, 2003, P NATL ACAD SCI USA, V100, P8292, DOI 10.1073/pnas.1532175100; Chen H., MOL IMMUNOL, V47, P1601; Cheng HC, 2007, GENET SEL EVOL, V39, P599, DOI 10.1051/gse:2007024; Chu K, 2005, DIABETES, V54, P1064, DOI 10.2337/diabetes.54.4.1064; Evans HK, 2001, GENOMICS, V77, P99, DOI 10.1006/geno.2001.6612; Fu JJ, 2009, PLACENTA, V30, P305, DOI 10.1016/j.placenta.2009.01.005; Joe MK, 2008, CELL SIGNAL, V20, P907, DOI 10.1016/j.cellsig.2008.01.005; JOSEPH R, 1994, BIOCHEM BIOPH RES CO, V201, P1227, DOI 10.1006/bbrc.1994.1836; Kagitani F, 1997, NUCLEIC ACIDS RES, V25, P3428, DOI 10.1093/nar/25.17.3428; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Suh YH, 2005, BIOCHEM BIOPH RES CO, V337, P481, DOI 10.1016/j.bbrc.2005.09.078; Wilson ME, 1998, BIOL REPROD, V58, P905, DOI 10.1095/biolreprod58.4.905; Zhou QY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-337	16	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43325	10.1371/journal.pone.0043325	http://dx.doi.org/10.1371/journal.pone.0043325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937033	gold, Green Submitted, Green Published			2022-12-25	WOS:000308225500040
J	Jeon, E; Yun, YR; Kang, W; Lee, S; Koh, YH; Kim, HW; Suh, CK; Jang, JH				Jeon, Eunyi; Yun, Ye-Rang; Kang, Wonmo; Lee, Sujin; Koh, Young-Hyag; Kim, Hae-Won; Suh, Chang Kook; Jang, Jun-Hyeog			Investigating the Role of FGF18 in the Cultivation and Osteogenic Differentiation of Mesenchymal Stem Cells	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; FACTOR (FGF)-18; OSTEOBLAST; PROLIFERATION; FACTOR-18; FGF-18; EXPRESSION; THERAPY; SIGNALS; PROTEIN	Fibroblast growth factor18 (FGF18) belongs to the FGF family and is a pleiotropic protein that stimulates proliferation in several tissues. Bone marrow mesenchymal stem cells (BMSCs) participate in the normal replacement of damaged cells and in disease healing processes within bone and the haematopoietic system. In this study, we constructed FGF18 and investigated its effects on rat BMSCs (rBMSCs). The proliferative effects of FGF18 on rBMSCs were examined using an MTS assay. To validate the osteogenic differentiation effects of FGF18, ALP and mineralization activity were examined as well as osteogenic differentiation-related gene levels. FGF18 significantly enhanced rBMSCs proliferation (p < 0.001) and induced the osteogenic differentiation by elevating ALP and mineralization activity of rBMSCs (p < 0.001). Furthermore, these osteogenic differentiation effects of FGF18 were confirmed via increasing the mRNA levels of collagen type I (Col I), bone morphogenetic protein 4 (BMP4), and Runt-related transcription factor 2 (Runx2) at 3 and 7 days. These results suggest that FGF18 could be used to improve bone repair and regeneration.	[Jeon, Eunyi; Kang, Wonmo; Lee, Sujin; Jang, Jun-Hyeog] Inha Univ, Sch Med, Dept Biochem, Inchon, South Korea; [Yun, Ye-Rang; Kim, Hae-Won] Dankook Univ, Inst Tissue Regenerat Engn, Cheonan 330714, South Korea; [Koh, Young-Hyag] Korea Univ, Dept Denatal Lab Sci & Engn, Seoul, South Korea; [Kim, Hae-Won] Dankook Univ, Grad Sch, Dept Nanobiomed Sci, Cheonan, South Korea; [Kim, Hae-Won] Dankook Univ, Grad Sch, WCU Res Ctr, Cheonan, South Korea; [Kim, Hae-Won] Dankook Univ, Sch Dent, Dept Biomat Sci, Cheonan, South Korea; [Suh, Chang Kook] Inha Univ, Sch Med, Dept Physiol & Biophys, Inchon, South Korea	Inha University; Dankook University; Korea University; Dankook University; Dankook University; Dankook University; Inha University	Jeon, E (corresponding author), Inha Univ, Sch Med, Dept Biochem, Inchon, South Korea.	kimhw@dku.edu; juhjang@inha.ac.kr			Priority Research Centers Program through the National Research Foundation (NRF) [2009-0093829]; WCU (World Class University) through the National Research Foundation (NRF) [R31-10069]; Basic Science Research program through the National Research Foundation (NRF); Ministry of Education, Science and Technology through the National Research Foundation (NRF) [2010-0022628]; Ministry of Education, Science and Technology; Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A110416]; Inha University	Priority Research Centers Program through the National Research Foundation (NRF); WCU (World Class University) through the National Research Foundation (NRF); Basic Science Research program through the National Research Foundation (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology through the National Research Foundation (NRF); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Inha University	This work was supported by Priority Research Centers Program (grant#: 2009-0093829) and WCU (World Class University) program (grant#: R31-10069) and Basic Science Research program through the National Research Foundation (NRF) funded by the Ministry of Education, Science and Technology (grant#: 2010-0022628) through the National Research Foundation (NRF) funded by the Ministry of Education, Science and Technology and a grant of the Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A110416) and Inha University Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behr B, 2011, TISSUE ENG PT A, V17, P2061, DOI [10.1089/ten.tea.2010.0719, 10.1089/ten.TEA.2010.0719]; Beyer Nardi N, 2006, HANDB EXP PHARM, V174, P249; Bond SR, 2011, J BONE MINER RES, V26, P2911, DOI 10.1002/jbmr.509; Davidson D, 2005, J BIOL CHEM, V280, P20509, DOI 10.1074/jbc.M410148200; Ellsworth JL, 2002, OSTEOARTHR CARTILAGE, V10, P308, DOI 10.1053/joca.2002.0514; Grayson WL, 2004, BIOTECHNOL PROGR, V20, P905, DOI 10.1021/bp034296z; Hamidouche Z, 2010, J CELL PHYSIOL, V224, P509, DOI 10.1002/jcp.22152; Hu MCT, 1999, ONCOGENE, V18, P2635, DOI 10.1038/sj.onc.1202616; Hu MCT, 1998, MOL CELL BIOL, V18, P6063, DOI 10.1128/MCB.18.10.6063; Hwang S, 2011, CELL BIOL I IN PRESS; Kassem M, 2006, ANN NY ACAD SCI, V1067, P436, DOI 10.1196/annals.1354.062; Kimelman N, 2006, REGEN MED, V1, P549, DOI 10.2217/17460751.1.4.549; Li YG, 2011, KNEE SURG SPORT TR A, V19, P2153, DOI 10.1007/s00167-011-1506-0; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602; Marie PJ, 2008, ARCH BIOCHEM BIOPHYS, V473, P98, DOI 10.1016/j.abb.2008.02.030; Marie PJ, 2006, REGEN MED, V1, P539, DOI 10.2217/17460751.1.4.539; Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456; Moore EE, 2005, OSTEOARTHR CARTILAGE, V13, P623, DOI 10.1016/j.joca.2005.03.003; Oh SA, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/475260; Ohbayashi N, 1998, J BIOL CHEM, V273, P18161, DOI 10.1074/jbc.273.29.18161; Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pri-Chen S, 1998, BONE, V23, P111, DOI 10.1016/S8756-3282(98)00087-8; Shimoaka T, 2002, J BIOL CHEM, V277, P7493, DOI 10.1074/jbc.M108653200; Smith SML, 2007, ARCH BIOCHEM BIOPHYS, V468, P244, DOI 10.1016/j.abb.2007.10.006; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; Teplyuk NM, 2008, J BIOL CHEM, V283, P27585, DOI 10.1074/jbc.M802453200; Yamaguchi A, 1996, BIOCHEM BIOPH RES CO, V220, P366, DOI 10.1006/bbrc.1996.0411; Yun YR, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/218142	31	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43982	10.1371/journal.pone.0043982	http://dx.doi.org/10.1371/journal.pone.0043982			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937141	gold, Green Submitted, Green Published			2022-12-25	WOS:000308225500132
J	Onodera, CS; Underwood, JG; Katzman, S; Jacobs, F; Greenberg, D; Salama, SR; Haussler, D				Onodera, Courtney S.; Underwood, Jason G.; Katzman, Sol; Jacobs, Frank; Greenberg, David; Salama, Sofie R.; Haussler, David			Gene Isoform Specificity through Enhancer-Associated Antisense Transcription	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; NEURAL DIFFERENTIATION; NONCODING RNAS; DNA METHYLATION; HUMAN PROMOTERS; HUMAN GENOME; REVEALS; EXPRESSION; CHROMATIN; IDENTIFICATION	Enhancers and antisense RNAs play key roles in transcriptional regulation through differing mechanisms. Recent studies have demonstrated that enhancers are often associated with non-coding RNAs (ncRNAs), yet the functional role of these enhancer: ncRNA associations is unclear. Using RNA-Sequencing to interrogate the transcriptomes of undifferentiated mouse embryonic stem cells (mESCs) and their derived neural precursor cells (NPs), we identified two novel enhancer-associated antisense transcripts that appear to control isoform-specific expression of their overlapping protein-coding genes. In each case, an enhancer internal to a protein-coding gene drives an antisense RNA in mESCs but not in NPs. Expression of the antisense RNA is correlated with expression of a shorter isoform of the associated sense gene that is not present when the antisense RNA is not expressed. We demonstrate that expression of the antisense transcripts as well as expression of the short sense isoforms correlates with enhancer activity at these two loci. Further, overexpression and knockdown experiments suggest the antisense transcripts regulate expression of their associated sense genes via cis-acting mechanisms. Interestingly, the protein-coding genes involved in these two examples, Zmynd8 and Brd1, share many functional domains, yet their antisense ncRNAs show no homology to each other and are not present in non-murine mammalian lineages, such as the primate lineage. The lack of homology in the antisense ncRNAs indicates they have evolved independently of each other and suggests that this mode of lineage-specific transcriptional regulation may be more widespread in other cell types and organisms. Our findings present a new view of enhancer action wherein enhancers may direct isoform-specific expression of genes through ncRNA intermediates.	[Onodera, Courtney S.; Underwood, Jason G.; Katzman, Sol; Jacobs, Frank; Greenberg, David; Salama, Sofie R.; Haussler, David] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Underwood, Jason G.; Katzman, Sol; Jacobs, Frank; Salama, Sofie R.; Haussler, David] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Underwood, Jason G.; Salama, Sofie R.; Haussler, David] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Greenberg, David] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Onodera, CS (corresponding author), Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA.	ssalama@soe.ucsc.edu	Jacobs, Frank/O-1809-2014; Salama, Sofie/K-6412-2019; Jacobs, Frank/GSD-3616-2022	Jacobs, Frank/0000-0003-4423-1479; Salama, Sofie/0000-0001-6999-7193	California Institute for Regenerative Medicine [T3-00006]; National Institutes of Health (NIH)/National Human Genome Research Institute [U41 HG004568-01]; NIH [1R03DA026061-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG004568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA026061] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health (NIH)/National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	CSO was supported in part by California Institute for Regenerative Medicine training grant T3-00006, and by National Institutes of Health (NIH)/National Human Genome Research Institute U41 HG004568-01. This study was funded in part by NIH 1R03DA026061-01 to SRS. DH is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Graham MJ, 2007, J LIPID RES, V48, P763, DOI 10.1194/jlr.C600025-JLR200; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Han JH, 2011, TRENDS CELL BIOL, V21, P336, DOI 10.1016/j.tcb.2011.03.003; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Ideue T, 2009, RNA, V15, P1578, DOI 10.1261/rna.1657609; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mishima Y, 2011, BLOOD, V118, P2443, DOI 10.1182/blood-2011-01-331892; Morrissy AS, 2011, GENOME RES, V21, P1203, DOI 10.1101/gr.113431.110; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Poleshko A, 2010, J BIOL CHEM, V285, P422, DOI 10.1074/jbc.M109.064667; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Sambrook J., 2006, COLD SPRING HARBOR P; Seidl CIM, 2006, EMBO J, V25, P3565, DOI 10.1038/sj.emboj.7601245; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Siepel A, 2005, STAT BIOL HEALTH, P325, DOI 10.1007/0-387-27733-1_12; Skarnes WC, 2000, METHOD ENZYMOL, V328, P592, DOI 10.1016/S0076-6879(00)28420-6; Smit A, 1996, REPEATMASKER OPEN 30; SMIT AFA, 1993, NUCLEIC ACIDS RES, V21, P1863, DOI 10.1093/nar/21.8.1863; Stavridis MP, 2003, BIOCHEM SOC T, V31, P45, DOI 10.1042/bst0310045; Tikole S, 2008, BIOCHEM BIOPH RES CO, V369, P1166, DOI 10.1016/j.bbrc.2008.03.008; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Underwood JG, 2010, NAT METHODS, V7, P995, DOI 10.1038/NMETH.1529; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Werner Andreas, 2005, RNA Biol, V2, P53, DOI 10.4161/rna.2.2.1852; Wu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018919; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Zeng WL, 2010, BIOCHEM BIOPH RES CO, V394, P1024, DOI 10.1016/j.bbrc.2010.03.115	63	20	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43511	10.1371/journal.pone.0043511	http://dx.doi.org/10.1371/journal.pone.0043511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937057	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500058
J	Nardozzi, JD; Wang, XW; Mbantenkhu, M; Wilkens, S; Chen, XJ				Nardozzi, Jonathan D.; Wang, Xiaowen; Mbantenkhu, MacMillan; Wilkens, Stephan; Chen, Xin Jie			A Properly Configured Ring Structure Is Critical for the Function of the Mitochondrial DNA Recombination Protein, Mgm101	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; RAD52 PROTEIN; HOMOLOGOUS RECOMBINATION; REPLICATION; MAINTENANCE; GENOME; REPAIR; DOMAIN; SEQUENCES	Mgm101 is a Rad52-type recombination protein of bacteriophage origin required for the repair and maintenance of mitochondrial DNA (mtDNA). It forms large oligomeric rings of similar to 14-fold symmetry that catalyze the annealing of single-stranded DNAs in vitro. In this study, we investigated the structural elements that contribute to this distinctive higher order structural organization and examined its functional implications. A pair of vicinal cysteines, Cys-216 and Cys-217, was found to be essential for mtDNA maintenance. Mutations to the polar serine, the negatively charged aspartic and glutamic acids, and the hydrophobic amino acid alanine all destabilize mtDNA in vivo. The alanine mutants have an increased propensity of forming macroscopic filaments. In contrast, mutations to aspartic acid drastically destabilize the protein and result in unstructured aggregates with severely reduced DNA binding activity. Interestingly, the serine mutants partially disassemble the Mgm101 rings into smaller oligomers. In the case of the C216S mutant, a moderate increase in DNA binding activity was observed. By using small angle x-ray scattering analysis, we found that Mgm101 forms rings of similar to 200 angstrom diameter in solution, consistent with the structure previously established by transmission electron microscopy. We also found that the C216A/C217A double mutant tends to form broken rings, which likely provide free ends for seeding the growth of the super-stable but functionally defective filaments. Taken together, our data underscore the importance of a delicately maintained ring structure critical for Mgm101 activity. We discuss a potential role of Cys-216 and Cys-217 in regulating Mgm101 function and the repair of damaged mtDNA under stress conditions.	[Nardozzi, Jonathan D.; Wang, Xiaowen; Mbantenkhu, MacMillan; Wilkens, Stephan; Chen, Xin Jie] State Univ New York Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Chen, XJ (corresponding author), State Univ New York Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	chenx@upstate.edu		Nardozzi, Jonathan/0000-0002-6655-4765	National Institutes of Health [R01AG023731, R01GM058600]; National Science Foundation; NIGMS, National Institutes of Health; NCRR, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AG023731 and R01GM058600 (to X. J. C. and S. W.).; We thank the Cornell High Energy Synchrotron Source (CHESS) and the Macromolecular Diffraction at CHESS (MacCHESS) facility for beam time; Richard Gillilan for advice in SAXS data collection and analysis; Stewart Loh for the use of FPLC, and Jeung-Hoi (Jenny) Ha for help in the analysis of DNA binding data. CHESS is supported by the National Science Foundation and NIGMS, National Institutes of Health, and the MacCHESS resource is supported by NCRR, National Institutes of Health.	Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; CHEN XJ, 1993, NUCLEIC ACIDS RES, V21, P3473, DOI 10.1093/nar/21.15.3473; ClarkWalker GD, 1996, MOL GEN GENET, V252, P746, DOI 10.1007/s004380050285; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; GAILLARD C, 1980, NATURE, V283, P218, DOI 10.1038/283218a0; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Itoh K, 2011, MITOCHONDRION, V11, P575, DOI 10.1016/j.mito.2011.03.002; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-8; Janicka S., 2012, PLANT J IN PRESS; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Kalifa L, 2012, GENETICS, V190, P951, DOI 10.1534/genetics.111.138214; Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Lim SI, 2008, J MOL BIOL, V384, P1098, DOI 10.1016/j.jmb.2008.10.047; LING F, 1995, EMBO J, V14, P4090, DOI 10.1002/j.1460-2075.1995.tb00081.x; Ling F, 2000, NUCLEIC ACIDS RES, V28, P4956, DOI 10.1093/nar/28.24.4956; Lopes A, 2010, NUCLEIC ACIDS RES, V38, P3952, DOI 10.1093/nar/gkq096; Mbantenkhu M, 2011, J BIOL CHEM, V286, P42360, DOI 10.1074/jbc.M111.307512; Meeusen S, 1999, J CELL BIOL, V145, P291, DOI 10.1083/jcb.145.2.291; Nagahara N, 2009, CURR MED CHEM, V16, P4419, DOI 10.2174/092986709789712880; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Nimonkar AV, 2009, P NATL ACAD SCI USA, V106, P3077, DOI 10.1073/pnas.0813247106; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Passy SI, 1999, P NATL ACAD SCI USA, V96, P4279, DOI 10.1073/pnas.96.8.4279; Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009; Ploquin M, 2008, CURR BIOL, V18, P1142, DOI 10.1016/j.cub.2008.06.071; Poteete AR, 2008, MOL MICROBIOL, V68, P66, DOI 10.1111/j.1365-2958.2008.06133.x; POTEETE AR, 1983, J MOL BIOL, V171, P401, DOI 10.1016/0022-2836(83)90037-2; Rothenberg E, 2008, P NATL ACAD SCI USA, V105, P20274, DOI 10.1073/pnas.0810317106; Samach A, 2011, PLANT CELL, V23, P4266, DOI 10.1105/tpc.111.091744; Shi I, 2009, J BIOL CHEM, V284, P33275, DOI 10.1074/jbc.M109.057752; Shibata T, 2007, MITOCHONDRION, V7, P17, DOI 10.1016/j.mito.2006.11.024; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; Stasiak AZ, 2000, CURR BIOL, V10, P337, DOI 10.1016/S0960-9822(00)00385-7; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; ZINN AR, 1988, P NATL ACAD SCI USA, V85, P2686, DOI 10.1073/pnas.85.8.2686; Zuo XM, 2007, FEMS YEAST RES, V7, P131, DOI 10.1111/j.1567-1364.2006.00141.x; Zuo XM, 2002, GENETICS, V160, P1389	44	9	9	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37259	37268		10.1074/jbc.M112.389965	http://dx.doi.org/10.1074/jbc.M112.389965			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22948312	Green Published, hybrid			2022-12-25	WOS:000310588500058
J	McAllister, CS; Taghavi, N; Samuel, CE				McAllister, Christopher S.; Taghavi, Nora; Samuel, Charles E.			Protein Kinase PKR Amplification of Interferon beta Induction Occurs through Initiation Factor eIF-2 alpha-mediated Translational Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; TOLL-LIKE-RECEPTORS; TRANSCRIPTION FACTORS; DEPENDENT ACTIVATION; REGULATORY FACTOR-3; TEMPORAL CONTROL; MESSENGER-RNA; RECOGNITION; MECHANISM	The protein kinase PKR is activated by RNA with double-stranded (ds) structure and subsequently impairs translation through phosphorylation of protein synthesis initiation factor eIF-2 alpha. PKR also mediates activation of signal transduction pathways leading to interferon beta (IFN-beta) gene induction following virus-infection or RNA transfection. We previously demonstrated in measles virus-infected cells that PKR is required for the maximal induction of IFN-beta gene expression by the interferon promoter stimulator gene 1(IPS-1) adaptor-dependent cytosolic RNA sensor pathway. While both IPS-1 and PKR are important mediators of IFN-beta induction, with PKR contributing to an enhanced NF-kappa B activation, the mechanism by which PKR enhances NF-kappa B activity and amplifies IFN-beta induction is unresolved. Herein we tested the possibility that PKR could activate signal transduction pathways indirectly through translational control responses. Following transfection with synthetic or natural dsRNAs or infection with measles virus, we observed increased mRNA but decreased protein levels for the inhibitor of NF-kappa B signaling, I kappa B-alpha, that correlated with PKR activation and eIF-2 alpha phosphorylation. Importantly, knockdown of PKR increased I kappa B-alpha protein levels and impaired IFN-beta induction. Additionally, inhibition of translation by cycloheximide treatment rescued IFN-beta induction following PKR knockdown but not IPS-1 knockdown. Mutation of eIF-2 alpha to prevent phosphorylation also impaired IFN-beta induction in PKR-sufficient virus-infected cells. These results suggest that an eIF-2 alpha-dependent translation inhibition mechanism is sufficient to explain the PKR-mediated amplification of IPS-1-dependent IFN-beta induction by foreign RNA.	[McAllister, Christopher S.; Taghavi, Nora; Samuel, Charles E.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Samuel, CE (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	samuel@lifesci.ucsb.edu			NIAID, National Institutes of Health, U.S. Public Health Service [AI-12520, AI-20611]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI012520, R01AI012520, R01AI020611] Funding Source: NIH RePORTER	NIAID, National Institutes of Health, U.S. Public Health Service; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by Research Grants AI-12520 and AI-20611 from the NIAID, National Institutes of Health, U.S. Public Health Service.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; Arnaud N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010575; Baltzis D, 2002, J BIOL CHEM, V277, P38364, DOI 10.1074/jbc.M203564200; Bevilacqua PC, 1998, BIOCHEMISTRY-US, V37, P6303, DOI 10.1021/bi980113j; BISCHOFF JR, 1989, VIROLOGY, V172, P106, DOI 10.1016/0042-6822(89)90112-8; Bonnet MC, 2006, CELL SIGNAL, V18, P1865, DOI 10.1016/j.cellsig.2006.02.010; CASHDOLLAR LW, 1984, VIROLOGY, V133, P191, DOI 10.1016/0042-6822(84)90438-0; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Das S, 2006, J BIOL CHEM, V281, P3244, DOI 10.1074/jbc.M510612200; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; DER SD, 1995, P NATL ACAD SCI USA, V92, P8841, DOI 10.1073/pnas.92.19.8841; Devaux P, 2008, J VIROL, V82, P5359, DOI 10.1128/JVI.00169-08; Devaux P, 2007, VIROLOGY, V360, P72, DOI 10.1016/j.virol.2006.09.049; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Heinicke LA, 2009, J MOL BIOL, V390, P319, DOI 10.1016/j.jmb.2009.05.005; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Karber G, 1931, N-S ARCH EX PATH PH, V162, P480, DOI 10.1007/BF01863914; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; LAMPSON GP, 1967, P NATL ACAD SCI USA, V58, P782, DOI 10.1073/pnas.58.2.782; Li ZQ, 2012, J VIROL, V86, P3787, DOI 10.1128/JVI.06307-11; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; McAllister CS, 2010, J VIROL, V84, P380, DOI 10.1128/JVI.02630-08; McAllister CS, 2009, J BIOL CHEM, V284, P1644, DOI 10.1074/jbc.M807888200; MCCORMACK SJ, 1992, VIROLOGY, V188, P47, DOI 10.1016/0042-6822(92)90733-6; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Saito T, 2008, J EXP MED, V205, P1523, DOI 10.1084/jem.20081210; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SAMUEL CE, 1979, P NATL ACAD SCI USA, V76, P600, DOI 10.1073/pnas.76.2.600; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007; Sen A, 2011, J VIROL, V85, P3717, DOI 10.1128/JVI.02634-10; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Taghavi N, 2012, VIROLOGY, V427, P208, DOI 10.1016/j.virol.2012.01.029; THOMIS DC, 1992, VIROLOGY, V188, P33, DOI 10.1016/0042-6822(92)90732-5; Thompson AJ, 2007, IMMUNOL CELL BIOL, V85, P435, DOI 10.1038/sj.icb.7100100; Toth A. M., 2006, PROG NUCL ACIDS RES, V81, P369; Toth AM, 2009, J VIROL, V83, P961, DOI 10.1128/JVI.01669-08; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zamanian-Daryoush M, 2000, MOL CELL BIOL, V20, P1278, DOI 10.1128/MCB.20.4.1278-1290.2000; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	61	61	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36384	36392		10.1074/jbc.M112.390039	http://dx.doi.org/10.1074/jbc.M112.390039			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948139	hybrid, Green Published			2022-12-25	WOS:000310364000058
J	Parmalee, NL; Schubert, C; Figueroa, M; Bird, AC; Peto, T; Gillies, MC; Bernstein, PS; Kiryluk, K; Terwilliger, JD; Allikmets, R				Parmalee, Nancy L.; Schubert, Carl; Figueroa, Maria; Bird, Alan C.; Peto, Tunde; Gillies, Mark C.; Bernstein, Paul S.; Kiryluk, Krzysztof; Terwilliger, Joseph D.; Allikmets, Rando		MacTel Project	Identification of a Potential Susceptibility Locus for Macular Telangiectasia Type 2	PLOS ONE			English	Article							JUXTAFOVEOLAR RETINAL TELANGIECTASIS; MONOZYGOTIC TWINS; CLASSIFICATION; ASSOCIATION; PREVALENCE	Macular Telangiectasia type 2 (MacTel) is a relatively rare macular disease of adult onset presenting with distortions in the visual field and leading to progressive loss of visual acuity. For the purpose of a gene mapping study, several pedigrees were ascertained with multiple affected family members. Seventeen families with a total of 71 individuals (including 45 affected or possibly affected) were recruited at clinical centers in 7 countries under the auspices of the MacTel Project. The disease inheritance was consistent with autosomal dominant segregation with reduced penetrance. Genome-wide linkage analysis was performed, followed by analysis of recombination breakpoints. Linkage analysis identified a single peak with multi-point LOD score of 3.45 on chromosome 1 at 1q41-42 under a dominant model. Recombination mapping defined a minimal candidate region of 15.6 Mb, from 214.32 (rs1579634; 219.96 cM) to 229.92 Mb (rs7542797; 235.07 cM), encompassing the 1q41-42 linkage peak. Sanger sequencing of the top 14 positional candidates genes under the linkage peak revealed no causal variants in these pedigrees.	[Parmalee, Nancy L.; Schubert, Carl; Allikmets, Rando] Columbia Univ, Dept Ophthalmol, New York, NY 10027 USA; [Parmalee, Nancy L.; Terwilliger, Joseph D.] Columbia Univ, Dept Genet & Dev, New York, NY USA; [Kiryluk, Krzysztof] Columbia Univ, Dept Med, New York, NY USA; [Terwilliger, Joseph D.] Columbia Univ, Dept Psychiat, New York, NY USA; [Terwilliger, Joseph D.] Columbia Univ, Columbia Genome Ctr, New York, NY USA; [Allikmets, Rando] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Figueroa, Maria] EMMES Corp, Rockville, MD USA; [Bird, Alan C.; Peto, Tunde] Moorfields Eye Hosp, London, England; [Gillies, Mark C.] Univ Sydney, Dept Clin Ophthalmol & Eye Hlth, Save Sight Inst, Sydney, NSW 2006, Australia; [Bernstein, Paul S.] Univ Utah, Sch Med, Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Emmes Corporation; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Sydney; Utah System of Higher Education; University of Utah	Parmalee, NL (corresponding author), Columbia Univ, Dept Ophthalmol, New York, NY 10027 USA.	rla22@columbia.edu	gillies, mark c/B-3242-2012; Peto, Tunde/G-8812-2018; Allikmets, Rando/ABD-4533-2021	Peto, Tunde/0000-0001-6265-0381; 	Lowy Medical Research Foundation through the MacTel Project; NEI Vision Training Grant; DoH NIHR BMRC MEH funding; NATIONAL EYE INSTITUTE [P30EY014800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK090207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084995] Funding Source: NIH RePORTER	Lowy Medical Research Foundation through the MacTel Project; NEI Vision Training Grant; DoH NIHR BMRC MEH funding; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work was funded by the Lowy Medical Research Foundation, through the MacTel Project. https://web.emmes.com/study/mactel/about/about.htm. N.L.P. has received a portion of her funding from the NEI Vision Training Grant. T. P. has received part of her funding from DoH NIHR BMRC MEH funding. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Maria Figueroa is an employee of The EMMES Corporation. The EMMES Corporation was contracted by the MacTel Project to provide data management services regarding patient enrollment.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Aung KZ, 2010, RETINA-J RET VIT DIS, V30, P473, DOI 10.1097/IAE.0b013e3181bd2c71; Chew E, 2006, ARCH OPHTHALMOL-CHIC, V124, P573, DOI 10.1001/archopht.124.4.573; CHEW EY, 1986, ARCH OPHTHALMOL-CHIC, V104, P71; Clemons TE, 2010, OPHTHAL EPIDEMIOL, V17, P66, DOI 10.3109/09286580903450361; Finger RP, 2009, INVEST OPHTH VIS SCI, V50, P1366, DOI 10.1167/iovs.08-2032; GASS JDM, 1993, OPHTHALMOLOGY, V100, P1536; Gillies MC, 2009, OPHTHALMOLOGY, V116, P2422, DOI 10.1016/j.ophtha.2009.05.010; Hannan SR, 2007, BRIT J OPHTHALMOL, V91, P1729, DOI 10.1136/bjo.2007.115675; HUTTON WL, 1978, ARCH OPHTHALMOL-CHIC, V96, P1362; Issa PC, 2009, EYE, V23, P435, DOI 10.1038/sj.eye.6703003; Issa PC, 2008, ACTA OPHTHALMOL, V86, P464, DOI 10.1111/j.1600-0420.2007.01041.x; Issa PC, 2008, INVEST OPHTH VIS SCI, V49, P1172, DOI 10.1167/iovs.07-0636; Issa PC, 2007, INVEST OPHTH VIS SCI, V48, P3788, DOI 10.1167/iovs.06-1272; Issa PC, 2009, DOC OPHTHALMOL, V119, P133, DOI 10.1007/s10633-009-9190-9; Issa PC, 2009, EXP EYE RES, V89, P25, DOI 10.1016/j.exer.2009.02.006; Klein R, 2010, AM J OPHTHALMOL, V150, P55, DOI 10.1016/j.ajo.2010.02.013; Menchini U, 2000, AM J OPHTHALMOL, V129, P401, DOI 10.1016/S0002-9394(99)00380-3; Oh KT, 1999, RETINA-J RET VIT DIS, V19, P246, DOI 10.1097/00006982-199903000-00012; Parmalee NL, 2010, MOL VIS, V16, P2718; Purcell S, PLINK WHOLE GENOME D; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Siddiqui N, 2005, AM J OPHTHALMOL, V139, P568, DOI 10.1016/j.ajo.2004.09.030; Yannuzzi LA, 2006, ARCH OPHTHALMOL-CHIC, V124, P450, DOI 10.1001/archopht.124.4.450	24	24	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e24268	10.1371/journal.pone.0024268	http://dx.doi.org/10.1371/journal.pone.0024268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952568	gold, Green Published			2022-12-25	WOS:000308221300001
J	Ulas, T; Riemer, SA; Zaparty, M; Siebers, B; Schomburg, D				Ulas, Thomas; Riemer, S. Alexander; Zaparty, Melanie; Siebers, Bettina; Schomburg, Dietmar			Genome-Scale Reconstruction and Analysis of the Metabolic Network in the Hyperthermophilic Archaeon Sulfolobus Solfataricus	PLOS ONE			English	Article							GENUS SULFOLOBUS; CARBON FIXATION; BINDING-PROTEIN; BACTERIA; PATHWAY; TRANSPORT; MODELS; P2; ACIDOCALDARIUS; DEHYDROGENASE	We describe the reconstruction of a genome-scale metabolic model of the crenarchaeon Sulfolobus solfataricus, a hyperthermoacidophilic microorganism. It grows in terrestrial volcanic hot springs with growth occurring at pH 2-4 (optimum 3.5) and a temperature of 75-80 degrees C (optimum 80 degrees C). The genome of Sulfolobus solfataricus P2 contains 2,992,245 bp on a single circular chromosome and encodes 2,977 proteins and a number of RNAs. The network comprises 718 metabolic and 58 transport/exchange reactions and 705 unique metabolites, based on the annotated genome and available biochemical data. Using the model in conjunction with constraint-based methods, we simulated the metabolic fluxes induced by different environmental and genetic conditions. The predictions were compared to experimental measurements and phenotypes of S. solfataricus. Furthermore, the performance of the network for 35 different carbon sources known for S. solfataricus from the literature was simulated. Comparing the growth on different carbon sources revealed that glycerol is the carbon source with the highest biomass flux per imported carbon atom (75% higher than glucose). Experimental data was also used to fit the model to phenotypic observations. In addition to the commonly known heterotrophic growth of S. solfataricus, the crenarchaeon is also able to grow autotrophically using the hydroxypropionate-hydroxybutyrate cycle for bicarbonate fixation. We integrated this pathway into our model and compared bicarbonate fixation with growth on glucose as sole carbon source. Finally, we tested the robustness of the metabolism with respect to gene deletions using the method of Minimization of Metabolic Adjustment (MOMA), which predicted that 18% of all possible single gene deletions would be lethal for the organism.	[Ulas, Thomas; Riemer, S. Alexander; Schomburg, Dietmar] Tech Univ Carolo Wilhelmina Braunschweig, Dept Bioinformat & Biochem, D-38106 Braunschweig, Germany; [Zaparty, Melanie] Univ Regensburg, Inst Mol & Cellular Anat, Regensburg, Germany; [Siebers, Bettina] Univ Duisburg Essen, Fac Chem, Biofilm Ctr, Essen, Germany	Braunschweig University of Technology; University of Regensburg; University of Duisburg Essen	Ulas, T (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Dept Bioinformat & Biochem, D-38106 Braunschweig, Germany.	d.schomburg@tu-bs.de		Schomburg, Dietmar/0000-0002-3354-822X; Siebers, Bettina/0000-0002-9905-541X	BMBF [0315004B, 0315004A]	BMBF(Federal Ministry of Education & Research (BMBF))	The project was performed in the course of the transnational SysMO initiative within the Sulfolobus Systemsbiology "SulfoSYS" project. Thomas Ulas was supported by the BMBF (0315004B) and Melanie Zaparty was supported by the BMBF (0315004A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers SV, 1999, J BACTERIOL, V181, P4285, DOI 10.1128/JB.181.14.4285-4291.1999; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ates O, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-12; Bannert C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-589; Bar-Even A, 2012, J EXP BOT, V63, P2325, DOI 10.1093/jxb/err417; Becker J, 2011, METAB ENG, V13, P159, DOI 10.1016/j.ymben.2011.01.003; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; Berg IA, 2010, NAT REV MICROBIOL, V8, P447, DOI 10.1038/nrmicro2365; Boyle NR, 2011, METAB ENG, V13, P150, DOI 10.1016/j.ymben.2011.01.005; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Brouns SJJ, 2006, J BIOL CHEM, V281, P27378, DOI 10.1074/jbc.M605549200; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Chong PK, 2007, J PROTEOME RES, V6, P3985, DOI 10.1021/pr070232y; Christen P, 2011, BIODEGRADATION, V22, P475, DOI 10.1007/s10532-010-9420-6; Chung BKS, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-50; COLLINS MD, 1981, MICROBIOL REV, V45, P316, DOI 10.1128/MMBR.45.2.316-354.1981; Cozzone AJ, 1998, ANNU REV MICROBIOL, V52, P127, DOI 10.1146/annurev.micro.52.1.127; Dal'Molin CGD, 2010, PLANT PHYSIOL, V152, P579, DOI 10.1104/pp.109.148817; Daniel RM, 2000, CELL MOL LIFE SCI, V57, P250, DOI 10.1007/PL00000688; Duggin IG, 2006, J BIOL CHEM, V281, P15029, DOI 10.1074/jbc.R500029200; Elferink MGL, 2001, MOL MICROBIOL, V39, P1494, DOI 10.1046/j.1365-2958.2001.02336.x; Esser D, 2012, J PROTEOME RES, V11, P4823, DOI 10.1021/pr300190k; Esser D, 2011, EXTREMOPHILES, V15, P711, DOI 10.1007/s00792-011-0392-1; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100046; GROGAN DW, 1989, J BACTERIOL, V171, P6710, DOI 10.1128/jb.171.12.6710-6719.1989; Han L, 2003, BIOPROC BIOSYST ENG, V25, P205, DOI 10.1007/s00449-002-0300-2; Hucka M., 2008, NAT PRECED, V58, DOI [10.1038/npre.2008.2715.1, DOI 10.1038/NPRE.2008.2715.1]; Izzo V, 2005, RES MICROBIOL, V156, P677, DOI 10.1016/j.resmic.2005.04.001; Jamshidi N, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-26; Janssen P, 2005, EMBO REP, V6, P397, DOI 10.1038/sj.embor.7400412; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Kieldsen KR, 2009, BIOTECHNOL BIOENG, V102, P583, DOI 10.1002/bit.22067; Koerdt A, 2012, EXTREMOPHILES, V16, P115, DOI 10.1007/s00792-011-0411-2; Kumar VS, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-28; Lamble HJ, 2003, J BIOL CHEM, V278, P34066, DOI 10.1074/jbc.M305818200; LUBBEN M, 1995, BBA-BIOENERGETICS, V1229, P1, DOI 10.1016/0005-2728(94)00174-4; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; NICOLAUS B, 1991, BIOTECHNOL LETT, V13, P667, DOI 10.1007/BF01086324; NICOLAUS B, 1992, SYST APPL MICROBIOL, V15, P18, DOI 10.1016/S0723-2020(11)80131-1; NICOLAUS B, 1993, FEMS MICROBIOL LETT, V109, P203, DOI 10.1111/j.1574-6968.1993.tb06168.x; Nunn CEM, 2010, J BIOL CHEM, V285, P33701, DOI 10.1074/jbc.M110.146332; Orita I, 2006, J BACTERIOL, V188, P4698, DOI 10.1128/JB.00492-06; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Pfeifer F, 1994, MOL BIOL ARCH BAS S; PIRT SJ, 1965, PROC R SOC SER B-BIO, V163, P224, DOI 10.1098/rspb.1965.0069; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Quester S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-376; Ren QH, 2004, NUCLEIC ACIDS RES, V32, pD284, DOI 10.1093/nar/gkh016; Schafer G, 1999, MICROBIOL MOL BIOL R, V63, P570; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; SCHONHEIT P, 1995, WORLD J MICROB BIOT, V11, P26, DOI 10.1007/BF00339135; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; Simon G, 2009, FEMS MICROBIOL LETT, V299, P255, DOI 10.1111/j.1574-6968.2009.01759.x; Snijders APL, 2006, PROTEOMICS, V6, P1518, DOI 10.1002/pmic.200402070; Teufel R, 2009, J BACTERIOL, V191, P4572, DOI 10.1128/JB.00068-09; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; WHITE RH, 1988, J BACTERIOL, V170, P4608, DOI 10.1128/jb.170.10.4608-4612.1988; Wieloch P, 2012, THESIS U BRAUNSCHWEI; YU JP, 1994, J BACTERIOL, V176, P325, DOI 10.1128/JB.176.2.325-332.1994; Zaparty M, 2010, EXTREMOPHILES, V14, P119, DOI 10.1007/s00792-009-0280-0; ZHOU D, 1989, J BACTERIOL, V171, P6610, DOI 10.1128/jb.171.12.6610-6616.1989; ZILLIG W, 1980, ARCH MICROBIOL, V125, P259, DOI 10.1007/BF00446886; Zillig W, 1991, CURR OPIN GENET DEV, V1, P544, DOI 10.1016/S0959-437X(05)80206-0; Zolghadr B, 2010, J BACTERIOL, V192, P104, DOI 10.1128/JB.01061-09	70	32	33	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43401	10.1371/journal.pone.0043401	http://dx.doi.org/10.1371/journal.pone.0043401			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952675	Green Submitted, Green Published, gold			2022-12-25	WOS:000308221300014
J	Afonso, JM; Bello, G; Guimaraes, ML; Sojka, M; Morgado, MG				Afonso, Joana Morais; Bello, Gonzalo; Guimaraes, Monick L.; Sojka, Marta; Morgado, Mariza G.			HIV-1 Genetic Diversity and Transmitted Drug Resistance Mutations among Patients from the North, Central and South Regions of Angola	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CIRCULATING RECOMBINANT; SURVEILLANCE; VARIABILITY; PREVENTION; AFRICA; ORIGIN	Background: Angola presents a very complex HIV-1 epidemic characterized by the co-circulation of several HIV-1 group M subtypes, intersubtype recombinants and unclassified (U) variants. The viral diversity outside the major metropolitan regions (Luanda and Cabinda) and the prevalence of transmitted drug resistance mutations (DRM) since the introduction of HAART in 2004, however, has been barely studied. Methods: One hundred and one individuals from the Central (n = 44), North (n = 35), and South (n = 22) regions of Angola were diagnosed as HIV-1 positive and had their blood collected between 2008 and 2010, at one of the National Referral Centers for HIV diagnosis, the Kifangondo Medical Center, located in the border between the Luanda and Bengo provinces. Angolan samples were genotyped based on phylogenetic and bootscanning analyses of the pol (PR/RT) gene and their drug resistance profile was analyzed. Results: Among the 101 samples analyzed, 51% clustered within a pure group M subtype, 42% were classified as intersubtype recombinants, and 7% were denoted as U. We observed an important variation in the prevalence of different HIV-1 genetic variants among country regions, with high frequency of subtype F1 in the North (20%), intersubtype recombinants in the Central (42%), and subtype C in the South (45%). Statistically significant difference in HIV-1 clade distribution was only observed in subtype C prevalence between North vs South (p = 0.0005) and Central vs South (p = 0.0012) regions. DRM to NRTI and/or NNRTI were detected in 16.3% of patients analyzed. Conclusions: These results demonstrate a heterogeneous distribution of HIV-1 genetic variants across different regions in Angola and also revealed an unexpected high frequency of DRM to RT inhibitors in patients that have reported no antiretroviral usage, which may decrease the efficiency of the standard first-line antiretroviral regimens currently used in the country.	[Afonso, Joana Morais; Bello, Gonzalo; Guimaraes, Monick L.; Morgado, Mariza G.] Inst Oswaldo Cruz FIOCRUZ, Lab AIDS & Imunol Mol, Rio De Janeiro, Brazil; [Afonso, Joana Morais] Univ Agostinho Neto, Fac Med, Luanda, Angola; [Sojka, Marta] Sao Lucas Med Ctr, Kifangondo, Angola	Fundacao Oswaldo Cruz; University Agostinho Neto	Afonso, JM (corresponding author), Inst Oswaldo Cruz FIOCRUZ, Lab AIDS & Imunol Mol, Rio De Janeiro, Brazil.	jmafonso.7@gmail.com; mmorgado@ioc.fiocruz.br	Bello, Gonzalo/E-6842-2013; Bentancor, Gonzalo Jose Bello/N-7377-2019	Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; Machado de Morais, Joana Filipa/0000-0002-4524-4055	Laboratory of Aids and Molecular Immunology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation; OWSDW (Organization for Women in Science for the Developing World), Faculty of Medicine - University Agostinho Neto, Angola	Laboratory of Aids and Molecular Immunology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation; OWSDW (Organization for Women in Science for the Developing World), Faculty of Medicine - University Agostinho Neto, Angola	The present study received the following financial support: Laboratory of Aids and Molecular Immunology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation; OWSDW (Organization for Women in Science for the Developing World), Faculty of Medicine - University Agostinho Neto, Angola. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis A., 2005, Infection Genetics and Evolution, V5, P231, DOI 10.1016/j.meegid.2004.07.007; Castelbranco EPAF, 2010, AIDS RES HUM RETROV, V26, P1313, DOI 10.1089/aid.2010.0111; [Anonymous], 1998, HIV DRUG RES DAT; Bartolo I, 2005, AIDS RES HUM RETROV, V21, P306, DOI 10.1089/aid.2005.21.306; Bartolo I, 2009, ANTIMICROB AGENTS CH, V53, P3156, DOI 10.1128/AAC.00110-09; Bartolo I, 2009, INFECT GENET EVOL, V9, P672, DOI 10.1016/j.meegid.2008.05.003; Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2008, ANTIVIR THER, V13, P1; Garrido C, 2008, J ANTIMICROB CHEMOTH, V61, P694, DOI 10.1093/jac/dkm515; Jordan MR, 2008, ANTIVIR THER, V13, P15; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Ministry of Health-Republic of Angola, UNGASS REP 2010; Ministry of Health-Republic of Angola, GUID ANT TREATM ANG; Niama FR, 2009, AIDS RES HUM RETROV, V25, P1345, DOI 10.1089/aid.2009.0169; Nkengasong JN, 2004, AIDS REV, V6, P4; Peeters M, 2003, AIDS, V17, P2547, DOI 10.1097/00002030-200312050-00002; RAY S, SIMPLOT V2 5 0; SANTOSFERREIRA MO, 1990, J ACQ IMMUN DEF SYND, V3, P780; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomson MA, 2005, AIDS, V19, P1155, DOI 10.1097/01.aids.0000176215.95119.1d; UNAIDS, 2010, EP FACT SHEET HIV AI; USAID, 2011, HIV AIDS HLTH PROF A; van de Vijver D, 2007, EPIDEMIOLOGY TRANSMI; Vidal N, 2000, J VIROL, V74, P10498, DOI 10.1128/JVI.74.22.10498-10507.2000	26	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e42996	10.1371/journal.pone.0042996	http://dx.doi.org/10.1371/journal.pone.0042996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952625	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206000015
J	Attar, H; Bedard, K; Migliavacca, E; Gagnebin, M; Dupre, Y; Descombes, P; Borel, C; Deutsch, S; Prokisch, H; Meitinger, T; Mehta, D; Wichmann, E; Delabar, JM; Dermitzakis, ET; Krause, KH; Antonarakis, SE				Attar, Homa; Bedard, Karen; Migliavacca, Eugenia; Gagnebin, Maryline; Dupre, Yann; Descombes, Patrick; Borel, Christelle; Deutsch, Samuel; Prokisch, Holger; Meitinger, Thomas; Mehta, Divya; Wichmann, Erich; Delabar, Jean Maurice; Dermitzakis, Emmanouil T.; Krause, Karl-Heinz; Antonarakis, Stylianos E.			Extensive Natural Variation for Cellular Hydrogen Peroxide Release Is Genetically Controlled	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; NADPH OXIDASE; DOWNS-SYNDROME; STEM-CELLS; NOX FAMILY; MUTATION; LINKAGE; IDENTIFICATION; MITOCHONDRIAL	Natural variation in DNA sequence contributes to individual differences in quantitative traits. While multiple studies have shown genetic control over gene expression variation, few additional cellular traits have been investigated. Here, we investigated the natural variation of NADPH oxidase-dependent hydrogen peroxide (H2O2 release), which is the joint effect of reactive oxygen species (ROS) production, superoxide metabolism and degradation, and is related to a number of human disorders. We assessed the normal variation of H2O2 release in lymphoblastoid cell lines (LCL) in a family-based 3-generation cohort (CEPH-HapMap), and in 3 population-based cohorts (KORA, GenCord, HapMap). Substantial individual variation was observed, 45% of which were associated with heritability in the CEPH-HapMap cohort. We identified 2 genome-wide significant loci of Hsa12 and Hsa15 in genome-wide linkage analysis. Next, we performed genome-wide association study (GWAS) for the combined KORA-GenCord cohorts (n = 279) using enhanced marker resolution by imputation (>1.4 million SNPs). We found 5 significant associations (p<5.00x10(-)8) and 54 suggestive associations (p<1.00x10-5), one of which confirmed the linked region on Hsa15. To replicate our findings, we performed GWAS using 58 HapMap individuals and similar to 2.1 million SNPs. We identified 40 genome-wide significant and 302 suggestive SNPs, and confirmed genome signals on Hsa1, Hsa12, and Hsa15. Genetic loci within 900 kb from the known candidate gene p67phox on Hsa1 were identified in GWAS in both cohorts. We did not find replication of SNPs across all cohorts, but replication within the same genomic region. Finally, a highly significant decrease in H2O2 release was observed in Down Syndrome (DS) individuals (p<2.88x10-12). Taken together, our results show strong evidence of genetic control of H2O2 in LCL of healthy and DS cohorts and suggest that cellular phenotypes, which themselves are also complex, may be used as proxies for dissection of complex disorders.	[Attar, Homa; Migliavacca, Eugenia; Gagnebin, Maryline; Dupre, Yann; Borel, Christelle; Deutsch, Samuel; Dermitzakis, Emmanouil T.; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Bedard, Karen; Krause, Karl-Heinz] Univ Geneva, Sch Med, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland; [Bedard, Karen; Krause, Karl-Heinz] Univ Hosp, Geneva, Switzerland; [Migliavacca, Eugenia] Univ Lausanne, Swiss Inst Bioinformat, Dorigny, Switzerland; [Descombes, Patrick] Univ Geneva, Sch Med, NCCR Frontiers Genet, Geneva, Switzerland; [Prokisch, Holger; Meitinger, Thomas; Mehta, Divya; Wichmann, Erich] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 1, Neuherberg, Germany; [Wichmann, Erich] Univ Munich, Chair Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Delabar, Jean Maurice] Univ Paris 07, Paris, France; [Delabar, Jean Maurice] CNRS, Paris, France	University of Geneva; University of Geneva; University of Geneva; Swiss Institute of Bioinformatics; University of Lausanne; University of Geneva; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS)	Attar, H (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	homa.attar@gmail.com; Stylianos.Antonarakis@unige.ch	Krause, Karl-Heinz/E-8030-2011; Mehta, Divya/ABD-4551-2021; borel, christelle/AAC-9645-2019; Meitinger, Thomas/O-1318-2015; Antonarakis, Stylianos E/N-8866-2014; Prokisch, Holger/N-8964-2013; Dermitzakis, Emmanouil/B-7687-2013	Krause, Karl-Heinz/0000-0002-9033-6768; Antonarakis, Stylianos E/0000-0001-8907-5823; Prokisch, Holger/0000-0003-2379-6286; Deutsch, Samuel/0000-0001-9456-7101; Meitinger, Thomas/0000-0002-8838-8403; Bedard, Karen/0000-0001-5864-5344; Mehta, Divya Deepak/0000-0002-7359-348X; Mehta, Divya/0000-0001-7971-7255	Swiss National Science Foundation; National Center for Competence in Research (NCCR) "Frontiers in Genetics"; European Union FP6 "AnEUploidy" integrated project	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center for Competence in Research (NCCR) "Frontiers in Genetics"(Swiss National Science Foundation (SNSF)); European Union FP6 "AnEUploidy" integrated project	The work was supported by grants from the Swiss National Science Foundation, the National Center for Competence in Research (NCCR) "Frontiers in Genetics," and the European Union FP6 "AnEUploidy" integrated project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Antonarakis SE, 2006, TRENDS MOL MED, V12, P473, DOI 10.1016/j.molmed.2006.08.005; Antonarakis SE, 2010, NAT REV GENET, V11, P380, DOI 10.1038/nrg2793; Arca M, 2008, ARTERIOSCL THROM VAS, V28, P752, DOI 10.1161/ATVBAHA.107.154823; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bedard K, 2009, HUM MUTAT, V30, P1123, DOI 10.1002/humu.21029; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Del Campo M, 2006, AM J HUM GENET, V78, P533, DOI 10.1086/501073; Deng AY, 2007, HUM MOL GENET, V16, pR195, DOI 10.1093/hmg/ddm126; Dermitzakis ET, 2009, SCIENCE, V326, P239, DOI 10.1126/science.1182009; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; DINAUER MC, 1991, P NATL ACAD SCI USA, V88, P11231, DOI 10.1073/pnas.88.24.11231; DINAUER MC, 1989, J CLIN INVEST, V84, P2012, DOI 10.1172/JCI114393; Dominiczak AF, 2004, CLIN EXP HYPERTENS, V26, P611, DOI 10.1081/CEH-200031939; ELROYSTEIN O, 1988, CELL, V52, P259, DOI 10.1016/0092-8674(88)90515-6; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gruhne B, 2009, P NATL ACAD SCI USA, V106, P2313, DOI 10.1073/pnas.0810619106; HANCOCK JT, 1987, BIOCHEM J, V242, P103, DOI 10.1042/bj2420103; Helguera P, 2005, J NEUROSCI, V25, P2295, DOI 10.1523/JNEUROSCI.5107-04.2005; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Holland SM, 2010, CLIN REV ALLERG IMMU, V38, P3, DOI 10.1007/s12016-009-8136-z; Hultqvist M, 2004, P NATL ACAD SCI USA, V101, P12646, DOI 10.1073/pnas.0403831101; Hultqvist M, 2007, J IMMUNOL, V179, P1431, DOI 10.4049/jimmunol.179.3.1431; Jose GS, 2008, CLIN SCI, V114, P173, DOI 10.1042/CS20070130; KEDZIORA J, 1988, FREE RADICAL BIO MED, V4, P317, DOI 10.1016/0891-5849(88)90052-4; KOBAYASHI S, 1995, J BIOCHEM, V117, P758, DOI 10.1093/oxfordjournals.jbchem.a124773; Krause KH, 2007, EXP GERONTOL, V42, P256, DOI 10.1016/j.exger.2006.10.011; Kuhns DB, 2010, NEW ENGL J MED, V363, P2600, DOI 10.1056/NEJMoa1007097; Lacy F, 2000, HYPERTENSION, V36, P878, DOI 10.1161/01.HYP.36.5.878; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matise TC, 2003, AM J HUM GENET, V73, P271, DOI 10.1086/377137; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; Mein CA, 2004, HUM MOL GENET, V13, pR169, DOI 10.1093/hmg/ddh078; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Moreno MU, 2006, J HYPERTENS, V24, P1299, DOI 10.1097/01.hjh.0000234110.54110.56; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Noack D, 1999, HUM GENET, V105, P460, DOI 10.1007/s004390051131; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Olofsson P, 2003, NAT GENET, V33, P25, DOI 10.1038/ng1058; Pellegrini-Calace M, 2006, BIOINFORMATICS, V22, P775, DOI 10.1093/bioinformatics/btl006; Piccoli C, 2005, J BIOL CHEM, V280, P26467, DOI 10.1074/jbc.M500047200; Piirila H, 2006, HUM MUTAT, V27, P1200, DOI 10.1002/humu.20405; Prandini P, 2007, AM J HUM GENET, V81, P252, DOI 10.1086/519248; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Romito A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009029; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Stearns SC, 2010, NAT REV GENET, V11, P611, DOI 10.1038/nrg2831; Stephenson A, 2004, GENOMICS, V83, P1105, DOI 10.1016/j.ygeno.2003.12.007; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85	64	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43566	10.1371/journal.pone.0043566	http://dx.doi.org/10.1371/journal.pone.0043566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952707	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206000041
J	McClanahan, TR; Donner, SD; Maynard, JA; MacNeil, MA; Graham, NAJ; Maina, J; Baker, AC; Alemu, IJB; Beger, M; Campbell, SJ; Darling, ES; Eakin, CM; Heron, SF; Jupiter, SD; Lundquist, CJ; McLeod, E; Mumby, PJ; Paddack, MJ; Selig, ER; van Woesik, R				McClanahan, Tim R.; Donner, Simon D.; Maynard, Jeffrey A.; MacNeil, M. Aaron; Graham, Nicholas A. J.; Maina, Joseph; Baker, Andrew C.; Alemu, Jahson B. I.; Beger, Maria; Campbell, Stuart J.; Darling, Emily S.; Eakin, C. Mark; Heron, Scott F.; Jupiter, Stacy D.; Lundquist, Carolyn J.; McLeod, Elizabeth; Mumby, Peter J.; Paddack, Michelle J.; Selig, Elizabeth R.; van Woesik, Robert			Prioritizing Key Resilience Indicators to Support Coral Reef Management in a Changing Climate	PLOS ONE			English	Article							MORTALITY; DEGRADATION; DIVERSITY; STABILITY; RESPONSES; STRESS; FISHES; SHIFTS	Managing coral reefs for resilience to climate change is a popular concept but has been difficult to implement because the empirical scientific evidence has either not been evaluated or is sometimes unsupportive of theory, which leads to uncertainty when considering methods and identifying priority reefs. We asked experts and reviewed the scientific literature for guidance on the multiple physical and biological factors that affect the ability of coral reefs to resist and recover from climate disturbance. Eleven key factors to inform decisions based on scaling scientific evidence and the achievability of quantifying the factors were identified. Factors important to resistance and recovery, which are important components of resilience, were not strongly related, and should be assessed independently. The abundance of resistant (heat-tolerant) coral species and past temperature variability were perceived to provide the greatest resistance to climate change, while coral recruitment rates, and macroalgae abundance were most influential in the recovery process. Based on the 11 key factors, we tested an evidence-based framework for climate change resilience in an Indonesian marine protected area. The results suggest our evidence-weighted framework improved upon existing un-weighted methods in terms of characterizing resilience and distinguishing priority sites. The evaluation supports the concept that, despite high ecological complexity, relatively few strong variables can be important in influencing ecosystem dynamics. This is the first rigorous assessment of factors promoting coral reef resilience based on their perceived importance, empirical evidence, and feasibility of measurement. There were few differences between scientists' perceptions of factor importance and the scientific evidence found in journal publications but more before and after impact studies will be required to fully test the validity of all the factors. The methods here will increase the feasibility and defensibility of including key resilience metrics in evaluations of coral reefs, as well as reduce costs. Adaptation, marine protected areas, priority setting, resistance, recovery.	[McClanahan, Tim R.] Wildlife Conservat Soc, Marine Programs, Bronx, NY USA; [Donner, Simon D.] Univ British Columbia, Dept Geog, Vancouver, BC V5Z 1M9, Canada; [MacNeil, M. Aaron] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Graham, Nicholas A. J.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Maina, Joseph] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Baker, Andrew C.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Biol & Fisheries, Miami, FL 33149 USA; [Alemu, Jahson B. I.] Inst Marine Affairs, Chaguaramas, Trinidad Tobago; [Beger, Maria] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Campbell, Stuart J.] Wildlife Conservat Soc, Indonesian Program, Bogor, Java, Indonesia; [Darling, Emily S.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Eakin, C. Mark] Natl Ocean & Atmospher Adm, Silver Spring, MD USA; [Heron, Scott F.] Natl Ocean & Atmospher Adm, Townsville, Qld, Australia; [Heron, Scott F.] James Cook Univ, Sch Engn & Phys Sci, Marine Geophys Lab, Townsville, Qld 4811, Australia; [Jupiter, Stacy D.] Wildlife Conservat Soc, Fiji Country Program, Suva, Fiji; [Lundquist, Carolyn J.] Natl Inst Water & Atmospher Res, Hamilton, New Zealand; [McLeod, Elizabeth] Nature Conservancy, Honolulu, HI USA; [Mumby, Peter J.] Univ Queensland, Sch Biol Sci, Marine Spatial Ecol Lab, St Lucia, Qld, Australia; [Paddack, Michelle J.] Santa Barbara City Coll, Dept Biol Sci, Santa Barbara, CA USA; [Selig, Elizabeth R.] Conservat Int, Sci Knowledge Div, Arlington, VA USA; [van Woesik, Robert] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA	Wildlife Conservation Society; University of British Columbia; Australian Institute of Marine Science; James Cook University; Macquarie University; University of Miami; University of Queensland; Wildlife Conservation Society - Indonesia; Simon Fraser University; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; James Cook University; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Nature Conservancy; University of Queensland; Conservation International; Florida Institute of Technology	McClanahan, TR (corresponding author), Wildlife Conservat Soc, Marine Programs, Bronx, NY USA.	tmcclanahan@wcs.org	McClanahan, Tim/K-4998-2019; MacNeil, M. Aaron/ABD-6444-2021; Graham, Nicholas AJ/C-8360-2014; McLean, Laurence JA/C-7367-2014; Beger, Maria/ABC-5975-2022; Heron, Scott F/E-7928-2011; MacNeil, Aaron/E-8196-2017; Mumby, Peter/F-9914-2010; Beger, Maria/F-9049-2013; Eakin, C. Mark/F-5585-2010	MacNeil, M. Aaron/0000-0001-8406-325X; Graham, Nicholas AJ/0000-0002-0304-7467; Beger, Maria/0000-0003-1363-3571; MacNeil, Aaron/0000-0001-8406-325X; Mumby, Peter/0000-0002-6297-9053; Beger, Maria/0000-0003-1363-3571; Eakin, C. Mark/0000-0002-5987-0858; McClanahan, Timothy/0000-0001-5821-3584; Maina, Joseph/0000-0003-1268-6137; Alemu I, Jahson/0000-0002-6936-2857; Campbell, Stuart/0000-0002-1158-3200; Baker, Andrew/0000-0002-7866-2587; Darling, Emily/0000-0002-1048-2838; Maynard, Dr Jeffrey/0000-0002-6444-6373; Lundquist, Carolyn/0000-0002-2101-7237; Heron, Scott/0000-0001-5262-6978; Jupiter, Stacy/0000-0001-9742-1677	John D. and Catherine T. MacArthur Foundation; Wildlife Conservation Society (Karimunjawa surveys); NERC [NE/G017344/1] Funding Source: UKRI; Natural Environment Research Council [NE/G017344/1] Funding Source: researchfish	John D. and Catherine T. MacArthur Foundation; Wildlife Conservation Society (Karimunjawa surveys); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by grants from the John D. and Catherine T. MacArthur Foundation to the lead author and benefited from support from the Wildlife Conservation Society (Karimunjawa surveys) and The Nature Conservancy for partial support of conference attendance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ateweberhan M, 2010, MAR POLLUT BULL, V60, P964, DOI 10.1016/j.marpolbul.2010.03.033; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Cheal AJ, 2010, CORAL REEFS, V29, P1005, DOI 10.1007/s00338-010-0661-y; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; HOLLING CS, 1992, ECOL MONOGR, V62, P447, DOI 10.2307/2937313; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Maynard JA, 2010, CORAL REEFS, V29, P381, DOI 10.1007/s00338-010-0603-8; McClanahan TR, 2008, OECOLOGIA, V155, P169, DOI 10.1007/s00442-007-0890-0; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; McClanahan TR, 2011, GLOBAL CHANGE BIOL, V17, P2023, DOI 10.1111/j.1365-2486.2011.02395.x; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2011, ECOL LETT, V14, P132, DOI 10.1111/j.1461-0248.2010.01562.x; Nystrom M, 2008, CORAL REEFS, V27, P795, DOI 10.1007/s00338-008-0426-z; Obura D, 2009, RESILIENCE ASSESSMEN; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Sale PF, 2011, OUR DYING PLANET: AN ECOLOGIST'S VIEW OF THE CRISIS WE FACE, P1; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Victor S, 2008, ESTUAR COAST SHELF S, V77, P175, DOI 10.1016/j.ecss.2007.09.009; West J, 2003, COMMENTARY, V115, P17; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x	32	160	166	8	167	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e42884	10.1371/journal.pone.0042884	http://dx.doi.org/10.1371/journal.pone.0042884			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952618	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000308206000013
J	Heinrich, S; Valentin, K; Frickenhaus, S; John, U; Wiencke, C				Heinrich, Sandra; Valentin, Klaus; Frickenhaus, Stephan; John, Uwe; Wiencke, Christian			Transcriptomic Analysis of Acclimation to Temperature and Light Stress in Saccharina latissima (Phaeophyceae)	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; SUPEROXIDE-DISMUTASE ACTIVITY; ASCORBATE-GLUTATHIONE CYCLE; REACTIVE OXYGEN-METABOLISM; KELP LAMINARIA-SACCHARINA; INDUCED OXIDATIVE STRESS; PROGRAMMED CELL-DEATH; GENE-EXPRESSION; COLD-ACCLIMATION; ECOTYPIC DIFFERENTIATION	Kelps, brown algae of the order Laminariales, dominate rocky shores and form huge kelp beds which provide habitat and nurseries for various marine organisms. Whereas the basic physiological and ecophysiological characteristics of kelps are well studied, the molecular processes underlying acclimation to different light and temperature conditions are still poorly understood. Therefore we investigated the molecular mechanisms underlying the physiological acclimation to light and temperature stress. Sporophytes of S. latissima were exposed to combinations of light intensities and temperatures, and microarray hybridizations were performed to determine changes in gene expression patterns. This first large-scale transcriptomic study of a kelp species shows that S. latissima responds to temperature and light stress with a multitude of transcriptional changes: up to 32% of genes showed an altered expression after the exposure experiments. High temperature had stronger effects on gene expression in S. latissima than low temperature, reflected by the higher number of temperature-responsive genes. We gained insights into underlying molecular processes of acclimation, which includes adjustment of the primary metabolism as well as induction of several ROS scavengers and a sophisticated regulation of Hsps. We show that S. latissima, as a cold adapted species, must make stronger efforts for acclimating to high than to low temperatures. The strongest response was caused by the combination of high temperatures with high light intensities, which proved most harmful for the alga.	[Heinrich, Sandra; Wiencke, Christian] Alfred Wegener Inst Polar & Marine Res, Dept Funct Ecol, Bremerhaven, Germany; [Valentin, Klaus] Alfred Wegener Inst Polar & Marine Res, Dept Polar Biol Oceanog, Bremerhaven, Germany; [Frickenhaus, Stephan] Hsch Bremerhaven, Dept Biotechnol, Bremerhaven, Germany; [John, Uwe] Alfred Wegener Inst Polar & Marine Res, Dept Ecol Chem, Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Heinrich, S (corresponding author), Alfred Wegener Inst Polar & Marine Res, Dept Funct Ecol, Bremerhaven, Germany.	Sandra.Heinrich@awi.de	Valentin, Klaus/G-5862-2014; john, uwe/S-3009-2016	Valentin, Klaus/0000-0001-7401-9423; john, uwe/0000-0002-1297-4086; Frickenhaus, Stephan/0000-0002-0356-9791	PACES (Coastal and Polar Systems: Polar Regions and Coasts in a changing Earth System) research program of the Alfred Wegener Institute, within the Helmholtz Foundation Initiative in Earth and Environment	PACES (Coastal and Polar Systems: Polar Regions and Coasts in a changing Earth System) research program of the Alfred Wegener Institute, within the Helmholtz Foundation Initiative in Earth and Environment	Financial support was provided by the PACES (Coastal and Polar Systems: Polar Regions and Coasts in a changing Earth System) research program of the Alfred Wegener Institute, within the Helmholtz Foundation Initiative in Earth and Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WW, 2004, BIOSCIENCE, V54, P41, DOI 10.1641/0006-3568(2004)054[0041:PSOOE]2.0.CO;2; ADAMS WW, 1987, PLANT PHYSIOL, V83, P213, DOI 10.1104/pp.83.1.213; Aguilera J, 2002, POLAR BIOL, V25, P432, DOI 10.1007/s00300-002-0362-2; Aguilera J, 2002, MAR BIOL, V140, P1087, DOI 10.1007/s00227-002-0792-y; Alexieva V., 2003, BULG J PLANT PHYSL, P1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson JM., 2001, PHOTOINHIBITION, P1; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Asada K., 1997, OXIDATIVE STRESS MOL; Bartsch I, 2008, EUR J PHYCOL, V43, P1, DOI 10.1080/09670260701711376; Bischof K, 2006, MAR ECOL PROG SER, V306, P165, DOI 10.3354/meps306165; Bischof K, 2003, SCI MAR, V67, P353, DOI 10.3989/scimar.2003.67n3353; Bischof K., 2012, RECENT ADV SEAWEED B; BOLTON JJ, 1982, MAR BIOL, V66, P89, DOI 10.1007/BF00397259; BOLTON JJ, 1983, PHYCOLOGIA, V22, P133, DOI 10.2216/i0031-8884-22-2-133.1; Borum J, 2002, MAR BIOL, V141, P11, DOI 10.1007/s00227-002-0806-9; Bruhn J, 1996, MAR BIOL, V125, P639, DOI 10.1007/BF00349245; Burritt DJ, 2002, PLANTA, V215, P829, DOI 10.1007/s00425-002-0805-6; Carlsen BP, 2007, POLAR BIOL, V30, P939, DOI 10.1007/s00300-007-0272-4; CHARPY-ROUBAUD C, 1990, Marine Microbial Food Webs, V4, P31; Chaves I, 2011, BIOL PLANTARUM, V55, P153, DOI 10.1007/s10535-011-0021-y; Collen J, 1999, PLANT CELL ENVIRON, V22, P1143, DOI 10.1046/j.1365-3040.1999.00477.x; Collen J, 1999, J PHYCOL, V35, P54, DOI 10.1046/j.1529-8817.1999.3510054.x; Collen J, 2001, J PHYCOL, V37, P474, DOI 10.1046/j.1529-8817.2001.037004474.x; Collen J, 2007, NEW PHYTOL, V176, P45, DOI 10.1111/j.1469-8137.2007.02152.x; Collen J, 2006, J EXP BOT, V57, P3869, DOI 10.1093/jxb/erl171; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Contreras L, 2009, AQUAT TOXICOL, V94, P94, DOI 10.1016/j.aquatox.2009.06.004; Cosse A, 2009, NEW PHYTOL, V182, P239, DOI 10.1111/j.1469-8137.2008.02745.x; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Crepineau F, 2000, PLANT MOL BIOL, V43, P503, DOI 10.1023/A:1006489920808; DAVISON IR, 1991, MAR BIOL, V110, P449, DOI 10.1007/BF01344363; DAVISON IR, 1987, BRIT PHYCOL J, V22, P77, DOI 10.1080/00071618700650101; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; Dittami S., 2009, GENOME BIOL, V10, P51; Dos Santos CV, 2006, TRENDS PLANT SCI, V11, P329, DOI 10.1016/j.tplants.2006.05.005; Dring MJ, 2006, ADV BOT RES, V43, P175, DOI 10.1016/S0065-2296(05)43004-9; DUNTON KH, 1985, J EXP MAR BIOL ECOL, V94, P181, DOI 10.1016/0022-0981(85)90057-7; Ensminger I, 2006, PHYSIOL PLANTARUM, V126, P28, DOI 10.1111/j.1399-3054.2006.00627.x; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Franklin LA, 1997, EUR J PHYCOL, V32, P207, DOI 10.1080/09670269710001737149; Fu WD, 2011, J APPL PHYCOL, V23, P681, DOI 10.1007/s10811-010-9561-3; Fu WD, 2009, MAR BIOTECHNOL, V11, P738, DOI 10.1007/s10126-009-9188-z; GERARD VA, 1988, MAR BIOL, V97, P575, DOI 10.1007/BF00391054; GERARD VA, 1988, MAR BIOL, V97, P25, DOI 10.1007/BF00391242; GERARD VA, 1990, MAR BIOL, V107, P519, DOI 10.1007/BF01313437; Gevaert F, 2003, MAR ECOL PROG SER, V247, P43, DOI 10.3354/meps247043; Gomez I, 2009, BOT MAR, V52, P593, DOI 10.1515/BOT.2009.073; Graham MH, 2007, P NATL ACAD SCI USA, V104, P16576, DOI 10.1073/pnas.0704778104; Grant CM, 2000, BBA-GENE STRUCT EXPR, V1490, P33, DOI 10.1016/S0167-4781(99)00234-1; Gravot A, 2010, NEW PHYTOL, V188, P98, DOI 10.1111/j.1469-8137.2010.03400.x; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Hader DP, 1997, PHOTOCHEM PHOTOBIOL, V66, P1, DOI 10.1111/j.1751-1097.1997.tb03132.x; Haghjou MM, 2009, PHYSIOL PLANTARUM, V135, P272, DOI 10.1111/j.1399-3054.2008.01193.x; Han TJ, 1996, EUR J PHYCOL, V31, P233, DOI 10.1080/09670269600651431; Hanelt D, 1997, J PHYCOL, V33, P387, DOI 10.1111/j.0022-3646.1997.00387.x; Hanelt D, 1998, MAR BIOL, V131, P361, DOI 10.1007/s002270050329; Heinrich S, 2012, EUR J PHYCOL, V47, P83, DOI 10.1080/09670262.2012.660639; Huner NPA, 1996, PHYSIOL PLANTARUM, V98, P358, DOI 10.1034/j.1399-3054.1996.980218.x; Jacquot JP, 2009, TRENDS PLANT SCI, V14, P336, DOI 10.1016/j.tplants.2009.03.005; Janknegt PJ, 2008, J PHYCOL, V44, P957, DOI 10.1111/j.1529-8817.2008.00553.x; Kaplan F, 2007, PLANT J, V50, P967, DOI 10.1111/j.1365-313X.2007.03100.x; Keren N, 2005, PLANT CELL, V17, P2768, DOI 10.1105/tpc.105.035048; KIRST GO, 1995, J PHYCOL, V31, P181, DOI 10.1111/j.0022-3646.1995.00181.x; Kumar M, 2010, J EXP MAR BIOL ECOL, V391, P27, DOI 10.1016/j.jembe.2010.06.001; Lehmann M, 2009, MOL PLANT, V2, P390, DOI 10.1093/mp/ssn080; Lemaire SD, 2007, CURR GENET, V51, P343, DOI 10.1007/s00294-007-0128-z; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Li R, 2004, MAR BIOL, V144, P205, DOI 10.1007/s00227-003-1190-9; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Lu IF, 2006, MAR BIOL, V150, P1, DOI 10.1007/s00227-006-0323-3; Ludlow MM, 1987, PHOTOINHIBITION, P89; Luikenhuis S, 1998, MOL BIOL CELL, V9, P1081, DOI 10.1091/mbc.9.5.1081; Luning K, 1990, SEAWEEDS THEIR ENV B; Machalek KM, 1996, PLANT CELL ENVIRON, V19, P1005, DOI 10.1111/j.1365-3040.1996.tb00207.x; Michelet L, 2006, PHOTOSYNTH RES, V89, P225, DOI 10.1007/s11120-006-9096-2; Moharikar S, 2006, J PHYCOL, V42, P423, DOI 10.1111/j.1529-8817.2006.00207.x; Muller R, 2008, CLIM RES, V37, P203, DOI 10.3354/cr00762; Muller R, 2009, BOT MAR, V52, P617, DOI 10.1515/BOT.2009.080; NAGAHISA E, 1995, BIOSCI BIOTECH BIOCH, V59, P2176, DOI 10.1271/bbb.59.2176; Nagao M, 2008, PLANT CELL ENVIRON, V31, P872, DOI 10.1111/j.1365-3040.2008.01804.x; Noctor G, 1998, PLANT PHYSIOL, V118, P471, DOI 10.1104/pp.118.2.471; Noctor G, 1997, PHYSIOL PLANTARUM, V100, P255, DOI 10.1034/j.1399-3054.1997.1000206.x; Noctor G, 2006, PLANT CELL ENVIRON, V29, P409, DOI 10.1111/j.1365-3040.2005.01476.x; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Noji M, 1998, J BIOL CHEM, V273, P32739, DOI 10.1074/jbc.273.49.32739; Nymark M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007743; Panchuk II, 2002, PLANT PHYSIOL, V129, P838, DOI 10.1104/pp.001362; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pearson GA, 2010, MAR BIOTECHNOL, V12, P195, DOI 10.1007/s10126-009-9208-z; Perelman A, 2006, J EXP MAR BIOL ECOL, V334, P229, DOI 10.1016/j.jembe.2006.02.009; Pfannschmidt T, 2003, TRENDS PLANT SCI, V8, P33, DOI 10.1016/S1360-1385(02)00005-5; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Qureshi MI, 2007, J PLANT PHYSIOL, V164, P1239, DOI 10.1016/j.jplph.2007.01.013; Roeder V, 2005, J PHYCOL, V41, P1227, DOI 10.1111/j.1529-8817.2005.00150.x; Roleda MY, 2007, PHOTOCHEM PHOTOBIOL, V83, P851, DOI 10.1562/2006-08-17-IR-1005; Rouhier N, 2004, CELL MOL LIFE SCI, V61, P1266, DOI 10.1007/s00018-004-3410-y; Rouhier N, 2006, J EXP BOT, V57, P1685, DOI 10.1093/jxb/erl001; Sakamoto T, 2011, BIOSCI BIOTECH BIOCH, V75, P561, DOI 10.1271/bbb.100794; SEEMANN JR, 1987, PLANT PHYSIOL, V84, P796, DOI 10.1104/pp.84.3.796; Segovia M, 2003, PLANT PHYSIOL, V132, P99, DOI 10.1104/pp.102.017129; Shiu CT, 2005, J EXP BOT, V56, P2851, DOI 10.1093/jxb/eri277; SMITH SV, 1981, SCIENCE, V211, P838, DOI 10.1126/science.211.4484.838; STARR RC, 1993, J PHYCOL, V29, P1, DOI 10.1111/j.0022-3646.1993.00001.x; Sundaram S, 2010, PLANTA, V231, P361, DOI 10.1007/s00425-009-1055-7; Surpin M, 2002, PLANT CELL, V14, pS327, DOI 10.1105/tpc.010446; Takahashi S, 2011, TRENDS PLANT SCI, V16, P53, DOI 10.1016/j.tplants.2010.10.001; Tan SX, 2010, J BIOL CHEM, V285, P6118, DOI 10.1074/jbc.M109.062844; Tanahashi N, 1999, MOL BIOL REP, V26, P3, DOI 10.1023/A:1006909522731; Tanaka K, 1997, MOL BIOL REP, V24, P3, DOI 10.1023/A:1006876904158; Timperio AM, 2008, J PROTEOMICS, V71, P391, DOI 10.1016/j.jprot.2008.07.005; Valles D, 2008, PROTEIN J, V27, P267, DOI 10.1007/s10930-008-9133-4; Vardi A, 1999, CURR BIOL, V9, P1061, DOI 10.1016/S0960-9822(99)80459-X; VAYDA ME, 1994, PLANT MOL BIOL, V24, P229, DOI 10.1007/BF00040590; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; WEIS E, 1981, PLANTA, V151, P33, DOI 10.1007/BF00384234; Wernberg T, 2010, ECOL LETT, V13, P685, DOI 10.1111/j.1461-0248.2010.01466.x; Wiencke C, 2006, J ECOL, V94, P455, DOI 10.1111/j.1365-2745.2006.01102.x; Wolfe-Simon F, 2005, J PHYCOL, V41, P453, DOI 10.1111/j.1529-8817.2005.00086.x; Wu TM, 2008, PHYCOLOGIA, V47, P346, DOI 10.2216/PH07-77.1	122	61	65	2	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44342	10.1371/journal.pone.0044342	http://dx.doi.org/10.1371/journal.pone.0044342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937172	Green Published, Green Submitted, gold			2022-12-25	WOS:000308213600103
J	Winkler, M; Bertram, S; Gnirss, K; Nehlmeier, I; Gawanbacht, A; Kirchhoff, F; Ehrhardt, C; Ludwig, S; Kiene, M; Moldenhauer, AS; Goedecke, U; Karsten, CB; Kuhl, A; Pohlmann, S				Winkler, Michael; Bertram, Stephanie; Gnirss, Kerstin; Nehlmeier, Inga; Gawanbacht, Ali; Kirchhoff, Frank; Ehrhardt, Christina; Ludwig, Stephan; Kiene, Miriam; Moldenhauer, Anna-Sophie; Goedecke, Ulrike; Karsten, Christina B.; Kuehl, Annika; Poehlmann, Stefan			Influenza A Virus Does Not Encode a Tetherin Antagonist with Vpu-Like Activity and Induces IFN-Dependent Tetherin Expression in Infected Cells	PLOS ONE			English	Article							HIV-1 RELEASE; RESTRICTION; GLYCOPROTEIN; PROTEIN; TYPE-1; RESPONSES; ANTIGEN; SURFACE; CD317	The interferon-induced host cell factor tetherin inhibits release of human immunodeficiency virus (HIV) from the plasma membrane of infected cells and is counteracted by the HIV-1 protein Vpu. Influenza A virus (FLUAV) also buds from the plasma membrane and is not inhibited by tetherin. Here, we investigated if FLUAV encodes a functional equivalent of Vpu for tetherin antagonism. We found that expression of the FLUAV protein NS1, which antagonizes the interferon (IFN) response, did not block the tetherin-mediated restriction of HIV release, which was rescued by Vpu. Similarly, tetherin-mediated inhibition of HIV release was not rescued by FLUAV infection. In contrast, FLUAV infection induced tetherin expression on target cells in an IFN-dependent manner. These results suggest that FLUAV escapes the antiviral effects of tetherin without encoding a tetherin antagonist with Vpu-like activity.	[Winkler, Michael; Bertram, Stephanie; Gnirss, Kerstin; Nehlmeier, Inga; Moldenhauer, Anna-Sophie; Goedecke, Ulrike; Karsten, Christina B.; Kuehl, Annika; Poehlmann, Stefan] German Primate Ctr, Gottingen, Germany; [Gnirss, Kerstin; Kiene, Miriam; Karsten, Christina B.; Kuehl, Annika; Poehlmann, Stefan] Hannover Med Sch, Inst Virol, D-3000 Hannover, Germany; [Gawanbacht, Ali; Kirchhoff, Frank] Univ Ulm, Med Ctr, Inst Mol Virol, Ulm, Germany; [Ehrhardt, Christina; Ludwig, Stephan] Univ Munster, Inst Mol Virol, Munster, Germany; [Karsten, Christina B.] Hannover Med Sch, Inst Cellular Chem, D-3000 Hannover, Germany	Deutsches Primatenzentrum (DPZ); Hannover Medical School; Ulm University; University of Munster; Hannover Medical School	Winkler, M (corresponding author), German Primate Ctr, Gottingen, Germany.	s.poehlmann@dpz.eu	Karsten, Christina B./GNH-2673-2022; Kirchhoff, Frank/O-8367-2018; Karsten, Christina B./J-8689-2019; Pöhlmann, Stefan/H-2395-2011	Kirchhoff, Frank/0000-0002-7052-2360; Karsten, Christina B./0000-0003-1934-6442; Pöhlmann, Stefan/0000-0001-6086-9136; Winkler, Michael/0000-0002-6198-554X; Ludwig, Stephan/0000-0003-4490-3052	Leibniz Association; International Research Training Group [1273]; Center for Infection Biology of Hannover Medical School;  [Sonderforschungsbereich 900]	Leibniz Association; International Research Training Group; Center for Infection Biology of Hannover Medical School; 	The study was supported by the Leibniz Association (MW SB IN ASM UG AK and SP), Sonderforschungsbereich 900 (CK SP), International Research Training Group 1273 (MK) and Center for Infection Biology of Hannover Medical School (KG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartee E, 2006, PLOS PATHOG, V2, P975, DOI 10.1371/journal.ppat.0020107; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Bruce EA, 2012, J GEN VIROL, V93, P963, DOI 10.1099/vir.0.038778-0; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Douglas JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000913; Ehrhardt C, 2010, MICROBES INFECT, V12, P81, DOI 10.1016/j.micinf.2009.09.007; EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247; Erikson E, 2011, P NATL ACAD SCI USA, V108, P13688, DOI 10.1073/pnas.1101684108; Evans DT, 2010, TRENDS MICROBIOL, V18, P388, DOI 10.1016/j.tim.2010.06.010; Gao F, 2003, AIDS RES HUM RETROV, V19, P817, DOI 10.1089/088922203769232610; Goffinet C, 2010, J VIROL, V84, P4089, DOI 10.1128/JVI.01549-09; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; Goto H, 1998, P NATL ACAD SCI USA, V95, P10224, DOI 10.1073/pnas.95.17.10224; Hammonds J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000749; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kawai S, 2006, ONCOL REP, V15, P361; Khurana S, 2007, J VIROL, V81, P12630, DOI 10.1128/JVI.01255-07; Kuhl A, 2011, J INFECT DIS, V204, pS850, DOI 10.1093/infdis/jir378; Kuhl A, 2010, NAT MED, V16, P155, DOI 10.1038/nm0210-155; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Lopez LA, 2012, J VIROL, V86, P5467, DOI 10.1128/JVI.06280-11; Lopez LA, 2010, J VIROL, V84, P7243, DOI 10.1128/JVI.02636-09; Mangeat B, 2012, J BIOL CHEM, V287, P22015, DOI 10.1074/jbc.M111.319996; Marzi A, 2006, J VIROL, V80, P6305, DOI 10.1128/JVI.02545-05; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; MOSCA JD, 1986, MOL CELL BIOL, V6, P2279, DOI 10.1128/MCB.6.6.2279; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nguyen KL, 2004, VIROLOGY, V319, P163, DOI 10.1016/j.virol.2003.11.021; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Radoshitzky SR, 2010, J VIROL, V84, P10569, DOI 10.1128/JVI.00103-10; Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Schmidt S, 2011, MBIO, V2, DOI 10.1128/mBio.00036-11; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009; Watanabe R, 2011, VIROLOGY, V417, P50, DOI 10.1016/j.virol.2011.05.006; Yondola MA, 2011, J VIROL, V85, P2480, DOI 10.1128/JVI.02188-10; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	46	24	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43337	10.1371/journal.pone.0043337	http://dx.doi.org/10.1371/journal.pone.0043337			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952667	Green Published, gold, Green Submitted			2022-12-25	WOS:000308044800026
J	Georgiev, D; Gonzalez-Burgos, G; Kikuchi, M; Minabe, Y; Lewis, DA; Hashimoto, T				Georgiev, Danko; Gonzalez-Burgos, Guillermo; Kikuchi, Mitsuru; Minabe, Yoshio; Lewis, David A.; Hashimoto, Takanori			Selective Expression of KCNS3 Potassium Channel alpha-Subunit in Parvalbumin-Containing GABA Neurons in the Human Prefrontal Cortex	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; K+ CHANNEL; NETWORK OSCILLATIONS; STRIATAL NEURONS; SCHIZOPHRENIA; HIPPOCAMPAL; RAT; CHOLECYSTOKININ; BINDING; KV2.1	The cognitive deficits of schizophrenia appear to be associated with altered cortical GABA neurotransmission in the subsets of inhibitory neurons that express either parvalbumin (PV) or somatostatin (SST). Identification of molecular mechanisms that operate selectively in these neurons is essential for developing targeted therapeutic strategies that do not influence other cell types. Consequently, we sought to identify, in the human cortex, gene products that are expressed selectively by PV and/or SST neurons, and that might contribute to their distinctive functional properties. Based on previously reported expression patterns in the cortex of mice and humans, we selected four genes: KCNS3, LHX6, KCNAB1, and PPP1R2, encoding K+ channel Kv9.3 modulatory alpha-subunit, LIM homeobox protein 6, K+ channel Kv beta 1 subunit, and protein phosphatase 1 regulatory subunit 2, respectively, and examined their colocalization with PV or SST mRNAs in the human prefrontal cortex using dual-label in situ hybridization with S-35-and digoxigenin-labeled antisense riboprobes. KCNS3 mRNA was detected in almost all PV neurons, but not in SST neurons, and PV mRNA was detected in >90% of KCNS3 mRNA-expressing neurons. LHX6 mRNA was detected in almost all PV and >90% of SST neurons, while among all LHX6 mRNA-expressing neurons 50% expressed PV mRNA and >44% expressed SST mRNA. KCNAB1 and PPP1R2 mRNAs were detected in much larger populations of cortical neurons than PV or SST neurons. These findings indicate that KCNS3 is a selective marker of PV neurons, whereas LHX6 is expressed by both PV and SST neurons. KCNS3 and LHX6 might be useful for characterizing cell-type specific molecular alterations of cortical GABA neurotransmission and for the development of novel treatments targeting PV and/or SST neurons in schizophrenia.	[Georgiev, Danko; Kikuchi, Mitsuru; Minabe, Yoshio; Hashimoto, Takanori] Kanazawa Univ, Grad Sch Med Sci, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa, Japan; [Gonzalez-Burgos, Guillermo; Lewis, David A.; Hashimoto, Takanori] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Kikuchi, Mitsuru; Minabe, Yoshio] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa, Japan; [Lewis, David A.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA	Kanazawa University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kanazawa University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Georgiev, D (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa, Japan.	takanori@med.kanazawa-u.ac.jp	Lewis, David A/G-4053-2014; Georgiev, Danko D./E-8676-2017	Lewis, David A/0000-0002-3225-6778; Georgiev, Danko D./0000-0001-6846-1194; Gonzalez-Burgos, Guillermo/0000-0002-1650-8111	Japan Society for the Promotion of Science [21390332, 21.09141]; National Institutes of Health [MH043784, MH084053]; National Institutes of Health; Commonwealth of Pennsylvania; Bristol-Myers Squibb; Curridium Ltd; Pfizer; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043784, R37MH043784, P50MH084053] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; Bristol-Myers Squibb(Bristol-Myers Squibb); Curridium Ltd; Pfizer(Pfizer); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Japan Society for the Promotion of Science (Postdoctoral Fellowship to DG and Grants-in-Aid 21390332, 21.09141 to TH) and National Institutes of Health (Grants MH043784, MH084053 to DAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: DAL currently receives investigator-initiated research support from the National Institutes of Health, Commonwealth of Pennsylvania, Bristol-Myers Squibb, Curridium Ltd and Pfizer and in 2010-2012 served as a consultant in the areas of target identification and validation and new compound development to BioLine RX, Bristol-Myers Squibb, and Merck. TH served as a consultant for Ono Pharmaceutical Co., Ltd. in 2012. None of above funders was involved in the study design; collection, analysis, and interpretation of data; writing of the paper; or decision to submit for publication of this study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Allen Institute for Brain Science, 2009, ALL BRAIN ATL; Arango V, 2001, NEUROPSYCHOPHARMACOL, V25, P892, DOI 10.1016/S0893-133X(01)00310-4; Beasley CL, 2002, BIOL PSYCHIAT, V52, P708, DOI 10.1016/S0006-3223(02)01360-4; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Bocksteins E, 2012, PHYSIOLOGY, V27, P73, DOI 10.1152/physiol.00023.2011; BRAHIC M, 1978, P NATL ACAD SCI USA, V75, P6125, DOI 10.1073/pnas.75.12.6125; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Cho RY, 2006, P NATL ACAD SCI USA, V103, P19878, DOI 10.1073/pnas.0609440103; Cobos I, 2006, CEREB CORTEX, V16, pI82, DOI 10.1093/cercor/bhk003; Daviss SR, 1995, PSYCHIAT RES, V59, P81, DOI 10.1016/0165-1781(95)02720-3; Du J, 1998, NEUROSCIENCE, V84, P37, DOI 10.1016/S0306-4522(97)00519-8; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Fung SJ, 2010, AM J PSYCHIAT, V167, P1479, DOI 10.1176/appi.ajp.2010.09060784; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; GERFEN CR, 1991, J NEUROSCI, V11, P1016; Glantz LA, 2000, BIOL PSYCHIAT, V48, P389, DOI 10.1016/S0006-3223(00)00923-9; Gonzalez-Albo MC, 2001, CEREB CORTEX, V11, P1170, DOI 10.1093/cercor/11.12.1170; Gonzalez-Burgos G, 2008, SCHIZOPHRENIA BULL, V34, P944, DOI 10.1093/schbul/sbn070; Gonzalez-Burgos G, 2010, CURR PSYCHIAT REP, V12, P335, DOI 10.1007/s11920-010-0124-8; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hashimoto T, 2008, MOL PSYCHIATR, V13, P147, DOI 10.1038/sj.mp.4002011; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Hashimoto T, 2008, AM J PSYCHIAT, V165, P479, DOI 10.1176/appi.ajp.2007.07081223; Hu H, 2010, SCIENCE, V327, P52, DOI 10.1126/science.1177876; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kerschensteiner D, 2005, P NATL ACAD SCI USA, V102, P6160, DOI 10.1073/pnas.0500468102; Kerschensteiner D, 2003, J BIOL CHEM, V278, P18154, DOI 10.1074/jbc.M213117200; Kubota Y, 1997, BRAIN RES, V752, P175, DOI 10.1016/S0006-8993(96)01446-1; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2009, J CLIN INVEST, V119, P706, DOI 10.1172/JCI37335; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Maylie B, 2002, J NEUROSCI, V22, P4786, DOI 10.1523/JNEUROSCI.22-12-04786.2002; MORINO P, 1994, EUR J NEUROSCI, V6, P681, DOI 10.1111/j.1460-9568.1994.tb00980.x; Morris HM, 2008, CEREB CORTEX, V18, P1575, DOI 10.1093/cercor/bhm186; Ohnuma T, 1999, NEUROSCIENCE, V93, P441, DOI 10.1016/S0306-4522(99)00189-X; Okaty BW, 2009, J NEUROSCI, V29, P7040, DOI 10.1523/JNEUROSCI.0105-09.2009; Patel AJ, 1997, EMBO J, V16, P6615, DOI 10.1093/emboj/16.22.6615; Pierri JN, 1999, AM J PSYCHIAT, V156, P1709; Rhodes KJ, 1996, J NEUROSCI, V16, P4846; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Sarmiere PD, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-112; SCHIFFMANN SN, 1991, J COMP NEUROL, V304, P219, DOI 10.1002/cne.903040206; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Terry-Lorenzo RT, 2002, J BIOL CHEM, V277, P46535, DOI 10.1074/jbc.M206960200; Volk DW, 2001, AM J PSYCHIAT, V158, P256, DOI 10.1176/appi.ajp.158.2.256; Volk DW, 2000, ARCH GEN PSYCHIAT, V57, P237, DOI 10.1001/archpsyc.57.3.237; Volk DW, 2012, AM J PSYCHI IN PRESS; Wonders C, 2005, NAT NEUROSCI, V8, P979, DOI 10.1038/nn0805-979; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Zhao Y, 2008, J COMP NEUROL, V510, P79, DOI 10.1002/cne.21772	53	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43904	10.1371/journal.pone.0043904	http://dx.doi.org/10.1371/journal.pone.0043904			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937123	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000308225500122
J	Graef, C; Schacherl, M; Waltersperger, S; Baumann, U				Graef, Christine; Schacherl, Magdalena; Waltersperger, Sandro; Baumann, Ulrich			Crystal Structures of Archaemetzincin Reveal a Moldable Substrate-Binding Site	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; CATALYTIC DOMAIN; INHIBITOR; METHIONINE; COMPLEX; PROTEIN; METZINCINS; FAMILY	Background: Archaemetzincins are metalloproteases occurring in archaea and some mammalia. They are distinct from all the other metzincins by their extended active site consensus sequence HEXXHXXGXXHCX(4)CXMX(17)CXXC featuring four conserved cysteine residues. Very little is known about their biological importance and structure-function relationships. Principal Findings: Here we present three crystal structures of the archaemetzincin AfAmzA (Uniprot O29917) from Archaeoglobus fulgidus, revealing a metzincin architecture featuring a zinc finger-like structural element involving the conserved cysteines of the consensus motif. The active sites in all three structures are occluded to different extents rendering the enzymes proteolytically inactive against a large variety of tested substrates. Owing to the different ligand binding there are significant differences in active site architecture, revealing a large flexibility of the loops covering the active site cleft. Conclusions: The crystal structures of AfAmzA provide the structural basis for the lack of activity in standard proteolytic assays and imply a triggered activity onset upon opening of the active site cleft.	[Graef, Christine; Schacherl, Magdalena; Waltersperger, Sandro; Baumann, Ulrich] Univ Bern, Dept Chem & Biochem, Bern, Switzerland	University of Bern	Graef, C (corresponding author), Blutspendedienst SRK Bern AG, Bern, Switzerland.	ubaumann@uni-koeln.de	Baumann, Ulrich/B-1220-2013; Schacherl, Magdalena/AAT-6362-2021; Schacherl, Magdalena/M-1590-2014	Schacherl, Magdalena/0000-0002-5478-2509; Schacherl, Magdalena/0000-0002-5478-2509; Henny, Christine/0000-0001-9716-5810	Swiss National Science Foundation [A3100-120174]; Berner Hochschulstiftung; Bern University	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Berner Hochschulstiftung; Bern University	This work has been supported by the Swiss National Science Foundation (www.snf.ch), Grant No. A3100-120174, the Berner Hochschulstiftung (www.forschungsstiftung.ch) and Bern University (www.uni-bern.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAUMANN U, 1995, J MOL BIOL, V248, P653, DOI 10.1006/jmbi.1995.0249; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; BROWNER MF, 1995, BIOCHEMISTRY-US, V34, P6602, DOI 10.1021/bi00020a004; Brunger AT, 1997, METHOD ENZYMOL, V277, P366, DOI 10.1016/S0076-6879(97)77021-6; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Diaz-Perales A, 2005, J BIOL CHEM, V280, P30367, DOI 10.1074/jbc.M504533200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; Gomis-Ruth FX, 2003, MOL BIOTECHNOLOGY, V24; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guevara T, 2010, J BIOL CHEM; Hege T, 2001, J BIOL CHEM, V276, P35087, DOI 10.1074/jbc.M104020200; Hege T, 2001, J MOL BIOL, V314, P181, DOI 10.1006/jmbi.2001.5125; Janda I, 2004, STRUCTURE, V12, P1901, DOI 10.1016/j.str.2004.08.003; JIANG WP, 1992, FEBS LETT, V312, P110, DOI 10.1016/0014-5793(92)80916-5; Kuzin A, 2010, CRYSTAL STRUCTURE ZI; Lovejoy B, 1999, NAT STRUCT BIOL, V6, P217; Maskos K, 2003, MOL BIOTECHNOL, V25, P241, DOI 10.1385/MB:25:3:241; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Mosca R, 2008, NUCLEIC ACIDS RES, V36, pW42, DOI 10.1093/nar/gkn197; NEURATH H, 1976, P NATL ACAD SCI USA, V73, P3825, DOI 10.1073/pnas.73.11.3825; Oberholzer AE, 2009, BIOL CHEM, V390, P875, DOI 10.1515/BC.2009.100; Orth P, 2004, J MOL BIOL, V335, P129, DOI 10.1016/j.jmb.2003.10.037; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Penalver-Mellado M, 2006, MOL MICROBIOL, V61, P910, DOI 10.1111/j.1365-2958.2006.05289.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Roe RR, 1999, J MOL MODEL, V5, P134, DOI 10.1007/s008940050113; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; STOCKER W, 1995, PROTEIN SCI, V4, P823; Tallant C, 2010, J BIOL CHEM, V285, P13951, DOI 10.1074/jbc.M109.083378; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Waltersperger S, 2010, PROTEINS, V78, P2720, DOI 10.1002/prot.22777; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Zaric SD, 2000, CHEM-EUR J, V6, P3935, DOI 10.1002/1521-3765(20001103)6:21<3935::AID-CHEM3935>3.0.CO;2-J; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	42	3	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43863	10.1371/journal.pone.0043863	http://dx.doi.org/10.1371/journal.pone.0043863			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937112	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500114
J	Hawlitschek, O; Nagy, ZT; Glaw, F				Hawlitschek, Oliver; Nagy, Zoltan T.; Glaw, Frank			Island Evolution and Systematic Revision of Comoran Snakes: Why and When Subspecies Still Make Sense	PLOS ONE			English	Article							INTEGRATIVE TAXONOMIC REVISION; BODY-SIZE EVOLUTION; SEXUAL DICHROMATISM; SPECIES CONCEPTS; PHYLOGENETIC-RELATIONSHIPS; CROTAPHYTUS-COLLARIS; GEOGRAPHIC-VARIATION; MAXIMUM-LIKELIHOOD; EMPIRICAL-EVIDENCE; NOSED SNAKE	Species delimitation and species concepts have been a matter of debate among biodiversity researchers in the last decades, resulting in integrative taxonomy approaches and the use of modern species concepts, such as the phylogenetic, evolutionary or general lineage species concepts. The discussion of subspecies status and concepts has been addressed much less extensively, with some researchers completely refraining from recognizing subspecies. However, allopatric insular populations that are particularly differentiated have traditionally been assigned subspecies status. We studied the molecular phylogeny and morphology of endemic Comoran tree snakes of the genus Lycodryas. Taking an integrative taxonomic approach, we used the concept of independent lines of evidence to discriminate between evidence for specific and subspecific status. Molecular (mtDNA) and morphological data provided sufficient evidence to support four different taxa within Comoran Lycodryas. In a revision of this group, we propose two species, each with two subspecies. We present a discussion of the strong sexual dichromatism unique to Comoran Lycodryas within the genus and related genera that may be explained by sexual selection in combination with the absence of major predators. Then, we discuss the effects of insular evolution and the "island rule" on morphological traits in Comoran Lycodryas and in Liophidium mayottensis, another snake endemic to the Comoros. The absence of larger-bodied snakes may have promoted an increase in body size and the number of dorsal scale rows in these species. Finally, we discuss the subspecies concept, its applications and its significance for integrative taxonomy and for limiting taxonomic inflation. We emphasize that taxon descriptions should be based on an integrative approach using several lines of evidence, preferably in combination with statements on the underlying species concepts or operational criteria, to increase the objectivity and comparability of descriptions.	[Hawlitschek, Oliver; Glaw, Frank] Zool Staatssammlung Munchen, Munich, Germany; [Nagy, Zoltan T.] Royal Belgian Inst Nat Sci, Joint Expt Mol Unit, Brussels, Belgium	Royal Belgian Institute of Natural Sciences	Hawlitschek, O (corresponding author), Zool Staatssammlung Munchen, Munich, Germany.	oliver.hawlitschek@gmx.de	Nagy, Zoltan T./C-6737-2011	Nagy, Zoltan T./0000-0002-8455-040X; Hawlitschek, Oliver/0000-0001-8010-4157	Mohamed bin Zayed Species Conservation Fund [0925157]; DAAD [D/09/49634]; "Deutsche Forschungsgemeinschaft" DFG [GL 314/1, BA2152/7-1]; Freunde der Zoologischen Staatssammlung Munchen; Society of the University of Munich; University of Munich;  [MNHNFR-TAF-2988]	Mohamed bin Zayed Species Conservation Fund; DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); "Deutsche Forschungsgemeinschaft" DFG(German Research Foundation (DFG)); Freunde der Zoologischen Staatssammlung Munchen; Society of the University of Munich; University of Munich; 	The research was financially supported by the Mohamed bin Zayed Species Conservation Fund (project 0925157) to FG and OH (http://www.mbzspeciesconservation.org/), by DAAD grant D/09/49634 to OH (http://www.daad.de/en/), the "Deutsche Forschungsgemeinschaft" DFG GL 314/1 to FG and BA2152/7-1 to Michael Balke (http://www.dfg.de/en/index.jsp). The "Freunde der Zoologischen Staatssammlung Munchen" (http://www.zsm.mwn. de/freunde/), the Society of the University of Munich (http://www.unigesellschaft.de/home.php) and EES funding program of the University of Munich (http://www.eeslmu.de/eeswiki/Main_ Page) provided additional financial support. The work at MNHN was financially supported by Synthesys grant FR-TAF-2988 to OH (http://www.synthesys.info/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Santos S.M., 2002, BIOL VIPERS, P445; AMADON DEAN, 1949, CONDOR, V51, P250, DOI 10.2307/1364805; ANDERSSON L, 1990, TAXON, V39, P375, DOI 10.2307/1223084; Andriatsimietry R, 2009, J ZOOL, V279, P410, DOI 10.1111/j.1469-7998.2009.00633.x; Auliya M, 2002, NATURWISSENSCHAFTEN, V89, P201, DOI 10.1007/s00114-002-0320-4; Avise J.C., 1990, Oxford Surveys in Evolutionary Biology, V7, P45; Barton NH, 1996, PHILOS T R SOC B, V351, P785, DOI 10.1098/rstb.1996.0073; BAUM DA, 1995, SYST BOT, V20, P560, DOI 10.2307/2419810; BOAG PT, 1981, SCIENCE, V214, P82, DOI 10.1126/science.214.4516.82; Boback SM, 2003, EVOLUTION, V57, P345; Boettger O., 1913, P269; Boggs CL, 2001, INT ENCY SOCIAL BEHA, P14855; Bohle UR, 1996, P NATL ACAD SCI USA, V93, P11740, DOI 10.1073/pnas.93.21.11740; BOHME W, 1978, Z ZOOL SYST EVOL, V16, P256; Bohme W, 1983, VERT HUNG, V21, P47; Boulenger G.A, 1896, CATALOGUE SNAKES BRI, VIII; Brammah M, 2010, HERPETOL J, V20, P91; BROWN RP, 1991, NATURE, V352, P60, DOI 10.1038/352060a0; Burbrink FT, 2000, EVOLUTION, V54, P2107, DOI 10.1554/0014-3820(2000)054[2107:MDPOTP]2.0.CO;2; CAPULA M, 1994, BIOL J LINN SOC, V52, P177; Carpenter C.C., 1977, P335; Carretero Miguel A., 2005, Herpetological Bulletin, V91, P19; CARSON HL, 1976, ANNU REV ECOL SYST, V7, P311, DOI 10.1146/annurev.es.07.110176.001523; Cirer AM, 1997, MONOGRAFIA HERPETOLO, V3, P542; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cole NC, 2005, BIOL CONSERV, V125, P467, DOI 10.1016/j.biocon.2005.04.017; Cooper WE, 1992, BIOL REPTILIA HORMON, V18, P298; Cracraft J., 1983, Current Ornithology, V1, P159; Darwin C. S., 1859, ORIGIN SPECIES MEANS; DARWIN CR, 1845, VOYAGE BEAGLE; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Desjardins J, 1831, ANN SCI NAT, V22, P292; Diamond J.M., 1984, P824; Diamond J.M., 1984, P191; Dobzhansky T, 1970, GENETICS EVOLUTIONAR; DOMERGUE C A, 1970, Bulletin du Museum National d'Histoire Naturelle, V42, P449; Domergue CA, 1995, ARCH I PASTEUR MADAG, V61, P121; DUARTE MR, 1995, STUD NEOTROP FAUNA E, V30, P1, DOI 10.1080/01650529509360936; Eldredge N., 1980, P1; Elliot DG, 1874, IBIS, V16, P330; Fitzpatrick John W., 2010, Ornithological Monographs, V67, P54; Font E, 2009, BIOL J LINN SOC, V97, P766, DOI 10.1111/j.1095-8312.2009.01251.x; FROST DR, 1990, HERPETOLOGICA, V46, P87; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Futuyma DJ, 1979, EVOLUTIONARY BIOL; Galan P, 2008, ANIM BIOL, V58, P173, DOI 10.1163/157075608X328026; Giribet G., 2005, SYST BIOL, V54, P176, DOI DOI 10.1080/10635150590905830; GLAW F, 2007, FIELDGUIDE AMPHIBIAN; Glaw F, 2007, ZOOL SCR, V36, P291, DOI 10.1111/j.1463-6409.2007.00278.x; Glaw Frank, 2010, Zootaxa, V2383, P1; GOODMAN S M, 1991, Bonner Zoologische Beitraege, V42, P21; Goodman SM, 1998, WILSON BULL, V110, P417; Gosliner T, 2009, ENCY ISLANDS, P357; Greene H. W., 1997, SNAKES EVOLUTION MYS; Gunther A., 1879, Annals of Natural History, V(5), P215; Gunther A, 1858, CATALOGUE COLUBRINE; Haig SM, 2006, CONSERV BIOL, V20, P1584, DOI 10.1111/j.1523-1739.2006.00530.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harris DJ, 2005, TRENDS ECOL EVOL, V20, P6, DOI 10.1016/j.tree.2004.11.004; Hart MW, 2007, BIOL LETTERS, V3, P509, DOI 10.1098/rsbl.2007.0307; Haszprunar G, 2011, ORG DIVERS EVOL, V11, P249, DOI 10.1007/s13127-011-0047-1; Hausdorf B, 2011, EVOLUTION, V65, P923, DOI 10.1111/j.1558-5646.2011.01231.x; Hawkins CE, 2008, J MAMMAL, V89, P64, DOI 10.1644/06-MAMM-A-366.1; Hawlitschek O, 2011, ZOOKEYS, P21, DOI 10.3897/zookeys.144.1648; HEANEY LR, 1978, EVOLUTION, V32, P29, DOI 10.1111/j.1558-5646.1978.tb01096.x; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Helbig AJ, 2002, IBIS, V144, P518, DOI 10.1046/j.1474-919X.2002.00091.x; HELLMICH WC, 1951, EVOLUTION, V5, P359, DOI 10.2307/2405681; Henle K., 1986, P254; Hennig W., 1966, P263; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Horner Paul, 2007, Beagle, P21; HORTON DR, 1972, SYST ZOOL, V21, P441, DOI 10.2307/2412438; Hume J., 2008, LOST LAND DODO; Inger RF, 1961, VERTEBRATE SPECIATIO, P262; Isaac NJB, 2004, TRENDS ECOL EVOL, V19, P464, DOI 10.1016/j.tree.2004.06.004; Jesus J, 2006, HERPETOL J, V16, P291; Karpanty SM, 1999, J RAPTOR RES, V33, P313; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kearney M, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P447, DOI 10.1007/978-90-481-2770-2_21; Keogh JS, 2005, EVOLUTION, V59, P226; Knapp S, 2005, TRENDS ECOL EVOL, V20, P7, DOI 10.1016/j.tree.2004.11.001; Krysko KL, 2005, AFR J HERPETOL, V54, P195, DOI 10.1080/21564574.2005.9635534; Kuhnelt W., 1943, Biologia Generalis Wien, V17, P106; Kuriyama T, 2011, J BIOGEOGR, V38, P259, DOI 10.1111/j.1365-2699.2010.02403.x; LeBas NR, 2000, P ROY SOC B-BIOL SCI, V267, P445, DOI 10.1098/rspb.2000.1020; Lee TM, 2011, P ROY SOC B-BIOL SCI, V278, P1329, DOI 10.1098/rspb.2010.1877; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; LOMOLINO MV, 1985, AM NAT, V125, P310, DOI 10.1086/284343; Louette M, 2004, STUDIES AFROTROPICAL, V293; Louette M, 2008, STUDIES AFROTROPICAL, V294; Luiselli L, 2006, OIKOS, V114, P193, DOI 10.1111/j.2006.0030-1299.14064.x; Macedonia JM, 2004, J HERPETOL, V38, P340, DOI 10.1670/183-03A; Macedonia JM, 2002, BIOL J LINN SOC, V77, P67, DOI 10.1046/j.1095-8312.2002.00092.x; Mallet J, 2005, TRENDS ECOL EVOL, V20, P8, DOI 10.1016/j.tree.2004.11.002; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Mallet J, 2004, SYST BIODIVERS, V1, P441; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; Manier MK, 2004, BIOL J LINN SOC, V83, P65, DOI 10.1111/j.1095-8312.2004.00373.x; Marques OAV, 2002, HERPETOLOGICA, V58, P303, DOI 10.1655/0018-0831(2002)058[0303:ANISOP]2.0.CO;2; Mason RT, 2010, J COMP PHYSIOL A, V196, P729, DOI 10.1007/s00359-010-0551-3; Mayden R. L., 1997, V54, P381; Mayr E., 1942, P1; MAYR E, 1982, AUK, V99, P593; Mayr E., 1991, PRINCIPLES SYSTEMATI; Mayr E., 1963, ANIMAL SPECIES EVOLU; MEIER H, 1986, Salamandra, V22, P11; Meiri S, 2011, J BIOGEOGR, V38, P89, DOI 10.1111/j.1365-2699.2010.02390.x; MEIRTE D, 2004, STUDIES AFROTROPICAL, V293, P199; Meirte D, 1992, BRIT HERPETOL SOC B, V39, P3; Mertens R, 1934, INSEL REPTILIEN IHRE; Michener C. D., 1970, EVOL BIOL, V4, P1; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Miralles A, 2011, ZOOL SCR, V40, P16, DOI 10.1111/j.1463-6409.2010.00453.x; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Mulcahy DG, 2008, MOL PHYLOGENET EVOL, V46, P1095, DOI 10.1016/j.ympev.2007.12.012; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nagy Zoltan T, 2012, PLoS One, V7, pe34506, DOI 10.1371/journal.pone.0034506; Nagy ZT, 2010, ZOOL SCR, V39, P426, DOI 10.1111/j.1463-6409.2010.00435.x; Nagy ZT, 2007, ORG DIVERS EVOL, V7, P241, DOI 10.1016/j.ode.2006.07.003; Nagy ZT, 2003, P ROY SOC B-BIOL SCI, V270, P2613, DOI 10.1098/rspb.2003.2547; Nunn P., 1994, OCEANIC ISLANDS; Padial JM, 2006, SYST BIOL, V55, P859, DOI 10.1080/1063515060081588; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Padial JM, 2009, ZOOL SCR, V38, P431, DOI 10.1111/j.1463-6409.2008.00381.x; Pascal O, 2002, PATRIMOINES NATURELS, V53; Patten Michael A., 2010, Ornithological Monographs, V67, P35; Pelzeln A, 1882, UEBER SENDUNG SAUGET, V1; Peters WCH, 1874, VORLAUFIGE MITTHEILU, P792; Phillimore AB, 2006, P R SOC B, V273, P1049, DOI 10.1098/rspb.2005.3425; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pough HF, 2001, HERPETOLOGY; Price JP, 2002, P ROY SOC B-BIOL SCI, V269, P2429, DOI 10.1098/rspb.2002.2175; Price JP, 2009, ENCY ISLANDS, P397; Rambaut A., 2007, TRACER V1 4; Rassmann K, 1997, MOL PHYLOGENET EVOL, V7, P158, DOI 10.1006/mpev.1996.0386; Remsen J.V. Jr, 2010, Ornithological Monographs, V67, P62; Rocha S, 2006, J BIOGEOGR, V33, P13, DOI 10.1111/j.1365-2699.2005.01375.x; Rocha S, 2009, MOL PHYLOGENET EVOL, V52, P530, DOI 10.1016/j.ympev.2009.03.032; Rocha S, 2007, MOL PHYLOGENET EVOL, V43, P685, DOI 10.1016/j.ympev.2006.07.010; Rocha Sara, 2010, Zootaxa, V2429, P1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Runemark A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-269; Salvador A., 1986, HDB REPTILIEN AMPHIB, V2, P231; Sanders KL, 2004, J EVOLUTION BIOL, V17, P721, DOI 10.1111/j.1420-9101.2004.00735.x; Schleip WD, 2010, ZOOKEYS, P29, DOI [10.3897/zookeys.66.683, 10.3897/zookeys.66.367]; Sclater PL, 1857, P ZOOL SOC L, V25, P15; Shine Richard, 1993, P49; Sillman AJ, 1997, J COMP PHYSIOL A, V181, P89, DOI 10.1007/s003590050096; Silvestro D., 2011, ORG DIVERS EVOL, V12, P335, DOI [10.1007/sI3127-011-0056-0, DOI 10.1007/S13127-011-0056-0]; SIMPSON GG, 1951, EVOLUTION, V5, P285, DOI 10.2307/2405675; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Takahashi K, 2001, MOL BIOL EVOL, V18, P2057, DOI 10.1093/oxfordjournals.molbev.a003747; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Templeton A.R., 1989, P3; TEMPLETON AR, 1992, GENETICS, V132, P619; Thebaud C, 2009, ENCY ISLANDS, P612; THORPE RS, 1987, EVOLUTION, V41, P256, DOI 10.1111/j.1558-5646.1987.tb05795.x; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Vasconcelos R, 2012, ZOOL J LINN SOC-LOND, V164, P328, DOI 10.1111/j.1096-3642.2011.00768.x; Vences Miguel, 2004, Salamandra, V40, P161; Vieites DR, 2010, SALAMANDRA, V46, P1; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Wallace A. R., 1865, Linn Trans, Vvol. xxv, P1; Warren BH, 2006, MOL ECOL, V15, P3769, DOI 10.1111/j.1365-294X.2006.03058.x; Wiens JJ, 2000, P ROY SOC B-BIOL SCI, V267, P631, DOI 10.1098/rspb.2000.1049; Wiens JJ, 2002, SYST BIOL, V51, P69, DOI 10.1080/106351502753475880; Wiens JJ, 2006, EVOLUTION, V60, P2585; WILEY EO, 1978, SYST ZOOL, V27, P17, DOI 10.2307/2412809; WILSON EO, 1953, SYST ZOOL, V2, P97, DOI 10.2307/2411818; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x	174	48	50	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42970	10.1371/journal.pone.0042970	http://dx.doi.org/10.1371/journal.pone.0042970			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937005	Green Published, gold			2022-12-25	WOS:000308225500024
J	Liu, HM; Aizaki, H; Machida, K; Ou, JHJ; Lai, MMC				Liu, Helene Minyi; Aizaki, Hideki; Machida, Keigo; Ou, J. -H. James; Lai, Michael M. C.			Hepatitis C Virus Translation Preferentially Depends on Active RNA Replication	PLOS ONE			English	Article							TRACT-BINDING PROTEIN; VIRAL TRANSLATION; CELL-LINES; POLIOVIRUS; COMPLEX; TRANSCRIPTION; POLYMERASE; MEMBRANE; DOMAIN; SITE	Hepatitis C virus (HCV) RNA initiates its replication on a detergent-resistant membrane structure derived from the endoplasmic reticulum (ER) in the HCV replicon cells. By performing a pulse-chase study of BrU-labeled HCV RNA, we found that the newly-synthesized HCV RNA traveled along the anterograde-membrane traffic and moved away from the ER. Presumably, the RNA moved to the site of translation or virion assembly in the later steps of viral life cycle. In this study, we further addressed how HCV RNA translation was regulated by HCV RNA trafficking. When the movement of HCV RNA from the site of RNA synthesis to the Golgi complex was blocked by nocodazole, an inhibitor of ER-Golgi transport, HCV protein translation was surprisingly enhanced, suggesting that the translation of viral proteins occurred near the site of RNA synthesis. We also found that the translation of HCV proteins was dependent on active RNA synthesis: inhibition of viral RNA synthesis by an NS5B inhibitor resulted in decreased HCV viral protein synthesis even when the total amount of intracellular HCV RNA remained unchanged. Furthermore, the translation activity of the replication-defective HCV replicons or viral RNA with an NS5B mutation was greatly reduced as compared to that of the corresponding wildtype RNA. By performing live cell labeling of newly synthesized HCV RNA and proteins, we further showed that the newly synthesized HCV proteins colocalized with the newly synthesized viral RNA, suggesting that HCV RNA replication and protein translation take place at or near the same site. Our findings together indicate that the translation of HCV RNA is coupled to RNA replication and that the both processes may occur at the same subcellular membrane compartments, which we term the replicasome.	[Liu, Helene Minyi; Aizaki, Hideki; Machida, Keigo; Ou, J. -H. James; Lai, Michael M. C.] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Lai, Michael M. C.] Acad Sinica, Inst Mol Biol, Taipei, Taiwan	University of Southern California; Academia Sinica - Taiwan	Liu, HM (corresponding author), Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.	michlai@gate.sinica.edu.tw	Lai, Michael M. C./I-7001-2012; Liu, Helene Minyi/Y-1834-2019	Liu, Helene Minyi/0000-0003-4837-5373; Machida, Keigo/0000-0002-9721-8553	National Institutes of Health [AI40038, CA108302]; Academia Sinica Institutional Fund; NATIONAL CANCER INSTITUTE [R01CA108302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI040038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academia Sinica Institutional Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants AI40038, CA108302, and Academia Sinica Institutional Fund. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Aizaki H, 2006, J BIOMED SCI, V13, P469, DOI 10.1007/s11373-006-9088-4; Ali N, 2000, J BIOL CHEM, V275, P27531; Annamalai P, 2006, J VIROL, V80, P10096, DOI 10.1128/JVI.01186-06; Bartenschlager R, 2006, CURR OPIN MICROBIOL, V9, P416, DOI 10.1016/j.mib.2006.06.012; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Bost AG, 2003, J VIROL, V77, P4401, DOI 10.1128/JVI.77.7.4401-4408.2003; Chang KS, 2006, VIRUS RES, V115, P1, DOI 10.1016/j.virusres.2005.06.012; Choi JN, 2004, HEPATOLOGY, V39, P81, DOI 10.1002/hep.20001; Domitrovich AM, 2005, VIROLOGY, V335, P72, DOI 10.1016/j.virol.2005.02.009; Egger D, 2000, J VIROL, V74, P6570, DOI 10.1128/JVI.74.14.6570-6580.2000; Egger D, 2005, J GEN VIROL, V86, P707, DOI 10.1099/vir.0.80442-0; Gamarnik AV, 2000, J VIROL, V74, P2219, DOI 10.1128/JVI.74.5.2219-2226.2000; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; GOLDBERG IH, 1962, P NATL ACAD SCI USA, V48, P2094, DOI 10.1073/pnas.48.12.2094; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Goueslain L, 2009, J VIROL; Guo JT, 2001, J VIROL, V75, P8516, DOI 10.1128/JVI.75.18.8516-8523.2001; Hamamoto I, 2005, J VIROL, V79, P13473, DOI 10.1128/JVI.79.21.13473-13482.2005; Hirashima S, 2006, J MED CHEM, V49, P4721, DOI 10.1021/jm060269e; Iborra FJ, 2001, SCIENCE, V293, P1139, DOI 10.1126/science.1061216; IOST I, 1995, EMBO J, V14, P3252, DOI 10.1002/j.1460-2075.1995.tb07328.x; IOST I, 1994, NATURE, V372, P193, DOI 10.1038/372193a0; Ito T, 1999, VIROLOGY, V254, P288, DOI 10.1006/viro.1998.9541; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kieft JS, 2002, NAT STRUCT BIOL, V9, P370, DOI 10.1038/nsb781; Kim JH, 2004, MOL CELL BIOL, V24, P7878, DOI 10.1128/MCB.24.18.7878-7890.2004; Lee KJ, 2004, J VIROL, V78, P3797, DOI 10.1128/JVI.78.7.3797-3802.2004; LIPPINCOTTSCHWARTZ J, 1995, J CELL BIOL, V128, P293, DOI 10.1083/jcb.128.3.293; Liu HM, 2009, VIROLOGY, V386, P249, DOI 10.1016/j.virol.2009.01.018; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Manna D, 2009, VIROLOGY; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; NOVAK JE, 1994, GENE DEV, V8, P1726, DOI 10.1101/gad.8.14.1726; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Perera R, 2007, J VIROL, V81, P8919, DOI 10.1128/JVI.01013-07; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Sanz MA, 2007, J VIROL, V81, P7061, DOI 10.1128/JVI.02529-06; Shi ST, 2003, J VIROL, V77, P4160, DOI 10.1128/JVI.77.7.4160-4168.2003; Shi ST, 2002, VIROLOGY, V292, P198, DOI 10.1006/viro.2001.1225; Sir D, 2012, J BIOL CHEM IN PRESS; Tedesco R, 2006, J MED CHEM, V49, P971, DOI 10.1021/jm050855s; Toyoda H, 2007, J VIROL, V81, P10017, DOI 10.1128/JVI.00516-07; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Watson P, 2005, NAT CELL BIOL, V7, P48, DOI 10.1038/ncb1206; Wolk B, 2008, J VIROL, V82, P10519, DOI 10.1128/JVI.00640-08	48	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43600	10.1371/journal.pone.0043600	http://dx.doi.org/10.1371/journal.pone.0043600			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937067	Green Submitted, gold, Green Published			2022-12-25	WOS:000308225500068
J	Wang, MJ; Zhao, XM; Takemoto, K; Xu, HS; Li, Y; Akutsu, T; Song, JN				Wang, Mingjun; Zhao, Xing-Ming; Takemoto, Kazuhiro; Xu, Haisong; Li, Yuan; Akutsu, Tatsuya; Song, Jiangning			FunSAV: Predicting the Functional Effect of Single Amino Acid Variants Using a Two-Stage Random Forest Model	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; SUPPORT VECTOR MACHINES; NUCLEOTIDE POLYMORPHISMS; GENOME SEQUENCE; DISEASE; MUTATIONS; INFORMATION; BIOINFORMATICS; COVARIATION; RESOURCE	Single amino acid variants (SAVs) are the most abundant form of known genetic variations associated with human disease. Successful prediction of the functional impact of SAVs from sequences can thus lead to an improved understanding of the underlying mechanisms of why a SAV may be associated with certain disease. In this work, we constructed a high-quality structural dataset that contained 679 high-quality protein structures with 2,048 SAVs by collecting the human genetic variant data from multiple resources and dividing them into two categories, i.e., disease-associated and neutral variants. We built a two-stage random forest (RF) model, termed as FunSAV, to predict the functional effect of SAVs by combining sequence, structure and residue-contact network features with other additional features that were not explored in previous studies. Importantly, a two-step feature selection procedure was proposed to select the most important and informative features that contribute to the prediction of disease association of SAVs. In cross-validation experiments on the benchmark dataset, FunSAV achieved a good prediction performance with the area under the curve (AUC) of 0.882, which is competitive with and in some cases better than other existing tools including SIFT, SNAP, Polyphen2, PANTHER, nsSNPAnalyzer and PhD-SNP. The sourcecodes of FunSAV and the datasets can be downloaded at http://sunflower.kuicr.kyoto-u.ac.jp/similar to sjn/FunSAV.	[Wang, Mingjun; Xu, Haisong; Li, Yuan; Song, Jiangning] Chinese Acad Sci, Natl Engn Lab Ind Enzymes, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China; [Wang, Mingjun; Xu, Haisong; Li, Yuan; Song, Jiangning] Chinese Acad Sci, Key Lab Syst Microbial Biotechnol, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China; [Zhao, Xing-Ming] Tongji Univ, Dept Comp Sci, Sch Elect & Informat Engn, Shanghai 200092, Peoples R China; [Takemoto, Kazuhiro] Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka, Japan; [Akutsu, Tatsuya; Song, Jiangning] Kyoto Univ, Bioinformat Ctr, Inst Chem Res, Uji, Kyoto, Japan; [Song, Jiangning] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Tongji University; Kyushu Institute of Technology; Kyoto University; Monash University	Wang, MJ (corresponding author), Chinese Acad Sci, Natl Engn Lab Ind Enzymes, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China.	Jiangning.Song@monash.edu	Song, Jiangning/F-9787-2010; wang, mingjun/C-8042-2013; Takemoto, Kazuhiro/H-2915-2019	Song, Jiangning/0000-0001-8031-9086; Takemoto, Kazuhiro/0000-0002-6355-1366; Akutsu, Tatsuya/0000-0001-9763-797X	National Health and Medical Research Council of Australia (NHMRC); Australian Research Council (ARC); Japan Society for the Promotion of Science (JSPS); Hundred Talents Program of the Chinese Academy of Sciences (CAS); Knowledge Innovation Program of CAS [KSCX2-EW-G-8]; Tianjin Municipal Science & Technology Commission [10ZCKFSY05600]; Hundred Talents Program of CAS; JSPS Short-term Invitation Fellowship to the Bioinformatics Center, Kyoto University, Japan	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hundred Talents Program of the Chinese Academy of Sciences (CAS); Knowledge Innovation Program of CAS(Knowledge Innovation Program of the Chinese Academy of Sciences); Tianjin Municipal Science & Technology Commission; Hundred Talents Program of CAS(Chinese Academy of Sciences); JSPS Short-term Invitation Fellowship to the Bioinformatics Center, Kyoto University, Japan	This work was supported by grants from the National Health and Medical Research Council of Australia (NHMRC), the Australian Research Council (ARC), the Japan Society for the Promotion of Science (JSPS), the Hundred Talents Program of the Chinese Academy of Sciences (CAS), the Knowledge Innovation Program of CAS (No. KSCX2-EW-G-8) and Tianjin Municipal Science & Technology Commission (No. 10ZCKFSY05600). JS is an NHMRC Peter Doherty Fellow and the Recipient of the Hundred Talents Program of CAS and the JSPS Short-term Invitation Fellowship to the Bioinformatics Center, Kyoto University, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Bao L, 2005, NUCLEIC ACIDS RES, V33, pW480, DOI 10.1093/nar/gki372; Bao L, 2005, BIOINFORMATICS, V21, P2185, DOI 10.1093/bioinformatics/bti365; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bork P, 1999, J MOL MED, V77, P754; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bromberg Y, 2008, BIOINFORMATICS, V24, P2397, DOI 10.1093/bioinformatics/btn435; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chasman D, 2001, J MOL BIOL, V307, P683, DOI 10.1006/jmbi.2001.4510; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cline MS, 2011, BIOINFORMATICS, V27, P441, DOI 10.1093/bioinformatics/btq695; DeLano W.L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Dobson RJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-217; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Ebina T, 2011, BIOINFORMATICS, V27, P487, DOI 10.1093/bioinformatics/btq700; Fernald GH, 2011, BIOINFORMATICS, V27, P1741, DOI 10.1093/bioinformatics/btr295; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gao S, 2009, HUM MUTAT, V30, P1161, DOI 10.1002/humu.21039; Gong S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009186; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Hamelryck T, 2005, PROTEINS, V59, P38, DOI 10.1002/prot.20379; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hardin C, 2002, CURR OPIN STRUC BIOL, V12, P176, DOI 10.1016/S0959-440X(02)00306-8; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; Kowarsch A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000923; Larson SM, 2000, J MOL BIOL, V303, P433, DOI 10.1006/jmbi.2000.4146; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li YZ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-14; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Martinez MA, 2005, MOL GENET METAB, V84, P317, DOI 10.1016/j.ymgme.2004.11.011; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Mingjun Wang, 2011, 2011 IEEE International Conference on Systems Biology (ISB), P18, DOI 10.1109/ISB.2011.6033115; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Sadras V, 2004, FIELD CROP RES, V90, P303, DOI 10.1016/j.fcr.2004.04.003; Samanta U, 2008, J BIOL CHEM, V283, P31617, DOI 10.1074/jbc.M804750200; Saunders CT, 2002, J MOL BIOL, V322, P891, DOI 10.1016/S0022-2836(02)00813-6; Schubert HL, 2006, BIOCHEMISTRY-US, V45, P15188, DOI 10.1021/bi061396f; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Song JN, 2008, BIOINFORMATICS, V24, P1489, DOI 10.1093/bioinformatics/btn222; Song JN, 2007, BIOINFORMATICS, V23, P3147, DOI 10.1093/bioinformatics/btm505; Song JN, 2010, BIOINFORMATICS, V26, P752, DOI 10.1093/bioinformatics/btq043; Stitziel NO, 2003, J MOL BIOL, V327, P1021, DOI 10.1016/S0022-2836(03)00240-7; Sunyaev SR, 1999, PROTEIN ENG, V12, P387, DOI 10.1093/protein/12.5.387; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Wainreb G, 2010, NUCLEIC ACIDS RES, V38, P7869, DOI 10.1093/nar/gkq1208; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang XF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026767; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Ye ZQ, 2007, BIOINFORMATICS, V23, P1444, DOI 10.1093/bioinformatics/btm119; Yip YL, 2004, HUM MUTAT, V23, P464, DOI 10.1002/humu.20021; Yuan Z, 2005, PROTEINS, V58, P905, DOI 10.1002/prot.20375; Zhao XM, 2005, NEURAL NETWORKS, V18, P1019, DOI 10.1016/j.neunet.2005.07.002	72	39	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43847	10.1371/journal.pone.0043847	http://dx.doi.org/10.1371/journal.pone.0043847			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937107	gold, Green Published, Green Submitted			2022-12-25	WOS:000308225500109
J	Juliana, C; Fernandes-Alnemri, T; Kang, S; Farias, A; Qin, FS; Alnemri, ES				Juliana, Christine; Fernandes-Alnemri, Teresa; Kang, Seokwon; Farias, Andrew; Qin, Fengsong; Alnemri, Emad S.			Non-transcriptional Priming and Deubiquitination Regulate NLRP3 Inflammasome Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; PYROPTOSOME; INHIBITORS	The NLRP3 inflammasome is a key component of the innate immune response to pathogenic infection and tissue damage. It is also involved in the pathogenesis of a number of human diseases, including gouty arthritis, silicosis, atherosclerosis, and type 2 diabetes. The assembly of the NLRP3 inflammasome requires a priming signal derived from pattern recognition or cytokine receptors, followed by a second signal derived from extracellular ATP, pore-forming toxins, or crystalline materials. How these two signals activate the NLRP3 inflammasome is not yet clear. Here, we show that in mouse macrophages, signaling by the pattern recognition receptor TLR4 through MyD88 can rapidly and non-transcriptionally prime NLRP3 by stimulating its deubiquitination. This process is dependent on mitochondrial reactive oxygen species production and can be inhibited by antioxidants. We further show that signaling by ATP can also induce deubiquitination of NLRP3 by a mechanism that is not sensitive to antioxidants. Pharmacological inhibition of NLRP3 deubiquitination completely blocked NLRP3 activation in both mouse and human cells, indicating that deubiquitination of NLRP3 is required for its activation. Our findings suggest that NLRP3 is activated by a two-step deubiquitination mechanism initiated by Toll-like receptor signaling and mitochondrial reactive oxygen species and further potentiated by ATP, which could explain how NLRP3 is activated by diverse danger signals.	[Alnemri, Emad S.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Alnemri, ES (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.	Emad.Alnemri@Jefferson.edu		Juliana, Christine/0000-0002-4314-1407	National Institutes of Health [AG14357, AR055398]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG14357 and AR055398 (to E. S. A.).	Aksentijevich I, 2007, ARTHRITIS RHEUM-US, V56, P1273, DOI 10.1002/art.22491; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	16	482	505	3	84	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36617	36622		10.1074/jbc.M112.407130	http://dx.doi.org/10.1074/jbc.M112.407130			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948162	Green Published, hybrid			2022-12-25	WOS:000310364000081
J	Timaru-Kast, R; Luh, C; Gotthardt, P; Huang, CS; Schafer, MK; Engelhard, K; Thal, SC				Timaru-Kast, Ralph; Luh, Clara; Gotthardt, Philipp; Huang, Changsheng; Schaefer, Michael K.; Engelhard, Kristin; Thal, Serge C.			Influence of Age on Brain Edema Formation, Secondary Brain Damage and Inflammatory Response after Brain Trauma in Mice	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; TUMOR-NECROSIS-FACTOR; PROSPECTIVE MULTICENTER TRIAL; NF-KAPPA-B; OXIDATIVE STRESS; GENE-EXPRESSION; OLDER-ADULTS; HEAD-INJURY; ENVIRONMENTAL ENRICHMENT; NEURONAL DEATH	After traumatic brain injury (TBI) elderly patients suffer from higher mortality rate and worse functional outcome compared to young patients. However, experimental TBI research is primarily performed in young animals. Aim of the present study was to clarify whether age affects functional outcome, neuroinflammation and secondary brain damage after brain trauma in mice. Young (2 months) and old (21 months) male C57Bl6N mice were anesthetized and subjected to a controlled cortical impact injury (CCI) on the right parietal cortex. Animals of both ages were randomly assigned to 15 min, 24 h, and 72 h survival. At the end of the observation periods, contusion volume, brain water content, neurologic function, cerebral and systemic inflammation (CD3+ T cell migration, inflammatory cytokine expression in brain and lung, blood differential cell count) were determined. Old animals showed worse neurological function 72 h after CCI and a high mortality rate (19.2%) compared to young (0%). This did not correlate with histopathological damage, as contusion volumes were equal in both age groups. Although a more pronounced brain edema formation was detected in old mice 24 hours after TBI, lack of correlation between brain water content and neurological deficit indicated that brain edema formation is not solely responsible for age-dependent differences in neurological outcome. Brains of old naive mice were about 8% smaller compared to young naive brains, suggesting age-related brain atrophy with possible decline in plasticity. Onset of cerebral inflammation started earlier and primarily ipsilateral to damage in old mice, whereas in young mice inflammation was delayed and present in both hemispheres with a characteristic T cell migration pattern. Pulmonary interleukin 1 beta expression was up-regulated after cerebral injury only in young, not aged mice. The results therefore indicate that old animals are prone to functional deficits and strong ipsilateral cerebral inflammation without major differences in morphological brain damage compared to young.	[Timaru-Kast, Ralph; Luh, Clara; Gotthardt, Philipp; Huang, Changsheng; Schaefer, Michael K.; Engelhard, Kristin; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anaesthesiol, Mainz, Germany; [Huang, Changsheng; Schaefer, Michael K.; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Timaru-Kast, R (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anaesthesiol, Mainz, Germany.	thal@uni-mainz.de	Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729; Huang, Changsheng/0000-0003-0535-1865	Focus Program Translational Neurosciences of the Johannes Gutenberg-University	Focus Program Translational Neurosciences of the Johannes Gutenberg-University	This work was supported by grants from the Focus Program Translational Neurosciences of the Johannes Gutenberg-University to SCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PLOS ONE; Arnett HA, 2003, J NEUROSCI, V23, P9824; Ashcroft GS, 2002, BIOGERONTOLOGY, V3, P337, DOI 10.1023/A:1021399228395; Badan I, 2003, J CEREBR BLOOD F MET, V23, P845, DOI 10.1097/01.WCB.0000071883.63724.A7; Barnes CJ, 1998, AGING-CLIN EXP RES, V10, P455, DOI 10.1007/BF03340159; Barreto G, 2010, J NEUROSURG ANESTH, V22, P214, DOI 10.1097/ANA.0b013e3181d56c98; Bieber AJ, 2003, ANN NEUROL, V53, P680, DOI 10.1002/ana.10578; Buchhold B, 2007, RESTOR NEUROL NEUROS, V25, P467; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Campbell SJ, 2007, NEUROPATH APPL NEURO, V33, P108, DOI 10.1111/j.1365-2990.2006.00773.x; Castillo-Ruiz MM, 2007, EXP GERONTOL, V42, P343, DOI 10.1016/j.exger.2006.10.008; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Correale J, 2004, J NEUROL, V251, P1304, DOI 10.1007/s00415-004-0649-z; COTMAN CW, 1979, MECH AGEING DEV, V9, P103, DOI 10.1016/0047-6374(79)90124-6; Felzien LK, 2001, BRAIN RES, V890, P137, DOI 10.1016/S0006-8993(00)03090-0; Ferger B, 2004, J NEUROCHEM, V89, P822, DOI 10.1111/j.1471-4159.2004.02399.x; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; Gilmer LK, 2010, J NEUROTRAUM, V27, P939, DOI 10.1089/neu.2009.1181; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Gregersen R, 2000, J CEREBR BLOOD F MET, V20, P53, DOI 10.1097/00004647-200001000-00009; GRIFFIN WST, 1994, NEUROSCI LETT, V176, P133, DOI 10.1016/0304-3940(94)90066-3; Gruver AL, 2007, J PATHOL, V211, P144, DOI 10.1002/path.2104; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; HAMM RJ, 1991, J NEUROSURG, V75, P916, DOI 10.3171/jns.1991.75.6.0916; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Johnstone B, 1998, BRAIN INJURY, V12, P569, DOI 10.1080/026990598122331; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Korhonen P, 1997, NEUROSCI LETT, V225, P61, DOI 10.1016/S0304-3940(97)00190-0; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Kyrkanides S, 2001, J NEUROIMMUNOL, V119, P269, DOI 10.1016/S0165-5728(01)00404-0; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; Luh C, 2010, J NEUROCHEM, V112, P1015, DOI 10.1111/j.1471-4159.2009.06514.x; Markus TM, 2005, ANN NEUROL, V58, P950, DOI 10.1002/ana.20676; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Popa-Wagner A, 2007, ACTA NEUROPATHOL, V113, P277, DOI 10.1007/s00401-006-0164-7; Popa-Wagner A, 2011, AGEING RES REV, V10, P71, DOI 10.1016/j.arr.2009.10.008; Popa-Wagner A, 2010, CURR NEUROVASC RES, V7, P251, DOI 10.2174/156720210792231813; Rapoport MJ, 2006, AM J GERIAT PSYCHIAT, V14, P456, DOI 10.1097/01.JGP.0000199339.79689.8a; Richmond TS, 2002, J AM GERIATR SOC, V50, P215, DOI 10.1046/j.1532-5415.2002.50051.x; Sandhir R, 2004, NEUROSCI LETT, V369, P28, DOI 10.1016/j.neulet.2004.07.032; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Sandhir R, 2010, NEUROCHEM INT, V56, P188, DOI 10.1016/j.neuint.2009.10.002; Sandhu SK, 2002, BIOGERONTOLOGY, V3, P161, DOI 10.1023/A:1015643107449; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Shao CX, 2006, FREE RADICAL BIO MED, V41, P77, DOI 10.1016/j.freeradbiomed.2006.03.007; Sharman KG, 2002, NEUROBIOL AGING, V23, P633, DOI 10.1016/S0197-4580(01)00329-3; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thal SC, 2007, J NEUROSCI METH, V159, P261, DOI 10.1016/j.jneumeth.2006.07.016; Thal SC, 2009, CRIT CARE MED, V37, P2228, DOI 10.1097/CCM.0b013e3181a068fc; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; UNTERBERG A, 1994, ACTA NEUROCHIR, P431; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vollmer D G, 1991, Neurosurg Clin N Am, V2, P437; WHITEGBADEBO D, 1993, J NEUROTRAUM, V10, P297, DOI 10.1089/neu.1993.10.297; Williams B, 2007, NEUROSCI LETT, V413, P110, DOI 10.1016/j.neulet.2006.11.040; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	79	65	69	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43829	10.1371/journal.pone.0043829	http://dx.doi.org/10.1371/journal.pone.0043829			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952778	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206500024
J	Bahlmann, J; Korb, FM; Gratton, C; Friederici, AD				Bahlmann, Joerg; Korb, Franziska M.; Gratton, Caterina; Friederici, Angela D.			Levels of Integration in Cognitive Control and Sequence Processing in the Prefrontal Cortex	PLOS ONE			English	Article							FRONTAL-CORTEX; HIERARCHICAL ORGANIZATION; SYNTACTIC STRUCTURE; WORKING-MEMORY; LANGUAGE; LEARNABILITY; INVOLVEMENT; FMRI	Cognitive control is necessary to flexibly act in changing environments. Sequence processing is needed in language comprehension to build the syntactic structure in sentences. Functional imaging studies suggest that sequence processing engages the left ventrolateral prefrontal cortex (PFC). In contrast, cognitive control processes additionally recruit bilateral rostral lateral PFC regions. The present study aimed to investigate these two types of processes in one experimental paradigm. Sequence processing was manipulated using two different sequencing rules varying in complexity. Cognitive control was varied with different cue-sets that determined the choice of a sequencing rule. Univariate analyses revealed distinct PFC regions for the two types of processing (i.e. sequence processing: left ventrolateral PFC and cognitive control processing: bilateral dorsolateral and rostral PFC). Moreover, in a common brain network (including left lateral PFC and intraparietal sulcus) no interaction between sequence and cognitive control processing was observed. In contrast, a multivariate pattern analysis revealed an interaction of sequence and cognitive control processing, such that voxels in left lateral PFC and parietal cortex showed different tuning functions for tasks involving different sequencing and cognitive control demands. These results suggest that the difference between the process of rule selection (i.e. cognitive control) and the process of rule-based sequencing (i.e. sequence processing) find their neuronal underpinnings in distinct activation patterns in lateral PFC. Moreover, the combination of rule selection and rule sequencing can shape the response of neurons in lateral PFC and parietal cortex.	[Bahlmann, Joerg; Gratton, Caterina] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Korb, Franziska M.; Friederici, Angela D.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Korb, Franziska M.] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA	University of California System; University of California Berkeley; Max Planck Society; Duke University	Bahlmann, J (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	bahlmann@berkeley.edu		Korb, Franziska/0000-0002-1005-0090	Leopoldina - National Academy of Science Grant [LPDS 2009-20]	Leopoldina - National Academy of Science Grant	This research was supported by the Leopoldina - National Academy of Science Grant (LPDS 2009-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badre D, 2007, J COGNITIVE NEUROSCI, V19, P2082, DOI 10.1162/jocn.2007.19.12.2082; Bahlmann J, 2008, NEUROIMAGE, V42, P525, DOI 10.1016/j.neuroimage.2008.04.249; Bahlmann J, 2009, BRAIN RES, V1298, P161, DOI 10.1016/j.brainres.2009.08.017; Bor D, 2003, NEURON, V37, P361, DOI 10.1016/S0896-6273(02)01171-6; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; Bunge Silvia A., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P564; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; Christoff K, 2009, BRAIN RES, V1286, P94, DOI 10.1016/j.brainres.2009.05.096; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; D'Esposito Mark, 2008, Handb Clin Neurol, V88, P237, DOI 10.1016/S0072-9752(07)88011-0; Danielmeier C, 2011, J NEUROSCI, V31, P1780, DOI 10.1523/JNEUROSCI.4299-10.2011; de Vries MH, 2008, COGNITION, V107, P763, DOI 10.1016/j.cognition.2007.09.002; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Forkstam C, 2006, NEUROIMAGE, V32, P956, DOI 10.1016/j.neuroimage.2006.03.057; Forstmann BU, 2005, NEUROPSYCHOLOGIA, V43, P943, DOI 10.1016/j.neuropsychologia.2004.08.008; Friederici AD, 2006, CEREB CORTEX, V16, P1709, DOI 10.1093/cercor/bhj106; Friederici AD, 2011, PHYSIOL REV, V91, P1357, DOI 10.1152/physrev.00006.2011; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fuster JM, 2004, TRENDS COGN SCI, V8, P143, DOI 10.1016/j.tics.2004.02.004; Gazzaley Adam, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P580, DOI 10.3758/CABN.4.4.580; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; Krawczyk DC, 2011, CORTEX, V47, P588, DOI 10.1016/j.cortex.2010.04.008; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Makuuchi M, 2009, P NATL ACAD SCI USA, V106, P8362, DOI 10.1073/pnas.0810928106; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mohr HM, 2006, J NEUROSCI, V26, P4465, DOI 10.1523/JNEUROSCI.5232-05.2006; Mueller JL, 2010, COGNITIVE SCI, V34, P338, DOI 10.1111/j.1551-6709.2009.01093.x; Newell A, 1994, UNIFIED THEORIES COG; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Opitz B, 2004, J NEUROSCI, V24, P8436, DOI 10.1523/JNEUROSCI.2220-04.2004; Perruchet P, 2005, PSYCHON B REV, V12, P307, DOI 10.3758/BF03196377; Petrides M, 2000, J NEUROSCI, V20, P7496; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Roder B, 2002, NEUROIMAGE, V15, P1003, DOI 10.1006/nimg.2001.1026; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Sakai K, 2008, ANNU REV NEUROSCI, V31, P219, DOI 10.1146/annurev.neuro.31.060407.125642; Santi A, 2010, NEUROIMAGE, V51, P1285, DOI 10.1016/j.neuroimage.2010.03.034; Serences JT, 2009, NEUROIMAGE, V44, P223, DOI 10.1016/j.neuroimage.2008.07.043; Tettamanti M, 2009, CORTEX, V45, P825, DOI 10.1016/j.cortex.2008.11.014; Udden J, 2008, BRAIN RES, V1224, P69, DOI 10.1016/j.brainres.2008.05.070; Woolgar A, 2011, J NEUROSCI, V31, P14592, DOI 10.1523/JNEUROSCI.2616-11.2011; Yee LTS, 2010, J NEUROPHYSIOL, V103, P557, DOI 10.1152/jn.91299.2008	45	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43774	10.1371/journal.pone.0043774	http://dx.doi.org/10.1371/journal.pone.0043774			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	997ZC	22952762	Green Published, gold			2022-12-25	WOS:000308206000050
J	Chen, CC; Wang, SH; Wang, HJ; Mao, XY; Zhang, TC; Ji, GH; Shi, X; Xia, T; Lu, WJ; Zhang, DP; Dai, JX; Guo, YJ				Chen, Changchun; Wang, Shuhui; Wang, Huajing; Mao, Xiaoyan; Zhang, Tiancheng; Ji, Guanghui; Shi, Xin; Xia, Tian; Lu, Weijia; Zhang, Dapeng; Dai, Jianxin; Guo, Yajun			Potent Neutralization of Botulinum Neurotoxin/B by Synergistic Action of Antibodies Recognizing Protein and Ganglioside Receptor Binding Domain	PLOS ONE			English	Article							CLOSTRIDIUM-BOTULINUM; MONOCLONAL-ANTIBODIES; HIGH-AFFINITY; B RECOGNIZES; HEAVY-CHAIN; SEROTYPE-A; IDENTIFICATION; SYNAPTOTAGMIN; TOXIN; SITES	Background: Botulinum neurotoxins (BoNTs), the causative agents for life-threatening human disease botulism, have been recognized as biological warfare agents. Monoclonal antibody (mAb) therapeutics hold considerable promise as BoNT therapeutics, but the potencies of mAbs against BoNTs are usually less than that of polyclonal antibodies (or oligoclonal antibodies). The confirmation of key epitopes with development of effective mAb is urgently needed. Methods and Findings: We selected 3 neutralizing mAbs which recognize different non-overlapping epitopes of BoNT/B from a panel of neutralizing antibodies against BoNT/B. By comparing the neutralizing effects among different combination groups, we found that 8E10, response to ganglioside receptor binding site, could synergy with 5G10 and 2F4, recognizing non-overlapping epitopes within Syt II binding sites. However, the combination of 5G10 with 2F4 blocking protein receptor binding sites did not achieve synergistical effects. Moreover, we found that the binding epitope of 8E10 was conserved among BoNT A, B, E, and F, which might cross-protect the challenge of different serotypes of BoNTs in vivo. Conclusions: The combination of two mAbs recognizing different receptors' binding domain in BoNTs has a synergistic effect. 8E10 is a potential universal partner for the synergistical combination with other mAb against protein receptor binding domain in BoNTs of other serotypes.	[Chen, Changchun; Wang, Shuhui] Shanghai Jiao Tong Univ, Minist Educ, Ctr Antibody Med, Sch Pharm, Shanghai 200030, Peoples R China; [Wang, Huajing; Zhang, Tiancheng; Ji, Guanghui; Shi, Xin; Xia, Tian; Zhang, Dapeng; Dai, Jianxin; Guo, Yajun] Second Mil Med Univ, Int Joint Canc Inst, Shanghai, Peoples R China; [Wang, Huajing; Zhang, Tiancheng; Ji, Guanghui; Shi, Xin; Xia, Tian; Zhang, Dapeng; Dai, Jianxin; Guo, Yajun] Natl Engn Res Ctr Antibody Med, State Key Lab Antibody Med & Targeting Therapy, Shanghai, Peoples R China; [Wang, Huajing; Zhang, Tiancheng; Ji, Guanghui; Shi, Xin; Xia, Tian; Zhang, Dapeng; Dai, Jianxin; Guo, Yajun] Shanghai Key Lab Cell Engn, Shanghai, Peoples R China; [Mao, Xiaoyan; Lu, Weijia] Lanzhou Inst Biol Prod, Lanzhou, Gansu, Peoples R China; [Dai, Jianxin; Guo, Yajun] Peoples Liberat Army Gen Hosp, Ctr Canc, Beijing, Peoples R China	Shanghai Jiao Tong University; Naval Medical University; Chinese People's Liberation Army General Hospital	Chen, CC (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Ctr Antibody Med, Sch Pharm, Shanghai 200030, Peoples R China.	jxdai@smmu.edu.cn; yjguo@smmu.edu.cn		xia, tian/0000-0002-1527-2194; Ji, Guanghui/0000-0003-3763-2311	National Nature Science Foundation for China; Ministry of Science & Technology of China; Shanghai Commission of Science Technology; Ministry of Science & Technology of China [2010ZX09401-407]; Shanghai Commission of Education	National Nature Science Foundation for China(National Natural Science Foundation of China (NSFC)); Ministry of Science & Technology of China(Ministry of Science and Technology, China); Shanghai Commission of Science Technology(Shanghai Science & Technology Committee); Ministry of Science & Technology of China(Ministry of Science and Technology, China); Shanghai Commission of Education	This work was supported by grants from National Nature Science Foundation for China, Ministry of Science & Technology of China (973 and 863 Program Projects), Shanghai Commission of Science & Technology (Key Laboratory and projects) as well as special program projects for infectious diseases and new drug development from Ministry of Science & Technology of China (2010ZX09401-407). Dr. Jianxin Dai is recipient of Pujiang Scholar Award from Shanghai Commission of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amersdorfer P, 2002, VACCINE, V20, P1640, DOI 10.1016/S0264-410X(01)00482-0; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; Darios F, 2010, P NATL ACAD SCI USA, V107, P18197, DOI 10.1073/pnas.1007125107; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2007, J CELL BIOL, V179, P1511, DOI 10.1083/jcb.200707184; Dong M, 2008, MOL BIOL CELL, V19, P5226, DOI 10.1091/mbc.E08-07-0765; Fu ZJ, 2009, BIOCHEMISTRY-US, V48, P5631, DOI 10.1021/bi9002138; Garcia-Rodriguez C, 2011, PROTEIN ENG DES SEL, V24, P321, DOI 10.1093/protein/gzq111; Hicks RP, 2005, CURR MED CHEM, V12, P667, DOI 10.2174/0929867053202223; Jin C, 2008, J ALLERGY CLIN IMMUN, V121, P185, DOI 10.1016/j.jaci.2007.07.047; Jin RS, 2006, NATURE, V444, P1092, DOI 10.1038/nature05387; Johnson EA, 2001, TOXICON, V39, P1703, DOI 10.1016/S0041-0101(01)00157-X; KIENLE E, 1989, MED MICROBIOL IMMUN, V178, P127, DOI 10.1007/BF00198011; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kumaran D, 2009, J MOL BIOL, V386, P233, DOI 10.1016/j.jmb.2008.12.027; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; LOMNETH R, 1991, J NEUROCHEM, V57, P1413, DOI 10.1111/j.1471-4159.1991.tb08308.x; MONTECUCCO C, 1986, TRENDS BIOCHEM SCI, V11, P314, DOI 10.1016/0968-0004(86)90282-3; Muraro L, 2009, BIOCHEM BIOPH RES CO, V380, P76, DOI 10.1016/j.bbrc.2009.01.037; Nishiki T, 1996, FEBS LETT, V378, P253, DOI 10.1016/0014-5793(95)01471-3; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; Perosa F, 2003, J IMMUNOL, V171, P1918, DOI 10.4049/jimmunol.171.4.1918; Rossetto Ornella, 2008, V184, P129; Rummel A, 2004, MOL MICROBIOL, V51, P631, DOI 10.1046/j.1365-2958.2003.03872.x; Rummel A, 2007, P NATL ACAD SCI USA, V104, P359, DOI 10.1073/pnas.0609713104; SCHIAVO G, 1993, J BIOL CHEM, V268, P23784; SCHIAVO G, 1993, J BIOL CHEM, V268, P11516; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; Sharma S, 2006, PROTEIN EXPRES PURIF, V45, P288, DOI 10.1016/j.pep.2005.07.020; SIMPSON LL, 1971, J NEUROCHEM, V18, P1751, DOI 10.1111/j.1471-4159.1971.tb03750.x; Singh BR, 2000, NAT STRUCT BIOL, V7, P617, DOI 10.1038/77900; Stenmark P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000129; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Wang H, 2010, MICROBES INFECT, V12, P1012, DOI 10.1016/j.micinf.2010.07.002; West M, 2005, DATE ISSUE 02 02 200	37	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43845	10.1371/journal.pone.0043845	http://dx.doi.org/10.1371/journal.pone.0043845			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952786	gold, Green Submitted, Green Published			2022-12-25	WOS:000308206000054
J	Almeida, OP; Yeap, BB; Alfonso, H; Hankey, GJ; Flicker, L; Norman, PE				Almeida, Osvaldo P.; Yeap, Bu B.; Alfonso, Helman; Hankey, Graeme J.; Flicker, Leon; Norman, Paul E.			Older Men Who Use Computers Have Lower Risk of Dementia	PLOS ONE			English	Article							LEISURE ACTIVITIES; WESTERN-AUSTRALIA; ALZHEIMER-DISEASE; STATE-EXAMINATION; INTERNET USAGE; PREVALENCE; ADULTS; POPULATION; LINKAGE; PREVENTION	Objective: To determine if older men who use computers have lower risk of developing dementia. Methods: Cohort study of 5506 community-dwelling men aged 69 to 87 years followed for up to 8.5 years. Use of computers measured as daily, weekly, less than weekly and never. Participants also reported their use of email, internet, word processors, games or other computer activities. The primary outcome was the incidence of ICD-10 diagnosis of dementia as recorded by the Western Australian Data Linkage System. Results: 1857/5506 (33.7%) men reported using computers and 347 (6.3%) received a diagnosis of dementia during an average follow up of 6.0 years (range: 6 months to 8.5 years). The hazard ratio (HR) of dementia was lower among computer users than non-users (HR = 0.62, 95%CI = 0.47-0.81, after adjustment for age, educational attainment, size of social network, and presence of depression or of significant clinical morbidity). The HR of dementia appeared to decrease with increasing frequency of computer use: 0.68 (95%CI = 0.41-1.13), 0.61 (95%CI = 0.39-0.94) and 0.59 (95%CI = 0.40-0.87) for less than weekly, at least weekly and daily. The HR of dementia was 0.66 (95%CI = 0.50-0.86) after the analysis was further adjusted for baseline cognitive function, as measured by the Mini-Mental State Examination. Conclusion: Older men who use computers have lower risk of receiving a diagnosis of dementia up to 8.5 years later. Randomised trials are required to determine if the observed associations are causal.	[Almeida, Osvaldo P.; Alfonso, Helman] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Almeida, Osvaldo P.; Alfonso, Helman; Flicker, Leon] Univ Western Australia, Med Res Ctr, Western Australian Ctr Hlth & Ageing, Perth, WA 6009, Australia; [Almeida, Osvaldo P.] Royal Perth Hosp, Dept Psychiat, Perth, WA, Australia; [Yeap, Bu B.; Hankey, Graeme J.; Flicker, Leon] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Yeap, Bu B.] Fremantle Hosp, Dept Endocrinol & Diabet, Fremantle, WA, Australia; [Hankey, Graeme J.] Royal Perth Hosp, Dept Neurol, Perth, WA, Australia; [Flicker, Leon] Royal Perth Hosp, Dept Geriatr Med, Perth, WA, Australia; [Norman, Paul E.] Univ Western Australia, Sch Surg, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia	Almeida, OP (corresponding author), Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia.	osvaldo.almeida@uwa.edu.au	Flicker, Leon/AAE-1530-2022; Norman, Paul E/C-5485-2013; Hankey, Graeme J/H-4968-2014; Almeida, Osvaldo P./A-4925-2008	Flicker, Leon/0000-0002-3650-0475; Norman, Paul E/0000-0003-3406-0506; Hankey, Graeme J/0000-0002-6044-7328; Almeida, Osvaldo P./0000-0002-8689-6199	National Health and Medical Research Council of Australia [279408, 379600, 403963, 513823]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funding provided by National Health and Medical Research Council of Australia project grant numbers 279408, 379600, 403963 and 513823. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2011, HOUS US INF TECHN AU; Akbaraly TN, 2009, NEUROLOGY, V73, P854, DOI 10.1212/WNL.0b013e3181b7849b; Almeida OP, 1999, INT J GERIATR PSYCH, V14, P858, DOI 10.1002/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8; Almeida OP, 2008, ARCH GEN PSYCHIAT, V65, P1286, DOI 10.1001/archpsyc.65.11.1286; Almeida OP, 2008, ARCH GEN PSYCHIAT, V65, P283, DOI 10.1001/archgenpsychiatry.2007.33; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Beasley R, 2003, EUR RESPIR J, V21, P374, DOI 10.1183/09031936.03.00039403; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; Forette F, 2002, ARCH INTERN MED, V162, P2046, DOI 10.1001/archinte.162.18.2046; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Hyde Z, 2010, ANN INTERN MED, V153, P693, DOI 10.7326/0003-4819-153-11-201012070-00002; KOENIG HG, 1993, PSYCHOSOMATICS, V34, P61, DOI 10.1016/S0033-3182(93)71928-3; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Lazarov O, 2010, TRENDS NEUROSCI, V33, P569, DOI 10.1016/j.tins.2010.09.003; Lobo A, 2007, ACTA PSYCHIAT SCAND, V116, P299, DOI 10.1111/j.1600-0447.2007.01006.x; Norman PE, 2009, INT J EPIDEMIOL, V38, P48, DOI 10.1093/ije/dyn041; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; Pink B, 2008, INTRO SOCIO EC INDEX; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ritchie K, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3885; Slegers K, 2008, J GERONTOL B-PSYCHOL, V63, pP176, DOI 10.1093/geronb/63.3.P176; Slegers K, 2009, AGING CLIN EXP RES, V21, P43, DOI 10.1007/BF03324898; Small GW, 2009, AM J GERIAT PSYCHIAT, V17, P116, DOI 10.1097/JGP.0b013e3181953a02; Tun PA, 2010, PSYCHOL AGING, V25, P560, DOI 10.1037/a0019543; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Wimo A, 2010, ALZHEIMERS DEMENT, V6, P98, DOI 10.1016/j.jalz.2010.01.010; Zilkens RR, 2009, NEUROEPIDEMIOLOGY, V32, P61, DOI 10.1159/000170908	34	43	44	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44239	10.1371/journal.pone.0044239	http://dx.doi.org/10.1371/journal.pone.0044239			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998CA	22937167	gold, Green Published, Green Submitted			2022-12-25	WOS:000308213600097
J	Green, CJ; Henriksen, TI; Pedersen, BK; Solomon, TPJ				Green, Charlotte J.; Henriksen, Tora I.; Pedersen, Bente K.; Solomon, Thomas P. J.			Glucagon Like Peptide-1-Induced Glucose Metabolism in Differentiated Human Muscle Satellite Cells Is Attenuated by Hyperglycemia	PLOS ONE			English	Article							PROTEIN-KINASE-C; RAT SKELETAL-MUSCLE; PHOSPHATIDYLINOSITOL 3-KINASE; HUMAN MYOCYTES; DIABETES-MELLITUS; POTENT INHIBITORS; 3T3-L1 ADIPOCYTES; DOWN-REGULATION; C2C12 MYOTUBES; L6 MYOTUBES	Background: Glucagon like peptide-1 (GLP-1) stimulates insulin secretion from the pancreas but also has extra-pancreatic effects. GLP-1 may stimulate glucose uptake in cultured muscle cells but the mechanism is not clearly defined. Furthermore, while the pancreatic effects of GLP-1 are glucose-dependent, the glucose-dependency of its extra-pancreatic effects has not been examined. Methods: Skeletal muscle satellite cells isolated from young (22.5+/-0.97 yr), lean (BMI 22.5+/-0.6 kg/m(2)), healthy males were differentiated in media containing either 22.5 mM (high) or 5 mM (normal) glucose for 7 days in the absence or presence of insulin and/or various GLP-1 concentrations. Myocellular effects of GLP-1, insulin and glucose were assessed by western-blot, glucose uptake and glycogen synthesis. Results: We firstly show that the GLP-1 receptor protein is expressed in differentiated human muscle satellite cells (myocytes). Secondly, we show that in 5 mM glucose media, exposure of myocytes to GLP-1 results in a dose dependent increase in glucose uptake, GLUT4 amount and subsequently glycogen synthesis in a PI3K dependent manner, independent of the insulin signaling cascade. Importantly, we provide evidence that differentiation of human satellite cells in hyperglycemic (22.5 mM glucose) conditions increases GLUT1 expression, and renders the cells insulin resistant and interestingly GLP-1 resistant in terms of glucose uptake and glycogen synthesis. Hyperglycemic conditions did not affect the ability of insulin to phosphorylate downstream targets, PKB or GSK3. Interestingly we show that at 5 mM glucose, GLP-1 increases GLUT4 protein levels and that this effect is abolished by hyperglycemia. Conclusions: GLP-1 increases glucose uptake and glycogen synthesis into fully-differentiated human satellite cells in a PI3-K dependent mechanism potentially through increased GLUT4 protein levels. The latter occurs independently of the insulin signaling pathway. Attenuation of both GLP-1 and insulin-induced glucose metabolism by hyperglycemia is likely to occur downstream of PI3K.	[Green, Charlotte J.] Univ Copenhagen, Rigshosp, Fac Hlth Sci, Ctr Inflammat & Metab,Dept Infect Dis, DK-1168 Copenhagen, Denmark; Univ Copenhagen, Rigshosp, Fac Hlth Sci, Copenhagen Muscle Res Ctr, DK-1168 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Green, CJ (corresponding author), Univ Copenhagen, Rigshosp, Fac Hlth Sci, Ctr Inflammat & Metab,Dept Infect Dis, DK-1168 Copenhagen, Denmark.	cgreen@inflammation-metabolism.dk	GREEN, Charlotte/B-9742-2014; Henriksen, Tora/AGK-6018-2022; Pedersen, Bente Klarlund/AGR-3217-2022; Solomon, Thomas PJ/I-4476-2019	GREEN, Charlotte/0000-0003-1631-3186; Henriksen, Tora/0000-0003-1568-8920; Pedersen, Bente Klarlund/0000-0001-6508-6288; Solomon, Thomas PJ/0000-0002-0579-284X	Danish National Research Foundation [02-512-55]; European Foundation for the Study of Diabetes/Amylin; Amylin Phamaceuticals, Inc, European Foundation for the Study of Diabetes	Danish National Research Foundation(Danmarks Grundforskningsfond); European Foundation for the Study of Diabetes/Amylin; Amylin Phamaceuticals, Inc, European Foundation for the Study of Diabetes	The Centre of Inflammation and Metabolism (CIM) is supported by a grant from the Danish National Research Foundation (no.02-512-55). This study was also partially supported by a Paul Langerhans program grant from the European Foundation for the Study of Diabetes/Amylin (TPJS). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; This project was partially funded by Amylin Phamaceuticals, Inc as part of the Paul Langerhans program grant from the European Foundation for the Study of Diabetes. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aas V, 2011, BBA-MOL BASIS DIS, V1812, P94, DOI 10.1016/j.bbadis.2010.09.014; Acitores A, 2004, J ENDOCRINOL, V180, P389, DOI 10.1677/joe.0.1800389; Alcantara AI, 1997, ARCH BIOCHEM BIOPHYS, V341, P1, DOI 10.1006/abbi.1997.9951; Alessi DR, 1997, FEBS LETT, V402, P121, DOI 10.1016/S0014-5793(96)01510-4; Arnes L, 2008, INT J MOL MED, V22, P127; Ayala JE, 2009, ENDOCRINOLOGY, V150, P1155, DOI 10.1210/en.2008-0945; Bandyopadhyay G, 1997, ENDOCRINOLOGY, V138, P4721, DOI 10.1210/en.138.11.4721; BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broholm C, 2012, AM J PHYSIOL-ENDOC M, V303, pE283, DOI 10.1152/ajpendo.00586.2011; Buteau J, 1999, DIABETOLOGIA, V42, P856, DOI 10.1007/s001250051238; Buteau J, 2006, DIABETES, V55, P1190, DOI 10.2337/db05-0825; Buteau J, 2001, DIABETES, V50, P2237, DOI 10.2337/diabetes.50.10.2237; Chai WD, 2012, DIABETES, V61, P888, DOI 10.2337/db11-1073; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; DELGADO E, 1995, PEPTIDES, V16, P225, DOI 10.1016/0196-9781(94)00175-8; Esguerra JL, 2011, PLOS ONE, V6; Foley K, 2011, BIOCHEMISTRY-US, V50, P3048, DOI 10.1021/bi2000356; GALANTE P, 1995, DIABETES, V44, P646, DOI 10.2337/diabetes.44.6.646; Gao H, 2007, ENDOCRINE, V32, P90, DOI 10.1007/s12020-007-9011-4; Giralt M, 1999, DIGEST DIS SCI, V44, P322, DOI 10.1023/A:1026654417697; Gonzalez N, 2005, REGUL PEPTIDES, V126, P203, DOI 10.1016/j.regpep.2004.10.002; Green CJ, 2011, DIABETES, V60, P2810, DOI 10.2337/db11-0263; Gromada J, 1997, PFLUG ARCH EUR J PHY, V434, P515, DOI 10.1007/s004240050431; Gutzwiller JP, 1999, AM J PHYSIOL-REG I, V276, pR1541, DOI 10.1152/ajpregu.1999.276.5.R1541; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; Holst JJ, 2009, MOL CELL ENDOCRINOL, V297, P127, DOI 10.1016/j.mce.2008.08.012; Kanzaki M, 2004, J CELL BIOL, V164, P279, DOI 10.1083/jcb.200306152; Kawano Y, 1999, DIABETOLOGIA, V42, P1071, DOI 10.1007/s001250051273; Luque MA, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730465; Moreno P, 2012, J MOL ENDOCRINOL, V48, P37, DOI 10.1530/JME-11-0127; SARABIA V, 1992, J CLIN INVEST, V90, P1386, DOI 10.1172/JCI116005; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Standaert ML, 1996, BIOCHEM J, V313, P1039, DOI 10.1042/bj3131039; Tolessa T, 1998, J CLIN INVEST, V102, P764, DOI 10.1172/JCI942; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Tsuchiya Y, 2010, J BIOL CHEM, V285, P34371, DOI 10.1074/jbc.M110.128520; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Wijesekara N, 2006, AM J PHYSIOL-ENDOC M, V290, pE1276, DOI 10.1152/ajpendo.00573.2005; XIA P, 1994, DIABETES, V43, P1122, DOI 10.2337/diabetes.43.9.1122; Xu G, 2007, DIABETES, V56, P1551, DOI 10.2337/db06-1033; Yang H, 1998, AM J PHYSIOL-CELL PH, V275, pC675, DOI 10.1152/ajpcell.1998.275.3.C675	42	44	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44284	10.1371/journal.pone.0044284	http://dx.doi.org/10.1371/journal.pone.0044284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937169	gold, Green Published, Green Submitted			2022-12-25	WOS:000308213600100
J	Keow, JY; Pond, ED; Cisar, JS; Cravatt, BF; Crawford, BD				Keow, Jonathan Y.; Pond, Eric D.; Cisar, Justin S.; Cravatt, Benjamin F.; Crawford, Bryan D.			Activity-Based Labeling of Matrix Metalloproteinases in Living Vertebrate Embryos	PLOS ONE			English	Article							ZEBRAFISH; EXPRESSION; FISH; MATRIX-METALLOPROTEINASE-9; PROTEASES; BIOLOGY; TARGET; CANCER; CELLS; GENE	Extracellular matrix (ECM) remodeling is a physiologically and developmentally essential process mediated by a family of zinc-dependent extracellular proteases called matrix metalloproteinases (MMPs). In addition to complex transcriptional control, MMPs are subject to extensive post-translational regulation. Because of this, classical biochemical, molecular and histological techniques that detect the expression of specific gene products provide useful but limited data regarding the biologically relevant activity of MMPs. Using benzophenone-bearing hydroxamate-based probes that interact with the catalytic zinc ion in MMPs, active proteases can be covalently 'tagged' by UV cross-linking. This approach has been successfully used to tag MMP-2 in vitro in tissue culture supernatants, and we show here that this probe tags proteins with mobilities consistent with known MMPs and detectable gelatinolytic activity in homogenates of zebrafish embryos. Furthermore, because of the transparency of the zebrafish embryo, UV-photocroslinking can be accomplished in vivo, and rhodamated benzophenone probe is detected in striking spatial patterns consistent with known distributions of active matrix remodeling in embryos. Finally, in metamorphosing Xenopus tadpoles, this probe can be used to biotinylate active MMP-2 by injecting it and cross-linking it in vivo, allowing the protein to be subsequently extracted and biochemically identified.	[Keow, Jonathan Y.; Pond, Eric D.; Crawford, Bryan D.] Univ New Brunswick, Dept Biol, Fredericton, NB E3B 6E1, Canada; [Cisar, Justin S.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	University of New Brunswick; Scripps Research Institute	Keow, JY (corresponding author), Univ New Brunswick, Dept Biol, Fredericton, NB E3B 6E1, Canada.	bryanc@unb.ca		Crawford, Bryan/0000-0002-0512-4649; Keow, Jonathan/0000-0001-5985-4770	National Sciences and Engineering Research Council (NSERC) of Canada [341540-07]; NSERC; Michael J. Smith Foundation; NATIONAL CANCER INSTITUTE [R37CA087660] Funding Source: NIH RePORTER	National Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael J. Smith Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant (341540-07) to BDC. JYK was supported by scholarships from NSERC and a travel grant from the Michael J. Smith Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009; Ali MAM, 2012, J CELL PHYSIOL, V227, P3397, DOI 10.1002/jcp.24040; Ali MAM, 2010, CIRCULATION, V122, P2039, DOI 10.1161/CIRCULATIONAHA.109.930222; Burrage PS, 2007, CURR DRUG TARGETS, V8, P293, DOI 10.2174/138945007779940098; Cauwe B, 2010, CRIT REV BIOCHEM MOL, V45, P351, DOI 10.3109/10409238.2010.501783; Cavallo-Medved D, 2009, EXP CELL RES, V315, P1234, DOI 10.1016/j.yexcr.2009.01.021; Chen CH, 2005, BIOSCI BIOTECH BIOCH, V72, P1586; Crawford BD, 2005, DEV BIOL, V286, P405, DOI 10.1016/j.ydbio.2005.06.035; Crawford BD, 2003, MOL BIOL CELL, V14, P3065, DOI 10.1091/mbc.E02-08-0537; Curran K, 2010, DEV BIOL, V344, P107, DOI 10.1016/j.ydbio.2010.04.023; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Duchossoy Y, 2001, MOL CELL NEUROSCI, V17, P945, DOI 10.1006/mcne.2001.0986; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Franz-Odendaal TA, 2008, DEV DYNAM, V237, P3240, DOI 10.1002/dvdy.21754; Hillegass JM, 2007, TOXICOL SCI, V100, P168, DOI 10.1093/toxsci/kfm192; Inohaya K, 1997, DEV GROWTH DIFFER, V39, P191; Jung JC, 2002, DEV DYNAM, V223, P402, DOI 10.1002/dvdy.10069; Kandasamy AD, 2010, CARDIOVASC RES, V85, P413, DOI 10.1093/cvr/cvp268; Kawaguchi M, 2005, FEBS J, V272, P4315, DOI 10.1111/j.1742-4658.2005.04845.x; Keow JY, 2011, MATRIX BIOL, V30, P169, DOI 10.1016/j.matbio.2011.01.003; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5; Krane SM, 2008, BONE, V43, P7, DOI 10.1016/j.bone.2008.03.020; Kudo N, 2004, ACTA CRYSTALLOGR D, V60, P725, DOI 10.1107/S0907444904001866; Lemaitre Vincent, 2006, Birth Defects Research, V78, P1, DOI 10.1002/bdrc.20065; Lombard C, 2005, BIOCHIMIE, V87, P265, DOI 10.1016/j.biochi.2005.01.007; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagy V, 2007, LEARN MEMORY, V14, P655, DOI 10.1101/lm.678307; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Packard BZ, 2009, MATRIX BIOL, V28, P3, DOI 10.1016/j.matbio.2008.10.001; Qi F, 2010, HEPATOLOGY, V52, P2158, DOI 10.1002/hep.23945; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; Schulz R, 2007, ANNU REV PHARMACOL, V47, P211, DOI 10.1146/annurev.pharmtox.47.120505.105230; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; van Hinsbergh VWM, 2008, CARDIOVASC RES, V78, P203, DOI 10.1093/cvr/cvm102; VanSaun Michael N., 2006, Birth Defects Research, V78, P69, DOI 10.1002/bdrc.20061; von Burstin J, 2008, INT J CANCER, V123, P2138, DOI 10.1002/ijc.23780; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wlodarczyk J, 2011, DEV NEUROBIOLOGY; Wyatt RA, 2009, ZEBRAFISH, V6, P347, DOI 10.1089/zeb.2009.0609; Yoong S, 2007, GENE EXPR PATTERNS, V7, P39, DOI 10.1016/j.modgep.2006.05.005; Zhang JS, 2003, MATRIX BIOL, V22, P279, DOI 10.1016/S0945-053X(03)00020-9; Zhang JS, 2003, DEV GENES EVOL, V213, P456, DOI 10.1007/s00427-003-0346-4	46	14	14	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43434	10.1371/journal.pone.0043434	http://dx.doi.org/10.1371/journal.pone.0043434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952682	gold, Green Published, Green Submitted			2022-12-25	WOS:000308213600024
J	Liu, KY; Shu, DY; Song, N; Gai, ZC; Yuan, Y; Li, J; Li, M; Guo, SY; Peng, JX; Hong, HZ				Liu, Kaiyu; Shu, Duanyang; Song, Na; Gai, Zhongchao; Yuan, Yuan; Li, Juan; Li, Min; Guo, Shuying; Peng, Jianxin; Hong, Huazhu			The Role of Cytochrome c on Apoptosis Induced by Anagrapha falcifera Multiple Nuclear Polyhedrosis Virus in Insect Spodoptera litura Cells	PLOS ONE			English	Article							CASPASE ACTIVATION; RELEASE; DEATH; MITOCHONDRIA; INVOLVEMENT; STARVATION; INDUCTION; PATHWAY; LINE; DATP	There are conflicting reports on the role of cytochrome c during insect apoptosis. Our previous studies have showed that cytochrome c released from the mitochondria was an early event by western blot analysis and caspase-3 activation was closely related to cytochrome c release during apoptosis induced by baculovirus in Spodoptera litura cells (Sl-1 cell line). In the present study, alteration in mitochondrial morphology was observed by transmission electron microscopy, and cytochrome c release from mitochondria in apoptotic Sl-1 cells induced with Anagrapha falcifera multiple nuclear polyhedrosis virus (AfMNPV) has further been confirmed by immunofluoresence staining protocol, suggesting that structural disruption of mitochondria and the release of cytochrome c are important events during Lepidoptera insect cell apoptosis. We also used Sl-1 cell-free extract system and the technique of RNA interference to further investigate the role of cytochrome c in apoptotic Sl-1 cells induced by AfMNPV. Caspase-3 activity in cell-free extracts supplemented with exogenous cytochrome c was determined and showed an increase with the extension of incubation time. DsRNA-mediated silencing of cytochrome c resulted in the inhibition of apoptosis and protected the cells from AfMNPV-induced cell death. Silencing of expression of cytochrome c had a remarkable effect on pro-caspase-3 and pro-caspase-9 activation and resulted in the reduction of caspase-3 and caspase-9 activity in Sl-1 cells undergoing apoptosis. Caspase-9 inhibitor could inhibit activation of pro-caspase-3, and the inhibition of the function of Apaf-1 with FSBA blocked apoptosis, hinting that Apaf-1 could be involved in Sl-1 cell apoptosis induced by AfMNPV. Taken together, these results strongly demonstrate that cytochrome c plays an important role in apoptotic signaling pathways in Lepidopteran insect cells.	[Liu, Kaiyu; Shu, Duanyang; Song, Na; Gai, Zhongchao; Yuan, Yuan; Li, Juan; Li, Min; Guo, Shuying; Peng, Jianxin; Hong, Huazhu] Cent China Normal Univ, Inst Entomol, Wuhan, Peoples R China; [Liu, Kaiyu; Peng, Jianxin; Hong, Huazhu] Cent China Normal Univ, Key Lab Pesticide & Chem Biol, Minist Educ, Wuhan, Peoples R China	Central China Normal University; Central China Normal University	Liu, KY (corresponding author), Cent China Normal Univ, Inst Entomol, Wuhan, Peoples R China.	jxpeng@mail.ccnu.edu.cn	Gai, Zhongchao/GON-5469-2022	Gai, Zhongchao/0000-0003-3367-3378	National Natural Science Foundation of China [30470073, 30970136]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding for this work was provided by the National Natural Science Foundation of China (30470073; 30970136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahid E, 2007, DEV CELL, V12, P793, DOI 10.1016/j.devcel.2007.04.004; Abdelwahid E, 2011, BBA-MOL CELL RES, V1813, P597, DOI 10.1016/j.bbamcr.2010.10.008; Arnoult D, 2002, J CELL BIOL, V159, P923, DOI 10.1083/jcb.200207071; Beem E, 2004, AM J PHYSIOL-CELL PH, V287, pC664, DOI 10.1152/ajpcell.00232.2003; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Chen CJ, 1996, J GEN VIROL, V77, P167, DOI 10.1099/0022-1317-77-2-167; Dorstyn L, 2004, J CELL BIOL, V167, P405, DOI 10.1083/jcb.200408054; Dorstyn L, 2006, CELL DEATH DIFFER, V13, P1049, DOI 10.1038/sj.cdd.4401918; He JL, 2000, J PHARMACOL EXP THER, V295, P896; Huang JF, 2011, PESTIC BIOCHEM PHYS, V100, P256, DOI 10.1016/j.pestbp.2011.04.010; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kanuka H, 1999, MOL CELL, V4, P757, DOI 10.1016/S1097-2765(00)80386-X; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kumarswamy R, 2009, INT J BIOCHEM CELL B, V41, P1430, DOI 10.1016/j.biocel.2008.12.009; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu KY, 2007, CYTOTECHNOLOGY, V54, P97, DOI 10.1007/s10616-007-9080-5; Liu LJ, 2007, CELL BIOL INT, V31, P996, DOI 10.1016/j.cellbi.2007.03.011; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Malagoli D, 2005, CELL TISSUE RES, V320, P337, DOI 10.1007/s00441-004-1050-z; Means JC, 2007, CELL DEATH DIFFER, V14, P383, DOI 10.1038/sj.cdd.4402036; Means J, 2006, CELL DEATH DIFFER, V13, P1222, DOI 10.1038/sj.cdd.4401821; Mohan M, 2003, CELL BIOL INT, V27, P483, DOI 10.1016/S1065-6995(03)00071-4; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Sahdev S, 2003, BIOCHEM BIOPH RES CO, V307, P483, DOI 10.1016/S0006-291X(03)01224-5; Shan SG, 2009, INSECT SCI, V16, P485, DOI 10.1111/j.1744-7917.2009.01278.x; Tian L, 2012, ARCH INSECT BIOCHEM, V79, P207, DOI 10.1002/arch.20457; Varkey J, 1999, J CELL BIOL, V144, P701, DOI 10.1083/jcb.144.4.701; Wei W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037457; Wu WX, 2011, J INSECT PHYSIOL, V57, P723, DOI 10.1016/j.jinsphys.2011.02.008; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zimmermann KC, 2002, J CELL BIOL, V156, P1077, DOI 10.1083/jcb.20112068; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	34	29	34	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e40877	10.1371/journal.pone.0040877	http://dx.doi.org/10.1371/journal.pone.0040877			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952575	Green Published, Green Submitted, gold			2022-12-25	WOS:000308213600001
J	Walter, J; Fletcher, E; Moussaoui, R; Gandhi, K; Weirauch, C				Walter, Jan; Fletcher, Erin; Moussaoui, Roba; Gandhi, Kumar; Weirauch, Christiane			Do Bites of Kissing Bugs Cause Unexplained Allergies? Results from a Survey in Triatomine-Exposed and Unexposed Areas in Southern California	PLOS ONE			English	Article							INSECT BITES; PROTRACTA; HETEROPTERA; ANAPHYLAXIS; REDUVIIDAE; COMMUNITY; DISEASE	Background: The bite of Triatominae can cause cutaneous allergic reactions and even anaphylaxis. Since the early 1980s, no population-based surveys have been done in Southern California, and none was ever carried out in inland Los Angeles or Riverside Counties. Objectives: To measure the frequency of insect sightings, bites and allergic reactions in a suburban area of eastern Los Angeles County and along with rural and urban sites in Riverside County. Methods: A door-to-door survey was done in triatomine exposed and unexposed areas. Logistic regression modeling was used for the analysis, and study participants were asked to collect insects. Results: Out of the 221 study participants in the exposed areas, 46 (20%) knew about the presence of Triatominae in their neighborhood. Fifteen (7%) persons reported triatomine sightings in their house during the month preceding the interview. Also, 15 (7%) participants reported ever being bitten by a triatomine. Ten (5%) participants collected either a Triatoma protracta Uhler and/or Paratriatoma hirsuta Barber in and around their house. Twenty-nine (13%) persons in the rural Riverside County reported symptoms compatible with allergy to triatomine bites. This was 4 times higher than in the urban control area where only 4 (3%) of 115 persons reported these symptoms. The association between living in a triatomine-exposed area and self-reported symptoms suggestive of allergies increased slightly when adjusted for the participant's sex and the age of their house (adjusted odds ratio: 5.1, 95% confidence interval: 1.2 to 22.0). Reporting these symptoms was associated with seeing Triatominae in the neighborhood and having been bitten. Conclusion: Allergies to triatomine bites could be a significant problem in inland Southern California. Further investigations, a diagnostic test and better information of persons living in triatomine-exposed areas are needed.	[Walter, Jan; Fletcher, Erin; Moussaoui, Roba; Gandhi, Kumar] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Weirauch, Christiane] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Walter, J (corresponding author), Zeltinger Str 64A, Berlin, Germany.	jan.walter@email.de		Walter, Jan/0000-0003-2247-5560	University of California Riverside	University of California Riverside(University of California System)	The authors acknowledge the University of California Riverside for financial assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Galvaao C, 2004, ZOOTAXA, V202, P1; Ibarra-Cerdena CN, 2009, ACTA TROP, V110, P178, DOI 10.1016/j.actatropica.2008.11.012; Jones JP., 1962, CALIF VECTOR VIEWS, V9, P33; Klotz JH, 2010, CLIN INFECT DIS, V50, P1629, DOI 10.1086/652769; Lane RS, 1999, AM J TROP MED HYG, V61, P850, DOI 10.4269/ajtmh.1999.61.850; Lent H., 1979, Bulletin of the American Museum of Natural History, V163, P125; Lo Vecchio F, 2004, AM J EMERG MED, V22, P631, DOI 10.1016/j.ajem.2004.09.020; LYNCH PJ, 1978, CUTIS, V22, P585; MARSHALL N, 1986, J MED ENTOMOL, V23, P117, DOI 10.1093/jmedent/23.2.117; MARSHALL NA, 1986, J ALLERGY CLIN IMMUN, V78, P430, DOI 10.1016/0091-6749(86)90029-1; Moffitt JE, 2003, ANN ALLERG ASTHMA IM, V91, P122, DOI 10.1016/S1081-1206(10)62165-5; NICHOLS N, 1963, CALIF MED, V98, P267; Paddock CD, 2001, J IMMUNOL, V167, P2694, DOI 10.4049/jimmunol.167.5.2694; PINNAS JL, 1986, J ALLERGY CLIN IMMUN, V77, P364, DOI 10.1016/S0091-6749(86)80119-1; Reisenman CE, 2010, EMERG INFECT DIS, V16, P400, DOI 10.3201/eid1603.090648; ROHR AS, 1984, J ALLERGY CLIN IMMUN, V73, P369, DOI 10.1016/0091-6749(84)90410-X; RYCKMAN R E, 1981, Bulletin of the Society of Vector Ecologists, V6, P167; RYCKMAN RAYMOND E., 1962, UNIV CALIF PUBLICATION ENTOMOL, V27, P93; TEO SK, 1973, J TROP MED HYG, V76, P161; Wood SF, 1941, AM J HYG, V34, P1; Wood SF, 1951, B SO CALIF ACAD SCI, V50, P108	21	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44016	10.1371/journal.pone.0044016	http://dx.doi.org/10.1371/journal.pone.0044016			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937146	Green Published, Green Submitted, gold			2022-12-25	WOS:000308213600070
J	Diez-Rivero, CM; Reche, PA				Diez-Rivero, Carmen M.; Reche, Pedro A.			CD8 T Cell Epitope Distribution in Viruses Reveals Patterns of Protein Biosynthesis	PLOS ONE			English	Article							DEFECTIVE RIBOSOMAL PRODUCTS; CLASS-I BINDING; PEPTIDE BINDING; WEB SERVER; ANTIGEN; PREDICTION; IMMUNODOMINANCE; DEGRADATION; INFLUENZA; DISCOVERY	Distinguishing T cell epitope distribution patterns is relevant for epitope- vaccine design. To that end, we invest0069gated the distribution of known CD8 T cell epitopes from Hepatitis C Virus, Human Immunodeficiency Virus-1 and Influenza A Virus using x 2 statistics. We found that epitopes are not distributed in the viral proteomes proportionally to the size of the source proteins. Specifically, capsid and matrix proteins pack significantly more epitopes than those expected by their size. Such non-homogeneous distribution cannot be accounted by underlying MHC I-peptide binding preferences nor it is related to sequence variability. Instead, we propose that it might be related to preferential protein translation/biosynthesis. Overall, these results support the prioritization of structural antigens for epitope identification and vaccine design.	[Diez-Rivero, Carmen M.; Reche, Pedro A.] Univ Complutense Madrid, Fac Med, Dept Immunol, Lab Immunomed, Madrid, Spain	Complutense University of Madrid	Diez-Rivero, CM (corresponding author), Univ Complutense Madrid, Fac Med, Dept Immunol, Lab Immunomed, Madrid, Spain.	parecheg@med.ucm.es	Reche, Pedro A/B-1881-2013	Reche, Pedro A/0000-0003-3966-5838	Ministerio de Ciencia e Innovacion of Spain [SAF2009-08103]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Ministerio de Ciencia e Innovacion of Spain (SAF2009-08103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang CXL, 2011, FRONT BIOSCI-LANDMRK, V16, P3014, DOI 10.2741/3895; Cheung TKW, 2007, ANN NY ACAD SCI, V1102, P1, DOI 10.1196/annals.1408.001; Crowe SR, 2006, VACCINE, V24, P452, DOI 10.1016/j.vaccine.2005.07.090; Diez-Rivero CM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-479; Diez-Rivero CM, 2010, PROTEINS, V78, P63, DOI 10.1002/prot.22535; Donnes P, 2005, PROTEIN SCI, V14, P2132, DOI 10.1110/ps.051352405; Draenert R, 2003, J IMMUNOL METHODS, V275, P19, DOI 10.1016/S0022-1759(02)00541-0; Eberl G, 1996, EUR J IMMUNOL, V26, P2709, DOI 10.1002/eji.1830261124; Flower Darren R, 2010, Immunome Res, V6 Suppl 2, pS1, DOI 10.1186/1745-7580-6-S2-S1; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia-Boronat M, 2008, NUCLEIC ACIDS RES, V36, pW35, DOI 10.1093/nar/gkn211; Goulder PJR, 2001, J EXP MED, V193, P181, DOI 10.1084/jem.193.2.181; KAUFMANN SHE, 1993, ANNU REV IMMUNOL, V11, P129, DOI 10.1146/annurev.iy.11.040193.001021; Khan S, 2001, J IMMUNOL, V167, P4801, DOI 10.4049/jimmunol.167.9.4801; Lafuente EM, 2009, CURR PHARM DESIGN, V15, P3209, DOI 10.2174/138161209789105162; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Overstreet MG, 2008, IMMUNOL REV, V225, P272, DOI 10.1111/j.1600-065X.2008.00671.x; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Qian SB, 2006, J IMMUNOL, V177, P227, DOI 10.4049/jimmunol.177.1.227; Reche PA, 2005, BIOINFORMATICS, V21, P2140, DOI 10.1093/bioinformatics/bti269; Reche PA, 2005, NUCLEIC ACIDS RES, V33, pW138, DOI 10.1093/nar/gki357; Reche PA, 2002, HUM IMMUNOL, V63, P701, DOI 10.1016/S0198-8859(02)00432-9; Reche Pedro A, 2006, Med Immunol, V5, P1, DOI 10.1186/1476-9433-5-1; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Sandberg JK, 1998, J IMMUNOL, V160, P3163; Tenzer S, 2005, CELL MOL LIFE SCI, V62, P1025, DOI 10.1007/s00018-005-4528-2; VILLARREAL LP, 1976, BIOCHEMISTRY-US, V15, P1663, DOI 10.1021/bi00653a012; WEISS RA, 1993, SCIENCE, V260, P1273, DOI 10.1126/science.8493571; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Yewdell JW, 1996, J IMMUNOL, V157, P1823; Yewdell JW, 2001, TRENDS CELL BIOL, V11, P294, DOI 10.1016/S0962-8924(01)02030-X; Zhong WM, 2003, J BIOL CHEM, V278, P45135, DOI 10.1074/jbc.M307417200	34	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43674	10.1371/journal.pone.0043674	http://dx.doi.org/10.1371/journal.pone.0043674			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952734	Green Submitted, gold, Green Published			2022-12-25	WOS:000308044800051
J	Ding, MZ; Wang, X; Liu, W; Cheng, JS; Yang, Y; Yuan, YJ				Ding, Ming-Zhu; Wang, Xin; Liu, Wei; Cheng, Jing-Sheng; Yang, Yang; Yuan, Ying-Jin			Proteomic Research Reveals the Stress Response and Detoxification of Yeast to Combined Inhibitors	PLOS ONE			English	Article							UNFOLDED-PROTEIN-RESPONSE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; ALCOHOL-DEHYDROGENASE; ALDEHYDE REDUCTION; GROWTH; ACID; FERMENTATION; ADAPTATION; TOLERANCE	The tolerant mechanism of yeast to the combination of three inhibitors (furfural, phenol and acetic acid) was investigated using 2-DE combined with MALDI-TOF/TOF-MS. The stress response and detoxification related proteins (e.g., Ahp1p, Hsp26p) were expressed higher in the tolerant yeast than in the parental yeast. The expressions of most nitrogen metabolism related proteins (e.g. Gdh1p, Met1p) were higher in the parental yeast, indicating that the tolerant yeast decreases its nitrogen metabolism rate to reserve energy, and possesses high resistance to the stress of combined inhibitors. Furthermore, upon exposure to the inhibitors, the proteins related to protein folding, degradation and translation (e.g., Ssc1p, Ubp14p, Efb1p) were all significantly affected and the oxidative stress related proteins (e.g., Ahp1p, Grx1p) were increased. Knockdown of genes related to the oxidative stress and unfolded protein response (Grx1, Gre2, Asc1) significantly decreased the tolerance of yeast to inhibitors, which further suggested that yeast responded to the inhibitors mainly by inducing unfolded protein response. This study reveals that increasing the detoxification and tolerating oxidative stress, and/or decreasing the nitrogen metabolism would be promising strategies in developing more tolerant strains to the multiple inhibitors in lignocellulose hydrolysates.	[Ding, Ming-Zhu] Tianjin Univ, Minist Educ, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China; Tianjin Univ, Sch Chem Engn & Technol, Dept Pharmaceut Engn, Tianjin 300072, Peoples R China	Tianjin University; Tianjin University	Ding, MZ (corresponding author), Tianjin Univ, Minist Educ, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China.	yjyuan@tju.edu.cn			National Natural Science Foundation of China [20736006, 21020102040]; National Basic Research Program of China ("973" Program) [2011CBA00802]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China ("973" Program)(National Basic Research Program of China)	The authors are grateful for the financial support from the National Natural Science Foundation of China (Key Program: 20736006, Major International Joint Research Project: 21020102040), and the National Basic Research Program of China ("973" Program: 2011CBA00802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers E, 1996, APPL ENVIRON MICROB, V62, P3187, DOI 10.1128/AEM.62.9.3187-3195.1996; Allen SA, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-2; Almeida B, 2009, PROTEOMICS, V9, P720, DOI 10.1002/pmic.200700816; Almeida JRM, 2007, J CHEM TECHNOL BIOT, V82, P340, DOI 10.1002/jctb.1676; Alvarez-Ordonez A, 2010, INT J FOOD MICROBIOL, V136, P278, DOI 10.1016/j.ijfoodmicro.2009.09.024; AXE DD, 1995, BIOTECHNOL BIOENG, V47, P8, DOI 10.1002/bit.260470103; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng JS, 2009, PROTEOMICS, V9, P4704, DOI 10.1002/pmic.200900249; Diaz De Villegas ME, 1992, ACTA BIOTECHNOL, V12, P351; Ding MZ, 2012, METABOLOMICS, V8, P232, DOI 10.1007/s11306-011-0303-6; HEIPIEPER HJ, 1994, TRENDS BIOTECHNOL, V12, P409, DOI 10.1016/0167-7799(94)90029-9; Hondorp ER, 2004, PLOS BIOL, V2, P1738, DOI 10.1371/journal.pbio.0020336; Horvath IS, 2003, APPL ENVIRON MICROB, V69, P4076, DOI 10.1128/AEM.69.7.4076-4086.2003; Larroy C, 2002, BIOCHEM J, V361, P163, DOI 10.1042/0264-6021:3610163; Li BZ, 2010, APPL MICROBIOL BIOT, V86, P1915, DOI 10.1007/s00253-010-2518-2; Lin FM, 2009, PROTEOMICS, V9, P5471, DOI 10.1002/pmic.200900100; Lin FM, 2009, APPL ENVIRON MICROB, V75, P3765, DOI 10.1128/AEM.02594-08; Liu ZL, 2006, APPL MICROBIOL BIOT, V73, P27, DOI 10.1007/s00253-006-0567-3; Liu ZL, 2008, APPL MICROBIOL BIOT, V81, P743, DOI 10.1007/s00253-008-1702-0; Ma Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026108; Martinez A, 2001, BIOTECHNOL PROGR, V17, P287, DOI 10.1021/bp0001720; Miller EN, 2009, APPL ENVIRON MICROB, V75, P6132, DOI 10.1128/AEM.01187-09; Modig T, 2002, BIOCHEM J, V363, P769, DOI 10.1042/0264-6021:3630769; Mollapour M, 2008, YEAST, V25, P169, DOI 10.1002/yea.1576; OURA E, 1977, PROCESS BIOCHEM, V12, P19; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P25, DOI 10.1016/S0960-8524(99)00161-3; Palmqvist E, 1999, BIOTECHNOL BIOENG, V62, P447, DOI 10.1002/(SICI)1097-0290(19990220)62:4<447::AID-BIT7>3.3.CO;2-S; Petersson A, 2006, YEAST, V23, P455, DOI 10.1002/yea.1370; Piper P, 2001, MICROBIOL-SGM, V147, P2635, DOI 10.1099/00221287-147-10-2635; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Shamu Caroline E., 1994, Trends in Cell Biology, V4, P56, DOI 10.1016/0962-8924(94)90011-6; VERDUYN C, 1990, J GEN MICROBIOL, V136, P405, DOI 10.1099/00221287-136-3-405; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; Weeks ME, 2006, PROTEOMICS, V6, P2772, DOI 10.1002/pmic.200500741; WEIGERT B, 1988, BIOTECHNOL LETT, V10, P895, DOI 10.1007/BF01027002; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200	38	38	41	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43474	10.1371/journal.pone.0043474	http://dx.doi.org/10.1371/journal.pone.0043474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952687	Green Published, gold, Green Submitted			2022-12-25	WOS:000308044800032
J	Kato, Y; Nozaki, M				Kato, Yuzuru; Nozaki, Masami			Distinct DNA Methylation Dynamics of Spermatogenic Cell-Specific Intronless Genes Is Associated with CpG Content	PLOS ONE			English	Article							DE-NOVO METHYLATION; MALE GERM-CELLS; HISTONE DEACETYLASE COMPLEX; BINDING-PROTEIN; MOUSE SPERMATOGENESIS; TRANSCRIPTIONAL REPRESSION; MAMMALIAN DEVELOPMENT; CYTOSINE METHYLATION; RESPONSIVE ELEMENT; MEIOTIC PROPHASE	In mammals, DNA methylation is restricted to cytosines of CpG dinucleotides, which are frequently found in short genomic regions including gene promoters. Methylation within CpG-rich regions around promoters tends to repress gene expression; thus, the CpG islands of housekeeping genes are normally unmethylated. We previously described a testis-specific single-exon gene containing a CpG-rich sequence that is methylated and thus repressed in somatic cells, whereas its expression in spermatogenic cells requires that it be hypomethylated. However, the relationship among the specific expression of spermatogenic genes, their methylation dynamics, and their CpG frequencies are poorly understood. Here, we analyzed the methylation patterns of the sphort genomic region around the transcription start site in spermatogenic cell-specific single-exon genes of various CpG contents. By using UniGene and Ensembl database analyses of the mouse genome and reverse transcription-PCR, we identified 39 single-exon genes that are exclusively expressed in spermatogeniccells. Regardless of their specific expression characteristics, genes containing higher (7 to 14 CpGs in 200 bp; mean = 12) and lower (2 to 6 CpGs in 200 bp; mean = 3.1) number of CpG were hypo-and hyper-methylated, respectively, in all cell types examined, including spermatogeniccells. We found that genes with intermediate number of CpG (2 to 11 CpGs in 200 bp; mean = 6.9) are methylated in somatic cells, but not in male germ cells. These results suggest that DNA methylation dynamics of spermatogenic cell-specific single-exon genes are associated with CpG content, and the methylation status are stably maintained throughout male germ cell development.	[Kato, Yuzuru; Nozaki, Masami] Osaka Univ, Microbial Dis Res Inst, Dept Cell Biol, Suita, Osaka 565, Japan	Osaka University	Kato, Y (corresponding author), Natl Inst Genet, Div Mammalian Dev, Genet Strains Res Ctr, Mishima, Sizuoka, Japan.	mnozaki@biken.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology Japan	Ministry of Education, Culture, Sports, Science and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grant-in-Aid for Science Research from the Ministry of Education, Culture, Sports, Science and Technology Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastos H, 2005, CYTOM PART A, V65A, P40, DOI 10.1002/cyto.a.20129; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; Brosius J, 1999, GENE, V238, P115, DOI 10.1016/S0378-1119(99)00227-9; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chen ZX, 2005, J CELL BIOCHEM, V95, P902, DOI 10.1002/jcb.20447; Choi E, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-256; Choi YC, 1997, MAMM GENOME, V8, P317, DOI 10.1007/s003359900431; DeSmet C, 1996, P NATL ACAD SCI USA, V93, P7149, DOI 10.1073/pnas.93.14.7149; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; Geyer CB, 2004, BIOL REPROD, V71, P837, DOI 10.1095/biolreprod.104.028969; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hata K, 2002, DEVELOPMENT, V129, P1983; Hata K, 2006, MOL REPROD DEV, V73, P116, DOI 10.1002/mrd.20387; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hickox DM, 2002, BIOL REPROD, V67, P917, DOI 10.1095/biolreprod.101.001446; Hisano M, 2003, NUCLEIC ACIDS RES, V31, P4797, DOI 10.1093/nar/gkg670; Hisano M, 2003, MOL REPROD DEV, V65, P148, DOI 10.1002/mrd.10276; Hong S, 2005, J BIOL CHEM, V280, P7685, DOI 10.1074/jbc.M412444200; IANNELLO RC, 1992, BIOL REPROD, V47, P48, DOI 10.1095/biolreprod47.1.48; Iannello RC, 2000, J BIOL CHEM, V275, P19603, DOI 10.1074/jbc.M001867200; Iannello RC, 1997, MOL CELL BIOL, V17, P612, DOI 10.1128/MCB.17.2.612; Ike A, 2004, FEBS LETT, V559, P159, DOI 10.1016/S0014-5793(04)00065-1; Imamura M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-34; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kleene KC, 1998, J MOL EVOL, V47, P275, DOI 10.1007/PL00006385; Lecuyer C, 2000, BIOL REPROD, V63, P1801, DOI 10.1095/biolreprod63.6.1801; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Martianov I, 2005, P NATL ACAD SCI USA, V102, P2808, DOI 10.1073/pnas.0406060102; Martins RP, 2007, P NATL ACAD SCI USA, V104, P8340, DOI 10.1073/pnas.0700076104; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Oakes CC, 2007, DEV BIOL, V307, P368, DOI 10.1016/j.ydbio.2007.05.002; Oakes CC, 2007, P NATL ACAD SCI USA, V104, P228, DOI 10.1073/pnas.0607521104; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Onishi M, 2004, GENOMICS, V83, P647, DOI 10.1016/j.ygeno.2003.09.018; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Santambrogio P, 2007, J HISTOCHEM CYTOCHEM, V55, P1129, DOI 10.1369/jhc.7A7273.2007; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Shiota K, 2002, GENES CELLS, V7, P961, DOI 10.1046/j.1365-2443.2002.00574.x; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Singal R, 2000, BIOL REPROD, V63, P1237, DOI 10.1095/biolreprod63.5.1237; Somboonthum P, 2005, NUCLEIC ACIDS RES, V33, P3401, DOI 10.1093/nar/gki652; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Suetake I, 2006, J BIOCHEM, V140, P553, DOI 10.1093/jb/mvj185; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Tanaka H, 2005, MOL CELL BIOL, V25, P7107, DOI 10.1128/MCB.25.16.7107-7119.2005; Tanaka H, 2003, BIOL REPROD, V69, P475, DOI 10.1095/biolreprod.103.015867; Tang HH, 2008, BIOL REPROD, V78, P455, DOI 10.1095/biolreprod.107.064964; THOMAS KH, 1989, BIOL REPROD, V41, P729, DOI 10.1095/biolreprod41.4.729; TRASLER JM, 1990, MOL CELL BIOL, V10, P1828, DOI 10.1128/MCB.10.4.1828; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Wang PJ, 2007, CHROMOSOME RES, V15, P623, DOI 10.1007/s10577-007-1141-2; WATT F, 1988, GENE DEV, V2, P1136, DOI 10.1101/gad.2.9.1136; WEBER J, 1994, CANCER RES, V54, P1766; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102; Yang F, 2007, GENE EXPR PATTERNS, V7, P131, DOI 10.1016/j.modgep.2006.06.002; Yoshimura Y, 1999, GENE, V237, P193, DOI 10.1016/S0378-1119(99)00287-5; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	73	7	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43658	10.1371/journal.pone.0043658	http://dx.doi.org/10.1371/journal.pone.0043658			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952732	Green Published, gold, Green Submitted			2022-12-25	WOS:000308044800050
J	Molnar, F; Caraco, T; Korniss, G				Molnar, Ferenc, Jr.; Caraco, Thomas; Korniss, Gyorgy			Extraordinary Sex Ratios: Cultural Effects on Ecological Consequences	PLOS ONE			English	Article							DEMOGRAPHIC STOCHASTICITY; SELECTION; DYNAMICS; EVOLUTION; INVASION; REPRODUCTION; POPULATIONS; INVESTMENT; NUCLEATION; EXTINCTION	We model sex-structured population dynamics to analyze pairwise competition between groups differing both genetically and culturally. A sex-ratio allele is expressed in the heterogametic sex only, so that assumptions of Fisher's analysis do not apply. Sex-ratio evolution drives cultural evolution of a group-associated trait governing mortality in the homogametic sex. The two-sex dynamics under resource limitation induces a strong Allee effect that depends on both sex ratio and cultural trait values. We describe the resulting threshold, separating extinction from positive growth, as a function of female and male densities. When initial conditions avoid extinction due to the Allee effect, different sex ratios cannot coexist; in our model, greater female allocation always invades and excludes a lesser allocation. But the culturally transmitted trait interacts with the sex ratio to determine the ecological consequences of successful invasion. The invading female allocation may permit population persistence at self-regulated equilibrium. For this case, the resident culture may be excluded, or may coexist with the invader culture. That is, a single sex-ratio allele in females and a cultural dimorphism in male mortality can persist; a low-mortality resident trait is maintained by father-to-son cultural transmission. Otherwise, the successfully invading female allocation excludes the resident allele and culture and then drives the population to extinction via a shortage of males. Finally, we show that the results obtained under homogeneous mixing hold, with caveats, in a spatially explicit model with local mating and diffusive dispersal in both sexes.	[Molnar, Ferenc, Jr.; Korniss, Gyorgy] Rensselaer Polytech Inst, Dept Phys Appl Phys & Astron, Troy, NY 12181 USA; [Caraco, Thomas] SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA	Rensselaer Polytechnic Institute; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Molnar, F (corresponding author), Rensselaer Polytech Inst, Dept Phys Appl Phys & Astron, Troy, NY 12181 USA.	korniss@rpi.edu	Korniss, Gyorgy/A-7360-2011	Caraco, Thomas/0000-0002-8538-6007; Molnar, Ferenc/0000-0002-5614-3989	National Science Foundation [DEB-0918413, DEB-0918392]; Division Of Environmental Biology [0918413] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the National Science Foundation under grant numbers DEB-0918413 and DEB-0918392. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allstadt A, 2007, EVOL ECOL RES, V9, P375; Allstadt A, 2009, J THEOR BIOL, V258, P537, DOI 10.1016/j.jtbi.2009.02.012; Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; [Anonymous], 1984, NATURE SELECTION EVO; Appleby BM, 1997, P ROY SOC B-BIOL SCI, V264, P1111, DOI 10.1098/rspb.1997.0153; Ashih AC, 2001, THEOR POPUL BIOL, V60, P93, DOI 10.1006/tpbi.2001.1527; Berec L, 2001, AM NAT, V157, P217, DOI 10.1086/318626; Berec L, 2007, TRENDS ECOL EVOL, V22, P185, DOI 10.1016/j.tree.2006.12.002; Boukal DS, 2002, J THEOR BIOL, V218, P375, DOI 10.1006/jtbi.2002.3084; CASWELL H, 1986, AM NAT, V128, P707, DOI 10.1086/284598; Cavalli-Sforza Luigi L., 1981, CULTURAL TRANSMISSIO; CHARNOV E L, 1982; DIAMOND JM, 1987, NATURE, V330, P16, DOI 10.1038/330016a0; DICKEMAN M, 1975, ANNU REV ECOL SYST, V6, P107, DOI 10.1146/annurev.es.06.110175.000543; DIJKSTRA C, 1990, FUNCT ECOL, V4, P143, DOI 10.2307/2389333; Engen S, 2003, ECOLOGY, V84, P2378, DOI 10.1890/02-0123; ESHEL I, 1975, HEREDITY, V34, P351, DOI 10.1038/hdy.1975.44; Fisher R.A., 1930, GENETICAL THEORY NAT; FRANK SA, 1986, THEOR POPUL BIOL, V29, P312, DOI 10.1016/0040-5809(86)90013-4; Gandhi A, 1999, J THEOR BIOL, V200, P121, DOI 10.1006/jtbi.1999.0978; Going BM, 2009, OECOLOGIA, V159, P839, DOI 10.1007/s00442-008-1264-y; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; HARRIS TE, 1974, ANN PROBAB, V2, P969, DOI 10.1214/aop/1176996493; HASTINGS IM, 1994, P ROY SOC B-BIOL SCI, V258, P83, DOI 10.1098/rspb.1994.0146; Hinrichsen H, 2000, ADV PHYS, V49, P815, DOI 10.1080/00018730050198152; Hrdy S.B., 1984, INFANTICIDE COMP EVO; Jaenike J, 2001, ANNU REV ECOL SYST, V32, P25, DOI 10.1146/annurev.ecolsys.32.081501.113958; Karlin S., 1986, THEORETICAL STUDIES; Komdeur J, 1997, NATURE, V385, P522, DOI 10.1038/385522a0; Korniss G, 2005, J THEOR BIOL, V233, P137, DOI 10.1016/j.jtbi.2004.09.018; Korniss G, 1997, PHYS REV E, V56, P4072, DOI 10.1103/PhysRevE.56.4072; Krutzen M, 2005, P NATL ACAD SCI USA, V102, P8939, DOI 10.1073/pnas.0500232102; KUMM J, 1994, THEOR POPUL BIOL, V46, P249, DOI 10.1006/tpbi.1994.1027; LALAND KN, 1995, CURR ANTHROPOL, V36, P131, DOI 10.1086/204346; Lande R, 1998, OIKOS, V83, P353, DOI 10.2307/3546849; LEWIS MA, 1993, THEOR POPUL BIOL, V43, P141, DOI 10.1006/tpbi.1993.1007; LIGGETT TM, 1999, STOCHASTIC INTERACTI; Lonsdorf EV, 2004, NATURE, V428, P715, DOI 10.1038/428715a; Marro J., 1999, NONEQUILIBRIUM PHASE, DOI 10.1017/CBO9780511524288; McKane AJ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041902; Miller TEX, 2011, AM NAT, V177, P549, DOI 10.1086/659628; Murray JD, 2003, MATH BIOL, V3; Nitta T, 2008, LECT NOTES COMPUT SC, V5191, P368, DOI 10.1007/978-3-540-79992-4_47; O'Malley L, 2006, THEOR POPUL BIOL, V70, P464, DOI 10.1016/j.tpb.2006.06.006; Oborny B, 2005, OIKOS, V109, P291; Press WH., 1992, NUMERICAL RECIPIES C, V2nd edn; Schiesser W. E., 1991, NUMERICAL METHOD LIN; SHAW RF, 1953, AM NAT, V87, P337, DOI 10.1086/281794; Shelton AO, 2010, AM NAT, V175, P302, DOI 10.1086/650374; Slagsvold T, 2011, PHILOS T R SOC B, V366, P969, DOI 10.1098/rstb.2010.0343; Tainaka K, 2006, EUROPHYS LETT, V74, P554, DOI 10.1209/epl/i2005-10558-3; UYENOYAMA MK, 1982, THEOR POPUL BIOL, V22, P43, DOI 10.1016/0040-5809(82)90035-1; van Kampen N. G., 1981, STOCHASTIC PROCESSES; West SA, 2009, MONOGR POPUL BIOL, V44, P162; Wolfram Research Inc., 2010, MATH VERS 8 0	55	1	1	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43364	10.1371/journal.pone.0043364	http://dx.doi.org/10.1371/journal.pone.0043364			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952669	Green Published, Green Submitted, gold			2022-12-25	WOS:000308044800027
J	Rolfe, PA; Bernstein, DA; Grisafi, P; Fink, GR; Gifford, DK				Rolfe, P. Alexander; Bernstein, Douglas A.; Grisafi, Paula; Fink, Gerald R.; Gifford, David K.			Ruler Arrays Reveal Haploid Genomic Structural Variation	PLOS ONE			English	Article							COPY NUMBER; DNA; POLYMORPHISMS; HYBRIDIZATION; DELETIONS; REPEATS; DISEASE; GENE	Despite the known relevance of genomic structural variants to pathogen behavior, cancer, development, and evolution, certain repeat based structural variants may evade detection by existing high-throughput techniques. Here, we present ruler arrays, a technique to detect genomic structural variants including insertions and deletions (indels), duplications, and translocations. A ruler array exploits DNA polymerase's processivity to detect physical distances between defined genomic sequences regardless of the intervening sequence. The method combines a sample preparation protocol, tiling genomic microarrays, and a new computational analysis. The analysis of ruler array data from two genomic samples enables the identification of structural variation between the samples. In an empirical test between two closely related haploid strains of yeast ruler arrays detected 78% of the structural variants larger than 100 bp.	[Rolfe, P. Alexander; Gifford, David K.] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Bernstein, Douglas A.; Grisafi, Paula; Fink, Gerald R.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Rolfe, PA (corresponding author), Pathogenica Inc, Boston, MA 02109 USA.	gfink@wi.mit.edu; gifford@mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	American Cancer Society [PF-09-072-01-MBC]; United States National Institutes of Health [R01GM069676]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069676] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DAB is funded by the American Cancer Society grant PF-09-072-01-MBC. PAR and DKG were funded by United States National Institutes of Health grant R01GM069676 to DKG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aradhya S, 2007, AM J MED GENET A, V143A, P1431, DOI 10.1002/ajmg.a.31773; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; Brandstrom M, 2007, GENETICS, V176, P1691, DOI 10.1534/genetics.107.070805; CHA JHJ, 1994, LIFE SCI, V54, P1459, DOI 10.1016/0024-3205(94)90012-4; Chen XN, 1998, AM J HUM GENET, V63, P625, DOI 10.1086/301973; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Engert JC, 2007, EUR J HUM GENET; FEENER CA, 1991, AM J HUM GENET, V48, P621; Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303; Johnston M, 1997, NATURE, V387, P87, DOI 10.1038/387s087; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Kraus J, 1997, HUM GENET, V99, P374, DOI 10.1007/s004390050375; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Rouchleau E, 2007, CLIN GENET, V72, P199; Salathia N, 2007, PLANT J, V51, P727, DOI 10.1111/j.1365-313X.2007.03194.x; Shastry BS, 2002, J HUM GENET, V47, P561, DOI 10.1007/s100380200086; Shen MH, 2007, CLIN GENET, V72, P238, DOI 10.1111/j.1399-0004.2007.00858.x; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Vogler AJ, 2006, J BACTERIOL, V188, P4253, DOI 10.1128/JB.00001-06; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Williams RM, 2002, J IND MICROBIOL BIOT, V28, P186, DOI 10.1038/sj/jim/7000200	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43210	10.1371/journal.pone.0043210	http://dx.doi.org/10.1371/journal.pone.0043210			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952647	gold, Green Published, Green Submitted			2022-12-25	WOS:000308044800022
J	Su, XY; Zhang, J; Mackie, RI; Cann, IKO				Su, Xiaoyun; Zhang, Jing; Mackie, Roderick I.; Cann, Isaac K. O.			Supplementing with Non-Glycoside Hydrolase Proteins Enhances Enzymatic Deconstruction of Plant Biomass	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; CALDICELLULOSIRUPTOR-BESCII; HYDROLYSIS; ENZYMES; CELLULASE; THERMOPHILUM; BINDING	The glycoside hydrolases (GH) of Caldicellulosiruptor bescii are thermophilic enzymes, and therefore they can hydrolyze plant cell wall polysaccharides at high temperatures. Analyses of two C. bescii glycoside hydrolases, CbCelA-TM1 and CbXyn10A with cellulase and endoxylanase activity, respectively, demonstrated that each enzyme is highly thermostable under static incubation at 70 degrees C. Both enzymes, however, rapidly lost their enzymatic activities when incubated at 70 degrees C with end-over-end shaking. Since crowding conditions, even at low protein concentrations, seem to influence enzymatic properties, three non-glycoside hydrolase proteins were tested for their capacity to stabilize the thermophilic proteins at high temperatures. The three proteins investigated were a small heat shock protein CbHsp18 from C. bescii, a histone MkHistone1 from Methanopyrus kandleri, and bovine RNase A, from a commercial source. Fascinatingly, each of these proteins increased the thermostability of the glycoside hydrolases at 70 degrees C during end-over-end shaking incubation, and this property translated into increases in hydrolysis of several substrates including the bioenergy feedstock Miscanthus. Furthermore, MkHistone1 and RNase A also altered the initial products released from the cello-oligosaccharide cellopentaose during hydrolysis with the cellodextrinase CbCdx1A, which further demonstrated the capacity of the three non-GH proteins to influence hydrolysis of substrates by the thermophilic glycoside hydrolases. The non-GH proteins used in the present report were small proteins derived from each of the three lineages of life, and therefore expand the space from which different polypeptides can be tested for their influence on plant cell wall hydrolysis, a critical step in the emerging biofuel industry.	[Su, Xiaoyun; Zhang, Jing; Mackie, Roderick I.; Cann, Isaac K. O.] Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA; [Su, Xiaoyun; Zhang, Jing; Mackie, Roderick I.; Cann, Isaac K. O.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Zhang, Jing; Mackie, Roderick I.; Cann, Isaac K. O.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Cann, Isaac K. O.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Su, XY (corresponding author), Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA.	icann@illinois.edu			Energy Biosciences Institute	Energy Biosciences Institute	This work was funded by the Energy Biosciences Institute, Discovery and Characterization of Hydrolytic Enzymes to Improve Biocatalysis and Conversion of Plant Cell Wall Polysaccharides to Biofuels Program at the University of Illinois, Urbana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae B, 2008, J BIOL CHEM, V283, P12415, DOI 10.1074/jbc.M706513200; Blumer-Schuette SE, 2010, APPL ENVIRON MICROB, V76, P8084, DOI 10.1128/AEM.01400-10; Borjesson J, 2007, ENZYME MICROB TECH, V41, P186, DOI 10.1016/j.enzmictec.2007.01.003; CavacoPaulo A, 1996, TEXT RES J, V66, P287, DOI 10.1177/004051759606600501; CAVACOPAULO A, 1994, BIOCATALYSIS, V10, P353, DOI 10.3109/10242429409065244; Dam P, 2011, NUCLEIC ACIDS RES, V39, P3240, DOI 10.1093/nar/gkq1281; Dodd D, 2009, GCB BIOENERGY, V1, P2, DOI 10.1111/j.1757-1707.2009.01004.x; Han YJ, 2007, ENZYME MICROB TECH, V41, P638, DOI 10.1016/j.enzmictec.2007.05.012; Han YJ, 2010, J BACTERIOL, V192, P4111, DOI 10.1128/JB.00257-10; Han YJ, 2010, BIOCHEM ENG J, V48, P218, DOI 10.1016/j.bej.2009.10.013; Hatters DM, 2002, J BIOL CHEM, V277, P7824, DOI 10.1074/jbc.M110429200; Hu ZH, 2008, BIOCHEM ENG J, V38, P369, DOI 10.1016/j.bej.2007.08.001; Iakiviak M, 2011, APPL ENVIRON MICROB, V77, P7541, DOI 10.1128/AEM.06088-11; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kim R, 1998, P NATL ACAD SCI USA, V95, P9129, DOI 10.1073/pnas.95.16.9129; Kitagawa M, 2002, EUR J BIOCHEM, V269, P2907, DOI 10.1046/j.1432-1033.2002.02958.x; KURR M, 1991, ARCH MICROBIOL, V156, P239, DOI 10.1007/BF00262992; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Lochner A, 2011, APPL ENVIRON MICROB, V77, P4042, DOI 10.1128/AEM.02811-10; Ma H, 2009, BIORESOURCE TECHNOL, V100, P1279, DOI 10.1016/j.biortech.2008.08.045; Merino ST, 2007, ADV BIOCHEM ENG BIOT, V108, P95, DOI 10.1007/10_2007_066; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Nakano S, 2009, J AM CHEM SOC, V131, P16881, DOI 10.1021/ja9066628; REESE ET, 1980, BIOTECHNOL BIOENG, V22, P323, DOI 10.1002/bit.260220207; Reeve JN, 1997, CELL, V89, P999, DOI 10.1016/S0092-8674(00)80286-X; Samaniuk JR, 2011, BIORESOURCE TECHNOL, V102, P4489, DOI 10.1016/j.biortech.2010.11.117; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Su X, 2012, APPL ENV MICROBIOL, DOI 101128/AEM06814-11; Tarasov SG, 2011, P NATL ACAD SCI USA, V108, P9798, DOI 10.1073/pnas.1014598108; Te'o VSJ, 2000, FEMS MICROBIOL LETT, V190, P13, DOI 10.1016/S0378-1097(00)00308-6; Tengborg C, 2001, BIOTECHNOL PROGR, V17, P110, DOI 10.1021/bp000145+; Totani K, 2008, J AM CHEM SOC, V130, P2101, DOI 10.1021/ja077570k; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007; Yang B, 2006, BIOTECHNOL BIOENG, V94, P611, DOI 10.1002/bit.20750; Yeoman CJ, 2010, ADV APPL MICROBIOL, V70, P1, DOI 10.1016/S0065-2164(10)70001-0; ZIMMERMAN SB, 1987, P NATL ACAD SCI USA, V84, P1871, DOI 10.1073/pnas.84.7.1871; Zverlov V, 1998, MICROBIOL-SGM, V144, P457, DOI 10.1099/00221287-144-2-457	39	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43828	10.1371/journal.pone.0043828	http://dx.doi.org/10.1371/journal.pone.0043828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952777	Green Published, gold, Green Submitted			2022-12-25	WOS:000308044800063
J	Cleret-Buhot, A; Mathieu, J; Tournier, JN; Quesnel-Hellmann, A				Cleret-Buhot, Aurelie; Mathieu, Jacques; Tournier, Jean-Nicolas; Quesnel-Hellmann, Anne			Both Lethal and Edema Toxins of Bacillus anthracis Disrupt the Human Dendritic Cell Chemokine Network	PLOS ONE			English	Article							INFECTION; SPORES; INHIBITION; RESPONSES	Bacillus anthracis, the agent of anthrax, produces two main virulence factors: a capsule and two toxins. Both lethal toxin (LT) and edema toxin (ET) paralyze the immune defense system. Here, we analyze the effects of LT and ET on the capacity of human monocyte-derived dendritic cells (MoDC) to produce proinflammatory chemokines. We show that both toxins disrupt proinflammatory chemokine production. LT has more pronounced effects than ET on CXCL8 production, which is correlated with impaired recruitment of neutrophils in vitro. Finally, we show that both toxins also differentially disrupt IL-12p70, IL-10, and TNF-alpha production. Taken together, these results demonstrate that both B. anthracis toxins alter MoDC functions and the activation of the innate immune system.	[Cleret-Buhot, Aurelie; Mathieu, Jacques; Tournier, Jean-Nicolas; Quesnel-Hellmann, Anne] Inst Rech Biomed Armees, Dept Microbiol, Unite Interact Hote Agents Pathogenes, La Tronche, France		Cleret-Buhot, A (corresponding author), Univ Montreal, Dept Microbiol & Immunol, Fac Med, Hop St Luc,CRCHUM, Pavillon Edouard Asselin, Montreal, PQ H3C 3J7, Canada.	quesnelhellmann@gmail.com	Tournier, Jean-Nicolas/A-7332-2011; Quesnel-Hellmann, Anne/M-7696-2014	Tournier, Jean-Nicolas/0000-0002-4542-2421; Quesnel-Hellmann, Anne/0000-0002-7589-8834	Delegation Generale pour l'Armement [CO010808]; Service de Sante des Armees [135OP3B LFR EMA]	Delegation Generale pour l'Armement; Service de Sante des Armees	This work was supported by grants from Delegation Generale pour l'Armement (CO010808) and Service de Sante des Armees (135OP3B LFR EMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2003, NATURE, V424, P329, DOI 10.1038/nature01794; Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Batty S, 2006, CELL MICROBIOL, V8, P130, DOI 10.1111/j.1462-5822.2005.00606.x; Brittingham KC, 2005, J IMMUNOL, V174, P5545, DOI 10.4049/jimmunol.174.9.5545; Cleret A, 2007, J IMMUNOL, V178, P7994, DOI 10.4049/jimmunol.178.12.7994; Cleret A, 2006, J INFECT DIS, V194, P86, DOI 10.1086/504686; Comer JE, 2005, INFECT IMMUN, V73, P8275, DOI 10.1128/IAI.73.12.8275-8281.2005; Duverger A, 2006, J IMMUNOL, V176, P1776, DOI 10.4049/jimmunol.176.3.1776; Frew BC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002659; Garraud K, 2012, INFECT IMMUN, V80, P131, DOI 10.1128/IAI.05988-11; Guidi-Rontani C, 2001, MOL MICROBIOL, V42, P931, DOI 10.1046/j.1365-2958.2001.02695.x; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Joshi SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000588; Klezovich-Benard M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002481; Levinsohn JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002638; Lui SH, 2010, CELL HOST MICROBE, V8, P455, DOI 10.1016/j.chom.2010.10.004; Maldonado-Arocho FJ, 2009, INFECT IMMUN, V77, P2036, DOI 10.1128/IAI.01329-08; Moayeri M, 2012, MICROBES INFECT, V14, P392, DOI 10.1016/j.micinf.2011.12.005; Paccani SR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000325; Pickering AK, 2004, INFECT IMMUN, V72, P6382, DOI 10.1128/IAI.72.11.6382-6389.2004; Quesnel-Hellmann A, 2006, VACCINE, V24, P699, DOI 10.1016/j.vaccine.2005.08.065; Raymond B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000359; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Tang WJ, 2009, MOL ASPECTS MED, V30, P423, DOI 10.1016/j.mam.2009.06.001; Tonello F, 2009, MOL ASPECTS MED, V30, P431, DOI 10.1016/j.mam.2009.07.006; Tournier JN, 2009, MOL ASPECTS MED, V30, P456, DOI 10.1016/j.mam.2009.06.002; Tournier JN, 2005, J IMMUNOL, V174, P4934, DOI 10.4049/jimmunol.174.8.4934; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	28	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43266	10.1371/journal.pone.0043266	http://dx.doi.org/10.1371/journal.pone.0043266			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937027	gold, Green Submitted, Green Published			2022-12-25	WOS:000308225500036
J	Tse, H; Tsang, AKL; Tsoi, HW; Leung, ASP; Ho, CC; Lau, SKP; Woo, PCY; Yuen, KY				Tse, Herman; Tsang, Alan K. L.; Tsoi, Hoi-Wah; Leung, Andy S. P.; Ho, Chi-Chun; Lau, Susanna K. P.; Woo, Patrick C. Y.; Yuen, Kwok-Yung			Identification of a Novel Bat Papillomavirus by Metagenomics	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; CORONAVIRUSES REVEALS; BINDING DOMAIN; VIRUS; E2; DIVERSITY; ALIGNMENT; PROTEIN; PICORNAVIRUSES; COEXISTENCE	The discovery of novel viruses in animals expands our knowledge of viral diversity and potentially emerging zoonoses. High-throughput sequencing (HTS) technology gives millions or even billions of sequence reads per run, allowing a comprehensive survey of the genetic content within a sample without prior nucleic acid amplification. In this study, we screened 156 rectal swab samples from apparently healthy bats (n = 96), pigs (n = 9), cattles (n = 9), stray dogs (n = 11), stray cats (n = 11) and monkeys (n = 20) using a HTS metagenomics approach. The complete genome of a novel papillomavirus (PV), Miniopterus schreibersii papillomavirus type 1 (MscPV1), with L1 of 60% nucleotide identity to Canine papillomavirus (CPV6), was identified in a specimen from a Common Bent- wing Bat (M. schreibersii). It is about 7.5kb in length, with a G+C content of 45.8% and a genomic organization similar to that of other PVs. Despite the higher nucleotide identity between the genomes of MscPV1 and CPV6, maximum-likelihood phylogenetic analysis of the L1 gene sequence showed that MscPV1 and Erethizon dorsatum papillomavirus (EdPV1) are most closely related. Estimated divergence time of MscPV1 from the EdPV1/MscPV1 common ancestor was approximately 60.2-91.9 millions of years ago, inferred under strict clocks using the L1 and E1 genes. The estimates were limited by the lack of reliable calibration points from co-divergence because of possible host shifts. As the nucleotide sequence of this virus only showed limited similarity with that of related animal PVs, the conventional approach of PCR using consensus primers would be unlikely to have detected the novel virus in the sample. Unlike the first bat papillomavirus RaPV1, MscPV1 was found in an asymptomatic bat with no apparent mucosal or skin lesions whereas RaPV1 was detected in the basosquamous carcinoma of a fruit bat Rousettus aegyptiacus. We propose MscPV1 as the first member of the novel Dyolambda-papillomavirus genus.	[Tse, Herman; Tsang, Alan K. L.; Tsoi, Hoi-Wah; Leung, Andy S. P.; Ho, Chi-Chun; Lau, Susanna K. P.; Woo, Patrick C. Y.; Yuen, Kwok-Yung] Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, State Key Lab Emerging Infect Dis, Pok Fu Lam, Hong Kong, Peoples R China	University of Hong Kong	Tse, H (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, State Key Lab Emerging Infect Dis, Pok Fu Lam, Hong Kong, Peoples R China.	kyyuen@hkucc.hku.hk	Lau, Susanna Kar Pui/AAJ-6848-2020; Woo, Patrick Chiu Yat/C-4449-2009	Lau, Susanna Kar Pui/0000-0002-1383-7374; Woo, Patrick Chiu Yat/0000-0001-9401-1832; Yuen, Kwok-yung/0000-0002-2083-1552	Research Grant Council; University Development Fund and Strategic Research Theme Fund; University of Hong Kong; Tung Wah Group of Hospitals Fund for Research in Infectious Diseases; HKSAR Research Fund for the Control of Infectious Diseases of the Health, Welfare and Food Bureau; Providence Foundation Limited; Consultancy Service for Enhancing Laboratory Surveillance of Emerging Infectious Disease for the HKSAR Department of Health	Research Grant Council(Hong Kong Research Grants Council); University Development Fund and Strategic Research Theme Fund; University of Hong Kong(University of Hong Kong); Tung Wah Group of Hospitals Fund for Research in Infectious Diseases; HKSAR Research Fund for the Control of Infectious Diseases of the Health, Welfare and Food Bureau; Providence Foundation Limited; Consultancy Service for Enhancing Laboratory Surveillance of Emerging Infectious Disease for the HKSAR Department of Health	This work is partly supported by the Research Grant Council, University Development Fund and Strategic Research Theme Fund, The University of Hong Kong; the Tung Wah Group of Hospitals Fund for Research in Infectious Diseases; the HKSAR Research Fund for the Control of Infectious Diseases of the Health, Welfare and Food Bureau; the Providence Foundation Limited, in memory of the late Dr. Lui Hac Minh; and the Consultancy Service for Enhancing Laboratory Surveillance of Emerging Infectious Disease for the HKSAR Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baylis SA, 2011, VACCINE, V29, P690, DOI 10.1016/j.vaccine.2010.11.028; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; Blomstrom AL, 2010, J CLIN MICROBIOL, V48, P4392, DOI 10.1128/JCM.01040-10; Chevreux B, 1999, GERMAN C BIOINFORMAT, V99, P45, DOI DOI 10.1.1.23/7465; Dahiya A, 2000, MOL CELL BIOL, V20, P6799, DOI 10.1128/MCB.20.18.6799-6805.2000; Day JM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-313; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; DiMaio D, 2001, ONCOGENE, V20, P7866, DOI 10.1038/sj.onc.1204915; Donaldson EF, 2010, J VIROL, V84, P13004, DOI 10.1128/JVI.01255-10; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Endy TP, 2011, EXP BIOL MED, V236, P897, DOI 10.1258/ebm.2011.011i01; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Gottschling M, 2011, MOL BIOL EVOL, V28, P2101, DOI 10.1093/molbev/msr030; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Greninger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013381; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HEGDE RS, 1992, NATURE, V359, P505, DOI 10.1038/359505a0; Hegde RS, 2002, ANNU REV BIOPH BIOM, V31, P343, DOI 10.1146/annurev.biophys.31.100901.142129; HIRT L, 1991, VIRUS RES, V18, P179, DOI 10.1016/0168-1702(91)90017-P; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kapoor A, 2011, P NATL ACAD SCI USA, V108, P11608, DOI 10.1073/pnas.1101794108; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kunz TH, 2003, BAT ECOLOGY, P3; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Lau SKP, 2008, J GEN VIROL, V89, P1840, DOI 10.1099/vir.0.2008/000380-0; Lau SKP, 2007, VIROLOGY, V367, P428, DOI 10.1016/j.virol.2007.06.009; Lau SKP, 2012, J VIROL, V86, P395, DOI 10.1128/JVI.06253-11; Lau SKP, 2011, J GEN VIROL, V92, P2047, DOI 10.1099/vir.0.033688-0; Lau SKP, 2011, J VIROL, V85, P8819, DOI 10.1128/JVI.02364-10; Lau SKP, 2010, J VIROL, V84, P11385, DOI 10.1128/JVI.01121-10; Lau SKP, 2010, VIROLOGY, V404, P106, DOI 10.1016/j.virol.2010.03.049; Lau SKP, 2010, J VIROL, V84, P2808, DOI 10.1128/JVI.02219-09; Li LL, 2011, J GEN VIROL, V92, P2534, DOI 10.1099/vir.0.034611-0; Li LL, 2011, J VIROL, V85, P9909, DOI 10.1128/JVI.05026-11; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; LI R, 1989, GENE DEV, V3, P510, DOI 10.1101/gad.3.4.510; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579; Ng TFF, 2011, J GEN VIROL, V92, P1318, DOI 10.1099/vir.0.029678-0; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Phan TG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002218; Rector A, 2005, VIROLOGY, V331, P449, DOI 10.1016/j.virol.2004.10.033; Rector A, 2006, VET MICROBIOL, V117, P267, DOI 10.1016/j.vetmic.2006.06.010; ROBERTS S, 1994, J VIROL, V68, P6432, DOI 10.1128/JVI.68.10.6432-6445.1994; Rosario K, 2011, J GEN VIROL, V92, P1302, DOI 10.1099/vir.0.030338-0; Shah SD, 2010, MOL BIOL EVOL, V27, P1301, DOI 10.1093/molbev/msq015; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; Sullivan PF, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-2; Tachezy R, 2002, VIROLOGY, V301, P313, DOI 10.1006/viro.2002.1566; Tachezy R, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-19; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Titolo S, 1999, J VIROL, V73, P5282, DOI 10.1128/JVI.73.7.5282-5293.1999; Tokarz R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021844; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Tse H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025619; Tse H, 2011, J GEN VIROL, V92, P1888, DOI 10.1099/vir.0.030817-0; Van Ranst M, 1995, MOL BASIS VIRUS EVOL, P455; VANRANST M, 1992, VIROLOGY, V190, P587, DOI 10.1016/0042-6822(92)90896-W; White PW, 2001, J BIOL CHEM, V276, P22426, DOI 10.1074/jbc.M101932200; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; Woo PCY, 2007, J VIROL, V81, P1574, DOI 10.1128/JVI.02182-06; Woo PCY, 2006, VIROLOGY, V351, P180, DOI 10.1016/j.virol.2006.02.041; Woo PCY, 2011, J VIROL, V85, P13473, DOI 10.1128/JVI.06356-11; Woo PCY, 2010, J GEN VIROL, V91, P2433, DOI 10.1099/vir.0.021717-0; Woo PCY, 2009, J VIROL, V83, P908, DOI 10.1128/JVI.01977-08; Woo PC, 2012, J VIROL; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	72	31	32	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43986	10.1371/journal.pone.0043986	http://dx.doi.org/10.1371/journal.pone.0043986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937142	Green Published, gold			2022-12-25	WOS:000308225500133
J	Acharya, G; Lee, CH; Lee, Y				Acharya, Gayathri; Lee, Chi H.; Lee, Yugyung			Optimization of Cardiovascular Stent against Restenosis: Factorial Design-Based Statistical Analysis of Polymer Coating Conditions	PLOS ONE			English	Article							DRUG-DELIVERY-SYSTEMS; S-NITROSO-GLUTATHIONE; NITRIC-OXIDE; NEOINTIMAL PROLIFERATION; OVERSTRETCH INJURY; IN-VITRO; NITROSOGLUTATHIONE; INHIBITION; MODEL; BIOCOMPATIBILITY	The objective of this study was to optimize the physicodynamic conditions of polymeric system as a coating substrate for drug eluting stents against restenosis. As Nitric Oxide (NO) has multifunctional activities, such as regulating blood flow and pressure, and influencing thrombus formation, a continuous and spatiotemporal delivery of NO loaded in the polymer based nanoparticles could be a viable option to reduce and prevent restenosis. To identify the most suitable carrier for S-Nitrosoglutathione (GSNO), a NO prodrug, stents were coated with various polymers, such as poly (lactic-co-glycolic acid) (PLGA), polyethylene glycol (PEG) and polycaprolactone (PCL), using solvent evaporation technique. Full factorial design was used to evaluate the effects of the formulation variables in polymer-based stent coatings on the GSNO release rate and weight loss rate. The least square regression model was used for data analysis in the optimization process. The polymer-coated stents were further assessed with Differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy analysis (FTIR), Scanning electron microscopy (SEM) images and platelet adhesion studies. Stents coated with PCL matrix displayed more sustained and controlled drug release profiles than those coated with PLGA and PEG. Stents coated with PCL matrix showed the least platelet adhesion rate. Subsequently, stents coated with PCL matrix were subjected to the further optimization processes for improvement of surface morphology and enhancement of the drug release duration. The results of this study demonstrated that PCL matrix containing GSNO is a promising system for stent surface coating against restenosis.	[Acharya, Gayathri; Lee, Chi H.] Univ Missouri, Sch Pharm, Div Pharmaceut Sci, Kansas City, MO 64110 USA; [Lee, Yugyung] Univ Missouri, Sch Comp & Engn, Dept Comp Sci & Elect Engn, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City	Acharya, G (corresponding author), Univ Missouri, Sch Pharm, Div Pharmaceut Sci, Kansas City, MO 64110 USA.	leech@umkc.edu; leeyu@umkc.edu	Acharya, Gayathri/U-3930-2019		Missouri Life Science Research Board Grant [09-117]	Missouri Life Science Research Board Grant	This work was supported by Missouri Life Science Research Board Grant (09-117; http://lifesciences.mo.gov/summary.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya G, 2012, J BIOMED MATER RES A, V100A, P1151, DOI 10.1002/jbm.a.34055; [Anonymous], J MINISTRY AGR; Berg R, 2007, CATHETER CARDIO INTE, V70, P871, DOI 10.1002/ccd.21299; Bertrand OF, 1998, J AM COLL CARDIOL, V32, P562, DOI 10.1016/S0735-1097(98)00289-7; Box GE., 1978, STAT EXPT; Brieger D, 1997, CARDIOVASC RES, V35, P405, DOI 10.1016/S0008-6363(97)00155-7; Cho HH, 2008, BIOMATERIALS, V29, P884, DOI 10.1016/j.biomaterials.2007.10.052; DEBELDER AJ, 1994, CARDIOVASC RES, V28, P691; Do YS, 2004, RADIOLOGY, V230, P377, DOI 10.1148/radiol.2302020417; EPSTEIN SE, 1994, J AM COLL CARDIOL, V23, P1278, DOI 10.1016/0735-1097(94)90368-9; Fischell TA, 1996, CIRCULATION, V94, P1494, DOI 10.1161/01.CIR.94.7.1494; Fisher RA, 1990, STAT METHODS EXPT DE; Frost MC, 2005, BIOMATERIALS, V26, P1685, DOI 10.1016/j.biomaterials.2004.06.006; George SJ, 2010, ATHEROSCLEROSIS: MOLECULAR AND CELLULAR MECHANISMS, P1, DOI 10.1002/9783527629589; Gonzalez-Rodriguez ML, 2007, INT J PHARMACEUT, V337, P336, DOI 10.1016/j.ijpharm.2007.01.024; Hou DM, 2005, CARDIOVASC INTER RAD, V28, P60, DOI 10.1007/s00270-004-0206-2; Kallinteri P, 2002, BIOMATERIALS, V23, P4819, DOI 10.1016/S0142-9612(02)00233-8; Kaposzta Z, 2001, CIRCULATION, V103, P2371; LANGFORD EJ, 1994, LANCET, V344, P1458, DOI 10.1016/S0140-6736(94)90287-9; Lee CH, 2011, DRUG DELIV TRANSL RE, V1, P201, DOI 10.1007/s13346-011-0026-2; Liu Y, 2011, J BIOMED MATER RES A, V99A, P485, DOI 10.1002/jbm.a.33209; Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042; Montgomery D.C., 2012, DESIGN ANAL EXPT; Pan CJ, 2007, J MATER SCI-MATER M, V18, P2193, DOI 10.1007/s10856-007-3075-9; Pan CJ, 2010, COLLOID SURFACE B, V77, P155, DOI 10.1016/j.colsurfb.2010.01.019; RAMSAY B, 1995, BRIT J CLIN PHARMACO, V40, P101, DOI 10.1111/j.1365-2125.1995.tb04545.x; Reichenbach Gustavo, 2005, Curr Drug Targets Cardiovasc Haematol Disord, V5, P65; Rhee YS, 2008, INT J PHARMACEUT, V364, P14, DOI 10.1016/j.ijpharm.2008.07.029; Shah M, 2010, AAPS PHARMSCITECH, V11, P489, DOI 10.1208/s12249-010-9414-z; Singh B, 2005, CRIT REV THER DRUG, V22, P27, DOI 10.1615/CritRevTherDrugCarrierSyst.v22.i1.20; Singh B, 2005, CRIT REV THER DRUG, V22, P215, DOI 10.1615/CritRevTherDrugCarrierSyst.v22.i3.10; Sorragi CD, 2011, CELL BIOCHEM FUNCT, V29, P207, DOI 10.1002/cbf.1738; Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u; Vilahur G, 2004, CARDIOVASC RES, V61, P806, DOI 10.1016/j.cardiores.2003.11.034; Vodovotz Y, 2000, INT J RADIAT ONCOL, V48, P1167, DOI 10.1016/S0360-3016(00)00730-6; Westedt U, 2006, J CONTROL RELEASE, V111, P235, DOI 10.1016/j.jconrel.2005.12.012; Yoo JW, 2010, J BIOMED MATER RES A, V92A, P1233, DOI 10.1002/jbm.a.32434; Yoo JW, 2009, BIOMATERIALS, V30, P3978, DOI 10.1016/j.biomaterials.2009.04.004; Yoon J, 2002, YONSEI MED J, V43, P242, DOI 10.3349/ymj.2002.43.2.242	39	35	37	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43100	10.1371/journal.pone.0043100	http://dx.doi.org/10.1371/journal.pone.0043100			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937015	Green Published, Green Submitted, gold			2022-12-25	WOS:000308286300034
J	Siu, MKY; Wong, ESY; Kong, DSH; Chan, HY; Jiang, L; Wong, OGW; Lam, EWF; Chan, KKL; Ngan, HYS; Le, XF; Cheung, AN				Siu, M. K. Y.; Wong, E. S. Y.; Kong, D. S. H.; Chan, H. Y.; Jiang, L.; Wong, O. G. W.; Lam, E. W-F; Chan, K. K. L.; Ngan, H. Y. S.; Le, X-F; Cheung, A. N.			Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers	ONCOGENE			English	Article						NANOG; cell migration and invasion; prognostic marker; therapeutic molecular target; ovarian cancer	CARCINOMA CELLS; DIFFERENTIAL EXPRESSION; TUMOR-CELLS; IDENTIFICATION; OVEREXPRESSION; PLURIPOTENCY; MODULATION; ACTIVATION; PROGNOSIS	Ovarian cancer is the most lethal of all gynecological malignancies, and the identification of novel prognostic and therapeutic targets for ovarian cancer is crucial. It is believed that only a small subset of cancer cells are endowed with stem cell properties, which are responsible for tumor growth, metastatic progression and recurrence. NANOG is one of the key transcription factors essential for maintaining self-renewal and pluripotency in stem cells. This study investigated the role of NANOG in ovarian carcinogenesis and showed overexpression of NANOG mRNA and protein in the nucleus of ovarian cancers compared with benign ovarian lesions. Increased nuclear NANOG expression was significantly associated with high-grade cancers, serous histological subtypes, reduced chemosensitivity, and poor overall and disease-free survival. Further analysis showed NANOG is an independent prognostic factor for overall and disease-free survival. Moreover, NANOG was highly expressed in ovarian cancer cell lines with metastasis-associated property and in clinical samples of metastatic foci. Stable knockdown of NANOG impeded ovarian cancer cell proliferation, migration and invasion, which was accompanied by an increase in mRNA expression of E-cadherin, caveolin-1, FOXO1, FOXO3a, FOXJ1 and FOXB1. Conversely, ectopic NANOG overexpression enhanced ovarian cancer cell migration and invasion along with decreased E-cadherin, caveolin-1, FOXO1, FOXO3a, FOXJ1 and FOXB1 mRNA expression. Importantly, we found Nanog-mediated cell migration and invasion involved its regulation of E-cadherin and FOXJ1. This is the first report revealing the association between NANOG expression and clinical outcome of patients with ovarian cancers, suggesting NANOG to be a potential prognostic marker and therapeutic molecular target in ovarian cancer.	[Siu, M. K. Y.; Wong, E. S. Y.; Kong, D. S. H.; Chan, H. Y.; Jiang, L.; Wong, O. G. W.; Cheung, A. N.] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Lam, E. W-F] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Chan, K. K. L.; Ngan, H. Y. S.] Univ Hong Kong, Queen Mary Hosp, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Le, X-F] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA	University of Hong Kong; Imperial College London; University of Hong Kong; University of Texas System; UTMD Anderson Cancer Center	Cheung, AN (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	mkysiu@hkucc.hku.hk; anycheun@hkucc.hku.hk	Lam, Eric W-F/AAW-8566-2020; Wong, Gee Wan/C-4661-2009; Chan, Karen/E-4041-2015; Cheung, Annie Nga Yin/C-4231-2009	Lam, Eric W-F/0000-0003-1274-3576; Ngan, Hextan Y S/0000-0003-3945-159X; Chan, Karen/0000-0001-9947-4713; Cheung, Annie Nga Yin/0000-0002-1584-7568	Hong Kong Anti-Cancer Society Grant; Strategic Research Theme of Cancer Award; Conference and Research grant from the University of Hong Kong; Cancer Research UK [12011] Funding Source: researchfish	Hong Kong Anti-Cancer Society Grant; Strategic Research Theme of Cancer Award; Conference and Research grant from the University of Hong Kong; Cancer Research UK(Cancer Research UK)	We thank Dr Judy Yam for providing the anti-caveolin-1 antibody. The work was supported by funding from the Hong Kong Anti-Cancer Society Grant, Strategic Research Theme of Cancer Award and the Conference and Research grant from the University of Hong Kong.	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cavaleri F, 2003, CELL, V113, P551, DOI 10.1016/S0092-8674(03)00394-5; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Darai E, 1997, HUM PATHOL, V28, P922, DOI 10.1016/S0046-8177(97)90007-1; Demircan B, 2009, GENE CHROMOSOME CANC, V48, P83, DOI 10.1002/gcc.20620; Di Fiore R, 2009, J CELL PHYSIOL, V219, P301, DOI 10.1002/jcp.21667; Fei M, 2009, CANCER INVEST, V27, P52, DOI 10.1080/07357900802146204; de Mattos SF, 2008, MOL CANCER THER, V7, P3237, DOI 10.1158/1535-7163.MCT-08-0398; Hu L, 2010, BRIT J CANCER, V102, P1276, DOI 10.1038/sj.bjc.6605626; Huff CA, 2006, BLOOD, V107, P431, DOI 10.1182/blood-2005-06-2517; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Jiang LL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-318; Klonisch T, 2008, TRENDS MOL MED, V14, P450, DOI 10.1016/j.molmed.2008.08.003; Kurman RJ, 2008, AM J OBSTET GYNECOL, V198, P351, DOI 10.1016/j.ajog.2008.01.005; Lin L, 2004, SCIENCE, V303, P1017, DOI 10.1126/science.1093889; MANN SC, 1991, INT J CANCER, V48, P866, DOI 10.1002/ijc.2910480613; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Miotti S, 2005, AM J PATHOL, V167, P1411, DOI 10.1016/S0002-9440(10)61228-X; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Pan YY, 2008, INT J CLIN EXP MED, V1, P260; PEREZ RP, 1991, SEMIN ONCOL, V18, P186; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Sawada K, 2008, CANCER RES, V68, P2329, DOI 10.1158/0008-5472.CAN-07-5167; Seidman JD, 2003, HEMATOL ONCOL CLIN N, V17, P909, DOI 10.1016/S0889-8588(03)00061-3; Singh SK, 2003, CANCER RES, V63, P5821; Siu MKY, 2008, AM J PATHOL, V173, P1165, DOI 10.2353/ajpath.2008.080288; Siu MKY, 2010, P NATL ACAD SCI USA, V107, P18622, DOI 10.1073/pnas.0907481107; Siu MKY, 2010, INT J CANCER, V127, P21, DOI 10.1002/ijc.25005; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; VEATCH AL, 1994, INT J CANCER, V58, P393, DOI 10.1002/ijc.2910580315; Wilson AP, 1999, HUM CELL, P25; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	37	116	120	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 25	2013	32	30					3500	3509		10.1038/onc.2012.363	http://dx.doi.org/10.1038/onc.2012.363			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	188UQ	22945654	Green Submitted			2022-12-25	WOS:000322220800003
J	Shen, Y; Li, NL; Wang, J; Liu, BM; Lester, S; Li, K				Shen, Yang; Li, Nan L.; Wang, Jie; Liu, Baoming; Lester, Sandra; Li, Kui			TRIM56 Is an Essential Component of the TLR3 Antiviral Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR; NF-KAPPA-B; INTERFERON REGULATORY FACTOR-3; HEPATITIS-C VIRUS; IFN-BETA PRODUCTION; FAMILY PROTEINS; ADAPTER; MOTIF; ACTIVATION; LIGASE	Members of the tripartite motif (TRIM) proteins are being recognized as important regulators of host innate immunity. However, specific TRIMs that contribute to TLR3-mediated antiviral defense have not been identified. We show here that TRIM56 is a positive regulator of TLR3 signaling. Overexpression of TRIM56 substantially potentiated extracellular dsRNA-induced expression of interferon (IFN)-beta and interferon-stimulated genes (ISGs), while knockdown of TRIM56 greatly impaired activation of IRF3, induction of IFN-beta and ISGs, and establishment of an antiviral state by TLR3 ligand and severely compromised TLR3-mediated chemokine induction following infection by hepatitis C virus. The ability to promote TLR3 signaling was independent of the E3 ubiquitin ligase activity of TRIM56. Rather, it correlated with a physical interaction between TRIM56 and TRIF. Deletion of the C-terminal portion of TRIM56 abrogated the TRIM56-TRIF interaction as well as the augmentation of TLR3-mediated IFN response. Together, our data demonstrate TRIM56 is an essential component of the TLR3 antiviral signaling pathway and reveal a novel role for TRIM56 in innate antiviral immunity.	[Shen, Yang; Li, Nan L.; Wang, Jie; Liu, Baoming; Lester, Sandra; Li, Kui] Univ Tennessee, Dept Microbiol Immunol & Biochem, Hlth Sci Ctr, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Li, K (corresponding author), Univ Tennessee, Dept Microbiol Immunol & Biochem, Hlth Sci Ctr, 858 Madison Ave, Memphis, TN 38163 USA.	kli1@uthsc.edu			National Institutes of Health [AI069285, AI078906]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI078906, R01AI069285, R56AI069285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported, in whole or in part, by National Institutes of Health Grant AI069285 (to K. L.).; Supported by an National Institutes of Health T32 Training Grant (AI078906).	Arimoto K, 2010, P NATL ACAD SCI USA, V107, P15856, DOI 10.1073/pnas.1004621107; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Chen ZH, 2007, VIROLOGY, V366, P277, DOI 10.1016/j.virol.2007.04.023; Chen ZH, 2007, J VIROL, V81, P964, DOI 10.1128/JVI.02076-06; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; Elco CP, 2005, J VIROL, V79, P3920, DOI 10.1128/JVI.79.7.3920-3929.2005; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Keskinen P, 1999, VIROLOGY, V263, P364, DOI 10.1006/viro.1999.9983; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Li K, 2012, HEPATOLOGY, V55, P666, DOI 10.1002/hep.24763; Liang QM, 2011, J IMMUNOL, V187, P4754, DOI 10.4049/jimmunol.1101704; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Munir M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3118jc2; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Short KM, 2006, J BIOL CHEM, V281, P8970, DOI 10.1074/jbc.M512755200; Tighe A, 2008, J CELL BIOL, V181, P893, DOI 10.1083/jcb.200712028; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang J, 2011, J VIROL, V85, P3733, DOI 10.1128/JVI.02546-10; Wang N, 2010, J BIOL CHEM, V285, P6080, DOI 10.1074/jbc.M109.054486; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zha FK, 2006, J IMMUNOL, V176, P1072, DOI 10.4049/jimmunol.176.2.1072; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhao W, 2012, J IMMUNOL, V188, P5311, DOI 10.4049/jimmunol.1103506	43	52	56	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36404	36413		10.1074/jbc.M112.397075	http://dx.doi.org/10.1074/jbc.M112.397075			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948160	hybrid, Green Published			2022-12-25	WOS:000310364000060
J	Tamaru, A; Nakajima, C; Wada, T; Wang, YJ; Inoue, M; Kawahara, R; Maekura, R; Ozeki, Y; Ogura, H; Kobayashi, K; Suzuki, Y; Matsumoto, S				Tamaru, Aki; Nakajima, Chie; Wada, Takayuki; Wang, Yajun; Inoue, Manabu; Kawahara, Ryuji; Maekura, Ryoji; Ozeki, Yuriko; Ogura, Hisashi; Kobayashi, Kazuo; Suzuki, Yasuhiko; Matsumoto, Sohkichi			Dominant Incidence of Multidrug and Extensively Drug-Resistant Specific Mycobacterium tuberculosis Clones in Osaka Prefecture, Japan	PLOS ONE			English	Article							RIFAMPIN RESISTANCE; BEIJING FAMILY; EAST-ASIA; GENOTYPE; TRANSMISSION; FITNESS; STRAINS	Infection and transmission of multidrug-resistant Mycobacterium tuberculosis (MDR-Mtb) and extensively drug-resistant M. tuberculosis (XDR-Mtb) is a serious health problem. We analyzed a total of 1,110 Mtb isolates in Osaka Prefecture and neighboring areas from April 2000 to March 2009. A total of 89 MDR-Mtb were identified, 36 (48.5%) of which were determined to be XDR-Mtb. Among the 89 MDR-Mtb isolates, 24 (27.0%) phylogenetically distributed into six clusters based on mycobacterial interspersed repetitive units-various number of tandem repeats (MIRU-VNTR) typing. Among these six clusters, the MIRU-VNTR patterns of four (OM-V02, OM-V03, OM-V04, and OM-V06) were only found for MDR-Mtb. Further analysis revealed that all isolates belonging to OM-V02 and OM-V03, and two isolates from OM-V04 were clonal. Importantly such genotypes were not observed for drug-sensitive isolates. These suggest that few but transmissible clones can transmit after acquiring multidrug resistance and colonize even in a country with a developed, well-organized healthcare system.	[Tamaru, Aki; Kawahara, Ryuji] Osaka Prefectural Inst Publ Hlth, Dept Infect Dis, Osaka 537, Japan; [Tamaru, Aki; Wang, Yajun; Inoue, Manabu; Matsumoto, Sohkichi] Osaka City Univ, Grad Sch Med, Dept Bacteriol, Osaka 558, Japan; [Nakajima, Chie; Suzuki, Yasuhiko] Hokkaido Univ, Res Ctr Zoonosis Control, Div Global Epidemiol, Sapporo, Hokkaido, Japan; [Wada, Takayuki] Osaka City Inst Publ Hlth & Environm Sci, Dept Microbiol, Osaka 543, Japan; [Maekura, Ryoji] Natl Toneyama Hosp, Natl Hosp Org, Dept Internal Med, Toyonaka, Osaka, Japan; [Ozeki, Yuriko] Sonoda Womens Univ, Dept Food & Nutr, Amagasaki, Hyogo, Japan; [Ogura, Hisashi] Osaka City Univ, Grad Sch Med, Dept Virol, Osaka 558, Japan; [Kobayashi, Kazuo] Natl Inst Infect Dis, Dept Immunol, Shinjyuku Ku, Tokyo, Japan; [Suzuki, Yasuhiko] Japan Int Cooperat Agcy Sci & Technol Res Partner, Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo, Japan	Osaka Prefectural Institute of Public Health; Osaka Metropolitan University; Hokkaido University; Osaka Metropolitan University; National Institute of Infectious Diseases (NIID); Japan Science & Technology Agency (JST)	Tamaru, A (corresponding author), Osaka Prefectural Inst Publ Hlth, Dept Infect Dis, Osaka 537, Japan.	tamaru@iph.pref.osaka.jp	Nakajima, Chie/A-5020-2012; Suzuki, Yasuhiko/F-6890-2012	Matsumoto, Sohkichi/0000-0002-6106-7538	Ministry of Health, Labour and Welfare (Research on Emerging and Reemerging Infectious Diseases, Health Sciences Research Grants); Osaka City University; United States-Japan Cooperative Medical Science Programs; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; MEXT; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [24590651] Funding Source: KAKEN	Ministry of Health, Labour and Welfare (Research on Emerging and Reemerging Infectious Diseases, Health Sciences Research Grants); Osaka City University; United States-Japan Cooperative Medical Science Programs; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Ministry of Health, Labour and Welfare (Research on Emerging and Reemerging Infectious Diseases, Health Sciences Research Grants) to AT, TW, KK and SM, and a grant from Osaka City University to SM, RM and AT, by a grant from United States-Japan Cooperative Medical Science Programs, by the Global Center of Excellence Program, "Establishment of International Collaboration Centers for Zoonosis Control", Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, by Grants-in-Aid for the Program of Founding Research Center for Emerging and Re-emerging Infectious Diseases from MEXT to YS as well as by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science to YS and CN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Caminero JA, 2006, INT J TUBERC LUNG D, V10, P829; Devaux I, 2009, EMERG INFECT DIS, V15, P1052, DOI 10.3201/eid1507.080994; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; Hanekom M, 2007, J CLIN MICROBIOL, V45, P1483, DOI 10.1128/JCM.02191-06; Iwamoto T, 2009, J CLIN MICROBIOL, V47, P3340, DOI 10.1128/JCM.01061-09; Jain A, 2008, J BIOSCIENCES, V33, P605, DOI 10.1007/s12038-008-0078-8; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Kubica T, 2005, INT J TUBERC LUNG D, V9, P646; Kubica T, 2004, INT J TUBERC LUNG D, V8, P1107; Lomtadze N, 2009, INT J TUBERC LUNG D, V13, P68; Mariam DH, 2004, ANTIMICROB AGENTS CH, V48, P1289, DOI 10.1128/AAC.48.4.1289-1294.2004; Masjedi MR, 2006, CLIN INFECT DIS, V43, P841, DOI 10.1086/507542; Ministry of Health Labour and Welfare, 2011, STAT AIDS 2010; Ministry of Health Labour and Welfare, 2011, STAT TUB 2010; Murase Y, 2008, J MED MICROBIOL, V57, P873, DOI 10.1099/jmm.0.47564-0; Murase Y, 2010, EMERG INFECT DIS, V16, P948, DOI 10.3201/eid1606.091844; O'Sullivan DM, 2010, J MED MICROBIOL, V59, P1533, DOI 10.1099/jmm.0.019091-0; PLIKAYTIS BB, 1994, J CLIN MICROBIOL, V32, P1542, DOI 10.1128/JCM.32.6.1542-1546.1994; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Shah NS, 2009, JAMA-J AM MED ASSOC, V300, P2153; Sun YJ, 2007, INT J TUBERC LUNG D, V11, P436; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Ti T, 2006, INT J TUBERC LUNG D, V10, P1111; Tuberculosis Research Committee (Ryoken), 2002, KEKKAKU, V82, P155; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Vazquez-Gallardo R, 2007, INT J TUBERC LUNG D, V11, P429; Wada T, 2009, FEMS MICROBIOL LETT, V291, P35, DOI 10.1111/j.1574-6968.2008.01431.x; Wada T, 2009, TUBERCULOSIS, V89, P252, DOI 10.1016/j.tube.2009.05.007; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC	31	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e42505	10.1371/journal.pone.0042505	http://dx.doi.org/10.1371/journal.pone.0042505			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952596	Green Submitted, Green Published, gold			2022-12-25	WOS:000308221300006
J	Fogli, A; Merle, C; Roussel, V; Schiffmann, R; Ughetto, S; Theisen, M; Boespflug-Tanguy, O				Fogli, Anne; Merle, Christine; Roussel, Veronique; Schiffmann, Raphael; Ughetto, Sylvie; Theisen, Manfred; Boespflug-Tanguy, Odile			CSF N-Glycan Profiles to Investigate Biomarkers in Brain Developmental Disorders: Application to Leukodystrophies Related to eIF2B Mutations	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; CONGENITAL DISORDERS; SERUM; GLYCOSYLATION; ASIALOTRANSFERRIN; IDENTIFICATION; PROTEINS; ATAXIA	Background: Primary or secondary abnormalities of glycosylation have been reported in various brain diseases. Decreased asialotransferrin to sialotransferrin ratio in cerebrospinal fluid (CSF) is a diagnostic marker of leukodystrophies related to mutations of genes encoding translation initiation factor, EIF2B. We investigated the CSF glycome of eIF2B-mutated patients and age-matched normal individuals in order to further characterize the glycosylation defect for possible use as a biomarker. Methodology/Principal Findings: We conducted a differential N-glycan analysis using MALDI-TOF/MS of permethylated N-glycans in CSF and plasma of controls and eIF2B-mutated patients. We found in control CSF that tri-antennary/bisecting and high mannose structures were highly represented in samples obtained between 1 to 5 years of age, whereas fucosylated, sialylated structures were predominant at later age. In CSF, but not in plasma, of eIF2B-mutated patient samples, we found increased relative intensity of bi-antennary structures and decreased tri-antennary/bisecting structures in N-glycan profiles. Four of these structures appeared to be biomarker candidates of glycomic profiles of eIF2B-related disorders. Conclusion: Our results suggest a dynamic development of normal CSF N-glycan profiles from high mannose type structures to complex sialylated structures that could be correlated with postnatal brain maturation. CSF N-glycome analysis shows relevant quantitative changes associated with eIF2B related disorders. This approach could be applied to other neurological disorders involving developmental gliogenesis/synaptogenesis abnormalities.	[Fogli, Anne; Boespflug-Tanguy, Odile] CNRS 6247, Lab GReD, Fac Med, UMR,INSERM,U931, Clermont Ferrand, France; [Fogli, Anne] CHU Clermont Ferrand, Serv Biochim Med, Clermont Ferrand, France; [Merle, Christine; Roussel, Veronique; Theisen, Manfred] Biopole Clermont Limagne, Proteodynamics, St Beauzire, France; [Schiffmann, Raphael] Baylor Res Inst, Inst Metab Dis, Dallas, TX USA; [Ughetto, Sylvie] CHU Clermont Ferrand, Dept Med Informat, Clermont Ferrand, France; [Boespflug-Tanguy, Odile] Hop Robert Debre, AP HP, Serv Neuropediat & Malad Metab, Ctr Reference Leucodystrophies, F-75019 Paris, France; [Boespflug-Tanguy, Odile] Univ Paris Diderot, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Clermont Ferrand; Baylor Scott & White Health; Baylor University Medical Center; CHU Clermont Ferrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Fogli, A (corresponding author), CNRS 6247, Lab GReD, Fac Med, UMR,INSERM,U931, Clermont Ferrand, France.	anne.fogli@inserm.u-clermont1.fr	Fogli, Anne/AAL-6640-2020	Fogli, Anne/0000-0002-2651-7441	European Leukodystrophy Association (ELA) research foundation; "Leukotreat" European consortium, FP7-Heath program [241622]	European Leukodystrophy Association (ELA) research foundation; "Leukotreat" European consortium, FP7-Heath program	This work was supported by grants of the European Leukodystrophy Association (ELA) research foundation and the "Leukotreat" European consortium supported by the FP7-Heath program (FP7#241622). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HJ, 2006, J PROTEOME RES, V5, P1626, DOI 10.1021/pr060010k; Boespflug-Tanguy O, 2008, CURR NEUROL NEUROSCI, V8, P217, DOI 10.1007/s11910-008-0034-x; Bugiani M, 2011, J NEUROPATH EXP NEUR, V70, P69, DOI 10.1097/NEN.0b013e318203ae74; Dastych M, 2010, SCAND J CLIN LAB INV, V70, P87, DOI 10.3109/00365510903521559; Dietrich J, 2005, NAT MED, V11, P277, DOI 10.1038/nm1195; Fogli A, 2004, NEUROLOGY, V62, P1509, DOI 10.1212/01.WNL.0000123259.67815.DB; Fogli A, 2006, BIOCHEM SOC T, V34, P22, DOI 10.1042/BST0340022; Fogli A, 2004, EUR J HUM GENET, V12, P561, DOI 10.1038/sj.ejhg.5201189; Geva M, 2010, BRAIN, V133, P2448, DOI 10.1093/brain/awq180; Goetz JA, 2009, GLYCOCONJUGATE J, V26, P117, DOI 10.1007/s10719-008-9170-4; Goldman R, 2009, CLIN CANCER RES, V15, P1808, DOI 10.1158/1078-0432.CCR-07-5261; Guillard M, 2011, CLIN CHEM, V57, P593, DOI 10.1373/clinchem.2010.153635; Horzinski L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008318; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kyselova Z, 2008, CLIN CHEM, V54, P1166, DOI 10.1373/clinchem.2007.087148; Kyselova Z, 2007, J PROTEOME RES, V6, P1822, DOI 10.1021/pr060664t; Marquardt T, 2003, EUR J PEDIATR, V162, P359, DOI 10.1007/s00431-002-1136-0; Mechref Y, 2009, J PROTEOME RES, V8, P2656, DOI 10.1021/pr8008385; Morelle W, 2007, NAT PROTOC, V2, P1585, DOI 10.1038/nprot.2007.227; PAREKH R, 1988, J EXP MED, V167, P1731, DOI 10.1084/jem.167.5.1731; Quarles RH, 1997, J MOL NEUROSCI, V8, P1, DOI 10.1007/BF02736858; Rakotomalala R., 2005, ACTES EGC 2005 RNTI; SCHIFFMANN R, 1994, ANN NEUROL, V35, P331, DOI 10.1002/ana.410350314; Sinha A, 2009, CLIN CHIM ACTA, V400, P14, DOI 10.1016/j.cca.2008.09.026; Stanta JL, 2010, J PROTEOME RES, V9, P4476, DOI 10.1021/pr1002356; Tang ZQ, 2010, J PROTEOME RES, V9, P104, DOI 10.1021/pr900397n; Taniguchi M, 2008, DEMENT GERIATR COGN, V26, P117, DOI 10.1159/000147479; van der Knaap MS, 2002, ANN NEUROL, V51, P264, DOI 10.1002/ana.10112; Vanderver A, 2008, NEUROLOGY, V70, P2226, DOI 10.1212/01.wnl.0000313857.54398.0e; Vanderver A, 2005, CLIN CHEM, V51, P2031, DOI 10.1373/clinchem.2005.055053; Vanhooren V, 2007, REJUV RES, V10, P521, DOI 10.1089/rej.2007.0556; Vanhooren V, 2010, EXP GERONTOL, V45, P738, DOI 10.1016/j.exger.2010.08.009; Wada Y, 2007, GLYCOBIOLOGY, V17, P411, DOI 10.1093/glycob/cwl086	33	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e42688	10.1371/journal.pone.0042688	http://dx.doi.org/10.1371/journal.pone.0042688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952606	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206000009
J	Krawetz, RJ; Wu, YE; Martin, L; Rattner, JB; Matyas, JR; Hart, DA				Krawetz, Roman J.; Wu, Yiru Elizabeth; Martin, Liam; Rattner, Jerome B.; Matyas, John R.; Hart, David A.			Synovial Fluid Progenitors Expressing CD90+from Normal but Not Osteoarthritic Joints Undergo Chondrogenic Differentiation without Micro-Mass Culture	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PARTIAL-THICKNESS DEFECTS; STROMAL CELLS; AGGREGATION; CLUSTERS; CRITERIA; THERAPY; REPAIR	Objective: Mesenchymal progenitor cells (MPCs) can differentiate into osteoblasts, adipocytes, and chondrocytes, and are in part responsible for maintaining tissue integrity. Recently, a progenitor cell population has been found within the synovial fluid that shares many similarities with bone marrow MPCs. These synovial fluid MPCs (sfMPCs) share the ability to differentiate into bone and fat, with a bias for cartilage differentiation. In this study, sfMPCs were isolated from human and canine synovial fluid collected from normal individuals and those with osteoarthritis (human: clinician-diagnosed, canine: experimental) to compare the differentiation potential of CD90+ vs. CD90- sfMPCs, and to determine if CD90 (Thy-1) is a predictive marker of synovial fluid progenitors with chondrogenic capacity in vitro. Methods: sfMPCs were derived from synovial fluid from normal and OA knee joints. These cells were induced to differentiate into chondrocytes and analyzed using quantitative PCR, immunofluorescence, and electron microscopy. Results: The CD90+ subpopulation of sfMPCs had increased chondrogenic potential compared to the CD90- population. Furthermore, sfMPCs derived from healthy joints did not require a micro-mass step for efficient chondrogenesis. Whereas sfMPCs from OA synovial fluid retain the ability to undergo chondrogenic differentiation, they require micro-mass culture conditions. Conclusions: Overall, this study has demonstrated an increased chondrogenic potential within the CD90+ fraction of human and canine sfMPCs and that this population of cells derived from healthy normal joints do not require a micro-mass step for efficient chondrogenesis, while sfMPCs obtained from OA knee joints do not differentiate efficiently into chondrocytes without the micro-mass procedure. These results reveal a fundamental shift in the chondrogenic ability of cells isolated from arthritic joint fluids, and we speculate that the mechanism behind this change of cell behavior is exposure to the altered milieu of the OA joint fluid, which will be examined in further studies.	[Krawetz, Roman J.; Wu, Yiru Elizabeth; Hart, David A.] Univ Calgary, Dept Surg, Calgary, AB, Canada; [Krawetz, Roman J.; Rattner, Jerome B.] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB, Canada; [Martin, Liam] Univ Calgary, Dept Med, Calgary, AB, Canada; [Matyas, John R.] Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary	Krawetz, RJ (corresponding author), Univ Calgary, Dept Surg, Calgary, AB, Canada.	rkrawetz@ucalgary.ca		Wu, Elizabeth/0000-0002-0660-9306	Pfizer; Alberta Innovates-Health Solutions; Canadian Institutes for Health Research [MOP 79384]; Pfizer Inc.	Pfizer(Pfizer); Alberta Innovates-Health Solutions; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Pfizer Inc.(Pfizer)	This study was supported by research grants from Pfizer, Alberta Innovates-Health Solutions team grant in osteoarthritis, and Canadian Institutes for Health Research (MOP 79384). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interest: This study was partly funded by Pfizer Inc. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Ando W, 2007, BIOMATERIALS, V28, P5462, DOI 10.1016/j.biomaterials.2007.08.030; Ando W, 2008, TISSUE ENG PT A, V14, P2041, DOI 10.1089/ten.tea.2008.0015; Archer Charles W., 2003, Birth Defects Research, V69, P144, DOI 10.1002/bdrc.10015; Barker TH, 2009, BBA-MOL CELL RES, V1793, P921, DOI 10.1016/j.bbamcr.2008.10.004; Bradley EW, 2011, J CELL PHYSIOL, V226, P1683, DOI 10.1002/jcp.22499; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fan JB, 2009, TISSUE ENG PART B-RE, V15, P75, DOI 10.1089/ten.teb.2008.0586; Gao F, 2008, TRANSL RES, V151, P293, DOI 10.1016/j.trsl.2008.03.003; Gigout A, 2008, J BIOL CHEM, V283, P31522, DOI 10.1074/jbc.M804234200; Han HS, 2010, J ORTHOP RES, V28, P1283, DOI 10.1002/jor.21129; Heng B, 2008, CYTOTECHNOLOGY, V58, P69, DOI 10.1007/s10616-008-9174-8; Horie M, 2009, STEM CELLS, V27, P878, DOI 10.1634/stemcells.2008-0616; Hunziker EB, 1996, J BONE JOINT SURG AM, V78A, P721, DOI 10.2106/00004623-199605000-00012; Hunziker EB, 2001, OSTEOARTHR CARTILAGE, V9, P22, DOI 10.1053/joca.2000.0346; Jones E, 2010, ANN RHEUM DIS, V69, P450, DOI 10.1136/ard.2008.106435; Jones EA, 2008, ARTHRITIS RHEUM-US, V58, P1731, DOI 10.1002/art.23485; Kanamoto Takashi, 2008, Clin Calcium, V18, P1744, DOI CliCa081217441749; Koelling S, 2009, EXPERT OPIN BIOL TH, V9, P1399, DOI 10.1517/14712590903246370; Koga H, 2008, CELL TISSUE RES, V333, P207, DOI 10.1007/s00441-008-0633-5; Koga H, 2007, STEM CELLS, V25, P689, DOI 10.1634/stemcells.2006-0281; Koga H, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2460; Kurth TB, 2011, ARTHRITIS RHEUM-US, V63, P1289, DOI 10.1002/art.30234; Lim JJ, 2011, BIOTECHNOL BIOENG, V108, P151, DOI 10.1002/bit.22909; Lorda-Diez CI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024546; Luo WJ, 2008, EXP CELL RES, V314, P3382, DOI 10.1016/j.yexcr.2008.07.003; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; McGonagle D, 2008, RHEUMATOLOGY, V47, P1114, DOI 10.1093/rheumatology/ken236; Morito T, 2008, RHEUMATOLOGY, V47, P1137, DOI 10.1093/rheumatology/ken114; Nagase T, 2008, ARTHRITIS RHEUM, V58, P1389, DOI 10.1002/art.23418; Okura H, 2010, TISSUE ENG PART C-ME, V16, P761, DOI [10.1089/ten.tec.2009.0208, 10.1089/ten.TEC.2009.0208]; P Mafi, 2011, Open Orthop J, V5, P253, DOI 10.2174/1874325001105010253; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Wei CJ, 2006, J CELL PHYSIOL, V206, P322, DOI 10.1002/jcp.20459	34	46	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43616	10.1371/journal.pone.0043616	http://dx.doi.org/10.1371/journal.pone.0043616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952721	Green Submitted, gold, Green Published			2022-12-25	WOS:000308206000044
J	Schurgers, LJ; Joosen, IA; Laufer, EM; Chatrou, MLL; Herfs, M; Winkens, MHM; Westenfeld, R; Veulemans, V; Krueger, T; Shanahan, CM; Jahnen-Dechent, W; Biessen, E; Narula, J; Vermeer, C; Hofstra, L; Reutelingsperger, CP				Schurgers, Leon J.; Joosen, Ivo A.; Laufer, Eduard M.; Chatrou, Martijn L. L.; Herfs, Marjolein; Winkens, Mark H. M.; Westenfeld, Ralf; Veulemans, Verena; Krueger, Thilo; Shanahan, Catherine M.; Jahnen-Dechent, Willi; Biessen, Erik; Narula, Jagat; Vermeer, Cees; Hofstra, Leonard; Reutelingsperger, Chris P.			Vitamin K-Antagonists Accelerate Atherosclerotic Calcification and Induce a Vulnerable Plaque Phenotype	PLOS ONE			English	Article							MATRIX GLA-PROTEIN; SMOOTH-MUSCLE-CELLS; CORONARY-ARTERY CALCIUM; BONE MORPHOGENETIC PROTEINS; VASCULAR CALCIFICATION; INTIMAL CALCIFICATION; MYOCARDIAL-INFARCTION; PHOSPHATE CRYSTALS; ENDOTHELIAL-CELLS; PROGNOSTIC VALUE	Background: Vitamin K-antagonists (VKA) are treatment of choice and standard care for patients with venous thrombosis and thromboembolic risk. In experimental animal models as well as humans, VKA have been shown to promote medial elastocalcinosis. As vascular calcification is considered an independent risk factor for plaque instability, we here investigated the effect of VKA on coronary calcification in patients and on calcification of atherosclerotic plaques in the ApoE(-/-) model of atherosclerosis. Methodology/Principal Findings: A total of 266 patients (133 VKA users and 133 gender and Framingham Risk Score matched non-VKA users) underwent 64-slice MDCT to assess the degree of coronary artery disease (CAD). VKA-users developed significantly more calcified coronary plaques as compared to non-VKA users. ApoE(-/-) mice (10 weeks) received a Western type diet (WTD) for 12 weeks, after which mice were fed a WTD supplemented with vitamin K-1 (VK1, 1.5 mg/g) or vitamin K-1 and warfarin (VK1 & W; 1.5 mg/g & 3.0 mg/g) for 1 or 4 weeks, after which mice were sacrificed. Warfarin significantly increased frequency and extent of vascular calcification. Also, plaque calcification comprised microcalcification of the intimal layer. Furthermore, warfarin treatment decreased plaque expression of calcification regulatory protein carboxylated matrix Gla-protein, increased apoptosis and, surprisingly outward plaque remodeling, without affecting overall plaque burden. Conclusions/Significance: VKA use is associated with coronary artery plaque calcification in patients with suspected CAD and causes changes in plaque morphology with features of plaque vulnerability in ApoE(-/-) mice. Our findings underscore the need for alternative anticoagulants that do not interfere with the vitamin K cycle.	[Schurgers, Leon J.; Chatrou, Martijn L. L.; Reutelingsperger, Chris P.] Maastricht Univ, Med Ctr, Dept Biochem, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Joosen, Ivo A.; Laufer, Eduard M.; Winkens, Mark H. M.; Hofstra, Leonard] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Cardiol, Maastricht, Netherlands; [Herfs, Marjolein; Vermeer, Cees] Maastricht Univ, VitaK, Maastricht, Netherlands; [Westenfeld, Ralf; Veulemans, Verena] Univ Hosp Dusseldorf, Div Cardiol, Dusseldorf, Germany; [Krueger, Thilo] Rhein Westfal TH Aachen, Div Nephrol & Clin Immunol, Aachen, Germany; [Shanahan, Catherine M.] Kings Coll London, Div Cardiovasc, London, England; [Jahnen-Dechent, Willi] Rhein Westfal TH Aachen, Dept Biomed Engn, Aachen, Germany; [Biessen, Erik] Maastricht Univ, Med Ctr, Dept Pathol, Maastricht, Netherlands; [Narula, Jagat] Mt Sinai Sch Med, Dept Cardiol, New York, NY USA; [Hofstra, Leonard] Cardiol Ctr Netherlands, Utrecht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; RWTH Aachen University; University of London; King's College London; RWTH Aachen University; Maastricht University; Icahn School of Medicine at Mount Sinai	Schurgers, LJ (corresponding author), Maastricht Univ, Med Ctr, Dept Biochem, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands.	l.schurgers@maastrichtuniversity.nl	Schurgers, Leon/AAT-7100-2021; Jahnen-Dechent, Willi/A-7608-2011	Biessen, Erik/0000-0002-6454-8548; Shanahan, Catherine/0000-0002-8352-8171; Jahnen-Dechent, Willi/0000-0003-1315-4407; Schurgers, Leon/0000-0001-7867-6957; Vermeer, Cees/0000-0002-2300-8561	European Interreg program IVA-VLANED-2.1; British Heart Foundation [RG/11/14/29056] Funding Source: researchfish	European Interreg program IVA-VLANED-2.1; British Heart Foundation(British Heart Foundation)	European research grant as principal investigator from the European Interreg program IVA-VLANED-2.1 was granted to Dr. C. Reutelingsperger. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Amann K, 2008, CLIN J AM SOC NEPHRO, V3, P1599, DOI 10.2215/CJN.02120508; Borissoff JI, 2011, NEW ENGL J MED, V364, P1746, DOI 10.1056/NEJMra1011670; Bouvet C, 2008, ARTERIOSCL THROM VAS, V28, P856, DOI 10.1161/ATVBAHA.107.153056; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Chatrou MLL, 2011, HAMOSTASEOLOGIE, V31, P251, DOI 10.5482/ha-1157; Chatrou MLL, 2012, BLOOD REV, V26, P155, DOI 10.1016/j.blre.2012.03.002; Chen NX, 2010, KIDNEY INT, V77, P436, DOI 10.1038/ki.2009.481; Clarke MCH, 2008, CIRC RES, V102, P1529, DOI 10.1161/CIRCRESAHA.108.175976; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Csiszar A, 2005, CIRCULATION, V111, P2364, DOI 10.1161/01.CIR.0000164201.40634.1D; D'Andrea G, 2008, BLOOD REV, V22, P127, DOI 10.1016/j.blre.2007.11.004; Detrano R, 1996, J AM COLL CARDIOL, V27, P285, DOI 10.1016/0735-1097(95)00460-2; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Doherty TM, 2004, ENDOCR REV, V25, P629, DOI 10.1210/er.2003-0015; Dumont EAWJ, 2000, CIRCULATION, V102, P1564, DOI 10.1161/01.CIR.102.13.1564; Ehara S, 2004, CIRCULATION, V110, P3424, DOI 10.1161/01.CIR.0000148131.41425.E9; El-Maadawy S, 2003, CONNECT TISSUE RES, V44, P272, DOI 10.1080/03008200390181762; Essalihi R, 2003, AM J HYPERTENS, V16, P103, DOI 10.1016/S0895-7061(02)03204-1; Ewence AE, 2008, CIRC RES, V103, pE28, DOI 10.1161/CIRCRESAHA.108.181305; Fujii K, 2005, AM J CARDIOL, V96, P352, DOI 10.1016/j.amjcard.2005.03.074; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Huang H, 2001, CIRCULATION, V103, P1051, DOI 10.1161/01.CIR.103.8.1051; Kolodgie Frank D., 2001, Cardiology Clinics, V19, P127, DOI 10.1016/S0733-8651(05)70199-5; Koos R, 2005, AM J CARDIOL, V96, P747, DOI 10.1016/j.amjcard.2005.05.014; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Lutgens E, 1999, CIRCULATION, V99, P276, DOI 10.1161/01.CIR.99.2.276; McCollough CH, 2007, RADIOLOGY, V243, P527, DOI 10.1148/radiol.2432050808; Motoyama S, 2007, J AM COLL CARDIOL, V50, P319, DOI 10.1016/j.jacc.2007.03.044; Motoyama S, 2009, J AM COLL CARDIOL, V54, P49, DOI 10.1016/j.jacc.2009.02.068; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Nadra I, 2005, CIRC RES, V96, P1248, DOI 10.1161/01.RES.0000171451.88616.c2; Naik V, 2012, CARDIOVASC RES, V94, P545, DOI 10.1093/cvr/cvs126; Nakagawa Y, 2010, ARTERIOSCL THROM VAS, V30, P1908, DOI 10.1161/ATVBAHA.110.206185; O'Young J, 2011, J AM CHEM SOC, V133, P18406, DOI 10.1021/ja207628k; Price PA, 1998, ARTERIOSCL THROM VAS, V18, P1400, DOI 10.1161/01.ATV.18.9.1400; PRICE PA, 1985, J BIOL CHEM, V260, P4971; Proudfoot D, 2000, CIRC RES, V87, P1055, DOI 10.1161/01.RES.87.11.1055; Raggi P, 2004, J AM COLL CARDIOL, V43, P1663, DOI 10.1016/j.jacc.2003.09.068; Rennenberg RJMW, 2009, VASC HEALTH RISK MAN, V5, P185; Rennenberg RJMW, 2010, BLOOD, V115, P5121, DOI 10.1182/blood-2010-01-264598; Roijers RB, 2011, AM J PATHOL, V178, P2879, DOI 10.1016/j.ajpath.2011.02.004; Schurgers LJ, 2007, J THROMB HAEMOST, V5, P2503, DOI 10.1111/j.1538-7836.2007.02758.x; Schurgers LJ, 2008, THROMB HAEMOSTASIS, V100, P593, DOI 10.1160/TH08-02-0087; Schurgers LJ, 2007, BLOOD, V109, P2823, DOI 10.1182/blood-2006-07-035345; Schurgers LJ, 2004, BLOOD, V104, P3231, DOI 10.1182/blood-2004-04-1277; SHANAHAN CM, 1994, J CLIN INVEST, V93, P2393, DOI 10.1172/JCI117246; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Spronk HMH, 2003, J VASC RES, V40, P531, DOI 10.1159/000075344; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Vengrenyuk Y, 2006, P NATL ACAD SCI USA, V103, P14678, DOI 10.1073/pnas.0606310103; Weijs B, 2011, EUR HEART J, V32, P2555, DOI 10.1093/eurheartj/ehr226; Yao YC, 2006, J BIOL CHEM, V281, P33921, DOI 10.1074/jbc.M604239200; Yao YC, 2010, CIRC RES, V107, P485, DOI 10.1161/CIRCRESAHA.110.219071; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200	55	113	115	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43229	10.1371/journal.pone.0043229	http://dx.doi.org/10.1371/journal.pone.0043229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952653	Green Published, Green Submitted, gold			2022-12-25	WOS:000308206000027
J	Arora, R; del Alcazar, CM; Morrisey, EE; Naiche, LA; Papaioannou, VE				Arora, Ripla; del Alcazar, Chelsea M.; Morrisey, Edward E.; Naiche, L. A.; Papaioannou, Virginia E.			Candidate Gene Approach Identifies Multiple Genes and Signaling Pathways Downstream of Tbx4 in the Developing Allantois	PLOS ONE			English	Article							BETA-CATENIN GENE; EMBRYONIC LETHALITY; MURINE ALLANTOIS; MOUSE EMBRYOS; VASCULAR DEVELOPMENT; DEFECTS; VASCULOGENESIS; HYALURONAN; MESODERM; GROWTH	Loss of Tbx4 results in absence of chorio-allantoic fusion and failure of formation of the primary vascular plexus of the allantois leading to embryonic death at E10.5. We reviewed the literature for genes implicated in chorio-allantoic fusion, cavitation and vascular plexus formation, processes affected in Tbx4 mutant allantoises. Using this candidate gene approach, we identified a number of genes downstream of Tbx4 in the allantois including extracellular matrix molecules Vcan, Has2, and Itga5, transcription factors Snai1 and Twist, and signaling molecules Bmp2, Bmp7, Notch2, Jag1 and Wnt2. In addition, we show that the canonical Wnt signaling pathway contributes to the vessel-forming potential of the allantois. Ex vivo, the Tbx4 mutant phenotype can be rescued using agonists of the Wnt signaling pathway and, in wildtype allantoises, an inhibitor of the canonical Wnt signaling pathway disrupts vascular plexus formation. In vivo, Tbx4 and Wnt2 double heterozygous placentas show decreased vasculature suggesting interactions between Tbx4 and the canonical Wnt signaling pathway in the process of allantois-derived blood vessel formation.	[Arora, Ripla; del Alcazar, Chelsea M.; Papaioannou, Virginia E.] Columbia Univ, Dept Genet & Dev, Med Ctr, New York, NY 10027 USA; [Morrisey, Edward E.] Univ Penn, Dept Med & Cell & Dev Biol, Philadelphia, PA 19104 USA; [Naiche, L. A.] NCI, Canc & Dev Biol Lab, Frederick, MD 21701 USA	Columbia University; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Arora, R (corresponding author), Columbia Univ, Dept Genet & Dev, Med Ctr, New York, NY 10027 USA.	vep1@columbia.edu		Naiche, L. A./0000-0002-5031-4804; Papaioannou, Virginia/0000-0001-7558-8601	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R37HD033082]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD033082] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The project was supported by grant number R37HD033082 (V. E. P.) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NICHD or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2007, DEV BIOL, V301, P218, DOI 10.1016/j.ydbio.2006.08.018; Argraves WS, 2005, ANAT REC PART A, V286A, P875, DOI 10.1002/ar.a.20232; Brault V, 2001, DEVELOPMENT, V128, P1253; BROWN JJG, 1993, DEVELOPMENT, V117, P483; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Crosby CV, 2005, BLOOD, V105, P2771, DOI 10.1182/blood-2004-06-2244; DAVIS CA, 1993, METHOD ENZYMOL, V225, P502; Downs KM, 2000, ANAT EMBRYOL, V202, P323, DOI 10.1007/s004290000118; Downs KM, 1998, DEVELOPMENT, V125, P4507; Downs KM, 2004, DEVELOPMENT, V131, P37, DOI 10.1242/dev.00906; Downs KM, 2001, DEV BIOL, V233, P347, DOI 10.1006/dbio.2001.0227; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; FENDERSON BA, 1993, DIFFERENTIATION, V54, P85; Francis SE, 2002, ARTERIOSCL THROM VAS, V22, P927, DOI 10.1161/01.ATV.0000016045.93313.F2; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gebelein B, 2001, MOL CELL BIOL, V21, P928, DOI 10.1128/MCB.21.3.928-939.2001; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Ghosh TK, 2001, HUM MOL GENET, V10, P1983, DOI 10.1093/hmg/10.18.1983; Giros A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022002; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Hamada Y, 1999, DEVELOPMENT, V126, P3415; Hooghe B, 2008, NUCLEIC ACIDS RES, V36, pW128, DOI 10.1093/nar/gkn195; Inman KE, 2007, GENESIS, V45, P237, DOI 10.1002/dvg.20281; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Jungers KA, 2005, GENE EXPR PATTERNS, V5, P609, DOI 10.1016/j.modgep.2005.03.004; Karner CM, 2010, DEV DYNAM, V239, P2014, DOI 10.1002/dvdy.22340; Klein D, 2008, HEPATOLOGY, V47, P1018, DOI 10.1002/hep.22084; LEPTIN M, 1991, GENE DEV, V5, P1568, DOI 10.1101/gad.5.9.1568; Lomeli Hilda, 2009, BMC Res Notes, V2, P22, DOI 10.1186/1756-0500-2-22; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; Monkley SJ, 1996, DEVELOPMENT, V122, P3343; Naiche LA, 2011, DEV DYNAM, V240, P2290, DOI 10.1002/dvdy.22731; Naiche LA, 2003, DEVELOPMENT, V130, P2681, DOI 10.1242/dev.00504; Ouimette JF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1036; PAPAIOANNOU VE, 2008, INBORN ERRORS DEV MO, P852; Patan S, 2000, J NEURO-ONCOL, V50, P1, DOI 10.1023/A:1006493130855; Rao AS, 2005, EUR J ENDOCRINOL, V153, P929, DOI 10.1530/eje.1.02038; Scotti M, 2012, DEVELOPMENT, V139, P731, DOI 10.1242/dev.075408; Solloway MJ, 1999, DEVELOPMENT, V126, P1753; Wang H, 2007, J BIOL CHEM, V282, P782, DOI 10.1074/jbc.M606610200; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yamamura H, 1997, DEV BIOL, V186, P58, DOI 10.1006/dbio.1997.8559; Zhang HB, 1996, DEVELOPMENT, V122, P2977	46	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43581	10.1371/journal.pone.0043581	http://dx.doi.org/10.1371/journal.pone.0043581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952711	Green Submitted, gold, Green Published			2022-12-25	WOS:000308213600033
J	Hermanson, SB; Carlson, CB; Riddle, SM; Zhao, J; Vogel, KW; Nichols, RJ; Bi, K				Hermanson, Spencer B.; Carlson, Coby B.; Riddle, Steven M.; Zhao, Jing; Vogel, Kurt W.; Nichols, R. Jeremy; Bi, Kun			Screening for Novel LRRK2 Inhibitors Using a High-Throughput TR-FRET Cellular Assay for LRRK2 Ser935 Phosphorylation	PLOS ONE			English	Article							DISEASE-ASSOCIATED MUTATIONS; KINASE 2 LRRK2; PARKINSONS-DISEASE; 14-3-3 BINDING; GTP-BINDING; PROTEIN	Background: Mutations in the leucine-rich repeat kinase-2 (LRRK2) have been linked to Parkinson's disease. Recent studies show that inhibition of LRRK2 kinase activity decreased the level of phosphorylation at its own Ser910 and Ser935, indicating that these sites are prime targets for cellular readouts of LRRK2 inhibition. Methodology/Principal Findings: Using Time-Resolved Forster Resonance Energy Transfer (TR-FRET) technology, we developed a high-throughput cellular assay for monitoring LRRK2 phosphorylation at Ser935. LRRK2-Green Fluorescence Protein (GFP) fusions were expressed in cells via BacMam. Phosphorylation at Ser935 in these cells is detected using a terbium labeled anti-phospho-Ser935 antibody that generates a TR-FRET signal between terbium and GFP. LRRK2 wild-type and G2019S are constitutively phosphorylated at Ser935 in cells as measured by TR-FRET. The phosphorylation level is reduced for the R1441C mutant and little could be detected for the kinase-dead mutant D1994A. The TR-FRET cellular assay was further validated using reported LRRK2 inhibitors including LRRK2-IN-1 and our results confirmed that inhibition of LRRK2 can reduce the phosphorylation level at Ser935. To demonstrate the utility of this assay for screening, we profiled a small library of 1120 compounds. Three known LRRK2 inhibitors were identified and 16 hits were followed up in the TR-FRET and a cytotoxicity assay. Interestingly, out of the top 16 hits, five are known inhibitors of I kappa B phosphorylation, two CHK1 and two CDC25 inhibitors. Thirteen hits were further tested in a biochemical LRRK2 kinase activity assay and Western blot analysis for their effects on the phosphorylation of Ser910, Ser935, Ser955 and Ser973. Conclusions/Significance: We developed a TR-FRET cellular assay for LRRK2 Ser935 phosphorylation that can be applied to the screening for LRRK2 inhibitors. We report for the first time that several compounds such as IKK16, CHK1 inhibitors and GW441756 can inhibit LRRK2 Ser935 phosphorylation in cells and LRRK2 kinase activity in vitro.	[Hermanson, Spencer B.; Carlson, Coby B.; Riddle, Steven M.; Vogel, Kurt W.; Bi, Kun] Life Technol Corp, Primary & Stem Cell Syst, Madison, WI USA; [Zhao, Jing; Nichols, R. Jeremy] Parkinsons Inst, Sunnyvale, CA USA	Thermo Fisher Scientific	Hermanson, SB (corresponding author), Life Technol Corp, Primary & Stem Cell Syst, Madison, WI USA.	Kun.Bi@lifetech.com	Zhao, Jing/C-7359-2016	Zhao, Jing/0000-0002-8575-8181; Nichols, R Jeremy/0000-0002-5228-7571	Michael J. Fox Foundation for Parkinson's Research; Brin/Wojciki foundation	Michael J. Fox Foundation for Parkinson's Research; Brin/Wojciki foundation	Support for this work by R. Jeremy Nichols was from grants from the Michael J. Fox Foundation for Parkinson's Research and the benevolence of the Brin/Wojciki foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre-Abarrategui J, 2009, HUM MOL GENET, V18, P4022, DOI 10.1093/hmg/ddp346; Anand VS, 2009, FEBS J, V276, P466, DOI 10.1111/j.1742-4658.2008.06789.x; Azorsa DO, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-43; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Covy JP, 2009, BIOCHEM BIOPH RES CO, V378, P473, DOI 10.1016/j.bbrc.2008.11.048; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Doggett EA, 2012, J NEUROCHEM, V120, P37, DOI 10.1111/j.1471-4159.2011.07537.x; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Guo LX, 2007, EXP CELL RES, V313, P3658, DOI 10.1016/j.yexcr.2007.07.007; Han YS, 2004, J PHARMACOL EXP THER, V309, P64, DOI 10.1124/jpet.103.059477; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Kamikawaji S, 2009, BIOCHEMISTRY-US, V48, P10963, DOI 10.1021/bi9011379; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kett LR, 2012, HUM MOL GENET, V21, P890, DOI 10.1093/hmg/ddr526; Lebakken CS, 2009, J BIOMOL SCREEN, V14, P924, DOI 10.1177/1087057109339207; Lee BD, 2010, NAT MED, V16, P998, DOI 10.1038/nm.2199; Leung-Pineda V, 2006, MOL CELL BIOL, V26, P7529, DOI 10.1128/MCB.00447-06; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Li XT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017153; Looyenga BD, 2011, P NATL ACAD SCI USA, V108, P1439, DOI 10.1073/pnas.1012500108; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Nichols RJ, 2009, BIOCHEM J, V424, P47, DOI 10.1042/BJ20091035; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Ramsden N, 2011, ACS CHEM BIOL, V6, P1021, DOI 10.1021/cb2002413; Reichling LJ, 2009, BIOCHEM BIOPH RES CO, V384, P255, DOI 10.1016/j.bbrc.2009.04.098; Robers MB, 2008, ANAL BIOCHEM, V372, P189, DOI 10.1016/j.ab.2007.09.012; Saunders-Pullman R, 2010, MOVEMENT DISORD, V25, P2536, DOI 10.1002/mds.23314; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Swinney DC, 2002, J BIOL CHEM, V277, P23573, DOI 10.1074/jbc.M200842200; Webber PJ, 2011, J MOL BIOL, V412, P94, DOI 10.1016/j.jmb.2011.07.033; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Wood ER, 2004, BIOORG MED CHEM LETT, V14, P953, DOI 10.1016/j.bmcl.2003.12.002; Zhang JW, 2012, BIOORG MED CHEM LETT, V22, P1864, DOI 10.1016/j.bmcl.2012.01.084	38	32	34	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43580	10.1371/journal.pone.0043580	http://dx.doi.org/10.1371/journal.pone.0043580			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952710	Green Submitted, Green Published, gold			2022-12-25	WOS:000308213600032
J	Jing, YY; Han, ZP; Liu, Y; Sun, K; Zhang, SS; Jiang, GC; Li, R; Gao, L; Zhao, X; Wu, D; Cai, X; Wu, MC; Wei, LX				Jing, Yingying; Han, Zhipeng; Liu, Yan; Sun, Kai; Zhang, Shanshan; Jiang, Guocheng; Li, Rong; Gao, Lu; Zhao, Xue; Wu, Dong; Cai, Xiong; Wu, Mengchao; Wei, Lixin			Mesenchymal Stem Cells in Inflammation Microenvironment Accelerates Hepatocellular Carcinoma Metastasis by Inducing Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							T-LYMPHOCYTE PROLIFERATION; BONE-MARROW; STROMAL CELLS; TGF-BETA; EXPRESSION; CANCER; GROWTH; TRANSPLANTATION; PROGRESSION	In response to inflammation, mesenchymal stem cells (MSCs) are known to migrate to tissue injury sites to participate in immune modulation, tissue remodeling and wound healing. Tumors apply persistent mechanical and pathological stress to tissues and causes continual infiltration of MSCs. Here, we demonstrate that MSCs promote human hepatocellular carcinoma (HCC) metastasis under the influence of inflammation. The metastasis promoting effect could be imitated with the supernatant of MSCs pretreated with IFN gamma and TNF alpha. Interestingly, treatment of HCC cells with the supernatant leads to epithelial-mesenchymal transition (EMT), an effect related to the production of TGF beta by cytokines stimulated MSCs. Importantly, the levels of MSCs expressing SSEA4 in clinical HCC samples significantly correlated with poor prognosis of HCC, and EMT of HCC was strongly associated with a shorter cancer-free interval (CFI) and a worse overall survival (OS). Therefore, our results suggest that MSCs in tumor inflammatory microenvironment could promote tumor metastasis through TGF beta-induced EMT.	[Jing, Yingying; Han, Zhipeng; Liu, Yan; Sun, Kai; Zhang, Shanshan; Jiang, Guocheng; Li, Rong; Gao, Lu; Zhao, Xue; Wu, Mengchao; Wei, Lixin] Second Mil Med Univ, Tumor Immunol & Gene Therapy Ctr, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China; [Wu, Dong; Cai, Xiong] Second Mil Med Univ, Dept Combined Treatment, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Jing, YY (corresponding author), Second Mil Med Univ, Tumor Immunol & Gene Therapy Ctr, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China.	weilixin@yahoo.com		Wei, Lixin/0000-0002-9526-5348	National Natural Science Foundation of China [81030041, 30901722, 31171321, 81000970, 81101622]; Key Basic Research Project of China [2010CB945600, 2011CB966200]; Special Funds for National key Sci-Tech Special Project of China [2008ZX10002-019, 2008ZX10002-025]; Shanghai Science and Technology Committee [10ZR1439600, 11ZR1449500, 10411963100, 10ZR1439900]; NSFC, China [30921006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Basic Research Project of China; Special Funds for National key Sci-Tech Special Project of China; Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); NSFC, China(National Natural Science Foundation of China (NSFC))	This project was supported by Key project of National Natural Science Foundation of China (grant no: 81030041); Key Basic Research Project of China (grant no: 2010CB945600, 2011CB966200); National Natural Science Foundation of China (grant no: 30901722, 31171321, 81000970,81101622); Special Funds for National key Sci-Tech Special Project of China (grant no: 2008ZX10002-019, 2008ZX10002-025); Shanghai Science and Technology Committee (grant no: 10ZR1439600, 11ZR1449500, 10411963100, 10ZR1439900) and Science Fund for Creative Research Groups, NSFC, China (grant no: 30921006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Chen LL, 2010, J CLIN INVEST, V120, P1178, DOI 10.1172/JCI40665; Coffelt SB, 2009, P NATL ACAD SCI USA, V106, P3806, DOI 10.1073/pnas.0900244106; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Hall B., 2007, V180, P263; Hu M, 2008, EUR J CANCER, V44, P2760, DOI 10.1016/j.ejca.2008.09.038; Jin H, 2010, BIOMED RES-TOKYO, V31, P105, DOI 10.2220/biomedres.31.105; Kumar S, 2008, GENE THER, V15, P711, DOI 10.1038/gt.2008.35; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Li GC, 2010, CANCER SCI, V101, P2546, DOI 10.1111/j.1349-7006.2010.01738.x; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martin FT, 2010, BREAST CANCER RES TR, V124, P317, DOI 10.1007/s10549-010-0734-1; Moutsatsos IK, 2001, MOL THER, V3, P449, DOI 10.1006/mthe.2001.0291; Nasef A, 2007, GENE EXPRESSION, V13, P217; Niess H, 2011, ANN SURG, V254, P767, DOI 10.1097/SLA.0b013e3182368c4f; Noel Daniele, 2002, Curr Opin Investig Drugs, V3, P1000; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poon RTP, 2007, ANN SURG, V245, P51, DOI 10.1097/01.sla.0000225255.01668.65; Popp FC, 2009, LIVER TRANSPLANT, V15, P1192, DOI 10.1002/lt.21862; Povero D, 2010, HISTOL HISTOPATHOL, V25, P1075, DOI 10.14670/HH-25.1075; Quintavalla J, 2002, BIOMATERIALS, V23, P109, DOI 10.1016/S0142-9612(01)00086-2; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Roger L, 2010, J CELL SCI, V123, P1295, DOI 10.1242/jcs.061002; Sun T, 2010, HEPATOLOGY, V51, P545, DOI 10.1002/hep.23311; Wu F, 2009, HEPATOLOGY, V50, P1839, DOI 10.1002/hep.23197; Xu WT, 2009, CANCER LETT, V281, P32, DOI 10.1016/j.canlet.2009.02.022; Xu WR, 2004, EXP BIOL MED, V229, P623, DOI 10.1177/153537020422900706; Yang MH, 2009, HEPATOLOGY, V50, P1464, DOI 10.1002/hep.23221; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008	34	82	89	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43272	10.1371/journal.pone.0043272	http://dx.doi.org/10.1371/journal.pone.0043272			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952657	gold, Green Submitted, Green Published			2022-12-25	WOS:000308213600018
J	Bao, B; Ahmad, A; Kong, DJ; Ali, S; Azmi, AS; Li, YW; Banerjee, S; Padhye, S; Sarkar, FH				Bao, Bin; Ahmad, Aamir; Kong, Dejuan; Ali, Shadan; Azmi, Asfar S.; Li, Yiwei; Banerjee, Sanjeev; Padhye, Subhash; Sarkar, Fazlul H.			Hypoxia Induced Aggressiveness of Prostate Cancer Cells Is Linked with Deregulated Expression of VEGF, IL-6 and miRNAs That Are Attenuated by CDF	PLOS ONE			English	Article							PANCREATIC-CANCER; STEM-CELLS; TUMOR HYPOXIA; LUNG-CANCER; PROGNOSTIC-FACTOR; DRUG-RESISTANCE; BREAST-CANCER; ANALOG CDF; MICRORNAS; INTERLEUKIN-6	Tumor hypoxia with deregulated expression of hypoxia inducing factor (HIF) and its biological consequence leads to poor prognosis of patients diagnosed with solid tumors, resulting in higher mortality, suggesting that understanding of the molecular relationship of hypoxia with other cellular features of tumor aggressiveness would be invaluable for developing newer targeted therapy for solid tumors. emerging evidence also suggest that hypoxia and HIF signaling pathways contributes to the acquisition of epithelial-to-mesenchymal transition (EMT), maintenance of cancer stem cell (CSC) functions, and also maintains the vicious cycle of inflammation, all of which contribute to radiation therapy and chemotherapy resistance. however, the detailed mechanism by which hypoxia/HIF drive these events are not fully understood. Here, we have shown that hypoxia leads to increased expression of VEGF, IL-6, and CSC marker genes such as Nanog, OCt4 and EZH2, and also increased the expression of miR-21, an oncogenic miRNA, in prostate cancer (PCa) cells (PC-3 and LNCaP). The treatment of PCa cell with CDF, a novel Curcumin-derived synthetic analogue previously showed anti-tumor activity in vivo, inhibited the productions of VEGF and IL-6, and down-regulated the expression of Nanog, Oct4, EZH2 mrNAs, as well as miR-21 under hypoxic condition. Moreover, CDF treatment of PCa cells led to decreased cell migration under hypoxic condition. taken together, these result suggest that the anti-tumor effect of CDF is in part mediated through deregulation of tumor hypoxic pathways, and thus CDF could become useful for cancer therapy.	[Bao, Bin; Ahmad, Aamir; Kong, Dejuan; Azmi, Asfar S.; Li, Yiwei; Banerjee, Sanjeev; Sarkar, Fazlul H.] Wayne State Univ, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48202 USA; [Ali, Shadan; Sarkar, Fazlul H.] Wayne State Univ, Dept Oncol, Karmanos Canc Inst, Detroit, MI 48202 USA; [Padhye, Subhash] ISTRA, Dept Chem, MCE Soc Abeda Inamdar Senior Coll Arts Sci & Comm, Pune, Maharashtra, India	Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Bao, B (corresponding author), Wayne State Univ, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48202 USA.	fsarkar@med.wayne.edu	Ahmad, Aamir/E-8747-2010	Ahmad, Aamir/0000-0003-1784-5723; AZMI, ASFAR/0000-0003-1178-9505	Puschelberg and Guido Foundations; National Cancer Institute, National Institutes of Health grants [5R01CA131151, 5R01CA132794, 1R01CA154321]; Department of Defense Exploration-Hypothesis Development Award [PC101482]; NATIONAL CANCER INSTITUTE [R01CA132794, R01CA131151, R01CA154321] Funding Source: NIH RePORTER	Puschelberg and Guido Foundations; National Cancer Institute, National Institutes of Health grants; Department of Defense Exploration-Hypothesis Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Puschelberg and Guido Foundations for their generous financial contribution, Grant support from the National Cancer Institute, National Institutes of Health grants 5R01CA131151, 5R01CA132794 and 1R01CA154321 (FHS), and the Department of Defense Exploration-Hypothesis Development Award PC101482 (BB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2012, CANCER LETT, V319, P173, DOI 10.1016/j.canlet.2012.01.013; Ali S, 2010, CANCER RES, V70, P3606, DOI 10.1158/0008-5472.CAN-09-4598; Bao B, 2012, CANCER RES, V72, P335, DOI 10.1158/0008-5472.CAN-11-2182; Bao B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017850; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Cao P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-108; Chan SY, 2010, CELL CYCLE, V9, P1072, DOI 10.4161/cc.9.6.11006; Conze D, 2001, CANCER RES, V61, P8851; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; DeSano JT, 2009, AAPS J, V11, P682, DOI 10.1208/s12248-009-9147-7; Devlin C, 2011, IUBMB LIFE, V63, P94, DOI [10.1002/iub.00427, 10.1002/iub.427]; Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x; Favaro E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010345; Fisman EZ, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-62; Gee HE, 2010, CANCER-AM CANCER SOC, V116, P2148, DOI 10.1002/cncr.25009; Hebert C, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-5; Heddleston JM, 2010, BRIT J CANCER, V102, P789, DOI 10.1038/sj.bjc.6605551; Ho AS, 2010, TRANSL ONCOL, V3, P109, DOI 10.1593/tlo.09256; Hu SJ, 2010, CIRCULATION, V122, pS124, DOI 10.1161/CIRCULATIONAHA.109.928424; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Huang X, 2010, TRENDS MOL MED, V16, P230, DOI 10.1016/j.molmed.2010.03.004; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Jiang JA, 2011, CANCER BIOL THER, V11, P714, DOI 10.4161/cbt.11.8.15274; Jubb AM, 2010, J CELL MOL MED, V14, P18, DOI 10.1111/j.1582-4934.2009.00944.x; Kong Bo, 2009, World J Stem Cells, V1, P8, DOI 10.4252/wjsc.v1.i1.8; Kong D, 2008, CANCER RES, V68, P1927, DOI 10.1158/0008-5472.CAN-07-3241; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Kulshreshtha R, 2007, CELL CYCLE, V6, P1426; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; McCord AM, 2009, MOL CANCER RES, V7, P489, DOI 10.1158/1541-7786.MCR-08-0360; Michaud DS, 2006, CANCER RES, V66, P4525, DOI 10.1158/0008-5472.CAN-05-3987; Moriyama T, 2009, MOL CANCER THER, V8, P1067, DOI 10.1158/1535-7163.MCT-08-0592; MOULDER JE, 1987, CANCER METAST REV, V5, P313, DOI 10.1007/BF00055376; Nie Y, 2011, INT J BIOL SCI, V7, P762, DOI 10.7150/ijbs.7.762; Nilsson CL, 2010, J PROTEOME RES, V9, P430, DOI 10.1021/pr9007927; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; Padhye S, 2010, MINI-REV MED CHEM, V10, P372, DOI 10.2174/138955710791330891; Padhye S, 2009, PHARM RES-DORDR, V26, P2438, DOI 10.1007/s11095-009-9955-6; Pang YX, 2010, ACTA BIOCH BIOPH SIN, V42, P363, DOI 10.1093/abbs/gmq038; Perera RF, 2007, BIODRUGS, V21, P97, DOI 10.2165/00063030-200721020-00004; Pietras A, 2010, CURR TOP MICROBIOL, V345, P1, DOI 10.1007/82_2010_72; Pocock R, 2011, PFLUG ARCH EUR J PHY, V461, P307, DOI 10.1007/s00424-010-0910-5; Puissegur MP, 2011, CELL DEATH DIFFER, V18, P465, DOI 10.1038/cdd.2010.119; Quero L, 2011, RADIOTHER ONCOL; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Sarkar FH, 2009, MINERVA CHIR, V64, P489; Scheller J, 2006, MED MICROBIOL IMMUN, V195, P173, DOI 10.1007/s00430-006-0019-9; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Wang Z, 2007, CANCER RES, V67, P11377; Wertz K, 2009, NUTR CANCER, V61, P775, DOI 10.1080/01635580903285023; Yi H, 2012, KOREAN J PHYSIOL PHA, V16, P11, DOI 10.4196/kjpp.2012.16.1.11; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	57	89	90	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43726	10.1371/journal.pone.0043726	http://dx.doi.org/10.1371/journal.pone.0043726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952749	Green Published, gold, Green Submitted			2022-12-25	WOS:000308044800055
J	Hammett, TM; Jarlais, DCD; Kling, R; Kieu, BT; McNicholl, JM; Wasinrapee, P; McDougal, JS; Liu, W; Chen, Y; Meng, DH; Doan, N; Nguyen, TH; Hoang, QN; Hoang, TV				Hammett, Theodore M.; Jarlais, Don C. Des; Kling, Ryan; Binh Thanh Kieu; McNicholl, Janet M.; Wasinrapee, Punneeporn; McDougal, J. Stephen; Liu, Wei; Chen, Yi; Meng, Donghua; Ngu Doan; Tho Huu Nguyen; Quyen Ngoc Hoang; Tren Van Hoang			Controlling HIV Epidemics among Injection Drug Users: Eight Years of Cross-Border HIV Prevention Interventions in Vietnam and China	PLOS ONE			English	Article							CAPTURE ENZYME-IMMUNOASSAY; TYPE-1 INCIDENCE; HARM REDUCTION; PREVALENCE; INFECTION; PATTERNS; PROVINCE; LAW	Introduction: HIV in Vietnam and Southern China is driven by injection drug use. We have implemented HIV prevention interventions for IDUs since 2002-2003 in Lang Son and Ha Giang Provinces, Vietnam and Ning Ming County (Guangxi), China. Methods: Interventions provide peer education and needle/syringe distribution. Evaluation employed serial cross-sectional surveys of IDUs 26 waves from 2002 to 2011, including interviews and HIV testing. Outcomes were HIV risk behaviors, HIV prevalence and incidence. HIV incidence estimation used two methods: 1) among new injectors from prevalence data; and 2) a capture enzyme immunoassay (BED testing) on all HIV+ samples. Results: We found significant declines in drug-related risk behaviors and sharp reductions in HIV prevalence among IDUs (Lang Son from 46% to 23% [p<0.001], Ning Ming: from 17% to 11% [p=0.003], and Ha Giang: from 51% to 18% [p<0.001]), reductions not experienced in other provinces without such interventions. There were significant declines in HIV incidence to low levels among new injectors through 36-48 months, then some rebound, particularly in Ning Ming, but BED-based estimates revealed significant reductions in incidence through 96 months. Discussion: This is one of the longest studies of HIV prevention among IDUs in Asia. The rebound in incidence among new injectors may reflect sexual transmission. BED-based estimates may overstate incidence (because of false-recent results in patients with long-term infection or on ARV treatment) but adjustment for false-recent results and survey responses on duration of infection generally confirm BED-based incidence trends. Combined trends from the two estimation methods show sharp declines in incidence to low levels. The significant downward trends in all primary outcome measures indicate that the Cross-Border interventions played an important role in bringing HIV epidemics among IDUs under control. The Cross-Border project offers a model of HIV prevention for IDUs that should be considered for large-scale replication.	[Hammett, Theodore M.; Kling, Ryan] ABT Associates Inc, Cambridge, MA 02138 USA; [Jarlais, Don C. Des] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA; [Binh Thanh Kieu] ABT Associates Inc, Hanoi, Vietnam; [McNicholl, Janet M.] Ctr Dis Control & Prevent, DHAP, Branch Lab, Atlanta, GA USA; [Wasinrapee, Punneeporn] Thai Minist Publ Hlth US CDC Collaborat, Nonthaburi, Thailand; [McDougal, J. Stephen] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS STDs & TB Prevent, Atlanta, GA USA; [Liu, Wei; Chen, Yi] Guangxi Ctr Dis Control, Nanning, Peoples R China; [Meng, Donghua] Ning Ming Cty Hlth Dept, Ning Ming City, Guangxi, Peoples R China; [Ngu Doan] ABT Associates Inc, Ho Chi Minh City, Vietnam; [Tho Huu Nguyen] Lang Son Prov HIV AIDS Ctr, Lang Son City, Vietnam; [Quyen Ngoc Hoang; Tren Van Hoang] Ha Giang Prov Hlth Serv, Ha Giang City, Vietnam	ABT Associates; Harvard University; Beth Israel Deaconess Medical Center; ABT Associates; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; ABT Associates	Hammett, TM (corresponding author), ABT Associates Inc, Cambridge, MA 02138 USA.	ted_hammett@abtassoc.com			National Institute on Drug Abuse, U.S. National Institutes of Health: NIDA [1 R01 DA-14703]; Ford Foundation (Hanoi office); United Kingdom Department for International Development; World Bank; Global Fund to Fight AIDS, Tuberculosis, and Malaria; AusAID HAARP Cross-Border Program; Ford Foundation (Beijing office); NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014703] Funding Source: NIH RePORTER	National Institute on Drug Abuse, U.S. National Institutes of Health: NIDA; Ford Foundation (Hanoi office); United Kingdom Department for International Development; World Bank(The World Bank India); Global Fund to Fight AIDS, Tuberculosis, and Malaria(United States Agency for International Development (USAID)); AusAID HAARP Cross-Border Program; Ford Foundation (Beijing office); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by: National Institute on Drug Abuse, U.S. National Institutes of Health: NIDA grant no. 1 R01 DA-14703 (www.nida.nih.gov); Ford Foundation (Hanoi and Beijing offices) (www.fordfound.org); United Kingdom Department for International Development (www.dfid.gov.uk); World Bank (www.worldbank.org); Global Fund to Fight AIDS, Tuberculosis, and Malaria (www.theglobalfund.org); AusAID HAARP Cross-Border Program (www.haarp-online.org); Anonymous Donor, New York City (see comments). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt Associates Inc. Beth Israel Medical Center, 2010, CROSS BORD PROJ IMPL; [Anonymous], 2007, PREV HIV INF INJ DRU; Beyrer C, 2000, AIDS, V14, P75, DOI 10.1097/00002030-200001070-00009; Broadhead RS, 2009, J DRUG ISSUES, V39, P829, DOI 10.1177/002204260903900403; Brookmeyer R, 2009, AIDS, V23, P485, DOI 10.1097/QAD.0b013e3283269e28; Cameron AC, 2003, MICROECONOMETRICS ME; Cohen DA, 2000, AIDS PATIENT CARE ST, V14, P37, DOI 10.1089/108729100318118; Commision on AIDS in Asia, 2008, RED AIDS AS CRAFT EF; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Des Jarlais DC, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-89; Des Jarlais DC, 2000, AIDS, V14, pS41, DOI 10.1097/00002030-200006001-00006; Greene William H., 2012, ECONOMETRIC ANAL, Vseventh; Hallett TB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005720; Hammett TM, 2008, ADDICTION, V103, P137, DOI 10.1111/j.1360-0443.2007.02053.x; Hammett TM, 2010, AIDS CARE, V22, P1466, DOI 10.1080/09540121003758580; Hammett TM, 2006, AIDS EDUC PREV, V18, P97, DOI 10.1521/aeap.2006.18.2.97; Hammett TM, 2005, INT J DRUG POLICY, V16, P235, DOI 10.1016/j.drugpo.2005.05.009; Hammett TM, 2005, J URBAN HEALTH, V82, pIV34, DOI 10.1093/jurban/jti106; Hammett TM, 2005, JAIDS-J ACQ IMM DEF, V38, P228, DOI 10.1097/00126334-200502010-00016; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Havashida T, 2008, AIDS RES HUM RETROV, V24, P495; Human Rights Watch, 2010, HUMAN RIGHTS WATCH; Human Rights Watch, 2011, HUMAN RIGHTS WATCH; Jarlais DC, 2005, AM J PUBLIC HEALTH, V95, P1439, DOI 10.2105/AJPH.2003.036517; Jarlais DCD, 2007, AIDS, V21, pS109, DOI 10.1097/01.aids.0000304705.79541.34; Jia MH, 2010, JAIDS-J ACQ IMM DEF, V53, pS34, DOI 10.1097/QAI.0b013e3181c7d6ff; Karita E, 2007, AIDS, V21, P403, DOI 10.1097/QAD.0b013e32801481b7; Laeyendecker O, 2012, AIDS RES HUM RETROVI; Laeyendecker O, 2012, AIDS RES HUM RETROV, V28, P816, DOI [10.1089/aid.2011.0258, 10.1089/AID.2011.0258]; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Marinda ET, 2010, JAIDS-J ACQ IMM DEF, V53, P496, DOI 10.1097/QAI.0b013e3181b61938; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; McDougal JS, 2006, AIDS RES HUM RETROV, V22, P945, DOI 10.1089/aid.2006.22.945; McDougal JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014748; McDougal JS, 2005, AIDS, V19, pS25, DOI 10.1097/01.aids.0000172874.90133.7a; Ministry of Health People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2010, 2009 EST HIV AIDS EP; National Institute on Drug Abuse, 1994, OUTR RISK RED STRAT; Needle RH, 2005, INT J DRUG POLICY, V16, pS45, DOI 10.1016/j.drugpo.2005.02.009; Needle RH, 2003, EVIDENCE ACTION EFFE; Ngo AD, 2009, INT J DRUG POLICY, V20, P179, DOI 10.1016/j.drugpo.2007.12.009; Office of Global AIDS Coordinator, 2010, UPD HIV 1 INC EST SU; Parekh BS, 2011, AIDS RES HUM RETROV, V27, P265, DOI 10.1089/aid.2010.0159; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Quan VM, 2010, ADDICTION, V106, P583, DOI DOI 10.1111/J.1360-0443.2010.03175.X; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Semaan S, 2002, J ACQ IMMUN DEF SYND, V30, pS73, DOI 10.1097/01.QAI.0000017613.32101.90; Stimson G., 1998, DRUG INJECTING HIV I; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Sullivan SG, 2007, INT J DRUG POLICY, V18, P118, DOI 10.1016/j.drugpo.2006.11.014; Vietnam Administration for HIV/AIDS Control (Ministry of Health) and Family Health International, 2009, 2007 HIV AIDS EST PR; Wasinrapee P, 2004, 15 INT AIDS C BANGK; Weibel W, 1993, INDIGENOUS LEADER OU; Welte A, 2010, EURO SURVEILL, V15, p[pii, 19589]; Welte A, 2009, AIDS RES HUM RETROV, V25, P125, DOI 10.1089/aid.2008.0150; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; World Health Organization, 2009, ASS COMP TREATM PEOP; Wu ZY, 2007, AIDS, V21, pS115, DOI 10.1097/01.aids.0000304706.79541.ef; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8	58	34	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43141	10.1371/journal.pone.0043141	http://dx.doi.org/10.1371/journal.pone.0043141			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	995WH	22952640	Green Submitted, Green Published, gold			2022-12-25	WOS:000308044800021
J	Jin, XX; Abbot, S; Zhang, XK; Kang, L; Voskinarian-Berse, V; Zhao, R; Kameneva, MV; Moore, LR; Chalmers, JJ; Zborowski, M				Jin, Xiaoxia; Abbot, Stewart; Zhang, Xiaokui; Kang, Lin; Voskinarian-Berse, Vanessa; Zhao, Rui; Kameneva, Marina V.; Moore, Lee R.; Chalmers, Jeffrey J.; Zborowski, Maciej			Erythrocyte Enrichment in Hematopoietic Progenitor Cell Cultures Based on Magnetic Susceptibility of the Hemoglobin	PLOS ONE			English	Article							RED-BLOOD-CELLS; EX-VIVO; MAGNETOPHORETIC SEPARATION; TRACKING VELOCIMETRY; IN-VIVO	Using novel media formulations, it has been demonstrated that human placenta and umbilical cord blood-derived CD34+ cells can be expanded and differentiated into erythroid cells with high efficiency. However, obtaining mature and functional erythrocytes from the immature cell cultures with high purity and in an efficient manner remains a significant challenge. A distinguishing feature of a reticulocyte and maturing erythrocyte is the increasing concentration of hemoglobin and decreasing cell volume that results in increased cell magnetophoretic mobility (MM) when exposed to high magnetic fields and gradients, under anoxic conditions. Taking advantage of these initial observations, we studied a noninvasive (label-free) magnetic separation and analysis process to enrich and identify cultured functional erythrocytes. In addition to the magnetic cell separation and cell motion analysis in the magnetic field, the cell cultures were characterized for cell sedimentation rate, cell volume distributions using differential interference microscopy, immunophenotyping (glycophorin A), hemoglobin concentration and shear-induced deformability (elongation index, EI, by ektacytometry) to test for mature erythrocyte attributes. A commercial, packed column high-gradient magnetic separator (HGMS) was used for magnetic separation. The magnetically enriched fraction comprised 80% of the maturing cells (predominantly reticulocytes) that showed near 70% overlap of EI with the reference cord blood-derived RBC and over 50% overlap with the adult donor RBCs. The results demonstrate feasibility of label-free magnetic enrichment of erythrocyte fraction of CD34+ progenitor-derived cultures based on the presence of paramagnetic hemoglobin in the maturing erythrocytes.	[Jin, Xiaoxia; Moore, Lee R.; Zborowski, Maciej] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA; [Jin, Xiaoxia; Chalmers, Jeffrey J.] Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA; [Abbot, Stewart; Zhang, Xiaokui; Kang, Lin; Voskinarian-Berse, Vanessa] Celgene Cellular Therapeut, Warren, NJ USA; [Zhao, Rui; Kameneva, Marina V.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA	Cleveland Clinic Foundation; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jin, XX (corresponding author), Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA.	zborowm@ccf.org	Chalmers, Jeffrey J/D-2305-2009		Defence Advanced Research Agency (DARPA) [BAA07-21]; National Health Institutes (NIH) [CA062349]; National Science Foundation (NSF) [BES-0124897]; Defence Advanced Research Projects Agency (DARPA); NATIONAL CANCER INSTITUTE [R01CA062349] Funding Source: NIH RePORTER	Defence Advanced Research Agency (DARPA); National Health Institutes (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Defence Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by funding from Defence Advanced Research Agency (DARPA) Projects, BAA07-21 "Continuous RBC Production" to SA; the National Health Institutes (NIH), CA062349 to MZ; and the National Science Foundation (NSF), BES-0124897 to JJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JJC, LRM and MZ are co-authors of patents assigned to Cleveland Clinic and The Ohio State University, issued, licensed and pending that are related to certain aspects of equipment and methods developed for the purpose of this study. SA, XZ, LK and VV-B are employees of Celgene Cellular Therapeutics, Inc. (CCT) who collaborate and share materials with the rest of co-authors as supported by Defence Advanced Research Projects Agency (DARPA) funding (see Financial Disclosure). This does not alter the authors' adherence to all PLoS ONE policies on sharing data and materials.	Chalmers JJ, 1999, J MAGN MAGN MATER, V194, P231, DOI 10.1016/S0304-8853(98)00557-5; Delaney C, 2005, BLOOD, V106, P2693, DOI 10.1182/blood-2005-03-1131; Furlani EP, 2007, J PHYS D APPL PHYS, V40, P1313, DOI 10.1088/0022-3727/40/5/001; Gerlach JC, 2010, TISSUE ENG PART C-ME, V16, P115, DOI [10.1089/ten.tec.2008.0654, 10.1089/ten.TEC.2008.0654]; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Han KH, 2006, IEE P-NANOBIOTECHNOL, V153, P67, DOI 10.1049/ip-nbt:20050019; Han KH, 2004, J APPL PHYS, V96, P5797, DOI 10.1063/1.1803628; Jin X, 2008, ANALYST, V133, P1767, DOI 10.1039/b802113a; Jing Y, 2007, BIOTECHNOL BIOENG, V96, P1139, DOI 10.1002/bit.21202; Lee SS, 2007, ARTIF ORGANS, V31, P80, DOI 10.1111/j.1525-1594.2007.00344.x; Lichtman MA., 2006, WILLIAMS HEMATOLOGY, V7th, P1183; Magnani M, 2003, ERYTHROCYTE ENG DRUG; Nakamura M, 2001, EXP FLUIDS, V30, P371, DOI 10.1007/s003480000211; Neildez-Nguyen TMA, 2002, NAT BIOTECHNOL, V20, P467, DOI 10.1038/nbt0502-467; Pauling L, 1936, P NATL ACAD SCI USA, V22, P210, DOI 10.1073/pnas.22.4.210; Salmon ED, 2001, CURRENT PROTOCOLS CE; Shapiro HM, 2003, PRACTICAL FLOW CYTOM; Sullivan MT, 2007, TRANSFUSION, V47, P385, DOI 10.1111/j.1537-2995.2007.01128.x; TAKAYASU M, 1982, IEEE T MAGN, V18, P1520, DOI 10.1109/TMAG.1982.1062072; Takayasu M, 2000, IEEE T APPL SUPERCON, V10, P927, DOI 10.1109/77.828383; Zborowski M, 2003, BIOPHYS J, V84, P2638, DOI 10.1016/S0006-3495(03)75069-3	21	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e39491	10.1371/journal.pone.0039491	http://dx.doi.org/10.1371/journal.pone.0039491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952572	Green Published, gold, Green Accepted			2022-12-25	WOS:000308044800002
J	van Kampen, SC; Oskam, L; Tuijn, CJ; Klatser, PR				van Kampen, Sanne C.; Oskam, Linda; Tuijn, Coosje J.; Klatser, Paul R.			Survey of the Diagnostic Retooling Process in National TB Reference Laboratories, with Special Focus on Rapid Speciation Tests Endorsed by WHO in 2007	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS COMPLEX; CAPILIA TB; IDENTIFICATION; PERFORMANCE; CULTURE; ASSAY	Background: Successful integration of new diagnostics in national tuberculosis (TB) control programs, also called 'retooling', is highly dependent on operational aspects related to test availability, accessibility and affordability. This survey aimed to find out whether recommendations to use new diagnostics lead to successful retooling in high TB endemic countries, using immunochromatographic tests (ICTs) for TB culture speciation as a case study. ICTs are recommended to accurately confirm the presence of bacteria of the Mycobacterium tuberculosis complex in liquid culture isolates. Methods and Findings: Questionnaires were sent to national TB reference laboratories (NRLs) in 42 high TB endemic countries to address their access to information on ICT implementation, logistics related to availability, accessibility and affordability of ICTs, and testing algorithms. Results from 16 responding countries indicated that half of the NRLs were aware of the contents of WHO guidance documents on liquid culture and ICT implementation, as well as their eligibility for a negotiated pricing agreement for ICT procurement. No major issues with availability and accessibility of ICTs were raised. When asked about testing algorithms, ICTs were not used as stand-alone or first test for TB culture identification as recommended by WHO. Conclusions: The low response rate was a limitation of this survey and together with NRLs managers' unawareness of global guidance, suggests a lack of effective communication between partners of the global laboratory network and NRLs. TB tests could become more affordable to high TB endemic countries, if the possibility to negotiate lower prices for commercial products is communicated to them more successfully. NRLs need additional guidance to identify where available technologies can be most usefully implemented and in what order, taking into account long-term laboratory strategies.	[van Kampen, Sanne C.; Oskam, Linda; Tuijn, Coosje J.; Klatser, Paul R.] Royal Trop Inst Biomed Res, Royal Trop Inst, Amsterdam, Netherlands		van Kampen, SC (corresponding author), Royal Trop Inst Biomed Res, Royal Trop Inst, Amsterdam, Netherlands.	sanne.vankampen@gmail.com		van Kampen, Sanne/0000-0002-1519-5248; Klatser, Paul/0000-0003-3868-2409; Klatser, Paul/0000-0003-2127-9138	World Health Organization/TDR	World Health Organization/TDR(World Health Organization)	Funding for this work was provided by World Health Organization/TDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WORK PLAN 2010 2011; BD Diagnostic, 2009, DB MGIT TBC ID TEST; Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024; Fabre M, 2011, PATHOL BIOL, V59, P26, DOI 10.1016/j.patbio.2010.08.007; Foundation for Innovative New Diagnostics, 2009, FIND PRIC BACTEC MGI; Global Laboratory Initiative, 2012, GLI TB LAB NETW LAB; Global Laboratory Initiative, 2010, ROADM ENS QUAL TUB D; Muyoyeta M, 2010, J CLIN MICROBIOL, V48, P3773, DOI 10.1128/JCM.01688-09; Ngamlert K, 2009, TROP MED INT HEALTH, V14, P748, DOI 10.1111/j.1365-3156.2009.02284.x; Retooling Taskforce of the Stop TB Partnership, 2008, CHECKL KEY ACT US LI; Said HM, 2011, J CLIN MICROBIOL, V49, P1939, DOI 10.1128/JCM.01906-10; Scarparo C, 2001, J CLIN MICROBIOL, V39, P3222, DOI 10.1128/JCM.39.9.3222-3227.2001; SD BIO Standard Diagnostics India, 2011, TB AG MPT64 TB AB; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20; Tauns, 2011, M TUBERCULOSIS COMPL; TREAT TB, 2010, DIAGNOSTIC TOOLS INI; van Kampen SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011649; WHO, 2011, WHO GLOBAL TUBERCULO; World Health Organization, 2007, POL STAT US LIQ MED; World Health Organization, 2010, EXPAND TB EXP ACC AC; World Health Organization, 2007, WHO POL US LIQ MED C	22	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43439	10.1371/journal.pone.0043439	http://dx.doi.org/10.1371/journal.pone.0043439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937050	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500051
J	Brandalise, F; Gerber, U; Rossi, P				Brandalise, Federico; Gerber, Urs; Rossi, Paola			Golgi Cell-Mediated Activation of Postsynaptic GABA(B) Receptors Induces Disinhibition of the Golgi Cell-Granule Cell Synapse in Rat Cerebellum	PLOS ONE			English	Article							LONG-TERM POTENTIATION; INPUT STAGE; WHOLE-CELL; GABAERGIC INHIBITION; TONIC ACTIVATION; NMDA RECEPTORS; TRANSMISSION; CURRENTS; NEURONS; CORTEX	In the cerebellar glomerulus, GABAergic synapses formed by Golgi cells regulate excitatory transmission from mossy fibers to granule cells through feed-forward and feedback mechanisms. In acute cerebellar slices, we found that stimulating Golgi cell axons with a train of 10 impulses at 100 Hz transiently inhibited both the phasic and the tonic components of inhibitory responses recorded in granule cells. This effect was blocked by the GABA(B) receptor blocker CGP35348, and could be mimicked by bath-application of baclofen (30 mu M). This depression of IPSCs was prevented when granule cells were dialyzed with GDP beta S. Furthermore, when synaptic transmission was blocked, GABA(A) currents induced in granule cells by localized muscimol application were inhibited by the GABA(B) receptor agonist baclofen. These findings indicate that postsynaptic GABA(B) receptors are primarily responsible for the depression of IPSCs. This inhibition of inhibitory events results in an unexpected excitatory action by Golgi cells on granule cell targets. The reduction of Golgi cell-mediated inhibition in the cerebellar glomerulus may represent a regulatory mechanism to shift the balance between excitation and inhibition in the glomerulus during cerebellar information processing.	[Brandalise, Federico; Rossi, Paola] Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, I-27100 Pavia, Italy; [Brandalise, Federico; Gerber, Urs] Univ Zurich, Brain Res Inst, Zurich, Switzerland	University of Pavia; University of Zurich	Brandalise, F (corresponding author), Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, Via Palestro 3, I-27100 Pavia, Italy.	paola.rossi@unipv.it	Rossi, Paola/A-4083-2016	Rossi, Paola/0000-0002-1134-4111; BRANDALISE, FEDERICO/0000-0002-2033-5719	European Community; SENSOPAC (Sensorimotor structuring of Perception and Action (EU framework 6)) [FP6-IST028056]; CNISM (Consorzio Nazionale Interuniversitario per le Scienze Fisiche della Materia); MIUR (Ministero Istruzione Universita Ricerca) of Italy; FAR (Progetto di Ricerca Finalizzata)	European Community(European Commission); SENSOPAC (Sensorimotor structuring of Perception and Action (EU framework 6)); CNISM (Consorzio Nazionale Interuniversitario per le Scienze Fisiche della Materia); MIUR (Ministero Istruzione Universita Ricerca) of Italy(Ministry of Education, Universities and Research (MIUR)); FAR (Progetto di Ricerca Finalizzata)	This work was supported by the European Community, SENSOPAC (Sensorimotor structuring of Perception and Action (EU framework 6)) FP6-IST028056, by the CNISM (Consorzio Nazionale Interuniversitario per le Scienze Fisiche della Materia, which provided funding for the grant called NEUROIMAGE) grant, NEUROIMAGE, by MIUR (Ministero Istruzione Universita Ricerca, which provided funding for the grants) of Italy, PRIN (Progetti di Rilevante Interesse Nazionale) and FAR (Progetto di Ricerca Finalizzata) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramian AM, 2010, J BIOL CHEM, V285, P41795, DOI 10.1074/jbc.M110.149229; Bengtsson F, 2009, P NATL ACAD SCI USA, V106, P2389, DOI 10.1073/pnas.0808428106; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Brickley SG, 1999, J NEUROSCI, V19, P2960; Capogna M, 2011, TRENDS NEUROSCI, V34, P101, DOI 10.1016/j.tins.2010.10.005; Carta M, 2004, J NEUROSCI, V24, P3746, DOI 10.1523/JNEUROSCI.0067-04.2004; Castillo PE, 2011, CURR OPIN NEUROBIOL, V21, P328, DOI 10.1016/j.conb.2011.01.006; Cathala L, 2003, J NEUROSCI, V23, P6074, DOI 10.1523/JNEUROSCI.23-14-06074.2003; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Chang EH, 2003, J NEUROPHYSIOL, V90, P1479, DOI 10.1152/jn.00386.2003; CHEN QX, 1995, J PHYSIOL-LONDON, V482, P353, DOI 10.1113/jphysiol.1995.sp020522; D'Angelo E, 1999, J NEUROPHYSIOL, V81, P277, DOI 10.1152/jn.1999.81.1.277; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; DANGELO E, 1993, NEUROSCIENCE, V53, P121, DOI 10.1016/0306-4522(93)90290-V; Deisz RA, 1997, SYNAPSE, V25, P62, DOI 10.1002/(SICI)1098-2396(199701)25:1<62::AID-SYN8>3.0.CO;2-D; Eccles JC, 1967, CEREBELLUM NEURONAL; ECKSTEIN F, 1979, J BIOL CHEM, V254, P9829; EDGLEY SA, 1987, J PHYSIOL-LONDON, V392, P315, DOI 10.1113/jphysiol.1987.sp016782; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Gall D, 2005, J NEUROSCI, V25, P4813, DOI 10.1523/JNEUROSCI.0410-05.2005; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; Heine SA, 2010, J NEUROSCI, V30, P17004, DOI 10.1523/JNEUROSCI.3513-10.2010; Holtzman T, 2011, J PHYSIOL-LONDON, V589, P3837, DOI 10.1113/jphysiol.2011.207167; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Ige AO, 2000, MOL BRAIN RES, V83, P72, DOI 10.1016/S0169-328X(00)00199-6; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; KANEDA M, 1995, J PHYSIOL-LONDON, V485, P419, DOI 10.1113/jphysiol.1995.sp020739; Kia A, 2011, J NEUROCHEM, V116, P1043, DOI 10.1111/j.1471-4159.2010.07156.x; Komatsu Y, 1996, J NEUROSCI, V16, P6342; KOMATSU Y, 1993, NEUROREPORT, V4, P907, DOI 10.1097/00001756-199307000-00017; Kotak VC, 2001, J NEUROPHYSIOL, V86, P536, DOI 10.1152/jn.2001.86.1.536; Kulik A, 2002, EUR J NEUROSCI, V15, P291, DOI 10.1046/j.0953-816x.2001.01855.x; Lei SB, 2003, J PHYSIOL-LONDON, V546, P439, DOI 10.1113/jphysiol.2002.034017; Liang FY, 2000, J COMP NEUROL, V416, P475, DOI 10.1002/(SICI)1096-9861(20000124)416:4<475::AID-CNE5>3.0.CO;2-V; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Maffei A, 2002, J NEUROPHYSIOL, V88, P627, DOI 10.1152/jn.2002.88.2.627; Mapelli J, 2007, J NEUROSCI, V27, P1285, DOI 10.1523/JNEUROSCI.4873-06.2007; Mapelli J, 2010, J NEUROPHYSIOL, V103, P250, DOI 10.1152/jn.00642.2009; Mapelli L, 2009, J NEUROPHYSIOL, V101, P3089, DOI 10.1152/jn.91190.2008; MISGELD U, 1995, PROG NEUROBIOL, V46, P423, DOI 10.1016/0301-0082(95)00012-K; MORISHITA W, 1995, NEUROSCIENCE, V68, P1127, DOI 10.1016/0306-4522(95)00206-X; Patenaude C, 2003, J PHYSIOL-LONDON, V553, P155, DOI 10.1113/jphysiol.2003.049015; Rancz EA, 2007, NATURE, V450, P1245, DOI 10.1038/nature05995; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; Rossi DJ, 2003, J PHYSIOL-LONDON, V548, P97, DOI 10.1113/jphysiol.2002.036459; Rossi P, 2006, EUR J NEUROSCI, V24, P419, DOI 10.1111/j.1460-9568.2006.04914.x; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; STELZER A, 1987, NATURE, V326, P698, DOI 10.1038/326698a0; Tia S, 1996, NEUROPHARMACOLOGY, V35, P1375, DOI 10.1016/S0028-3908(96)00018-4; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; Vos BP, 1999, EUR J NEUROSCI, V11, P2621, DOI 10.1046/j.1460-9568.1999.00678.x; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; Yamada K, 1999, J NEUROPHYSIOL, V81, P2875, DOI 10.1152/jn.1999.81.6.2875	54	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43417	10.1371/journal.pone.0043417	http://dx.doi.org/10.1371/journal.pone.0043417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937048	gold, Green Published, Green Submitted			2022-12-25	WOS:000308286300050
J	Balasuriya, D; Stewart, AP; Crottes, D; Borgese, F; Soriani, O; Edwardson, JM				Balasuriya, Dilshan; Stewart, Andrew P.; Crottes, David; Borgese, Franck; Soriani, Olivier; Edwardson, J. Michael			The Sigma-1 Receptor Binds to the Nav1.5 Voltage-gated Na+ Channel with 4-Fold Symmetry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; METHYL-D-ASPARTATE; CANCER CELL-LINES; POTASSIUM CHANNELS; LIPID RAFTS; CORTICAL-NEURONS; SODIUM-CHANNELS; IN-VITRO; MODULATION; EXPRESSION	The sigma-1 receptor (Sig1R) is up-regulated in many human tumors and plays a role in the control of cancer cell proliferation and invasiveness. At the molecular level, the Sig1R modulates the activity of various ion channels, apparently through a direct interaction. We have previously shown using atomic force microscopy imaging that the Sig1R binds to the trimeric acid-sensing ion channel 1A with 3-fold symmetry. Here, we investigated the interaction between the Sig1R and the Nav1.5 voltage-gated Na+ channel, which has also been implicated in promoting the invasiveness of cancer cells. We show that the Sig1R and Nav1.5 can be co-isolated from co-transfected cells, consistent with an intimate association between the two proteins. Atomic force microscopy imaging of the co-isolated proteins revealed complexes in which Nav1.5 was decorated by Sig1Rs. Frequency distributions of angles between pairs of bound Sig1Rs had two peaks, at similar to 90 degrees and similar to 180 degrees, and the 90 degrees peak was about twice the size of the 180 peak. These results demonstrate that the Sig1R binds to Nav1.5 with 4-fold symmetry. Hence, each set of six transmembrane regions in Nav1.5 likely constitutes a Sig1R binding site, suggesting that the Sig1R interacts with the transmembrane regions of its partners. Interestingly, two known Sig1R ligands, haloperidol and (+)-pentazocine, disrupted the Nav1.5/Sig1R interaction both in vitro and in living cells. Finally, we show that endogenously expressed Sig1R and Nav1.5 also functionally interact.	[Balasuriya, Dilshan; Stewart, Andrew P.; Edwardson, J. Michael] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Crottes, David; Borgese, Franck; Soriani, Olivier] Univ Nice Sophia Antipolis, Inst Biol Valrose, CNRS UMR 7277, Fac Sci,INSERM UNS U1091, F-06108 Nice 2, France	University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Edwardson, JM (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	jme1000@cam.ac.uk		soriani, olivier/0000-0001-9485-3992; BORGESE, Franck/0000-0001-7718-2111	Jean Shanks Foundation; University of Cambridge; Centre National de la Recherche Scientifique (CNRS); Region Provence Alpes Cote d'Azur Fellowship; University of Nice Sophia Antipolis; CNRS; Association Ti'Toine Normandie; Wellcome Trust	Jean Shanks Foundation; University of Cambridge(University of Cambridge); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Region Provence Alpes Cote d'Azur Fellowship(Region Provence-Alpes-Cote d'Azur); University of Nice Sophia Antipolis; CNRS(Centre National de la Recherche Scientifique (CNRS)); Association Ti'Toine Normandie; Wellcome Trust(Wellcome Trust)	This work was supported by the Jean Shanks Foundation and the James Baird Fund of the University of Cambridge (to A. P. S.), a Centre National de la Recherche Scientifique (CNRS) and Region Provence Alpes Cote d'Azur Fellowship (to D. C.), the University of Nice Sophia Antipolis, the CNRS, and the Association Ti'Toine Normandie (to O. S.), and the Wellcome Trust (to J. M. E.).	Albagli-Curiel O, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-85; Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Aydar E, 2006, CANCER LETT, V242, P245, DOI 10.1016/j.canlet.2005.11.011; Brisson L, 2011, ONCOGENE, V30, P2070, DOI 10.1038/onc.2010.574; Carnally SM, 2008, BIOCHEM BIOPH RES CO, V372, P752, DOI 10.1016/j.bbrc.2008.05.100; Carnally SM, 2010, BIOPHYS J, V98, P1182, DOI 10.1016/j.bpj.2009.12.4293; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chioni AM, 2009, INT J BIOCHEM CELL B, V41, P1216, DOI 10.1016/j.biocel.2008.11.001; Crottes D, 2011, J BIOL CHEM, V286, P27947, DOI 10.1074/jbc.M111.226738; Eshcol JO, 2008, AM J PHYSIOL-CELL PH, V295, pC732, DOI 10.1152/ajpcell.00514.2007; Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127; Gillet L, 2009, J BIOL CHEM, V284, P8671, DOI 10.1074/jbc.M806891200; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; HAYASHI T, 1995, J PHARMACOL EXP THER, V275, P207; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Herrera Y, 2008, J PHARMACOL EXP THER, V327, P491, DOI 10.1124/jpet.108.143974; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Johannessen M, 2011, AM J PHYSIOL-CELL PH, V300, pC328, DOI 10.1152/ajpcell.00383.2010; Johannessen M, 2009, AM J PHYSIOL-CELL PH, V296, pC1049, DOI 10.1152/ajpcell.00431.2008; KENNEDY C, 1990, NEUROSCIENCE, V35, P725, DOI 10.1016/0306-4522(90)90343-3; Kinoshita M, 2012, BRAIN RES, V1452, P1, DOI 10.1016/j.brainres.2012.02.070; Kume T, 2002, EUR J PHARMACOL, V455, P91, DOI 10.1016/S0014-2999(02)02582-7; Lupardus PJ, 2000, J PHYSIOL-LONDON, V526, P527, DOI 10.1111/j.1469-7793.2000.00527.x; LYSKO PG, 1992, STROKE, V23, P414, DOI 10.1161/01.STR.23.3.414; Monnet FP, 2005, BIOL CELL, V97, P873; Monnet FP, 2003, J PHARMACOL EXP THER, V307, P705, DOI 10.1124/jpet.103.053447; MONNET FP, 1990, EUR J PHARMACOL, V179, P441, DOI 10.1016/0014-2999(90)90186-A; Neaves KJ, 2009, NUCLEIC ACIDS RES, V37, P2053, DOI 10.1093/nar/gkp042; Pal A, 2007, MOL PHARMACOL, V72, P921, DOI 10.1124/mol.107.038307; Pal A, 2008, J BIOL CHEM, V283, P19646, DOI 10.1074/jbc.M802192200; Palmer CP, 2007, CANCER RES, V67, P11166, DOI 10.1158/0008-5472.CAN-07-1771; Renaudo A, 2007, J BIOL CHEM, V282, P2259, DOI 10.1074/jbc.M607915200; Roger S, 2003, BBA-BIOMEMBRANES, V1616, P107, DOI 10.1016/j.bbamem.2003.07.001; Schneider SW, 1998, PFLUG ARCH EUR J PHY, V435, P362, DOI 10.1007/s004240050524; SCOTT DW, 1979, BIOMETRIKA, V66, P605, DOI 10.1093/biomet/66.3.605; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Spruce BA, 2004, CANCER RES, V64, P4875, DOI 10.1158/0008-5472.CAN-03-3180; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Wilke RA, 1999, J BIOL CHEM, V274, P18387, DOI 10.1074/jbc.274.26.18387; Wong W, 2004, J BIOL CHEM, V279, P444, DOI 10.1074/jbc.M304675200; Zhang HL, 2005, J PHARMACOL EXP THER, V313, P1387, DOI 10.1124/jpet.105.084152; Zhang HL, 2002, J NEUROPHYSIOL, V87, P2867, DOI 10.1152/jn.2002.87.6.2867	43	54	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37021	37029		10.1074/jbc.M112.382077	http://dx.doi.org/10.1074/jbc.M112.382077			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22952230	Green Published, hybrid			2022-12-25	WOS:000310588500037
J	Castilho, A; Neumann, L; Daskalova, S; Mason, HS; Steinkellner, H; Altmann, F; Strasser, R				Castilho, Alexandra; Neumann, Laura; Daskalova, Sasha; Mason, Hugh S.; Steinkellner, Herta; Altmann, Friedrich; Strasser, Richard			Engineering of Sialylated Mucin-type O-Glycosylation in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; HAMSTER OVARY CELLS; N-GLYCOSYLATION; NICOTIANA-BENTHAMIANA; ENHANCED SIALYLATION; BIOLOGICAL-ACTIVITY; IN-VITRO; EXPRESSION; BIOSYNTHESIS; CARBOHYDRATE	Proper N- and O-glycosylation of recombinant proteins is important for their biological function. Although the N-glycan processing pathway of different expression hosts has been successfully modified in the past, comparatively little attention has been paid to the generation of customized O-linked glycans. Plants are attractive hosts for engineering of O-glycosylation steps, as they contain no endogenous glycosyltransferases that perform mammalian-type Ser/Thr glycosylation and could interfere with the production of defined O-glycans. Here, we produced mucin-type O-GalNAc and core 1 O-linked glycan structures on recombinant human erythropoietin fused to an IgG heavy chain fragment (EPO-Fc) by transient expression in Nicotiana benthamiana plants. Furthermore, for the generation of sialylated core 1 structures constructs encoding human polypeptide: N-acetylgalactosaminyltransferase 2, Drosophila melanogaster core 1 beta 1,3-galactosyltransferase, human alpha 2,3-sialyltransferase, and Mus musculus alpha 2,6-sialyltransferase were transiently co-expressed in N. benthamiana together with EPO-Fc and the machinery for sialylation of N-glycans. The formation of significant amounts of mono-and disialylated O-linked glycans was confirmed by liquid chromatography-electrospray ionization-mass spectrometry. Analysis of the three EPO glycopeptides carrying N-glycans revealed the presence of biantennary structures with terminal sialic acid residues. Our data demonstrate that N. benthamiana plants are amenable to engineering of the O-glycosylation pathway and can produce well defined human-type O- and N-linked glycans on recombinant therapeutics.	[Castilho, Alexandra; Steinkellner, Herta; Strasser, Richard] Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, A-1190 Vienna, Austria; [Neumann, Laura; Altmann, Friedrich] Univ Nat Resources & Life Sci, Dept Chem, A-1190 Vienna, Austria; [Daskalova, Sasha; Mason, Hugh S.] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; [Daskalova, Sasha; Mason, Hugh S.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Strasser, R (corresponding author), Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Muthgasse 18, A-1190 Vienna, Austria.	richard.strasser@boku.ac.at	Strasser, Richard/AAD-2916-2020; Steinkellner, Herta/N-4267-2016; Castilho, Alexandra/AAC-8927-2020	Steinkellner, Herta/0000-0003-4823-1505; Castilho, Alexandra/0000-0003-4114-7861; Altmann, Friedrich/0000-0002-0112-7877; Strasser, Richard/0000-0001-8764-6530	Federal Ministry of Transport, Innovation, and Technology (bmvit); Austrian Science Fund (FWF) TRP [242-B20]; PhD program "BioToP-Biomolecular Technology of Proteins" from the Austrian Science Fund (FWF) Project [W1224-B09]; Austrian Research Promotion Agency (FFG) Laura Bassi Centres of Expertise project [822757]; Austrian Science Fund (FWF) [TRP 242, L 575] Funding Source: researchfish	Federal Ministry of Transport, Innovation, and Technology (bmvit); Austrian Science Fund (FWF) TRP(Austrian Science Fund (FWF)); PhD program "BioToP-Biomolecular Technology of Proteins" from the Austrian Science Fund (FWF) Project(Austrian Science Fund (FWF)); Austrian Research Promotion Agency (FFG) Laura Bassi Centres of Expertise project; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by a grant (to R. S.) from the Federal Ministry of Transport, Innovation, and Technology (bmvit) and Austrian Science Fund (FWF) TRP 242-B20 (to R. S.), by the PhD program "BioToP-Biomolecular Technology of Proteins" from the Austrian Science Fund (FWF) Project W1224-B09 (to L. N.), and by a grant from the Austrian Research Promotion Agency (FFG) Laura Bassi Centres of Expertise project 822757 (to H. S.).	Amano K, 2008, P NATL ACAD SCI USA, V105, P3232, DOI 10.1073/pnas.0710412105; Badirou I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037508; Bork K, 2007, FEBS LETT, V581, P4195, DOI 10.1016/j.febslet.2007.07.060; Castilho A, 2008, PLANT PHYSIOL, V147, P331, DOI 10.1104/pp.108.117572; Castilho A, 2011, GLYCOBIOLOGY, V21, P813, DOI 10.1093/glycob/cwr009; Castilho A, 2010, J BIOL CHEM, V285, P15923, DOI 10.1074/jbc.M109.088401; Chung SM, 2005, TRENDS PLANT SCI, V10, P357, DOI 10.1016/j.tplants.2005.06.001; Daskalova SM, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-62; DELORME E, 1992, BIOCHEMISTRY-US, V31, P9871, DOI 10.1021/bi00156a003; DUBE S, 1988, J BIOL CHEM, V263, P17516; Egrie JC, 2003, EXP HEMATOL, V31, P290, DOI 10.1016/S0301-472X(03)00006-7; Elliott S, 2004, EXP HEMATOL, V32, P1146, DOI 10.1016/j.exphem.2004.08.004; FUKUDA MN, 1989, BLOOD, V73, P84; Ghaderi D, 2012, BIOTECHNOL GENET ENG, V28, P147, DOI 10.5661/bger-28-147; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256; Harrison RL, 2006, ADV VIRUS RES, V68, P159, DOI 10.1016/S0065-3527(06)68005-6; HOKKE CH, 1995, EUR J BIOCHEM, V228, P981, DOI 10.1111/j.1432-1033.1995.tb20350.x; Jacobs PP, 2009, NAT PROTOC, V4, P58, DOI 10.1038/nprot.2008.213; Jefferis R, 2012, ARCH BIOCHEM BIOPHYS, V526, P159, DOI 10.1016/j.abb.2012.03.021; Ju TZ, 2011, ANGEW CHEM INT EDIT, V50, P1770, DOI 10.1002/anie.201002313; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Karnoup AS, 2005, GLYCOBIOLOGY, V15, P965, DOI 10.1093/glycob/cwi077; KODAMA S, 1993, EUR J BIOCHEM, V211, P903, DOI 10.1111/j.1432-1033.1993.tb17624.x; Kolarich D, 2012, NAT PROTOC, V7, P1285, DOI 10.1038/nprot.2012.062; Leonard R, 2005, J BIOL CHEM, V280, P7932, DOI 10.1074/jbc.M410407200; Loos A, 2012, ARCH BIOCHEM BIOPHYS, V526, P167, DOI 10.1016/j.abb.2012.05.011; Marillonnet S, 2005, NAT BIOTECHNOL, V23, P718, DOI 10.1038/nbt1094; Mattu TS, 1998, J BIOL CHEM, V273, P2260, DOI 10.1074/jbc.273.4.2260; Maxmen A, 2012, NATURE, V485, P160, DOI 10.1038/485160a; Moriguchi R, 2011, BIOSCI BIOTECH BIOCH, V75, P994, DOI 10.1271/bbb.100884; Nagels B, 2012, J BIOTECHNOL, V160, P242, DOI 10.1016/j.jbiotec.2012.03.003; Pinkhasov J, 2011, PLANT BIOTECHNOL J, V9, P991, DOI 10.1111/j.1467-7652.2011.00614.x; SASAKI H, 1987, J BIOL CHEM, V262, P12059; Son YD, 2011, GLYCOBIOLOGY, V21, P1019, DOI 10.1093/glycob/cwr034; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/NMETH.1731, 10.1038/nmeth.1731]; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Strasser R, 2007, PLANT PHYSIOL, V145, P5, DOI 10.1104/pp.107.101162; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Taschwer M, 2012, J BIOTECHNOL, V157, P295, DOI 10.1016/j.jbiotec.2011.11.014; TSUDA E, 1990, EUR J BIOCHEM, V188, P405, DOI 10.1111/j.1432-1033.1990.tb15417.x; VANDIJK W, 1983, BIOCHEM J, V214, P1003, DOI 10.1042/bj2141003; Velasquez SM, 2011, SCIENCE, V332, P1401, DOI 10.1126/science.1206657; WASLEY LC, 1991, BLOOD, V77, P2624; Weise A, 2007, PLANT BIOTECHNOL J, V5, P389, DOI 10.1111/j.1467-7652.2007.00248.x; Yang Z, 2012, PLANT PHYSIOL, V160, P450, DOI 10.1104/pp.112.198200; Yang Z, 2012, J BIOL CHEM, V287, P11911, DOI 10.1074/jbc.M111.312918; Zeleny R, 2006, PLANTA, V224, P222, DOI 10.1007/s00425-005-0206-8; Zimran A, 2011, BLOOD, V118, P5767, DOI 10.1182/blood-2011-07-366955	50	64	69	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36518	36526		10.1074/jbc.M112.402685	http://dx.doi.org/10.1074/jbc.M112.402685			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948156	Green Published, hybrid			2022-12-25	WOS:000310364000071
J	Ramani, K; Tomasi, ML; Yang, HP; Ko, K; Lu, SC				Ramani, Komal; Tomasi, Maria Lauda; Yang, Heping; Ko, Kwangsuk; Lu, Shelly C.			Mechanism and Significance of Changes in Glutamate-Cysteine Ligase Expression during Hepatic Fibrogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT RESPONSE ELEMENT; ACTIVATED RECEPTOR-GAMMA; TRANSCRIPTIONAL REGULATION; COORDINATED ACTIVATION; SYNTHETIC ENZYMES; GLUTATHIONE; NRF2; PROTEINS; SUMOYLATION; INDUCTION	GSH is synthesized sequentially by glutamate-cysteine ligase (GCL) and GSH synthase and defends against oxidative stress, which promotes hepatic stellate cell (HSC) activation. Changes in GSH synthesis during HSC activation are poorly characterized. Here, we examined the expression of GSH synthetic enzymes in rat HSC activation and reversion to quiescence. Expression of the GCL catalytic subunit (GCLC) fell during HSC activation and increased when activated HSCs revert back to quiescence. Blocking the increase in GCLC expression kept HSCs in an activated state. Activated HSCs have higher nuclear levels and binding activity of MafG to the antioxidant response element (ARE) of GCLC but lower Nrf2/MafG heterodimer binding to the ARE. Quiescent HSCs have a lower nuclear MafG level but higher Nrf2/MafG heterodimer binding to ARE. This occurred because of enhanced sumoylation of Nrf2 and MafG by SUMO-1, which promoted Nrf2 binding to ARE and heterodimerization with MafG. In vivo, knockdown of GCLC exacerbated bile duct ligation-induced liver injury and fibrosis. Ursodeoxycholic acid and S-adenosylmethionine are anti-fibrotic in bile duct ligation, but this effect was nearly lost if GCLC induction was blocked. In conclusion, sumoylation of Nrf2 and MafG enhances heterodimerization and increases GCLC expression, which keeps HSCs in a quiescent state. Antifibrotic agents require activation of GCLC to fully exert their protective effect.	[Ramani, Komal; Tomasi, Maria Lauda; Yang, Heping; Ko, Kwangsuk; Lu, Shelly C.] Univ So Calif, Div Gastroenterol & Liver Dis, USC Res Ctr Liver Dis,Kech Sch Med, So Calif Res Ctr Alcohol & Pancreat Dis & Cirrhos, Los Angeles, CA 90033 USA	University of Southern California	Lu, SC (corresponding author), Univ So Calif, Div Gastroenterol & Liver Dis, USC Res Ctr Liver Dis,Kech Sch Med, So Calif Res Ctr Alcohol & Pancreat Dis & Cirrhos, HMR415,2011 Zonal Ave, Los Angeles, CA 90033 USA.	shellylu@usc.edu	Lu, Shelly/AAH-5937-2021; Ramani, Komal/AAH-5913-2021; tomasi, maria lauda/AAI-1819-2021	Lu, Shelly/0000-0003-2128-5407; 	National Institutes of Health [K99AA017774, R01DK092407, R01AT1576, F32AA020150, P30DK48522, R24 AA12885-07]; National Center for Complementary & Integrative Health [R01AT001576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522, R01DK092407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F32AA020150, R24AA012885, K99AA017774, R00AA017774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants K99AA017774 (to K. R.), R01DK092407 and R01AT1576 (to S. C. L. and H. Y.), and F32AA020150 (to M. L. T.).; 293T cells and isolated mouse hepatocytes were provided by the Cell Culture Core, and pathological sections and staining were done by the Imaging Core of the University of Southern California Research Center for Liver Diseases (supported by National Institutes of Health Grant P30DK48522). Hepatic stellate cells from sham and BDL rats were provided by the Non-Parenchymal Cell Core of the University of Southern California-UCLA Research Center for Alcoholic Liver and Pancreatic Diseases and Cirrhosis (supported by National Institutes of Health Grant R24 AA12885-07).	Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; BURT AD, 1993, J PATHOL, V170, P105, DOI 10.1002/path.1711700203; Dhakshinamoorthy S, 2002, ONCOGENE, V21, P5301, DOI 10.1038/sj.onc.1205642; Dhakshinamoorthy S, 2000, J BIOL CHEM, V275, P40134, DOI 10.1074/jbc.M003531200; Franklin CC, 2002, AM J PATHOL, V160, P1887, DOI 10.1016/S0002-9440(10)61135-2; Fu YM, 2008, MOL PHARMACOL, V73, P1465, DOI 10.1124/mol.107.040634; Furlan-Magaril M, 2009, METHODS MOL BIOL, V543, P253, DOI 10.1007/978-1-60327-015-1_17; Haque JA, 2010, LAB INVEST, V90, P1704, DOI 10.1038/labinvest.2010.112; Iredale JP, 2001, SEMIN LIVER DIS, V21, P427, DOI 10.1055/s-2001-17557; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Levy S, 2010, IUBMB LIFE, V62, P237, DOI 10.1002/iub.314; Li W, 2008, BBA-MOL CELL RES, V1783, P1847, DOI 10.1016/j.bbamcr.2008.05.024; Lu SC, 2000, INT J BIOCHEM CELL B, V32, P391, DOI 10.1016/S1357-2725(99)00139-9; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Maubach G, 2011, WORLD J GASTROENTERO, V17, P2748, DOI [10.3748/wjg.v17.i22., 10.3748/wjg.v17.i22.2748]; Motohashi H, 2006, MOL CELL BIOL, V26, P4652, DOI 10.1128/MCB.02193-05; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Nguyen T, 2000, J BIOL CHEM, V275, P15466, DOI 10.1074/jbc.M000361200; Niture SK, 2010, TOXICOL APPL PHARM, V244, P37, DOI 10.1016/j.taap.2009.06.009; Ohshima T, 2004, J BIOL CHEM, V279, P29551, DOI 10.1074/jbc.M403866200; She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; Sung CK, 2004, AM J PHYSIOL-GASTR L, V286, pG722, DOI 10.1152/ajpgi.00411.2003; Tsukamoto H, 1996, AM J PHYSIOL-GASTR L, V270, pG581, DOI 10.1152/ajpgi.1996.270.4.G581; Xia M, 2010, J BIOL CHEM, V285, P20015, DOI 10.1074/jbc.M109.094821; Yang HP, 2010, HEPATOLOGY, V51, P1291, DOI 10.1002/hep.23471; Yang HP, 2009, HEPATOLOGY, V49, P1982, DOI 10.1002/hep.22908; Yang HP, 2005, BIOCHEM J, V391, P399, DOI 10.1042/BJ20050795; Zheng SZ, 2007, FREE RADICAL BIO MED, V43, P444, DOI 10.1016/j.freeradbiomed.2007.04.016	30	39	41	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36341	36355		10.1074/jbc.M112.370775	http://dx.doi.org/10.1074/jbc.M112.370775			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22942279	Green Published, hybrid			2022-12-25	WOS:000310364000055
J	Gaugler-Senden, IPM; Tamsma, JT; van der Bent, C; Kusters, R; Steegers, EAP; de Groot, CJM				Gaugler-Senden, Ingrid P. M.; Tamsma, Jouke T.; van der Bent, Chris; Kusters, Ron; Steegers, Eric A. P.; de Groot, Christianne J. M.			Angiogenic Factors in Women Ten Years after Severe Very Early Onset Preeclampsia	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ISCHEMIC-HEART-DISEASE; TYROSINE KINASE 1; ADHESION MOLECULES; POTENTIAL ROLE; SERUM-LEVELS; RISK; HISTORY; HYPERTENSION; PROTEINURIA	Background: Women with a history of mainly severe and early onset preeclampsia have an increased risk of future cardiovascular disease. During these complicated pregnancies increased levels of anti-angiogenic factors can be found. We hypothesize that women with a history of severe very early onset preeclampsia still have increased levels of these biomarkers years after this pregnancy, resulting in increased risk for cardiovascular disease. Methods: Twenty women with severe early onset preeclampsia before 24 weeks' gestation, who delivered between 1993-2003 in a tertiary referral centre and twenty matched controls with uncomplicated pregnancies and healthy term infants, were addressed for participation in the study. Venous plasma samples were analyzed for basic fibroblast growth factor (bFGF), placental growth factor (PLGF), soluble fms-like tyrosine kinase-1 (sFlt-1), vascular endothelial growth factor (VEGF), E-and P-selectin, soluble intercellular adhesion molecule-3 (sICAM-3) and thrombomodulin by ELISA. Results: Sixteen case subjects and 18 control subjects consented participation. The median time interval index pregnancy to study was 9.4 and 9.7 years for cases and controls, respectively. Median levels for cases-controls (p-value) were not different; bFGF: 17.43-11.11 pg/mL (0.33), sFlt-1: 102.98-101.92 pg/ml (0.84), PLGF: 3.57-4.20 pg/mL (0.38), VEGF: 64.05-45.72 pg/mL (0.73), E-selectin: 5.11-4.68 ng/mL (0.20), P-selectin: 85.35-71.69 ng/mL (0.69), sICAM-3: 0.42-0.63 ng/mL (0.41) and Thrombomodulin: 0.92-0.93 ng/mL (0.59). Conclusion: There were no differences in angiogenic biomarkers between women with a history of severe early onset preeclampsia versus uncomplicated pregnancy almost 10 years later, suggesting that these angiogenic factors will not contribute to the early detection of women at risk for future cardiovascular disease.	[Gaugler-Senden, Ingrid P. M.] Jeroen Bosch Hosp, Dept Obstet & Gynecol, Shertogenbosch, Netherlands; [Tamsma, Jouke T.; van der Bent, Chris] Leiden Univ, Med Ctr, Dept Endocrinol & Gastro Intestinal Med, Leiden, Netherlands; [Kusters, Ron] Jeroen Bosch Hosp, Dept Clin Chem, Shertogenbosch, Netherlands; [Steegers, Eric A. P.] Univ Med Ctr Rotterdam, Erasmus MC, Div Obstet & Prenatal Med, Dept Obstet & Gynecol, Rotterdam, Netherlands; [de Groot, Christianne J. M.] Vrije Univ Amsterdam Med Ctr, Dept Obstet & Gynecol, Amsterdam, Netherlands	Jeroen Bosch Ziekenhuis; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Jeroen Bosch Ziekenhuis; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Gaugler-Senden, IPM (corresponding author), Jeroen Bosch Hosp, Dept Obstet & Gynecol, Shertogenbosch, Netherlands.	i.gaugler@jbz.nl		de Groot, Christianne/0000-0003-3277-2542				Alber HF, 2005, HEART, V91, P365, DOI 10.1136/hrt.2003.021311; Belgore FM, 2001, AM J CARDIOL, V87, P805, DOI 10.1016/S0002-9149(00)01512-5; Berks D, 2009, OBSTET GYNECOL, V114, P1307, DOI 10.1097/AOG.0b013e3181c14e3e; Blankenberg S, 2001, CIRCULATION, V104, P1336, DOI 10.1161/hc3701.095949; Cassidy A, 2009, ARTERIOSCL THROM VAS, V29, P134, DOI 10.1161/ATVBAHA.108.171066; Chedraui P, 2009, J MATERN-FETAL NEO M, V22, P565, DOI 10.1080/14767050902801769; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Gaugler-Senden IPM, 2008, EUR J OBSTET GYN R B, V140, P171, DOI 10.1016/j.ejogrb.2008.03.004; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; Jonsdottir LS, 1995, ACTA OBSTET GYN SCAN, V74, P772; Karumanchi SA, 2005, KIDNEY INT, V67, P2101, DOI 10.1111/j.1523-1755.2005.00316.x; Khurana R, 2005, CIRCULATION, V111, P2828, DOI 10.1161/CIRCULATIONAHA.104.495887; Kim SY, 2011, ANGIOLOGY, V62, P176, DOI 10.1177/0003319710370963; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Livingston JC, 2000, AM J OBSTET GYNECOL, V183, P1554, DOI 10.1067/mob.2000.108022; Malik I, 2001, LANCET, V358, P971, DOI 10.1016/S0140-6736(01)06104-9; Masuyama H, 2010, BJOG-INT J OBSTET GY, V117, P314, DOI 10.1111/j.1471-0528.2009.02453.x; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; MEEKINS JW, 1994, BRIT J OBSTET GYNAEC, V101, P669, DOI 10.1111/j.1471-0528.1994.tb13182.x; Nakajima K, 2004, CLIN CARDIOL, V27, P281, DOI 10.1002/clc.4960270509; Noori M, 2005, NY TIMES        1026, V122, P478; Ong CYT, 2001, OBSTET GYNECOL, V98, P608, DOI 10.1016/S0029-7844(01)01528-9; Rana S, 2007, HYPERTENSION, V50, P137, DOI 10.1161/HYPERTENSIONAHA.107.087700; Ray JG, 2005, LANCET, V366, P1797, DOI 10.1016/S0140-6736(05)67726-4; Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6; Salahuddin S, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.010; Sattar N, 2003, HYPERTENSION, V42, P39, DOI 10.1161/01.HYP.0000074428.11168.EE; Saxena AR, 2010, HYPERTENSION, V55, P1239, DOI 10.1161/HYPERTENSIONAHA.109.147595; Simas TAM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.030; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Su YN, 2001, OBSTET GYNECOL, V97, P898, DOI 10.1016/S0029-7844(01)01341-2; Torry DS, 1998, AM J OBSTET GYNECOL, V179, P1539, DOI 10.1016/S0002-9378(98)70021-3; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Wolf M, 2004, J CLIN ENDOCR METAB, V89, P6239, DOI 10.1210/jc.2004-0548; Yinon Y, 2010, CIRCULATION, V122, P1846, DOI 10.1161/CIRCULATIONAHA.110.948455	36	15	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43637	10.1371/journal.pone.0043637	http://dx.doi.org/10.1371/journal.pone.0043637			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952728	Green Published, gold, Green Submitted			2022-12-25	WOS:000308221300019
J	Kowalczykiewicz, D; Pawlak, P; Lechniak, D; Wrzesinski, J				Kowalczykiewicz, Dorota; Pawlak, Piotr; Lechniak, Dorota; Wrzesinski, Jan			Altered Expression of Porcine Piwi Genes and piRNA during Development	PLOS ONE			English	Article							SMALL RNAS; ARGONAUTE FAMILY; DNA METHYLATION; BIOGENESIS; PROTEINS; PATHWAY; MILI; RETROTRANSPOSON; IDENTIFICATION; AMPLIFICATION	Three Sus scrofa Piwi genes (Piwil1, Piwil2 and Piwil4) encoding proteins of 861, 985 and 853 aminoacids, respectively, were cloned and sequenced. Alignment of the Piwi proteins showed the high identity between Sus scrofa and Homo sapiens. Relative transcript abundance of porcine Piwil1, Piwil2 and Piwil4 genes in testes, ovaries and oocytes derived from sexually immature and mature animals was examined using Real-Time PCR. Expression of the three Piwi mRNAs was proved to be tissue specific and restricted exclusively to the gonads. In testes of adult pigs the highest relative transcript abundance was observed for the Sus scrofa Piwil1 gene. On the other hand, in testes of neonatal pigs the Piwil1 transcript level was over 2-fold reduced while the level of Piwil2 transcript was higher. As regards the expression of the Piwil4 transcript, its level was 34-fold elevated in testes of neonatal piglet when compared to adult male. In ovaries of prepubertal and pubertal female pigs transcript abundance of the three Piwi genes was significantly reduced in comparison with testes. However, similarly to testes, in ovaries of neonatal pigs the Piwil2 gene was characterized by the highest relative transcript abundance among the three Piwi genes analysed. In prepubertal and pubertal oocytes Piwil1 transcript was the most abundant whereas the expression of Piwil4 was undetectable. We also demonstrated that expression of piRNA occurs preferentially in the gonads of adult male and female pigs. Moreover, a piRNA subset isolated from ovaries was 2-3 nucleotides longer than the piRNA from testes.	[Kowalczykiewicz, Dorota; Wrzesinski, Jan] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland; [Pawlak, Piotr; Lechniak, Dorota] Univ Life Sci, Dept Genet & Anim Breeding, Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Poznan University of Life Sciences	Kowalczykiewicz, D (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland.	wrzesinj@ibch.poznan.pl	Pawlak, Piotr/AAX-7094-2020	Pawlak, Piotr/0000-0003-3489-1684; Wrzesinski, Jan/0000-0002-3777-4320; LECHNIAK, DOROTA Marta/0000-0001-8543-0752	Polish Ministry of Science and Higher Education [N N303 414237, DPN/N103/COST/2009]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the Polish Ministry of Science and Higher Education (N N303 414237 and DPN/N103/COST/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Choi Y, 2008, BIOL REPROD, V79, P442, DOI 10.1095/biolreprod.108.069393; De Fazio S, 2011, NATURE, V480, P259, DOI 10.1038/nature10547; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Gu AH, 2010, HUM REPROD, V25, P2955, DOI 10.1093/humrep/deq274; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Gunawardane LS, 2002, GENE DEV, V16, P2733; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Hunter MG, 2000, REV REPROD, V5, P122, DOI 10.1530/revreprod/5.2.122; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Kawaoka S, 2008, BIOCHEM BIOPH RES CO, V367, P755, DOI 10.1016/j.bbrc.2008.01.013; Kim VN, 2006, GENE DEV, V20, P1993, DOI 10.1101/gad.1456106; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Lakshmi SS, 2008, NUCLEIC ACIDS RES, V36, pD173, DOI 10.1093/nar/gkm696; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee EJ, 2011, RNA, V17, P1090, DOI 10.1261/rna.2565011; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Liu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034770; Liu QH, 2010, ANNU REV BIOCHEM, V79, P295, DOI 10.1146/annurev.biochem.052208.151733; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Ma L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000635; Ohnishi Y, 2010, NUCLEIC ACIDS RES, V38, P5141, DOI 10.1093/nar/gkq229; Pillai RS, 2012, DEV GROWTH DIFFER, V54, P78, DOI 10.1111/j.1440-169X.2011.01320.x; Reuter M, 2011, NATURE, V480, P264, DOI 10.1038/nature10672; Ro S, 2007, RNA, V13, P2366, DOI 10.1261/rna.754207; Ro S, 2007, RNA, V13, P1693, DOI 10.1261/rna.640307; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Saito K, 2010, DEV CELL, V19, P687, DOI 10.1016/j.devcel.2010.10.011; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Seto AG, 2007, MOL CELL, V26, P603, DOI 10.1016/j.molcel.2007.05.021; Simon B, 2011, STRUCTURE, V19, P172, DOI 10.1016/j.str.2010.11.015; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Siomi MC, 2010, GENE DEV, V24, P636, DOI 10.1101/gad.1899210; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Tanaka T, 2011, P NATL ACAD SCI USA, V108, P10579, DOI 10.1073/pnas.1015447108; Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327; Tian YA, 2011, P NATL ACAD SCI USA, V108, P903, DOI 10.1073/pnas.1017762108; Warzych E, 2007, MOL REPROD DEV, V74, P280, DOI 10.1002/mrd.20610; Wei KF, 2012, J CELL BIOCHEM, V113, P2576, DOI 10.1002/jcb.24133; Wilczynska A, 2009, RNA, V15, P337, DOI 10.1261/rna.1422509; Yan Z, 2011, NUCLEIC ACIDS RES, V39, P6596, DOI 10.1093/nar/gkr298; Zhou X, 2010, GENETICA, V138, P805, DOI 10.1007/s10709-010-9462-z	50	22	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43816	10.1371/journal.pone.0043816	http://dx.doi.org/10.1371/journal.pone.0043816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952772	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206500023
J	Taylor, WR; Nguyen, K; Nguyen, D; Nguyen, H; Horby, P; Nguyen, HL; Lien, T; Tran, G; Tran, N; Nguyen, HM; Nguyen, T; Nguyen, HH; Nguyen, T; Tran, G; Farrar, J; de Jong, M; Schultsz, C; Tran, H; Nguyen, D; Vu, B; Le, H; Dao, T; Nguyen, T; Wertheim, H				Taylor, Walter R.; Nguyen, Kinh; Nguyen, Duc; Nguyen, Huyen; Horby, Peter; Nguyen, Ha L.; Lien, Trinh; Tran, Giang; Tran, Ninh; Nguyen, Ha M.; Nguyen, Thai; Nguyen, Ha H.; Nguyen, Thanh; Tran, Giap; Farrar, Jeremy; de Jong, Menno; Schultsz, Constance; Tran, Huong; Nguyen, Diep; Vu, Bich; Le, Hoa; Dao, Trinh; Nguyen, Trung; Wertheim, Heiman			The Spectrum of Central Nervous System Infections in an Adult Referral Hospital in Hanoi, Vietnam	PLOS ONE			English	Article							ACUTE BACTERIAL-MENINGITIS; TUBERCULOUS MENINGITIS; CEREBROSPINAL-FLUID; JAPANESE ENCEPHALITIS; BACTERIOLOGICAL DIAGNOSIS; MENINGOCOCCAL DISEASE; ANTIBIOTIC THERAPY; CHILDREN; PCR; FEATURES	Objectives: To determine prospectively the causative pathogens of central nervous system (CNS) infections in patients admitted to a tertiary referral hospital in Hanoi, Vietnam. Methods: From May 2007 to December 2008, cerebrospinal fluid (CSF) samples from 352 adults with suspected meningitis or encephalitis underwent routine testing, staining (Gram, Ziehl-Nielsen, India ink), bacterial culture and polymerase chain reaction targeting Neisseria meningitidis, Streptococcus pneumoniae, S. suis, Haemophilus influenzae type b, Herpes simplex virus (HSV), Varicella Zoster virus (VZV), enterovirus, and 16S ribosomal RNA. Blood cultures and clinically indicated radiology were also performed. Patients were classified as having confirmed or suspected bacterial (BM), tuberculous (TBM), cryptococcal (CRM), eosinophilic (EOM) meningitis, aseptic encephalitis/meningitis (AEM), neurocysticercosis and others. Results: 352 (male: 66%) patients were recruited: median age 34 years (range 13-85). 95/352 (27.3%) diagnoses were laboratory confirmed and one by cranial radiology: BM (n = 62), TBM (n = 9), AEM (n = 19), CRM (n = 5), and neurocysticercosis (n = 1, cranial radiology). S. suis predominated as the cause of BM [48/62 (77.4%)]; Listeria monocytogenese (n = 1), S. pasteurianus (n = 1) and N. meningitidis (n = 2) were infrequent. AEM viruses were: HSV (n = 12), VZV (n = 5) and enterovirus (n = 2). 5 patients had EOM. Of 262/352 (74.4%) patients with full clinical data, 209 (79.8%) were hospital referrals and 186 (71%) had been on antimicrobials. 21 (8%) patients died: TBM (15.2%), AEM (10%), and BM (2.8%). Conclusions: Most infections lacked microbiological confirmation. S. suis was the most common cause of BM in this setting. Improved diagnostics are needed for meningoencephalitic syndromes to inform treatment and prevention strategies.	[Taylor, Walter R.; Horby, Peter; Wertheim, Heiman] Univ Oxford, Clin Res Unit, Hanoi, Vietnam; [Taylor, Walter R.; Horby, Peter; Farrar, Jeremy; de Jong, Menno; Schultsz, Constance; Wertheim, Heiman] Churchill Hosp, Ctr Vaccinol & Trop Med, Oxford OX3 7LJ, England; [Nguyen, Kinh; Nguyen, Duc; Nguyen, Huyen; Nguyen, Ha L.; Lien, Trinh; Tran, Giang; Tran, Ninh; Nguyen, Ha M.; Nguyen, Thai; Nguyen, Ha H.; Nguyen, Thanh; Tran, Giap; Tran, Huong; Nguyen, Diep; Vu, Bich; Le, Hoa; Dao, Trinh; Nguyen, Trung] Natl Hosp Trop Dis, Hanoi, Vietnam; [Farrar, Jeremy; de Jong, Menno; Schultsz, Constance] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam	University of Oxford; University of Oxford; National Hospital of Tropical Diseases; University of Oxford	Taylor, WR (corresponding author), Univ Oxford, Clin Res Unit, Hanoi, Vietnam.	bob@tropmedres.ac	Horby, Peter/D-1585-2013; Farrar, Jeremy J./HGA-7610-2022; Wertheim, Heiman FL/F-3338-2016	Wertheim, Heiman FL/0000-0002-5003-5565; Horby, Peter/0000-0002-9822-1586; Farrar, Jeremy/0000-0002-2700-623X; Tran Thi Hai, Ninh/0000-0003-4350-9985	Wellcome Trust of Grat Britain	Wellcome Trust of Grat Britain	The funding for this study came from core funds, provided mostly by the Wellcome Trust of Grat Britain. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrab A, 2010, JPN J INFECT DIS, V63, P128; BECK RW, 1984, NEUROLOGY, V34, P105, DOI 10.1212/WNL.34.1.105; Beld M, 2004, J CLIN MICROBIOL, V42, P3059, DOI 10.1128/JCM.42.7.3059-3064.2004; Cardosa MJ, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-9; Chan YC, 2001, ANN ACAD MED SINGAP, V30, P659; CHAU TTH, 2010, PLOS MED, V0007; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; CUTLER RWP, 1968, BRAIN, V91, P707, DOI 10.1093/brain/91.4.707; DAVIS SD, 1975, AM J DIS CHILD, V129, P802, DOI 10.1001/archpedi.1975.02120440028007; de Jong MD, 2000, J CLIN MICROBIOL, V38, P2568, DOI 10.1128/JCM.38.7.2568-2573.2000; FEELEY EJ, 1965, J AMER MED ASSOC, V191, P412, DOI 10.1001/jama.1965.03080050058021; FELDMAN WE, 1978, AM J DIS CHILD, V132, P672, DOI 10.1001/archpedi.1978.02120320032006; GEISELER PJ, 1980, REV INFECT DIS, V2, P725; Girgis NI, 1998, AM J TROP MED HYG, V58, P28, DOI 10.4269/ajtmh.1998.58.28; Glaser CA, 2006, CLIN INFECT DIS, V43, P1565, DOI 10.1086/509330; Guillaume V, 2004, J VIROL METHODS, V120, P229, DOI 10.1016/j.jviromet.2004.05.018; HO DTN, 2011, PLOS ONE, V0006; Hosoglu S, 2003, EUR J EPIDEMIOL, V18, P337, DOI 10.1023/A:1023673532656; Le VT, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000854; Le-Van-Hoa, 1965, Bull Soc Pathol Exot Filiales, V58, P236; Lowry PW, 1998, AM J TROP MED HYG, V58, P324, DOI 10.4269/ajtmh.1998.58.324; Mai NTH, 2007, NEW ENGL J MED, V357, P2431, DOI 10.1056/NEJMoa070852; MARTON KI, 1986, ANN INTERN MED, V104, P840, DOI 10.7326/0003-4819-104-6-840; Michael B, 2010, EMERG MED J, V27, P433, DOI 10.1136/emj.2009.075598; Moon SY, 2010, EUR J CLIN MICROBIOL, V29, P793, DOI 10.1007/s10096-010-0929-8; Nair D, 2009, EPIDEMIOL INFECT, V137, P570, DOI 10.1017/S0950268808001398; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Nguyen THM, 2009, CLIN INFECT DIS, V49, P1387, DOI 10.1086/630207; Nigrovic LE, 2008, PEDIATRICS, V122, P726, DOI 10.1542/peds.2007-3275; OBERTI J, 1981, B WORLD HEALTH ORGAN, V59, P585; Ooi MH, 2008, CLIN INFECT DIS, V47, P458, DOI 10.1086/590008; PICKENS S, 1978, SCAND J INFECT DIS, V10, P183, DOI 10.3109/inf.1978.10.issue-3.05; Poyart C, 2002, INT J SYST EVOL MICR, V52, P1247, DOI 10.1099/00207713-52-4-1247; PUNYAGUPTA S, 1990, J NEUROL SCI, V96, P241, DOI 10.1016/0022-510X(90)90136-B; Queuche F, 1997, Sante, V7, P155; Ramakrishnan M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-47; RANKIN J, 1957, Scott Med J, V2, P200; Ray P, 2007, AM J EMERG MED, V25, P179, DOI 10.1016/j.ajem.2006.07.012; SCIARRA D, 1952, JAMA-J AM MED ASSOC, V148, P841, DOI 10.1001/jama.1952.02930100059013; Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5; SPANOS A, 1989, JAMA-J AM MED ASSOC, V262, P2700, DOI 10.1001/jama.262.19.2700; STEWART SM, 1953, J CLIN PATHOL, V6, P241, DOI 10.1136/jcp.6.3.241; Sturt AS, 2010, J CLIN MICROBIOL, V48, P2247, DOI 10.1128/JCM.00081-10; Sun W, 2008, ORAL SURG ORAL MED O, V105, P566, DOI 10.1016/j.tripleo.2007.08.015; Taylor WRJ, 2009, CLIN INFECT DIS, V49, pE79, DOI 10.1086/605533; THE P H, 1989, Acta Leidensia, V57, P229; Thomas KE, 2002, CLIN INFECT DIS, V35, P46, DOI 10.1086/340979; Thomson RB, 2001, INFECT DIS CLIN N AM, V15, P1047, DOI 10.1016/S0891-5520(05)70186-0; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Thwaites GE, 2004, J CLIN MICROBIOL, V42, P996, DOI 10.1128/JCM.42.3.996-1002.2004; Thwaites GE, 2004, J CLIN MICROBIOL, V42, P378, DOI 10.1128/JCM.42.1.378-379.2004; Thwaites GE, 2002, LANCET, V360, P1287, DOI 10.1016/S0140-6736(02)11318-3; Thwaites G, 2009, J INFECTION, V59, P167, DOI 10.1016/j.jinf.2009.06.011; Torok ME, 2007, AM J TROP MED HYG, V77, P555, DOI 10.4269/ajtmh.2007.77.555; Torok ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001772; Trinh P., 1974, Bulletin Soc Path Exot, V67, P298; TUGWELL P, 1976, Q J MED, V45, P583; Uga S, 2009, Nepal Med Coll J, V11, P75; van Doornum GJJ, 2003, J CLIN MICROBIOL, V41, P576, DOI 10.1128/JCM.41.2.576-580.2003; WENGER JD, 1990, J INFECT DIS, V162, P1316, DOI 10.1093/infdis/162.6.1316; Wertheim HFL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005973; Yaramis A, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.5.e49	62	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e42099	10.1371/journal.pone.0042099	http://dx.doi.org/10.1371/journal.pone.0042099			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952590	Green Published, Green Submitted, gold			2022-12-25	WOS:000308206500003
J	Bezerra, GA; Dobrovetsky, E; Dong, AP; Seitova, A; Crombett, L; Shewchuk, LM; Hassell, AM; Sweitzer, SM; Sweitzer, TD; McDevitt, PJ; Johanson, KO; Kennedy-Wilson, KM; Cossar, D; Bochkarev, A; Gruber, K; Dhe-Paganon, S				Bezerra, Gustavo Arruda; Dobrovetsky, Elena; Dong, Aiping; Seitova, Almagul; Crombett, Lissete; Shewchuk, Lisa M.; Hassell, Annie M.; Sweitzer, Sharon M.; Sweitzer, Thomas D.; McDevitt, Patrick J.; Johanson, Kyung O.; Kennedy-Wilson, Karen M.; Cossar, Doug; Bochkarev, Alexey; Gruber, Karl; Dhe-Paganon, Sirano			Structures of Human DPP7 Reveal the Molecular Basis of Specific Inhibition and the Architectural Diversity of Proline-Specific Peptidases	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; PROLYL OLIGOPEPTIDASE; SUBSTRATE-SPECIFICITY; SERINE-PROTEASE; DIPEPTIDYL; PURIFICATION; IV; AMINOPEPTIDASE; POTENT; MODEL	Proline-specific dipeptidyl peptidases (DPPs) are emerging targets for drug development. DPP4 inhibitors are approved in many countries, and other dipeptidyl peptidases are often referred to as DPP4 activity-and/or structure-homologues (DASH). Members of the DASH family have overlapping substrate specificities, and, even though they share low sequence identity, therapeutic or clinical cross-reactivity is a concern. Here, we report the structure of human DPP7 and its complex with a selective inhibitor Dab-Pip (L-2,4-diaminobutyryl-piperidinamide) and compare it with that of DPP4. Both enzymes share a common catalytic domain (alpha/beta-hydrolase). The catalytic pocket is located in the interior of DPP7, deep inside the cleft between the two domains. Substrates might access the active site via a narrow tunnel. The DPP7 catalytic triad is completely conserved and comprises Ser162, Asp418 and His443 (corresponding to Ser630, Asp708 and His740 in DPP4), while other residues lining the catalytic pockets differ considerably. The "specificity domains" are structurally also completely different exhibiting a b-propeller fold in DPP4 compared to a rare, completely helical fold in DPP7. Comparing the structures of DPP7 and DPP4 allows the design of specific inhibitors and thus the development of less cross-reactive drugs. Furthermore, the reported DPP7 structures shed some light onto the evolutionary relationship of prolyl-specific peptidases through the analysis of the architectural organization of their domains.	[Bezerra, Gustavo Arruda; Gruber, Karl] Graz Univ, Inst Mol Biosci, Graz, Austria; [Dobrovetsky, Elena; Dong, Aiping; Seitova, Almagul; Crombett, Lissete; Cossar, Doug; Bochkarev, Alexey; Dhe-Paganon, Sirano] Univ Toronto, MaRS Ctr, Struct Genom Consortium, Toronto, ON, Canada; [Dhe-Paganon, Sirano] Univ Toronto, MaRS Ctr, Dept Physiol, Toronto, ON, Canada; [Sweitzer, Sharon M.; Sweitzer, Thomas D.; McDevitt, Patrick J.; Johanson, Kyung O.; Kennedy-Wilson, Karen M.] GlaxoSmithKline, Collegeville, PA USA	University of Graz; University of Toronto; Structural Genomics Consortium; University of Toronto; GlaxoSmithKline	Bezerra, GA (corresponding author), Graz Univ, Inst Mol Biosci, Graz, Austria.	karl.gruber@uni-graz.at; sirano.dhepaganon@utoronto.ca	Gruber, Karl/GPP-6706-2022	Gruber, Karl/0000-0002-3485-9740; Arruda Bezerra, Gustavo/0000-0003-4471-821X	Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Doktoratskolleg "Molecular Enzymology" from Austrian Science Fund; UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Doktoratskolleg "Molecular Enzymology" from Austrian Science Fund; UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. Additional funding was provided by the Doktoratskolleg "Molecular Enzymology" Grant W901-B05 from the Austrian Science Fund (to KG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. We thank Curt Haffner (GlaxoSmithKline) for synthesizing Dab-Pip.	Adams PD, 2011, METHODS; Aertgeerts K, 2005, J BIOL CHEM, V280, P19441, DOI 10.1074/jbc.C500092200; Ahn JH, 2008, BIOORG MED CHEM LETT, V18, P6525, DOI 10.1016/j.bmcl.2008.10.076; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Araki H, 2001, J BIOCHEM-TOKYO, V129, P279, DOI 10.1093/oxfordjournals.jbchem.a002855; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bricogne G, 2009, BUSTER 2 8 0; Busek P, 2004, INT J BIOCHEM CELL B, V36, P408, DOI 10.1016/S1357-2725(03)00262-0; Chen R, 2009, J PROTEOME RES, V8, P651, DOI 10.1021/pr8008012; Chiravuri M, 2000, J IMMUNOL, V165, P5695, DOI 10.4049/jimmunol.165.10.5695; Chiravuri M, 2000, J BIOL CHEM, V275, P26994; CUMMINS P, 1992, Biochemical Society Transactions, V20, p56S; Danilova O, 2007, BIOORG MED CHEM LETT, V17, P507, DOI 10.1016/j.bmcl.2006.10.012; Danilova OV, 2009, ENDOCRINOLOGY, V150, P5240, DOI 10.1210/en.2009-0386; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel M, 2003, P NATL ACAD SCI USA, V100, P5063, DOI 10.1073/pnas.0230620100; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Goettig P, 2002, EMBO J, V21, P5343, DOI 10.1093/emboj/cdf552; Goldstone DC, 2010, PROTEINS, V78, P1457, DOI 10.1002/prot.22662; Gorrell MD, 2001, SCAND J IMMUNOL, V54, P249, DOI 10.1046/j.1365-3083.2001.00984.x; Hiramatsu H, 2004, BIOL CHEM, V385, P561, DOI 10.1515/BC.2004.068; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Kozarich JW, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-87; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leiting B, 2003, BIOCHEM J, V371, P525, DOI 10.1042/BJ20021643; Li M, 2010, J BIOL CHEM, V285, P21487, DOI 10.1074/jbc.M109.092692; Lusty CJ, 1999, J APPL CRYSTALLOGR, V32, P106, DOI 10.1107/S002188989801053X; Matteucci E, 2009, CURR MED CHEM, V16, P2943, DOI 10.2174/092986709788803114; Medrano FJ, 1998, EMBO J, V17, P1, DOI 10.1093/emboj/17.1.1; Mele DA, 2009, CELL CYCLE, V8, P2425, DOI 10.4161/cc.8.15.9144; MENTLEIN R, 1989, J NEUROCHEM, V52, P1284, DOI 10.1111/j.1471-4159.1989.tb01877.x; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Rasmussen HB, 2003, NAT STRUCT BIOL, V10, P19, DOI 10.1038/nsb882; Renault L, 2005, CHEM-BIOL INTERACT, V157, P339, DOI 10.1016/j.cbi.2005.10.100; Rosenblum JS, 2003, CURR OPIN CHEM BIOL, V7, P496, DOI 10.1016/S1367-5931(03)00084-X; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sentandreu MA, 2000, J AGR FOOD CHEM, V48, P5014, DOI 10.1021/jf990892q; Senten K, 2003, J MED CHEM, V46, P5005, DOI 10.1021/jm0308803; Soisson SM, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-16; Stockel-Maschek A, 2000, BBA-PROTEIN STRUCT M, V1479, P15, DOI 10.1016/S0167-4838(00)00054-6; Strop P, 2004, J MOL BIOL, V343, P1055, DOI 10.1016/j.jmb.2004.09.003; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thoma R, 2003, STRUCTURE, V11, P947, DOI 10.1016/S0969-2126(03)00160-6; Underwood R, 1999, J BIOL CHEM, V274, P34053, DOI 10.1074/jbc.274.48.34053; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Xu ZJ, 2011, J MED CHEM, V54, P5607, DOI 10.1021/jm200644r; Yamada H, 2007, PROTEIN SCI, V16, P1389, DOI 10.1110/ps.072851407; YARON A, 1993, CRIT REV BIOCHEM MOL, V28, P31, DOI 10.3109/10409239309082572; Yazbeck R, 2009, TRENDS PHARMACOL SCI, V30, P600, DOI 10.1016/j.tips.2009.08.003; Yoshimoto T, 1999, J BIOCHEM, V126, P559, DOI 10.1093/oxfordjournals.jbchem.a022486	60	17	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43019	10.1371/journal.pone.0043019	http://dx.doi.org/10.1371/journal.pone.0043019			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952628	gold, Green Submitted, Green Published			2022-12-25	WOS:000308206000016
J	Ge, XJ; Hsu, TW; Hung, KH; Lin, CJ; Huang, CC; Huang, CC; Chiang, YC; Chiang, TY				Ge, Xue-Jun; Hsu, Tsai-Wen; Hung, Kuo-Hsiang; Lin, Chung-Jian; Huang, Chi-Chung; Huang, Chao-Ching; Chiang, Yu-Chung; Chiang, Tzen-Yuh			Inferring Multiple Refugia and Phylogeographical Patterns in Pinus massoniana Based on Nucleotide Sequence Variation and DNA Fingerprinting	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; MICROSATELLITE LOCI; SOFTWARE; PINACEAE; FLOW; NUMBER; SPACER; LIMITS; RANGE; TESTS	Background: Pinus massoniana, an ecologically and economically important conifer, is widespread across central and southern mainland China and Taiwan. In this study, we tested the central-marginal paradigm that predicts that the marginal populations tend to be less polymorphic than the central ones in their genetic composition, and examined a founders' effect in the island population. Methodology/Principal Findings: We examined the phylogeography and population structuring of the P. massoniana based on nucleotide sequences of cpDNA atpB-rbcL intergenic spacer, intron regions of the AdhC2 locus, and microsatellite fingerprints. SAMOVA analysis of nucleotide sequences indicated that most genetic variants resided among geographical regions. High levels of genetic diversity in the marginal populations in the south region, a pattern seemingly contradicting the central-marginal paradigm, and the fixation of private haplotypes in most populations indicate that multiple refugia may have existed over the glacial maxima. STRUCTURE analyses on microsatellites revealed that genetic structure of mainland populations was mediated with recent genetic exchanges mostly via pollen flow, and that the genetic composition in east region was intermixed between south and west regions, a pattern likely shaped by gene introgression and maintenance of ancestral polymorphisms. As expected, the small island population in Taiwan was genetically differentiated from mainland populations. Conclusions/Significance: The marginal populations in south region possessed divergent gene pools, suggesting that the past glaciations might have low impacts on these populations at low latitudes. Estimates of ancestral population sizes interestingly reflect a recent expansion in mainland from a rather smaller population, a pattern that seemingly agrees with the pollen record.	[Ge, Xue-Jun] Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, S China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Hsu, Tsai-Wen; Huang, Chao-Ching] Endem Species Res Inst, Nantou, Taiwan; [Hung, Kuo-Hsiang] Pingtung Univ Sci & Technol, Grad Inst Bioresources, Pingtung, Taiwan; [Lin, Chung-Jian; Huang, Chi-Chung; Chiang, Tzen-Yuh] Cheng Kung Univ, Dept Life Sci, Tainan, Taiwan; [Chiang, Yu-Chung] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan	Chinese Academy of Sciences; South China Botanical Garden, CAS; National Pingtung University Science & Technology; National Cheng Kung University; National Sun Yat Sen University	Ge, XJ (corresponding author), Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, S China Bot Garden, Guangzhou, Guangdong, Peoples R China.	yuchung@mail.npust.edu.tw; tychiang@mail.ncku.edu.tw	Chiang, Yu-Chung/E-9143-2011; Chiang, Tzen-Yuh/F-7383-2014; Ge, Xue-Jun/AAP-5967-2020	Ge, Xue-Jun/0000-0002-5008-9475; Huang, Chao-Ching/0000-0003-2799-7181	National Basic Research Program of China (973 Program) [2007CB411600]; Council of Agriculture (COA) of Taiwan	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Council of Agriculture (COA) of Taiwan	This work was financially supported by the National Basic Research Program of China (973 Program) (2007CB411600) and a grant from the Council of Agriculture (COA) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod D., 1996, FLORISTIC CHARACTERI, P43; Belshaw R, 2005, BIOINFORMATICS, V21, P122, DOI 10.1093/bioinformatics/bth459; BENNETT KD, 1990, PALEOBIOLOGY, V16, P11, DOI 10.1017/S0094837300009684; Chen KM, 2008, MOL ECOL, V17, P4276, DOI 10.1111/j.1365-294X.2008.03911.x; Chiang TY, 2006, TAXON, V55, P31, DOI 10.2307/25065526; Chiang TY, 1998, BOT BULL ACAD SINICA, V39, P245; Chiang TY, 2004, ANN MO BOT GARD, V91, P207; Chiang YC, 2006, MOL ECOL, V15, P765, DOI 10.1111/j.1365-294X.2005.02833.x; Chiang YC, 2003, AM J BOT, V90, P561, DOI 10.3732/ajb.90.4.561; Chiang YC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-161; CRANDALL KA, 1993, GENETICS, V134, P959; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1994, GENETICS, V136, P343; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; FU YX, 1993, GENETICS, V133, P693; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Huang S, 2001, MOL ECOL, V10, P2669, DOI 10.1046/j.0962-1083.2001.01395.x; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Hung KH, 2012, BOT STUD, V53, P191; Juan C, 2000, TRENDS ECOL EVOL, V15, P104, DOI 10.1016/S0169-5347(99)01776-0; Karhu A, 2006, J EVOLUTION BIOL, V19, P167, DOI 10.1111/j.1420-9101.2005.00982.x; KLIMAN RM, 1993, GENETICS, V133, P375; Kremenetski CV, 1998, ARCTIC ALPINE RES, V30, P317, DOI 10.2307/1552004; Laurance WF, 2008, SCIENCE, V319, P1184, DOI 10.1126/science.319.5867.1184b; Le Maitre D. C., 1998, P407; Lei Zuo-Qi, 1993, Acta Botanica Sinica, V35, P128; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu J, 1977, ACTA PALAEONTOL, V16, P10; LIU KB, 1992, QUATERNARY RES, V38, P32, DOI 10.1016/0033-5894(92)90028-H; Lu SY, 2001, GENOME, V44, P797, DOI 10.1139/gen-44-5-797; Lusk C, 2008, NEW PHYTOL, V178, P1, DOI 10.1111/j.1469-8137.2008.02371.x; Muir G, 2005, MOL ECOL, V14, P549, DOI 10.1111/j.1365-294X.2004.02418.x; Naydenov K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-233; Ohsako T, 2008, GENES GENET SYST, V83, P89, DOI 10.1266/ggs.83.89; Ota H, 1998, RES POPUL ECOL, V40, P189, DOI 10.1007/BF02763404; Parchman TL, 2011, AM J BOT, V98, P669, DOI 10.3732/ajb.1000378; Perry DJ, 1996, P NATL ACAD SCI USA, V93, P13020, DOI 10.1073/pnas.93.23.13020; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard J, 2003, DOCUMENTATION STRUCT; Pritchard JK, 2000, GENETICS, V155, P945; Richardson David M., 1998, P3; Salim K, 2010, HEREDITAS, V147, P165, DOI 10.1111/j.1601-5223.2010.02176.x; Sang T, 2002, CRIT REV BIOCHEM MOL, V37, P121, DOI 10.1080/10409230290771474; Schaal BA, 2000, P NATL ACAD SCI USA, V97, P7024, DOI 10.1073/pnas.97.13.7024; Schneider S, 1999, GENETICS, V152, P1079; SLATKIN M, 1991, GENETICS, V129, P555; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Templeton Alan R., 2000, Plant Species Biology, V15, P211, DOI 10.1046/j.1442-1984.2000.00041.x; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; Wachowiak W, 2011, HEREDITY, V106, P775, DOI 10.1038/hdy.2010.118; Wang XR, 1999, AM J BOT, V86, P1742, DOI 10.2307/2656672; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Xu XW, 2008, THEOR APPL GENET, V116, P835, DOI 10.1007/s00122-008-0717-3; Zhou YF, 2010, EVOLUTION, V64, P2342, DOI 10.1111/j.1558-5646.2010.00988.x	62	24	26	9	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43717	10.1371/journal.pone.0043717	http://dx.doi.org/10.1371/journal.pone.0043717			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952747	Green Submitted, gold, Green Published			2022-12-25	WOS:000308206000047
J	Negishi, T; Oshima, K; Hattori, M; Kanai, M; Mano, S; Nishimura, M; Yoshida, K				Negishi, Takashi; Oshima, Kenshiro; Hattori, Masahira; Kanai, Masatake; Mano, Shoji; Nishimura, Mikio; Yoshida, Kumi			Tonoplast- and Plasma Membrane-Localized Aquaporin-Family Transporters in Blue Hydrangea Sepals of Aluminum Hyperaccumulating Plant	PLOS ONE			English	Article							FULL-LENGTH CDNA; INTRINSIC PROTEINS; COLOR DEVELOPMENT; TOLERANCE; FACILITATE; CLONING; DIFFUSION; TOXICITY; SYSTEM; GENES	Hydrangea (Hydrangea macrophylla) is tolerant of acidic soils in which toxicity generally arises from the presence of the soluble aluminum (Al) ion. When hydrangea is cultivated in acidic soil, its resulting blue sepal color is caused by the Al complex formation of anthocyanin. The concentration of vacuolar Al in blue sepal cells can reach levels in excess of approximately 15 mM, suggesting the existence of an Al-transport and/or storage system. However, until now, no Al transporter has been identified in Al hyperaccumulating plants, animals or microorganisms. To identify the transporter being responsible for Al hyperaccumulation, we prepared a cDNA library from blue sepals according to the sepal maturation stage, and then selected candidate genes using a microarray analysis and an in silico study. Here, we identified the vacuolar and plasma membrane-localized Al transporters genes vacuolar Al transporter (VALT) and plasma membrane Al transporter 1 (PALT1), respectively, which are both members of the aquaporin family. The localization of each protein was confirmed by the transient co-expression of the genes. Reverse transcription-PCR and immunoblotting results indicated that VALT and PALT1 are highly expressed in sepal tissue. The overexpression of VALT and PALT1 in Arabidopsis thaliana conferred Al-tolerance and Al-sensitivity, respectively.	[Negishi, Takashi; Yoshida, Kumi] Nagoya Univ, Grad Sch Informat Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Negishi, Takashi; Yoshida, Kumi] Nagoya Univ, G COE Chem, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Oshima, Kenshiro; Hattori, Masahira] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Kanai, Masatake; Mano, Shoji; Nishimura, Mikio] Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 444, Japan; [Mano, Shoji; Nishimura, Mikio] Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan	Nagoya University; Nagoya University; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Negishi, T (corresponding author), Nagoya Univ, Grad Sch Informat Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	yoshidak@is.nagoya-u.ac.jp	Hattori, Masahira/AAD-3785-2019; Hattori, Masahira/C-6958-2016; Yoshida, Kumi/AAJ-2078-2020	Hattori, Masahira/0000-0001-9467-0344; Mano, Shoji/0000-0003-1323-3308; Nishimura, Mikio/0000-0001-7960-9721; Kanai, Masatake/0000-0001-7808-8258	Global Centers of Excellence Program in Chemistry, Nagoya University, Creative Scientific Research in Priority Areas [16GS0206]; Ministry of Education, Culture, Sports, Science and Technology, Japan [16370021, 24380062]; National Institute for Basic Biology Cooperative Research Program [10-301, 11-301]; Japan Advanced Plant Science Network; Grants-in-Aid for Scientific Research [22112523] Funding Source: KAKEN	Global Centers of Excellence Program in Chemistry, Nagoya University, Creative Scientific Research in Priority Areas; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute for Basic Biology Cooperative Research Program; Japan Advanced Plant Science Network; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant in aid for scientific research by the Global Centers of Excellence Program in Chemistry, Nagoya University, Creative Scientific Research in Priority Areas (No. 16GS0206), (B) (No. 16370021 and 24380062) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, the National Institute for Basic Biology Cooperative Research Program (No. 10-301 and 11-301), and Japan Advanced Plant Science Network. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	'ALLEN R. C., 1943, Contributions. Boyce Thompson Institute for Plant Research, V13, P221; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Bienert GP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-26; Carninci P, 1996, GENOMICS, V37, P327, DOI 10.1006/geno.1996.0567; Carninci P, 2001, GENOMICS, V77, P79, DOI 10.1006/geno.2001.6601; Cerbah M, 2001, THEOR APPL GENET, V103, P45, DOI 10.1007/s001220000529; Chenery E.M., 1937, J ROY HORTIC SOC, V62, P604; Delhaize E, 2004, P NATL ACAD SCI USA, V101, P15249, DOI 10.1073/pnas.0406258101; Ezaki B, 1998, FEMS MICROBIOL LETT, V159, P99, DOI 10.1016/S0378-1097(97)00554-5; Famoso AN, 2010, PLANT PHYSIOL, V153, P1678, DOI 10.1104/pp.110.156794; Foy CD, 1962, SOIL SCI SOC AM J, V27, P403; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Hanikenne M, 2011, CURR OPIN PLANT BIOL, V14, P252, DOI 10.1016/j.pbi.2011.04.003; Hayashi K., 1953, MISC REP RES I NAT R, V29, P1; Hedfalk K, 2006, CURR OPIN STRUC BIOL, V16, P447, DOI 10.1016/j.sbi.2006.06.009; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hove RM, 2011, PLANT MOL BIOL, V75, P413, DOI 10.1007/s11103-011-9737-5; Ito D, 2009, BIOSCI BIOTECH BIOCH, V73, P1054, DOI 10.1271/bbb.80831; Jahn TP, 2004, FEBS LETT, V574, P31, DOI 10.1016/j.febslet.2004.08.004; Kakimoto M, 2005, BIOMETALS, V18, P467, DOI 10.1007/s10534-005-4663-0; KAMMERLOHER W, 1994, PLANT J, V6, P187, DOI 10.1046/j.1365-313X.1994.6020187.x; KINRAIDE TB, 1991, PLANT SOIL, V134, P167, DOI 10.1007/BF00010729; Kondo T, 2005, TETRAHEDRON LETT, V46, P6645, DOI 10.1016/j.tetlet.2005.07.146; Lawrence WJC, 1938, BIOCHEM J, V32, P1661, DOI 10.1042/bj0321661; Liu LH, 2003, PLANT PHYSIOL, V133, P1220, DOI 10.1104/pp.103.027409; Loque D, 2005, PLANT PHYSIOL, V137, P671, DOI 10.1104/pp.104.051268; Ma JF, 1997, NATURE, V390, P569, DOI 10.1038/37518; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Ma JF, 2006, NATURE, V440, P688, DOI 10.1038/nature04590; Matsumoto H, 2000, INT REV CYTOL, V200, P1, DOI 10.1016/S0074-7696(00)00001-2; MATSUMOTO H, 1976, PLANT CELL PHYSIOL, V17, P627; Maurel C, 2009, CURR OPIN PLANT BIOL, V12, P690, DOI 10.1016/j.pbi.2009.09.002; Mitsuhashi N, 2000, PLANT CELL PHYSIOL, V41, P993, DOI 10.1093/pcp/pcd040; Morita A, 2004, PHYTOCHEMISTRY, V65, P2775, DOI 10.1016/j.phytochem.2004.08.043; Robinson GM, 1939, J AM CHEM SOC, V61, P1606, DOI 10.1021/ja01875a510; Rouge P, 2008, BIOCHEM BIOPH RES CO, V367, P60, DOI 10.1016/j.bbrc.2007.12.079; Ryan PR, 2011, J EXP BOT, V62, P9, DOI 10.1093/jxb/erq272; Savage DF, 2010, P NATL ACAD SCI USA, V107, P17164, DOI 10.1073/pnas.1009864107; Schott EJ, 1997, MOL GEN GENET, V254, P63, DOI 10.1007/s004380050391; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; SUHAYDA CG, 1986, PHYSIOL PLANTARUM, V68, P189, DOI 10.1111/j.1399-3054.1986.tb01913.x; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; TAKEDA K, 1990, PHYTOCHEMISTRY, V29, P1089, DOI 10.1016/0031-9422(90)85409-9; TAKEDA K, 1985, PHYTOCHEMISTRY, V24, P2251, DOI 10.1016/S0031-9422(00)83019-8; Tanaka M, 2008, PLANT CELL, V20, P2860, DOI 10.1105/tpc.108.058628; Tanaka Y, 2009, INT J MOL SCI, V10, P5350, DOI 10.3390/ijms10125350; Toyama-Kato Y, 2003, BIOCHEM ENG J, V14, P237, DOI 10.1016/S1369-703X(02)00220-6; Vert G, 2009, PLANTA, V229, P1171, DOI 10.1007/s00425-009-0904-8; Wudick MM, 2009, NEW PHYTOL, V184, P289, DOI 10.1111/j.1469-8137.2009.02985.x; Xia JX, 2010, P NATL ACAD SCI USA, V107, P18381, DOI 10.1073/pnas.1004949107; Yang JL, 2008, PLANT PHYSIOL, V146, P602, DOI 10.1104/pp.107.111989; Yoshida K, 2003, PLANT CELL PHYSIOL, V44, P262, DOI 10.1093/pcp/pcg033; Yoshida K, 2009, NAT PROD REP, V26, P884, DOI 10.1039/b800165k	53	74	86	9	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43189	10.1371/journal.pone.0043189	http://dx.doi.org/10.1371/journal.pone.0043189			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952644	Green Submitted, Green Published, gold			2022-12-25	WOS:000308206000021
J	Waldbauer, JR; Rodrigue, S; Coleman, ML; Chisholm, SW				Waldbauer, Jacob R.; Rodrigue, Sebastien; Coleman, Maureen L.; Chisholm, Sallie W.			Transcriptome and Proteome Dynamics of a Light-Dark Synchronized Bacterial Cell Cycle	PLOS ONE			English	Article							MESSENGER-RNA; GENE-EXPRESSION; STATISTICAL-MODEL; GENOMIC ANALYSIS; PROCHLOROCOCCUS; TANDEM; CYANOTHECE; GROWTH; SYNECHOCOCCUS; CYANOBACTERIA	Background: Growth of the ocean's most abundant primary producer, the cyanobacterium Prochlorococcus, is tightly synchronized to the natural 24-hour light-dark cycle. We sought to quantify the relationship between transcriptome and proteome dynamics that underlie this obligate photoautotroph's highly choreographed response to the daily oscillation in energy supply. Methodology/Principal Findings: Using RNA-sequencing transcriptomics and mass spectrometry-based quantitative proteomics, we measured timecourses of paired mRNA-protein abundances for 312 genes every 2 hours over a light-dark cycle. These temporal expression patterns reveal strong oscillations in transcript abundance that are broadly damped at the protein level, with mRNA levels varying on average 2.3 times more than the corresponding protein. The single strongest observed protein-level oscillation is in a ribonucleotide reductase, which may reflect a defense strategy against phage infection. The peak in abundance of most proteins also lags that of their transcript by 2-8 hours, and the two are completely antiphase for some genes. While abundant antisense RNA was detected, it apparently does not account for the observed divergences between expression levels. The redirection of flux through central carbon metabolism from daytime carbon fixation to nighttime respiration is associated with quite small changes in relative enzyme abundances. Conclusions/Significance: Our results indicate that expression responses to periodic stimuli that are common in natural ecosystems (such as the diel cycle) can diverge significantly between the mRNA and protein levels. Protein expression patterns that are distinct from those of cognate mRNA have implications for the interpretation of transcriptome and metatranscriptome data in terms of cellular metabolism and its biogeochemical impact.	[Waldbauer, Jacob R.; Rodrigue, Sebastien; Coleman, Maureen L.; Chisholm, Sallie W.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Waldbauer, Jacob R.] Woods Hole Oceanog Inst, Joint Program Chem Oceanog, Cambridge, MA USA; [Coleman, Maureen L.; Chisholm, Sallie W.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution; Massachusetts Institute of Technology (MIT)	Waldbauer, JR (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.	chisholm@mit.edu		Chisholm, Sallie/0000-0003-1480-2445; Coleman, Maureen/0000-0001-5065-0106	Gordon and Betty Moore Foundation Marine Microbiology Initiative; MIT Energy Initiative, Department of Energy Genomics:GtL program; NSF Center for Microbial Oceanography: Research and Education (C-MORE); Office of Naval Research NDSEG Fellowship; NSF Graduate Research Fellowship; NSERC; FQRNT	Gordon and Betty Moore Foundation Marine Microbiology Initiative(Gordon and Betty Moore Foundation); MIT Energy Initiative, Department of Energy Genomics:GtL program; NSF Center for Microbial Oceanography: Research and Education (C-MORE)(National Science Foundation (NSF)); Office of Naval Research NDSEG Fellowship(Office of Naval Research); NSF Graduate Research Fellowship(National Science Foundation (NSF)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); FQRNT(FQRNT)	This work was supported in large part by a grant from the Gordon and Betty Moore Foundation Marine Microbiology Initiative. Additional funding support was from the MIT Energy Initiative, Department of Energy Genomics:GtL program, and the NSF Center for Microbial Oceanography: Research and Education (C-MORE). JRW was supported by an Office of Naval Research NDSEG Fellowship and an NSF Graduate Research Fellowship. SR was supported by postdoctoral fellowships from NSERC and FQRNT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Aryal UK, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-194; Axmann IM, 2009, J BACTERIOL, V191, P5342, DOI 10.1128/JB.00419-09; Bandyopadhyay A, 2011, MBIO, V2, DOI 10.1128/mBio.00214-11; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; Britos L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018179; CHISHOLM SW, 1988, NATURE, V334, P340, DOI 10.1038/334340a0; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; Doherty MK, 2006, EXPERT REV PROTEOMIC, V3, P97, DOI 10.1586/14789450.3.1.97; Evguenieva-Hackenberg E, 2011, CURR OPIN MICROBIOL, V14, P587, DOI 10.1016/j.mib.2011.07.025; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Futschik ME, 2008, BIOINFORMATICS, V24, P1063, DOI 10.1093/bioinformatics/btn072; Garcia-Pichel F, 2003, ALGOLOGICAL STUDIES, V109, P15; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Grunenfelder B, 2001, P NATL ACAD SCI USA, V98, P4681, DOI 10.1073/pnas.071538098; GURLAND J, 1971, AM STAT, V25, P30, DOI 10.2307/2682923; Halbeisen RE, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000105; Helbling DE, 2012, ISME J, V6, P902, DOI [10.1038/ISMEJ.2011.158, 10.1038/ismej.2011.158]; Holtzendorff J, 2001, J BACTERIOL, V183, P915, DOI 10.1128/JB.183.3.915-920.2001; Hsiao CA, 2009, CLASSIFICATION OUTLI; Ito H, 2009, P NATL ACAD SCI USA, V106, P14168, DOI 10.1073/pnas.0902587106; Jacquet S, 2001, APPL ENVIRON MICROB, V67, P782, DOI 10.1128/AEM.67.2.782-790.2001; Jayapal KP, 2010, J PROTEOME RES, V9, P2087, DOI 10.1021/pr9007738; Jayapal KP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002097; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kelly L, 2012, NUCLEIC ACIDS RES, V40, pD632, DOI 10.1093/nar/gkr1022; Kielbasa SM, 2007, GENOME INFORM SER, V18, P1; Kramer G, 2010, MOL CELL PROTEOMICS, V9, P2508, DOI 10.1074/mcp.M110.001826; Kucho K, 2005, J BACTERIOL, V187, P2190, DOI 10.1128/JB.187.6.2190-2199.2005; Lasa I, 2011, P NATL ACAD SCI USA, V108, P20172, DOI 10.1073/pnas.1113521108; Lee PS, 2003, BIOTECHNOL BIOENG, V84, P834, DOI 10.1002/bit.10841; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li XJ, 2003, ANAL CHEM, V75, P6648, DOI 10.1021/ac034633i; MacLean B, 2006, BIOINFORMATICS, V22, P2830, DOI 10.1093/bioinformatics/btl379; Mary I, 2003, FEMS MICROBIOL LETT, V226, P135, DOI 10.1016/S0378-1097(03)00587-1; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; Moore LR, 2007, LIMNOL OCEANOGR-METH, V5, P353, DOI 10.4319/lom.2007.5.353; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Picard F, 2009, CR BIOL, V332, P958, DOI 10.1016/j.crvi.2009.09.005; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; REDDY KJ, 1993, J BACTERIOL, V175, P1284, DOI 10.1128/JB.175.5.1284-1292.1993; Richter JD, 2011, CURR OPIN GENET DEV, V21, P363, DOI 10.1016/j.gde.2011.06.001; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Rust MJ, 2011, SCIENCE, V331, P220, DOI 10.1126/science.1197243; Shalapyonok A, 1998, APPL ENVIRON MICROB, V64, P1066; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sherman LA, 2010, ADV EXP MED BIOL, V675, P275, DOI 10.1007/978-1-4419-1528-3_16; Shi T, 2010, ISME J, V4, P621, DOI 10.1038/ismej.2009.148; Shi YM, 2011, ISME J, V5, P999, DOI 10.1038/ismej.2010.189; Shteynberg D, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007690; Smith DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010487; Steglich C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r54; Stoeckel J, 2008, P NATL ACAD SCI USA, V105, P6156, DOI 10.1073/pnas.0711068105; Stockel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016680; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Straub C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016208; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; Thompson LR, 2011, P NATL ACAD SCI USA, V108, pE757, DOI 10.1073/pnas.1102164108; VAULOT D, 1995, SCIENCE, V268, P1480, DOI 10.1126/science.268.5216.1480; Vijayan V, 2009, P NATL ACAD SCI USA, V106, P22564, DOI 10.1073/pnas.0912673106; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P2890, DOI 10.1093/nar/gkg398; Wang JD, 2009, NAT REV MICROBIOL, V7, P822, DOI 10.1038/nrmicro2202; Welsh EA, 2008, P NATL ACAD SCI USA, V105, P15094, DOI 10.1073/pnas.0805418105; Zinser ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005135	70	100	102	2	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43432	10.1371/journal.pone.0043432	http://dx.doi.org/10.1371/journal.pone.0043432			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952681	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206000035
J	Cox, JL; Wilder, PJ; Desler, M; Rizzino, A				Cox, Jesse L.; Wilder, Phillip J.; Desler, Michelle; Rizzino, Angie			Elevating SOX2 Levels Deleteriously Affects the Growth of Medulloblastoma and Glioblastoma Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; TUMOR-INITIATING CELLS; LARGE GENE LISTS; TRANSCRIPTIONAL REGULATION; BRAIN-TUMORS; MOUSE; EXPRESSION; CANCER; PHOSPHORYLATION; DIFFERENTIATION	Medulloblastomas and glioblastomas are devastating tumors that respond poorly to treatment. These tumors have been shown to express SOX2 and overexpression of SOX2 has been correlated with poor prognosis. Although knockdown of SOX2 impairs the growth and tumorigenicity of brain tumor cells, it was unclear how elevating SOX2 levels would affect their fate. Interestingly, studies conducted with neural stem cells have shown that small increases or decreases in the level of this transcription factor significantly alter their fate. Here, we report that elevating SOX2 3-fold above endogenous levels in U87 and U118 glioblastoma, and DAOY medulloblastoma cells significantly impairs their ability to proliferate. We extended these findings and determined that elevating SOX2 in DAOY cells remodels their cell-cycle profile by increasing the proportion of cells in the G1-compartment, and induces the expression of genes associated with differentiation. Furthermore, we show that elevating SOX2 leads to a dramatic induction of CD133 expression in DAOY cells, yet inhibits the ability of both CD133(+) and CD133(-) cells to form neurospheres. Together, these findings argue that SOX2 levels must be carefully controlled in glioblastomas and medulloblastomas to maintain their fate. Equally important, our data suggests that increases in the expression of SOX2 during brain tumor progression are likely to be linked closely with changes in other critical genes that work in concert with SOX2 to enhance the tumorigenicity of brain tumors. Importantly, we demonstrate that this is also likely to be true for other cancers that express SOX2. Moreover, these studies demonstrate the advantage of using inducible promoters to study the effects of SOX2 elevation, as compared to gene expression systems that rely on constitutive expression.	[Cox, Jesse L.; Wilder, Phillip J.; Desler, Michelle; Rizzino, Angie] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Cox, JL (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	arizzino@unmc.edu			Nebraska Department of Health [2011 29, 2012 33]	Nebraska Department of Health	This work was supported by the Nebraska Department of Health; Contract grant number: (2011 29; 2012 33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026740; Annovazzi L, 2011, CANCER GENOM PROTEOM, V8, P139; Baltus GA, 2009, STEM CELLS, V27, P2175, DOI 10.1002/stem.168; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Christensen K, 2011, J NEURO-ONCOL, V104, P129, DOI 10.1007/s11060-010-0488-y; Cox JL, 2011, J CELL SCI, V124, P2654, DOI 10.1242/jcs.083238; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Engelkamp D, 1999, DEVELOPMENT, V126, P3585; Fang XF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-11; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang Xi, 2010, J Vis Exp, DOI 10.3791/2086; Jenkin D, 1998, MED PEDIATR ONCOL, V31, P506, DOI 10.1002/(SICI)1096-911X(199812)31:6<506::AID-MPO7>3.0.CO;2-X; Jeong CH, 2010, STEM CELLS, V28, P2141, DOI 10.1002/stem.540; Jia XP, 2011, J MOL CELL BIOL, V3, P230, DOI 10.1093/jmcb/mjr002; Kingsley-Kallesen M, 2001, IN VITRO CELL DEV-AN, V37, P684; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Krex D, 2007, BRAIN, V130, P2596, DOI 10.1093/brain/awm204; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Mallanna SK, 2010, STEM CELLS, V28, P1715, DOI 10.1002/stem.494; McCord AM, 2009, MOL CANCER RES, V7, P489, DOI 10.1158/1541-7786.MCR-08-0360; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakatsugawa M, 2011, LAB INVEST, V91, P1796, DOI 10.1038/labinvest.2011.140; Perek D, 1998, CHILD NERV SYST, V14, P582, DOI 10.1007/s003810050276; RIEDERER BM, 1995, J HISTOCHEM CYTOCHEM, V43, P1269, DOI 10.1177/43.12.8537643; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Sutter R, 2010, ONCOGENE, V29, P1845, DOI 10.1038/onc.2009.472; TELFORD WG, 1991, CELL PROLIFERAT, V24, P447, DOI 10.1111/j.1365-2184.1991.tb01173.x; Tsuruzoe S, 2006, BIOCHEM BIOPH RES CO, V351, P920, DOI 10.1016/j.bbrc.2006.10.130; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Zhao HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027026	41	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44087	10.1371/journal.pone.0044087	http://dx.doi.org/10.1371/journal.pone.0044087			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937156	gold, Green Submitted, Green Published			2022-12-25	WOS:000308213600076
J	Adekeye, OA; Heiman, HJ; Onyeabor, OS; Hyacinth, HI				Adekeye, Oluwatoyosi A.; Heiman, Harry J.; Onyeabor, Onyekachi S.; Hyacinth, Hyacinth I.			The New Invincibles: HIV Screening among Older Adults in the US	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; AIDS RISK BEHAVIORS; AGED 50; INFECTION; TUBERCULOSIS; POPULATION; PREVENTION; DIAGNOSES; KNOWLEDGE; COLLEGE	Background: Thirteen percent of the U.S. population is ages 65 and older, a number projected to reach 20% by 2030. By 2015, 50% of Human Immunodeficiency Virus (HIV)-infected individuals in the U. S. are expected to be ages 50 and older. Current Centers for Disease Control and Prevention guidelines recommend "opt-out" HIV screening for individuals ages 13-64. The purpose of this study was to assess the occurrence and barriers to HIV screening in older adults, and to evaluate the rationale for expanding routine HIV screening to this population. Methods: The study used 2009 National Health Interview Survey (NHIS) data. A total of 12,366 (unweighted) adults, ages 50 and older, participated in the adult section of the NHIS and answered questions on the HIV/AIDS, Sexually Transmitted Diseases, and Tuberculosis components. Associations between HIV screening, socio-demographic variables, and knowledge of HIV-related disease were examined using logistic regression models. Results: The HIV screening rate within this population was 25.4%. Race had no statistically significant effect. Low risk perception of HIV exposure (84.1%) accounted for low likelihood of planned screening (3.5%) within 12 months post survey. A routine medical check-up was the single most common reason for HIV screening (37.6%), with only about half (52.7%) of the tests suggested by a health care provider. Conclusion: It is imperative that practices and policies are developed and implemented to increase HIV awareness and screening in the older adult population. Increased health care provider awareness of the importance of HIV screening, especially for those 65 and older, is critical. Health policies and clinical guidelines should be revised to promote and support screening of all adults.	[Adekeye, Oluwatoyosi A.] Morehouse Sch Med, Natl Ctr Primary Care, Atlanta, GA 30310 USA; [Heiman, Harry J.; Onyeabor, Onyekachi S.] Morehouse Sch Med, Satcher Hlth Leadership Inst, Atlanta, GA 30310 USA; [Hyacinth, Hyacinth I.] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA	Morehouse School of Medicine; Morehouse School of Medicine; Morehouse School of Medicine	Adekeye, OA (corresponding author), Morehouse Sch Med, Natl Ctr Primary Care, Atlanta, GA 30310 USA.	oadekeye@msm.edu	Hyacinth, Hyacinth/U-5722-2017	Hyacinth, Hyacinth/0000-0002-1991-7463	Department of Health and Human Services, Public Health Service [MPCMP101051-01-01]; Office of Minority Health [MPCMP061011, OMH-MSM-1-06]; National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) [R21HL092358, NIH/NCRR-5P20RR0111044]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL092358] Funding Source: NIH RePORTER	Department of Health and Human Services, Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Office of Minority Health(United States Department of Health & Human Services); National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors were supported in part by the following grants: MPCMP101051-01-01, from the Department of Health and Human Services, Public Health Service, a grant from the Office of Minority Health, Cooperative Agreement Number: MPCMP061011 and Project Number: OMH-MSM-1-06, National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) - R21HL092358 and NIH/NCRR-5P20RR0111044. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Its content are solely the responsibility of the authors and do not necessarily represent the official views of the Department of Health and Human Services.	Ajuluchukwu DC, 2003, NAT HIV PREV C JUL A; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P845; [Anonymous], 2008, CLIN INTERV AGING; [Anonymous], 2009, HIV TEST IMPL GUID C; Beckwith CG, 2010, JAIDS-J ACQ IMM DEF, V55, pS49, DOI 10.1097/QAI.0b013e3181f9c0f7; Braithwaite RL, 2003, AM J PUBLIC HEALTH, V93, P759, DOI 10.2105/AJPH.93.5.759; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Centers for Disease Control and Prevention, 2010, HIV US FACT SHEET; Centers for Disease Control and Prevention, 2010, HIV AIDS AFR AM YOUT; Centers for Disease Control and Prevention (CDC), 2005, HIV PREV 3 DEC; DeHertogh DA, 1994, INFECT MED, V11, P361; DeHertogh DA, 1994, INFECT MED, V11, P370; FITTERLING JM, 1993, ADDICTION, V88, P1257, DOI 10.1111/j.1360-0443.1993.tb02148.x; Gott CM, 2001, HEALTH SOC CARE COMM, V9, P72, DOI 10.1046/j.1365-2524.2001.00285.x; Grabar S, 2006, J ANTIMICROB CHEMOTH, V57, P4, DOI 10.1093/jac/dki411; Jittimanee SX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006360; Kirk JB, 2009, J AM GERIATR SOC, V57, P2129, DOI 10.1111/j.1532-5415.2009.02494.x; LEIGH BC, 1993, AM J PUBLIC HEALTH, V83, P1400, DOI 10.2105/AJPH.83.10.1400; Linley L, 2007, NAT HIV PREV C ATL G, P136; Longo B, 2008, AIDS PATIENT CARE ST, V22, P365, DOI 10.1089/apc.2007.0168; Mahendradhata Y, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-385; Malhotra S., 2008, J AM PHYS SURG, V13, P88; McNair LD, 1998, J SEX MARITAL THER, V24, P29, DOI 10.1080/00926239808414666; Moody HR, 2009, AGING CONCEPTS CONTR, pxxi; Newmann S, 2000, INT J STD AIDS, V11, P250, DOI 10.1258/0956462001915796; Orchi N, 2008, AIDS CARE, V20, P419, DOI 10.1080/09540120701867073; Paul SM, 2007, J AM GERIATR SOC, V55, P1393, DOI 10.1111/j.1532-5415.2007.01295.x; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Qaseem A, 2009, ANN INTERN MED, V150, P125, DOI 10.7326/0003-4819-150-2-200901200-00300; Reid A, 2006, LANCET INFECT DIS, V6, P483, DOI 10.1016/S1473-3099(06)70549-7; Sanders GD, 2008, ANN INTERN MED, V148, P889, DOI 10.7326/0003-4819-148-12-200806170-00002; Shisana O, 2004, SAMJ S AFR MED J, V94, P537; Smith RD, 2010, AIDS, V24, P2109, DOI 10.1097/QAD.0b013e32833c7b9c; STALL R, 1994, ARCH INTERN MED, V154, P57, DOI 10.1001/archinte.154.1.57; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Vance DE, 2011, CLIN INTERV AGING, V6, P181, DOI 10.2147/CIA.S14726; REPORT GLOBAL HIV AI	37	39	39	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43618	10.1371/journal.pone.0043618	http://dx.doi.org/10.1371/journal.pone.0043618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	995WH	22952722	Green Published, gold, Green Submitted			2022-12-25	WOS:000308044800044
J	Kisand, V; Valente, A; Lahm, A; Tanet, G; Lettieri, T				Kisand, Veljo; Valente, Angelica; Lahm, Armin; Tanet, Gerard; Lettieri, Teresa			Phylogenetic and Functional Metagenomic Profiling for Assessing Microbial Biodiversity in Environmental Monitoring	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; NEW-GENERATION; DATABASE; SERVER; SOIL; IDENTIFICATION; COMMUNITIES; ANNOTATION; ABUNDANCE; PATHWAYS	Decisions guiding environmental management need to be based on a broad and comprehensive understanding of the biodiversity and functional capability within ecosystems. Microbes are of particular importance since they drive biogeochemical cycles, being both producers and decomposers. Their quick and direct responses to changes in environmental conditions modulate the ecosystem accordingly, thus providing a sensitive readout. Here we have used direct sequencing of total DNA from water samples to compare the microbial communities of two distinct coastal regions exposed to different anthropogenic pressures: the highly polluted Port of Genoa and the protected area of Montecristo Island in the Mediterranean Sea. Analysis of the metagenomes revealed significant differences in both microbial diversity and abundance between the two areas, reflecting their distinct ecological habitats and anthropogenic stress conditions. Our results indicate that the combination of next generation sequencing (NGS) technologies and bioinformatics tools presents a new approach to monitor the diversity and the ecological status of aquatic ecosystems. Integration of metagenomics into environmental monitoring campaigns should enable the impact of the anthropogenic pressure on microbial biodiversity in various ecosystems to be better assessed and also predicted.	[Kisand, Veljo] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia; [Kisand, Veljo; Valente, Angelica; Tanet, Gerard; Lettieri, Teresa] European Commiss Joint Res Ctr, Inst Environm & Sustainabil, Ispra, VA, Italy; [Lahm, Armin] Bioinformat Project Support, Rome, Italy	University of Tartu; European Commission Joint Research Centre; EC JRC ISPRA Site	Kisand, V (corresponding author), Univ Tartu, Inst Technol, Ulikooli 18, EE-50090 Tartu, Estonia.	teresa.lettieri@jrc.ec.europa.eu	Kisand, Veljo/H-2466-2012	Kisand, Veljo/0000-0002-5535-1639; Lettieri, Teresa/0000-0002-3363-9666	European Commission; European Regional Development Fund through the Center of Excellence in Chemical Biology, Estonia	European Commission(European CommissionEuropean Commission Joint Research Centre); European Regional Development Fund through the Center of Excellence in Chemical Biology, Estonia	This work was funded by the European Commission and partly funded by the European Regional Development Fund through the Center of Excellence in Chemical Biology, Estonia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Aoki-Kinoshita Kiyoko F., 2007, V396, P71; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Balzer S, 2011, BIOINFORMATICS, V27, pI304, DOI 10.1093/bioinformatics/btr251; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bertolotto RM, 2005, MAR POLLUT BULL, V50, P348, DOI 10.1016/j.marpolbul.2004.12.002; Bodour AA, 2003, ENVIRON MICROBIOL, V5, P888, DOI 10.1046/j.1462-2920.2003.00481.x; Brennerova MV, 2009, ENVIRON MICROBIOL, V11, P2216, DOI 10.1111/j.1462-2920.2009.01943.x; Brochier-Armanet C, 2011, ISME J, V5, P1291, DOI 10.1038/ismej.2011.16; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Falciani R, 2000, J ANAL ATOM SPECTROM, V15, P561, DOI 10.1039/b000742k; Feingersch R, 2010, ISME J, V4, P78, DOI 10.1038/ismej.2009.92; Gianoulis TA, 2009, P NATL ACAD SCI USA, V106, P1374, DOI 10.1073/pnas.0808022106; Gifford SM, 2011, ISME J, V5, P461, DOI 10.1038/ismej.2010.141; Gilbert JA, 2011, ANNU REV MAR SCI, V3, P347, DOI 10.1146/annurev-marine-120709-142811; Golubiewsk N, 2010, ENCY EARTH; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Hong SH, 2009, ISME J, V3, P1365, DOI 10.1038/ismej.2009.89; Huang Y, 2009, BIOINFORMATICS, V25, P1338, DOI 10.1093/bioinformatics/btp161; Iyer LM, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-45; Jeon S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-222; Johnston EL, 2009, ENVIRON POLLUT, V157, P1745, DOI 10.1016/j.envpol.2009.02.017; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Kristiansson E, 2009, BIOINFORMATICS, V25, P2737, DOI 10.1093/bioinformatics/btp508; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li WZ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-359; Lingner T, 2011, NUCLEIC ACIDS RES, V39, pW518, DOI 10.1093/nar/gkr388; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Metzger KJ, 2011, ECOL INFORM, V6, P4, DOI 10.1016/j.ecoinf.2010.11.003; Niemi G, 2004, ENVIRON HEALTH PERSP, V112, P979, DOI 10.1289/ehp.6903; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pavan M, 1989, ISOLA MONTECRISTO RI, V77, P125; Raffaelli D.G., 2010, ECOSYSTEM ECOLOGY NE; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Selengut JD, 2010, J BACTERIOL, V192, P5788, DOI 10.1128/JB.00425-10; Sinigalliano CD, 2010, WATER RES, V44, P3763, DOI 10.1016/j.watres.2010.04.026; Spellerberg I. F., 2005, MONITORING ECOLOGICA, DOI DOI 10.1017/CBO9780511614699; Sumpter JP, 2009, PHILOS T R SOC A, V367, P3877, DOI 10.1098/rsta.2009.0106; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Vaughan H, 2001, ENVIRON MONIT ASSESS, V67, P3, DOI 10.1023/A:1006423432114; Wade TJ, 2003, ENVIRON HEALTH PERSP, V111, P1102, DOI 10.1289/ehp.6241	50	35	36	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43630	10.1371/journal.pone.0043630	http://dx.doi.org/10.1371/journal.pone.0043630			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952724	Green Submitted, Green Published, gold			2022-12-25	WOS:000308044800046
J	Patra, R; Chattopadhyay, S; De, R; Ghosh, P; Ganguly, M; Chowdhury, A; Ramamurthy, T; Nair, GB; Mukhopadhyay, AK				Patra, Rajashree; Chattopadhyay, Santanu; De, Ronita; Ghosh, Prachetash; Ganguly, Mou; Chowdhury, Abhijit; Ramamurthy, T.; Nair, G. B.; Mukhopadhyay, Asish K.			Multiple Infection and Microdiversity among Helicobacter pylori Isolates in a Single Host in India	PLOS ONE			English	Article							GENETIC DIVERSITY; POPULATION-STRUCTURE; LENGTH-POLYMORPHISM; ALLELIC DIVERSITY; GENOME DIVERSITY; GASTRIC-CANCER; STRAINS; SEQUENCE; VACA; RECOMBINATION	Helicobacter pylori is one of the most diverse bacterial species that chronically infects more than 70% of Indian population. Interestingly, data showing microdiversity of the H. pylori strains within a particular gastric niche remained scarce. To understand the extent of genetic diversity among H. pylori strains within a given host, 30 patients with gastro-duodenal problems were subjected to endoscopy and from each patient 10 single colonies were isolated. Characterization of each of these 10 single colonies by DNA fingerprinting as well as genotyping of several important genetic markers viz. cagA, vacA, iceA, vapD, cag PAI empty site, IS605, RFLP and two other genetic segments within cag PAI revealed that all of the 30 patients were infected with more than one strain and sometimes strains with 5 to 6 types of genetic variants. Analyses of certain genetic loci showed the microdiversity among the colonies from single patient, which may be due to the recombination events during long-term carriage of the pathogen. These results suggest that most of the patients have acquired H. pylori due to repeated exposure to this pathogen with different genetic make-up, which may increase the possibility of super infections. Genetic exchanges between these unrelated H. pylori strains may support certain H. pylori variant to grow better in a given host than the parental strain and thereby increasing the possibility for the severity of the infection.	[Patra, Rajashree; Chattopadhyay, Santanu; De, Ronita; Ghosh, Prachetash; Ganguly, Mou; Ramamurthy, T.; Nair, G. B.; Mukhopadhyay, Asish K.] Natl Inst Cholera & Enter Dis, Kolkata, India; [Chowdhury, Abhijit] Inst Post Grad Med Educ & Res, Liver Res Ctr, Sch Digest & Liver Dis, Kolkata, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Patra, R (corresponding author), Natl Inst Cholera & Enter Dis, Kolkata, India.	asish_mukhopadhyay@yahoo.com	Mukhopadhyay, Asish/ABE-7697-2020; DE, RONITA/HDM-7066-2022; Das, Rajashree/AAS-4747-2020; Das, Rajashree/D-1755-2017	Das, Rajashree/0000-0003-1202-4942; De, Ronita/0000-0002-1469-6139; Chattopadhyay, Santanu/0000-0002-6275-8568	Indian Council of Medical Research and Department of Biotechnology, India [BT/PR10407/BRB/10/604/2008]	Indian Council of Medical Research and Department of Biotechnology, India(Indian Council of Medical Research (ICMR))	The work was supported in part by the Indian Council of Medical Research and Department of Biotechnology, India (Sanction No. BT/PR10407/BRB/10/604/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akada JK, 2003, MICROBIOL-SGM, V149, P1901, DOI 10.1099/mic.0.26129-0; AKOPYANZ N, 1992, NUCLEIC ACIDS RES, V20, P5137, DOI 10.1093/nar/20.19.5137; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Azuma T, 2004, J GASTROENTEROL, V39, P97, DOI 10.1007/s00535-003-1279-4; Berg DE, 1997, TRENDS MICROBIOL, V5, P468, DOI 10.1016/S0966-842X(97)01164-5; Berg Douglas E., 1994, Methods in Molecular and Cellular Biology, V5, P13; Burucoa C, 1999, J CLIN MICROBIOL, V37, P4071, DOI 10.1128/JCM.37.12.4071-4080.1999; Cao P, 1997, J BACTERIOL, V179, P2852, DOI 10.1128/jb.179.9.2852-2856.1997; Chattopadhyay S, 2004, J CLIN MICROBIOL, V42, P2821, DOI 10.1128/JCM.42.6.2821-2824.2004; Cooke CL, 2005, FEMS IMMUNOL MED MIC, V45, P11, DOI 10.1016/j.femsim.2005.04.002; Correa P, 1997, J Physiol Pharmacol, V48 Suppl 4, P19; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; GARNER JA, 1995, J INFECT DIS, V172, P290, DOI 10.1093/infdis/172.1.290; Gill H H, 1993, Indian J Gastroenterol, V12, P9; Go MF, 1996, J BACTERIOL, V178, P3934, DOI 10.1128/jb.178.13.3934-3938.1996; GRAHAM DY, 1991, DIGEST DIS SCI, V36, P1084, DOI 10.1007/BF01297451; Han SR, 2000, J CLIN MICROBIOL, V38, P3646, DOI 10.1128/JCM.38.10.3646-3651.2000; Israel DA, 2001, P NATL ACAD SCI USA, V98, P14625, DOI 10.1073/pnas.251551698; Ito Y, 1998, J INFECT DIS, V178, P1391, DOI 10.1086/314435; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jiang Q, 1996, MOL MICROBIOL, V20, P833, DOI 10.1111/j.1365-2958.1996.tb02521.x; Kersulyte D, 1999, MOL MICROBIOL, V31, P31, DOI 10.1046/j.1365-2958.1999.01140.x; Kitamoto N, 1998, HELICOBACTER, V3, P152, DOI 10.1046/j.1523-5378.1998.08703.x; Kuo CH, 1999, J INFECT DIS, V180, P2064, DOI 10.1086/315130; LOPEZ CR, 1993, FEMS MICROBIOL LETT, V110, P37, DOI 10.1111/j.1574-6968.1993.tb06292.x; Marshall DG, 1996, J APPL BACTERIOL, V81, P509; Miehlke S, 1999, J CLIN MICROBIOL, V37, P245, DOI 10.1128/JCM.37.1.245-247.1999; Morales-Espinosa R, 2008, BIOQUIMIA, V33, P43; Mukhopadhyay AK, 2000, J BACTERIOL, V182, P3219, DOI 10.1128/JB.182.11.3219-3227.2000; NEALE KR, 1995, ALIMENT PHARM THER, V9, P77; OWEN RJ, 1994, J CLIN MICROBIOL, V32, P1203, DOI 10.1128/JCM.32.5.1203-1210.1994; Parsonnet J, 1998, INFECT DIS CLIN N AM, V12, P185, DOI 10.1016/S0891-5520(05)70417-7; PARSONNET J, 1995, ALIMENT PHARM THERAP, V9, P45; PRASAD S, 1994, J GASTROEN HEPATOL, V9, P501, DOI 10.1111/j.1440-1746.1994.tb01281.x; Shortridge VD, 1997, J CLIN MICROBIOL, V35, P471, DOI 10.1128/JCM.35.2.471-473.1997; SMITH JM, 1991, NATURE, V349, P29, DOI 10.1038/349029a0; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; TAYLOR DE, 1992, J BACTERIOL, V174, P6800, DOI 10.1128/JB.174.21.6800-6806.1992; TAYLOR NS, 1995, J CLIN MICROBIOL, V33, P918, DOI 10.1128/JCM.33.4.918-923.1995; TEE W, 1992, J CLIN MICROBIOL, V30, P1562, DOI 10.1128/JCM.30.6.1562-1567.1992; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; van Doorn LJ, 1998, J CLIN MICROBIOL, V36, P2597, DOI 10.1128/JCM.36.9.2597-2603.1998; Yakoob J, 2001, CLIN MICROBIOL INFEC, V7, P187, DOI 10.1046/j.1198-743x.2001.00226.x; YAMADA T, 1994, JAMA-J AM MED ASSOC, V272, P65, DOI 10.1001/jama.272.1.65; Yamaoka Y, 1998, J CLIN MICROBIOL, V36, P2258, DOI 10.1128/JCM.36.8.2258-2263.1998	47	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43370	10.1371/journal.pone.0043370	http://dx.doi.org/10.1371/journal.pone.0043370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952670	Green Published, Green Submitted, gold			2022-12-25	WOS:000308044800028
J	Mello, MLS; Vidal, BC				Mello, Maria Luiza S.; Vidal, B. C.			Changes in the Infrared Microspectroscopic Characteristics of DNA Caused by Cationic Elements, Different Base Richness and Single-Stranded Form	PLOS ONE			English	Article							AMIDE-I-BAND; CRITICAL ELECTROLYTE CONCENTRATION; POSSIBLE COMMON BIOMARKERS; NUCLEIC-ACIDS; MID-IR; FT-IR; SPECTROSCOPY; PROTAMINE; COLLAGEN; HETEROCHROMATIN	Background: The infrared (IR) analysis of dried samples of DNA and DNA-polypeptide complexes is still scarce. Here we have studied the FT-IR profiles of these components to further the understanding of the FT-IR signatures of chromatin and cell nuclei. Methodology/Principal Findings: Calf thymus and salmon testis DNA, and complexes of histone H1, protamine, poly-L-lysine and poly-L-arginine (histone-mimic macromolecules) with DNA were analyzed in an IR microspectroscope equipped with an attenuated total reflection diamond objective and Grams software. Conditions including polypeptides bound to the DNA, DNA base composition, and single-stranded form were found to differently affect the vibrational characteristics of the chemical groups (especially, PO2-) in the nucleic acid. The antisymmetric stretching (nu(as)) of the DNA PO2- was greater than the symmetric stretching (nu(s)) of these groups and increased in the polypeptide-DNA complexes. A shift of the nas of the DNA PO2- to a lower frequency and an increased intensity of this vibration were induced especially by lysine-rich histones. Lysine richness additionally contributed to an increase in the vibrational stretching of the amide I group. Even in simple molecules such as inorganic phosphates, the vibrational characteristics of the phosphate anions were differently affected by different cations. As a result of the optimization of the DNA conformation by binding to arginine-rich polypeptides, enhancements of the vibrational characteristics in the FT-IR fingerprint could be detected. Although different profiles were obtained for the DNA with different base compositions, this situation was no longer verified in the polypeptide-DNA complexes and most likely in isolated chromatin or cell nuclei. However, the nu(as) PO2-/nu(s) PO2- ratio could discriminate DNA with different base compositions and DNA in a single-stranded form. Conclusions/Significance: FT-IR spectral profiles are a valuable tool for establishing the vibrational characteristics of individualized chromatin components, such as DNA and DNA-polypeptide complexes in dried samples.	[Mello, Maria Luiza S.; Vidal, B. C.] Univ Campinas Unicamp, Inst Biol, Dept Struct & Physiol Biol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas	Mello, MLS (corresponding author), Univ Campinas Unicamp, Inst Biol, Dept Struct & Physiol Biol, Sao Paulo, Brazil.	camposvi@unicamp.br	Mello, Maria Luiza Silveira/D-9158-2012; Vidal, Benedicto/I-3227-2012; de Campos Vidal, Benedicto/ABH-6617-2020	Mello, Maria Luiza Silveira/0000-0003-1629-5619; Vidal, Benedicto/0000-0003-1629-5619; de Campos Vidal, Benedicto/0000-0003-0285-1653	Sao Paulo State Research Foundation (FAPESP) [2010/50015-6, 2007/58251-8]; Brazilian Council for Research and Development (CNPq) [472936/2009-7]; CNPq [301943/2009-5]	Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Council for Research and Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants no. 2010/50015-6 and 2007/58251-8 from the Sao Paulo State Research Foundation (FAPESP) and grant no. 472936/2009-7 from the Brazilian Council for Research and Development (CNPq). MLSM received a research fellowship from CNPq (301943/2009-5). The funders had no role in study deign, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEX S, 1989, INORG CHIM ACTA, V157, P271, DOI 10.1016/S0020-1693(00)80552-6; Anastassopoulou J, 2009, VIB SPECTROSC, V51, P270, DOI 10.1016/j.vibspec.2009.07.005; Argov S, 2002, J BIOMED OPT, V7, P248, DOI 10.1117/1.1463051; Balhorn R, 2000, MOL REPROD DEV, V56, P230, DOI 10.1002/(SICI)1098-2795(200006)56:2+<230::AID-MRD3>3.3.CO;2-M; Banyay M, 2003, BIOPHYS CHEM, V104, P477, DOI 10.1016/S0301-4622(03)00035-8; Bird B, 2008, BMC CLIN PATHOL, V8, DOI 10.1186/1472-6890-8-8; BLOCH DP, 1969, GENETICS, V61, P93; Brewer L, 2003, J BIOL CHEM, V278, P42403, DOI 10.1074/jbc.M303610200; Brewer LR, 1999, SCIENCE, V286, P120, DOI 10.1126/science.286.5437.120; CHARGAFF E, 1951, J BIOL CHEM, V192, P223; Cherng JY, 2009, J PHARM PHARM SCI, V12, P346, DOI 10.18433/J3859K; Cheung KT, 2011, ANALYST, V136, P2047, DOI 10.1039/c0an00972e; Clark J., 2000, FINGERPRINT REGION I; Cree LH, 2011, PROTEIN PEPTIDE LETT, V18, P802; Diem M, 2004, ANALYST, V129, P880, DOI 10.1039/b408952a; DIEM M, 2008, VIBRATIONAL SPECTROS; Dukor R.K., 2002, BIOMEDICAL APPL, V5, P3335, DOI [DOI 10.1002/0470027320.S8107, 10.1002/0470027320.s8107]; Froehlich E, 2011, BIOMACROMOLECULES, V12, P511, DOI 10.1021/bm1013102; Hembram KPSS, 2009, MAT SCI ENG C-BIO S, V29, P1093, DOI 10.1016/j.msec.2008.09.021; Holton SE, 2011, BIOPHYS J, V101, P1513, DOI 10.1016/j.bpj.2011.07.055; Kanakis CD, 2009, J PHOTOCH PHOTOBIO B, V95, P204, DOI 10.1016/j.jphotobiol.2009.03.006; LAZAREV YA, 1985, BIOPOLYMERS, V24, P1449, DOI 10.1002/bip.360240804; Le-Tien C, 2007, TALANTA, V71, P1969, DOI 10.1016/j.talanta.2006.09.003; Li MJ, 2002, ULTRASTRUCT PATHOL, V26, P365, DOI 10.1080/01913120290104674; LIQUIER J, 1991, SPECTROCHIM ACTA A, V47, P177, DOI 10.1016/0584-8539(91)80089-2; LIQUIERS J, 1990, J BIOMOL STRUCT DYN, V8, P295, DOI 10.1080/07391102.1990.10507806; Marty R, 2009, NUCLEIC ACIDS RES, V37, P849, DOI 10.1093/nar/gkn1003; MELLO MLS, 1989, CYTOBIOS, V59, P87; Mordechai S, 2004, J MICROSC-OXFORD, V215, P86, DOI 10.1111/j.0022-2720.2004.01356.x; PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105; Pijanka JK, 2009, ANALYST, V134, P1176, DOI 10.1039/b821112d; PIVEC L, 1972, BIOCHIM BIOPHYS ACTA, V272, P179, DOI 10.1016/0005-2787(72)90242-0; Poplineau M, 2011, EPIGENOMICS-UK, V3, P785, DOI [10.2217/EPI.11.102, 10.2217/epi.11.102]; Sahu RK, 2008, BIOPOLYMERS, V89, P993, DOI 10.1002/bip.21048; Sahu RK, 2010, FUTURE ONCOL, V6, P1653, DOI 10.2217/FON.10.120; Sahu RK, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2080368; Sahu RK, 2004, TECHNOL CANCER RES T, V3, P629, DOI 10.1177/153303460400300613; Singh B, 2012, CURR SCI INDIA, V102, P232; TAILLANDIER E, 1992, METHOD ENZYMOL, V211, P307; VIDAL BC, 1972, BEITR PATHOL, V145, P269; VIDAL BD, 1989, ACTA HISTOCHEM CYTOC, V22, P471; VIDAL BDC, 1979, HISTOCHEMISTRY, V60, P309; Vidal BD, 2011, MICRON, V42, P283, DOI 10.1016/j.micron.2010.09.010; Yang Y, 2005, BIOPOLYMERS, V78, P311, DOI 10.1002/bip.20297; Zelig U, 2011, BBA-GEN SUBJECTS, V1810, P827, DOI 10.1016/j.bbagen.2011.06.010	45	105	107	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43169	10.1371/journal.pone.0043169	http://dx.doi.org/10.1371/journal.pone.0043169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937023	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500035
J	Shamu, S; Abrahams, N; Temmerman, M; Shefer, T; Zarowsky, C				Shamu, Simukai; Abrahams, Naeemah; Temmerman, Marleen; Shefer, Tamara; Zarowsky, Christina			"That Pregnancy Can Bring Noise into the Family'': Exploring Intimate Partner Sexual Violence during Pregnancy in the Context of HIV in Zimbabwe	PLOS ONE			English	Article							ANTENATAL CLINICS; WOMEN; RAPE; BEHAVIOR; COERCION; AFRICA; GENDER; HEALTH; ABUSE; POWER	Background: Globally, studies report a high prevalence of intimate partner sexual violence (IPSV) and an association with HIV infection. Despite the criminalisation of IPSV and deliberate sexual HIV infection in Zimbabwe, IPSV remains common. This study explored women's and health workers' perspectives and experiences of sexuality and sexual violence in pregnancy, including in relation to HIV testing. Methods: This qualitative study was part of a larger study of the dynamics of intimate partner violence and HIV in pregnancy in Zimbabwe. Key informant interviews were conducted with health workers and focus group discussions were held with 64 pregnant or nursing mothers attending antenatal and postnatal care clinics in low-income neighbourhoods of Harare, covering the major thematic areas of validated sexual violence research instruments. Thematic content analysis of audio-recorded and transcribed data was conducted. Results: While women reported some positive experiences of sex in pregnancy, most participants commonly experienced coercive sexual practices. They reported that men failed to understand, or refused to accept, pregnancy and its associated emotional changes, and often forced painful and degrading sexual acts on them, usually while the men were under the influence of alcohol or illicit drugs. Men often refused or delayed HIV testing, and participants reported accounts of HIV-positive men not disclosing their status to their partners and deliberately infecting or attempting to infect them. Women's passive acceptance of sexual violence was influenced by advice they received from other females to subordinate to their partners and to not deprive men of their conjugal sexual rights. Conclusions: Cultural and societal factors, unequal gender norms and practices, women's economic vulnerability, and men's failure to understand pregnancy and emotional changes, influence men to perpetrate IPSV, leading to high risk of HIV infection.	[Shamu, Simukai; Abrahams, Naeemah; Zarowsky, Christina] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Abrahams, Naeemah] MRC, Gender & Hlth Res Unit, Cape Town, South Africa; [Temmerman, Marleen] Univ Ghent, Int Ctr Reprod Hlth, B-9000 Ghent, Belgium	University of the Western Cape; Ghent University	Shamu, S (corresponding author), Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa.	shamuts@yahoo.com	Abrahams, Naeemah/AAF-1144-2020; Abrahams, Naeemah/C-5577-2013	Shamu, Simukai/0000-0002-2290-0515; Zarowsky, Christina/0000-0002-0850-6212; Abrahams, Naeemah/0000-0002-6138-6256	University of the Western Cape; University of the Western Cape's Faculty Research grant	University of the Western Cape; University of the Western Cape's Faculty Research grant	The first author received funding for PhD studies from the Flemish Inter-University cooperation with the University of the Western Cape to which this paper contributes, whilst fieldwork for this paper was supported by the University of the Western Cape's Faculty Research grant (through Professor CZ). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brou H, 2007, PLOS MED, V4, P1912, DOI 10.1371/journal.pmed.0040342; Chandisarewa W, 2007, B WORLD HEALTH ORGAN, V85, P843, DOI 10.2471/BLT.06.035188; Chirawu S, 2006, CARDOZO J LAW GENDER, V13; Clowes L, 2009, AGENDA-EMPOWER WOMEN, V23, P22, DOI 10.1080/10130950.2009.9676236; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Gielen AC, 2002, AIDS BEHAV, V6; Guo SF, 2004, INT J GYNECOL OBSTET, V84, P281, DOI 10.1016/j.ijgo.2003.08.019; Heise L, 2002, INT J GYNECOLOGY OBS, V78; Jewkes R, 2006, INT J EPIDEMIOL, V35, P1461, DOI 10.1093/ije/dyl218; Jewkes R, 2002, SOC SCI MED, V55, P1231, DOI 10.1016/S0277-9536(01)00242-8; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Jewkes R, 2001, S AFR MED J, V91, P421; Jewkes R., 2009, UNDERSTANDING MENS H; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Kahn L, 2008, SEXUAL SUBJECTS FEMI; Kambarami M., 2006, FEMININITY SEXUALITY; Koenig MA, 2004, INT FAM PLAN PERSPEC, V30, P156, DOI 10.1363/3015604; Lesch E, 2004, S AFR J PSYCHOL, V34, P464, DOI 10.1177/008124630403400308; [Macro International Inc Central Statistical Office (CSO) [Zimbabwe]], 2007, ZIMB DEM HLTH SURV 2; Mahoney P., 2007, SEXUAL ASSAULT MARRI; Mlay R, 2008, AIDS CARE, V20, P356, DOI 10.1080/09540120701561304; Njovana Eunice, 1996, REPROD HEALTH MATTER, V4, P46, DOI DOI 10.1016/S0968-8080(96)90005-1; Osirim M, 2002, AFRICAN STUDIES Q, V7; Pronyk PM, 2008, AIDS, V22, P1659, DOI 10.1097/QAD.0b013e328307a040; Reddy S, 2007, SEXUALITIES, V10, P157, DOI DOI 10.1177/1363460707075797; Roelens K, 2008, EUR J OBSTET GYN R B, V137, P37, DOI 10.1016/j.ejogrb.2007.04.013; Shamu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017591; Shefer T, 2009, INTERSECTIONS GENDER; Shefer T, 2009, S AFRICAN J PSYCHOL, V30, P28; Shefer T, 2002, CULTURE HLTH SEXUALI, V3, P375; Shefer T, 2008, FEM PSYCHOL, V18, P157, DOI 10.1177/0959353507088265; Shefer T, 2012, AJAR-AFR J AIDS RES, V11, P113, DOI 10.2989/16085906.2012.698078; Silberschmidt M, 2001, WORLD DEV, V29, P657, DOI 10.1016/S0305-750X(00)00122-4; Silberschmidt M, 2001, SOC SCI MED, V52, P1815, DOI 10.1016/S0277-9536(00)00299-9; Stesyfin K, 2008, BRIEF OVERVIEW RECEN; Swidler A, 2007, STUD FAMILY PLANN, V38, P147, DOI 10.1111/j.1728-4465.2007.00127.x; von Sydow K, 1999, J PSYCHOSOM RES, V47, P27, DOI 10.1016/S0022-3999(98)00106-8; WATTS C, 1998, REPROD HEALTH MATTER, V6, P57, DOI DOI 10.1016/S0968-8080(98)90008-8; WHO, 2005, MULT STUD WOM HLTH D; Wood K, 2005, CULT HEALTH SEX, V7, P303, DOI 10.1080/13691050500100724; Wood K, 1998, LOVE IS DANGEROUS TH; Wood K, 2007, MED ANTHROPOL Q, V21, P277, DOI 10.1525/maq.2007.21.3.277; World Health Organization, 2001, PUTT WOM 1 ETH SAF R	44	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43148	10.1371/journal.pone.0043148	http://dx.doi.org/10.1371/journal.pone.0043148			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998GM	22937018	Green Published, gold			2022-12-25	WOS:000308225500031
J	Lipinski, RJ; Hammond, P; O'Leary-Moore, SK; Ament, JJ; Pecevich, SJ; Jiang, Y; Budin, F; Parnell, SE; Suttie, M; Godin, EA; Everson, JL; Dehart, DB; Oguz, I; Holloway, HT; Styner, MA; Johnson, GA; Sulik, KK				Lipinski, Robert J.; Hammond, Peter; O'Leary-Moore, Shonagh K.; Ament, Jacob J.; Pecevich, Stephen J.; Jiang, Yi; Budin, Francois; Parnell, Scott E.; Suttie, Michael; Godin, Elizabeth A.; Everson, Joshua L.; Dehart, Deborah B.; Oguz, Ipek; Holloway, Hunter T.; Styner, Martin A.; Johnson, G. Allan; Sulik, Kathleen K.			Ethanol-Induced Face-Brain Dysmorphology Patterns Are Correlative and Exposure-Stage Dependent	PLOS ONE			English	Article							FETAL-ALCOHOL-SYNDROME; MAGNETIC-RESONANCE; SPECTRUM DISORDERS; FACIAL MORPHOLOGY; OCULAR MANIFESTATIONS; ACUTE INSULT; MOUSE MODEL; MICE; SCHIZOPHRENIA; ABNORMALITIES	Prenatal ethanol exposure is the leading preventable cause of congenital mental disability. Whereas a diagnosis of fetal alcohol syndrome (FAS) requires identification of a specific pattern of craniofacial dysmorphology, most individuals with behavioral and neurological sequelae of heavy prenatal ethanol exposure do not exhibit these defining facial characteristics. Here, a novel integration of MRI and dense surface modeling-based shape analysis was applied to characterize concurrent face-brain phenotypes in C57Bl/6J fetuses exposed to ethanol on gestational day (GD)7 or GD8.5. The facial phenotype resulting from ethanol exposure depended upon stage of insult and was predictive of unique patterns of corresponding brain abnormalities. Ethanol exposure on GD7 produced a constellation of dysmorphic facial features characteristic of human FAS, including severe midfacial hypoplasia, shortening of the palpebral fissures, an elongated upper lip, and deficient philtrum. In contrast, ethanol exposure on GD8.5 caused mild midfacial hypoplasia and palpebral fissure shortening, a shortened upper lip, and a preserved philtrum. These distinct, stage-specific facial phenotypes were associated with unique volumetric and shape abnormalities of the septal region, pituitary, and olfactory bulbs. By demonstrating that early prenatal ethanol exposure can cause more than one temporally-specific pattern of defects, these findings illustrate the need for an expansion of current diagnostic criteria to better capture the full range of facial and brain dysmorphology in fetal alcohol spectrum disorders.	[Lipinski, Robert J.; O'Leary-Moore, Shonagh K.; Ament, Jacob J.; Pecevich, Stephen J.; Parnell, Scott E.; Godin, Elizabeth A.; Everson, Joshua L.; Dehart, Deborah B.; Holloway, Hunter T.; Sulik, Kathleen K.] Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27515 USA; [O'Leary-Moore, Shonagh K.; Budin, Francois; Oguz, Ipek; Styner, Martin A.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Hammond, Peter; Suttie, Michael] UCL, Inst Child Hlth, London, England; [Jiang, Yi; Johnson, G. Allan] Duke Univ, Ctr In Vivo Microscopy, Durham, NC USA; [Parnell, Scott E.; Dehart, Deborah B.; Sulik, Kathleen K.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of London; University College London; Duke University; University of North Carolina; University of North Carolina Chapel Hill	Lipinski, RJ (corresponding author), Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27515 USA.	lipinski@med.unc.edu	Styner, Martin/AAS-9949-2020; (CHANL), Chapel Hill Analytical and Nanofabrication Laboratory/AAA-9271-2022	Styner, Martin/0000-0002-8747-5118; Johnson, G.Allan/0000-0002-7606-5447; Lipinski, Robert/0000-0002-1994-4090; Everson, Josh/0000-0002-2887-8574; Suttie, Michael/0000-0002-5538-8431	National Institutes of Health [AA011605, AA017124, AA007573, DE-16215-05, U24 CA092656, U24 RR021760, T90DE021986-01, P41 EB015897, P30 HD003110]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003110] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U24CA092656] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE016215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA011605, P50AA011605, R00AA018697, U01AA017124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health grants AA011605, AA017124, AA007573, DE-16215-05, U24 CA092656, U24 RR021760, T90DE021986-01, P41 EB015897, and P30 HD003110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1986, LANCET, V2, P1222; Akers KG, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-29; AMMANN AJ, 1982, AM J DIS CHILD, V136, P906, DOI 10.1001/archpedi.1982.03970460036008; Astley SJ, 2000, ALCOHOL ALCOHOLISM, V35, P400, DOI 10.1093/alcalc/35.4.400; Astley SJ, 2009, ALCOHOL CLIN EXP RES, V33, P1671, DOI 10.1111/j.1530-0277.2009.01004.x; Beaton EA, 2010, PSYCHIAT RES-NEUROIM, V181, P108, DOI 10.1016/j.pscychresns.2009.10.009; Brisch R, 2007, EUR ARCH PSY CLIN N, V257, P140, DOI 10.1007/s00406-006-0697-8; Brisch R, 2008, PSYCHIAT RES-NEUROIM, V164, P265, DOI 10.1016/j.pscychresns.2007.12.007; CHAN T, 1991, BRIT J OPHTHALMOL, V75, P524, DOI 10.1136/bjo.75.9.524; Chen YY, 2011, ALCOHOL CLIN EXP RES, V35, P1293, DOI 10.1111/j.1530-0277.2011.01465.x; CLARREN SK, 1978, NEW ENGL J MED, V298, P1063, DOI 10.1056/NEJM197805112981906; Downing C, 2009, ALCOHOL CLIN EXP RES, V33, P1238, DOI 10.1111/j.1530-0277.2009.00949.x; Dunty WC, 2001, ALCOHOL CLIN EXP RES, V25, P1523, DOI 10.1111/j.1530-0277.2001.tb02156.x; Famy C, 1998, AM J PSYCHIAT, V155, P552, DOI 10.1176/ajp.155.4.552; Galarza M, 2004, J NEUROPSYCH CLIN N, V16, P41, DOI 10.1176/appi.neuropsych.16.1.41; Gilliam DM, 1996, ALCOHOL, V13, P47, DOI 10.1016/0741-8329(95)02010-1; Godin EA, 2010, ALCOHOL CLIN EXP RES, V34, P98, DOI 10.1111/j.1530-0277.2009.01071.x; Hammond P, 2008, MOL PSYCHIATR, V13, P614, DOI 10.1038/mp.2008.18; Hammond P, 2005, AM J HUM GENET, V77, P999, DOI 10.1086/498396; Hammond P, 2004, AM J MED GENET A, V126A, P339, DOI 10.1002/ajmg.a.20665; Hammond P, 2011, ALCOHOLISM CLIN EXPT, V35, p266A; Hammond P, 2012, HUM MUTAT, V33, P817, DOI 10.1002/humu.22054; Hammond P, 2012, EUR J HUM GENET, V20, P33, DOI 10.1038/ejhg.2011.135; Hoyme HE, 2005, PEDIATRICS, V115, P39, DOI 10.1542/peds.2004-0259; Hu D, 2009, DEVELOPMENT, V136, P107, DOI 10.1242/dev.026583; Hutton TJ, 2003, IEEE T MED IMAGING, V22, P747, DOI 10.1109/TMI.2003.814784; Johnson GA, 2007, NEUROIMAGE, V37, P82, DOI 10.1016/j.neuroimage.2007.05.013; Jolin EM, 2009, CURR PSYCHIAT REP, V11, P99, DOI 10.1007/s11920-009-0016-y; Keen CL, 2010, BIOFACTORS, V36, P125, DOI 10.1002/biof.89; KOTCH LE, 1992, INT J DEV NEUROSCI, V10, P273, DOI 10.1016/0736-5748(92)90016-S; KRETSCHM.R, 1968, NEW ENGL J MED, V279, P1295, DOI 10.1056/NEJM196812122792401; LOHR JB, 1989, SCHIZOPHRENIA BULL, V15, P595, DOI 10.1093/schbul/15.4.595; Marcucio RS, 2011, GENESIS, V49, P177, DOI 10.1002/dvg.20710; Marcucio RS, 2005, DEV BIOL, V284, P48, DOI 10.1016/j.ydbio.2005.04.030; May PA, 2009, DEV DISABIL RES REV, V15, P176, DOI 10.1002/ddrr.68; O'Leary-Moore SK, 2010, BIRTH DEFECTS RES A, V88, P953, DOI 10.1002/bdra.20719; Oguz I, 2011, P SOC PHOTOOPTICAL I, V7962; Parnell SE, 2006, ALCOHOL CLIN EXP RES, V30, P1791, DOI 10.1111/j.1530-0277.2006.00212.x; Parnell SE, 2009, ALCOHOL CLIN EXP RES, V33, P1001, DOI 10.1111/j.1530-0277.2009.00921.x; Parsons TE, 2011, DEV DYNAM, V240, P2233, DOI 10.1002/dvdy.22729; Ribeiro IM, 2007, EUR J OPHTHALMOL, V17, P104, DOI 10.1177/112067210701700114; Riley EP, 2011, NEUROPSYCHOL REV, V21, P73, DOI 10.1007/s11065-011-9166-x; Sulik K K, 1986, Am J Med Genet Suppl, V2, P97; Sulik KK, 2005, EXP BIOL MED, V230, P366, DOI 10.1177/15353702-0323006-04; SULIK KK, 1981, SCIENCE, V214, P936, DOI 10.1126/science.6795717; Swayze VW, 1997, PEDIATRICS, V99, P232, DOI 10.1542/peds.99.2.232; Yang Y, 2011, CEREBRAL CORTEX; Yang Y, 2011, ALCOHOLISM CLIN EXPT; Zhou DM, 2011, NEUROIMAGE, V58, P16, DOI 10.1016/j.neuroimage.2011.06.026	49	101	102	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43067	10.1371/journal.pone.0043067	http://dx.doi.org/10.1371/journal.pone.0043067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937012	Green Published, Green Submitted, gold			2022-12-25	WOS:000308286300033
J	Norris, AM; Gore, A; Balboni, A; Young, A; Longnecker, DS; Korc, M				Norris, A. M.; Gore, A.; Balboni, A.; Young, A.; Longnecker, D. S.; Korc, M.			AGR2 is a SMAD4-suppressible gene that modulates MUC1 levels and promotes the initiation and progression of pancreatic intraepithelial neoplasia	ONCOGENE			English	Article						TGF-beta; AGR2; pancreatic cancer; MUC1; SMAD4	GROWTH-FACTOR RECEPTOR; TGF-BETA; ANTERIOR GRADIENT-2; EXPRESSION PATTERNS; HUMAN HOMOLOG; TUMOR-GROWTH; CANCER; PROTEIN; ADENOCARCINOMA; ANTIGEN	The mechanisms controlling expression of the putative oncogene Anterior gradient 2 (AGR2) in pancreatic ductal adenocarcinoma (PDAC) are not well understood. We now show that AGR2 is a transforming growth factor-beta (TGF-beta)-responsive gene in human pancreatic cancer cells, whose downregulation is SMAD4 dependent. We also provide evidence supporting a role for AGR2 as an ER-chaperone for the cancer-associated mucin, MUC1. AGR2 is both sufficient and required for MUC1 expression in pancreatic cancer cells. Furthermore, AGR2 is coexpressed with MUC1 in mouse pancreatic intraepithelial neoplasia (mPanIN)-like lesions and in the cancer cells of four distinct genetically engineered mouse models of PDAC. We also show that Pdx1-Cre/LSL-Kras(G12D)/Smad4(lox/lox) mice heterozygous for Agr2 exhibit a delay in mPanIN initiation and progression to PDAC. It is proposed that loss of Smad4 may convert TGF-beta from a tumor suppressor to a tumor promoter by causing the upregulation of AGR2, which then leads to increased MUC1 expression, at which point both AGR2 and MUC1 facilitate mPanIN initiation and progression to PDAC.	[Norris, A. M.; Young, A.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Med, Hanover, NH 03756 USA; [Gore, A.; Korc, M.] Indiana Univ Sch Med, Melvin & Bren Simon Canc Ctr, Dept Med, Indianapolis, IN 46202 USA; [Gore, A.; Korc, M.] Indiana Univ Sch Med, Melvin & Bren Simon Canc Ctr, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Gore, A.; Korc, M.] Pancreat Canc Signature Ctr, Indianapolis, IN USA; [Balboni, A.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03756 USA; [Longnecker, D. S.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Pathol, Hanover, NH 03756 USA	Dartmouth College; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Dartmouth College; Dartmouth College	Korc, M (corresponding author), Indiana Univ Sch Med, Dept Med, 980 West Walnut St, Indianapolis, IN 46202 USA.	mkorc@iupui.edu			US Public Health Service [CA-R37-075059]; National Cancer Institute; NRSA Molecular and Toxicology Program fellowship [5T32CA009658-18]; Program in Experimental and Molecular Medicine; NATIONAL CANCER INSTITUTE [R37CA075059, R01CA075059, T32CA009658] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NRSA Molecular and Toxicology Program fellowship; Program in Experimental and Molecular Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Ted R Hupp (U of Edinburgh) for the AGR2-RFP and pcDNA-AGR2 plasmids; Dr Park (UCSF) for providing the Agr2<SUP>-/-</SUP> mice; Dr J Gore for helpful discussions; and Ms Catherine Chen for excellent laboratory work. This research was supported by the US Public Health Service Grant CA-R37-075059, awarded by the National Cancer Institute to MK. AMN was supported by the NRSA Molecular and Toxicology Program fellowship 5T32CA009658-18. AB was supported by the Program in Experimental and Molecular Medicine.	Ambolet-Camoit A, 2010, TOXICOL SCI, V115, P501, DOI 10.1093/toxsci/kfq082; AMERICAN CANCER SOCIETY, 2007, CANC FACTS FIG; Andrianifahanana M, 2001, CLIN CANCER RES, V7, P4033; Arnold NB, 2005, J BIOL CHEM, V280, P21858, DOI 10.1074/jbc.M500583200; Arnold NB, 2004, CANCER RES, V64, P3599, DOI 10.1158/0008-5472.CAN-03-2999; BALAGUE C, 1994, GASTROENTEROLOGY, V106, P1054, DOI 10.1016/0016-5085(94)90767-6; Baldwin RL, 1996, INT J CANCER, V67, P283, DOI 10.1002/(SICI)1097-0215(19960717)67:2<283::AID-IJC21>3.0.CO;2-B; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Besmer DM, 2011, CANCER RES, V71, P4432, DOI 10.1158/0008-5472.CAN-10-4439; Brychtova V, 2011, CANCER LETT, V304, P1, DOI 10.1016/j.canlet.2010.12.023; Carraway KL, 2002, PROG NUCLEIC ACID RE, V71, P149, DOI 10.1016/S0079-6603(02)71043-X; Carriere C, 2007, P NATL ACAD SCI USA, V104, P4437, DOI 10.1073/pnas.0701117104; Carriere C, 2011, GASTROENTEROLOGY, V141, P1091, DOI 10.1053/j.gastro.2011.05.041; Chang Ken Chien-Neng, 2007, V383, P31; Chen R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-149; Choudhury A, 2000, J BIOCHEM-TOKYO, V128, P233, DOI 10.1093/oxfordjournals.jbchem.a022746; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dumartin L, 2011, CANCER RES, V71, P7091, DOI 10.1158/0008-5472.CAN-11-1367; FORSTNER G, 1995, ANNU REV PHYSIOL, V57, P585, DOI 10.1146/annurev.ph.57.030195.003101; FRIESS H, 1993, GASTROENTEROLOGY, V105, P1846, DOI 10.1016/0016-5085(93)91084-U; Fritzsche FR, 2006, CLIN CANCER RES, V12, P1728, DOI 10.1158/1078-0432.CCR-05-2057; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hahn SA, 1996, CANCER RES, V56, P490; Hansel DE, 2003, ANNU REV GENOM HUM G, V4, P237, DOI 10.1146/annurev.genom.4.070802.110341; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Higa A, 2011, J BIOL CHEM, V286, P44855, DOI 10.1074/jbc.M111.275529; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hrstka R, 2010, ONCOGENE, V29, P4838, DOI 10.1038/onc.2010.228; Hruban RH, 2000, AM J PATHOL, V156, P1821, DOI 10.1016/S0002-9440(10)65054-7; Iacobuzio-Donahue CA, 2003, AM J PATHOL, V162, P1151, DOI 10.1016/S0002-9440(10)63911-9; Innes HE, 2006, BRIT J CANCER, V94, P1057, DOI 10.1038/sj.bjc.6603065; Jaffee EM, 2002, CANCER CELL, V2, P25, DOI 10.1016/S1535-6108(02)00093-4; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kleeff J, 1999, BIOCHEM BIOPH RES CO, V255, P268, DOI 10.1006/bbrc.1999.0171; Kristiansen G, 2005, J PATHOL, V205, P359, DOI 10.1002/path.1676; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Levi E, 2004, J CLIN PATHOL, V57, P456, DOI 10.1136/jcp.2003.013292; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Liu D, 2005, CANCER RES, V65, P3796, DOI 10.1158/0008-5472.CAN-04-3823; Lowe AW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000323; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Moniaux N, 2004, BRIT J CANCER, V91, P1633, DOI 10.1038/sj.bjc.6602163; Nagata K, 2007, J HEPATO-BILIARY-PAN, V14, P243, DOI 10.1007/s00534-006-1169-2; Norris AM, 2009, PANCREATIC CANC; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; Persson S, 2005, MOL PHYLOGENET EVOL, V36, P734, DOI 10.1016/j.ympev.2005.04.002; Pohler E, 2004, MOL CELL PROTEOMICS, V3, P534, DOI 10.1074/mcp.M300089-MCP200; Ramachandran V, 2008, CANCER RES, V68, P7811, DOI 10.1158/0008-5472.CAN-08-1320; Riener MO, 2009, HISTOL HISTOPATHOL, V24, P1121, DOI 10.14670/HH-24.1121; Riggins GJ, 1996, NAT GENET, V13, P347, DOI 10.1038/ng0796-347; Roy LD, 2011, ONCOGENE, V30, P1449, DOI 10.1038/onc.2010.526; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Sempere LF, 2011, CANCER BIOL THER, V12, P198, DOI 10.4161/cbt.12.3.15979; Sipos B, 2003, VIRCHOWS ARCH, V442, P444, DOI 10.1007/s00428-003-0784-4; Thompson DA, 1998, BIOCHEM BIOPH RES CO, V251, P111, DOI 10.1006/bbrc.1998.9440; van Heek T, 2002, AM J CLIN PATHOL, V117, P755; Wagner M, 1998, INT J CANCER, V78, P255, DOI 10.1002/(SICI)1097-0215(19981005)78:2<255::AID-IJC21>3.0.CO;2-8; Wang Z, 2008, CANCER RES, V68, P492, DOI 10.1158/0008-5472.CAN-07-2930; Wilentz R E, 1998, Surg Oncol Clin N Am, V7, P43; Wilentz RE, 2000, CANCER RES, V60, P2002; Wilson CL, 2006, ENDOCR-RELAT CANCER, V13, P617, DOI 10.1677/erc.1.01165; Yamamoto M, 1997, J BIOL CHEM, V272, P12492, DOI 10.1074/jbc.272.19.12492; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang JS, 2005, GENE CHROMOSOME CANC, V43, P249, DOI 10.1002/gcc.20188; Zhang YX, 2010, CANCER RES, V70, P240, DOI 10.1158/0008-5472.CAN-09-2904; Zheng W, 2006, GENES IMMUN, V7, P11, DOI 10.1038/sj.gene.6364263	69	43	44	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 15	2013	32	33					3867	3876		10.1038/onc.2012.394	http://dx.doi.org/10.1038/onc.2012.394			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	202JH	22945649	Green Accepted			2022-12-25	WOS:000323210200009
J	Wang, JF; Zurawski, TH; Meng, JH; Lawrence, GW; Aoki, KR; Wheeler, L; Dolly, JO				Wang, Jiafu; Zurawski, Tomas H.; Meng, Jianghui; Lawrence, Gary W.; Aoki, K. Roger; Wheeler, Larry; Dolly, J. Oliver			Novel chimeras of botulinum and tetanus neurotoxins yield insights into their distinct sites of neuroparalysis	FASEB JOURNAL			English	Article						neuromuscular junction; neurotransmission; retrograde axonal transport; SNAREs; spinal cord	CENTRAL-NERVOUS-SYSTEM; BLOCK NEUROTRANSMITTER RELEASE; RETROGRADE AXONAL-TRANSPORT; CLOSTRIDIAL NEUROTOXINS; HIPPOCAMPAL-NEURONS; C-FRAGMENT; SEROTYPE-F; TOXIN-A; PROTEIN; BINDING	Botulinum neurotoxin (BoNT) A or E and tetanus toxin (TeTx) bind to motor-nerve endings and undergo distinct trafficking; their light-chain (LC) proteases cleave soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs) peripherally or centrally and cause flaccid or spastic paralysis, respectively. To seek protein domains responsible for local blockade of transmitter release (BoNTs) rather than retroaxonal transport to spinal neurons (TeTx), their acceptor-binding moieties (H-C)-or in one case, heavy chain (HC)-were exchanged by gene recombination. Each chimera, expressed and purified from Escherichia coli, entered rat cerebellar neurons to cleave their substrates, blocked in vitro nerve-induced muscle contractions, and produced only flaccid paralysis in mice. Thus, the local cytosolic delivery of BoNT/A or BoNT/E proteases and the contrasting retrograde transport of TeTx are not specified solely by their HC or HC; BoNT/A LC translocated locally irrespective of being targeted by either of the latter TeTx domains. In contrast, BoNT/E protease fused to a TeTx enzymatically inactive mutant (TeTIM) caused spastic paralysis and cleaved SNAP-25 in spinal cord but not the injected muscle. Apparently, TeTIM precludes cytosolic release of BoNT/E protease at motor nerve endings. It is deduced that the LCs of the toxins, acting in conjunction with HC domains, dictate their local or distant destinations.-Wang, J., Zurawski, T. H., Meng, J., Lawrence, G. W., Aoki, K. R., Wheeler, L., Dolly, J. O. Novel chimeras of botulinum and tetanus neurotoxins yield insights into their distinct sites of neuroparalysis. FASEB J. 26, 5035-5048 (2012). www.fasebj.org	[Wang, Jiafu; Zurawski, Tomas H.; Meng, Jianghui; Lawrence, Gary W.; Dolly, J. Oliver] Dublin City Univ, Int Ctr Neurotherapeut, Dublin 9, Ireland; [Aoki, K. Roger; Wheeler, Larry] Allergan Pharmaceut Inc, Irvine, CA 92715 USA	Dublin City University; AbbVie; Allergan	Dolly, JO (corresponding author), Dublin City Univ, Int Ctr Neurotherapeut, Dublin 9, Ireland.	oliver.dolly@dcu.ie	Dolly, Oliver/G-1532-2012; Wang, Jiafu/AAX-9388-2020; Meng, Jianghui/H-4302-2014; Dolly, Oliver/ABH-6677-2020	Dolly, Oliver/0000-0002-0861-5320; Wang, Jiafu/0000-0002-3654-4400; Dolly, Oliver/0000-0002-0861-5320; Meng, Jianghui/0000-0002-3107-4200	Science Foundation Ireland; Neuroscience section of the Programme for Research in Third Level Institutions (PRTLI); European Regional Development Fund (ERDF), European Union Structural Funds Programme	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Neuroscience section of the Programme for Research in Third Level Institutions (PRTLI); European Regional Development Fund (ERDF), European Union Structural Funds Programme	The authors thank Liam Ryan and Catherine Hagedorn for assistance with purifying the recombinant proteins and testing their activities in vivo. This work was supported by a PI award from Science Foundation Ireland, and the Neuroscience section of the Programme for Research in Third Level Institutions (PRTLI) Cycle 4. The PRTLI is cofunded through the European Regional Development Fund (ERDF), part of the European Union Structural Funds Programme 2007-2013.	Antonucci F, 2008, J NEUROSCI, V28, P3689, DOI 10.1523/JNEUROSCI.0375-08.2008; Aoki KR, 2001, TOXICON, V39, P1815, DOI 10.1016/S0041-0101(01)00101-5; BLACK JD, 1986, J CELL BIOL, V103, P535, DOI 10.1083/jcb.103.2.535; Blum FC, 2012, INFECT IMMUN, V80, P1662, DOI 10.1128/IAI.00057-12; Bohnert S, 2005, J BIOL CHEM, V280, P42336, DOI 10.1074/jbc.M506750200; Brunger AT, 2009, TOXICON, V54, P550, DOI 10.1016/j.toxicon.2008.12.027; Chaddock JA, 2002, PROTEIN EXPRES PURIF, V25, P219, DOI 10.1016/S1046-5928(02)00002-5; Chen C, 2009, J BIOL CHEM, V284, P26569, DOI 10.1074/jbc.M109.027391; Coen L, 1997, P NATL ACAD SCI USA, V94, P9400, DOI 10.1073/pnas.94.17.9400; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; DEPAIVA A, 1993, J BIOL CHEM, V268, P20838; Dolly J. O., 1990, NEUROMUSCULAR TRANSM, P107; Dolly JO, 2009, CURR OPIN PHARMACOL, V9, P326, DOI 10.1016/j.coph.2009.03.004; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2007, J CELL BIOL, V179, P1511, DOI 10.1083/jcb.200707184; Dong M, 2008, MOL BIOL CELL, V19, P5226, DOI 10.1091/mbc.E08-07-0765; FERNANDEZSALAS E, 2005, 5 INT C BAS THER ASP; Figueiredo DM, 1997, EXP NEUROL, V145, P546, DOI 10.1006/exnr.1997.6490; FISHMAN PS, 1990, J NEUROL SCI, V98, P311, DOI 10.1016/0022-510X(90)90272-O; Fishman PS, 1999, NAT TOXINS, V7, P151, DOI 10.1002/(SICI)1522-7189(199907/08)7:4<151::AID-NT51>3.3.CO;2-B; Foran PG, 2003, J BIOL CHEM, V278, P1363, DOI 10.1074/jbc.M209821200; FRANCIS JW, 1995, J BIOL CHEM, V270, P15434, DOI 10.1074/jbc.270.25.15434; Fu ZJ, 2009, BIOCHEMISTRY-US, V48, P5631, DOI 10.1021/bi9002138; Geny B, 2006, BIOL CELL, V98, P633, DOI 10.1042/BC20060038; HABERMANN E, 1980, N-S ARCH PHARMACOL, V311, P33, DOI 10.1007/BF00500299; Humeau Y, 2000, BIOCHIMIE, V82, P427, DOI 10.1016/S0300-9084(00)00216-9; Kumaran D, 2009, J MOL BIOL, V386, P233, DOI 10.1016/j.jmb.2008.12.027; Lalli G, 2003, TRENDS MICROBIOL, V11, P431, DOI 10.1016/S0966-842X(03)00210-5; Li Y, 2001, J BIOL CHEM, V276, P31394, DOI 10.1074/jbc.M103517200; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; MAISEY EA, 1988, EUR J BIOCHEM, V177, P683, DOI 10.1111/j.1432-1033.1988.tb14423.x; MATSUDA M, 1982, BIOCHEM BIOPH RES CO, V104, P799, DOI 10.1016/0006-291X(82)90708-2; Matteoli M, 1996, P NATL ACAD SCI USA, V93, P13310, DOI 10.1073/pnas.93.23.13310; MELLANBY J, 1968, J GEN MICROBIOL, V54, P161, DOI 10.1099/00221287-54-2-161; Montal M, 2010, ANNU REV BIOCHEM, V79, P591, DOI 10.1146/annurev.biochem.051908.125345; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; Montecucco C, 2004, TRENDS MICROBIOL, V12, P442, DOI 10.1016/j.tim.2004.08.002; Morgan J. C., 2002, SCI THERAPEUTIC ASPE, P151; PARTON RG, 1987, J NEUROCHEM, V49, P1057; Peng LS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002008; PRICE DL, 1975, SCIENCE, V188, P945, DOI 10.1126/science.49080; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SCHWAB ME, 1979, J CELL BIOL, V82, P798, DOI 10.1083/jcb.82.3.798; SIMPSON LL, 1984, BRAIN RES, V305, P177, DOI 10.1016/0006-8993(84)91136-3; SIMPSON LL, 1985, J PHARMACOL EXP THER, V234, P100; SIMPSON LL, 1994, J PHARMACOL EXP THER, V269, P256; Sun SH, 2011, CELL HOST MICROBE, V10, P237, DOI 10.1016/j.chom.2011.06.012; Toivonen JM, 2010, TOXINS, V2, P2622, DOI 10.3390/toxins2112622; Verderio C, 1999, J NEUROCHEM, V73, P372, DOI 10.1046/j.1471-4159.1999.0730372.x; Verderio C, 2007, TRAFFIC, V8, P142, DOI 10.1111/j.1600-0854.2006.00520.x; Wang JF, 2008, J BIOL CHEM, V283, P16993, DOI 10.1074/jbc.M710442200; Wang JF, 2012, BIOCHEM J, V444, P59, DOI 10.1042/BJ20120100; Wang JF, 2011, J BIOL CHEM, V286, P6375, DOI 10.1074/jbc.M110.181784; Ward AB, 2007, CLINICAL USES OF BOTULINUM TOXINS, P1, DOI 10.1017/CBO9780511544842; WELLER U, 1986, TOXICON, V24, P1055, DOI 10.1016/0041-0101(86)90132-7; WILLIAMSON LC, 1994, J NEUROCHEM, V63, P2342; Yeh FL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001207	58	27	30	0	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2012	26	12					5035	5048		10.1096/fj.12-210112	http://dx.doi.org/10.1096/fj.12-210112			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22942075				2022-12-25	WOS:000311838300025
J	Runyan, CE; Liu, ZY; Schnaper, HW				Runyan, Constance E.; Liu, Zongyi; Schnaper, H. William			Phosphatidylinositol 3-Kinase and Rab5 GTPase Inversely Regulate the Smad Anchor for Receptor Activation (SARA) Protein Independently of Transforming Growth Factor-beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; FYVE DOMAIN PROTEIN; PHOSPHOINOSITIDE 3-KINASE; INTRACELLULAR TRAFFICKING; P85-ALPHA SUBUNIT; KINASE B; WORTMANNIN; INHIBITION; BINDS; ENDOCYTOSIS	SARA has been shown to be a regulator of epithelial cell phenotype, with reduced expression during TGF-beta 1-mediated epithelial-to-mesenchymal transition. Examination of the pathways that might play a role in regulating SARA expression identified phosphatidylinositol 3-kinase (PI3K) pathway inhibition as sufficient to reduce SARA expression. The mechanism of PI3K inhibition-mediated SARA down-regulation differs from that induced by TGF-beta 1 in that, unlike TGF-beta 1, PI3K-dependent depletion of SARA was apparent within 6 h and did not occur at the mRNA or promoter level but was blocked by inhibition of proteasome-mediated degradation. This effect was independent of Akt activity because neither reducing nor enhancing Akt activity modulated the expression of SARA. Therefore, this is likely a direct effect of p85 alpha action, and co-immunoprecipitation of SARA and p85 alpha confirmed that these proteins interact. Both SARA and PI3K have been shown to be associated with endosomes, and either LY294002 or p85 alpha knockdown enlarged SARA-containing endocytic vesicles. Inhibition of clathrin-mediated endocytosis blocked SARA down-regulation, and a localization-deficient mutant SARA was protected against down-regulation. As inhibiting PI3K can activate the endosomal fusion-regulatory small GTPase Rab5, we expressed GTPase-deficient Rab5 and observed endosomal enlargement and reduced SARA protein expression, similar to that seen with PI3K inhibition. Importantly, either interference with PI3K via LY294002 or p85 alpha knockdown, or constitutive activity of the Rab5 pathway, enhanced the expression of smooth muscle alpha-actin. Together, these data suggest that although TGF-beta 1 can induce epithelial-to-mesenchymal transition through reduction in SARA expression, SARA is also basally regulated by its interaction with PI3K.	[Runyan, Constance E.; Liu, Zongyi; Schnaper, H. William] Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA	Northwestern University	Runyan, CE (corresponding author), Northwestern Univ, Dept Pediat, 310 W Super St,Searle 4-490, Chicago, IL 60611 USA.	c-runyan@northwestern.edu		Liu, Cheri/0000-0002-2394-750X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK049362, R01DK049362, R01DK075663] Funding Source: NIH RePORTER; NIDDK NIH HHS [R56 DK049362, R01 DK075663, R01 DK049362] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Anderson DH, 2005, METHOD ENZYMOL, V403, P552, DOI 10.1016/S0076-6879(05)03048-X; Awwad HO, 2007, EXP CELL RES, V313, P2586, DOI 10.1016/j.yexcr.2007.04.034; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chamberlain MD, 2004, J BIOL CHEM, V279, P48607, DOI 10.1074/jbc.M409769200; Chen XM, 2001, EMBO REP, V2, P842, DOI 10.1093/embo-reports/kve179; Chen XM, 2001, EMBO REP, V2, P68, DOI 10.1093/embo-reports/kve005; DAVIDSON HW, 1995, J CELL BIOL, V130, P797, DOI 10.1083/jcb.130.4.797; Ernst S, 2004, CELL MOL LIFE SCI, V61, P1684, DOI 10.1007/s00018-004-4116-x; Fruman DA, 2010, CURR TOP MICROBIOL, V346, P225, DOI 10.1007/82_2010_39; Gillooly DJ, 1999, BIOCHEM J, V344, P605, DOI 10.1042/0264-6021:3440605; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Grille SJ, 2003, CANCER RES, V63, P2172; Houle S, 2003, BIOCHEM J, V375, P151, DOI 10.1042/BJ20030872; Hu Y, 2002, J CELL SCI, V115, P4755, DOI 10.1242/jcs.00177; Itoh F, 2002, GENES CELLS, V7, P321, DOI 10.1046/j.1365-2443.2002.00519.x; JOLY M, 1995, J BIOL CHEM, V270, P13225, DOI 10.1074/jbc.270.22.13225; JOLY M, 1994, SCIENCE, V263, P684, DOI 10.1126/science.8303278; Jones AT, 1998, MOL BIOL CELL, V9, P323, DOI 10.1091/mbc.9.2.323; Kok K, 2009, TRENDS BIOCHEM SCI, V34, P115, DOI 10.1016/j.tibs.2009.01.003; Kurashima K, 1998, J BIOL CHEM, V273, P20828, DOI 10.1074/jbc.273.33.20828; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Mellor P, 2012, BIOCHEM J, V441, P23, DOI 10.1042/BJ20111164; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Mills IG, 1999, MOL MEMBR BIOL, V16, P73, DOI 10.1080/096876899294788; MIN BH, 1990, J BIOL CHEM, V265, P16667; Mousavi SA, 2003, BIOCHEM J, V372, P861, DOI 10.1042/BJ20021136; Nakajima Y, 1997, MOL BIOL CELL, V8, P577, DOI 10.1091/mbc.8.4.577; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Racusen LC, 1997, J LAB CLIN MED, V129, P318, DOI 10.1016/S0022-2143(97)90180-3; Runyan CE, 2005, J BIOL CHEM, V280, P8300, DOI 10.1074/jbc.M407939200; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Runyan CE, 2009, J BIOL CHEM, V284, P25181, DOI 10.1074/jbc.M109.032847; Shpetner H, 1996, J CELL BIOL, V132, P595, DOI 10.1083/jcb.132.4.595; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Winbanks CE, 2007, INT J BIOCHEM CELL B, V39, P206, DOI 10.1016/j.biocel.2006.08.004; Worou ME, 2011, CARDIOVASC RES, V91, P320, DOI 10.1093/cvr/cvr072; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhao YQ, 2008, TRAFFIC, V9, P2253, DOI 10.1111/j.1600-0854.2008.00819.x	43	16	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35815	35824		10.1074/jbc.M112.380493	http://dx.doi.org/10.1074/jbc.M112.380493			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22942286	Green Published, hybrid			2022-12-25	WOS:000310364000005
J	Shulga, YV; Anderson, RA; Topham, MK; Epand, RM				Shulga, Yulia V.; Anderson, Richard A.; Topham, Matthew K.; Epand, Richard M.			Phosphatidylinositol-4-phosphate 5-Kinase Isoforms Exhibit Acyl Chain Selectivity for Both Substrate and Lipid Activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIACYLGLYCEROL KINASE-ZETA; MOLECULAR-SPECIES ANALYSIS; PHOSPHATE KINASE; 4-PHOSPHATE 5-KINASE; I-ALPHA; ARACHIDONOYL SPECIFICITY; ACID; GAMMA; MEMBRANE; BETA	Phosphatidylinositol 4,5-bisphosphate is mostly produced in the cell by phosphatidylinositol-4-phosphate 5-kinases (PIP5K) and has a crucial role in numerous signaling events. Here we demonstrate that in vitro all three isoforms of PIP5K, alpha, beta, and gamma, discriminate among substrates with different acyl chains for both the substrates phosphatidylinositol 4-phosphate (PtdIns4P) and phosphatidylinositol (PtdIns) although to different extents, with isoform gamma being the most selective. Fully saturated dipalmitoyl-PtdIns4P was a poor substrate for all three isoforms, but both the 1-stearoyl-2-arachidonoyl and the 1-stearoyl-2-oleoyl forms of PtdIns4P were good substrates. V-max was greater for the 1-stearoyl-2-arachidonoyl form compared with the 1-stearoyl-2-oleoyl form, although for PIP5K beta the difference was small. For the alpha and gamma isoforms, K-m was much lower for 1-stearoyl-2-oleoyl PtdIns4P, making this lipid the better substrate of the two under most conditions. Activation of PIP5K by phosphatidic acid is also acyl chain-dependent. Species of phosphatidic acid with two unsaturated acyl chains are much better activators of PIP5K than those containing one saturated and one unsaturated acyl chain. PtdIns is a poor substrate for PIP5K, but it also shows acyl chain selectivity. Curiously, there is no acyl chain discrimination among species of phosphatidic acid in the activation of the phosphorylation of PtdIns. Together, our findings indicate that PIP5K isoforms alpha, beta, and gamma act selectively on substrates and activators with different acyl chains. This could be a tightly regulated mechanism of producing physiologically active unsaturated phosphatidylinositol 4,5-bisphosphate species in the cell.	[Shulga, Yulia V.; Epand, Richard M.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada; [Anderson, Richard A.] Univ Wisconsin, Sch Med, Mol & Cellular Pharmacol Program, Madison, WI 53706 USA; [Topham, Matthew K.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	McMaster University; University of Wisconsin System; University of Wisconsin Madison; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Epand, RM (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, 1280 Main St W, Hamilton, ON L8S 4K1, Canada.	epand@mcmaster.ca	, Richard/R-2316-2019	, Richard/0000-0002-9602-9558; Anderson, Richard/0000-0001-6265-8359	National Institutes of Health, NCI [CA095463, R01CA104708]; Natural Sciences and Engineering Research Council of Canada [9848]; NATIONAL CANCER INSTITUTE [P30CA014520, R01CA095463, R01CA104708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057549] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grants CA095463 (to M. K. T.) and R01CA104708 (to R. A. A.). This study was also supported by Natural Sciences and Engineering Research Council of Canada Grant 9848 (to R. M. E.).	Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Lacalle RA, 2007, J CELL BIOL, V179, P1539, DOI 10.1083/jcb.200705044; Balgoma D, 2008, FEBS J, V275, P6180, DOI 10.1111/j.1742-4658.2008.06742.x; Cazzolli R, 2007, DIABETOLOGIA, V50, P1732, DOI 10.1007/s00125-007-0709-x; Chen MZ, 2009, J BIOL CHEM, V284, P23743, DOI 10.1074/jbc.M109.036509; Chilton FH, 1996, BBA-LIPID LIPID MET, V1299, P1, DOI 10.1016/0005-2760(95)00169-7; Coppolino MG, 2002, J BIOL CHEM, V277, P43849, DOI 10.1074/jbc.M209046200; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; Doughman RL, 2003, J BIOL CHEM, V278, P23036, DOI 10.1074/jbc.M211397200; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Epand RM, 2012, BBA-BIOMEMBRANES, V1818, P957, DOI 10.1016/j.bbamem.2011.07.018; Epand RM, 2004, BIOCHEMISTRY-US, V43, P14778, DOI 10.1021/bi0484724; Fairn GD, 2009, J CELL BIOL, V187, P701, DOI 10.1083/jcb.200909025; Galiano FJ, 2002, J CELL BIOCHEM, V85, P131, DOI 10.1002/jcb.10100; Haucke V, 2005, BIOCHEM SOC T, V33, P1285, DOI 10.1042/BST0331285; Heck JN, 2007, CRIT REV BIOCHEM MOL, V42, P15, DOI 10.1080/10409230601162752; HENDRICKSON HS, 1984, J BIOL CHEM, V259, P5734; Hicks AM, 2006, BBA-MOL CELL BIOL L, V1761, P1022, DOI 10.1016/j.bbalip.2006.05.010; HILL TL, 1978, P NATL ACAD SCI USA, V75, P1101, DOI 10.1073/pnas.75.3.1101; Hodgkin MN, 1998, TRENDS BIOCHEM SCI, V23, P200, DOI 10.1016/S0968-0004(98)01200-6; HOLBROOK PG, 1992, J BIOL CHEM, V267, P16834; Ishihara H, 1996, J BIOL CHEM, V271, P23611, DOI 10.1074/jbc.271.39.23611; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Itoh T, 1998, J BIOL CHEM, V273, P20292, DOI 10.1074/jbc.273.32.20292; Jarquin-Pardo M, 2007, J CELL BIOCHEM, V100, P112, DOI 10.1002/jcb.21027; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; Jones DR, 2000, FEBS LETT, V476, P160, DOI 10.1016/S0014-5793(00)01702-6; KLOTZ IM, 1977, P NATL ACAD SCI USA, V74, P4959, DOI 10.1073/pnas.74.11.4959; Kunz J, 2002, J BIOL CHEM, V277, P5611, DOI 10.1074/jbc.M110775200; LEE C, 1991, J BIOL CHEM, V266, P22837; Li F, 2001, J MOL NEUROSCI, V16, P205, DOI 10.1385/JMN:16:2-3:205; Li W, 2012, MOL CELL, V45, P25, DOI 10.1016/j.molcel.2011.11.017; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Loijens JC, 1996, J BIOL CHEM, V271, P32937, DOI 10.1074/jbc.271.51.32937; LOUIE K, 1988, BIOCHEMISTRY-US, V27, P9014, DOI 10.1021/bi00425a020; Luo B, 2004, CELL SIGNAL, V16, P891, DOI 10.1016/j.cellsig.2004.01.010; Manes S, 2010, FASEB J, V24, P3381, DOI 10.1096/fj.09-153106; Mellman DL, 2008, NATURE, V451, P1013, DOI 10.1038/nature06666; MORITZ A, 1992, J BIOL CHEM, V267, P7207; Neau DB, 2009, BIOCHEMISTRY-US, V48, P7906, DOI 10.1021/bi900084m; Noda Y, 2012, P NATL ACAD SCI USA, V109, P1725, DOI 10.1073/pnas.1107808109; Parker G J, 1998, Methods Mol Biol, V105, P127; PESSIN MS, 1989, J BIOL CHEM, V264, P8729; Pettitt TR, 1997, J BIOL CHEM, V272, P17354, DOI 10.1074/jbc.272.28.17354; PETTITT TR, 1993, BIOCHEM J, V289, P487, DOI 10.1042/bj2890487; Pettitt TR, 2001, BIOCHEM J, V360, P707, DOI 10.1042/0264-6021:3600707; Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z; Rao VD, 1998, CELL, V94, P829, DOI 10.1016/S0092-8674(00)81741-9; Rincon E, 2012, PROG LIPID RES, V51, P1, DOI 10.1016/j.plipres.2011.10.001; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; Schill NJ, 2009, BIOCHEM J, V422, P473, DOI 10.1042/BJ20090638; Schmid AC, 2004, FEBS LETT, V576, P9, DOI 10.1016/j.febslet.2004.08.052; Shulga YV, 2011, FEBS LETT, V585, P4025, DOI 10.1016/j.febslet.2011.11.016; Shulga YV, 2011, CHEM REV, V111, P6186, DOI 10.1021/cr1004106; Shulga YV, 2011, J MOL BIOL, V409, P101, DOI 10.1016/j.jmb.2011.03.071; Sinha SC, 2005, EMBO J, V24, P663, DOI 10.1038/sj.emboj.7600573; Sugimoto H, 1999, BBA-MOL CELL BIOL L, V1438, P264, DOI 10.1016/S1388-1981(99)00059-1; Sugiura T, 1996, J LIPID MEDIAT CELL, V14, P51, DOI 10.1016/0929-7855(96)00508-1; Sun Y, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2471; Thapa N, 2012, DEV CELL, V22, P116, DOI 10.1016/j.devcel.2011.10.030; Toker A, 1998, CURR OPIN CELL BIOL, V10, P254, DOI 10.1016/S0955-0674(98)80148-8; Tolias KF, 1998, J BIOL CHEM, V273, P18040, DOI 10.1074/jbc.273.29.18040; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Vasudevan L, 2009, J CELL SCI, V122, P2567, DOI 10.1242/jcs.048124; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Wieffer M, 2012, METHOD CELL BIOL, V108, P209, DOI 10.1016/B978-0-12-386487-1.00011-0; Yu YL, 2011, J BIOL CHEM, V286, P9657, DOI 10.1074/jbc.M110.185124; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200	70	36	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35953	35963		10.1074/jbc.M112.370155	http://dx.doi.org/10.1074/jbc.M112.370155			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22942276	Green Published, hybrid			2022-12-25	WOS:000310364000017
J	Wei, ZK; Lei, X; Seldin, MM; Wong, GW				Wei, Zhikui; Lei, Xia; Seldin, Marcus M.; Wong, G. William			Endopeptidase Cleavage Generates a Functionally Distinct Isoform of C1q/Tumor Necrosis Factor-related Protein-12 (CTRP12) with an Altered Oligomeric State and Signaling Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; GENE; ACRP30/ADIPONECTIN; ADIPOKINE; GLUCOSE; FAMILY; DEGENERATION; ACTIVATION; MUTATION; MODEL	Adipose tissue-derived adipokines are an important class of secreted metabolic regulators that mediate tissue cross-talk to control systemic energy balance. We recently described C1q/TNF-related protein-12 (CTRP12), a novel insulin-sensitizing adipokine that regulates glucose metabolism in liver and adipose tissue. However, the biochemical properties of CTRP12 and its naturally occurring cleaved isoform have not been characterized. Here, we show that CTRP12 is a secreted hormone subjected to multiple functionally relevant posttranslational modifications at highly conserved residues. For example, Asn(39) is glycosylated, whereas Cys(85) mediates the assembly of higher order oligomeric structure. Endopeptidase cleavage at Lys(91) generates a cleaved globular gCTRP12 isoform, the expression of which is increased by insulin. PCSK3/furin was identified as the major proprotein convertase expressed by adipocytes that mediates the endogenous cleavage of CTRP12. Cleavage at Lys(91) is context-dependent: mutation of the charged Arg(93) to Ala on the P2' position enhanced cleavage, and triple mutations (K90A/K91A/R93A) abolished cleavage. Importantly, the two isoforms of CTRP12 differ in oligomeric structures and are functionally distinct. The full-length protein forms trimers and larger complexes, and the cleaved isoform consisted of predominantly dimers. Whereas full-length fCTRP12 strongly activated Akt signaling in H4IIE hepatocytes and 3T3-L1 adipocytes, gCTRP12 preferentially activated MAP kinase (ERK1/2 and p38 MAPK) signaling. Further, only fCTRP12 improved insulin-stimulated glucose uptake in adipocytes. These results reveal a novel mechanism controlling signaling specificity and function of a hormone via cleavage-dependent alteration in oligomeric state.	[Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 855 N Wolfe St, Baltimore, MD 21205 USA.	gwwong@jhmi.edu		Wei, Zhikui/0000-0002-2311-9800; Wong, G. William/0000-0002-5286-6506	National Institutes of Health Grant [DK084171]; American Heart Association Grant [SDG2260721]; American Heart Association Fellowship [PRE3790034]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084171] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Grant(American Heart Association); American Heart Association Fellowship(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK084171 (to G. W. W.). This work was also supported by American Heart Association Grant SDG2260721.; Supported by American Heart Association Fellowship PRE3790034.	Ayyagari R, 2005, INVEST OPHTH VIS SCI, V46, P3363, DOI 10.1167/iovs.05-0159; Basak S, 2004, BIOCHEM J, V380, P505, DOI 10.1042/BJ20031405; Briggs DB, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-24; Chavali VRM, 2011, HUM MOL GENET, V20, P2000, DOI 10.1093/hmg/ddr080; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Hayward C, 2003, HUM MOL GENET, V12, P2657, DOI 10.1093/hmg/ddg289; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Kopp A, 2010, ENDOCRINOLOGY, V151, P5267, DOI 10.1210/en.2010-0571; Kopp A, 2010, CYTOKINE, V49, P51, DOI 10.1016/j.cyto.2009.10.001; Lasser G, 2006, BLOOD, V107, P423, DOI 10.1182/blood-2005-04-1425; Maeda T, 2006, J CELL PHYSIOL, V206, P537, DOI 10.1002/jcp.20493; Maeda T, 2001, J BIOL CHEM, V276, P3628, DOI 10.1074/jbc.M007898200; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Seidah NG, 2011, METHODS MOL BIOL, V768, P23, DOI 10.1007/978-1-61779-204-5_3; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Tsao TS, 2002, J BIOL CHEM, V277, P29359, DOI 10.1074/jbc.C200312200; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Yan AX, 2005, J BIOL CHEM, V280, P3121, DOI 10.1074/jbc.R400036200; Zheng QJ, 2011, ARTERIOSCL THROM VAS, V31, P2616, DOI 10.1161/ATVBAHA.111.231050	28	35	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35804	35814		10.1074/jbc.M112.365965	http://dx.doi.org/10.1074/jbc.M112.365965			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22942287	Green Published, hybrid			2022-12-25	WOS:000310364000004
J	Asati, A; Kachurina, O; Kachurin, A				Asati, Atul; Kachurina, Olga; Kachurin, Anatoly			Simultaneous Measurements of Auto-Immune and Infectious Disease Specific Antibodies Using a High Throughput Multiplexing Tool	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; ANTI-GM1 ANTIBODIES; GANGLIOSIDE COMPLEXES; NEUROPATHY; GM1; AUTOANTIBODIES; CERAMIDASE; VACCINE	Considering importance of ganglioside antibodies as biomarkers in various immune-mediated neuropathies and neurological disorders, we developed a high throughput multiplexing tool for the assessment of gangliosides-specific antibodies based on Biolpex/Luminex platform. In this report, we demonstrate that the ganglioside high throughput multiplexing tool is robust, highly specific and demonstrating, similar to 100-fold higher concentration sensitivity for IgG detection than ELISA. In addition to the ganglioside-coated array, the high throughput multiplexing tool contains beads coated with influenza hemagglutinins derived from H1N1 A/Brisbane/59/07 and H1N1 A/California/07/09 strains. Influenza beads provided an added advantage of simultaneous detection of ganglioside-and influenza-specific antibodies, a capacity important for the assay of both infectious antigen-specific and autoimmune antibodies following vaccination or disease. Taken together, these results support the potential adoption of the ganglioside high throughput multiplexing tool for measuring ganglioside antibodies in various neuropathic and neurological disorders.	[Asati, Atul; Kachurina, Olga; Kachurin, Anatoly] Sanofi Pasteur, Orlando, FL USA	Sanofi-Aventis	Asati, A (corresponding author), Sanofi Pasteur, VaxDesign Campus, Orlando, FL USA.	Anatoly.Kachurin@sanofipasteur.com			Biomedical Advanced Research and Development Authority, Department of Health and Human Services [HHSO100201000035C]	Biomedical Advanced Research and Development Authority, Department of Health and Human Services	This project has been funded in whole or in part with Federal funds from Biomedical Advanced Research and Development Authority, Department of Health and Human Services, under Contract No. HHSO100201000035C. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Alaedini A, 2002, J NEUROIMMUNOL, V127, P145, DOI 10.1016/S0165-5728(02)00102-9; Alaedini A, 2002, J NEUROL SCI, V196, P41, DOI 10.1016/S0022-510X(02)00022-9; Alaedini A, 2001, J CLIN LAB ANAL, V15, P96, DOI 10.1002/jcla.8; Cats EA, 2010, NEUROLOGY, V75, P1961, DOI 10.1212/WNL.0b013e3181ff94c2; Colasanti T, 2010, AUTOIMMUN REV, V9, P807, DOI 10.1016/j.autrev.2010.07.008; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Hartung HP, 2001, CURR OPIN NEUROL, V14, P597, DOI 10.1097/00019052-200110000-00008; Kaida K, 2010, J NEUROIMMUNOL, V223, P5, DOI 10.1016/j.jneuroim.2010.02.001; Kanter JL, 2006, NAT MED, V12, P138, DOI 10.1038/nm1344; KARPIAK SE, 1976, SCIENCE, V194, P735, DOI 10.1126/science.982041; KARPIAK SE, 1981, EPILEPSIA, V22, P189, DOI 10.1111/j.1528-1157.1981.tb04101.x; Kirvan CA, 2003, NAT MED, V9, P914, DOI 10.1038/nm892; Kita K, 2000, BBA-MOL CELL BIOL L, V1485, P111, DOI 10.1016/S1388-1981(00)00029-9; Koga M, 2001, J NEUROL NEUROSUR PS, V71, P123, DOI 10.1136/jnnp.71.1.123; KORNBERG AJ, 1994, MUSCLE NERVE, V17, P100, DOI 10.1002/mus.880170115; Kusunoki S, 1996, ANN NEUROL, V39, P424, DOI 10.1002/ana.410390404; Kusunoki S, 2011, J NEUROCHEM, V116, P828, DOI 10.1111/j.1471-4159.2010.07029.x; Lardone RD, 2010, J NEUROL NEUROSUR PS, V81, P629, DOI 10.1136/jnnp.2009.183665; LEDEEN RW, 1982, METHOD ENZYMOL, V83, P139; Lehmann HC, 2010, LANCET INFECT DIS, V10, P643, DOI 10.1016/S1473-3099(10)70140-7; Liljeblad A, 2010, ORG BIOMOL CHEM, V8, P886, DOI 10.1039/b920939p; Lopez PHH, 2002, J NEUROIMMUNOL, V128, P69, DOI 10.1016/S0165-5728(02)00139-X; Martinez Z, 2007, BIOCHEMISTRY-US, V46, P1868, DOI 10.1021/bi061749a; Meinl E., 2010, CLIN EXP NEUROIMMUNO, V1, P47; Mudrak B, 2010, TOXINS, V2, P1445, DOI 10.3390/toxins2061445; Nachamkin I, 2008, J INFECT DIS, V198, P226, DOI 10.1086/589624; O'Hanlon GM, 2000, AUTOIMMUNITY, V32, P133, DOI 10.3109/08916930008994083; Ogawa G, 2009, J NEUROIMMUNOL, V214, P125, DOI 10.1016/j.jneuroim.2009.06.017; REES JH, 1995, ANN NEUROL, V38, P809, DOI 10.1002/ana.410380516; Sadatipour BT, 1998, ANN NEUROL, V44, P980, DOI 10.1002/ana.410440621; SADIQ SA, 1990, NEUROLOGY, V40, P1067, DOI 10.1212/WNL.40.7.1067; Tani M, 2000, J BIOL CHEM, V275, P3462, DOI 10.1074/jbc.275.5.3462; VANDENBERG LH, 1992, J NEUROL NEUROSUR PS, V55, P8, DOI 10.1136/jnnp.55.1.8; VANHEYNINGEN S, 1974, SCIENCE, V183, P656, DOI 10.1126/science.183.4125.656; VANSCHAIK IN, 1994, J NEUROIMMUNOL, V54, P109, DOI 10.1016/0165-5728(94)90237-2; Wang DJ, 2011, INFLUENZA O IN PRESS	37	1	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e42681	10.1371/journal.pone.0042681	http://dx.doi.org/10.1371/journal.pone.0042681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952605	Green Submitted, Green Published, gold			2022-12-25	WOS:000308206500006
J	Buckle, CH; De Leenheer, E; Lawson, MA; Yong, K; Rabin, N; Perry, M; Vanderkerken, K; Croucher, PI				Buckle, Clive Henry; De Leenheer, Evy; Lawson, Michelle Anne; Yong, Kwee; Rabin, Neil; Perry, Mark; Vanderkerken, Karen; Croucher, Peter Ian			Soluble Rank Ligand Produced by Myeloma Cells Causes Generalised Bone Loss in Multiple Myeloma	PLOS ONE			English	Article							KAPPA-B LIGAND; SERUM OSTEOPROTEGERIN LEVELS; RECEPTOR ACTIVATOR; OSTEOCLAST DIFFERENTIATION; POSTMENOPAUSAL WOMEN; FRACTURE RISK; MURINE MODEL; EXPRESSION; DENOSUMAB; DISEASE	Patients with multiple myeloma commonly develop focal osteolytic bone disease, as well as generalised osteoporosis. The mechanisms underlying the development of osteoporosis in patients with myeloma are poorly understood. Although disruption of the RANKL/OPG pathway has been shown to underlie formation of focal osteolytic lesions, its role in the development of osteoporosis in myeloma remains unclear. Increased soluble RANKL in serum from patients with myeloma raises the possibility that this molecule plays a key role. The aim of the present study was to establish whether sRANKL produced by myeloma cells contributes directly to osteoporosis. C57BL/KaLwRij mice were injected with either 5T2MM or 5T33MM murine myeloma cells. 5T2MM-bearing mice developed osteolytic bone lesions (p<0.05) with increased osteoclast surface (p<0.01) and reduced trabecular bone volume (p<0.05). Bone volume was also reduced at sites where 5T2MM cells were not present (p<0.05). In 5T2MM-bearing mice soluble mRANKL was increased (p<0.05), whereas OPG was not altered. In contrast, 5T33MM-bearing mice had no changes in osteoclast surface or trabecular bone volume and did not develop osteolytic lesions. Soluble mRANKL was undetectable in serum from 5T33MM-bearing mice. In separate experiments, RPMI-8226 human myeloma cells were transduced with an human RANKL/eGFP construct, or eGFP alone. RPMI-8226/hRANKL/eGFP cells, but not RPMI-8226/eGFP cells, stimulated osteoclastic bone resorption (p<0.05) in vitro. Sub-cutaneous injection of NOD/SCID mice with RPMI-8226/hRANKL/eGFP or RPMI-8226/eGFP cells resulted in tumour development in all mice. RPMI-8226/hRANKL/eGFP-bearing mice exhibited increased serum soluble hRANKL (p<0.05) and a three-fold increase in osteoclast number (p<0.05) compared to RPMI-8226/eGFP-bearing mice. This was associated with reduced trabecular bone volume (27%, p<0.05), decreased trabecular number (29%, p<0.05) and increased trabecular thickness (8%, p<0.05). Our findings demonstrate that soluble RANKL produced by myeloma cells causes generalised bone loss, suggesting that targeting RANKL may prevent osteoporosis in patients with myeloma.	[Buckle, Clive Henry; De Leenheer, Evy; Lawson, Michelle Anne; Croucher, Peter Ian] Univ Sheffield, Fac Med Dent & Hlth, Dept Human Metab, Sheffield, S Yorkshire, England; [Yong, Kwee; Rabin, Neil] UCL, Dept Haematol, London, England; [Perry, Mark] Univ Bristol, Dept Anat, Bristol, Avon, England; [Vanderkerken, Karen] Vrije Univ Brussel, Dept Haematol & Immunol, Brussels, Belgium; [Croucher, Peter Ian] Garvan Inst Med Res, Sydney, NSW, Australia	University of Sheffield; University of London; University College London; University of Bristol; Vrije Universiteit Brussel; Garvan Institute of Medical Research	Buckle, CH (corresponding author), Univ Sheffield, Fac Med Dent & Hlth, Dept Human Metab, Sheffield, S Yorkshire, England.	p.croucher@garvan.org.au	Lawson, Michelle/M-6095-2019; Vanderkerken, Karin/I-3513-2013	Lawson, Michelle/0000-0002-5446-923X; Croucher, Peter/0000-0002-7102-2413; Vanderkerken, Karin/0000-0002-2137-7179	Leukaemia and Lymphoma Research [09021]; Fonds voor Wetenschappelijk Onderzoek (FWO) - Vlaanderen; Onderzoeksraad-VUB; The Multiple Myeloma Research Foundation [10/2003]	Leukaemia and Lymphoma Research; Fonds voor Wetenschappelijk Onderzoek (FWO) - Vlaanderen(FWO); Onderzoeksraad-VUB; The Multiple Myeloma Research Foundation	These studies were supported by grants from the following organisations: Leukaemia and Lymphoma Research - (no 09021) (leukaemialymphomaresearch.org.uk) - provided support for staff and recurrent costs to support the project; the Fonds voor Wetenschappelijk Onderzoek (FWO) - Vlaanderen, Onderzoeksraad-VUB (www.fwo.be) - provided support for staff and recurrent costs to support the project; The Multiple Myeloma Research Foundation - contract 10/2003 (www.themmrf.org) -provided support for maintaining the mouse models of myeloma used in this project; and the Ernest Heine Family Foundation and Mrs Janice Gibson (no url or number) provide support for PIC. The authors confirm that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Body JJ, 2010, J BONE MINER RES, V25, P440, DOI 10.1359/jbmr.090810; Body JJ, 2006, CLIN CANCER RES, V12, P1221, DOI 10.1158/1078-0432.CCR-05-1933; Croucher PI, 2001, BLOOD, V98, P3534, DOI 10.1182/blood.V98.13.3534; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Dougall WC, 2006, CANCER METAST REV, V25, P541, DOI 10.1007/s10555-006-9021-3; Farrugia AN, 2003, CANCER RES, V63, P5438; Garrett IR, 1997, BONE, V20, P515, DOI 10.1016/S8756-3282(97)00056-2; Giuliani N, 2001, BLOOD, V98, P3527, DOI 10.1182/blood.V98.13.3527; Giuliani N, 2002, BLOOD, V100, P4615, DOI 10.1182/blood-2002-04-1121; Hanawa H, 2002, MOL THER, V5, P242, DOI 10.1006/mthe.2002.0549; Hargreaves PG, 1998, BRIT J HAEMATOL, V101, P694, DOI 10.1046/j.1365-2141.1998.00754.x; Heath DJ, 2007, CANCER RES, V67, P202, DOI 10.1158/0008-5472.CAN-06-1287; Heider U, 2003, CLIN CANCER RES, V9, P1436; Holen I, 2001, BRIT J HAEMATOL, V114, P414, DOI 10.1046/j.1365-2141.2001.02963.x; Ikeda T, 2001, ENDOCRINOLOGY, V142, P1419, DOI 10.1210/en.142.4.1419; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lipton A, 2002, CLIN CANCER RES, V8, P2306; Lum L, 1999, J BIOL CHEM, V274, P13613, DOI 10.1074/jbc.274.19.13613; Matsuzaki K, 1998, BIOCHEM BIOPH RES CO, V246, P199, DOI 10.1006/bbrc.1998.8586; McCloskey EV, 2004, MULTIPLE MYELOMA REL; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; Melton LJ, 2005, J BONE MINER RES, V20, P487, DOI 10.1359/JBMR.041131; Melton LJ, 2004, J BONE MINER RES, V19, P25, DOI 10.1359/JBMR.0301212; Nakashima T, 2000, BIOCHEM BIOPH RES CO, V275, P768, DOI 10.1006/bbrc.2000.3379; Pearse RN, 2001, P NATL ACAD SCI USA, V98, P11581, DOI 10.1073/pnas.201394498; RADL J, 1979, J IMMUNOL, V122, P609; RADL J, 1988, AM J PATHOL, V132, P593; Schlondorff J, 2001, J BIOL CHEM, V276, P14665, DOI 10.1074/jbc.M010741200; Seidel C, 2001, BLOOD, V98, P2269, DOI 10.1182/blood.V98.7.2269; Sezer O, 2002, BLOOD, V99, P4646, DOI 10.1182/blood-2002-01-0148; Shipman CM, 2003, CANCER RES, V63, P912; SHIPMAN CM, 2000, BLOOD, V96, P1552; Terpos E, 2003, INT J CANCER, V106, P455, DOI 10.1002/ijc.11247; Terpos E, 2003, BLOOD, V102, P1064, DOI 10.1182/blood-2003-02-0380; Vanderkerken K, 1999, BLOOD, V93, P235, DOI 10.1182/blood.V93.1.235.401k17_235_241; Vanderkerken Karin, 2005, V113, P191, DOI 10.1385/1-59259-916-8:191; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Yaccoby S, 2002, BRIT J HAEMATOL, V116, P278, DOI 10.1046/j.1365-2141.2002.03257.x	40	27	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e41127	10.1371/journal.pone.0041127	http://dx.doi.org/10.1371/journal.pone.0041127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952578	Green Accepted, Green Published, gold			2022-12-25	WOS:000308206000003
J	Li, TT; Chen, JH; Qiu, SA; Zhang, YJ; Wang, PK; Yang, LW; Lu, Y; Shi, JS				Li, Tingting; Chen, Jinhui; Qiu, Shuai; Zhang, Yanjuan; Wang, Pengkai; Yang, Liwei; Lu, Ye; Shi, Jisen			Deep Sequencing and Microarray Hybridization Identify Conserved and Species-Specific MicroRNAs during Somatic Embryogenesis in Hybrid Yellow Poplar	PLOS ONE			English	Article							CELL-WALL; COMPARATIVE GENOMICS; GENE-EXPRESSION; SMALL RNAS; IDENTIFICATION; PREDICTION; TARGETS; EVOLUTION; RESOURCE; DIVERSE	Background: To date, several studies have indicated a major role for microRNAs (miRNAs) in regulating plant development, but miRNA-mediated regulation of the developing somatic embryo is poorly understood, especially during early stages of somatic embryogenesis in hardwood plants. In this study, Solexa sequencing and miRNA microfluidic chips were used to discover conserved and species-specific miRNAs during somatic embryogenesis of hybrid yellow poplar (Liriodendron tulipiferaxL. chinense). Methodology/Principal Findings: A total of 17,214,153 reads representing 7,421,623 distinct sequences were obtained from a short RNA library generated from small RNAs extracted from all stages of somatic embryos. Through a combination of deep sequencing and bioinformatic analyses, we discovered 83 sequences with perfect matches to known miRNAs from 33 conserved miRNA families and 273 species-specific candidate miRNAs. MicroRNA microarray results demonstrated that many conserved and species-specific miRNAs were expressed in hybrid yellow poplar embryos. In addition, the microarray also detected another 149 potential miRNAs, belonging to 29 conserved families, which were not discovered by deep sequencing analysis. The biological processes and molecular functions of the targets of these miRNAs were predicted by carrying out BLAST search against Arabidopsis thaliana GenBank sequences and then analyzing the results with Gene Ontology. Conclusions: Solexa sequencing and microarray hybridization were used to discover 232 candidate conserved miRNAs from 61 miRNA families and 273 candidate species-specific miRNAs in hybrid yellow poplar. In these predicted miRNAs, 64 conserved miRNAs and 177 species-specific miRNAs were detected by both sequencing and microarray hybridization. Our results suggest that miRNAs have wide-ranging characteristics and important roles during all stages of somatic embryogenesis in this economically important species.	[Li, Tingting; Chen, Jinhui; Qiu, Shuai; Zhang, Yanjuan; Wang, Pengkai; Yang, Liwei; Lu, Ye; Shi, Jisen] Nanjing Forestry Univ, Minist Educ, Key Lab Forest Genet & Gene Engn, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University	Li, TT (corresponding author), Nanjing Forestry Univ, Minist Educ, Key Lab Forest Genet & Gene Engn, Nanjing, Jiangsu, Peoples R China.	jshi@njfu.edu.cn			National Key Basic Research Program of China [2012CB114500]; National Science Foundation of China [30930077, 30901156, 31170619]; Natural Science Foundation of Jiangsu University [09KJA220001]; Doctorate Fellowship Foundation of Nanjing Forestry University [163010107]; Priority Academic Program Development of Jiangsu Higher Education Institutions fund	National Key Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu University(Natural Science Foundation of Jiangsu Province); Doctorate Fellowship Foundation of Nanjing Forestry University; Priority Academic Program Development of Jiangsu Higher Education Institutions fund	This work was supported by National Key Basic Research Program of China grant 2012CB114500; National Science Foundation of China grants 30930077, 30901156 and 31170619; Natural Science Foundation of Jiangsu University grant 09KJA220001; Doctorate Fellowship Foundation of Nanjing Forestry University grant 163010107; and Priority Academic Program Development of Jiangsu Higher Education Institutions fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert VA, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-5; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Barozai MYK, 2008, PLANT PHYSIOL BIOCH, V46, P739, DOI 10.1016/j.plaphy.2008.05.009; Barozai MYK, 2012, GENE, V499, P163, DOI 10.1016/j.gene.2012.03.006; BERGER F, 1994, SCIENCE, V263, P1421, DOI 10.1126/science.263.5152.1421; Bilban M, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-19; Bisgrove SR, 2001, PLANTA, V212, P648, DOI 10.1007/s004250000434; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Bonnet E, 2010, BIOINFORMATICS, V26, P1566, DOI 10.1093/bioinformatics/btq233; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chuck G, 2009, CURR OPIN PLANT BIOL, V12, P81, DOI 10.1016/j.pbi.2008.09.008; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Dai JL, 2004, IN VITRO CELL DEV-PL, V40, P376, DOI 10.1079/IVP2004538; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; De Craene LPR, 2003, INT J PLANT SCI, V164, pS329, DOI 10.1086/377063; Dudits D., 1995, In vitro embryogenesis in plants., P267; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Grigg SP, 2009, CURR BIOL, V19, P1485, DOI 10.1016/j.cub.2009.06.070; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Havecker ER, 2010, PLANT CELL, V22, P321, DOI 10.1105/tpc.109.072199; Hunt D, 1998, MAGNOLIAS THEIR ALLI, P304; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Kim KD, 2005, ENVIRON MANAGE, V36, P1, DOI 10.1007/s00267-004-1089-3; Li HY, 2011, PLANTA, V233, P611, DOI 10.1007/s00425-010-1327-2; Liang HY, 2008, TREE GENET GENOMES, V4, P419, DOI 10.1007/s11295-007-0120-2; Liang HY, 2011, TREE GENET GENOMES, V7, P941, DOI 10.1007/s11295-011-0386-2; Lu David P, 2005, J RNAi Gene Silencing, V1, P44; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Mariani TJ, 2002, FASEB J, V16, P321, DOI 10.1096/fj.02-0351fje; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; MERKLE SA, 1993, PLANT CELL TISS ORG, V34, P191, DOI 10.1007/BF00036101; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Nodine MD, 2010, GENE DEV, V24, P2678, DOI 10.1101/gad.1986710; Oh TJ, 2008, NEW PHYTOL, V179, P67, DOI 10.1111/j.1469-8137.2008.02448.x; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Qiu DY, 2009, GENE, V436, P37, DOI 10.1016/j.gene.2009.01.006; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Ranocha P, 2002, PLANT PHYSIOL, V129, P145, DOI 10.1104/pp.010988; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Shi J, 2011, Patent No. [CN 102037896 A, 102037896]; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang XW, 2005, BIOINFORMATICS, V21, P3610, DOI 10.1093/bioinformatics/bti562; Wei Zhong-Xin, 1993, Acta Botanica Yunnanica, V15, P163; Willmann MR, 2011, PLANT PHYSIOL, V155, P1871, DOI 10.1104/pp.110.171355; Wu XM, 2011, PLANTA, V233, P495, DOI 10.1007/s00425-010-1312-9; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhang BH, 2006, FEBS LETT, V580, P3753, DOI 10.1016/j.febslet.2006.05.063; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3	65	50	55	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43451	10.1371/journal.pone.0043451	http://dx.doi.org/10.1371/journal.pone.0043451			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952685	gold, Green Submitted, Green Published			2022-12-25	WOS:000308206000036
J	Budulac, SE; Boezen, HM; Hiemstra, PS; Lapperre, TS; Vonk, JM; Timens, W; Postma, DS				Budulac, Simona E.; Boezen, H. Marike; Hiemstra, Pieter S.; Lapperre, Therese S.; Vonk, Judith M.; Timens, Wim; Postma, Dirkje S.		GLUCOLD Study Grp	Toll-Like Receptor (TLR2 and TLR4) Polymorphisms and Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							TOLL-LIKE-RECEPTOR-2 EXPRESSION; COPD; SALMETEROL; SMOKERS; CELLS	Toll-like receptors (TLRs) participate in the defence against bacterial infections that are common in patients with Chronic Obstructive Pulmonary Disease (COPD). We studied all tagging SNPs in TLR2 and TLR4 and their associations with the level and change over time of both FEV1 and sputum inflammatory cells in moderate-to-severe COPD. Nine TLR2 SNPs and 17 TLR4 SNPs were genotyped in 110 COPD patients. Associations of SNPs with lung function and inflammatory cells in induced sputum were analyzed cross-sectionally with linear regression and longitudinally with linear mixed-effect models. Two SNPs in TLR2 (rs1898830 and rs11938228) were associated with a lower level of FEV1 and accelerated decline of FEV1 and higher numbers of sputum inflammatory cells. None of the TLR4 SNPs was associated with FEV1 level. Eleven out of 17 SNPs were associated with FEV1 decline, including rs12377632 and rs10759931, which were additionally associated with higher numbers of sputum inflammatory cells at baseline and with increase over time. This is the first longitudinal study showing that tagging SNPs in TLR2 and TLR4 are associated with the level and decline of lung function as well as with inflammatory cell numbers in induced sputum in COPD patients, suggesting a role in the severity and progression of COPD.	[Budulac, Simona E.; Boezen, H. Marike; Vonk, Judith M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Hiemstra, Pieter S.; Lapperre, Therese S.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands; [Timens, Wim] Univ Groningen, Dept Pathol, Univ Med Ctr Groningen, Groningen, Netherlands; [Postma, Dirkje S.] Univ Groningen, Dept Pulmonol, Univ Med Ctr Groningen, Groningen, Netherlands; [Budulac, Simona E.; Boezen, H. Marike; Vonk, Judith M.; Timens, Wim; Postma, Dirkje S.] Univ Groningen, GRIAC, Univ Med Ctr Groningen, Groningen, Netherlands	University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; University of Groningen; University of Groningen	Budulac, SE (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	s.budulac@umcg.nl	Rabe, Klaus F./AAW-6296-2021; Vonk, Judith M/ABA-3009-2020; Vonk, Judith/K-8477-2019; Mauad, Thais/G-1254-2012; Timens, Wim/K-5570-2013; Hiemstra, Pieter S/K-8587-2018; /V-8478-2019; Sont, Jacob K/J-8071-2015	Rabe, Klaus F./0000-0002-7020-1401; Vonk, Judith M/0000-0001-7531-4547; Vonk, Judith/0000-0001-7531-4547; Mauad, Thais/0000-0002-3354-1466; Timens, Wim/0000-0002-4146-6363; Hiemstra, Pieter S/0000-0002-0238-5982; Sont, Jacob K/0000-0002-5840-0651; Kerstjens, Huib/0000-0001-7705-7927; Lapperre, Therese/0000-0002-5176-0101	Graduate School for Drug Exploration (GUIDE), University Medical Center Groningen, University of Groningen, the Netherlands; Netherlands Organization for Scientific Research (NWO) [940-35-033]; Netherlands Asthma Foundation (NAF) [37.97.74, 3.2.02.51]; GlaxoSmithKline (NL); Leiden University Medical Center (LUMC); University of Groningen (RUG); AstraZeneca; GSK; Nycomed; Chiesi; Amgen; Boehringer Ingelheim; Centocor; Galapagos; GlaxoSmithKline; Glaxo-SmithKline; Netherlands Asthma Funds	Graduate School for Drug Exploration (GUIDE), University Medical Center Groningen, University of Groningen, the Netherlands(Netherlands Government); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Asthma Foundation (NAF); GlaxoSmithKline (NL); Leiden University Medical Center (LUMC); University of Groningen (RUG); AstraZeneca(AstraZeneca); GSK(GlaxoSmithKline); Nycomed; Chiesi(Chiesi Pharmaceuticals Inc); Amgen(Amgen); Boehringer Ingelheim(Boehringer Ingelheim); Centocor; Galapagos(Galapagos NV); GlaxoSmithKline(GlaxoSmithKline); Glaxo-SmithKline(GlaxoSmithKline); Netherlands Asthma Funds	This work was supported by the Graduate School for Drug Exploration (GUIDE), University Medical Center Groningen, University of Groningen, the Netherlands; The GLUCOLD study was supported by unrestricted grants of the Netherlands Organization for Scientific Research (NWO; 940-35-033), the Netherlands Asthma Foundation (NAF; 37.97.74 and 3.2.02.51), GlaxoSmithKline (NL), Leiden University Medical Center (LUMC), and University of Groningen (RUG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: SEB has no competing interests. DSP received funding for research from AstraZeneca, GSK, Nycomed. Travel to ERS or ATS has been partially funded by AstraZeneca, GSK, Chiesi, Nycomed. DSP has been consultant to AstraZeneca, Boehringer Ingelheim, Chiesi, GSK, Nycomed, TEVA. PSH has received unrestricted research grants for the Department of Pulmonology (Leiden University Medical Center) from Amgen, Boehringer Ingelheim, Centocor, Galapagos and GlaxoSmithKline. TSL has no competing interests. JMV has no competing interests. HMB has no competing interests. WT has received an unrestricted grant from Glaxo-SmithKline and a sponsored grant from Netherlands Asthma Funds. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; [Anonymous], 2010, GLOBAL STRATEGY DIAG; Baines KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018426; Bochud PY, 2003, J IMMUNOL, V170, P3451, DOI 10.4049/jimmunol.170.7.3451; Budulac SE, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-60; Chen KH, 2011, SHOCK, V35, P35, DOI 10.1097/SHK.0b013e3181eb45b3; Doss CGP, 2008, FUNCT INTEGR GENOMIC, V8, P309, DOI 10.1007/s10142-008-0086-7; Droemann D, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-68; Homma T, 2004, AM J RESP CELL MOL, V31, P463, DOI 10.1165/rcmb.2004-0161OC; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kerkhof M, 2010, THORAX, V65, P690, DOI 10.1136/thx.2009.119636; Kurt-Jones EA, 2002, BLOOD, V100, P1860, DOI 10.1182/blood.V100.5.1860.h81702001860_1860_1868; Lapperre TS, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-85; Lapperre TS, 2009, ANN INTERN MED, V151, P517, DOI 10.7326/0003-4819-151-8-200910200-00004; Lapperre TS, 2004, AM J RESP CRIT CARE, V170, P499, DOI 10.1164/rccm.200401-112OC; MacRedmond RE, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-84; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Nadigel J, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-149; Pabst S, 2009, LUNG, V187, P173, DOI 10.1007/s00408-009-9144-8; Pace E, 2011, HUM IMMUNOL, V72, P54, DOI 10.1016/j.humimm.2010.09.009; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pons J, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-64; Rohde G, 2006, RESP MED, V100, P892, DOI 10.1016/j.rmed.2005.08.018; Sabroe I, 2004, THORAX, V59, P81; Sarir H, 2008, EUR J PHARMACOL, V585, P346, DOI 10.1016/j.ejphar.2008.03.009; Schleimer Robert P, 2005, Proc Am Thorac Soc, V2, P342, DOI 10.1513/pats.200504-030SR; Schmitt C, 2002, CLIN CHEM, V48, P1661; Speletas M, 2009, CLIN DEV IMMUNOL, DOI 10.1155/2009/260286; Veen JCCMI, 1996, EUR RESPIR J, V9, P2441, DOI 10.1183/09031936.96.09122441; von Scheele I, 2011, RESP MED, V105, P1222, DOI 10.1016/j.rmed.2011.02.012; Zuany-Amorim C, 2002, NAT REV DRUG DISCOV, V1, P797, DOI 10.1038/nrd914	33	37	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43124	10.1371/journal.pone.0043124	http://dx.doi.org/10.1371/journal.pone.0043124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952638	gold, Green Submitted, Green Published			2022-12-25	WOS:000308213600017
J	Doetsch, M; Gluch, A; Poznanovic, G; Bode, J; Vidakovic, M				Doetsch, Martina; Gluch, Angela; Poznanovic, Goran; Bode, Juergen; Vidakovic, Melita			YY1-Binding Sites Provide Central Switch Functions in the PARP-1 Gene Expression Network	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE PROMOTER; TRANSCRIPTION FACTOR YY1; AUG INITIATOR CODON; BINDING PROTEIN; CELL-DEATH; NUCLEAR; ELEMENT; METHYLATION; REPRESSION; CLEAVAGE	Evidence is presented for the involvement of the interplay between transcription factor Yin Yang 1 (YY1) and poly(ADP-ribose) polymerase-1 (PARP-1) in the regulation of mouse PARP-1 gene (muPARP-1) promoter activity. We identified potential YY1 binding motifs (BM) at seven positions in the muPARP-1 core-promoter (-574/+200). Binding of YY1 was observed by the electrophoretic supershift assay using anti-YY1 antibody and linearized or supercoiled forms of plasmids bearing the core promoter, as well as with 30 bp oligonucleotide probes containing the individual YY1 binding motifs and four muPARP-1 promoter fragments. We detected YY1 binding to BM1 (-587/-558), BM4 (-348/-319) and a very prominent association with BM7 (+86/+115). Inspection of BM7 reveals overlap of the muPARP-1 translation start site with the Kozak sequence and YY1 and PARP-1 recognition sites. Site-directed mutagenesis of the YY1 and PARP-1 core motifs eliminated protein binding and showed that YY1 mediates PARP-1 binding next to the Kozak sequence. Transfection experiments with a reporter gene under the control of the muPARP-1 promoter revealed that YY1 binding to BM1 and BM4 independently repressed the promoter. Mutations at these sites prevented YY1 binding, allowing for increased reporter gene activity. In PARP-1 knockout cells subjected to PARP-1 overexpression, effects similar to YY1 became apparent; over expression of YY1 and PARP-1 revealed their synergistic action. Together with our previous findings these results expand the PARP-1 autoregulatory loop principle by YY1 actions, implying rigid limitation of muPARP-1 expression. The joint actions of PARP-1 and YY1 emerge as important contributions to cell homeostasis.	[Doetsch, Martina; Gluch, Angela; Bode, Juergen; Vidakovic, Melita] Helmholtz Ctr Infect Res Epigenet Regulat, Braunschweig, Germany; [Doetsch, Martina] Univ Vienna, Max F Perutz Labs, Dept Biochem & Mol Cell Biol, Vienna, Austria; [Gluch, Angela] BIOBASE GmbH, Wolfenbuettel, Germany; [Poznanovic, Goran; Vidakovic, Melita] Univ Belgrade, Inst Biol Res, Dept Mol Biol, Belgrade, Serbia; [Bode, Juergen] Hannover Med Sch MHH, Hannover, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Belgrade; Hannover Medical School	Doetsch, M (corresponding author), Helmholtz Ctr Infect Res Epigenet Regulat, Braunschweig, Germany.	melita@ibiss.bg.ac.rs	Poznanovic, Goran/E-6349-2015; Vidaković, Melita/G-6747-2016	Poznanovic, Goran/0000-0003-0839-7017; Vidaković, Melita/0000-0001-8410-6264	Ministry of Education, Science and Technological Development of the Republic of Serbia [173020]; Excellence Initiative REBIRTH (Regenerative Biology to Reconstructive Therapy); ReGene (Regenerative Medicine and Biology) Grant from the Bundesministerium fur Bildung und Forschung; Alexander von Humboldt Foundation [IV-SER/1121681 STP];  [SFB 738]	Ministry of Education, Science and Technological Development of the Republic of Serbia; Excellence Initiative REBIRTH (Regenerative Biology to Reconstructive Therapy); ReGene (Regenerative Medicine and Biology) Grant from the Bundesministerium fur Bildung und Forschung; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); 	This work was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia, Project No. 173020. Work in the laboratories of J.B. at HZI and at MHH was supported by the Excellence Initiative REBIRTH (Regenerative Biology to Reconstructive Therapy), the SFB 738 (Optimierung konventioneller und innovativer Transplantate), and a ReGene (Regenerative Medicine and Biology) Grant from the Bundesministerium fur Bildung und Forschung. M.V.'s work in the lab of J.B. was enabled by the Alexander von Humboldt Foundation Grant (Roman Herzog stipend IV-SER/1121681 STP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aker M, 2010, J BIOL CHEM, V285, P37589, DOI 10.1074/jbc.M110.174532; ALVAREZGONZALEZ R, 1989, MUTAT RES, V218, P67, DOI 10.1016/0921-8777(89)90012-8; Austen M, 1997, J BIOL CHEM, V272, P1709, DOI 10.1074/jbc.272.3.1709; BASU A, 1993, J BIOL CHEM, V268, P4188; BAUKNECHT T, 1995, J VIROL, V69, P1; Beneke S, 2008, NUCLEIC ACIDS RES, V36, P6309, DOI 10.1093/nar/gkn615; Bode J, 2006, J MOL BIOL, V358, P597, DOI 10.1016/j.jmb.2005.11.073; Burkle A, 2001, BIOESSAYS, V23, P795, DOI 10.1002/bies.1115; Burkle A, 2004, EXP GERONTOL, V39, P1599, DOI 10.1016/j.exger.2004.07.010; Caiafa P, 2009, FASEB J, V23, P672, DOI 10.1096/fj.08-123265; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Chevanne M, 2005, THROMB HAEMOSTASIS, V93, P220, DOI 10.1160/TH04-09-0605; Crawford RS, 2010, SURGERY, V148, P110, DOI 10.1016/j.surg.2009.12.006; Cuzzocrea S, 2005, PHARMACOL RES, V52, P72, DOI 10.1016/j.phrs.2005.02.016; Duprez L, 2009, MICROBES INFECT, V11, P1050, DOI 10.1016/j.micinf.2009.08.013; Faraone-Mennella MR, 2005, BIOCHEM CELL BIOL, V83, P396, DOI 10.1139/o05-042; Fry CJ, 1999, J BIOL CHEM, V274, P29583, DOI 10.1074/jbc.274.42.29583; Garnier P, 2003, J NEUROSCI, V23, P7967; GASTON K, 1994, FEBS LETT, V347, P289, DOI 10.1016/0014-5793(94)00567-2; GASTON K, 1995, GENE, V157, P257, DOI 10.1016/0378-1119(95)00120-U; Giansanti V, 2010, BIOCHEM PHARMACOL, V80, P1869, DOI 10.1016/j.bcp.2010.04.022; Gien LT, 2010, J ONCOL, V2010, DOI 10.1155/2010/151750; Gluch A., 2008, V186, P67, DOI 10.1007/978-3-540-72843-6_4; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Griesenbeck J, 1999, FEBS LETT, V443, P20, DOI 10.1016/S0014-5793(98)01671-8; GRUBE K, 1992, P NATL ACAD SCI USA, V89, P11759, DOI 10.1073/pnas.89.24.11759; Guastafierro T, 2008, J BIOL CHEM, V283, P21873, DOI 10.1074/jbc.M801170200; GUO B, 1995, P NATL ACAD SCI USA, V92, P10526, DOI 10.1073/pnas.92.23.10526; He F, 1996, BIOCHEMISTRY-US, V35, P1775, DOI 10.1021/bi9525987; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; Houbaviy HB, 1996, P NATL ACAD SCI USA, V93, P13577, DOI 10.1073/pnas.93.24.13577; Kim JS, 1996, NUCLEIC ACIDS RES, V24, P4341, DOI 10.1093/nar/24.21.4341; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kirkland JB, 2010, EXP BIOL MED, V235, P561, DOI 10.1258/ebm.2010.009280; Klar M, 2005, GENE, V364, P79, DOI 10.1016/j.gene.2005.07.023; Klar M, 2005, MOL CELL BIOL, V25, P10159, DOI 10.1128/MCB.25.22.10159-10170.2005; Klar M, 2005, THESIS TU BRAUNSCHWE; Klar Martin, 2011, Critical Reviews in Oncogenesis, V16, P239; Koh DW, 2005, PHARMACOL RES, V52, P5, DOI 10.1016/j.phrs.2005.02.011; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; KOZAK M, 1984, NATURE, V308, P241, DOI 10.1038/308241a0; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; LABRIE C, 1995, NUCLEIC ACIDS RES, V23, P3732, DOI 10.1093/nar/23.18.3732; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laniel MA, 2004, BBA-GENE STRUCT EXPR, V1679, P37, DOI 10.1016/j.bbaexp.2004.04.003; Laniel MA, 2001, J BIOL CHEM, V276, P20766, DOI 10.1074/jbc.M010360200; Li WW, 1997, MOL CELL BIOL, V17, P61, DOI 10.1128/MCB.17.1.61; McNeil S, 1998, J CELL BIOCHEM, V68, P500, DOI 10.1002/(SICI)1097-4644(19980315)68:4<500::AID-JCB9>3.3.CO;2-T; NATESAN S, 1993, GENE DEV, V7, P2497, DOI 10.1101/gad.7.12b.2497; Nehlsen K, 2012, MINICIRCLE PLASMID D; Oei SL, 2001, BIOCHEM BIOPH RES CO, V285, P27, DOI 10.1006/bbrc.2001.5115; Oei SL, 2001, BIOCHEM BIOPH RES CO, V284, P450, DOI 10.1006/bbrc.2001.4985; Oei SL, 1997, BIOCHEM BIOPH RES CO, V240, P108, DOI 10.1006/bbrc.1997.7621; OEI SL, 1994, MOL CELL BIOCHEM, V138, P99, DOI 10.1007/BF00928449; Pacini A, 1999, J BIOL CHEM, V274, P35107, DOI 10.1074/jbc.274.49.35107; Peralta-Leal A, 2008, CLIN TRANSL ONCOL, V10, P318, DOI 10.1007/s12094-008-0207-8; POTVIN F, 1992, FEBS LETT, V302, P269, DOI 10.1016/0014-5793(92)80457-R; Scovassi AI, 2004, BIOCHEM PHARMACOL, V68, P1041, DOI 10.1016/j.bcp.2004.04.023; SETO E, 1991, NATURE, V354, P241, DOI 10.1038/354241a0; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Soldatenkov VA, 1999, ONCOGENE, V18, P3954, DOI 10.1038/sj.onc.1202778; Soldatenkov VA, 2002, J BIOL CHEM, V277, P665, DOI 10.1074/jbc.M108551200; Telli Melinda L, 2010, Clin Adv Hematol Oncol, V8, P629; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Tulin A, 2003, CURR TOP DEV BIOL, V56, P55, DOI 10.1016/S0070-2153(03)01007-X; Usheva A, 1996, P NATL ACAD SCI USA, V93, P13571, DOI 10.1073/pnas.93.24.13571; USHEVA A, 1994, CELL, V76, P1115, DOI 10.1016/0092-8674(94)90387-5; Vidakovic M, 2009, J CELL BIOCHEM, V107, P1205, DOI 10.1002/jcb.22225; Vidakovic M, 2009, J MOL BIOL, V388, P730, DOI 10.1016/j.jmb.2009.03.032; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Walker J M, 1994, Methods Mol Biol, V32, P5; Xi HL, 2007, GENOME RES, V17, P798, DOI 10.1101/gr.5754707; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; Yelamos J, 2011, AM J CANCER RES, V1, P328; Yokoyama NN, 2010, NUCLEIC ACIDS RES, V38, P6375, DOI 10.1093/nar/gkq492; YOKOYAMA Y, 1990, EUR J BIOCHEM, V194, P521, DOI 10.1111/j.1432-1033.1990.tb15647.x; Zaremba T, 2011, BIOCHEM J, V436, P671, DOI 10.1042/BJ20101723; Ziegler M, 2001, BIOESSAYS, V23, P543, DOI 10.1002/bies.1074	83	12	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44125	10.1371/journal.pone.0044125	http://dx.doi.org/10.1371/journal.pone.0044125			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937159	Green Published, gold, Green Submitted			2022-12-25	WOS:000308213600079
J	Huang, S; Belliveau, JW; Tengshe, C; Ahveninen, J				Huang, Samantha; Belliveau, John W.; Tengshe, Chinmayi; Ahveninen, Jyrki			Brain Networks of Novelty-Driven Involuntary and Cued Voluntary Auditory Attention Shifting	PLOS ONE			English	Article							EVENT-RELATED FMRI; MEDIAL FRONTAL-CORTEX; SCALE NEURAL-NETWORK; SPATIAL ATTENTION; MISMATCH NEGATIVITY; CORTICAL NETWORK; PREFRONTAL CORTEX; PARIETAL CORTEX; ACOUSTIC NOISE; INCREASED DISTRACTIBILITY	In everyday life, we need a capacity to flexibly shift attention between alternative sound sources. However, relatively little work has been done to elucidate the mechanisms of attention shifting in the auditory domain. Here, we used a mixed event-related/sparse-sampling fMRI approach to investigate this essential cognitive function. In each 10-sec trial, subjects were instructed to wait for an auditory "cue" signaling the location where a subsequent "target" sound was likely to be presented. The target was occasionally replaced by an unexpected "novel" sound in the uncued ear, to trigger involuntary attention shifting. To maximize the attention effects, cues, targets, and novels were embedded within dichotic 800-Hz vs. 1500-Hz pure-tone "standard" trains. The sound of clustered fMRI acquisition (starting at t = 7.82 sec) served as a controlled trial-end signal. Our approach revealed notable activation differences between the conditions. Cued voluntary attention shifting activated the superior intra-parietal sulcus (IPS), whereas novelty-triggered involuntary orienting activated the inferior IPS and certain subareas of the precuneus. Clearly more widespread activations were observed during voluntary than involuntary orienting in the premotor cortex, including the frontal eye fields. Moreover, we found -evidence for a frontoinsular-cingular attentional control network, consisting of the anterior insula, inferior frontal cortex, and medial frontal cortices, which were activated during both target discrimination and voluntary attention shifting. Finally, novels and targets activated much wider areas of superior temporal auditory cortices than shifting cues.	[Huang, Samantha; Belliveau, John W.; Tengshe, Chinmayi; Ahveninen, Jyrki] Harvard Univ, Sch Med, Massachusetts Gen Hosp,Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Belliveau, John W.] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University	Huang, S (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp,Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA.	samhuang@nmr.mgh.harvard.edu			National Institutes of Health [R01MH083744, R21DC010060, R01HD040712, R01NS037462, P41RR14075];  [S10RR014978];  [S10RR021110];  [S10RR019307];  [S10RR023401]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040712] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR021110, P41RR014075, S10RR019307, S10RR023401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC010060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health awards R01MH083744, R21DC010060, R01HD040712, R01NS037462, and P41RR14075. The research environment was supported by Shared Instrumentation grants S10RR014978, S10RR021110, S10RR019307, and S10RR023401. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts E, 2009, NEUROPSYCHOLOGIA, V47, P2089, DOI 10.1016/j.neuropsychologia.2009.03.019; Ahveninen J, 2002, NEUROIMAGE, V16, P1052, DOI 10.1006/nimg.2002.1142; Ahveninen J, 2000, AUDIOL NEURO-OTOL, V5, P303, DOI 10.1159/000013896; Ahveninen J, 2000, ALCOHOL CLIN EXP RES, V24, P1850, DOI 10.1097/00000374-200012000-00014; Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; Ahveninen J, 2011, P NATL ACAD SCI USA, V108, P4182, DOI 10.1073/pnas.1016134108; Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Alain C, 1998, BRAIN RES, V812, P23, DOI 10.1016/S0006-8993(98)00851-8; Alain C, 2008, J COGNITIVE NEUROSCI, V20, P285, DOI 10.1162/jocn.2008.20014; Alain C, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00202; ALHO K, 1995, EAR HEARING, V16, P38, DOI 10.1097/00003446-199502000-00004; Alho K, 1998, PSYCHOPHYSIOLOGY, V35, P211, DOI 10.1111/1469-8986.3520211; Alho K, 1997, NEUROREPORT, V8, P3233, DOI 10.1097/00001756-199710200-00010; ALHO K, 1994, ELECTROEN CLIN NEURO, V91, P353, DOI 10.1016/0013-4694(94)00173-1; Anderson JS, 2010, P NATL ACAD SCI USA, V107, P20110, DOI 10.1073/pnas.1011616107; Astafiev SV, 2006, EUR J NEUROSCI, V23, P591, DOI 10.1111/j.1460-9568.2005.04573.x; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Cate AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004645; Cho ZH, 1998, MAGNET RESON MED, V39, P331, DOI 10.1002/mrm.1910390224; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Crottaz-Herbette S, 2006, J COGNITIVE NEUROSCI, V18, P766, DOI 10.1162/jocn.2006.18.5.766; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Doeller CF, 2003, NEUROIMAGE, V20, P1270, DOI 10.1016/S1053-8119(03)00389-6; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Eckert MA, 2008, HUM BRAIN MAPP, V29, P848, DOI 10.1002/hbm.20560; Eckert MA, 2009, HUM BRAIN MAPP, V30, P2530, DOI 10.1002/hbm.20688; Escera C, 2000, AUDIOL NEURO-OTOL, V5, P151, DOI 10.1159/000013877; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Fajardo C, 2008, NEUROSCI LETT, V435, P215, DOI 10.1016/j.neulet.2008.02.048; Falchier A, 2002, J NEUROSCI, V22, P5749; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Garg A, 2007, NEUROPSYCHOLOGIA, V45, P2307, DOI 10.1016/j.neuropsychologia.2007.02.015; Geng JJ, 2009, J COGNITIVE NEUROSCI, V21, P1584, DOI 10.1162/jocn.2009.21103; Gougoux F, 2005, PLOS BIOL, V3, P324, DOI 10.1371/journal.pbio.0030027; Greenberg AS, 2010, J NEUROSCI, V30, P14330, DOI 10.1523/JNEUROSCI.4248-09.2010; Grosbras MH, 1999, CEREB CORTEX, V9, P705, DOI 10.1093/cercor/9.7.705; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; Hommel B, 2009, ATTEN PERCEPT PSYCHO, V71, P385, DOI 10.3758/APP.71.2.385; Indovina I, 2007, CEREB CORTEX, V17, P1701, DOI 10.1093/cercor/bhl081; Jaaskelainen Iiro P, 2010, Open Neuroimag J, V4, P30, DOI 10.2174/1874440001004020030; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; Kahkonen S, 2002, CLIN NEUROPHYSIOL, V113, P1894, DOI 10.1016/S1388-2457(02)00305-X; Kiehl KA, 2001, J PSYCHOPHYSIOL, V15, P221, DOI 10.1027//0269-8803.15.4.221; Kim YH, 1999, NEUROIMAGE, V9, P269, DOI 10.1006/nimg.1999.0408; Kincade JM, 2005, J NEUROSCI, V25, P4593, DOI 10.1523/JNEUROSCI.0236-05.2005; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; KNIGHT RT, 1984, ELECTROEN CLIN NEURO, V59, P9, DOI 10.1016/0168-5597(84)90016-9; MacSweeney M, 2000, NEUROREPORT, V11, P1729, DOI 10.1097/00001756-200006050-00026; Mayer AR, 2009, HUM BRAIN MAPP, V30, P1652, DOI 10.1002/hbm.20631; Mayer AR, 2004, J COGNITIVE NEUROSCI, V16, P1262, DOI 10.1162/0898929041920531; Mazard A, 2002, J COGNITIVE NEUROSCI, V14, P172, DOI 10.1162/089892902317236821; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Mesulam MM, 2001, NEUROIMAGE, V13, P1065, DOI 10.1006/nimg.2001.0768; Muller BW, 2002, NEUROIMAGE, V17, P231, DOI 10.1006/nimg.2002.1176; NAATANEN R, 1992, NEUROREPORT, V3, P493; Naatanen R, 1980, Prog Brain Res, V54, P343, DOI 10.1016/S0079-6123(08)61645-3; Naatanen R, 2000, AUDIOL NEURO-OTOL, V5, P105, DOI 10.1159/000013874; Naatanen R., 2018, ATTENTION BRAIN FUNC; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; Novitski N, 2001, NEUROIMAGE, V14, P244, DOI 10.1006/nimg.2001.0797; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Olulade O, 2011, HEARING RES, V277, P67, DOI 10.1016/j.heares.2011.03.008; Passchier-Vermeer W, 2000, ENVIRON HEALTH PERSP, V108, P123, DOI 10.1289/ehp.00108s1123; Peelen MV, 2004, NEUROIMAGE, V22, P822, DOI 10.1016/j.neuroimage.2004.01.044; Petkov CI, 2004, NAT NEUROSCI, V7, P658, DOI 10.1038/nn1256; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Raij T, 2010, EUR J NEUROSCI, V31, P1772, DOI 10.1111/j.1460-9568.2010.07213.x; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Reuss Heiko, 2011, Adv Cogn Psychol, V7, P82, DOI 10.2478/v10053-008-0091-3; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rinne T, 2000, NEUROIMAGE, V12, P14, DOI 10.1006/nimg.2000.0591; Rinne T, 2007, NEUROSCI LETT, V416, P247, DOI 10.1016/j.neulet.2007.01.077; Rinne T, 2009, J NEUROSCI, V29, P13338, DOI 10.1523/JNEUROSCI.3012-09.2009; Rosen AC, 1999, J COGNITIVE NEUROSCI, V11, P135, DOI 10.1162/089892999563283; Salmi J, 2009, BRAIN RES, V1286, P155, DOI 10.1016/j.brainres.2009.06.083; SanMiguel I, 2010, BIOL PSYCHOL, V83, P143, DOI 10.1016/j.biopsycho.2009.11.012; Schroger E, 1998, COGNITIVE BRAIN RES, V7, P71, DOI 10.1016/S0926-6410(98)00013-5; Schroger E, 1998, NEUROREPORT, V9, P3355, DOI 10.1097/00001756-199810260-00003; Serences JT, 2007, CEREB CORTEX, V17, P284, DOI 10.1093/cercor/bhj146; Shah NJ, 1999, J MAGN RESON IMAGING, V9, P19, DOI 10.1002/(SICI)1522-2586(199901)9:1<19::AID-JMRI3>3.0.CO;2-K; Shomstein S, 2006, J NEUROSCI, V26, P435, DOI 10.1523/JNEUROSCI.4408-05.2006; Shomstein S, 2004, J NEUROSCI, V24, P10702, DOI 10.1523/JNEUROSCI.2939-04.2004; Silver MA, 2009, TRENDS COGN SCI, V13, P488, DOI 10.1016/j.tics.2009.08.005; Simpson GV, 2011, J NEUROSCI, V31, P13880, DOI 10.1523/JNEUROSCI.1519-10.2011; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; Smith DV, 2010, J COGNITIVE NEUROSCI, V22, P347, DOI 10.1162/jocn.2009.21241; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Sterzer P, 2010, BRAIN STRUCT FUNCT, V214, P611, DOI 10.1007/s00429-010-0252-2; Stevens FL, 2011, J NEUROPSYCH CLIN N, V23, P120, DOI 10.1176/appi.neuropsych.23.2.121; Strobel A, 2008, NEUROIMAGE, V40, P869, DOI 10.1016/j.neuroimage.2007.10.065; Szczepanski SM, 2010, J NEUROSCI, V30, P148, DOI 10.1523/JNEUROSCI.3862-09.2010; Talati A, 2005, J COGNITIVE NEUROSCI, V17, P981, DOI 10.1162/0898929054475226; Tomasi D, 2005, NEUROIMAGE, V27, P377, DOI 10.1016/j.neuroimage.2005.04.010; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Voisin J, 2006, J NEUROSCI, V26, P273, DOI 10.1523/JNEUROSCI.2967-05.2006; Weeks R, 2000, J NEUROSCI, V20, P2664; Wilson KD, 2005, NEUROIMAGE, V25, P668, DOI 10.1016/j.neuroimage.2004.07.075; Woods DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005183; WOODS DL, 1986, NEUROLOGY, V36, P212, DOI 10.1212/WNL.36.2.212; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Wu CT, 2007, BRAIN RES, V1134, P187, DOI 10.1016/j.brainres.2006.11.088	115	41	41	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44062	10.1371/journal.pone.0044062	http://dx.doi.org/10.1371/journal.pone.0044062			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937153	Green Published, Green Submitted, gold			2022-12-25	WOS:000308213600073
J	Wang, YW; Zhou, YA; Zhou, HX; Jia, G; Liu, J; Han, B; Cheng, ZX; Jiang, HC; Pan, SH; Sun, B				Wang, Yongwei; Zhou, Yinan; Zhou, Haoxin; Jia, Guang; Liu, Ji; Han, Bing; Cheng, Zhuoxin; Jiang, Hongchi; Pan, Shangha; Sun, Bei			Pristimerin Causes G1 Arrest, Induces Apoptosis, and Enhances the Chemosensitivity to Gemcitabine in Pancreatic Cancer Cells	PLOS ONE			English	Article							FACTOR-KAPPA-B; DOWN-REGULATION; CYCLE ARREST; IN-VITRO; INDUCTION; INHIBITION; ACTIVATION; BCL-2; PROLIFERATION; EXPRESSION	Despite rapid advances in chemotherapy and surgical resection strategies, pancreatic cancer remains the fourth leading cause of cancer related deaths in the United States with a 5-year survival rate of less than 5%. Therefore, novel therapeutic agents for the prevention and treatment of pancreatic cancer are urgently needed. The aim of this study was to investigate the effect of pristimerin, a quinonemethide triterpenoid compound isolated from Celastraceae and Hippocrateaceae, on inhibition of cell proliferation and induction of apoptosis in three pancreatic cancer cells, BxPC-3, PANC-1 and AsPC-1, in both monotherapy and in combination with gemcitabine. Treatment with pristimerin decreased the cell proliferation of all three pancreatic cancer cells in a dose-and time-dependent manner. Treatment of pancreatic cancer cells with pristimerin also resulted in G1-phase arrest which was strongly associated with a marked decrease in the level of cyclins (D1 and E) and cyclin-dependent kinases (cdk2, cdk4 and cdk6) with concomitant induction of WAF1/p21 and KIP1/p27. Pristimerin treatment also resulted in apoptotic cell death, cleavage of caspase-3, modulation in the expressions of Bcl-2 family proteins, inhibition of the translocation and DNA-binding activity of NF-kappa B. In addition, pristimerin potentiated the growth inhibition and apoptosis inducing effects of gemcitabine in all three pancreatic cancer cells, at least in part, by inhibiting constitutive as well as gemcitabine-induced activation of NF-kappa B in both its DNA-binding activity and transcriptional activity. Taken together, these data provide the first evidence that pristimerin has strong potential for development as a novel agent against pancreatic cancer.	[Wang, Yongwei; Zhou, Yinan; Zhou, Haoxin; Jia, Guang; Liu, Ji; Han, Bing; Cheng, Zhuoxin; Jiang, Hongchi; Pan, Shangha; Sun, Bei] Harbin Med Univ, Affiliated Hosp 1, Dept Pancreat & Biliary Surg, Harbin, Peoples R China	Harbin Medical University	Wang, YW (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Pancreat & Biliary Surg, Harbin, Peoples R China.	sunbei70@tom.com	Jiang, HongChi/M-5031-2018	Jiang, HongChi/0000-0001-8215-8984	New Century Support Foundation for Elitist of Chinese Ministry of Education [NCET-07-0248]; Scientific Foundation for Prominent Youth of Heilongjiang Province, China [JC200717]; Scientific and Technological Project of Heilongjiang Province, China [GC09C407-2]; research Special Fund For public welfare industry of health [201202007]; National Natural Scientific Foundation of China [81170431, 81101799]	New Century Support Foundation for Elitist of Chinese Ministry of Education; Scientific Foundation for Prominent Youth of Heilongjiang Province, China; Scientific and Technological Project of Heilongjiang Province, China; research Special Fund For public welfare industry of health; National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by grants from the New Century Support Foundation for Elitist of Chinese Ministry of Education (NCET-07-0248), the Scientific Foundation for Prominent Youth of Heilongjiang Province, China (JC200717), the Scientific and Technological Project of Heilongjiang Province, China (GC09C407-2), the research Special Fund For public welfare industry of health (201202007) and the National Natural Scientific Foundation of China (81170431, 81101799). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Arlt A, 2003, ONCOGENE, V22, P3243, DOI 10.1038/sj.onc.1206390; Arora S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021573; Bentires-Alj M, 2003, ONCOGENE, V22, P90, DOI 10.1038/sj.onc.1206056; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Byun JY, 2009, MOL PHARMACOL, V76, P734, DOI 10.1124/mol.109.056259; Call JA, 2008, LANCET ONCOL, V9, P1002, DOI 10.1016/S1470-2045(08)70209-2; Chen H, 2010, J CANCER RES CLIN, V136, P897, DOI 10.1007/s00432-009-0731-0; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Dirsch VM, 1997, EUR J PHARMACOL, V336, P211, DOI 10.1016/S0014-2999(97)01245-4; Duffy John P, 2003, Mol Cancer, V2, P12, DOI 10.1186/1476-4598-2-12; Fujioka S, 2003, CLIN CANCER RES, V9, P346; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Greten FR, 2002, GASTROENTEROLOGY, V123, P2052, DOI 10.1053/gast.2002.37075; Gupta S, 2002, ONCOGENE, V21, P3727, DOI 10.1038/sj.onc.1205474; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jutooru I, 2010, J BIOL CHEM, V285, P25332, DOI 10.1074/jbc.M109.095240; Kornmann M, 1998, ONCOLOGY-BASEL, V55, P363, DOI 10.1159/000011879; Li L, 2004, CANCER-AM CANCER SOC, V101, P2351, DOI 10.1002/cncr.20605; Liptay S, 2003, INT J CANCER, V105, P735, DOI 10.1002/ijc.11081; Llambi F, 2011, CURR OPIN GENET DEV, V21, P12, DOI 10.1016/j.gde.2010.12.001; Maier HJ, 2010, CANCER LETT, V295, P214, DOI 10.1016/j.canlet.2010.03.003; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Molinari M, 2000, CELL PROLIFERAT, V33, P261, DOI 10.1046/j.1365-2184.2000.00191.x; Murtaza I, 2009, INT J CANCER, V125, P2465, DOI 10.1002/ijc.24628; Nakanishi M, 2006, CANCER SCI, V97, P984, DOI 10.1111/j.1349-7006.2006.00289.x; Neumann M, 2007, FASEB J, V21, P2642, DOI 10.1096/fj.06-7615rev; Pan X, 2008, CLIN CANCER RES, V14, P8143, DOI 10.1158/1078-0432.CCR-08-1539; Pestell RG, 1999, ENDOCR REV, V20, P501, DOI 10.1210/er.20.4.501; Pucci B, 2000, NEOPLASIA, V2, P291, DOI 10.1038/sj.neo.7900101; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sliva D, 2004, CURR CANCER DRUG TAR, V4, P327, DOI 10.2174/1568009043332961; Srivastava SK, 2004, CARCINOGENESIS, V25, P1701, DOI 10.1093/carcin/bgh179; Swanton C, 2004, LANCET ONCOL, V5, P27, DOI 10.1016/S1470-2045(03)01321-4; Tiedemann RE, 2009, BLOOD, V113, P4027, DOI 10.1182/blood-2008-09-179796; Wang SJ, 2010, CANCER LETT, V293, P99, DOI 10.1016/j.canlet.2010.01.001; Wang YW, 2012, J CANCER RES CLIN, V138, P785, DOI 10.1007/s00432-012-1152-z; Weichert W, 2007, BRIT J CANCER, V97, P523, DOI 10.1038/sj.bjc.6603878; Wu CC, 2005, MOL CANCER THER, V4, P1277, DOI 10.1158/1535-7163.MCT-05-0027; Xiong HQ, 2004, INT J CANCER, V108, P181, DOI 10.1002/ijc.11562; Yang HJ, 2008, J CELL BIOCHEM, V103, P234, DOI 10.1002/jcb.21399; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307	44	55	55	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43826	10.1371/journal.pone.0043826	http://dx.doi.org/10.1371/journal.pone.0043826			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952775	Green Submitted, Green Published, gold			2022-12-25	WOS:000308213600048
J	Kuras, Z; Yun, YH; Chimote, AA; Neumeier, L; Conforti, L				Kuras, Zerrin; Yun, Yeo-Heung; Chimote, Ameet A.; Neumeier, Lisa; Conforti, Laura			KCa3.1 and TRPM7 Channels at the Uropod Regulate Migration of Activated Human T Cells	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNEL; NONSELECTIVE CATION CHANNEL; IMMUNOLOGICAL SYNAPSE; KV1.3 CHANNEL; ION CHANNELS; POTASSIUM CHANNELS; CALCIUM INFLUX; LYMPHOCYTES; TRAFFICKING; CRAC	The migration of T lymphocytes is an essential part of the adaptive immune response as T cells circulate around the body to carry out immune surveillance. During the migration process T cells polarize, forming a leading edge at the cell front and a uropod at the cell rear. Our interest was in studying the involvement of ion channels in the migration of activated human T lymphocytes as they modulate intracellular Ca2+ levels. Ca2+ is a key regulator of cellular motility. To this purpose, we created protein surfaces made of the bio-polymer PNMP and coated with ICAM-1, ligand of LFA-1. The LFA-1 and ICAM-1 interaction facilitates T cell movement from blood into tissues and it is critical in immune surveillance and inflammation. Activated human T lymphocytes polarized and migrated on ICAM-1 surfaces by random walk with a mean velocity of similar to 6 mu m/min. Confocal microscopy indicated that Kv1.3, CRAC, and TRPM4 channels positioned in the leading-edge, whereas KCa3.1 and TRPM7 channels accumulated in the uropod. The localization of KCa3.1 and TRPM7 at the uropod was associated with oscillations in intracellular Ca2+ levels that we measured in this cell compartment. Further studies with blockers against Kv1.3 (ShK), KCa3.1 (TRAM-34), CRAC (SKF-96365), TRPM7 (2-APB), and TRPM4 (glibenclamide) indicated that blockade of KCa3.1 and TRPM7, and not Kv1.3, CRAC or TRPM4, inhibits the T cell migration. The involvement of TRPM7 in cell migration was confirmed with siRNAs against TRPM7. Downregulation of TRPM7 significantly reduced the number of migrating T cells and the mean velocity of the migrating T cells. These results indicate that KCa3.1 and TRPM7 selectively localize at the uropod of migrating T lymphocytes and are key components of the T cell migration machinery.	[Kuras, Zerrin; Chimote, Ameet A.; Neumeier, Lisa] Univ Cincinnati, Dept Internal Med, Cincinnati, OH 45221 USA; [Conforti, Laura] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH USA; [Yun, Yeo-Heung] N Carolina Agr & Tech State Univ, Dept Bioengn, Greensboro, NC USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of North Carolina; North Carolina A&T State University	Kuras, Z (corresponding author), Univ Cincinnati, Dept Internal Med, Cincinnati, OH 45221 USA.	Laura.Conforti@uc.edu	Chimote, Ameet A/R-5357-2016	Chimote, Ameet/0000-0001-5163-0123	National Institutes of Health [1R21AI083076, 2R01CA095286]; NATIONAL CANCER INSTITUTE [R01CA095286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083076] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by National Institutes of Health grants 1R21AI083076 and 2R01CA095286 to LC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbet G, 2008, NAT IMMUNOL, V9, P1148, DOI 10.1038/ni.1648; Bisaillon JM, 2010, AM J PHYSIOL-CELL PH, V298, pC993, DOI 10.1152/ajpcell.00325.2009; Cahalan MD, 2005, SEMIN IMMUNOL, V17, P442, DOI 10.1016/j.smim.2005.09.001; CAHALAN MD, 1985, J PHYSIOL-LONDON, V358, P197, DOI 10.1113/jphysiol.1985.sp015548; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Castillo B, 2010, J BIOMOL SCREEN, V15, P498, DOI 10.1177/1087057110368294; Chen JP, 2010, CELL CALCIUM, V47, P425, DOI 10.1016/j.ceca.2010.03.003; Cheong A, 2011, CARDIOVASC RES, V89, P282, DOI 10.1093/cvr/cvq305; Chimote AA, 2012, J BIOL CHEM, V287, P2055, DOI 10.1074/jbc.M111.274209; Demion M, 2007, CARDIOVASC RES, V73, P531, DOI 10.1016/j.cardiores.2006.11.023; Doh J, 2006, P NATL ACAD SCI USA, V103, P5700, DOI 10.1073/pnas.0509404103; Feske S, 2005, J EXP MED, V202, P651, DOI 10.1084/jem.20050687; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Gerard A, 2007, J CELL BIOL, V176, P863, DOI 10.1083/jcb.200608161; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Gomez TS, 2008, ADV IMMUNOL, V97, P1, DOI 10.1016/S0065-2776(08)00001-1; Inada H, 2006, BIOCHEM BIOPH RES CO, V350, P762, DOI 10.1016/j.bbrc.2006.09.111; Irvine DJ, 2007, SEMIN IMMUNOL, V19, P245, DOI 10.1016/j.smim.2007.02.011; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; Katz JS, 2006, LANGMUIR, V22, P353, DOI 10.1021/la0523098; Kindzelskii AL, 2005, EUR BIOPHYS J BIOPHY, V35, P1, DOI 10.1007/s00249-005-0001-2; Kuras Z, 2012, AM J PHYSL CELL PHYS; LEE SC, 1992, J GEN PHYSIOL, V99, P771, DOI 10.1085/jgp.99.5.771; Levite M, 2000, J EXP MED, V191, P1167, DOI 10.1084/jem.191.7.1167; LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623, DOI 10.1146/annurev.iy.13.040195.003203; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Matzner N, 2008, J IMMUNOL, V181, P6803, DOI 10.4049/jimmunol.181.10.6803; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Nicolaou SA, 2007, J IMMUNOL, V179, P346, DOI 10.4049/jimmunol.179.1.346; Nicolaou SA, 2007, AM J PHYSIOL-CELL PH, V292, pC1431, DOI 10.1152/ajpcell.00376.2006; Nicolaou SA, 2010, CELL CALCIUM, V47, P19, DOI 10.1016/j.ceca.2009.11.001; Nicolaou SA, 2009, J IMMUNOL, V183, P6296, DOI 10.4049/jimmunol.0900613; Nutile-McMenemy N, 2007, J NEUROCHEM, V103, P2035, DOI 10.1111/j.1471-4159.2007.04889.x; Panyi G, 2004, IMMUNOL LETT, V92, P55, DOI 10.1016/j.imlet.2003.11.020; Panyi G, 2003, P NATL ACAD SCI USA, V100, P2592, DOI 10.1073/pnas.0438057100; Park KH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001595; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Robbins JR, 2005, J PHYSIOL-LONDON, V564, P131, DOI 10.1113/jphysiol.2004.081893; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Schwab A, 2008, PHYSIOLOGY, V23, P212, DOI 10.1152/physiol.00003.2008; Shimizu T, 2009, CELL CALCIUM, V45, P226, DOI 10.1016/j.ceca.2008.10.005; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Su LT, 2011, BIOCHEM J, V434, P513, DOI 10.1042/BJ20101678; Svensson L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015090; Syme CA, 2003, J BIOL CHEM, V278, P8476, DOI 10.1074/jbc.M210072200; Szabo I, 1997, PFLUG ARCH EUR J PHY, V433, P626, DOI 10.1007/s004240050323; Varga Z, 2010, IMMUNOL LETT, V130, P19, DOI 10.1016/j.imlet.2009.12.015; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wang HY, 2009, P NATL ACAD SCI USA, V106, P12436, DOI 10.1073/pnas.0900510106; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	55	64	69	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43859	10.1371/journal.pone.0043859	http://dx.doi.org/10.1371/journal.pone.0043859			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952790	Green Submitted, Green Published, gold			2022-12-25	WOS:000308044800068
J	Ye, W; Qin, F; Zhang, J; Luo, R; Chen, HF				Ye, Wei; Qin, Fang; Zhang, Jian; Luo, Ray; Chen, Hai-Feng			Atomistic Mechanism of MicroRNA Translation Upregulation via Molecular Dynamics Simulations	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; SWISS-MODEL; RNA-BINDING; CRYSTAL-STRUCTURE; KH DOMAIN; RECOGNITION; FXR1; ACTIVATION; MUTATION; MOTIF	MicroRNAs are endogenous 23-25 nt RNAs that play important gene-regulatory roles in animals and plants. Recently, miR369-3 was found to upregulate translation of TNF alpha mRNA in quiescent (G0) mammalian cell lines. Knock down and immunofluorescence experiments suggest that microRNA-protein complexes (with FXR1 and AGO2) are necessary for the translation upregulation. However the molecular mechanism of microRNA translation activation is poorly understood. In this study we constructed the microRNA-mRNA-AGO2-FXR1 quadruple complex by bioinformatics and molecular modeling, followed with all atom molecular dynamics simulations in explicit solvent to investigate the interaction mechanisms for the complex. A combined analysis of experimental and computational data suggests that AGO2-FXR1 complex relocalize microRNA: mRNA duplex to polysomes in G0. The two strands of dsRNA are then separated upon binding of AGO2 and FXR1. Finally, polysomes may improve the translation efficiency of mRNA. The mutation research confirms the stability of microRNA-mRNA-FXR1 and illustrates importance of key residue of Ile304. This possible mechanism can shed more light on the microRNA- dependent upregulation of translation.	[Ye, Wei; Qin, Fang; Chen, Hai-Feng] Shanghai Jiao Tong Univ, Dept Bioinformat & Biostat, State Key Lab Microbial Metab, Coll Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Zhang, Jian] Shanghai Jiao Tong Univ, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis, Chinese Minist Educ,Sch Med, Shanghai 200030, Peoples R China; [Luo, Ray] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Chen, Hai-Feng] Shanghai Ctr Bioinformat Technol, Dept Computat Biol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of California System; University of California Irvine; Chinese Academy of Sciences	Ye, W (corresponding author), Shanghai Jiao Tong Univ, Dept Bioinformat & Biostat, State Key Lab Microbial Metab, Coll Life Sci & Biotechnol, Shanghai 200030, Peoples R China.	jian.zhang@sjtu.edu.cn; rluo@uci.edu; haifengchen@sjtu.edu.cn	Zhang, Jian/GXA-1303-2022; Luo, Ray/M-3035-2019; Luo, Ray/I-6928-2012; Chen, Haifeng/AAT-7444-2020	Zhang, Jian/0000-0002-6558-791X; Luo, Ray/0000-0002-6346-8271; Luo, Ray/0000-0002-6346-8271; Ye, Wei/0000-0001-6268-2703	Ministry of Science and Technology China [2012CB721003]; National High-tech R&D Program of China (863 Program) [2012AA020403]; Innovation Program of Shanghai Education Committee [12ZZ023]; Shanghai Pujiang Program [10PJD010, 10PJ1406800]; Natural Science Foundation of Shanghai from China [10ZR1414500]; Medical Engineering Cross Fund of Shanghai Jiaotong University [YG2010MS67]	Ministry of Science and Technology China(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea); National High-tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); Innovation Program of Shanghai Education Committee; Shanghai Pujiang Program(Shanghai Pujiang Program); Natural Science Foundation of Shanghai from China; Medical Engineering Cross Fund of Shanghai Jiaotong University	This work was sponsored by grants from Ministry of Science and Technology China (2012CB721003), by National High-tech R&D Program of China (863 Program) (2012AA020403), by Innovation Program of Shanghai Education Committee (grant no. 12ZZ023), by Shanghai Pujiang Program (10PJD010 and 10PJ1406800), by the Natural Science Foundation of Shanghai from China (grant no. 10ZR1414500), and by Medical Engineering Cross Fund of Shanghai Jiaotong University (YG2010MS67). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bechara EG, 2009, PLOS BIOL, V7, P133, DOI 10.1371/journal.pbio.1000016; Bhattacharyya SN, 2007, CELL, V128, P1027, DOI 10.1016/j.cell.2007.02.033; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; CASE DA, 2004, AMBER 8; Chen HF, 2008, J CHEM THEORY COMPUT, V4, P1360, DOI 10.1021/ct800030s; Chen HF, 2007, J AM CHEM SOC, V129, P2930, DOI 10.1021/ja0678774; Chen HF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006516; Chen HF, 2009, COMPUT BIOL CHEM, V33, P41, DOI 10.1016/j.compbiolchem.2008.07.023; Chen Y, 2010, BIOPOLYMERS, V93, P578, DOI 10.1002/bip.21405; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Garcia-Garcia C, 2003, J MOL BIOL, V331, P75, DOI 10.1016/S0022-2836(03)00615-6; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P638, DOI 10.1093/nar/29.3.638; Huang ZM, 2011, NUCLEIC ACIDS RES, V39, pD663, DOI 10.1093/nar/gkq1022; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jin JY, 2011, NUCLEIC ACIDS RES, V39, P3724, DOI 10.1093/nar/gkq1350; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kirkpatrick LL, 1999, GENOMICS, V59, P193, DOI 10.1006/geno.1999.5868; Kirkpatrick LL, 2001, GENOMICS, V78, P169, DOI 10.1006/geno.2001.6667; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Lewis HA, 1999, STRUCTURE, V7, P191, DOI 10.1016/S0969-2126(99)80025-2; Luo R, 2002, J COMPUT CHEM, V23, P1244, DOI 10.1002/jcc.10120; Lwin TZ, 2006, PROTEIN SCI, V15, P2642, DOI 10.1110/ps.062438006; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Macke TJ, 1998, ACS SYM SER, V682, P379; Mortensen RD, 2011, P NATL ACAD SCI USA, V108, P8281, DOI 10.1073/pnas.1105401108; Pande VS, 1999, P NATL ACAD SCI USA, V96, P9062, DOI 10.1073/pnas.96.16.9062; Plante I, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/64347; Plante I, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/16806; Qin F, 2012, PHYS CHEM CHEM PHYS, V14, P538, DOI 10.1039/c1cp22610j; Qin F, 2011, PHYS CHEM CHEM PHYS, V13, P1407, DOI 10.1039/c0cp00701c; Qin F, 2010, RNA, V16, P1053, DOI 10.1261/rna.2008110; Qin F, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3224126; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Rusk N, 2008, NAT METHODS, V5, P122, DOI 10.1038/nmeth0208-122a; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Vasudevan S, 2008, CELL CYCLE, V7, P1545, DOI 10.4161/cc.7.11.6018; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129	53	12	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43788	10.1371/journal.pone.0043788	http://dx.doi.org/10.1371/journal.pone.0043788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952765	Green Published, gold			2022-12-25	WOS:000308044800059
J	Zhao, JK; Lama, M; Korenromp, E; Aylward, P; Shargie, E; Filler, S; Komatsu, R; Atun, R				Zhao, Jinkou; Lama, Marcel; Korenromp, Eline; Aylward, Patrick; Shargie, Estifanos; Filler, Scott; Komatsu, Ryuichi; Atun, Rifat			Adoption of Rapid Diagnostic Tests for the Diagnosis of Malaria, a Preliminary Analysis of the Global Fund Program Data, 2005 to 2010	PLOS ONE			English	Article							IMPLEMENTATION	Introduction: The World Health Organization Guidelines for the Treatment of Malaria, in 2006 and 2010, recommend parasitological confirmation of malaria before commencing treatment. Although microscopy has been the mainstay of malaria diagnostics, the magnitude of diagnostic scale up required to follow the Guidelines suggests that rapid diagnostic tests (RDTs) will be a large component. This study analyzes the adoption of rapid diagnostic testing in malaria programs supported by the Global Fund to fight AIDS, Tuberculosis and Malaria (Global Fund), the leading international funder of malaria control globally. Methods and Findings: We analyzed, for the period 2005 to 2010, Global Fund programmatic data for 81 countries on the quantity of RDTs planned; actual quantities of RDTs and artemisinin-based combination treatments (ACTs) procured in 2009 and 2010; RDT-related activities including RDTs distributed, RDTs used, total diagnostic tests including RDTs and microscopy performed, health facilities equipped with RDTs; personnel trained to perform rapid diagnostic malaria test; and grant budgets allocated to malaria diagnosis. In 2010, diagnosis accounted for 5.2% of malaria grant budget. From 2005 to 2010, the procurement plans include 148 million RDTs through 96 malaria grants in 81 countries. Around 115 million parasitological tests, including RDTs, had reportedly been performed from 2005 to 2010. Over this period, 123, 132 health facilities were equipped with RDTs and 137,140 health personnel had been trained to perform RDT examinations. In 2009 and 2010, 41 million RDTs and 136 million ACTs were purchased. The ratio of procured RDTs to ACTs was 0.26 in 2009 and 0.34 in 2010. Conclusions/significance: Global Fund financing has enabled 81 malaria-endemic countries to adopt WHO guidelines by investing in RDTs for malaria diagnosis, thereby helping improve case management of acute febrile illness in children. However, roll-out of parasitological diagnosis lags behind the roll-out of ACT-based treatment, and will require prioritization of investments.	[Zhao, Jinkou; Lama, Marcel; Korenromp, Eline; Aylward, Patrick; Shargie, Estifanos; Filler, Scott; Komatsu, Ryuichi] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Zhao, Jinkou] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Korenromp, Eline] Erasmus Univ, Med Ctr, Rotterdam, Netherlands; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, London, England	Jiangsu Provincial Center for Disease Control & Prevention; Erasmus University Rotterdam; Erasmus MC; Imperial College London	Zhao, JK (corresponding author), Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland.	jinkou.zhao@theglobalfound.org	Atun, Rifat/AAH-5537-2021	Atun, Rifat/0000-0002-1531-5983; Zhao, Jinkou/0000-0001-9184-3385	Global Fund to fight AIDS, Tuberculosis and Malaria	Global Fund to fight AIDS, Tuberculosis and Malaria	The analysis was supported by the Global Fund to fight AIDS, Tuberculosis and Malaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgader TM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-11; Abuya TO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008937; [Anonymous], 2011, MAL RAP DIAGN TEST P; [Anonymous], 2011, UN ACC MAL DIAGN TES; [Anonymous], 2011, MAK DIFF GLOB FUND R; [Anonymous], GUID TREATM MAL; Atun RA, 2007, INT J INNOV MANAG, V11, P299, DOI 10.1142/S1363919607001709; Bisoffi Z, 2010, MALARIA J, V9, P19; Bjorkman A, 2010, CLIN INFECT DIS, V51, P512, DOI 10.1086/655689; D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; Graz B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-136; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Reilley B, 2002, TROP MED INT HEALTH, V7, P744, DOI 10.1046/j.1365-3156.2002.00919.x; Roger E.M, 2003, DIFFUSION INNOVATION; Roll Back Malaria, 2008, GLOB MAL ACT PLAN FR; Roll Back Malaria Partnership, 2011, REF UPD GMAP OBJ TAR; The Global Fund, 2012, GLOB FUND STRAT 2012; The Presidents Malaria Initiative, 2011, MAL OP PLANS FISC YE; The Presidents Malaria Initiative, 2011, 5 ANN REP C APR; Thiam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018419; WHO, 2006, GUID TREATM MAL; WHO, 2012, TEST TREAT TRACK INI; World Health Organization, WOLD MAL REP 2011; WORLDHEALTH ORGANIZATION (WHO), 2008, WORLD MAL REP 2008; Zhao JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028932	26	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43549	10.1371/journal.pone.0043549	http://dx.doi.org/10.1371/journal.pone.0043549			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952703	Green Submitted, Green Published, gold			2022-12-25	WOS:000308044800037
J	Diamantopoulos, AP; Rohde, G; Johnsrud, I; Skoie, IM; Hochberg, M; Haugeberg, G				Diamantopoulos, Andreas P.; Rohde, Gudrun; Johnsrud, Irene; Skoie, Inger M.; Hochberg, Marc; Haugeberg, Glenn			The Epidemiology of Low- and High-Energy Distal Radius Fracture in Middle-Aged and Elderly Men and Women in Southern Norway	PLOS ONE			English	Article							BONE-MINERAL DENSITY; OSTEOPOROTIC FRACTURES; SEASONAL-VARIATION; RISK-FACTOR; POPULATION; URBAN	Background: Distal radius is one of the most frequent sites for fractures in the elderly population. Despite this, there is a paucity of epidemiological data for distal radius fracture, in particular, distinguishing between high-and low-energy fractures. Our aim was to study the epidemiology of high-and low-energy distal radius fracture in middle-aged and elderly men and women in Southern Norway, and search for associates with high-or low-energy distal radius fracture in this population. Methodology/Principal Findings: Patients with distal radius fractures aged >= 50 years were identified from all four hospitals in Southern Norway between 2004 and 2005. Age-adjusted and age-specific incidence rates for men and women were calculated, and potential associates with high-and low-energy distal radius fracture were explored both in univariate and multivariate analyses. A total of 799 individuals (118 men and 681 women) aged >= 50 years with low-energy and 84 (48 men and 36 women) with high-energy distal radius fracture were identified. The overall age-adjusted incidence rate per 10,000 person-years was 18.9 for men (low energy, 12.8 vs. high-energy, 6.1) and 75.1 for women (low energy, 71.1 vs. high energy, 4.0). In multivariate model, younger age, male gender, summer season, and living in a rural area were independently associated with an increased risk of high-energy fracture. Conclusion: An approximately fourfold higher age-adjusted incidence rate for distal radius fracture was found among women, when compared with men. However, the proportion of patients with high-energy distal radius fracture was approximately fivefold higher in men than in women. Our data suggest that younger age, male gender, summer seasons, and living in rural areas are independent risk factors for increased risk of high-energy distal radius fracture.	[Diamantopoulos, Andreas P.; Rohde, Gudrun; Johnsrud, Irene; Skoie, Inger M.; Haugeberg, Glenn] Hosp So Norway, Dept Rheumatol, Kristiansand, Norway; [Rohde, Gudrun] Univ Agder, Fac Hlth & Sport, Kristiansand, Norway; [Hochberg, Marc] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Hochberg, Marc] Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; [Diamantopoulos, Andreas P.; Haugeberg, Glenn] Norwegian Univ Sci & Technol, INM, Dept Neurosci, N-7034 Trondheim, Norway	University of Agder; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Norwegian University of Science & Technology (NTNU)	Diamantopoulos, AP (corresponding author), Hosp So Norway, Dept Rheumatol, Kristiansand, Norway.	andreas.diamantopoulos@sshf.no			Competence Development Fund of Southern Norway; Hospital of Southern Norway HF (HelseForetak-Health trust)	Competence Development Fund of Southern Norway; Hospital of Southern Norway HF (HelseForetak-Health trust)	This work has been supported and funded by the Competence Development Fund of Southern Norway and the Hospital of Southern Norway HF (HelseForetak-Health trust). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brogren E, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-48; CUMMINGS SR, 1985, EPIDEMIOL REV, V7, P178, DOI 10.1093/oxfordjournals.epirev.a036281; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Diamantopoulos AP, 2011, AGE AGEING; Flinkkila T, 2011, OSTEOPOROSIS INT, V22, P2307, DOI 10.1007/s00198-010-1463-3; HOVE LM, 1995, SCAND J PLAST RECONS, V29, P263, DOI 10.3109/02844319509050137; JONSSON B, 1992, OSTEOPOROSIS INT, V2, P269, DOI 10.1007/BF01623181; Kirkwood BR, 2008, ESSENTIAL MED STAT; Lofthus CM, 2008, OSTEOPOROSIS INT, V19, P781, DOI 10.1007/s00198-007-0499-5; Lunt M, 1997, J BONE MINER RES, V12, P1883, DOI 10.1359/jbmr.1997.12.11.1883; MALLMIN H, 1992, ACTA ORTHOP SCAND, V63, P213, DOI 10.3109/17453679209154826; Meyer HE, 2004, AM J EPIDEMIOL, V160, P1039, DOI 10.1093/aje/kwh337; O'Neill TW, 2001, OSTEOPOROSIS INT, V12, P555, DOI 10.1007/s001980170076; Omsland TK, 2009, OSTEOPOROSIS INT, V20, P631, DOI 10.1007/s00198-008-0699-7; Omsland TK, 2011, J BONE MINER RES, V26, P850, DOI 10.1002/jbmr.280; Oyen J, 2010, OSTEOPOROSIS INT, V21, P1257, DOI 10.1007/s00198-009-1068-x; Oyen J, 2010, OSTEOPOROSIS INT, V21, P1247, DOI 10.1007/s00198-009-1065-0; Oyen J, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-67; Oyen J, 2011, J BONE JOINT SURG AM, V93A, P348, DOI 10.2106/JBJS.J.00303; Oyen J, 2011, BONE, V48, P1140, DOI 10.1016/j.bone.2011.01.021; SOLGAARD S, 1985, ACTA ORTHOP SCAND, V56, P391, DOI 10.3109/17453678508994354; Thompson PW, 2004, INJURY, V35, P462, DOI 10.1016/S0020-1383(03)00117-7; Tsai CH, 2011, OSTEOPOROSIS INT, V22, P2809, DOI 10.1007/s00198-010-1489-6	23	66	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43367	10.1371/journal.pone.0043367	http://dx.doi.org/10.1371/journal.pone.0043367			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937040	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000308225500044
J	Elliott, GN; Thomas, N; MacRae, M; Campbell, CD; Ogden, ID; Singh, BK				Elliott, Geoffrey N.; Thomas, Nadine; MacRae, Marion; Campbell, Colin D.; Ogden, Iain D.; Singh, Brajesh K.			Multiplex T-RFLP Allows for Increased Target Number and Specificity: Detection of Salmonella enterica and Six Species of Listeria in a Single Test	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; REAL-TIME PCR; RAPID IDENTIFICATION; ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; POPULATION-DYNAMICS; BACTERIA; COMMUNITY; DIVERSITY; SEDIMENTS	A multiplex T-RFLP test was developed to detect and identify Salmonella enterica and all six species of Listeria inoculated into milk at minimal levels. Extensive in silico analysis was used to design a fifteen-primer, six-amplimer methodology and in vitro application showed target organism DNA, when amplified individually, yielded the predicted terminal restriction fragments (TRFs) following digestion. Non-target organisms were either not-amplified or yielded TRFs which did not interfere with target identification. Multiple target DNA analysis gave over 86% detection of total TRFs predicted, and this was improved to over 90% detection of total TRFs predicted when only two target DNA extracts were combined analysed. Co-inoculation of milk with five strains each of the target species of S. enterica and L. monocytogenes, along with five strains of the non-target species E. coli was followed by enrichment in SEL medium for M-TRFLP analysis. This allowed for detection of both target species in all samples, with detection of one S. enterica and two Listeria TRFs in all cases, and detection of a second S. enterica TRF in 91% of cases. This was from an initial inoculum of <5 cfu per 25 ml milk with a background of competing E. coli present, and gave a result from sampling of under 20 hours. The ability to increase target species number without loss of sensitivity means that extensive screening can be performed at reduced cost due to a reduction in the number of tests required.	[Elliott, Geoffrey N.; Thomas, Nadine; Campbell, Colin D.] James Hutton Inst, Aberdeen, Scotland; [MacRae, Marion; Ogden, Iain D.] Univ Aberdeen, Dept Med Microbiol, Aberdeen, Scotland; [Singh, Brajesh K.] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia; [Campbell, Colin D.] Swedish Univ Agr Sci, Dept Soil & Environm, Uppsala, Sweden	James Hutton Institute; University of Aberdeen; Western Sydney University; Swedish University of Agricultural Sciences	Elliott, GN (corresponding author), James Hutton Inst, Aberdeen, Scotland.	geoff.elliott@hutton.ac.uk	Singh, Brajesh/R-6321-2019; Elliott, Geoff/G-4485-2012; Campbell, Colin D/B-3944-2010	Singh, Brajesh/0000-0003-4413-4185; Campbell, Colin D/0000-0002-5163-7656; Elliott, Geoff/0000-0001-5853-2737	Scottish Enterprise Proof of Concept programme [8-FAD-003]; James Hutton Institute [8-FAD-003]	Scottish Enterprise Proof of Concept programme; James Hutton Institute	This work was jointly funded by the Scottish Enterprise Proof of Concept programme and the James Hutton Institute (formerly the Macaulay Institute) project 8-FAD-003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoh A, 2009, ALIMENT PHARM THER, V29, P75, DOI 10.1111/j.1365-2036.2008.03860.x; Andronov EE, 2009, MICROBIOLOGY+, V78, P474, DOI 10.1134/S0026261709040110; AVANISSAGHAJANI E, 1994, BIOTECHNIQUES, V17, P144; AvanissAghajani E, 1996, J CLIN MICROBIOL, V34, P98, DOI 10.1128/JCM.34.1.98-102.1996; BAILEY JS, 1992, J FOOD PROTECT, V55, P256, DOI 10.4315/0362-028X-55.4.256; Braker G, 2001, APPL ENVIRON MICROB, V67, P1893, DOI 10.1128/AEM.67.4.1893-1901.2001; Brandal LT, 2007, J MICROBIOL METH, V68, P331, DOI 10.1016/j.mimet.2006.09.013; Bruce KD, 1997, APPL ENVIRON MICROB, V63, P4914, DOI 10.1128/AEM.63.12.4914-4919.1997; Christensen JE, 2003, J CLIN MICROBIOL, V41, P3790, DOI 10.1128/JCM.41.8.3790-3800.2003; Dicksved J, 2009, J MED MICROBIOL, V58, P509, DOI 10.1099/jmm.0.007302-0; Elizaquivel P, 2008, FOOD MICROBIOL, V25, P705, DOI 10.1016/j.fm.2008.03.002; European commission, 2005, OFFICIAL J EUR UNION, pL338; Hein I, 2006, J MICROBIOL METH, V66, P538, DOI 10.1016/j.mimet.2006.02.008; Hernandez SM, 1999, J CLIN MICROBIOL, V37, P3688, DOI 10.1128/JCM.37.11.3688-3692.1999; Hoorfar J, 2011, APMIS, V119, P1, DOI 10.1111/j.1600-0463.2011.02767.x; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Kim HC, 2008, APPL ENVIRON MICROB, V74, P4853, DOI 10.1128/AEM.02756-07; Li XM, 2000, INT J FOOD MICROBIOL, V56, P167, DOI 10.1016/S0168-1605(99)00209-3; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Malorny B, 2004, APPL ENVIRON MICROB, V70, P7046, DOI 10.1128/AEM.70.12.7046-7052.2004; Marsh TL, 1999, CURR OPIN MICROBIOL, V2, P323, DOI 10.1016/S1369-5274(99)80056-3; Marsh TL, 2000, APPL ENVIRON MICROB, V66, P3616, DOI 10.1128/AEM.66.8.3616-3620.2000; Martin A, 2007, J MICROBIOL METH, V71, P39, DOI 10.1016/j.mimet.2007.07.008; McMahan L, 2011, APPL MICROBIOL BIOT, V92, P1287, DOI 10.1007/s00253-011-3520-z; Mitchell RJ, 2010, PLANT SOIL, V333, P417, DOI 10.1007/s11104-010-0357-7; Mukhopadhyay A, 2007, J MICROBIOL METH, V68, P193, DOI 10.1016/j.mimet.2006.07.009; Nam H M, 2004, Foodborne Pathog Dis, V1, P37, DOI 10.1089/153531404772914446; Nilsson WB, 2002, DIS AQUAT ORGAN, V48, P175, DOI 10.3354/dao048175; Nishizawa T, 2010, MICROBES ENVIRON, V25, P204, DOI 10.1264/jsme2.ME10108; Pandey J, 2007, J MICROBIOL METH, V68, P633, DOI 10.1016/j.mimet.2006.11.012; Rademaker JLW, 2006, INT DAIRY J, V16, P457, DOI 10.1016/j.idairyj.2005.05.009; Rantsiou K, 2008, INT J FOOD MICROBIOL, V121, P99, DOI 10.1016/j.ijfoodmicro.2007.11.006; Schutte UME, 2008, APPL MICROBIOL BIOT, V80, P365, DOI 10.1007/s00253-008-1565-4; Singh B, 2012, United States Patent, Patent No. [8,133,676, 8133676]; Singh BK, 2007, APPL ENVIRON MICROB, V73, P5153, DOI 10.1128/AEM.00620-07; Singh BK, 2006, NAT PROTOC, V1, P2428, DOI 10.1038/nprot.2006.392; Singh BK, 2006, APPL ENVIRON MICROB, V72, P7278, DOI 10.1128/AEM.00510-06; Strategic Consulting Inc., 2008, FOOD MICRO2008 2013; Stres B., 2007, ACTA AGR SLOVENICA, V88, P65; Tom-Petersen A, 2003, FEMS MICROBIOL ECOL, V46, P53, DOI 10.1016/S0168-6496(03)00192-2; Vianna ME, 2009, ORAL MICROBIOL IMMUN, V24, P417, DOI 10.1111/j.1399-302X.2009.00539.x; von Felten A, 2011, J MICROBIOL METH, V84, P379, DOI 10.1016/j.mimet.2010.11.012; Wang M, 2009, J CLIN MICROBIOL, V47, P3178, DOI 10.1128/JCM.00366-09; Whang LM, 2009, WATER SCI TECHNOL, V59, P223, DOI 10.2166/wst.2009.848; Wierner D, 2011, INT J MED MICROBIOL, V301, P577; Yu M, 2009, J PLANT PATHOL, V91, P417; Zhou GP, 2011, INT J FOOD MICROBIOL, V145, P293, DOI 10.1016/j.ijfoodmicro.2011.01.014	47	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43672	10.1371/journal.pone.0043672	http://dx.doi.org/10.1371/journal.pone.0043672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937073	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500075
J	Vandevijvere, S; Amsalkhir, S; Van Oyen, H; Moreno-Reyes, R				Vandevijvere, Stefanie; Amsalkhir, Sihame; Van Oyen, Herman; Moreno-Reyes, Rodrigo			High Prevalence of Vitamin D Deficiency in Pregnant Women: A National Cross-Sectional Survey	PLOS ONE			English	Article							25-HYDROXYVITAMIN D; ELDERLY-WOMEN; D INADEQUACY; RISK; BONE; PREVENTION; HEALTH; CANCER; SUPPLEMENTATION; PHOTOSYNTHESIS	An increasing number of studies suggest that vitamin D deficiency during pregnancy is associated with multiple adverse health outcomes in mothers, neonates and children. There are no representative country data available on vitamin D status of pregnant women in Europe. The aim of this study was to estimate the prevalence of vitamin D deficiency among Belgian pregnant women and to assess the determinants of vitamin D status in the first and third trimester of pregnancy. The women were selected via a multi-stage proportionate-to-size sampling design. Blood samples were collected and a questionnaire was completed face-to-face. 55 obstetric clinics were randomly selected and 1311 pregnant women participated in the study. The median serum 25-hydroxyvitamin D [25-(OH) D] concentration was significantly lower in the first trimester (20.4 ng/ml) than in third trimester (22.7 ng/ml). Of all women, 74.1% (95% CI = 71.8-76.5%) were vitamin D insufficient (25-(OH) D < 30 ng/ml), 44.6% (95% CI = 41.9-47.3%) were vitamin D deficient (25-(OH) D < 20 ng/ml), while 12.1% (95% CI = 10.3-13.8%) were severely vitamin D deficient (25-(OH) D < 10 ng/ml). Of all women included, 62.0% reported taking vitamin D-containing multivitamins, of which only 24.2% started taking those before pregnancy. The risk of vitamin D deficiency (25-(OH) D < 20 ng/ml) was significantly higher for less educated women and women who reported not going on holidays to sunny climates. The risk of severe vitamin D deficiency (25-(OH) D < 10 ng/ml) decreased for women who reported alcohol consumption during pregnancy, decreased with more frequent use of sunscreen lotion and increased for smokers and women who reported preference for shadow. In conclusion, vitamin D deficiency is highly prevalent among pregnant women in Belgium and this raises concerns about the health consequences for the mother and the offspring. A targeted screening strategy to detect and treat women at high risk of severe vitamin D deficiency is needed in Belgium and in Europe.	[Vandevijvere, Stefanie; Van Oyen, Herman] Sci Inst Publ Hlth, Dept Publ Hlth & Surveillance, Brussels, Belgium; [Amsalkhir, Sihame; Moreno-Reyes, Rodrigo] Univ Libre Bruxelles, Hop Erasme, Dept Nucl Med, Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Vandevijvere, S (corresponding author), Sci Inst Publ Hlth, Dept Publ Hlth & Surveillance, Brussels, Belgium.	stefanie.vandevijvere@wiv-isp.be		Van Oyen, Herman/0000-0003-2119-4433	Federal Public Service of Health, Food Chain Safety and Environment; Belgian Fonds de la Recherche Scientifique Medicale [3.4578.09]	Federal Public Service of Health, Food Chain Safety and Environment; Belgian Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS)	The survey was funded by the Federal Public Service of Health, Food Chain Safety and Environment. Rodrigo Moreno-Reyes received support of the Belgian Fonds de la Recherche Scientifique Medicale (Convention no. 3.4578.09). The funder had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andersen R, 2005, EUR J CLIN NUTR, V59, P533, DOI 10.1038/sj.ejcn.1602108; Barrett H, 2010, BEST PRACT RES CL EN, V24, P527, DOI 10.1016/j.beem.2010.05.010; Bhan A, 2010, ENDOCRIN METAB CLIN, V39, P321, DOI 10.1016/j.ecl.2010.02.001; Bodnar LM, 2007, J NUTR, V137, P447, DOI 10.1093/jn/137.2.447; Bodnar LM, 2009, J NUTR, V139, P1157, DOI 10.3945/jn.108.103168; BOUILLON RA, 1987, AM J CLIN NUTR, V45, P755, DOI 10.1093/ajcn/45.4.755; Brot C, 1999, EUR J CLIN NUTR, V53, P920, DOI 10.1038/sj.ejcn.1600870; CLEMENS TL, 1982, CLIN CHIM ACTA, V121, P301, DOI 10.1016/0009-8981(82)90239-X; Dijkstra SH, 2007, ARCH DIS CHILD, V92, P750, DOI 10.1136/adc.2006.105577; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Dror DK, 2011, CURR OPIN OBSTET GYN, V23, P422, DOI 10.1097/GCO.0b013e32834cb791; Dror DK, 2010, NUTR REV, V68, P465, DOI 10.1111/j.1753-4887.2010.00306.x; Farrerons J, 1998, BRIT J DERMATOL, V139, P422; Garland CF, 2007, J STEROID BIOCHEM, V103, P708, DOI 10.1016/j.jsbmb.2006.12.007; Gorham ED, 2007, AM J PREV MED, V32, P210, DOI 10.1016/j.amepre.2006.11.004; Goswami R, 2000, AM J CLIN NUTR, V72, P472; Grant WB, 2003, AM FAM PHYSICIAN, V67, P465; Grant WB, 2002, J INTERN MED, V252, P178, DOI 10.1046/j.1365-2796.2002.01016.x; Grant WB, 2005, ALTERN MED REV, V10, P94; Grant WB, 2011, BIOL RES NURS, V13, P120, DOI 10.1177/1099800410391243; Hensel KJ, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.013; Hill T R, 2006, Ir Med J, V99, P48; Hill TR, 2008, BRIT J NUTR, V99, P1061, DOI 10.1017/S0007114507842826; Hintzpeter B, 2008, EUR J CLIN NUTR, V62, P1079, DOI 10.1038/sj.ejcn.1602825; Hintzpeter B, 2008, J NUTR, V138, P1482, DOI 10.1093/jn/138.8.1482; Hirani V, 2005, AGE AGEING, V34, P485, DOI 10.1093/ageing/afi153; Hoge Gezondheidsraad, 2009, VOED BELG HERZ 2009; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; HOLICK MF, 1981, J INVEST DERMATOL, V77, P51, DOI 10.1111/1523-1747.ep12479237; HOLICK MF, 1981, SCIENCE, V211, P590, DOI 10.1126/science.6256855; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Holick MF, 2010, ENDOCRIN METAB CLIN, V39, P381, DOI [10.1016/j.rdc.2012.03.013, 10.1016/j.ecl.2010.02.016]; Hollis BW, 2007, J BONE MINER RES, V22, pV39, DOI 10.1359/JBMR.07S215; Huybrechts I, 2011, EUR J CLIN NUTR, V65, P1039, DOI 10.1038/ejcn.2011.71; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Jackson C, 2007, QJM-INT J MED, V100, P185, DOI 10.1093/qjmed/hcm005; Jacques PF, 1997, AM J CLIN NUTR, V66, P929, DOI 10.1093/ajcn/66.4.929; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Lee K, 2012, NUTR RES PRACT, V6, P86, DOI 10.4162/nrp.2012.6.1.86; Lips P, 2011, BEST PRACT RES CL EN, V25, P585, DOI 10.1016/j.beem.2011.05.002; Lucas RM, 2008, NUTR REV, V66, P710, DOI 10.1111/j.1753-4887.2008.00126.x; Martini LA, 2006, NUTR REV, V64, P479, DOI 10.1111/j.1753-4887.2006.tb00180.x; MCKENNA MJ, 1992, AM J MED, V93, P69, DOI 10.1016/0002-9343(92)90682-2; Milman N, 2012, J PERINAT MED, V40, P57, DOI 10.1515/JPM.2011.120; Moreno-Reyes R, 2009, EUR J NUTR, V48, P31, DOI 10.1007/s00394-008-0756-1; NEED AG, 1993, AM J CLIN NUTR, V58, P882, DOI 10.1093/ajcn/58.6.882; Neuprez A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-64; OOMS ME, 1995, J CLIN ENDOCR METAB, V80, P1052, DOI 10.1210/jc.80.4.1052; Pettifor JM, 2011, BEST PRACT RES CL EN, V25, P573, DOI 10.1016/j.beem.2011.06.010; Sullivan KM, 2000, URINARY IODINE ASSES; Valimaki VV, 2004, J CLIN ENDOCR METAB, V89, P76, DOI 10.1210/jc.2003-030817; van der Meer IM, 2011, OSTEOPOROSIS INT, V22, P1009, DOI 10.1007/s00198-010-1279-1; van der Meer IM, 2006, AM J CLIN NUTR, V84, P350; van der Sluis IM, 2002, HORM RES, V57, P170, DOI 10.1159/000058378; Webb AR, 2006, PHOTOCHEM PHOTOBIOL, V82, P1697, DOI 10.1562/2006-09-01-RA-670; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Zittermann A, 2003, BRIT J NUTR, V89, P552, DOI 10.1079/BJN2003837	58	92	97	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43868	10.1371/journal.pone.0043868	http://dx.doi.org/10.1371/journal.pone.0043868			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937114	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500116
J	Loomis, WF; Fuller, D; Gutierrez, E; Groisman, A; Rappel, WJ				Loomis, William F.; Fuller, Danny; Gutierrez, Edgar; Groisman, Alex; Rappel, Wouter-Jan			Innate Non-Specific Cell Substratum Adhesion	PLOS ONE			English	Article							MUTANT-CELLS; WILD-TYPE; DICTYOSTELIUM; MOTILITY; TALIN; CHEMOTAXIS; MIGRATION	Adhesion of motile cells to solid surfaces is necessary to transmit forces required for propulsion. Unlike mammalian cells, Dictyostelium cells do not make integrin mediated focal adhesions. Nevertheless, they can move rapidly on both hydrophobic and hydrophilic surfaces. We have found that adhesion to such surfaces can be inhibited by addition of sugars or amino acids to the buffer. Treating whole cells with alpha-mannosidase to cleave surface oligosaccharides also reduces adhesion. The results indicate that adhesion of these cells is mediated by van der Waals attraction of their surface glycoproteins to the underlying substratum. Since glycoproteins are prevalent components of the surface of most cells, innate adhesion may be a common cellular property that has been overlooked.	[Loomis, William F.; Fuller, Danny] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Gutierrez, Edgar; Groisman, Alex; Rappel, Wouter-Jan] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Rappel, Wouter-Jan] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Loomis, WF (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	wloomis@ucsd.edu	Groisman, Alexander/AAU-7843-2021		National Institutes of Health [PO1 GM078586]; Direct For Mathematical & Physical Scien [1308264] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM078586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (PO1 GM078586). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799; Cornillon S, 2000, J BIOL CHEM, V275, P34287, DOI 10.1074/jbc.M006725200; Cornillon S, 2008, EUKARYOT CELL, V7, P1600, DOI 10.1128/EC.00155-08; Decave E, 2002, BIOPHYS J, V82, P2383, DOI 10.1016/S0006-3495(02)75583-5; del Alamo JC, 2007, P NATL ACAD SCI USA, V104, P13343, DOI 10.1073/pnas.0705815104; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Fey P, 2002, J CELL BIOL, V159, P1109, DOI 10.1083/jcb.200206067; Fuller D, 2010, P NATL ACAD SCI USA, V107, P9656, DOI 10.1073/pnas.0911178107; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; GERISCH G, 1989, CELL MOTIL CYTOSKEL, V14, P75, DOI 10.1002/cm.970140115; Israelachvilli J.N., 1992, INTERMOLECULAR SURFA; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lee H, 2007, NATURE, V448, P338, DOI 10.1038/nature05968; Mahdavi A, 2008, P NATL ACAD SCI USA, V105, P2307, DOI 10.1073/pnas.0712117105; Malawista SE, 1997, P NATL ACAD SCI USA, V94, P11577, DOI 10.1073/pnas.94.21.11577; Niewohner J, 1997, J CELL BIOL, V138, P349, DOI 10.1083/jcb.138.2.349; NIR S, 1977, J MEMBRANE BIOL, V31, P1, DOI 10.1007/BF01869396; Parsegian VA., 2006, VANDERWAALS FORCES; Renkawitz J, 2009, NAT CELL BIOL, V11, P1438, DOI 10.1038/ncb1992; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sebe-Pedros A, 2010, P NATL ACAD SCI USA, V107, P10142, DOI 10.1073/pnas.1002257107; Simson R, 1998, BIOPHYS J, V74, P514, DOI 10.1016/S0006-3495(98)77808-7; Skoge M, 2010, INTEGR BIOL-UK, V2, P659, DOI 10.1039/c0ib00033g; Song LL, 2006, EUR J CELL BIOL, V85, P981, DOI 10.1016/j.ejcb.2006.01.012; Tsujioka M, 2008, EUKARYOT CELL, V7, P906, DOI 10.1128/EC.00464-07; Uchida KSK, 2004, J CELL SCI, V117, P1443, DOI 10.1242/jcs.01015; VARNUM B, 1986, DEV BIOL, V113, P218, DOI 10.1016/0012-1606(86)90124-7; WEBER I, 1995, J CELL SCI, V108, P1519; West C. M., 2005, DICTYOSTELIUM GENOMI, P235	29	44	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e42033	10.1371/journal.pone.0042033	http://dx.doi.org/10.1371/journal.pone.0042033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952588	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300004
J	Blodget, E; Shen, CY; Aldrovandi, G; Rollie, A; Gupta, SK; Stein, JH; Dube, MP				Blodget, Emily; Shen, Changyu; Aldrovandi, Grace; Rollie, Adrienne; Gupta, Samir K.; Stein, James H.; Dube, Michael P.			Relationship between Microbial Translocation and Endothelial Function in HIV Infected Patients	PLOS ONE			English	Article							COMBINATION ANTIRETROVIRAL THERAPY; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR RISK; MYOCARDIAL-INFARCTION; IMMUNE ACTIVATION; DYSFUNCTION; ATHEROSCLEROSIS; ASSOCIATION; PROGRESSION; HEALTH	Background: Circulating levels of microbial products are increased in HIV infection, and provoke endothelial dysfunction in other disease settings. Methodology/Principal Findings: We examined data from a cross-sectional single site study at Indiana University (Indiana, N = 85) and a 24-week multicenter prospective study of antiretroviral therapy (ART) initiation (ACTG 5152s, N = 75). Brachial artery flow-mediated dilation (FMD) was measured by ultrasound. Plasma lipopolysaccharide (LPS) and soluble CD14 (sCD14) levels were measured from stored specimens and correlated with FMD values using Pearson correlations. The Indiana subjects were 63% male with a mean age of 39 years and a median CD4 count of 406 cells/mm(3) (388 not on ART, 464 on ART). The 5152s subjects were 92% were male with a mean age of 35 years and a median CD4 count of 251 cells/mm(3) at entry which increased to 396 cells/mm(3) on ART. When analyzing the two cohorts individually or in combination neither sCD14 nor LPS correlated significantly with FMD. In a pre-specified subgroup analysis of the Indiana subjects receiving ART (N = 46, mean ART duration 40 months) LPS was inversely correlated with FMD (r = -0.33, p = 0.02), but not sCD14 (r = -0.01, p = 0.9). Multivariate analysis confirmed LPS as an independent predictor of FMD in this subgroup (p = 0.02). Conclusions/Significance: In HIV-infected individuals on prolonged ART, higher LPS levels are associated with worse endothelial function but not in untreated subjects or at 24 weeks after ART initiation. Persistent microbial translocation may contribute to arterial dysfunction and the increased cardiovascular disease risk observed in individuals on long-term ART.	[Blodget, Emily; Dube, Michael P.] Univ So Calif, Keck Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90033 USA; [Shen, Changyu] Indiana Univ, Sch Med, Dept Biostat 3, Indianapolis, IN 46204 USA; [Gupta, Samir K.] Indiana Univ, Sch Med 5, Dept Infect Dis, Indianapolis, IN 46204 USA; [Aldrovandi, Grace; Rollie, Adrienne] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA; [Stein, James H.] Univ Wisconsin, Sch Med & Publ Hlth, Div Cardiovasc Med, Madison, WI USA	University of Southern California; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Children's Hospital Los Angeles; University of Wisconsin System; University of Wisconsin Madison	Blodget, E (corresponding author), Univ So Calif, Keck Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90033 USA.	eblodget@usc.edu	Dubé, Marie-Pierre/B-9364-2008	Dubé, Marie-Pierre/0000-0001-8442-4393; Stein, James/0000-0002-2770-8223	NIH [AI091492, HL72711, RR00750, RR16176]; Southern California Clinical Translational Science Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000130] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016176, M01RR000750] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI091492] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Southern California Clinical Translational Science Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants AI091492, HL72711, RR00750 and RR16176 from the NIH and a pilot grant from the Southern California Clinical Translational Science Institute. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Anderson TJ, 2007, CIRCULATION, V115, P2373, DOI 10.1161/CIRCULATIONAHA.107.697045; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Cassol E, 2011, J INFECT DIS, V203, P747, DOI 10.1093/infdis/jiq109; Cassol E, 2010, J INFECT DIS, V202, P723, DOI 10.1086/655229; Dauphinee SM, 2006, LAB INVEST, V86, P9, DOI 10.1038/labinvest.3700366; Dube MP, 2010, AIDS RES HUM RETROV, V26, P847, DOI 10.1089/aid.2010.0007; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Hsue PY, 2009, AIDS, V23, P2021, DOI 10.1097/QAD.0b013e32832e7140; Kinlay S, 1997, AM J CARDIOL, V80, pI11, DOI 10.1016/S0002-9149(97)00793-5; Lepper PM, 2011, ATHEROSCLEROSIS, V219, P291, DOI 10.1016/j.atherosclerosis.2011.06.001; Murphy RL, 2010, AIDS, V24, P885, DOI 10.1097/QAD.0b013e3283352ed5; Nolan D, 2003, QJM-INT J MED, V96, P825, DOI 10.1093/qjmed/hcg145; Nowroozalizadeh S, 2010, J INFECT DIS, V201, P1150, DOI 10.1086/651430; Redd AD, 2011, J INFECT DIS, V203, P744, DOI 10.1093/infdis/jiq107; Redd AD, 2009, P NATL ACAD SCI USA, V106, P6718, DOI 10.1073/pnas.0901983106; Riddler SA, 2008, JAIDS-J ACQ IMM DEF, V48, P281, DOI 10.1097/QAI.0b013e31817bbbf0; Sankaran S, 2008, J VIROL, V82, P538, DOI 10.1128/JVI.01449-07; Solages A, 2006, CLIN INFECT DIS, V42, P1325, DOI 10.1086/503261; Stein JH, 2001, CIRCULATION, V104, P257, DOI 10.1161/01.CIR.104.3.257; Stoll LL, 2004, ARTERIOSCL THROM VAS, V24, P2227, DOI 10.1161/01.ATV.0000147534.69062.dc; Torriani FJ, 2008, J AM COLL CARDIOL, V52, P569, DOI 10.1016/j.jacc.2008.04.049; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Wiedermann CJ, 1999, J AM COLL CARDIOL, V34, P1975, DOI 10.1016/S0735-1097(99)00448-9; Yeboah J, 2007, CIRCULATION, V115, P2390, DOI 10.1161/CIRCULATIONAHA.106.678276	27	29	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e42624	10.1371/journal.pone.0042624	http://dx.doi.org/10.1371/journal.pone.0042624			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952600	Green Submitted, Green Published, gold			2022-12-25	WOS:000308206500005
J	Honeycutt, CF; Perreault, EJ				Honeycutt, Claire Fletcher; Perreault, Eric Jon			Planning of Ballistic Movement following Stroke: Insights from the Startle Reflex	PLOS ONE			English	Article							PHASIC MUSCLE ACTIVATION; DECEREBRATE CAT; EXECUTION; CORTEX; ELBOW; ARM; COORDINATION; IMPAIRMENT; GENERATION; LOCOMOTION	Following stroke, reaching movements are slow, segmented, and variable. It is unclear if these deficits result from a poorly constructed movement plan or an inability to voluntarily execute an appropriate plan. The acoustic startle reflex provides a means to initiate a motor plan involuntarily. In the presence of a movement plan, startling acoustic stimulus triggers non-voluntary early execution of planned movement, a phenomenon known as the startReact response. In unimpaired individuals, the startReact response is identical to a voluntarily initiated movement, except that it is elicited 30-40 ms. As the startReact response is thought to be mediated by brainstem pathways, we hypothesized that the startReact response is intact in stroke subjects. If startReact is intact, it may be possible to elicit more task-appropriate patterns of muscle activation than can be elicited voluntarily. We found that startReact responses were intact following stroke. Responses were initiated as rapidly as those in unimpaired subjects, and with muscle coordination patterns resembling those seen during unimpaired volitional movements. Results were striking for elbow flexion movements, which demonstrated no significant differences between the startReact responses elicited in our stroke and unimpaired subject groups. The results during planned extension movements were less straightforward for stroke subjects, since the startReact response exhibited task inappropriate activity in the flexors. This inappropriate activity diminished over time. This adaptation suggests that the inappropriate activity was transient in nature and not related to the underlying movement plan. We hypothesize that the task-inappropriate flexor activity during extension results from an inability to suppress the classic startle reflex, which primarily influences flexor muscles and adapts rapidly with successive stimuli. These results indicate that stroke subjects are capable of planning ballistic elbow movements, and that when these planned movements are involuntarily executed they can be as rapid and appropriate as those in unimpaired individuals.	[Honeycutt, Claire Fletcher; Perreault, Eric Jon] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Honeycutt, Claire Fletcher] Northwestern Univ, Dept Elect Engn & Comp Sci, Chicago, IL 60611 USA; [Perreault, Eric Jon] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Perreault, Eric Jon] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA	Shirley Ryan AbilityLab; Northwestern University; Northwestern University; Northwestern University	Honeycutt, CF (corresponding author), Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA.	c-honeycutt@northwestern.edu	Perreault, Eric/B-7632-2009		National Institutes of Health [K12 GM088020, T32 HD07418-18, R01 NS053813]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health grants K12 GM088020, T32 HD07418-18, and R01 NS053813. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibiglou L, 2012, J PHYSIOL-LONDON, V590, DOI 10.1113/jphysiol.2011.219592; Beer RF, 2007, MUSCLE NERVE, V36, P242, DOI 10.1002/mus.20817; Blouin JS, 2006, J PHYSIOL-LONDON, V573, P857, DOI 10.1113/jphysiol.2006.108274; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; BROWN SH, 1990, J NEUROPHYSIOL, V63, P455, DOI 10.1152/jn.1990.63.3.455; Buford JA, 2004, EXP BRAIN RES, V159, P284, DOI 10.1007/s00221-004-1956-4; CANEDO A, 1993, J PHYSIOL-LONDON, V463, P475, DOI 10.1113/jphysiol.1993.sp019606; Carlsen AN, 2004, J MOTOR BEHAV, V36, P253, DOI 10.3200/JMBR.36.3.253-264; Carlsen AN, 2003, EXP BRAIN RES, V152, P510, DOI 10.1007/s00221-003-1575-5; Carlsen AN, 2011, NEUROSCI BIOBEHAV R, V35, P366, DOI 10.1016/j.neubiorev.2010.04.009; Cirstea MC, 2000, BRAIN, V123, P940, DOI 10.1093/brain/123.5.940; COOKE JD, 1990, J NEUROPHYSIOL, V63, P465, DOI 10.1152/jn.1990.63.3.465; Cressman EK, 2006, EXP BRAIN RES, V171, P278, DOI 10.1007/s00221-006-0459-x; DAVIS M, 1977, J COMP PHYSIOL PSYCH, V91, P549, DOI 10.1037/h0077345; DEWALD JPA, 1995, BRAIN, V118, P495, DOI 10.1093/brain/118.2.495; Hedeker D, 2006, LONGITUDINAL DATA AN; Honeycutt CF, 2010, J NEUROPHYSIOL, V103, P3266, DOI 10.1152/jn.00764.2009; Honeycutt CF, 2009, J NEUROPHYSIOL, V101, P2751, DOI 10.1152/jn.91040.2008; Jang SH, 2009, NEUROREHABILITATION, V24, P285, DOI 10.3233/NRE-2009-0480; Jankelowitz SK, 2004, NEUROLOGY, V62, P114, DOI 10.1212/01.WNL.0000101711.48946.35; JINNAI K, 1984, BRAIN RES, V291, P145, DOI 10.1016/0006-8993(84)90661-9; Kamper DG, 2002, ARCH PHYS MED REHAB, V83, P702, DOI 10.1053/apmr.2002.32446; Kandel E., 2000, PRINCIPLES NEURAL SC; Krakauer JW, 2005, SEMIN NEUROL, V25, P384, DOI 10.1055/s-2005-923533; Kumru H, 2006, EXP BRAIN RES, V169, P427, DOI 10.1007/s00221-005-0156-1; Kumru Hatice, 2006, Suppl Clin Neurophysiol, V58, P101; Kuypers H, 1981, AM PHYSL SOC, P597; Lance J, 1980, S SYNOPSIS; LEVIN MF, 1994, BRAIN RES, V657, P23, DOI 10.1016/0006-8993(94)90949-0; Levin MF, 1996, BRAIN, V119, P281, DOI 10.1093/brain/119.1.281; Lyalka VF, 2005, J NEUROPHYSIOL, V94, P3677, DOI 10.1152/jn.00538.2005; Maslovat D, 2011, J NEUROPHYSIOL, V106, P885, DOI 10.1152/jn.00166.2011; MCCREA DA, 1995, J PHYSIOL-LONDON, V487, P527, DOI 10.1113/jphysiol.1995.sp020897; Mohr D, 2009, BEHAV BRAIN RES, V202, P58, DOI 10.1016/j.bbr.2009.03.014; Moore K.L., 2017, CLIN ORIENTED ANATOM, V8th ed.; MORI S, 1987, PROG NEUROBIOL, V28, P161, DOI 10.1016/0301-0082(87)90010-4; Musienko PE, 2008, BEHAV BRAIN RES, V190, P124, DOI 10.1016/j.bbr.2008.02.011; Pearson KG, 1995, CURR OPIN NEUROBIOL, V5, P786, DOI 10.1016/0959-4388(95)80107-3; Perfiliev S, 2010, J NEUROPHYSIOL, V104, P2423, DOI 10.1152/jn.01133.2009; Rho MJ, 1997, J COMP NEUROL, V388, P228, DOI 10.1002/(SICI)1096-9861(19971117)388:2<228::AID-CNE4>3.0.CO;2-3; Rothwell J C, 2006, Suppl Clin Neurophysiol, V58, P223; Rushworth MFS, 2003, NEUROIMAGE, V20, pS89, DOI 10.1016/j.neuroimage.2003.09.011; Sakai ST, 2009, NEUROSCIENCE, V163, P1158, DOI 10.1016/j.neuroscience.2009.07.036; Saladin K.S., 2012, ANATOMY PHYSL UNITY, V6th ed.).; Sangani SG, 2007, MUSCLE NERVE, V36, P694, DOI 10.1002/mus.20852; Schmit BD, 2000, ARCH PHYS MED REHAB, V81, P269; Shemmell J, 2009, J NEUROSCI, V29, P13255, DOI 10.1523/JNEUROSCI.0892-09.2009; SHIK M. L., 1968, BIOFIZIKA, V13, P127; Siegmund GP, 2008, EXERC SPORT SCI REV, V36, P76, DOI 10.1097/JES.0b013e318168f1ce; Simpson LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019431; Stinear CM, 2009, BRAIN STIMUL, V2, P152, DOI 10.1016/j.brs.2009.01.001; Trumbower RD, 2010, J NEUROPHYSIOL, V104, P3612, DOI 10.1152/jn.00804.2009; Valls-Sole J, 1999, J PHYSIOL-LONDON, V516, P931, DOI 10.1111/j.1469-7793.1999.0931u.x; Valls-Sole J, 2008, EXP BRAIN RES, V187, P497, DOI 10.1007/s00221-008-1402-0; VallsSole J, 1997, BRAIN RES, V751, P155, DOI 10.1016/S0006-8993(97)00027-9; van Beers RJ, 2004, J NEUROPHYSIOL, V91, P1050, DOI 10.1152/jn.00652.2003; YAMSHON L J, 1949, Arch Phys Med Rehabil, V30, P706; Yao J, 2009, NEUROIMAGE, V45, P490, DOI 10.1016/j.neuroimage.2008.12.002; Yeomans JS, 1995, BRAIN RES REV, V21, P301, DOI 10.1016/0165-0173(96)00004-5; Zackowski KM, 2004, BRAIN, V127, P1035, DOI 10.1093/brain/awh116; [No title captured]; [No title captured]	62	66	67	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43097	10.1371/journal.pone.0043097	http://dx.doi.org/10.1371/journal.pone.0043097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952634	gold, Green Submitted, Green Published			2022-12-25	WOS:000308206500008
J	Imbert, AM; Garulli, C; Choquet, E; Koubi, M; Aurrand-Lions, M; Chabannon, C				Imbert, Anne-Marie; Garulli, Celine; Choquet, Elodie; Koubi, Myriam; Aurrand-Lions, Michel; Chabannon, Christian			CD146 Expression in Human Breast Cancer Cell Lines Induces Phenotypic and Functional Changes Observed in Epithelial to Mesenchymal Transition	PLOS ONE			English	Article							E-CADHERIN; TUMOR PROGRESSION; POOR-PROGNOSIS; UP-REGULATION; MELANOMA; PROMOTES; SNAIL; MUC18; SLUG; METASTASIS	Background: Metastasis is an important step in tumor progression leading to a disseminated and often incurable disease. First steps of metastasis include down-regulation of cell adhesion molecules, alteration of cell polarity and reorganization of cytoskeleton, modifications associated with enhanced migratory properties and resistance of tumor cells to anoikis. Such modifications resemble Epithelial to Mesenchymal Transition (EMT). In breast cancer CD146 expression is associated with poor prognosis and enhanced motility. Methodology/Principal Findings: On 4 different human breast cancer cell lines, we modified CD146 expression either with shRNA technology in CD146 positive cells or with stable transfection of CD146 in negative cells. Modifications in morphology, growth and migration were evaluated. Using Q-RT-PCR, we analyzed the expression of different EMT markers. We demonstrate that high levels of CD146 are associated with loss of cell-cell contacts, expression of EMT markers, increased cell motility and increased resistance to doxorubicin or docetaxel. Experimental modulation of CD146 expression induces changes consistent with the above described characteristics: morphology, motility, growth in anchorage independent conditions and Slug mRNA variations are strictly correlated with CD146 expression. These changes are associated with modifications of ER (estrogen receptor) and Erb receptors and are enhanced by simultaneous and opposite modulation of JAM-A, or exposure to heregulin, an erb-B4 ligand. Conclusions: CD146 expression is associated with an EMT phenotype. Several molecules are affected by CD146 expression: direct or indirect signaling contributes to EMT by increasing Slug expression. CD146 may also interact with Erb signaling by modifying cell surface expression of ErbB3 and ErbB4 and increased resistance to chemotherapy. Antagonistic effects of JAM-A, a tight junction-associated protein, on CD146 promigratory effects underline the complexity of the adhesion molecules network in tumor cell migration and metastasis.	[Imbert, Anne-Marie; Garulli, Celine; Chabannon, Christian] Ctr Therapie Cellulaire, Ctr Ressources Biol Oncol, Inst Paoli Calmettes, Marseille, France; [Imbert, Anne-Marie; Garulli, Celine; Choquet, Elodie; Koubi, Myriam; Chabannon, Christian] CRCM, Equipe Rech Clin, INSERM, UMR1068, Marseille, France; [Choquet, Elodie; Koubi, Myriam; Aurrand-Lions, Michel; Chabannon, Christian] Univ Aix Marseille, Marseille, France; [Aurrand-Lions, Michel] CRCM, Equipe Mol Adhes & Interact Hote Tumeur, INSERM, UMR1068, Marseille, France	UNICANCER; Institut Paoli-Calmette (IPC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Imbert, AM (corresponding author), Ctr Therapie Cellulaire, Ctr Ressources Biol Oncol, Inst Paoli Calmettes, Marseille, France.	imbertam@marseille.fnclcc.fr	Aurrand-Lions, Michel/O-9953-2016; Choquet, Élodie/AAK-6363-2021	Aurrand-Lions, Michel/0000-0002-8361-3034; Choquet, Élodie/0000-0002-9173-0740	Institut Paoli-Calmettes; "Institut National du Cancer" (INCa)	Institut Paoli-Calmettes; "Institut National du Cancer" (INCa)(Institut National du Cancer (INCA) France)	This work was supported in part by Institut Paoli-Calmettes, and by an "Institut National du Cancer" (INCa) "Appel a Projets Libres 2007" to Christian Chabannon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldovini D, 2006, INT J CANCER, V119, P1920, DOI 10.1002/ijc.22082; Atlas E, 2003, MOL CANCER RES, V1, P165; Bardin N, 2001, BLOOD, V98, P3677, DOI 10.1182/blood.V98.13.3677; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Breuleux M, 2007, CELL MOL LIFE SCI, V64, P2358, DOI 10.1007/s00018-007-7120-0; Chan B, 2005, DEV DYNAM, V232, P232, DOI 10.1002/dvdy.20220; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Cheng LS, 2009, CANCER LETT, V280, P50, DOI 10.1016/j.canlet.2009.02.007; Delorme B, 2008, BLOOD, V111, P2631, DOI 10.1182/blood-2007-07-099622; de Herreros AG, 2010, J MAMMARY GLAND BIOL, V15, P135, DOI 10.1007/s10911-010-9179-8; GIOANNI J, 1990, BRIT J CANCER, V62, P8, DOI 10.1038/bjc.1990.219; Guezguez B, 2007, J IMMUNOL, V179, P6673, DOI 10.4049/jimmunol.179.10.6673; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kristiansen G, 2003, ANAL CELL PATHOL, V25, P77, DOI 10.1155/2003/574829; LEHMANN JM, 1989, P NATL ACAD SCI USA, V86, P9891, DOI 10.1073/pnas.86.24.9891; Li G, 2003, ONCOGENE, V22, P6891, DOI 10.1038/sj.onc.1206819; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McSherry EA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2853; McSherry EA, 2009, INT J CANCER, V125, P1343, DOI 10.1002/ijc.24498; Mostert B, 2011, BREAST CANCER RES TR, V127, P33, DOI 10.1007/s10549-010-0879-y; Naik MU, 2008, CANCER RES, V68, P2194, DOI 10.1158/0008-5472.CAN-07-3057; Naik UP, 2008, CELL ADHES MIGR, V2, P249, DOI 10.4161/cam.2.4.6753; Nava P, 2011, EMBO REP, V12, P314, DOI 10.1038/embor.2011.16; Park SH, 2008, MOL ENDOCRINOL, V22, P2085, DOI 10.1210/me.2007-0512; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pickl WF, 1997, J IMMUNOL, V158, P2107; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Savagner P, 1997, J CELL BIOL, V137, P1403, DOI 10.1083/jcb.137.6.1403; SERS C, 1993, P NATL ACAD SCI USA, V90, P8514, DOI 10.1073/pnas.90.18.8514; Sharpe R, 2011, CLIN CANCER RES, V17, P5275, DOI 10.1158/1078-0432.CCR-10-2727; Shi IM, 1999, J PATHOL, V189, P4, DOI 10.1002/(SICI)1096-9896(199909)189:1<4::AID-PATH332>3.0.CO;2-P; Shih IM, 1997, CANCER RES, V57, P3835; Shtutman M, 2006, CANCER RES, V66, P11370, DOI 10.1158/0008-5472.CAN-06-2106; Storci G, 2008, J PATHOL, V214, P25, DOI 10.1002/path.2254; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsukamoto Y, 2003, INT J ONCOL, V23, P1671; Wu GJ, 2005, J UROLOGY, V173, P1778, DOI 10.1097/01.ju.0000154643.30048.2c; Wu GJ, 2004, GENE, V327, P201, DOI 10.1016/j.gene.2003.11.018; Ye Y, 2010, ONCOGENE, V29, P1451, DOI 10.1038/onc.2009.433; Zabouo G, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2215; Zeng GF, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-113; Zeng GF, 2012, GENE, V492, P229, DOI 10.1016/j.gene.2011.10.024; Zeng QQ, 2012, P NATL ACAD SCI USA, V109, P1127, DOI 10.1073/pnas.1111053108	44	45	48	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43752	10.1371/journal.pone.0043752	http://dx.doi.org/10.1371/journal.pone.0043752			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952755	Green Submitted, Green Published, gold			2022-12-25	WOS:000308206500021
J	Yao, D; Xie, XH; Wang, XL; Wan, C; Lee, YW; Chen, SH; Pei, DQ; Wang, YX; Li, G; Qin, L				Yao, Dong; Xie, Xin-Hui; Wang, Xin-Luan; Wan, Chao; Lee, Yuk-Wai; Chen, Shi-Hui; Pei, Duan-Qing; Wang, Yi-Xiang; Li, Gang; Qin, Ling			Icaritin, an Exogenous Phytomolecule, Enhances Osteogenesis but Not Angiogenesis-An In Vitro Efficacy Study	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; FIBROBLAST-GROWTH-FACTOR; OSTEOBLAST DIFFERENTIATION; HERBA-EPIMEDII; BONE REGENERATION; BREVICORNUM-MAXIM; RATS; PROLIFERATION; ADIPOGENESIS	We found that Icaritin, an intestinal metabolite of Epimedium-derived flavonoids (EF) enhanced osteoblastic differentiation of mesenchymal stem cells (MSCs) only under osteogenic induction conditions. We also demonstrated its effect on inhibition of adipogenic differentiation of MSCs. Unlike the findings of others on EF compounds, we showed that Icaritin was unable to promote proliferation, migration and tube like structure formation by human umbilical vein endothelial cells (HUVECs) in vitro. These results suggested that the exogenous phytomolecule Icaritin possessed the potential for enhancing bone formation via its osteopromotive but not an osteoinductive mechanism. Though some flavonoids were shown to regulate the coupling process of angiogenesis and osteogenesis during bone repair, our results suggested that Icaritin did not have direct effect on enhancing angiogenesis in vitro.	[Yao, Dong; Xie, Xin-Hui; Wang, Xin-Luan; Lee, Yuk-Wai; Chen, Shi-Hui; Qin, Ling] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China; [Xie, Xin-Hui] Soochow Univ, Affiliated Hosp 1, Dept Orthoped, Suzhou, Peoples R China; [Wang, Xin-Luan] Chinese Acad Sci, Translat Med Res & Dev Ctr, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Wan, Chao] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Stem Cell & Regenerat Program, Hong Kong, Hong Kong, Peoples R China; [Wan, Chao] Jinan Univ, Chinese Univ Hong Kong, Minist Educ, Key Lab Regenerat Med, Hong Kong, Hong Kong, Peoples R China; [Pei, Duan-Qing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol,Stem Cell & Canc Biol Grp, Guangzhou, Guangdong, Peoples R China; [Wang, Yi-Xiang] Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Hong Kong, Hong Kong, Peoples R China; [Li, Gang] Chinese Univ Hong Kong, Sch Biomed Sci, Dept Orthopaed & Traumatol, Stem Cells & Regenerat Program, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Soochow University - China; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese University of Hong Kong; Chinese University of Hong Kong	Yao, D (corresponding author), Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.	lingqin@cuhk.edu.hk	Qin, Ling/J-9047-2018; Li, Gang/J-7830-2018; Lee, Wayne YW/H-8298-2013; Wan, Chao/J-9277-2013; Wang, Yi Xiang/I-5952-2016	Qin, Ling/0000-0001-6173-6167; Li, Gang/0000-0002-3981-2239; Lee, Wayne YW/0000-0002-0486-360X; Wan, Chao/0000-0001-6780-2006; Wang, Yi Xiang/0000-0001-5697-0717; Yao, Dong/0000-0001-8883-5384	Hong Kong Innovation and Technology Support Program ITF Tier 2 [ITS/451/09FP]; Hong Kong General Research Fund [GRF CUHK-473710/473011]	Hong Kong Innovation and Technology Support Program ITF Tier 2; Hong Kong General Research Fund	The project was supported by Hong Kong Innovation and Technology Support Program ITF Tier 2 (ITS/451/09FP) and Hong Kong General Research Fund (GRF CUHK-473710/473011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282; AUBIN JE, 1995, BONE, V17, pS77, DOI 10.1016/8756-3282(95)00183-E; Barnes GL, 1999, J BONE MINER RES, V14, P1805, DOI 10.1359/jbmr.1999.14.11.1805; Bocci G, 2002, CANCER RES, V62, P6938; Brandi ML, 2006, J BONE MINER RES, V21, P183, DOI 10.1359/JBMR.050917; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chen KM, 2007, PHARMAZIE, V62, P785, DOI 10.1691/ph.2007.10.7504; Chen KM, 2007, PHARMAZIE, V62, P388, DOI 10.1691/ph.2007.5.6682; Chen KM, 2005, PHARMAZIE, V60, P939; Chen WF, 2011, BRIT J NUTR, V105, P180, DOI 10.1017/S0007114510003247; Chung BH, 2008, BIOCHEM BIOPH RES CO, V376, P404, DOI 10.1016/j.bbrc.2008.09.001; Cool SM, 2005, INT J BIOCHEM CELL B, V37, P1739, DOI 10.1016/j.biocel.2005.03.006; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7; Fotsis T, 1997, CANCER RES, V57, P2916; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Grasser WA, 2007, INT ORTHOP, V31, P759, DOI 10.1007/s00264-007-0407-9; Heim M, 2004, ENDOCRINOLOGY, V145, P848, DOI 10.1210/en.2003-1014; Heino TJ, 2004, EXP CELL RES, V294, P458, DOI 10.1016/j.yexcr.2003.11.016; Hidaka S, 1999, PHYTOTHER RES, V13, P14, DOI 10.1002/(SICI)1099-1573(199902)13:1&lt;14::AID-PTR375&gt;3.0.CO;2-V; Hidaka S, 1997, CALCIFIED TISSUE INT, V61, P239, DOI 10.1007/s002239900329; HIRATA S, 1989, ARTHRITIS RHEUM, V32, P1065, DOI 10.1002/anr.1780320903; Huang J, 2007, LIFE SCI, V81, P832, DOI 10.1016/j.lfs.2007.07.015; Janderova L, 2003, OBES RES, V11, P65, DOI 10.1038/oby.2003.11; Kalghatgi S, 2010, ANN BIOMED ENG, V38, P748, DOI 10.1007/s10439-009-9868-x; Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08; Kubler N R, 1999, Mund Kiefer Gesichtschir, V3 Suppl 1, pS134, DOI 10.1007/PL00014500; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Li HY, 1999, BIOL PHARM BULL, V22, P391, DOI 10.1248/bpb.22.391; Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002; Liu HY, 2011, BIOMATERIALS, V32, P6773, DOI 10.1016/j.biomaterials.2011.05.080; Ma HP, 2010, J CELL BIOCH; Margolin MD, 1998, J PERIODONTOL, V69, P911, DOI 10.1902/jop.1998.69.8.911; Meng FH, 2005, PHYTOMEDICINE, V12, P189, DOI 10.1016/j.phymed.2004.03.007; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Neubauer M, 2004, FEBS LETT, V577, P277, DOI 10.1016/j.febslet.2004.10.020; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Otto WR, 2004, CELL PROLIFERAT, V37, P97, DOI 10.1111/j.1365-2184.2004.00303.x; Park JS, 2008, J MICROBIOL BIOTECHN, V18, P110; Peng SL, 2009, BONE, V45, P534, DOI 10.1016/j.bone.2009.05.022; Peng Y, 2003, J CELL BIOCHEM, V90, P1149, DOI 10.1002/jcb.10744; PEPPER MS, 1992, BIOCHEM BIOPH RES CO, V189, P824, DOI 10.1016/0006-291X(92)92277-5; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Qian GF, 2006, ENDOCR J, V53, P87, DOI 10.1507/endocrj.53.87; Qin L, 2005, J BONE MINER METAB, V23, P55, DOI 10.1007/BF03026324; Sakamoto S, 2000, EUR J ENDOCRINOL, V143, P139, DOI 10.1530/eje.0.1430139; Sasamura H, 2002, BRIT J CANCER, V86, P768, DOI 10.1038/sj.bjc.6600152; Schipani E, 2001, GENE DEV, V15, P2865; Schipani E, 2009, J BONE MINER RES, V24, P1347, DOI [10.1359/JBMR.090602, 10.1359/jbmr.090602]; Schmitt B, 2003, DIFFERENTIATION, V71, P567, DOI 10.1111/j.1432-0436.2003.07109003.x; Setchell KDR, 2001, J NUTR, V131, p1362S, DOI 10.1093/jn/131.4.1362S; Sheng Hui H, 2007, J Orthop Surg Res, V2, P15, DOI 10.1186/1749-799X-2-15; Solchaga LA, 2005, J CELL PHYSIOL, V203, P398, DOI 10.1002/jcp.20238; STEIN GS, 1990, FASEB J, V4, P3111, DOI 10.1096/fasebj.4.13.2210157; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Xie F, 2005, EVID-BASED COMPL ALT, V2, P353, DOI 10.1093/ecam/neh101; Xie XH, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/5/054109; Yuan JP, 2007, MOL NUTR FOOD RES, V51, P765, DOI 10.1002/mnfr.200600262; Zhang G, 2006, BONE, V38, P818, DOI 10.1016/j.bone.2005.11.019; Zhang G, 2009, BONE, V44, P345, DOI 10.1016/j.bone.2008.10.035; Zhao J, 2008, BIOCHEM BIOPH RES CO, V369, P444, DOI 10.1016/j.bbrc.2008.02.054; Zhao JY, 2010, TISSUE ENG PT A, V16, P233, DOI [10.1089/ten.tea.2009.0165, 10.1089/ten.TEA.2009.0165]	63	43	47	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e41264	10.1371/journal.pone.0041264	http://dx.doi.org/10.1371/journal.pone.0041264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952579	gold, Green Published			2022-12-25	WOS:000308206500002
J	Senter, P; Kirkland, JI; DeBlieux, DD				Senter, Phil; Kirkland, James I.; DeBlieux, Donald D.			Martharaptor greenriverensis, a New Theropod Dinosaur from the Lower Cretaceous of Utah	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; THERIZINOSAUROID DINOSAUR; NORTHWESTERN CHINA; EVOLUTION; FEATHERS; AFFINITIES; PYGOSTYLE; MONGOLIA; YUNNAN	Background: The Yellow Cat Member of the Cedar Mountain Formation (Early Cretaceous, Barremian?) of Utah has yielded a rich dinosaur fauna, including the basal therizinosauroid theropod Falcarius utahensis at its base. Recent excavation uncovered a new possible therizinosauroid taxon from a higher stratigraphic level in the Cedar Mountain Formation than F. utahensis. Methodology/Principal Findings: Here we describe a fragmentary skeleton of the new theropod and perform a phylogenetic analysis to determine its phylogenetic position. The skeleton includes fragments of vertebrae, a scapula, forelimb and hindlimb bones, and an ischium. It also includes several well-preserved manual unguals. Manual and pedal morphology show that the specimen is distinct from other theropods from the Cedar Mountain Formation and from previously described therizinosauroids. It is here named as the holotype of a new genus and species, Martharaptor greenriverensis. Phylogenetic analysis places M. greenriverensis within Therizinosauroidea as the sister taxon to Alxasaurus + Therizinosauridae, although support for this placement is weak. Conclusions/Significance: The new specimen adds to the known dinosaurian fauna of the Yellow Cat Member of the Cedar Mountain Formation. If the phylogenetic placement is correct, it also adds to the known diversity of Therizinosauroidea.	[Senter, Phil] Fayetteville State Univ, Dept Biol Sci, Fayetteville, NC USA; [Kirkland, James I.; DeBlieux, Donald D.] Utah Geol Survey, Salt Lake City, UT USA	University of North Carolina; Fayetteville State University	Senter, P (corresponding author), Fayetteville State Univ, Dept Biol Sci, Fayetteville, NC USA.	psenter@uncfsu.edu						Barrett PM, 2009, PALAEONTOLOGY, V52, P681, DOI 10.1111/j.1475-4983.2009.00887.x; Barsbold R, 2000, ACTA PALAEONTOL POL, V45, P97; Barsbold R., 1980, Acta Palaeontologica Polonica, V25, P187; BARSBOLD R, 1976, SOVIET MONGOLIAN PAL, V3, P76; Choiniere JN, 2010, SCIENCE, V327, P571, DOI 10.1126/science.1182143; Dong Z., 1979, MESOZOIC CENOZOIC RE, P342; GREENHALGH B.W., 2007, CENTRAL UTAH DIVERSE, V36, P81; Harris J. D., 1998, NEW MEXICO MUSEUM NA, V14, P225; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Kirkland J.I., 1993, HUNTERIA, V2, P1; Kirkland JI, 2005, NATURE, V435, P84, DOI 10.1038/nature03468; Kirkland JI, 2001, J VERTEBR PALEONTOL, V21, P410, DOI 10.1671/0272-4634(2001)021[0410:FDTDTF]2.0.CO;2; KIRKLAND JI, 1998, NEW MEXICO MUSEUM NA, V14, P239; Kirkland JI, 2007, UTAH GEOLOGICAL ASS, V35, P1; Li DQ, 2008, CAN J EARTH SCI, V45, P769, DOI 10.1139/E08-021; Li DQ, 2007, ACTA GEOL SIN-ENGL, V81, P539; MALEEV E. A., 1952, DOKLADY AKAD NAUK SSSR, V87, P131; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Owen R, 1842, 11 M BRIT ASS ADV SC, P60; Perle A., 1981, SOVMESTNAYA SOVETSKO, V8, P50; Perle A., 1979, T JOINT SOVIET MONGO, V8, P45; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2107, DOI 10.1139/e93-183; Seeley, 1887, P R SOC LONDON, V63, P165; Senter P, 2011, PLOS ONE, V5, P1; Senter P., 2012, PLOS ONE, V7, P1; Senter Phil, 2010, Bulletin of Gunma Museum of Natural History, V14, P1; Senter Phil, 2007, Bulletin of Gunma Museum of Natural History, V11, P1; Suarez MB, 2007, PALAIOS, V22, P513, DOI 10.2110/palo.2006.p06-014r; Swofford D.L., 2001, PAUP PHYLOGENETIC AN; VONHUENE F, 1914, CENTRALBLATT MINERAL, P154; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670; Xu X, 2003, ACTA GEOL SIN-ENGL, V77, P294; Xu X, 2001, J VERTEBR PALEONTOL, V21, P477, DOI 10.1671/0272-4634(2001)021[0477:ANTFTL]2.0.CO;2; Xu Xing, 2002, Vertebrata Palasiatica, V40, P228; Xu X, 2009, P NATL ACAD SCI USA, V106, P832, DOI 10.1073/pnas.0810055106; Zanno LE, 2006, J VERTEBR PALEONTOL, V26, P636, DOI 10.1671/0272-4634(2006)26[636:TPGAFO]2.0.CO;2; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108; Zanno LE, 2010, ZOOL J LINN SOC-LOND, V158, P196, DOI 10.1111/j.1096-3642.2009.00464.x; Zanno LE, 2009, P ROY SOC B-BIOL SCI, V276, P3505, DOI 10.1098/rspb.2009.1029; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447; Zhang Xiao-Hong, 2001, Vertebrata Palasiatica, V39, P282	41	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43911	10.1371/journal.pone.0043911	http://dx.doi.org/10.1371/journal.pone.0043911			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952806	gold, Green Published			2022-12-25	WOS:000308206000059
J	Taylor, WR; Morley, R; Krasavin, A; Gregory, L; Wilkinson, DG; Poliakov, A				Taylor, William R.; Morley, Rosalind; Krasavin, Alexey; Gregory, Lauren; Wilkinson, David G.; Poliakov, Alexei			A Mechanical Model of Cell Segregation Driven by Differential Adhesion	PLOS ONE			English	Article							E-CADHERIN; SIMULATION; RHO	From simulations that begin with a random mix of two cell types, we monitor progress towards segregation driven by contact-mediated linkage of model cells, which is equivalent to the cell-cell adhesion of real cells. In comparison with real cell experiments, we show that this mechanical model can account for the observed extent of segregation obtained by differential adhesion in a 2D cell culture assay of cells with differentially expressed cadherin molecules. Calibration of virtual to real time allowed us to estimate a time course for these experiments that was within 50% agreement for the simulations compared to differential adhesion of cells. In contrast, simulations of differential adhesion do not account for the rate of segregation driven by interactions between EphB2 receptor and ephrinB1 expressing cells which occurs an order of magnitude faster. The latter result suggests that mechanisms additional or alternative to differential adhesion contribute to Eph-ephrin mediated cell segregation.	[Taylor, William R.; Morley, Rosalind; Gregory, Lauren; Wilkinson, David G.; Poliakov, Alexei] MRC Natl Inst Med Res, Div Math Biol, London, England; [Taylor, William R.; Morley, Rosalind; Gregory, Lauren; Wilkinson, David G.; Poliakov, Alexei] MRC Natl Inst Med Res, Div Dev Neurobiol, London, England; [Krasavin, Alexey] Kings Coll London, Dept Phys, London WC2R 2LS, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research; University of London; King's College London	Taylor, WR (corresponding author), MRC Natl Inst Med Res, Div Math Biol, London, England.	wtaylor@nimr.mrc.ac.uk	Poliakov, Alexei/C-6362-2008	Poliakov, Alexei/0000-0001-7428-4040; Wilkinson, David/0000-0001-6757-7080	Medical Research Council (UK); Medical Research Council [MC_U117532048] Funding Source: researchfish; MRC [MC_U117532048] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by the Medical Research Council (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batlle E, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008227; Dahmann C, 2011, NAT REV GENET, V12, P43, DOI 10.1038/nrg2902; Duguay D, 2003, DEV BIOL, V253, P309, DOI 10.1016/S0012-1606(02)00016-7; Dupre-Crochet S, 2007, MOL CELL BIOL, V27, P3804, DOI 10.1128/MCB.01590-06; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Niessen CM, 2002, J CELL BIOL, V156, P389, DOI 10.1083/jcb.200108040; Noren NK, 2004, CELL SIGNAL, V16, P655, DOI 10.1016/j.cellsig.2003.10.006; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Poliakov A, 2008, J CELL BIOL, V183, P933, DOI 10.1083/jcb.200807151; Shan WS, 2000, J CELL BIOL, V148, P579, DOI 10.1083/jcb.148.3.579; Solanas G, 2011, NAT CELL BIOL, V13, P1100, DOI 10.1038/ncb2298; Steinberg MS, 2007, CURR OPIN GENET DEV, V17, P281, DOI 10.1016/j.gde.2007.05.002; STEINBERG MS, 1970, J EXP ZOOL, V173, P395, DOI 10.1002/jez.1401730406; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; Taylor W, 2011, J BIOINF COMPUT BIOL, V9, P91, DOI 10.1142/S0219720011005318; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058	19	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43226	10.1371/journal.pone.0043226	http://dx.doi.org/10.1371/journal.pone.0043226			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952652	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206000026
J	Hicks, KA; Howe, DK; Leung, A; Denver, DR; Estes, S				Hicks, Kiley A.; Howe, Dana K.; Leung, Aubrey; Denver, Dee R.; Estes, Suzanne			In Vivo Quantification Reveals Extensive Natural Variation in Mitochondrial Form and Function in Caenorhabditis briggsae	PLOS ONE			English	Article							C-ELEGANS; LIFE-HISTORY; COMPLEX-I; INTERPOPULATION HYBRIDS; TIGRIOPUS-CALIFORNICUS; PATERNAL MITOCHONDRIA; OXIDATIVE DAMAGE; RNAI SCREEN; MORPHOLOGY; EVOLUTION	In We have analyzed natural variation in mitochondrial form and function among a set of Caenorhabditis briggsae isolates known to harbor mitochondrial DNA structural variation in the form of a heteroplasmic nad5 gene deletion (nad5 Delta) that correlates negatively with organismal fitness. We performed in vivo quantification of 24 mitochondrial phenotypes including reactive oxygen species level, membrane potential, and aspects of organelle morphology, and observed significant amongisolate variation in 18 traits. Although several mitochondrial phenotypes were non-linearly associated with nad5D levels, most of the among-isolate phenotypic variation could be accounted for by phylogeographic clade membership. In particular, isolate-specific mitochondrial membrane potential was an excellent predictor of clade membership. We interpret this result in light of recent evidence for local adaptation to temperature in C. briggsae. Analysis of mitochondrial-nuclear hybrid strains provided support for both mtDNA and nuclear genetic variation as drivers of natural mitochondrial phenotype variation. This study demonstrates that multicellular eukaryotic species are capable of extensive natural variation in organellar phenotypes and highlights the potential of integrating evolutionary and cell biology perspectives.	[Hicks, Kiley A.; Estes, Suzanne] Portland State Univ, Dept Biol, Portland, OR 97207 USA; [Howe, Dana K.; Leung, Aubrey; Denver, Dee R.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Howe, Dana K.; Leung, Aubrey; Denver, Dee R.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA	Portland State University; Oregon State University; Oregon State University	Hicks, KA (corresponding author), Portland State Univ, Dept Biol, Portland, OR 97207 USA.	estess@pdx.edu			National Institutes of Health grant [5 R01 GM087628-02]; PSU Faculty Enhancement grant; American Heart Association Predoctoral Fellowship [11PRE4880069]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087628] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PSU Faculty Enhancement grant; American Heart Association Predoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health grant 5 R01 GM087628-02 to DRD and SE, PSU Faculty Enhancement grant to SE, and an American Heart Association Predoctoral Fellowship 11PRE4880069 to KAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Arnqvist G, 2010, EVOLUTION, V64, P3354, DOI 10.1111/j.1558-5646.2010.01135.x; Baer CF, 2005, P NATL ACAD SCI USA, V102, P5785, DOI 10.1073/pnas.0406056102; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Ballard JWO, 2010, MOL ECOL, V19, P1523, DOI 10.1111/j.1365-294X.2010.04594.x; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Biskup S, 2006, BIOESSAYS, V28, P963, DOI 10.1002/bies.20471; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Burton RS, 2006, AM NAT, V168, pS14, DOI 10.1086/509046; Burton RS, 2007, GENE, V403, P53, DOI 10.1016/j.gene.2007.07.026; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Clark K, SELFISH LIT IN PRESS; Cutter AD, 2006, GENETICS, V173, P2021, DOI 10.1534/genetics.106.058651; Cutter AD, 2010, MOL ECOL, V19, P798, DOI 10.1111/j.1365-294X.2009.04491.x; Denver DR, 2003, MOL BIOL EVOL, V20, P393, DOI 10.1093/molbev/msg044; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Dingley S., 2009, MITOCHONDRION; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Ellison CK, 2008, J EVOLUTION BIOL, V21, P1844, DOI 10.1111/j.1420-9101.2008.01608.x; Ellison CK, 2010, J EVOLUTION BIOL, V23, P528, DOI 10.1111/j.1420-9101.2009.01917.x; Ellison CK, 2006, EVOLUTION, V60, P1382, DOI 10.1111/j.0014-3820.2006.tb01217.x; Estes S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-11; Falk MJ, 2008, MOL GENET METAB, V93, P388, DOI 10.1016/j.ymgme.2007.11.007; Fangue NA, 2009, J EXP BIOL, V212, P514, DOI 10.1242/jeb.024034; Fontaine KM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000892; Gaskova D, 2007, BIOCHEM BIOPH RES CO, V354, P814, DOI 10.1016/j.bbrc.2007.01.073; Gershoni M, 2009, BIOESSAYS, V31, P642, DOI 10.1002/bies.200800139; Gotelli NJ, 2004, PRIMER ECOLOGICAL GE; Grad LI, 2005, P NATL ACAD SCI USA, V102, P18367, DOI 10.1073/pnas.0506939102; Graef M, 2011, EMBO J, V30, P2101, DOI 10.1038/emboj.2011.104; Gupta BP., 2007, GENOMICS BIOL NEMATO; Haas RH, 2010, DEV DISABIL RES REV, V16, P144, DOI 10.1002/ddrr.112; Halliwell B., 2007, FREE RADICALS BIOL M; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Howe DK, 2010, GENOME BIOL EVOL, V2, P29, DOI 10.1093/gbe/evp055; Howe DK, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-62; Ichishita R, 2008, J BIOCHEM, V143, P449, DOI 10.1093/jb/mvm245; Ienco E. C., 2011, INT J ALZHEIMERS DIS, V2011; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Jovelin R, 2011, GENETICS, V189, P967, DOI 10.1534/genetics.111.132795; Kayser EB, 2004, MECH AGEING DEV, V125, P455, DOI 10.1016/j.mad.2004.04.002; Keller I, 2012, MOL ECOL, V21, P782, DOI 10.1111/j.1365-294X.2011.05397.x; Koboldt DC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-236; Koopman WJH, 2006, CYTOM PART A, V69A, P1, DOI 10.1002/cyto.a.20198; Kuznetsov AV, 2011, ANAL BIOANAL CHEM, V400, P2383, DOI 10.1007/s00216-011-4764-2; Kuznetsov AV, 2009, INT J MOL SCI, V10, P1911, DOI 10.3390/ijms10041911; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lemire BD, 2009, MECH AGEING DEV, V130, P461, DOI 10.1016/j.mad.2009.05.001; LEWIS JA, 1980, NEUROSCIENCE, V5, P967, DOI 10.1016/0306-4522(80)90180-3; Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Montooth KL, 2010, EVOLUTION, V64, P3364, DOI 10.1111/j.1558-5646.2010.01077.x; Morley SA, 2009, COMP BIOCHEM PHYS A, V152, P423, DOI 10.1016/j.cbpa.2008.11.015; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Pham NA, 2004, MICROSC MICROANAL, V10, P247, DOI 10.1017/S143192760404005X; Prasad A, 2011, EVOLUTION, V65, P52, DOI 10.1111/j.1558-5646.2010.01110.x; Raboin MJ, 2010, MOL BIOL EVOL, V27, P1087, DOI 10.1093/molbev/msp318; Ross JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002174; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; Russ J. C., 2002, IMAGE PROCESSING HDB, V4th, DOI DOI 10.1201/9781420040760; Sato M, 2011, SCIENCE, V334, P1141, DOI 10.1126/science.1210333; Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741; Schon EA, 2010, TRENDS MOL MED; Sedensky MM, 2006, EXP GERONTOL, V41, P237, DOI 10.1016/j.exger.2006.01.004; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Sudhaus W, 2007, ZOOTAXA, P45, DOI 10.11646/zootaxa.1456.1.2; Tuma R, 2001, Sci Aging Knowledge Environ, V2001, poa5; Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Ventura N, 2006, EXP GERONTOL, V41, P974, DOI 10.1016/j.exger.2006.06.060; Verkaart S, 2007, BBA-MOL BASIS DIS, V1772, P373, DOI 10.1016/j.bbadis.2006.12.009; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Waters JC, 2009, J CELL BIOL, V185, P1135, DOI 10.1083/jcb.200903097; Weber SB, 2011, P BIOL SCI; Willett CS, 2004, MOL BIOL EVOL, V21, P443, DOI 10.1093/molbev/msh031; Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013; Wolff JN, 2008, GENETICS, V179, P1029, DOI 10.1534/genetics.107.085274; Zhou QH, 2011, CELL RES, V21, P1662, DOI 10.1038/cr.2011.182; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028; ZOUROS E, 1994, P NATL ACAD SCI USA, V91, P7463, DOI 10.1073/pnas.91.16.7463	90	20	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43837	10.1371/journal.pone.0043837	http://dx.doi.org/10.1371/journal.pone.0043837			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952781	Green Published, Green Submitted, gold			2022-12-25	WOS:000308213600050
J	Lu, J; Du, ZX; Kong, J; Chen, LN; Qiu, YH; Li, GF; Meng, XH; Zhu, SF				Lu, Jie; Du, Zhi-Xin; Kong, Jun; Chen, Ling-Na; Qiu, Yan-Hong; Li, Gui-Fen; Meng, Xiao-Hua; Zhu, Shui-Fang			Transcriptome Analysis of Nicotiana tabacum Infected by Cucumber mosaic virus during Systemic Symptom Development	PLOS ONE			English	Article							GENE-EXPRESSION; RNA-SEQ; RESISTANCE; TOOL; ASSOCIATION; RECOVERY; PLANTS	Virus infection of plants may induce a variety of disease symptoms. However, little is known about the molecular mechanism of systemic symptom development in infected plants. Here we performed the first next-generation sequencing study to identify gene expression changes associated with disease development in tobacco plants (Nicotiana tabacum cv. Xanthi nc) induced by infection with the M strain of Cucumber mosaic virus (M-CMV). Analysis of the tobacco transcriptome by RNA-Seq identified 95,916 unigenes, 34,408 of which were new transcripts by database searches. Deep sequencing was subsequently used to compare the digital gene expression (DGE) profiles of the healthy plants with the infected plants at six sequential disease development stages, including vein clearing, mosaic, severe chlorosis, partial and complete recovery, and secondary mosaic. Thousands of differentially expressed genes were identified, and KEGG pathway analysis of these genes suggested that many biological processes, such as photosynthesis, pigment metabolism and plant-pathogen interaction, were involved in systemic symptom development. Our systematic analysis provides comprehensive transcriptomic information regarding systemic symptom development in virus-infected plants. This information will help further our understanding of the detailed mechanisms of plant responses to viral infection.	[Lu, Jie; Du, Zhi-Xin; Kong, Jun; Chen, Ling-Na; Qiu, Yan-Hong; Li, Gui-Fen; Zhu, Shui-Fang] Chinese Acad Inspect & Quarantine, Inst Plant Quarantine, Beijing, Peoples R China; [Du, Zhi-Xin; Qiu, Yan-Hong] China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China; [Meng, Xiao-Hua] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China	Chinese Academy of Inspection & Quarantine; China Agricultural University; Beijing Genomics Institute (BGI)	Lu, J (corresponding author), Chinese Acad Inspect & Quarantine, Inst Plant Quarantine, Beijing, Peoples R China.	zhushf020420@gmail.com			Basic Scientific Research Foundation of the Chinese Academy of Inspection and Quarantine [2011JK002, 2009JK032]	Basic Scientific Research Foundation of the Chinese Academy of Inspection and Quarantine	This work was supported by the Basic Scientific Research Foundation of the Chinese Academy of Inspection and Quarantine (2011JK002 and 2009JK032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimov SV, 2008, CURR PHARM BIOTECHNO, V9, P338, DOI 10.2174/138920108785915148; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Babu M, 2008, J GEN VIROL, V89, P1069, DOI 10.1099/vir.0.83531-0; Babu M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-325; Bajda A, 2009, PHYSIOL PLANTARUM, V135, P351, DOI 10.1111/j.1399-3054.2009.01204.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Catoni M, 2009, MOL PLANT MICROBE IN, V22, P1504, DOI 10.1094/MPMI-22-12-1504; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dardick C, 2007, MOL PLANT MICROBE IN, V20, P1004, DOI 10.1094/MPMI-20-8-1004; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Golem S, 2003, MOL PLANT MICROBE IN, V16, P681, DOI 10.1094/MPMI.2003.16.8.681; Grant JJ, 2003, MOL PLANT MICROBE IN, V16, P669, DOI 10.1094/MPMI.2003.16.8.669; Gruden Kristina, 2008, V451, P583, DOI 10.1007/978-1-59745-102-4_40; Guo ZJ, 2004, PLANT MOL BIOL, V55, P607, DOI 10.1007/s11103-004-1521-3; Hagen C, 2008, PHYTOPATHOLOGY, V98, P1029, DOI 10.1094/PHYTO-98-9-1029; Hanssen IM, 2011, PLANT PHYSIOL, V156, P301, DOI 10.1104/pp.111.173906; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Huang ZL, 2005, PLANT PHYSIOL, V137, P1147, DOI 10.1104/pp.104.056028; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jovel J, 2007, J VIROL, V81, P12285, DOI 10.1128/JVI.01192-07; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; Lee YW, 2010, PLANT CELL, V22, P2781, DOI 10.1105/tpc.110.076778; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Marathe R, 2004, PLANT MOL BIOL, V55, P501, DOI 10.1007/s11103-004-0439-0; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MOSSOP DW, 1976, VIROLOGY, V74, P544, DOI 10.1016/0042-6822(76)90361-5; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Palukaitis P, 2003, ADV VIRUS RES, V62, P241, DOI 10.1016/S0065-3527(03)62005-1; PALUKAITIS P, 1992, ADV VIRUS RES, V41, P281, DOI 10.1016/B978-0-12-394314-9.00013-0; Peng XX, 2009, CURR OPIN MICROBIOL, V12, P432, DOI 10.1016/j.mib.2009.06.003; Pompe-Novak M, 2005, PHYSIOL MOL PLANT P, V67, P237, DOI 10.1016/j.pmpp.2006.02.005; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Senthil G, 2005, J GEN VIROL, V86, P2615, DOI 10.1099/vir.0.81043-0; Shi C, 2005, MOL GENET GENOMICS, V273, P450, DOI 10.1007/s00438-004-1103-8; Smith CM, 2004, NEW PHYTOL, V164, P123, DOI 10.1111/j.1469-8137.2004.01151.x; Soosaar JLM, 2005, NAT REV MICROBIOL, V3, P789, DOI 10.1038/nrmicro1239; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Uzarowska A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-15; Veitch NJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-124; Wang XB, 2011, PLANT CELL, V23, P1625, DOI 10.1105/tpc.110.082305; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Whitham SA, 2003, PLANT J, V33, P271, DOI 10.1046/j.1365-313X.2003.01625.x; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Xiao SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011377; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031	52	74	77	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43447	10.1371/journal.pone.0043447	http://dx.doi.org/10.1371/journal.pone.0043447			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952684	gold, Green Published, Green Submitted			2022-12-25	WOS:000308213600026
J	Sarkinen, T; Staats, M; Richardson, JE; Cowan, RS; Bakker, FT				Saerkinen, Tiina; Staats, Martijn; Richardson, James E.; Cowan, Robyn S.; Bakker, Freek T.			How to Open the Treasure Chest? Optimising DNA Extraction from Herbarium Specimens	PLOS ONE			English	Article							ANCIENT DNA; AMPLIFICATION; PCR; PRESERVATION; BARCODE; BONES	Herbarium collections are potentially an enormous resource for DNA studies, but the use of herbarium specimens in molecular studies has thus far been slowed down by difficulty in obtaining amplifiable DNA. Here we compare a set of commercially available DNA extraction protocols and their performance in terms of DNA purity and yield, and PCR amplification success as measured by using three differentially sized markers, the rbcL barcoding marker (cpDNA), the LEAFY exon 3 (nrDNA), and the trnL((UAA)) P6 loop (cpDNA). Results reveal large differences between extraction methods, where DNA purity rather than yield is shown to be strongly correlated with PCR success. Amplicon size shows similarly strong correlation with PCR success, with the shortest fragment showing the highest success rate (78%, P6 loop, 10-143 base pairs (bp)) and the largest fragment the lowest success (10%, rbcL, 670 bp). The effect of specimen preparation method on PCR success was also tested. Results show that drying method strongly affects PCR success, especially the availability of fragments longer than 250 bp, where longer fragments are more available for PCR amplification in air dried material compared to alcohol dried specimens. Results from our study indicate that projects relying on poor-quality starting material such as herbarium or scat samples should focus on extracting pure DNA and aim to amplify short target regions (<200-300 bp) in order to maximise outcomes. Development of shorter barcoding regions, or mini-barcodes within existing ones should be of high importance as only a few options are currently available; this is particularly important if we hope to incorporate the millions of herbarium samples available into barcoding initiatives and other molecular studies.	[Saerkinen, Tiina; Richardson, James E.] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Saerkinen, Tiina] Nat Hist Museum, London SW7 5BD, England; [Staats, Martijn; Bakker, Freek T.] Wageningen Univ, Biosystemat Grp, Wageningen, Netherlands; [Richardson, James E.] Univ Los Andes, Bogota, Colombia; [Cowan, Robyn S.] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England	Natural History Museum London; Wageningen University & Research; Universidad de los Andes (Colombia); Royal Botanic Gardens, Kew	Sarkinen, T (corresponding author), Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland.	tiina.sarkinen@nhm.ac.uk	Richardson, James-Edward/L-2768-2016	Richardson, James-Edward/0000-0001-9014-4865; Bakker, Freek T./0000-0003-0227-6687	European Community [226506-CP-CSA-Infra]	European Community(European Commission)	The work was funded by the European Community Research Infrastructures program under FP7 call 'Synthesis of Systematic Resources', grant number 226506-CP-CSA-Infra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shayji Y, 2004, ACTA BIOTECHNOL, V14, P163; Barnwell P, 1998, PLANT MOL BIOL REP, V16, P133, DOI 10.1023/A:1007473302551; Bebber DP, 2010, P NATL ACAD SCI USA, V107, P22169, DOI 10.1073/pnas.1011841108; Brockington SF, 2008, TAXON, V57, P944, DOI 10.1002/tax.573022; de la Cruz M, 1997, PLANT MOL BIOL REP, V15, P319, DOI 10.1023/A:1007428818078; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; DOYLE JJ, 1987, TAXON, V36, P715, DOI 10.2307/1221122; Drabkova L, 2002, PLANT MOL BIOL REP, V20, P161, DOI 10.1007/BF02799431; Erkens RHJ, 2008, BLUMEA, V53, P407, DOI 10.3767/000651908X608052; Fleischmann A, 2009, ANAL JARDIN BOT MAD, V66, P209, DOI 10.3989/ajbm.2198; Frohlich MW, 1997, INT J PLANT SCI, V158, pS131, DOI 10.1086/297513; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; HANNI C, 1995, NUCLEIC ACIDS RES, V23, P881, DOI 10.1093/nar/23.5.881; HARRIS SA, 1993, PLANT SYST EVOL, V188, P57, DOI 10.1007/BF00937835; Hofreiter M, 2000, MOL ECOL, V9, P1975, DOI 10.1046/j.1365-294X.2000.01106.x; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; Holmgren P.K., 1990, INDEX HERBARIORUM 1; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; Ivanova NV, 2008, PLANT MOL BIOL REP, V26, P186, DOI 10.1007/s11105-008-0029-4; Jankowiak K, 2005, TAXON, V54, P335, DOI 10.2307/25065361; JOBES DV, 1995, TAXON, V44, P379, DOI 10.2307/1223408; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P554, DOI 10.1098/rspb.2010.1004; Kalmar T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e67; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Li FW, 2010, MOL ECOL RESOUR, V10, P92, DOI 10.1111/j.1755-0998.2009.02745.x; Medellin-Leal F, 1975, B SOC BOT MEX, V34, P3; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Michiels A, 2003, ANAL BIOCHEM, V315, P85, DOI 10.1016/S0003-2697(02)00665-6; Paabo S., 1990, PCR PROTOCOLS GUIDE, P159; Pan XH, 2008, P NATL ACAD SCI USA, V105, P15499, DOI 10.1073/pnas.0808028105; PYLE MM, 1989, TAXON, V38, P576, DOI 10.2307/1222632; Raye G, 2011, ECOL RES, V26, P265, DOI 10.1007/s11284-010-0780-5; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; SAVOLAINEN V, 1995, PLANT SYST EVOL, V197, P87, DOI 10.1007/BF00984634; Schenck H, 1889, KEW B, P19; Schenck H, 1888, B TORREY BOT CLUB, P292; Schenck H, 1887, BOT CENTRALBLATT, V35, P175; SHETLER S G, 1969, Proceedings of the Biological Society of Washington, V82, P687; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; SOLTIS PS, 1993, NEW ZEAL J BOT, V31, P203, DOI 10.1080/0028825X.1993.10419497; Staats M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028448; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Telle S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003584; Thompson JF, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-217; Weising K., 1995, DNA fingerprinting in plants and fungi.; Zimmermann J, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-18	49	162	177	0	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43808	10.1371/journal.pone.0043808	http://dx.doi.org/10.1371/journal.pone.0043808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952770	Green Published, gold, Green Submitted			2022-12-25	WOS:000308213600045
J	Gupta, VA; Kawahara, G; Myers, JA; Chen, AT; Hall, TE; Manzini, MC; Currie, PD; Zhou, Y; Zon, LI; Kunkel, LM; Beggs, AH				Gupta, Vandana A.; Kawahara, Genri; Myers, Jennifer A.; Chen, Aye T.; Hall, Thomas E.; Manzini, M. Chiara; Currie, Peter D.; Zhou, Yi; Zon, Leonard I.; Kunkel, Louis M.; Beggs, Alan H.			A Splice Site Mutation in Laminin-alpha 2 Results in a Severe Muscular Dystrophy and Growth Abnormalities in Zebrafish	PLOS ONE			English	Article							LAMININ ALPHA-2; LAMA2 GENE; MEROSIN; MODEL; MUTANT; POPULATION; PHENOTYPE; MICE	Congenital muscular dystrophy (CMD) is a clinically and genetically heterogeneous group of inherited muscle disorders. In patients, muscle weakness is usually present at or shortly after birth and is progressive in nature. Merosin deficient congenital muscular dystrophy (MDC1A) is a form of CMD caused by a defect in the laminin-alpha 2 gene (LAMA2). Laminin-alpha 2 is an extracellular matrix protein that interacts with the dystrophin-dystroglycan (DGC) complex in membranes providing stability to muscle fibers. In an N-ethyl-N-nitrosourea mutagenesis screen to develop zebrafish models of neuromuscular diseases, we identified a mutant fish that exhibits severe muscular dystrophy early in development. Genetic mapping identified a splice site mutation in the lama2 gene. This splice site is highly conserved in humans and this mutation results in mis-splicing of RNA and a loss of protein function. Homozygous lama2 mutant zebrafish, designated lama2(cl501/cl501), exhibited reduced motor function and progressive degeneration of skeletal muscles and died at 8-15 days post fertilization. The skeletal muscles exhibited damaged myosepta and detachment of myofibers in the affected fish. Laminin-alpha 2 deficiency also resulted in growth defects in the brain and eye of the mutant fish. This laminin-alpha 2 deficient mutant fish represents a novel disease model to develop therapies for modulating splicing defects in congenital muscular dystrophies and to restore the muscle function in human patients with CMD.	[Gupta, Vandana A.; Kawahara, Genri; Myers, Jennifer A.; Manzini, M. Chiara; Kunkel, Louis M.; Beggs, Alan H.] Harvard Univ, Sch Med, Boston Childrens Hosp, Genom Program,Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Gupta, Vandana A.; Kawahara, Genri; Myers, Jennifer A.; Manzini, M. Chiara; Kunkel, Louis M.; Beggs, Alan H.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Genet,Manton Ctr Orphan Dis Res, Boston, MA USA; [Chen, Aye T.; Zhou, Yi; Zon, Leonard I.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Chen, Aye T.; Zhou, Yi; Zon, Leonard I.] Harvard Univ, Sch Med, Boston Childrens Hosp, Stem Cell Program, Boston, MA USA; [Currie, Peter D.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia; [Zon, Leonard I.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Australian Regenerative Medicine Institute; Monash University; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Gupta, VA (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Genom Program,Manton Ctr Orphan Dis Res, Boston, MA 02115 USA.	beggs@enders.tch.harvard.edu	Hall, Thomas/J-2125-2014	Hall, Thomas/0000-0002-7718-7614; SanMiguel, Jennifer/0000-0002-5882-0752; Currie, Peter/0000-0001-8874-8862; Beggs, Alan/0000-0001-8818-0568; Manzini, M. Chiara/0000-0001-7175-1096; Gupta, Vandana/0000-0002-4057-8451	Muscular Dystrophy Association [MDA201302]; National Institute of Health (NIH) grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR044345]; Lee and Penny Anderson Family Foundation; William Randolph Hearst Fund; NIH from the National Institute of Arthritis and Musculoskeletal and Skin Diseases [K01 AR062601-01]; National Institute of Child Health and Human Development [P30HD18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044345, K01AR062601] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); National Institute of Health (NIH) grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases; Lee and Penny Anderson Family Foundation; William Randolph Hearst Fund; NIH from the National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Muscular Dystrophy Association (MDA201302); National Institute of Health (NIH) grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR044345); by the Lee and Penny Anderson Family Foundation; and the William Randolph Hearst Fund. VAG was supported by NIH K01 AR062601-01 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. DNA sequencing was performed by the Children's Hospital Boston Genomics Program Molecular Genetics Core supported in part by National Institute of Child Health and Human Development grant (P30HD18655). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett DI, 2003, DEVELOPMENT, V130, P5851, DOI 10.1242/dev.00799; Collins J, 2010, CURR NEUROL NEUROSCI, V10, P83, DOI 10.1007/s11910-010-0092-8; Di Blasi Claudia, 2011, BMC Res Notes, V4, P534, DOI 10.1186/1756-0500-4-534; Doe JA, 2011, J CELL SCI, V124, P2287, DOI 10.1242/jcs.083311; Geranmayeh F, 2010, NEUROMUSCULAR DISORD, V20, P241, DOI 10.1016/j.nmd.2010.02.001; Girgenrath M, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-7; Gupta V, 2011, HUM MOL GENET, V20, P1712, DOI 10.1093/hmg/ddr047; Guyon JR, 2003, HUM MOL GENET, V12, P601, DOI 10.1093/hmg/ddg071; Hall TE, 2007, P NATL ACAD SCI USA, V104, P7092, DOI 10.1073/pnas.0700942104; Hayashi YK, 2001, NEUROMUSCULAR DISORD, V11, P350, DOI 10.1016/S0960-8966(00)00203-0; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Jones KJ, 1998, J MED GENET, V35, P379, DOI 10.1136/jmg.35.5.379; Jones KJ, 2001, J MED GENET, V38, P649, DOI 10.1136/jmg.38.10.649; Kawahara G, 2011, P NATL ACAD SCI USA, V108, P5331, DOI 10.1073/pnas.1102116108; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Kuang W, 1999, LAB INVEST, V79, P1601; Lawson ND, 2011, DEV CELL, V21, P48, DOI 10.1016/j.devcel.2011.06.007; Mendell JR, 2006, PEDIATR DEVEL PATHOL, V9, P427, DOI 10.2350/06-07-0127.1; Messina S, 2010, NEUROLOGY, V75, P898, DOI 10.1212/WNL.0b013e3181f11dd5; Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7; Miyagoe-Suzuki Y, 2000, MICROSC RES TECHNIQ, V48, P181, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<181::AID-JEMT6>3.0.CO;2-Q; O'Brien DP, 2001, J NEUROL SCI, V189, P37, DOI 10.1016/S0022-510X(01)00559-7; Osorio FG, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002847; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; Patton BL, 2008, J CELL SCI, V121, P1593, DOI 10.1242/jcs.015354; Philpot J, 1999, ARCH DIS CHILD, V80, P542, DOI 10.1136/adc.80.6.542; Relucio J, 2009, J NEUROSCI, V29, P11794, DOI 10.1523/JNEUROSCI.0888-09.2009; Rooney JE, 2012, AM J PATHOL; Sumanasekera C, 2008, BIOCHEM SOC T, V36, P483, DOI 10.1042/BST0360483; Sztal T, 2011, DEV DYNAM, V240, P422, DOI 10.1002/dvdy.22537; Theodore M, 2011, CURR OPIN PEDIATR, V23, P581, DOI 10.1097/MOP.0b013e32834cd693; Topaloglu H, 1998, NEUROMUSCULAR DISORD, V8, P169, DOI 10.1016/S0960-8966(98)00013-3; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Vigliano P, 2009, EUR J PAEDIATR NEURO, V13, P72, DOI 10.1016/j.ejpn.2008.01.010; Westerfield M, 2007, ZEBRAFISH BOOK; Wewer UM, 1996, NEUROMUSCULAR DISORD, V6, P409, DOI 10.1016/S0960-8966(96)00384-7; XU H, 1994, NAT GENET, V8, P297, DOI 10.1038/ng1194-297; Zhou Y, 2011, METHOD CELL BIOL, V104, P287, DOI 10.1016/B978-0-12-374814-0.00016-1; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	40	32	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43794	10.1371/journal.pone.0043794	http://dx.doi.org/10.1371/journal.pone.0043794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952766	Green Published, gold, Green Submitted			2022-12-25	WOS:000308044800060
J	Loganathan, S; Kandala, PK; Gupta, P; Srivastava, SK				Loganathan, Sivakumar; Kandala, Prabodh K.; Gupta, Parul; Srivastava, Sanjay K.			Inhibition of EGFR-AKT Axis Results in the Suppression of Ovarian Tumors In Vitro and in Preclinical Mouse Model	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL-CYCLE ARREST; CANCER CELLS; LUNG-CANCER; SIGNALING PATHWAY; ACTIVATION; KINASE; CARCINOMA; PHOSPHORYLATION; APOPTOSIS	Ovarian cancer is the leading cause of cancer related deaths in women. Genetic alterations including overexpression of EGFR play a crucial role in ovarian carcinogenesis. Here we evaluated the effect of phenethyl isothiocyanate (PEITC) in ovarian tumor cells in vitro and in vivo. Oral administration of 12 mmol PEITC resulted in drastically suppressing ovarian tumor growth in a preclinical mouse model. Our in vitro studies demonstrated that PEITC suppress the growth of SKOV-3, OVCAR-3 and TOV-21G human ovarian cancer cells by inducing apoptosis in a concentration-dependent manner. Growth inhibitory effects of PEITC were mediated by inhibition of EGFR and AKT, which are known to be overexpressed in ovarian tumors. PEITC treatment caused significant down regulation of constitutive protein levels as well as phosphorylation of EGFR at Tyr1068 in various ovarian cancer cells. In addition, PEITC treatment drastically reduced the phosphorylation of AKT which is downstream to EGFR and disrupted mTOR signaling. PEITC treatment also inhibited the kinase activity of AKT as observed by the down regulation of p-GSK in OVCAR-3 and TOV-21G cells. AKT overexpression or TGF treatment blocked PEITC induced apoptosis in ovarian cancer cells. These results suggest that PEITC targets EGFR/AKT pathway in our model. In conclusion, our study suggests that PEITC could be used alone or in combination with other therapeutic agents to treat ovarian cancer.	[Loganathan, Sivakumar; Srivastava, Sanjay K.] Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15260 USA; [Loganathan, Sivakumar; Srivastava, Sanjay K.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA; [Kandala, Prabodh K.; Gupta, Parul; Srivastava, Sanjay K.] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Amarillo, TX USA; [Kandala, Prabodh K.; Gupta, Parul; Srivastava, Sanjay K.] Texas Tech Univ, Hlth Sci Ctr, Canc Biol Ctr, Amarillo, TX USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Loganathan, S (corresponding author), Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15260 USA.	sanjay.srivastava@ttuhsc.edu	GUPTA, PARUL/AAF-1118-2019; Srivastava, Sanjay K./AAE-7635-2020		National Cancer Institute [CA106953, CA129038]; NATIONAL CANCER INSTITUTE [R01CA106953, R01CA129038] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported in part by R01 grants CA106953 and CA129038 (to S.K.S.) awarded by the National Cancer Institute. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ahmed N, 2006, AM J PHYSIOL-CELL PH, V290, pC1532, DOI 10.1152/ajpcell.00478.2005; Alper O, 2001, J NATL CANCER I, V93, P1375, DOI 10.1093/jnci/93.18.1375; Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Medel NIB, 2010, J ONCOL, V2010, DOI 10.1155/2010/314326; Bast RC, 1998, INT J BIOL MARKER, V13, P179, DOI 10.1177/172460089801300402; Beugnet A, 2003, J BIOL CHEM, V278, P40717, DOI 10.1074/jbc.M308573200; Boreddy SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025799; Boreddy SR, 2011, CLIN CANCER RES, V17, P1784, DOI 10.1158/1078-0432.CCR-10-1891; Bosetti C, 2001, INT J CANCER, V93, P911, DOI 10.1002/ijc.1422; Casanova ML, 2002, CANCER RES, V62, P3402; Chen A, 2006, ONCOGENE, V25, P278, DOI [10.1038/sj.onc.1209019, 10.1038/sj.onc.1209573]; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Flynn JF, 2009, J ONCOL, V2009, DOI 10.1155/2009/526963; FONTANINI G, 1995, EUR J CANCER, V31A, P178, DOI 10.1016/0959-8049(93)00421-M; Galbaugh T, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-34; Gao N, 2004, AM J PHYSIOL-CELL PH, V287, pC281, DOI 10.1152/ajpcell.00422.2003; HECHT SS, 1995, CANCER EPIDEM BIOMAR, V4, P877; Hecht SS, 1996, ADV EXP MED BIOL, V401, P1; Huong LD, 2011, J AGR FOOD CHEM, V59, P8124, DOI 10.1021/jf2006358; Jang K, 2010, ONCOL REP, V24, P787, DOI 10.3892/or_00000922; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Ji Y, 2005, PHARM RES-DORDR, V22, P1658, DOI 10.1007/s11095-005-7097-z; Johnson SM, 2009, ANTICANCER RES, V29, P3185; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kandala PK, 2012, ONCOTARGET; Kandala PK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-9; Kandala PK, 2012, J PHARMACOL EXP THER, V341, P24, DOI 10.1124/jpet.111.188706; Kandala PK, 2010, MOL PHARMACOL, V78, P297, DOI 10.1124/mol.110.063750; Kim SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026615; Levy DS, 2009, BLOOD, V113, P1723, DOI 10.1182/blood-2008-02-137737; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; Milligan SA, 2009, CLIN CANCER RES, V15, P4885, DOI 10.1158/1078-0432.CCR-09-0109; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Nishioka C, 2008, LEUKEMIA RES, V32, P865, DOI 10.1016/j.leukres.2007.09.017; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Ozols RF, 2006, GYNECOL ONCOL, V103, P1, DOI 10.1016/j.ygyno.2006.06.026; PERRIMON N, 1994, CURR OPIN CELL BIOL, V6, P260, DOI 10.1016/0955-0674(94)90145-7; Phelps SLB, 2008, GYNECOL ONCOL, V109, P411, DOI 10.1016/j.ygyno.2008.02.030; Pramanik KC, 2012, ANTIOXID REDOX SIGNA; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Rho JK, 2010, MOL CANCER THER, V9, P3233, DOI 10.1158/1535-7163.MCT-10-0625; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Satyan KS, 2006, GYNECOL ONCOL, V103, P261, DOI 10.1016/j.ygyno.2006.03.002; Sherwood ER, 1998, BRIT J CANCER, V77, P855, DOI 10.1038/bjc.1998.142; Stewart JR, 2004, INVEST NEW DRUG, V22, P107, DOI 10.1023/B:DRUG.0000011787.75522.ec; Suh Y, 2010, CARCINOGENESIS, V31, P1424, DOI 10.1093/carcin/bgq115; Thoennissen NH, 2010, ONCOGENE, V29, P285, DOI 10.1038/onc.2009.335; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Turner T, 1996, CLIN EXP METASTAS, V14, P409, DOI 10.1007/BF00123400; Ueda S, 2006, CANCER RES, V66, P5346, DOI 10.1158/0008-5472.CAN-05-3684; Watanabe H, 1998, Nihon Jibiinkoka Gakkai Kaiho, V101, P967; West KA, 2002, DRUG RESIST UPDATE, V5, P234, DOI 10.1016/S1368-7646(02)00120-6; Wu HY, 2007, BIOMARK INSIGHTS, V2, P469; Yan HQ, 2011, BRIT J NUTR, V106, P1779, DOI 10.1017/S0007114511002315; Ye LX, 2002, CLIN CHIM ACTA, V316, P43, DOI 10.1016/S0009-8981(01)00727-6; Zeineldin R, 2010, J ONCOL, V2010, DOI 10.1155/2010/414676; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zhang M, 2002, BRIT J CANCER, V86, P712, DOI 10.1038/sj.bjc.6600085	59	33	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43577	10.1371/journal.pone.0043577	http://dx.doi.org/10.1371/journal.pone.0043577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952709	gold, Green Published, Green Accepted			2022-12-25	WOS:000308044800040
J	Qin, J; Huang, ZX; Chen, J; Zou, Q; You, WW; Ke, CH				Qin, Ji; Huang, Zixia; Chen, Jun; Zou, Quan; You, Weiwei; Ke, Caihuan			Sequencing and de novo Analysis of Crassostrea angulata (Fujian Oyster) from 8 Different Developing Phases Using 454 GSFlx	PLOS ONE			English	Article							INSULIN-LIKE SYSTEM; PACIFIC OYSTER; GASTROPOD MOLLUSK; TRANSCRIPTOME; EXPRESSION; GIGAS; METAMORPHOSIS; HEMOCYTES; MORTALITY; SELECTION	Research on the mechanism for early development of shellfish, such as body plan, shell formation, settlement and metamorphosis is currently an active research field. However, studies were still limited and not deep enough because of the lack of genomic resources such as genome or transcriptome sequences. In the present research, de novo transcriptome sequencing was performed for Crassostrea angulata, the most economically important cultured oyster species in China, at eight early developmental stages using the 454 sequencing technology. A total of 555,215 reads were produced with an average length of 309 nucleotides that were then assembled into 10,462 contigs. As determined by GO annotation and KEGG pathway mapping, functional annotation of the unigenes recovered diverse biological functions and processes. Six unique sequences related to settlement, metamorphosis and growth were subsequently analyzed by real-time PCR. Given the lack of whole genome information for oysters, transcriptome and de novo analysis of C. angulata from the eight different developing phases will provide important and useful information on early development mechanism and help genetic breeding of shellfish.	[Qin, Ji; Huang, Zixia; Chen, Jun; You, Weiwei; Ke, Caihuan] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Qin, Ji; Huang, Zixia; Chen, Jun; You, Weiwei; Ke, Caihuan] Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Peoples R China; [Zou, Quan] Xiamen Univ, Coll Informat Sci & Technol, Xiamen, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Qin, J (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	chke@xmu.edu.cn	Huang, Zixia/AAO-6936-2021; Ke, CH/G-4635-2010; Zou, Quan/A-7801-2015	Huang, Zixia/0000-0002-1298-0486	National Basic Research Program of China [2010CB1264000]; Hi-Tech Research and Development (863) Program of China [2010AA10A110]; Shellfish Modern Agro-industry Technology Research System [nycytx-47]	National Basic Research Program of China(National Basic Research Program of China); Hi-Tech Research and Development (863) Program of China; Shellfish Modern Agro-industry Technology Research System	This study was funded by The National Basic Research Program of China (No. 2010CB1264000), Hi-Tech Research and Development (863) Program of China (No. 2010AA10A110) and Shellfish Modern Agro-industry Technology Research System (No. nycytx-47). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleyard SA, 2006, AQUACULTURE, V254, P148, DOI 10.1016/j.aquaculture.2005.10.017; Bieler R, 2006, ZOOL J LINN SOC-LOND, V148, P223, DOI 10.1111/j.1096-3642.2006.00255.x; BONAR DB, 1990, B MAR SCI, V46, P484; Butt D, 2008, DEV COMP IMMUNOL, V32, P299, DOI 10.1016/j.dci.2007.06.006; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; Clark MS, 2010, PLOS ONE, V6; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COON SL, 1987, NEUROSCIENCE, V23, P1169, DOI 10.1016/0306-4522(87)90190-4; Craft JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008875; Degremont L, 2007, AQUACULTURE, V262, P41, DOI 10.1016/j.aquaculture.2006.10.025; Evans S, 2006, AQUACULTURE, V261, P546, DOI 10.1016/j.aquaculture.2006.07.037; *FAO, 2000, FISHSTAT PLUS UN SOF; Feng BB, 2010, MAR BIOTECHNOL, V12, P282, DOI 10.1007/s10126-009-9216-z; Fiedler TJ, 2010, COMP BIOCHEM PHYS D, V5, P165, DOI 10.1016/j.cbd.2010.03.003; Fleury E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-341; Franchini Paolo, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-59; Gregory DJ, 2004, ANIM GENET, V35, P425, DOI 10.1111/j.1365-2052.2004.01193.x; Gricourt L, 2006, AQUACULTURE, V251, P85, DOI 10.1016/j.aquaculture.2005.05.015; Gricourt L, 2003, GEN COMP ENDOCR, V134, P44, DOI 10.1016/S0016-6480(03)00217-X; Guo X. M., 2004, Bulletin of the Aquaculture Association of Canada, V104, P26; Heyland A, 2011, J EXP ZOOL PART B, V316B, P113, DOI 10.1002/jez.b.21383; Hinman VF, 2003, EVOL DEV, V5, P508, DOI 10.1046/j.1525-142X.2003.03056.x; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Huan P, 2012, MAR BIOTECHNOL, V14, P69, DOI 10.1007/s10126-011-9389-0; Jackson D, 2002, INT J DEV BIOL, V46, P679; Joubert C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-613; Lebel JM, 1996, BIOL CELL, V86, P67, DOI 10.1016/0248-4900(96)89526-8; Li Q, 2011, GENES GENOM, V33, P313, DOI 10.1007/s13258-011-0021-5; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Milan M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-234; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; Pedersen TM, 2008, J MARINE SYST, V73, P185, DOI 10.1016/j.jmarsys.2007.10.008; Reyes-Bermudez A, 2009, MAR GENOM, V2, P149, DOI 10.1016/j.margen.2009.07.002; Sauvage C, 2009, VIRUS RES, V142, P181, DOI 10.1016/j.virusres.2009.02.013; Serpentini A, 2000, J EXP ZOOL, V287, P275, DOI 10.1002/1097-010X(20000901)287:4&lt;275::AID-JEZ2&gt;3.0.CO;2-8; Wang HY, 2010, J SHELLFISH RES, V29, P857, DOI 10.2983/035.029.0420; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031	37	48	51	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43653	10.1371/journal.pone.0043653	http://dx.doi.org/10.1371/journal.pone.0043653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952730	Green Submitted, Green Published, gold			2022-12-25	WOS:000308044800049
J	Capitan, JA; Borge-Holthoefer, J; Gomez, S; Martinez-Romo, J; Araujo, L; Cuesta, JA; Arenas, A				Capitan, Jose A.; Borge-Holthoefer, Javier; Gomez, Sergio; Martinez-Romo, Juan; Araujo, Lourdes; Cuesta, Jose A.; Arenas, Alex			Local-Based Semantic Navigation on a Networked Representation of Information	PLOS ONE			English	Article							COMPLEX NETWORKS	The size and complexity of actual networked systems hinders the access to a global knowledge of their structure. This fact pushes the problem of navigation to suboptimal solutions, one of them being the extraction of a coherent map of the topology on which navigation takes place. In this paper, we present a Markov chain based algorithm to tag networked terms according only to their topological features. The resulting tagging is used to compute similarity between terms, providing a map of the networked information. This map supports local-based navigation techniques driven by similarity. We compare the efficiency of the resulting paths according to their length compared to that of the shortest path. Additionally we claim that the path steps towards the destination are semantically coherent. To illustrate the algorithm performance we provide some results from the Simple English Wikipedia, which amounts to several thousand of pages. The simplest greedy strategy yields over an 80% of average success rate. Furthermore, the resulting content-coherent paths most often have a cost between one- and threefold compared to shortest-path lengths.	[Capitan, Jose A.; Gomez, Sergio; Arenas, Alex] Univ Rovira & Virgili, Dept Engn Informat & Matemat, Tarragona, Spain; [Capitan, Jose A.] Consejo Super Invest Cient INTA, Ctr Astrobiol, Madrid, Spain; [Capitan, Jose A.; Cuesta, Jose A.] Grp Interdisciplinar Sistemas Complejos, Madrid, Spain; [Borge-Holthoefer, Javier; Arenas, Alex] Univ Zaragoza, Inst Biocomputac & Fis Sistemas Complejos, Zaragoza, Spain; [Martinez-Romo, Juan; Araujo, Lourdes] Univ Nacl Educ Distancia, Dept Lenguajes & Sistemas Informat, E-28040 Madrid, Spain; [Cuesta, Jose A.] Univ Carlos III Madrid, Escuela Politecn Super, Dept Matemat, Madrid, Spain	Universitat Rovira i Virgili; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); University of Zaragoza; Universidad Nacional de Educacion a Distancia (UNED); Universidad Carlos III de Madrid	Capitan, JA (corresponding author), Univ Rovira & Virgili, Dept Engn Informat & Matemat, Tarragona, Spain.	joseangel.capitan@cab.inta-csic.es	Arenas, Alex/A-5216-2009; Cuesta, Jose A/A-7157-2008; Araujo, Lourdes/G-6272-2015; Cuesta, Jose A/Z-4696-2019; Borge-Holthoefer, Javier/J-9187-2013; Gómez, Sergio/B-2113-2010; Capitan, Jose A./D-8669-2012; Martinez-Romo, Juan/R-9483-2019	Arenas, Alex/0000-0003-0937-0334; Cuesta, Jose A/0000-0001-9890-9367; Araujo, Lourdes/0000-0002-7657-4794; Borge-Holthoefer, Javier/0000-0001-9036-8463; Gómez, Sergio/0000-0003-1820-0062; Capitan, Jose A./0000-0002-6245-0088; Martinez-Romo, Juan/0000-0002-6905-7051	Ministerio de Educacion y Ciencia in Spain [FIS2008-01240, FIS2009-13364-C02-01]; Holopedia from Ministerio de Educacion y Ciencia in Spain [TIN2010-21128-C02-01]; MOSAICO from Ministerio de Educacion y Ciencia in Spain [FIS2006-01485]; PRODIEVO from Ministerio de Educacion y Ciencia in Spain [FIS2011-22449]; Research Networks MODELICO-CM [S2009/ESP-1691]; MA2VICMR from Comunidad de Madrid [S2009/TIC-1542]; Generalitat de Catalunya [Network 2009-SGR-838]	Ministerio de Educacion y Ciencia in Spain(Spanish Government); Holopedia from Ministerio de Educacion y Ciencia in Spain(German Research Foundation (DFG)); MOSAICO from Ministerio de Educacion y Ciencia in Spain(German Research Foundation (DFG)); PRODIEVO from Ministerio de Educacion y Ciencia in Spain(German Research Foundation (DFG)); Research Networks MODELICO-CM; MA2VICMR from Comunidad de Madrid; Generalitat de Catalunya(Generalitat de Catalunya)	The authors acknowledge financial support through Grant No. FIS2008-01240, FIS2009-13364-C02-01, Holopedia (Grant No. TIN2010-21128-C02-01), MOSAICO (Grant No. FIS2006-01485), PRODIEVO (Grant No. FIS2011-22449), and Complexity-NET RESINEE, all of them from Ministerio de Educacion y Ciencia in Spain, as well as support from Research Networks MODELICO-CM (Grant No. S2009/ESP-1691) and MA2VICMR (Grant No. S2009/TIC-1542) from Comunidad de Madrid, and Network 2009-SGR-838 from Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic LA, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.046135; Alvarez-Hamelin J.I., 2006, ADV NEURAL INFORM PR, P41; Arenas A, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/5/053009; ATKINSON AB, 1970, J ECON THEORY, V2, P244, DOI 10.1016/0022-0531(70)90039-6; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Blondel VD, 2004, SIAM REV, V46, P647, DOI 10.1137/S0036144502415960; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boguna M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1063; Boguna M, 2009, NAT PHYS, V5, P74, DOI 10.1038/NPHYS1130; Borge-Holthoefer J, 2010, EUR PHYS J B, V74, P265, DOI 10.1140/epjb/e2010-00058-9; Borge-Holthoefer J, 2010, ENTROPY-SWITZ, V12, P1264, DOI 10.3390/e12051264; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; COLLINS AM, 1969, J VERB LEARN VERB BE, V8, P240, DOI 10.1016/S0022-5371(69)80069-1; Costa LD, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016102; Erola P, 2012, INT J BIFUR IN PRESS; Erola P., 2011, INT J COMPUT SYST SC, V1, P37; Guimera R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.248701; Holme P, 2009, MODEL SIMUL SCI ENG, P189, DOI 10.1007/978-0-8176-4751-3_11; Jaccard P., 1901, B SOC VAUD SCI NAT, V37, P241, DOI DOI 10.5169/SEALS-266440; Jeh G., 2002, P 8 ACM SIGKDD INT C, P538, DOI DOI 10.1145/775047.775126; Jiang J.J., 1997, P INT C RES COMP LIN, P19; Kleinberg J., 2000, Proceedings of the Thirty Second Annual ACM Symposium on Theory of Computing, P163, DOI 10.1145/335305.335325; Kleinberg J., 2006, P INT C MATH ICM EUR, V3, P1019; Lambiotte R, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.017102; Lee SH, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.128701; Lee S, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.017102; Leicht EA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.026120; Martinez-Romo J, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046108; Milgram S., 1967, PSYCHOL TODAY, V2; Miller G. A., 1990, INT J LEXICOGR, V3, P235, DOI DOI 10.1093/IJL/3.4.235; MILLER GA, 1991, LANG COGNITIVE PROC, V6, P1, DOI 10.1080/01690969108406936; Noh JD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118701; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; QUILLIAN MR, 1967, BEHAV SCI, V12, P410, DOI 10.1002/bs.3830120511; Ravasz E, 2002, HIERARCHICAL ORG MOD; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Salton G., 1989, AUTOMATIC TEXT PROCE, VVolume 169; Salton G, 1983, INTRO MODERN INFORM; Sinatra R, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.030103; TRAVERS J, 1969, SOCIOMETRY, V32, P425, DOI 10.2307/2786545; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Watts DJ, 2002, SCIENCE, V296, P1302, DOI 10.1126/science.1070120; Yang SJ, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.016107	44	15	15	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43694	10.1371/journal.pone.0043694	http://dx.doi.org/10.1371/journal.pone.0043694			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998GM	22937081	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500083
J	Chang, JR; Chen, YY; Huang, TS; Huang, WF; Kuo, SC; Tseng, FC; Su, IJ; Lin, CH; Chen, YS; Sun, JR; Chiueh, TS; Dou, HY				Chang, Jia-Ru; Chen, Yih-Yuan; Huang, Tsi-Shu; Huang, Wei-Feng; Kuo, Shu-Chen; Tseng, Fan-Chen; Su, Ih-Jen; Lin, Chien-Hsing; Chen, Yao-Shen; Sun, Jun-Ren; Chiueh, Tzong-Shi; Dou, Horng-Yunn			Clonal Expansion of Both Modern and Ancient Genotypes of Mycobacterium tuberculosis in Southern Taiwan	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; BEIJING GENOTYPE; ASSOCIATION; SETTLEMENT	We present the first comprehensive analysis of Mycobacterium tuberculosis isolates circulating in the Kaohsiung region of southern Taiwan. The major spoligotypes found in the 224 isolates studied were Beijing lineages (n = 97; 43.3%), EAI lineages (n = 72; 32.1%) and Haarlem lineages (n = 18; 8.0%). By 24 MIRU-VNTR typing, 174 patterns were identified, including 24 clusters of 74 isolates and 150 unique patterns. The combination of spoligotyping and 12-MIRU-VNTR revealed that 129 (57.6%) of the 224 isolates were clustered in 18 genotypes. Moreover, 63.6% (7/11) of infected persons younger than 30 years had a Beijing strain, which could suggest recent spread among younger persons by this family of TB strains in Kaohsiung. Among the 94 Beijing family (SIT1, SIT250 and SIT1674) isolates further analyzed for SNPs by mass spectrometry, the most frequent strain found was ST10 (n = 49; 52%), followed by ST22 (n = 17; 18%) and ST19 (n = 11; 12%). Among the EAI-Manila family isolates analyzed by region deletion-based subtyping, the most frequent strain found was RD type 1 (n = 63; 87.5%), followed by RD type 2 (n = 9; 12.5%). In our previous study, the proportion of modern Beijing strains (52.5%) in northern Taiwan was significantly higher than the proportion of EAI strains (11%). In contrast, in the present study, EAI strains comprised up to 32% of Beijing strains in southern Taiwan. In conclusion, both 'modern' (Beijing) and 'ancient' (EAI) M. tuberculosis strains are prevalent in the Kaohsiung region, perhaps suggesting that both strains are somehow more adapted to southern Taiwan. It will be interesting to investigate the dynamics of the lineage composition by different selection pressures.	[Chang, Jia-Ru; Chen, Yih-Yuan; Huang, Wei-Feng; Kuo, Shu-Chen; Tseng, Fan-Chen; Su, Ih-Jen; Dou, Horng-Yunn] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Miaoli, Taiwan; [Lin, Chien-Hsing] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Miaoli, Taiwan; [Huang, Tsi-Shu; Chen, Yao-Shen] Kaohsiung Vet Gen Hosp, Dept Microbiol, Kaohsiung, Taiwan; [Sun, Jun-Ren; Chiueh, Tzong-Shi] Tri Serv Gen Hosp, Div Clin Pathol, Dept Pathol, Taipei, Taiwan; [Sun, Jun-Ren; Chiueh, Tzong-Shi] Natl Def Med Ctr, Taipei, Taiwan; [Dou, Horng-Yunn] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; Kaohsiung Veterans General Hospital; Tri-Service General Hospital; National Defense Medical Center; Taipei Medical University	Chang, JR (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Miaoli, Taiwan.	hydou@nhri.org.tw	Kuo, Shu-Chen/G-9108-2011; Dou, horng-yunn/F-1966-2015; Dou, Horng-Yunn/B-2652-2010; Su, Ih-Jen/B-2655-2010; Tseng, Fan-Chen/D-2097-2010	Sun, jun-ren/0000-0002-8769-9170; Chen, Yih-Yuan/0000-0001-9507-291X	National Health Research Institutes; National Science Council, Taiwan [NSC 100-3111-B-400-001]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This project was supported by grants from the National Health Research Institutes and National Science Council (NSC 100-3111-B-400-001), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Chang JR, 2011, CLIN MICROBIOL INFEC, V17, P1391, DOI 10.1111/j.1469-0691.2010.03436.x; Clinical and Laboratory Standards Institute, 2005, CLIN LAB STAND I DOC; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Dou HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-170; Frink S, 2011, J CLIN MICROBIOL, V49, P1951, DOI 10.1128/JCM.01338-10; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Gray RD, 2000, NATURE, V405, P1052, DOI 10.1038/35016575; Han H, 2007, J MED MICROBIOL, V56, P1219, DOI 10.1099/jmm.0.47005-0; Huang SF, 2012, INFECT GENET EVOL, V12, P28, DOI 10.1016/j.meegid.2011.10.001; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Iwamoto T, 2008, ANTIMICROB AGENTS CH, V52, P3805, DOI 10.1128/AAC.00579-08; Iwamoto T, 2009, J CLIN MICROBIOL, V47, P3340, DOI 10.1128/JCM.01061-09; KOLK AHJ, 1992, J CLIN MICROBIOL, V30, P2567, DOI 10.1128/JCM.30.10.2567-2575.1992; Kremer K, 2009, EMERG INFECT DIS, V15, P335, DOI 10.3201/eid1502.080795; Li WM, 2005, INT J TUBERC LUNG D, V9, P1314; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Mokrousov I, 2005, GENOME RES, V15, P1357, DOI 10.1101/gr.3840605; Pope KO, 2008, J BIOGEOGR, V35, P1, DOI 10.1111/j.1365-2699.2007.01797.x; Shamputa IC, 2010, J CLIN MICROBIOL, V48, P387, DOI 10.1128/JCM.02167-09; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Struelens M. J., 1996, Clin Microbiol Infect, V2, P2, DOI 10.1111/j.1469-0691.1996.tb00193.x; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; van Soolingen D, 2001, EMERG INFECT DIS, V7, P763; Vitol I, 2006, INFECT GENET EVOL, V6, P491, DOI 10.1016/j.meegid.2006.03.003; Wan KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029190	30	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43018	10.1371/journal.pone.0043018	http://dx.doi.org/10.1371/journal.pone.0043018			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937008	Green Submitted, Green Published, gold			2022-12-25	WOS:000308225500026
J	Mikonranta, L; Friman, VP; Laakso, J				Mikonranta, Lauri; Friman, Ville-Petri; Laakso, Jouni			Life History Trade-Offs and Relaxed Selection Can Decrease Bacterial Virulence in Environmental Reservoirs	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; CAMPYLOBACTER-JEJUNI; GALLERIA-MELLONELLA; SHIGA TOXIN; EVOLUTION; SERRATIA; MULTIPLE; HOST; AGGRESSIVENESS; PATHOGENICITY	Pathogen virulence is usually thought to evolve in reciprocal selection with the host. While this might be true for obligate pathogens, the life histories of opportunistic pathogens typically alternate between within-host and outside-host environments during the infection-transmission cycle. As a result, opportunistic pathogens are likely to experience conflicting selection pressures across different environments, and this could affect their virulence through life-history trait correlations. We studied these correlations experimentally by exposing an opportunistic bacterial pathogen Serratia marcescens to its natural protist predator Tetrahymena thermophila for 13 weeks, after which we measured changes in bacterial traits related to both anti-predator defence and virulence. We found that anti-predator adaptation (producing predator-resistant biofilm) caused a correlative attenuation in virulence. Even though the direct mechanism was not found, reduction in virulence was most clearly connected to a predator-driven loss of a red bacterial pigment, prodigiosin. Moreover, life-history trait evolution was more divergent among replicate populations in the absence of predation, leading also to lowered virulence in some of the 'predator absent' selection lines. Together these findings suggest that the virulence of non-obligatory, opportunistic bacterial pathogens can decrease in environmental reservoirs through life history trade-offs, or random accumulation of mutations that impair virulence traits under relaxed selection.	[Mikonranta, Lauri; Friman, Ville-Petri; Laakso, Jouni] Univ Jyvaskyla, Ctr Excellence Biol Interact, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Friman, Ville-Petri; Laakso, Jouni] Univ Helsinki, Dept Biol & Environm Sci, Helsinki, Finland; [Friman, Ville-Petri] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Jyvaskyla; University of Helsinki; University of Oxford	Mikonranta, L (corresponding author), Univ Jyvaskyla, Ctr Excellence Biol Interact, Dept Biol & Environm Sci, Jyvaskyla, Finland.	lauri.mikonranta@jyu.fi	Laakso, Jouni/I-7794-2013	Laakso, Jouni/0000-0001-8245-9912; Friman, Ville-Petri/0000-0002-1592-157X	Finnish Academy [1130724]; Finnish Cultural Foundation [12256]; Marie Curie Intra European Fellowship within the 7th European Community Framework Programme	Finnish Academy(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Marie Curie Intra European Fellowship within the 7th European Community Framework Programme(European Commission)	The study was funded by the Finnish Academy (http://www.aka.fi/en-GB/A/Project #1130724, J.L.), the Finnish Cultural Foundation (http://www.skr.fi/default.asp?docId = 12256 L.M.), and Marie Curie Intra European Fellowship within the 7th European Community Framework Programme (V.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2011, TRENDS MICROBIOL, V19, P24, DOI 10.1016/j.tim.2010.09.005; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Barrett LG, 2011, ECOL LETT, V14, P1149, DOI 10.1111/j.1461-0248.2011.01687.x; Brown SP, 2012, TRENDS MICROBIOL, V20, P336, DOI 10.1016/j.tim.2012.04.005; Brown SP, 2009, EVOL APPL, V2, P32, DOI 10.1111/j.1752-4571.2008.00059.x; Buckling A, 2008, HEREDITY, V100, P484, DOI 10.1038/sj.hdy.6801093; Carson ML, 1998, PLANT DIS, V82, P1043, DOI 10.1094/PDIS.1998.82.9.1043; Casadevall A, 2007, EUKARYOT CELL, V6, P2169, DOI 10.1128/EC.00308-07; Cirillo JD, 1999, INFECT IMMUN, V67, P4427, DOI 10.1128/IAI.67.9.4427-4434.1999; Coulthurst SJ, 2004, MICROBIOL-SGM, V150, P1901, DOI 10.1099/mic.0.26946-0; Deorukhkar AA, 2007, RES MICROBIOL, V158, P399, DOI 10.1016/j.resmic.2007.02.010; Duriez P, 2008, APPL ENVIRON MICROB, V74, P3935, DOI 10.1128/AEM.02710-07; Fenner L, 2006, CRIT CARE MED, V34, P823, DOI 10.1097/01.CCM.0000201878.51343.F1; Fineran PC, 2007, J BACTERIOL, V189, P7653, DOI 10.1128/JB.00671-07; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Friman VP, 2008, P ROY SOC B-BIOL SCI, V275, P1625, DOI 10.1098/rspb.2008.0174; Friman VP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017651; Friman VP, 2011, AM NAT, V177, P334, DOI 10.1086/658364; Friman VP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006761; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; GRIMONT PAD, 1978, ANNU REV MICROBIOL, V32, P221, DOI 10.1146/annurev.mi.32.100178.001253; Hall AR, 2008, J EVOLUTION BIOL, V21, P610, DOI 10.1111/j.1420-9101.2007.01473.x; Harb OS, 2000, ENVIRON MICROBIOL, V2, P251, DOI 10.1046/j.1462-2920.2000.00112.x; Harrison F, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-21; HENRICHSEN J, 1972, BACTERIOL REV, V36, P478, DOI 10.1128/MMBR.36.4.478-503.1972; Hershberg R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r164; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Josenhans C, 2002, INT J MED MICROBIOL, V291, P605, DOI 10.1078/1438-4221-00173; Kannan P, 2009, CURR MICROBIOL, V59, P641, DOI 10.1007/s00284-009-9486-8; Kimura MA, 1985, NEUTRAL THEORY MOL E; KROLL JS, 1988, J BACTERIOL, V170, P859, DOI 10.1128/jb.170.2.859-864.1988; Lahti DC, 2009, TRENDS ECOL EVOL, V24, P487, DOI 10.1016/j.tree.2009.03.010; Lainhart W, 2009, J BACTERIOL, V191, P5116, DOI 10.1128/JB.00508-09; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Lenski RE, 2011, NAT GENET, V43, P1174, DOI 10.1038/ng.1011; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Lipsitch M, 1997, TRENDS MICROBIOL, V5, P31, DOI 10.1016/S0966-842X(97)81772-6; Loriia Zh K, 1977, Mikrobiologiia, V46, P647; Mahlen SD, 2011, CLIN MICROBIOL REV, V24, P755, DOI 10.1128/CMR.00017-11; Malik-Kale P, 2007, APPL ENVIRON MICROB, V73, P3123, DOI 10.1128/AEM.01399-06; Marques JT, 2007, TRENDS GENET, V23, P359, DOI 10.1016/j.tig.2007.04.004; Matsuyama T, 2011, MICROBIOL MONOGR, V20, P93, DOI 10.1007/978-3-642-14490-5_4; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Maynard Smith J, 1989, EVOLUTIONARY PROGR; Steinberg KM, 2007, P ROY SOC B-BIOL SCI, V274, P1921, DOI 10.1098/rspb.2007.0245; Meyer JR, 2007, NATURE, V446, P432, DOI 10.1038/nature05599; Miyata S, 2003, INFECT IMMUN, V71, P2404, DOI 10.1128/IAI.71.5.2404-2413.2003; Montarry J, 2007, FUNCT ECOL, V21, P603, DOI 10.1111/j.1365-2435.2007.01252.x; NEWELL DG, 1985, J HYG-CAMBRIDGE, V94, P45, DOI 10.1017/S0022172400061118; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Racey D, 2010, EVOLUTION, V64, P515, DOI 10.1111/j.1558-5646.2009.00821.x; Rasmussen MA, 2005, INFECT IMMUN, V73, P4668, DOI 10.1128/IAI.73.8.4668-4675.2005; Seed KD, 2008, INFECT IMMUN, V76, P1267, DOI 10.1128/IAI.01249-07; Sturm A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002143; Tan MW, 2002, ANNU REV MICROBIOL, V56, P539, DOI 10.1146/annurev.micro.56.012302.161110; Thelaus J, 2009, FEMS MICROBIOL ECOL, V67, P69, DOI 10.1111/j.1574-6941.2008.00612.x; THOMPSON JN, 1992, NATURE, V360, P121, DOI 10.1038/360121a0; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Vial L, 2010, ISME J, V4, P49, DOI 10.1038/ismej.2009.95	62	35	36	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43801	10.1371/journal.pone.0043801	http://dx.doi.org/10.1371/journal.pone.0043801			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937098	gold, Green Submitted, Green Published			2022-12-25	WOS:000308225500100
J	Nakanishi, A; Kobayashi, N; Suzuki-Hirano, A; Nishihara, H; Sasaki, T; Hirakawa, M; Sumiyama, K; Shimogori, T; Okada, N				Nakanishi, Akiko; Kobayashi, Naoki; Suzuki-Hirano, Asuka; Nishihara, Hidenori; Sasaki, Takeshi; Hirakawa, Mika; Sumiyama, Kenta; Shimogori, Tomomi; Okada, Norihiro			A SINE-Derived Element Constitutes a Unique Modular Enhancer for Mammalian Diencephalic Fgf8	PLOS ONE			English	Article							MOBILE ELEMENTS; GENE-REGULATION; EVOLUTION; EXPRESSION; SEQUENCES; GENOME; OXYTOCIN; SYSTEM; IDENTIFICATION; TELENCEPHALON	Transposable elements, including short interspersed repetitive elements (SINEs), comprise nearly half the mammalian genome. Moreover, they are a major source of conserved non-coding elements (CNEs), which play important functional roles in regulating development-related genes, such as enhancing and silencing, serving for the diversification of morphological and physiological features among species. We previously reported a novel SINE family, AmnSINE1, as part of mammalian-specific CNEs. One AmnSINE1 locus, named AS071, showed an enhancer property in the developing mouse diencephalon. Indeed, AS071 appears to recapitulate the expression of diencephalic fibroblast growth factor 8 (Fgf8). Here we established three independent lines of AS071-transgenic mice and performed detailed expression profiling of AS071-enhanced lacZ in comparison with that of Fgf8 across embryonic stages. We demonstrate that AS071 is a distal enhancer that directs Fgf8 expression in the developing diencephalon. Furthermore, enhancer assays with constructs encoding partially deleted AS071 sequence revealed a unique modular organization in which AS071 contains at least three functionally distinct sub-elements that cooperatively direct the enhancer activity in three diencephalic domains, namely the dorsal midline and the lateral wall of the diencephalon, and the ventral midline of the hypothalamus. Interestingly, the AmnSINE1-derived sub-element was found to specify the enhancer activity to the ventral midline of the hypothalamus. To our knowledge, this is the first discovery of an enhancer element that could be separated into respective sub-elements that determine regional specificity and/or the core enhancing activity. These results potentiate our understanding of the evolution of retroposon-derived cis-regulatory elements as well as the basis for future studies of the molecular mechanism underlying the determination of domain-specificity of an enhancer.	[Nakanishi, Akiko; Kobayashi, Naoki; Nishihara, Hidenori; Sasaki, Takeshi; Okada, Norihiro] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 227, Japan; [Suzuki-Hirano, Asuka; Shimogori, Tomomi] RIKEN Brain Sci Inst, Wako, Saitama, Japan; [Hirakawa, Mika] Kyoto Univ, Bioinformat Ctr, Inst Chem Res, Uji, Kyoto, Japan; [Sumiyama, Kenta] Natl Inst Genet, Mishima, Shizuoka 411, Japan	Tokyo Institute of Technology; RIKEN; Kyoto University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Nakanishi, A (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 227, Japan.	nokada@bio.titech.ac.jp	Sumiyama, Kenta/ABD-5577-2020; Shimogori, Tomomi/L-2893-2013; Sumiyama, Kenta/L-5902-2013; Nishihara, Hidenori/B-9324-2015	Sumiyama, Kenta/0000-0001-8785-5439; Shimogori, Tomomi/0000-0002-6931-5401; Sumiyama, Kenta/0000-0001-8785-5439; Nishihara, Hidenori/0000-0002-5843-9994	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [23123504] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (S) and a Grant-in-Aid for Scientific Research on Innovative Areas "Genetic Bases for the Evolution of Complex Adaptive Traits" from the Ministry of Education, Culture, Sports, Science and Technology of Japan to NO. This work was also supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Neural Diversity and neocortical Organization" from the Ministry of Education, Culture, Sports, Science and Technology of Japan to HN, and Grant-in-Aid for JSPS follows to ASH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beermann F, 2006, GENESIS, V44, P1, DOI 10.1002/gene.20177; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Brooks LR, 2010, ENDOCRINE, V38, P174, DOI 10.1007/s12020-010-9366-9; BROSIUS J, 1992, P NATL ACAD SCI USA, V89, P10706, DOI 10.1073/pnas.89.22.10706; Capdevila J, 2001, ANNU REV CELL DEV BI, V17, P87, DOI 10.1146/annurev.cellbio.17.1.87; Chen JM, 2005, HUM GENET, V117, P411, DOI 10.1007/s00439-005-1321-0; Choleris E, 2009, FRONT NEUROENDOCRIN, V30, P442, DOI 10.1016/j.yfrne.2009.05.003; COLLIN JP, 1989, ARCH HISTOL CYTOL, V52, P441, DOI 10.1679/aohc.52.Suppl_441; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; Crossley PH, 2001, NEUROSCIENCE, V108, P183, DOI 10.1016/S0306-4522(01)00411-0; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; Dermitzakis ET, 2003, SCIENCE, V302, P1033, DOI 10.1126/science.1087047; Echevarria D, 2005, BRAIN RES REV, V49, P150, DOI 10.1016/j.brainresrev.2004.12.035; Falcon J, 2009, ANN NY ACAD SCI, V1163, P101, DOI 10.1111/j.1749-6632.2009.04435.x; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Franchini LF, 2011, P NATL ACAD SCI USA, V108, P15270, DOI 10.1073/pnas.1104997108; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Fukada Y, 2002, MOL NEUROBIOL, V25, P19, DOI 10.1385/MN:25:1:019; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Girard L, 1999, DEV GENET, V25, P291, DOI 10.1002/(SICI)1520-6408(1999)25:4<291::AID-DVG2>3.0.CO;2-5; Grove EA, 1998, DEVELOPMENT, V125, P2315; Hirakawa M, 2009, GENE, V441, P100, DOI 10.1016/j.gene.2008.12.009; Hobert O, 2010, CURR BIOL, V20, pR697, DOI 10.1016/j.cub.2010.07.035; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Inoue F, 2008, DEV BIOL, V316, P471, DOI 10.1016/j.ydbio.2008.01.013; Kataoka A, 2008, DEVELOPMENT, V135, P2873, DOI 10.1242/dev.021618; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Komisarczuk AZ, 2009, DEV BIOL, V336, P301, DOI 10.1016/j.ydbio.2009.09.029; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Ladher RK, 2005, GENE DEV, V19, P603, DOI 10.1101/gad.1273605; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; Martinez S, 1999, DEVELOPMENT, V126, P1189; Martinez-Ferre A, 2009, J NEUROSCI, V29, P13389, DOI 10.1523/JNEUROSCI.2625-09.2009; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Nishihara H, 2006, GENOME RES, V16, P864, DOI 10.1101/gr.5255506; Nishimori K, 1996, P NATL ACAD SCI USA, V93, P11699, DOI 10.1073/pnas.93.21.11699; Okada N, 2010, GENES CELLS, V15, P801, DOI 10.1111/j.1365-2443.2010.01429.x; Pedersen CA, 2006, GENES BRAIN BEHAV, V5, P274, DOI 10.1111/j.1601-183X.2005.00162.x; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Santangelo AM, 2007, PLOS GENET, V3, P1813, DOI 10.1371/journal.pgen.0030166; Sasaki T, 2008, P NATL ACAD SCI USA, V105, P4220, DOI 10.1073/pnas.0709398105; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Shinya M, 2001, DEVELOPMENT, V128, P4153; Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Storm EE, 2003, P NATL ACAD SCI USA, V100, P1757, DOI 10.1073/pnas.0337736100; Suda Y, 2010, DEVELOPMENT, V137, P2939, DOI 10.1242/dev.048843; Suzuki-Hirano A, 2009, SEMIN CELL DEV BIOL, V20, P719, DOI 10.1016/j.semcdb.2009.04.002; Tashiro K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028497; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Tsai PS, 2011, FRONT NEUROENDOCRIN, V32, P95, DOI 10.1016/j.yfrne.2010.11.002; Tsujimura T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001245; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Young KA, 2011, FRONT NEUROENDOCRIN, V32, P53, DOI 10.1016/j.yfrne.2010.07.006	62	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43785	10.1371/journal.pone.0043785	http://dx.doi.org/10.1371/journal.pone.0043785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937095	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500097
J	Nikitina, IY; Kondratuk, NA; Kosmiadi, GA; Amansahedov, RB; Vasilyeva, IA; Ganusov, VV; Lyadova, IV				Nikitina, Irina Yu; Kondratuk, Natalya A.; Kosmiadi, George A.; Amansahedov, Rasul B.; Vasilyeva, Irina A.; Ganusov, Vitaly V.; Lyadova, Irina V.			Mtb-Specific CD27(low) CD4 T Cells as Markers of Lung Tissue Destruction during Pulmonary Tuberculosis in Humans	PLOS ONE			English	Article							IFN-GAMMA; ACTIVE TUBERCULOSIS; CUTTING EDGE; INFECTION; DIAGNOSIS; RESPONSES; ASSAY; ANTIGEN; BLOOD	Background: Effector CD4 T cells represent a key component of the host's anti-tuberculosis immune defense. Successful differentiation and functioning of effector lymphocytes protects the host against severe M. tuberculosis (Mtb) infection. On the other hand, effector T cell differentiation depends on disease severity/activity, as T cell responses are driven by antigenic and inflammatory stimuli released during infection. Thus, tuberculosis (TB) progression and the degree of effector CD4 T cell differentiation are interrelated, but the relationships are complex and not well understood. We have analyzed an association between the degree of Mtb-specific CD4 T cell differentiation and severity/activity of pulmonary TB infection. Methodology/Principal Findings: The degree of CD4 T cell differentiation was assessed by measuring the percentages of highly differentiated CD27(low) cells within a population of Mtb-specific CD4 T lymphocytes ("CD27(low) IFN-gamma(+)" cells). The percentages of CD27(low) IFN-gamma(+) cells were low in healthy donors (median, 33.1%) and TB contacts (21.8%) but increased in TB patients (47.3%, p<0.0005). Within the group of patients, the percentages of CD27(low) IFN-gamma(+) cells were uniformly high in the lungs (>76%), but varied in blood (12-92%). The major correlate for the accumulation of CD27(low) IFN-gamma(+) cells in blood was lung destruction (r = 0.65, p = 2.7x10(-7)). A cutoff of 47% of CD27(low) IFN-gamma(+) cells discriminated patients with high and low degree of lung destruction (sensitivity 89%, specificity 74%); a decline in CD27(low) IFN-gamma(+) cells following TB therapy correlated with repair and/or reduction of lung destruction (p<0.01). Conclusions: Highly differentiated CD27(low) Mtb-specific (CD27(low) IFN-gamma(+)) CD4 T cells accumulate in the lungs and circulate in the blood of patients with active pulmonary TB. Accumulation of CD27(low) IFN-gamma(+) cells in the blood is associated with lung destruction. The findings indicate that there is no deficiency in CD4 T cell differentiation during TB; evaluation of CD27(low) IFN-gamma(+) cells provides a valuable means to assess TB activity, lung destruction, and tissue repair following TB therapy.	[Nikitina, Irina Yu; Kondratuk, Natalya A.; Kosmiadi, George A.; Lyadova, Irina V.] Cent TB Res Inst, Dept Immunol, Moscow, Russia; [Amansahedov, Rasul B.] Cent TB Res Inst, Dept Radiol, Moscow, Russia; [Vasilyeva, Irina A.] Cent TB Res Inst, Dept Phtisiol, Moscow, Russia; [Ganusov, Vitaly V.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Ganusov, Vitaly V.] Natl Inst Math & Biol Synth NIMBioS, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Nikitina, IY (corresponding author), Cent TB Res Inst, Dept Immunol, Moscow, Russia.	ivlyadova@mail.ru	Nikitina, Irina/U-2226-2017; Lyadova, Irina V/T-7806-2017	Nikitina, Irina/0000-0002-9232-5210; Lyadova, Irina V/0000-0003-3147-5386; Ganusov, Vitaly/0000-0001-6572-1691	CTRI RAMS; National Institutes of Health grant [1RO1AI078899]; Russian Foundation for Basic Research grant [10-04-01128]; National Institute for Mathematical and Biological Synthesis [EF-0832858]; University of Tennessee, Knoxville; ISTC grant [4072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078899] Funding Source: NIH RePORTER	CTRI RAMS; National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Foundation for Basic Research grant(Russian Foundation for Basic Research (RFBR)); National Institute for Mathematical and Biological Synthesis; University of Tennessee, Knoxville; ISTC grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by CTRI RAMS; National Institutes of Health grant # 1RO1AI078899 (IL) (www.nih.gov); Russian Foundation for Basic Research grant #10-04-01128 (IL) (www.rfbr.ru); National Institute for Mathematical and Biological Synthesis, award #EF-0832858, with additional support from The University of Tennessee, Knoxville (IN and VG) (www.nimbios.org); and partially by ISTC grant # 4072 (IL) (www.istc.ru). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; Appay V, 2002, J IMMUNOL, V168, P5954, DOI 10.4049/jimmunol.168.11.5954; APT AS, 1993, CLIN EXP IMMUNOL, V94, P322, DOI 10.1111/j.1365-2249.1993.tb03451.x; Baars PA, 2005, EUR J IMMUNOL, V35, P3131, DOI 10.1002/eji.200425770; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; de Bree GJ, 2007, J INFECT DIS, V195, P1718, DOI 10.1086/517612; den Hertog AL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002207; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Efron B., 1994, INTRO BOOTSTRAP; Elkington P, 2011, J CLIN INVEST, V121, P1827, DOI 10.1172/JCI45666; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Fritsch RD, 2005, J IMMUNOL, V175, P6489, DOI 10.4049/jimmunol.175.10.6489; Hamann D, 1999, INT IMMUNOL, V11, P1027, DOI 10.1093/intimm/11.7.1027; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Jasmer RM, 2002, NEW ENGL J MED, V347, P1860, DOI 10.1056/NEJMcp021045; Jiang J, 2010, J CLIN IMMUNOL, V30, P566, DOI 10.1007/s10875-010-9418-1; Kapina MA, 2007, J IMMUNOL, V178, P976, DOI 10.4049/jimmunol.178.2.976; Kaveh DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021566; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; Lyadova IV, 2004, CLIN EXP IMMUNOL, V138, P21, DOI 10.1111/j.1365-2249.2004.02573.x; Marzo AL, 2007, J IMMUNOL, V179, P36, DOI 10.4049/jimmunol.179.1.36; Meier T, 2005, EUR J CLIN MICROBIOL, V24, P529, DOI 10.1007/s10096-005-1377-8; Menzies D, 2008, ANN INTERN MED, V148, P398, DOI 10.7326/0003-4819-148-5-200803040-00011; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; Nolte MA, 2009, IMMUNOL REV, V229, P216, DOI 10.1111/j.1600-065X.2009.00774.x; O'Kane CM, 2010, AM J RESP CELL MOL, V43, P465, DOI 10.1165/rcmb.2009-0211OC; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2010, CURR OPIN PULM MED, V16, P271, DOI 10.1097/MCP.0b013e328338094f; Pinto LM, 2011, MED PRIN PRACT, V21, P4, DOI 10.1159/000331583; Sargentini V, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-99; Schuetz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027284; Streitz M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000735; Streitz M, 2011, J INFECT DIS, V203, P378, DOI 10.1093/infdis/jiq065; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Zikos TA, 2011, CANCER IMMUNOL IMMUN, V60, P819, DOI 10.1007/s00262-011-0996-4	37	43	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43733	10.1371/journal.pone.0043733	http://dx.doi.org/10.1371/journal.pone.0043733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937086	gold, Green Published, Green Submitted			2022-12-25	WOS:000308225500088
J	Siqueira, T; Bini, LM; Roque, FO; Cottenie, K				Siqueira, Tadeu; Bini, Luis M.; Roque, Fabio O.; Cottenie, Karl			A Metacommunity Framework for Enhancing the Effectiveness of Biological Monitoring Strategies	PLOS ONE			English	Article							TAXONOMIC SUFFICIENCY; BIODIVERSITY SURVEYS; COMMUNITY ECOLOGY; INDICATOR GROUPS; AQUATIC INSECTS; SPECIES DATA; CONSERVATION; PATTERNS; NICHE; TRICHOPTERA	Because of inadequate knowledge and funding, the use of biodiversity indicators is often suggested as a way to support management decisions. Consequently, many studies have analyzed the performance of certain groups as indicator taxa. However, in addition to knowing whether certain groups can adequately represent the biodiversity as a whole, we must also know whether they show similar responses to the main structuring processes affecting biodiversity. Here we present an application of the metacommunity framework for evaluating the effectiveness of biodiversity indicators. Although the metacommunity framework has contributed to a better understanding of biodiversity patterns, there is still limited discussion about its implications for conservation and biomonitoring. We evaluated the effectiveness of indicator taxa in representing spatial variation in macroinvertebrate community composition in Atlantic Forest streams, and the processes that drive this variation. We focused on analyzing whether some groups conform to environmental processes and other groups are more influenced by spatial processes, and on how this can help in deciding which indicator group or groups should be used. We showed that a relatively small subset of taxa from the metacommunity would represent 80% of the variation in community composition shown by the entire metacommunity. Moreover, this subset does not have to be composed of predetermined taxonomic groups, but rather can be defined based on random subsets. We also found that some random subsets composed of a small number of genera performed better in responding to major environmental gradients. There were also random subsets that seemed to be affected by spatial processes, which could indicate important historical processes. We were able to integrate in the same theoretical and practical framework, the selection of biodiversity surrogates, indicators of environmental conditions, and more importantly, an explicit integration of environmental and spatial processes into the selection approach.	[Siqueira, Tadeu] Univ Estadual Paulista, UNESP, Dept Ecol, Sao Paulo, Brazil; [Bini, Luis M.] Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil; [Roque, Fabio O.] Univ Fed Mato Grosso do Sul, Dept Biol, Campo Grande, MS, Brazil; [Cottenie, Karl] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	Universidade Estadual Paulista; Universidade Federal de Goias; Universidade Federal de Mato Grosso do Sul; University of Guelph	Siqueira, T (corresponding author), Univ Estadual Paulista, UNESP, Dept Ecol, Sao Paulo, Brazil.	tsiqueira@rc.unesp.br	Bini, Luis Mauricio/D-5865-2013; Siqueira, Tadeu/A-6978-2009; Roque, Fabio/B-5514-2013	Bini, Luis Mauricio/0000-0003-3398-9399; Siqueira, Tadeu/0000-0001-5069-2904; Cottenie, Karl/0000-0001-9498-8483	CNPq [150922/2010-8, 303293/2009-8]; NSERC	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	TS was supported by a CNPq postdoctoral grant (process 150922/2010-8). FOR receives a productivity grant from the CNPq (process 303293/2009-8). KC was supported by a NSERC discovery grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bini LM, 2006, DIVERS DISTRIB, V12, P475, DOI 10.1111/j.1366-9516.2006.00286.x; Bonada N, 2006, ANNU REV ENTOMOL, V51, P495, DOI 10.1146/annurev.ento.51.110104.151124; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brown J. H., 1998, BIOGEOGRAPHY; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Economo EP, 2011, AM NAT, V177, pE167, DOI 10.1086/659946; Feld CK, 2009, OIKOS, V118, P1862, DOI 10.1111/j.1600-0706.2009.17860.x; Fleishman E, 2009, CONSERV BIOL, V23, P1109, DOI 10.1111/j.1523-1739.2009.01246.x; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gilbert B, 2010, J APPL ECOL, V47, P1071, DOI 10.1111/j.1365-2664.2010.01861.x; Griffith DA, 2006, ECOLOGY, V87, P2603, DOI 10.1890/0012-9658(2006)87[2603:SMIETF]2.0.CO;2; Halley JM, 2011, P NATL ACAD SCI USA, V108, P2316, DOI 10.1073/pnas.1011217108; Heino J, 2008, LANDSCAPE ECOL, V23, P417, DOI 10.1007/s10980-008-9199-6; Heino Jani, 2009, Freshwater Reviews, V2, P1, DOI 10.1608/FRJ-2.1.1; Hering D, 2009, AQUAT SCI, V71, P3, DOI 10.1007/s00027-009-9159-5; Hitt NP, 2011, J N AM BENTHOL SOC, V30, P296, DOI 10.1899/09-155.1; Holzenthal RW, 2007, ZOOTAXA, P639; Howard PC, 1998, NATURE, V394, P472, DOI 10.1038/28843; Hubbell Stephen P., 2001, V32, pi; JACKSON DA, 1995, ECOSCIENCE, V2, P297, DOI 10.1080/11956860.1995.11682297; Johnson RK, 2006, HYDROBIOLOGIA, V566, P115, DOI 10.1007/s10750-006-0101-8; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Landeiro VL, 2012, ECOL INDIC, V23, P366, DOI 10.1016/j.ecolind.2012.04.023; Larsen FW, 2009, DIVERS DISTRIB, V15, P70, DOI 10.1111/j.1472-4642.2008.00507.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; Lindenmayer DB, 2009, TRENDS ECOL EVOL, V24, P482, DOI 10.1016/j.tree.2009.03.005; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; Lopes PM, 2011, ECOL INDIC, V11, P1171, DOI 10.1016/j.ecolind.2010.12.017; Loyola RD, 2007, DIVERS DISTRIB, V13, P389, DOI 10.1111/j.1472-4642.2007.00345.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McGeoch MA, 1998, BIOL REV, V73, P181, DOI 10.1017/S000632319700515X; Melo AS, 2005, ARCH HYDROBIOL, V164, P309, DOI 10.1127/0003-9136/2005/0164-0309; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Ng ISY, 2009, HYDROBIOLOGIA, V619, P133, DOI 10.1007/s10750-008-9605-8; Pawar SS, 2007, DIVERS DISTRIB, V13, P53, DOI 10.1111/j.1472-4642.2006.00298.x; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Pressey RL, 2004, CONSERV BIOL, V18, P1677, DOI 10.1111/j.1523-1739.2004.00434.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rabeni CF, 2001, ENVIRON MONIT ASSESS, V71, P177, DOI 10.1023/A:1017523115381; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Roque FO, 2010, FRESHWATER BIOL, V55, P847, DOI 10.1111/j.1365-2427.2009.02314.x; Rosenberg D.M.., 1993, FRESHWATER BIOMONITO; Siqueira T, 2008, AUSTRAL ECOL, V33, P902, DOI 10.1111/j.1442-9993.2008.01885.x; Siqueira T, 2012, ECOGRAPHY, V35, P183, DOI 10.1111/j.1600-0587.2011.06875.x; Siqueira T, 2009, HYDROBIOLOGIA, V636, P163, DOI 10.1007/s10750-009-9945-z; Smith TW, 2010, ECOGRAPHY, V33, P648, DOI 10.1111/j.1600-0587.2009.06105.x; Statzner B, 2011, INT REV HYDROBIOL, V96, P121, DOI 10.1002/iroh.201111325; Su JC, 2004, CONSERV BIOL, V18, P167, DOI 10.1111/j.1523-1739.2004.00337.x; Suriano MT, 2011, ENVIRON MONIT ASSESS, V175, P87, DOI 10.1007/s10661-010-1495-3; Terlizzi A, 2003, MAR POLLUT BULL, V46, P556, DOI 10.1016/S0025-326X(03)00066-3; Tognelli MF, 2005, BIOL CONSERV, V121, P409, DOI 10.1016/j.biocon.2004.05.013; Vellend M, 2008, J APPL ECOL, V45, P161, DOI 10.1111/j.1365-2664.2007.01413.x; Vinson MR, 1998, ANNU REV ENTOMOL, V43, P271, DOI 10.1146/annurev.ento.43.1.271; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Winegardner AK, 2012, TRENDS ECOL EVOL, V27, P253, DOI 10.1016/j.tree.2012.01.007	62	62	64	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43626	10.1371/journal.pone.0043626	http://dx.doi.org/10.1371/journal.pone.0043626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937068	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500069
J	Caballo, C; Palomo, M; Cases, A; Galan, AM; Molina, P; Vera, M; Bosch, X; Escolar, G; Diaz-Ricart, M				Caballo, Carolina; Palomo, Marta; Cases, Aleix; Galan, Ana M.; Molina, Patricia; Vera, Manel; Bosch, Xavier; Escolar, Gines; Diaz-Ricart, Maribel			NF kappa B in the Development of Endothelial Activation and Damage in Uremia: An In Vitro Approach	PLOS ONE			English	Article							GLUCOSE DEGRADATION-PRODUCTS; PERITONEAL-DIALYSIS; CARDIOVASCULAR-DISEASE; HEMODIALYSIS-PATIENTS; DEPENDENT VASODILATION; ADHESION MOLECULES; RENAL-FAILURE; CELLS; DYSFUNCTION; EXPRESSION	Impaired hemostasis coexists with accelerated atherosclerosis in patients with chronic kidney disease (CKD). The elevated frequency of atherothrombotic events has been associated with endothelial dysfunction. The relative contribution of the uremic state and the impact of the renal replacement therapies have been often disregarded. Plasma markers of endothelial activation and damage were evaluated in three groups of patients with CKD: under conservative treatment (predialysis), on hemodialysis, and on peritoneal dialysis. Activation of p38 MAPK and the transcription factor NFkB was assessed in endothelial cell (EC) cultures exposed to pooled sera from each group of patients. Most of the markers evaluated (VCAM-1, ICAM-1, VWF, circulating endothelial cells) were significantly higher in CDK patients than in controls, being significantly more increased in the group of peritoneal dialysis patients. These results correlated with the activation of both p38 MAPK and NFkB in EC cells exposed to the same sera samples, and also to the peritoneal dialysis fluids. Hemodialysis did not further contribute to the endothelial damage induced by the uremic state observed in predialysis patients, probably due to the improved biocompatibility of the hemodialysis technique in recent years, resulting in lower cellular activation. However, peritoneal dialysis seemed to exert a significant proinflammatory effect on the endothelium that could be related to the high glucose concentrations and glucose degradation products present in the dialysis fluid. Although peritoneal dialysis has been traditionally considered a more physiological technique, our results raise some doubts with respect to inflammation and EC damage.	[Caballo, Carolina; Palomo, Marta; Galan, Ana M.; Molina, Patricia; Escolar, Gines; Diaz-Ricart, Maribel] Univ Barcelona, Hemotherapy Hemostasis Dept, Ctr Diagnost Biomed, Inst Invest Biomed August Pi & Sunyer,Hosp Clin, Barcelona, Spain; [Cases, Aleix; Vera, Manel] Univ Barcelona, Dept Nephrol, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Bosch, Xavier] Univ Barcelona, Dept Cardiol, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Caballo, C (corresponding author), Univ Barcelona, Hemotherapy Hemostasis Dept, Ctr Diagnost Biomed, Inst Invest Biomed August Pi & Sunyer,Hosp Clin, Barcelona, Spain.	mdiaz@clinic.ub.es	vera, manel/AAC-7133-2021; Escolar, Gines/I-1530-2015; Palomo, Marta/AAY-5510-2021; Albaladejo, Gines Escolar/AAC-9695-2020; Escolar, Gines/ABF-9003-2021; Bosch, Xavier/E-7890-2014; Palomo, Marta/AAY-4484-2021; Cases, Aleix/N-4736-2018	Escolar, Gines/0000-0002-6658-0381; Albaladejo, Gines Escolar/0000-0002-6658-0381; Bosch, Xavier/0000-0002-0133-1587; Palomo, Marta/0000-0002-3261-6577; Cases, Aleix/0000-0002-6962-8184; DIAZ-RICART, MARIBEL/0000-0003-1122-0052; VERA, MANEL/0000-0001-9937-7235	Ministerio de Economia y Competitividad [SAF2011-28214, SAF 2009-10365]; Fondo de Investigaciones de la Seguridad Social [PI08/0156, CP04-00112, PS09/00664]; German Jose Carreras Leukaemia Foundation [R 07/41v]; Red HERACLES, Instituto de Salud Carlos III [RD06/0009/1003]	Ministerio de Economia y Competitividad(Spanish Government); Fondo de Investigaciones de la Seguridad Social; German Jose Carreras Leukaemia Foundation; Red HERACLES, Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work has been partially supported by grants: SAF2011-28214, SAF 2009-10365 (Ministerio de Economia y Competitividad); PI08/0156, CP04-00112, PS09/00664 (Fondo de Investigaciones de la Seguridad Social); German Jose Carreras Leukaemia Foundation (R 07/41v); and RD06/0009/1003 (Red HERACLES, Instituto de Salud Carlos III). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AznarSalatti J, 1995, NEPHROL DIAL TRANSPL, V10, P2199, DOI 10.1093/ndt/10.12.2199; Blann A, 2009, HAEMATOLOGICA, V94, P149; Blann AD, 2005, THROMB HAEMOSTASIS, V93, P228, DOI 10.1160/TH04-09-0578; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carbo C, 2008, AM J KIDNEY DIS, V51, P603, DOI 10.1053/j.ajkd.2007.11.029; Cheng LT, 2008, PERITON DIALYSIS INT, V28, P397; Cines DB, 1998, BLOOD, V91, P3527; Constans J, 2006, CLIN CHIM ACTA, V368, P33, DOI 10.1016/j.cca.2005.12.030; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Di Angelantonio E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4986; EBERST ME, 1994, AM J MED, V96, P168, DOI 10.1016/0002-9343(94)90138-4; Gordge M P, 1991, Platelets, V2, P115, DOI 10.3109/09537109109006021; GRIS JC, 1994, KIDNEY INT, V46, P807, DOI 10.1038/ki.1994.336; HERBELIN A, 1991, KIDNEY INT, V39, P954, DOI 10.1038/ki.1991.120; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Johnson DW, 2009, CLIN J AM SOC NEPHRO, V4, P1620, DOI 10.2215/CJN.01750309; Koc M, 2005, KIDNEY INT, V67, P1078, DOI 10.1111/j.1523-1755.2005.00173.x; Koc M, 2003, AM J KIDNEY DIS, V42, P704, DOI 10.1016/S0272-6386(03)00906-5; Kokame K, 2005, BRIT J HAEMATOL, V129, P93, DOI 10.1111/j.1365-2141.2005.05420.x; Konings CJAM, 2002, PERITON DIALYSIS INT, V22, P477; KOYAMA H, 1989, LANCET, V1, P991; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Levey AS, 1999, NEPHROL DIAL TRANSPL, V14, P828, DOI 10.1093/ndt/14.4.828; LINDNER A, 1974, NEW ENGL J MED, V290, P697, DOI 10.1056/NEJM197403282901301; Merino A, 2010, CLIN J AM SOC NEPHRO, V5, P227, DOI 10.2215/CJN.03260509; Morgan LW, 2003, KIDNEY INT, V64, P1854, DOI 10.1046/j.1523-1755.2003.00265.x; Muller-Krebs S, 2008, EUR J CLIN INVEST, V38, P296, DOI 10.1111/j.1365-2362.2008.01945.x; Nordfors L, 2000, KIDNEY INT, V57, P1713, DOI 10.1046/j.1523-1755.2000.00016.x; Passauer J, 2000, J AM SOC NEPHROL, V11, P1726, DOI 10.1681/ASN.V1191726; Passlick-Deetjen J, 2001, SEMIN DIALYSIS, V14, P384, DOI 10.1046/j.1525-139X.2001.00100.x; Pecoits-Filho R, 2004, PERITON DIALYSIS INT, V24, P327; PERTOSA G, 1993, KIDNEY INT, V43, pS149; Price DT, 1999, AM J MED, V107, P85, DOI 10.1016/S0002-9343(99)00153-9; Ringoir S, 1997, KIDNEY INT, V52, pS2; Serradell M, 2003, NEPHROL DIAL TRANSPL, V18, P1079, DOI 10.1093/ndt/gfg161; Serradell M, 2002, HAEMATOLOGICA, V87, P1053; Serradell M, 2001, THROMB HAEMOSTASIS, V86, P1099; Sung B, 2010, CANCER RES, V70, P3259, DOI 10.1158/0008-5472.CAN-09-4230; U.S. Renal Data System (USRDS), 2011, USRDS 2011 ANN DAT R; vanGuldener C, 1997, NEPHROL DIAL TRANSPL, V12, P14; Versteeg HH, 2000, BIOCHEM J, V350, P717, DOI 10.1042/0264-6021:3500717; Witowski J, 2000, J AM SOC NEPHROL, V11, P729, DOI 10.1681/ASN.V114729; Zemel D, 1996, BLOOD PURIFICAT, V14, P198, DOI 10.1159/000170263; Zimmermann J, 1999, KIDNEY INT, V55, P648, DOI 10.1046/j.1523-1755.1999.00273.x	45	33	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43374	10.1371/journal.pone.0043374	http://dx.doi.org/10.1371/journal.pone.0043374			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937042	gold, Green Published, Green Submitted			2022-12-25	WOS:000308286300046
J	Drechsler, J; Grotzinger, J; Hermanns, HM				Drechsler, Johannes; Groetzinger, Joachim; Hermanns, Heike M.			Characterization of the Rat Oncostatin M Receptor Complex Which Resembles the Human, but Differs from the Murine Cytokine Receptor	PLOS ONE			English	Article							LEUKEMIA-INHIBITORY FACTOR; CILIARY NEUROTROPHIC FACTOR; T-CELL DEVELOPMENT; SWISS-MODEL; FETAL LIVER; INTERLEUKIN-6-TYPE CYTOKINES; RHEUMATOID-ARTHRITIS; SIGNAL-TRANSDUCTION; GROWTH-REGULATOR; IN-VITRO	Evaluation of a pathophysiological role of the interleukin-6-type cytokine oncostatin M (OSM) for human diseases has been complicated by the fact that mouse models of diseases targeting either OSM or the OSM receptor (OSMR) complex cannot fully reflect the human situation. This is due to earlier findings that human OSM utilizes two receptor complexes, glycoprotein 130 (gp130)/leukemia inhibitory factor receptor (LIFR) (type I) and gp130/OSMR (type II), both with wide expression profiles. Murine OSM on the other hand only binds to the gp130/OSMR (type II) receptor complex with high affinity. Here, we characterize the receptor usage for rat OSM. Using different experimental approaches (knock-down of the OSMR expression by RNA interference, blocking of the LIFR by LIF-05, an antagonistic LIF variant and stably transfected Ba/F3 cells) we can clearly show that rat OSM surprisingly utilizes both, the type I and type II receptor complex, therefore mimicking the human situation. Furthermore, it displays cross-species activities and stimulates cells of human as well as murine origin. Its signaling capacities closely mimic those of human OSM in cell types of different origin in the way that strong activation of the Jak/STAT, the MAP kinase as well as the PI3K/Akt pathways can be observed. Therefore, rat disease models would allow evaluation of the relevance of OSM for human biology.	[Drechsler, Johannes; Hermanns, Heike M.] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, Wurzburg, Germany; [Groetzinger, Joachim] Univ Kiel, Inst Biochem, D-2300 Kiel, Germany	German Research Foundation (DFG); University of Wurzburg; University of Kiel	Drechsler, J (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, Wurzburg, Germany.	Heike.Hermanns@virchow.uni-wuerzburg.de			Deutsche Forschungsgemeinschaft (DFG) [FZ82]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, FZ82) to H. M. H. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albasanz-Puig A, 2011, ATHEROSCLEROSIS, V216, P292, DOI 10.1016/j.atherosclerosis.2011.02.003; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Boileau C, 2000, J IMMUNOL, V164, P5713, DOI 10.4049/jimmunol.164.11.5713; Bonifati C, 1998, ARCH DERMATOL RES, V290, P9, DOI 10.1007/s004030050269; BROWN TJ, 1987, J IMMUNOL, V139, P2977; Broxmeyer HE, 2002, IMMUNITY, V16, P815, DOI 10.1016/S1074-7613(02)00319-9; Clahsen T, 2005, CELL SIGNAL, V17, P559, DOI 10.1016/j.cellsig.2004.09.016; Clegg CH, 1996, NATURE, V384, P261, DOI 10.1038/384261a0; Deller MC, 2000, STRUCT FOLD DES, V8, P863, DOI 10.1016/S0969-2126(00)00176-3; Dreuw A, 2005, J INVEST DERMATOL, V124, P28, DOI 10.1111/j.0022-202X.2004.23499.x; Gazel A, 2006, J INVEST DERMATOL, V126, P2647, DOI 10.1038/sj.jid.5700461; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; Grenier A, 2001, LAB INVEST, V81, P133, DOI 10.1038/labinvest.3780220; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haan C, 2011, CHEM BIOL, V18, P314, DOI 10.1016/j.chembiol.2011.01.012; Hara Takahiko, 1997, Leukemia (Basingstoke), V11, P449; Hermanns HM, 2000, J BIOL CHEM, V275, P40742, DOI 10.1074/jbc.M005408200; Hintzen C, 2008, J IMMUNOL, V181, P7341, DOI 10.4049/jimmunol.181.10.7341; Hintzen C, 2009, ARTHRITIS RHEUM-US, V60, P1932, DOI 10.1002/art.24602; Hohensinner PJ, 2009, FASEB J, V23, P774, DOI 10.1096/fj.08-108035; Hui W, 1997, ANN RHEUM DIS, V56, P184, DOI 10.1136/ard.56.3.184; JEFFERY E, 1993, CYTOKINE, V5, P107, DOI 10.1016/1043-4666(93)90048-A; Juan TSC, 2009, VET PATHOL, V46, P124, DOI 10.1354/vp.46-1-124; Kallen KJ, 1999, J BIOL CHEM, V274, P11859, DOI 10.1074/jbc.274.17.11859; Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127; Kinoshita T, 1999, P NATL ACAD SCI USA, V96, P7265, DOI 10.1073/pnas.96.13.7265; Kinoshita T, 2001, EXP HEMATOL, V29, P1091, DOI 10.1016/S0301-472X(01)00686-5; Kubin T, 2011, CELL STEM CELL, V9, P420, DOI 10.1016/j.stem.2011.08.013; Langdon C, 2000, AM J PATHOL, V157, P1187, DOI 10.1016/S0002-9440(10)64634-2; Langdon C, 2003, J IMMUNOL, V170, P548, DOI 10.4049/jimmunol.170.1.548; Lee MJ, 2007, INT J BIOCHEM CELL B, V39, P650, DOI 10.1016/j.biocel.2006.11.003; Lehmann U, 2003, J BIOL CHEM, V278, P661, DOI 10.1074/jbc.M210552200; Lindberg RA, 1998, MOL CELL BIOL, V18, P3357, DOI 10.1128/MCB.18.6.3357; LINSLEY PS, 1990, MOL CELL BIOL, V10, P1882, DOI 10.1128/MCB.10.5.1882; MALIK N, 1989, MOL CELL BIOL, V9, P2847, DOI 10.1128/MCB.9.7.2847; MALIK N, 1995, MOL CELL BIOL, V15, P2349; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; Nakamura K, 2004, HEPATOLOGY, V39, P635, DOI 10.1002/hep.20086; Okaya A, 2005, AM J PATHOL, V166, P709, DOI 10.1016/S0002-9440(10)62292-4; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plater-Zyberk C, 2001, ARTHRITIS RHEUM, V44, P2697, DOI 10.1002/1529-0131(200111)44:11<2697::AID-ART450>3.0.CO;2-#; ROSE TM, 1991, P NATL ACAD SCI USA, V88, P8641, DOI 10.1073/pnas.88.19.8641; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Suda T, 2002, CYTOKINE, V17, P335, DOI 10.1006/cyto.2002.1023; Tanaka M, 2003, BLOOD, V102, P3154, DOI 10.1182/blood-2003-02-0367; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Vasse M, 1999, ARTERIOSCL THROM VAS, V19, P1835, DOI 10.1161/01.ATV.19.8.1835; Vernallis AB, 1997, J BIOL CHEM, V272, P26947, DOI 10.1074/jbc.272.43.26947; Wallace PM, 1999, J IMMUNOL, V162, P5547; Yao LB, 1996, J EXP MED, V184, P81, DOI 10.1084/jem.184.1.81; ZARLING JM, 1986, P NATL ACAD SCI USA, V83, P9739, DOI 10.1073/pnas.83.24.9739	51	23	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43155	10.1371/journal.pone.0043155	http://dx.doi.org/10.1371/journal.pone.0043155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937020	Green Published, Green Submitted, gold			2022-12-25	WOS:000308286300035
J	Gujral, TS; Karp, RL; Finski, A; Chan, M; Schwartz, PE; MacBeath, G; Sorger, P				Gujral, T. S.; Karp, R. L.; Finski, A.; Chan, M.; Schwartz, P. E.; MacBeath, G.; Sorger, P.			Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays	ONCOGENE			English	Article						reverse-phase protein arrays; breast cancer; tumor lysate; cell signaling; MET; AXL	C-MET; HGF TRANSCRIPTION; AXL; RECEPTOR; PATHWAYS; METASTASIS; RESISTANCE; DISCOVERY; SURVIVAL; KINASE	Measuring the states of cell signaling pathways in tumor samples promises to advance the understanding of oncogenesis and identify response biomarkers. Here, we describe the use of Reverse Phase Protein Arrays (RPPAs or RPLAs) to profile signaling proteins in 56 breast cancers and matched normal tissue. In RPPAs, hundreds to thousands of lysates are arrayed in dense regular grids and each grid is probed with a different antibody (100 in the current work, of which 71 yielded strong signals with breast tissue). Although RPPA technology is quite widely used, measuring changes in phosphorylation reflective of protein activation remains challenging. Using repeat deposition and well-validated antibodies, we show that diverse patterns of phosphorylation can be monitored in tumor samples and changes mapped onto signaling networks in a coherent fashion. The patterns are consistent with biomarker-based classification of breast cancers and known mechanisms of oncogenesis. We explore in detail one tumor-associated pattern that involves changes in the abundance of the Axl receptor tyrosine kinase (RTK) and phosphorylation of the cMet RTK. Both cMet and Axl have been implicated in breast cancer, or in resistance to anticancer drugs, but the two RTKs are not known to be linked functionally. Protein depletion and overexpression studies in a 'triple-negative' breast cell line reveal cross talk between Axl and cMet involving Axl-mediated modification of cMet, a requirement for cMet in efficient and timely signal transduction by the Axl ligand Gas6 and the potential for the two receptors to interact physically. These findings have potential therapeutic implications, as they imply that bi-specific receptor inhibitors (for example, ATP-competitive small-kinase inhibitors such as GSK1363089, BMS-777607 or MP470) may be more efficacious than the mono-specific therapeutic antibodies currently in development (for example, Onartuzumab).	[Gujral, T. S.; Karp, R. L.; Finski, A.; Chan, M.; MacBeath, G.; Sorger, P.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Gujral, T. S.; MacBeath, G.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Finski, A.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Schwartz, P. E.] Prot Biotechnol Inc, Ramona, CA USA	Harvard University; Harvard Medical School; Harvard University; Harvard University	MacBeath, G (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, WAB 438,200 Longwood Ave, Boston, MA 02115 USA.	gavin_macbeath@hms.harvard.edu; peter_sorger@hms.harvard.edu		Sorger, Peter/0000-0002-3364-1838; Gujral, Taran/0000-0002-4453-3031	National Institutes of Health [R33 CA128726, R21 CA126720, 5RC1-HG005354]; Stand Up to Cancer Project [AACR-SU2C-DT0409]; NSF [0856285]; NATIONAL CANCER INSTITUTE [R21CA126720, R33CA128726] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC1HG005354] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stand Up to Cancer Project; NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by grants from the National Institutes of Health (R33 CA128726, R21 CA126720, and 5RC1-HG005354) and from the Stand Up to Cancer Project (AACR-SU2C-DT0409). TSG is a Human Frontier Science Program Fellow. RLK is partially supported by NSF 0856285. Supplementary Information accompanies the paper on the Oncogene website.	Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Bowers PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r35; Burstein HJ, 2003, J CLIN ONCOL, V21, P2889, DOI 10.1200/JCO.2003.02.018; Carey MS, 2010, CLIN CANCER RES, V16, P2852, DOI 10.1158/1078-0432.CCR-09-2502; Demarchi F, 2001, J BIOL CHEM, V276, P31738, DOI 10.1074/jbc.M104457200; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Gonzalez-Angulo Ana M, 2011, Clin Proteomics, V8, P11, DOI 10.1186/1559-0275-8-11; Grubb RL, 2003, PROTEOMICS, V3, P2142, DOI 10.1002/pmic.200300598; Hafizi S, 2006, CYTOKINE GROWTH F R, V17, P295, DOI 10.1016/j.cytogfr.2006.04.004; Hennessy Bryan T, 2010, Clin Proteomics, V6, P129, DOI 10.1007/s12014-010-9055-y; Herrero J, 2001, BIOINFORMATICS, V17, P126, DOI 10.1093/bioinformatics/17.2.126; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; ISOLA JJ, 1993, J PATHOL, V170, P31, DOI 10.1002/path.1711700106; Janes KA, 2008, CELL, V135, P343, DOI 10.1016/j.cell.2008.08.034; Jiang RC, 2006, PROTEOMICS, V6, P2964, DOI 10.1002/pmic.200500555; Kataoka Y, 2012, INVEST NEW DRUG, V30, P1352, DOI 10.1007/s10637-011-9699-0; Kolch W, 2010, NAT REV CANCER, V10, P618, DOI 10.1038/nrc2900; Lengyel E, 2005, INT J CANCER, V113, P678, DOI 10.1002/ijc.20598; Lim CT, 2007, BIOSENS BIOELECTRON, V22, P1197, DOI 10.1016/j.bios.2006.06.005; Lin Y, 2003, CLIN CHEM LAB MED, V41, P139, DOI 10.1515/CCLM.2003.023; Liu GG, 2010, ADV EXP MED BIOL, V680, P253, DOI 10.1007/978-1-4419-5913-3_29; Luckert K, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002372; Mackiewicz M, 2011, BREAST CANCER RES TR, V130, P663, DOI 10.1007/s10549-011-1690-0; Mahadevan D, 2007, ONCOGENE, V26, P3909, DOI 10.1038/sj.onc.1210173; Makretsov NA, 2004, CLIN CANCER RES, V10, P6143, DOI 10.1158/1078-0432.CCR-04-0429; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Menashe I, 2010, CANCER RES, V70, P4453, DOI 10.1158/0008-5472.CAN-09-4502; Mood K, 2006, MOL BIOL CELL, V17, P3717, DOI 10.1091/mbc.E06-03-0244; Morgillo F, 2006, CANCER RES, V66, P10100, DOI 10.1158/0008-5472.CAN-06-1684; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Nanjundan M, 2010, J THORAC ONCOL, V5, P1894, DOI 10.1097/JTO.0b013e3181f2a266; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Pe'er D, 2011, CELL, V144, P864, DOI 10.1016/j.cell.2011.03.001; Previdi S, 2012, MOL CANCER THER, V11, P214, DOI 10.1158/1535-7163.MCT-11-0277; Sam MR, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-69; Sevecka M, 2006, NAT METHODS, V3, P825, DOI 10.1038/nmeth931; Sevecka M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005363; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spruessel A, 2004, BIOTECHNIQUES, V36, P1030, DOI 10.2144/04366RR04; Storey John D, 2003, Methods Mol Biol, V224, P149; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Underiner TL, 2010, ANTI-CANCER AGENT ME, V10, P7, DOI 10.2174/1871520611009010007; VanMeter A, 2007, EXPERT REV MOL DIAGN, V7, P625, DOI 10.1586/14737159.7.5.625; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Wojcik EJ, 2006, ONCOGENE, V25, P2773, DOI 10.1038/sj.onc.1209306; Yeh CY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-139; Zhang YX, 2008, CANCER RES, V68, P1905, DOI 10.1158/0008-5472.CAN-07-2661	54	54	56	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 18	2013	32	29					3470	3476		10.1038/onc.2012.378	http://dx.doi.org/10.1038/onc.2012.378			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	186AZ	22945653	Green Accepted			2022-12-25	WOS:000322014900008
J	Seritrakul, P; Samarut, E; Lama, TTS; Gibert, Y; Laudet, V; Jackman, WR				Seritrakul, Pawat; Samarut, Eric; Lama, Tenzing T. S.; Gibert, Yann; Laudet, Vincent; Jackman, William R.			Retinoic acid expands the evolutionarily reduced dentition of zebrafish	FASEB JOURNAL			English	Article						teeth; neural crest cells; retinaldehyde dehydrogenase	MEDAKA ORYZIAS-LATIPES; CRANIAL NEURAL CREST; HOX GENES; TOOTH DEVELOPMENT; EMBRYONIC-DEVELOPMENT; PHARYNGEAL DENTITION; DOLLOS LAW; DLX GENES; IN-VIVO; EXPRESSION	Zebrafish lost anterior teeth during evolution but retain a posterior pharyngeal dentition that requires retinoic acid (RA) cell-cell signaling for its development. The purposes of this study were to test the sufficiency of RA to induce tooth development and to assess its role in evolution. We found that exposure of embryos to exogenous RA induces a dramatic anterior expansion of the number of pharyngeal teeth that later form and shifts anteriorly the expression patterns of genes normally expressed in the posterior tooth-forming region, such as pitx2 and dlx2b. After RA exposure, we also observed a correlation between cartilage malformations and ectopic tooth induction, as well as abnormal cranial neural crest marker gene expression. Additionally, we observed that the RA-induced zebrafish anterior teeth resemble in pattern and number the dentition of fish species that retain anterior pharyngeal teeth such as medaka but that medaka do not express the aldh1a2 RA-synthesizing enzyme in tooth-forming regions. We conclude that RA is sufficient to induce anterior ectopic tooth development in zebrafish where teeth were lost in evolution, potentially by altering neural crest cell development, and that changes in the location of RA synthesis correlate with evolutionary changes in vertebrate dentitions.-Seritrakul, P., Samarut, E., Lama, T. T. S., Gibert, Y., Laudet, V., Jackman, W. R. Retinoic acid expands the evolutionarily reduced dentition of zebrafish. FASEB J. 26, 5014-5024 (2012). www.fasebj.org	[Seritrakul, Pawat; Lama, Tenzing T. S.; Jackman, William R.] Bowdoin Coll, Dept Biol, Brunswick, ME 04011 USA; [Samarut, Eric; Laudet, Vincent] Univ Lyon 1, Ctr Natl Rech Sci, Ecole Normale Super Lyon, Inst Natl Rech Agron,Inst Genom Fonct Lyon,Mol Zo, F-69365 Lyon, France; [Gibert, Yann] Deakin Univ, Sch Med, Waurn Ponds, Vic, Australia	Bowdoin College; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Deakin University	Jackman, WR (corresponding author), Bowdoin Coll, Dept Biol, 6500 Coll Stn, Brunswick, ME 04011 USA.	wjackman@bowdoin.edu		SAMARUT, ERIC/0000-0001-7818-2009; Seritrakul, Pawat/0000-0002-8320-6789	U.S. National Institutes of Health [5P20-RR-016463-12, 8P20-GM-103423-12]; Agence Nationale de la Recherche [ANR-09-BLAN-0127-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103423] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de la Recherche(French National Research Agency (ANR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are very grateful to Kristin Artinger (University of Colorado, Aurora, CO, USA) for sharing ideas, pre-publication data, and reagents; Vicki Prince (University of Chicago, Chicago, IL, USA) and Paul Henion (Ohio State University, Columbus, OH, USA) for reagents; and Mike Palopoli, Andrea Jowdry, and David Rivers for helpful suggestions. This work was supported by U.S. National Institutes of Health grants 5P20-RR-016463-12 and 8P20-GM-103423-12 (to W.R.J.) and Agence Nationale de la Recherche grant ANR-09-BLAN-0127-01 (to V.L.).	AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Alexandre D, 1996, DEVELOPMENT, V122, P735; Allan D, 2001, DEV BIOL, V240, P46, DOI 10.1006/dbio.2001.0455; Baker CVH, 1997, MECH DEVELOP, V69, P13, DOI 10.1016/S0925-4773(97)00129-9; Begemann G, 2001, DEVELOPMENT, V128, P3081; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Birkholz DA, 2009, DEV DYNAM, V238, P2575, DOI 10.1002/dvdy.22090; Bohnsack BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022991; Britz R, 2009, P ROY SOC B-BIOL SCI, V276, P2179, DOI 10.1098/rspb.2009.0141; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chiang EFL, 2001, DEV BIOL, V231, P149, DOI 10.1006/dbio.2000.0129; Crump JG, 2004, DEVELOPMENT, V131, P5703, DOI 10.1242/dev.01444; DEBEER GR, 1947, PROC R SOC SER B-BIO, V134, P377; Debiais-Thibaud M, 2007, J EXP ZOOL PART B, V308B, P693, DOI 10.1002/jez.b.21183; Dollo L., 1893, B SOC BELG GEOL, V7, P164; Dorsky RI, 1999, MECH DEVELOP, V86, P147, DOI 10.1016/S0925-4773(99)00101-X; Ellies DL, 1997, MECH DEVELOP, V61, P23, DOI 10.1016/S0925-4773(96)00616-8; Feng L, 2010, DEV BIOL, V338, P1, DOI 10.1016/j.ydbio.2009.10.029; Galis F, 2010, EVOLUTION, V64, P2466, DOI 10.1111/j.1558-5646.2010.01041.x; Gibert Y, 2010, FASEB J, V24, P3298, DOI 10.1096/fj.09-147488; Goldberg EE, 2008, EVOLUTION, V62, P2727, DOI 10.1111/j.1558-5646.2008.00505.x; Gordon CT, 2010, EVOL DEV, V12, P459, DOI 10.1111/j.1525-142X.2010.00432.x; GOSLINE WA, 1973, COPEIA, P761; Grande L, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011114; Hernandez-Lagunas L, 2005, DEV BIOL, V278, P347, DOI 10.1016/j.ydbio.2004.11.014; Houle M, 2003, DEVELOPMENT, V130, P6555, DOI 10.1242/dev.00889; Hunter MP, 2002, DEV BIOL, V247, P367, DOI 10.1006/dbio.2002.0701; Huysseune A, 1998, ANAT EMBRYOL, V198, P289, DOI 10.1007/s004290050185; Ignatius MS, 2008, DEV BIOL, V313, P568, DOI 10.1016/j.ydbio.2007.10.045; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Jackman WR, 2006, P NATL ACAD SCI USA, V103, P19390, DOI 10.1073/pnas.0609575103; Jackman WR, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-119; Jackman WR, 2004, DEV BIOL, V274, P139, DOI 10.1016/j.ydbio.2004.07.003; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klein OD, 2008, DEVELOPMENT, V135, P377, DOI 10.1242/dev.015081; KRONMILLER JE, 1995, ARCH ORAL BIOL, V40, P589, DOI 10.1016/0003-9969(95)00014-G; Kumar S, 2010, DEV BIOL, V340, P67, DOI 10.1016/j.ydbio.2010.01.027; LANDE R, 1978, EVOLUTION, V32, P73, DOI 10.1111/j.1558-5646.1978.tb01099.x; Laue K, 2008, DEVELOPMENT, V135, P3775, DOI 10.1242/dev.021238; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lister JA, 1999, DEVELOPMENT, V126, P3757; LOHNES D, 1994, DEVELOPMENT, V120, P2723; Luo RS, 2001, DEV DYNAM, V220, P169, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1097>3.0.CO;2-1; Mallo M, 2010, DEV BIOL, V344, P7, DOI 10.1016/j.ydbio.2010.04.024; Manzanares M, 2000, NATURE, V408, P854, DOI 10.1038/35048570; MARK M, 1995, INT J DEV BIOL, V39, P111; MARSHALL CR, 1994, P NATL ACAD SCI USA, V91, P12283, DOI 10.1073/pnas.91.25.12283; Marshall H, 1996, FASEB J, V10, P969, DOI 10.1096/fasebj.10.9.8801179; McDonald J., 2009, HDB BIOL STAT, P70; McGraw HF, 2011, DEVELOPMENT, V138, P3921, DOI 10.1242/dev.062554; Mercader N, 2006, DEVELOPMENT, V133, P2805, DOI 10.1242/dev.02455; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; Mucchielli ML, 1997, DEV BIOL, V189, P275, DOI 10.1006/dbio.1997.8672; Nelson JS, 1984, FISHES WORLD; Nichols J. T., 1930, COPEIA, V1930, P148; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Patterson C., 1993, P621; Peters H, 1999, TRENDS GENET, V15, P59, DOI 10.1016/S0168-9525(98)01662-X; Portz DE, 2004, ENVIRON BIOL FISH, V71, P233, DOI 10.1007/s10641-004-0300-y; Prince VE, 1998, DEVELOPMENT, V125, P407; Schilling TF, 1996, DEVELOPMENT, V123, P329; Sibbing F., 1991, CYPRINID FISHES SYST, P377; Sperber SM, 2008, DEV BIOL, V314, P59, DOI 10.1016/j.ydbio.2007.11.005; Stock DW, 2007, J EXP ZOOL PART B, V308B, P523, DOI 10.1002/jez.b.21187; Stock DW, 2001, PHILOS T R SOC B, V356, P1633, DOI 10.1098/rstb.2001.0917; Talbot JC, 2010, DEVELOPMENT, V137, P2506, DOI 10.1242/dev.049700; Trinh LA, 2007, BIOTECHNIQUES, V42, P756, DOI 10.2144/000112476; Van der Heyden C, 2000, DEV DYNAM, V219, P486; Venugopalan SR, 2011, J BIOL CHEM, V286, P21372, DOI 10.1074/jbc.M111.252031; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; White RJ, 2007, PLOS BIOL, V5, P2522, DOI 10.1371/journal.pbio.0050304; WILSON JG, 1953, AM J ANAT, V92, P189, DOI 10.1002/aja.1000920202; Yamaguchi M, 1998, P NATL ACAD SCI USA, V95, P7491, DOI 10.1073/pnas.95.13.7491	75	18	19	1	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2012	26	12					5014	5024		10.1096/fj.12-209304	http://dx.doi.org/10.1096/fj.12-209304			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22942074	Green Published			2022-12-25	WOS:000311838300023
J	Peng, ZM; Liao, ZP; Dziegielewska, B; Matsumoto, Y; Thomas, S; Wan, YH; Yang, A; Tomkinson, AE				Peng, Zhimin; Liao, Zhongping; Dziegielewska, Barbara; Matsumoto, Yoshi; Thomas, Stefani; Wan, Yunhu; Yang, Austin; Tomkinson, Alan E.			Phosphorylation of Serine 51 Regulates the Interaction of Human DNA Ligase I with Replication Factor C and Its Participation in DNA Replication and Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; CLAMP LOADER; DAMAGE; SITE; PHOSPHOPROTEOME; IDENTIFICATION; QUANTITATION; EUKARYOTES; SENESCENCE; MECHANISM	Human DNA ligase I (hLigI) joins Okazaki fragments during DNA replication and completes excision repair via interactions with proliferating cell nuclear antigen and replication factor C (RFC). Unlike proliferating cell nuclear antigen, the interaction with RFC is regulated by hLigI phosphorylation. To identity of the site(s) involved in this regulation, we analyzed phosphorylated hLigI purified from insect cells by mass spectrometry. These results suggested that serine 51 phosphorylation negatively regulates the interaction with RFC. Therefore, we constructed versions of hLigI in which serine 51 was replaced with either alanine (hLigI51A) to prevent phosphorylation or aspartic acid (hLigI51D) to mimic phosphorylation. hLigI51D but not hLigI51A was defective in binding to purified RFC and in associating with RFC in cell extracts. Although DNA synthesis and proliferation of hLigI-deficient cells expressing either hLig51A or hLig51 was reduced compared with cells expressing wild-type hLigI, cellular senescence was only observed in the cells expressing hLigI51D. Notably, these cells had increased levels of spontaneous DNA damage and phosphorylated CHK2. In addition, although expression of hLigI51A complemented the sensitivity of hLigI-deficient cells to a poly (ADP-ribose polymerase (PARP) inhibitor, expression of hLig151D did not, presumably because these cells are more dependent upon PARP-dependent repair pathways to repair the damage resulting from the abnormal DNA replication. Finally, neither expression of hLigI51D nor hLigI51A fully complemented the sensitivity of hLigI-deficient cells to DNA alkylation. Thus, phosphorylation of serine 51 on hLigI plays a critical role in regulating the interaction between hLigI and RFC, which is required for efficient DNA replication and repair.	[Peng, Zhimin; Matsumoto, Yoshi; Tomkinson, Alan E.] Univ New Mexico, Univ New Mexico Canc Ctr, Albuquerque, NM 87131 USA; [Liao, Zhongping; Thomas, Stefani; Wan, Yunhu; Yang, Austin] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Dziegielewska, Barbara] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Radiat Oncol Res Lab,Dept Radiat Oncol, Baltimore, MD 21201 USA; [Peng, Zhimin; Matsumoto, Yoshi; Tomkinson, Alan E.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA	University of New Mexico; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of New Mexico	Tomkinson, AE (corresponding author), Univ New Mexico 1, Dept Internal Med, 915 Camino Salud NE, Albuquerque, NM 87131 USA.	atomkinson@salud.unm.edu	Dziegielewska, Barbara/J-5538-2019; peng, zhimin/B-4536-2010; Thomas, Stefani/AAF-4212-2021; Classen, Scott/AAY-8176-2020	Thomas, Stefani/0000-0003-1679-5453; 	National Institutes of Health [R01 GM 57479, P01 CA 92584, R01 AG25323]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM 57479 and P01 CA 92584 (to A. E. T.) and R01 AG25323 (to A. Y.).	Arakawa H, 2012, NUCLEIC ACIDS RES, V40, P2599, DOI 10.1093/nar/gkr1024; Balakrishnan L, 2011, J BIOL CHEM, V286, P6865, DOI 10.1074/jbc.R110.209502; BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; Bentley DJ, 1996, NAT GENET, V13, P489, DOI 10.1038/ng0896-489; Bentley DJ, 2002, J CELL SCI, V115, P1551; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen RQ, 2009, CANCER RES, V69, P2663, DOI 10.1158/0008-5472.CAN-08-3222; Christensen GL, 2010, MOL CELL PROTEOMICS, V9, P1540, DOI 10.1074/mcp.M900550-MCP200; Cripps D, 2006, J BIOL CHEM, V281, P10825, DOI 10.1074/jbc.M512786200; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fazlieva R, 2009, NUCLEIC ACIDS RES, V37, P2854, DOI 10.1093/nar/gkp155; Ferrari G, 2003, J BIOL CHEM, V278, P37761, DOI 10.1074/jbc.M304462200; Harrison C, 2002, CANCER RES, V62, P4065; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Iliuk AB, 2010, MOL CELL PROTEOMICS, V9, P2162, DOI 10.1074/mcp.M110.000091; Krude T, 1999, EXP CELL RES, V247, P148, DOI 10.1006/excr.1998.4342; LASKO DD, 1990, J BIOL CHEM, V265, P12618; LEHMANN AR, 1988, CANCER RES, V48, P6343; Levin DS, 2000, CURR BIOL, V10, P919, DOI 10.1016/S0960-9822(00)00619-9; Levin DS, 2004, J BIOL CHEM, V279, P55196, DOI 10.1074/jbc.M409250200; Levin DS, 1997, P NATL ACAD SCI USA, V94, P12863, DOI 10.1073/pnas.94.24.12863; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Montecucco A, 1998, EMBO J, V17, P3786, DOI 10.1093/emboj/17.13.3786; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Porcedda P, 2008, CYTOM PART A, V73A, P508, DOI 10.1002/cyto.a.20566; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Rossi R, 1999, EMBO J, V18, P5745, DOI 10.1093/emboj/18.20.5745; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Song W, 2007, J BIOL CHEM, V282, P22721, DOI 10.1074/jbc.M703774200; Soza S, 2009, MOL CELL BIOL, V29, P2032, DOI 10.1128/MCB.01730-08; Stein J. L., 1989, CELL SYNCHRONIZATION, P133; Vijayakumar S, 2009, MOL CELL BIOL, V29, P2042, DOI 10.1128/MCB.01732-08; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Wahl GM, 2001, NAT CELL BIOL, V3, pE277, DOI 10.1038/ncb1201-e277; WANG YCJ, 1994, J BIOL CHEM, V269, P31923; Wang YT, 2010, J PROTEOME RES, V9, P5582, DOI 10.1021/pr100394u	37	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36711	36719		10.1074/jbc.M112.383570	http://dx.doi.org/10.1074/jbc.M112.383570			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22952233	hybrid, Green Published			2022-12-25	WOS:000310588500009
J	Lindstedt, F; Karshikoff, B; Schalling, M; Hoglund, CO; Ingvar, M; Lekander, M; Kosek, E				Lindstedt, Fredrik; Karshikoff, Bianka; Schalling, Martin; Hoglund, Caroline Olgart; Ingvar, Martin; Lekander, Mats; Kosek, Eva			Serotonin-1A Receptor Polymorphism (rs6295) Associated with Thermal Pain Perception	PLOS ONE			English	Article							NOCICEPTIVE FLEXION REFLEX; NOXIOUS CONDITIONING STIMULATION; SPINAL 5-HT1A RECEPTORS; DORSAL RAPHE NEURONS; HEAT PAIN; ANTIDEPRESSANT RESPONSE; SUBJECTIVE EXPERIENCE; POSTOPERATIVE PAIN; GENETIC-VARIATION; NFR THRESHOLD	Background: Serotonin (5-HT) is highly involved in pain regulation and serotonin-1A (5-HT1A) receptors are important in determining central 5-HT tone. Accordingly, variation in the 5-HT1A receptor gene (HTR1A) may contribute to inter-individual differences in human pain sensitivity. The minor G-allele of the HTR1A single nucleotide polymorphism (SNP) rs6295 attenuates firing of serotonergic neurons and reduces postsynaptic expression of the receptor. Experiments in rodents suggest that 5-HT1A-agonism modulates pain in opposite directions at mild compared to high noxious intensities. Based upon this and several other similar observations, we hypothesized that G-carriers would exhibit a relative hypoalgesia at mild thermal stimuli but tend towards hyperalgesia at higher noxious intensities. Methods: Fourty-nine healthy individuals were selectively genotyped for rs6295. Heat-and cold-pain thresholds were assessed along with VAS-ratings of a range of suprathreshold noxious heat intensities (45 degrees C-49 degrees C). Nociceptive-flexion reflex (NFR) thresholds were also assessed. Results: Volunteers did not deviate significantly from Hardy-Weinberg equilibrium. G-carriers were less sensitive to threshold-level thermal pain. This relative hypoalgesia was abolished at suprathreshold noxious intensities where G-carriers instead increased their ratings of heat-pain significantly more than C-homozygotes. No differences with regard to NFR-thresholds emerged. Conclusion/Significance: To the best of our knowledge this is the first study of human pain perception on the basis of variation in HTR1A. The results illustrate the importance of including a range of stimulus intensities in assessments of pain sensitivity. In speculation, we propose that an attenuated serotonergic tone may be related to a 'hypo- to hyperalgesic' response-pattern. The involved mechanisms could be of clinical interest as variation in pain regulation is known to influence the risk of developing pain pathologies. Further investigations are therefore warranted.	[Lindstedt, Fredrik; Karshikoff, Bianka; Hoglund, Caroline Olgart; Ingvar, Martin; Lekander, Mats; Kosek, Eva] Karolinska Inst, Osher Ctr Integrat Med, Stockholm, Sweden; [Lindstedt, Fredrik; Karshikoff, Bianka; Ingvar, Martin; Kosek, Eva] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Hoglund, Caroline Olgart] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Schalling, Martin] Karolinska Inst, Dept Mol Med & Surg, Neurogenet Unit, Stockholm, Sweden; [Schalling, Martin] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Lekander, Mats] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Stockholm University	Lindstedt, F (corresponding author), Karolinska Inst, Osher Ctr Integrat Med, Stockholm, Sweden.	fredrik.lindstedt@ki.se	Schalling, Martin/F-1518-2015; Karshikoff, Bianka/I-9602-2019	Schalling, Martin/0000-0001-5011-2922; Karshikoff, Bianka/0000-0003-1154-8103; Ingvar, Martin/0000-0002-9041-5714; Kosek, Eva/0000-0003-0488-8177	Karolinska Institute; Swedish Rheumatism Association and Stockholm County Council; Swedish Research Council [2011-4807]; Swedish Heart-Lung Foundation; Petrus and Augusta Hedlunds Stiftelse; Center for Allergy Research; Swedish Council for Working Life and Social Research; Swedish Society for Medicine; National board of Health and Welfare and Stockholm Stress Center	Karolinska Institute(Karolinska Institutet); Swedish Rheumatism Association and Stockholm County Council; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Petrus and Augusta Hedlunds Stiftelse; Center for Allergy Research; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Society for Medicine; National board of Health and Welfare and Stockholm Stress Center	This study was funded by The Karolinska Institute, Swedish Rheumatism Association and Stockholm County Council (EK); The Swedish Research Council (www.vr.se), grant nr 2011-4807 (MS); The Swedish Heart-Lung Foundation (COH); Petrus and Augusta Hedlunds Stiftelse, The Center for Allergy Research, Swedish Heart-Lung Foundation, Swedish Council for Working Life and Social Research, The Swedish Society for Medicine, The National board of Health and Welfare and Stockholm Stress Center (ML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguglia A, J AFFECTIVE IN PRESS; Albert PR, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00035; Albert PR, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-21; Arnold LM, 2004, ARTHRITIS RHEUM-US, V50, P944, DOI 10.1002/art.20042; Bar KJ, 2011, J CLIN PSYCHOPHARM, V31, P103, DOI 10.1097/JCP.0b013e3182046797; Bardin L, 2004, EUR J PAIN, V8, P253, DOI 10.1016/j.ejpain.2003.09.002; Bardin L, 2011, BEHAV PHARMACOL, V22, P390, DOI 10.1097/FBP.0b013e328349aae4; Benarroch EE, 2008, NEUROLOGY, V71, P217, DOI 10.1212/01.wnl.0000318225.51122.63; Bingel U, 2008, PHYSIOLOGY, V23, P371, DOI 10.1152/physiol.00024.2008; Bonnefont J, 2005, PAIN, V114, P482, DOI 10.1016/j.pain.2005.01.019; Bouali S, 2003, EUR J NEUROSCI, V18, P2203, DOI 10.1046/j.1460-9568.2003.02960.x; Buono MJ, 2007, PHYSIOL MEAS, V28, P855, DOI 10.1088/0967-3334/28/8/008; Buritova J, 2005, EUR J PHARMACOL, V514, P121, DOI 10.1016/j.ejphar.2005.03.016; Buritova J, 2003, BRAIN RES, V974, P212, DOI 10.1016/S0006-8993(03)02582-4; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Clauw Daniel J, 2009, Am J Med, V122, pS3, DOI 10.1016/j.amjmed.2009.09.006; Coggeshall RE, 2005, PROG NEUROBIOL, V77, P299, DOI 10.1016/j.pneurobio.2005.11.002; Coghill RC, 2003, P NATL ACAD SCI USA, V100, P8538, DOI 10.1073/pnas.1430684100; Coghill RC, 2010, HEADACHE, V50, P1531, DOI 10.1111/j.1526-4610.2010.01763.x; Corruble E, 2000, PSYCHOPATHOLOGY, V33, P307, DOI 10.1159/000029163; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Craig ADB, 2003, TRENDS NEUROSCI, V26, P303, DOI 10.1016/S0166-2236(03)00123-1; Czesak M, 2006, J NEUROSCI, V26, P1864, DOI 10.1523/JNEUROSCI.2643-05.2006; Czesak M, 2012, J BIOL CHEM, V287, P6615, DOI 10.1074/jbc.M111.293027; David SP, 2005, J NEUROSCI, V25, P2586, DOI 10.1523/JNEUROSCI.3769-04.2005; de Almeida J, 2008, J NEUROCHEM, V107, P488, DOI 10.1111/j.1471-4159.2008.05649.x; Dickens C, 2003, PSYCHOSOM MED, V65, P369, DOI 10.1097/01.PSY.0000041622.69462.06; FASMER OB, 1986, PHARMACOL BIOCHEM BE, V25, P883, DOI 10.1016/0091-3057(86)90402-8; Fishbain DA, 1997, CLIN J PAIN, V13, P116, DOI 10.1097/00002508-199706000-00006; Foulkes T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000086; France CR, 2009, PAIN, V145, P211, DOI 10.1016/j.pain.2009.06.022; Granot M, 2011, CLIN J PAIN; Granot M, 2009, CURR OPIN ANESTHESIO, V22, P425, DOI 10.1097/ACO.0b013e32832a40e1; HOYER D, 1986, BRAIN RES, V376, P85, DOI 10.1016/0006-8993(86)90902-9; Huang YY, 2004, INT J NEUROPSYCHOPH, V7, P441, DOI 10.1017/S1461145704004663; Huo FQ, 2008, PAIN, V139, P398, DOI 10.1016/j.pain.2008.05.013; Huo FQ, 2010, NEUROCHEM INT, V57, P749, DOI 10.1016/j.neuint.2010.08.011; Jovanovic H, 2011, NEUROIMAGE, V55, P1178, DOI 10.1016/j.neuroimage.2010.12.060; Kato M, 2009, AM J MED GENET B, V150B, P115, DOI 10.1002/ajmg.b.30783; Kosek E, 2000, PAIN, V88, P69, DOI 10.1016/S0304-3959(00)00310-9; Kosek E, 1997, PAIN, V70, P41, DOI 10.1016/S0304-3959(96)03295-2; Kosek E, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-37; Kraus A, 2009, PAIN, V143, P179, DOI 10.1016/j.pain.2008.12.018; LaCroix-Fralish ML, 2009, ANNU REV PHARMACOL, V49, P97, DOI 10.1146/annurev-pharmtox-061008-103222; Lautenbacher J S, 1998, PSYCHOSOM MED, V61, P822; LAUTENBACHER S, 1992, PERCEPT PSYCHOPHYS, V52, P685, DOI 10.3758/BF03211705; Le Francois B, 2008, NEUROPHARMACOLOGY, V55, P977, DOI 10.1016/j.neuropharm.2008.06.046; LEBARS D, 1979, PAIN, V6, P283, DOI 10.1016/0304-3959(79)90049-6; Lemonde S, 2004, INT J NEUROPSYCHOPH, V7, P501, DOI 10.1017/S1461145704004699; Lemonde S, 2003, J NEUROSCI, V23, P8788; Leo Raphael J, 2005, Curr Treat Options Neurol, V7, P403, DOI 10.1007/s11940-005-0032-0; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; LINDBLOM B, 1988, GENE ANAL TECH, V5, P97, DOI 10.1016/0735-0651(88)90003-9; Lindstedt F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018252; Lindstedt F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017752; Loucif AJC, 2006, J NEUROBIOL, V66, P1475, DOI 10.1002/neu.20321; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; Malaguti A, 2011, DEPRESS ANXIETY, V28, P568, DOI 10.1002/da.20815; Markkula R, 2009, EUR J PAIN, V13, P744, DOI 10.1016/j.ejpain.2008.09.007; Martikainen IK, 2007, BRAIN RES, V1172, P21, DOI 10.1016/j.brainres.2007.07.036; Matsukawa T, 2000, CRIT CARE MED, V28, P532, DOI 10.1097/00003246-200002000-00041; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Millan MJ, 1995, SEMIN NEUROSCI, V7, P409, DOI 10.1016/1044-5765(95)90005-5; Neziri AY, 2010, EUROPEAN J IN PRESS; Ohayon MM, 2009, J PSYCHIATR RES, V43, P1243, DOI 10.1016/j.jpsychires.2009.10.007; Ohno Yukihiro, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P148; Orii R, 2003, ANESTHESIOLOGY, V98, P1223, DOI 10.1097/00000542-200305000-00026; Perrin FE, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.98; Polter AM, 2010, CELL SIGNAL, V22, P1406, DOI 10.1016/j.cellsig.2010.03.019; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; Rhudy JL, 2007, PAIN, V128, P244, DOI 10.1016/j.pain.2006.09.024; Riley JL, 1999, PAIN, V81, P225, DOI 10.1016/S0304-3959(98)00258-9; Ruoff GE, 1996, J FAM PRACTICE, V43, pS25; Sandrini G, 2005, PROG NEUROBIOL, V77, P353, DOI 10.1016/j.pneurobio.2005.11.003; Savitz J, 2009, PROG NEUROBIOL, V88, P17, DOI 10.1016/j.pneurobio.2009.01.009; Serretti A, 2006, CURR DRUG TARGETS, V7, P1659, DOI 10.2174/138945006779025419; Skljarevski V, 2002, PAIN, V96, P3, DOI 10.1016/S0304-3959(02)00018-0; Sodhi MSK, 2004, INT REV NEUROBIOL, V59, P111; Sommer Claudia, 2006, Curr Pain Headache Rep, V10, P101, DOI 10.1007/s11916-006-0020-4; SPROUSE JS, 1987, SYNAPSE, V1, P3, DOI 10.1002/syn.890010103; Valencia C, 2011, J PAIN, V12, P133, DOI 10.1016/j.jpain.2010.06.002; Wang YY, 2009, J CHEM NEUROANAT, V38, P75, DOI 10.1016/j.jchemneu.2009.04.003; Wasserman Danuta, 2006, Behav Brain Funct, V2, P14, DOI 10.1186/1744-9081-2-14; Wu S, 1999, PSYCHIATR GENET, V9, P105, DOI 10.1097/00041444-199906000-00010; Wust S, 2009, PSYCHONEUROENDOCRINO, V34, P972, DOI 10.1016/j.psyneuen.2009.01.011; YARNITSKY D, 1995, PAIN, V60, P329, DOI 10.1016/0304-3959(94)00132-X; Yarnitsky D, 2008, PAIN, V138, P22, DOI 10.1016/j.pain.2007.10.033; Yarnitsky D, 2010, EUR J PAIN, V14, P339, DOI 10.1016/j.ejpain.2010.02.004; Young EE, 2011, J MED GENETICS; Zhou HY, 2007, J NEUROPHYSIOL, V97, P871, DOI 10.1152/jn.00964.2006; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	91	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43221	10.1371/journal.pone.0043221	http://dx.doi.org/10.1371/journal.pone.0043221			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952650	gold, Green Published			2022-12-25	WOS:000308221300010
J	Bosco, A; Crish, SD; Steele, MR; Romero, CO; Inman, DM; Horner, PJ; Calkins, DJ; Vetter, ML				Bosco, Alejandra; Crish, Samuel D.; Steele, Michael R.; Romero, Cesar O.; Inman, Denise M.; Horner, Philip J.; Calkins, David J.; Vetter, Monica L.			Early Reduction of Microglia Activation by Irradiation in a Model of Chronic Glaucoma	PLOS ONE			English	Article							OPTIC-NERVE HEAD; ELEVATED INTRAOCULAR-PRESSURE; RETINAL GANGLION-CELLS; DBA/2 MOUSE MODEL; MICROARRAY ANALYSIS; GENE-EXPRESSION; CRANIAL IRRADIATION; INHERITED GLAUCOMA; GLIAL RESPONSES; MYELOID CELLS	Glaucoma is a neurodegenerative disease that results in the progressive decline and ultimate death of retinal ganglion cells (RGCs). While multiple risk factors are associated with glaucoma, the mechanisms leading to onset and progression of the disease remain unknown. Molecular analysis in various glaucoma models has revealed involvement of non-neuronal cell populations, including astrocytes, Mueller glia and microglia, at early stages of glaucoma. High-dose irradiation was reported to have a significant long-term protective effect in the DBA/2J (D2) mouse model of glaucoma, although the cellular and molecular basis for this effect remains unclear. In particular, the acute effects of irradiation on specific cell populations, including non-neuronal cells, in the D2 retina and nerve have not been assessed. Here we report that irradiation induces transient reduction in proliferating microglia within the optic nerve head and glial lamina within the first week post-irradiation. This was accompanied by reduced microglial activation, with no effect on astrocyte gliosis in those regions. At later stages we confirm that early high-dose irradiation of the mouse head results in improvement of axonal structural integrity and anterograde transport function, without reduction of intraocular pressure. Thus reduced microglial activation induced by irradiation at early stages is associated with reduced optic nerve and retinal neurodegeneration in the D2 mouse model of glaucoma.	[Bosco, Alejandra; Steele, Michael R.; Romero, Cesar O.; Vetter, Monica L.] Univ Utah, Dept Neurobiol, Salt Lake City, UT 84112 USA; [Crish, Samuel D.; Calkins, David J.] Vanderbilt Univ, Dept Ophthalmol & Visual Sci, Nashville, TN USA; [Inman, Denise M.; Horner, Philip J.] Univ Washington, Dept Neurosurg, Seattle, WA 98195 USA	Utah System of Higher Education; University of Utah; Vanderbilt University; University of Washington; University of Washington Seattle	Bosco, A (corresponding author), Univ Utah, Dept Neurobiol, Salt Lake City, UT 84112 USA.	monica@neuro.utah.edu	Horner, Philip J./AAF-7012-2021; Inman, Denise/AAA-8074-2019	Inman, Denise/0000-0002-8522-4112; Calkins, David/0000-0002-8475-9959; BOSCO, ALEJANDRA/0000-0003-3743-5414; Vetter, Monica/0000-0001-6262-8504	Melza M. and Frank Theodore Barr Foundation through the Glaucoma Research Foundation; NIH [R01EY02878]; NATIONAL EYE INSTITUTE [P30EY014800, P30EY008126, R01EY020878] Funding Source: NIH RePORTER	Melza M. and Frank Theodore Barr Foundation through the Glaucoma Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funded by a generous grant from the Melza M. and Frank Theodore Barr Foundation through the Glaucoma Research Foundation (www.glaucoma.org/) (Catalyst for a Cure to MLV, PJH and DJC) and NIH grant # R01EY02878 to MLV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 2004, INVEST OPHTH VIS SCI, V45, P1247, DOI 10.1167/iovs.03-1123; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Anderson MG, 2005, P NATL ACAD SCI USA, V102, P4566, DOI 10.1073/pnas.0407357102; Ben Abdallah NMB, 2007, HIPPOCAMPUS, V17, P1230, DOI 10.1002/hipo.20358; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bosco A, 2008, INVEST OPHTH VIS SCI, V49, P1437, DOI 10.1167/iovs.07-1337; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Burgoyne CF, 2011, EXP EYE RES, V93, P120, DOI 10.1016/j.exer.2010.09.005; Chen M, 2012, GLIA, V60, P833, DOI 10.1002/glia.22315; Crish SD, 2011, NEUROSCIENCE, V176, P1, DOI 10.1016/j.neuroscience.2010.12.036; Crish SD, 2010, P NATL ACAD SCI USA, V107, P5196, DOI 10.1073/pnas.0913141107; Fan W, 2010, OPHTHALMOL EYE DIS, V2, P23; Fike JR, 2011, REV NEUROL-FRANCE, V167, P746, DOI 10.1016/j.neurol.2011.07.005; Giuliari GP, 2011, ACTA ONCOL, V50, P6, DOI 10.3109/0284186X.2010.500299; Gupta Abha, 2007, BMC Ophthalmol, V7, P6, DOI 10.1186/1471-2415-7-6; Gupta N, 2007, CURR OPIN OPHTHALMOL, V18, P110, DOI 10.1097/ICU.0b013e3280895aea; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Horgan N, 2010, CURR OPIN OPHTHALMOL, V21, P233, DOI 10.1097/ICU.0b013e3283386687; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Howell GR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-45; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Howell GR, 2012, J CLIN INVESTIGATION; Hwang SY, 2006, NEUROBIOL DIS, V21, P457, DOI 10.1016/j.nbd.2005.08.006; Inman DM, 2007, GLIA, V55, P942, DOI 10.1002/glia.20516; Inman DM, 2006, INVEST OPHTH VIS SCI, V47, P986, DOI 10.1167/iovs.05-0925; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Johnson EC, 2007, INVEST OPHTH VIS SCI, V48, P3161, DOI 10.1167/iovs.06-1282; Johnson EC, 2009, J GLAUCOMA, V18, P341, DOI 10.1097/IJG.0b013e31818c6ef6; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kalm M, 2009, J NEUROIMMUNOL, V206, P70, DOI 10.1016/j.jneuroim.2008.11.002; Kaneko H, 2008, INVEST OPHTH VIS SCI, V49, P4162, DOI 10.1167/iovs.08-1738; Lam TT, 2003, INVEST OPHTH VIS SCI, V44, P638, DOI 10.1167/iovs.02-0255; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Libby RT, 2005, PLOS GENET, V1, P17, DOI 10.1371/journal.pgen.0010004; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Miyahara T, 2003, INVEST OPHTH VIS SCI, V44, P4347, DOI 10.1167/iovs.02-1032; Muther PS, 2010, INVEST OPHTH VIS SCI, V51, P4831, DOI 10.1167/iovs.09-4923; Neufeld AH, 1999, ARCH OPHTHALMOL-CHIC, V117, P1050; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Reichstein D, 2007, EXP EYE RES, V84, P13, DOI 10.1016/j.exer.2006.08.009; Rosi S, 2008, CANCER RES, V68, P9763, DOI 10.1158/0008-5472.CAN-08-1861; Sappington RM, 2010, INVEST OPHTH VIS SCI, V51, P207, DOI 10.1167/iovs.09-3947; Sarkissian V, 2005, NEUROSCI LETT, V382, P118, DOI 10.1016/j.neulet.2005.02.068; Schlamp CL, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-66; Sommer A, 1996, Curr Opin Ophthalmol, V7, P93, DOI 10.1097/00055735-199604000-00016; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Steele MR, 2006, INVEST OPHTH VIS SCI, V47, P977, DOI 10.1167/iovs.05-0865; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; Whitmore AV, 2005, PROG RETIN EYE RES, V24, P639, DOI 10.1016/j.preteyeres.2005.04.004; Wu KL, 2010, J NEUROPATH EXP NEUR, V69, P272, DOI 10.1097/NEN.0b013e3181d1afe4; Xu HP, 2007, GLIA, V55, P1189, DOI 10.1002/glia.20535; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	57	97	98	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43602	10.1371/journal.pone.0043602	http://dx.doi.org/10.1371/journal.pone.0043602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952717	Green Submitted, Green Published, gold			2022-12-25	WOS:000308206500015
J	Hersmus, R; Stoop, H; van de Geijn, GJ; Eini, R; Biermann, K; Oosterhuis, JW; DHooge, C; Schneider, DT; Meijssen, IC; Dinjens, WNM; Dubbink, HJ; Drop, SLS; Looijenga, LHJ				Hersmus, Remko; Stoop, Hans; van de Geijn, Gert Jan; Eini, Ronak; Biermann, Katharina; Oosterhuis, J. Wolter; DHooge, Catharina; Schneider, Dominik T.; Meijssen, Isabelle C.; Dinjens, Winand N. M.; Dubbink, Hendrikus Jan; Drop, Stenvert L. S.; Looijenga, Leendert H. J.			Prevalence of c-KIT Mutations in Gonadoblastoma and Dysgerminomas of Patients with Disorders of Sex Development (DSD) and Ovarian Dysgerminomas	PLOS ONE			English	Article							GERM-CELL TUMORS; GASTROINTESTINAL STROMAL TUMORS; GENOME-WIDE ASSOCIATION; Y-CHROMOSOME; TESTICULAR SEMINOMA; INTERSTITIAL-CELLS; EXPRESSION; GENE; RECEPTOR; FEMALE	Activating c-KIT mutations (exons 11 and 17) are found in 10-40% of testicular seminomas, the majority being missense point mutations (codon 816). Malignant ovarian dysgerminomas represent similar to 3% of all ovarian cancers in Western countries, resembling testicular seminomas, regarding chromosomal aberrations and c-KIT mutations. DSD patients with specific Y-sequences have an increased risk for Type II Germ Cell Tumor/Cancer, with gonadoblastoma as precursor progressing to dysgerminoma. Here we present analysis of c-KIT exon 8, 9, 11, 13 and 17, and PDGFRA exon 12, 14 and 18 by conventional sequencing together with mutational analysis of c-KIT codon 816 by a sensitive and specific LightCycler melting curve analysis, confirmed by sequencing. The results are combined with data on TSPY and OCT3/4 expression in a series of 16 DSD patients presenting with gonadoblastoma and dysgerminoma and 15 patients presenting pure ovarian dysgerminomas without DSD. c-KIT codon 816 mutations were detected in five out of the total of 31 cases (all found in pure ovarian dysgerminomas). A synonymous SNP (rs 5578615) was detected in two patients, one DSD patient (with bilateral disease) and one patient with dysgerminoma. Next to these, three codon N822K mutations were detected in the group of 15 pure ovarian dysgerminomas. In total activating c-KIT mutations were found in 53% of ovarian dysgerminomas without DSD. In the group of 16 DSD cases a N505I and D820E mutation was found in a single tumor of a patient with gonadoblastoma and dysgerminoma. No PDGFRA mutations were found. Positive OCT3/4 staining was present in all gonadoblastomas and dysgerminomas investigated, TSPY expression was only seen in the gonadoblastoma/dysgerminoma lesions of the 16 DSD patients. This data supports the existence of two distinct but parallel pathways in the development of dysgerminoma, in which mutational status of c-KIT might parallel the presence of TSPY.	[Hersmus, Remko; Stoop, Hans; van de Geijn, Gert Jan; Eini, Ronak; Biermann, Katharina; Oosterhuis, J. Wolter; Looijenga, Leendert H. J.] Erasmus MC Univ Med Ctr Rotterdam, Dept Pathol, Josephine Nefkens Inst, Dr Daniel Den Hoed Canc Ctr, Rotterdam, Netherlands; [DHooge, Catharina] Univ Hosp Ghent, Div Pediat Hematooncol, Dept Pediat, Ghent, Belgium; [Schneider, Dominik T.] Municipal Hosp Dortmund, Pediat Clin, Dortmund, Germany; [Meijssen, Isabelle C.; Dinjens, Winand N. M.; Dubbink, Hendrikus Jan] Erasmus MC Univ Med Ctr Rotterdam, Dept Pathol, Josephine Nefkens Inst, Rotterdam, Netherlands; [Drop, Stenvert L. S.] Sophia Childrens Univ Hosp, Erasmus MC Univ Med Ctr Rotterdam, Dept Pediat Endocrinol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital	Hersmus, R (corresponding author), Erasmus MC Univ Med Ctr Rotterdam, Dept Pathol, Josephine Nefkens Inst, Dr Daniel Den Hoed Canc Ctr, Rotterdam, Netherlands.	l.looijenga@erasmusmc.nl	Hersmus, Remko/AAE-9953-2019; Looijenga, Leendert/B-8145-2019	Looijenga, Leendert/0000-0002-8146-1911; Hersmus, Remko/0000-0001-5250-3572; Schneider, Dominik T./0000-0001-8153-1601	Translational Research Grant Erasmus MC; Dutch Cancer Society [3607]; EuroDSD	Translational Research Grant Erasmus MC; Dutch Cancer Society(KWF Kankerbestrijding); EuroDSD	This work was financially supported by Translational Research Grant Erasmus MC 2006 (RH), the Dutch Cancer Society project 2006 #3607 (RE), and supported by the EuroDSD (www.euroDSD.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto C, 2010, P NATL ACAD SCI USA, V107, P19891, DOI 10.1073/pnas.1010307107; Biermann K, 2007, J PATHOL, V213, P311, DOI 10.1002/path.2225; Cheng L, 2004, AM J SURG PATHOL, V28, P1341, DOI 10.1097/01.pas.0000135528.03942.1f; Cheng L, 2011, CANCER-AM CANCER SOC, V117, P2096, DOI 10.1002/cncr.25794; Cools M, 2006, ENDOCR REV, V27, P468, DOI 10.1210/er.2006-0005; Cools M, 2006, J CLIN ENDOCR METAB, V91, P2404, DOI 10.1210/jc.2005-2554; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Corless CL, 2004, J CLIN ONCOL, V22, P3813, DOI 10.1200/JCO.2004.05.140; Dalgaard MD, 2012, J MED GENET, V49, P58, DOI 10.1136/jmedgenet-2011-100174; de Jong J, 2005, J PATHOL, V206, P242, DOI 10.1002/path.1766; Feng F, 2003, WORLD J GASTROENTERO, V9, P2548; FORMAN D, 1994, BRIT MED J, V308, P1393, DOI 10.1136/bmj.308.6941.1393; Galani E, 2005, GYNECOL ONCOL, V96, P254, DOI 10.1016/j.ygyno.2004.09.047; Guo TH, 2009, CLIN CANCER RES, V15, P6862, DOI 10.1158/1078-0432.CCR-09-1315; Heinrich MC, 2002, J CLIN ONCOL, V20, P1692, DOI 10.1200/JCO.2002.20.6.1692; Hersmus R, 2008, J PATHOL, V215, P31, DOI 10.1002/path.2335; Hersmus R, 2008, MOL CELL ENDOCRINOL, V291, P1, DOI 10.1016/j.mce.2008.02.028; Hoei-Hansen CE, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-12; Honecker F, 2004, J PATHOL, V203, P849, DOI 10.1002/path.1587; Hughes IA, 2006, ARCH DIS CHILD, V91, P554, DOI [10.1136/adc.2006.098319, 10.1016/j.jpurol.2006.03.004]; Joensuu H, 2002, LANCET ONCOL, V3, P655, DOI 10.1016/S1470-2045(02)00899-9; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; Kemmer K, 2004, AM J PATHOL, V164, P305, DOI 10.1016/S0002-9440(10)63120-3; Kido T, 2005, GENESIS, V42, P263, DOI 10.1002/gene.20147; Kitamura Y, 2001, MUTAT RES-FUND MOL M, V477, P165, DOI 10.1016/S0027-5107(01)00117-8; Kraggerud SM, 2000, CANCER RES, V60, P3025; Lau YFC, 2000, CYTOGENET CELL GENET, V91, P160, DOI 10.1159/000056838; Lau YFC, 2009, BIRTH DEFECTS RES C, V87, P114, DOI 10.1002/bdrc.20144; Looijenga LHJ, 2003, CANCER RES, V63, P2244; Looijenga LHJ, 2006, CANCER RES, V66, P290, DOI 10.1158/0008-5472.CAN-05-2936; Lux ML, 2000, AM J PATHOL, V156, P791, DOI 10.1016/S0002-9440(10)64946-2; McIntyre A, 2005, CANCER RES, V65, P8085, DOI 10.1158/0008-5472.CAN-05-0471; Nakai Y, 2005, BIOCHEM BIOPH RES CO, V337, P289, DOI 10.1016/j.bbrc.2005.09.042; Pedersini R, 2007, LANCET ONCOL, V8, P1039, DOI 10.1016/S1470-2045(07)70344-3; Przygodzki RM, 2002, LAB INVEST, V82, P1369, DOI 10.1097/01.LAB.0000032410.46986.7B; Rajpert-De Meyts E, 2004, HUM REPROD, V19, P1338, DOI 10.1093/humrep/deh265; Rapley EA, 2004, BRIT J CANCER, V90, P2397, DOI 10.1038/sj.bjc.6601880; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; Reilly JT, 2002, BRIT J HAEMATOL, V116, P744, DOI 10.1046/j.0007-1048.2001.03294.x; Robinson TL, 2000, AM J PATHOL, V156, P1157, DOI 10.1016/S0002-9440(10)64984-X; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Runyan C, 2006, DEVELOPMENT, V133, P4861, DOI 10.1242/dev.02688; Sakuma Y, 2004, CANCER SCI, V95, P716, DOI 10.1111/j.1349-7006.2004.tb03251.x; Shahsiah R, 2011, J CLIN PATHOL, V64, P973, DOI 10.1136/jcp.2011.090738; Stoop H, 2005, HUM REPROD, V20, P1466, DOI 10.1093/humrep/deh800; Tu JJ, 2007, REPRODUCTION, V134, P757, DOI 10.1530/REP-07-0161; Verzijl A, 2007, DERMATOLOGY, V214, P15, DOI 10.1159/000096907; Went PT, 2004, J CLIN ONCOL, V22, P4514, DOI 10.1200/JCO.2004.10.125; Willmore C, 2004, AM J CLIN PATHOL, V122, P206, DOI 10.1309/4E6UYBY62N2FCA6N; Willmore-Payne C, 2006, MOD PATHOL; WOODWARD PJ, 2004, WHO CLASSIFICATION T, P217; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055	52	28	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43952	10.1371/journal.pone.0043952	http://dx.doi.org/10.1371/journal.pone.0043952			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937135	Green Published, Green Submitted, gold			2022-12-25	WOS:000308213600063
J	Ogawa, H; Hatano, S; Sugiura, N; Nagai, N; Sato, T; Shimizu, K; Kimata, K; Narimatsu, H; Watanabe, H				Ogawa, Hiroyasu; Hatano, Sonoko; Sugiura, Nobuo; Nagai, Naoko; Sato, Takashi; Shimizu, Katsuji; Kimata, Koji; Narimatsu, Hisashi; Watanabe, Hideto			Chondroitin Sulfate Synthase-2 Is Necessary for Chain Extension of Chondroitin Sulfate but Not Critical for Skeletal Development	PLOS ONE			English	Article							MOLECULAR-CLONING; HEPARAN-SULFATE; CAENORHABDITIS-ELEGANS; POLYMERIZING FACTOR; GROWTH-FACTOR; PROTEOGLYCANS; GLUCURONOSYLTRANSFERASE; MORPHOGENESIS; PLEIOTROPHIN; BINDING	Chondroitin sulfate (CS) is a linear polysaccharide consisting of repeating disaccharide units of N-acetyl-D-galactosamine and D-glucuronic acid residues, modified with sulfated residues at various positions. Based on its structural diversity in chain length and sulfation patterns, CS provides specific biological functions in cell adhesion, morphogenesis, neural network formation, and cell division. To date, six glycosyltransferases are known to be involved in the biosynthesis of chondroitin saccharide chains, and a hetero-oligomer complex of chondroitin sulfate synthase-1 (CSS1)/chondroitin synthase-1 and chondroitin sulfate synthase-2 (CSS2)/chondroitin polymerizing factor is known to have the strongest polymerizing activity. Here, we generated and analyzed CSS2(-/-) mice. Although they were viable and fertile, exhibiting no overt morphological abnormalities or osteoarthritis, their cartilage contained CS chains with a shorter length and at a similar number to wild type. Further analysis using CSS2(-/-) chondrocyte culture systems, together with siRNA of CSS1, revealed the presence of two CS chain species in length, suggesting two steps of CS chain polymerization; i.e., elongation from the linkage region up to Mr similar to 10,000, and further extension. There, CSS2 mainly participated in the extension, whereas CSS1 participated in both the extension and the initiation. Our study demonstrates the distinct function of CSS1 and CSS2, providing a clue in the elucidation of the mechanism of CS biosynthesis.	[Ogawa, Hiroyasu; Hatano, Sonoko; Sugiura, Nobuo; Nagai, Naoko; Watanabe, Hideto] Aichi Med Univ, Inst Mol Sci Med, Nagakute, Aichi 48011, Japan; [Sato, Takashi; Narimatsu, Hisashi] Adv Ind Sci & Technol, Res Ctr Med Glycosci, Nagakute, Aichi, Japan; [Ogawa, Hiroyasu; Shimizu, Katsuji] Gifu Univ, Dept Orthopaed Surg, Grad Sch Med, Gifu, Japan	Aichi Medical University; National Institute of Advanced Industrial Science & Technology (AIST); Gifu University	Ogawa, H (corresponding author), Aichi Med Univ, Inst Mol Sci Med, Nagakute, Aichi 48011, Japan.	wannabee@aichi-med-u.ac.jp	Narimatsu, Hisashi/M-4757-2018; Sato, Takashi/M-2577-2018	Narimatsu, Hisashi/0000-0002-8402-133X; Sato, Takashi/0000-0002-9973-8923; Watanabe, Hideto/0000-0001-5291-0696; Ogawa, Hiroyasu/0000-0002-4737-6481	MEXT [S1101027]; Grants-in-Aid for Scientific Research [23570176] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research (B) (KAKENHI) to H. W., Grants-in-aid for priority areas to H. W., and MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2011-2015(S1101027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao XF, 2005, J BIOL CHEM, V280, P35318, DOI 10.1074/jbc.M507304200; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Choocheep K, 2010, J BIOL CHEM, V285, P21114, DOI 10.1074/jbc.M109.096479; Deepa SS, 2004, J BIOL CHEM, V279, P37368, DOI 10.1074/jbc.M403031200; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Gotoh M, 2002, J BIOL CHEM, V277, P38179, DOI 10.1074/jbc.M202601200; Hogan B, 1994, MANIPULATING MOUSE E; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Izumikawa T, 2008, J BIOL CHEM, V283, P11396, DOI 10.1074/jbc.M707549200; Izumikawa T, 2007, BIOCHEM J, V403, P545, DOI 10.1042/BJ20061876; Kim JS, 2007, J BIOL CHEM, V282, P29359, DOI 10.1074/jbc.M700965200; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kwok JCF, 2011, DEV NEUROBIOL, V71, P1073, DOI 10.1002/dneu.20974; Laabs TL, 2007, J NEUROSCI, V27, P14494, DOI 10.1523/JNEUROSCI.2807-07.2007; Li Y, 2010, AM J HUM GENET, V87, P757, DOI 10.1016/j.ajhg.2010.10.003; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Muramatsu T, 2002, J BIOCHEM, V132, P359, DOI 10.1093/oxfordjournals.jbchem.a003231; Ogawa H, 2010, J BIOL CHEM, V285, P34155, DOI 10.1074/jbc.M110.109553; Oohira A, 2000, ARCH BIOCHEM BIOPHYS, V374, P24, DOI 10.1006/abbi.1999.1598; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Prydz K, 2000, J CELL SCI, V113, P193; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Sato T, 2003, J BIOL CHEM, V278, P3063, DOI 10.1074/jbc.M208886200; Sato T, 2011, J BIOL CHEM, V286, P5803, DOI 10.1074/jbc.M110.159244; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Tian J, 2010, AM J HUM GENET, V87, P768, DOI 10.1016/j.ajhg.2010.11.005; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Uyama T, 2003, J BIOL CHEM, V278, P3072, DOI 10.1074/jbc.M209446200; Watanabe H, 1998, J BIOCHEM, V124, P687, DOI 10.1093/oxfordjournals.jbchem.a022166; Watanabe Y, 2010, BIOCHEM J, V432, P47, DOI 10.1042/BJ20100847; Wilson DG, 2012, DEV BIOL, V363, P413, DOI 10.1016/j.ydbio.2012.01.005; Yada T, 2003, J BIOL CHEM, V278, P39711, DOI 10.1074/jbc.M304421200; Yada T, 2003, J BIOL CHEM, V278, P30235, DOI 10.1074/jbc.M303657200	40	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43806	10.1371/journal.pone.0043806	http://dx.doi.org/10.1371/journal.pone.0043806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952769	Green Published, gold, Green Submitted			2022-12-25	WOS:000308213600044
J	Lee, JY; Lee, HK; Lee, DC; Lee, JW				Lee, Jee-Yon; Lee, Hyang-Kyu; Lee, Duk-Chul; Lee, Ji-Won			Serum Carcinoembryonic Antigen Is Associated with Abdominal Visceral Fat Accumulation in Female Korean Nonsmokers	PLOS ONE			English	Article							ADIPOSE-TISSUE; OBESITY; CARCINOMAS; EXPRESSION; CANCER; WOMEN	Background: Carcinoembryonic antigen (CEA) is a tumor marker overexpressed in adenocarcinoma that has proinflammatory properties. Recent studies have reported that CEA is positively associated with carotid atherosclerosis and metabolic syndrome. Because visceral obesity is a known risk factor for cardiometabolic diseases, CEA may also be associated with visceral adiposity. Therefore, we investigated the relationship between serum CEA concentration and visceral obesity in female Korean nonsmokers. Methods: A total of 270 Korean female nonsmokers were enrolled during their routine health check-ups. Biomarkers of metabolic risk factors were assessed along with body composition by computed tomography. Serum CEA levels were measured by using a chemiluminescence immunoassay analyzer. Results: Serum CEA levels correlated with visceral fat area, fasting glucose, and triglyceride levels after adjusting for age and BMI. The mean visceral fat area increased significantly with the increasing CEA tirtiles. In a step-wise multiple regression analysis, age (beta = 0.26, p<0.01) and visceral fat area (beta = 0.19, p = 0.03) were identified as explanatory variables for serum CEA level. Conclusions: This study suggested that CEA may be a mediator that links metabolic disturbance and tumorigenesis in visceral obesity. Further studies are required to better understand the clinical and pathophysiological significance of our findings.	[Lee, Jee-Yon; Lee, Duk-Chul; Lee, Ji-Won] Yonsei Univ, Severance Hosp, Dept Family Med, Coll Med, Seoul 120749, South Korea; [Lee, Hyang-Kyu] Yonsei Univ, Dept Clin Nursing Sci, Coll Nursing, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, JY (corresponding author), Yonsei Univ, Severance Hosp, Dept Family Med, Coll Med, Seoul 120749, South Korea.	indi5645@yuhs.ac		Lee, Duk Chul/0000-0001-9166-1813; LEE, JI WON/0000-0002-2666-4249	Yonsei University College of Medicine [6-2011-0137]	Yonsei University College of Medicine(General Electric)	This study was supported by a faculty research grant from Yonsei University College of Medicine for 2011 (6-2011-0137). The authors did not receive any additional financial support from private companies or individuals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATE N, 1995, J CLIN INVEST, V96, P88, DOI 10.1172/JCI118083; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; CHAKRABARTY S, 1988, CANCER RES, V48, P4059; DESPRES JP, 1993, NUTRITION, V9, P452; FEINLEIB M, 1985, ANN INTERN MED, V103, P1019, DOI 10.7326/0003-4819-103-6-1019; FLETCHER RH, 1986, ANN INTERN MED, V104, P66, DOI 10.7326/0003-4819-104-1-66; GOLD P, 1965, J EXP MED, V121, P439, DOI 10.1084/jem.121.3.439; GREINER JW, 1991, CANCER RES, V51, P4155; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Ishizaka N, 2008, ARTERIOSCL THROM VAS, V28, P160, DOI 10.1161/ATVBAHA.107.155465; JESSUP JM, 1988, CANCER RES, V48, P1689; LAPIDUS L, 1984, BMJ-BRIT MED J, V289, P1257, DOI 10.1136/bmj.289.6454.1257; Lee JW, 2007, CLIN ENDOCRINOL, V66, P572, DOI 10.1111/j.1365-2265.2007.02780.x; Lee JW, 2011, CLIN CHIM ACTA, V412, P527, DOI 10.1016/j.cca.2010.11.033; Lysaght J, 2011, CANC LETT; MANN GV, 1974, NEW ENGL J MED, V291, P178, DOI 10.1056/NEJM197407252910405; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Pazaitou-Panayiotou K, 2006, ADIPONECTIN LINK OBE; Percik R, 2009, EXP CLIN ENDOCR DIAB, V117, P563, DOI 10.1055/s-0029-1241870; Ruibal Morell A., 1992, International Journal of Biological Markers, V7, P160; STEVENS DP, 1973, LANCET, V2, P1238; Trayhurn P, 2005, ACTA PHYSIOL SCAND, V184, P285, DOI 10.1111/j.1365-201X.2005.01468.x; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wang D, 2012, J BIOSCIENCES, V37, P91, DOI 10.1007/s12038-011-9172-4; WITHERSPOON LR, 1983, J NUCL MED, V24, P916	26	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43518	10.1371/journal.pone.0043518	http://dx.doi.org/10.1371/journal.pone.0043518			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952699	Green Published, Green Submitted, gold			2022-12-25	WOS:000308044800035
J	Wall, DP; Dally, R; Luyster, R; Jung, JY; DeLuca, TF				Wall, Dennis P.; Dally, Rebecca; Luyster, Rhiannon; Jung, Jae-Yoon; DeLuca, Todd F.			Use of Artificial Intelligence to Shorten the Behavioral Diagnosis of Autism	PLOS ONE			English	Article							SPECTRUM DISORDERS; INTERVIEW; BIOINFORMATICS; RELIABILITY; RESOURCE	The Autism Diagnostic Interview-Revised (ADI-R) is one of the most commonly used instruments for assisting in the behavioral diagnosis of autism. The exam consists of 93 questions that must be answered by a care provider within a focused session that often spans 2.5 hours. We used machine learning techniques to study the complete sets of answers to the ADI-R available at the Autism Genetic Research Exchange (AGRE) for 891 individuals diagnosed with autism and 75 individuals who did not meet the criteria for an autism diagnosis. Our analysis showed that 7 of the 93 items contained in the ADI-R were sufficient to classify autism with 99.9% statistical accuracy. We further tested the accuracy of this 7-question classifier against complete sets of answers from two independent sources, a collection of 1654 individuals with autism from the Simons Foundation and a collection of 322 individuals with autism from the Boston Autism Consortium. In both cases, our classifier performed with nearly 100% statistical accuracy, properly categorizing all but one of the individuals from these two resources who previously had been diagnosed with autism through the standard ADI-R. Our ability to measure specificity was limited by the small numbers of non-spectrum cases in the research data used, however, both real and simulated data demonstrated a range in specificity from 99% to 93.8%. With incidence rates rising, the capacity to diagnose autism quickly and effectively requires careful design of behavioral assessment methods. Ours is an initial attempt to retrospectively analyze large data repositories to derive an accurate, but significantly abbreviated approach that may be used for rapid detection and clinical prioritization of individuals likely to have an autism spectrum disorder. Such a tool could assist in streamlining the clinical diagnostic process overall, leading to faster screening and earlier treatment of individuals with autism.	[Wall, Dennis P.; Dally, Rebecca; Jung, Jae-Yoon; DeLuca, Todd F.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Wall, Dennis P.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Luyster, Rhiannon] Boston Childrens Hosp, Labs Cognit Neurosci, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital	Wall, DP (corresponding author), Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA.	dpwall@hms.harvard.edu			National Institutes of Health [1R01MH090611-01A1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090611] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work was supported by the National Institutes of Health under Grant No. 1R01MH090611-01A1 awarded to DPW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge FJ, 2012, J AUTISM DEV DISORD, V42, P294, DOI 10.1007/s10803-011-1242-9; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bernier R, 2010, CHILD ADOL PSYCH CL, V19, P855, DOI 10.1016/j.chc.2010.07.005; Berument SK, 1999, BRIT J PSYCHIAT, V175, P444, DOI 10.1192/bjp.175.5.444; BREIMAN L., 1984, CRC PRESS; Cicchetti DV, 2008, J AUTISM DEV DISORD, V38, P764, DOI 10.1007/s10803-007-0448-3; Cohen WW, 1995, 12 INT C MACH LEARN, P115, DOI DOI 10.1016/B978-1-55860-377-6.50023-2; Eaves LC, 2006, J DEV BEHAV PEDIATR, V27, pS95, DOI 10.1097/00004703-200604002-00007; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Frank E., 2001, P 12 EUR C MACH LEAR, P145, DOI DOI 10.1007/3-540-44795-4_13; Frank E, 1998, GENERATING ACCURATE; Freund Y., 1996, Machine Learning. Proceedings of the Thirteenth International Conference (ICML '96), P148; Freund Y, 1999, MACHINE LEARNING, PROCEEDINGS, P124; Gaines B. R., 1995, Journal of Intelligent Information Systems: Integrating Artificial Intelligence and Database Technologies, V5, P211, DOI 10.1007/BF00962234; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Gura GF, 2011, J DEV BEHAV PEDIATR, V32, P48, DOI 10.1097/DBP.0b013e3182040aea; Hall M., 2009, SIGKDD EXPLOR, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Hill A, 2001, PSYCHOPATHOLOGY, V34, P187, DOI 10.1159/000049305; Holmes G PB, 2001, P 13 EUR C MACH LEAR, P161; HOLTE RC, 1993, MACH LEARN, V11, P63, DOI 10.1023/A:1022631118932; Howlin P., 1998, CHILDREN AUTISM ASPE; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C, 2012, ARCH GEN PSYCHIAT, V69, P306, DOI 10.1001/archgenpsychiatry.2011.148; Martin B., 1995, INSTANCE BASED LEARN; Pinto-Martin JA, 2008, J DEV BEHAV PEDIATR, V29, P345, DOI 10.1097/DBP.0b013e31818914cf; Pisula E, 2003, ARCH PSYCHIAT PSYCHO, V4, P51; Poustka F, 1996, PSYCHOPATHOLOGY, V29, P145, DOI 10.1159/000284984; Quinlan R., 1993, C4 5; Risi S, 2006, J AM ACAD CHILD PSY, V45, P1094, DOI 10.1097/01.chi.0000227880.42780.0e; Robins DL, 2001, J AUTISM DEV DISORD, V31, P131, DOI 10.1023/A:1010738829569; Schanding Jr. GT, 2011, J AUTISM DEV DISORD; Shi H., 2007, THESIS U WAIKATO; Wall DP, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.10; Warren Z, 2012, AUTISM RES, V5, P31, DOI 10.1002/aur.230; Wiggins LD, 2006, J DEV BEHAV PEDIATR, V27, pS79, DOI 10.1097/00004703-200604002-00005; Wilkinson DJ, 2007, BRIEF BIOINFORM, V8, P109, DOI 10.1093/bib/bbm007	39	81	88	6	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43855	10.1371/journal.pone.0043855	http://dx.doi.org/10.1371/journal.pone.0043855			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	995WH	22952789	gold, Green Published, Green Submitted			2022-12-25	WOS:000308044800067
J	Yilmaz, LS; Loy, A; Wright, ES; Wagner, M; Noguera, DR				Yilmaz, L. Safak; Loy, Alexander; Wright, Erik S.; Wagner, Michael; Noguera, Daniel R.			Modeling Formamide Denaturation of Probe-Target Hybrids for Improved Microarray Probe Design in Microbial Diagnostics	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; OLIGONUCLEOTIDE MICROARRAY; PHYLOGENETIC MICROARRAY; THERMAL-DISSOCIATION; DUPLEX FORMATION; DNA-MICROARRAYS; M-VALUES; HYBRIDIZATION; IDENTIFICATION; DENSITY	Application of high-density microarrays to the diagnostic analysis of microbial communities is challenged by the optimization of oligonucleotide probe sensitivity and specificity, as it is generally unfeasible to experimentally test thousands of probes. This study investigated the adjustment of hybridization stringency using formamide with the idea that sensitivity and specificity can be optimized during probe design if the hybridization efficiency of oligonucleotides with target and non-target molecules can be predicted as a function of formamide concentration. Sigmoidal denaturation profiles were obtained using fluorescently labeled and fragmented 16S rRNA gene amplicon of Escherichia coli as the target with increasing concentrations of formamide in the hybridization buffer. A linear free energy model (LFEM) was developed and microarray-specific nearest neighbor rules were derived. The model simulated formamide melting with a denaturant m-value that increased hybridization free energy (Delta G degrees) by 0.173 kcal/mol per percent of formamide added (v/v). Using the LFEM and specific probe sets, free energy rules were systematically established to predict the stability of single and double mismatches, including bulged and tandem mismatches. The absolute error in predicting the position of experimental denaturation profiles was less than 5% formamide for more than 90 percent of probes, enabling a practical level of accuracy in probe design. The potential of the modeling approach for probe design and optimization is demonstrated using a dataset including the 16S rRNA gene of Rhodobacter sphaeroides as an additional target molecule. The LFEM and thermodynamic databases were incorporated into a computational tool (ProbeMelt) that is freely available at http://DECIPHER.cee.wisc.edu.	[Yilmaz, L. Safak] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Wright, Erik S.; Noguera, Daniel R.] Univ Wisconsin, Dept Civil & Environm Engn, Madison, WI 53706 USA; [Loy, Alexander; Wagner, Michael] Univ Vienna, Fac Life Sci, Dept Microbial Ecol, Vienna Ecol Ctr, Vienna, Austria	University of Massachusetts System; University of Massachusetts Worcester; University of Wisconsin System; University of Wisconsin Madison; University of Vienna	Yilmaz, LS (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	lutfu.yilmaz@umassmed.edu	Wagner, Michael/A-7801-2011; Loy, Alexander/A-8182-2008	Wagner, Michael/0000-0002-9778-7684; Loy, Alexander/0000-0001-8923-5882; Noguera, Daniel/0000-0003-0372-3063	National Science Foundation [CBET-0606894, CBET-0636533]; Austrian Science Fund [P20185-B17]; Austrian Federal Ministry of Science and Research (GEN-AU III InflammoBiota); Austrian Science Fund (FWF) [P 20185] Funding Source: researchfish	National Science Foundation(National Science Foundation (NSF)); Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Federal Ministry of Science and Research (GEN-AU III InflammoBiota); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was supported by National Science Foundation grants CBET-0606894 to DRN and CBET-0636533 to DRN and LSY, the Austrian Science Fund (P20185-B17 to AL), and the Austrian Federal Ministry of Science and Research (GEN-AU III InflammoBiota to MW and AL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Berthouex P.M., 1994, STAT ENV ENG; Binder H, 2005, LANGMUIR, V21, P9287, DOI 10.1021/la051231s; Bommarito S, 2000, NUCLEIC ACIDS RES, V28, P1929, DOI 10.1093/nar/28.9.1929; Bourdelat-Parks BN, 2004, BIOCHEMISTRY-US, V43, P9918, DOI 10.1021/bi049161w; Brodie EL, 2006, APPL ENVIRON MICROB, V72, P6288, DOI 10.1128/AEM.00246-06; Burden C.J., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1095, DOI 10.2202/1544-6115.1095]; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Courtenay ES, 2000, PROTEINS, P72; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; El Fantroussi S, 2003, APPL ENVIRON MICROB, V69, P2377, DOI 10.1128/AEM.69.4.2377-2382.2003; GAMPER HB, 1987, J MOL BIOL, V197, P349, DOI 10.1016/0022-2836(87)90128-8; Goodfellow, 1991, NUCL ACID TECHNIQUES, P177; Halperin A, 2005, BIOPHYS J, V89, P796, DOI 10.1529/biophysj.105.063479; He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2; Held GA, 2003, P NATL ACAD SCI USA, V100, P7575, DOI 10.1073/pnas.0832500100; Hesselsoe M, 2009, ISME J IN PRESS; Hooyberghs J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp109; KE SH, 1995, BIOCHEMISTRY-US, V34, P4593, DOI 10.1021/bi00014a012; Kelly JJ, 2005, WATER RES, V39, P3229, DOI 10.1016/j.watres.2005.05.044; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Li SZ, 2008, NUCLEIC ACIDS RES, V36, P6585, DOI 10.1093/nar/gkn740; Liu WT, 2001, ENVIRON MICROBIOL, V3, P619, DOI 10.1046/j.1462-2920.2001.00233.x; Loy A, 2005, APPL ENVIRON MICROB, V71, P1373, DOI 10.1128/AEM.71.3.1373-1386.2005; Loy A, 2002, APPL ENVIRON MICROB, V68, P5064, DOI 10.1128/AEM.68.10.5064-5081.2002; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Mei R, 2003, P NATL ACAD SCI USA, V100, P11237, DOI 10.1073/pnas.1534744100; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Naiser T, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-48; Palmer C, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj007; Peplies J, 2003, APPL ENVIRON MICROB, V69, P1397, DOI 10.1128/AEM.69.3.1397-1407.2003; Peterson AW, 2001, NUCLEIC ACIDS RES, V29, P5163, DOI 10.1093/nar/29.24.5163; Pozhitkov A, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl133; Pozhitkov Alex E., 2007, Briefings in Functional Genomics & Proteomics, V6, P141, DOI 10.1093/bfgp/elm014; Pozhitkov AE, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm154; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Sanguin H, 2006, ENVIRON MICROBIOL, V8, P289, DOI 10.1111/j.1462-2920.2005.00895.x; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; SCHELLMAN JA, 1978, BIOPOLYMERS, V17, P1305, DOI 10.1002/bip.1978.360170515; SCHMIDT TM, 1991, J BACTERIOL, V173, P4371, DOI 10.1128/JB.173.14.4371-4378.1991; Schonmann S, 2009, ENVIRON MICROBIOL, V11, P779, DOI 10.1111/j.1462-2920.2008.01800.x; Seber GAF, 2003, NONLINEAR REGRESSION, Vxx; Shchepinov MS, 1997, NUCLEIC ACIDS RES, V25, P1155, DOI 10.1093/nar/25.6.1155; Siripong S, 2006, ENVIRON MICROBIOL, V8, P1564, DOI 10.1111/j.1462-2920.2006.01047.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stahl D.A., 1991, NUCL ACID TECHNIQUES, P205; Stedtfeld RD, 2007, APPL ENVIRON MICROB, V73, P380, DOI 10.1128/AEM.01785-06; Steger D, 2011, APPL ENVIRON MICROB, V77, P1231, DOI 10.1128/AEM.01352-10; Stralis-Pavese N, 2004, ENVIRON MICROBIOL, V6, P347, DOI 10.1111/j.1462-2920.2004.00582.x; Sugimoto N, 2000, BIOCHEMISTRY-US, V39, P11270, DOI 10.1021/bi000819p; Turner D. H., 2000, NUCL ACIDS STRUCTURE; Urakawa H, 2002, APPL ENVIRON MICROB, V68, P235, DOI 10.1128/AEM.68.1.235-244.2002; Urisman A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r78; Wagner M, 2003, CURR OPIN MICROBIOL, V6, P302, DOI 10.1016/S1369-5274(03)00054-7; Wagner M, 2007, MICROB ECOL, V53, P498, DOI 10.1007/s00248-006-9197-7; Watson M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r190; Wick LM, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj024; Wilson KH, 2002, APPL ENVIRON MICROB, V68, P2535, DOI 10.1128/AEM.68.5.2535-2541.2002; Wong CW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r93; Yilmaz LS, 2008, ENVIRON MICROBIOL, V10, P2872, DOI 10.1111/j.1462-2920.2008.01719.x; Yilmaz LS, 2007, BIOTECHNOL BIOENG, V96, P349, DOI 10.1002/bit.21114; Yilmaz LS, 2004, APPL ENVIRON MICROB, V70, P7126, DOI 10.1128/AEM.70.12.7126-7139.2004; Zhang L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1064	66	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43862	10.1371/journal.pone.0043862	http://dx.doi.org/10.1371/journal.pone.0043862			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952791	Green Published, Green Submitted, gold			2022-12-25	WOS:000308044800069
J	Johnson, EK; Zhang, LW; Adams, ME; Phillips, A; Freitas, MA; Froehner, SC; Green-Church, KB; Montanaro, F				Johnson, Eric K.; Zhang, Liwen; Adams, Marvin E.; Phillips, Alistair; Freitas, Michael A.; Froehner, Stanley C.; Green-Church, Kari B.; Montanaro, Federica			Proteomic Analysis Reveals New Cardiac-Specific Dystrophin-Associated Proteins	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; DUCHENNE MUSCULAR-DYSTROPHY; DECOY SEARCH STRATEGY; DILATED CARDIOMYOPATHY; SKELETAL-MUSCLE; ALPHA-DYSTROBREVIN; GLYCOPROTEIN COMPLEX; SYNTROPHIN BINDING; MASS-SPECTROMETRY; ANIMAL-MODELS	Mutations affecting the expression of dystrophin result in progressive loss of skeletal muscle function and cardiomyopathy leading to early mortality. Interestingly, clinical studies revealed no correlation in disease severity or age of onset between cardiac and skeletal muscles, suggesting that dystrophin may play overlapping yet different roles in these two striated muscles. Since dystrophin serves as a structural and signaling scaffold, functional differences likely arise from tissue-specific protein interactions. To test this, we optimized a proteomics-based approach to purify, identify and compare the interactome of dystrophin between cardiac and skeletal muscles from as little as 50 mg of starting material. We found selective tissue-specific differences in the protein associations of cardiac and skeletal muscle full length dystrophin to syntrophins and dystrobrevins that couple dystrophin to signaling pathways. Importantly, we identified novel cardiac-specific interactions of dystrophin with proteins known to regulate cardiac contraction and to be involved in cardiac disease. Our approach overcomes a major challenge in the muscular dystrophy field of rapidly and consistently identifying bona fide dystrophin-interacting proteins in tissues. In addition, our findings support the existence of cardiac-specific functions of dystrophin and may guide studies into early triggers of cardiac disease in Duchenne and Becker muscular dystrophies.	[Johnson, Eric K.; Montanaro, Federica] Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH USA; [Johnson, Eric K.; Montanaro, Federica] Ohio State Univ, Biochem Program, Columbus, OH 43210 USA; [Zhang, Liwen; Green-Church, Kari B.] Ohio State Univ, Ctr Biomed EPR Spect & Imaging, Columbus, OH 43210 USA; [Adams, Marvin E.; Froehner, Stanley C.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Phillips, Alistair] Cincinnati Childrens Hosp, Inst Heart, Div Cardiothorac Surg, Cincinnati, OH USA; [Freitas, Michael A.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Montanaro, Federica] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Washington; University of Washington Seattle; Cincinnati Children's Hospital Medical Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Johnson, EK (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH USA.	montanaf@pediatrics.ohio-state.edu	Zhang, Liwen/P-1111-2016; Freitas, Michael/C-8953-2009; Montanaro, Federica/GRJ-5139-2022	Freitas, Michael/0000-0002-3103-8410; Montanaro, Federica/0000-0002-3338-0498	Parent Project Muscular Dystrophy grant; Research Institute at Nationwide Children's Hospital; American Heart Association; National Institutes of Health [RO1 NS33145, PO1 NS046788]; NICHD; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS046788, R01NS033145] Funding Source: NIH RePORTER	Parent Project Muscular Dystrophy grant; Research Institute at Nationwide Children's Hospital(Ohio State University); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a Parent Project Muscular Dystrophy grant and the Research Institute at Nationwide Children's Hospital (to F. M.), an American Heart Association fellowship (to E.K.J.), and National Institutes of Health grants RO1 NS33145 and PO1 NS046788 (to S. C. F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. C. Miranda, P. Martin, and D. Guttridge for their critical review of this manuscript and C. Penton, R. Orellana and A. Macke for helpful discussions and technical assistance. The hybridoma cell lines for the MANDYS1 and MANDAG2 antibodies developed by Glenn E. Morris (Center for Inherited Neuromuscular Disease, RJAH Orthopedic Hospital, Oswestry, UK) and for the MW8 antibody developed by Paul H. Patterson (Division of Biology, California Institute of Technology, Pasadena, CA) were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242.	Adams ME, 2001, J CELL BIOL, V155, P113, DOI 10.1083/jcb.200106158; Albrecht DE, 2002, NEUROSIGNALS, V11, P123, DOI 10.1159/000065053; Allamand V, 2000, HUM MOL GENET, V9, P2459, DOI 10.1093/hmg/9.16.2459; Arimura T, 2009, CARDIOVASC RES, V83, P80, DOI 10.1093/cvr/cvp119; Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; Bia BL, 1999, J MOL CELL CARDIOL, V31, P1857, DOI 10.1006/jmcc.1999.1018; Blake DJ, 1996, J BIOL CHEM, V271, P7802, DOI 10.1074/jbc.271.13.7802; Bostick B, 2009, MOL THER, V17, P253, DOI 10.1038/mt.2008.264; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Chu V, 2002, MUSCLE NERVE, V26, P513, DOI 10.1002/mus.10223; Cohen N, 2004, HEART, V90, P835, DOI 10.1136/hrt.2003.023390; Colinge J, 2005, ANAL CHEM, V77, P596, DOI 10.1021/ac0488513; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Ervasti JM, 2008, INT REV CYTOL, V265, P191, DOI 10.1016/S0074-7696(07)65005-0; Gavillet B, 2006, CIRC RES, V99, P407, DOI 10.1161/01.RES.0000237466.13252.5e; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; Haase H, 2005, FASEB J, V19, P1969, DOI 10.1096/fj.05-3997com; Hershberger RE, 2008, CTS-CLIN TRANSL SCI, V1, P21, DOI 10.1111/j.1752-8062.2008.00017.x; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; Inagaki N, 2006, BIOCHEM BIOPH RES CO, V342, P379, DOI 10.1016/j.bbrc.2006.01.154; Judge DP., 2011, AM J CARDIOVASC DRUG; Kaspar RW, 2009, CIRC-CARDIOVASC GENE, V2, P544, DOI 10.1161/CIRCGENETICS.109.867242; Kaspar RW, 2009, J AM ACAD NURSE PRAC, V21, P241, DOI 10.1111/j.1745-7599.2009.00404.x; Lai Y, 2009, J CLIN INVEST, V119, P624, DOI 10.1172/JCI36612; Lewis C, 2010, ANAL BIOCHEM, V404, P197, DOI 10.1016/j.ab.2010.05.017; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; MAN NT, 1993, AM J HUM GENET, V52, P1057; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Nakamori M, 2008, NEUROLOGY, V70, P677, DOI 10.1212/01.wnl.0000302174.08951.cf; Newey SE, 2000, CURR BIOL, V10, P1295, DOI 10.1016/S0960-9822(00)00760-0; NIGRO G, 1994, NEUROMUSCULAR DISORD, V4, P371, DOI 10.1016/0960-8966(94)90073-6; Percival JM, 2010, J CLIN INVEST, V120, P816, DOI 10.1172/JCI40736; Peters MF, 1998, J CELL BIOL, V142, P1269, DOI 10.1083/jcb.142.5.1269; PETERS MF, 1994, NEUROREPORT, V5, P1577, DOI 10.1097/00001756-199408150-00009; Peters MF, 1997, J CELL BIOL, V138, P81, DOI 10.1083/jcb.138.1.81; Rajab A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000874; Reilich P, 2010, NEUROMUSCULAR DISORD, V20, P255, DOI 10.1016/j.nmd.2010.01.012; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sacconi S, 2012, NEUROMUSCULAR DISORD, V22, P66, DOI 10.1016/j.nmd.2011.07.004; Santana LF, 1997, J PHYSIOL-LONDON, V503, P21, DOI 10.1111/j.1469-7793.1997.021bi.x; Shastry S, 2010, AM J MED GENET A, V152A, P2245, DOI 10.1002/ajmg.a.33578; TINSLEY JM, 1992, NATURE, V360, P591, DOI 10.1038/360591a0; Townsend D, 2007, MOL THER, V15, P1086, DOI 10.1038/sj.mt.6300144; Vainzof M, 2008, J MOL NEUROSCI, V34, P241, DOI 10.1007/s12031-007-9023-9; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; Wehling-Henricks M, 2005, HUM MOL GENET, V14, P1921, DOI 10.1093/hmg/ddi197; Yoshida M, 2000, HUM MOL GENET, V9, P1033, DOI 10.1093/hmg/9.7.1033; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276	52	51	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43515	10.1371/journal.pone.0043515	http://dx.doi.org/10.1371/journal.pone.0043515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937058	Green Submitted, Green Published, gold			2022-12-25	WOS:000308225500059
J	Kumar, S; Badireddy, S; Pal, K; Sharma, S; Arora, C; Garg, SK; Alam, MS; Agrawal, P; Anand, GS; Swaminathan, K				Kumar, Shiva; Badireddy, Suguna; Pal, Kuntal; Sharma, Shikha; Arora, Chandni; Garg, Saurabh K.; Alam, Mohamed Suhail; Agrawal, Pushpa; Anand, Ganesh Srinivasan; Swaminathan, Kunchithapadam			Interaction of Mycobacterium tuberculosis RshA and SigH Is Mediated by Salt Bridges	PLOS ONE			English	Article							STREPTOMYCES-COELICOLOR A3(2); STRESS-RESPONSE; OXIDATIVE STRESS; GENE-EXPRESSION; I-TASSER; TRANSCRIPTIONAL CONTROL; FACTOR SIGMA(H); REDOX SWITCH; HEAT-SHOCK; PROTEIN	The alternate sigma factor sigH of Mycobacterium tuberculosis is expressed under stress and acts as a major regulator of several genes, including some other sigma factors and redox systems. While it is auto-regulated by its own promoter at the transcriptional level, its regulation at the post-translational level is through its cognate protein, an anti-sigma factor, RshA. Hither before RshA was believed to be a zinc-associated anti-sigma factor (ZAS) and the binding of RshA to SigH is redox dependent. Here, we show that RshA coordinates a [2Fe-2S] cluster using cysteines as ligands and native RshA has more affinity to [2Fe-2S] cluster than to zinc. Furthermore, we used amide hydrogen deuterium exchange mass spectrometry (HDX-MS), followed by site-directed mutagenesis in SigH and RshA, to elucidate the interaction mechanism of RshA and SigH and the potential role of metal ion clustering in SigH regulation. Three regions in SigH, comprising of residues 1-25, 58-69, 90-111, 115-132 and 157-196 and residues 35-57 of RshA show decreased deuterium exchange and reflect decreased solvent accessibility upon complexation with SigH. Of the three RshA mutants, created based on the HDX results, the RsHA E37A mutant shows stronger interaction with SigH, relative to WT RshA, while the H49A mutant abolishes interactions and the C(53) XXC(56) AXXA mutant has no effect on complexation with SigH. The D22A, D160A and E162 SigH mutants show significantly decreased binding to RshA and the E168A mutant completely abolished interactions with RshA, indicating that the SigH-RshA interaction is mediated by salt bridges. In addition, SigH-RshA interaction does not require clustering of metal ions. Based on our results, we propose a molecular model of the SigH-RshA interaction.	[Kumar, Shiva; Badireddy, Suguna; Pal, Kuntal; Anand, Ganesh Srinivasan; Swaminathan, Kunchithapadam] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Sharma, Shikha; Arora, Chandni; Garg, Saurabh K.; Alam, Mohamed Suhail; Agrawal, Pushpa] CSIR, Inst Microbial Technol, Sect 39A, Chandigarh, India	National University of Singapore; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Kumar, S (corresponding author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.	pushpa@imtech.res.in; dbsgsa@nus.edu.sg; dbsks@nus.edu.sg	Pal, Kuntal/W-6348-2019; sarkar, sabyasachi/A-9896-2010; Anand, Ganesh/H-8473-2012	sarkar, sabyasachi/0000-0002-8954-4375; PAL, KUNTAL/0000-0001-7094-2456	Ministry of Education (Faculty Research Council) [R154-000-439-112]; Biomedical Research Council, Singapore [R154-000-424-305]; Council of Scientific and Industrial Research (CSIR) [SIP-10]	Ministry of Education (Faculty Research Council); Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	KS acknowledges the funding support from the Ministry of Education (Faculty Research Council, R154-000-439-112) and Biomedical Research Council (R154-000-424-305), Singapore. PA acknowledges the funding support from the SIP-10 project of Council of Scientific and Industrial Research (CSIR) for this project and for SS. Both SKG and MSA were recipients of the CSIR, India Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MS, 2007, MOL MICROBIOL, V63, P1414, DOI 10.1111/j.1365-2958.2007.05589.x; Badireddy S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.110.004390; Barik S, 2010, MOL MICROBIOL, V75, P592, DOI 10.1111/j.1365-2958.2009.07008.x; Bateman RH, 2002, J AM SOC MASS SPECTR, V13, P792, DOI 10.1016/S1044-0305(02)00420-8; Campbell EA, 2003, MOL CELL, V11, P1067, DOI 10.1016/S1097-2765(03)00148-5; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Fernandes ND, 1999, J BACTERIOL, V181, P4266, DOI 10.1128/JB.181.14.4266-4274.1999; Gaskell AA, 2007, J BIOL CHEM, V282, P31812, DOI 10.1074/jbc.M705160200; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; Hahn MY, 2005, J BACTERIOL, V187, P7062, DOI 10.1128/JB.187.20.7062-7071.2005; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Hu JM, 1999, J BACTERIOL, V181, P469, DOI 10.1128/JB.181.2.469-476.1999; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Jakob U, 2000, J BIOL CHEM, V275, P38302, DOI 10.1074/jbc.M005957200; Jeong EH, 2006, BIOCHEM BIOPH RES CO, V339, P392, DOI 10.1016/j.bbrc.2005.11.032; Jung YG, 2011, NUCLEIC ACIDS RES, V39, P7586, DOI 10.1093/nar/gkr477; Kang JG, 1999, EMBO J, V18, P4292, DOI 10.1093/emboj/18.15.4292; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Kiley PJ, 2003, CURR OPIN MICROBIOL, V6, P181, DOI 10.1016/S1369-5274(03)00039-0; Lane WJ, 2006, PLOS BIOL, V4, P1491, DOI 10.1371/journal.pbio.0040269; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; Li W, 2002, J MOL BIOL, V323, P225, DOI 10.1016/S0022-2836(02)00948-8; Li XJ, 2003, BRIT J DERMATOL, V149, P642, DOI 10.1046/j.1365-2133.2003.05564.x; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Manganelli R, 2002, MOL MICROBIOL, V45, P365, DOI 10.1046/j.1365-2958.2002.03005.x; Mehra S, 2009, J BACTERIOL, V191, P3965, DOI 10.1128/JB.00064-09; Nakano S, 2005, MOL MICROBIOL, V55, P498, DOI 10.1111/j.1365-2958.2004.04395.x; Newman TA, 2001, BRAIN, V124, P2203, DOI 10.1093/brain/124.11.2203; Ohno H, 2003, CELL MICROBIOL, V5, P637, DOI 10.1046/j.1462-5822.2003.00307.x; Paget MSB, 1998, EMBO J, V17, P5776, DOI 10.1093/emboj/17.19.5776; Paget MSB, 2001, MOL MICROBIOL, V42, P1007, DOI 10.1046/j.1365-2958.2001.02675.x; Park ST, 2008, P NATL ACAD SCI USA, V105, P13105, DOI 10.1073/pnas.0801143105; Raghava GPS, 2000, BIOTECHNIQUES, V29, P108, DOI 10.2144/00291bc02; RAINWATER R, 1995, MOL CELL BIOL, V15, P3892; Raman S, 2001, J BACTERIOL, V183, P6119, DOI 10.1128/JB.183.20.6119-6125.2001; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sambrook J., 2001, MOL CLONING LAB MANU, P1881; Shen Z, 2009, MOL CELL PROTEOMICS, V8, P2443, DOI 10.1074/mcp.M900187-MCP200; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Song TS, 2003, MOL MICROBIOL, V50, P949, DOI 10.1046/j.1365-2958.2003.03739.x; Stewart GR, 2002, COMPAR FUNCT GENOM, V3, P348, DOI 10.1002/cfg.183; Takano H, 2003, GENE, V320, P127, DOI 10.1016/S0378-1119(03)00818-7; Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025; Wu QL, 1997, J BACTERIOL, V179, P2922, DOI 10.1128/jb.179.9.2922-2929.1997; Zdanowski K, 2006, BIOCHEMISTRY-US, V45, P8294, DOI 10.1021/bi060711v; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zuber P, 2004, J BACTERIOL, V186, P1911, DOI 10.1128/JB.186.7.1911-1918.2004	52	7	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43676	10.1371/journal.pone.0043676	http://dx.doi.org/10.1371/journal.pone.0043676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937074	gold, Green Published, Green Submitted			2022-12-25	WOS:000308225500076
J	Lee, YT; Su, TH; Lo, WC; Lyu, PC; Sue, SC				Lee, Yun-Tzai; Su, Tz-Hsiang; Lo, Wei-Cheng; Lyu, Ping-Chiang; Sue, Shih-Che			Circular Permutation Prediction Reveals a Viable Backbone Disconnection for Split Proteins: An Approach in Identifying a New Functional Split Intein	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; SYNECHOCYSTIS SP PCC6803; BETA-LACTAMASE; DNAE INTEIN; DIHYDROFOLATE-REDUCTASE; NOSTOC-PUNCTIFORME; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; IN-VIVO; RESOLUTION	Split-protein systems have emerged as a powerful tool for detecting biomolecular interactions and reporting biological reactions. However, reliable methods for identifying viable split sites are still unavailable. In this study, we demonstrated the feasibility that valid circular permutation (CP) sites in proteins have the potential to act as split sites and that CP prediction can be used to search for internal permissive sites for creating new split proteins. Using a protein ligase, intein, as a model, CP predictor facilitated the creation of circular permutants in which backbone opening imposes the least detrimental effects on intein folding. We screened a series of predicted intein CPs and identified stable and native-fold CPs. When the valid CP sites were introduced as split sites, there was a reduction in folding enthalpy caused by the new backbone opening; however, the coincident loss in entropy was sufficient to be compensated, yielding a favorable free energy for self-association. Since split intein is exploited in protein semi-synthesis, we tested the related protein trans-splicing (PTS) activities of the corresponding split inteins. Notably, a novel functional split intein composed of the N-terminal 36 residues combined with the remaining C-terminal fragment was identified. Its PTS activity was shown to be better than current reported two-piece intein with a short N-terminal segment. Thus, the incorporation of in silico CP prediction facilitated the design of split intein as well as circular permutants.	[Lee, Yun-Tzai; Su, Tz-Hsiang; Lo, Wei-Cheng; Lyu, Ping-Chiang; Sue, Shih-Che] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Sue, Shih-Che] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Lyu, Ping-Chiang] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan; [Lo, Wei-Cheng] Natl Chiao Tung Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Yang Ming Chiao Tung University	Lee, YT (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan.	pclyu@mx.nthu.edu.tw; scsue@life.nthu.edu.tw		Lo, Wei-Cheng/0000-0001-8865-5113	National Science Council (NSC), Taiwan [NSC 100-2627-B-007-006, NSC 100-2627-B-007-011, NSC 100-2627-B-007-019]; NTHU; NSC	National Science Council (NSC), Taiwan(Ministry of Science and Technology, Taiwan); NTHU; NSC(Ministry of Science and Technology, Taiwan)	The authors thank the National Science Council (NSC), Taiwan, for support [NSC 100-2627-B-007-006, NSC 100-2627-B-007-011 and NSC 100-2627-B-007-019]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the NMR facility at NTHU, which is supported by NTHU and NSC.	Aranko AS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005185; Busche AEL, 2009, ANGEW CHEM INT EDIT, V48, P6128, DOI 10.1002/anie.200901488; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Carey J, 2007, PROTEIN SCI, V16, P2317, DOI 10.1110/ps.072985007; Chatani E, 2002, PROTEIN SCI, V11, P72, DOI 10.1101/ps.31102; Cody V, 1998, ANTI-CANCER DRUG DES, V13, P307; CUNNINGHAM BA, 1979, P NATL ACAD SCI USA, V76, P3218, DOI 10.1073/pnas.76.7.3218; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Goddard TD, SPARKY 3; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; GRZESIEK S, 1992, BIOCHEMISTRY-US, V31, P8180, DOI 10.1021/bi00150a009; Heinemann U, 1995, PROG BIOPHYS MOL BIO, V64, P121, DOI 10.1016/0079-6107(95)00013-5; HEINEMANN U, 1995, TRENDS BIOCHEM SCI, V20, P349, DOI 10.1016/S0968-0004(00)89073-8; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; Iwakura M, 2000, NAT STRUCT BIOL, V7, P580, DOI 10.1038/76811; JELSCH C, 1993, PROTEINS, V16, P364, DOI 10.1002/prot.340160406; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Lindqvist Y, 1997, CURR OPIN STRUC BIOL, V7, P422, DOI 10.1016/S0959-440X(97)80061-9; Lo WC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r11; Lo WC, 2012, NUCLEIC ACIDS RES, V40, pW232, DOI 10.1093/nar/gks529; Lo WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031791; Lo WC, 2009, NUCLEIC ACIDS RES, V37, pD328, DOI 10.1093/nar/gkn679; Lo WC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-307; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Martin DD, 2001, BIOCHEMISTRY-US, V40, P1393, DOI 10.1021/bi001786g; METZLER WJ, 1993, BIOCHEMISTRY-US, V32, P13818, DOI 10.1021/bi00213a010; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Muralidharan V, 2006, NAT METHODS, V3, P429, DOI 10.1038/NMETH886; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Oeemig JS, 2009, FEBS LETT, V583, P1451, DOI 10.1016/j.febslet.2009.03.058; Ooi AT, 2006, BIOCHEMISTRY-US, V45, P3620, DOI 10.1021/bi0517032; Paulmurugan R, 2007, ANAL CHEM, V79, P2346, DOI 10.1021/ac062053q; Pelletier JN, 1998, P NATL ACAD SCI USA, V95, P12141, DOI 10.1073/pnas.95.21.12141; Pieper U, 1997, BIOCHEMISTRY-US, V36, P8767, DOI 10.1021/bi9705117; Porter JR, 2008, J AM CHEM SOC, V130, P6488, DOI 10.1021/ja7114579; Qian Z, 2005, J AM CHEM SOC, V127, P13466, DOI 10.1021/ja053932h; RICHARDS FM, 1959, J BIOL CHEM, V234, P1459; Shah NH, 2011, ANGEW CHEM INT EDIT, V50, P6511, DOI 10.1002/anie.201102909; Shi JX, 2005, J AM CHEM SOC, V127, P6198, DOI 10.1021/ja042287w; Stains CI, 2005, J AM CHEM SOC, V127, P10782, DOI 10.1021/ja051969w; Stephen P, 2012, CHEM COMMUN, V48, P2612, DOI 10.1039/c2cc17376j; Sun P, 2005, J MOL BIOL, V353, P1093, DOI 10.1016/j.jmb.2005.09.039; Sun WC, 2004, J BIOL CHEM, V279, P35281, DOI 10.1074/jbc.M405491200; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Vila-Perello M, 2010, CELL, V143, P191, DOI 10.1016/j.cell.2010.09.031; Whitehead TA, 2009, PROTEIN ENG DES SEL, V22, P607, DOI 10.1093/protein/gzp034; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yu Y, 2011, TRENDS BIOTECHNOL, V29, P18, DOI 10.1016/j.tibtech.2010.10.004	50	14	14	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43820	10.1371/journal.pone.0043820	http://dx.doi.org/10.1371/journal.pone.0043820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937103	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500105
J	Thorne, LH; Johnston, DW; Urban, DL; Tyne, J; Bejder, L; Baird, RW; Yin, S; Rickards, SH; Deakos, MH; Mobley, JR; Pack, AA; Hill, MC				Thorne, Lesley H.; Johnston, David W.; Urban, Dean L.; Tyne, Julian; Bejder, Lars; Baird, Robin W.; Yin, Suzanne; Rickards, Susan H.; Deakos, Mark H.; Mobley, Joseph R., Jr.; Pack, Adam A.; Hill, Marie Chapla			Predictive Modeling of Spinner Dolphin (Stenella longirostris) Resting Habitat in the Main Hawaiian Islands	PLOS ONE			English	Article							SPECIES DISTRIBUTION; MAXIMUM-ENTROPY; DISTRIBUTIONS; PREY; PERFORMANCE; DIVERSITY; PATTERNS; PORPOISE; BEHAVIOR	Predictive habitat models can provide critical information that is necessary in many conservation applications. Using Maximum Entropy modeling, we characterized habitat relationships and generated spatial predictions of spinner dolphin (Stenella longirostris) resting habitat in the main Hawaiian Islands. Spinner dolphins in Hawai'i exhibit predictable daily movements, using inshore bays as resting habitat during daylight hours and foraging in offshore waters at night. There are growing concerns regarding the effects of human activities on spinner dolphins resting in coastal areas. However, the environmental factors that define suitable resting habitat remain unclear and must be assessed and quantified in order to properly address interactions between humans and spinner dolphins. We used a series of dolphin sightings from recent surveys in the main Hawaiian Islands and a suite of environmental variables hypothesized as being important to resting habitat to model spinner dolphin resting habitat. The model performed well in predicting resting habitat and indicated that proximity to deep water foraging areas, depth, the proportion of bays with shallow depths, and rugosity were important predictors of spinner dolphin habitat. Predicted locations of suitable spinner dolphin resting habitat provided in this study indicate areas where future survey efforts should be focused and highlight potential areas of conflict with human activities. This study provides an example of a presence-only habitat model used to inform the management of a species for which patterns of habitat availability are poorly understood.	[Thorne, Lesley H.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Thorne, Lesley H.; Johnston, David W.; Bejder, Lars] Duke Univ, Marine Lab, Div Marine Sci & Conservat, Nicholas Sch Environm, Beaufort, NC 28516 USA; [Johnston, David W.; Yin, Suzanne; Rickards, Susan H.; Deakos, Mark H.; Pack, Adam A.; Hill, Marie Chapla] Pacific Islands Photo Identificat Network, Honolulu, HI USA; [Johnston, David W.; Tyne, Julian; Bejder, Lars] Murdoch Univ, Cetacean Res Unit, Ctr Fish Fisheries & Aquat Ecosyst Res, Murdoch, WA 6150, Australia; [Urban, Dean L.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Baird, Robin W.] Cascadia Res Collect, Olympia, WA USA; [Yin, Suzanne; Rickards, Susan H.] Hawaii Marine Mammal Consortium, Kamuela, HI USA; [Deakos, Mark H.] Hawaii Assoc Marine Educ & Res Inc, Lahaina, HI USA; [Deakos, Mark H.; Pack, Adam A.] Dolphin Inst, Honolulu, HI USA; [Mobley, Joseph R., Jr.] Marine Mammal Res Consultants, Honolulu, HI USA; [Pack, Adam A.] Univ Hawaii, Dept Psychol, Hilo, HI 96720 USA; [Pack, Adam A.] Univ Hawaii, Dept Biol, Hilo, HI 96720 USA; [Hill, Marie Chapla] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Duke University; Murdoch University; Duke University; University of Hawaii System; University Hawaii Hilo; University of Hawaii System; University Hawaii Hilo; University of Hawaii System; University of Hawaii Manoa	Thorne, LH (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	lesley.thorne@stonybrook.edu	Bejder, Lars/D-1772-2017; Johnston, David/AAJ-5013-2020; Baird, Robin/Y-8230-2019	Bejder, Lars/0000-0001-8138-8606; Johnston, David/0000-0003-2424-036X; Tyne, Julian/0000-0002-0676-5659; Thorne, Lesley/0000-0002-6297-0091; Baird, Robin/0000-0002-9419-6336	LeBurta Atherton	LeBurta Atherton	Portions of this research were supported by LeBurta Atherton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews KR, 2010, MOL ECOL, V19, P732, DOI 10.1111/j.1365-294X.2010.04521.x; Andrews KR, 2009, THESIS U HAWAII HONO; Bejder L, 2006, ANIM BEHAV, V72, P1149, DOI 10.1016/j.anbehav.2006.04.003; Benoit-Bird KJ, 2004, MAR BIOL, V145, P435, DOI 10.1007/s00227-004-1339-1; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; Berger AL, 1996, COMPUT LINGUIST, V22, P39; Buse J, 2007, BIOL CONSERV, V137, P372, DOI 10.1016/j.biocon.2007.02.025; Carroll C, 1999, CONSERV BIOL, V13, P1344, DOI 10.1046/j.1523-1739.1999.98364.x; Courbis S, 2007, TOURISM MARINE ENV, V4, P1, DOI DOI 10.3727/154427307784835697; Courbis S, 2009, MAR MAMMAL SCI, V25, P430, DOI 10.1111/j.1748-7692.2008.00254.x; Danil Kerri, 2005, Aquatic Mammals, V31, P403, DOI 10.1578/AM.31.4.2005.403; DUKAS R, 1995, ECOLOGY, V76, P1320, DOI 10.2307/1940938; Dunn DC, 2009, MAR ECOL PROG SER, V377, P1, DOI 10.3354/meps07839; Edren SMC, 2010, ECOGRAPHY, V33, P698, DOI 10.1111/j.1600-0587.2009.05901.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; FITCH JE, 1968, J FISH RES BOARD CAN, V25, P2561, DOI 10.1139/f68-227; Friedlaender AS, 2011, DEEP-SEA RES PT II, V58, P1729, DOI 10.1016/j.dsr2.2010.11.018; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hu WY, 2009, MAR RESOUR ECON, V24, P61, DOI 10.1086/mre.24.1.42629645; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Johnston David W., 2008, Journal of Cetacean Research and Management, V10, P59; Karczmarski L, 2005, BEHAV ECOL, V16, P675, DOI 10.1093/beheco/ari028; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Kuffner IB, 2007, ENVIRON BIOL FISH, V78, P71, DOI 10.1007/s10641-006-9078-4; Kumar S., 2009, J ECOLOGY NATURAL EN, V1, P94, DOI 10.5897/ JENE.9000071; Lammers Marc O., 2004, Aquatic Mammals, V30, P237, DOI 10.1578/AM.30.2.2004.237; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; Moura AE, 2012, ACTA OECOL, V38, P24, DOI 10.1016/j.actao.2011.08.006; Norris K.S., 1994, HAWAIIAN SPINNER DOL; NORRIS KS, 1980, FISH B-NOAA, V77, P821; Notarbartolo di Sciara G, 2008, J MAR BIOL ASSOC UK, V89, P211; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; PERRIN WF, 1973, FISH B-NOAA, V71, P1077; Perrin WF, 1999, MAR MAMMAL SCI, V15, P1029, DOI 10.1111/j.1748-7692.1999.tb00876.x; PERRIN WF, 1990, P BIOL SOC WASH, V103, P453; Perrin William F., 1998, Mammalian Species, V599, P1; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; POOLE M, 1995, THESIS U CALIFORNIA; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; REID SB, 1991, MAR BIOL, V109, P427, DOI 10.1007/BF01313508; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SMOLKER RA, 1992, BEHAVIOUR, V123, P38, DOI 10.1163/156853992X00101; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; Vierling KT, 2008, FRONT ECOL ENVIRON, V6, P90, DOI 10.1890/070001; Wilson MFJ, 2007, MAR BIOL, V15; Yost AC, 2008, ECOL INFORM, V3, P375, DOI 10.1016/j.ecoinf.2008.08.004	59	52	57	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43167	10.1371/journal.pone.0043167	http://dx.doi.org/10.1371/journal.pone.0043167			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937022	Green Published, gold			2022-12-25	WOS:000308225500034
J	Wium, E; Dulhunty, AF; Beard, NA				Wium, Elize; Dulhunty, Angela F.; Beard, Nicole A.			A Skeletal Muscle Ryanodine Receptor Interaction Domain in Triadin	PLOS ONE			English	Article							RETICULUM GLYCOPROTEIN TRIADIN; SARCOPLASMIC-RETICULUM; CALCIUM-RELEASE; BIOCHEMICAL-CHARACTERIZATION; LUMINAL CA2+; BETA-STRAND; CALSEQUESTRIN; JUNCTIN; BINDING; PROTEIN	Excitation-contraction coupling in skeletal muscle depends, in part, on a functional interaction between the ligand-gated ryanodine receptor (RyR1) and integral membrane protein Trisk 95, localized to the sarcoplasmic reticulum membrane. Various domains on Trisk 95 can associate with RyR1, yet the domain responsible for regulating RyR1 activity has remained elusive. We explored the hypothesis that a luminal Trisk 95 KEKE motif (residues 200-232), known to promote RyR1 binding, may also form the RyR1 activation domain. Peptides corresponding to Trisk 95 residues 200-232 or 200-231 bound to RyR1 and increased the single channel activity of RyR1 by 1.49 +/- 0.11-fold and 1.8 +/- 0.15-fold respectively, when added to its luminal side. A similar increase in [H-3] ryanodine binding, which reflects open probability of the channels, was also observed. This RyR1 activation is similar to activation induced by full length Trisk 95. Circular dichroism showed that both peptides were intrinsically disordered, suggesting a defined secondary structure is not necessary to mediate RyR1 activation. These data for the first time demonstrate that Trisk 959s 200-231 region is responsible for RyR1 activation. Furthermore, it shows that no secondary structure is required to achieve this activation, the Trisk 95 residues themselves are critical for the Trisk 95-RyR1 interaction.	[Wium, Elize; Dulhunty, Angela F.; Beard, Nicole A.] John Curtin Sch Med Res, Canberra, ACT, Australia	Australian National University; John Curtin School of Medical Research	Wium, E (corresponding author), John Curtin Sch Med Res, Canberra, ACT, Australia.	nicole.beard@anu.edu.au	Dulhunty, Angela/AAO-5421-2020	Dulhunty, Angela/0000-0001-9493-4944	Australian Research Council [DP1094219]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council (DP1094219 to A.F.D. and N.A.B.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard NA, 2005, BIOPHYS J, V88, P3444, DOI 10.1529/biophysj.104.051441; Beard NA, 2002, BIOPHYS J, V82, P310, DOI 10.1016/S0006-3495(02)75396-4; Beard NA, 2008, CELL CALCIUM, V44, P363, DOI 10.1016/j.ceca.2008.01.005; Caswell AH, 1999, BIOCHEMISTRY-US, V38, P90, DOI 10.1021/bi981306+; CASWELL AH, 1991, BIOCHEMISTRY-US, V30, P7507, DOI 10.1021/bi00244a020; Chopra N, 2009, P NATL ACAD SCI USA, V106, P7636, DOI 10.1073/pnas.0902919106; Fan GC, 2007, BIOCHEM BIOPH RES CO, V352, P617, DOI 10.1016/j.bbrc.2006.11.093; Goonasekera SA, 2007, J GEN PHYSIOL, V130, P365, DOI 10.1085/jgp.200709790; Guo W, 1996, J BIOL CHEM, V271, P458, DOI 10.1074/jbc.271.1.458; GUO W, 1995, J BIOL CHEM, V270, P9027, DOI 10.1074/jbc.270.16.9027; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; Gyorke I, 1998, BIOPHYS J, V75, P2801, DOI 10.1016/S0006-3495(98)77723-9; HYMEL L, 1988, P NATL ACAD SCI USA, V85, P441, DOI 10.1073/pnas.85.2.441; Kimura T, 2007, BIOCHEM J, V401, P317, DOI 10.1042/BJ20060686; KNUDSON CM, 1993, J BIOL CHEM, V268, P12637; KNUDSON CM, 1993, J BIOL CHEM, V268, P12646; Kobayashi YM, 2000, J BIOL CHEM, V275, P17639, DOI 10.1074/jbc.M002091200; Kobayashi YM, 1999, J BIOL CHEM, V274, P28660, DOI 10.1074/jbc.274.40.28660; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; Lan W, 2009, CELL CALCIUM, V45, P474, DOI 10.1016/j.ceca.2009.03.006; LAVER DR, 1995, J MEMBRANE BIOL, V147, P7; Lee HG, 2001, J BIOL CHEM, V276, P39533, DOI 10.1074/jbc.M010664200; Lee JM, 2004, J BIOL CHEM, V279, P6994, DOI 10.1074/jbc.M312446200; LIU GH, 1994, J BIOL CHEM, V269, P33028; Marty I, 2009, J PHYSIOL-LONDON, V587, P3117, DOI 10.1113/jphysiol.2009.171892; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; NAGESH N, 1995, J BIOCHEM BIOPH METH, V30, P1, DOI 10.1016/0165-022X(94)00057-K; OSTERMAN DG, 1985, J CELL BIOCHEM, V29, P57, DOI 10.1002/jcb.240290202; PERUTZ M, 1994, PROTEIN SCI, V3, P1629, DOI 10.1002/pro.5560031002; REALINI C, 1994, FEBS LETT, V348, P109, DOI 10.1016/0014-5793(94)00569-9; Shen XH, 2007, J BIOL CHEM, V282, P37864, DOI 10.1074/jbc.M705702200; Shin DW, 2000, FEBS LETT, V486, P178, DOI 10.1016/S0014-5793(00)02246-8; Thevenon D, 2003, BIOCHEM BIOPH RES CO, V303, P669, DOI 10.1016/S0006-291X(03)00406-6; Vassilopoulos S, 2005, J BIOL CHEM, V280, P28601, DOI 10.1074/jbc.M501484200; Wang Y, 2009, CELL CALCIUM, V45, P29, DOI 10.1016/j.ceca.2008.05.006; Wei L, 2006, BIOPHYS J, V91, P1288, DOI 10.1529/biophysj.106.082610; Wei L, 2009, INT J BIOCHEM CELL B, V41, P2214, DOI 10.1016/j.biocel.2009.04.017; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389	38	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43817	10.1371/journal.pone.0043817	http://dx.doi.org/10.1371/journal.pone.0043817			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937102	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500104
J	Xu, Y				Xu, Yong			Quaternion-Based Discriminant Analysis Method for Color Face Recognition	PLOS ONE			English	Article							SINGULAR-VALUE DECOMPOSITION; ALGORITHMS; MATRICES; SIGNAL	Pattern recognition techniques have been used to automatically recognize the objects, personal identities, predict the function of protein, the category of the cancer, identify lesion, perform product inspection, and so on. In this paper we propose a novel quaternion-based discriminant method. This method represents and classifies color images in a simple and mathematically tractable way. The proposed method is suitable for a large variety of real-world applications such as color face recognition and classification of the ground target shown in multispectrum remote images. This method first uses the quaternion number to denote the pixel in the color image and exploits a quaternion vector to represent the color image. This method then uses the linear discriminant analysis algorithm to transform the quaternion vector into a lower-dimensional quaternion vector and classifies it in this space. The experimental results show that the proposed method can obtain a very high accuracy for color face recognition.	[Xu, Yong] Harbin Inst Technol, Shenzhen Grad Sch, Biocomp Res Ctr, Shenzhen, Guangdong, Peoples R China; [Xu, Yong] Key Lab Network Oriented Intelligent Computat, Shenzhen, Peoples R China	Harbin Institute of Technology; University Town of Shenzhen	Xu, Y (corresponding author), Harbin Inst Technol, Shenzhen Grad Sch, Biocomp Res Ctr, Shenzhen, Guangdong, Peoples R China.	laterfall2@yahoo.com.cn			Program for New Century Excellent Talents in University [NCET-08-0156]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was partially supported by Program for New Century Excellent Talents in University (NCET-08-0156). No additional external funding was received for this study.	Angulo J, 2009, LECT NOTES COMPUT SC, V5646, P91, DOI 10.1007/978-3-642-03265-3_10; Chengjun L, 2008, IEEE T INFORM FORENS, V3; Choi JY, 2012, IEEE T IMAGE PROCESS, V21, P1366, DOI 10.1109/TIP.2011.2168413; Denis P, 2007, COMPUT VIS IMAGE UND, V107, P74, DOI 10.1016/j.cviu.2006.11.019; Felsberg M, 1999, LECT NOTES COMPUT SC, V1689, P209; Hypercomplex BT, 1999, SPECTRAL SIGNAL REPR; Janovska D, 2008, WORLD ACAD SCI ENG T, V47, P141; Jones CF, 2004, EURASIP J APPL SIG P, V2004, P522, DOI 10.1155/S1110865704401073; Kittler J, 2004, LECT NOTES COMPUT SC, V3077, P354; Le Bihan N, 2004, SIGNAL PROCESS, V84, P1177, DOI 10.1016/j.sigpro.2004.04.001; Le Bihan N, 2002, QUATERNION SUBSPACE, P637; Le Bihan N, 2003, P 2003 INT C IM PROC; Lilong S, 2008, QUATERNION COLOR CUR, P338; Liu ZM, 2008, IEEE T IMAGE PROCESS, V17, P1975, DOI 10.1109/TIP.2008.2002837; Miron S, 2006, IEEE T SIGNAL PROCES, V54, P1218, DOI 10.1109/TSP.2006.870630; Neagoe V.E., 2006, WSEAS T SIGNAL PROCE, V2; Sangwine SJ, 1998, ELECTRON LETT, V34, P969, DOI 10.1049/el:19980697; Sangwine SJ, 2006, APPL MATH COMPUT, V182, P727, DOI 10.1016/j.amc.2006.04.032; Shi LL, 2007, COMPUT VIS IMAGE UND, V107, P88, DOI 10.1016/j.cviu.2006.11.014; Shih PC, 2006, IEEE IMAGE PROC, P1001, DOI 10.1109/ICIP.2006.312668; Soo C, 2003, P 2003 INT C IM PROC; Soo-Chang P, 2001, IEEE T SIGNAL PROCES, V49; Soo-Chang P, 1997, IEEE T COMMUNICATION, V45; Soo-Chang P., 2004, IEEE T SIGNAL PROCES, V52; Suhre A, 2011, OPT ENG, V50, DOI 10.1117/1.3574071; Tsagaris V, 2009, OPT ENG, V48, DOI 10.1117/1.3153331; Wang SJ, 2012, IEEE T NEUR NET LEAR, V23, P876, DOI 10.1109/TNNLS.2012.2191620; Wang SJ, 2011, IEEE T IMAGE PROCESS, V20, P2490, DOI 10.1109/TIP.2011.2121084; Xu Y, 2007, NEUROCOMPUTING, V70, P1056, DOI 10.1016/j.neucom.2006.09.005; Yang J, 2008, IEEE T NEURAL NETWOR, V19, P2088, DOI 10.1109/TNN.2008.2003187; Yihui Y, 2011, OPTICAL ENG, V50; Yong X, 2003, PATTERN RECOGNITION, V36; Yong X, 2008, NEUROCOMPUTING, V71; Yong X, 2010, PATTERN RECOGNITION, V43; Zhang D., 2008, ADV PATTERN RECOGNIT; Zhang FZ, 1997, LINEAR ALGEBRA APPL, V251, P21, DOI 10.1016/0024-3795(95)00543-9; Zhiming L, 2010, PATTERN RECOGNITION, V43	38	6	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43493	10.1371/journal.pone.0043493	http://dx.doi.org/10.1371/journal.pone.0043493			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937054	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500055
J	Barroilhet, L; Yang, J; Hasselblatt, K; Paranal, RM; Ng, SK; Rauh-Hain, JA; Welch, WR; Bradner, JE; Berkowitz, RS; Ng, SW				Barroilhet, L.; Yang, J.; Hasselblatt, K.; Paranal, R. M.; Ng, S-K; Rauh-Hain, J. A.; Welch, W. R.; Bradner, J. E.; Berkowitz, R. S.; Ng, S-W			C-terminal binding protein-2 regulates response of epithelial ovarian cancer cells to histone deacetylase inhibitors	ONCOGENE			English	Article						ovarian cancer; tumor antigens; HDAC inhibitors	TRANSCRIPTIONAL COREPRESSOR; BETA-CATENIN; CTBP; REPRESSOR; BINDING-PROTEIN-1; ASSOCIATION	Ovarian cancer survival rates have stagnated in the last 20 years despite the development of novel chemotherapeutic agents. Modulators of gene expression, such as histone deacetylase (HDAC) inhibitors, are among the new agents being used in clinical trials. Predictors of sensitivity to chemotherapy have remained elusive. In this study, we show that the expression of the transcriptional corepressor C-terminal binding protein-2 (CtBP2) is elevated in human ovarian tumors. Downregulation of CtBP2 expression in ovarian cancer cell lines using short-hairpin RNA strategy suppressed the growth rate and migration of the resultant cancer cells. The knockdown cell lines also showed upregulation of HDAC activity and increased sensitivity to selected HDAC inhibitors. Conversely, forced expression of wild-type CtBP2 in the knockdown cell lines reversed HDAC activity and partially rescued cellular sensitivity to the HDAC inhibitors. We propose that CtBP2 is an ovarian cancer oncogene that regulates gene expression program by modulating HDAC activity. CtBP2 expression may be a surrogate indicator of cellular sensitivity to HDAC inhibitors.	[Barroilhet, L.; Yang, J.; Hasselblatt, K.; Rauh-Hain, J. A.; Berkowitz, R. S.; Ng, S-W] Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [Paranal, R. M.; Bradner, J. E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Ng, S-K] Griffith Univ, Griffith Hlth Inst, Sch Med, Meadowbrook, Qld 4131, Australia; [Welch, W. R.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Griffith University; Menzies Health Institute Queensland; Harvard University; Brigham & Women's Hospital	Ng, SW (corresponding author), Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, 221 Longwood Ave BLI-449A, Boston, MA 02115 USA.	sng@partners.org		Ng, Shu Kay/0000-0002-6865-9384	Ruth N White Gynecologic Oncology Research Fellowship; Robert and Deborah First Fund; Sperling Family Fund Foundation; Women's Cancer Program; Gillette Center for Women's Cancer from Dana-Farber Cancer Institute; Ovarian Cancer Research Foundation; Adler Foundation, Inc.; Friends of Dana-Farber Cancer Institute	Ruth N White Gynecologic Oncology Research Fellowship; Robert and Deborah First Fund; Sperling Family Fund Foundation; Women's Cancer Program; Gillette Center for Women's Cancer from Dana-Farber Cancer Institute; Ovarian Cancer Research Foundation; Adler Foundation, Inc.; Friends of Dana-Farber Cancer Institute	We thank critical reading of the manuscript by Professor YF Wong. We acknowledge the provision of belinostat, vorinostat, MGCD0103 from Selleck Inc. LB was supported by Ruth N White Gynecologic Oncology Research Fellowship. The Laboratory of Gynecologic Oncology was partly supported by Robert and Deborah First Fund, the Sperling Family Fund Foundation, Women's Cancer Program and Gillette Center for Women's Cancer from Dana-Farber Cancer Institute, Ovarian Cancer Research Foundation, Adler Foundation, Inc., and Friends of Dana-Farber Cancer Institute.	Altekruse SF, 2010, SEER CANC STAT REV 1; BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Cuilliere-Dartigues P, 2006, ONCOGENE, V25, P4441, DOI 10.1038/sj.onc.1209471; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Engers R, 2000, J CANCER RES CLIN, V126, P682, DOI 10.1007/s004320000148; Fang M, 2006, EMBO J, V25, P2735, DOI 10.1038/sj.emboj.7601153; Fournel M, 2008, MOL CANCER THER, V7, P759, DOI 10.1158/1535-7163.MCT-07-2026; Glaser KB, 2007, BIOCHEM PHARMACOL, V74, P659, DOI 10.1016/j.bcp.2007.04.007; Grooteclaes M, 2003, P NATL ACAD SCI USA, V100, P4568, DOI 10.1073/pnas.0830998100; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Hamada F, 2004, DEV CELL, V7, P677, DOI 10.1016/j.devcel.2004.08.022; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Huang KC, 2006, INT J CANCER, V118, P2433, DOI 10.1002/ijc.21671; Katsanis N, 1998, GENOMICS, V47, P294, DOI 10.1006/geno.1997.5115; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Tang LD, 2010, EUR J CANCER, V46, P170, DOI 10.1016/j.ejca.2009.10.003; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhang CL, 2001, J BIOL CHEM, V276, P35, DOI 10.1074/jbc.M007364200; Zhao LJ, 2006, J BIOL CHEM, V281, P4183, DOI 10.1074/jbc.M509051200	29	25	26	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 15	2013	32	33					3896	3903		10.1038/onc.2012.380	http://dx.doi.org/10.1038/onc.2012.380			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	202JH	22945647				2022-12-25	WOS:000323210200012
J	Ramakrishnan, NA; Drescher, MJ; Khan, KM; Hatfield, JS; Drescher, DG				Ramakrishnan, Neeliyath A.; Drescher, Marian J.; Khan, Khalid M.; Hatfield, James S.; Drescher, Dennis G.			HCN1 and HCN2 Proteins Are Expressed in Cochlear Hair Cells HCN1 CAN FORM A TERNARY COMPLEX WITH PROTOCADHERIN 15 CD3 AND F-ACTIN-BINDING FILAMIN A OR CAN INTERACT WITH HCN2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERPOLARIZATION-ACTIVATED CHANNEL; INWARDLY RECTIFYING CURRENTS; NUCLEOTIDE-GATED CHANNELS; MOUSE INNER-EAR; PACEMAKER CHANNELS; MECHANOELECTRICAL TRANSDUCTION; MOLECULAR CHARACTERIZATION; INSTANTANEOUS CURRENT; MAMMALIAN COCHLEA; CATION CHANNELS	A unique coupling between HCN1 and stereociliary tip-link protein protocadherin 15 has been described for a teleost vestibular hair-cell model and mammalian organ of Corti (OC) (Ramakrishnan, N. A., Drescher, M. J., Barretto, R. L., Beisel, K. W., Hatfield, J. S., and Drescher, D. G. (2009) J. Biol. Chem. 284, 3227-3238). We now show that Ca2+-dependent interaction of the organ of Corti HCN1 and protocadherin 15 CD3 is mediated by amino-terminal sequence specific to HCN1 and is not replicated by analogous specific peptides for HCN2 or HCN4 nor by amino-terminal sequence conserved across HCN isoforms utilized in channel formation. Furthermore, the HCN1-specific peptide binds both phosphatidylinositol (3,4,5)-trisphosphate and phosphatidylinositol (4,5)-bisphosphate but not phosphatidylinositol 4-phosphate. Singly isolated cochlear inner and outer hair cells express HCN1 transcript, and HCN1 and HCN2 protein is immunolocalized to hair-cell stereocilia by both z-stack confocal and pre-embedding EM immunogold microscopy, with stereociliary tip-link and subcuticular plate sites. Quantitative PCR indicates HCN1/HCN2/HCN3/HCN4 = 9:9:1:89 in OC of the wild-type mouse, with HCN4 protein primarily attributable to inner sulcus cells. A mutant form of HCN1 mRNA and protein is expressed in the OC of an HCN1 mutant, corresponding to a full-length sequence with the in-frame deletion of pore-S6 domains, predicted by construct. The mutant transcript of HCN1 is similar to 9-fold elevated relative to wild-type levels, possibly representing molecular compensation, with unsubstantial changes in HCN2, HCN3, and HCN4. Immunoprecipitation protocols indicate alternate interactions of full-length proteins; HCN1 can interact with protocadherin 15 CD3 and F-actin-binding filamin A forming a complex that does not include HCN2, or HCN1 can interact with HCN2 forming a complex without protocadherin 15 CD3 but including F-actin-binding fascin-2.	[Ramakrishnan, Neeliyath A.; Drescher, Marian J.; Drescher, Dennis G.] Wayne State Univ, Sch Med, Lab Biootol, Dept Otolaryngol, Detroit, MI 48201 USA; [Khan, Khalid M.] Kuwait Univ, Fac Med, Dept Anat, Safat 13110, Kuwait; [Hatfield, James S.] Vet Affairs Med Ctr, Electron Microscopy Lab, Detroit, MI 48201 USA; [Drescher, Dennis G.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	Wayne State University; Kuwait University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Wayne State University	Drescher, MJ (corresponding author), Wayne State Univ, Sch Med, Lab Biootol, Dept Otolaryngol, 261 Lande Med Res Bldg,540 E Canfield Ave, Detroit, MI 48201 USA.	mdresche@med.wayne.edu			National Institutes of Health [R01 DC004076, R01 DC000156]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004076, R01DC000156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DC004076 (to M. J. D.) and R01 DC000156 (to D. G. D.).	Ahmed ZM, 2003, HUM MOL GENET, V12, P3215, DOI 10.1093/hmg/ddg358; Azene EM, 2005, CARDIOVASC RES, V67, P263, DOI 10.1016/j.cardiores.2005.03.006; Barrow AJ, 2009, J NEUROSCI, V29, P5841, DOI 10.1523/JNEUROSCI.5746-08.2009; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Calloe K, 2005, BIOPHYS J, V89, P2159, DOI 10.1529/biophysj.105.063792; Cao XJ, 2011, J NEUROPHYSIOL, V106, P630, DOI 10.1152/jn.00015.2010; Chen XD, 2010, J NEUROSCI, V30, P2611, DOI 10.1523/JNEUROSCI.3771-09.2010; Cho WJ, 2003, NEUROSCIENCE, V118, P525, DOI 10.1016/S0306-4522(02)00913-2; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Crumling MA, 2009, NEUROSCIENCE, V161, P1144, DOI 10.1016/j.neuroscience.2009.02.076; Decher N, 2003, PFLUG ARCH EUR J PHY, V446, P633, DOI 10.1007/s00424-003-1127-7; Drescher Dennis G., 2009, V493, P323, DOI 10.1007/978-1-59745-523-7_20; Drescher MJ, 2010, NEUROSCIENCE, V171, P1054, DOI 10.1016/j.neuroscience.2010.09.051; Drescher MJ, 2002, MOL BRAIN RES, V98, P1, DOI 10.1016/S0169-328X(01)00289-3; Ehrlicher AJ, 2011, NATURE, V478, P260, DOI 10.1038/nature10430; Emery EC, 2011, SCIENCE, V333, P1462, DOI 10.1126/science.1206243; Farris HE, 2006, J NEUROSCI, V26, P12526, DOI 10.1523/JNEUROSCI.3569-06.2006; Gagnon LH, 2006, J NEUROSCI, V26, P10188, DOI 10.1523/JNEUROSCI.2166-06.2006; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Grati M, 2011, P NATL ACAD SCI USA, V108, P11476, DOI 10.1073/pnas.1104161108; Gravante B, 2004, J BIOL CHEM, V279, P43847, DOI 10.1074/jbc.M401598200; HACKNEY CM, 1992, P ROY SOC B-BIOL SCI, V248, P215, DOI 10.1098/rspb.1992.0064; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; HOLT JR, 1995, J NEUROPHYSIOL, V73, P1484, DOI 10.1152/jn.1995.73.4.1484; Homma K, 2010, BBA-BIOMEMBRANES, V1798, P1029, DOI 10.1016/j.bbamem.2010.02.001; Horwitz GC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008627; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Jagger DJ, 1999, PFLUG ARCH EUR J PHY, V438, P8, DOI 10.1007/s004240050873; Karasawa T, 2008, J CELL SCI, V121, P2871, DOI 10.1242/jcs.023705; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Knop GC, 2008, EUR J NEUROSCI, V28, P2221, DOI 10.1111/j.1460-9568.2008.06512.x; KOLESNIKOV SS, 1991, FEBS LETT, V290, P167, DOI 10.1016/0014-5793(91)81251-3; Lin W, 2007, BIOPHYS J, V92, P1559, DOI 10.1529/biophysj.106.092478; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Macri V, 2004, J BIOL CHEM, V279, P16832, DOI 10.1074/jbc.M400518200; Macri V, 2002, J BIOL CHEM, V277, P35939, DOI 10.1074/jbc.M203485200; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; Marcotti W, 2006, J PHYSIOL-LONDON, V574, P677, DOI 10.1113/jphysiol.2005.095661; Mistrik P, 2006, PFLUG ARCH EUR J PHY, V452, P718, DOI 10.1007/s00424-006-0095-0; MOCKETT BG, 1994, J NEUROSCI, V14, P6992; Much B, 2003, J BIOL CHEM, V278, P43781, DOI 10.1074/jbc.M306958200; Mukherjea D, 2008, J NEUROSCI, V28, P13056, DOI 10.1523/JNEUROSCI.1307-08.2008; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Oh CK, 1999, MOL BRAIN RES, V70, P135, DOI 10.1016/S0169-328X(99)00110-2; Pian P, 2007, PFLUG ARCH EUR J PHY, V455, P125, DOI 10.1007/s00424-007-0295-2; Proenza C, 2006, J GEN PHYSIOL, V127, P183, DOI 10.1085/jgp.200509389; Proenza C, 2002, J BIOL CHEM, V277, P5101, DOI 10.1074/jbc.M106974200; Ramakrishnan NA, 2009, J BIOL CHEM, V284, P3227, DOI 10.1074/jbc.M806177200; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; Seiler C, 2005, DEVELOPMENT, V132, P615, DOI 10.1242/dev.01591; Selvakumar D, 2012, BIOCHEM J, V443, P463, DOI 10.1042/BJ20111255; Steigelman KA, 2011, J NEUROSCI, V31, P12241, DOI 10.1523/JNEUROSCI.6531-10.2011; Stepanyan RS, 2011, JARO-J ASSOC RES OTO, V12, P729, DOI 10.1007/s10162-011-0288-x; Sugihara I, 1996, J PHYSIOL-LONDON, V495, P665, DOI 10.1113/jphysiol.1996.sp021624; Tran N, 2002, J BIOL CHEM, V277, P43588, DOI 10.1074/jbc.M208477200; Trapani JG, 2011, J NEUROSCI, V31, P1614, DOI 10.1523/JNEUROSCI.3369-10.2011; van Aken AFJ, 2008, J PHYSIOL-LONDON, V586, P5403, DOI 10.1113/jphysiol.2008.156992; van Netten SM, 2009, PFLUG ARCH EUR J PHY, V458, P273, DOI 10.1007/s00424-008-0617-z; Webb SW, 2011, DEVELOPMENT, V138, P1607, DOI 10.1242/dev.060061; Ye B, 2009, J BIOL CHEM, V284, P25553, DOI 10.1074/jbc.M109.007583; Yi EY, 2010, J NEUROPHYSIOL, V103, P2532, DOI 10.1152/jn.00506.2009	62	25	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.375832	http://dx.doi.org/10.1074/jbc.M112.375832			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22948144	Green Published, hybrid			2022-12-25	WOS:000310642200005
J	Ford, CG; Kolappan, S; Phan, HTH; Waldor, MK; Winther-Larsen, HC; Craig, L				Ford, Christopher G.; Kolappan, Subramaniapillai; Phan, Hanh T. H.; Waldor, Matthew K.; Winther-Larsen, Hanne C.; Craig, Lisa			Crystal Structures of a CTX phi pIII Domain Unbound and in Complex with a Vibrio cholerae TolA Domain Reveal Novel Interaction Interfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MINOR COAT PROTEIN; FILAMENTOUS PHAGE INFECTION; SINGLE-STRANDED-DNA; N-TERMINAL DOMAINS; ESCHERICHIA-COLI; COLONIZATION FACTOR; BACTERIOPHAGE FD; PILUS; PENETRATION; SITE	Vibrio cholerae colonize the small intestine where they secrete cholera toxin, an ADP-ribosylating enzyme that is responsible for the voluminous diarrhea characteristic of cholera disease. The genes encoding cholera toxin are located on the genome of the filamentous bacteriophage, CTX phi, that integrates as a prophage into the V. cholerae chromosome. CTX phi infection of V. cholerae requires the toxin-coregulated pilus and the periplasmic protein TolA. This infection process parallels that of Escherichia coli infection by the Ff family of filamentous coliphage. Here we demonstrate a direct interaction between the N-terminal domain of the CTX phi minor coat protein pIII (pIII-N1) and the C-terminal domain of TolA (TolA-C) and present x-ray crystal structures of pIII-N1 alone and in complex with TolA-C. The structures of CTX phi pIII-N1 and V. cholerae TolA-C are similar to coliphage pIII-N1 and E. coli TolA-C, respectively, yet these proteins bind via a distinct interface that in E. coli TolA corresponds to a colicin binding site. Our data suggest that the TolA binding site on pIII-N1 of CTX phi is accessible in the native pIII protein. This contrasts with the Ff family phage, where the TolA binding site on pIII is blocked and requires a pilus-induced unfolding event to become exposed. We propose that CTX phi pIII accesses the periplasmic TolA through retraction of toxin-coregulated pilus, which brings the phage through the outer membrane pilus secretin channel. These data help to explain the process by which CTX phi converts a harmless marine microbe into a deadly human pathogen.	[Ford, Christopher G.; Kolappan, Subramaniapillai; Craig, Lisa] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Phan, Hanh T. H.; Winther-Larsen, Hanne C.] Univ Oslo, Sch Pharm, N-0316 Oslo, Norway; [Phan, Hanh T. H.; Winther-Larsen, Hanne C.] Univ Oslo, Lab Microbial Dynam, N-0316 Oslo, Norway; [Waldor, Matthew K.] Harvard Univ, Div Infect Dis, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Waldor, Matthew K.] Howard Hughes Med Inst, Boston, MA 02115 USA	Simon Fraser University; University of Oslo; University of Oslo; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Craig, L (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	licraig@sfu.ca		Craig, Lisa/0000-0001-8515-9915; Waldor, Matthew/0000-0003-1843-7000	Natural Sciences and Engineering Research Council; National Institutes of Health [NIH R37 AI-42347]; Howard Hughes Medical Institute; Kristine Bonnevie fellowship; EMBIO fellowship; University of Oslo; Research Council of Norway; Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042347] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Kristine Bonnevie fellowship; EMBIO fellowship; University of Oslo; Research Council of Norway(Research Council of Norway); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Natural Sciences and Engineering Research Council, National Institutes of Health Grant NIH R37 AI-42347, and the Howard Hughes Medical Institute.; Supported in part by the Kristine Bonnevie and EMBIO fellowships, University of Oslo, and by the Research Council of Norway.; Supported by a New Investigator Award from the Canadian Institutes of Health Research and a Scholar Award from the Michael Smith Foundation for Health Research. To whom correspondence should be addressed. Tel.: 778-782-7140; Fax: 778-782-5583; E-mail: licraig@sfu.ca.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bennett NJ, 2006, J MOL BIOL, V356, P266, DOI 10.1016/j.jmb.2005.11.069; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Cascales E, 2001, MOL MICROBIOL, V42, P795, DOI 10.1046/j.1365-2958.2001.02673.x; Clarke M, 2008, DANCING TIMES, V98, P105; Click EM, 1998, J BACTERIOL, V180, P1723, DOI 10.1128/JB.180.7.1723-1728.1998; CRISSMAN JW, 1984, VIROLOGY, V132, P445, DOI 10.1016/0042-6822(84)90049-7; Davis BM, 2000, J BACTERIOL, V182, P6992, DOI 10.1128/JB.182.24.6992-6998.2000; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deng LW, 1999, VIROLOGY, V253, P271, DOI 10.1006/viro.1998.9509; Deng LW, 2002, J MOL BIOL, V319, P603, DOI 10.1016/S0022-2836(02)00260-7; DEZWAIG RN, 1967, J BACTERIOL, V94, P1112, DOI 10.1128/JB.94.4.1112-1123.1967; DIRITA VJ, 1991, P NATL ACAD SCI USA, V88, P5403, DOI 10.1073/pnas.88.12.5403; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan QR, 1997, NATURE, V389, P96, DOI 10.1038/38028; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Goemaere EL, 2007, J MOL BIOL, V366, P1424, DOI 10.1016/j.jmb.2006.12.020; GOLDBERG I, 1986, J BACTERIOL, V165, P723, DOI 10.1128/jb.165.3.723-731.1986; Gonzalez A, 2008, J APPL CRYSTALLOGR, V41, P176, DOI 10.1107/S0021889807057822; GRANT RA, 1981, J BIOL CHEM, V256, P539; GRAY CW, 1981, J MOL BIOL, V146, P621, DOI 10.1016/0022-2836(81)90050-4; Heilpern AJ, 2000, J BACTERIOL, V182, P1739, DOI 10.1128/JB.182.6.1739-1747.2000; Heilpern AJ, 2003, J BACTERIOL, V185, P1037, DOI 10.1128/JB.185.3.1037-1044.2003; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487; Holliger P, 1997, STRUCTURE, V5, P265, DOI 10.1016/S0969-2126(97)00184-6; Holliger P, 1999, J MOL BIOL, V288, P649, DOI 10.1006/jmbi.1999.2720; HUFF JP, 1990, BIOTECHNIQUES, V9, P570; JACOBSON A, 1972, J VIROL, V10, P835, DOI 10.1128/JVI.10.4.835-843.1972; Jakob RP, 2012, MOL MICROBIOL, V84, P1124, DOI 10.1111/j.1365-2958.2012.08079.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karaolis DKR, 1998, P NATL ACAD SCI USA, V95, P3134, DOI 10.1073/pnas.95.6.3134; Kirn TJ, 2003, MOL MICROBIOL, V49, P81, DOI 10.1046/j.1365-2958.2003.03546.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAZZARONI JC, 1981, J BACTERIOL, V145, P1351, DOI 10.1128/JB.145.3.1351-1358.1981; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; LEVENGOOD SK, 1991, P NATL ACAD SCI USA, V88, P5939, DOI 10.1073/pnas.88.14.5939; Li C, 2012, J BIOL CHEM, V287, P19048, DOI 10.1074/jbc.M112.342246; LOPEZ J, 1982, J VIROL, V42, P1099, DOI 10.1128/JVI.42.3.1099-1107.1982; Lorenz SH, 2011, J MOL BIOL, V405, P989, DOI 10.1016/j.jmb.2010.11.030; Lubkowski J, 1999, STRUCTURE, V7, P711, DOI 10.1016/S0969-2126(99)80092-6; Lubkowski J, 1998, NAT STRUCT BIOL, V5, P140, DOI 10.1038/nsb0298-140; Martin A, 2003, J MOL BIOL, V331, P1131, DOI 10.1016/S0022-2836(03)00864-7; Marvin DA, 1998, CURR OPIN STRUC BIOL, V8, P150, DOI 10.1016/S0959-440X(98)80032-8; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Megli CJ, 2011, J MOL BIOL, V409, P146, DOI 10.1016/j.jmb.2011.03.027; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PEARSON GDN, 1993, P NATL ACAD SCI USA, V90, P3750, DOI 10.1073/pnas.90.8.3750; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rakonjac J, 1998, J MOL BIOL, V282, P25, DOI 10.1006/jmbi.1998.2006; Rakonjac J, 2011, CURR ISSUES MOL BIOL, V13, P51, DOI 10.21775/cimb.013.051; Riechmann L, 1997, CELL, V90, P351, DOI 10.1016/S0092-8674(00)80342-6; RUSSEL M, 1988, J BACTERIOL, V170, P5312, DOI 10.1128/jb.170.11.5312-5316.1988; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; Scott Jamie K., 1994, Current Opinion in Biotechnology, V5, P40, DOI 10.1016/S0958-1669(05)80068-0; Skorupski K, 1997, MOL MICROBIOL, V25, P1003, DOI 10.1046/j.1365-2958.1997.5481909.x; STENGELE I, 1990, J MOL BIOL, V212, P143, DOI 10.1016/0022-2836(90)90311-9; Sturgis JN, 2001, J MOL MICROB BIOTECH, V3, P113; SUN TP, 1986, J BACTERIOL, V165, P107, DOI 10.1128/jb.165.1.107-115.1986; SUN TP, 1987, J BACTERIOL, V169, P2667, DOI 10.1128/jb.169.6.2667-2674.1987; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; WEBSTER RE, 1991, MOL MICROBIOL, V5, P1005, DOI 10.1111/j.1365-2958.1991.tb01873.x; Wen ZQ, 1997, BIOCHEMISTRY-US, V36, P7810, DOI 10.1021/bi970342q; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469	67	13	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36258	36272		10.1074/jbc.M112.403386	http://dx.doi.org/10.1074/jbc.M112.403386			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22942280	Green Published, hybrid			2022-12-25	WOS:000310364000047
J	Randak, CO; Heul, ARV; Welsh, MJ				Randak, Christoph O.; Heul, Amanda R. Ver; Welsh, Michael J.			Demonstration of Phosphoryl Group Transfer Indicates That the ATP-binding Cassette (ABC) Transporter Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Exhibits Adenylate Kinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MALTOSE TRANSPORTER; MOLECULAR-BASIS; PROTEIN-KINASE; DOMAIN; SITE; AMP; IDENTIFICATION; NUCLEOTIDES; MECHANISM	Cystic fibrosis transmembrane conductance regulator (CFTR) is a membrane-spanning adenosine 5'-triphosphate (ATP)-binding cassette (ABC) transporter. ABC transporters and other nuclear and cytoplasmic ABC proteins have ATPase activity that is coupled to their biological function. Recent studies with CFTR and two nonmembrane-bound ABC proteins, the DNA repair enzyme Rad50 and a structural maintenance of chromosome (SMC) protein, challenge the model that the function of all ABC proteins depends solely on their associated ATPase activity. Patch clamp studies indicated that in the presence of physiologically relevant concentrations of adenosine 5'-monophosphate (AMP), CFTR Cl- channel function is coupled to adenylate kinase activity (ATP+AMP reversible arrow 2 ADP). Work with Rad50 and SMC showed that these enzymes catalyze both ATPase and adenylate kinase reactions. However, despite the supportive electrophysiological results with CFTR, there are no biochemical data demonstrating intrinsic adenylate kinase activity of a membrane-bound ABC transporter. We developed a biochemical assay for adenylate kinase activity, in which the radioactive gamma-phosphate of a nucleotide triphosphate could transfer to a photoactivatable AMP analog. UV irradiation could then trap the P-32 on the adenylate kinase. With this assay, we discovered phosphoryl group transfer that labeled CFTR, thereby demonstrating its adenylate kinase activity. Our results also suggested that the interaction of nucleotide triphosphate with CFTR at ATP-binding site 2 is required for adenylate kinase activity. These biochemical data complement earlier biophysical studies of CFTR and indicate that the ABC transporter CFTR can function as an adenylate kinase.	[Randak, Christoph O.; Heul, Amanda R. Ver] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Randak, CO (corresponding author), Univ Iowa, Dept Pediat, 500 EMRB, Iowa City, IA 52242 USA.	christoph-randak@uiowa.edu		Randak, Christoph/0000-0003-3264-4137; Welsh, Michael/0000-0002-1646-6206	National Institutes of Health [K08HL097071, HL51670, HL091842, HL102288]; Cystic Fibrosis Foundation (CFF) [RANDAK09Q0]; Harry Shwachman Cystic Fibrosis Clinical Investigator Award; Parker B. Francis Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL091842, U01HL102288, P01HL051670, K08HL097071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation (CFF); Harry Shwachman Cystic Fibrosis Clinical Investigator Award; Parker B. Francis Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants K08HL097071 (to C.O.R.) and HL51670, HL091842, and HL102288 (to M.J.W.). This work was also supported by Cystic Fibrosis Foundation (CFF) Grant RANDAK09Q0.; The recipient of a Harry Shwachman Cystic Fibrosis Clinical Investigator Award and of a Parker B. Francis Fellowship. To whom correspondence should be addressed: Dept. of Pediatrics, University of Iowa, 500 EMRB, Iowa City, IA 52242. Tel.: 319-335-6540; Fax: 319-335-7623; E-mail: christoph-randak@uiowa.edu.	Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; Al-Shawi MK, 2011, ESSAYS BIOCHEM, V50, P63, DOI [10.1042/BSE0500063, 10.1042/bse0500063]; Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; Berger AL, 2005, P NATL ACAD SCI USA, V102, P455, DOI 10.1073/pnas.0408575102; BERRY MB, 1994, PROTEINS, V19, P183, DOI 10.1002/prot.340190304; Bhaskara V, 2007, MOL CELL, V25, P647, DOI 10.1016/j.molcel.2007.01.028; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cheung JC, 2008, ARCH BIOCHEM BIOPHYS, V476, P95, DOI 10.1016/j.abb.2008.03.033; CZARNECKI JJ, 1984, BIOCHIM BIOPHYS ACTA, V800, P41, DOI 10.1016/0304-4165(84)90092-8; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DONOHUE J, 1960, J MOL BIOL, V2, P363, DOI 10.1016/S0022-2836(60)80047-2; EVANS FE, 1974, FEBS LETT, V41, P253, DOI 10.1016/0014-5793(74)81223-8; French PJ, 1997, AM J PHYSIOL-CELL PH, V273, pC747, DOI 10.1152/ajpcell.1997.273.2.C747; Frizzell RA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009563; FRY DC, 1987, BIOCHEMISTRY-US, V26, P1645, DOI 10.1021/bi00380a024; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; GREGORY RJ, 1990, NATURE, V347, P382, DOI 10.1038/347382a0; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Holland I. B., 2003, ABC PROTEINS BACTERI; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; HOPPE J, 1978, EUR J BIOCHEM, V90, P427, DOI 10.1111/j.1432-1033.1978.tb12621.x; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; Lammens A, 2010, J MOL BIOL, V401, P265, DOI 10.1016/j.jmb.2010.06.029; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; OGAWA Y, 1981, J IMMUNOL, V127, P1369; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; OSTEDGAARD LS, 1992, J BIOL CHEM, V267, P26142; Polshakov D, 2005, BIOCHEMISTRY-US, V44, P11241, DOI 10.1021/bi050859z; POTTER RL, 1983, METHOD ENZYMOL, V91, P613; Ramjeesingh M, 2008, BIOCHEM J, V412, P315, DOI 10.1042/BJ20071719; Randak C, 2003, CELL, V115, P837, DOI 10.1016/S0092-8674(03)00983-8; Randak CO, 2005, P NATL ACAD SCI USA, V102, P2216, DOI 10.1073/pnas.0409787102; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; RIORDAN JR, 1989, SCIENCE, V245, P1066; SALVUCCI ME, 1992, BIOCHEMISTRY-US, V31, P4479, DOI 10.1021/bi00133a014; Schneider E, 1998, FEMS MICROBIOL REV, V22, P1; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; TRAVIS SM, 1993, J BIOL CHEM, V268, P15336; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Yan HG, 1999, ADV ENZYMOL RAMB, V73, P103, DOI 10.1002/9780470123195.ch4	46	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36105	36110		10.1074/jbc.M112.408450	http://dx.doi.org/10.1074/jbc.M112.408450			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948143	Green Published, hybrid			2022-12-25	WOS:000310364000032
J	Srivastava, DP; Copits, BA; Xie, Z; Huda, R; Jones, KA; Mukherji, S; Cahill, ME; VanLeeuwen, JE; Woolfrey, KM; Rafalovich, I; Swanson, GT; Penzes, P				Srivastava, Deepak P.; Copits, Bryan A.; Xie, Zhong; Huda, Rafiq; Jones, Kelly A.; Mukherji, Srishti; Cahill, Michael E.; VanLeeuwen, Jon-Eric; Woolfrey, Kevin M.; Rafalovich, Igor; Swanson, Geoffrey T.; Penzes, Peter			Afadin Is Required for Maintenance of Dendritic Structure and Excitatory Tone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC ADHESION; SPINE; MECHANISMS; PLASTICITY; BRAIN; MORPHOGENESIS; TRANSCRIPTION; DENSITY; NECTIN; GROWTH	The dendritic field of a neuron, which is determined by both dendritic architecture and synaptic strength, defines the synaptic input of a cell. Once established, a neuron's dendritic field is thought to remain relatively stable throughout a cell's lifetime. Perturbations in a dendritic structure or excitatory tone of a cell and thus its dendritic field are cellular alterations thought to be correlated with a number of psychiatric disorders. Although several proteins are known to regulate the development of dendritic arborization, much less is known about the mechanisms that maintain dendritic morphology and synaptic strength. In this study, we find that afadin, a component of N-cadherin.beta-catenin.alpha-N-catenin adhesion complexes, is required for the maintenance of established dendritic arborization and synapse number. We further demonstrate that afadin directly interacts with AMPA receptors and that loss of this protein reduces the surface expression of GluA1- and GluA2-AMPA receptor sub-units. Collectively, these data suggest that afadin is required for the maintenance of dendritic structure and excitatory tone.	[Srivastava, Deepak P.; Mukherji, Srishti] Kings Coll London, Inst Psychiat, James Black Ctr, Dept Neurosci, London SE5 9NU, England; [Srivastava, Deepak P.; Mukherji, Srishti] Kings Coll London, Inst Psychiat, James Black Ctr, Ctr Cellular Basis Behav, London SE5 9NU, England; [Srivastava, Deepak P.; Xie, Zhong; Huda, Rafiq; Jones, Kelly A.; Cahill, Michael E.; VanLeeuwen, Jon-Eric; Woolfrey, Kevin M.; Rafalovich, Igor; Penzes, Peter] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Copits, Bryan A.; Swanson, Geoffrey T.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Penzes, Peter] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA	University of London; King's College London; University of London; King's College London; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Srivastava, DP (corresponding author), Kings Coll London, Inst Psychiat, James Black Ctr, Dept Neurosci, London SE5 9NU, England.	deepak.srivastava@kcl.ac.uk; p-penzes@northwestern.edu	Xie, Zhong/B-6829-2011; Penzes, Peter/L-3987-2016	Xie, Zhong/0000-0002-8348-4455; Penzes, Peter/0000-0001-5449-1640; Cahill, Michael/0000-0003-0574-2655; Srivastava, Deepak Prakash/0000-0001-6512-9065; Huda, Rafiq/0000-0002-6814-9966	National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service Awards [1F31MH087043, 1F31AG031621, 1F31MH085362]; NIH, NIMH [MH071316, MH097216]; NIH, NINDS [NS44322]; Royal Society UK; American Heart Association (AHA); National Alliance for Research on Schizophrenia and Depression (NARSAD); Autism Speaks, NARSAD, Brain Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097216, R01MH071316, F31MH085362, F31MH087043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044322, R01NS071952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG031621] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service Awards; NIH, NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Royal Society UK(Royal Society of London); American Heart Association (AHA)(American Heart Association); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Autism Speaks, NARSAD, Brain Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service Awards 1F31MH087043 (to J. E. V.), 1F31AG031621 (to M. E. C.), and 1F31MH085362 (to K. A. J.); NIH, NIMH, Grants MH071316 and MH097216 (to P. P.); and NIH, NINDS, Grant NS44322 (to G. T. S.). This work was also supported by grants from the Royal Society UK, American Heart Association (AHA), and National Alliance for Research on Schizophrenia and Depression (NARSAD) (to D. P. S.); an AHA predoctoral fellowship (to K. M. W.); and an Autism Speaks, NARSAD, Brain Research Foundation grant (to P. P.).	Arikkath J, 2009, MOL NEUROBIOL, V40, P46, DOI 10.1007/s12035-009-8068-x; Beaudoin GMJ, 2012, J NEUROSCI, V32, P99, DOI 10.1523/JNEUROSCI.4565-11.2012; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; Charych EI, 2006, J NEUROSCI, V26, P10164, DOI 10.1523/JNEUROSCI.2379-06.2006; Chow DK, 2009, NAT NEUROSCI, V12, P116, DOI 10.1038/nn.2255; El-Hussein AE, 2000, SCIENCE, V290, P1364; GREENOUGH WT, 1984, TRENDS NEUROSCI, V7, P229, DOI 10.1016/S0166-2236(84)80211-8; Huang WN, 2011, MOL CELL BIOL, V31, P388, DOI 10.1128/MCB.00969-10; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Katsel P, 2005, SCHIZOPHR RES, V79, P157, DOI 10.1016/j.schres.2005.06.007; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kojima SI, 2004, BIOTECHNIQUES, V36, P74, DOI 10.2144/04361ST02; Lin YC, 2010, ANNU REV NEUROSCI, V33, P349, DOI 10.1146/annurev-neuro-060909-153204; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Majima T, 2009, BIOCHEM BIOPH RES CO, V385, P539, DOI 10.1016/j.bbrc.2009.05.097; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; Nishioka H, 2000, J COMP NEUROL, V424, P297, DOI 10.1002/1096-9861(20000821)424:2<297::AID-CNE8>3.0.CO;2-J; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Peng YR, 2009, NEURON, V61, P71, DOI 10.1016/j.neuron.2008.11.015; Raymond GV, 1996, ACTA NEUROPATHOL, V91, P117; Rogers C. A., 2001, SOC NEUR ABSTR, V27, P16; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Srivastava DP, 2008, P NATL ACAD SCI USA, V105, P14650, DOI 10.1073/pnas.0801581105; Srivastava DP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001350; Srivastava DP, 2011, JOVE-J VIS EXP, DOI 10.3791/2794; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Togashi H, 2006, J CELL BIOL, V174, P141, DOI 10.1083/jcb.200601089; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Woolfrey KM, 2009, NAT NEUROSCI, V12, P1275, DOI 10.1038/nn.2386; Xie Z, 2008, J NEUROSCI, V28, P6079, DOI 10.1523/JNEUROSCI.1170-08.2008; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yang SZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004474; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	37	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35964	35974		10.1074/jbc.M112.363358	http://dx.doi.org/10.1074/jbc.M112.363358			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948147	hybrid, Green Published			2022-12-25	WOS:000310364000018
J	Valente, RM; Ehlers, E; Xu, DS; Ahmad, H; Steadman, A; Blasnitz, L; Zhou, Y; Kastanek, L; Meng, B; Zhang, LW				Valente, Robert M.; Ehlers, Erica; Xu, Dongsheng; Ahmad, Humera; Steadman, Andrew; Blasnitz, Laura; Zhou, You; Kastanek, Lisa; Meng, Bin; Zhang, Luwen			Toll-Like Receptor 7 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; INTERFERON REGULATORY FACTOR-7; NF-KAPPA-B; DISEASE-ACTIVITY; KAPOSIS SARCOMA; I INTERFERON; LEUKOCYTE INTERFERON; AUTOIMMUNE-DISEASES; INFECTED CELLS; INCREASED RISK	Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus. Toll-like receptor 7 (TLR7) is involved in host innate immunity against pathogens, and its aberrant activation is linked to the development of systemic lupus erythematosus (SLE, also called "lupus"). Type I interferons (IFN) are apparently driving forces for lupus pathogenesis. Previously, we found that EBV latent membrane protein 1 (LMP1) primes cells for IFN production. In this report, the relationship among EBV LMP1, TLRs, and IFN production are examined. We find that TLR7 activation increases the expression of EBV LMP1, and IFN regulatory factor 7 (IRF7) is involved in the stimulation process. TLR7 activation did not induce IFNs from EBV-infected cells, but potentiates those cells for IFN production by TLR3 or TLR9 activation. In addition, we find that LMP1 and IFNs are co-expressed in the same cells in some lupus patients. Therefore, the aberrant activation of TLR7 might induce LMP1 expression and LMP1-expression cells may be producing IFNs in lupus patients. These results suggest EBV might be an exacerbating factor in some lupus patients via promoting IFN production.	[Valente, Robert M.; Kastanek, Lisa] Arthrit Ctr Nebraska, Lincoln, NE USA; [Ehlers, Erica; Xu, Dongsheng; Ahmad, Humera; Steadman, Andrew; Blasnitz, Laura; Zhang, Luwen] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Zhou, You; Zhang, Luwen] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA; [Zhou, You] Univ Nebraska, Ctr Biotechnol, Lincoln, NE USA; [Meng, Bin] Shandong Univ, Sch Med, Dept Pathol, Jinan 250100, Shandong, Peoples R China	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Shandong University	Valente, RM (corresponding author), Arthrit Ctr Nebraska, Lincoln, NE USA.	lzhang2@unlnotes.unl.edu			Layman Foundation, National Institutes of Health (NIH) [CA138213, CA108951, RR15635]; Undergraduate Creative Activities and Research Experiences program; IDeA Networks of Biomedical Research Excellence; NATIONAL CANCER INSTITUTE [R01CA108951, R01CA138213] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER	Layman Foundation, National Institutes of Health (NIH); Undergraduate Creative Activities and Research Experiences program; IDeA Networks of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by grants from the Layman Foundation, National Institutes of Health (NIH) grants CA138213, CA108951, and RR15635 (LZ). HA was partially supported by The Undergraduate Creative Activities and Research Experiences program. LB was partially supported by the IDeA Networks of Biomedical Research Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAN P, 1990, EMBO J, V9, P147, DOI 10.1002/j.1460-2075.1990.tb08090.x; Baechler EC, 2004, CURR OPIN IMMUNOL, V16, P801, DOI 10.1016/j.coi.2004.09.014; Banchereau J, 2004, IMMUNITY, V20, P539, DOI 10.1016/S1074-7613(04)00108-6; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Barrat FJ, 2008, IMMUNOL REV, V223, P271, DOI 10.1111/j.1600-065X.2008.00630.x; Barrat FJ, 2007, EUR J IMMUNOL, V37, P3582, DOI 10.1002/eji.200737815; Beal Eleanor, 2010, Nat Rev Rheumatol, V6, P437, DOI 10.1038/nrrheum.2010.113; BENBASSAT H, 1977, INT J CANCER, V19, P27, DOI 10.1002/ijc.2910190105; Bengtsson AA, 2000, LUPUS, V9, P664, DOI 10.1191/096120300674499064; Berner BR, 2005, CELL IMMUNOL, V235, P29, DOI 10.1016/j.cellimm.2005.06.010; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; BOOS H, 1987, VIROLOGY, V159, P161, DOI 10.1016/0042-6822(87)90360-6; Buyon JP, 2005, ANN INTERN MED, V142, P953, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00004; Cahir-McFarland ED, 2004, J VIROL, V78, P4108, DOI 10.1128/JVI.78.8.4108-4119.2004; Cahir-McFarland ED, 2000, P NATL ACAD SCI USA, V97, P6055, DOI 10.1073/pnas.100119497; Carter KL, 2002, J VIROL, V76, P10427, DOI 10.1128/JVI.76.20.10427-10436.2002; Crow MK, 2003, ARTHRITIS RHEUM, V48, P2396, DOI 10.1002/art.11226; DESTEFANO E, 1982, J INFECT DIS, V146, P451, DOI 10.1093/infdis/146.4.451; Dror Y, 1998, AM J KIDNEY DIS, V32, P825, DOI 10.1016/S0272-6386(98)70140-4; Feederle R, 2000, EMBO J, V19, P3080, DOI 10.1093/emboj/19.12.3080; Frost V, 2001, J GEN VIROL, V82, P3057, DOI 10.1099/0022-1317-82-12-3057; Fu QO, 2011, ARTHRITIS RHEUM-US, V63, P749, DOI 10.1002/art.30193; Fujii K, 2000, J VIROL, V74, P2550, DOI 10.1128/JVI.74.6.2550-2557.2000; Garcia-Ortiz H, 2010, ANN RHEUM DIS, V69, P1861, DOI 10.1136/ard.2009.124313; Gayed M, 2009, LUPUS, V18, P479, DOI 10.1177/0961203309102556; Gires O, 1997, EMBO J, V16, P6131, DOI 10.1093/emboj/16.20.6131; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Gregory SM, 2009, P NATL ACAD SCI USA, V106, P11725, DOI 10.1073/pnas.0905316106; Gross AJ, 2005, J IMMUNOL, V174, P6599, DOI 10.4049/jimmunol.174.11.6599; Guiducci C, 2010, NATURE, V465, P937, DOI 10.1038/nature09102; HENDERSON A, 1983, P NATL ACAD SCI-BIOL, V80, P1987, DOI 10.1073/pnas.80.7.1987; Hong GK, 2005, J VIROL, V79, P13993, DOI 10.1128/JVI.79.22.13993-14003.2005; HURLEY EA, 1991, J VIROL, V65, P3958, DOI 10.1128/JVI.65.7.3958-3963.1991; Incaprera M, 1998, CLIN EXP RHEUMATOL, V16, P289; James JA, 1997, ANN NY ACAD SCI, V815, P124, DOI 10.1111/j.1749-6632.1997.tb52054.x; Kalkner KM, 1998, QJM-MON J ASSOC PHYS, V91, P393, DOI 10.1093/qjmed/91.6.393; KANDA K, 1992, MOL CELL BIOL, V12, P4930, DOI 10.1128/MCB.12.11.4930; Kang I, 2004, J IMMUNOL, V172, P1287, DOI 10.4049/jimmunol.172.2.1287; Kasapcopur O, 2005, RHEUMATOL INT, P1; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kawasaki A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3277; Kieff E, 1996, VIROLOGY, P2343; Kono DH, 2003, AUTOIMMUNITY, V36, P503, DOI 10.1080/08916930310001624665; Lam N, 2004, J VIROL, V78, P1657, DOI 10.1128/JVI.78.4.1657-1664.2004; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284; Martin HJ, 2007, J VIROL, V81, P9748, DOI 10.1128/JVI.01122-07; McFarland EDC, 1999, ONCOGENE, V18, P6959, DOI 10.1038/sj.onc.1203217; Mitarnun Winyou, 2002, Journal of the Medical Association of Thailand, V85, P552; Moon UY, 2004, ARTHRITIS RES THER, V6, pR295, DOI 10.1186/ar1181; Niewold TB, 2008, ARTHRITIS RHEUM, V58, P2481, DOI 10.1002/art.23613; Ning S, 2003, J VIROL, V77, P9359, DOI 10.1128/JVI.77.17.9359-9368.2003; Nonkwelo C, 1996, J VIROL, V70, P623, DOI 10.1128/JVI.70.1.623-627.1996; Pagano JS, 1999, P ASSOC AM PHYSICIAN, V111, P573, DOI 10.1046/j.1525-1381.1999.t01-1-99220.x; Pascual V, 2003, CURR OPIN RHEUMATOL, V15, P548, DOI 10.1097/00002281-200309000-00005; Patole PS, 2005, J AM SOC NEPHROL, V16, P1326, DOI 10.1681/ASN.2004100820; Peters AL, 2010, J IMMUNOL, V185, P4053, DOI 10.4049/jimmunol.0904065; Petri M, 2005, NEW ENGL J MED, V353, P2550, DOI 10.1056/NEJMoa051135; PREBLE OT, 1982, SCIENCE, V216, P429, DOI 10.1126/science.6176024; Ronnblom L, 2001, TRENDS IMMUNOL, V22, P427, DOI 10.1016/S1471-4906(01)01955-X; RONNBLOM LE, 1991, ACTA ONCOL, V30, P537; Salloum R, 2010, ARTHRITIS RHEUM-US, V62, P553, DOI 10.1002/art.27182; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Shen N, 2010, P NATL ACAD SCI USA, V107, P15838, DOI 10.1073/pnas.1001337107; Souza TA, 2005, P NATL ACAD SCI USA, V102, P18093, DOI 10.1073/pnas.0509311102; Stowell NC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-43; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; TAKEDA K, 2007, CURR PROTOC IMMUNOL, pCH14, DOI DOI 10.1002/0471142735.IM1412S77; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Veeranki S, 2010, IMMUNOL LETT, V133, P1, DOI 10.1016/j.imlet.2010.06.008; Verdolini R, 2002, BRIT J DERMATOL, V146, P877, DOI 10.1046/j.1365-2133.2002.04627.x; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Wu HL, 2001, INT J PHARM, V220, P63, DOI 10.1016/S0378-5173(01)00671-8; Xu DS, 2008, J VIROL, V82, P6251, DOI 10.1128/JVI.00163-08; Xu DS, 2007, J VIROL, V81, P6068, DOI 10.1128/JVI.02743-06; Xu DS, 2006, J BIOL CHEM, V281, P9163, DOI 10.1074/jbc.M511884200; Xu Y, 2001, LUPUS, V10, P841, DOI 10.1191/096120301701548481; Yamazaki M, 2005, CLIN EXP IMMUNOL, V139, P558, DOI 10.1111/j.1365-2249.2004.02704.x; Yu SF, 2005, MED MICROBIOL IMMUN, V194, P115, DOI 10.1007/s00430-004-0230-5; Zacny VL, 1999, J VIROL, V73, P7271, DOI 10.1128/JVI.73.9.7271-7277.1999; Zhang J, 2005, J VIROL, V79, P5640, DOI 10.1128/JVI.79.9.5640-5652.2005; Zhang J, 2004, J BIOL CHEM, V279, P46335, DOI 10.1074/jbc.M403966200; Zhang LW, 2004, J VIROL, V78, P12987, DOI 10.1128/JVI.78.23.12987-12995.2004; Zhang LW, 1997, MOL CELL BIOL, V17, P5748, DOI 10.1128/MCB.17.10.5748; Zhang LW, 2002, J INTERF CYTOK RES, V22, P95, DOI 10.1089/107999002753452700; Zhang LW, 2001, SEMIN CANCER BIOL, V11, P445, DOI 10.1006/scbi.2001.0411; Zhang LW, 2001, J VIROL, V75, P12393, DOI 10.1128/JVI.75.24.12393-12401.2001; Zhang LW, 2001, J VIROL, V75, P341, DOI 10.1128/JVI.75.1.341-350.2001; Zhang LW, 1999, MOL CELL BIOL, V19, P3216; Zhang LW, 2000, J VIROL, V74, P1061, DOI 10.1128/JVI.74.3.1061-1068.2000	93	21	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43317	10.1371/journal.pone.0043317	http://dx.doi.org/10.1371/journal.pone.0043317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952664	gold, Green Published			2022-12-25	WOS:000308221300012
J	Guo, CY; Gu, Y; Li, L; Jia, EZ; Li, CJ; Wang, LS; Yang, ZJ; Cao, KJ; Ma, WZ				Guo, Chang-Yan; Gu, Yan; Li, Li; Jia, En-Zhi; Li, Chun-Jian; Wang, Lian-Sheng; Yang, Zhi-Jian; Cao, Ke-Jiang; Ma, Wen-Zhu			Association of SNP Rs6903956 on Chromosome 6p24.1 with Angiographical Characteristics of Coronary Atherosclerosis in a Chinese Population	PLOS ONE			English	Article							ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; RISK-FACTOR; SMOKING; MEN	Objective: To explore the association between rs6903956 and severity of coronary artery disease (CAD) in a Chinese population. Methods: A cohort of 1075 consecutive patients who underwent coronary arteriography for suspected or known coronary atherosclerosis was enrolled in our study. Coronary atherosclerosis severity was defined by Gensini's Score System and counts of diseased vessels. Results: Gensini score frequencies and counts of diseased vessels differed among GG, AG, AA genotype groups at the rs6903956 locus (p = 0.025 for Gensini score frequencies vs. p = 0.024 for counts of diseased vessels, respectively). A univariate logistic regression analysis revealed that the genotype distribution of this SNP was associated significantly with angiographical characteristics of coronary atherosclerosis risk (p = 0.030, odds ratio (OR) = 1.444, 95% confidence interval (CI) = 1.036 similar to 2.013 for AG vs. GG; p = 0.021, OR = 5.896, 95% CI = 1.299 similar to 26.750 for AA vs. GG and p = 0.007, OR = 1.564, 95% CI = 1.132 similar to 2.162 for combined (AG+AA) vs. GG). A multivariate logistic regression analysis indicated that the genotype distribution of the rs6903956 polymorphism be associated significantly with the angiographical characteristics of coronary atherosclerosis risk (p = 0.004, OR = 1.578, 95% CI = 1.155 similar to 2.154 for GG vs. AG vs. AA; p = 0.013, OR = 1.541, 95% CI = 1.097 similar to 2.163 for GG vs. GA+AA). A stratification analysis revealed that male subjects and smoking subjects had a higher frequency of the rs6903956 heterozygous mutant among higher Gensini score subjects than among lower Gensini score subjects (p = 0.023, OR = 1.579, 95% CI = 1.064 similar to 2.344 for male subgroup; p = 0.005, OR = 2.075, 95% CI = 1.249 similar to 3.448 for smoking subgroup). Conclusions: Allele A is a risk factor for CAD and the G-to-A allele substitution may underlie the association between rs6903956 and CAD.	[Guo, Chang-Yan; Gu, Yan; Li, Li; Jia, En-Zhi; Li, Chun-Jian; Wang, Lian-Sheng; Yang, Zhi-Jian; Cao, Ke-Jiang; Ma, Wen-Zhu] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Guo, CY (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Nanjing, Jiangsu, Peoples R China.	enzhijia@yahoo.cn	Jia, Enzhi/AGX-9137-2022		National Natural Science Foundation of China [30400173, 30971257]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grant numbers 30400173 and 30971257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Charchar FJ, 2012, LANCET, V379, P915, DOI 10.1016/S0140-6736(11)61453-0; Dandona S, 2010, CAN J CARDIOL, V26, p56A, DOI 10.1016/S0828-282X(10)71064-3; Franceschini N, 2011, CIRC-CARDIOVASC GENE, V4, P662, DOI 10.1161/CIRCGENETICS.111.960096; Franchini M, 2008, TRENDS CARDIOVAS MED, V18, P157, DOI 10.1016/j.tcm.2008.04.003; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2; Girelli D, 2009, SEMIN THROMB HEMOST, V35, P671, DOI 10.1055/s-0029-1242721; Gu DF, 2005, CIRCULATION, V112, P658, DOI 10.1161/CIRCULATIONAHA.104.515072; Iltumur K, 2005, CRIT CARE, V9, pR416, DOI 10.1186/cc3727; Jia EZ, 2009, CLIN EXP PHARMACOL P, V36, P690, DOI 10.1111/j.1440-1681.2008.05134.x; Kim HJ, 2012, MOL BIOL REP, V39, P5425, DOI 10.1007/s11033-011-1342-9; Larson MG, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S5; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Padmanabhan S, 2010, INDIAN J MED RES, V132, P567; Rembek M, 2010, KARDIOL POL, V68, P157; Saito Y, 2010, J ATHEROSCLER THROMB, V17, P270, DOI 10.5551/jat.2782; Satoh H, 2009, J ATHEROSCLER THROMB, V16, P792; Trachsel LD, 2010, SWISS MED WKLY, V140, P133, DOI smw-12955; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Wang Q, 2005, CURR OPIN CARDIOL, V20, P182, DOI 10.1097/01.hco.0000160373.77190.f1; Woodward M, 2005, INT J EPIDEMIOL, V34, P1036, DOI 10.1093/ije/dyi104; Yarnell J, 2003, INT J EPIDEMIOL, V32, P71, DOI 10.1093/ije/dyg038	21	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43732	10.1371/journal.pone.0043732	http://dx.doi.org/10.1371/journal.pone.0043732			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952750	Green Published, Green Submitted, gold			2022-12-25	WOS:000308206000048
J	Kadekar, S; Silins, I; Korhonen, A; Dreij, K; Al-Anati, L; Hogberg, J; Stenius, U				Kadekar, Sandeep; Silins, Ilona; Korhonen, Anna; Dreij, Kristian; Al-Anati, Lauy; Hogberg, Johan; Stenius, Ulla			Exocrine Pancreatic Carcinogenesis and Autotaxin Expression	PLOS ONE			English	Article							ACINAR-CELL CARCINOMAS; LYSOPHOSPHATIDIC ACID; CANCER-RISK; RECEPTORS; LPA; MATRIX-METALLOPROTEINASE-9; INDUCTION; KRAS; DIISOCYANATE; OSTEOBLASTS	Exocrine pancreatic cancer is an aggressive disease with an exceptionally high mortality rate. Genetic analysis suggests a causative role for environmental factors, but consistent epidemiological support is scarce and no biomarkers for monitoring the effects of chemical pancreatic carcinogens are available. With the objective to identify common traits for chemicals inducing pancreatic tumors we studied the National Toxicology Program (NTP) bioassay database. We found that male rats were affected more often than female rats and identified eight chemicals that induced exocrine pancreatic tumors in males only. For a hypothesis generating process we used a text mining tool to analyse published literature for suggested mode of actions (MOA). The resulting MOA analysis suggested inflammatory responses as common feature. In cell studies we found that all the chemicals increased protein levels of the inflammatory protein autotaxin (ATX) in Panc-1, MIA PaCa-2 or Capan-2 cells. Induction of MMP-9 and increased invasive migration were also frequent effects, consistent with ATX activation. Testosterone has previously been implicated in pancreatic carcinogenesis and we found that it increased ATX levels. Our data show that ATX is a target for chemicals inducing pancreatic tumors in rats. Several lines of evidence implicate ATX and its product lysophosphatidic acid in human pancreatic cancer. Mechanisms of action may include stimulated invasive growth and metastasis. ATX may interact with hormones or onco- or suppressor-genes often deregulated in exocrine pancreatic cancer. Our data suggest that ATX is a target for chemicals promoting pancreatic tumor development.	[Kadekar, Sandeep; Silins, Ilona; Dreij, Kristian; Al-Anati, Lauy; Hogberg, Johan; Stenius, Ulla] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Korhonen, Anna] Univ Cambridge, Comp Lab, Cambridge CB2 3QG, England	Karolinska Institutet; University of Cambridge	Kadekar, S (corresponding author), Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden.	ilona.silins@ki.se	Dreij, Kristian/I-6083-2012	Dreij, Kristian/0000-0001-8445-4293	Swedish Research Council for Environment, Agriculture Science and Spatial Planning (Formas); Swedish Research Council; Royal Society, UK	Swedish Research Council for Environment, Agriculture Science and Spatial Planning (Formas)(Swedish Research Council Formas); Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Society, UK(Royal Society of London)	This study was financed by the Swedish Research Council for Environment, Agriculture Science and Spatial Planning (Formas) (http://www.formas.se/), Swedish Research Council (http://www.vr.se/) and the Royal Society, UK (http://royalsociety.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers HMHG, 2010, P NATL ACAD SCI USA, V107, P7257, DOI 10.1073/pnas.1001529107; Arita Y, 2008, WORLD J GASTROENTERO, V14, P4473, DOI 10.3748/wjg.14.4473; Azare J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027851; Birk T, 2009, J OCCUP ENVIRON MED, V51, P373, DOI 10.1097/JOM.0b013e3181973e19; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Choi S, 2007, AM J PHYSIOL-GASTR L, V292, pG1366, DOI 10.1152/ajpgi.00516.2006; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Dietrich C, 2010, CARCINOGENESIS, V31, P1319, DOI 10.1093/carcin/bgq028; FRENCH DL, 1994, ANN NY ACAD SCI, V732, P324, DOI 10.1111/j.1749-6632.1994.tb24747.x; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Fuss B, 1997, J NEUROSCI, V17, P9095; Genkinger JM, 2010, INT J CANC; Gonzalez-Arenas A, 2008, BBA-MOL CELL RES, V1783, P253, DOI 10.1016/j.bbamcr.2007.11.014; Gorelick FS, 2009, CLIN GASTROENTEROL H, V7, pS10, DOI 10.1016/j.cgh.2009.07.036; Goulioumis AK, 2011, ISRN ONCOL; Graham TR, 2010, BREAST CANCER RES TR, V123, P139, DOI 10.1007/s10549-009-0623-7; Grippo PJ, 2003, CANCER RES, V63, P2016; Gu BJ, 2006, BLOOD, V107, P4946, DOI 10.1182/blood-2005-07-2994; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Hama K, 2006, LIFE SCI, V79, P1736, DOI 10.1016/j.lfs.2006.06.002; Harper K, 2010, CANCER RES, V70, P4634, DOI 10.1158/0008-5472.CAN-09-3813; Hattis D, 2009, CRIT REV TOXICOL, V39, P97, DOI 10.1080/10408440802307467 ; Heid I, 2011, GASTROENTEROLOGY, V141, P719, DOI 10.1053/j.gastro.2011.04.043; Hurst-Kennedy J, 2010, J STEROID BIOCHEM, V122, P264, DOI 10.1016/j.jsbmb.2010.05.010; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Joslin EJ, 2010, MOL BIOSYST, V6, P1293, DOI 10.1039/c003921g; Kadekar S, 2012, TOXICOL PATHOL; Komachi M, 2009, CARCINOGENESIS, V30, P457, DOI 10.1093/carcin/bgp011; Koorstra JBM, 2008, PANCREATOLOGY, V8, P110, DOI 10.1159/000123838; Korhonen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033427; Korhonen A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-303; Kortlever RM, 2008, MOL CANCER RES, V6, P1452, DOI 10.1158/1541-7786.MCR-08-0066; Kunzli BM, 2007, AM J PHYSIOL-GASTR L, V292, pG223, DOI 10.1152/ajpgi.00259.2006; Lau MK, 2010, PANCREAS, V39, P458, DOI 10.1097/MPA.0b013e3181bd6489; Levi F, 2003, PANCREAS, V27, P139, DOI 10.1097/00006676-200308000-00006; LHOSTE E F, 1987, Pancreas, V2, P38, DOI 10.1097/00006676-198701000-00006; LHOSTE EF, 1987, CARCINOGENESIS, V8, P699, DOI 10.1093/carcin/8.5.699; Li HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025941; Li S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-18; Liu PS, 2006, TOXICOL APPL PHARM, V211, P106, DOI 10.1016/j.taap.2005.06.019; Liu PS, 2006, TOXICOLOGY, V219, P167, DOI 10.1016/j.tox.2005.11.012; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Logsdon CD, 2009, CLIN GASTROENTEROL H, V7, pS40, DOI 10.1016/j.cgh.2009.07.040; Longnecker D S, 1990, IARC Sci Publ, P241; LONGNECKER DS, 1990, INT J PANCREATOL, V7, P159; Malbon Craig C, 2005, Sci STKE, V2005, ppe35, DOI 10.1126/stke.2922005pe35; Michaud DS, 2010, CANCER CAUSE CONTROL, V21, P1213, DOI 10.1007/s10552-010-9548-z; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Mroczko B, 2009, PANCREAS, V38, P613, DOI 10.1097/MPA.0b013e3181a488a0; Mueller NT, 2010, CANCER EPIDEM BIOMAR, V19, P447, DOI 10.1158/1055-9965.EPI-09-0862; Nakai Y, 2011, CLIN BIOCHEM, V44, P576, DOI 10.1016/j.clinbiochem.2011.03.128; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Nam SW, 2000, ONCOGENE, V19, P241, DOI 10.1038/sj.onc.1203263; Nyska A, 2004, ENVIRON HEALTH PERSP, V112, P903, DOI 10.1289/ehp.6869; Okudaira S, 2010, BIOCHIMIE, V92, P698, DOI 10.1016/j.biochi.2010.04.015; Panupinthu N, 2008, J CELL BIOL, V181, P859, DOI 10.1083/jcb.200708037; Panupinthu N, 2007, J BIOL CHEM, V282, P3403, DOI 10.1074/jbc.M605620200; Park SY, 2010, ONCOGENE; Puri S, 2010, DEV CELL, V18, P342, DOI 10.1016/j.devcel.2010.02.005; Raimondi S, 2009, NAT REV GASTRO HEPAT, V6, P699, DOI 10.1038/nrgastro.2009.177; RAO MS, 1987, CANCER METAST REV, V6, P665, DOI 10.1007/BF00047473; ROSS J, 1987, GUT, V28, P197, DOI 10.1136/gut.28.Suppl.197; Sautin YY, 2001, AM J PHYSIOL-CELL PH, V281, pC2010, DOI 10.1152/ajpcell.00077.2001; Seifert A, 2009, TOXICOL LETT, V184, P26, DOI 10.1016/j.toxlet.2008.10.026; Shah AU, 2009, AM J PHYSIOL-GASTR L, V297, pG967, DOI 10.1152/ajpgi.00181.2009; Silins I, 2012, INTEGR ENVIRON ASSES, V8, P412, DOI 10.1002/ieam.1278; Sistare FD, 2011, TOXICOL PATHOL, V39, P716, DOI 10.1177/0192623311406935; Stelow EB, 2010, AM J SURG PATHOL, V34, P510, DOI 10.1097/PAS.0b013e3181cfcac7; Stewart Sherri L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Sun L, 2009, P NAT LANG PROC BIOM; Sun WJ, 2010, CELL SIGNAL, V22, P1799, DOI 10.1016/j.cellsig.2010.05.007; Tani Y, 2004, TOXICOL PATHOL, V32, P41, DOI 10.1080/01926230490260952; TERHUNE PG, 1994, MOL CARCINOGEN, V10, P110, DOI 10.1002/mc.2940100209; Terhune PG, 1998, PANCREAS, V16, P6, DOI 10.1097/00006676-199801000-00002; Terhune PG, 1998, CANCER EPIDEM BIOMAR, V7, P515; Tice DA, 2002, J BIOL CHEM, V277, P14329, DOI 10.1074/jbc.M200334200; Vrieling A, 2010, INT J CANCER, V126, P2394, DOI 10.1002/ijc.24907; Wang ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020537; Wolk A, 2012, BR J CANC; WOUTERSEN RA, 1991, MUTAT RES, V248, P291, DOI 10.1016/0027-5107(91)90063-T; Yamada T, 2004, J BIOL CHEM, V279, P6595, DOI 10.1074/jbc.M308133200; Yu SX, 2008, JNCI-J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378; Zhou J, 2010, CANCER CAUSE CONTROL, V21, P853, DOI 10.1007/s10552-010-9512-y; Zhu LQ, 2007, AM J PATHOL, V171, P263, DOI 10.2353/ajpath.2007.061176	87	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43209	10.1371/journal.pone.0043209	http://dx.doi.org/10.1371/journal.pone.0043209			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952646	gold, Green Submitted, Green Published			2022-12-25	WOS:000308206000023
J	Osborn, DPJ; Horsfall, L; Hassiotis, A; Petersen, I; Walters, K; Nazareth, I				Osborn, David P. J.; Horsfall, Laura; Hassiotis, Angela; Petersen, Irene; Walters, Kate; Nazareth, Irwin			Access to Cancer Screening in People with Learning Disabilities in the UK: Cohort Study in the Health Improvement Network, a Primary Care Research Database	PLOS ONE			English	Article							INTELLECTUAL DISABILITIES	Objectives: To assess whether people with learning disability in the UK have poorer access to cancer screening. Design: Four cohort studies comparing people with and without learning disability, within the recommended age ranges for cancer screening in the UK. We used Poisson regression to determine relative incidence rates of cancer screening. Setting: The Health Improvement Network, a UK primary care database with over 450 General practices. Participants: Individuals with a recorded diagnosis of learning disability including general diagnostic terms, specific syndromes, chromosomal abnormalities and autism in their General Practitioner computerised notes. For each type of cancer screening, a comparison cohort of up to six people without learning disability was selected for each person with a learning disability, using stratified sampling on age within GP practice. Main outcome measures: Incidence rate ratios for receiving 1) a cervical smear test, 2) a mammogram, 3) a faecal occult blood test and 4) a prostate specific antigen test. Results: Relative rates of screening for all four cancers were significantly lower for people with learning disability. The adjusted incidence rate ratios (95% confidence intervals) were Cervical smears: Number eligible with learning disability = 6,254; IRR = 0.54 (0.52-0.56). Mammograms: Number eligible with learning disability = 2,956; IRR = 0.76 (0.72-0.81); Prostate Specific Antigen: Number eligible = 3,520; IRR = 0.87 (0.80-0.96) and Faecal Occult Blood Number eligible = 6,566; 0.86 (0.78-0.94). Differences in screening rates were less pronounced in more socially deprived areas. Disparities in cervical screening rates narrowed over time, but were 45% lower in 2008/9, those for breast cancer screening appeared to widen and were 35% lower in 2009. Conclusion: Despite recent incentives, people with learning disability in the UK are significantly less likely to receive screening tests for cancer that those without learning disability. Other methods for reducing inequalities in access to cancer screening should be considered.	[Osborn, David P. J.; Hassiotis, Angela] UCL, Mental Hlth Sci Unit, London, England; [Horsfall, Laura; Petersen, Irene; Walters, Kate; Nazareth, Irwin] UCL, Res Dept Primary Care & Populat Hlth, London, England	University of London; University College London; University of London; University College London	Osborn, DPJ (corresponding author), UCL, Mental Hlth Sci Unit, London, England.	d.osborn@ucl.ac.uk	Petersen, Irene/I-2751-2012; Petersen, Irene/C-5702-2009; Osborn PhD FRCPsych, David/B-8165-2009	Petersen, Irene/0000-0002-0037-7524; Walters, Kate/0000-0003-2173-2430; Hassiotis, Angela/0000-0002-9800-3909; Osborn PhD FRCPsych, David/0000-0003-2519-1539; Nazareth, Irwin/0000-0003-2146-9628	National Health Service (NHS) Cancer Screening Programme on behalf of the Department of Health for England [JP/pat/L1623]	National Health Service (NHS) Cancer Screening Programme on behalf of the Department of Health for England	The study was commissioned by the National Health Service (NHS) Cancer Screening Programme on behalf of the Department of Health for England. (Grant reference: JP/pat/L1623.) The funder had no role in the data collection/extraction, data analysis, decision to publish, or preparation of the manuscript.	Ali A, 2008, BMJ-BRIT MED J, V336, P570, DOI 10.1136/bmj.39490.543137.80; [Anonymous], 2006, CANC SCREEN SER NHS; [Anonymous], 2010, ACC HLTH CAR PEOPL L; Booth N, 1994, Health Libr Rev, V11, P177; Cooper SA, 2004, BMJ-BRIT MED J, V329, P414, DOI 10.1136/bmj.329.7463.414; Dave S, 2009, PHARMACOEPIDEM DR S, V18, P704, DOI 10.1002/pds.1770; Department of Health, 2001, VAL PEOPL NEW STRAT; Disability Rights Commission, 2006, EQ TREATM CLOS GAP H; Disability Rights Commission, 2007, EQ TREATM CLOS GAP O; Maguire A, 2009, PHARMACOEPIDEM DR S, V18, P76, DOI 10.1002/pds.1688; MICHAEL J, 2008, HEALTHCARE ALL INDEP; NHS Employers, DIR ENH SERV 2011 12; Osborn DPJ, 2011, SCHIZOPHR RES, V129, P104, DOI 10.1016/j.schres.2011.04.003; Raftery J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7627; Sasieni P, 2009, BRIT MED J, V339, pb2968, DOI DOI 10.1136/BMJ.B2968; Stark JR, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3601; Townsend P., 1986, INEQUALITIES HLTH NO	17	40	40	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43841	10.1371/journal.pone.0043841	http://dx.doi.org/10.1371/journal.pone.0043841			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952783	Green Published, gold, Green Submitted			2022-12-25	WOS:000308206000053
J	Thomsen, PF; Kielgast, J; Iversen, LL; Moller, PR; Rasmussen, M; Willerslev, E				Thomsen, Philip Francis; Kielgast, Jos; Iversen, Lars Lonsmann; Moller, Peter Rask; Rasmussen, Morten; Willerslev, Eske			Detection of a Diverse Marine Fish Fauna Using Environmental DNA from Seawater Samples	PLOS ONE			English	Article							ANCIENT DNA; SEDIMENTS; REVEALS; PLANT; ICE; PALEOECOLOGY; VEGETATION; COLLAPSE; RECOVERY; RECORDS	Marine ecosystems worldwide are under threat with many fish species and populations suffering from human over-exploitation. This is greatly impacting global biodiversity, economy and human health. Intriguingly, marine fish are largely surveyed using selective and invasive methods, which are mostly limited to commercial species, and restricted to particular areas with favourable conditions. Furthermore, misidentification of species represents a major problem. Here, we investigate the potential of using metabarcoding of environmental DNA (eDNA) obtained directly from seawater samples to account for marine fish biodiversity. This eDNA approach has recently been used successfully in freshwater environments, but never in marine settings. We isolate eDNA from 1/2-litre seawater samples collected in a temperate marine ecosystem in Denmark. Using next-generation DNA sequencing of PCR amplicons, we obtain eDNA from 15 different fish species, including both important consumption species, as well as species rarely or never recorded by conventional monitoring. We also detect eDNA from a rare vagrant species in the area; European pilchard (Sardina pilchardus). Additionally, we detect four bird species. Records in national databases confirmed the occurrence of all detected species. To investigate the efficiency of the eDNA approach, we compared its performance with 9 methods conventionally used in marine fish surveys. Promisingly, eDNA covered the fish diversity better than or equal to any of the applied conventional methods. Our study demonstrates that even small samples of seawater contain eDNA from a wide range of local fish species. Finally, in order to examine the potential dispersal of eDNA in oceans, we performed an experiment addressing eDNA degradation in seawater, which shows that even small (100-bp) eDNA fragments degrades beyond detectability within days. Although further studies are needed to validate the eDNA approach in varying environmental conditions, our findings provide a strong proof-of-concept with great perspectives for future monitoring of marine biodiversity and resources.	[Thomsen, Philip Francis; Kielgast, Jos; Rasmussen, Morten; Willerslev, Eske] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Iversen, Lars Lonsmann] Univ Copenhagen, Dept Biol, Freshwater Biol Sect, Hillerod, Denmark; [Moller, Peter Rask] Univ Copenhagen, Nat Hist Museum Denmark, Vertebrate Dept, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Thomsen, PF (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Oster Voldgade, Copenhagen, Denmark.	pfthomsen@snm.ku.dk; ewillerslev@snm.ku.dk	Thomsen, Philip Francis/AAE-9354-2019; Møller, Peter/A-8807-2013; Willerslev, Eske/A-9619-2011; Willerslev, Eske/AAA-5686-2019	Thomsen, Philip Francis/0000-0002-9867-4366; Møller, Peter/0000-0002-0177-0977; Willerslev, Eske/0000-0002-7081-6748; 	Danish National Research Foundation; Aage V. Jensen Charity Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond); Aage V. Jensen Charity Foundation	This study was funded as basic research by the Danish National Research Foundation and the Aage V. Jensen Charity Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen K, 2012, MOL ECOL, V21, P1966, DOI 10.1111/j.1365-294X.2011.05261.x; Anderson-Carpenter LL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-30; Baldwin C.C., 1996, METHODS TECHNIQUES U, P11; Beare D, 2004, GLOBAL CHANGE BIOL, V10, P1209, DOI 10.1111/j.1529-8817.2003.00790.x; Becker S, 2011, MITOCHONDR DNA, V22, P3, DOI 10.3109/19401736.2010.535528; Collette BB, 2011, SCIENCE, V333, P291, DOI 10.1126/science.1208730; Corinaldesi C, 2005, APPL ENVIRON MICROB, V71, P46, DOI 10.1128/AEM.71.1.46-50.2005; Costanza R, 1999, ECOL ECON, V31, P199, DOI 10.1016/S0921-8009(99)00079-8; Daan N., 2001, ICES CM, V3, P1; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Dell'Anno A, 2004, APPL ENVIRON MICROB, V70, P4384, DOI 10.1128/AEM.70.7.4384-4386.2004; FAO Fisheries Department, 2010, STAT WORLD FISH AQ 2; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Haile J, 2007, MOL BIOL EVOL, V24, P982, DOI 10.1093/molbev/msm016; Haile J, 2009, P NATL ACAD SCI USA, V106, P22352, DOI 10.1073/pnas.0912510106; Hiiesalu I, 2012, MOL ECOL, V21, P2004, DOI 10.1111/j.1365-294X.2011.05390.x; Hofreiter M, 2003, CURR BIOL, V13, pR693, DOI 10.1016/j.cub.2003.08.039; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Hutchings JA, 2000, NATURE, V406, P882, DOI 10.1038/35022565; ICES, 2011, MAN BALT INT TRAWL S; ICES, 2010, MAN INT BOTT TRAWL S; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Jorgensen T, 2012, MOL ECOL, V21, P1980, DOI 10.1111/j.1365-294X.2011.05278.x; Jorgensen T, 2012, MOL ECOL, V21, P1989, DOI 10.1111/j.1365-294X.2011.05287.x; Love MS, 2010, B MAR SCI, V86, P35; Lydolph MC, 2005, APPL ENVIRON MICROB, V71, P1012, DOI 10.1128/AEM.71.2.1012-1017.2005; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Rogers SI, 2000, ICES J MAR SCI, V57, P866, DOI 10.1006/jmsc.2000.0574; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schnell IB, 2012, CURR BIOL, V22, pR262, DOI 10.1016/j.cub.2012.02.058; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sonstebo JH, 2010, MOL ECOL RESOUR, V10, P1009, DOI 10.1111/j.1755-0998.2010.02855.x; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Thomsen PF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005048; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Willerslev E, 2004, TRENDS ECOL EVOL, V19, P141, DOI 10.1016/j.tree.2003.11.010; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yoccoz NG, 2012, MOL ECOL, V21, P3647, DOI 10.1111/j.1365-294X.2012.05545.x	50	483	530	35	550	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e41732	10.1371/journal.pone.0041732	http://dx.doi.org/10.1371/journal.pone.0041732			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952584	gold, Green Published, Green Submitted			2022-12-25	WOS:000308206000004
J	Watanabe, M; Morimoto, K; Houten, SM; Kaneko-Iwasaki, N; Sugizaki, T; Horai, Y; Mataki, C; Sato, H; Murahashi, K; Arita, E; Schoonjans, K; Suzuki, T; Itoh, H; Auwerx, J				Watanabe, Mitsuhiro; Morimoto, Kohkichi; Houten, Sander M.; Kaneko-Iwasaki, Nao; Sugizaki, Taichi; Horai, Yasushi; Mataki, Chikage; Sato, Hiroyuki; Murahashi, Karin; Arita, Eri; Schoonjans, Kristina; Suzuki, Tatsuya; Itoh, Hiroshi; Auwerx, Johan			Bile Acid Binding Resin Improves Metabolic Control through the Induction of Energy Expenditure	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; TYPE-2 DIABETES-MELLITUS; NEGATIVE FEEDBACK-REGULATION; NUCLEAR RECEPTOR; GLYCEMIC CONTROL; COLESEVELAM HYDROCHLORIDE; GLUCOSE-HOMEOSTASIS; DOUBLE-BLIND; CHOLESTYRAMINE; THERAPY	Background: Besides well-established roles of bile acids (BA) in dietary lipid absorption and cholesterol homeostasis, it has recently become clear that BA is also a biological signaling molecule. We have shown that strategies aimed at activating TGR5 by increasing the BA pool size with BA administration may constitute a significant therapeutic advance to combat the metabolic syndrome and suggest that such strategies are worth testing in a clinical setting. Bile acid binding resin (BABR) is known not only to reduce serum cholesterol levels but also to improve glucose tolerance and insulin resistance in animal models and humans. However, the mechanisms by which BABR affects glucose homeostasis have not been established. We investigated how BABR affects glycemic control in diet-induced obesity models. Methods and Findings: We evaluated the metabolic effect of BABR by administrating colestimide to animal models for the metabolic syndrome. Administration of BABR increased energy expenditure, translating into significant weight reduction and insulin sensitization. The metabolic effects of BABR coincide with activation of cholesterol and BA synthesis in liver and thermogenesis in brown adipose tissue. Interestingly, these effects of BABR occur despite normal food intake and triglyceride absorption. Administration of BABR and BA had similar effects on BA composition and thermogenesis, suggesting that they both are mediated via TGR5 activation. Conclusion: Our data hence suggest that BABR could be useful for the management of the impaired glucose tolerance of the metabolic syndrome, since they not only lower cholesterol levels, but also reduce obesity and improve insulin resistance.	[Watanabe, Mitsuhiro; Morimoto, Kohkichi; Kaneko-Iwasaki, Nao; Sugizaki, Taichi; Horai, Yasushi; Murahashi, Karin; Arita, Eri; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan; [Houten, Sander M.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Mataki, Chikage; Schoonjans, Kristina; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lausanne, Switzerland; [Sato, Hiroyuki] Ehime Univ, Grad Sch Med, Dept Biosci, Matsuyama, Ehime 790, Japan; [Suzuki, Tatsuya] Nippon Med Sch, Tokyo 113, Japan; [Watanabe, Mitsuhiro] Keio Univ, Grad Sch Media & Governance, Fujisawa, Kanagawa, Japan	Keio University; University of Amsterdam; Academic Medical Center Amsterdam; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Ehime University; Nippon Medical School; Keio University	Watanabe, M (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan.	wmitsu@sc.itc.keio.ac.jp; johan.auwerx@epfl.ch	Auwerx, Johan/ABE-9307-2021; Houten, Sander/Y-3599-2019	Houten, Sander/0000-0002-6167-9147; Schoonjans, Kristina/0000-0003-1247-4265; Auwerx, Johan/0000-0002-5065-5393	Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation; NIH; Uehara Memorial Foundation; Takeda science foundation; Sumitomo Foundation; Ono Medical Foundation; Astellas Foundation for Research on Metabolic Disorders; Novartis Foundation (Japan) for Promotion of Science; Japan Health Foundation; Kowa life science foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan	Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda science foundation(Takeda Science Foundation (TSF)); Sumitomo Foundation; Ono Medical Foundation; Astellas Foundation for Research on Metabolic Disorders; Novartis Foundation (Japan) for Promotion of Science(Novartis); Japan Health Foundation(Japan Health Foundation); Kowa life science foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding was provided by grants of the Ecole Polytechnique Federale de Lausanne, the Swiss National Science Foundation, NIH, the Uehara Memorial Foundation, Takeda science foundation, the Sumitomo Foundation, Ono Medical Foundation, Astellas Foundation for Research on Metabolic Disorders, the Novartis Foundation (Japan) for Promotion of Science, the Japan Health Foundation, Kowa life science foundation and the Ministry of Education, Culture, Sports, Science and Technology of Japan for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bays HE, 2008, ARCH INTERN MED, V168, P1975, DOI 10.1001/archinte.168.18.1975; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Brendel C, 2002, MOL ENDOCRINOL, V16, P2065, DOI 10.1210/me.2001-0194; Brufau G, 2010, HEPATOLOGY, V52, P1455, DOI 10.1002/hep.23831; Brufau G, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-73; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fonseca VA, 2008, DIABETES CARE, V31, P1479, DOI 10.2337/dc08-0283; GARBUTT JT, 1972, J CLIN INVEST, V51, P2781, DOI 10.1172/JCI107100; GARG A, 1994, ANN INTERN MED, V121, P416, DOI 10.7326/0003-4819-121-6-199409150-00004; Goldberg RB, 2008, ARCH INTERN MED, V168, P1531, DOI 10.1001/archinte.168.14.1531; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Homma Y, 1997, ATHEROSCLEROSIS, V129, P241, DOI 10.1016/S0021-9150(96)06034-0; Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049; Houten SM, 2004, ANN MED, V36, P482, DOI 10.1080/07853890410018790; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Kajiyama G, 1996, J CLIN THER MED, V12, P1349; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Kerr TA, 2002, DEV CELL, V2, P713, DOI 10.1016/S1534-5807(02)00154-5; Kobayashi M, 2007, DIABETES, V56, P239, DOI 10.2337/db06-0353; KOGIRE M, 1992, PANCREAS, V7, P15, DOI 10.1097/00006676-199201000-00003; KOOP I, 1988, EUR J CLIN INVEST, V18, P517, DOI 10.1111/j.1365-2362.1988.tb01050.x; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Mataki C, 2007, MOL CELL BIOL, V27, P8330, DOI 10.1128/MCB.00852-07; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Prawitt J, 2011, DIABETES, V60, P1861, DOI 10.2337/db11-0030; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; SAKAKURA H, 1993, J CHROMATOGR-BIOMED, V621, P123, DOI 10.1016/0378-4347(93)80087-K; SHIDO O, 1989, JPN J PHYSIOL, V39, P359, DOI 10.2170/jjphysiol.39.359; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Stroeve JHM, 2010, LAB INVEST, V90, P1457, DOI 10.1038/labinvest.2010.107; Suzuki T, 2012, J DIABETES COMPLICAT, V26, P34, DOI 10.1016/j.jdiacomp.2011.11.008; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Watanabe M, 2011, J BIOL CHEM; YOSHIMATSU H, 1992, BRAIN RES, V597, P298, DOI 10.1016/0006-8993(92)91486-X; Zieve FJ, 2007, CLIN THER, V29, P74, DOI 10.1016/j.clinthera.2007.01.003	49	83	83	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e38286	10.1371/journal.pone.0038286	http://dx.doi.org/10.1371/journal.pone.0038286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952571	Green Published, Green Submitted, gold			2022-12-25	WOS:000308206000002
J	Chon, SH; Douglass, JD; Zhou, YX; Malik, N; Dixon, JL; Brinker, A; Quadro, L; Storch, J				Chon, Su-Hyoun; Douglass, John D.; Zhou, Yin Xiu; Malik, Nashmia; Dixon, Joseph L.; Brinker, Anita; Quadro, Loredana; Storch, Judith			Over-Expression of Monoacylglycerol Lipase (MGL) in Small Intestine Alters Endocannabinoid Levels and Whole Body Energy Balance, Resulting in Obesity	PLOS ONE			English	Article							MONOGLYCERIDE LIPASE; DIACYLGLYCEROL ACYLTRANSFERASE; TRIGLYCERIDE SYNTHESIS; ADIPOSE-TISSUE; PLASMA LEPTIN; FOOD-INTAKE; MICE; ENZYME; IDENTIFICATION; METABOLISM	The function of small intestinal monoacylglycerol lipase (MGL) is unknown. Its expression in this tissue is surprising because one of the primary functions of the small intestine is to convert diet-derived MGs to triacylglycerol (TG), and not to degrade them. To elucidate the function of intestinal MGL, we generated transgenic mice that over-express MGL specifically in small intestine (iMGL mice). After only 3 weeks of high fat feeding, iMGL mice showed an obese phenotype; body weight gain and body fat mass were markedly higher in iMGL mice, along with increased hepatic and plasma TG levels compared to wild type littermates. The iMGL mice were hyperphagic and displayed reduced energy expenditure despite unchanged lean body mass, suggesting that the increased adiposity was due to both increased caloric intake and systemic effects resulting in a hypometabolic rate. The presence of the transgene resulted in lower levels of most MG species in intestinal mucosa, including the endocannabinoid 2-arachidonoyl glycerol (2-AG). The results therefore suggest a role for intestinal MGL, and intestinal 2-AG and perhaps other MG species, in whole body energy balance via regulation of food intake as well as metabolic rate.	[Chon, Su-Hyoun; Douglass, John D.; Zhou, Yin Xiu; Malik, Nashmia; Dixon, Joseph L.; Brinker, Anita; Storch, Judith] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08903 USA; [Quadro, Loredana] Rutgers State Univ, Dept Food Sci Rutgers, New Brunswick, NJ 08903 USA; [Chon, Su-Hyoun; Douglass, John D.; Zhou, Yin Xiu; Malik, Nashmia; Dixon, Joseph L.; Brinker, Anita; Quadro, Loredana; Storch, Judith] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Chon, SH (corresponding author), Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08903 USA.	storch@aesop.rutgers.edu	Zhou, yixin/HGE-2329-2022	Storch, Judith/0000-0001-5482-1777	National Institutes of Health [DK38389]; New Jersey Agricultural Experiment Station; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK038389, R01DK038389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Agricultural Experiment Station; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by National Institutes of Health grant DK38389 (JS) and by funds from the New Jersey Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley RL, 1999, DIABETES, V48, P272, DOI 10.2337/diabetes.48.2.272; Breen DM, 2011, DIABETES-METAB RES, V27, P113, DOI 10.1002/dmrr.1160; Burdyga G, 2004, J NEUROSCI, V24, P2708, DOI 10.1523/JNEUROSCI.5404-03.2004; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chanda PK, 2010, MOL PHARMACOL, V78, P996, DOI 10.1124/mol.110.068304; Chen HC, 2003, AM J PHYSIOL-ENDOC M, V284, pE213, DOI 10.1152/ajpendo.00248.2002; Cheng D, 2003, J BIOL CHEM, V278, P13611, DOI 10.1074/jbc.C300042200; Cheng D, 2008, J BIOL CHEM, V283, P29802, DOI 10.1074/jbc.M800494200; Chon SH, 2007, J BIOL CHEM, V282, P33346, DOI 10.1074/jbc.M706994200; COHN SM, 1992, J CELL BIOL, V119, P27, DOI 10.1083/jcb.119.1.27; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Dinh TP, 2004, MOL PHARMACOL, V66, P1260, DOI 10.1124/mol.104.002071; DiPatrizio NV, 2011, P NATL ACAD SCI USA, V108, P12904, DOI 10.1073/pnas.1104675108; Douglass JD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00025; Duncan M, 2008, AM J PHYSIOL-GASTR L, V295, pG1255, DOI 10.1152/ajpgi.90500.2008; FOLCH J, 1957, J BIOL CHEM, V226, P497; FREDRIKSON G, 1986, BIOCHIM BIOPHYS ACTA, V876, P288, DOI 10.1016/0005-2760(86)90286-9; Fu J, 2007, J BIOL CHEM, V282, P1518, DOI 10.1074/jbc.M607809200; Gillum MP, 2008, CELL, V135, P813, DOI 10.1016/j.cell.2008.10.043; Gomez R, 2002, J NEUROSCI, V22, P9612; Guzman M, 2004, J BIOL CHEM, V279, P27849, DOI 10.1074/jbc.M404087200; Hajri T, 2007, DIABETES, V56, P1872, DOI 10.2337/db06-1699; Ho SY, 2002, J BIOL CHEM, V277, P1816, DOI 10.1074/jbc.M108027200; Homan R, 1998, J CHROMATOGR B, V708, P21, DOI 10.1016/S0378-4347(97)00651-8; Izzo AA, 2001, BRIT J PHARMACOL, V134, P563, DOI 10.1038/sj.bjp.0704293; Izzo AA, 2009, BRIT J PHARMACOL, V158, P451, DOI 10.1111/j.1476-5381.2009.00183.x; Johansson A, 2010, OBESITY, V18, P803, DOI 10.1038/oby.2009.359; JOHNSTON JM, 1967, BIOCHIM BIOPHYS ACTA, V137, P578, DOI 10.1016/0005-2760(67)90140-3; Karlsson M, 1997, J BIOL CHEM, V272, P27218, DOI 10.1074/jbc.272.43.27218; KAYDEN HJ, 1967, J CLIN INVEST, V46, P1695, DOI 10.1172/JCI105660; Krempler F, 1998, ARTERIOSCL THROM VAS, V18, P1686, DOI 10.1161/01.ATV.18.11.1686; Luan Y, 2002, DIABETES RES CLIN PR, V57, P75, DOI 10.1016/S0168-8227(02)00026-8; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; Newberry EP, 2006, HEPATOLOGY, V44, P1191, DOI 10.1002/hep.21369; Poirier H, 1997, AM J PHYSIOL-GASTR L, V273, pG289, DOI 10.1152/ajpgi.1997.273.2.G289; Ranganathan S, 1998, J LIPID RES, V39, P724; Russell CD, 1998, AM J PHYSIOL-ENDOC M, V275, pE507, DOI 10.1152/ajpendo.1998.275.3.E507; Saario SM, 2007, CHEM BIODIVERS, V4, P1903, DOI 10.1002/cbdv.200790158; Satoh Y, 2006, AM J PHYSIOL-REG I, V290, pR1276, DOI 10.1152/ajpregu.00775.2005; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Shi YG, 2009, AM J PHYSIOL-ENDOC M, V297, pE10, DOI 10.1152/ajpendo.90949.2008; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Storch J., 2001, Nutrient-gene interactions in health and disease, P101; Storch J, 2008, J LIPID RES, V49, P1762, DOI 10.1194/jlr.M800116-JLR200; Storr MA, 2007, CURR OPIN PHARMACOL, V7, P575, DOI 10.1016/j.coph.2007.08.008; Taschler U, 2011, J BIOL CHEM, V286, P17467, DOI 10.1074/jbc.M110.215434; TORNQVIST H, 1974, J LIPID RES, V15, P291; TORNQVIST H, 1976, J BIOL CHEM, V251, P813; Tso P, 2002, BIOCH PHYSL ASPECTS, P125; Ueno N, 2007, ENDOCRINE, V32, P192, DOI 10.1007/s12020-007-9016-z; Wang PYT, 2008, NATURE, V452, P1012, DOI 10.1038/nature06852; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200; Yen CLE, 2005, J LIPID RES, V46, P2388, DOI 10.1194/jlr.M500168-JLR200; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899	59	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43962	10.1371/journal.pone.0043962	http://dx.doi.org/10.1371/journal.pone.0043962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937137	Green Published, Green Submitted, gold			2022-12-25	WOS:000308213600065
J	Favre, G; Lavenex, PB; Lavenex, P				Favre, Gregoire; Lavenex, Pamela Banta; Lavenex, Pierre			miRNA Regulation of Gene Expression: A Predictive Bioinformatics Analysis in the Postnatally Developing Monkey Hippocampus	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; RNA INTERFERENCE; MEMORY; MICRORNAS; DATABASE; TARGETS; EVOLUTION; RESOURCE; MIRBASE; CLUSTER	Regulation of gene expression in the postnatally developing hippocampus might contribute to the emergence of selective memory function. However, the mechanisms that underlie the co-regulation of expression of hundreds of genes in different cell types at specific ages in distinct hippocampal regions have yet to be elucidated. By performing genome-wide microarray analyses of gene expression in distinct regions of the monkey hippocampal formation during early postnatal development, we identified one particular group of genes exhibiting a down-regulation of expression, between birth and six months of age in CA1 and after one year of age in CA3, to reach expression levels observed at 6-12 years of age. Bioinformatics analyses using NCBI, miRBase, TargetScan, microRNA.org and Affymetrix tools identified a number of miRNAs capable of regulating the expression of these genes simultaneously in different cell types, i.e., in neurons, astrocytes and oligodendrocytes. Interestingly, sixty-five percent of these miRNAs are conserved across species, from rodents to humans; whereas thirty-five percent are specific to primates, including humans. In addition, we found that some genes exhibiting greater down-regulation of their expression were the predicted targets of a greater number of these miRNAs. In sum, miRNAs may play a fundamental role in the co-regulation of gene expression in different cell types. This mechanism is partially conserved across species, and may thus contribute to the similarity of basic hippocampal characteristics across mammals. This mechanism also exhibits a phylogenetic diversity that may contribute to more subtle species differences in hippocampal structure and function observed at the cellular level.	[Favre, Gregoire; Lavenex, Pamela Banta; Lavenex, Pierre] Univ Fribourg, Lab Brain & Cognit Dev, Dept Med, CH-1700 Fribourg, Switzerland	University of Fribourg	Favre, G (corresponding author), Univ Fribourg, Lab Brain & Cognit Dev, Dept Med, CH-1700 Fribourg, Switzerland.	pierre.lavenex@unifr.ch		Lavenex, Pierre/0000-0002-9278-1312; Banta Lavenex, Pamela/0000-0001-8868-2912	Department of Psychiatry and Behavioral Sciences, University of California Davis; National Alliance for Research on Schizophrenia and Depression (NARSAD); Swiss National Science Foundation [PP00A-106701, PP00P3-124536]; California National Primate Research Center [RR00169]; Department of Medicine, University of Fribourg; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER	Department of Psychiatry and Behavioral Sciences, University of California Davis; National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); California National Primate Research Center; Department of Medicine, University of Fribourg; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding came from the Joe P. Tupin award, Department of Psychiatry and Behavioral Sciences, University of California Davis to PL, National Alliance for Research on Schizophrenia and Depression (NARSAD 2004 Young Investigator Award) to PL, the Swiss National Science Foundation, Grant numbers: PP00A-106701; PP00P3-124536 to PL, California National Primate Research Center Grant number: RR00169, and the Department of Medicine, University of Fribourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2004, NAT NEUROSCI, V7, P357, DOI 10.1038/nn1212; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Altemus KL, 2005, NEUROSCIENCE, V136, P741, DOI 10.1016/j.neuroscience.2005.07.001; Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Artzi S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-39; Bani-Yaghoub M, 2006, DEV BIOL, V295, P52, DOI 10.1016/j.ydbio.2006.03.007; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bauer PJ, 2006, TRENDS COGN SCI, V10, P175, DOI 10.1016/j.tics.2006.02.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Boneva NB, 2011, HIPPOCAMPUS, V21, P162, DOI 10.1002/hipo.20732; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; Denayer E, 2008, J NEUROSCI, V28, P14443, DOI 10.1523/JNEUROSCI.4698-08.2008; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dinger ME, 2008, J MOL ENDOCRINOL, V40, P151, DOI 10.1677/JME-07-0160; Duxbury MS, 2005, BIOCHEM BIOPH RES CO, V331, P459, DOI 10.1016/j.bbrc.2005.03.199; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Fiore Roberto, 2007, ScientificWorldJournal, V7, P167; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; FLEXNER JB, 1963, SCIENCE, V141, P57, DOI 10.1126/science.141.3575.57; Glazov EA, 2008, MOL BIOL EVOL, V25, P939, DOI 10.1093/molbev/msn045; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jabes A, 2011, J COMP NEUROL, V519, P1051, DOI 10.1002/cne.22549; Jabes A, 2010, EUR J NEUROSCI, V31, P273, DOI 10.1111/j.1460-9568.2009.07061.x; Jose AM, 2007, ANNU REV GENET, V41, P305, DOI 10.1146/annurev.genet.41.110306.130216; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lavenex PB, 2009, HIPPOCAMPUS, V19, P8, DOI 10.1002/hipo.20485; Lavenex PB, 2006, J NEUROSCI, V26, P4546, DOI 10.1523/JNEUROSCI.5412-05.2006; Lavenex P, 2007, DEV NEUROSCI-BASEL, V29, P179, DOI 10.1159/000096222; Lavenex P, 2011, HIPPOCAMPUS, V21, P142, DOI 10.1002/hipo.20730; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lopez-Salon M, 2001, EUR J NEUROSCI, V14, P1820, DOI 10.1046/j.0953-816x.2001.01806.x; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Morris R., 2007, HIPPOCAMPUS BOOK, P581; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Oberheim NA, 2006, TRENDS NEUROSCI, V29, P547, DOI 10.1016/j.tins.2006.08.004; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Parsons MJ, 2008, MAMM GENOME, V19, P552, DOI 10.1007/s00335-008-9116-y; Peng S, 2010, INT J MOL SCI, V11, P222, DOI 10.3390/ijms11010222; Peter ME, 2010, ONCOGENE, V29, P2161, DOI 10.1038/onc.2010.59; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sahni V, 2010, J NEUROSCI, V30, P1839, DOI 10.1523/JNEUROSCI.4459-09.2010; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; STANTON PK, 1984, J NEUROSCI, V4, P3080; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Xie KQ, 2010, NAT NEUROSCI, V13, P661, DOI 10.1038/nn.2549; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Zhang R, 2008, MOL BIOL EVOL, V25, P1493, DOI 10.1093/molbev/msn094	62	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43435	10.1371/journal.pone.0043435	http://dx.doi.org/10.1371/journal.pone.0043435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952683	Green Submitted, Green Published, gold			2022-12-25	WOS:000308213600025
J	Queiroga, CSF; Tomasi, S; Wideroe, M; Alves, PM; Vercelli, A; Vieira, HLA				Queiroga, Claudia S. F.; Tomasi, Simone; Wideroe, Marius; Alves, Paula M.; Vercelli, Alessandro; Vieira, Helena L. A.			Preconditioning Triggered by Carbon Monoxide (CO) Provides Neuronal Protection Following Perinatal Hypoxia-Ischemia	PLOS ONE			English	Article							MITOCHONDRIAL-MEMBRANE PERMEABILIZATION; BRAIN-DAMAGE; HEME OXYGENASE-1; RAT MODEL; REDUCES APOPTOSIS; CEREBRAL-ISCHEMIA; CELL-DEATH; INJURY; TOLERANCE; NEUROPROTECTION	Perinatal hypoxia-ischemia is a major cause of acute mortality in newborns and cognitive and motor impairments in children. Cerebral hypoxia-ischemia leads to excitotoxicity and necrotic and apoptotic cell death, in which mitochondria play a major role. Increased resistance against major damage can be achieved by preconditioning triggered by subtle insults. CO, a toxic molecule that is also generated endogenously, may have a role in preconditioning as low doses can protect against inflammation and apoptosis. In this study, the role of CO-induced preconditioning on neurons was addressed in vitro and in vivo. The effect of 1 h of CO treatment on neuronal death (plasmatic membrane permeabilization and chromatin condensation) and bcl-2 expression was studied in cerebellar granule cells undergoing to glutamate-induced apoptosis. CO's role was studied in vivo in the Rice-Vannucci model of neonatal hypoxia-ischemia (common carotid artery ligature +75 min at 8% oxygen). Apoptotic cells, assessed by Nissl staining were counted with a stereological approach and cleaved caspase 3-positive profiles in the hippocampus were assessed. Apoptotic hallmarks were analyzed in hippocampal extracts by Western Blot. CO inhibited excitotoxicity-induced cell death and increased Bcl-2 mRNA in primary cultures of neurons. In vivo, CO prevented hypoxia-ischemia induced apoptosis in the hippocampus, limited cytochrome c released from mitochondria and reduced activation of caspase-3. Still, Bcl-2 protein levels were higher in hippocampus of CO pre-treated rat pups. Our results show that CO preconditioning elicits a molecular cascade that limits neuronal apoptosis. This could represent an innovative therapeutic strategy for high-risk cerebral hypoxia-ischemia patients, in particular neonates.	[Queiroga, Claudia S. F.; Alves, Paula M.; Vieira, Helena L. A.] Univ Nova Lisboa, Chron Dis Res Ctr CEDOC, Fac Ciencias Med, P-1200 Lisbon, Portugal; [Queiroga, Claudia S. F.; Vieira, Helena L. A.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, IBET, Oeiras, Portugal; [Tomasi, Simone; Vercelli, Alessandro] AOU San Luigi Gonzaga, NICO, Turin, Italy; [Tomasi, Simone; Vercelli, Alessandro] Univ Turin, Sch Med, Dept Anat Pharmacol & Forens Med, Turin, Italy; [Wideroe, Marius] Norwegian Univ Sci & Technol, Dept Lab Med, N-7034 Trondheim, Norway	Universidade Nova de Lisboa; Universidade Nova de Lisboa; University of Turin; Norwegian University of Science & Technology (NTNU)	Queiroga, CSF (corresponding author), Univ Nova Lisboa, Chron Dis Res Ctr CEDOC, Fac Ciencias Med, P-1200 Lisbon, Portugal.	helena.vieira@fcm.unl.pt	Tomasi, Simone/D-8427-2011; Alves, Paula M/C-1070-2008; Vieira, Helena/AAZ-9562-2021; Vercelli, Alessandro/A-1926-2012	Alves, Paula M/0000-0003-1445-3556; Vieira, Helena/0000-0001-9415-3742; Vercelli, Alessandro/0000-0002-5909-2128; Queiroga, Claudia/0000-0002-3984-9576	Portuguese Fundacao para a Ciencia e Tecnologia [PTDC/SAU-NEU/64327/2006, PTDCS/SAU-NEU/098747/2008, SFRH/BPD/27125/2006, SFRH/BD/43387/2008]; Fundação para a Ciência e a Tecnologia [PTDC/SAU-NEU/64327/2006] Funding Source: FCT	Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This work was supported by the Portuguese Fundacao para a Ciencia e Tecnologia (PTDC/SAU-NEU/64327/2006; PTDCS/SAU-NEU/098747/2008) and the Portuguese Fundacao para a Ciencia e Tecnologia, for HLAV's SFRH/BPD/27125/2006 and for CSFQ's SFRH/BD/43387/2008 fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom K, 2009, ACTA ANAESTH SCAND, V53, P1036, DOI 10.1111/j.1399-6576.2009.01992.x; Ahmad AS, 2006, NEUROSCIENCE, V141, P1703, DOI 10.1016/j.neuroscience.2006.05.035; Alkan T, 2008, TURK NEUROSURG, V18, P165; Almeida AS, 2012, J BIOL CHEM, V287, P10761, DOI 10.1074/jbc.M111.306738; Ara J, 2011, NEUROBIOL DIS, V43, P473, DOI 10.1016/j.nbd.2011.04.021; Arpino Carla, 2005, Ann Ist Super Sanita, V41, P229; Biermann J, 2012, INVEST OPHTHALMOL, V51, P3784; Bloch KD, 2007, CARDIOVASC RES, V75, P339, DOI 10.1016/j.cardiores.2007.04.014; Bonifacio SL, 2011, NAT REV NEUROL, V7, P485, DOI 10.1038/nrneurol.2011.119; Cai JM, 2008, NEUROSCI LETT, V441, P167, DOI 10.1016/j.neulet.2008.05.077; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Chora AA, 2007, J CLIN INVEST, V117, P438, DOI 10.1172/JCI28844; Dirnagl U, 2008, NEUROPHARMACOLOGY, V55, P334, DOI 10.1016/j.neuropharm.2008.02.017; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Fitting S, 2008, HIPPOCAMPUS, V18, P135, DOI 10.1002/hipo.20376; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; Ge W, 2011, CELL DEATH DIFFER; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Gunn AJ, 2008, CLIN PERINATOL, V35, P735, DOI 10.1016/j.clp.2008.07.012; Hagberg H, 2004, J BIOENERG BIOMEMBR, V36, P369, DOI 10.1023/B:JOBB.0000041770.00567.4f; Heazell AEP, 2008, J OBSTET GYNAECOL, V28, P147, DOI 10.1080/01443610801912618; Kirino T, 2002, J CEREBR BLOOD F MET, V22, P1283, DOI 10.1097/01.WCB.0000040942.89393.88; Kroemer G, 2003, BIOCHEM BIOPH RES CO, V304, P433, DOI 10.1016/S0006-291X(03)00614-4; Levene H., 1960, CONTRIBUTIONS PROBAB, P278, DOI DOI 10.1137/1003016; LEVINE S, 1960, AM J PATHOL, V36, P1; Li Q, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.33; McAuliffe JJ, 2007, ANESTH ANALG, V104, P1066, DOI 10.1213/01.ane.0000260321.62377.74; Motterlini R, 2007, BIOCHEM SOC T, V35, P1142, DOI 10.1042/BST0351142; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Nakao A, 2010, J HEART LUNG TRANSPL, V29, P544, DOI 10.1016/j.healun.2009.10.011; Ness JM, 2006, BRAIN RES, V1099, P150, DOI 10.1016/j.brainres.2006.04.132; Otterbein LE, 2005, CELL MOL BIOL, V51, P433, DOI 10.1170/T647; Queiroga CSF, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-10; Queiroga CSF, 2010, J BIOL CHEM, V285, P17077, DOI 10.1074/jbc.M109.065052; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Robinson BRH, 2009, CURR OPIN CRIT CARE, V15, P1, DOI 10.1097/MCC.0b013e3283220e34; Ryang YM, 2011, CRIT CARE MED, V39, P1448, DOI 10.1097/CCM.0b013e31821209be; Sanders RD, 2004, BRIT MED BULL, V71, P115, DOI 10.1093/bmb/ldh034; SCHOUSBOE I, 1989, INT J DEV NEUROSCI, V7, P115, DOI 10.1016/0736-5748(89)90050-6; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Stein AB, 2012, J MOL CELL CARDIOL, V52, P228, DOI 10.1016/j.yjmcc.2011.11.005; Stenzel-Poore MP, 2007, STROKE, V38, P680, DOI 10.1161/01.STR.0000251444.56487.4c; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tsujimoto Y, 2006, BBA-BIOENERGETICS, V1757, P1297, DOI 10.1016/j.bbabio.2006.03.017; Vannucci RC, 1999, J NEUROSCI RES, V55, P158, DOI 10.1002/(SICI)1097-4547(19990115)55:2<158::AID-JNR3>3.0.CO;2-1; Vannucci RC, 1997, ANN NY ACAD SCI, V835, P234, DOI 10.1111/j.1749-6632.1997.tb48634.x; Vannucci SJ, 2004, J EXP BIOL, V207, P3149, DOI 10.1242/jeb.01064; Vieira HLA, 2008, J NEUROCHEM, V107, P375, DOI 10.1111/j.1471-4159.2008.05610.x; Wang B, 2011, STROKE, V42, P2605, DOI 10.1161/STROKEAHA.110.607101; Wideroe M, 2009, NEUROIMAGE, V45, P880, DOI 10.1016/j.neuroimage.2008.12.007; Yabluchanskiy A, 2012, CRIT CARE MED, V40, P544, DOI 10.1097/CCM.0b013e31822f0d64; Zeynalov E, 2009, NEUROTOX RES, V15, P133, DOI 10.1007/s12640-009-9014-4; Zimmermann A, 2007, AM J PHYSIOL-HEART C, V293, pH2501, DOI 10.1152/ajpheart.00354.2007; Zuckerbraun BS, 2003, J EXP MED, V198, P1707, DOI 10.1084/jem.20031003	55	33	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e42632	10.1371/journal.pone.0042632	http://dx.doi.org/10.1371/journal.pone.0042632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952602	Green Published, Green Submitted, gold			2022-12-25	WOS:000308213600006
J	Sano, W; Nakamura, T; Yoshiuchi, K; Kitajima, T; Tsuchiya, A; Esaki, Y; Yamamoto, Y; Iwata, N				Sano, Wataru; Nakamura, Toru; Yoshiuchi, Kazuhiro; Kitajima, Tsuyoshi; Tsuchiya, Akiko; Esaki, Yuichi; Yamamoto, Yoshiharu; Iwata, Nakao			Enhanced Persistency of Resting and Active Periods of Locomotor Activity in Schizophrenia	PLOS ONE			English	Article							MOTOR-ACTIVITY; NEUROLOGICAL SIGNS; BASAL GANGLIA; OLANZAPINE; RISPERIDONE; ACTIGRAPHY; PSYCHOSIS; RHYTHMS; PEOPLE; SLEEP	Patients with schizophrenia frequently exhibit behavioral abnormalities associated with its pathological symptoms. Therefore, a quantitative evaluation of behavioral dynamics could contribute to objective diagnoses of schizophrenia. However, such an approach has not been fully established because of the absence of quantitative biobehavioral measures. Recently, we studied the dynamical properties of locomotor activity, specifically how resting and active periods are interwoven in daily life. We discovered universal statistical laws ("behavioral organization") and their alterations in patients with major depressive disorder. In this study, we evaluated behavioral organization of schizophrenic patients (n = 19) and healthy subjects (n = 11) using locomotor activity data, acquired by actigraphy, to investigate whether the laws could provide objective and quantitative measures for a possible diagnosis and assessment of symptoms. Specifically, we evaluated the cumulative distributions of resting and active periods, defined as the periods with physical activity counts successively below and above a predefined threshold, respectively. Here we report alterations in the laws governing resting and active periods; resting periods obeyed a power-law cumulative distribution with significantly lower parameter values (power-law scaling exponents), whereas active periods followed a stretched exponential distribution with significantly lower parameter values (stretching exponents), in patients. Our findings indicate enhanced persistency of both lower and higher locomotor activity periods in patients with schizophrenia, probably reflecting schizophrenic pathophysiology.	[Sano, Wataru; Kitajima, Tsuyoshi; Tsuchiya, Akiko; Esaki, Yuichi; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi, Japan; [Nakamura, Toru; Yamamoto, Yoshiharu] Univ Tokyo, Grad Sch Educ, Educ Physiol Lab, Tokyo, Japan; [Yoshiuchi, Kazuhiro] Univ Tokyo, Dept Psychosomat Med, Grad Sch Med, Tokyo, Japan	Fujita Health University; University of Tokyo; University of Tokyo	Sano, W (corresponding author), Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi, Japan.	sano-w@fujita-hu.ac.jp	Kitajima, Tsuyoshi/GQH-5130-2022	nakamura, toru/0000-0002-5340-6333; esaki, yuichi/0000-0001-5165-6171; Yamamoto, Yoshiharu/0000-0002-1132-0355; Kitajima, Tsuyoshi/0000-0002-8785-9330	Ministry of Education, Culture, Sports, Science and Technology [23240094, 23700795]; Core Research for Evolutional Science and Technology from Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [23700795, 23240094] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology from Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-In-Aid for Scientific Research (A) [23240094] (to YY) and Grant-In-Aid for Young Scientists (B) [23700795] (to TN) from the Ministry of Education, Culture, Sports, Science and Technology, and by Core Research for Evolutional Science and Technology from Japan Science and Technology Agency (to YY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso P, 2011, PSYCHIAT RES, V189, P62, DOI 10.1016/j.psychres.2010.12.031; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Andreasen NC, 1997, SCHIZOPHR RES, V28, P105, DOI 10.1016/S0920-9964(97)00112-6; Berle Jan O, 2010, BMC Res Notes, V3, P149, DOI 10.1186/1756-0500-3-149; Bombin I, 2005, SCHIZOPHRENIA BULL, V31, P962, DOI 10.1093/schbul/sbi028; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; COLE RJ, 1992, SLEEP, V15, P461, DOI 10.1093/sleep/15.5.461; Dazzan P, 2002, BRIT J PSYCHIAT, V181, pS50, DOI 10.1192/bjp.181.43.s50; Deo AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009714; Eklund M, 2004, EUR PSYCHIAT, V19, P34, DOI 10.1016/j.eurpsy.2003.07.008; Farrow TFD, 2005, BRIT J PSYCHIAT, V187, P481, DOI 10.1192/bjp.187.5.481; Farrow Tom F D, 2009, Open Neuroimag J, V3, P48, DOI 10.2174/1874440000903010048; Folsom DP, 2009, SCHIZOPHR RES, V108, P207, DOI 10.1016/j.schres.2008.12.008; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Hauge ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016291; HEINRICHS DW, 1988, AM J PSYCHIAT, V145, P11; Henry BL, 2010, NEUROSCI BIOBEHAV R, V34, P1296, DOI 10.1016/j.neubiorev.2010.04.002; Jeste DV, 2011, SCHIZOPHRENIA BULL, V37, P451, DOI 10.1093/schbul/sbr026; Kiang M, 2003, J PSYCHIATR NEUROSCI, V28, P293; Mayoral M, 2012, J CHILD PSYCHOL PSYC, V53, P323, DOI 10.1111/j.1469-7610.2011.02475.x; Minassian A, 2010, J AFFECT DISORDERS, V120, P200, DOI 10.1016/j.jad.2009.04.018; Mizrahi R, 2007, AM J PSYCHIAT, V164, P630, DOI 10.1176/appi.ajp.164.4.630; Morrens M, 2007, SCHIZOPHRENIA BULL, V33, P1038, DOI 10.1093/schbul/sbl051; Nakamura T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138103; Nakamura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002050; Pantelis C, 2009, NEUROPSYCHOL REV, V19, P385, DOI 10.1007/s11065-009-9114-1; Shepherd S, 2012, SCHIZOPHRENIA BULL, V38, P295, DOI 10.1093/schbul/sbq075; Szoke A, 2008, BRIT J PSYCHIAT, V192, P248, DOI 10.1192/bjp.bp.106.029009; TEICHER MH, 1995, HARVARD REV PSYCHIAT, V3, P18, DOI 10.3109/10673229509017161; TEICHER MH, 1988, ARCH GEN PSYCHIAT, V45, P913; van der Gaag M, 2006, SCHIZOPHR RES, V85, P280, DOI 10.1016/j.schres.2006.03.021; Walther S, 2011, PSYCHIAT RES-NEUROIM, V192, P117, DOI 10.1016/j.pscychresns.2010.12.002; Walther S, 2011, NEUROBIOL DIS, V42, P276, DOI 10.1016/j.nbd.2011.01.017; Walther S, 2010, J CLIN PSYCHOPHARM, V30, P181, DOI 10.1097/JCP.0b013e3181d2ef6f; Walther S, 2009, PSYCHIAT RES, V169, P187, DOI 10.1016/j.psychres.2008.06.020; Walther S, 2009, NEUROPSYCHOBIOLOGY, V60, P80, DOI 10.1159/000236448; Wichniak A, 2011, J PSYCHIATR RES, V45, P1381, DOI 10.1016/j.jpsychires.2011.05.009; Wirz-Justice A, 2001, SCHIZOPHRENIA BULL, V27, P497, DOI 10.1093/oxfordjournals.schbul.a006890; Wood SJ, 2008, SCHIZOPHRENIA BULL, V34, P322, DOI 10.1093/schbul/sbm149	40	41	42	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43539	10.1371/journal.pone.0043539	http://dx.doi.org/10.1371/journal.pone.0043539			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998CA	22952701	Green Submitted, Green Published, gold			2022-12-25	WOS:000308213600031
J	Okello, E; Kakande, B; Sebatta, E; Kayima, J; Kuteesa, M; Mutatina, B; Nyakoojo, W; Lwabi, P; Mondo, CK; Odoi-Adome, R; Juergen, F				Okello, Emmy; Kakande, Barbara; Sebatta, Elias; Kayima, James; Kuteesa, Monica; Mutatina, Boniface; Nyakoojo, Wilson; Lwabi, Peter; Mondo, Charles K.; Odoi-Adome, Richard; Juergen, Freers			Socioeconomic and Environmental Risk Factors among Rheumatic Heart Disease Patients in Uganda	PLOS ONE			English	Article							FEVER; EPIDEMIOLOGY; DISTANCE; CHILDREN; ACCESS	Background: Although low socioeconomic status, and environmental factors are known risk factors for rheumatic heart disease in other societies, risk factors for rheumatic heart disease remain less well described in Uganda. Aims and Objective: The objective of this study was to investigate the role of socio-economic and environmental factors in the pathogenesis of rheumatic heart disease in Ugandan patients. Methods: This was a case control study in which rheumatic heart disease cases and normal controls aged 5-60 years were recruited and investigated for socioeconomic and environmental risk factors such as income status, employment status, distance from the nearest health centre, number of people per house and space area per person. Results: 486 participants (243 cases and 243 controls) took part in the study. Average age was 32.37+/-14.6 years for cases and 35.75+/-12.6 years for controls. At univariate level, Cases tended to be more overcrowded than controls; 8.0+/-3.0 versus 6.0+/-3.0 persons per house. Controls were better spaced at 25.2 square feet versus 16.9 for cases. More controls than cases were employed; 45.3% versus 21.1%. Controls lived closer to health centers than the cases; 4.8+/-3.8 versus 3.3+/-12.9 kilometers. At multivariate level, the odds of rheumatic heart disease was 1.7 times higher for unemployment status (OR = 1.7, 95% CI = 1.05-8.19) and 1.3 times higher for overcrowding (OR = 1.35, 95% CI = 1.1-1.56). There was interaction between overcrowding and longer distance from the nearest health centre (OR = 1.20, 95% CI = 1.05-1.42). Conclusion: The major findings of this study were that there was a trend towards increased risk of rheumatic heart disease in association with overcrowding and unemployment. There was interaction between overcrowding and distance from the nearest health center, suggesting that the effect of overcrowding on the risk of acquiring rheumatic heart disease increases with every kilometer increase from the nearest health center.	[Okello, Emmy; Kakande, Barbara; Sebatta, Elias; Kayima, James; Mondo, Charles K.; Juergen, Freers] Makerere Univ, Dept Med, Div Cardiol, Kampala, Uganda; [Okello, Emmy; Kakande, Barbara; Sebatta, Elias; Nyakoojo, Wilson; Lwabi, Peter; Mondo, Charles K.] Mulago Hosp, Uganda Heart Inst, Kampala, Uganda; [Odoi-Adome, Richard] Makerere Univ, Sch Pharm, Kampala, Uganda; [Kuteesa, Monica] Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Mutatina, Boniface] Makerere Univ, Coll Hlth Sci, Kampala, Uganda	Makerere University; Mulago National Referral Hospital; Makerere University; University of Sydney; Makerere University	Okello, E (corresponding author), Makerere Univ, Dept Med, Div Cardiol, Kampala, Uganda.	emmkol@hotmail.com	Kawooya, Ismael/O-4541-2016	Kawooya, Ismael/0000-0002-7159-7153; Lwabi, Peter/0000-0002-2895-3626; Okello, Emmy/0000-0002-6109-0092	Office of the United States Global Aids Coordinator; National Institutes of Health and Health Resources and Services Administration; Millennium Science initiative;  [R24TW008861]; FOGARTY INTERNATIONAL CENTER [R24TW008861] Funding Source: NIH RePORTER	Office of the United States Global Aids Coordinator; National Institutes of Health and Health Resources and Services Administration(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Millennium Science initiative; ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The study was supported by Grant Number R24TW008861 supported by Office of the United States Global Aids Coordinator, National Institutes of Health and Health Resources and Services Administration, and the Millennium Science initiative. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ADANJA B, 1988, Journal of Hygiene Epidemiology Microbiology and Immunology (Prague), V32, P329; AGARWAL BL, 1981, LANCET, V2, P910; Al-Taiar A, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-38; Beaton A, 2011, CARDIOVASC J AFR, V22, pS3; Beaton A, 2012, CIRCULATION, V125, P3127, DOI 10.1161/CIRCULATIONAHA.112.092312; Carapetis JR, 2007, NEW ENGL J MED, V357, P439, DOI 10.1056/NEJMp078039; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cheng TO, 2009, INT J CARDIOL, V3, P132; Dobson J, 2012, PEDIATR CARDIOL, V33, P332, DOI 10.1007/s00246-011-0139-x; DODU S R A, 1989, World Health Forum, V10, P203; Feikin DR, 2009, TROP MED INT HEALTH, V14, P54, DOI 10.1111/j.1365-3156.2008.02193.x; GORDIS L, 1969, J CHRON DIS, V21, P655, DOI 10.1016/0021-9681(69)90037-X; GROVER A, 1993, B WORLD HEALTH ORGAN, V71, P59; IBRAHIMKHALIL S, 1992, J EPIDEMIOL COMMUN H, V46, P477, DOI 10.1136/jech.46.5.477; Jaine R, 2011, PEDIATR INFECT DIS J, V30, P315, DOI 10.1097/INF.0b013e3181fbd85b; KAPLAN EL, 1989, J INFECT DIS, V159, P101, DOI 10.1093/infdis/159.1.101; Kayima J., 2011, CARDIOVASC J AFR, V22, pS9; Kerdemelidis M, 2010, J PAEDIATR CHILD H, V46, P534, DOI 10.1111/j.1440-1754.2010.01854.x; Kleinbaum D. G., 2002, LOGISTIC REGRESSION; Longo-Mbenza B, 1998, INT J CARDIOL, V63, P287, DOI 10.1016/S0167-5273(97)00311-2; MCLAREN MJ, 1975, BRIT MED J, V3, P474, DOI 10.1136/bmj.3.5981.474; Mood E.W., 1986, APHA CDC RECOMMENDED; Noor AM, 2003, TROP MED INT HEALTH, V8, P917, DOI 10.1046/j.1365-3156.2003.01112.x; OTTO CM, 2004, TXB CLIN ECHOCARDIOG, P281; Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011; Prasad BG, 1970, J INDIAN MED ASSOC, V55, P189; Sliwa K, 2010, EUR HEART J, V31, P719, DOI 10.1093/eurheartj/ehp530; Sliwa K, 2010, CLIN RES CARDIOL, V99, P65, DOI 10.1007/s00392-009-0094-1; Steer AC, 2002, J PAEDIATR CHILD H, V38, P229, DOI 10.1046/j.1440-1754.2002.00772.x; STOCK R, 1983, SOC SCI MED, V17, P563, DOI 10.1016/0277-9536(83)90298-8; Veasy LG, 1990, NEW ENGL J MED, V8, P421; VLAJINAC H, 1991, EUR J EPIDEMIOL, V7, P702, DOI 10.1007/BF00218687; VLAJINAC H, 1989, Journal of Hygiene Epidemiology Microbiology and Immunology (Prague), V33, P471; Wannamaker L., 1954, STREPTOCOCCAL INFECT, P157	34	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43917	10.1371/journal.pone.0043917	http://dx.doi.org/10.1371/journal.pone.0043917			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952810	Green Published, Green Submitted, gold			2022-12-25	WOS:000308044800075
J	Ban, L; Tata, LJ; West, J; Fiaschi, L; Gibson, JE				Ban, Lu; Tata, Laila J.; West, Joe; Fiaschi, Linda; Gibson, Jack E.			Live and Non-Live Pregnancy Outcomes among Women with Depression and Anxiety: A Population-Based Study	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; SPONTANEOUS-ABORTION; ANTIDEPRESSANT USE; MATERNAL USE; RISK; MULTICENTER; EXPOSURE; FLUOXETINE; CHLORDIAZEPOXIDE; BENZODIAZEPINES	Background: Women taking antidepressant or anti-anxiety medications during early pregnancy have high risks of non-live pregnancy outcomes, although the contribution of the underlying illnesses to these risks remains unclear. We examined the impacts of antenatal depression and anxiety and of commonly prescribed treatments on the risks of non-live pregnancy outcomes. Methods: We identified all pregnancies and their outcome (live birth, perinatal death, miscarriage or termination) among women aged 15-45 years between 1990 and 2009 from a large primary care database in the United Kingdom. Women were grouped according to whether they had no history of depression and anxiety, a diagnosis of such illness prior to pregnancy, illness during pregnancy and illness during pregnancy with use of medication (stratified by medication type). Multinomial logistic regression models were used to compare risks of non-live outcomes among these groups, adjusting for major socio-demographic and lifestyle characteristics. Results: Among 512,574 pregnancies in 331,414 women, those with antenatal drug exposure showed the greatest increased risks for all non-live pregnancy outcomes, relative to those with no history of depression or anxiety, although women with prior (but not currently medicated) illness also showed modest increased risks. Compared with un-medicated antenatal morbidity, there was weak evidence of an excess risk in women taking tricyclic antidepressants, and stronger evidence for other medications. Conclusions: Women with depression or anxiety have higher risks of miscarriage, perinatal death and decisions to terminate a pregnancy if prescribed psychotropic medication during early pregnancy than if not. Although underlying disease severity could also play a role, avoiding or reducing use of these drugs during early pregnancy may be advisable.	[Ban, Lu; Tata, Laila J.; West, Joe; Fiaschi, Linda; Gibson, Jack E.] Univ Nottingham, City Hosp Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [West, Joe] Nottingham Univ Hosp Natl Hlth Serv Trust, Nottingham Digest Dis Ctr, Natl Inst Hlth Res, Biomed Res Unit,Queens Med Ctr, Nottingham, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; Nottingham University Hospital NHS Trust; University of Nottingham	Ban, L (corresponding author), Univ Nottingham, City Hosp Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England.	mcxlb4@nottingham.ac.uk; jack.gibson@nottingham.ac.uk	Fiaschi, Linda/AAB-4905-2022; Gibson, Jack E/A-5746-2009; West, Joe/M-3867-2019; West, Joe/I-6637-2012; Tata, Laila/J-5227-2012	Fiaschi, Linda/0000-0002-3780-5895; Gibson, Jack E/0000-0003-1717-0252; West, Joe/0000-0002-1135-9356; West, Joe/0000-0002-1135-9356; Ban, Lu/0000-0001-9388-9141; Tata, Laila/0000-0002-6404-8658	University of Nottingham/National Institute for Health Research (NIHR)	University of Nottingham/National Institute for Health Research (NIHR)	JW is supported by a University of Nottingham/National Institute for Health Research (NIHR) Senior Clinical Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SE, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.07.036; [Anonymous], 2014, BRIT NATL FORMULARY; Blackmore ER, 2011, BRIT J PSYCHIAT, V198, P373, DOI 10.1192/bjp.bp.110.083105; Bonari L, 2004, CAN J PSYCHIAT, V49, P726, DOI 10.1177/070674370404901103; Chambers CD, 1996, NEW ENGL J MED, V335, P1010, DOI 10.1056/NEJM199610033351402; Chun-Fai-Chan B, 2005, AM J OBSTET GYNECOL, V192, P932, DOI 10.1016/j.ajog.2004.09.027; Clark DA, 1996, AM J REPROD IMMUNOL, V35, P330; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; Cooper WO, 2007, AM J OBSTET GYNECOL, V196, P544, DOI 10.1016/j.ajog.2007.01.033; COSTE J, 1991, HUM REPROD, V6, P1332, DOI 10.1093/oxfordjournals.humrep.a137535; Dayan J, 2002, AM J EPIDEMIOL, V155, P293, DOI 10.1093/aje/155.4.293; Department of Health, 2009, AB STAT ENGL WAL 200; Diav-Citrin O, 2008, BRIT J CLIN PHARMACO, V66, P695, DOI 10.1111/j.1365-2125.2008.03261.x; Einarson A, 2001, J PSYCHIATR NEUROSCI, V26, P44; Einarson A, 2001, AM J PSYCHIAT, V158, P1728, DOI 10.1176/appi.ajp.158.10.1728; Einarson A, 2009, J OBSTET GYNAECOL CA, V31, P452, DOI 10.1016/S1701-2163(16)34177-9; Einarson A, 2003, CAN J PSYCHIAT, V48, P106, DOI 10.1177/070674370304800207; Hanlon C, 2009, TROP MED INT HEALTH, V14, P156, DOI 10.1111/j.1365-3156.2008.02198.x; HARTZ SC, 1975, NEW ENGL J MED, V292, P726, DOI 10.1056/NEJM197504032921405; Hemels MEH, 2005, ANN PHARMACOTHER, V39, P803, DOI 10.1345/aph.1E547; Klieger-Grossmann C, 2012, J CLIN PHARMACOL, V52, P766, DOI 10.1177/0091270011405524; Kulin NA, 1998, JAMA-J AM MED ASSOC, V279, P609, DOI 10.1001/jama.279.8.609; Kurki T, 2000, OBSTET GYNECOL, V95, P487, DOI 10.1016/S0029-7844(99)00602-X; LAEGREID L, 1992, NEUROPEDIATRICS, V23, P18, DOI 10.1055/s-2008-1071305; Lennestal R, 2007, J CLIN PSYCHOPHARM, V27, P607, DOI 10.1097/jcp.0b013e31815ac4d2; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; MILKOVICH L, 1974, NEW ENGL J MED, V291, P1268, DOI 10.1056/NEJM197412122912402; MORRIS R, 1991, J PUBLIC HEALTH MED, V13, P318; Nakhai-Pour HR, 2010, CAN MED ASSOC J, V182, P1031, DOI 10.1503/cmaj.091208; NHS Direct Wales, MISC; Office for National Statistics, 2009, BIRTH STAT ENGL WAL; Ornoy A, 1998, REPROD TOXICOL, V12, P511, DOI 10.1016/S0890-6238(98)00035-5; PASTUSZAK A, 1993, JAMA-J AM MED ASSOC, V269, P2246, DOI 10.1001/jama.269.17.2246; Rondo PHC, 2003, EUR J CLIN NUTR, V57, P266, DOI 10.1038/sj.ejcn.1601526; Santone G, 2009, EPIDEMIOL PSICHIAT S, V18, P240, DOI 10.1017/S1121189X0000052X; Swann C, 2003, TEENAGE PREGNANCY PA; Udechuku A, 2010, AUST NZ J PSYCHIAT, V44, P978, DOI 10.3109/00048674.2010.507543; Wen SW, 2006, AM J OBSTET GYNECOL, V194, P961, DOI 10.1016/j.ajog.2006.02.019; Wikner BN, 2007, PHARMACOEPIDEM DR S, V16, P1203, DOI 10.1002/pds.1457; Yonkers KA, 2011, EPIDEMIOLOGY, V22, P848, DOI 10.1097/EDE.0b013e3182306847; Zhu SH, 2002, ADDICT BEHAV, V27, P649, DOI 10.1016/S0306-4603(01)00199-X	41	41	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43462	10.1371/journal.pone.0043462	http://dx.doi.org/10.1371/journal.pone.0043462			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998GM	22937052	gold, Green Published, Green Submitted			2022-12-25	WOS:000308225500053
J	Kang, W; Shin, EC				Kang, Wonseok; Shin, Eui-Cheol			Colorimetric Focus-Forming Assay with Automated Focus Counting by Image Analysis for Quantification of Infectious Hepatitis C Virions	PLOS ONE			English	Article							CELL-CULTURE; VIRUS-INFECTION; PLAQUE-ASSAY; REPLICATION; SYSTEM	Hepatitis C virus (HCV) infection is the leading cause of liver transplantation in Western countries. Studies of HCV infection using cell culture-produced HCV (HCVcc) in vitro systems require quantification of infectious HCV virions, which has conventionally been performed by immunofluorescence-based focus-forming assay with manual foci counting; however, this is a laborious and time-consuming procedure with potentially biased results. In the present study, we established and optimized a method for convenient and objective quantification of HCV virions by colorimetric focus-forming assay with automated focus counting by image analysis. In testing different enzymes and chromogenic substrates, we obtained superior foci development using alkaline phosphatase-conjugated secondary antibody with BCIP/NBT chromogenic substrate. We additionally found that type I collagen coating minimized cell detachment during vigorous washing of the assay plate. After the colorimetric focus-forming assay, the foci number was determined using an ELISpot reader and image analysis software. The foci number and the calculated viral titer determined by this method strongly correlated with those determined by immunofluorescence-based focus-forming assay and manual foci counting. These results indicate that colorimetric focus-forming assay with automated focus counting by image analysis is applicable as a more-efficient and objective method for quantification of infectious HCV virions.	[Kang, Wonseok; Shin, Eui-Cheol] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Immunol & Infect Dis, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Kang, W (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Immunol & Infect Dis, Taejon 305701, South Korea.	ecshin@kaist.ac.kr	Shin, Eui-Cheol/C-1690-2011	Shin, Eui-Cheol/0000-0002-6308-9503	National Research Foundation from the Korean government (Ministry of Education, Science, and Technology) [2010-0004539, 2010-0030075]; Korea Health Technology R&D Project, of the Ministry of Health and Welfare, Republic of Korea [A110279]; KAIST (Korea Advanced Institute of Science and Technology) Future Systems Healthcare Project from the Ministry of Education, Science, and Technology	National Research Foundation from the Korean government (Ministry of Education, Science, and Technology); Korea Health Technology R&D Project, of the Ministry of Health and Welfare, Republic of Korea; KAIST (Korea Advanced Institute of Science and Technology) Future Systems Healthcare Project from the Ministry of Education, Science, and Technology	This work was supported by National Research Foundation grants from the Korean government (Ministry of Education, Science, and Technology) (2010-0004539 and 2010-0030075), and a grant from the Korea Health Technology R&D Project, of the Ministry of Health and Welfare, Republic of Korea (A110279). This work was also partly supported by the KAIST (Korea Advanced Institute of Science and Technology) Future Systems Healthcare Project from the Ministry of Education, Science, and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; ANDERSON DA, 1987, J MED VIROL, V22, P35, DOI 10.1002/jmv.1890220106; Anderson DA, 1997, J MED VIROL, V52, P354, DOI 10.1002/(SICI)1096-9071(199708)52:4&lt;354::AID-JMV2&gt;3.0.CO;2-0; Chang DY, 2009, J LEUKOCYTE BIOL, V86, P33, DOI [10.1189/jlb.1208772, 10.1189/JLB.1208772]; Gottwein JM, 2007, GASTROENTEROLOGY, V133, P1614, DOI 10.1053/j.gastro.2007.08.005; Jensen TB, 2008, J INFECT DIS, V198, P1756, DOI 10.1086/593021; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kato T, 2001, J MED VIROL, V64, P334, DOI 10.1002/jmv.1055; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Rodrigo WWSI, 2009, AM J TROP MED HYG, V80, P61; Scheel TKH, 2008, P NATL ACAD SCI USA, V105, P997, DOI 10.1073/pnas.0711044105; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yang DP, 1998, CLIN DIAGN LAB IMMUN, V5, P780, DOI 10.1128/CDLI.5.6.780-783.1998; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zielinska E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-84	19	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43960	10.1371/journal.pone.0043960	http://dx.doi.org/10.1371/journal.pone.0043960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937136	gold, Green Submitted, Green Published			2022-12-25	WOS:000308225500129
J	Miyamoto, M; Tsuboi, Y; Honda, K; Kobayashi, M; Takamiya, K; Huganir, RL; Kondo, M; Shinoda, M; Sessle, BJ; Katagiri, A; Kita, D; Suzuki, I; Oi, Y; Iwata, K				Miyamoto, Makiko; Tsuboi, Yoshiyuki; Honda, Kuniya; Kobayashi, Masayuki; Takamiya, Kogo; Huganir, Richard L.; Kondo, Masahiro; Shinoda, Masamichi; Sessle, Barry J.; Katagiri, Ayano; Kita, Daiju; Suzuki, Ikuko; Oi, Yoshiyuki; Iwata, Koichi			Involvement of AMPA Receptor GluR2 and GluR3 Trafficking in Trigeminal Spinal Subnucleus Caudalis and C1/C2 Neurons in Acute-Facial Inflammatory Pain	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; TOOTH-PULP STIMULATION; DORSAL-HORN NEURONS; TEMPOROMANDIBULAR-JOINT; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; NERVE LIGATION; CORD; PHOSPHORYLATION	To evaluate the involvement of trafficking of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) GluR2 and GluR3 subunits in an acute inflammatory orofacial pain, we analyzed nocifensive behavior, phosphorylated extracellular signal-regulated kinase (pERK) and Fos expression in Vi/Vc, Vc and C1/C2 in GluR2 delta7 knock-in (KI), GluR3 delta7 KI mice and wild-type mice. We also studied Vc neuronal activity to address the hypothesis that trafficking of GluR2 and GluR3 subunits plays an important role in Vi/Vc, Vc and C1/C2 neuronal activity associated with orofacial inflammation in these mice. Late nocifensive behavior was significantly depressed in GluR2 delta7 KI and GluR3 delta7 KI mice. In addition, the number of pERK-immunoreactive (IR) cells was significantly decreased bilaterally in the Vi/Vc, Vc and C1/C2 in GluR2 delta7 KI and GluR3 delta7 KI mice compared to wild-type mice at 40 min after formalin injection, and was also significantly smaller in GluR3 delta7 KI compared to GluR2 delta7 KI mice. The number of Fos protein-IR cells in the ipsilateral Vi/Vc, Vc and C1/C2 was also significantly smaller in GluR2 delta7 KI and GluR3 delta7 KI mice compared to wild-type mice 40 min after formalin injection. Nociceptive neurons functionally identified as wide dynamic range neurons in the Vc, where pERK- and Fos protein-IR cell expression was prominent, showed significantly lower spontaneous activity in GluR2 delta7 KI and GluR3 delta7 KI mice than wild-type mice following formalin injection. These findings suggest that GluR2 and GluR3 trafficking is involved in the enhancement of Vi/Vc, Vc and C1/C2 nociceptive neuronal excitabilities at 16-60 min following formalin injection, resulting in orofacial inflammatory pain.	[Miyamoto, Makiko; Oi, Yoshiyuki] Nihon Univ, Sch Dent, Dept Anesthesiol, Chiyoda Ku, Tokyo 101, Japan; [Miyamoto, Makiko; Tsuboi, Yoshiyuki; Honda, Kuniya; Kondo, Masahiro; Shinoda, Masamichi; Katagiri, Ayano; Kita, Daiju; Suzuki, Ikuko; Iwata, Koichi] Nihon Univ, Sch Dent, Dept Physiol, Chiyoda Ku, Tokyo 101, Japan; [Tsuboi, Yoshiyuki; Kondo, Masahiro; Shinoda, Masamichi; Iwata, Koichi] Nihon Univ, Sch Dent, Dent Res Ctr, Div Funct Morphol,Chiyoda Ku, Tokyo 101, Japan; [Honda, Kuniya] Nihon Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Chiyoda Ku, Tokyo 101, Japan; [Kobayashi, Masayuki] Nihon Univ, Sch Dent, Dept Pharmacol, Chiyoda Ku, Tokyo 101, Japan; [Takamiya, Kogo] Miyazaki Univ, Fac Med, Grad Sch Med, Dept Med Sci,Sect Integrat Physiol, Miyazaki, Japan; [Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA; [Sessle, Barry J.] Univ Toronto, Dept Physiol, Toronto, ON, Canada	Nihon University; Nihon University; Nihon University; Nihon University; Nihon University; University of Miyazaki; Howard Hughes Medical Institute; Johns Hopkins University; University of Toronto	Miyamoto, M (corresponding author), Nihon Univ, Sch Dent, Dept Anesthesiol, Chiyoda Ku, Tokyo 101, Japan.	iwata-k@dent.nihon-u.ac.jp	Sessle, Barry/AAD-7771-2022; Kondo, Mari/N-2461-2015	Takamiya, Kogo/0000-0001-7240-6307	Nihon University School of Dentistry; Dental Research Center, Nihon University School of Dentistry; Nihon University; Ministry of Education, Culture, Sports, Science, and Technology; National Institutes of Health [DE015420]; Japan-Canada (CIHR) Joint Health Research Program; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015420] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24659832] Funding Source: KAKEN	Nihon University School of Dentistry; Dental Research Center, Nihon University School of Dentistry; Nihon University; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan-Canada (CIHR) Joint Health Research Program(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Research Grants from Sato and Uemura Funds from Nihon University School of Dentistry, and a grant from the Dental Research Center, Nihon University School of Dentistry; a Nihon University multidisciplinary research grant for KI; grants from the Ministry of Education, Culture, Sports, Science, and Technology to promote the multidisciplinary research project "Translational Research Network on Orofacial Neurological Disorders" at Nihon University School of Dentistry; Japan-Canada (CIHR) Joint Health Research Program, and National Institutes of Health grant DE015420. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atianjoh FE, 2010, PAIN, V151, P226, DOI 10.1016/j.pain.2010.07.017; Chiang CY, 1998, J NEUROPHYSIOL, V80, P2621, DOI 10.1152/jn.1998.80.5.2621; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; Dai Y, 2002, J NEUROSCI, V22, P7737; Engelman HS, 1999, J NEUROSCI, V19, P2081; Hartmann B, 2004, NEURON, V44, P637, DOI 10.1016/j.neuron.2004.10.029; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Honda K, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-59; Hu JW, 2005, BRAIN RES, V1044, P93, DOI 10.1016/j.brainres.2005.03.004; Imbe H, 2001, CELLS TISSUES ORGANS, V169, P238, DOI 10.1159/000047887; Iwata K, 1999, J NEUROPHYSIOL, V82, P1244, DOI 10.1152/jn.1999.82.3.1244; Ji RR, 2002, J NEUROSCI, V22, P478, DOI 10.1523/JNEUROSCI.22-02-00478.2002; Katano T, 2008, EUR J NEUROSCI, V27, P3161, DOI 10.1111/j.1460-9568.2008.06293.x; Larsson M, 2009, MOL NEUROBIOL, V40, P260, DOI 10.1007/s12035-009-8086-8; Lin Q, 2002, J NEUROPHYSIOL, V88, P214, DOI 10.1152/jn.2002.88.1.214; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Luccarini P, 2006, J PAIN, V7, P908, DOI 10.1016/j.jpain.2006.04.010; Ma WY, 2002, PAIN, V99, P175, DOI 10.1016/S0304-3959(02)00097-0; Noma N, 2008, J COMP NEUROL, V507, P1428, DOI 10.1002/cne.21620; Okada-Ogawa A, 2009, J NEUROSCI, V29, P15828, DOI 10.1523/JNEUROSCI.3623-09.2009; Park JS, 2009, J NEUROSCI, V29, P3206, DOI 10.1523/JNEUROSCI.4514-08.2009; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Polgar E, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-5; Shimizu K, 2006, BRAIN RES, V1072, P99, DOI 10.1016/j.brainres.2005.12.040; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Suzuki I, 2007, J OROFAC PAIN, V21, P225; Takeda M, 2005, EXP BRAIN RES, V160, P107, DOI 10.1007/s00221-004-1990-2; Youn DH, 2008, PAIN, V136, P158, DOI 10.1016/j.pain.2007.07.001; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022	30	14	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e44055	10.1371/journal.pone.0044055	http://dx.doi.org/10.1371/journal.pone.0044055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937151	gold, Green Published, Green Submitted			2022-12-25	WOS:000308225500137
J	Rasala, BA; Lee, PA; Shen, ZX; Briggs, SP; Mendez, M; Mayfield, SP				Rasala, Beth A.; Lee, Philip A.; Shen, Zhouxin; Briggs, Steven P.; Mendez, Michael; Mayfield, Stephen P.			Robust Expression and Secretion of Xylanase1 in Chlamydomonas reinhardtii by Fusion to a Selection Gene and Processing with the FMDV 2A Peptide	PLOS ONE			English	Article							FLUORESCENT PROTEIN GFP; NUCLEAR TRANSFORMATION; HSP70A PROMOTER; FOREIGN GENE; MICROALGAE; TRANSGENE; RESISTANCE; ALGAE; BIOTECHNOLOGY; CLEAVAGE	Microalgae have recently received attention as a potential low-cost host for the production of recombinant proteins and novel metabolites. However, a major obstacle to the development of algae as an industrial platform has been the poor expression of heterologous genes from the nuclear genome. Here we describe a nuclear expression strategy using the foot-and-mouth-disease-virus 2A self-cleavage peptide to transcriptionally fuse heterologous gene expression to antibiotic resistance in Chlamydomonas reinhardtii. We demonstrate that strains transformed with ble-2A-GFP are zeocin-resistant and accumulate high levels of GFP that is properly 'cleaved' at the FMDV 2A peptide resulting in monomeric, cytosolic GFP that is easily detectable by in-gel fluorescence analysis or fluorescent microscopy. Furthermore, we used our ble2A nuclear expression vector to engineer the heterologous expression of the industrial enzyme, xylanase. We demonstrate that linking xyn1 expression to ble2A expression on the same open reading frame led to a dramatic (similar to 100-fold) increase in xylanase activity in cells lysates compared to the unlinked construct. Finally, by inserting an endogenous secretion signal between the ble2A and xyn1 coding regions, we were able to target monomeric xylanase for secretion. The novel microalgae nuclear expression strategy described here enables the selection of transgenic lines that are efficiently expressing the heterologous gene-of-interest and should prove valuable for basic research as well as algal biotechnology.	[Rasala, Beth A.; Lee, Philip A.; Shen, Zhouxin; Briggs, Steven P.; Mayfield, Stephen P.] Univ Calif San Diego, San Diego Ctr Algae Biotechnol, San Diego, CA 92103 USA; [Rasala, Beth A.; Lee, Philip A.; Shen, Zhouxin; Briggs, Steven P.; Mayfield, Stephen P.] Univ Calif San Diego, Div Mol Biol, San Diego, CA 92103 USA; [Lee, Philip A.; Mendez, Michael] Sapphire Energy, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Rasala, BA (corresponding author), Univ Calif San Diego, San Diego Ctr Algae Biotechnol, San Diego, CA 92103 USA.	smayfield@ucsd.edu			U.S. Department of Energy [DE-EE0003373]; California Energy Commission (CILMSF) [500-10-039]	U.S. Department of Energy(United States Department of Energy (DOE)); California Energy Commission (CILMSF)	This work was supported by the U.S. Department of Energy (DE-EE0003373) (http://energy.gov/) and California Energy Commission (CILMSF #500-10-039) (http://www.energy.ca.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Beer LL, 2009, CURR OPIN BIOTECH, V20, P264, DOI 10.1016/j.copbio.2009.06.002; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Berthold P, 2002, PROTIST, V153, P401, DOI 10.1078/14344610260450136; Cerutti H, 1997, PLANT CELL, V9, P925, DOI 10.1105/tpc.9.6.925; Chisti Y, 2008, TRENDS BIOTECHNOL, V26, P126, DOI 10.1016/j.tibtech.2007.12.002; DAY A, 1990, PHYSIOL PLANTARUM, V78, P254; de Felipe Pablo, 2004, Genet Vaccines Ther, V2, P13, DOI 10.1186/1479-0556-2-13; De Wilde C, 2000, PLANT MOL BIOL, V43, P347, DOI 10.1023/A:1006464304199; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Dreesen IAJ, 2010, J BIOTECHNOL, V145, P273, DOI 10.1016/j.jbiotec.2009.12.006; DUMAS P, 1994, EMBO J, V13, P2483, DOI 10.1002/j.1460-2075.1994.tb06535.x; Eichler-Stahlberg A, 2009, PLANTA, V229, P873, DOI 10.1007/s00425-008-0879-x; Fuhrmann M, 2004, PLANT MOL BIOL, V55, P869, DOI 10.1007/s11103-004-2150-6; Fuhrmann M, 1999, PLANT J, V19, P353, DOI 10.1046/j.1365-313X.1999.00526.x; Ge Y, 2007, ANAL BIOCHEM, V362, P63, DOI 10.1016/j.ab.2006.11.034; Gong YM, 2011, J IND MICROBIOL BIOT, V38, P1879, DOI 10.1007/s10295-011-1032-6; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Hallmann A., 2007, TRANSGENIC PLANT J, V1, P81, DOI DOI 10.3390/IJMS12010633; Halpin C, 2005, PLANT BIOTECHNOL J, V3, P141, DOI 10.1111/j.1467-7652.2004.00113.x; Harris E.H, 2009, INTRO CHLAMYDOMONAS; He DM, 2007, COLLOID SURFACE B, V55, P26, DOI 10.1016/j.colsurfb.2006.10.042; Jones CS, 2011, CURR OPIN BIOTECHNOL; Leon R, 2007, ADV EXP MED BIOL, V616, P1; Leon-Banares R, 2004, TRENDS BIOTECHNOL, V22, P45, DOI 10.1016/j.tibtech.2003.11.003; Lodha M, 2008, EUKARYOT CELL, V7, P172, DOI 10.1128/EC.00055-07; Luke GA, 2010, BIOTECHNOL GENET ENG, V26, P223; Lumbreras V, 1998, PLANT J, V14, P441, DOI 10.1046/j.1365-313X.1998.00145.x; Manuell AL, 2007, PLANT BIOTECHNOL J, V5, P402, DOI 10.1111/j.1467-7652.2007.00249.x; Mayfield SP, 2005, VACCINE, V23, P1828, DOI 10.1016/j.vaccine.2004.11.013; Mayfield SP, 2003, P NATL ACAD SCI USA, V100, P438, DOI 10.1073/pnas.0237108100; Mayfield SP, 2007, CURR OPIN BIOTECH, V18, P126, DOI 10.1016/j.copbio.2007.02.001; Meslet-Cladiere L, 2011, EUKARYOT CELL, V10, P1670, DOI 10.1128/EC.05043-11; Neupert J, 2009, PLANT J, V57, P1140, DOI 10.1111/j.1365-313X.2008.03746.x; Polizeli MLTM, 2005, APPL MICROBIOL BIOT, V67, P577, DOI 10.1007/s00253-005-1904-7; Pulz O, 2004, APPL MICROBIOL BIOT, V65, P635, DOI 10.1007/s00253-004-1647-x; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; Rasala Beth A, 2011, Bioeng Bugs, V2, P50, DOI 10.4161/bbug.2.1.13423; Rasala BA, 2010, PLANT BIOTECHNOL J, V8, P719, DOI 10.1111/j.1467-7652.2010.00503.x; Rosales-Mendoza S, 2012, PLANT CELL REP, V31, P479, DOI 10.1007/s00299-011-1186-8; Rosenberg JN, 2008, CURR OPIN BIOTECH, V19, P430, DOI 10.1016/j.copbio.2008.07.008; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; Schroda M, 2002, PLANT J, V31, P445, DOI 10.1046/j.1365-313X.2002.01371.x; Schroda M, 2000, PLANT J, V21, P121, DOI 10.1046/j.1365-313x.2000.00652.x; Shaver S, 2010, EPIGENETICS-US, V5, P301, DOI 10.4161/epi.5.4.11608; Shimogawara K, 1998, GENETICS, V148, P1821; Specht E, 2010, BIOTECHNOL LETT, V32, P1373, DOI 10.1007/s10529-010-0326-5; Spolaore P, 2006, J BIOSCI BIOENG, V101, P87, DOI 10.1263/jbb.101.87; Stevens DR, 1996, MOL GEN GENET, V251, P23; Sun M, 2003, BIOTECHNOL LETT, V25, P1087, DOI 10.1023/A:1024140114505; Surzycki R, 2009, BIOLOGICALS, V37, P133, DOI 10.1016/j.biologicals.2009.02.005; TAM LW, 1993, GENETICS, V135, P375; TENKANEN M, 1992, ENZYME MICROB TECH, V14, P566, DOI 10.1016/0141-0229(92)90128-B; Tran M, 2009, BIOTECHNOL BIOENG, V104, P663, DOI 10.1002/bit.22446; Walker TL, 2005, PLANT CELL REP, V24, P629, DOI 10.1007/s00299-005-0004-6; Wang XF, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-87; Wu JX, 2008, CHIN J OCEANOL LIMN, V26, P242, DOI 10.1007/s00343-008-0242-x; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Yang ZQ, 2006, CHINESE SCI BULL, V51, P1703, DOI 10.1007/s11434-006-2041-0; Yu WL, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-91	59	164	171	6	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43349	10.1371/journal.pone.0043349	http://dx.doi.org/10.1371/journal.pone.0043349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937037	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500042
J	Bauer, M; Chicca, A; Tamborrini, M; Eisen, D; Lerner, R; Lutz, B; Poetz, O; Pluschke, G; Gertsch, J				Bauer, Mark; Chicca, Andrea; Tamborrini, Marco; Eisen, David; Lerner, Raissa; Lutz, Beat; Poetz, Oliver; Pluschke, Gerd; Gertsch, Juerg			Identification and Quantification of a New Family of Peptide Endocannabinoids (Pepcans) Showing Negative Allosteric Modulation at CB1 Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECTROMETRY-BASED QUANTIFICATION; HEMOGLOBIN-DERIVED PEPTIDES; CANNABINOID CB1; ADENYLATE-CYCLASE; SIGNAL-TRANSDUCTION; MOUSE-BRAIN; INHIBITION; AGONIST; BINDING; PHARMACOLOGY	The alpha-hemoglobin-derived dodecapeptide RVD-hemopressin (RVDPVNFKLLSH) has been proposed to be an endogenous agonist for the cannabinoid receptor type 1 (CB1). To study this peptide, we have raised mAbs against its C-terminal part. Using an immunoaffinity mass spectrometry approach, a whole family of N-terminally extended peptides in addition to RVD-Hp alpha were identified in rodent brain extracts and human and mouse plasma. We designated these peptides Pepcan-12 (RVDPVNFKLLSH) to Pepcan-23 (SALSDLHAHKLRVDPVNFKLLSH), referring to peptide length. The most abundant Pepcans found in the brain were tested for CB1 receptor binding. In the classical radioligand displacement assay, Pepcan-12 was the most efficacious ligand but only partially displaced both [H-3] CP55,940 and [H-3] WIN55,212-2. The data were fitted with the allosteric ternary complex model, revealing a cooperativity factor value alpha < 1, thus indicating a negative allosteric modulation. Dissociation kinetic studies of [3H] CP55,940 in the absence and presence of Pepcan-12 confirmed these results by showing increased dissociation rate constants induced by Pepcan-12. A fluorescently labeled Pepcan-12 analog was synthesized to investigate the binding to CB1 receptors. Competition binding studies revealed K-t values of several Pepcans in the nanomolar range. Accordingly, using competitive ELISA, we found low nanomolar concentrations of Pepcans in human plasma and similar to 100 pmol/g in mouse brain. Surprisingly, Pepcan-12 exhibited potent negative allosteric modulation of the orthosteric agonist-induced cAMP accumulation, [S-35] GTP gamma S binding, and CB1 receptor internalization. Pepcans are the first endogenous allosteric modulators identified forCB(1) receptors. Given their abundance in the brain, Pepcans could play an important physiological role in modulating endocannabinoid signaling.	[Bauer, Mark; Chicca, Andrea; Gertsch, Juerg] Univ Bern, Inst Biochem & Mol Med, Natl Ctr Competence Res TransCure, CH-3012 Bern, Switzerland; [Bauer, Mark; Tamborrini, Marco; Pluschke, Gerd] Univ Basel, CH-4003 Basel, Switzerland; [Bauer, Mark; Tamborrini, Marco; Pluschke, Gerd] Swiss Trop & Publ Hlth Inst, CH-4002 Basel, Switzerland; [Eisen, David; Poetz, Oliver] Univ Tubingen, Nat & Med Sci Inst, D-72770 Reutlingen, Germany; [Lerner, Raissa; Lutz, Beat] Johannes Gutenberg Univ Mainz, Inst Physiol Chem, Univ Med Ctr, D-55128 Mainz, Germany	University of Bern; University of Basel; University of Basel; Swiss Tropical & Public Health Institute; Eberhard Karls University of Tubingen; Johannes Gutenberg University of Mainz	Gertsch, J (corresponding author), Univ Bern, Inst Biochem & Mol Med, Natl Ctr Competence Res TransCure, Buhlstr 28, CH-3012 Bern, Switzerland.	gertsch@ibmm.unibe.ch	Lutz, Beat/AFK-6229-2022; Lutz, Beat/AAG-4538-2022; Chicca, Andrea/AAP-7156-2020	Gertsch, Jurg/0000-0003-0978-1555; Chicca, Andrea/0000-0001-9593-636X	Swiss National Science Foundation [31003A_141174/1]; National Center of Competence in Research TransCure; University of Bern Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research TransCure; University of Bern Research Foundation	This work was supported by Swiss National Science Foundation Grant 31003A_141174/1 (to J. G.), the National Center of Competence in Research TransCure, and the University of Bern Research Foundation.	Abadji V, 1999, J NEUROCHEM, V72, P2032, DOI 10.1046/j.1471-4159.1999.0722032.x; Anderson NL, 2004, J PROTEOME RES, V3, P235, DOI 10.1021/pr034086h; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; Bazinet RP, 2005, NEUROCHEM RES, V30, P597, DOI 10.1007/s11064-005-2746-5; Bonhaus DW, 1998, J PHARMACOL EXP THER, V287, P884; Calandra B, 1999, EUR J PHARMACOL, V374, P445, DOI 10.1016/S0014-2999(99)00349-0; Che FY, 2005, MOL CELL PROTEOMICS, V4, P1391, DOI 10.1074/mcp.T500010-MCP200; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chicca A, 2012, BRIT J PHARMACOL, V167, P1596, DOI 10.1111/j.1476-5381.2012.02059.x; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; DeSilva B, 2003, PHARM RES-DORDR, V20, P1885, DOI 10.1023/B:PHAM.0000003390.51761.3d; Devlin MG, 2007, J PEPT SCI, V13, P856, DOI 10.1002/psc.912; Devlin MG, 2002, J NEUROCHEM, V80, P1095, DOI 10.1046/j.0022-3042.2002.00797.x; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Dodd GT, 2010, J NEUROSCI, V30, P7369, DOI 10.1523/JNEUROSCI.5455-09.2010; Dufield DR, 2012, METHODS, V56, P236, DOI 10.1016/j.ymeth.2011.08.012; Eglen RM, 2011, PHARMACEUTICALS, V4, P244, DOI 10.3390/ph4020244; Felder CC, 1998, J PHARMACOL EXP THER, V284, P291; FELDER CC, 1992, MOL PHARMACOL, V42, P838; Fowler CJ, 2008, CURR PHARM DESIGN, V14, P2254, DOI 10.2174/138161208785740126; Gelman JS, 2010, J NEUROCHEM, V113, P871, DOI 10.1111/j.1471-4159.2010.06653.x; Gertsch J, 2008, P NATL ACAD SCI USA, V105, P9099, DOI 10.1073/pnas.0803601105; Glass M, 1997, J NEUROSCI, V17, P5327, DOI 10.1523/jneurosci.17-14-05327.1997; Gomes I, 2010, AAPS J, V12, P658, DOI 10.1208/s12248-010-9217-x; Gomes I, 2009, FASEB J, V23, P3020, DOI 10.1096/fj.09-132142; Hanus LO, 2009, MED RES REV, V29, P213, DOI 10.1002/med.20135; Heimann AS, 2007, P NATL ACAD SCI USA, V104, P20588, DOI 10.1073/pnas.0706980105; Hoeppe S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002857; Horswill JG, 2007, BRIT J PHARMACOL, V152, P805, DOI 10.1038/sj.bjp.0707347; HOWLETT AC, 1988, MOL PHARMACOL, V33, P297; HOWLETT AC, 1984, MOL PHARMACOL, V26, P532; HOWLETT AC, 1986, MOL PHARMACOL, V29, P307; Howlett AC, 2000, CHEM PHYS LIPIDS, V108, P53, DOI 10.1016/S0009-3084(00)00187-0; Hsieh C, 1999, J NEUROCHEM, V73, P493, DOI 10.1046/j.1471-4159.1999.0730493.x; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Kleyer J, 2012, BIOCHEM PHARMACOL, V83, P1393, DOI 10.1016/j.bcp.2012.02.014; Kurzeder C, 2007, INT J MOL MED, V19, P325; Leach K, 2011, CURR PROTOC PHARM; Leonti M, 2010, BIOCHEM PHARMACOL, V79, P1815, DOI 10.1016/j.bcp.2010.02.015; Litschig S, 1999, MOL PHARMACOL, V55, P453; LUNELLI L, 1994, BIOPOLYMERS, V34, P747, DOI 10.1002/bip.360340607; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Maneuf YP, 1997, BRIT J PHARMACOL, V120, P1397, DOI 10.1038/sj.bjp.0701101; Maple L, 2004, J IMMUNOL METHODS, V295, P169, DOI 10.1016/j.jim.2004.09.012; Massa F, 2010, J NEUROSCI, V30, P6273, DOI 10.1523/JNEUROSCI.2648-09.2010; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; MRABET NT, 1986, J BIOL CHEM, V261, P1111; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Navarro HA, 2009, BRIT J PHARMACOL, V156, P1178, DOI 10.1111/j.1476-5381.2009.00124.x; Neubig RR, 2003, PHARMACOL REV, V55, P597, DOI 10.1124/pr.55.4.4; Nicol GR, 2008, MOL CELL PROTEOMICS, V7, P1974, DOI 10.1074/mcp.M700476-MCP200; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 2005, HANDB EXP PHARMACOL, V168, P1; Piscitelli F, 2012, J MED CHEM, V55, P5627, DOI 10.1021/jm201485c; Poetz O, 2005, PROTEOMICS, V5, P2402, DOI 10.1002/pmic.200401299; Poetz O, 2009, PROTEOMICS, V9, P1518, DOI 10.1002/pmic.200800842; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; Raduner S, 2006, J BIOL CHEM, V281, P14192, DOI 10.1074/jbc.M601074200; Reggio PH, 2005, HANDB EXP PHARMACOL, V168, P247; Ross RA, 2007, TRENDS PHARMACOL SCI, V28, P567, DOI 10.1016/j.tips.2007.10.006; Scrima M, 2010, BIOCHEMISTRY-US, V49, P10449, DOI 10.1021/bi1011833; Skold K, 2007, PROTEOMICS, V7, P4445, DOI 10.1002/pmic.200700142; Tamborrini M, 2006, ANGEW CHEM INT EDIT, V45, P6581, DOI 10.1002/anie.200602048; Tamborrini M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-314; Urwyler S, 2001, MOL PHARMACOL, V60, P963, DOI 10.1124/mol.60.5.963; Watson C, 2005, MOL PHARMACOL, V67, P1268, DOI 10.1124/mol.104.008565; Whiteaker JR, 2007, ANAL BIOCHEM, V362, P44, DOI 10.1016/j.ab.2006.12.023; Whiteaker JR, 2010, MOL CELL PROTEOMICS, V9, P184, DOI 10.1074/mcp.M900254-MCP200; Zahn K, 2002, J PHARMACOL EXP THER, V301, P720, DOI 10.1124/jpet.301.2.720; Zhou HZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006087	73	124	128	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36944	36967		10.1074/jbc.M112.382481	http://dx.doi.org/10.1074/jbc.M112.382481			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22952224	hybrid, Green Published			2022-12-25	WOS:000310588500031
J	Murphy, SM; Wimp, GM; Lewis, D; Denno, RF				Murphy, Shannon M.; Wimp, Gina M.; Lewis, Danny; Denno, Robert F.			Nutrient Presses and Pulses Differentially Impact Plants, Herbivores, Detritivores and Their Natural Enemies	PLOS ONE			English	Article							BOTTOM-UP; SPARTINA-ALTERNIFLORA; RESOURCE PULSES; SALT MARSHES; TOP-DOWN; FOOD-WEB; TERRESTRIAL ECOSYSTEMS; NITROGEN ADDITION; INSECT COMMUNITY; NORTH-CAROLINA	Anthropogenic nutrient inputs into native ecosystems cause fluctuations in resources that normally limit plant growth, which has important consequences for associated food webs. Such inputs from agricultural and urban habitats into nearby natural systems are increasing globally and can be highly variable, spanning the range from sporadic to continuous. Despite the global increase in anthropogenically-derived nutrient inputs into native ecosystems, the consequences of variation in subsidy duration on native plants and their associated food webs are poorly known. Specifically, while some studies have examined the effects of nutrient subsidies on native ecosystems for a single year (a nutrient pulse), repeated introductions of nutrients across multiple years (a nutrient press) better reflect the persistent nature of anthropogenic nutrient enrichment. We therefore contrasted the effects of a one-year nutrient pulse with a four-year nutrient press on arthropod consumers in two salt marshes. Salt marshes represent an ideal system to address the differential impacts of nutrient pulses and presses on ecosystem and community dynamics because human development and other anthropogenic activities lead to recurrent introductions of nutrients into these natural systems. We found that plant biomass and %N as well as arthropod density fell after the nutrient pulse ended but remained elevated throughout the nutrient press. Notably, higher trophic levels responded more strongly than lower trophic levels to fertilization, and the predator/prey ratio increased each year of the nutrient press, demonstrating that food web responses to anthropogenic nutrient enrichment can take years to fully manifest themselves. Vegetation at the two marshes also exhibited an apparent tradeoff between increasing %N and biomass in response to fertilization. Our research emphasizes the need for long-term, spatially diverse studies of nutrient enrichment in order to understand how variation in the duration of anthropogenic nutrient subsidies affects native ecosystems.	[Murphy, Shannon M.] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA; [Wimp, Gina M.; Lewis, Danny] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Denno, Robert F.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	University of Denver; Georgetown University; University System of Maryland; University of Maryland College Park	Murphy, SM (corresponding author), Univ Denver, Dept Biol Sci, Denver, CO 80208 USA.	Shannon.M.Murphy@du.edu	Wimp, Gina/AAT-3776-2020; Murphy, Shannon M./Q-2139-2017	Murphy, Shannon M./0000-0002-5746-6536	National Parks Ecological Research Fellowship Program; Andrew W. Mellon Foundation	National Parks Ecological Research Fellowship Program; Andrew W. Mellon Foundation	This research was funded by the National Parks Ecological Research Fellowship Program, a partnership between the National Park Service, the Ecological Society of America and the National Park Foundation that was funded by the Andrew W. Mellon Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew AM, 2003, BIOL BULL-US, V205, P238, DOI 10.2307/1543273; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Bakelaar GR, 1978, ECOLOGY, V59, P660; Bertness M, 2004, AM SCI, V92, P54; Bertness MD, 2002, P NATL ACAD SCI USA, V99, P1395, DOI 10.1073/pnas.022447299; Boyer EW, 2002, BIOGEOCHEMISTRY, V57, P137, DOI 10.1023/A:1015709302073; Carmichael RH, 2004, MAR POLLUT BULL, V48, P137, DOI 10.1016/S0025-326X(03)00372-2; Clark CM, 2007, ECOL LETT, V10, P596, DOI 10.1111/j.1461-0248.2007.01053.x; Cole ML, 2004, J ENVIRON QUAL, V33, P124, DOI 10.2134/jeq2004.0124; Crawley MJ, 2005, AM NAT, V165, P179, DOI 10.1086/427270; Denno RF, 2002, ECOLOGY, V83, P1443, DOI 10.1890/0012-9658(2002)083[1443:BUFMNE]2.0.CO;2; Denno RF, 2003, ECOLOGY, V84, P1032, DOI 10.1890/0012-9658(2003)084[1032:PRARSO]2.0.CO;2; Dobel Hartmut G., 1994, P325; Finke DL, 2002, ECOLOGY, V83, P643, DOI 10.1890/0012-9658(2002)083[0643:IPDICS]2.0.CO;2; Galvan K, 2008, THESIS STATE U LOUIS; Gough L, 2000, OIKOS, V89, P428, DOI 10.1034/j.1600-0706.2000.890302.x; Gratton C, 2003, ECOLOGY, V84, P2692, DOI 10.1890/02-0666; Gruner DS, 2006, OECOLOGIA, V147, P714, DOI 10.1007/s00442-005-0337-4; Haddad NM, 2000, OECOLOGIA, V124, P73, DOI 10.1007/s004420050026; Hoekman D, 2011, ECOLOGY, V92, P2063, DOI 10.1890/11-0160.1; Howarth RW, 1996, BIOGEOCHEMISTRY, V35, P75, DOI 10.1007/BF02179825; Howarth RW, 2002, AMBIO, V31, P88, DOI 10.1639/0044-7447(2002)031[0088:NUITUS]2.0.CO;2; HUNTER MD, 1992, ECOLOGY, V73, P724; HURD LE, 1974, ECOL MONOGR, V44, P465, DOI 10.2307/1942450; Huxel GR, 1998, AM NAT, V152, P460, DOI 10.1086/286182; INOUYE RS, 1995, ECOLOGY, V76, P1872, DOI 10.2307/1940720; KIRCHNER TB, 1977, ECOLOGY, V58, P1334, DOI 10.2307/1935085; Matsumura M, 2004, ECOLOGY, V85, P2601, DOI 10.1890/03-0629; Mayer B, 2002, BIOGEOCHEMISTRY, V57, P171, DOI 10.1023/A:1015744002496; McCall BD, OECOLOGIA IN PRESS; McFarlin CR, 2008, ESTUAR COAST, V31, P313, DOI 10.1007/s12237-008-9036-9; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; MENDELSSOHN IA, 1979, ECOLOGY, V60, P574, DOI 10.2307/1936078; MENDELSSOHN IA, 1979, ESTUARIES, V2, P106, DOI 10.2307/1351634; Murphy SM, 2012, DRYAD DIGITAL REPOSI; Nowlin WH, 2008, ECOLOGY, V89, P647, DOI 10.1890/07-0303.1; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Pennings SC, 2005, OIKOS, V110, P547, DOI 10.1111/j.0030-1299.2005.13792.x; Pennings SC, 2001, ECOLOGY, V82, P1344, DOI 10.1890/0012-9658(2001)082[1344:LDIPPI]2.0.CO;2; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Polis GA, 1998, ECOLOGY, V79, P490, DOI 10.2307/176948; ROBINSON D, 1994, NEW PHYTOL, V127, P635, DOI 10.1111/j.1469-8137.1994.tb02969.x; Ruxton GD, 2010, ANIM BEHAV, V80, P937, DOI 10.1016/j.anbehav.2010.08.002; Siemann E, 1998, ECOLOGY, V79, P2057, DOI 10.1890/0012-9658(1998)079[2057:ETOEOP]2.0.CO;2; SILVANIMA JVC, 1991, ECOL ENTOMOL, V16, P221, DOI 10.1111/j.1365-2311.1991.tb00212.x; Stiling P, 1997, ECOLOGY, V78, P1602, DOI 10.1890/0012-9658(1997)078[1602:EMOTDA]2.0.CO;2; STRAUSS SY, 1987, ECOLOGY, V68, P1670, DOI 10.2307/1939859; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; TILMAN D, 1987, ECOL MONOGR, V57, P189, DOI 10.2307/2937080; Tilman D, 1999, P NATL ACAD SCI USA, V96, P5995, DOI 10.1073/pnas.96.11.5995; TURNER RE, 1976, CONTRIB MAR SCI, V20, P47; VALIELA I, 1978, AM NAT, V112, P461, DOI 10.1086/283290; VALIELA I, 1979, NATURE, V280, P652, DOI 10.1038/280652a0; VALIELA I, 1976, LIMNOL OCEANOGR, V21, P245, DOI 10.4319/lo.1976.21.2.0245; Valiela I, 2002, ENVIRON POLLUT, V118, P239, DOI 10.1016/S0269-7491(01)00316-5; Valiela I, 2002, ECOSYSTEMS, V5, P92, DOI 10.1007/s10021-001-0058-4; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wimp GM, 2010, ECOLOGY, V91, P3303, DOI 10.1890/09-1291.1; Wimp GM, OECOLOGIA IN PRESS; Yang LH, 2004, SCIENCE, V306, P1565, DOI 10.1126/science.1103114; Yang LH, 2008, ECOLOGY, V89, P621, DOI 10.1890/07-0175.1; Zimmer M, 2004, ESTUARIES, V27, P753, DOI 10.1007/BF02912038	63	32	32	2	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43929	10.1371/journal.pone.0043929	http://dx.doi.org/10.1371/journal.pone.0043929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952814	gold, Green Published, Green Submitted			2022-12-25	WOS:000308213600058
J	Raphel, L; Talasila, A; Cheung, C; Sinha, S				Raphel, Linda; Talasila, Amarnath; Cheung, Christine; Sinha, Sanjay			Myocardin Overexpression Is Sufficient for Promoting the Development of a Mature Smooth Muscle Cell-Like Phenotype from Human Embryonic Stem Cells	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; GENE-EXPRESSION; DIFFERENTIATION; TRANSCRIPTION; REGULATOR; COFACTOR; SWITCH	Background: Myocardin is thought to have a key role in smooth muscle cell (SMC) development by acting on CArG-dependent genes. However, it is unclear whether myocardin-induced SMC maturation and increases in agonist-induced calcium signalling are also associated with increases in the expression of non-CArG-dependent SMC-specific genes. Moreover, it is unknown whether myocardin promotes SMC development from human embryonic stem cells. Methodology/Principal: Findings The effects of adenoviral-mediated myocardin overexpression on SMC development in human ESC-derived embryoid bodies were investigated using immunofluorescence, flow cytometry and real time RT-PCR. Myocardin overexpression from day 10 to day 28 of embryoid body differentiation increased the number of smooth muscle alpha-actin(+) and smooth muscle myosin heavy chain(+) SMC-like cells and increased carbachol-induced contractile function. However, myocardin was found to selectively regulate only CArG-dependent SMC-specific genes. Nevertheless, myocardin expression appeared to be sufficient to specify the SMC lineage. Conclusions/Significance: Myocardin increases the development and maturation of SMC-like cells from human embryonic stem cells despite not activating the full repertoire of SMC genes. These findings have implications for vascular tissue engineering and other applications requiring large numbers of functional SMCs.	[Raphel, Linda; Talasila, Amarnath; Cheung, Christine; Sinha, Sanjay] Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge, England	University of Cambridge	Raphel, L (corresponding author), Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge, England.	ss661@cam.ac.uk	Cheung, Christine/J-9721-2017; Sinha, Sanjay/AAF-1692-2021	Cheung, Christine/0000-0001-7127-9107; Sinha, Sanjay/0000-0001-5900-1209	Wellcome Trust [GR078390MA]; British Heart Foundation [PG/10/007]; Cambridge Biomedical Research Centre; MRC [G0800784, G1000847] Funding Source: UKRI; British Heart Foundation [PG/10/007/28184] Funding Source: researchfish; Medical Research Council [G1000847, G0800784] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); Cambridge Biomedical Research Centre(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust (Intermediate Fellowship GR078390MA) (http://www.wellcome.ac.uk/), British Heart Foundation (Project grant PG/10/007) (http://www.bhf.org.uk/), and Cambridge Biomedical Research Centre (http://cambridge-brc.org.uk/new/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Cheung C, 2012, NAT BIOTECHNOL, V30, P165, DOI 10.1038/nbt.2107; Cheung C, 2011, J MOL CELL CARDIOL, V51, P651, DOI 10.1016/j.yjmcc.2011.07.014; Drab M, 1997, FASEB J, V11, P905, DOI 10.1096/fasebj.11.11.9285489; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Hoofnagle MH, 2011, AM J PHYSIOL-HEART C, V300, pH1707, DOI 10.1152/ajpheart.01192.2010; Huang HR, 2006, BIOCHEM BIOPH RES CO, V351, P321, DOI 10.1016/j.bbrc.2006.09.171; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Lockman K, 2007, CIRC RES, V101, pE115, DOI 10.1161/CIRCRESAHA.107.164178; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; Long XC, 2007, P NATL ACAD SCI USA, V104, P16570, DOI 10.1073/pnas.0708253104; Ooboshi H, 1997, AM J PHYSIOL-HEART C, V273, pH265, DOI 10.1152/ajpheart.1997.273.1.H265; Pipes GCT, 2005, DEV BIOL, V288, P502, DOI 10.1016/j.ydbio.2005.10.014; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Yoshida T, 2004, ARTERIOSCL THROM VAS, V24, P1596, DOI 10.1161/01.ATV.0000137190.63214.c5; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09	23	24	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44052	10.1371/journal.pone.0044052	http://dx.doi.org/10.1371/journal.pone.0044052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937150	Green Submitted, gold, Green Published			2022-12-25	WOS:000308213600072
J	Husaini, Y; Qiu, MR; Lockwood, GP; Luo, XW; Shang, P; Kuffner, T; Tsai, VWW; Jiang, LL; Russell, PJ; Brown, DA; Breit, SN				Husaini, Yasmin; Qiu, Min Ru; Lockwood, Glen P.; Luo, Xu Wei; Shang, Ping; Kuffner, Tamara; Tsai, Vicky Wang-Wei; Jiang, Lele; Russell, Pamela J.; Brown, David A.; Breit, Samuel N.			Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15) Slows Cancer Development but Increases Metastases in TRAMP Prostate Cancer Prone Mice	PLOS ONE			English	Article							GROWTH-DIFFERENTIATION FACTOR-15; TGF-BETA SUPERFAMILY; GENE-EXPRESSION; TRANSGENIC ADENOCARCINOMA; STROMAL STORES; COLON-CANCER; CELLS; SERUM; MOUSE; MODEL	Macrophage inhibitory cytokine-1 (MIC-1/GDF15), a divergent member of the TGF-beta superfamily, is over-expressed by many common cancers including those of the prostate (PCa) and its expression is linked to cancer outcome. We have evaluated the effect of MIC-1/GDF15 overexpression on PCa development and spread in the TRAMP transgenic model of spontaneous prostate cancer. TRAMP mice were crossed with MIC-1/GDF15 overexpressing mice (MIC-1(fms)) to produce syngeneic TRAMP(fmsmic-1) mice. Survival rate, prostate tumor size, histopathological grades and extent of distant organ metastases were compared. Metastasis of TC1-T5, an androgen independent TRAMP cell line that lacks MIC-1/GDF15 expression, was compared by injecting intravenously into MIC-1(fms) and syngeneic C57BL/6 mice. Whilst TRAMP(fmsmic-1) survived on average 7.4 weeks longer, had significantly smaller genitourinary (GU) tumors and lower PCa histopathological grades than TRAMP mice, more of these mice developed distant organ metastases. Additionally, a higher number of TC1-T5 lung tumor colonies were observed in MIC-1(fms) mice than syngeneic WT C57BL/6 mice. Our studies strongly suggest that MIC-1/GDF15 has complex actions on tumor behavior: it limits local tumor growth but may with advancing disease, promote metastases. As MIC-1/GDF15 is induced by all cancer treatments and metastasis is the major cause of cancer treatment failure and cancer deaths, these results, if applicable to humans, may have a direct impact on patient care.	[Husaini, Yasmin; Lockwood, Glen P.; Luo, Xu Wei; Shang, Ping; Kuffner, Tamara; Tsai, Vicky Wang-Wei; Jiang, Lele; Brown, David A.; Breit, Samuel N.] St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia; [Husaini, Yasmin; Lockwood, Glen P.; Luo, Xu Wei; Shang, Ping; Kuffner, Tamara; Tsai, Vicky Wang-Wei; Jiang, Lele; Brown, David A.; Breit, Samuel N.] Univ New S Wales, Sydney, NSW, Australia; [Qiu, Min Ru] St Vincents Hosp, Dept Anat Pathol, SydPath, Sydney, NSW 2010, Australia; [Russell, Pamela J.] Queensland Univ Technol, Princess Alexandra Hosp, Australian Prostate Canc Res Ctr Queensland, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	St Vincents Hospital Sydney; University of New South Wales Sydney; St Vincents Hospital Sydney; Queensland University of Technology (QUT)	Husaini, Y (corresponding author), St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia.	s.breit@amr.org.au	Russell, Pamela J/G-1685-2010; Russell, Pamela/O-8504-2019	Russell, Pamela J/0000-0002-3995-1239; Brown, David/0000-0003-1382-9419; Jiang, Lele/0000-0002-1326-5871	Prostate Cancer Foundation of Australia; Cancer Council New South Wales; National Health and Medical Research Council of Australia	Prostate Cancer Foundation of Australia; Cancer Council New South Wales(Cancer Council New South Wales); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by the Prostate Cancer Foundation of Australia (http://www.prostate.org.au), Cancer Council New South Wales (http://www.cancercouncil.com.au/) and The National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au/). DAB is a National Health and Medical Research Council Biomedical Career Development Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertoni M, 2002, ONCOGENE, V21, P4212, DOI 10.1038/sj.onc.1205610; American C, 2011, CANC FACTS FIGURES; Baek KE, 2009, CLIN CHIM ACTA, V401, P128, DOI 10.1016/j.cca.2008.12.008; Baek SJ, 2006, GASTROENTEROLOGY, V131, P1553, DOI 10.1053/j.gastro.2006.09.015; Baek SJ, 2001, MOL PHARMACOL, V59, P901, DOI 10.1124/mol.59.4.901; Bauskin AR, 2005, CANCER RES, V65, P2330, DOI 10.1158/0008-5472.CAN-04-3827; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Bauskin AR, 2010, J INTERF CYTOK RES, V30, P389, DOI 10.1089/jir.2009.0052; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Boyer J, 2006, CANCER RES, V66, P2765, DOI 10.1158/0008-5472.CAN-05-2693; Boyle GM, 2009, J INVEST DERMATOL, V129, P383, DOI 10.1038/jid.2008.270; Breit SN, 2011, GROWTH FACTORS, V29, P187, DOI 10.3109/08977194.2011.607137; Brown DA, 2006, CLIN CANCER RES, V12, P89, DOI 10.1158/1078-0432.CCR-05-1331; Brown DA, 2003, CLIN CANCER RES, V9, P2642; Brown DA, 2012, CANCER EPIDEM BIOMAR, V21, P337, DOI 10.1158/1055-9965.EPI-11-0786; Brown DA, 2009, CLIN CANCER RES, V15, P6658, DOI 10.1158/1078-0432.CCR-08-3126; Brown DC, 2007, AI EDAM, V21, P1, DOI 10.1017/S0890060407070011; Chen SJ, 2007, PROSTATE, V67, P557, DOI 10.1002/pros.20551; Cheung PK, 2004, CANCER RES, V64, P5929, DOI 10.1158/0008-5472.CAN-04-1216; Fluge O, 2006, THYROID, V16, P161; Foster BA, 1997, CANCER RES, V57, P3325; Gingrich JR, 1999, PROSTATE CANCER P D, V2, P70, DOI 10.1038/sj/pcan/4500296; Gingrich JR, 1996, CANCER RES, V56, P4096; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Huang CY, 2007, CLIN CANCER RES, V13, P5825, DOI 10.1158/1078-0432.CCR-07-1037; Hurwitz Arthur A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2005s45; Jeet V, 2008, PROSTATE, V68, P548, DOI 10.1002/pros.20714; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Joiner MC, 2011, RADIOTHER ONCOL, V101, P233, DOI 10.1016/j.radonc.2011.05.068; Kelly JA, 2009, CANCER LETT, V277, P38, DOI 10.1016/j.canlet.2008.11.013; Kim JS, 2005, MOL CANCER THER, V4, P487; Kim KK, 2008, CARCINOGENESIS, V29, P704, DOI 10.1093/carcin/bgn031; Koopmann J, 2006, CLIN CANCER RES, V12, P442, DOI 10.1158/1078-0432.CCR-05-0564; Koopmann J, 2004, CLIN CANCER RES, V10, P2386, DOI 10.1158/1078-0432.CCR-03-0165; Lee DH, 2003, CANCER RES, V63, P4648; Lee SH, 2005, BIOCHEM BIOPH RES CO, V328, P63, DOI 10.1016/j.bbrc.2004.12.138; Liu T, 2003, CANCER RES, V63, P5034; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Modlich O, 2004, CLIN CANCER RES, V10, P6418, DOI 10.1158/1078-0432.CCR-04-1031; Nakamura T, 2003, BRIT J CANCER, V88, P1101, DOI 10.1038/sj.bjc.6600869; Noorali S, 2007, DIFFERENTIATION, V75, P325, DOI 10.1111/j.1432-0436.2006.00142.x; Pang RP, 2007, CANCER LETT, V251, P268, DOI 10.1016/j.canlet.2006.11.032; Rasiah KK, 2006, CANCER EPIDEM BIOMAR, V15, P711, DOI 10.1158/1055-9965.EPI-05-0752; Selander KS, 2007, CANCER EPIDEM BIOMAR, V16, P532, DOI 10.1158/1055-9965.EPI-06-0841; Senapati S, 2010, ONCOGENE, V29, P1293, DOI 10.1038/onc.2009.420; Shnaper S, 2009, INT J CANCER, V125, P2624, DOI 10.1002/ijc.24639; Staff AC, 2011, CLIN CANCER RES, V17, P4825, DOI 10.1158/1078-0432.CCR-11-0715; Staff AC, 2010, GYNECOL ONCOL, V118, P237, DOI 10.1016/j.ygyno.2010.05.032; Suesskind D, 2011, GRAEFES ARCH CLIN EX; Wallin U, 2011, BRIT J CANCER, V104, P1619, DOI 10.1038/bjc.2011.112; Weber F, 2005, J CLIN ENDOCR METAB, V90, P2512, DOI 10.1210/jc.2004-2028; Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100; Yang H, 2003, MOL CANCER THER, V2, P1023; Zhang L, 2009, ORAL ONCOL, V45, P627, DOI 10.1016/j.oraloncology.2008.07.017; Zhao LL, 2009, CANCER RES, V69, P7696, DOI 10.1158/0008-5472.CAN-08-4901; Zimmers TA, 2006, J SURG RES, V130, P45, DOI 10.1016/j.jss.2005.07.036; Zimmers TA, 2010, J CANCER RES CLIN, V136, P571, DOI 10.1007/s00432-009-0691-4	57	53	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43833	10.1371/journal.pone.0043833	http://dx.doi.org/10.1371/journal.pone.0043833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952779	Green Published, Green Submitted, gold			2022-12-25	WOS:000308044800064
J	Koga, T; Kai, Y; Fukuda, R; Morino-Koga, S; Suico, MA; Koyama, K; Sato, T; Shuto, T; Kai, H				Koga, Tomoaki; Kai, Yukari; Fukuda, Ryosuke; Morino-Koga, Saori; Suico, Mary Ann; Koyama, Kosuke; Sato, Takashi; Shuto, Tsuyoshi; Kai, Hirofumi			Mild Electrical Stimulation and Heat Shock Ameliorates Progressive Proteinuria and Renal Inflammation in Mouse Model of Alport Syndrome	PLOS ONE			English	Article							NF-KAPPA-B; GLOMERULAR PODOCYTE; EPITHELIAL-CELLS; HEME OXYGENASE-1; IV COLLAGEN; DISEASE; BLOCKADE; INJURY; HSP72; MICE	Alport syndrome is a hereditary glomerulopathy with proteinuria and nephritis caused by defects in genes encoding type IV collagen in the glomerular basement membrane. All male and most female patients develop end-stage renal disease. Effective treatment to stop or decelerate the progression of proteinuria and nephritis is still under investigation. Here we showed that combination treatment of mild electrical stress (MES) and heat stress (HS) ameliorated progressive proteinuria and renal injury in mouse model of Alport syndrome. The expressions of kidney injury marker neutrophil gelatinase-associated lipocalin and pro-inflammatory cytokines interleukin-6, tumor necrosis factor-a and interleukin-1 beta were suppressed by MES+HS treatment. The anti-proteinuric effect of MES+ HS treatment is mediated by podocytic activation of phosphatidylinositol 3-OH kinase (PI3K)-Akt and heat shock protein 72 (Hsp72)-dependent pathways in vitro and in vivo. The anti-inflammatory effect of MES+ HS was mediated by glomerular activation of c-jun NH2-terminal kinase 1/2 (JNK1/2) and p38-dependent pathways ex vivo. Collectively, our studies show that combination treatment of MES and HS confers anti-proteinuric and anti-inflammatory effects on Alport mice likely through the activation of multiple signaling pathways including PI3K-Akt, Hsp72, JNK1/2, and p38 pathways, providing a novel candidate therapeutic strategy to decelerate the progression of patho-phenotypes in Alport syndrome.	[Koga, Tomoaki; Kai, Yukari; Fukuda, Ryosuke; Morino-Koga, Saori; Suico, Mary Ann; Koyama, Kosuke; Sato, Takashi; Shuto, Tsuyoshi; Kai, Hirofumi] Kumamoto Univ, Dept Mol Med, Grad Sch Pharmaceut Sci, Kumamoto, Japan; [Koga, Tomoaki; Kai, Yukari; Fukuda, Ryosuke; Morino-Koga, Saori; Suico, Mary Ann; Koyama, Kosuke; Sato, Takashi; Shuto, Tsuyoshi; Kai, Hirofumi] Kumamoto Univ, Global COE Cell Fate Regulat Res & Educ Unit, Kumamoto, Japan; [Koga, Tomoaki] Japan Soc Promot Sci, Tokyo, Japan; [Koga, Tomoaki] Kyushu Univ, Dept Med Biochem, Grad Sch Med Sci, Fukuoka 812, Japan	Kumamoto University; Kumamoto University; Japan Society for the Promotion of Science; Kyushu University	Koga, T (corresponding author), Kumamoto Univ, Dept Mol Med, Grad Sch Pharmaceut Sci, Kumamoto, Japan.	hirokai@gpo.kumamoto-u.ac.jp	Sato, Takashi/AHB-5258-2022	Sato, Takashi/0000-0003-4203-0999; Suico, Mary Ann/0000-0002-6751-8352; Shuto, Tsuyoshi/0000-0003-1275-4988	Ministry of Education, Science, Sports and Culture (MEXT) of Japan [19390045]; Global COE Program (Cell Fate Regulation Research and Education Unit); JSPS [20-8140]	Ministry of Education, Science, Sports and Culture (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program (Cell Fate Regulation Research and Education Unit)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Ministry of Education, Science, Sports and Culture (MEXT) of Japan (#19390045), from the Global COE Program (Cell Fate Regulation Research and Education Unit) to H.K., and grant-in-aid from JSPS Research fellow (20-8140) to T.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson DR, 2009, J AM SOC NEPHROL, V20, P1471, DOI 10.1681/ASN.2008101086; Akcay A, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/137072; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Chuang PY, 2009, NEPHRON PHYSIOL, V111, P9, DOI 10.1159/000191075; Clauss S, 2009, J PATHOL, V218, P40, DOI 10.1002/path.2505; de Zeeuw D, 2004, KIDNEY INT, V65, P2309, DOI 10.1111/j.1523-1755.2004.00653.x; Duan Y, 2008, P NATL ACAD SCI USA, V105, P11418, DOI 10.1073/pnas.0804954105; Endemann M, 2007, AM J PHYSIOL-RENAL, V292, pF47, DOI 10.1152/ajprenal.00503.2005; Furst R, 2006, J PHARMACOL EXP THER, V318, P389, DOI 10.1124/jpet.106.102251; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Gross O, 2003, KIDNEY INT, V63, P438, DOI 10.1046/j.1523-1755.2003.00779.x; Huber TB, 2003, HUM MOL GENET, V12, P3397, DOI 10.1093/hmg/ddg360; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Jedlicka J, 2010, HUM PATHOL, V41, P582, DOI 10.1016/j.humpath.2009.08.024; Jo SK, 2006, J AM SOC NEPHROL, V17, P3082, DOI 10.1681/ASN.2005101077; Kai H, 2009, INT J HYPERTHER, V25, P655, DOI 10.3109/02656730903039605; Kaito H, 2006, PEDIATR NEPHROL, V21, P1824, DOI 10.1007/s00467-006-0270-8; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kietzmann T, 2003, J BIOL CHEM, V278, P17927, DOI 10.1074/jbc.M203929200; Kondo T, 2010, OBES RES CLIN PRACT, V4, pE101, DOI 10.1016/j.orcp.2009.09.007; Lian KC, 2010, TOXICOL APPL PHARM, V245, P21, DOI 10.1016/j.taap.2010.01.003; Meehan DT, 2009, KIDNEY INT, V76, P968, DOI 10.1038/ki.2009.324; Morino S, 2008, J PHARMACOL SCI, V108, P222, DOI 10.1254/jphs.08180SC; Morino S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004068; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Ninichuk V, 2005, J AM SOC NEPHROL, V16, P977, DOI 10.1681/ASN.2004100871; Oba M, 2010, J SURG RES, V162, P213, DOI 10.1016/j.jss.2009.03.093; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Proesmans W, 2004, PEDIATR NEPHROL, V19, P271, DOI 10.1007/s00467-003-1366-z; Rheault MN, 2004, J AM SOC NEPHROL, V15, P1466, DOI 10.1097/01.ASN.0000130562.90255.8F; Rico M, 2005, AM J PHYSIOL-RENAL, V289, pF431, DOI 10.1152/ajprenal.00389.2004; Ruchalski K, 2003, AM J PHYSIOL-CELL PH, V285, pC1483, DOI 10.1152/ajpcell.00049.2003; Sanchez-Wandelmer J, 2009, BBA-BIOMEMBRANES, V1788, P1731, DOI 10.1016/j.bbamem.2009.05.002; Sayers R, 1999, KIDNEY INT, V56, P1662, DOI 10.1046/j.1523-1755.1999.00744.x; Seegers JC, 2001, MED HYPOTHESES, V57, P224, DOI 10.1054/mehy.2001.1292; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Wang XM, 2006, AM J RESP CELL MOL, V34, P434, DOI 10.1165/rcmb.2005-0376OC; Wang YH, 2001, AM J PHYSIOL-CELL PH, V281, pC1667, DOI 10.1152/ajpcell.2001.281.5.C1667; Welsh GI, 2010, CELL METAB, V12, P329, DOI 10.1016/j.cmet.2010.08.015; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zeisberg M, 2006, PLOS MED, V3, P535, DOI 10.1371/journal.pmed.0030100; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925	42	19	20	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43852	10.1371/journal.pone.0043852	http://dx.doi.org/10.1371/journal.pone.0043852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937108	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500110
J	Patel, A; Dong, JC; Trost, B; Richardson, JS; Tohme, S; Babiuk, S; Kusalik, A; Kung, SKP; Kobinger, GP				Patel, Ami; Dong, Jessica C.; Trost, Brett; Richardson, Jason S.; Tohme, Sarah; Babiuk, Shawn; Kusalik, Anthony; Kung, Sam K. P.; Kobinger, Gary P.			Pentamers Not Found in the Universal Proteome Can Enhance Antigen Specific Immune Responses and Adjuvant Vaccines	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; NK CELLS; T-CELLS; PEPTIDE; SEQUENCES; VIRUS; CPG; EPITOPES; MOTIFS; AGE	Certain short peptides do not occur in humans and are rare or non-existent in the universal proteome. Antigens that contain rare amino acid sequences are in general highly immunogenic and may activate different arms of the immune system. We first generated a list of rare, semi-common, and common 5-mer peptides using bioinformatics tools to analyze the UniProtKB database. Experimental observations indicated that rare and semi-common 5-mers generated stronger cellular responses in comparison with common-occurring sequences. We hypothesized that the biological process responsible for this enhanced immunogenicity could be used to positively modulate immune responses with potential application for vaccine development. Initially, twelve rare 5-mers, 9-mers, and 13-mers were incorporated in frame at the end of an H5N1 hemagglutinin (HA) antigen and expressed from a DNA vaccine. The presence of some 5-mer peptides induced improved immune responses. Adding one 5-mer peptide exogenously also offered improved clinical outcome and/or survival against a lethal H5N1 or H1N1 influenza virus challenge in BALB/c mice and ferrets, respectively. Interestingly, enhanced anti-HBsAg antibody production by up to 25-fold in combination with a commercial Hepatitis B vaccine (Engerix-B, GSK) was also observed in BALB/c mice. Mechanistically, NK cell activation and dependency was observed with enhancing peptides ex vivo and in NK-depleted mice. Overall, the data suggest that rare or non-existent oligopeptides can be developed as immunomodulators and supports the further evaluation of some 5-mer peptides as potential vaccine adjuvants.	[Patel, Ami; Dong, Jessica C.; Richardson, Jason S.; Tohme, Sarah; Kobinger, Gary P.] Publ Hlth Agcy Canada, Special Pathogens Program, Natl Microbiol Lab, Winnipeg, MB, Canada; [Patel, Ami; Kobinger, Gary P.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Dong, Jessica C.; Babiuk, Shawn; Kung, Sam K. P.; Kobinger, Gary P.] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Trost, Brett; Kusalik, Anthony] Univ Saskatchewan, Dept Comp Sci, Saskatoon, SK S7N 0W0, Canada; [Babiuk, Shawn] Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada	Public Health Agency of Canada; University of Manitoba; University of Manitoba; University of Saskatchewan; Canadian Food Inspection Agency	Patel, A (corresponding author), San Raffaele Telethon Inst Gene Therapy, Milan, Italy.	gary_kobinger@phac-aspc.gc.ca	Trost, Brett/K-4127-2016	Trost, Brett/0000-0003-4863-7273	Public Health Agency of Canada grant [531252]; Canadian Institutes of Health Research	Public Health Agency of Canada grant; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The research in this manuscript was supported by the Public Health Agency of Canada grant #531252 and a grant from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blackman MA, 2011, CURR OPIN IMMUNOL, V23, P537, DOI 10.1016/j.coi.2011.05.005; Blondelle SE, 2008, BIOPOLYMERS, V90, P683, DOI 10.1002/bip.21020; Bresell A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-346; Capone G, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-383; CHALUFOUR A, 1987, ANN INST PASTEUR IMM, V138, P671, DOI 10.1016/S0769-2625(87)80023-5; CLAVERIE JM, 1988, EUR J IMMUNOL, V18, P1547, DOI 10.1002/eji.1830181012; Coban C, 2005, J LEUKOCYTE BIOL, V78, P647, DOI 10.1189/jlb.1104627; De Gregorio E, 2009, CURR OPIN IMMUNOL, V21, P339, DOI 10.1016/j.coi.2009.05.003; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Frasca D, 2009, CURR OPIN IMMUNOL, V21, P425, DOI 10.1016/j.coi.2009.06.001; Fu XP, 2010, HUM GENE THER, V21, P1687, DOI 10.1089/hum.2010.080; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Ishii KJ, 2007, J CLIN IMMUNOL, V27, P363, DOI 10.1007/s10875-007-9087-x; Jennings P, 2009, J IMMUNOL, V182, P2879, DOI 10.4049/jimmunol.0803220; Kanduc D, 2008, CURR PHARM DESIGN, V14, P289, DOI 10.2174/138161208783413257; Kanduc D, 2008, ADV EXP MED BIOL, V640, P198, DOI 10.1007/978-0-387-09789-3_15; Kanduc D, 2008, CANCER IMMUNOL IMMUN, V57, P1215, DOI 10.1007/s00262-008-0456-y; Kanduc D, 2010, PEPTIDES, V31, P983, DOI 10.1016/j.peptides.2010.02.003; Kobinger GP, 2010, J INFECT DIS, V201, P1000, DOI 10.1086/651171; Kusalik A, 2009, PEPTIDES, V30, P1940, DOI 10.1016/j.peptides.2009.06.035; Landrigan A, 2011, J IMMUNOL, V187, P3033, DOI 10.4049/jimmunol.1003414; Lucchese G, 2007, AMINO ACIDS, V33, P703, DOI 10.1007/s00726-006-0458-z; Mahnke YD, 2011, VACCINE, V29, P8606, DOI 10.1016/j.vaccine.2011.09.019; Mariani E, 1998, INT IMMUNOL, V10, P981, DOI 10.1093/intimm/10.7.981; Narni-Mancinelli E, 2011, INT IMMUNOL, V23, P427, DOI 10.1093/intimm/dxr035; Nicholls EF, 2010, ANN NY ACAD SCI, V1213, P46, DOI 10.1111/j.1749-6632.2010.05787.x; Ogata K, 1997, CLIN IMMUNOL IMMUNOP, V84, P269, DOI 10.1006/clin.1997.4401; Otaki JM, 2005, PROTEIN SCI, V14, P617, DOI 10.1110/ps.041092605; Otaki JM, 2008, BIOTECHNOL ANN REV, V14, P109, DOI 10.1016/S1387-2656(08)00004-5; Patel A, 2009, VACCINE, V27, P3083, DOI 10.1016/j.vaccine.2009.03.023; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Pillet S, 2011, VACCINE, V29, P6793, DOI 10.1016/j.vaccine.2010.12.059; Saenz R, 2010, VACCINE, V28, P7556, DOI 10.1016/j.vaccine.2010.08.054; SANSONI P, 1993, BLOOD, V82, P2767; Sivori S, 2006, EUR J IMMUNOL, V36, P961, DOI 10.1002/eji.200535781; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Sweet C, 1999, FERRET ANIMAL MODEL; Tuller T, 2007, PROTEIN SCI, V16, P2251, DOI 10.1110/ps.073067607; van der Laan JW, 2008, EXPERT REV VACCINES, V7, P783, DOI 10.1586/14760584.7.6.783; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Weeratna R, 2003, IMMUNOL CELL BIOL, V81, P59, DOI 10.1046/j.1440-1711.2003.01135.x	43	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43802	10.1371/journal.pone.0043802	http://dx.doi.org/10.1371/journal.pone.0043802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937099	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500101
J	Rathcke, CN; Thomsen, SB; Linneberg, A; Vestergaard, H				Rathcke, Camilla Noelle; Thomsen, Stine Brinkloev; Linneberg, Allan; Vestergaard, Henrik			Variations of CHI3L1, Levels of the Encoded Glycoprotein YKL-40 and Prediction of Fatal and Non-fatal Ischemic Stroke	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; HELICOBACTER-PYLORI INFECTION; ALL-CAUSE MORTALITY; PLASMA YKL-40; GENERAL-POPULATION; DANISH ADULTS; SERUM-LEVELS; ASSOCIATION; BIOMARKER	Background: Polymorphisms of CHI3L1 are associated with inter-individual YKL-40 levels and YKL-40 is associated with an increased mortality and is elevated in patients with cardiovascular disease. We investigated the association between single nucleotide polymorphisms (SNPs) of CHI3L1, serum YKL-40 levels and all-cause and cardiovascular mortality and first-time incidence of myocardial infarction, ischemic heart disease (IHD) and stroke. Methodology/Principal Findings: 12 SNPs of CHI3L1 were genotyped and serum YKL-40 was measured in 2656 Danes representative of the general population. Median follow-up period was 15 (0-16) years. Admission data and deaths were ascertained from registers from the Danish National Board of Health. Fourth quartile YKL-40 levels were associated with an increased mortality risk of ischemic stroke (HR 2.44 (1.01-5.88), p = 0.041) and so were homozygotes of the minor allele of rs872129 (HR 9.35 (1.25-69.87, p = 0.022)). Both continuous YKL-40 levels and 4th quartile YKL-40 values (>85 ng/ml) were associated with all-cause mortality (HRs 1.22 (95% CI, 1.10-1.35), p<0.0001, and 1.40 (1.15-1.71), p<0.0001), an increased risk of first-time stroke (HR 1.16 (1.01-1.33), p = 0.04, and 1.63 (1.23-2.16), p = 0.001) and a decreased risk of incidence of IHD (HR 0.77 (0.65-0.91), p = 0.002, and 0.61 (0.44-0.85), p = 0.003). Conclusions/Signficance: High YKL-40 levels (. 85 ng/ml) and rs872129 were associated with an increased mortality risk of ischemic stroke, but high YKL-40 levels were also inverse related with the risk of incidence of IHD. This could be a chance finding but could also elucidate that YKL-40 plays different roles in development of thromboembolisms versus the formation of local thrombosis.	[Rathcke, Camilla Noelle; Thomsen, Stine Brinkloev; Vestergaard, Henrik] Copenhagen Univ Hosp Herlev, Ctr Endocrinol & Metab, Copenhagen, Denmark; [Rathcke, Camilla Noelle] Copenhagen Univ Hosp Hilleroed, Dept Cardiol & Endocrinol, Copenhagen, Denmark; [Linneberg, Allan] Copenhagen Univ Hosp Glostrup, Res Ctr Prevent & Hlth, Copenhagen, Denmark; [Vestergaard, Henrik] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Rathcke, CN (corresponding author), Copenhagen Univ Hosp Herlev, Ctr Endocrinol & Metab, Copenhagen, Denmark.	cnr@dadlnet.dk		Vestergaard, Henrik/0000-0003-3090-269X; Linneberg, Allan/0000-0002-0994-0184	Danish Council for Independent Research, Medical Sciences, of the Danish Agency for Science, Technology and Innovation, Ministry of Science, Technology and Innovation	Danish Council for Independent Research, Medical Sciences, of the Danish Agency for Science, Technology and Innovation, Ministry of Science, Technology and Innovation	The study was supported by a grant from The Danish Council for Independent Research, Medical Sciences, of the Danish Agency for Science, Technology and Innovation, Ministry of Science, Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bojesen SE, 2011, CLIN CHIM ACTA, V412, P709, DOI 10.1016/j.cca.2011.01.022; Boot RG, 1999, ARTERIOSCL THROM VAS, V19, P687, DOI 10.1161/01.ATV.19.3.687; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Hedegaard A, 2010, SCAND J CLIN LAB INV, V70, P80, DOI 10.3109/00365510903518191; Henningsen KM, 2010, INFLAMM RES, V59, P463, DOI 10.1007/s00011-009-0146-z; Henningsen KM, 2009, EUROPACE, V11, P1032, DOI 10.1093/europace/eup103; Hu FB, 2007, ARCH INTERN MED, V167, P875, DOI 10.1001/archinte.167.9.875; Johansen JS, 2008, CLIN EXP IMMUNOL, V151, P260, DOI 10.1111/j.1365-2249.2007.03561.x; Johansen JS, 2006, DAN MED BULL, V53, P172; Johansen JS, 2010, CLIN CHEM, V56, P1580, DOI 10.1373/clinchem.2010.146530; JORGENSEN T, 1987, AM J EPIDEMIOL, V126, P912, DOI 10.1093/oxfordjournals.aje.a114728; Kastrup J, 2009, EUR HEART J, V30, P1066, DOI 10.1093/eurheartj/ehp049; Kjaergaard AD, 2010, ANN NEUROL, V68, P672, DOI 10.1002/ana.22220; Kruit A, 2007, RESP MED, V101, P1563, DOI 10.1016/j.rmed.2006.12.006; Kucur M, 2007, CORONARY ARTERY DIS, V18, P391, DOI 10.1097/MCA.0b013e328241d991; Ling H, 2004, BIOCHEM J, V380, P651, DOI 10.1042/BJ20040099; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; McCarthy Mark I, 2003, Curr Diab Rep, V3, P159, DOI 10.1007/s11892-003-0040-y; Michelsen AE, 2010, ATHEROSCLEROSIS, V211, P589, DOI 10.1016/j.atherosclerosis.2010.02.035; Nojgaard C, 2008, CORONARY ARTERY DIS, V19, P257, DOI 10.1097/MCA.0b013e3282f40dd5; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Rathcke CN, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-61; Rathcke CN, 2010, INT J CARDIOL, V143, P35, DOI 10.1016/j.ijcard.2009.01.043; Rathcke CN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006106; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; ROSE G, 1977, BRIT J PREV SOC MED, V31, P42; Rosenstock S, 1997, GUT, V41, P169, DOI 10.1136/gut.41.2.169; ROSENSTOCK SJ, 1995, GUT, V36, P819, DOI 10.1136/gut.36.6.819; Rosenstock SJ, 2000, SCAND J PUBLIC HEALT, V28, P32, DOI 10.1080/713797374; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; ROWE DJF, 1990, ANN CLIN BIOCHEM, V27, P297, DOI 10.1177/000456329002700404; Sohn MH, 2009, AM J RESP CRIT CARE, V179, P449, DOI 10.1164/rccm.200809-1422OC; Wang YZ, 2008, SCAND CARDIOVASC J, V42, P295, DOI 10.1080/14017430802220567; Zheng JL, 2011, CYTOKINE, V54, P51, DOI 10.1016/j.cyto.2010.12.018; Zheng JL, 2010, ATHEROSCLEROSIS, V210, P590, DOI 10.1016/j.atherosclerosis.2009.12.016	36	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43498	10.1371/journal.pone.0043498	http://dx.doi.org/10.1371/journal.pone.0043498			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937056	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500057
J	Cheng, X; Folco, EJ; Shimizu, K; Libby, P				Cheng, Xiang; Folco, Eduardo J.; Shimizu, Koichi; Libby, Peter			Adiponectin Induces Pro-inflammatory Programs in Human Macrophages and CD4(+) T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY-HEART-DISEASE; ADIPOSE-SPECIFIC PROTEIN; PLASMA ADIPONECTIN; TNF-ALPHA; ALTERNATIVE ACTIVATION; INSULIN-RESISTANCE; METABOLIC SYNDROME; IMMUNE-RESPONSES; EXPRESSION; HYPOADIPONECTINEMIA	Abundant experimental and clinical data support a modulatory role for adiponectin in inflammation, dysmetabolism, and disease. Because the activation of cells involved in innate and adaptive immunity contributes to the pathogenesis of diseases such as atherosclerosis and obesity, this study investigated the role of adiponectin in human macrophage polarization and T cell differentiation. Examination of the adiponectin-induced transcriptome in primary human macrophages revealed that adiponectin promotes neither classical (M1) nor alternative (M2) macrophage activation but elicits a pro-inflammatory response that resembles M1 more closely than M2. Addition of adiponectin to polyclonally activated CD4(+) T lymphocytes did not affect cell proliferation but induced mRNA expression and protein secretion of interferon (IFN)-gamma and interleukin (IL)-6. Adiponectin treatment of CD4(+) T cells increased phosphorylation of p38 mitogen-activated protein kinase (MAPK) and signal transducer and activation of transcription (STAT) 4 and augmented T-bet expression. Inhibition of p38 with SB203580 abrogated adiponectin-induced IFN-gamma production, indicating that adiponectin enhances T(H)1 differentiation through the activation of the p38-STAT4-T-bet axis. Collectively, our results demonstrate that adiponectin can induce pro-inflammatory functions in isolated macrophages and T cells, concurring with previous observations that adiponectin induces a limited program of inflammatory activation that likely desensitizes these cells to further pro-inflammatory stimuli.	[Libby, Peter] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Libby, P (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc Med, 77 Ave Louis Pasteur,NRB 741, Boston, MA 02115 USA.	plibby@rics.bwh.harvard.edu	Libby, Peter/AAY-6404-2021	Libby, Peter/0000-0002-1502-502X				Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Cui GL, 2009, J BIOL CHEM, V284, P28420, DOI 10.1074/jbc.M109.012674; Folco EJ, 2009, J BIOL CHEM, V284, P25569, DOI 10.1074/jbc.M109.019786; Goldstein BJ, 2009, NAT CLIN PRACT CARD, V6, P27, DOI 10.1038/ncpcardio1398; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Iwashima Y, 2004, HYPERTENSION, V43, P1318, DOI 10.1161/01.HYP.0000129281.03801.4b; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kato H, 2006, ARTERIOSCL THROM VAS, V26, P224, DOI 10.1161/01.ATV.0000194076.84568.81; Kazumi T, 2004, METABOLISM, V53, P589, DOI 10.1016/j.metabol.2003.12.008; Kumada M, 2004, CIRCULATION, V109, P2046, DOI 10.1161/01.CIR.0000127953.98131.ED; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Lawlor DA, 2005, J CLIN ENDOCR METAB, V90, P5677, DOI 10.1210/jc.2005-0825; Lee MH, 2008, BIOCHEMISTRY-US, V47, P11682, DOI 10.1021/bi801451f; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Lindsay RS, 2005, ARTERIOSCL THROM VAS, V25, pE15, DOI 10.1161/01.ATV.0000153090.21990.8c; Lovren F, 2010, AM J PHYSIOL-HEART C, V299, pH656, DOI 10.1152/ajpheart.00115.2010; Mandal P, 2011, J BIOL CHEM, V286, P13460, DOI 10.1074/jbc.M110.204644; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Matsubara M, 2002, J CLIN ENDOCR METAB, V87, P2764, DOI 10.1210/jc.87.6.2764; Nawrocki AR, 2010, ARTERIOSCL THROM VAS, V30, P1159, DOI 10.1161/ATVBAHA.109.195826; Nishihara T, 2006, GASTROENTEROLOGY, V131, P853, DOI 10.1053/j.gastro.2006.06.015; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182; Okamoto Y, 2008, CIRC RES, V102, P218, DOI 10.1161/CIRCRESAHA.107.164988; Okamoto Y, 2009, TRANSPLANTATION, V88, P879, DOI 10.1097/TP.0b013e3181b6efbf; Otake H, 2008, AM J CARDIOL, V101, P1, DOI 10.1016/j.amjcard.2007.07.041; Ouchi N, 2003, HYPERTENSION, V42, P231, DOI 10.1161/01.HYP.0000083488.67550.B8; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; Palmer C, 2008, HEPATOLOGY, V48, P374, DOI 10.1002/hep.22387; Park PH, 2007, J BIOL CHEM, V282, P21695, DOI 10.1074/jbc.M701419200; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Sattar N, 2006, CIRCULATION, V114, P623, DOI 10.1161/CIRCULATIONAHA.106.618918; Schulte S, 2008, AM J PATHOL, V172, P1500, DOI 10.2353/ajpath.2008.070776; Schulze MB, 2004, DIABETES CARE, V27, P1680, DOI 10.2337/diacare.27.7.1680; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takahashi T, 2005, J INT MED RES, V33, P207, DOI 10.1177/147323000503300208; Thakur V, 2006, AM J PHYSIOL-GASTR L, V290, pG998, DOI 10.1152/ajpgi.00553.2005; Trujillo ME, 2005, J INTERN MED, V257, P167, DOI 10.1111/j.1365-2796.2004.01426.x; Tsatsanis C, 2005, BIOCHEM BIOPH RES CO, V335, P1254, DOI 10.1016/j.bbrc.2005.07.197; Uji Y, 2009, SURGERY, V145, P550, DOI 10.1016/j.surg.2009.01.010; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Wilk S, 2011, EUR J IMMUNOL, V41, P2323, DOI 10.1002/eji.201041349; Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130; Yamaguchi N, 2005, FEBS LETT, V579, P6821, DOI 10.1016/j.febslet.2005.11.019; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Zhu WD, 2008, CLIN SCI, V114, P361, DOI 10.1042/CS20070347	51	89	94	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36896	36904		10.1074/jbc.M112.409516	http://dx.doi.org/10.1074/jbc.M112.409516			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22948153	Green Published, hybrid			2022-12-25	WOS:000310588500026
J	Serneels, J; Tournu, H; Van Dijck, P				Serneels, Joke; Tournu, Helene; Van Dijck, Patrick			Tight Control of Trehalose Content Is Required for Efficient Heat-induced Cell Elongation in Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; PROTEIN-COUPLED RECEPTOR; DECREASES INFECTIVITY; ASPERGILLUS-FUMIGATUS; TRANSCRIPTION FACTOR; OSMOLYTE TREHALOSE; OXIDATIVE STRESS; HYPHA FORMATION; GENE; TREHALOSE-6-PHOSPHATE	The ability to form hyphae in the human pathogenic fungus Candida albicans is a prerequisite for virulence. It contributes to tissue infection, biofilm formation, as well as escape from phagocytes. Cell elongation triggered by human body temperature involves the essential heat shock protein Hsp90, which negatively governs a filamentation program dependent upon the Ras-protein kinase A (PKA) pathway. Tight regulation of Hsp90 function is required to ensure fast appropriate response and maintenance of a wide range of regulatory and signaling proteins. Client protein activation by Hsp90 relies on a conformational change of the chaperone, whose ATPase activity is competitively inhibited by geldanamycin. We demonstrate a novel regulatory mechanism of heat- and Hsp90-dependent induced morphogenesis, whereby the nonreducing disaccharide trehalose acts as a negative regulator of Hsp90 release. By means of a mutant strain deleted for Gpr1, the G protein-coupled receptor upstream of PKA, we demonstrate that elevated trehalose content in that strain, resulting from misregulation of enzymatic activities involved in trehalose metabolism, disrupts the filamentation program in response to heat. Addition of geldanamycin does not result in hyphal extensions at 30 C in the gpr1 Delta/gpr1 Delta mutant as it does in wild type cells. In addition, validamycin, a specific inhibitor of trehalase, the trehalose-degrading enzyme, inhibits cell elongation in response to heat and geldanamycin. These results place Gpr1 as a regulator of trehalose metabolism in C. albicans and illustrate that trehalose modulates Hsp90-dependent activation of client proteins and signaling pathways leading to filamentation in the human fungal pathogen.	[Van Dijck, Patrick] Katholieke Univ Leuven, VIB, Dept Mol Microbiol, B-3001 Heverlee, Belgium; Katholieke Univ Leuven, Mol Cell Biol Lab, B-3001 Heverlee, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven	Van Dijck, P (corresponding author), Katholieke Univ Leuven, VIB, Dept Mol Microbiol, Kasteelpk,Arenberg 31,Bus 2438, B-3001 Heverlee, Belgium.	patrick.vandijck@mmbio.vib-kuleuven.be			Flemish Science Foundation, FWO [G.0804.11, WO.026.11N]; research funds of KU Leuven [GOA/2007/08, CREA/11/012]	Flemish Science Foundation, FWO(FWO); research funds of KU Leuven	This work was funded by Flemish Science Foundation, FWO Grants G.0804.11 and WO.026.11N and by research funds of KU Leuven Grants GOA/2007/08 and CREA/11/012.	Al-Bader N, 2010, INFECT IMMUN, V78, P3007, DOI 10.1128/IAI.00813-09; Alvarez-Peral FJ, 2000, RES MICROBIOL, V151, P837, DOI 10.1016/S0923-2508(00)01150-5; ASANO N, 1987, J ANTIBIOT, V40, P526, DOI 10.7164/antibiotics.40.526; Bahn YS, 2003, MOL MICROBIOL, V50, P391, DOI 10.1046/j.1365-2958.2003.03692.x; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; BLAZQUEZ MA, 1993, FEBS LETT, V329, P51, DOI 10.1016/0014-5793(93)80191-V; Bockmuhl DP, 2001, MOL MICROBIOL, V42, P1243, DOI 10.1046/j.1365-2958.2001.02688.x; Cao F, 2006, MOL BIOL CELL, V17, P295, DOI 10.1091/mbc.E05-06-0502; Colombo S, 1998, EMBO J, V17, P3326, DOI 10.1093/emboj/17.12.3326; Conlin LK, 2007, MOL CELL BIOL, V27, P1505, DOI 10.1128/MCB.01158-06; Eck R, 1997, MICROBIOL-UK, V143, P3747, DOI 10.1099/00221287-143-12-3747; Elliott B, 1996, GENETICS, V144, P923; Fillinger S, 2001, MICROBIOL-SGM, V147, P1851, DOI 10.1099/00221287-147-7-1851; FONZI WA, 1993, GENETICS, V134, P717; Foster AJ, 2003, EMBO J, V22, P225, DOI 10.1093/emboj/cdg018; KAMEDA Y, 1986, J ANTIBIOT, V39, P1491, DOI 10.7164/antibiotics.39.1491; Kaushik JK, 2003, J BIOL CHEM, V278, P26458, DOI 10.1074/jbc.M300815200; Kraakman L, 1999, MOL MICROBIOL, V32, P1002, DOI 10.1046/j.1365-2958.1999.01413.x; Lemaire K, 2004, MOL CELL, V16, P293, DOI 10.1016/j.molcel.2004.10.004; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maidan MM, 2005, MOL BIOL CELL, V16, P1971, DOI 10.1091/mbc.E04-09-0780; Maidan MM, 2008, INFECT IMMUN, V76, P1686, DOI 10.1128/IAI.01497-07; Ngamskulrungroj P, 2009, INFECT IMMUN, V77, P4584, DOI 10.1128/IAI.00565-09; Nicholls S, 2009, MOL MICROBIOL, V74, P844, DOI 10.1111/j.1365-2958.2009.06883.x; Nwaka S, 1998, PROG NUCLEIC ACID RE, V58, P197; Pedreno Y, 2007, MICROBIOL-SGM, V153, P1372, DOI 10.1099/mic.0.2006/003921-0; Pernambuco MB, 1996, MICROBIOL-SGM, V142, P1775, DOI 10.1099/13500872-142-7-1775; Petzold EW, 2006, INFECT IMMUN, V74, P5877, DOI 10.1128/IAI.00624-06; PIPER PW, 1988, FEMS MICROBIOL LETT, V49, P245; Puttikamonkul S, 2010, MOL MICROBIOL, V77, P891, DOI 10.1111/j.1365-2958.2010.07254.x; Reinders A, 1997, MOL MICROBIOL, V24, P687, DOI 10.1046/j.1365-2958.1997.3861749.x; Rocha CRC, 2001, MOL BIOL CELL, V12, P3631, DOI 10.1091/mbc.12.11.3631; Rolland F, 2001, FEMS YEAST RES, V1, P33, DOI 10.1111/j.1567-1364.2001.tb00011.x; Sebollela A, 2004, INT J BIOCHEM CELL B, V36, P900, DOI 10.1016/j.biocel.2003.10.006; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Shapiro RS, 2012, CURR BIOL, V22, P461, DOI 10.1016/j.cub.2012.01.062; Shapiro RS, 2009, CURR BIOL, V19, P621, DOI 10.1016/j.cub.2009.03.017; Singer MA, 1998, MOL CELL, V1, P639, DOI 10.1016/S1097-2765(00)80064-7; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tapia H, 2010, MOL BIOL CELL, V21, P63, DOI 10.1091/mbc.E09-05-0376; THEVELEIN JM, 1984, MICROBIOL REV, V48, P42, DOI 10.1128/MMBR.48.1.42-59.1984; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Van Dijck P, 2002, INFECT IMMUN, V70, P1772, DOI 10.1128/IAI.70.4.1772-1782.2002; Whiteway M, 2007, ANNU REV MICROBIOL, V61, P529, DOI 10.1146/annurev.micro.61.080706.093341; Xu WJ, 2012, CURR BIOL, V22, pR225, DOI 10.1016/j.cub.2012.02.037; Zaragoza O, 1998, J BACTERIOL, V180, P3809, DOI 10.1128/JB.180.15.3809-3815.1998; Zaragoza O, 2003, INT MICROBIOL, V6, P121, DOI 10.1007/s10123-003-0119-y; Zaragoza O, 2002, MICROBIOL-SGM, V148, P1281, DOI 10.1099/00221287-148-5-1281	50	18	19	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36873	36882		10.1074/jbc.M112.402651	http://dx.doi.org/10.1074/jbc.M112.402651			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22952228	hybrid, Green Published			2022-12-25	WOS:000310588500024
J	Wong, A; Zhang, YW; Jeschke, GR; Turk, BE; Rudnick, G				Wong, Albert; Zhang, Yuan-Wei; Jeschke, Grace R.; Turk, Benjamin E.; Rudnick, Gary			Cyclic GMP-dependent Stimulation of Serotonin Transport Does Not Involve Direct Transporter Phosphorylation by cGMP-dependent Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; SUBSTRATE; SPECIFICITY; TRAFFICKING; MODULATION; ACTIVATION	The serotonin transporter (SERT) is responsible for reuptake of serotonin (5-hydroxytryptamine) after its exocytotic release from neurons. It is the primary target for antidepressants and stimulants, including "ecstasy" (3,4-methylenedioxymethamphetamine). SERT is regulated by several processes, including a cyclic GMP signaling pathway involving nitric oxide synthase, guanylyl cyclase, and cGMP-dependent protein kinase (PKG). Here, we show that SERT was phosphorylated in a PKG I alpha-dependent manner in vitro, but that SERT was not a direct substrate of PKG. We generated an analog-sensitive gatekeeper residue mutant of PKG I alpha (M438G) that efficiently used the ATP analog N-6-benzyl-ATP. This mutant, but not the wild type (WT) kinase, used the ATP analog to phosphorylate both a model peptide substrate as well as an established protein substrate of PKG (vasodilator-stimulated phosphoprotein). PKG I alpha M438G effectively substituted for the WT kinase in stimulating SERT-mediated 5-hydroxytryptamine transport in cultured cells. Addition of either WT or mutant PKG I alpha M438G to membranes containing SERT in vitro led to radiolabel incorporation from [gamma-P-33]ATP but not from similarly labeled N-6-benzyl-ATP, indicating that SERT was phosphorylated by another kinase that could not utilize the ATP analog. These results are consistent with the proposed SERT phosphorylation site, Thr-276, being highly divergent from the consensus PKG phosphorylation site sequence, which we verified through peptide library screening. Another proposed SERT kinase, the p38 mitogen-activated protein kinase, could not substitute for PKG in this assay, and p38 inhibitors did not block PKG-dependent phosphorylation of SERT. The results suggest that PKG initiates a kinase cascade that leads to phosphorylation of SERT by an as yet unidentified protein kinase.	[Wong, Albert; Zhang, Yuan-Wei; Jeschke, Grace R.; Turk, Benjamin E.; Rudnick, Gary] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Rudnick, G (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	gary.rudnick@yale.edu		ZHANG, YUAN-WEI/0000-0002-4276-9251; Jeschke, Grace/0000-0001-6271-7750	National Institutes of Health from the USPHS [R01 DA008213, R01 GM079498]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008213] Funding Source: NIH RePORTER	National Institutes of Health from the USPHS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants R01 DA008213 (to G. R.) and R01 GM079498 (to B. E. T.) from the USPHS.	Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; Bauman AL, 2000, J NEUROSCI, V20, P7571; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Blethrow Justin, 2004, Curr Protoc Mol Biol, VChapter 18, DOI 10.1002/0471142727.mb1811s66; Boyle SN, 2007, BIOCHEMISTRY-US, V46, P11614, DOI 10.1021/bi701119s; Carlson SM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002010; Chanrion B, 2007, P NATL ACAD SCI USA, V104, P8119, DOI 10.1073/pnas.0610964104; Ciccone MA, 2008, NEUROPHARMACOLOGY, V55, P763, DOI 10.1016/j.neuropharm.2008.06.018; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Goldsmith EJ, 2007, CHEM REV, V107, P5065, DOI 10.1021/cr068221w; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Kilic F, 2003, MOL PHARMACOL, V64, P440, DOI 10.1124/mol.64.2.440; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lohmann SM, 2005, FRONT BIOSCI, V10, P1313, DOI 10.2741/1621; MILLER KJ, 1994, J BIOL CHEM, V269, P27351; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; MITCHELL RD, 1995, BIOCHEMISTRY-US, V34, P528, DOI 10.1021/bi00002a018; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Prasad HC, 2005, P NATL ACAD SCI USA, V102, P11545, DOI 10.1073/pnas.0501432102; Ramamoorthy S, 2007, J BIOL CHEM, V282, P11639, DOI 10.1074/jbc.M611353200; Samuvel DJ, 2005, J NEUROSCI, V25, P29, DOI 10.1523/JNEUROSCI.3754-04.2005; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Sheridan DL, 2008, J BIOL CHEM, V283, P19511, DOI 10.1074/jbc.M801074200; Smolenski A, 1998, J BIOL CHEM, V273, P20029, DOI 10.1074/jbc.273.32.20029; Steiner JA, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-26; TEGGE W, 1995, BIOCHEMISTRY-US, V34, P10569, DOI 10.1021/bi00033a032; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Zhang YW, 2007, J NEUROSCI, V27, P10878, DOI 10.1523/JNEUROSCI.0034-07.2007; Zhang YW, 2011, J BIOL CHEM, V286, P2461, DOI 10.1074/jbc.M110.203935; Zhu CB, 2004, MOL PHARMACOL, V65, P1462, DOI 10.1124/mol.65.6.1462; Zhu CB, 2005, J BIOL CHEM, V280, P15649, DOI 10.1074/jbc.M410858200; Zhu CB, 2011, MOL PHARMACOL, V80, P458, DOI 10.1124/mol.111.071399	33	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36051	36058		10.1074/jbc.M112.394726	http://dx.doi.org/10.1074/jbc.M112.394726			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22942288	Green Published, hybrid			2022-12-25	WOS:000310364000027
J	Wurzburg, BA; Kim, B; Tarchevskaya, SS; Eggel, A; Vogel, M; Jardetzky, TS				Wurzburg, Beth A.; Kim, Beomkyu; Tarchevskaya, Svetlana S.; Eggel, Alexander; Vogel, Monique; Jardetzky, Theodore S.			An Engineered Disulfide Bond Reversibly Traps the IgE-Fc(3-4) in a Closed, Nonreceptor Binding Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; CRYSTAL-STRUCTURE; IMMUNOGLOBULIN-E; HUMAN IGE; ANTIIMMUNOGLOBULIN-E; REVEALS; ASTHMA; FLEXIBILITY; INHIBITION	IgE antibodies interact with the high affinity IgE Fc receptor, Fc epsilon RI, and activate inflammatory pathways associated with the allergic response. The IgE-Fc region, comprising the C-terminal domains of the IgE heavy chain, binds Fc epsilon RI and can adopt different conformations ranging from a closed form incompatible with receptor binding to an open, receptor-bound state. A number of intermediate states are also observed in different IgE-Fc crystal forms. To further explore this apparent IgE-Fc conformational flexibility and to potentially trap a closed, inactive state, we generated a series of disulfide bond mutants. Here we describe the structure and biochemical properties of an IgE-Fc mutant that is trapped in the closed, non-receptor binding state via an engineered disulfide at residue 335 (Cys-335). Reduction of the disulfide at Cys-335 restores the ability of IgE-Fc to bind to its high affinity receptor, Fc epsilon RI alpha. The structure of the Cys-335 mutant shows that its conformation is within the range of previously observed, closed form IgE-Fc structures and that it retains the hydrophobic pocket found in the hinge region of the closed conformation. Locking the IgE-Fc into the closed state with the Cys-335 mutation does not affect binding of two other IgE-Fc ligands, omalizumab and DARP in E2_79, demonstrating selective blocking of the high affinity receptor binding.	[Wurzburg, Beth A.; Kim, Beomkyu; Tarchevskaya, Svetlana S.; Jardetzky, Theodore S.] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA; [Eggel, Alexander; Vogel, Monique] Univ Bern, Inst Immunol, Bern, Switzerland	Stanford University; University of Bern	Jardetzky, TS (corresponding author), Gilbert Biol Sci Bldg,371 Serra Mall,Rm 2, Stanford, CA 94305 USA.	tjardetz@stanford.edu	Kim, Beomkyu/AAM-7220-2020; Eggel, Alexander/J-8177-2019	Eggel, Alexander/0000-0001-8746-3339	National Institutes of Health [AI-18939]; American Asthma Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI018939, R01AI018939] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI-18939 (to T. S. J.). This work was also supported by an American Asthma Foundation Senior Investigator Award.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barnes PJ, 2006, PHARMACOL THERAPEUT, V109, P238, DOI 10.1016/j.pharmthera.2005.08.001; Baumann MJ, 2010, IMMUNOL LETT, V133, P78, DOI 10.1016/j.imlet.2010.07.005; Berger WE, 2006, ALLERGY ASTHMA PROC, V27, pS29; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Dhaliwal B, 2012, P NATL ACAD SCI USA, V109, P12686, DOI 10.1073/pnas.1207278109; Eggel A, 2011, ALLERGY, V66, P961, DOI 10.1111/j.1398-9995.2011.02546.x; Eggel A, 2009, J MOL BIOL, V393, P598, DOI 10.1016/j.jmb.2009.08.014; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garman SC, 2000, NATURE, V406, P259, DOI 10.1038/35018500; Garman SC, 2001, J MOL BIOL, V311, P1049, DOI 10.1006/jmbi.2001.4929; Garman SC, 1998, CELL, V95, P951, DOI 10.1016/S0092-8674(00)81719-5; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; GUDDAT LW, 1993, P NATL ACAD SCI USA, V90, P4271, DOI 10.1073/pnas.90.9.4271; Holdom MD, 2011, NAT STRUCT MOL BIOL, V18, P571, DOI 10.1038/nsmb.2044; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W., 2001, INT TABLES CRYSTALLO, VF; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kraft S, 2004, INT ARCH ALLERGY IMM, V135, P62, DOI 10.1159/000080231; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lutteke T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-69; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nowak D, 2006, RESP MED, V100, P1907, DOI 10.1016/j.rmed.2005.10.004; Owen CE, 2007, PHARMACOL THERAPEUT, V113, P121, DOI 10.1016/j.pharmthera.2006.07.003; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Vogel M, 2007, ANN NY ACAD SCI, V1109, P9, DOI 10.1196/annals.1398.002; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wan T, 2002, NAT IMMUNOL, V3, P681, DOI 10.1038/ni811; Wurzburg BA, 2000, IMMUNITY, V13, P375, DOI 10.1016/S1074-7613(00)00037-6; Wurzburg BA, 2002, MOL IMMUNOL, V38, P1063, DOI 10.1016/S0161-5890(02)00035-4; Wurzburg BA, 2009, J MOL BIOL, V393, P176, DOI 10.1016/j.jmb.2009.08.012; Zheng L, 2008, BIOCHEM BIOPH RES CO, V375, P619, DOI 10.1016/j.bbrc.2008.08.055	32	9	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36251	36257		10.1074/jbc.M112.407502	http://dx.doi.org/10.1074/jbc.M112.407502			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948141	Green Published, hybrid			2022-12-25	WOS:000310364000046
J	Liu, MC; Liu, XQ; Wang, W; Shen, XF; Che, HL; Guo, YY; Zhao, MG; Chen, JY; Luo, WJ				Liu, Ming-Chao; Liu, Xin-Qin; Wang, Wen; Shen, Xue-Feng; Che, Hong-Lei; Guo, Yan-Yan; Zhao, Ming-Gao; Chen, Jing-Yuan; Luo, Wen-Jing			Involvement of Microglia Activation in the Lead Induced Long-Term Potentiation Impairment	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RAT DENTATE GYRUS; IN-VIVO; EXPOSURE; MEMORY; BRAIN; MINOCYCLINE; MODEL; HIPPOCAMPUS; MANGANESE	Exposure of Lead (Pb), a known neurotoxicant, can impair spatial learning and memory probably via impairing the hippocampal long-term potentiation (LTP) as well as hippocampal neuronal injury. Activation of hippocampal microglia also impairs spatial learning and memory. Thus, we raised the hypothesis that activation of microglia is involved in the Pb exposure induced hippocampal LTP impairment and neuronal injury. To test this hypothesis and clarify its underlying mechanisms, we investigated the Pb-exposure on the microglia activation, cytokine release, hippocampal LTP level as well as neuronal injury in in vivo or in vitro model. The changes of these parameters were also observed after pretreatment with minocycline, a microglia activation inhibitor. Long-term low dose Pb exposure (100 ppm for 8 weeks) caused significant reduction of LTP in acute slice preparations, meanwhile, such treatment also significantly increased hippocampal microglia activation as well as neuronal injury. In vitro Pb-exposure also induced significantly increase of microglia activation, up-regulate the release of cytokines including tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta) and inducible nitric oxide synthase (iNOS) in microglia culture alone as well as neuronal injury in the co-culture with hippocampal neurons. Inhibiting the microglia activation with minocycline significantly reversed the above-mentioned Pb-exposure induced changes. Our results showed that Pb can cause microglia activation, which can up-regulate the level of IL-1 beta, TNF-alpha and iNOS, these proinflammatory factors may cause hippocampal neuronal injury as well as LTP deficits.	[Liu, Ming-Chao; Liu, Xin-Qin; Shen, Xue-Feng; Che, Hong-Lei; Chen, Jing-Yuan; Luo, Wen-Jing] Fourth Mil Med Univ, Dept Occupat & Environm Hlth, Xian 710032, Peoples R China; [Liu, Ming-Chao; Liu, Xin-Qin; Shen, Xue-Feng; Che, Hong-Lei; Chen, Jing-Yuan; Luo, Wen-Jing] Fourth Mil Med Univ, Minist Educ, Key Lab Hazard Assessment & Control Special Opera, Sch Publ Hlth, Xian 710032, Peoples R China; [Wang, Wen] Fourth Mil Med Univ, Dept Anat Histol & Embryol, KK Leung Brain Res Ctr, Xian 710032, Peoples R China; [Guo, Yan-Yan; Zhao, Ming-Gao] Fourth Mil Med Univ, Dept Pharmacol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Liu, MC (corresponding author), Fourth Mil Med Univ, Dept Occupat & Environm Hlth, Xian 710032, Peoples R China.	jy_chen@fmmu.edu.cn; luowenj@fmmu.edu.cn		Zhao, Ming-gao/0000-0002-7539-3887	National Basic Research Program of China (973 Program) [2012CB525002]; National Natural Science Foundation of China [30830087, 81001233, 30901176]; Program for New Century Excellent Talents in University; Science and Technology Innovation Projects of Shaanxi Province [2011KTCL03-19]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Science and Technology Innovation Projects of Shaanxi Province; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by: National Basic Research Program of China (973 Program, #2012CB525002); Grants from National Natural Science Foundation of China: #30830087, URL: http://159.226.244.22/portal/Proj_List. asp; #81001233, URL: http://159.226.244.22/portal/Proj_List.asp; #30901176, URL: http://159.226.244.22/portal/Proj_List.asp; Program for New Century Excellent Talents in University, URL: http://news.fmmu.edu.cn/nr.jsp?urltype = news. NewsContentUrl&wbnewsid = 77637&wbtreeid = 1004; Science and Technology Innovation Projects of Shaanxi Province (#2011KTCL03-19); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saleh I, 2009, J ENVIRON PATHOL TOX, V28, P283, DOI 10.1615/JEnvironPatholToxicolOncol.v28.i4.40; Arvin KL, 2002, ANN NEUROL, V52, P54, DOI 10.1002/ana.10242; Bellinger DC, 2004, PEDIATRICS, V113, P1016; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brewer GJ, 1997, J NEUROSCI METH, V71, P143, DOI 10.1016/S0165-0270(96)00136-7; BROWN S, 1971, ARCH ENVIRON HEALTH, V22, P370, DOI 10.1080/00039896.1971.10665857; Cao Xiu-Jing, 2010, Shengli Xuebao, V62, P225; Cao XJ, 2009, BIOMED ENVIRON SCI, V22, P70, DOI 10.1016/S0895-3988(09)60025-8; Chu YX, 2010, BRAIN BEHAV IMMUN, V24, P1176, DOI 10.1016/j.bbi.2010.06.001; Espinosa-Oliva AM, 2011, NEUROBIOL AGING, V32, P85, DOI 10.1016/j.neurobiolaging.2009.01.012; Finkelstein Y, 1998, BRAIN RES REV, V27, P168, DOI 10.1016/S0165-0173(98)00011-3; Frigo DE, 2005, TOXICOL LETT, V155, P227, DOI 10.1016/j.toxlet.2004.09.008; Gilbert ME, 2007, NEUROTOXICOL TERATOL, V29, P385, DOI 10.1016/j.ntt.2007.01.006; Keblesh JP, 2009, J NEUROIMMUNE PHARM, V4, P317, DOI 10.1007/s11481-009-9161-7; Koller K, 2004, ENVIRON HEALTH PERSP, V112, P987, DOI 10.1289/ehp.6941; Liu MC, 2009, NEUROTOX RES, V16, P42, DOI 10.1007/s12640-009-9045-x; Morris RGM, 1997, PHILOS T ROY SOC B, V352, P1489, DOI 10.1098/rstb.1997.0136; Nakajima K, 2001, J BIOCHEM-TOKYO, V130, P169, DOI 10.1093/oxfordjournals.jbchem.a002969; Needleman HL, 2002, NEUROTOXICOL TERATOL, V24, P711, DOI 10.1016/S0892-0362(02)00269-6; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Potter SM, 2001, J NEUROSCI METH, V110, P17, DOI 10.1016/S0165-0270(01)00412-5; Reza B, 2008, INDIAN J PHARMACOL, V40, P69, DOI 10.4103/0253-7613.41041; ROSEN JF, 1995, TOXICOLOGY, V97, P11, DOI 10.1016/0300-483X(94)02963-U; Schlegelmilch T, 2011, CURR OPIN NEUROBIOL, V21, P5, DOI 10.1016/j.conb.2010.08.004; She JQ, 2008, N-S ARCH PHARMACOL, V379, P517; Song Bo, 2006, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V24, P399; Tanaka S, 2006, J NEUROSCI RES, V83, P557, DOI 10.1002/jnr.20752; Tanaka S, 2011, J NEUROSCI RES, V89, P506, DOI 10.1002/jnr.22582; Tomas-Camardiel M, 2004, NEUROBIOL DIS, V16, P190, DOI 10.1016/j.nbd.2004.01.010; van Rossum D, 2004, METAB BRAIN DIS, V19, P393, DOI 10.1023/B:MEBR.0000043984.73063.d8; Wei F, 2001, NAT NEUROSCI, V4, P164, DOI 10.1038/83993; Xiong HG, 2003, J NEUROSCI RES, V71, P600, DOI 10.1002/jnr.10503; Yang YX, 2003, EXP NEUROL, V184, P489, DOI 10.1016/S0014-4886(03)00272-3; Yin ST, 2008, TOXICOLOGY, V249, P45, DOI 10.1016/j.tox.2008.04.006; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Yu ACH, 2005, NEUROCHEM RES, V30, P1289, DOI 10.1007/s11064-005-8800-5; Zhao F, 2009, TOXICOL SCI, V107, P156, DOI 10.1093/toxsci/kfn213; Zhao MG, 2005, NEURON, V47, P859, DOI 10.1016/j.neuron.2005.08.014; Zhou LJ, 2011, BRAIN BEHAV IMMUN, V25, P322, DOI 10.1016/j.bbi.2010.09.025	40	65	72	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43924	10.1371/journal.pone.0043924	http://dx.doi.org/10.1371/journal.pone.0043924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952811	Green Published, Green Submitted, gold			2022-12-25	WOS:000308221300034
J	Ali, N; Flutter, B; Rodriguez, RS; Sharif-Paghaleh, E; Barber, LD; Lombardi, G; Nestle, FO				Ali, Niwa; Flutter, Barry; Rodriguez, Robert Sanchez; Sharif-Paghaleh, Ehsan; Barber, Linda D.; Lombardi, Giovanna; Nestle, Frank O.			Xenogeneic Graft-versus-Host-Disease in NOD-scid IL-2R gamma(null) Mice Display a T-Effector Memory Phenotype	PLOS ONE			English	Article							CUTANEOUS LYMPHOCYTE ANTIGEN; HUMAN ISLET ALLOREACTIVITY; SELECTIVE HOMING RECEPTOR; GAMMA-CHAIN GENE; BIOMEDICAL-RESEARCH; CELL EXPRESSION; HUMANIZED MICE; MOUSE MODEL; SKIN; GVHD	The occurrence of Graft-versus-Host Disease (GvHD) is a prevalent and potentially lethal complication that develops following hematopoietic stem cell transplantation. Humanized mouse models of xenogeneic-GvHD based upon immunodeficient strains injected with human peripheral blood mononuclear cells (PBMC; "Hu-PBMC mice") are important tools to study human immune function in vivo. The recent introduction of targeted deletions at the interleukin-2 common gamma chain (IL-2R gamma(null)), notably the NOD-scid IL-2R gamma(null) (NSG) and BALB/c-Rag2(null) IL-2R gamma(null) (BRG) mice, has led to improved human cell engraftment. Despite their widespread use, a comprehensive characterisation of engraftment and GvHD development in the Hu-PBMC NSG and BRG models has never been performed in parallel. We compared engrafted human lymphocyte populations in the peripheral blood, spleens, lymph nodes and bone marrow of these mice. Kinetics of engraftment differed between the two strains, in particular a significantly faster expansion of the human CD45(+) compartment and higher engraftment levels of CD3(+) T-cells were observed in NSG mice, which may explain the faster rate of GvHD development in this model. The pathogenesis of human GvHD involves anti-host effector cell reactivity and cutaneous tissue infiltration. Despite this, the presence of T-cell subsets and tissue homing markers has only recently been characterised in the peripheral blood of patients and has never been properly defined in Hu-PBMC models of GvHD. Engrafted human cells in NSG mice shows a prevalence of tissue homing cells with a T-effector memory (T-EM) phenotype and high levels of cutaneous lymphocyte antigen (CLA) expression. Characterization of Hu-PBMC mice provides a strong preclinical platform for the application of novel immunotherapies targeting T-EM-cell driven GvHD.	[Ali, Niwa; Flutter, Barry; Rodriguez, Robert Sanchez; Nestle, Frank O.] Kings Coll London, St Johns Inst Dermatol, London WC2R 2LS, England; [Ali, Niwa; Flutter, Barry; Rodriguez, Robert Sanchez; Sharif-Paghaleh, Ehsan; Lombardi, Giovanna; Nestle, Frank O.] NIHR Biomed Res Ctr, London, England; [Ali, Niwa; Sharif-Paghaleh, Ehsan; Lombardi, Giovanna] Kings Coll London, MRC Ctr Transplantat, London WC2R 2LS, England; [Barber, Linda D.] Kings Coll London, Dept Haematol Med, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London; University of London; King's College London	Ali, N (corresponding author), Kings Coll London, St Johns Inst Dermatol, London WC2R 2LS, England.	frank.nestle@kcl.ac.uk		Flutter, Barry/0000-0002-8084-6369; Sanchez Rodriguez, Robert/0000-0002-0789-1737; Ali, Niwa/0000-0003-4473-8747	Wellcome Trust [GR078173MA]; Medical Research Council UK [G0601387]; National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London; Medical Research Council (MRC) Centre for Transplantation; British Heart Foundation [RG/08/005/25303] Funding Source: researchfish; Medical Research Council [G0601387, G0600698B, MR/J006742/1] Funding Source: researchfish; MRC [G0601387] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London; Medical Research Council (MRC) Centre for Transplantation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work would not have been possible without the generous help of healthy volunteers from Guy's and St. Thomas' Hospital, London. The authors acknowledge support from the Wellcome Trust Programme GR078173MA, Medical Research Council UK Programme G0601387. The research was funded/supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. N.A and E. S. P are supported by PhD studentships from the Medical Research Council (MRC) Centre for Transplantation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERG EL, 1991, J EXP MED, V174, P1461, DOI 10.1084/jem.174.6.1461; Carroll RG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003289; CHAMPLIN R, 1990, BLOOD, V76, P418; Chen BJ, 2007, BLOOD, V109, P3115, DOI 10.1182/blood-2006-04-016410; Chu CC, 2012, J EXPT MED; Engelhardt BG, 2011, BONE MARROW TRANSPL, V46, P436, DOI 10.1038/bmt.2010.127; FERRARA JLM, 1991, NEW ENGL J MED, V324, P667; Fuhlbrigge RC, 1997, NATURE, V389, P978, DOI 10.1038/40166; Gallardo D, 1997, BONE MARROW TRANSPL, V20, P945, DOI 10.1038/sj.bmt.1701008; Gregoire-Gauthier J, 2012, BONE MARROW TRANSPL, V47, P439, DOI 10.1038/bmt.2011.93; GREINER DL, 1995, AM J PATHOL, V146, P888; HOFFMANNFEZER G, 1993, BLOOD, V81, P3440; Ito R, 2009, TRANSPLANTATION, V87, P1654, DOI 10.1097/TP.0b013e3181a5cb07; King MA, 2009, CLIN EXP IMMUNOL, V157, P104, DOI 10.1111/j.1365-2249.2009.03933.x; King M, 2008, CLIN IMMUNOL, V126, P303, DOI 10.1016/j.clim.2007.11.001; King M, 2007, ANN NY ACAD SCI, V1103, P90, DOI 10.1196/annals.1394.011; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Lee SJ, 2005, BLOOD, V105, P4200, DOI 10.1182/blood-2004-10-4023; LEUNG DYM, 1995, J EXP MED, V181, P747, DOI 10.1084/jem.181.2.747; Matthews K, 2009, HAEMATOL-HEMATOL J, V94, P956, DOI 10.3324/haematol.2008.003103; Mutis T, 2006, CLIN CANCER RES, V12, P5520, DOI 10.1158/1078-0432.CCR-06-0035; Nervi B, 2007, EXP HEMATOL, V35, P1823, DOI 10.1016/j.exphem.2007.06.007; PICKER LJ, 1993, J IMMUNOL, V150, P1122; Reddy P, 2003, BLOOD REV, V17, P187, DOI 10.1016/S0268-960X(03)00009-2; Sagoo P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002076; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Shultz LD, 2011, ANN NY ACAD SCI, V1245, P50, DOI 10.1111/j.1749-6632.2011.06310.x; Tsuchiyama J, 2009, BONE MARROW TRANSPL, V43, P863, DOI 10.1038/bmt.2008.392; van Rijn RS, 2007, EXP HEMATOL, V35, P117, DOI 10.1016/j.exphem.2006.09.018; van Rijn RS, 2003, BLOOD, V102, P2522, DOI 10.1182/blood-2002-10-3241; Vlad G, 2009, HUM IMMUNOL, V70, P663, DOI 10.1016/j.humimm.2009.06.001; Wager EJ, 2000, J IMMUNOL, V165, P518, DOI 10.4049/jimmunol.165.1.518; Zheng H, 2009, J IMMUNOL, V182, P5938, DOI 10.4049/jimmunol.0802212	36	117	124	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44219	10.1371/journal.pone.0044219	http://dx.doi.org/10.1371/journal.pone.0044219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937164	Green Published, Green Submitted, gold			2022-12-25	WOS:000308213600093
J	Chen, H; Hiler, KA; Tolley, EA; Matta, SG; Sharp, BM				Chen, Hao; Hiler, Katie A.; Tolley, Elizabeth A.; Matta, Shannon G.; Sharp, Burt M.			Genetic Factors Control Nicotine Self-Administration in Isogenic Adolescent Rat Strains	PLOS ONE			English	Article							LOCOMOTOR-ACTIVITY; SMOKING-CESSATION; CYP2A6 GENOTYPE; GENOME SEQUENCE; INBRED RATS; TOBACCO USE; DEPENDENCE; LEWIS; FISCHER-344; MORPHINE	Adult cigarette smokers usually become dependent on cigarettes during adolescence. Despite recent advances in addiction genetics, little data delineates the genetic factors that account for the vulnerability of humans to smoke tobacco. We studied the operant nicotine self-administration (SA) behavior of six inbred strains of adolescent male rats (Fisher 344, Brown Norway, Dark Agouti, Spontaneous Hypertensive Rat, Wistar Kyoto and Lewis) and six selected F1 hybrids. All rats were trained to press a lever to obtain food starting on postnatal day (PN) 32, and then nicotine (0.03 mg/kg/infusion, i.v.) reinforcement was made available on PN41-42 (10 consecutive daily 2 h sessions). Of the 12 isogenic strains, Fisher rats self-administered the fewest nicotine infusions (1.45+/-0.36/d) during the last 3 d, while Lewis rats took the most nicotine (13.0+/-1.4/d). These strains sorted into high, intermediate and low self-administration groups in 2, 2, and 8 strains, respectively. The influence of heredity on nicotine SA (0.64) is similar to that reported for humans. Therefore, this panel of isogenic rat strains effectively models the overall impact of genetics on the vulnerability to acquire nicotine-reinforced behavior during adolescence. Separate groups of rats responded for food starting on PN41. The correlation between nicotine and food reward was not significant. Hence, the genetic control of the motivation to obtain nicotine is distinctly different from food reward, indicating the specificity of the underlying genetic mechanisms. Lastly, the behavior of F1 hybrids was not predicted from the additive behavior of the parental strains, indicating the impact of significant gene-gene interactions on the susceptibility to nicotine reward. Taken together, the behavioral characteristics of this model indicate its strong potential to identify specific genes mediating the human vulnerability to smoke cigarettes.	[Chen, Hao; Hiler, Katie A.; Matta, Shannon G.; Sharp, Burt M.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; [Tolley, Elizabeth A.] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Chen, H (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA.	hchen@uthsc.edu; bsharp@uthsc.edu	Sharp, Burt/X-6200-2019; Chen, Hao/AAX-5849-2020	Sharp, Burt/0000-0002-3765-8848; Chen, Hao/0000-0002-2680-6921	National Institutes of Health [RC2 DA 028962]; NATIONAL INSTITUTE ON DRUG ABUSE [RC2DA028962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health RC2 DA 028962. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; AMBROSIO E, 1995, BEHAV PHARMACOL, V6, P229; Atanur SS, 2010, GENOME RES, V20, P791, DOI 10.1101/gr.103499.109; Bergen AW, 2009, NEUROPSYCHOPHARMACOL, V34, P2252, DOI 10.1038/npp.2009.52; Chaudhri N, 2005, PSYCHOPHARMACOLOGY, V180, P258, DOI 10.1007/s00213-005-2152-3; Chen H, 2008, NEUROPSYCHOPHARMACOL, V33, P721, DOI 10.1038/sj.npp.1301466; Chen H, 2007, NEUROPSYCHOPHARMACOL, V32, P700, DOI 10.1038/sj.npp.1301135; Chen H, 2011, NEUROPSYCHOPHARMACOL, V36, P2629, DOI 10.1038/npp.2011.149; Contet C, 2010, PSYCHOPHARMACOLOGY, V212, P283, DOI 10.1007/s00213-010-1950-4; Corrigall WA, 2000, PSYCHOPHARMACOLOGY, V149, P107, DOI 10.1007/s002139900355; CORRIGALL WA, 1989, PSYCHOPHARMACOLOGY, V99, P473, DOI 10.1007/BF00589894; Corrigall WA, 2001, PSYCHOPHARMACOLOGY, V158, P190, DOI 10.1007/s002130100869; De Ruyck K, 2010, PHARMACOGENOMICS, V11, P1053, DOI 10.2217/pgs.10.75; Ducci F, 2011, BIOL PSYCHIAT, V69, P650, DOI 10.1016/j.biopsych.2010.09.055; Eissenberg T, 2000, DRUG ALCOHOL DEPEN, V59, pS41; Falconer D. S, 1996, INTRO QUANTITATIVE G; Feltenstein MW, 2012, DRUG ALCOHOL DEPEN, V121, P240, DOI 10.1016/j.drugalcdep.2011.09.001; Fowler CD, 2011, NEUROPHARMACOLOGY, V61, P687, DOI 10.1016/j.neuropharm.2011.05.012; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GLYNN TJ, 1993, PREV MED, V22, P568, DOI 10.1006/pmed.1993.1049; Haile CN, 2005, BRAIN RES, V1055, P186, DOI 10.1016/j.brainres.2005.07.012; Haile CN, 2001, J PHARMACOL EXP THER, V299, P509; Ho MK, 2009, CLIN PHARMACOL THER, V85, P635, DOI 10.1038/clpt.2009.19; Kendler KS, 2012, NAT NEUROSCI, V15, P181, DOI 10.1038/nn.3018; Kosten TA, 2007, BEHAV NEUROSCI, V121, P380, DOI 10.1037/0735-7044.121.2.380; Lea Rod, 2005, N Z Med J, V118, pU1773; Li MD, 2003, AM J MED SCI, V326, P168, DOI 10.1097/00000441-200310000-00003; Liu T, 2011, ADDICTION, V106, P985, DOI 10.1111/j.1360-0443.2010.03353.x; Martin S, 1999, BRAIN RES, V821, P350, DOI 10.1016/S0006-8993(99)01122-1; Martin S, 2003, BRAIN RES, V973, P205, DOI 10.1016/S0006-8993(03)02482-X; Meyer AC, 2010, GENES BRAIN BEHAV, V9, P790, DOI 10.1111/j.1601-183X.2010.00616.x; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Saar K, 2008, NAT GENET, V40, P560, DOI 10.1038/ng.124; Saccone NL, 2009, CANCER RES, V69, P6848, DOI 10.1158/0008-5472.CAN-09-0786; Sanchez-Cardoso P, 2007, NEUROPHARMACOLOGY, V52, P931, DOI 10.1016/j.neuropharm.2006.10.011; Sharp BM, 2011, GENES BRAIN BEHAV, V10, P778, DOI 10.1111/j.1601-183X.2011.00716.x; Suriyaprom K, 2012, J MOL NEUROSCI; Tang X, 2009, PHARMACOGENET GENOM, V19, P345, DOI 10.1097/FPC.0b013e328329893c; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Valentine JD, 1997, PSYCHOPHARMACOLOGY, V133, P300, DOI 10.1007/s002130050405; Verde Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026668; Xian H, 2008, ADDICTION, V103, P1391, DOI 10.1111/j.1360-0443.2008.02243.x	45	27	27	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44234	10.1371/journal.pone.0044234	http://dx.doi.org/10.1371/journal.pone.0044234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937166	gold, Green Published, Green Submitted			2022-12-25	WOS:000308213600096
J	Singh, SK; Veo, BL; Kagalwala, MN; Shi, WW; Liang, SD; Majumder, S				Singh, Sanjay K.; Veo, Bethany L.; Kagalwala, Mohamedi N.; Shi, Weiwei; Liang, Shoudan; Majumder, Sadhan			Dynamic Status of REST in the Mouse ESC Pluripotency Network	PLOS ONE			English	Article							STEM-CELLS; TRANSCRIPTIONAL NETWORK; DIFFERENTIATION; CHROMATIN; REGULATORS; CIRCUITRY; PROTEIN; FATE	Background: REST is abundantly expressed in mouse embryonic stem cells (ESCs). Many genome-wide analyses have found REST to be an integral part of the ESC pluripotency network. However, experimental systems have produced contradictory findings: (1) REST is required for the maintenance of ESC pluripotency and loss of REST causes increased expression of differentiation markers, (2) REST is not required for the maintenance of ESC pluripotency and loss of REST does not change expression of differentiation markers, and (3) REST is not required for the maintenance of ESC pluripotency but loss of REST causes decreased expression of differentiation markers. These reports highlight gaps in our knowledge of the ESC network. Methods: Employing biochemical and genome-wide analyses of various culture conditions and ESC lines, we have attempted to resolve some of the discrepancies in the literature. Results: We show that Rest+/2 and Rest-/- AB-1 mutant ESCs, which did not exhibit a role of REST in ESC pluripotency when cultured in the presence of feeder cells, did show impaired self-renewal when compared with the parental cells under feeder-free culture conditions, but only in early passage cells. In late passage cells, both Rest+/2 and Rest-/- AB-1 ESCs restored pluripotency, suggesting a passage and culture condition-dependent response. Genome-wide analysis followed by biochemical validation supported this response and further indicated that the restoration of pluripotency was associated by increased expression of the ESC pluripotency factors. E14Tg2a. 4 ESCs with REST-knockdown, which earlier showed a REST-dependent pluripotency when cultured under feeder-free conditions, as well as Rest-/- AB-1 ESCs, showed no REST-dependent pluripotency when cultured in the presence of either feeder cells or laminin, indicating that extracellular matrix components can rescue REST's role in ESC pluripotency. Conclusions: REST regulates ESC pluripotency in culture condition-and ESC line-dependent fashion and ESC pluripotency needs to be evaluated in a context dependent manner.	[Singh, Sanjay K.; Veo, Bethany L.; Kagalwala, Mohamedi N.; Majumder, Sadhan] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Shi, Weiwei; Liang, Shoudan] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat, Houston, TX 77030 USA; [Majumder, Sadhan] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Majumder, Sadhan] Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA; [Majumder, Sadhan] Univ Texas Grad Sch Biomed Sci Houston, Program Genes & Dev, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Singh, SK (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	ssinghk@gmail.com; smajumder@mdanderson.org			NCI [CA97124, CA81255]; NATIONAL CANCER INSTITUTE [R01CA097124, R01CA081255] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partly supported by grants from the NCI (CA97124 and CA81255). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Buckley NJ, 2009, NATURE, V457, pE5, DOI 10.1038/nature07784; Chen LY, 2008, HUM MOL GENET, V17, pR23, DOI 10.1093/hmg/ddn050; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; Choder M, 2004, TRENDS BIOCHEM SCI, V29, P674, DOI 10.1016/j.tibs.2004.10.007; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Daley GQ, 2010, J CLIN INVEST, V120, P8, DOI 10.1172/JCI41801; Gekas C, 2010, J EXP MED, V207, P2781, DOI 10.1084/jem.20102428; Gopalakrishnan V, 2009, FUTUR NEUROL, V4, P317, DOI 10.2217/FNL.09.1; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Inoue H, 2011, CLIN PHARMACOL THER, V89, P655, DOI 10.1038/clpt.2011.38; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Jorgensen HF, 2010, NATURE, V467, pE3, DOI 10.1038/nature09305; Jorgensen HF, 2009, NATURE, V457, pE4, DOI 10.1038/nature07783; Kagalwala MN, 2008, COLD SH Q B, V73, P227, DOI 10.1101/sqb.2008.73.042; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Loh YH, 2011, ANNU REV GENOM HUM G, V12, P165, DOI 10.1146/annurev-genom-082410-101506; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Orkin SH, 2008, COLD SH Q B, V73, P195, DOI 10.1101/sqb.2008.72.001; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Qureshi IA, 2010, CELL CYCLE, V9, P4477, DOI 10.4161/cc.9.22.13973; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schulz H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006804; Shiraki N, 2009, BIOCHEM BIOPH RES CO, V381, P694, DOI 10.1016/j.bbrc.2009.02.120; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yamada Y, 2010, CELL STEM CELL, V6, P10, DOI 10.1016/j.stem.2009.12.003; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhu H, 2011, NAT REV GENET, V12, P266, DOI 10.1038/nrg2951	39	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43659	10.1371/journal.pone.0043659	http://dx.doi.org/10.1371/journal.pone.0043659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952733	Green Submitted, Green Published, gold			2022-12-25	WOS:000308213600035
J	Adrianto, I; Lin, CP; Hale, JJ; Levin, AM; Datta, I; Parker, R; Adler, A; Kelly, JA; Kaufman, KM; Lessard, CJ; Moser, KL; Kimberly, RP; Harley, JB; Iannuzzi, MC; Rybicki, BA; Montgomery, CG				Adrianto, Indra; Lin, Chee Paul; Hale, Jessica J.; Levin, Albert M.; Datta, Indrani; Parker, Ryan; Adler, Adam; Kelly, Jennifer A.; Kaufman, Kenneth M.; Lessard, Christopher J.; Moser, Kathy L.; Kimberly, Robert P.; Harley, John B.; Iannuzzi, Michael C.; Rybicki, Benjamin A.; Montgomery, Courtney G.			Genome-Wide Association Study of African and European Americans Implicates Multiple Shared and Ethnic Specific Loci in Sarcoidosis Susceptibility	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; MAJOR HISTOCOMPATIBILITY COMPLEX; OCCUPATIONAL RISK-FACTORS; MHC CLASS-II; ENDOTHELIAL-CELLS; CROHNS-DISEASE; LUNG-CANCER; ULCERATIVE-COLITIS; FUNCTIONAL VARIANT; GENE-EXPRESSION	Sarcoidosis is a systemic inflammatory disease characterized by the formation of granulomas in affected organs. Genome-wide association studies (GWASs) of this disease have been conducted only in European population. We present the first sarcoidosis GWAS in African Americans (AAs, 818 cases and 1,088 related controls) followed by replication in independent sets of AAs (455 cases and 557 controls) and European Americans (EAs, 442 cases and 2,284 controls). We evaluated >6 million SNPs either genotyped using the Illumina Omni1-Quad array or imputed from the 1000 Genomes Project data. We identified a novel sarcoidosis-associated locus, NOTCH4, that reached genome-wide significance in the combined AA samples (rs715299, PAA-meta = 6.51 x 10(-10)) and demonstrated the independence of this locus from others in the MHC region in the same sample. We replicated previous European GWAS associations within HLA-DRA, HLA-DRB5, HLA-DRB1, BTNL2, and ANXA11 in both our AA and EA datasets. We also confirmed significant associations to the previously reported HLA-C and HLA-B regions in the EA but not AA samples. We further identified suggestive associations with several other genes previously reported in lung or inflammatory diseases.	[Adrianto, Indra; Lin, Chee Paul; Hale, Jessica J.; Parker, Ryan; Adler, Adam; Kelly, Jennifer A.; Lessard, Christopher J.; Moser, Kathy L.; Montgomery, Courtney G.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, Oklahoma City, OK 73104 USA; [Levin, Albert M.; Datta, Indrani; Rybicki, Benjamin A.] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA; [Kaufman, Kenneth M.; Harley, John B.] Cincinnati Childrens Hosp Med Ctr, Div Rheumatol, Cincinnati, OH USA; [Kaufman, Kenneth M.; Harley, John B.] United States Dept Vet Affairs Med Ctr, Cincinnati, OH USA; [Lessard, Christopher J.; Moser, Kathy L.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Kimberly, Robert P.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Iannuzzi, Michael C.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY USA	Oklahoma Medical Research Foundation; Henry Ford Health System; Henry Ford Hospital; Cincinnati Children's Hospital Medical Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Alabama System; University of Alabama Birmingham; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Adrianto, I (corresponding author), Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Courtney-Montgomery@omrf.org	Adrianto, Indra/D-4214-2013; Rybicki, Benjamin/L-4614-2019	Adrianto, Indra/0000-0002-9973-3057; Rybicki, Benjamin/0000-0003-3190-3467; Kelly, Jennifer/0000-0002-3203-2467; Lessard, Christopher J./0000-0003-2440-3843; Montgomery, Courtney/0000-0002-9606-3772; Kimberly, Robert/0000-0002-5330-3086	United States National Institutes of Health (NIH) [1RC2HL101499, R56-AI072727, R01-HL092576, R01-HL54306, U01-HL060263, R01-AR043274, R37-AI024717, R01-AR042460, P20-RR020143, N01-AR62277, P01-AR049084, P01-AI083194]; United States Department of Veterans Affairs; United States Department of Defense [PR094002]; NATIONAL CANCER INSTITUTE [R01CA133996, P50CA093459, P50CA097007] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020143] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101499, R01HL054306, U01HL060263, R01HL092576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI072727, R37AI024717, P01AI083194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049084, R01AR042460, R01AR043274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011740] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veterans Affairs(US Department of Veterans Affairs); United States Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the United States National Institutes of Health (NIH) grants: 1RC2HL101499 to CGM, R56-AI072727 and R01-HL092576 to BAR, R01-HL54306 and U01-HL060263 awarded to MCI, R01-AR043274 to KLM, R37-AI024717, R01-AR042460, and P20-RR020143 to JBH, N01-AR62277 to JBH and KLM, P01-AR049084 to JBH and RPK, P01-AI083194 to JBH, KMK and RPK. Other institution supports include the United States Department of Veterans Affairs to JBH and KMK and the United States Department of Defense PR094002 to JBH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Alaedini A, 2008, AUTOIMMUNITY, V41, P19, DOI 10.1080/08916930701619219; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Barcellos LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000696; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Baughman RP, 1999, J CLIN EPIDEMIOL, V52, P1173; Berlin M, 1997, AM J RESP CRIT CARE, V156, P1601, DOI 10.1164/ajrccm.156.5.9704069; BREWERTON DA, 1977, CLIN EXP IMMUNOL, V27, P227; Candi E, 2002, J INVEST DERMATOL, V119, P670, DOI 10.1046/j.1523-1747.2002.01853.x; Cecener G, 2008, TUMORI, V94, P845; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Collins BJ, 2004, SEMIN CANCER BIOL, V14, P357, DOI 10.1016/j.semcancer.2004.04.015; Cozier YC, 2011, CHEST, V139, P144, DOI 10.1378/chest.10-0413; CUMMINGS M M, 1956, Postgrad Med, V19, P437; Demopoulos K, 2002, J CELL MOL MED, V6, P215, DOI 10.1111/j.1582-4934.2002.tb00188.x; Dubaniewicz A, 2007, RESP MED, V101, P2213, DOI 10.1016/j.rmed.2007.06.004; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Duvefelt K, 2004, TISSUE ANTIGENS, V63, P13, DOI 10.1111/j.1399-0039.2004.00135.x; EDMONDSTONE WM, 1985, BRIT J DIS CHEST, V79, P27, DOI 10.1016/0007-0971(85)90004-X; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Franke A, 2008, GASTROENTEROLOGY, V135, P1207, DOI 10.1053/j.gastro.2008.07.017; Fukui H, 2011, INFLAMM BOWEL DIS, V17, P1177, DOI 10.1002/ibd.21473; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Genovese G, 2010, KIDNEY INT, V78, P698, DOI 10.1038/ki.2010.251; Gorlova O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002178; Gray-McGuire C, 2006, HUM GENET, V120, P420, DOI 10.1007/s00439-006-0201-6; Grigorian A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-27; Grunewald J, 2004, AM J RESP CRIT CARE, V169, P696, DOI 10.1164/rccm.200303-459OC; GRUSBY MJ, 1995, ANNU REV IMMUNOL, V13, P417, DOI 10.1146/annurev.iy.13.040195.002221; GUNDELFINGER B, 1961, AM REV RESPIR DIS, V84, P109; Haase D, 2007, ONCOGENE, V26, P4464, DOI 10.1038/sj.onc.1210225; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hofmann S, 2011, EUR RESP J; Hofmann S, 2008, NAT GENET, V40, P1103, DOI 10.1038/ng.198; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Iannuzzi MC, 2005, GENES IMMUN, V6, P509, DOI 10.1038/sj.gene.6364235; Iannuzzi MC, 2003, AM J RESP CRIT CARE, V167, P1225, DOI 10.1164/rccm.200209-1097OC; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; IWAI K, 1993, ACTA PATHOL JAPON, V43, P372; Jacob J, 2003, EMBO REP, V4, P761, DOI 10.1038/sj.embor.embor896; JAMES DG, 1994, SARCOIDOSIS, V11, P2; James DG, 1997, CLIN CHEST MED, V18, P663, DOI 10.1016/S0272-5231(05)70411-1; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; KELLER AD, 1991, GENE DEV, V5, P868, DOI 10.1101/gad.5.5.868; KIM IG, 1993, J BIOL CHEM, V268, P12682; Kucera GP, 2003, CHEST, V123, P1527, DOI 10.1378/chest.123.5.1527; Li XN, 2011, J ALLERGY CLIN IMMUN, V127, P1457, DOI 10.1016/j.jaci.2011.01.056; Li Y, 2006, THORAX, V61, P273, DOI 10.1136/thx.2005.056564; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Luo XG, 2004, BIOL PSYCHIAT, V55, P112, DOI 10.1016/S0006-3223(03)00588-2; Maillard I, 2003, IMMUNITY, V19, P781, DOI 10.1016/S1074-7613(03)00325-X; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mehul B, 2006, EXP DERMATOL, V15, P469, DOI 10.1111/j.1600-0625.2006.00433.x; Miniati D, 2010, AM J PHYSIOL-LUNG C, V298, pL169, DOI 10.1152/ajplung.00188.2009; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Nath SK, 2008, NAT GENET, V40, P152, DOI 10.1038/ng.71; Newman LS, 2004, AM J RESP CRIT CARE, V170, P1324, DOI 10.1164/rccm.200402-249OC; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; Noseda M, 2004, MOL CELL BIOL, V24, P8813, DOI 10.1128/MCB.24.20.8813-8822.2004; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quillard T, 2010, BIOCHEM PHARMACOL, V80, P2032, DOI 10.1016/j.bcp.2010.07.010; Rasmussen A, 2011, RHEUMATOLOGY, V50, P47, DOI 10.1093/rheumatology/keq302; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Renner M, 2007, GASTROENTEROLOGY, V133, P1499, DOI 10.1053/j.gastro.2007.08.007; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rosenstiel P, 2007, J IMMUNOL, V178, P8203, DOI 10.4049/jimmunol.178.12.8203; Rossman MD, 2003, AM J HUM GENET, V73, P720, DOI 10.1086/378097; RUBIN LA, 1994, ARTHRITIS RHEUM, V37, P1212, DOI 10.1002/art.1780370816; Rybicki BA, 2011, GENES IMMUN, V12, P67, DOI 10.1038/gene.2010.56; Rybicki BA, 2005, SARCOIDOSIS VASC DIF, V22, P115; Rybicki BA, 1997, AM J EPIDEMIOL, V145, P234, DOI 10.1093/oxfordjournals.aje.a009096; Rybicki BA, 2005, AM J HUM GENET, V77, P491, DOI 10.1086/444435; Rybicki BA, 2004, SARCOIDOSIS VASC DIF, V21, P49; Rybicki BA, 2001, AM J RESP CRIT CARE, V164, P2085, DOI 10.1164/ajrccm.164.11.2106001; SARTWELL PE, 1974, AM J EPIDEMIOL, V99, P250, DOI 10.1093/oxfordjournals.aje.a121609; Schurmann M, 2001, AM J RESP CRIT CARE, V164, P840, DOI 10.1164/ajrccm.164.5.2007056; Shin MS, 2002, BLOOD, V99, P4094, DOI 10.1182/blood.V99.11.4094; SILTZBACH LE, 1974, AM J MED, V57, P847, DOI 10.1016/0002-9343(74)90160-0; Sklar P, 2001, NAT GENET, V28, P126, DOI 10.1038/88836; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; TODD JA, 1988, SCIENCE, V240, P1003, DOI 10.1126/science.3368786; Uemura N, 2009, INT J CANCER, V124, P2106, DOI 10.1002/ijc.24194; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Xu KL, 2012, ADV EXP MED BIOL, V727, P89, DOI 10.1007/978-1-4614-0899-4_7; Xu ZL, 2011, PROSTATE, V71, P881, DOI 10.1002/pros.21304	100	84	85	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43907	10.1371/journal.pone.0043907	http://dx.doi.org/10.1371/journal.pone.0043907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952805	Green Submitted, Green Published, gold			2022-12-25	WOS:000308044800074
J	King, AM; MacRae, TH				King, Allison M.; MacRae, Thomas H.			The Small Heat Shock Protein p26 Aids Development of Encysting Artemia Embryos, Prevents Spontaneous Diapause Termination and Protects against Stress	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; MOSQUITO CULEX-PIPIENS; CHAPERONE ACTIVITY; INSECT DIAPAUSE; OVERWINTERING DIAPAUSE; ENVIRONMENTAL-STRESSES; DROSOPHILA-TRIAURARIA; MOLECULAR CHAPERONES; GENE-EXPRESSION; PUPAL DIAPAUSE	Artemia franciscana embryos enter diapause as encysted gastrulae, a physiological state of metabolic dormancy and enhanced stress resistance. The objective of this study was to use RNAi to investigate the function of p26, an abundant, diapause-specific small heat shock protein, in the development and behavior of encysted Artemia embryos (cysts). RNAi methodology was developed where injection of Artemia females with dsRNA specifically eliminated p26 from cysts. p26 mRNA and protein knock down were, respectively, confirmed by RT-PCR and immuno-probing of western blots. ArHsp21 and ArHsp22, diapause-related small heat shock proteins in Artemia cysts sharing a conserved alpha-crystallin domain with p26, were unaffected by injection of females with dsRNA for p26, demonstrating the specificity of protein knock down. Elimination of p26 delayed cyst release from females demonstrating that this molecular chaperone influences the development of diapause-destined embryos. Although development was slowed the metabolic activities of cysts either containing or lacking p26 were similar. p26 inhibited diapause termination after prolonged incubation of cysts in sea water perhaps by a direct effect on termination or indirectly because p26 is necessary for the preservation of diapause maintenance. Cyst diapause was however, terminated by desiccation and freezing, a procedure leading to high mortality within cyst populations lacking p26 and indicating the protein is required for stress tolerance. Cysts lacking p26 were also less resistant to heat shock. This is the first in vivo study to show that knock down of a small heat shock protein slows the development of diapause-destined embryos, suggesting a role for p26 in the developmental process. The same small heat shock protein prevents spontaneous termination of diapause and provides stress protection to encysted embryos.	[King, Allison M.; MacRae, Thomas H.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Dalhousie University	King, AM (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	tmacrae@dal.ca			NSERC Discovery Grant [RGPIN/7661-2011]	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was supported by an NSERC Discovery Grant, RGPIN/7661-2011, to THM (URL:http://www.nserc-crsng.gc.ca). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aruda AM, 2011, J INSECT PHYSIOL, V57, P665, DOI 10.1016/j.jinsphys.2011.03.007; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; Chen J, 2010, J MOL BIOL, V398, P122, DOI 10.1016/j.jmb.2010.02.022; Chen T, 2007, FEBS J, V274, P1093, DOI 10.1111/j.1742-4658.2007.05659.x; Clark MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029365; Clegg JS, 2007, BIOL BULL-US, V212, P74, DOI 10.2307/25066582; Clegg James S., 2002, P129; Clegg JS, 1996, PHYSIOL ZOOL, V69, P49, DOI 10.1086/physzool.69.1.30164200; CLEGG JS, 1995, EXP CELL RES, V219, P1, DOI 10.1006/excr.1995.1197; Clegg JS, 1997, J EXP BIOL, V200, P467; CLEGG JS, 1994, EXP CELL RES, V212, P77, DOI 10.1006/excr.1994.1120; Copf T, 2004, P NATL ACAD SCI USA, V101, P17711, DOI 10.1073/pnas.0407327102; Copf T, 2006, DEV BIOL, V298, P87, DOI 10.1016/j.ydbio.2006.07.024; Dai JQ, 2008, J BIOL CHEM, V283, P1705, DOI 10.1074/jbc.M707853200; Dai L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020187; Denekamp NY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-108; Goto SG, 1998, J INSECT PHYSIOL, V44, P1009, DOI 10.1016/S0022-1910(97)00143-1; Goto SG, 2004, GENE, V326, P117, DOI 10.1016/j.gene.2003.10.017; Hahn DA, 2011, ANNU REV ENTOMOL, V56, P103, DOI 10.1146/annurev-ento-112408-085436; Hand SC, 2011, J INSECT PHYSIOL, V57, P584, DOI 10.1016/j.jinsphys.2011.02.010; Hilario E, 2011, J MOL BIOL, V408, P74, DOI 10.1016/j.jmb.2011.02.004; Hu Y, 2011, CELL STRESS CHAPERON, V16, P133, DOI 10.1007/s12192-010-0225-7; Jackson SA, 1996, DEV GROWTH DIFFER, V38, P153; Jehle S, 2011, P NATL ACAD SCI USA, V108, P6409, DOI 10.1073/pnas.1014656108; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kostal V, 2011, J INSECT PHYSIOL, V57, P538, DOI 10.1016/j.jinsphys.2010.10.006; Lavens P., 1987, P27; Li AQ, 2007, J INSECT PHYSIOL, V53, P385, DOI 10.1016/j.jinsphys.2007.01.003; Liang P, 1997, J BIOL CHEM, V272, P19051, DOI 10.1074/jbc.272.30.19051; Liang P, 1997, EUR J BIOCHEM, V243, P225, DOI 10.1111/j.1432-1033.1997.0225a.x; Liang P, 1999, DEV BIOL, V207, P445, DOI 10.1006/dbio.1998.9138; Liao JH, 2009, MOL VIS, V15, P1429; Liu YL, 2009, J BIOL CHEM, V284, P16931, DOI 10.1074/jbc.M109.004051; MacRae TH, 2003, SEMIN CELL DEV BIOL, V14, P251, DOI 10.1016/j.semcdb.2003.09.019; MacRae TH, 2010, CELL MOL LIFE SCI, V67, P2405, DOI 10.1007/s00018-010-0311-0; McDonald ET, 2012, BIOCHEMISTRY-US, V51, P1257, DOI 10.1021/bi2017624; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; Pasupuleti N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.3; Qiu ZJ, 2008, FEBS J, V275, P3556, DOI 10.1111/j.1742-4658.2008.06501.x; Qiu Z, 2007, MECH DEVELOP, V124, P856, DOI 10.1016/j.mod.2007.09.001; Qu ZJ, 2008, BIOCHEM J, V411, P605, DOI 10.1042/BJ20071472; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Robbins HM, 2010, J EXP BIOL, V213, P1464, DOI 10.1242/jeb.041772; Sim C, 2008, P NATL ACAD SCI USA, V105, P6777, DOI 10.1073/pnas.0802067105; Sim C, 2011, J INSECT PHYSIOL, V57, P628, DOI 10.1016/j.jinsphys.2011.01.012; Sun Y, 2006, FEBS J, V273, P1020, DOI 10.1111/j.1742-4658.2006.05129.x; Sun Y, 2005, FEBS J, V272, P5230, DOI 10.1111/j.1742-4658.2005.04920.x; Sun Y, 2004, J BIOL CHEM, V279, P39999, DOI 10.1074/jbc.M406999200; Takeda K, 2011, J STRUCT BIOL, V174, P92, DOI 10.1016/j.jsb.2010.12.006; Treweek TM, 2010, EXP EYE RES, V91, P691, DOI 10.1016/j.exer.2010.08.015; Villenueve TS, 2006, CELL STRESS CHAPERON, V11, P71, DOI 10.1379/CSC-154R.1; Warner A.H., 1979, Methods in Enzymology, V60, P298; Wu Y, 2010, BIOCHEM CELL BIOL, V88, P937, DOI 10.1139/O10-143; Yang YS, 2003, ASSAY DRUG DEV TECHN, V1, P461, DOI 10.1089/154065803322163777; Yocum GD, 1998, INSECT BIOCHEM MOLEC, V28, P677, DOI 10.1016/S0965-1748(98)00046-0; Zhao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032129	57	44	46	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43723	10.1371/journal.pone.0043723	http://dx.doi.org/10.1371/journal.pone.0043723			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952748	gold, Green Submitted, Green Published			2022-12-25	WOS:000308044800054
J	Qu, ZL; Chung, D				Qu, Zhilin; Chung, Douglas			Mechanisms and Determinants of Ultralong Action Potential Duration and Slow Rate-Dependence in Cardiac Myocytes	PLOS ONE			English	Article							LONG-QT SYNDROME; INDUCED EARLY AFTERDEPOLARIZATIONS; TORSADE-DE-POINTES; T-WAVE ALTERNANS; TRIGGERED ACTIVITY; VENTRICULAR MYOCYTES; ELECTRICAL ALTERNANS; HEART-CELLS; ARRHYTHMIA; REPOLARIZATION	In normal cardiac myocytes, the action potential duration (APD) is several hundred milliseconds. However, experimental studies showed that under certain conditions, APD could be excessively long (or ultralong), up to several seconds. Unlike the normal APD, the ultralong APD increases sensitively with pacing cycle length even when the pacing rate is very slow, exhibiting a sensitive slow rate-dependence. In addition, these long action potentials may or may not exhibit early afterdepolarizations (EADs). Although these phenomena are well known, the underlying mechanisms and ionic determinants remain incompletely understood. In this study, computer simulations were performed with a simplified action potential model. Modifications to the L-type calcium current (I-Ca,I-L) kinetics and the activation time constant of the delayed rectifier K current were used to investigate their effects on APD. We show that: 1) the ultralong APD and its sensitive slow rate-dependence are determined by the steady-state window and pedestal I-Ca,I-L currents and the activation speed and the recovery of the delayed rectifier K current; 2) whether an ultralong action potential exhibits EADs or not depends on the kinetics of I-Ca,I-L; 3) increasing inward currents elevates the plateau voltage, which in general prolongs APD, however, this can also shorten APD when the APD is already ultralong under certain conditions; and 4) APD alternans occurs at slow pacing rates due to the sensitive slow rate-dependence and the ionic determinants are different from the ones causing APD alternans at fast heart rates.	[Qu, Zhilin; Chung, Douglas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med Cardiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Qu, ZL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med Cardiol, Los Angeles, CA 90095 USA.	zqu@mednet.ucla.edu			National Institutes of Health/National Heart, Lung, and Blood Institute NIH/NHLBI [P01 HL078931, R01 HL093205]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093205, P01HL078931] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by the National Institutes of Health/National Heart, Lung, and Blood Institute NIH/NHLBI P01 HL078931 and R01 HL093205. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alseikhan BA, 2002, P NATL ACAD SCI USA, V99, P17185, DOI 10.1073/pnas.262372999; Antoons G, 2007, J PHYSIOL-LONDON, V579, P147, DOI 10.1113/jphysiol.2006.124222; Antzelevitch C, 2001, EUR HEART J SUPPL, V3, pK2, DOI 10.1016/S1520-765X(01)90001-X; Antzelevitch C, 1999, J CARDIOVASC ELECTR, V10, P1124, DOI 10.1111/j.1540-8167.1999.tb00287.x; Chang MG, 2012, BIOPHYS J, V102, P2706, DOI 10.1016/j.bpj.2012.05.011; Choi BR, 2002, J PHYSIOL-LONDON, V543, P615, DOI 10.1113/jphysiol.2002.024570; Clancy CE, 2003, CIRCULATION, V107, P2233, DOI 10.1161/01.CIR.0000069273.51375.BD; Clancy CE, 2002, J CLIN INVEST, V110, P1251, DOI 10.1172/JCI200215928; Clancy CE, 1999, NATURE, V400, P566, DOI 10.1038/23034; DAMIANO BP, 1984, CIRCULATION, V69, P1013, DOI 10.1161/01.CIR.69.5.1013; de Lange E, 2012, BIOPHYS J, V103, P365, DOI 10.1016/j.bpj.2012.06.007; Fox JJ, 2002, AM J PHYSIOL-HEART C, V282, pH516, DOI 10.1152/ajpheart.00612.2001; Greenstein JL, 2000, CIRC RES, V87, P1026, DOI 10.1161/01.RES.87.11.1026; HIRANO Y, 1992, CIRC RES, V70, P445, DOI 10.1161/01.RES.70.3.445; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; JANUARY CT, 1988, CIRC RES, V62, P563, DOI 10.1161/01.RES.62.3.563; JANUARY CT, 1989, CIRC RES, V64, P977, DOI 10.1161/01.RES.64.5.977; Keener J., 1998, MATH PHYSL; Koller ML, 1998, AM J PHYSIOL-HEART C, V275, pH1635, DOI 10.1152/ajpheart.1998.275.5.H1635; Koval OM, 2010, P NATL ACAD SCI USA, V107, P4996, DOI 10.1073/pnas.0913760107; Lemay M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002399; Liu GX, 2012, J PHYSIOL-LONDON, V590, P1171, DOI 10.1113/jphysiol.2011.218164; LUO CH, 1991, CIRC RES, V68, P1501, DOI 10.1161/01.RES.68.6.1501; Madhvani RV, 2011, J PHYSIOL-LONDON, V589, P6081, DOI 10.1113/jphysiol.2011.219600; Mahajan A, 2008, BIOPHYS J, V94, P392, DOI 10.1529/biophysj.106.98160; Mahajan A, 2008, BIOPHYS J, V94, P411, DOI 10.1529/biophysj.106.98590; Maoz A, 2009, HEART RHYTHM, V6, P813, DOI 10.1016/j.hrthm.2009.02.043; NOBLE D, 1966, PHYSIOL REV, V46, P1; NORDIN C, 1995, AM J PHYSIOL-HEART C, V268, pH2440, DOI 10.1152/ajpheart.1995.268.6.H2440; Pastore JM, 1999, CIRCULATION, V99, P1385, DOI 10.1161/01.CIR.99.10.1385; Qu ZL, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00154; SANGUINETTI MC, 1986, J GEN PHYSIOL, V88, P369, DOI 10.1085/jgp.88.3.369; Sarkar AX, 2011, HEART RHYTHM, V8, P1749, DOI 10.1016/j.hrthm.2011.05.023; Sarkar AX, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000914; Sato D, 2009, P NATL ACAD SCI USA, V106, P2983, DOI 10.1073/pnas.0809148106; Saucerman JJ, 2004, CIRC RES, V95, P1216, DOI 10.1161/01.RES.0000150055.06226.4e; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Tran DX, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.258103; Tristani-Firouzi M, 1998, J PHYSIOL-LONDON, V510, P37, DOI 10.1111/j.1469-7793.1998.037bz.x; Viswanathan PC, 1999, CARDIOVASC RES, V42, P530, DOI 10.1016/S0008-6363(99)00035-8; Viswanathan PC, 2000, CIRCULATION, V101, P1192, DOI 10.1161/01.CIR.101.10.1192; Volders PGA, 2000, CARDIOVASC RES, V46, P376, DOI 10.1016/S0008-6363(00)00022-5; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wegener FT, 2008, EUROPACE, V10, P112, DOI 10.1093/europace/eum252; Xie YF, 2010, BIOPHYS J, V98, p531A, DOI 10.1016/j.bpj.2009.12.2880; ZENG JL, 1995, CIRC RES, V77, P140, DOI 10.1161/01.RES.77.1.140; ZENG JL, 1995, BIOPHYS J, V68, P949, DOI 10.1016/S0006-3495(95)80271-7; Zhao ZH, 2012, CARDIOVASC RES, V95, P308, DOI 10.1093/cvr/cvs183; Zhao ZZ, 2012, AM J PHYSIOL-HEART C, V302, pH1636, DOI 10.1152/ajpheart.00742.2011	49	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43587	10.1371/journal.pone.0043587	http://dx.doi.org/10.1371/journal.pone.0043587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952713	gold, Green Published, Green Submitted			2022-12-25	WOS:000308044800041
J	Brumme, CJ; Swenson, LC; Wynhoven, B; Yip, B; Skinner, S; Lima, VD; Montaner, JSG; Harrigan, PR				Brumme, Chanson J.; Swenson, Luke C.; Wynhoven, Brian; Yip, Benita; Skinner, Stuart; Lima, Viviane Dias; Montaner, Julio S. G.; Harrigan, P. Richard			Technical and Regulatory Shortcomings of the TaqMan Version 1 HIV Viral Load Assay	PLOS ONE			English	Article							ROCHE COBAS AMPLICOR; VIRUS TYPE-1 RNA; ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; PCR ASSAY; PLASMA; QUANTIFICATION; INDIVIDUALS; RECOMMENDATIONS; INTERMITTENT	Background: The lower limit of detection of the original Roche Amplicor HIV plasma viral load (pVL) assay (50 copies/mL) has defined HIV treatment success. The Amplicor assay, however, has been replaced by the Roche TaqMan assay(s). Changes to the limits of detection and calibration have not been validated for clinical utility. Sudden increases in the number of patients with detectable pVL have been reported following the introduction of the TaqMan version 1 assay. Methods: Between October 2009 and April 2010 all routine pVL samples from British Columbia, Canada, with 40250 copies/mL by TaqMan were re-tested by Amplicor (N = 1198). Subsequent short-term virological and resistance outcomes were followed in patients with unchanged therapy (N = 279; median 3.2 months follow-up). Results: TaqMan and Amplicor values correlated poorly at low pVL values. Low-level pVL by TaqMan was not associated with impending short-term virological failure; only 17% of patients with 40-250 copies/mL by TaqMan had detectable pVL by Amplicor at follow-up. During the follow-up period only 20% of patients had an increase in pVL by TaqMan (median [IQR]: 80 [36-283] copies/mL). In addition, in similar to 2.4% of samples pVL was dramatically underestimated by TaqMan due to poor binding of the proprietary TaqMan primers. Conclusions: The replacement of Amplicor with the TaqMan assay has altered the previously accepted definition of HIV treatment failure without any evidence to support the clinical relevance of the new definition. Given the systematic differences in measurement in the low pVL range the British Columbia HIV treatment guidelines now use a threshold of >250 copies/mL by TaqMan to define treatment failure.	[Brumme, Chanson J.; Swenson, Luke C.; Wynhoven, Brian; Yip, Benita; Lima, Viviane Dias; Montaner, Julio S. G.; Harrigan, P. Richard] St Pauls Hosp, BC Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Skinner, Stuart] Univ Saskatchewan, Dept Med, Saskatoon, SK S7N 0W0, Canada; [Lima, Viviane Dias; Montaner, Julio S. G.; Harrigan, P. Richard] Univ British Columbia, Div Aids, Vancouver, BC V5Z 1M9, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of Saskatchewan; University of British Columbia	Brumme, CJ (corresponding author), St Pauls Hosp, BC Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.	prharrigan@cfenet.ubc.ca	Montaner, Julio/K-7621-2012; Swenson, Luke/E-8549-2014	Swenson, Luke/0000-0001-5381-7709; Brumme, Chanson/0000-0003-2722-5288	Vanier Graduate Scholarship from the Canadian Institutes of Health Research (CIHR); CIHR Frederick Banting and Charles Best Canada Graduate Scholarship; Michael Smith Foundation for Health Research; GlaxoSmithKline/CIHR Chair in Clinical Virology	Vanier Graduate Scholarship from the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Frederick Banting and Charles Best Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); GlaxoSmithKline/CIHR Chair in Clinical Virology(GlaxoSmithKline)	Some for the Amplicor v1.5 and TaqMan v2 testing were donated by Roche Molecular Diagnostics (Laval, Quebec, Canada). Kits for the Abbott RealTime assay were donated by Abbott Molecular Canada (Toronto, Ontario, Canada). CJB is supported by a Vanier Graduate Scholarship from the Canadian Institutes of Health Research (CIHR). LCS is supported by a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship. VDL is supported through a fellowship from the Michael Smith Foundation for Health Research. PRH is supported through a GlaxoSmithKline/CIHR Chair in Clinical Virology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CS, 2001, AIDS, V15, P601, DOI 10.1097/00002030-200103300-00009; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Chui C, 2006, AIDS RES HUM RETROV, V22, P615, DOI 10.1089/aid.2006.22.615; Damond F, 2007, J CLIN MICROBIOL, V45, P3436, DOI 10.1128/JCM.00973-07; De Bel A, 2010, J CLIN MICROBIOL, V48, P1337, DOI 10.1128/JCM.01226-09; Department of agriculture forestry and fisheries, 2012, GUID US ANT AG HIV 1, P1; Do T, 2011, J CLIN VIROL, V52, pS83, DOI 10.1016/j.jcv.2011.09.022; Doyle T, 2012, CLIN INFECT DIS, V54, P724, DOI 10.1093/cid/cir936; Garcia-Gasco P, 2008, J ANTIMICROB CHEMOTH, V61, P699, DOI 10.1093/jac/dkm516; Grennan JT, 2012, J INFECT DIS, V205, P1230, DOI 10.1093/infdis/jis104; Greub G, 2002, AIDS, V16, P1967, DOI 10.1097/00002030-200209270-00017; Gueudin M, 2007, JAIDS-J ACQ IMM DEF, V44, P500, DOI 10.1097/QAI.0b013e31803260df; Havlir DV, 2001, JAMA-J AM MED ASSOC, V286, P171, DOI 10.1001/jama.286.2.171; Hogg RS, 1999, CAN MED ASSOC J, V160, P659; Lima V, 2009, JAIDS-J ACQ IMM DEF, V51, P3, DOI 10.1097/QAI.0b013e31819e721b; Manavi K, 2008, HIV CLIN TRIALS, V9, P283, DOI 10.1310/hct0904-283; Montaner J, 2011, THERAPEUTIC GUIDELIN; Oliver AR, 2007, J CLIN MICROBIOL, V45, P3616, DOI 10.1128/JCM.00221-07; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Schumacher W, 2007, J CLIN VIROL, V38, P304, DOI 10.1016/j.jcv.2006.12.022; Smit E, 2009, JAIDS-J ACQ IMM DEF, V51, P364, DOI 10.1097/QAI.0b013e3181aa13b3; Sun R, 1998, J CLIN MICROBIOL, V36, P2964, DOI 10.1128/JCM.36.10.2964-2969.1998; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Verhofstede C, 2007, J MED VIROL, V79, P1254, DOI 10.1002/jmv.20950; Willig JH, 2010, JAIDS-J ACQ IMM DEF, V54, P442, DOI 10.1097/QAI.0b013e3181d01d1d; Wirden M, 2011, J CLIN MICROBIOL, V49, P2700, DOI 10.1128/JCM.00061-11	26	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43882	10.1371/journal.pone.0043882	http://dx.doi.org/10.1371/journal.pone.0043882			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937116	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500118
J	Henning, F; Meyer, A				Henning, Frederico; Meyer, Axel			Eggspot Number and Sexual Selection in the Cichlid Fish Astatotilapia burtoni	PLOS ONE			English	Article							ARTIFICIAL SELECTION; EGG-SPOTS; MATING PREFERENCES; WATER TURBIDITY; MANIPULATION; EVOLUTION; DUMMIES; CHOICE	Sexual selection on male coloration is one of the main mechanisms proposed to explain the explosive speciation rates in East African cichlid fish. True eggspots are color patterns characteristic of the most species-rich lineage of cichlids, the Haplochromini, and have been suggested to be causally related to the speciation processes. Eggspots are thought to have originated by sensory exploitation and subsequently gained several roles in sexual advertisement. However, for most of these functions the evidence is equivocal. In addition, the genetic architecture of this trait still is largely unknown. We conducted bidirectional selective breeding experiments for eggspot numbers in the model cichlid, Astatotilapia burtoni. After two generations, low lines responded significantly, whereas the high lines did not. Body size was both phenotypically and genotypically correlated with eggspot number and showed correlated response to selection. Males with higher numbers of eggspots were found to sire larger offspring. Despite the potential to act as honest indicators of fitness, the behavioral experiments showed no evidence of a role in either intra- or inter-sexual selection. Visual-based female preference was instead explained by courtship intensity. The evolution of this trait has been interpreted in light of adaptive theories of sexual selection, however the present and published results suggest the influence of non-adaptive factors such as sensory exploitation, environmental constraints and sexual antagonism.	[Henning, Frederico; Meyer, Axel] Univ Konstanz, Dept Biol, Lehrstuhl Zool & Evolutionsbiol, Constance, Germany	University of Konstanz	Henning, F (corresponding author), Univ Konstanz, Dept Biol, Lehrstuhl Zool & Evolutionsbiol, Constance, Germany.	axel.meyer@uni-konstanz.de	Meyer, Axel/C-9826-2009; Henning, Frederico/M-8042-2017; Henning, Frederico/AAS-2090-2020	Meyer, Axel/0000-0002-0888-8193; Henning, Frederico/0000-0002-5359-504X; Henning, Frederico/0000-0002-5359-504X	Brazilian National Counsel of Technological and Scientific Development (CNPq)/German Academic Exchange Program (DAAD) cooperation program [GDE 290049/2007-5]; Deutsche Forschungsgemeinschaft; University of Konstanz	Brazilian National Counsel of Technological and Scientific Development (CNPq)/German Academic Exchange Program (DAAD) cooperation program; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Konstanz	FH is supported by the Brazilian National Counsel of Technological and Scientific Development (CNPq)/German Academic Exchange Program (DAAD) cooperation program (GDE 290049/2007-5). AM is funded by the Deutsche Forschungsgemeinschaft and the University of Konstanz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Arnqvist G, 2006, PHILOS T R SOC B, V361, P375, DOI 10.1098/rstb.2005.1790; Baer CF, 2000, EVOLUTION, V54, P238, DOI 10.1111/j.0014-3820.2000.tb00024.x; Baerends GP, 1950, AN INTRODUCTION TO T; Castillo Cajas Ruth F, 2012, Int J Evol Biol, V2012, P161306, DOI 10.1155/2012/161306; Couldridge VCK, 2002, J FISH BIOL, V60, P726, DOI 10.1006/jfbi.2002.1896; Couldridge VCK, 2001, J FISH BIOL, V59, P667, DOI 10.1006/jfbi.2001.1679; Cox RM, 2009, AM NAT, V173, P176, DOI 10.1086/595841; Crapon de Caprona M, 1983, NETH J ZOOL, V34, P503; Egger B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025601; Endler JA, 2001, AM NAT, V158, P36, DOI 10.1086/320862; Engstrom-Ost J, 2007, BEHAV ECOL, V18, P393, DOI 10.1093/beheco/arl097; Falconer D. S., 1996, Introduction to quantitative genetics.; FERNALD R D, 1977, Environmental Biology of Fishes, V2, P299, DOI 10.1007/BF00005997; FERNALD RD, 1977, ANIM BEHAV, V25, P964, DOI 10.1016/0003-3472(77)90048-3; Frommen JG, 2006, BIOL LETTERS, V2, P232, DOI 10.1098/rsbl.2005.0432; Fuller RC, 2005, INTEGR COMP BIOL, V45, P391, DOI 10.1093/icb/45.3.391; GOLDSCHMIDT T, 1990, ACTA BIOTHEOR, V38, P125, DOI 10.1007/BF00047549; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; HERT E, 1989, ANIM BEHAV, V37, P726, DOI 10.1016/0003-3472(89)90058-4; HERT E, 1991, J FISH BIOL, V38, P951, DOI 10.1111/j.1095-8649.1991.tb03634.x; Heule C, 2011, J FISH BIOL, V78, P1588, DOI 10.1111/j.1095-8649.2011.02944.x; HILL WG, 1992, ANNU REV ECOL SYST, V23, P287, DOI 10.1146/annurev.es.23.110192.001443; HOUDE AE, 1994, P ROY SOC B-BIOL SCI, V256, P125, DOI 10.1098/rspb.1994.0059; Jarvenpaa M, 2004, P ROY SOC B-BIOL SCI, V271, P2361, DOI 10.1098/rspb.2004.2870; KIRKPATRICK M, 1991, NATURE, V350, P33, DOI 10.1038/350033a0; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Konings A., 2016, MALAWI CICHLIDS THEI; Konings A, 2015, TANGANYIKA CICHLIDS; Kotiaho JS, 2008, TRENDS ECOL EVOL, V23, P1, DOI 10.1016/j.tree.2007.09.012; Lehtonen TK, 2008, ANIM BEHAV, V75, P55, DOI 10.1016/j.anbehav.2007.04.011; Lehtonen TK, 2011, P ROY SOC B-BIOL SCI, V278, P2318, DOI 10.1098/rspb.2010.2483; Lynch Michael, 1998; Maruska KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037612; Mulimbwa N, 2010, AQUAT ECOSYST HEALTH, V13, P11, DOI 10.1080/14634981003627342; NICOLETTO PF, 1991, BEHAV ECOL SOCIOBIOL, V28, P365, DOI 10.1007/BF00164386; R Development Core Team, 2009, R FDN STAT COMP; Rowland WJ, 1995, BEHAVIOUR, V132, P951, DOI 10.1163/156853995X00388; Salzburger W, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-17; Salzburger W, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-51; Schielzeth H, 2012, EVOLUTION, V66, P18, DOI 10.1111/j.1558-5646.2011.01431.x; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Theis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029878; Tobler Michael, 2006, Zeitschrift fuer Fischkunde, V8, P39; Verheyen E, 2003, SCIENCE, V300, P325, DOI 10.1126/science.1080699; WICKLER W, 1962, NATURE, V194, P1092, DOI 10.1038/1941092a0; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x; ZEILEIS A., 2006, J STAT SOFTW, V16, P1, DOI DOI 10.18637/JSS.V016.I09	49	9	9	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43695	10.1371/journal.pone.0043695	http://dx.doi.org/10.1371/journal.pone.0043695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937082	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500084
J	Lei, B				Lei, Bo			Rod-Driven OFF Pathway Responses in the Distal Retina: Dark-Adapted Flicker Electroretinogram in Mouse	PLOS ONE			English	Article							CONE BIPOLAR CELLS; STATIONARY NIGHT BLINDNESS; RHODOPSIN KNOCKOUT MOUSE; OSCILLATORY POTENTIALS; MAMMALIAN RETINA; IN-VIVO; MODEL; ERG; PHOTORECEPTORS; GENE	Purpose: The rodent retina does not exhibit a positive OFF-response in the electroretinogram (ERG), which makes it difficult to evaluate its OFF-pathway functions in vivo. We studied the rod-driven OFF pathway responses by using a dark-adapted 10-Hz flicker ERG procedure in mouse. Materials and Methods: Conventional ERGs and 10-Hz dark-adapted flicker ERGs were obtained in wild-type mice (C57BL/6), in mice with pure rod (cpfl1) or pure cone (rho(-/-)) function, and in nob1 mice which have a selective ON-pathway defect. To isolate the response from ON or OFF pathway, glutamate analogs 2-amino-4-phosphobutyric acid (APB, an ON pathway blocker) and cis-2, 3-piperidine-dicarboxylic acid (PDA, an OFF pathway blocker), were injected intravitreally. Results: The amplitude-intensity profile of the dark-adapted 10-Hz flicker ERG in the wild-type mice exhibits two peaks at middle and high light intensities. The two peaks represent rod-and cone-driven responses respectively. In APB-treated C57BL/6 mice and in nob1 mice, the dark-adapted ERG b-waves were absent. However, both rod-and cone-driven OFF pathway responses were evident with flicker ERG recording. At middle light intensities that activate only rod system, the flicker ERG responses in saline-injected nob1 mice were similar to those in APB-injected cpfl1 mice and wild-type mice. These responses are sensitive to PDA. The amplitudes of these rod-driven OFF pathway responses were approximately 20% of the total rod-driven flicker ERG responses. Conclusion: We demonstrate that the rod-OFF bipolar cell pathway is functional in the outer retina. The dark-adapted flicker ERG is practical for the evaluation of rod-and cone-driven responses, and the residual OFF pathway signals in subjects with ON pathway defects.	[Lei, Bo] Chongqing Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol,Chongqing Eye Inst, Chongqing, Peoples R China; [Lei, Bo] Univ Missouri, Dept Ophthalmol, Dept Vet Med & Surg, Columbia, MO USA	Chongqing Medical University; University of Missouri System; University of Missouri Columbia	Lei, B (corresponding author), Chongqing Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol,Chongqing Eye Inst, Chongqing, Peoples R China.	bolei99@126.com		Lei, Bo/0000-0002-5497-0905	National Natural Science Foundation (NNSF) of China [30973251]; Chongqing Municipal Health Bureau [2010-113]; University of Missouri Research Board [1912]; Chongqing Key Laboratory of Ophthalmology (CSTC) [2008 CA5003]	National Natural Science Foundation (NNSF) of China(National Natural Science Foundation of China (NSFC)); Chongqing Municipal Health Bureau; University of Missouri Research Board; Chongqing Key Laboratory of Ophthalmology (CSTC)(Natural Science Foundation Project of CQ CSTC)	Supported in part by National Natural Science Foundation (NNSF) of China (30973251, www.nsfc.gov.cn), Chongqing Municipal Health Bureau (2010-113, www.cqwsj.gov.cn), University of Missouri Research Board (# 1912 research.missouri.edu/funding/board) and the Project of Chongqing Key Laboratory of Ophthalmology (CSTC, 2008 CA5003, www.ctin.ac.cn). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER KR, 1992, INVEST OPHTH VIS SCI, V33, P477; Chang B, 2006, VISUAL NEUROSCI, V23, P11, DOI 10.1017/S095252380623102X; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; Fyk-Kolodziej B, 2003, J COMP NEUROL, V464, P104, DOI 10.1002/cne.10784; Gregg RG, 2003, INVEST OPHTH VIS SCI, V44, P378, DOI 10.1167/iovs.02-0501; Hack I, 1999, P NATL ACAD SCI USA, V96, P14130, DOI 10.1073/pnas.96.24.14130; Hornstein EP, 2005, J NEUROSCI, V25, P11201, DOI 10.1523/JNEUROSCI.3416-05.2005; Jaissle GB, 2001, INVEST OPHTH VIS SCI, V42, P506; Kondo M, 2002, INVEST OPHTH VIS SCI, V43, P2500; Kondo M, 2001, INVEST OPHTH VIS SCI, V42, P305; Krishna VR, 2002, J NEUROPHYSIOL, V87, P42, DOI 10.1152/jn.00489.2001; Lei B, 2000, INVEST OPHTH VIS SCI, V41, P262; Lei B, 2006, INVEST OPHTH VIS SCI, V47, P2732, DOI 10.1167/iovs.05-1461; Li W, 2004, J COMP NEUROL, V474, P1, DOI 10.1002/cne.20075; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; Mataruga A, 2007, J COMP NEUROL, V502, P1123, DOI 10.1002/cne.21367; Miyake Y, 1996, JPN J OPHTHALMOL, V40, P511; Nusinowitz S, 2007, EXP EYE RES, V84, P1104, DOI 10.1016/j.exer.2007.02.009; Pang JJ, 2010, P NATL ACAD SCI USA, V107, P395, DOI 10.1073/pnas.0907178107; Pardue MT, 1998, INVEST OPHTH VIS SCI, V39, P2443; Protti DA, 2005, J NEUROPHYSIOL, V93, P3479, DOI 10.1152/jn.00839.2004; Ridder WH, 2006, VISION RES, V46, P902, DOI 10.1016/j.visres.2005.09.006; Robson JG, 2004, VISION RES, V44, P3253, DOI 10.1016/j.visres.2004.09.002; Rodieck R.W., 1998, 1 STEPS SEEING; Saszik SM, 2002, J PHYSIOL-LONDON, V543, P899, DOI 10.1113/jphysiol.2002.019703; Schmucker C, 2004, VISION RES, V44, P1857, DOI 10.1016/j.visres.2004.03.011; Scholl HPN, 2002, INVEST OPHTH VIS SCI, V43, P1248; Scholl HPN, 2001, INVEST OPHTH VIS SCI, V42, P2728; Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712; Sharma S, 2005, VISUAL NEUROSCI, V22, P631, DOI 10.1017/S0952523805225129; Sharpe LT, 1999, TRENDS NEUROSCI, V22, P497, DOI 10.1016/S0166-2236(99)01458-7; SHARPE LT, 1993, VISION RES, V33, P2705, DOI 10.1016/0042-6989(93)90230-T; SIEVING PA, 1994, VISUAL NEUROSCI, V11, P519, DOI 10.1017/S0952523800002431; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; Strettoi E, 2010, PROG RETIN EYE RES, V29, P272, DOI 10.1016/j.preteyeres.2010.03.005; Toda K, 1999, VISUAL NEUROSCI, V16, P391, DOI 10.1017/S0952523899162187; Tsukamoto Y, 2001, J NEUROSCI, V21, P8616, DOI 10.1523/JNEUROSCI.21-21-08616.2001; Tsukamoto Y, 2007, J NEUROSCI, V27, P6261, DOI 10.1523/JNEUROSCI.5646-06.2007; Volgyi B, 2004, J NEUROSCI, V24, P11182, DOI 10.1523/JNEUROSCI.3096-04.2004; Yao G, 2006, CURR EYE RES, V31, P925, DOI 10.1080/02713680600932308; Zeitz C, 2005, INVEST OPHTH VIS SCI, V46, P4328, DOI 10.1167/iovs.05-0526; Zhang K, 2007, DOC OPHTHALMOL, V115, P85, DOI 10.1007/s10633-007-9061-1	44	11	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43856	10.1371/journal.pone.0043856	http://dx.doi.org/10.1371/journal.pone.0043856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937111	Green Submitted, Green Published, gold			2022-12-25	WOS:000308225500113
J	Wang, RJ; Jian, FC; Zhang, LX; Ning, CS; Liu, AQ; Zhao, JF; Feng, YY; Qi, M; Wang, HL; Lv, CC; Zhao, GH; Xiao, LH				Wang, Rongjun; Jian, Fuchun; Zhang, Longxian; Ning, Changshen; Liu, Aiqin; Zhao, Jinfeng; Feng, Yaoyu; Qi, Meng; Wang, Helei; Lv, Chaochao; Zhao, Guanghui; Xiao, Lihua			Multilocus Sequence Subtyping and Genetic Structure of Cryptosporidium muris and Cryptosporidium andersoni	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; POPULATION STRUCTURES; MOLECULAR ANALYSIS; NATURAL INFECTION; APICOMPLEXA; PREVALENCE; GENOTYPE; IDENTIFICATION; INDIVIDUALS; PARASITES	In this study, nine C. muris and 43 C. andersoni isolates from various animals in China were subtyped by a multilocus sequence typing (MLST) tool. DNA sequence analyses showed the presence of 1-2 subtypes of C. muris and 2-6 subtypes of C. andersoni at each of the four loci (MS1, MS2, MS3, and MS16), nine of which represented new subtypes. Altogether, two C. muris and 10 C. andersoni MLST subtypes were detected. Linkage disequilibrium analysis indicated although the overall population structure of the two parasites was clonal, the Chinese C. andersoni in cattle has an epidemic structure. Three and two clusters were produced in the C. muris and C. andersoni populations by Structure 2.3.3 analysis, with Chinese C. muris and C. andersoni substructures differing from other countries. Thus, this study suggested the prevalence of C. andersoni in China is not attributed to the introduction of dairy cattle. More studies involving more genetic loci and systematic sampling are needed to better elucidate the population genetic structure of C. muris and C. andersoni in the world and the genetic basis for the difference in host specificity among the two most common gastric parasites.	[Wang, Rongjun; Jian, Fuchun; Zhang, Longxian; Ning, Changshen; Zhao, Jinfeng; Qi, Meng; Wang, Helei; Lv, Chaochao] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China; [Liu, Aiqin] Harbin Med Univ, Dept Parasitol, Harbin, Peoples R China; [Feng, Yaoyu] E China Univ Sci & Technol, Sch Resource & Environm Engn, Shanghai 200237, Peoples R China; [Zhao, Guanghui] NW A&F Univ, Coll Vet Med, Yangling, Peoples R China; [Xiao, Lihua] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA	Henan Agricultural University; Harbin Medical University; East China University of Science & Technology; Northwest A&F University - China; Centers for Disease Control & Prevention - USA	Wang, RJ (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China.	zhanglx8999@yahoo.com.cn; lxiao@cdc.gov	Feng, Yaoyu/S-1979-2019; Zhang, Longxian/R-7799-2019; Zhang, Longxian/I-9223-2019; Xiao, Lihua/B-1704-2013; Zhang, Longxian/HGE-1918-2022; Feng, Yaoyu/B-3076-2014	Feng, Yaoyu/0000-0002-8380-1246; Zhang, Longxian/0000-0002-5706-131X; Xiao, Lihua/0000-0001-8532-2727; Feng, Yaoyu/0000-0002-8380-1246	National Natural Science Foundation of China [31172311, 31101805]; Key National Science and Technology Specific Projects [2012ZX10004220-001]; International Cooperation and Exchange of the National Natural Science Foundation of China [31110103901]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key National Science and Technology Specific Projects; International Cooperation and Exchange of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China (No. 31172311, 31101805)(http://www.nsfc.gov.cn/Portal0/default152.htm); the Key National Science and Technology Specific Projects (No. 2012ZX10004220-001)(http://www.nmp.gov.cn/); the International Cooperation and Exchange of the National Natural Science Foundation of China (No. 31110103901)(http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Brikan Faten A., 2008, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V38, P645; Dubey JP, 2002, VET PATHOL, V39, P363, DOI 10.1354/vp.39-3-363; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Feng YY, 2011, J CLIN MICROBIOL, V49, P34, DOI 10.1128/JCM.01329-10; Gatei W, 2002, EMERG INFECT DIS, V8, P204, DOI 10.3201/eid0802.010256; Gatei W, 2003, J CLIN MICROBIOL, V41, P1458, DOI 10.1128/JCM.41.4.1458-1462.2003; Gatei W, 2006, AM J TROP MED HYG, V75, P78, DOI 10.4269/ajtmh.2006.75.78; Guyot K, 2001, J CLIN MICROBIOL, V39, P3472, DOI 10.1128/JCM.39.10.3472-3480.2001; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hikosaka K, 2005, PARASITOL RES, V97, P373, DOI 10.1007/s00436-005-1459-7; Hurkova L, 2003, J WILDLIFE DIS, V39, P441; Jiang XS, 1989, J SW U, V15, P18; Katsumata T, 2000, AM J TROP MED HYG, V62, P70, DOI 10.4269/ajtmh.2000.62.70; Kodadkova A, 2010, J PARASITOL, V96, P211, DOI 10.1645/GE-2212.1; Kvac M, 2008, VET PARASITOL, V153, P363, DOI 10.1016/j.vetpar.2008.01.033; Kvac M, 2009, VET PARASITOL, V160, P319, DOI 10.1016/j.vetpar.2008.11.007; Leoni F, 2006, J MED MICROBIOL, V55, P703, DOI 10.1099/jmm.0.46251-0; Lindsay DS, 2000, J EUKARYOT MICROBIOL, V47, P91, DOI 10.1111/j.1550-7408.2000.tb00016.x; Lupo PJ, 2008, AM J TROP MED HYG, V78, P917, DOI 10.4269/ajtmh.2008.78.917; Lv CC, 2009, APPL ENVIRON MICROB, V75, P7692, DOI 10.1128/AEM.01386-09; Mallon M, 2003, J MOL EVOL, V56, P407, DOI 10.1007/s00239-002-2412-3; Matsubayashi M, 2005, VET PARASITOL, V129, P165, DOI 10.1016/j.vetpar.2005.01.003; Morgan UM, 2000, PARASITOLOGY, V120, P457, DOI 10.1017/S0031182099005703; Morse TD, 2007, EPIDEMIOL INFECT, V135, P1307, DOI 10.1017/S0950268806007758; Muthusamy D, 2006, J CLIN MICROBIOL, V44, P632, DOI 10.1128/JCM.44.2.632-634.2006; Ng J, 2006, APPL ENVIRON MICROB, V72, P7548, DOI 10.1128/AEM.01352-06; Ngouanesavanh T, 2006, J EUKARYOT MICROBIOL, V53, pS33, DOI 10.1111/j.1550-7408.2006.00166.x; Palmer CJ, 2003, EMERG INFECT DIS, V9, P1174; Pavlasek I, 2007, VET PARASITOL, V144, P349, DOI 10.1016/j.vetpar.2006.10.005; Santin M, 2005, J PARASITOL, V91, P712, DOI 10.1645/GE-3438RN; Santin M, 2006, VET PARASITOL, V141, P334, DOI 10.1016/j.vetpar.2006.06.004; Tanriverdi S, 2008, APPL ENVIRON MICROB, V74, P7227, DOI 10.1128/AEM.01576-08; Tiangtip R, 2002, TROP MED INT HEALTH, V7, P357, DOI 10.1046/j.1365-3156.2002.00855.x; Wang RJ, 2008, PARASITOL RES, V102, P915, DOI 10.1007/s00436-007-0851-x; Wang RJ, 2011, PARASITOL INT, V60, P1, DOI 10.1016/j.parint.2010.09.002; Wang RJ, 2011, J CLIN MICROBIOL, V49, P1077, DOI 10.1128/JCM.02194-10; Wang YL, 2010, PARASITOL RES, V106, P341, DOI 10.1007/s00436-009-1664-x; Warren KS, 2003, AUST VET J, V81, P739, DOI 10.1111/j.1751-0813.2003.tb14602.x; Xiao LH, 2001, J INFECT DIS, V183, P492, DOI 10.1086/318090; Xiao Lihua, 2007, P119; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Zhang KZ, 2003, CHINA ANIMAL HUSBAND, V11, P26; Zintl A, 2007, PARASITOLOGY, V134, P1575, DOI 10.1017/S0031182007002983	43	32	38	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43782	10.1371/journal.pone.0043782	http://dx.doi.org/10.1371/journal.pone.0043782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937094	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500096
J	Jasuja, S; Thompson, ND; Peters, PJ; Khudyakov, YE; Patel, MT; Linchangco, P; Thai, HT; Switzer, WM; Shankar, A; Heneine, W; Hu, DJ; Moorman, AC; Gerber, SI				Jasuja, Supriya; Thompson, Nicola D.; Peters, Philip J.; Khudyakov, Yury E.; Patel, Megan T.; Linchangco, Purisima; Thai, Hong T.; Switzer, William M.; Shankar, Anupama; Heneine, Walid; Hu, Dale J.; Moorman, Anne C.; Gerber, Susan I.			Investigation of Hepatitis B Virus and Human Immunodeficiency Virus Transmission among Severely Mentally Ill Residents at a Long Term Care Facility	PLOS ONE			English	Article							BLOOD-BORNE INFECTIONS; UNITED-STATES; HIV; ILLNESS; HEALTH; RECOMMENDATIONS; OUTBREAK; ADULTS	Background: A high prevalence of hepatitis B virus (HBV) and human immunodeficiency virus (HIV) infections have been reported among persons with severe mental illness. In October, 2009, the Cook County Department of Public Health (CCDPH) initiated an investigation following notification of a cluster of HBV infections among mentally ill residents at a long term care facility (LTCF). Methods: LTCF staff were interviewed and resident medical records were reviewed. Residents were offered testing for HBV, HCV, and HIV. Serum specimens from residents diagnosed with HBV or HIV infection were sent to the Centers for Disease Control and Prevention (CDC) for analysis. Results: Eleven newly diagnosed HBV infections were identified among mentally ill residents at the LTCF. Of these 11 infections, 4 serum specimens were available for complete HBV genome sequencing; all 4 genomes were found to be closely related. Four newly diagnosed HIV infections were identified within this same population. Upon molecular analysis, 2 of 4 HIV sequences from these new infections were found to be nearly identical and formed a tight phylogenetic cluster. Conclusions: HBV and HIV transmission was identified among mentally ill residents of this LTCF. Continued efforts are needed to prevent bloodborne pathogen transmission among mentally ill residents in LTCFs.	[Jasuja, Supriya; Patel, Megan T.; Linchangco, Purisima; Gerber, Susan I.] Cook Cty Dept Publ Hlth, Oak Forest, IL USA; [Thompson, Nicola D.; Khudyakov, Yury E.; Thai, Hong T.; Hu, Dale J.; Moorman, Anne C.] Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr HIV Hepatitis STD & TB Prevent, Atlanta, GA USA; [Peters, Philip J.; Switzer, William M.; Shankar, Anupama; Heneine, Walid] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis STD & TB Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Jasuja, S (corresponding author), Cook Cty Dept Publ Hlth, Oak Forest, IL USA.	sjasuja@cookcountyhhs.org; sgerber@cookcountyhhs.org		Moorman, Anne/0000-0003-2411-2798				Angelino Andrew F, 2008, Top HIV Med, V16, P99; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brooks JT, 2006, AIDS, V20, P923, DOI 10.1097/01.aids.0000218558.82402.59; Brunette MF, 2003, PSYCHIAT SERV, V54, P860, DOI 10.1176/appi.ps.54.6.860; de Oliveira T, 2006, NATURE, V444, P836, DOI 10.1038/444836a; Forbi JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011615; Jafa K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005416; Mast Eric E., 2006, Morbidity and Mortality Weekly Report, V55, P1; Rosenberg SD, 2001, AM J PUBLIC HEALTH, V91, P31, DOI 10.2105/AJPH.91.1.31; Rosenberg SD, 2003, PSYCHIAT SERV, V54, P827, DOI 10.1176/appi.ps.54.6.827; Thompson ND, 2009, ANN INTERN MED, V150, P33, DOI 10.7326/0003-4819-150-1-200901060-00007; Willenbring ML, 2005, AIDS, V19, pS227, DOI 10.1097/01.aids.0000192094.84624.c2; Wise ME, 2012, AM J INFECT CONTROL, V40, P16, DOI 10.1016/j.ajic.2011.04.331	13	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43252	10.1371/journal.pone.0043252	http://dx.doi.org/10.1371/journal.pone.0043252			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937026	Green Submitted, Green Published, gold			2022-12-25	WOS:000308286300038
J	To, MD; Rosario, RD; Westcott, PMK; Banta, KL; Balmain, A				To, M. D.; Rosario, R. D.; Westcott, P. M. K.; Banta, K. L.; Balmain, A.			Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis	ONCOGENE			English	Article						Ras; Hras; Kras; Nras; skin carcinogenesis; lung carcinogenesis	MOUSE SKIN; SPINDLE CARCINOMAS; HUMAN CANCER; PAS1 LOCUS; K-RAS; PROGRESSION; MUTATIONS; EXPRESSION; TUMORS; SUSCEPTIBILITY	Ras oncogenes (Hras, Kras and Nras) are important drivers of carcinogenesis. However, tumors with Ras mutations often show loss of the corresponding wild-type (WT) allele, suggesting that proto-oncogenic forms of Ras can function as a suppressor of carcinogenesis. In vitro studies also suggest that WT Ras proteins can suppress the tumorigenic properties of alternate mutant Ras family members, but in vivo evidence for these heterologous interactions is lacking. We have investigated the genetic interactions between different combinations of mutant and WT Ras alleles in vivo using carcinogen-induced lung and skin carcinogenesis in mice with targeted deletion of different Ras family members. The major suppressor effect of WT Kras is observed only in mutant Kras-driven lung carcinogenesis, where loss of one Kras allele led to increased tumor number and size. Deletion of one Hras allele dramatically reduced the number of skin papillomas with Hras mutations, consistent with Hras as the major target of mutation in these tumors. However, skin carcinoma numbers were very similar, suggesting that WT Hras functions as a suppressor of progression from papillomas to invasive squamous carcinomas. In the skin, the Kras proto-oncogene functions cooperatively with mutant Hras to promote papilloma development, although the effect is relatively small. In contrast, the Hras proto-oncogene attenuated the activity of mutant Kras in lung carcinogenesis. Interestingly, loss of Nras increased the number of mutant Kras-induced lung tumors, but decreased the number of mutant Hras-induced skin papillomas. These results show that the strongest suppressor effects of WT Ras are only seen in the context of mutation of the cognate Ras protein, and only relatively weak effects are detected on tumor development induced by mutations in alternative family members. The data also underscore the complex and context-dependent nature of interactions between proto-oncogenic and oncogenic forms of different Ras family members during tumor development.	[To, M. D.] Univ Calif San Francisco, Dept Surg, Thorac Oncol Program, San Francisco, CA 94115 USA; [To, M. D.; Rosario, R. D.; Westcott, P. M. K.; Banta, K. L.; Balmain, A.] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94115 USA; [Westcott, P. M. K.; Balmain, A.] Univ Calif San Francisco, Pharmaceut Sci & Pharmacogen Program, San Francisco, CA 94115 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	To, MD (corresponding author), Univ Calif San Francisco, Dept Surg, Thorac Oncol Program, 2340 Sutter St,Room N219, San Francisco, CA 94115 USA.	mto@cc.ucsf.edu; abalmain@cc.ucsf.edu			NCI [CA111834-01, CA84244]; NIH [T32 GM007175]; National Science Foundation Graduate Research Fellowship; Nan Tucker McEvoy Research Fund in Thoracic Oncology; Barbara Bass Bakar Chair in Cancer Genetics; NATIONAL CANCER INSTITUTE [U01CA084244, R01CA111834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007175] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Nan Tucker McEvoy Research Fund in Thoracic Oncology; Barbara Bass Bakar Chair in Cancer Genetics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Dr Motoya Katsuki and Dr Hiroki Nagase for the Hras<SUP>KO</SUP> mice, and Dr Tyler Jacks for the LSL-Kras<SUP>G12D</SUP> mice. This work was supported by NCI Grants CA111834-01 and CA84244 to AB. PMKW is supported by NIH Training Grant T32 GM007175 and a National Science Foundation Graduate Research Fellowship. MDT acknowledges the support from the Nan Tucker McEvoy Research Fund in Thoracic Oncology. AB acknowledges support from the Barbara Bass Bakar Chair in Cancer Genetics.	BALMAIN A, 1983, NATURE, V303, P72, DOI 10.1038/303072a0; BOS JL, 1989, CANCER RES, V49, P4682; BREMNER R, 1990, CELL, V61, P407, DOI 10.1016/0092-8674(90)90523-H; BUCHMANN A, 1991, CANCER RES, V51, P4097; Cui W, 1996, CELL, V86, P531, DOI 10.1016/S0092-8674(00)80127-0; Diaz R, 2005, INT J CANCER, V113, P241, DOI 10.1002/ijc.20563; Diaz R, 2002, CANCER RES, V62, P4514; Dworkin AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001136; Hager JH, 2004, CANCER RES, V64, P2406, DOI 10.1158/0008-5472.CAN-03-3522; HENNINGS H, 1993, CARCINOGENESIS, V14, P2353, DOI 10.1093/carcin/14.11.2353; Ise K, 2000, ONCOGENE, V19, P2951, DOI 10.1038/sj.onc.1203600; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Lee KE, 2010, CANCER CELL, V18, P448, DOI 10.1016/j.ccr.2010.10.020; Manenti G, 2008, ONCOGENE, V27, P5753, DOI 10.1038/onc.2008.194; Mao JH, 2004, GENE DEV, V18, P1800, DOI 10.1101/gad.1213804; Modrek B, 2009, MOL CANCER RES, V7, P1244, DOI 10.1158/1541-7786.MCR-08-0532; Nagase H, 2003, CANCER RES, V63, P4849; NAGASE H, 1995, NAT GENET, V10, P424, DOI 10.1038/ng0895-424; Perez-Losada J, 2003, NAT REV CANCER, V3, P434, DOI 10.1038/nrc1095; Quinlan MP, 2008, CELL CYCLE, V7, P1332, DOI 10.4161/cc.7.10.5927; Sweet-Cordero A, 2006, GENE CHROMOSOME CANC, V45, P338, DOI 10.1002/gcc.20296; To MD, 2008, NAT GENET, V40, P1240, DOI 10.1038/ng.211; To MD, 2006, NAT GENET, V38, P926, DOI 10.1038/ng1836; To MD, 2011, MOL CANCER RES, V9, P1339, DOI 10.1158/1541-7786.MCR-11-0219; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; YOU M, 1989, P NATL ACAD SCI USA, V86, P3070, DOI 10.1073/pnas.86.9.3070; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721	29	51	51	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 22	2013	32	34					4028	4033		10.1038/onc.2012.404	http://dx.doi.org/10.1038/onc.2012.404			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	209IC	22945650	Green Submitted, Green Accepted			2022-12-25	WOS:000323748100011
J	Nam, KH; Ding, F; Haitjema, C; Huang, QQ; DeLisa, MP; Ke, AL				Nam, Ki Hyun; Ding, Fran; Haitjema, Charles; Huang, Qingqiu; DeLisa, Matthew P.; Ke, Ailong			Double-stranded Endonuclease Activity in Bacillus halodurans Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated Cas2 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROVIDES ACQUIRED-RESISTANCE; CRISPR/CAS SYSTEM; CRYSTAL-STRUCTURE; IMMUNE-SYSTEM; RNA; BACTERIA; DEFENSE; DNA; RECOGNITION; SEQUENCE	The CRISPR (clustered regularly interspaced short palindromic repeats) system is a prokaryotic RNA-based adaptive immune system against extrachromosomal genetic elements. Cas2 is a universally conserved core CRISPR-associated protein required for the acquisition of new spacers for CRISPR adaptation. It was previously characterized as an endoribonuclease with preference for single-stranded (ss) RNA. Here, we show using crystallography, mutagenesis, and isothermal titration calorimetry that the Bacillus halodurans Cas2 (Bha_Cas2) from the subtype I-C/Dvulg CRISPR instead possesses metal-dependent endonuclease activity against double-stranded (ds) DNA. This activity is consistent with its putative function in producing new spacers for insertion into the 5'-end of the CRISPR locus. Mutagenesis and isothermal titration calorimetry studies revealed that a single divalent metal ion (Mg2+ or Mn2+), coordinated by a symmetric Asp pair in the Bha_Cas2 dimer, is involved in the catalysis. We envision that a pH-dependent conformational change switches Cas2 into a metal-binding competent conformation for catalysis. We further propose that the distinct substrate preferences among Cas2 proteins may be determined by the sequence and structure in the beta 1-alpha 1 loop.	[Nam, Ki Hyun; Ding, Fran; Huang, Qingqiu; Ke, Ailong] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Haitjema, Charles; DeLisa, Matthew P.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA; [Huang, Qingqiu] Cornell Univ, Macromol Diffract Facil, CHESS, Ithaca, NY 14853 USA; [DeLisa, Matthew P.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA; [DeLisa, Matthew P.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Cornell University; Cornell University	Ke, AL (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	ak425@cornell.edu	DeLisa, Matthew/AAE-7361-2019; Nam, Ki Hyun/N-6812-2019	Nam, Ki Hyun/0000-0003-3268-354X; DeLisa, Matthew/0000-0003-3226-1566	Public Health Service [GM-086766, GM-059604]; National Research Foundation of Korea; Korean Ministry of Education, Science, and Technology [NRF-2010-357-C00106]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646, P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059604, R01GM086766, R01GM102543] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Research Foundation of Korea(National Research Foundation of Korea); Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by the Public Health Service Grants GM-086766 and GM-059604 (to A. K.) and by the National Research Foundation of Korea Grant from the Korean Ministry of Education, Science, and Technology NRF-2010-357-C00106 (to K. H. N.).	Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beloglazova N, 2008, J BIOL CHEM, V283, P20361, DOI 10.1074/jbc.M803225200; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Ebihara A, 2006, PROTEIN SCI, V15, P1494, DOI 10.1110/ps.062131106; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Han D, 2009, FEBS LETT, V583, P1928, DOI 10.1016/j.febslet.2009.04.047; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Nam KH, 2011, J BIOL CHEM, V286, P30759, DOI 10.1074/jbc.M111.256263; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Lawrence CM, 2011, STRUCTURE, V19, P142, DOI 10.1016/j.str.2011.01.003; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Nam KH, 2012, STRUCTURE, V20, P1574, DOI 10.1016/j.str.2012.06.016; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Samai P, 2010, ACTA CRYSTALLOGR F, V66, P1552, DOI 10.1107/S1744309110039801; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Shah SA, 2009, BIOCHEM SOC T, V37, P23, DOI 10.1042/BST0370023; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Wang RY, 2011, STRUCTURE, V19, P257, DOI 10.1016/j.str.2010.11.014; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	48	62	70	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35943	35952		10.1074/jbc.M112.382598	http://dx.doi.org/10.1074/jbc.M112.382598			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22942283	Green Published, hybrid			2022-12-25	WOS:000310364000016
J	Frevert, U; Movila, A; Nikolskaia, OV; Raper, J; Mackey, ZB; Abdulla, M; McKerrow, J; Grab, DJ				Frevert, Ute; Movila, Alexandru; Nikolskaia, Olga V.; Raper, Jayne; Mackey, Zachary B.; Abdulla, Maha; McKerrow, James; Grab, Dennis J.			Early Invasion of Brain Parenchyma by African Trypanosomes	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BRUCEI-BRUCEI; SLEEPING SICKNESS; BARRIER DAMAGE; BLOOD; INFECTION; MODEL; MICE; CELL; MENINGOENCEPHALITIS	Human African trypanosomiasis or sleeping sickness is a vector-borne parasitic disease that has a major impact on human health and welfare in sub-Saharan countries. Based mostly on data from animal models, it is currently thought that trypanosome entry into the brain occurs by initial infection of the choroid plexus and the circumventricular organs followed days to weeks later by entry into the brain parenchyma. However, Trypanosoma brucei bloodstream forms rapidly cross human brain microvascular endothelial cells in vitro and appear to be able to enter the murine brain without inflicting cerebral injury. Using a murine model and intravital brain imaging, we show that bloodstream forms of T. b. brucei and T. b. rhodesiense enter the brain parenchyma within hours, before a significant level of microvascular inflammation is detectable. Extravascular bloodstream forms were viable as indicated by motility and cell division, and remained detectable for at least 3 days post infection suggesting the potential for parasite survival in the brain parenchyma. Vascular inflammation, as reflected by leukocyte recruitment and emigration from cortical microvessels, became apparent only with increasing parasitemia at later stages of the infection, but was not associated with neurological signs. Extravascular trypanosomes were predominantly associated with postcapillary venules suggesting that early brain infection occurs by parasite passage across the neuroimmunological blood brain barrier. Thus, trypanosomes can invade the murine brain parenchyma during the early stages of the disease before meningoencephalitis is fully established. Whether individual trypanosomes can act alone or require the interaction from a quorum of parasites remains to be shown. The significance of these findings for disease development is now testable.	[Frevert, Ute; Movila, Alexandru] NYU, Sch Med, Dept Microbiol, Div Med Parasitol, New York, NY 10016 USA; [Nikolskaia, Olga V.; Grab, Dennis J.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Grab, Dennis J.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Raper, Jayne] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; [Mackey, Zachary B.; Abdulla, Maha; McKerrow, James] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	New York University; Johns Hopkins University; Johns Hopkins University; City University of New York (CUNY) System; Hunter College (CUNY); University of California System; University of California San Francisco	Frevert, U (corresponding author), NYU, Sch Med, Dept Microbiol, Div Med Parasitol, New York, NY 10016 USA.	dgrab1@jhmi.edu		Mackey, Zachary/0000-0002-4533-0973; Frevert, Ute/0000-0001-9556-7330; Raper, Jayne/0000-0002-8723-9748	National Institutes of Health (NIH) [5R01AI082695]; Dana Foundation; NIH [S10 RR019288]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082695] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by grants from the National Institutes of Health (NIH)(5R01AI082695) to DJG, and Brain & Immuno Imaging Grant from the Dana Foundation and NIH (S10 RR019288) to UF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abdulla MH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000298; ABOLARIN MO, 1986, T ROY SOC TROP MED H, V80, P618, DOI 10.1016/0035-9203(86)90160-4; Alfonso MO, 1996, 20 INT C ENT FIR IT; Amrouni D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016891; Amrouni D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009211; Baer K, 2007, PLOS PATHOG, V3, P1651, DOI 10.1371/journal.ppat.0030171; Balmer O, 2006, ACTA TROP, V97, P94, DOI 10.1016/j.actatropica.2005.09.002; Belluscio L., 2005, CURR PROTOC NEUROSCI, V32, DOI [10.1002/0471142301.ns0209s32, DOI 10.1002/0471142301.NS0209S32]; Bonkowski D, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-8; Buguet A, 2001, SLEEP MED REV, V5, P139, DOI 10.1053/smrv.2000.0130; Carroll RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013124; Chevrier C, 2005, ACTA TROP, V95, P33, DOI 10.1016/j.actatropica.2005.04.011; Chung YC, 2010, BMB REP, V43, P225, DOI 10.5483/BMBRep.2010.43.4.225; Darsaud A, 2004, TROP MED INT HEALTH, V9, P83, DOI 10.1046/j.1365-3156.2003.01154.x; FINK E, 1979, TROPENMED PARASITOL, V30, P206; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Girard M, 2005, MOL BIOCHEM PARASIT, V139, P41, DOI 10.1016/j.molbiopara.2004.09.008; Grab DJ, 2011, CELL MICROBIOL, V13, P1470, DOI 10.1111/j.1462-5822.2011.01661.x; Grab DJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001249; Grab DJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000479; Grab DJ, 2008, J NEUROVIROL, V14, P344, DOI 10.1080/13550280802282934; Grab DJ, 2004, J PARASITOL, V90, P970, DOI 10.1645/GE-287R; Haldar K, 2007, ANNU REV PATHOL-MECH, V2, P217, DOI 10.1146/annurev.pathol.2.010506.091913; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Holman DW, 2011, BBA-MOL BASIS DIS, V1812, P220, DOI 10.1016/j.bbadis.2010.07.019; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; HUNTER CA, 1992, J NEUROIMMUNOL, V36, P91, DOI 10.1016/0165-5728(92)90040-R; Jennings F W, 1983, Contrib Microbiol Immunol, V7, P147; JENNINGS FW, 1979, INT J PARASITOL, V9, P381, DOI 10.1016/0020-7519(79)90089-4; JENNINGS FW, 1993, T ROY SOC TROP MED H, V87, P224, DOI 10.1016/0035-9203(93)90502-H; JENNINGS FW, 1982, Z PARASITENKD, V67, P337, DOI 10.1007/BF00927669; Kennedy PGE, 2008, ANN NEUROL, V64, P116, DOI 10.1002/ana.21429; Kennedy PGE, 2004, J CLIN INVEST, V113, P496, DOI 10.1172/JCI200421052; Kennedy PGE, 1997, P NATL ACAD SCI USA, V94, P4167, DOI 10.1073/pnas.94.8.4167; Kennedy PGE, 2003, BRAIN, V126, P1683, DOI 10.1093/brain/awg160; Kristensson K, 2011, NAT REV NEUROSCI, V12, P345, DOI 10.1038/nrn3029; Kristensson K, 2010, PROG NEUROBIOL, V91, P152, DOI 10.1016/j.pneurobio.2009.12.001; LeBowitz JH, 2005, P NATL ACAD SCI USA, V102, P14485, DOI 10.1073/pnas.0507523102; Lok J, 2007, NEUROCHEM RES, V32, P2032, DOI 10.1007/s11064-007-9342-9; MacLean LM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000906; MANUELIDIS ELIAS E., 1965, ACTA NEUROPATHOL, V5, P176; Masocha W, 2008, SCAND J IMMUNOL, V68, P484, DOI 10.1111/j.1365-3083.2008.02170.x; Masocha W, 2007, PHYSIOL BEHAV, V92, P110, DOI 10.1016/j.physbeh.2007.05.045; Moxon CA, 2009, MOL BIOCHEM PARASIT, V166, P99, DOI 10.1016/j.molbiopara.2009.03.006; Mulenga C, 2001, NEUROPATH APPL NEURO, V27, P77, DOI 10.1046/j.0305-1846.2001.00306.x; Nacer A, 2012, NEUROIMMUNOLOG UNPUB; Ngotho M, 2011, ACTA TROP, V119, P14, DOI 10.1016/j.actatropica.2011.02.013; Nikolskaia OV, 2008, J CLIN INVEST, V118, P1974, DOI 10.1172/JCI27798C1; Nikolskaia OV, 2006, J CLIN INVEST, V116, P2739, DOI [10.1172/JC127798, 10.1172/JCI27798.]; Owens T, 2008, J NEUROPATH EXP NEUR, V67, P1113, DOI 10.1097/NEN.0b013e31818f9ca8; Pardridge William M, 2005, NeuroRx, V2, P3; Pardridge WM, 2005, MOL BIOTECHNOL, V30, P57, DOI 10.1385/MB:30:1:057; PENTREATH VW, 1995, T ROY SOC TROP MED H, V89, P9, DOI 10.1016/0035-9203(95)90637-1; PENTREATH VW, 1992, ANN TROP MED PARASIT, V86, P29, DOI 10.1080/00034983.1992.11812627; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; PHILIP KA, 1994, ANN TROP MED PARASIT, V88, P607, DOI 10.1080/00034983.1994.11812911; POLTERA AA, 1980, CLIN EXP IMMUNOL, V40, P496; POLTERA AA, 1977, VIRCHOWS ARCH A, V373, P249, DOI 10.1007/BF00432240; Pouratian N., 2002, BRAIN MAPPING METHOD, V2nd, P97; Reale M, 2009, BRAIN BEHAV IMMUN, V23, P55, DOI 10.1016/j.bbi.2008.07.003; Rodgers J, 2011, AM J TROP MED HYG, V84, P344, DOI 10.4269/ajtmh.2011.10-0487; Ross MH., 1995, HISTOLOGY TEXT ATLAS, V3; SCHMIDT H, 1983, VIRCHOWS ARCH A, V399, P333, DOI 10.1007/BF00612951; SCHULTZBERG M, 1988, J NEUROSCI RES, V21, P56, DOI 10.1002/jnr.490210109; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sternberg JM, 2005, J NEUROIMMUNOL, V167, P81, DOI 10.1016/j.jneuroim.2005.06.017; STEVENS DR, 1977, ACTA NEUROPATHOL, V38, P173, DOI 10.1007/BF00688062; Stoppini L, 2000, INT J MED MICROBIOL, V290, P105; Untucht C, 2011, MICROBIOL-SGM, V157, P2933, DOI 10.1099/mic.0.049106-0; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; VANMARCK EAE, 1981, ANN SOC BELG MED TR, V61, P57; WHITELAW DD, 1985, PARASITOLOGY, V90, P255, DOI 10.1017/S0031182000050964; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wolburg H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034304; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	76	42	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43913	10.1371/journal.pone.0043913	http://dx.doi.org/10.1371/journal.pone.0043913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952808	Green Published, gold			2022-12-25	WOS:000308221300033
J	Kyongo, JK; Jespers, V; Goovaerts, O; Michiels, J; Menten, J; Fichorova, RN; Crucitti, T; Vanham, G; Arien, KK				Kyongo, Jordan K.; Jespers, Vicky; Goovaerts, Odin; Michiels, Johan; Menten, Joris; Fichorova, Raina N.; Crucitti, Tania; Vanham, Guido; Arien, Kevin K.			Searching for Lower Female Genital Tract Soluble and Cellular Biomarkers: Defining Levels and Predictors in a Cohort of Healthy Caucasian Women	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ECTOPIC PROSTATIC TISSUE; VAGINAL EPITHELIAL-CELLS; BACTERIAL VAGINOSIS; HETEROSEXUAL TRANSMISSION; ANTIRETROVIRAL THERAPY; HIV-1 TRANSMISSION; MENSTRUAL-CYCLE; POSITIVE WOMEN; UTERINE CERVIX	Background: High concentrations of pro-inflammatory cytokines have been previously observed in the genital fluids of women enrolled in microbicide trials and may explain observed increased HIV transmission in some of these trials. Although the longitudinal nature of these studies allows within-subject comparisons of post-product levels to baseline levels, the fact that the physiologic variations of these cytokines and other markers of immune activation are not fully defined in different populations, makes it difficult to assess changes that can be directly attributed to microbicide use as opposed to other biological and behavioural factors. Methods: Cervicovaginal lavage samples were collected from 30 healthy Caucasian and assayed for concentrations of ten cytokines/chemokines, total protein content and two antimicrobial proteins using a multiplex immunoassay and ELISA. Cellular markers were characterized by flow cytometry on mononuclear cells collected from the endocervix using flocked swabs. Bacterial quantification was performed using quantitative PCR. Results: Ectopy, menstrual cycle phase, prostate-specific antigen and presence of leucocytes in endocervical cells' supernatant were associated with the concentrations of cyto-/chemokines in cervicovaginal secretions. Approximately 3% of endocervical cells collected were monocytes of which a median of 52% (SD = 17) expressed both CD4 and CCR5 markers. Approximately 1% of the total cells were T-cells with a median of 61% (SD = 10) CD4 and CCR5 expression. Around 5% of the monocytes and 16% of the T-cells expressed the immune activation marker HLA-DR. Higher percentages of T-cells were associated with greater quantities of IL-1RA, GM-CSF and elafin. Conclusion: We demonstrate the presence of selected soluble and cellular immune activation markers and identify their predictors in the female genital tract of healthy women. Future clinical trials should consider ectopy, sexual activity, menstrual cycle phase and presence of bacterial species as possible confounders when evaluating the possible inflammatory effects of microbicide compounds.	[Kyongo, Jordan K.; Michiels, Johan; Vanham, Guido; Arien, Kevin K.] Inst Trop Med, Dept Biomed Sci, Virol Unit, Div Microbiol, B-2000 Antwerp, Belgium; [Jespers, Vicky] Inst Trop Med, ITM HIV AIDS Ctr, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Goovaerts, Odin] Inst Trop Med, Immunol Unit, Div Microbiol, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Menten, Joris] Inst Trop Med, Clin Trials Unit, Dept Clin Sci, B-2000 Antwerp, Belgium; [Fichorova, Raina N.] Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Lab Genital Tract Biol,Brigham & Womens Hosp, Boston, MA 02115 USA; [Crucitti, Tania] Inst Trop Med, Dept Clin Sci, HIV STI Reference Lab, B-2000 Antwerp, Belgium; [Vanham, Guido] Univ Brussels, Fac Med & Pharmacol, Brussels, Belgium; [Vanham, Guido] Univ Antwerp, Fac Pharmaceut Vet & Biomed Sci, B-2020 Antwerp, Belgium	Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Institute of Tropical Medicine (ITM); University of Antwerp	Kyongo, JK (corresponding author), Inst Trop Med, Dept Biomed Sci, Virol Unit, Div Microbiol, B-2000 Antwerp, Belgium.	karien@itg.be	Crucitti, Tania/AAB-9967-2019; Fichorova, Raina/G-9969-2014; Crucitti, Tania/AAH-1902-2021; Crucitti, Tania/AEQ-9792-2022	Crucitti, Tania/0000-0002-2235-6038; Crucitti, Tania/0000-0002-2235-6038	European Commission [503558, CHAARM 242135]; Foundation Dormeur, Switzerland	European Commission(European CommissionEuropean Commission Joint Research Centre); Foundation Dormeur, Switzerland	This work was supported by the European Commission [European Microbicides Project 503558 and CHAARM 242135] and by the Foundation Dormeur, Switzerland. The authors are grateful to the participants and the study's physicians, Dr. Ilse Collier, Dr. Christiane Van Ghijseghem and Dr. Kristien Wouters. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Harthi L, 2001, AIDS, V15, P1535, DOI 10.1097/00002030-200108170-00011; Al-Harthi L, 2000, J INTERF CYTOK RES, V20, P719, DOI 10.1089/10799900050116426; Anukam KC, 2006, SEX TRANSM DIS, V33, P59, DOI 10.1097/01.olq.0000175367.15559.c4; Bebell LM, 2008, J INFECT DIS, V198, P710, DOI 10.1086/590503; Berlier W, 2006, HUM REPROD, V21, P1135, DOI 10.1093/humrep/dei496; Breen EC, 2011, CLIN VACCINE IMMUNOL, V18, P1229, DOI 10.1128/CVI.05032-11; Cauci S, 2003, MOL HUM REPROD, V9, P53, DOI 10.1093/molehr/gag003; Cauci S, 2002, AM J REPROD IMMUNOL, V47, P257, DOI 10.1034/j.1600-0897.2002.01096.x; Celum C, 2012, CURR OPIN INFECT DIS, V25, P51, DOI 10.1097/QCO.0b013e32834ef5ef; Cherpes TL, 2008, SEX TRANSM DIS, V35, P78, DOI 10.1097/OLQ.0b013e318156a5d0; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cone RA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-90; Crowley-Nowick PA, 2000, J INFECT DIS, V181, P939, DOI 10.1086/315311; Dezzutti CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023136; Dziak R, 2011, CAN SOC FORENSIC SCI, V44, P59, DOI 10.1080/00085030.2011.10768142; Fahey JV, 2008, MUCOSAL IMMUNOL, V1, P317, DOI 10.1038/mi.2008.20; Fichorova RN, 2011, MBIO, V2, DOI 10.1128/mBio.00168-11; Fichorova RN, 2011, CYTOKINE, V55, P134, DOI 10.1016/j.cyto.2011.03.016; Fichorova RN, 1999, BIOL REPROD, V60, P508, DOI 10.1095/biolreprod60.2.508; Fichorova RN, 2004, BIOL REPROD, V71, P761, DOI 10.1095/biolreprod.104.029603; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Fichorova RN, 2004, J ACQUIR IMMUNE D S3, V37, P184; Fleming DC, 2003, FERTIL STERIL, V79, P856, DOI 10.1016/S0015-0282(02)04930-0; Francis SC, 2012, INT MICR C SYDN AUST; Gali Y, 2010, ANTIMICROB AGENTS CH, V54, P5105, DOI 10.1128/AAC.00456-10; Gargiulo AR, 2004, FERTIL STERIL, V82, P1226, DOI 10.1016/j.fertnstert.2004.03.039; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gupta P, 2002, J VIROL, V76, P9868, DOI 10.1128/JVI.76.19.9868-9876.2002; HILLIER SL, 1993, CLIN INFECT DIS, V16, P273; Hwang LY, 2011, J REPROD IMMUNOL, V88, P66, DOI 10.1016/j.jri.2010.07.008; Jespers V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-83; Jespers V, 2011, AM J REPROD IMMUNOL, V65, P368, DOI 10.1111/j.1600-0897.2010.00938.x; Jespers VA, 2007, JAIDS-J ACQ IMM DEF, V44, P154, DOI 10.1097/QAI.0b013e31802bb35f; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Khan SS, 2004, CYTOM PART B-CLIN CY, V61B, P35, DOI 10.1002/cyto.b.20021; KLEBANOFF SJ, 1991, J EXP MED, V174, P289, DOI 10.1084/jem.174.1.289; Lajoie J, 2008, MUCOSAL IMMUNOL, V1, P309, DOI 10.1038/mi.2008.18; Lajoie J, 2010, J CLIN IMMUNOL, V30, P90, DOI 10.1007/s10875-009-9343-3; Lieberman JA, 2008, CLIN VACCINE IMMUNOL, V15, P49, DOI 10.1128/CVI.00216-07; McCluggage WG, 2006, AM J SURG PATHOL, V30, P209, DOI 10.1097/01.pas.0000180446.17517.b8; Moreira C, 2009, CLIN INFECT DIS, V49, P991, DOI 10.1086/605540; MOSS GB, 1991, J INFECT DIS, V164, P588, DOI 10.1093/infdis/164.3.588; Myer L, 2006, SEX TRANSM DIS, V33, P683, DOI 10.1097/01.olq.0000216026.67352.f9; Nucci MR, 2000, AM J SURG PATHOL, V24, P1224, DOI 10.1097/00000478-200009000-00005; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; PLOURDE PJ, 1994, J INFECT DIS, V170, P313, DOI 10.1093/infdis/170.2.313; Scott ME, 2011, CYTOKINE, V56, P430, DOI 10.1016/j.cyto.2011.06.011; Sharkey DJ, 2007, MOL HUM REPROD, V13, P491, DOI 10.1093/molehr/gam028; Sharkey DJ, 2012, J IMMUNOL, V188, P2445, DOI 10.4049/jimmunol.1102736; Spear GT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019560; Spurbeck RR, 2011, FUTURE MICROBIOL, V6, P567, DOI [10.2217/FMB.11.36, 10.2217/fmb.11.36]; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Stephenson J, 2000, JAMA-J AM MED ASSOC, V284, P949, DOI 10.1001/jama.284.8.949; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; van de Wijgert JHHM, 2009, SEX TRANSM DIS, V36, P357, DOI 10.1097/OLQ.0b013e3181a4f695; Wallace C, 2001, AM J SURG PATHOL, V25, P1215, DOI 10.1097/00000478-200109000-00016; WHO/CONRAD, 2004, MAN STAND COLP EV VA; Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4	59	65	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43951	10.1371/journal.pone.0043951	http://dx.doi.org/10.1371/journal.pone.0043951			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952818	Green Published, gold, Green Submitted			2022-12-25	WOS:000308221300036
J	Roberts, KL; Shelton, H; Stilwell, P; Barclay, WS				Roberts, Kim L.; Shelton, Holly; Stilwell, Peter; Barclay, Wendy S.			Transmission of a 2009 H1N1 Pandemic Influenza Virus Occurs before Fever Is Detected, in the Ferret Model	PLOS ONE			English	Article							A H1N1; INFECTIOUS-DISEASE; OUTBREAK; PATHOGENESIS; REPLICATION; DYNAMICS; ILLNESS; SIGNS; MICE	During the early phase of the 2009 influenza pandemic, attempts were made to contain the spread of the virus. Success of reactive control measures may be compromised if the proportion of transmission that occurs before overt clinical symptoms develop is high. In this study we investigated the timing of transmission of an early prototypic strain of pandemic H1N1 2009 influenza virus in the ferret model. Ferrets are the only animal model in which this can be assessed because they display typical influenza-like clinical signs including fever and sneezing after infection. We assessed transmission from infected animals to sentinels that were placed either in direct contact or in adjacent cages, the latter reflecting the respiratory droplet (RD) transmission route. We found that pre-symptomatic influenza transmission occurred via both contact and respiratory droplet exposure before the earliest clinical sign, fever, developed. Three of 3 animals exposed in direct contact between day 1 and 2 after infection of the donor animals became infected, and 2/3 of the animals exposed at this time period by the RD route acquired the infection, with the third animal becoming seropositive indicating either a low level infection or significant exposure. Moreover, this efficient transmission did not temporally correlate with respiratory symptoms, such as coughs and sneezes, but rather with the peak viral titre in the nose. Indeed respiratory droplet transmission did not occur late in infection, even though this was when sneezing and coughing were most apparent. None of the 3 animals exposed at this time by the RD route became infected and these animals remained seronegative at the end of the experiment. These data have important implications for pandemic planning strategies and suggest that successful containment is highly unlikely for a human-adapted influenza virus that transmits efficiently within a population.	[Roberts, Kim L.; Shelton, Holly; Stilwell, Peter; Barclay, Wendy S.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis, Virol Sect, London, England	Imperial College London	Roberts, KL (corresponding author), Trinity Coll Dublin, Moyne Inst Prevent Med, Dept Microbiol, Dublin, Ireland.	w.barclay@imperial.ac.uk		Stilwell, Peter/0000-0002-4169-4200; shelton, Holly/0000-0002-5776-0735; Barclay, Wendy/0000-0002-3948-0895	Medical Research Council [G06000504]; National Institute for Health Research (NIHR) Imperial Biomedical Research Centre [P26591]; MRC [G0600504] Funding Source: UKRI; Medical Research Council [G0600504] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Imperial Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a Medical Research Council project grant G06000504 to WB and by a National Institute for Health Research (NIHR) Imperial Biomedical Research Centre award P26591 to WB and KR. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2004, PHILOS T R SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Brookes SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009068; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Charleston B, 2011, SCIENCE, V332, P726, DOI 10.1126/science.1199884; COATES DM, 1985, J GEN VIROL, V66, P1627, DOI 10.1099/0022-1317-66-7-1627; Cowling BJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-82; Cui FQ, 2011, J EPIDEMIOL, V21, P271, DOI 10.2188/jea.JE20100119; De Serres G, 2010, EMERG INFECT DIS, V16, P783, DOI 10.3201/eid1605.091894; Donnelly CA, 2011, CLIN INFECT DIS, V52, pS123, DOI 10.1093/cid/ciq028; Duan SS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001022; Elleman CJ, 2004, VIROLOGY, V321, P144, DOI 10.1016/j.virol.2003.12.009; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; France AM, 2010, J INFECT DIS, V201, P984, DOI 10.1086/651145; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Ghani AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004383; Gu Y, 2011, EMERG INFECT DIS, V17, P1737, DOI 10.3201/eid1709.101411; Gustin KM, 2011, P NATL ACAD SCI USA, V108, P8432, DOI 10.1073/pnas.1100768108; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Herlocher ML, 2001, J INFECT DIS, V184, P542, DOI 10.1086/322801; Hermes J, 2011, INFLUENZA OTHER RESP; Jayaraman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017616; Killingley B, 2012, J INFECT DIS, V205, P35, DOI 10.1093/infdis/jir701; Koster F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033118; Lau LLH, 2010, J INFECT DIS, V201, P1509, DOI 10.1086/652241; Lowen Anice C., 2007, Infectious Disorders - Drug Targets, V7, P318; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Pappas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011158; Patrozou E, 2009, PUBLIC HEALTH REP, V124, P193, DOI 10.1177/003335490912400205; Pawelek KA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002588; Piso RJ, 2011, INFECTION, V39, P149, DOI 10.1007/s15010-011-0084-x; REUMAN PD, 1989, J VIROL METHODS, V24, P27, DOI 10.1016/0166-0934(89)90004-9; Roberts KL, 2011, J GEN VIROL; Saenz RA, 2010, J VIROL, V84, P3974, DOI 10.1128/JVI.02078-09; SCHULMAN JL, 1963, J EXP MED, V118, P257, DOI 10.1084/jem.118.2.257; SCHULMAN JL, 1963, J EXP MED, V118, P267, DOI 10.1084/jem.118.2.267; Sheat K, 1992, COMMUNICABLE DIS NZ, V92, P18; Stelzer-Braid S, 2009, J MED VIROL, V81, P1674, DOI 10.1002/jmv.21556; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Yamagishi T, 2010, JPN J INFECT DIS, V63, P327	44	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43303	10.1371/journal.pone.0043303	http://dx.doi.org/10.1371/journal.pone.0043303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952661	Green Submitted, gold, Green Published			2022-12-25	WOS:000308206000030
J	Barker, G; Lim, R; Georgiou, HM; Lappas, M				Barker, Gillian; Lim, Ratana; Georgiou, Harry M.; Lappas, Martha			Omentin-1 Is Decreased in Maternal Plasma, Placenta and Adipose Tissue of Women with Pre-Existing Obesity	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; FACTOR-KAPPA-B; INSULIN-RESISTANCE; IN-VITRO; CIRCULATING OMENTIN; GENE-EXPRESSION; PREGNANCY; GLUCOSE; ADIPOCYTOKINE; INFLAMMATION	Objective: The aim of this study was to determine (i) the effect of maternal obesity and gestational diabetes mellitus (GDM) on (i) the circulating levels of omentin-1 in cord and maternal plasma, and (ii) gene expression and release of omentin-1 from human placenta and adipose tissue. The effect of pregnancy on circulating omentin-1 levels was also determined. Design: Omentin-1 levels were measured in maternal and cord plasma from obese and non-obese normal glucose tolerant women (NGT; n = 44) and women with GDM (n = 39) at the time of term elective Caesarean section. Placenta and adipose tissue expression and release of omentin-1 was measured from 22 NGT and 22 GDM women collected at the time of term elective Caesarean section. Omentin-1 levels were also measured in maternal plasma from 13 NGT women at 11 and 28 weeks gestation and 7 weeks postpartum. Results: Maternal obesity was associated with significantly lower omentin-1 levels in maternal plasma; however, there was no effect of maternal obesity on cord omentin levels. Omentin-1 gene expression was lower in placenta and adipose tissue obtained from women with pre-existing obesity. In addition to this, adipose tissue release of omentin-1 was significantly lower from obese pregnant women. Omentin-1 levels were significantly lower in non-obese GDM compared to non-obese NGT women. However, there was no difference in omentin-1 levels between obese NGT and obese GDM women. There was no effect of GDM on cord omentin levels, and placental and adipose tissue omentin-1 expression. Maternal omentin-1 levels were negatively correlated with fetal birthweight and fetal ponderal index. Conclusions: The data presented in this study demonstrate that pre-existing maternal obesity is associated with lower omentin-1 expression in placenta, adipose tissue and maternal plasma. Alteration in omentin-1 in pregnancy may influence the development of metabolic disorders in offspring later in life.	[Barker, Gillian; Lim, Ratana; Georgiou, Harry M.; Lappas, Martha] Univ Melbourne, Dept Obstet & Gynaecol, Australia Mercy Perinatal Res Ctr, Mercy Hosp Women, Heidelberg, Vic, Australia	University of Melbourne	Barker, G (corresponding author), Univ Melbourne, Dept Obstet & Gynaecol, Australia Mercy Perinatal Res Ctr, Mercy Hosp Women, Heidelberg, Vic, Australia.	mlappas@unimelb.edu.au	Georgiou, A/Prof Harry/C-7143-2008	Georgiou, A/Prof Harry/0000-0003-0553-9489	National Health and Medical Research Council (NHMRC) [454777]; NHMRC [454310]; Medical Research Foundation for Women and Babies	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Foundation for Women and Babies	Dr Martha Lappas was a recipient of a National Health and Medical Research Council (NHMRC) RD Wright Fellowship (grant no. 454777). The work described in this manuscript was funded by a project grant from the NHMRC (grant no. 454310). Funding for the iQ5 multicolour RT-PCR machine (in-part) and xMark Microplate Absorbance Spectrophotometer was provided by the Medical Research Foundation for Women and Babies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal MM, 2005, DIABETIC MED, V22, P1731, DOI 10.1111/j.1464-5491.2005.01706.x; Auguet T, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-60; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Baptiste-Roberts K, 2009, AM J MED, V122, P207, DOI 10.1016/j.amjmed.2008.09.034; Barbour LA, 2007, DIABETES CARE, V30, pS112, DOI 10.2337/dc07-s202; Barker G, 2012, J MATERNAL FETAL NEO; Batista CMDS, 2007, DIABETES, V56, P1655, DOI 10.2337/db06-1506; Briana DD, 2011, METABOLISM, V60, P486, DOI 10.1016/j.metabol.2010.04.014; Cai Run-Ce, 2009, Zhonghua Yi Xue Za Zhi, V89, P381; Catalano PM, 2003, J NUTR, V133, p1674S, DOI 10.1093/jn/133.5.1674S; Chu SY, 2008, NEW ENGL J MED, V358, P1444, DOI 10.1056/NEJMoa0706786; Colomiere M, 2010, J MOL ENDOCRINOL, V44, P213, DOI 10.1677/JME-09-0091; Colomiere M, 2009, EUR J ENDOCRINOL, V160, P567, DOI 10.1530/EJE-09-0031; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Denison FC, 2010, REPRODUCTION, V140, P373, DOI 10.1530/REP-10-0074; Fu M, 2004, DIABETES, V53, pA59; Georgiou HM, 2008, ACTA DIABETOL, V45, P157, DOI 10.1007/s00592-008-0037-8; Hehir MP, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-6; KRZYSZTOF L, 2010, GINEKOL POL, V81, P907; Lappas M, 2004, J CLIN ENDOCR METAB, V89, P2365, DOI 10.1210/jc.2003-031385; Lappas M, 2003, J CLIN ENDOCR METAB, V88, P1723, DOI 10.1210/jc.2002-021677; Lappas M, 2002, BIOL REPROD, V67, P668, DOI 10.1095/biolreprod67.2.668; Lappas M, 2011, BIOL REPROD, V84, P167, DOI 10.1095/biolreprod.110.086983; Lehingue Y, 1998, AM J HUM BIOL, V10, P327, DOI 10.1002/(SICI)1520-6300(1998)10:3<327::AID-AJHB8>3.0.CO;2-F; Liu R, 2011, DIABETES RES CLIN PR, V93, P21, DOI 10.1016/j.diabres.2011.03.001; Moreno-Navarrete JM, 2011, OBESITY, V19, P1552, DOI 10.1038/oby.2010.351; Moreno-Navarrete JM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-27; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Pan HY, 2010, DIABETES RES CLIN PR, V88, P29, DOI 10.1016/j.diabres.2010.01.013; Pathmaperuma AN, 2010, PLACENTA, V31, P230, DOI 10.1016/j.placenta.2009.12.013; Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311; Reynolds LP, 2001, BIOL REPROD, V64, P1033, DOI 10.1095/biolreprod64.4.1033; Salihu HM, 2009, OBSTET GYNECOL, V114, P333, DOI 10.1097/AOG.0b013e3181ae9a47; Tan BK, 2008, DIABETES, V57, P801, DOI 10.2337/db07-0990; Yamawaki H, 2011, BIOCHEM BIOPH RES CO, V408, P339, DOI 10.1016/j.bbrc.2011.04.039; Yan P, 2011, EXP CLIN ENDOCR DIAB, V119, P257, DOI 10.1055/s-0030-1269912; Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004; Yang RZ, 2003, DIABETES, V52, pA1; Zhong X, 2011, ACTA PHARMACOL SIN, V32, P873, DOI 10.1038/aps.2011.26	39	50	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e42943	10.1371/journal.pone.0042943	http://dx.doi.org/10.1371/journal.pone.0042943			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952622	Green Published, gold, Green Submitted			2022-12-25	WOS:000308213600010
J	Husek, J; Weidinger, K; Adamik, P; Slagsvold, T				Husek, Jan; Weidinger, Karel; Adamik, Peter; Slagsvold, Tore			Impact of Nesting Mortality on Avian Breeding Phenology: A Case Study on the Red-Backed Shrike (Lanius collurio)	PLOS ONE			English	Article							CLUTCH SIZE VARIATION; LIFE-HISTORY; CLIMATE-CHANGE; PREDATION RISK; SEASONAL DECLINES; HABITAT SELECTION; POPULATION-SIZE; ARRIVAL DATE; TITS PARUS; REPRODUCTION	The seasonal timing of avian reproduction is supposed primarily to coincide with favourable feeding conditions. Long-term changes in avian breeding phenology are thus mostly scrutinized in relation to climatic factors and matching of the food supplies, while the role of nesting mortality is largely unexplored. Here we show that higher seasonal mean daily mortality rate leads to a shift in the distribution of breeding times of the successful nests to later dates in an an open-nesting passerine bird, the red-backed shrike Lanius collurio. The effect appeared to be strong enough to enhance or counteract the influence of climatic factors and breeding density on the inter-annual variation in mean hatching dates. Moreover, the seasonal distribution of reproductive output was shifted to larger, or smaller, broods early in the season when the nesting mortality increased, or decreased, respectively, during the season. We suggest that population level changes in timing of breeding caused by a general advancement of spring and of the food supplies might be altered by the seasonality in nesting mortality. Hence, we argue that consideration of nesting mortality is of major importance for understanding long-term trends in avian phenology, particularly in species capable of renesting.	[Husek, Jan; Slagsvold, Tore] Univ Oslo, Dept Biol, CEES, Oslo, Norway; [Weidinger, Karel; Adamik, Peter] Palacky Univ, Ornithol Lab, CR-77147 Olomouc, Czech Republic; [Weidinger, Karel; Adamik, Peter] Palacky Univ, Dept Zool, CR-77147 Olomouc, Czech Republic; [Adamik, Peter] Museum Nat Hist, Olomouc, Czech Republic	University of Oslo; Palacky University Olomouc; Palacky University Olomouc; National Museum	Husek, J (corresponding author), Univ Oslo, Dept Biol, CEES, Oslo, Norway.	jan.husek@bio.uio.no	Husek, Jan/R-9513-2019; Adamik, Peter/I-2057-2013; Husek, Jan/AAP-8012-2020; Weidinger, Karel/J-6758-2012; Adamik, Peter/AFK-0073-2022	Adamik, Peter/0000-0003-1566-1234; Husek, Jan/0000-0001-9589-8519; Adamik, Peter/0000-0003-1566-1234	Centre for Ecological and Evolutionary Synthesis (CEES), Department of Biology, University of Oslo; Czech Science Foundation [GACR 206/07/0483]; Ministry of Education of the Czech Republic [MSM 6198959212]	Centre for Ecological and Evolutionary Synthesis (CEES), Department of Biology, University of Oslo; Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This study was supported by the Centre for Ecological and Evolutionary Synthesis (CEES), Department of Biology, University of Oslo; by the Czech Science Foundation (GACR 206/07/0483) and by the Ministry of Education of the Czech Republic (MSM 6198959212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamik P, 2008, J ZOOL, V275, P209, DOI 10.1111/j.1469-7998.2008.00415.x; Antczak M, 2009, ETHOL ECOL EVOL, V21, P127, DOI 10.1080/08927014.2009.9522501; ARNOLD SJ, 1984, EVOLUTION, V38, P709, DOI 10.1111/j.1558-5646.1984.tb00344.x; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; BRINKHOF MWG, 1993, J ANIM ECOL, V62, P577, DOI 10.2307/5206; Chmielewski FM, 2005, INT J BIOMETEOROL, V50, P96, DOI 10.1007/s00484-005-0275-1; Coppack T, 2004, ADV ECOL RES, V35, P131, DOI 10.1016/S0065-2504(04)35007-5; COULSON J. C, 1960, IBIS, V102, P71; Cramp S., 1993, BIRDS W PALEARCTIC, V7; Decker KL, 2012, EVOL ECOL, V26, P683, DOI 10.1007/s10682-011-9521-7; Einum S, 2000, EVOLUTION, V54, P628, DOI 10.1111/j.0014-3820.2000.tb00064.x; Fontaine JJ, 2006, AM NAT, V168, P811, DOI 10.1086/508297; GEER TA, 1982, IBIS, V124, P159, DOI 10.1111/j.1474-919X.1982.tb03754.x; Gotmark F, 2002, OECOLOGIA, V130, P25, DOI 10.1007/s004420100769; Hahn TP, 2008, PHILOS T R SOC B, V363, P267, DOI 10.1098/rstb.2007.2139; Hairston N.G. Jr, 1987, P281; Husek Jan, 2006, Sylvia, V42, P38; Husek J, 2008, J ORNITHOL, V149, P97, DOI 10.1007/s10336-007-0222-5; Husek J, 2010, ACTA ORNITHOL, V45, P43, DOI 10.3161/000164510X516074; Husek J, 2009, ANN ZOOL FENN, V46, P439, DOI 10.5735/086.046.0605; LACK D, 1950, IBIS, V92, P288, DOI 10.1111/j.1474-919X.1950.tb01753.x; LANDA K, 1992, EVOLUTION, V46, P121, DOI [10.1111/j.1558-5646.1992.tb01989.x, 10.2307/2409809]; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.1111/j.1558-5646.1983.tb00236.x, 10.2307/2408842]; Li DQ, 2002, P ROY SOC B-BIOL SCI, V269, P2155, DOI 10.1098/rspb.2002.2140; LINDEN M, 1989, TRENDS ECOL EVOL, V4, P367, DOI 10.1016/0169-5347(89)90101-8; MOller AP, 2010, EFFECTS CLIMATE CHAN; Monkkonen M, 2009, BIOL LETTERS, V5, P176, DOI 10.1098/rsbl.2008.0631; Morosinotto C, 2010, J ANIM ECOL, V79, P327, DOI 10.1111/j.1365-2656.2009.01638.x; MORTON ES, 1971, SCIENCE, V171, P920, DOI 10.1126/science.171.3974.920; Muller M, 2005, OECOLOGIA, V143, P37, DOI 10.1007/s00442-004-1770-5; Naef-Daenzer B, 2001, J ANIM ECOL, V70, P730, DOI 10.1046/j.0021-8790.2001.00533.x; Nagy LR, 2005, ECOLOGY, V86, P675, DOI 10.1890/04-0155; Nietschke BS, 2007, CROP PROT, V26, P1444, DOI 10.1016/j.cropro.2006.12.006; Nilsson JA, 1996, P ROY SOC B-BIOL SCI, V263, P711, DOI 10.1098/rspb.1996.0106; NILSSON JA, 1988, J ANIM ECOL, V57, P917, DOI 10.2307/5101; Perrins CM, 1970, P BIOL SCI, V276, p[112, 288]; PIENKOWSKI MW, 1984, J ZOOL, V202, P83; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; Preston KL, 2006, CONDOR, V108, P832, DOI 10.1650/0010-5422(2006)108[832:TROFNP]2.0.CO;2; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ricklefs R., 1969, SMITHSON CONTRIB ZOO, P1, DOI [10.5479/si.00810282.9, DOI 10.5479/SI.00810282.9]; Saino N, 2011, P ROY SOC B-BIOL SCI, V278, P835, DOI 10.1098/rspb.2010.1778; *SAS I INC, 2004, SAS ONL DOC; Scheuerlein A, 2001, P ROY SOC B-BIOL SCI, V268, P1575, DOI 10.1098/rspb.2001.1691; Schmidt KA, 2010, OIKOS, V119, P245, DOI 10.1111/j.1600-0706.2009.17824.x; Schwartz M.D., 2003, PHENOLOGY INTEGRATIV; Shaffer TL, 2004, AUK, V121, P526, DOI 10.1642/0004-8038(2004)121[0526:AUATAN]2.0.CO;2; Shine R, 2008, PHILOS T R SOC B, V363, P363, DOI 10.1098/rstb.2007.2144; SIH A, 1993, AM NAT, V142, P947, DOI 10.1086/285583; Siriwardena GM, 2000, J APPL ECOL, V37, P128, DOI 10.1046/j.1365-2664.2000.00484.x; SLAGSVOLD T, 1984, J ANIM ECOL, V53, P945, DOI 10.2307/4669; SLAGSVOLD T, 1982, OECOLOGIA, V54, P159, DOI 10.1007/BF00378388; SMITH HG, 1989, J ANIM ECOL, V58, P383, DOI 10.2307/4837; Sparks TH, 2010, ECOL ENTOMOL, V35, P788, DOI 10.1111/j.1365-2311.2010.01226.x; Stenseth NC, 2002, P NATL ACAD SCI USA, V99, P13379, DOI 10.1073/pnas.212519399; Svensson E, 1997, EVOLUTION, V51, P1276, DOI 10.1111/j.1558-5646.1997.tb03974.x; Thomas DW, 2001, SCIENCE, V291, P2598, DOI 10.1126/science.1057487; Tryjanowski P, 2003, BELG J ZOOL, V133, P157; Tryjanowski P, 2001, INT J BIOMETEOROL, V45, P217, DOI 10.1007/s00484-001-0112-0; VANNOORDWIJK AJ, 1995, J ANIM ECOL, V64, P451, DOI 10.2307/5648; Varpe O, 2007, OIKOS, V116, P1331, DOI 10.1111/j.2007.0030-1299.15893.x; Vegvari Z, 2010, GLOBAL CHANGE BIOL, V16, P1, DOI 10.1111/j.1365-2486.2009.01876.x; Verboven N, 2001, ARDEA, V89, P387; VERHULST S, 1991, J ANIM ECOL, V60, P269, DOI 10.2307/5459; Verhulst S, 2008, PHILOS T R SOC B, V363, P399, DOI 10.1098/rstb.2007.2146; Visser ME, 2009, P ROY SOC B-BIOL SCI, V276, P2323, DOI 10.1098/rspb.2009.0213; Vonesh JR, 2005, OIKOS, V110, P241, DOI 10.1111/j.0030-1299.2005.13759.x; WIKLUND CG, 1984, BEHAV ECOL SOCIOBIOL, V15, P311, DOI 10.1007/BF00292994; Winkler DW, 2002, P NATL ACAD SCI USA, V99, P13595, DOI 10.1073/pnas.212251999; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wright LJ, 2009, J ANIM ECOL, V78, P1191, DOI 10.1111/j.1365-2656.2009.01582.x; YOUNG BE, 1994, CONDOR, V96, P341, DOI 10.2307/1369319	73	3	3	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43944	10.1371/journal.pone.0043944	http://dx.doi.org/10.1371/journal.pone.0043944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937131	Green Published, gold, Green Submitted			2022-12-25	WOS:000308213600062
J	Seehase, S; Lauenstein, HD; Schlumbohm, C; Switalla, S; Neuhaus, V; Forster, C; Fieguth, HG; Pfennig, O; Fuchs, E; Kaup, FJ; Bleyer, M; Hohlfeld, JM; Braun, A; Sewald, K; Knauf, S				Seehase, Sophie; Lauenstein, Hans-Dieter; Schlumbohm, Christina; Switalla, Simone; Neuhaus, Vanessa; Foerster, Christine; Fieguth, Hans-Gerd; Pfennig, Olaf; Fuchs, Eberhard; Kaup, Franz-Josef; Bleyer, Martina; Hohlfeld, Jens M.; Braun, Armin; Sewald, Katherina; Knauf, Sascha			LPS-Induced Lung Inflammation in Marmoset Monkeys - An Acute Model for Anti-Inflammatory Drug Testing	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CALLITHRIX-JACCHUS; NONHUMAN PRIMATE; COMMON MARMOSET; ANIMAL-MODELS; PHOSPHODIESTERASE-4 INHIBITOR; LIPOPOLYSACCHARIDE EXPOSURE; BACTERIAL-ENDOTOXIN; HEALTHY-SUBJECTS; ROFLUMILAST	Increasing incidence and substantial morbidity and mortality of respiratory diseases requires the development of new human-specific anti-inflammatory and disease-modifying therapeutics. Therefore, new predictive animal models that closely reflect human lung pathology are needed. In the current study, a tiered acute lipopolysaccharide (LPS)-induced inflammation model was established in marmoset monkeys (Callithrix jacchus) to reflect crucial features of inflammatory lung diseases. Firstly, in an ex vivo approach marmoset and, for the purposes of comparison, human precision-cut lung slices (PCLS) were stimulated with LPS in the presence or absence of the phosphodiesterase-4 (PDE4) inhibitor roflumilast. Pro-inflammatory cytokines including tumor necrosis factor-alpha (TNF-alpha) and macrophage inflammatory protein-1 beta (MIP-1 beta) were measured. The corticosteroid dexamethasone was used as treatment control. Secondly, in an in vivo approach marmosets were pre-treated with roflumilast or dexamethasone and unilaterally challenged with LPS. Ipsilateral bronchoalveolar lavage (BAL) was conducted 18 hours after LPS challenge. BAL fluid was processed and analyzed for neutrophils, TNF-alpha, and MIP-1 beta. TNF-alpha release in marmoset PCLS correlated significantly with human PCLS. Roflumilast treatment significantly reduced TNF-alpha secretion ex vivo in both species, with comparable half maximal inhibitory concentration (IC50). LPS instillation into marmoset lungs caused a profound inflammation as shown by neutrophilic influx and increased TNF-alpha and MIP-1 beta levels in BAL fluid. This inflammatory response was significantly suppressed by roflumilast and dexamethasone. The close similarity of marmoset and human lungs regarding LPS-induced inflammation and the significant anti-inflammatory effect of approved pharmaceuticals assess the suitability of marmoset monkeys to serve as a promising model for studying anti-inflammatory drugs.	[Seehase, Sophie; Lauenstein, Hans-Dieter; Switalla, Simone; Neuhaus, Vanessa; Hohlfeld, Jens M.; Braun, Armin; Sewald, Katherina; Knauf, Sascha] Fraunhofer Inst Toxicol & Expt Med, Hannover, Germany; [Seehase, Sophie; Lauenstein, Hans-Dieter; Kaup, Franz-Josef; Bleyer, Martina; Knauf, Sascha] Leibniz Inst Primate Res, Pathol Unit, German Primate Ctr, Gottingen, Germany; [Schlumbohm, Christina; Fuchs, Eberhard] Encepharm GmbH, Gottingen, Germany; [Foerster, Christine; Pfennig, Olaf] Klinikum Reg Hannover Klinikum Nordstadt, Inst Pathol, Hannover, Germany; [Fieguth, Hans-Gerd] Klinikum Reg Hannover Klinikum Oststadt Heidehaus, Div Thorac Surg, Hannover, Germany	Fraunhofer Gesellschaft; Deutsches Primatenzentrum (DPZ)	Seehase, S (corresponding author), Fraunhofer Inst Toxicol & Expt Med, Hannover, Germany.	katherina.sewald@item.fraunhofer.de; sascha.knauf@item.fraunhofer.de	Braun, Armin/B-8750-2009; Knauf, Sascha/F-1661-2017	Braun, Armin/0000-0002-1142-1463; Knauf, Sascha/0000-0001-5744-4946; Hohlfeld, Jens/0000-0003-2646-6186; Fieguth, Hans G./0000-0003-1559-158X	Fraunhofer Society; AstraZeneca; Novartis; Nycomed; Pfizer	Fraunhofer Society; AstraZeneca(AstraZeneca); Novartis(Novartis); Nycomed; Pfizer(Pfizer)	The work was funded by the Fraunhofer Society. The Fraunhofer ITEM is a public non-profit research organisation doing contract research for e. g. pharmaceutical and biotech industry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Fraunhofer ITEM is a public non-profit research organisation doing contract research for e. g. pharmaceutical and biotech industry. The institution of JMH has received research grants from AstraZeneca, Novartis, Nycomed, and Pfizer to conduct clinical trials using LPS-induced inflammation. Encepharm is a research organisation doing contract research for e. g. pharmaceutical and biotech industry. The institution has received no grants to conduct preclinical trials using LPS-induced inflammation in marmoset monkeys. Encepharm confirms that this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. CF declares affiliation to the company Klinikum Region Hannover GmbH. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Barbier A, 2000, RESP PHYSIOL, V120, P167, DOI 10.1016/S0034-5687(00)00105-5; Barnes PJ, 2006, LAB INVEST, V86, P867, DOI 10.1038/labinvest.3700456; Barnes Peter J, 2004, COPD, V1, P59, DOI 10.1081/COPD-120028701; Barnes PJ, 2004, PHARMACOL REV, V56, P515, DOI 10.1124/pr.56.4.2; Bergers WWA, 2004, INHAL TOXICOL, V16, P141, DOI 10.1080/08958370490270963; Bundschuh DS, 2001, J PHARMACOL EXP THER, V297, P280; Cazzola M, 2012, EUR RESP J; Chrousos G.P., 1986, Advances in Experimental Medicine and Biology, V196, P129; Coffman RL, 2005, J EXP MED, V201, P1875, DOI 10.1084/jem.20050901; de Marco R, 2007, AM J RESP CRIT CARE, V175, P32, DOI 10.1164/rccm.200603-381OC; European Medicines Agency, 2009, EMEAHC001109; Fabbri LM, 2010, NAT REV DRUG DISCOV, V9, P761, DOI 10.1038/nrd3276; Faffe DS, 2000, EUR RESPIR J, V15, P85, DOI 10.1183/09031936.00.15108500; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Gross NJ, 2010, COPD, V7, P141, DOI 10.3109/15412551003758304; Hanania NA, 2011, RESPIR MED SER, P1, DOI 10.1007/978-1-59745-357-8; Hasday JD, 1999, CHEST, V115, P829, DOI 10.1378/chest.115.3.829; Hicks A, 2010, INFLAMMATION, V33, P144, DOI 10.1007/s10753-009-9168-5; Hohlfeld JM, 2008, PULM PHARMACOL THER, V21, P616, DOI 10.1016/j.pupt.2008.02.002; Igarashi T, 1997, ARCH BIOCHEM BIOPHYS, V339, P85, DOI 10.1006/abbi.1996.9852; Jagessar SA, 2011, J NEUROIMMUNE PHARM; Kap YS, 2010, J NEUROIMMUNE PHARM, V5, P220, DOI 10.1007/s11481-009-9178-y; KENNEDY SM, 1987, AM REV RESPIR DIS, V135, P194; Kohu K, 2008, TOHOKU J EXP MED, V215, P167, DOI 10.1620/tjem.215.167; Kurata Y, 1997, TOXICOL LETT, V92, P209, DOI 10.1016/S0378-4274(97)00059-3; Lamontagne F, 2010, J CRIT CARE, V25, P420, DOI 10.1016/j.jcrc.2009.08.009; Lunniss CJ, 2009, BIOORG MED CHEM LETT, V19, P1380, DOI 10.1016/j.bmcl.2009.01.045; Mansfield K, 2003, COMPARATIVE MED, V53, P383; Maris NA, 2005, AM J RESP CRIT CARE, V172, P878, DOI 10.1164/rccm.200503-451OC; Martinez FJ, 2011, LANCET, V378, P1027, DOI 10.1016/S0140-6736(11)61047-7; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Michel O, 2007, PULM PHARMACOL THER, V20, P676, DOI 10.1016/j.pupt.2006.08.002; Mitchell LA, 2010, AM J PHYSIOL-LUNG C, V299, pL891, DOI 10.1152/ajplung.00366.2009; NEUBERT R, 1997, DRUG TOXICITY EMBRYO, P41; O'Grady NP, 2001, AM J RESP CRIT CARE, V163, P1591, DOI 10.1164/ajrccm.163.7.2009111; Plopper CG, 2008, PULM PHARMACOL THER, V21, P755, DOI 10.1016/j.pupt.2008.01.008; Rocco PRM, 2003, EUR RESPIR J, V22, P20, DOI 10.1183/09031936.03.00108603; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sakuma T, 1997, CARCINOGENESIS, V18, P1985, DOI 10.1093/carcin/18.10.1985; SANDSTROM T, 1992, EUR RESPIR J, V5, P992; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Seehase S, 2011, J APPL PHYSIOL, V111, P791, DOI 10.1152/japplphysiol.00162.2011; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Smith D, 2001, LAB ANIM-UK, V35, P117, DOI 10.1258/0023677011911444; Switalla S., 2010, TOXICOL APPL PHARM; Thorn J, 1998, THORAX, V53, P1047, DOI 10.1136/thx.53.12.1047; Toward TJ, 2001, J PHARMACOL EXP THER, V298, P298; Tralau-Stewart CJ, 2011, J PHARMACOL EXP THER, V337, P145, DOI 10.1124/jpet.110.173690; Vernooy JHJ, 2002, AM J RESP CELL MOL, V26, P152, DOI 10.1165/ajrcmb.26.1.4652; Whelan G, 1999, LAB ANIM, V33, P24, DOI 10.1258/002367799780578453; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008	52	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43709	10.1371/journal.pone.0043709	http://dx.doi.org/10.1371/journal.pone.0043709			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952743	Green Published, Green Submitted, gold			2022-12-25	WOS:000308213600038
J	Yanez, C; Canete-Rosales, P; Castillo, JP; Catalan, N; Undabeytia, T; Morillo, E				Yanez, Claudia; Canete-Rosales, Paulina; Pablo Castillo, Juan; Catalan, Nicole; Undabeytia, Tomas; Morillo, Esmeralda			Cyclodextrin Inclusion Complex to Improve Physicochemical Properties of Herbicide Bentazon: Exploring Better Formulations	PLOS ONE			English	Article							BETA-CYCLODEXTRIN; PHOTODEGRADATION; NORFLURAZON; SOLUBILITY; DEGRADATION; TOXICITY; SOILS	The knowledge of the host-guest complexes using cyclodextrins (CDs) has prompted an increase in the development of new formulations. The capacity of these organic host structures of including guest within their hydrophobic cavities, improves physicochemical properties of the guest. In the case of pesticides, several inclusion complexes with cyclodextrins have been reported. However, in order to explore rationally new pesticide formulations, it is essential to know the effect of cyclodextrins on the properties of guest molecules. In this study, the inclusion complexes of bentazon (Btz) with native beta CD and two derivatives, 2-hydroxypropyl-beta-cyclodextrin (HPCD) and sulfobutylether-beta-cyclodextrin (SBECD), were prepared by two methods: kneading and freeze-drying, and their characterization was investigated with different analytical techniques including Fourier transform infrared spectroscopy (FT-IR), differential thermal analysis (DTA), X-ray diffractometry (XRD) and differential pulse voltammetry (DPV). All these approaches indicate that Btz forms inclusion complexes with CDs in solution and in solid state, with a stoichiometry of 1: 1, although some of them are obtained in mixtures with free Btz. The calculated association constant of the Btz/HPCD complex by DPV was 244 +/- 19 M-1 being an intermediate value compared with those obtained with beta CD and SBECD. The use of CDs significantly increases Btz photostability, and depending on the CDs, decreases the surface tension. The results indicated that bentazon forms inclusion complexes with CDs showing improved physicochemical properties compared to free bentazon indicating that CDs may serve as excipient in herbicide formulations.	[Yanez, Claudia; Canete-Rosales, Paulina; Pablo Castillo, Juan; Catalan, Nicole] Univ Chile, Dept Quim Organ & Fisicoquim, Fac Ciencias Quim & Farmaceut, Santiago, Chile; [Undabeytia, Tomas; Morillo, Esmeralda] CSIC, Inst Recursos Nat & Agrobiol, Seville, Spain	Universidad de Chile; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS)	Yanez, C (corresponding author), Univ Chile, Dept Quim Organ & Fisicoquim, Fac Ciencias Quim & Farmaceut, Santiago, Chile.	cyanez@ciq.uchile.cl	Yañez, Claudia A/I-2840-2013; Sierra-Rosales, Paulina/K-4733-2019; Morillo, Esmeralda/E-2180-2017	Sierra-Rosales, Paulina/0000-0001-7077-785X; Morillo, Esmeralda/0000-0002-4485-2315	Fondecyt [1090254]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This research was supported by Fondecyt, grant 1090254 (http://www.fondecyt.cl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Agency USEP Programs OoP], 1985, CHEM FACT SHEET BENT; ALKHATIB K, 1995, WEED TECHNOL, V9, P426, DOI 10.1017/S0890037X00023630; Carrizosa MJ, 2004, SOIL SCI SOC AM J, V68, P1863, DOI 10.2136/sssaj2004.1863; Davezza M, 2012, CHEMOSPHERE, V86, P335, DOI 10.1016/j.chemosphere.2011.09.011; Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9; Dodziuk H., 2006, CYCLODEXTRINS THEIR; Dua Kamal, 2007, Current Drug Delivery, V4, P21, DOI 10.2174/156720107779314776; Food and Agriculture Organization Of The United Nations F, 1999, SPEC SPEC EV PLANT P; Galhano V, 2010, ENVIRON TOXICOL, V25, P147, DOI 10.1002/tox.20486; de Araujo MV, 2007, BIOORGAN MED CHEM, V15, P5752, DOI 10.1016/j.bmc.2007.06.013; Ge X, 2011, SPECTROCHIM ACTA A, V81, P397, DOI 10.1016/j.saa.2011.06.028; Hanna K, 2004, SCI TOTAL ENVIRON, V332, P51, DOI 10.1016/j.scitotenv.2004.04.022; Hashimoto H, 2002, J INCL PHENOM MACRO, V44, P57, DOI 10.1023/A:1023036406829; Ibrahim MS, 2002, J PHARMACEUT BIOMED, V28, P217, DOI 10.1016/S0731-7085(01)00624-0; [International Program on Chemical S International Labour O World Health O United Nations Environment P], 1990, BENT HLTH SAF GUID; Job P, 1928, ANN CHIM FRANCE, V9, P113; KAMIYA M, 1995, ENVIRON INT, V21, P299, DOI 10.1016/0160-4120(95)00026-H; Kawasaki N, 2001, J COLLOID INTERF SCI, V238, P215, DOI 10.1006/jcis.2001.7517; Leclercq L, 2007, J COLLOID INTERF SCI, V307, P481, DOI 10.1016/j.jcis.2006.12.001; Loftsson T, 1996, J PHARM SCI, V85, P1017, DOI 10.1021/js950534b; Mayo D. W., 2004, COURSE NOTES INTERPR; Misiuk W, 2009, CARBOHYD POLYM, V77, P482, DOI 10.1016/j.carbpol.2009.01.033; Morillo E, 2006, CYCLODEXTRINS THEIR, P459; Mount D, 2005, Patent No. [6,896,892, 6896892]; Nogueiras-Nieto L, 2009, J PHYS CHEM B, V113, P2773, DOI 10.1021/jp809806w; Orgovanyi J, 2005, MICROCHEM J, V79, P77, DOI 10.1016/j.microc.2004.10.022; Perez-Martinez JI, 1999, CHEMOSPHERE, V39, P2047, DOI 10.1016/S0045-6535(99)00093-4; Peschka M, 2007, ANAL BIOANAL CHEM, V388, P1227, DOI 10.1007/s00216-007-1349-1; Porini JA, 2011, ANAL METHODS-UK, V3, P1494, DOI 10.1039/c1ay05028a; POURATA R, 2009, DESALINATION, V249, P301, DOI [DOI 10.1016/J.DESAL.2008.10.033, DOI 10.1016/j.desal.2008.10.033]; Ribeiro AB, 2011, SEP PURIF TECHNOL, V79, P193, DOI 10.1016/j.seppur.2011.01.045; Szejtli J, 2004, PURE APPL CHEM, V76, P1825, DOI 10.1351/pac200476101825; Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c; Ureta-Zanartu MS, 2004, J ELECTROANAL CHEM, V569, P275, DOI 10.1016/j.jelechem.2004.03.011; Villaverde J, 2005, CHEMOSPHERE, V60, P656, DOI 10.1016/j.chemosphere.2005.01.030; Villaverde J, 2004, J AGR FOOD CHEM, V52, P864, DOI 10.1021/jf0350358; Villaverde J, 2007, CHEMOSPHERE, V69, P575, DOI 10.1016/j.chemosphere.2007.03.022; Villaverde J, 2007, J HAZARD MATER, V142, P184, DOI 10.1016/j.jhazmat.2006.08.005; Yanez C, 2003, ELECTROANAL, V15, P1771, DOI 10.1002/elan.200302720; Yanez C, 2010, J INCL PHENOM MACRO, V68, P237, DOI 10.1007/s10847-010-9750-3; Yanez C, 2007, J PHYS ORG CHEM, V20, P499, DOI 10.1002/poc.1186; Zeng Q, 2003, B ENVIRON CONTAM TOX, V71, P668, DOI 10.1007/s00128-003-0185-z	42	46	46	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e41072	10.1371/journal.pone.0041072	http://dx.doi.org/10.1371/journal.pone.0041072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952577	Green Published, gold, Green Submitted			2022-12-25	WOS:000308044800004
J	Zang, QS; Martinez, B; Yao, X; Maass, DL; Ma, LS; Wolf, SE; Minei, JP				Zang, Qun S.; Martinez, Bobbie; Yao, Xiao; Maass, David L.; Ma, Lisha; Wolf, Steven E.; Minei, Joseph P.			Sepsis-Induced Cardiac Mitochondrial Dysfunction Involves Altered Mitochondrial-Localization of Tyrosine Kinase Src and Tyrosine Phosphatase SHP2	PLOS ONE			English	Article							ADENINE-NUCLEOTIDE TRANSLOCASE; ORGAN DYSFUNCTION; BURN INJURY; OXIDATIVE-PHOSPHORYLATION; SEPTIC SHOCK; IDENTIFICATION; PROTEINS; FAILURE; ASSOCIATION; SUPEROXIDE	Our previous research demonstrated that sepsis produces mitochondrial dysfunction with increased mitochondrial oxidative stress in the heart. The present study investigated the role of mitochondria-localized signaling molecules, tyrosine kinase Src and tyrosine phosphatase SHP2, in sepsis-induced cardiac mitochondrial dysfunction using a rat pneumonia-related sepsis model. SD rats were given an intratracheal injection of Streptococcus pneumoniae, 4610 6 CFU per rat, (or vehicle for shams); heart tissues were then harvested and subcellular fractions were prepared. By Western blot, we detected a gradual and significant decrease in Src and an increase in SHP2 in cardiac mitochondria within 24 hours post-inoculation. Furthermore, at 24 hours post-inoculation, sepsis caused a near 70% reduction in tyrosine phosphorylation of all cardiac mitochondrial proteins. Decreased tyrosine phosphorylation of certain mitochondrial structural proteins (porin, cyclophilin D and cytochrome C) and functional proteins (complex II subunit 30kD and complex I subunit NDUFB8) were evident in the hearts of septic rats. In vitro, pre-treatment of mitochondrial fractions with recombinant active Src kinase elevated OXPHOS complex I and II-III activity, whereas the effect of SHP2 phosphatase was opposite. Neither Src nor SHP2 affected complex IV and V activity under the same conditions. By immunoprecipitation, we showed that Src and SHP2 consistently interacted with complex I and III in the heart, suggesting that complex I and III contain putative substrates of Src and SHP2. In addition, in vitro treatment of mitochondrial fractions with active Src suppressed sepsis-associated mtROS production and protected aconitase activity, an indirect marker of mitochondrial oxidative stress. On the contrary, active SHP2 phosphatase overproduced mtROS and deactivated aconitase under the same in vitro conditions. In conclusion, our data suggest that changes in mitochondria-localized signaling molecules Src and SHP2 constitute a potential signaling pathway to affect mitochondrial dysfunction in the heart during sepsis.	[Zang, Qun S.; Martinez, Bobbie; Yao, Xiao; Maass, David L.; Ma, Lisha; Wolf, Steven E.; Minei, Joseph P.] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Zang, QS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA.	qun.zang@utsouthwestern.edu		Zang, Qun (Sophia)/0000-0002-6397-8896; Wolf, Steven/0000-0003-2972-3440	American Heart Association [09BGIA2220114]; University of Texas Southwestern Medical Center (UTSW) Department of Surgery	American Heart Association(American Heart Association); University of Texas Southwestern Medical Center (UTSW) Department of Surgery	This project was supported by American Heart Association south central affiliate Beginning-in-Aid Grant 09BGIA2220114 and University of Texas Southwestern Medical Center (UTSW) Department of Surgery internal funding to Q. S. Zang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 2004, J NEUROCHEM, V89, P248, DOI 10.1111/j.1471-4159.2004.02323.x; Angus Derek C., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P207; Arachiche A, 2008, J BIOL CHEM, V283, P24406, DOI 10.1074/jbc.M709217200; Augereau O, 2005, CELL MOL LIFE SCI, V62, P1478, DOI 10.1007/s00018-005-5005-7; Ballinger SW, 2005, FREE RADICAL BIO MED, V38, P1278, DOI 10.1016/j.freeradbiomed.2005.02.014; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Budas GR, 2010, CARDIOVASC RES, V88, P83, DOI 10.1093/cvr/cvq154; Cairns CB, 1997, J TRAUMA, V42, P532, DOI 10.1097/00005373-199703000-00023; Callahan LA, 2007, J APPL PHYSIOL, V102, P44, DOI 10.1152/japplphysiol.01204.2005; Chatelain EH, 2011, CELL MOL LIFE SCI, V68, P2603, DOI 10.1007/s00018-010-0573-6; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chou HC, 2010, FREE RADICAL BIO MED, V49, P96, DOI 10.1016/j.freeradbiomed.2010.04.001; Court O, 2002, CRIT CARE, V6, P500, DOI 10.1186/cc1822; Crouser ED, 2004, MITOCHONDRION, V4, P729, DOI 10.1016/j.mito.2004.07.023; Deng N, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000117; Di Pancrazio F, 2006, PROTEOMICS, V6, P921, DOI 10.1002/pmic.200500077; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Feng JH, 2010, AM J PHYSIOL-CELL PH, V298, pC740, DOI 10.1152/ajpcell.00310.2009; Fink MP, 2002, CRIT CARE, V6, P491, DOI 10.1186/cc1824; Fink MP, 2001, CRIT CARE CLIN, V17, P219, DOI 10.1016/S0749-0704(05)70161-5; Fullerton JN, 2011, SEMIN RESP CRIT CARE, V32, P581, DOI 10.1055/s-0031-1287866; Greenhalgh DG, 2007, J BURN CARE RES, V28, P776, DOI 10.1097/BCR.0b013e3181599bc9; Gu YP, 2001, MOL CELL BIOCHEM, V223, P35, DOI 10.1023/A:1017941625858; Guo JF, 2010, AM J PHYSIOL-CELL PH, V299, pC770, DOI 10.1152/ajpcell.00170.2010; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; Hebert-Chatelain E, 2012, BBA-BIOENERGETICS, V1817, P718, DOI 10.1016/j.bbabio.2012.01.014; Jakob S, 2009, AGING-US, V1, P664, DOI 10.18632/aging.100063; Japiassu AM, 2011, CRIT CARE MED, V39, P1056, DOI 10.1097/CCM.0b013e31820eda5c; KAYAR SR, 1987, RESP PHYSIOL, V70, P275, DOI 10.1016/0034-5687(87)90010-7; Korge P, 2008, CIRC RES, V103, P873, DOI 10.1161/CIRCRESAHA.108.180869; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Levy RJ, 2007, SHOCK, V28, P24, DOI 10.1097/01.shk.0000235089.30550.2d; Lewandrowski U, 2008, FEBS LETT, V582, P1104, DOI 10.1016/j.febslet.2008.02.077; LUNARDI J, 1991, J BIOL CHEM, V266, P16534; Melendez J, 2004, J BIOL CHEM, V279, P53516, DOI 10.1074/jbc.M408475200; Miyazaki T, 2003, J CELL BIOL, V160, P709, DOI 10.1083/jcb.200209098; Monick MM, 2008, J IMMUNOL, V180, P7485, DOI 10.4049/jimmunol.180.11.7485; O'Brien JM, 2007, AM J MED, V120, P1012, DOI 10.1016/j.amjmed.2007.01.035; PARRILLO JE, 1990, ANN INTERN MED, V113, P227, DOI 10.7326/0003-4819-113-3-227; Puceat M, 1998, J CELL BIOL, V141, P1637, DOI 10.1083/jcb.141.7.1637; Rudiger A, 2007, CRIT CARE MED, V35, P1599, DOI 10.1097/01.CCM.0000266683.64081.02; Ruggieri AJ, 2010, CRIT CARE CLIN, V26, P567, DOI 10.1016/j.ccc.2010.04.007; Sabri A, 2003, J BIOL CHEM, V278, P11714, DOI 10.1074/jbc.M213091200; Salvi M, 2002, BBA-MOL CELL RES, V1589, P181, DOI 10.1016/S0167-4889(02)00174-X; Salvi M, 2007, FEBS LETT, V581, P5579, DOI 10.1016/j.febslet.2007.11.005; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sheeran PW, 1998, J SURG RES, V76, P192, DOI 10.1006/jsre.1998.5352; Starkov AA, 2010, METHODS MOL BIOL, V648, P245, DOI 10.1007/978-1-60761-756-3_16; Tao WK, 2005, SHOCK, V24, P495, DOI 10.1097/01.shk.0000183431.78973.cd; Tibaldi E, 2008, J CELL BIOCHEM, V104, P840, DOI 10.1002/jcb.21670; Tsutsui Hiroyuki, 2008, Circ J, V72 Suppl A, pA31, DOI 10.1253/circj.CJ-08-0014; Vyssokikh MY, 2003, ACTA BIOCHIM POL, V50, P389; Wang L, 2010, BURNS, V36, P232, DOI 10.1016/j.burns.2009.02.019; Wang YX, 2011, AM J PHYSIOL-CELL PH, V301, pC695, DOI 10.1152/ajpcell.00322.2010; Watts JA, 2004, J MOL CELL CARDIOL, V36, P141, DOI 10.1016/j.yjmcc.2003.10.015; White J, 2003, AM J PHYSIOL-HEART C, V285, pH47, DOI 10.1152/ajpheart.00833.2002; Zang Q, 2007, J APPL PHYSIOL, V102, P103, DOI 10.1152/japplphysiol.00359.2006; Zang Qun, 2007, Surg Infect (Larchmt), V8, P41, DOI 10.1089/sur.2006.033; Zang QS, 2012, AM J PHYSIOL-HEART C, V302, pH1847, DOI 10.1152/ajpheart.00203.2011; Zang QS, 2010, AM J PHYSIOL-HEART C, V298, pH1951, DOI 10.1152/ajpheart.00927.2009; Zanotti-Cavazzoni SL, 2009, CURR OPIN CRIT CARE, V15, P392, DOI 10.1097/MCC.0b013e3283307a4e; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zou YZ, 1999, J BIOL CHEM, V274, P9760, DOI 10.1074/jbc.274.14.9760	66	29	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43424	10.1371/journal.pone.0043424	http://dx.doi.org/10.1371/journal.pone.0043424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952679	Green Published, Green Submitted, gold			2022-12-25	WOS:000308044800031
J	Birkhofer, K; Schoning, I; Alt, F; Herold, N; Klarner, B; Maraun, M; Marhan, S; Oelmann, Y; Wubet, T; Yurkov, A; Begerow, D; Berner, D; Buscot, F; Daniel, R; Diekotter, T; Ehnes, RB; Erdmann, G; Fischer, C; Foesel, B; Groh, J; Gutknecht, J; Kandeler, E; Lang, C; Lohaus, G; Meyer, A; Nacke, H; Nather, A; Overmann, J; Polle, A; Pollierer, MM; Scheu, S; Schloter, M; Schulze, ED; Schulze, W; Weinert, J; Weisser, WW; Wolters, V; Schrumpf, M				Birkhofer, Klaus; Schoening, Ingo; Alt, Fabian; Herold, Nadine; Klarner, Bernhard; Maraun, Mark; Marhan, Sven; Oelmann, Yvonne; Wubet, Tesfaye; Yurkov, Andrey; Begerow, Dominik; Berner, Doreen; Buscot, Francois; Daniel, Rolf; Diekoetter, Tim; Ehnes, Roswitha B.; Erdmann, Georgia; Fischer, Christiane; Foesel, Baerbel; Groh, Janine; Gutknecht, Jessica; Kandeler, Ellen; Lang, Christa; Lohaus, Gertrud; Meyer, Annabel; Nacke, Heiko; Naether, Astrid; Overmann, Joerg; Polle, Andrea; Pollierer, Melanie M.; Scheu, Stefan; Schloter, Michael; Schulze, Ernst-Detlef; Schulze, Waltraud; Weinert, Jan; Weisser, Wolfgang W.; Wolters, Volkmar; Schrumpf, Marion			General Relationships between Abiotic Soil Properties and Soil Biota across Spatial Scales and Different Land-Use Types	PLOS ONE			English	Article							MICROARTHROPOD COMMUNITY; BIODIVERSITY; DIVERSITY; RESPONSES; PATTERNS; NITROGEN	Very few principles have been unraveled that explain the relationship between soil properties and soil biota across large spatial scales and different land-use types. Here, we seek these general relationships using data from 52 differently managed grassland and forest soils in three study regions spanning a latitudinal gradient in Germany. We hypothesize that, after extraction of variation that is explained by location and land-use type, soil properties still explain significant proportions of variation in the abundance and diversity of soil biota. If the relationships between predictors and soil organisms were analyzed individually for each predictor group, soil properties explained the highest amount of variation in soil biota abundance and diversity, followed by land-use type and sampling location. After extraction of variation that originated from location or land-use, abiotic soil properties explained significant amounts of variation in fungal, meso-and macrofauna, but not in yeast or bacterial biomass or diversity. Nitrate or nitrogen concentration and fungal biomass were positively related, but nitrate concentration was negatively related to the abundances of Collembola and mites and to the myriapod species richness across a range of forest and grassland soils. The species richness of earthworms was positively correlated with clay content of soils independent of sample location and land-use type. Our study indicates that after accounting for heterogeneity resulting from large scale differences among sampling locations and land-use types, soil properties still explain significant proportions of variation in fungal and soil fauna abundance or diversity. However, soil biota was also related to processes that act at larger spatial scales and bacteria or soil yeasts only showed weak relationships to soil properties. We therefore argue that more general relationships between soil properties and soil biota can only be derived from future studies that consider larger spatial scales and different land-use types.	[Birkhofer, Klaus; Groh, Janine] Lund Univ, Dept Biol Biodivers & Conservat Sci, Lund, Sweden; [Schoening, Ingo; Herold, Nadine; Schulze, Ernst-Detlef; Schrumpf, Marion] Max Planck Inst Biogeochem, Jena, Germany; [Alt, Fabian; Oelmann, Yvonne] Univ Tubingen, Tubingen, Germany; [Klarner, Bernhard; Maraun, Mark; Ehnes, Roswitha B.; Erdmann, Georgia; Pollierer, Melanie M.; Scheu, Stefan] Univ Gottingen, Dept Anim Ecol, JF Blumenbach Inst Zool & Anthropol, Gottingen, Germany; [Marhan, Sven; Berner, Doreen; Kandeler, Ellen] Univ Hohenheim, Inst Soil Sci & Land Evaluat, Soil Biol Sect, Hohenheim, Germany; [Wubet, Tesfaye; Buscot, Francois; Gutknecht, Jessica] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Germany; [Yurkov, Andrey; Begerow, Dominik] Ruhr Univ Bochum, Bochum, Germany; [Buscot, Francois] Univ Leipzig, Inst Biol, Chair Soil Ecol, Leipzig, Germany; [Daniel, Rolf; Nacke, Heiko] Univ Gottingen, Inst Microbiol & Genet, Gottingen, Germany; [Diekoetter, Tim; Wolters, Volkmar] Univ Giessen, Dept Anim Ecol, Giessen, Germany; [Fischer, Christiane] Univ Potsdam, Dept Biodivers Res Systemat Bot, Inst Biochem & Biol, Potsdam, Germany; [Foesel, Baerbel; Overmann, Joerg] Leibniz Inst DSMZ German Collect Microorganism &, Braunschweig, Germany; [Lang, Christa; Lohaus, Gertrud; Polle, Andrea] Univ Gottingen, Busgen Inst, Dept Forest Bot & Tree Physiol, Gottingen, Germany; [Naether, Astrid] Univ Bremen, Dept Microbial Ecophysiol, D-28359 Bremen, Germany; [Meyer, Annabel] Tech Univ Munich, Chair Soil Ecol, Munich, Germany; [Schloter, Michael] Helmholtz Zentrum Munchen, Res Unit Environm Genom, Munich, Germany; [Schulze, Waltraud] Max Planck Inst Mol Plant Physiol, Jena, Germany; [Weisser, Wolfgang W.] FSU Jena, Inst Ecol, Jena, Germany; [Weinert, Jan] Univ Cologne, Inst Zool, Dept Terr Ecol, Cologne, Germany	Lund University; Max Planck Society; Eberhard Karls University of Tubingen; University of Gottingen; University Hohenheim; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Ruhr University Bochum; Leipzig University; University of Gottingen; Justus Liebig University Giessen; University of Potsdam; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); University of Gottingen; University of Bremen; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society; Friedrich Schiller University of Jena; University of Cologne	Birkhofer, K (corresponding author), Lund Univ, Dept Biol Biodivers & Conservat Sci, Lund, Sweden.	Klaus.Birkhofer@biol.lu.se	Herold, Nadine/I-7996-2013; Daniel, Rolf/AAQ-5933-2021; Buscot, Francois/A-4125-2016; Wubet, Tesfaye/C-6241-2012; Weisser, Wolfgang W/B-9718-2014; Oelmann, Yvonne/J-8730-2016; Schulze, Waltraud X/E-9800-2011; Wolters, Volkmar/B-4635-2010; Foesel, Baerbel/ABC-6477-2021; Pollierer, Melanie Mira/J-9336-2019; Birkhofer, Klaus/AAA-2374-2021; Foesel, Baerbel/ABC-6483-2021; Scheu, Stefan/H-7049-2015; Schöning, Ingo/D-3341-2009; Schloter, 1Michael/H-9151-2013; Schrumpf, Marion/C-1671-2013; Diekötter, Tim/L-2463-2016; Yurkov, Andrey M./E-7854-2011; Gutknecht, Jessica/AAI-3682-2021; Schulze, Ernst-Detlef/K-9627-2014	Daniel, Rolf/0000-0002-8646-7925; Buscot, Francois/0000-0002-2364-0006; Wubet, Tesfaye/0000-0001-8572-4486; Weisser, Wolfgang W/0000-0002-2757-8959; Oelmann, Yvonne/0000-0003-3513-6568; Schulze, Waltraud X/0000-0001-9957-7245; Wolters, Volkmar/0000-0002-7556-4578; Foesel, Baerbel/0000-0001-8872-836X; Birkhofer, Klaus/0000-0002-9301-2443; Schöning, Ingo/0000-0002-9830-5026; Yurkov, Andrey M./0000-0002-1072-5166; Begerow, Dominik/0000-0002-8286-1597; Nacke, Heiko/0000-0001-6169-6169; Schrumpf, Marion/0000-0003-4219-4125; , Roswitha/0000-0003-2457-7130; Overmann, Jorg/0000-0003-3909-7201; Klarner, Bernhard/0000-0003-1867-4911; Kandeler, Ellen/0000-0002-2854-0012; Polle, Andrea/0000-0001-8697-6394	DFG (Deutsche Forschungsgemeinschaft) [1374]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was funded by the DFG (Deutsche Forschungsgemeinschaft) Priority Program 1374 "Infrastructure-Biodiversity-Exploratories". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Baath E, 2003, SOIL BIOL BIOCHEM, V35, P955, DOI 10.1016/S0038-0717(03)00154-8; Bardgett RD., 2005, THE BIOL OF SOIL, DOI [10.1093/acprof:oso/9780198525035.001.0001, DOI 10.1093/ACPROF:OSO/9780198525035.001.0001]; Birkhofer K, 2008, SOIL BIOL BIOCHEM, V40, P2297, DOI 10.1016/j.soilbio.2008.05.007; Birkhofer K, 2011, SOIL BIOL BIOCHEM, V43, P2200, DOI 10.1016/j.soilbio.2011.07.008; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Brussaard L, 1997, AMBIO, V26, P563; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Cole L, 2005, SOIL BIOL BIOCHEM, V37, P1707, DOI 10.1016/j.soilbio.2005.02.005; Collins SA, 2004, AGRON J, V96, P1272, DOI 10.2134/agronj2004.1272; Curry J.P., 1994, GRASSLAND INVERTEBRA; Decaens T, 2010, GLOBAL ECOL BIOGEOGR, V19, P287, DOI 10.1111/j.1466-8238.2009.00517.x; Eisenhauer N, 2008, EUR J SOIL BIOL, V44, P141, DOI 10.1016/j.ejsobi.2007.10.002; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2009, SOIL BIOL BIOCHEM, V41, P2249, DOI 10.1016/j.soilbio.2009.06.009; Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Fountain MT, 2008, B ENTOMOL RES, V98, P283, DOI 10.1017/S000748530700555X; Hansen B, 2001, AGR ECOSYST ENVIRON, V83, P11, DOI 10.1016/S0167-8809(00)00257-7; Hawkes CV, 2011, GLOBAL CHANGE BIOL, V17, P1637, DOI 10.1111/j.1365-2486.2010.02327.x; HENDRIX PF, 1992, SOIL BIOL BIOCHEM, V24, P1357, DOI 10.1016/0038-0717(92)90118-H; Hollister EB, 2010, ISME J, V4, P829, DOI 10.1038/ismej.2010.3; Hopkin S.P., 1997, BIOL SPRINGTAILS INS; IUSS Working Group WRB, 2006, WORLD REFERENCE BASE; Jandl R, 2003, RESTOR ECOL, V11, P239, DOI 10.1046/j.1526-100X.2003.00179.x; Kappes H, 2011, BIODIVERS CONSERV, V20, P2297, DOI 10.1007/s10531-011-0089-x; Kempson D., 1963, Pedobiologia, V3, P1; Killham K., 1994, SOIL ECOLOGY, V4th ed.; Kooijman AM, 2009, BIOL FERT SOILS, V45, P449, DOI 10.1007/s00374-009-0354-2; Lindberg N, 2004, FOREST ECOL MANAG, V188, P125, DOI 10.1016/j.foreco.2003.07.012; Magill AH, 1997, ECOL APPL, V7, P402, DOI 10.1890/1051-0761(1997)007[0402:BROFET]2.0.CO;2; Maraun M, 2001, BIOL FERT SOILS, V34, P222; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; MOSSE B, 1971, J GEN MICROBIOL, V69, P157, DOI 10.1099/00221287-69-2-157; READ DJ, 1991, FRONTIERS IN MYCOLOGY, P101; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schmidt SK, 2007, ECOLOGY, V88, P1379, DOI 10.1890/06-0164; Treseder KK, 2004, NEW PHYTOL, V164, P347, DOI 10.1111/j.1469-8137.2004.01159.x; VISHNIAC HS, 1995, MICROBIAL ECOL, V30, P309, DOI 10.1007/BF00171937; Wall DH, 2008, GLOBAL CHANGE BIOL, V14, P2661, DOI 10.1111/j.1365-2486.2008.01672.x; Williams JP, 2009, ENVIRON MICROBIOL, V11, P3292, DOI 10.1111/j.1462-2920.2009.02079.x; Yurkov AM, 2012, FUNGAL ECOL, V5, P24, DOI 10.1016/j.funeco.2011.07.004	44	114	117	4	286	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43292	10.1371/journal.pone.0043292	http://dx.doi.org/10.1371/journal.pone.0043292			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937029	Green Published, gold, Green Submitted			2022-12-25	WOS:000308286300039
J	Mazemondet, O; John, M; Leye, S; Rolfs, A; Uhrmacher, AM				Mazemondet, Orianne; John, Mathias; Leye, Stefan; Rolfs, Arndt; Uhrmacher, Adelinde M.			Elucidating the Sources of beta-Catenin Dynamics in Human Neural Progenitor Cells	PLOS ONE			English	Article							EXACT STOCHASTIC SIMULATION; SIGNALING PROTEINS; NOISE-REDUCTION; FEEDBACK LOOP; STEM-CELLS; WNT; DIFFERENTIATION; PATHWAY; INHIBITOR; THERAPY	Human neural progenitor cells (hNPCs) form a new prospect for replacement therapies in the context of neurodegenerative diseases. The Wnt/beta-catenin signaling pathway is known to be involved in the differentiation process of hNPCs. RVM cells form a common cell model of hNPCs for in vitro investigation. Previous observations in RVM cells raise the question of whether observed kinetics of the Wnt/beta-catenin pathway in later differentiation phases are subject to self-induced signaling. However, a concern when investigating RVM cells is that experimental results are possibly biased by the asynchrony of cells w.r.t. the cell cycle. In this paper, we present, based on experimental data, a computational modeling study on the Wnt/beta-catenin signaling pathway in RVM cell populations asynchronously distributed w.r.t. to their cell cycle phases. Therefore, we derive a stochastic model of the pathway in single cells from the reference model in literature and extend it by means of cell populations and cell cycle asynchrony. Based on this, we show that the impact of the cell cycle asynchrony on wet-lab results that average over cell populations is negligible. We then further extend our model and the thus-obtained simulation results provide additional evidence that self-induced Wnt signaling occurs in RVM cells. We further report on significant stochastic effects that directly result from model parameters provided in literature and contradict experimental observations.	[Mazemondet, Orianne; Leye, Stefan; Uhrmacher, Adelinde M.] Univ Rostock, Inst Comp Sci, Modelling & Simulat Grp, Rostock, Germany; [John, Mathias] Univ Lille 1, BioComp Grp, Lille, France; [Rolfs, Arndt] Univ Rostock, Ctr Mental Hlth, Albrecht Kossel Inst Neuroregenerat AKos, Rostock, Germany	University of Rostock; Universite de Lille - ISITE; Universite de Lille; University of Rostock	Mazemondet, O (corresponding author), Univ Rostock, Inst Comp Sci, Modelling & Simulat Grp, Rostock, Germany.	lin@informatik.uni-rostock.de			research training group dIEM oSiRiS (The integrative development of modeling and simulation methods for regenerative systems); research project dIER MoSiS (Discrete event multi-level modeling and simulation for systems biology); German foundation for research	research training group dIEM oSiRiS (The integrative development of modeling and simulation methods for regenerative systems); research project dIER MoSiS (Discrete event multi-level modeling and simulation for systems biology); German foundation for research(German Research Foundation (DFG))	This work has been supported as part of the research training group dIEM oSiRiS (The integrative development of modeling and simulation methods for regenerative systems) and the research project dIER MoSiS (Discrete event multi-level modeling and simulation for systems biology), both financed by the German foundation for research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam S, 2004, BIOTECHNOL BIOENG, V88, P332, DOI 10.1002/bit.20246; Bundschuh R, 2003, J THEOR BIOL, V220, P261, DOI 10.1006/jtbi.2003.3164; Canning CA, 2007, DEV BIOL, V305, P276, DOI 10.1016/j.ydbio.2007.02.009; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Cho KH, 2006, FEBS LETT, V580, P3665, DOI 10.1016/j.febslet.2006.05.053; Ciocchetta F, 2009, LECT NOTES COMPUT SC, V5750, P45; Clelland CD, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E8; Cotter D, 1999, ACTA NEUROPATHOL, V98, P465, DOI 10.1007/s004010051111; Coudreuse D, 2007, DEVELOPMENT, V134, P3, DOI 10.1242/dev.02699; Donato R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-36; Fradkin LG, 2010, TRENDS NEUROSCI, V33, P84, DOI 10.1016/j.tins.2009.11.005; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Himmelspach J, 2007, PROC ANNU SIMUL SYMP, P137, DOI 10.1109/ANSS.2007.34; HOOKE R, 1961, J ACM, V8, P212, DOI 10.1145/321062.321069; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hubner R, 2010, BIOCHEM BIOPH RES CO, V400, P358, DOI 10.1016/j.bbrc.2010.08.066; Israsena N, 2004, DEV BIOL, V268, P220, DOI 10.1016/j.ydbio.2003.12.024; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kim D, 2007, ONCOGENE, V26, P4571, DOI 10.1038/sj.onc.1210230; Kofahl B, 2010, BIOCHEM SOC T, V38, P1281, DOI 10.1042/BST0381281; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Lorenowicz MJ, 2009, EXP CELL RES, V315, P2683, DOI 10.1016/j.yexcr.2009.06.015; Lu WY, 2010, BIOCHEMISTRY-US, V49, P4635, DOI 10.1021/bi1001486; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mazemondet O, 2011, CELL MOL BIOL LETT, V16, P515, DOI 10.2478/s11658-011-0021-0; Mazemondet O, 2009, WINT SIMUL C PROC, P878; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; McNeill H, 2010, NAT REV MOL CELL BIO, V11, P404, DOI 10.1038/nrm2902; Michaelidis TM, 2008, CELL TISSUE RES, V331, P193, DOI 10.1007/s00441-007-0476-5; Mirams GR, 2010, J MATH BIOL, V60, P131, DOI 10.1007/s00285-009-0262-y; Morgan PJ, 2009, NEUROREPORT, V20, P1225, DOI 10.1097/WNR.0b013e32832fbf49; Morishita Y, 2004, J THEOR BIOL, V228, P315, DOI 10.1016/j.jtbi.2004.01.007; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Olivier BG, 2004, BIOINFORMATICS, V20, P2143, DOI 10.1093/bioinformatics/bth200; Orrell D, 2006, PHYSICA D, V217, P64, DOI 10.1016/j.physd.2006.03.010; Schilling M, 2005, FEBS J, V272, P6400, DOI 10.1111/j.1742-4658.2005.05037.x; Schlicht R, 2008, J MATH BIOL, V57, P613, DOI 10.1007/s00285-008-0178-y; Schmitz Y, 2011, J THEOR BIOL, V279, P132, DOI 10.1016/j.jtbi.2011.03.018; Schmole AC, 2010, BIOORGAN MED CHEM, V18, P6785, DOI 10.1016/j.bmc.2010.07.045; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; Tan CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031882; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tymchyshyn O, 2008, LECT N BIOINFORMAT, V5054, P63, DOI 10.1007/978-3-540-68413-8_5; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Leeuwen IMM, 2007, J THEOR BIOL, V247, P77, DOI 10.1016/j.jtbi.2007.01.019; Wawra C, 2007, FEBS LETT, V581, P4043, DOI 10.1016/j.febslet.2007.07.043; Wexler EM, 2009, STEM CELLS, V27, P1130, DOI 10.1002/stem.36; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Wolkenhauer O, 2004, IEEE T NANOBIOSCI, V3, P200, DOI 10.1109/TNB.2004.833694; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455	59	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42792	10.1371/journal.pone.0042792	http://dx.doi.org/10.1371/journal.pone.0042792			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22952611	Green Submitted, Green Published, gold			2022-12-25	WOS:000307733800028
J	Li, LH; Yin, XY; Yao, CY; Zhu, XC; Wu, XH				Li, Lihua; Yin, Xueyan; Yao, Chaoyong; Zhu, Xuechuang; Wu, Xinhua			Vitamin D, Parathyroid Hormone and Their Associations with Hypertension in a Chinese Population	PLOS ONE			English	Article							25-HYDROXYVITAMIN D LEVELS; BLOOD-PRESSURE; INCIDENT HYPERTENSION; METABOLIC SYNDROME; OLDER-ADULTS; PREVALENCE; WOMEN; RISK; DISEASE; SYSTEM	Background: Conflicting reports support or refute an association between vitamin D deficiency with high levels of parathyroid hormone (PTH) and raised blood pressure or hypertension. Objective: To explore the associations of serum vitamin D and PTH levels with blood pressure and risk of hypertension in a Chinese population. Methods: A population-based cross-sectional study was conducted among 1,420 Chinese participants, aged 20-83 years, in 2010. Anthropometric phenotypes and blood pressure were evaluated. Serum lipids, 25-hydroxyvitamin D [25(OH) D] and PTH were measured. Results: One thousand four hundred and twenty participants, including 566 women (39.9%), were evaluated in 2010. Four hundred and eighty seven were hypertensive (34.3%), of whom 214 (43.9%) received antihypertensive treatment. The median concentrations of serum 25(OH) D and PTH were 22.0 ng/ml and 2.83 pmol/l, respectively. Serum 25(OH) D and natural log of PTH levels were not independently associated with blood pressure in a multivariable adjusted linear regression analysis of 1,206 participants not receiving antihypertensive treatment (P>0.05). In logistic regression analyses, serum 25(OH) D levels were not associated with risk of hypertension in single and multiple regression models. One unit increments of natural log of PTH levels were significantly associated with risk of hypertension in the crude model (OR = 1.78, 95% confidence interval 1.38-2.28, P<0.0001) and model adjusted for age and sex (OR = 1.41, 95% confidence interval 1.08-1.83, P = 0.01). However, these associations were attenuated and became nonsignificant (OR = 1.29, 95% confidence interval 0.98-1.70, P = 0.07) after further adjustment for body mass index, current alcohol intake, current smoking, glomerular filtration rate and family history of hypertension. Conclusions: Serum vitamin D and PTH levels are not independently associated with blood pressure or risk of hypertension in a Chinese population.	[Li, Lihua; Yin, Xueyan; Yao, Chaoyong; Zhu, Xuechuang; Wu, Xinhua] Dali Univ Sch Med, Dept Internal Med, Dali, Yunnan Province, Peoples R China	Dali University	Li, LH (corresponding author), Dali Univ Sch Med, Dept Internal Med, Dali, Yunnan Province, Peoples R China.	lilihuayncn@gmail.com	Li, Li-Hua/AAD-7235-2020		Chinese Ministry of Science and Technology [30960137]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	The Chinese Ministry of Science and Technology (30960137, http://www.nsfc.gov.cn/Portal0/default152.htm) supported this research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandari SK, 2011, J CLIN HYPERTENS, V13, P170, DOI 10.1111/j.1751-7176.2010.00408.x; Chan R, 2012, J HUM HYPERTENS, V26, P20, DOI 10.1038/jhh.2010.126; DELUCA HF, 1979, NUTR REV, V37, P161, DOI 10.1111/j.1753-4887.1979.tb06660.x; Dong J, 2012, EUR HEART J     0411; Dorjgochoo T, 2012, BR J NUTR, P1; Elamin MB, 2011, J CLIN ENDOCR METAB, V96, P1931, DOI 10.1210/jc.2011-0398; Forman JP, 2008, HYPERTENSION, V52, P828, DOI 10.1161/HYPERTENSIONAHA.108.117630; Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Hagenau T, 2009, OSTEOPOROSIS INT, V20, P133, DOI 10.1007/s00198-008-0626-y; He JL, 2011, AM J HYPERTENS, V24, P911, DOI 10.1038/ajh.2011.73; Holick MF, 2006, MAYO CLIN PROC, V81, P353, DOI 10.4065/81.3.353; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Jablonski KL, 2011, HYPERTENSION, V57, P63, DOI 10.1161/HYPERTENSIONAHA.110.160929; Jorde R, 2010, HYPERTENSION, V55, P792, DOI 10.1161/HYPERTENSIONAHA.109.143990; Kim MK, 2010, CLIN ENDOCRINOL, V73, P330, DOI 10.1111/j.1365-2265.2010.03798.x; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Li YC, 2004, J STEROID BIOCHEM, V89-90, P387, DOI 10.1016/j.jsbmb.2004.03.004; Looker AC, 2002, BONE, V30, P771, DOI 10.1016/S8756-3282(02)00692-0; Lu L, 2009, DIABETES CARE, V32, P1278, DOI 10.2337/dc09-0209; Margolis KL, 2012, AM J EPIDEMIOL, V175, P22, DOI 10.1093/aje/kwr274; Perkovic V, 2003, KIDNEY BLOOD PRESS R, V26, P27, DOI 10.1159/000069761; Pilz S, 2009, NAT REV CARDIOL, V6, P621, DOI 10.1038/nrcardio.2009.135; Rashid G, 2007, AM J PHYSIOL-RENAL, V292, pF1215, DOI 10.1152/ajprenal.00406.2006; Reis JP, 2007, DIABETES CARE, V30, P1549, DOI 10.2337/dc06-2438; Rostand SG, 1997, HYPERTENSION, V30, P150, DOI 10.1161/01.HYP.30.2.150; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; Snijder MB, 2007, J INTERN MED, V261, P558, DOI 10.1111/j.1365-2796.2007.01778.x; Taylor EN, 2008, J HYPERTENS, V26, P1390, DOI 10.1097/HJH.0b013e3282ffb43b; Vaidya A, 2010, HYPERTENSION, V56, P774, DOI 10.1161/HYPERTENSIONAHA.109.140160; Zhao GX, 2010, J HYPERTENS, V28, P1821, DOI 10.1097/HJH.0b013e32833bc5b4	31	29	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43344	10.1371/journal.pone.0043344	http://dx.doi.org/10.1371/journal.pone.0043344			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22937036	Green Submitted, gold, Green Published			2022-12-25	WOS:000307824300041
J	Fujita, N; Gogate, SS; Chiba, K; Toyama, Y; Shapiro, IM; Risbud, MV				Fujita, Nobuyuki; Gogate, Shilpa S.; Chiba, Kazuhiro; Toyama, Yoshiaki; Shapiro, Irving M.; Risbud, Makarand V.			Prolyl Hydroxylase 3 (PHD3) Modulates Catabolic Effects of Tumor Necrosis Factor-alpha (TNF-alpha) on Cells of the Nucleus Pulposus through Co-activation of Nuclear Factor kappa B (NF-kappa B)/p65 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INTERVERTEBRAL DISC; HYPOXIA-RESPONSIVE ELEMENT; DEGENERATION; EXPRESSION; HIF-1; IDENTIFICATION; DEGRADATION; HIF-1-ALPHA; PROMOTES; PATHWAY	Recent studies suggest a differential role of prolyl hydroxylase (PHD) isoforms in controlling hypoxia-inducible factor (HIF)-alpha degradation and activity in nucleus pulposus (NP) cells. However, the regulation and function of PHDs under inflammatory conditions that characterize disc disease are not yet known. Here, we show that in NP cells, TNF-alpha and IL-1 beta induce PHD3 expression through NF-kappa B. Lentiviral delivery of Sh-p65 and Sh-IKK beta confirms that cytokine-mediated PHD3 expression is NF-kappa B-dependent. It is noteworthy that although both cytokines induce HIF activity, mechanistic studies using Sh-HIF-1 alpha and PHD3 promoter/enhancer constructs harboring well characterized hypoxia response element (HRE) show lack of HIF involvement in cytokine-mediated PHD3 expression. Loss-of-function studies clearly indicate that PHD3 serves as a co-activator of NF-kappa B signaling activity in NP cells; PHD3 interacts with, and co-localizes with, p65. We observed that when PHD3 is silenced, there is a significant decrease in TNF-alpha-induced expression of catabolic markers that include ADAMTS5, syndecan4, MMP13, and COX2, and at the same time, there is restoration of aggrecan and collagen type II expression. It is noteworthy that hydroxylase function of PHDs is not required for mediating cytokine-dependent gene expression. These findings show that by enhancing the activity of inflammatory cytokines, PHD3 may serve a critical role in degenerative disc disease.	[Fujita, Nobuyuki; Gogate, Shilpa S.; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA; [Fujita, Nobuyuki; Gogate, Shilpa S.; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Grad Program Cell & Dev Biol, Philadelphia, PA 19107 USA; [Fujita, Nobuyuki; Toyama, Yoshiaki] Keio Univ, Dept Orthopaed Surg, Sch Med, Tokyo 1088345, Japan; [Chiba, Kazuhiro] Kitasato Univ, Dept Orthopaed Surg, Kitasato Inst Hosp, Tokyo 1088641, Japan	Jefferson University; Jefferson University; Keio University; Kitasato University	Risbud, MV (corresponding author), Thomas Jefferson Univ, Dept Orthopaed Surg, 1015 Walnut St,Ste 501 Curtis Bldg, Philadelphia, PA 19107 USA.	makarand.risbud@jefferson.edu	Toyama, Yoshiaki/K-5743-2013; Fujita, Nobuyuki/L-4800-2013		National Institutes of Health [R01-AR050087, R01-AR055655]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050087, R01AR055655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AR050087 and R01-AR055655 (to M.V.R.).	Bartels EM, 1998, SPINE, V23, P1, DOI 10.1097/00007632-199801010-00001; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; Fu J, 2010, J BIOL CHEM, V285, P8927, DOI 10.1074/jbc.M109.078600; Fujita N, 2012, J BIOL CHEM, V287, P16975, DOI 10.1074/jbc.M111.334466; Fujita N, 2012, J BONE MINER RES, V27, P401, DOI 10.1002/jbmr.538; Gruber HE, 2005, SPINE, V30, P2593, DOI 10.1097/01.brs.0000187877.30149.83; HASSLER O, 1969, ACTA ORTHOP SCAND, V40, P765, DOI 10.3109/17453676908989540; Johansen JL, 2010, J NEUROCHEM, V115, P209, DOI 10.1111/j.1471-4159.2010.06917.x; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732; Lee JM, 2011, J ORTHOP RES, V29, P265, DOI 10.1002/jor.21210; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; Nam SY, 2011, BRIT J CANCER, V104, P166, DOI 10.1038/sj.bjc.6606020; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; RUDERT M, 1993, ACTA ORTHOP SCAND, V64, P37, DOI 10.3109/17453679308994524; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Seguin CA, 2005, SPINE, V30, P1940, DOI 10.1097/01.brs.0000176188.40263.f9; Seguin CA, 2006, MATRIX BIOL, V25, P409, DOI 10.1016/j.matbio.2006.07.002; Shamji MF, 2010, ARTHRITIS RHEUM-US, V62, P1974, DOI 10.1002/art.27444; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Wang JR, 2011, J BIOL CHEM, V286, P39738, DOI 10.1074/jbc.M111.264549; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Weiler C, 2005, SPINE, V30, P44, DOI 10.1097/01.brs.0000149186.63457.20; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153; Yeramian A, 2011, LAB INVEST, V91, P859, DOI 10.1038/labinvest.2011.58	29	61	63	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.375964	http://dx.doi.org/10.1074/jbc.M112.375964			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	22948157	Green Published, hybrid			2022-12-25	WOS:000311233800062
J	Berntsson, RPA; Schuurman-Wolters, GK; Dunny, G; Slotboom, DJ; Poolman, B				Berntsson, Ronnie P. -A.; Schuurman-Wolters, Gea K.; Dunny, Gary; Slotboom, Dirk-Jan; Poolman, Bert			Structure and Mode of Peptide Binding of Pheromone Receptor PrgZ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAECALIS PLASMID PCF10; ENTEROCOCCUS-FAECALIS; SEX-PHEROMONE; MACROMOLECULAR STRUCTURES; PROTEIN OPPA; CONJUGATION; EXPRESSION; CCF10; CRYSTALLOGRAPHY; VALIDATION	Wepresent the crystal structure of the pheromone receptor protein PrgZ from Enterococcus faecalis in complex with the heptapeptide cCF10 (LVTLVFV), which is used in signaling between conjugative recipient and donor cells. Comparison of PrgZ with homologous oligopeptide-binding proteins (AppA and OppA) explains the high specificity of PrgZ for hydrophobic heptapeptides versus the promiscuity of peptide binding in the homologous proteins.	[Berntsson, Ronnie P. -A.; Schuurman-Wolters, Gea K.; Slotboom, Dirk-Jan; Poolman, Bert] Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Netherlands Prote Ctr, NL-9747 AG Groningen, Netherlands; [Berntsson, Ronnie P. -A.; Schuurman-Wolters, Gea K.; Slotboom, Dirk-Jan; Poolman, Bert] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands; [Dunny, Gary] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA	University of Groningen; University of Groningen; University of Minnesota System; University of Minnesota Twin Cities	Poolman, B (corresponding author), Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Netherlands Prote Ctr, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	b.poolman@rug.nl	Institute, Zernike/W-7033-2019; Berntsson, Ronnie/J-3535-2019	Berntsson, Ronnie/0000-0001-6848-322X	National Institutes of Health [GM49530]; The Netherlands Organisation for Scientific Research (NWO) [700.56.302]; European Union; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM49530 (to G. D.). This work was also supported by a Vici grant (to D.-J. S.) and TOP Subsidy Grant 700.56.302 (to B. P.) from The Netherlands Organisation for Scientific Research (NWO) and by the European Union European Drug Initiative on Channels and Transporters (EDICT) Program.	Antiporta MH, 2002, J BACTERIOL, V184, P1155, DOI 10.1128/jb.184.4.1155-1162.2002; Bae T, 2000, J MOL BIOL, V297, P861, DOI 10.1006/jmbi.2000.3628; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Berntsson RPA, 2011, J BACTERIOL, V193, P4254, DOI 10.1128/JB.00447-11; Berntsson RPA, 2009, EMBO J, V28, P1332, DOI 10.1038/emboj.2009.65; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Courvalin P, 2006, CLIN INFECT DIS, V42, pS25, DOI 10.1086/491711; Cowtan K, 2000, ACTA CRYSTALLOGR D, V56, P1612, DOI 10.1107/S0907444900013263; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Dunny GM, 2007, PHILOS T R SOC B, V362, P1185, DOI 10.1098/rstb.2007.2043; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fixen KR, 2007, J BACTERIOL, V189, P1399, DOI 10.1128/JB.01226-06; Fukami-Kobayashi K, 1999, J MOL BIOL, V286, P279, DOI 10.1006/jmbi.1998.2454; Geertsma ER, 2007, NAT METHODS, V4, P705, DOI 10.1038/NMETH1073; Hunt CP, 1998, BRIT J BIOMED SCI, V55, P149; JETT BD, 1994, CLIN MICROBIOL REV, V7, P462, DOI 10.1128/CMR.7.4.462-478.1994; Johnson CM, 2010, J BACTERIOL, V192, P1634, DOI 10.1128/JB.01525-09; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Klepsch MM, 2011, J MOL BIOL, V414, P75, DOI 10.1016/j.jmb.2011.09.043; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kozlowicz BK, 2006, MOL MICROBIOL, V62, P958, DOI 10.1111/j.1365-2958.2006.05434.x; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leonard BAB, 1996, P NATL ACAD SCI USA, V93, P260, DOI 10.1073/pnas.93.1.260; Levdikov VM, 2005, J MOL BIOL, V345, P879, DOI 10.1016/j.jmb.2004.10.089; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Maqbool A, 2011, J BIOL CHEM, V286, P31512, DOI 10.1074/jbc.M111.267179; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; MORI M, 1984, FEBS LETT, V178, P97, DOI 10.1016/0014-5793(84)81248-X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nickitenko AV, 1995, BIOCHEMISTRY-US, V34, P16585, DOI 10.1021/bi00051a006; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Shi K, 2005, P NATL ACAD SCI USA, V102, P18596, DOI 10.1073/pnas.0506163102; Tame JRH, 1995, STRUCTURE, V3, P1395, DOI 10.1016/S0969-2126(01)00276-3; TAME JRH, 1994, SCIENCE, V264, P1578, DOI 10.1126/science.8202710; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	35	16	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37165	37170		10.1074/jbc.M112.386334	http://dx.doi.org/10.1074/jbc.M112.386334			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22948145	hybrid, Green Published			2022-12-25	WOS:000310588500050
J	Ozaki, S; Noguchi, Y; Hayashi, Y; Miyazaki, E; Katayama, T				Ozaki, Shogo; Noguchi, Yasunori; Hayashi, Yasuhisa; Miyazaki, Erika; Katayama, Tsutomu			Differentiation of the DnaA-oriC Subcomplex for DNA Unwinding in a Replication Initiation Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AAA PLUS PROTEIN; ESCHERICHIA-COLI CHROMOSOME; SINGLE-STRANDED-DNA; ORIGIN RECOGNITION; E. COLI; REGULATORY INACTIVATION; NUCLEOPROTEIN COMPLEXES; SEQUENTIAL BINDING; STRUCTURAL BASIS; GENE-EXPRESSION	In Escherichia coli, ATP-DnaA multimers formed on the replication origin oriC promote duplex unwinding, which leads to helicase loading. Based on a detailed functional analysis of the oriC sequence motifs, we previously proposed that the left half of oriC forms an ATP-DnaA subcomplex competent for oriC unwinding, whereas the right half of oriC forms a distinct ATP-DnaA subcomplex that facilitates helicase loading. However, the molecular basis for the functional difference between these ATP-DnaA subcomplexes remains unclear. By analyzing a series of novel DnaA mutants, we found that structurally distinct DnaA multimers form on each half of oriC. DnaA AAA + domain residues Arg-227 and Leu-290 are specifically required for oriC unwinding. Notably, these residues are required for the ATP-DnaA-specific structure of DnaA multimers in complex with the left half of oriC but not for that with the right half. These results support the idea that the ATP-DnaA multimers formed on oriC are not uniform and that they can adopt different conformations. Based on a structural model, we propose that Arg-227 and Leu-290 play a crucial role in inter-ATP-DnaA interaction and are a prerequisite for the formation of unwinding-competent DnaA subcomplexes on the left half of oriC. These residues are not required for the interaction with DnaB, nucleotide binding, or regulatory DnaA-ATP hydrolysis, which further supports their important role in inter-DnaA interaction. The corresponding residues are evolutionarily conserved and are required for unwinding in the initial complexes of Thermotoga maritima, an ancient hyperthermophile. Therefore, our findings suggest a novel and common mechanism for ATP-DnaA-dependent activation of initial complexes.	[Ozaki, Shogo; Noguchi, Yasunori; Hayashi, Yasuhisa; Miyazaki, Erika; Katayama, Tsutomu] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University	Katayama, T (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	katayama@phar.kyushu-u.ac.jp		Ozaki, Shogo/0000-0002-4384-1366; Katayama, Tsutomu/0000-0001-9994-1684	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for Promotion of Science [19370077, 17080005, 21770187]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Japan Society for Promotion of Science (Grants 19370077, 17080005, and 21770187).	Abe Y, 2007, J BIOL CHEM, V282, P17816, DOI 10.1074/jbc.M701841200; Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; CASSLER MR, 1995, EMBO J, V14, P5833, DOI 10.1002/j.1460-2075.1995.tb00271.x; Charbon G, 2011, MOL MICROBIOL, V79, P914, DOI 10.1111/j.1365-2958.2010.07493.x; Clarey MG, 2006, NAT STRUCT MOL BIOL, V13, P684, DOI 10.1038/nsmb1121; Diffley JFX, 2011, PHILOS T R SOC B, V366, P3545, DOI 10.1098/rstb.2011.0073; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Duderstadt KE, 2008, CRIT REV BIOCHEM MOL, V43, P163, DOI [10.1080/10409230802058296, 10.1080/10409230802058296 ]; Duderstadt KE, 2011, NATURE, V478, P209, DOI 10.1038/nature10455; Duderstadt KE, 2010, J BIOL CHEM, V285, P28229, DOI 10.1074/jbc.M110.147975; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Erzberger JP, 2002, EMBO J, V21, P4763, DOI 10.1093/emboj/cdf496; Felczak MM, 2005, J BIOL CHEM, V280, P24627, DOI 10.1074/jbc.M503684200; Fujikawa N, 2003, NUCLEIC ACIDS RES, V31, P2077, DOI 10.1093/nar/gkg309; Fujimitsu K, 2008, J BACTERIOL, V190, P5368, DOI 10.1128/JB.00044-08; Fujimitsu K, 2009, GENE DEV, V23, P1221, DOI 10.1101/gad.1775809; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Gon S, 2006, EMBO J, V25, P1137, DOI 10.1038/sj.emboj.7600990; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; HWANG DS, 1992, J BIOL CHEM, V267, P23083; Indiani C, 2006, NAT REV MOL CELL BIO, V7, P751, DOI 10.1038/nrm2022; Kaguni JM, 2011, CURR OPIN CHEM BIOL, V15, P606, DOI 10.1016/j.cbpa.2011.07.016; Katayama T, 1998, CELL, V94, P61, DOI 10.1016/S0092-8674(00)81222-2; Katayama T, 2010, NAT REV MICROBIOL, V8, P163, DOI 10.1038/nrmicro2314; Kato J, 2001, EMBO J, V20, P4253, DOI 10.1093/emboj/20.15.4253; Kawakami H, 2005, J BIOL CHEM, V280, P27420, DOI 10.1074/jbc.M502764200; Kawakami H, 2006, MOL MICROBIOL, V62, P1310, DOI 10.1111/j.1365-2958.2006.05450.x; Kawakami H, 2010, BIOCHEM CELL BIOL, V88, P49, DOI [10.1139/o09-154, 10.1139/O09-154]; Keyamura K, 2007, GENE DEV, V21, P2083, DOI 10.1101/gad.1561207; Keyamura K, 2011, J BIOL CHEM, V286, P29336, DOI 10.1074/jbc.M111.233403; Keyamura K, 2009, J BIOL CHEM, V284, P25038, DOI 10.1074/jbc.M109.002717; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Kurokawa K, 1999, EMBO J, V18, P6642, DOI 10.1093/emboj/18.23.6642; Langklotz S, 2012, BBA-MOL CELL RES, V1823, P40, DOI 10.1016/j.bbamcr.2011.08.015; Leonard AC, 2005, MOL MICROBIOL, V55, P978, DOI 10.1111/j.1365-2958.2004.04467.x; Leonard AC, 2010, CURR OPIN MICROBIOL, V13, P766, DOI 10.1016/j.mib.2010.10.001; Makowska-Grzyska M, 2010, MOL CELL, V37, P90, DOI 10.1016/j.molcel.2009.12.031; Margulies C, 1996, J BIOL CHEM, V271, P17035, DOI 10.1074/jbc.271.29.17035; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; McGarry KC, 2004, P NATL ACAD SCI USA, V101, P2811, DOI 10.1073/pnas.0400340101; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Nakamura K, 2010, MOL MICROBIOL, V76, P302, DOI 10.1111/j.1365-2958.2010.07074.x; Neuwald AF, 1999, GENOME RES, V9, P27; Nievera C, 2006, MOL CELL, V24, P581, DOI 10.1016/j.molcel.2006.09.016; Nozaki S, 2008, MICROBIOL-SGM, V154, P3379, DOI 10.1099/mic.0.2008/019745-0; Ozaki S, 2006, GENES CELLS, V11, P425, DOI 10.1111/j.1365-2443.2006.00950.x; Ozaki S, 2008, J BIOL CHEM, V283, P8351, DOI 10.1074/jbc.M708684200; Ozaki S, 2012, NUCLEIC ACIDS RES, V40, P1648, DOI 10.1093/nar/gkr832; Ozaki S, 2009, PLASMID, V62, P71, DOI 10.1016/j.plasmid.2009.06.003; Riber L, 2009, MOL MICROBIOL, V71, P107, DOI 10.1111/j.1365-2958.2008.06516.x; Rozgaja TA, 2011, MOL MICROBIOL, V82, P475, DOI 10.1111/j.1365-2958.2011.07827.x; Ryan VT, 2002, MOL MICROBIOL, V46, P113, DOI 10.1046/j.1365-2958.2002.03129.x; SAMITT CE, 1989, EMBO J, V8, P989, DOI 10.1002/j.1460-2075.1989.tb03462.x; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Saxena R, 2011, J BIOL CHEM, V286, P33770, DOI 10.1074/jbc.M111.223495; SCHAPER S, 1995, J BIOL CHEM, V270, P17622, DOI 10.1074/jbc.270.29.17622; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Soultanas P, 2012, MOL MICROBIOL, V84, P6, DOI 10.1111/j.1365-2958.2012.08012.x; Speck C, 2001, EMBO J, V20, P1469, DOI 10.1093/emboj/20.6.1469; Stepankiw N, 2009, MOL MICROBIOL, V74, P467, DOI 10.1111/j.1365-2958.2009.06877.x; Stillman B, 2005, FEBS LETT, V579, P877, DOI 10.1016/j.febslet.2004.12.011; Su'etsugu M, 2008, J BIOL CHEM, V283, P36118, DOI 10.1074/jbc.M803158200; Sutton MD, 1998, J BIOL CHEM, V273, P34255, DOI 10.1074/jbc.273.51.34255; Weigel C, 2002, MOL MICROBIOL, V46, P1149, DOI 10.1046/j.1365-2958.2002.03232.x; Weigel C, 2001, MOL MICROBIOL, V40, P498, DOI 10.1046/j.1365-2958.2001.02409.x	67	41	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37458	37471		10.1074/jbc.M112.372052	http://dx.doi.org/10.1074/jbc.M112.372052			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22942281	Green Published, hybrid			2022-12-25	WOS:000310588500075
J	Abate, E; Belayneh, M; Gelaw, A; Idh, J; Getachew, A; Alemu, S; Diro, E; Fikre, N; Britton, S; Elias, D; Aseffa, A; Stendahl, O; Schon, T				Abate, Ebba; Belayneh, Meseret; Gelaw, Aschalew; Idh, Jonna; Getachew, Assefa; Alemu, Shitaye; Diro, Ermias; Fikre, Nigussu; Britton, Sven; Elias, Daniel; Aseffa, Abraham; Stendahl, Olle; Schon, Thomas			The Impact of Asymptomatic Helminth Co-Infection in Patients with Newly Diagnosed Tuberculosis in North-West Ethiopia	PLOS ONE			English	Article							INFECTION; RESPONSES; RISK	Background: Areas endemic of helminth infection, tuberculosis (TB) and HIV are to a large extent overlapping. The aim of this study was to assess the impact of asymptomatic helminth infection on the immunological response among TB patients with and without HIV, their house hold contacts and community controls. Methodology: Consecutive smear positive TB patients (n = 112), their household contacts (n = 71) and community controls (n = 112) were recruited in Gondar town, Ethiopia. Stool microscopy, HIV serology, serum IgE level, eosinophil and CD4 counts were performed and tuberculosis patients were followed up for 3 months after initiation of anti-TB treatment. Results: Helminth co-infection rate was 29% in TB patients and 21% in both community control and household contacts (p = 0.3) where Ascaris lumbricoides was the most prevalent parasite. In TB patients the seroprevalence of HIV was 47% (53/112). Eosinophilia and elevated IgE level were significantly associated with asymptomatic helminth infection. During TB treatment, the worm infection rate of HIV+/TB patients declined from 31% (10/32) at week 0 to 9% (3/32) at week 2 of TB treatment, whereas HIV2/TB patients showed no change from baseline to week 2, 29% (13/45) vs. 22.2% (10/45). This trend was stable at week 8 and 12 as well. Conclusion: One third of smear positive TB patients were infected with helminths. Eosinophilia and elevated IgE level correlated with asymptomatic worm infection, indicating an effect on host immunity. The rate of worm infection declined during TB treatment in HIV+/TB co-infected patients whereas no decline was seen in HIV2/TB group.	[Abate, Ebba; Gelaw, Aschalew] Univ Gondar, Dept Immunol & Mol Biol, Gondar, Ethiopia; [Abate, Ebba; Idh, Jonna; Stendahl, Olle; Schon, Thomas] Linkoping Univ, Dept Med Microbiol, S-58185 Linkoping, Sweden; [Belayneh, Meseret] Univ Addis Ababa, Sch Med Lab Sci, Fac Med, Addis Ababa, Ethiopia; [Getachew, Assefa] Univ Gondar, Dept Radiol, Gondar, Ethiopia; [Alemu, Shitaye; Diro, Ermias] Univ Gondar, Dept Internal Med, Gondar, Ethiopia; [Fikre, Nigussu] Univ Addis Ababa, Fac Med, Dept Parasitol, Addis Ababa, Ethiopia; [Britton, Sven] Karolinska Hosp, Dept Infect Dis, S-10401 Stockholm, Sweden; [Elias, Daniel] Univ So Denmark, Inst Mol Med, Dept Canc & Inflammat, Odense, Denmark; [Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Schon, Thomas] Kalmar Cty Hosp, Dept Clin Microbiol, Kalmar, Sweden	University of Gondar; Linkoping University; Addis Ababa University; University of Gondar; University of Gondar; Addis Ababa University; Karolinska Institutet; Karolinska University Hospital; University of Southern Denmark	Abate, E (corresponding author), Univ Gondar, Dept Immunol & Mol Biol, Gondar, Ethiopia.	ebbaabate@yahoo.com	Aseffa, Abraham/J-3248-2016	Aseffa, Abraham/0000-0002-8028-1150	Swedish Agency for Research Cooperation with Developing Countries; Swedish International Development Cooperation Agency (SAREC/SIDA); European-Developing Countries Clinical Trials Partnership (EU/EDCTP) [JP 10800.006]; Swedish Research Council; Swedish Heart and Lung Foundation (Oscar II Jubilee Foundation)	Swedish Agency for Research Cooperation with Developing Countries; Swedish International Development Cooperation Agency (SAREC/SIDA); European-Developing Countries Clinical Trials Partnership (EU/EDCTP); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation (Oscar II Jubilee Foundation)	This study was supported by Swedish Agency for Research Cooperation with Developing Countries and Swedish International Development Cooperation Agency (SAREC/SIDA), European-Developing Countries Clinical Trials Partnership (EU/EDCTP) JP 10800.006, the Swedish Research Council and the Swedish Heart and Lung Foundation (Oscar II Jubilee Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentwich Z, 1996, CLIN EXP IMMUNOL, V103, P239, DOI 10.1046/j.1365-2249.1996.d01-612.x; Borkow G, 2001, SCAND J INFECT DIS, V33, P568, DOI 10.1080/00365540110026656; Carr A, 1998, LANCET, V351, P256, DOI 10.1016/S0140-6736(97)07529-6; Chiodini PL, 2001, ATLAS MED HELMINTHOL, P13; Diniz LM, 2010, CLIN EXP IMMUNOL, V161, P142, DOI 10.1111/j.1365-2249.2010.04164.x; Elias D, 2006, TROP MED INT HEALTH, V11, P551, DOI 10.1111/j.1365-3156.2006.01578.x; Elias D, 2001, CLIN EXP IMMUNOL, V123, P219, DOI 10.1046/j.1365-2249.2001.01446.x; Fehintola FA, 2009, T R SOC TROP MED HYG, V77, P363; Hagan P, 1985, CLIN EXPT IMMUNOLOGY, V161, P142; Kassu A, 2007, TROP DOCT, V37, P222, DOI 10.1258/004947507782333026; MacDonald AS, 2002, INFECT IMMUN, V70, P427, DOI 10.1128/IAI.70.2.427-433.2002; Mele R, 2003, INT J PARASITOL, V33, P757, DOI 10.1016/S0020-7519(03)00093-6; MILLER HRP, 1971, IMMUNOLOGY, V20, P277; Murphy L, 2011, PARASITE IMMUNOL, V33, P287, DOI 10.1111/j.1365-3024.2011.01281.x; Co TR, 2007, CLIN EXP IMMUNOL, V147, P45, DOI 10.1111/j.1365-2249.2006.03247.x; SLEIGH A, 1982, T ROY SOC TROP MED H, V76, P403, DOI 10.1016/0035-9203(82)90201-2; STURROCK RF, 1983, T ROY SOC TROP MED H, V77, P363, DOI 10.1016/0035-9203(83)90166-9; Tristão-Sá Ricardo, 2002, Rev. Soc. Bras. Med. Trop., V35, P533, DOI 10.1590/S0037-86822002000500020; Tsegaye A, 1999, CLIN DIAGN LAB IMMUN, V6, P410, DOI 10.1128/CDLI.6.3.410-414.1999; Valerie G, 2006, AM J RESP CRIT CARE, V173, P7803; Wakabi W, 2008, LANCET, V372, P880, DOI 10.1016/S0140-6736(08)61381-1; Wilson MS, 2004, CLIN REV ALLERG IMMU, V26, P35, DOI 10.1385/CRIAI:26:1:35	22	39	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e42901	10.1371/journal.pone.0042901	http://dx.doi.org/10.1371/journal.pone.0042901			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952620	gold, Green Published, Green Submitted			2022-12-25	WOS:000308206000014
J	Fraser, JA; Alves-Pereira, A; Junqueira, AB; Peroni, N; Clement, CR				Fraser, James Angus; Alves-Pereira, Alessandro; Junqueira, Andre Braga; Peroni, Nivaldo; Clement, Charles Roland			Convergent Adaptations: Bitter Manioc Cultivation Systems in Fertile Anthropogenic Dark Earths and Floodplain Soils in Central Amazonia	PLOS ONE			English	Article							MANIHOT-ESCULENTA CRANTZ; GENETIC DIVERSITY; TRADITIONAL MANAGEMENT; CASSAVA; DYNAMICS; DOMESTICATION; CONSERVATION; ECOLOGY	Shifting cultivation in the humid tropics is incredibly diverse, yet research tends to focus on one type: long-fallow shifting cultivation. While it is a typical adaptation to the highly-weathered nutrient-poor soils of the Amazonian terra firme, fertile environments in the region offer opportunities for agricultural intensification. We hypothesized that Amazonian people have developed divergent bitter manioc cultivation systems as adaptations to the properties of different soils. We compared bitter manioc cultivation in two nutrient-rich and two nutrient-poor soils, along the middle Madeira River in Central Amazonia. We interviewed 249 farmers in 6 localities, sampled their manioc fields, and carried out genetic analysis of bitter manioc landraces. While cultivation in the two richer soils at different localities was characterized by fast-maturing, low-starch manioc landraces, with shorter cropping periods and shorter fallows, the predominant manioc landraces in these soils were generally not genetically similar. Rather, predominant landraces in each of these two fertile soils have emerged from separate selective trajectories which produced landraces that converged for fast-maturing low-starch traits adapted to intensified swidden systems in fertile soils. This contrasts with the more extensive cultivation systems found in the two poorer soils at different localities, characterized by the prevalence of slow-maturing high-starch landraces, longer cropping periods and longer fallows, typical of previous studies. Farmers plant different assemblages of bitter manioc landraces in different soils and the most popular landraces were shown to exhibit significantly different yields when planted in different soils. Farmers have selected different sets of landraces with different perceived agronomic characteristics, along with different fallow lengths, as adaptations to the specific properties of each agroecological micro-environment. These findings open up new avenues for research and debate concerning the origins, evolution, history and contemporary cultivation of bitter manioc in Amazonia and beyond.	[Fraser, James Angus] Univ Andes Bogota, Dept Anthropol, Cundinamarca, Colombia; [Fraser, James Angus] Univ Andes Bogota, Dept Hist, Cundinamarca, Colombia; [Fraser, James Angus] Univ Sussex, Dept Anthropol, E Sussex, England; [Alves-Pereira, Alessandro] Univ Sao Paulo, Postgrad Program Genet & Plant Breeding, Piracicaba, SP, Brazil; [Alves-Pereira, Alessandro; Clement, Charles Roland] Univ Fed Amazonas, Lab Evolucao Aplicada, Manaus, Amazonas, Brazil; [Junqueira, Andre Braga; Clement, Charles Roland] Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil; [Junqueira, Andre Braga] Wageningen Univ, Ctr Crop Syst Anal Technol, Wageningen, Gelderland, Netherlands; [Junqueira, Andre Braga] Wageningen Univ, Agr Dev Grp, Wageningen, Gelderland, Netherlands; [Peroni, Nivaldo] Univ Fed Santa Catarina, Dept Ecol & Zool, Florianopolis, SC, Brazil	University of Sussex; Universidade de Sao Paulo; Universidade Federal de Amazonas; Institute Nacional de Pesquisas da Amazonia; Wageningen University & Research; Wageningen University & Research; Universidade Federal de Santa Catarina (UFSC)	Fraser, JA (corresponding author), Univ Andes Bogota, Dept Anthropol, Cundinamarca, Colombia.	james.angus.fraser@gmail.com	Clement, Charles Roland/G-6081-2010; Peroni, Nivaldo/AAU-4701-2020; Fraser, James A/E-6119-2014; Peroni, Nivaldo/ABA-2663-2021; Peroni, Nivaldo/G-2091-2012; Alves-Pereira, Alessandro/I-6595-2012; Junqueira, Andre Braga/M-1142-2016	Clement, Charles Roland/0000-0002-8421-1029; Peroni, Nivaldo/0000-0002-6770-5377; Peroni, Nivaldo/0000-0002-6770-5377; Peroni, Nivaldo/0000-0002-6770-5377; Alves-Pereira, Alessandro/0000-0002-3012-6355; Junqueira, Andre Braga/0000-0003-3681-1705; Fraser, James/0000-0003-0718-6832	Leverhulme Trust [F/00 230/W]; CNPq (Brazilian National Research Council) (CT Amazonia) [575588/08-0]	Leverhulme Trust(Leverhulme Trust); CNPq (Brazilian National Research Council) (CT Amazonia)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The research was funded by Leverhulme Trust (Grant F/00 230/W) and the CNPq (Brazilian National Research Council) (CT Amazonia 575588/08-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves Pereira A, 2011, DINAMICA EVOLUTIVA M; Alves-Pereira A, 2011, GENETICA, V139, P1259, DOI 10.1007/s10709-011-9627-4; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Arroyo-Kalin M., 2010, Diversity, V2, P473; Arroyo-Kalin M, 2012, QUATERN INT, V249, P4, DOI 10.1016/j.quaint.2011.08.004; Barker G, 2012, RAINFOREST FORAGING; Bernard HR, 2006, RES METHODS ANTHR QU, V4th; Boserup E, 1993, CONDITIONS AGR GROWT; Boster J., 1984, ADV EC BOT, V1, P34; BOSTER JS, 1985, ECON BOT, V39, P310, DOI 10.1007/BF02858802; BROOKFIELD H, 1994, ENVIRONMENT, V36, P6, DOI 10.1080/00139157.1994.9929164; Bryman A., 2008, SOCIAL RES METHODS, V3rd; Chavarriaga-Aguirre P, 1998, THEOR APPL GENET, V97, P493, DOI 10.1007/s001220050922; CONKLIN HC, 1961, CURR ANTHROPOL, V2, P27, DOI 10.1086/200160; de Castro F, 2009, AMAZON PEASANT SOCIETIES IN A CHANGING ENVIRONMENT, P157, DOI 10.1007/978-1-4020-9283-1_8; de Lima RMB, 2000, CENTRAL AMAZON FLOODPLAIN: ACTUAL USE AND OPTIONS FOR A SUSTAINABLE MANAGEMENT, P243; Deletre M, 2011, P NATL ACAD SCI USA, V108, P18249, DOI 10.1073/pnas.1106259108; Denevan William M., 2001, CULTIVATED LANDSCAPE; Denevan WM, 1996, ANN ASSOC AM GEOGR, V86, P654, DOI 10.1111/j.1467-8306.1996.tb01771.x; DENEVAN WM, 1984, FRONTIER EXPANSION A, P311; Denham T, 2008, HOLOCENE, V18, P481, DOI 10.1177/0959683607087936; Elias M, 2000, ACTA OECOL, V21, P223, DOI 10.1016/S1146-609X(00)00053-9; Elias M, 2004, ECON BOT, V58, P242, DOI 10.1663/0013-0001(2004)058[0242:GDOTSA]2.0.CO;2; Elias M, 2001, EUPHYTICA, V120, P143, DOI 10.1023/A:1017501017031; Elias M, 2001, MOL ECOL, V10, P1895, DOI 10.1046/j.0962-1083.2001.01331.x; Elias Marianne, 2000, Journal of Ethnobiology, V20, P239; Ellen R., 2012, Ethnobotany Research and Applications, V10, P15; Emperaire L., 1998, NAT SCI SOC, V6, P27, DOI DOI 10.1016/S1240-1307(98)80006-X; Emperaire L, 2007, HUM ECOL, V35, P761, DOI 10.1007/s10745-007-9121-x; Erickson CL, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P157, DOI 10.1007/978-0-387-74907-5_11; Fraser J. A., 2010, Diversity, V2, P586; Fraser J A, 2009, THESIS U SUSSEX; Fraser J, 2011, AREA, V43, P264, DOI 10.1111/j.1475-4762.2011.00999.x; Fraser JA, 2010, HUM ECOL, V38, P651, DOI 10.1007/s10745-010-9338-y; Fraser James A., 2008, Bol. Mus. Para. Emílio Goeldi. Ciênc. hum., V3, P175; Fraser JA, 2011, HUM ECOL, V39, P395, DOI 10.1007/s10745-011-9405-z; German L, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P179, DOI 10.1007/1-4020-2597-1_10; German LA, 2004, HUM ECOL, V32, P653, DOI 10.1007/s10745-004-6831-1; German LA, 2003, GEODERMA, V111, P307, DOI 10.1016/S0016-7061(02)00270-7; GERMAN LA, 2001, THESIS U GEORGIA; Glaser B., 2004, AMAZONIAN DARK EARTH; Glaser B, 2012, GEOCHIM COSMOCHIM AC, V82, P39, DOI 10.1016/j.gca.2010.11.029; GRENAND F, 1993, MAN BIOSPH, V13, P447; Gutjahr E, 2000, CENTRAL AMAZON FLOODPLAIN: ACTUAL USE AND OPTIONS FOR A SUSTAINABLE MANAGEMENT, P141; Harlan JR, 1992, CROPS MAN; Heckenberger M, 2009, ANNU REV ANTHROPOL, V38, P251, DOI 10.1146/annurev-anthro-091908-164310; Heckler S, 2008, HUM ECOL, V36, P679, DOI 10.1007/s10745-008-9193-2; Hershey CH, 1994, INT CROP NETWORK SER; Hiraoka M, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P387, DOI 10.1007/1-4020-2597-1_20; Iglesias MP, 2002, ENCICLOPEDIA FLOREST, P147; Irion G., 1984, AMAZON LIMNOLOGY LAN, P201, DOI DOI 10.1007/978-94-009-6542-3_7; Jones W. O., 1959, MANIOC IN AFRICA; Kensinger KM, 1975, CASHINAHUA E PERU, V1, P9; Kingwell-Banham E, 2012, QUATERN INT, V249, P84, DOI 10.1016/j.quaint.2011.05.025; Kuzyakov Y, 2009, SOIL BIOL BIOCHEM, V41, P210, DOI 10.1016/j.soilbio.2008.10.016; Lathrap DW, 1970, UPPER AMAZON; Lebot V., 2008, Tropical root and tuber crops: cassava, sweet potato, yams and aroids, pxv, DOI 10.1079/9781845934248.0000; LEHMANN J, 2003, AMAZONIAN DARK EARTH; Lima Deborah, 2012, Bol. Mus. Para. Emílio Goeldi. Ciênc. hum., V7, P371; Mba REC, 2001, THEOR APPL GENET, V102, P21, DOI 10.1007/s001220051614; McCune B, 2002, ANAL ECOLOGICAL COMM; McKey D, 2001, GENET SEL EVOL, V33, pS465, DOI 10.1186/BF03500895; McKey D, 2010, CHEMOECOLOGY, V20, P109, DOI 10.1007/s00049-010-0047-1; Meggers B. J, 1971, AMAZONIA MAN CULTURE; Neumann K, 2012, QUATERN INT, V249, P53, DOI 10.1016/j.quaint.2011.03.024; Neves EG, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P359, DOI 10.1007/978-0-387-74907-5_20; Noda SD, 2000, CENTRAL AMAZON FLOODPLAIN: ACTUAL USE AND OPTIONS FOR A SUSTAINABLE MANAGEMENT, P215; Nye P. H., 1960, TECHNICAL COMMUNICAT; Ohly JJ, 1999, ADV ECON BOTANY, V13, P283; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pereira KJC, 2008, THESIS U SAO PAULO S; Peroni N, 1998, THESIS U SAO PAULO S; Peroni N, 2007, GENET RESOUR CROP EV, V54, P1333, DOI 10.1007/s10722-006-9116-2; Peterson J.B., 2001, UNKNOWN AMAZON CULTU, P86; Pujol B, 2002, ECON BOT, V56, P366, DOI [10.1663/0013-0001(2002)056[0366:GEOCME]2.0.CO;2, 10.1111/j.1461-0248.2004.00708.x]; Pujol B, 2007, BIOL CONSERV, V136, P541, DOI 10.1016/j.biocon.2006.12.025; Ricardo CA, 2000, POVOS INDIGENAS BRAS; Rival L, 2008, CURR ANTHROPOL, V49, P1116, DOI 10.1086/593119; Roosevelt A. C., 1980, PARMANA PREHISTORIC; Salick J, 1997, ECON BOT, V51, P6, DOI 10.1007/BF02910400; Schmidt MJ, 2010, THESIS U FLORIDA; SMITH NJH, 1980, ANN ASSOC AM GEOGR, V70, P553, DOI 10.1111/j.1467-8306.1980.tb01332.x; SMITH NJH, 1999, AMAZON RIVER FOREST; Stahl PW, 2002, REV ARCHAEOLOGY, V23, P39; Steward J., 1948, B BUREAU AM ETHNOLOG, V143; Steward Julian, 1948, HDB S AM INDIANS, V143; STOCKER P, 2006, THESIS U EDINBURGH; Sutrop Urmas, 2001, FIELD METHOD, V13, P263; Wilson W, 2002, CULTURE AGR, V24, P20; Woods W.I., 2009, AMAZONIAN DARK EARTH; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694	91	29	30	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43636	10.1371/journal.pone.0043636	http://dx.doi.org/10.1371/journal.pone.0043636			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952727	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000308206000045
J	Alisi, A; Arciello, M; Petrini, S; Conti, B; Missale, G; Balsano, C				Alisi, Anna; Arciello, Mario; Petrini, Stefania; Conti, Beatrice; Missale, Gabriele; Balsano, Clara			Focal Adhesion Kinase (FAK) Mediates the Induction of Pro-Oncogenic and Fibrogenic Phenotypes in Hepatitis C Virus (HCV)-Infected Cells	PLOS ONE			English	Article							HCV CORE PROTEIN; HEPATOCELLULAR-CARCINOMA; STELLATE CELLS; LIVER-CANCER; THERAPEUTIC STRATEGIES; VIRAL-HEPATITIS; EXPRESSION; PROLIFERATION; ACTIVATION; MIGRATION	Hepatitis C Virus (HCV) infection is one of the most common etiological factors involved in fibrosis development and its progression to hepatocellular carcinoma (HCC). The pivotal role of hepatic stellate cells (HCSs) and extracellular matrix (ECM) in fibrogenesis is now certainly accepted, while the network of molecular interactions connecting HCV is emerging as a master regulator of several biological processes including proliferation, inflammation, cytoskeleton and ECM remodeling. In this study, the effects of HCV proteins expression on liver cancer cells, both pro-invasive and pro-fibrogenic phenotypes were explored. As a model of HCV infection, we used permissive Huh7.5.1 hepatoma cells infected with JFH1-derived ccHCV. Conditioned medium from these cells was used to stimulate LX-2 cells, a line of HSCs. We found that the HCV infection of Huh7.5.1 cells decreased adhesion, increased migration and caused the delocalization of alpha-actinin from plasma membrane to cytoplasm and increased expression levels of paxillin. The treatment of LX-2 cells, with conditioned medium from HCV-infected Huh7.5.1 cells, caused an increase in cell proliferation, expression of alpha-smooth muscle actin, hyaluronic acid release and apoptosis rate measured as cleaved poly ADP-ribose polymerase (PARP). These effects were accompanied in Huh7.5.1 cells by an HCV-dependent increasing of FAK activation that physically interacts with phosphorylated paxillin and alpha-actinin, and a rising of tumor necrosis factor alpha production/release. Silencing of FAK by siRNA reverted all effects of HCV infection, both those directed on Huh7.5.1 cells, and those indirect effects on the LX-2 cells. Moreover and interestingly, FAK inhibition enhances apoptosis in HCV-conditioned LX-2 cells. In conclusion, our findings demonstrate that HCV, through FAK activation, may promote cytoskeletal reorganization and a pro-oncogenic phenotype in hepatocyte-like cells, and a fibrogenic phenotype in HSCs.	[Alisi, Anna] Bambino Gesu Pediat Hosp, IRCCS, Confocal Microscopy Facil, Liver Res Unit, Rome, Italy; [Arciello, Mario; Conti, Beatrice; Balsano, Clara] Univ Roma La Sapienza, A Cesalpino Fdn, Lab Mol Virol & Oncol, Rome, Italy; [Arciello, Mario; Conti, Beatrice] Univ Aquila, Dept Internal Med, I-67100 Laquila, Italy; [Missale, Gabriele] Azienda Osped Univ Parma, Unit Infect Dis & Hepatol, Parma, Italy; [Balsano, Clara] IBPM, Rome, Italy	IRCCS Bambino Gesu; Sapienza University Rome; University of L'Aquila; University of Parma; University Hospital of Parma; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Alisi, A (corresponding author), Bambino Gesu Pediat Hosp, IRCCS, Confocal Microscopy Facil, Liver Res Unit, Rome, Italy.	anna.alisi@opbg.net; clara.balsano@uniroma1.it	Balsano, Clara/AAK-9870-2020; Missale, Gabriele/J-6083-2016; Petrini, Stefania/I-1464-2018; Arciello, Mario/G-9278-2016; Alisi, Anna/A-6469-2010	Balsano, Clara/0000-0002-9615-7031; Missale, Gabriele/0000-0001-6691-8701; Petrini, Stefania/0000-0002-3249-0003; Arciello, Mario/0000-0001-8599-6297; Alisi, Anna/0000-0001-7241-6329	A. Cesalpino Foundation; Associazione Italiana Per La Ricerca Sul Cancro (AIRC) Grant	A. Cesalpino Foundation; Associazione Italiana Per La Ricerca Sul Cancro (AIRC) Grant(Fondazione AIRC per la ricerca sul cancro)	This study was supported by A. Cesalpino Foundation, and Associazione Italiana Per La Ricerca Sul Cancro (AIRC) Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisi A, 2005, J CELL PHYSIOL, V205, P25, DOI 10.1002/jcp.20363; Alisi A, 2003, ONCOGENE, V22, P2573, DOI 10.1038/sj.onc.1206333; Alisi A, 2011, J HEPATOL, V54, P956, DOI 10.1016/j.jhep.2010.08.016; Alisi A, 2009, INT J MOL MED, V24, P319, DOI 10.3892/ijmm_00000235; Amann T, 2009, CANCER SCI, V100, P646, DOI 10.1111/j.1349-7006.2009.01087.x; Ariumi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014517; Bai XM, 2009, ONCOL REP, V21, P129, DOI 10.3892/or_00000199; Balsano C, 2007, DIG LIVER DIS S1, pS46; Balsano C, 2009, CURR DRUG TARGETS, V10, P505, DOI 10.2174/138945009788488459; Battaglia S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004355; Boosani CS, 2009, INVEST OPHTH VIS SCI, V50, P4567, DOI 10.1167/iovs.09-3473; Carloni V, 1997, GASTROENTEROLOGY, V112, P522, DOI 10.1053/gast.1997.v112.pm9024306; Chen JS, 2010, CLIN EXP METASTAS, V27, P71, DOI 10.1007/s10585-010-9306-3; Clement S, 2010, J HEPATOL, V52, P635, DOI 10.1016/j.jhep.2009.10.035; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Desmouliere A, 2004, INT J DEV BIOL, V48, P509, DOI 10.1387/ijdb.041802ad; Dolganiuc A, 2003, J IMMUNOL, V170, P5615, DOI 10.4049/jimmunol.170.11.5615; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fang CY, 2006, PROTEOMICS, V6, P519, DOI 10.1002/pmic.200500233; Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97; Fujii T, 2004, J HEPATOL, V41, P104, DOI 10.1016/j.jhep.2004.03.029; Giannelli G, 2003, HISTOL HISTOPATHOL, V18, P1267, DOI 10.14670/HH-18.1267; GONZALEZAMARO R, 1994, J EXP MED, V179, P841, DOI 10.1084/jem.179.3.841; Hosomura N, 2011, DIGEST DIS SCI, V56, P1057, DOI 10.1007/s10620-010-1395-y; Itoh S, 2004, CLIN CANCER RES, V10, P2812, DOI 10.1158/1078-0432.CCR-1046-03; Izaguirre G, 2001, J BIOL CHEM, V276, P28676, DOI 10.1074/jbc.M101678200; Jiang HQ, 2004, WORLD J GASTROENTERO, V10, P3001; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Li HG, 2005, WORLD J GASTROENTERO, V11, P1445; Li JT, 2008, J GASTROENTEROL, V43, P419, DOI 10.1007/s00535-008-2180-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo SH, 2006, DEV BIOL, V294, P280, DOI 10.1016/j.ydbio.2006.03.029; McGivern DR, 2011, ONCOGENE, V30, P1969, DOI 10.1038/onc.2010.594; Mehal W, 2010, SEMIN LIVER DIS, V30, P226, DOI 10.1055/s-0030-1255352; Mon NN, 2006, ANN NY ACAD SCI, V1086, P199, DOI 10.1196/annals.1377.019; Neuman MG, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/231210; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Sancho-Bru P, 2010, LIVER INT, V30, P31, DOI 10.1111/j.1478-3231.2009.02161.x; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Talaat RM, 2010, VIRAL IMMUNOL, V23, P151, DOI 10.1089/vim.2009.0089; Tarrats N, 2011, HEPATOLOGY, V54, P319, DOI 10.1002/hep.24388; Tseng WP, 2010, J CELL PHYSIOL, V223, P389, DOI 10.1002/jcp.22047; von Sengbusch A, 2005, AM J PATHOL, V166, P585, DOI 10.1016/S0002-9440(10)62280-8; Wu X Z, 2006, Minerva Gastroenterol Dietol, V52, P407; Wu YM, 2009, CELL BIOL INT, V33, P199, DOI 10.1016/j.cellbi.2008.11.006; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Yuan Z, 2010, J CANCER RES CLIN, V136, P1489, DOI 10.1007/s00432-010-0806-y; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	51	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44147	10.1371/journal.pone.0044147	http://dx.doi.org/10.1371/journal.pone.0044147			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937161	gold, Green Published, Green Submitted			2022-12-25	WOS:000308213600082
J	Fernandez-Caggiano, M; Barallobre-Barreiro, J; Rego-Perez, I; Crespo-Leiro, MG; Paniagua, MJ; Grille, Z; Blanco, FJ; Domenech, N				Fernandez-Caggiano, Mariana; Barallobre-Barreiro, Javier; Rego-Perez, Ignacio; Crespo-Leiro, Maria G.; Jesus Paniagua, Maria; Grille, Zulaika; Blanco, Francisco J.; Domenech, Nieves			Mitochondrial Haplogroups H and J: Risk and Protective Factors for Ischemic Cardiomyopathy	PLOS ONE			English	Article							DEGENERATIVE DISEASES; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; MTDNA VARIATION; DNA; ATHEROSCLEROSIS; ASSOCIATION; CANCER; HYPERTENSION; LONGEVITY	Background: Since mitochondria are the principal source of reactive oxygen species (ROS), these organelles may play an important role in ischemic cardiomyopathy (IC) development. The mitochondrial genome may influence this disease. The aim of the present study was to test the relationship between IC development and the impact of single nucleotide polymorphisms (SNPs) in mitochondrial DNA (mtDNA) defining the mitochondrial haplogroups in a population study. Methodology and principal findings: Ten major European haplogroups were identified by using the single base extension technique and by polymerase chain reaction-restriction fragment length polymorphism. Frequencies and Odds Ratios for the association between IC patients (n = 358) and healthy controls (n = 423) were calculated. No convincing associations between classical risk factors for ischemic cardiomyopathy development and haplogroups were found. However, compared to healthy controls, the prevalence of haplogroup H was significantly higher in IC patients (40.0% vs 50.0%, p-value = 0.039) while the frequency of haplogroup J was significantly lower (11.1% vs 5.6%, p-value = 0.048). The analysis of the SNPs characterizing the European mtDNA haplogroups showed that the m. 7028C allele (40.0% vs 50.0%, p-value = 0.005) and m. 14766C allele (43.0% vs 54.2%, p-value = 0.002) were overrepresented in IC patients, meanwhile the m. 10398G allele (19.8% vs 13.1%, p-value = 0.015) and m. 4216C allele (22.2% vs 16.5%, p-value = 0.044) were found as protective factors against IC. Conclusions and significance: Our results showed that the haplogroups H and J were found as a risk and protective factors for ischemic cardiomyopathy development, respectively.	[Fernandez-Caggiano, Mariana; Barallobre-Barreiro, Javier; Domenech, Nieves] INIBIC Complejo Hosp Univ A Coruna, Cardiac Biomarkers Grp, Res Unit, La Coruna, Spain; [Rego-Perez, Ignacio; Blanco, Francisco J.] INIBIC Complejo Hosp Univ A Coruna, Genom Lab, Div Rheumatol, La Coruna, Spain; [Crespo-Leiro, Maria G.; Jesus Paniagua, Maria; Grille, Zulaika] INIBIC Complejo Hosp Univ A Coruna, Dept Cardiol, Adv Heart Failure & Heart Transplant Unit, La Coruna, Spain; [Crespo-Leiro, Maria G.; Jesus Paniagua, Maria; Grille, Zulaika] Inst Salud Carlos III, Spanish Cardiovasc Res Network RECAVA, Madrid, Spain	Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Instituto de Salud Carlos III	Fernandez-Caggiano, M (corresponding author), INIBIC Complejo Hosp Univ A Coruna, Cardiac Biomarkers Grp, Res Unit, La Coruna, Spain.	nieves.domenech.garcia@sergas.es	; DOMENECH, NIEVES/E-5812-2012; Blanco Garcia, Francisco J/C-3192-2014; Rego-Perez, Ignacio/B-1665-2012	Fernandez-Caggiano, Mariana/0000-0001-5180-0866; DOMENECH, NIEVES/0000-0002-2056-9400; Barallobre-Barreiro, Javier/0000-0001-6236-2304; Blanco Garcia, Francisco J/0000-0001-9821-7635; Crespo-Leiro, Maria Generosa/0000-0002-3085-167X; Rego-Perez, Ignacio/0000-0003-1754-1164	Fondo de Investigacion Sanitaria [PS09/00840]; Conselleria de Educacion	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Conselleria de Educacion	The work described in this manuscript was supported by grants from Fondo de Investigacion Sanitaria-PS09/00840. Contrato Maria Barbeito from Conselleria de Educacion supported MFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia J, 2009, JAMA-J AM MED ASSOC, V301, P74, DOI 10.1001/jama.2008.901; Beckstead WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005836; Benn M, 2008, CIRCULATION, V117, P2492, DOI 10.1161/CIRCULATIONAHA.107.756809; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Cai XY, 2009, PLOS ONE, V29, p4(7); Castro MG, 2006, INT J CARDIOL, V112, P202, DOI 10.1016/j.ijcard.2005.09.008; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chinnery PF, 2010, LANCET NEUROL, V9, P498, DOI 10.1016/S1474-4422(10)70083-1; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Fang HZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-421; Gallardo ME, 2012, EUR HEART J, V33, P346, DOI 10.1093/eurheartj/ehr280; Herrnstadt C, 2004, MITOCHONDRION, V4, P791, DOI 10.1016/j.mito.2004.07.041; Kobayashi S, 2003, ARTERIOSCL THROM VAS, V23, P1398, DOI 10.1161/01.ATV.0000081637.36475.BC; Kofler B, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-35; Kojda G, 1999, CARDIOVASC RES, V43, P562, DOI 10.1016/S0008-6363(99)00169-8; Kondo T, 2009, J ATHEROSCLER THROMB, V16, P532, DOI 10.5551/jat.1255; Li XY, 2011, MITOCHONDRION, V11, P27, DOI 10.1016/j.mito.2010.06.005; Little J, 2009, HUM GENET, V125, P131, DOI 10.1007/s00439-008-0592-7; Mancuso M, 2004, NEUROSCI LETT, V371, P158, DOI 10.1016/j.neulet.2004.08.060; Marcuello A, 2009, MITOCHONDRION, V9, P27, DOI 10.1016/j.mito.2008.10.002; Martinez-Redondo D, 2010, MITOCHONDRION, V10, P102, DOI 10.1016/j.mito.2009.11.005; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Mozaffari MS, 2003, HYPERTENSION, V42, P1042, DOI 10.1161/01.HYP.0000095614.91961.40; Navab M, 1996, ARTERIOSCL THROM VAS, V16, P831, DOI 10.1161/01.ATV.16.7.831; Nishigaki Y, 2007, HUM GENET, V120, P827, DOI 10.1007/s00439-006-0269-z; Palacin M, 2011, MITOCHONDRION, V11, P176, DOI 10.1016/j.mito.2010.09.004; Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303; Radford Martha J, 2005, Circulation, V112, P1888, DOI 10.1161/CIRCULATIONAHA.105.170073; Rego I, 2010, ANN RHEUM DIS, V69, P210, DOI 10.1136/ard.2008.105254; Rego-Perez I, 2008, ARTHRITIS RHEUM-US, V58, P2387, DOI 10.1002/art.23659; Rosa A, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-57; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Santoro A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012037; Sawabe M, 2011, J ATHEROSCLER THROMB, V18, P166, DOI 10.5551/jat.6742; Suissa S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000474; Torroni A, 1996, GENETICS, V144, P1835; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 2003, COLD SPRING HARB SYM, V68, P479; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	42	32	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44128	10.1371/journal.pone.0044128	http://dx.doi.org/10.1371/journal.pone.0044128			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937160	Green Published, gold, Green Submitted			2022-12-25	WOS:000308213600081
J	Kuypers, KPC; Legrand, SA; Ramaekers, JG; Verstraete, AG				Kuypers, Kim Paula Colette; Legrand, Sara-Ann; Ramaekers, Johannes Gerardus; Verstraete, Alain Gaston			A Case-Control Study Estimating Accident Risk for Alcohol, Medicines and Illegal Drugs	PLOS ONE			English	Article							ORAL FLUID; CANNABIS; DRIVERS; CRASHES	Background: The aim of the present study was to assess the risk of having a traffic accident after using alcohol, single drugs, or a combination, and to determine the concentrations at which this risk is significantly increased. Methods: A population-based case-control study was carried out, collecting whole blood samples of both cases and controls, in which a number of drugs were detected. The risk of having an accident when under the influence of drugs was estimated using logistic regression adjusting for gender, age and time period of accident (cases)/sampling (controls). The main outcome measures were odds ratio (OR) for accident risk associated with single and multiple drug use. In total, 337 cases (negative: 176; positive: 161) and 2726 controls (negative: 2425; positive: 301) were included in the study. Results: Main findings were that 1) alcohol in general (all the concentrations together) caused an elevated crash risk; 2) cannabis in general also caused an increase in accident risk; at a cut-off of 2 ng/mL THC the risk of having an accident was four times the risk associated with the lowest THC concentrations; 3) when ranking the adjusted OR from lowest to highest risk, alcohol alone or in combination with other drugs was related to a very elevated crash risk, with the highest risk for stimulants combined with sedatives. Conclusion: The study demonstrated a concentration-dependent crash risk for THC positive drivers. Alcohol and alcohol-drug combinations are by far the most prevalent substances in drivers and subsequently pose the largest risk in traffic, both in terms of risk and scope.	[Kuypers, Kim Paula Colette; Ramaekers, Johannes Gerardus] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands; [Kuypers, Kim Paula Colette; Legrand, Sara-Ann; Verstraete, Alain Gaston] Univ Ghent, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium	Maastricht University; Ghent University	Kuypers, KPC (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands.	k.kuypers@maastrichtuniversity.nl	Kuypers, Kim/L-1206-2019; Verstraete, Alain G/B-4150-2013	Kuypers, Kim/0000-0001-7634-3809; Verstraete, Alain G/0000-0002-0956-3315	European Commission within EU	European Commission within EU	This article has been produced under the project Driving Under Influence of Drugs, Alcohol and Medicines (DRUID, www.druid-project.eu) financed by the European Commission within the framework of the EU 6th Framework Program. This report reflects only the authors' view. The European commission is not liable for any use that may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	AAAM, 2008, INT INJ SCAL; Blomberg RD, 2005, CRASH RISK ALCOHOL I; Borkenstein R.F., 1974, BLUTALKOHOL, V11, P1; Brookhuis K, 1998, HUM PSYCHOPHARM CLIN, V13, pS64; Charlier C, 1998, Rev Med Liege, V53, P25; Dassanayake T, 2011, DRUG SAFETY, V34, P125, DOI 10.2165/11539050-000000000-00000; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Drummer Olaf H., 2009, P93, DOI 10.1007/978-3-7643-9923-8_7; EMCDDA, 2007, SEL ISS 2007 DRUGS D; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Garthe E, 1999, J TRAUMA, V47, P309, DOI 10.1097/00005373-199908000-00016; Gjerde H, 2011, ACCIDENT ANAL PREV, V43, P1197, DOI 10.1016/j.aap.2010.12.034; Gjerde H, 2010, FORENSIC SCI INT, V195, P153, DOI 10.1016/j.forsciint.2009.12.011; Houwing S., 2011, PREVALENCE ALCOHOL 1; Houwing Sjoerd, 2009, P107, DOI 10.1007/978-3-7643-9923-8_8; Isalberti C., 2011, PREVALENCE ALCOHOL O; Khiabani Hassan Z, 2006, Traffic Inj Prev, V7, P111, DOI 10.1080/15389580600550172; Kruger HP, 2004, ACCIDENT ANAL PREV, V36, P125, DOI 10.1016/S0001-4575(02)00134-3; Laumon B, 2005, BRIT MED J, V331, P1371, DOI 10.1136/bmj.38648.617986.1F; Moskowitz H, 2002, REV EXPT STUDIES LOW, P4; Movig KLL, 2004, ACCIDENT ANAL PREV, V36, P631, DOI 10.1016/S0001-4575(03)00084-8; Mura P, 2003, FORENSIC SCI INT, V133, P79, DOI 10.1016/S0379-0738(03)00052-5; Nemes S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-56; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Raes E, 2008, FORENSIC SCI HDB ANA, P646; Ramaekers JG, 2006, DRUG ALCOHOL DEPEN, V85, P114, DOI 10.1016/j.drugalcdep.2006.03.015; Ramaekers JG, 2004, DRUG ALCOHOL DEPEN, V73, P109, DOI 10.1016/j.drugalcdep.2003.10.008; Romano E, 2011, J STUD ALCOHOL DRUGS, V72, P567, DOI 10.15288/jsad.2011.72.567; Wille SMR, 2009, THER DRUG MONIT, V31, P511, DOI 10.1097/FTD.0b013e3181ae46ea; Woratanarat P, 2009, ACCIDENT ANAL PREV, V41, P651, DOI 10.1016/j.aap.2009.03.002	30	52	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43496	10.1371/journal.pone.0043496	http://dx.doi.org/10.1371/journal.pone.0043496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998CA	22952694	gold, Green Published			2022-12-25	WOS:000308213600028
J	Li, BQ; Feng, KY; Chen, L; Huang, T; Cai, YD				Li, Bi-Qing; Feng, Kai-Yan; Chen, Lei; Huang, Tao; Cai, Yu-Dong			Prediction of Protein-Protein Interaction Sites by Random Forest Algorithm with mRMR and IFS	PLOS ONE			English	Article							SECONDARY-STRUCTURE; SEQUENCE PROFILE; HOT-SPOTS; CLASSIFICATION; INTERFACES; PROGRAM; RESIDUE; IDENTIFICATION; INFORMATION; DATABASE	Prediction of protein-protein interaction (PPI) sites is one of the most challenging problems in computational biology. Although great progress has been made by employing various machine learning approaches with numerous characteristic features, the problem is still far from being solved. In this study, we developed a novel predictor based on Random Forest (RF) algorithm with the Minimum Redundancy Maximal Relevance (mRMR) method followed by incremental feature selection (IFS). We incorporated features of physicochemical/biochemical properties, sequence conservation, residual disorder, secondary structure and solvent accessibility. We also included five 3D structural features to predict protein-protein interaction sites and achieved an overall accuracy of 0.672997 and MCC of 0.347977. Feature analysis showed that 3D structural features such as Depth Index (DPX) and surface curvature (SC) contributed most to the prediction of protein-protein interaction sites. It was also shown via site-specific feature analysis that the features of individual residues from PPI sites contribute most to the determination of protein-protein interaction sites. It is anticipated that our prediction method will become a useful tool for identifying PPI sites, and that the feature analysis described in this paper will provide useful insights into the mechanisms of interaction.	[Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Li, Bi-Qing; Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Li, Bi-Qing; Huang, Tao] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Feng, Kai-Yan] Beijing Genom Inst, Shenzhen, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China; [Huang, Tao] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Beijing Genomics Institute (BGI); Shanghai Maritime University; Icahn School of Medicine at Mount Sinai	Cai, YD (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	cai_yud@yahoo.com.cn	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]; Shanghai Municipal Education Commission [12ZZ087]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by grants from National Basic Research Program of China (2011CB510102, 2011CB510101) and Innovation Program of Shanghai Municipal Education Commission (12ZZ087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 1989, MOL BIOL CELL; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Aytuna AS, 2005, BIOINFORMATICS, V21, P2850, DOI 10.1093/bioinformatics/bti443; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bernardes JS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-492; Bradford JR, 2006, J MOL BIOL, V362, P365, DOI 10.1016/j.jmb.2006.07.028; Bradford JR, 2005, BIOINFORMATICS, V21, P1487, DOI 10.1093/bioinformatics/bti242; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bunescu R, 2005, ARTIF INTELL MED, V33, P139, DOI 10.1016/j.artmed.2004.07.016; Chen XW, 2009, BIOINFORMATICS, V25, P585, DOI 10.1093/bioinformatics/btp039; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Davis J, 2006, P 23 INT C MACH LEAR, P233, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Fariselli P, 2002, EUR J BIOCHEM, V269, P1356, DOI 10.1046/j.1432-1033.2002.02767.x; Gallet X, 2000, J MOL BIOL, V302, P917, DOI 10.1006/jmbi.2000.4092; Grabe M, 2003, BIOPHYS J, V84, P854, DOI 10.1016/S0006-3495(03)74904-2; Guharoy M, 2007, BIOINFORMATICS, V23, P1909, DOI 10.1093/bioinformatics/btm274; Hoskins J, 2006, PROTEIN SCI, V15, P1017, DOI 10.1110/ps.051589106; Jian-Tao Y, 2008, PREDICTION PROTEIN P, P100; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; KINI RM, 1995, BIOCHEM BIOPH RES CO, V212, P1115, DOI 10.1006/bbrc.1995.2084; Kohavi R., 1995, INT JOINT C ART INT, V14, P1137, DOI DOI 10.1067/MOD.2000.109031; Koike A, 2004, PROTEIN ENG DES SEL, V17, P165, DOI 10.1093/protein/gzh020; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039308; Li BQ, 2012, J PROTEOMICS, V75, P1654, DOI 10.1016/j.jprot.2011.12.003; Li MH, 2007, BIOINFORMATICS, V23, P597, DOI 10.1093/bioinformatics/btl660; Li N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-553; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu JF, 2002, J MOL BIOL, V322, P53, DOI 10.1016/S0022-2836(02)00736-2; Mihel J, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-21; Monji H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S39; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; Nguyen MN, 2006, PROTEIN PROTEIN INTE, P1; Ofran Y, 2003, FEBS LETT, V544, P236, DOI 10.1016/S0014-5793(03)00456-3; Ofran Y, 2007, BIOINFORMATICS, V23, pE13, DOI 10.1093/bioinformatics/btl303; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Sikic M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000278; Stein A, 2011, NUCLEIC ACIDS RES, V39, pD718, DOI 10.1093/nar/gkq962; STEWART DE, 1990, J MOL BIOL, V214, P253, DOI 10.1016/0022-2836(90)90159-J; Talavera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021053; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Wang B, 2006, FEBS LETT, V580, P380, DOI 10.1016/j.febslet.2005.11.081; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xia JF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-174; Zhou HX, 2001, PROTEINS, V44, P336, DOI 10.1002/prot.1099; Zhou WQ, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S1	54	77	78	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43927	10.1371/journal.pone.0043927	http://dx.doi.org/10.1371/journal.pone.0043927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937126	Green Published, Green Submitted, gold			2022-12-25	WOS:000308213600057
J	Bargaje, R; Gupta, S; Sarkeshik, A; Park, R; Xu, T; Sarkar, M; Halimani, M; Roy, SS; Yates, J; Pillai, B				Bargaje, Rhishikesh; Gupta, Shivani; Sarkeshik, Ali; Park, Robin; Xu, Tao; Sarkar, Maharnob; Halimani, Mahantappa; Roy, Soumya Sinha; Yates, John; Pillai, Beena			Identification of Novel Targets for miR-29a Using miRNA Proteomics	PLOS ONE			English	Article							TANDEM MASS-SPECTRA; TUMOR-SUPPRESSOR; MICRORNA TARGETS; DOWN-REGULATION; MIR-34 FAMILY; GENE LISTS; PROTEIN; CANCER; APOPTOSIS; EXPRESSION	MicroRNAs (miRNAs) are short regulatory RNA molecules that interfere with the expression of target mRNA by binding to complementary sequences. Currently, the most common method for identification of targets of miRNAs is computational prediction based on free energy change calculations, target site accessibility and conservation. Such algorithms predict hundreds of targets for each miRNA, necessitating tedious experimentation to identify the few functional targets. Here we explore the utility of miRNA-proteomics as an approach to identifying functional miRNA targets. We used Stable Isotope Labeling by amino acids in cell culture (SILAC) based proteomics to detect differences in protein expression induced by the over-expression of miR-34a and miR-29a. Over-expression of miR-29a, a miRNA expressed in the brain and in cells of the blood lineage, resulted in the differential expression of a set of proteins. Gene Ontology based classification showed that a significant sub-set of these targets, including Voltage Dependent Anion Channel 1 and 2 (VDAC1 and VDAC2) and ATP synthetase, were mitochondrial proteins involved in apoptosis. Using reporter assays, we established that miR-29a targets the 39 Untranslated Regions (39 UTR) of VDAC1 and VDAC2. However, due to the limited number of proteins identified using this approach and the inability to differentiate between primary and secondary effects we conclude that miRNA-proteomics is of limited utility as a high-throughput alternative for sensitive and unbiased miRNA target identification. However, this approach was valuable for rapid assessment of the impact of the miRNAs on the cellular proteome and its biological role in apoptosis.	[Bargaje, Rhishikesh; Gupta, Shivani; Sarkar, Maharnob; Halimani, Mahantappa; Roy, Soumya Sinha; Pillai, Beena] Inst Genom & Integrat Biol, Funct Genom Unit, Council Sci Ind Res, Delhi, India; [Sarkeshik, Ali; Park, Robin; Xu, Tao; Yates, John] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Scripps Research Institute	Bargaje, R (corresponding author), Inst Genom & Integrat Biol, Funct Genom Unit, Council Sci Ind Res, Delhi, India.	jyates@scripps.edu; beena@igib.in		Sinha Roy, Soumya/0000-0002-4135-0141; Pillai, Beena/0000-0002-9302-9878	Council of Scientific and Industrial Research, India, "Cutting Edge Technology Network on Proteomics" of ISTAD, CSIR, and Comparative genomics and biology of Non-coding RNA in the human genome [NWP0036]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER	Council of Scientific and Industrial Research, India, "Cutting Edge Technology Network on Proteomics" of ISTAD, CSIR, and Comparative genomics and biology of Non-coding RNA in the human genome; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Council of Scientific and Industrial Research, India, "Cutting Edge Technology Network on Proteomics" of ISTAD, CSIR, and Comparative genomics and biology of Non-coding RNA in the human genome (NWP0036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia JK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-117; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beitzinger M, 2011, METHODS MOL BIOL, V732, P153, DOI 10.1007/978-1-61779-083-6_12; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen QR, 2011, J PROTEOME RES, V10, P479, DOI 10.1021/pr1006697; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cociorva Daniel, 2007, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1304s16; Cora D, 2011, PLOS ONE, V6; Corney DC, 2010, CLIN CANCER RES, V16, P1119, DOI 10.1158/1078-0432.CCR-09-2642; De Pinto V, 2010, BBA-BIOENERGETICS, V1797, P1268, DOI 10.1016/j.bbabio.2010.01.031; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Ferdin J, 2010, TECHNOL CANCER RES T, V9, P123, DOI 10.1177/153303461000900202; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Ghosh T, 2008, NUCLEIC ACIDS RES, V36, P6318, DOI 10.1093/nar/gkn624; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Han YC, 2010, J EXP MED, V207, P475, DOI 10.1084/jem.20090831; Hariharan M, 2005, BIOCHEM BIOPH RES CO, V337, P1214, DOI 10.1016/j.bbrc.2005.09.183; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Jovanovic M, 2010, NAT METHODS, V7, P837, DOI [10.1038/NMETH.1504, 10.1038/nmeth.1504]; Kaller M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010462; Kole AJ, 2011, GENE DEV, V25, P125, DOI 10.1101/gad.1975411; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Li XH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-44; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Park SK, 2010, CURR PROTOC BIOINFOR, DOI 10.1002/0471250953.bi1312s29; Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/NMETH.1195, 10.1038/nmeth.1195]; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Roshan R, 2012, RNA BIOL, V9, P891, DOI 10.4161/rna.19876; Rostovtseva TK, 2005, J BIOENERG BIOMEMBR, V37, P129, DOI 10.1007/s10863-005-6566-8; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Vinther J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl590; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wen JY, 2011, RNA, V17, P820, DOI 10.1261/rna.2387911; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yan GR, 2011, PROTEOMICS, V11, P912, DOI 10.1002/pmic.201000539; Yang Y, 2010, MOL BIOSYST, V6, P1873, DOI 10.1039/c004401f; Yang Y, 2009, PROTEOMICS, V9, P1374, DOI 10.1002/pmic.200800551; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356	66	40	45	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43243	10.1371/journal.pone.0043243	http://dx.doi.org/10.1371/journal.pone.0043243			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952654	Green Submitted, Green Published, gold			2022-12-25	WOS:000308044800024
J	Knops, JMH; Koenig, WD				Knops, Johannes M. H.; Koenig, Walter D.			Sex Allocation in California Oaks: Trade-Offs or Resource Tracking?	PLOS ONE			English	Article							LIFE-HISTORY; VALLEY OAK; QUERCUS-LOBATA; SIZE; REPRODUCTION; GROWTH; PLANTS; EVOLUTION; RATIO; POPULATION	Trade-offs in sex resource allocation are commonly inferred from a negative correlation between male and female reproduction. We found that for three California oak species, aboveground annual net productivity (ANP) differences among individuals were primarily correlated with water availability and soil fertility. Reproductive biomass increased with ANP, but the relative allocation to reproduction was constant, indicating that reproduction tracked productivity, which in turn tracked site quality. Although there was a negative correlation between male and female reproduction, this was not the result of a resource investment trade-off, but rather a byproduct of the positive correlation between female reproductive biomass and ANP combined with the greater overall resource allocation to female, compared to male, function. Thus, we reject the hypothesis of a trade-off between these key life-history components within individuals of these species. For long-lived individuals, a plastic resource tracking response to environmental fluctuations may be more adaptive than directly linking life-history traits through trade-offs.	[Knops, Johannes M. H.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68583 USA; [Koenig, Walter D.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; [Koenig, Walter D.] Cornell Univ, Ornithol Lab, Ithaca, NY USA	University of Nebraska System; University of Nebraska Lincoln; Cornell University; Cornell University	Knops, JMH (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68583 USA.	jknops2@unl.edu	Knops, Johannes/AAA-8546-2020	Koenig, Walter/0000-0001-6207-1427	University of California's Integrated Hardwoods Range Management Program; National Science Foundation [DEB-0816691]; Direct For Biological Sciences [0816691] Funding Source: National Science Foundation	University of California's Integrated Hardwoods Range Management Program; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Data collection was supported by the University of California's Integrated Hardwoods Range Management Program and National Science Foundation grant DEB-0816691. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There were no other external funding sources for this study.	Abraham ST, 2011, INT J PLANT SCI, V172, P691, DOI 10.1086/659646; ASHMAN TL, 1994, AM NAT, V144, P300, DOI 10.1086/285676; Barrett SCH, 1998, TRENDS PLANT SCI, V3, P335, DOI 10.1016/S1360-1385(98)01299-0; Barringer BC, 2012, OECOLOGIA IN PRESS; BURD M, 1988, EVOLUTION, V42, P403, DOI 10.2307/2409245; Campbell DR, 2000, TRENDS ECOL EVOL, V15, P227, DOI 10.1016/S0169-5347(00)01872-3; Cattelino P. J., 1986, Northern Journal of Applied Forestry, V3, P73; CHARNOV E L, 1982; CHARNOV EL, 1977, NATURE, V266, P828, DOI 10.1038/266828a0; DEJONG G, 1993, FUNCT ECOL, V7, P75, DOI 10.2307/2389869; DEJONG TJ, 1994, J ECOL, V82, P399, DOI 10.2307/2261307; Dorken ME, 2008, AM NAT, V171, P828; Dow BD, 1998, J HERED, V89, P62, DOI 10.1093/jhered/89.1.62; FOX JF, 1991, ECOLOGY, V72, P1013, DOI 10.2307/1940601; FREEMAN DC, 1976, SCIENCE, V193, P597, DOI 10.1126/science.193.4253.597; FREEMAN DC, 1980, OECOLOGIA, V47, P222, DOI 10.1007/BF00346825; FREEMAN DC, 1981, EVOLUTION, V35, P194, DOI 10.1111/j.1558-5646.1981.tb04875.x; Friedman J, 2011, EVOLUTION, V65, P2061, DOI 10.1111/j.1558-5646.2011.01284.x; Galen C, 2000, AM NAT, V156, P72, DOI 10.1086/303373; Guillon JM, 2006, J EVOLUTION BIOL, V19, P500, DOI 10.1111/j.1420-9101.2005.01012.x; HAYNES RJ, 1980, COMMUN SOIL SCI PLAN, V11, P459, DOI 10.1080/00103628009367053; Hesse E, 2011, ANN BOT-LONDON, V107, P1039, DOI 10.1093/aob/mcr046; HORVITZ CC, 1988, ECOLOGY, V69, P1741, DOI 10.2307/1941152; Hulshof CM, 2012, ECOLOGY, V93, P180, DOI 10.1890/11-0740.1; Ishida TA, 2005, J PLANT RES, V118, P193, DOI 10.1007/s10265-005-0206-6; Kazuhiko M, 2007, AM J BOT, V94, P1450, DOI 10.3732/ajb.94.9.1450; Klinkhamer PGL, 1997, TRENDS ECOL EVOL, V12, P260, DOI 10.1016/S0169-5347(97)01078-1; Knops J. M., 1994, MADRONO, V41, P290; Knops JMH, 1996, ECOL MONOGR, V66, P159, DOI 10.2307/2963473; Knops JMH, 1997, PLANT ECOL, V130, P121, DOI 10.1023/A:1009798327200; Knops Johannes M. H., 2000, Madrono, V47, P106; Knops JMH, 2007, P NATL ACAD SCI USA, V104, P16982, DOI 10.1073/pnas.0704251104; Koenig WD, 2009, AM NAT, V173, P682, DOI 10.1086/597605; Koenig WD, 2005, AM SCI, V93, P340, DOI 10.1511/2005.54.970; Koenig WD, 2003, TRENDS ECOL EVOL, V18, P157, DOI 10.1016/S0169-5347(03)00034-X; KOENIG WD, 1994, ECOLOGY, V75, P99, DOI 10.2307/1939386; LINHART YB, 1985, AM J BOT, V72, P181, DOI 10.2307/2443545; LLOYD DG, 1980, NEW PHYTOL, V86, P69, DOI 10.1111/j.1469-8137.1980.tb00780.x; LLOYD DG, 1984, EVOL BIOL, V17, P255; LOWTHER JR, 1980, COMMUN SOIL SCI PLAN, V11, P175, DOI 10.1080/00103628009367026; Masaka K, 2006, J THEOR BIOL, V240, P114, DOI 10.1016/j.jtbi.2005.09.001; Ne'eman G, 2011, ANN BOT-LONDON, V108, P197, DOI 10.1093/aob/mcr104; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Pillsbury NH, 1978, HARWOOD VOLUME WEIGH; Reekie EG, 1987, AM NAT, V129, P987; Sakai A, 2003, J THEOR BIOL, V222, P283, DOI 10.1016/S0022-5193(03)00024-9; SAMSON DA, 1986, AM NAT, V127, P667, DOI 10.1086/284512; Sarkissian TS, 2001, ECOLOGY, V82, P360, DOI 10.1890/0012-9658(2001)082[0360:GVISLA]2.0.CO;2; Satake A, 2000, J THEOR BIOL, V203, P63, DOI 10.1006/jtbi.1999.1066; Satake A, 2002, ECOLOGY, V83, P993, DOI 10.1890/0012-9658(2002)083[0993:SLPEAA]2.0.CO;2; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; SOLOMON BP, 1989, AM MIDL NAT, V121, P209, DOI 10.2307/2426024; Sork VL, 2002, MOL ECOL, V11, P1657, DOI 10.1046/j.1365-294X.2002.01574.x; SORK VL, 2002, 5 S OAK WOODL OAKS C, P427; Stearns S.C., 1992, pi; Stehlik I, 2008, P NATL ACAD SCI USA, V105, P10847, DOI 10.1073/pnas.0801964105; TRAVESET A, 1992, AM MIDL NAT, V127, P309, DOI 10.2307/2426537; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; WOLF B, 1982, COMMUN SOIL SCI PLAN, V13, P1035, DOI 10.1080/00103628209367332; Yasumura Y, 2006, FOREST ECOL MANAG, V229, P228, DOI 10.1016/j.foreco.2006.04.003; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006; Zhang D.-Y., 2006, ECOLOGY EVOLUTION FL, P41, DOI DOI 10.1034/J.1600-0706.2001.950118.X; Zhang DY, 2002, J EVOLUTION BIOL, V15, P74, DOI 10.1046/j.1420-9101.2002.00369.x	63	11	11	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43492	10.1371/journal.pone.0043492	http://dx.doi.org/10.1371/journal.pone.0043492			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952692	gold, Green Published			2022-12-25	WOS:000308044800033
J	Liu, J; Chen, M; Li, R; Yang, F; Shi, XR; Zhu, LC; Wang, HM; Yao, W; Liu, QJ; Meng, FG; Sun, JP; Pang, Q; Yu, X				Liu, Jing; Chen, Ming; Li, Rong; Yang, Fan; Shi, Xuanren; Zhu, Lichao; Wang, Hong-Mei; Yao, Wei; Liu, Qiji; Meng, Fan-Guo; Sun, Jin-Peng; Pang, Qi; Yu, Xiao			Biochemical and Functional Studies of Lymphoid-Specific Tyrosine Phosphatase (Lyp) Variants S201F and R266W	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PROTEIN-KINASE P50(CSK); OF-FUNCTION VARIANT; PTPN22; RECEPTOR; ASSOCIATION; POLYMORPHISM; CELLS; IDENTIFICATION; ACTIVATION	The Lymphoid specific tyrosine phosphatase (Lyp) has elicited tremendous research interest due to the high risk of its missense mutation R620W in a wide spectrum of autoimmune diseases. While initially characterized as a gain-of-function mutant, R620W was thought to lead to autoimmune diseases through loss-of-function in T cell signaling by a recent study. Here we investigate the biochemical characters and T cell signaling functions of two uncharacterized Lyp variants S201F and R266W, together with a previously characterized Lyp variant R263Q, which had reduced risk in several autoimmune diseases, including systemic lupus erythematosus (SLE), ulcerative colitis (UC) and rheumatoid arthritis (RA). Our kinetic and functional studies of R263Q polymorphism basically reproduced previous findings that it was a loss-of-function mutant. The other variant S201F reduced Lyp phosphatase activity moderately and decreased Lyp function in T cell slightly, while R266W severely impaired phosphatase activity and was a loss-of-function variant in T cell signaling. A combined kinetic and structure analysis suggests that the R266W variant may decrease its phosphatase activity through perturbing either the Q-loop or the WPD loop of Lyp. As both R266W and R263Q significantly change their phosphatase activity and T cell functions, future work could be considered to evaluate these mutants in a broader spectrum of autoimmune diseases.	[Liu, Jing; Li, Rong; Yang, Fan; Shi, Xuanren; Zhu, Lichao; Wang, Hong-Mei; Yao, Wei; Liu, Qiji; Sun, Jin-Peng; Yu, Xiao] Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan 250100, Shandong, Peoples R China; [Chen, Ming] 309th Hosp PLA, Beijing, Peoples R China; [Meng, Fan-Guo] Tsinghua Univ, Yangtze Delta Reg Inst, Hangzhou, Zhejiang, Peoples R China; [Sun, Jin-Peng; Pang, Qi] Shandong Univ, Shandong Prov Hosp, Jinan 250100, Shandong, Peoples R China	Shandong University; Tsinghua University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Liu, J (corresponding author), Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan 250100, Shandong, Peoples R China.	pangqi@sdu.edu.cn; yuxiao@sdu.edu.cn	SUN, JINPENG/F-9551-2013; wang, hongmei/HGT-7374-2022; sun, Jinpeng/AAR-9196-2020	wang, hongmei/0000-0002-6975-9467; Yu, Xiao/0000-0003-1119-8334; Pang, Qi/0000-0001-8333-5647	National Natural Science Foundation of China [31000362, 31100580]; Foundation for Excellent Young Scientists of Shandong University [2010JQ014]; "Eleventh Five-year Plan" for Medical Science Development of PLA [10MA017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Excellent Young Scientists of Shandong University; "Eleventh Five-year Plan" for Medical Science Development of PLA	This work was supported by grants from the National Natural Science Foundation of China (31000362, 31100580), the Foundation for Excellent Young Scientists of Shandong University (2010JQ014), and the "Eleventh Five-year Plan" for Medical Science Development of PLA (10MA017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arechiga AF, 2009, J IMMUNOL, V182, P3343, DOI 10.4049/jimmunol.0713370; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Cohen S, 1999, BLOOD, V93, P2013, DOI 10.1182/blood.V93.6.2013.406k25_2013_2024; Davidson D, 1997, J BIOL CHEM, V272, P23455, DOI 10.1074/jbc.272.37.23455; Diaz-Gallo LM, 2011, INFLAMM BOWEL DIS, V17, P2287, DOI 10.1002/ibd.21630; Fiorillo E, 2010, J BIOL CHEM, V285, P26506, DOI 10.1074/jbc.M110.111104; Ghose R, 2001, NAT STRUCT BIOL, V8, P998, DOI 10.1038/nsb1101-998; Gjorloff-Wingren A, 1999, EUR J IMMUNOL, V29, P3845, DOI 10.1002/(SICI)1521-4141(199912)29:12<3845::AID-IMMU3845>3.0.CO;2-U; Keng YF, 1999, EUR J BIOCHEM, V259, P809, DOI 10.1046/j.1432-1327.1999.00090.x; Kleppe M, 2011, BLOOD, V117, P7090, DOI 10.1182/blood-2010-10-314286; Kosco KA, 2008, MOL IMMUNOL, V45, P510, DOI 10.1016/j.molimm.2007.05.024; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Lamsyah H, 2009, TISSUE ANTIGENS, V74, P228, DOI 10.1111/j.1399-0039.2009.01304.x; Lea WW, 2011, LUPUS, V20, P51, DOI 10.1177/0961203310381774; Maziarz M, 2010, GENES IMMUN, V11, P406, DOI 10.1038/gene.2010.12; Menard L, 2011, J CLIN INVEST, V121, P3635, DOI 10.1172/JCI45790; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Orru V, 2009, HUM MOL GENET, V18, P569, DOI 10.1093/hmg/ddn363; Pannifer ADB, 1998, J BIOL CHEM, V273, P10454, DOI 10.1074/jbc.273.17.10454; Pedersen AK, 2004, BIOCHEM J, V378, P421, DOI 10.1042/BJ20030565; Rodriguez-Rodriguez L, 2011, ARTHRITIS RHEUM-US, V63, P365, DOI 10.1002/art.30145; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Sun JP, 2003, J BIOL CHEM, V278, P12406, DOI 10.1074/jbc.M212491200; Totaro MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024292; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Wang WQ, 2004, J BIOL CHEM, V279, P30459, DOI 10.1074/jbc.M402217200; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200; Xie LP, 2002, BIOCHEMISTRY-US, V41, P4032, DOI 10.1021/bi015904r; Yu X, 2007, P NATL ACAD SCI USA, V104, P19767, DOI 10.1073/pnas.0706233104; Yu X, 2011, J BIOL CHEM, V286, P30526, DOI 10.1074/jbc.M111.254722; Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904; Zhang YL, 1999, BIOCHEMISTRY-US, V38, P12111, DOI 10.1021/bi990836i; Zhang ZY, 2003, PROG NUCLEIC ACID RE, V73, P171, DOI 10.1016/S0079-6603(03)01006-7; ZHANG ZY, 1994, P NATL ACAD SCI USA, V91, P1624, DOI 10.1073/pnas.91.5.1624; Zhu JW, 2011, IMMUNITY, V35, P757, DOI 10.1016/j.immuni.2011.09.011	41	14	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43631	10.1371/journal.pone.0043631	http://dx.doi.org/10.1371/journal.pone.0043631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952725	Green Submitted, Green Published, gold			2022-12-25	WOS:000308044800047
J	Treas, JN; Tyagi, T; Singh, KP				Treas, Justin N.; Tyagi, Tulika; Singh, Kamaleshwar P.			Effects of Chronic Exposure to Arsenic and Estrogen on Epigenetic Regulatory Genes Expression and Epigenetic Code in Human Prostate Epithelial Cells	PLOS ONE			English	Article							HISTONE MODIFICATION PATTERNS; DNA METHYLATION; TRANSCRIPTIONAL ACTIVATION; CANCER; METHYLTRANSFERASE; HYPERMETHYLATION; IDENTIFICATION; TUMORIGENESIS; ACETYLATION; DIAGNOSIS	Chronic exposures to arsenic and estrogen are known risk factors for prostate cancer. Though the evidence suggests that exposure to arsenic or estrogens can disrupt normal DNA methylation patterns and histone modifications, the mechanisms by which these chemicals induce epigenetic changes are not fully understood. Moreover, the epigenetic effects of co-exposure to these two chemicals are not known. Therefore, the objective of this study was to evaluate the effects of chronic exposure to arsenic and estrogen, both alone and in combination, on the expression of epigenetic regulatory genes, their consequences on DNA methylation, and histone modifications. Human prostate epithelial cells, RWPE-1, chronically exposed to arsenic and estrogen alone and in combination were used for analysis of epigenetic regulatory genes expression, global DNA methylation changes, and histone modifications at protein level. The result of this study revealed that exposure to arsenic, estrogen, and their combination alters the expression of epigenetic regulatory genes and changes global DNA methylation and histone modification patterns in RWPE-1 cells. These changes were significantly greater in arsenic and estrogen combination treated group than individually treated group. The findings of this study will help explain the epigenetic mechanism of arsenic- and/or estrogen-induced prostate carcinogenesis.	[Treas, Justin N.; Tyagi, Tulika; Singh, Kamaleshwar P.] Texas Tech Univ, Dept Environm Toxicol, Inst Environm & Human Hlth TIEHH, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Treas, JN (corresponding author), Texas Tech Univ, Dept Environm Toxicol, Inst Environm & Human Hlth TIEHH, Lubbock, TX 79409 USA.	kamaleshwar.singh@TIEHH.TTU.edu	Singh, Kamaleshwar Prasad/AAE-9166-2020					Albany C, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/580318; Aoyama T, 2008, BIOCHEM BIOPH RES CO, V365, P124, DOI 10.1016/j.bbrc.2007.10.135; Ayotte JD, 2003, ENVIRON SCI TECHNOL, V37, P2075, DOI 10.1021/es026211g; Barman HK, 2008, BIOCHEM BIOPH RES CO, V373, P624, DOI 10.1016/j.bbrc.2008.06.100; Benbrahim-Tallaa L, 2005, TOXICOL APPL PHARM, V206, P288, DOI 10.1016/j.taap.2004.11.017; Benbrahim-Tallaa L, 2008, ENVIRON HEALTH PERSP, V116, P158, DOI 10.1289/ehp.10423; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chai CY, 2007, TOXICOL LETT, V173, P48, DOI 10.1016/j.toxlet.2007.06.006; Chanda S, 2006, TOXICOL SCI, V89, P431, DOI 10.1093/toxsci/kfj030; CHEN CJ, 1990, CANCER RES, V50, P5470; Chen H, 2004, CARCINOGENESIS, V25, P1779, DOI 10.1093/carcin/bgh161; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cooper CS, 2009, BRIT J CANCER, V100, P240, DOI 10.1038/sj.bjc.6604771; Crawford ED, 2003, UROLOGY, V62, P3, DOI 10.1016/j.urology.2003.10.013; Cui X, 2006, HUM PATHOL, V37, P298, DOI 10.1016/j.humpath.2005.10.013; Deng T, 2009, BIOCHEM BIOPH RES CO, V387, P611, DOI 10.1016/j.bbrc.2009.07.093; Dobosy JR, 2007, J UROLOGY, V177, P822, DOI 10.1016/j.juro.2006.10.063; Espada J, 2004, J BIOL CHEM, V279, P37175, DOI 10.1074/jbc.M404842200; Fukushige S, 2008, BIOCHEM BIOPH RES CO, V377, P600, DOI 10.1016/j.bbrc.2008.10.016; Gonzalgo ML, 1997, CANCER RES, V57, P594; GRAFF JR, 1995, CANCER RES, V55, P5195; Hashimoto H, 2010, EPIGENOMICS-UK, V2, P657, DOI 10.2217/EPI.10.44; Henckel A, 2009, HUM MOL GENET, V18, P3375, DOI 10.1093/hmg/ddp277; Hu WY, 2011, ENDOCRINOLOGY, V152, P2150, DOI 10.1210/en.2010-1377; IARC (International Agency for Research on Cancer), 2004, IARC MONOGR EVAL CAR, V84, P39; Jensen TJ, 2009, TOXICOL APPL PHARM, V235, P39, DOI 10.1016/j.taap.2008.10.013; Jo WJ, 2009, TOXICOL APPL PHARM, V241, P294, DOI 10.1016/j.taap.2009.08.027; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kapaj S, 2006, J ENVIRON SCI HEAL A, V41, P2399, DOI 10.1080/10934520600873571; Ke XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004687; Kristensen LS, 2009, EUR J PHARMACOL, V625, P131, DOI 10.1016/j.ejphar.2009.10.011; Lennartsson A, 2009, BBA-GEN SUBJECTS, V1790, P863, DOI 10.1016/j.bbagen.2008.12.006; Li LC, 2005, JNCI-J NATL CANCER I, V97, P103, DOI 10.1093/jnci/dji010; Liang GG, 2002, METHODS, V27, P150, DOI 10.1016/S1046-2023(02)00068-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; Patra SK, 2003, BIOCHEM BIOPH RES CO, V302, P759, DOI 10.1016/S0006-291X(03)00253-5; Prins GS, 2007, REPROD TOXICOL, V23, P374, DOI 10.1016/j.reprotox.2006.10.001; Pritchard C, 2009, CANCER RES, V69, P1739, DOI 10.1158/0008-5472.CAN-07-6817; Ramirez T, 2008, CHROMOSOMA, V117, P147, DOI 10.1007/s00412-007-0133-5; Ren XF, 2011, ENVIRON HEALTH PERSP, V119, P11, DOI 10.1289/ehp.1002114; Ruzov A, 2009, DEVELOPMENT, V136, P2277, DOI 10.1242/dev.032227; Sansom OJ, 2003, ONCOGENE, V22, P7130, DOI 10.1038/sj.onc.1206850; Schulz WA, 2009, SEMIN CANCER BIOL, V19, P172, DOI 10.1016/j.semcancer.2009.02.006; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Singh KP, 2011, CHEM RES TOXICOL, V24, P340, DOI 10.1021/tx1003112; Singh KP, 2010, J CELL BIOCHEM, V111, P123, DOI 10.1002/jcb.22674; Timms BG, 2005, P NATL ACAD SCI USA, V102, P7014, DOI 10.1073/pnas.0502544102; Tokar EJ, 2011, TOXICOL SCI, V120, pS192, DOI 10.1093/toxsci/kfq342; Tourneur L, 2010, TRENDS IMMUNOL, V31, P260, DOI 10.1016/j.it.2010.05.005; Vaissiere T, 2008, MUTAT RES-REV MUTAT, V659, P40, DOI 10.1016/j.mrrev.2008.02.004; Waalkes MP, 2004, JNCI-J NATL CANCER I, V96, P466, DOI 10.1093/jnci/djh070; Walton TJ, 2008, PROSTATE, V68, P210, DOI 10.1002/pros.20673; Wong YC, 2003, INT REV CYTOL, V227, P65, DOI 10.1016/S0074-7696(03)01008-8; Woodson K, 2003, PROSTATE, V55, P199, DOI 10.1002/pros.10236; Xiong YN, 2005, GYNECOL ONCOL, V96, P601, DOI 10.1016/j.ygyno.2004.11.047; Yamagata Y, 2009, HUM REPROD, V24, P1126, DOI 10.1093/humrep/dep015; Yao S, 2011, CANCER CAUSE CONTROL, V22, P1121, DOI 10.1007/s10552-011-9787-7; Yu S, 2011, CANCER LETT, V304, P8, DOI 10.1016/j.canlet.2011.01.003; Zhang H, 2012, J BIOL CHEM, V287, P6573, DOI 10.1074/jbc.M111.312637	60	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43880	10.1371/journal.pone.0043880	http://dx.doi.org/10.1371/journal.pone.0043880			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952798	Green Published, Green Submitted, gold			2022-12-25	WOS:000308044800071
J	Ma, Q; Nie, XM; Yu, M; Wang, ZJ; Yang, SW; Jia, DA; Zhou, YJ				Ma, Qian; Nie, Xiaomin; Yu, Miao; Wang, Zhijian; Yang, Shiwei; Jia, Dean; Zhou, Yujie			Rapamycin Regulates the Expression and Activity of Kruppel-Like Transcription Factor 2 in Human Umbilical Vein Endothelial Cells	PLOS ONE			English	Article							TISSUE FACTOR EXPRESSION; DRUG-ELUTING STENT; PERCUTANEOUS CORONARY INTERVENTION; NITRIC-OXIDE SYNTHASE; PROGENITOR CELLS; KLF2 EXPRESSION; IN-VIVO; THROMBOSIS; KINASE; ACTIVATION	Background: Although rapamycin has been reported to increase procoagulants and decrease anticoagulants in human umbilical vein endothelial cells (HUVECs), there is no significant difference in the incidence of stent thrombosis between patients with drug-eluting stents (DESs) and those with bare metal stents (BMSs). Kruppel-like transcription factor 2 (KLF2) has been identified as a key regulator of endothelial antithrombotic function. We hypothesized that rapamycin might induce the expression and activity of KLF2, thereby counteracting coronary endothelial dysfunction induced by DESs. Methods and Results: Expression of KLF2, tissue factor (TF) and endothelial NO synthase (eNOS) were assessed in HUVECs treated with rapamycin at concentrations of 2, 20, 200 and 2000 ng/ml for 24 and 48 hours without or with thrombin. Rapamycin strongly induced the expression and activity of KLF2 in high dose groups (p<0.01). Compared with control group, the expression of TF was increased by rapamycin, which inhibited the expression of eNOS after treating for 24 hours (p<0.01). Furthermore, small-interfering RNA-mediated knockdown of KLF2 strongly magnified the ability of rapamycin to induce TF and reduce eNOS accumulation in HUVECs. Conclusions: Rapamycin-dependent induction of KLF2 might partly counteract coronary endothelial dysfunction and thereby provided a novel molecular target to prevent stent thrombosis induced by DESs.	[Ma, Qian; Nie, Xiaomin; Yu, Miao; Wang, Zhijian; Yang, Shiwei; Jia, Dean; Zhou, Yujie] Capital Med Univ, Dept Cardiol, Beijing Anzhen Hosp, Beijing, Peoples R China	Capital Medical University	Ma, Q (corresponding author), Capital Med Univ, Dept Cardiol, Beijing Anzhen Hosp, Beijing, Peoples R China.	azzyj12@163.com	Yang, Wei/HIA-0360-2022; Zhou, Yu/HHN-3071-2022		National Nature Science Foundation of China [30971238]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors disclose receipt of the following financial support for the research, authorship, and/or publication of this article: supported by the National Nature Science Foundation of China (#30971238). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Bavry AA, 2005, AM J CARDIOL, V95, P1469, DOI 10.1016/j.amjcard.2005.02.015; Bavry AA, 2005, J AM COLL CARDIOL, V45, P941, DOI 10.1016/j.jacc.2004.11.064; Blum S, 2001, J BIOL CHEM, V276, P33428, DOI 10.1074/jbc.M105474200; Bu DX, 2010, J CLIN INVEST, V120, P1961, DOI 10.1172/JCI41384; Camenzind E, 2006, WORLD C CARD BARC SP; Camici GG, 2010, EUR HEART J, V31, P236, DOI 10.1093/eurheartj/ehp259; Chen TG, 2006, CELL PROLIFERAT, V39, P117, DOI 10.1111/j.1365-2184.2006.00375.x; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Eto M, 2002, CIRCULATION, V105, P1756, DOI 10.1161/01.CIR.0000015465.73933.3B; Gallo R, 1999, CIRCULATION, V99, P2164, DOI 10.1161/01.CIR.99.16.2164; Gracia-Sancho J, 2010, CARDIOVASC RES, V85, P514, DOI 10.1093/cvr/cvp337; Griese DP, 2003, CIRCULATION, V108, P2710, DOI 10.1161/01.CIR.0000096490.16596.A6; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Holmes DR, 2004, CIRCULATION, V109, P634, DOI 10.1161/01.CIR.0000112572.57794.22; Huddleson JP, 2006, J BIOL CHEM, V281, P15121, DOI 10.1074/jbc.M513406200; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Jin HK, 2009, BIOL PHARM BULL, V32, P988, DOI 10.1248/bpb.32.988; Kereiakes Dean J, 2004, Rev Cardiovasc Med, V5, P9; Klugherz BD, 2002, CORONARY ARTERY DIS, V13, P183, DOI 10.1097/00019501-200205000-00008; Li JM, 1999, EUR HEART J, V20, P406, DOI 10.1053/euhj.1998.1308; Lin ZY, 2006, ARTERIOSCL THROM VAS, V26, P1185, DOI 10.1161/01.ATV.0000215638.53414.99; Lin ZY, 2005, CIRC RES, V96, pE48, DOI 10.1161/01.RES.0000159707.05637.a1; Luscher TF, 2007, CIRCULATION, V115, P1051, DOI 10.1161/CIRCULATIONAHA.106.675934; Ma Q, 2012, ANGIOLOGY, V2; MARX SO, 1995, CIRC RES, V76, P412, DOI 10.1161/01.RES.76.3.412; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Moreno R, 2005, J AM COLL CARDIOL, V45, P954, DOI 10.1016/j.jacc.2004.11.065; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Moss SC, 2010, J BIOL CHEM, V285, P11991, DOI 10.1074/jbc.M109.066621; Muldowney JAS, 2007, ARTERIOSCL THROM VAS, V27, P400, DOI 10.1161/01.ATV.0000254677.12861.b8; Ong ATL, 2005, J AM COLL CARDIOL, V45, P2088, DOI 10.1016/j.jacc.2005.02.086; Parmar KM, 2005, J BIOL CHEM, V280, P26714, DOI 10.1074/jbc.C500144200; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Roque M, 2001, LAB INVEST, V81, P895, DOI 10.1038/labinvest.3780298; Sako K, 2009, J BIOL CHEM, V284, P5592, DOI 10.1074/jbc.M806928200; Schwartz RS, 2004, J AM COLL CARDIOL, V44, P1373, DOI 10.1016/j.jacc.2004.04.060; Sen-Banerjee S, 2005, CIRCULATION, V112, P720, DOI 10.1161/CIRCULATIONAHA.104.525774; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Steffel J, 2006, CIRCULATION, V113, P722, DOI 10.1161/CIRCULATIONAHA.105.567297; Steffel J, 2005, CIRCULATION, V112, P2002, DOI 10.1161/CIRCULATIONAHA.105.569129; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Stone GW, 2004, CIRCULATION, V109, P1942, DOI 10.1161/01.CIR.0000127110.49192.72; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Suzuki T, 2001, CIRCULATION, V104, P1188, DOI 10.1161/hc3601.093987; Urao N, 2006, CIRC RES, V98, P1405, DOI 10.1161/01.RES.0000224117.59417.f3; *US FDA, CYPHER SIR EL COR ST; van Thienen JV, 2006, CARDIOVASC RES, V72, P231, DOI 10.1016/j.cardiores.2006.07.008; Viswambharan H, 2004, CIRC RES, V94, P918, DOI 10.1161/01.RES.0000124302.20396.B7; Zhao FH, 2008, MED HYPOTHESES, V70, P512, DOI 10.1016/j.mehy.2007.05.055; Zhu Weiwei, 2009, J Bioequivalence Bioavailab, V1, P3	52	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43315	10.1371/journal.pone.0043315	http://dx.doi.org/10.1371/journal.pone.0043315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937032	gold, Green Submitted, Green Published			2022-12-25	WOS:000308225500039
J	Mu, DS; Shi, L; Ren, A; Li, MJ; Wu, FL; Jiang, AL; Zhao, MW				Mu, Dashuai; Shi, Liang; Ren, Ang; Li, Mengjiao; Wu, Fengli; Jiang, Ailiang; Zhao, Mingwen			The Development and Application of a Multiple Gene Co-Silencing System Using Endogenous URA3 as a Reporter Gene in Ganoderma lucidum	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; MOLECULAR-CLONING; EXPRESSION; FUNGUS; INTERFERENCE; PCR; IDENTIFICATION; TRANSFORMATION; OPTIMIZATION; SUPPRESSION	Ganoderma lucidum is one of the most important medicinal mushrooms; however, molecular genetics research on this species has been limited due to a lack of reliable reverse genetic tools. In this study, the endogenous orotidine 5'-monophosphate decarboxylase gene (URA3) was cloned as a silencing reporter, and four gene-silencing methods using hairpin, sense, antisense, and dual promoter constructs, were introduced into G. lucidum through a simple electroporation procedure. A comparison and evaluation of silencing efficiency demonstrated that all of the four methods differentially suppressed the expression of URA3. Our data unequivocally indicate that the dual promoter silencing vector yields the highest rate of URA3 silencing compared with other vectors (up to 81.9%). To highlight the advantages of the dual promoter system, we constructed a co-silencing system based on the dual promoter method and succeeded in co-silencing URA3 and laccase in G. lucidum. The reduction of the mRNA levels of the two genes were correlated. Thus, the screening efficiency for RNAi knockdown of multiple genes may be improved by the co-silencing of an endogenous reporter gene. The molecular tools developed in this study should facilitate the isolation of genes and the characterization of the functions of multiple genes in this pharmaceutically important species, and these tools should be highly useful for the study of other basidiomycetes.	[Mu, Dashuai; Shi, Liang; Ren, Ang; Li, Mengjiao; Wu, Fengli; Jiang, Ailiang; Zhao, Mingwen] Nanjing Agr Univ, Coll Life Sci, Key Lab Microbiol Engn Agr Environm, Minist Agr, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Mu, DS (corresponding author), Nanjing Agr Univ, Coll Life Sci, Key Lab Microbiol Engn Agr Environm, Minist Agr, Nanjing, Jiangsu, Peoples R China.	mwzhao@njau.edu.cn	Zhao, Ming-Wen/AAS-1510-2020	zhao, mingwen/0000-0002-9413-1743	National Natural Science Foundation of China [30970042]; Fundamental Research Funds for the Central Universities [KYZ201121]; Science and Technology Pillar Program of Jiangsu Province, China [BE2011312]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Science and Technology Pillar Program of Jiangsu Province, China; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (Project No. 30970042), the Fundamental Research Funds for the Central Universities (Project No. KYZ201121), the Science and Technology Pillar Program of Jiangsu Province, China (Project No. BE2011312) and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamec J, 2009, J SEP SCI, V32, P4052, DOI 10.1002/jssc.200900496; Ah-Fong AMV, 2008, FUNGAL GENET BIOL, V45, P1197, DOI 10.1016/j.fgb.2008.05.009; Bose I, 2011, J MICROBIOL METH, V86, P156, DOI 10.1016/j.mimet.2011.04.014; Carneiro JS, 2010, FUNGAL GENET BIOL, V47, P399, DOI 10.1016/j.fgb.2010.02.005; Chen JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000202; Chuang HW, 2009, FEMS MICROBIOL LETT, V293, P205, DOI 10.1111/j.1574-6968.2009.01533.x; Cogoni C, 1997, P NATL ACAD SCI USA, V94, P10233, DOI 10.1073/pnas.94.19.10233; Costa ASMB, 2009, J MICROBIOL BIOTECHN, V19, P271, DOI 10.4014/jmb.0806.398; Cottrell TR, 2003, TRENDS MICROBIOL, V11, P37, DOI 10.1016/S0966-842X(02)00004-5; de Jong JF, 2006, APPL ENVIRON MICROB, V72, P1267, DOI 10.1128/AEM.72.2.1267-1269.2006; Ding YX, 2008, BIOSCI BIOTECH BIOCH, V72, P1571, DOI 10.1271/bbb.80067; Eo SK, 1999, J ETHNOPHARMACOL, V68, P129, DOI 10.1016/S0378-8741(99)00067-7; Fei X, 2006, J MICROBIOL, V44, P515; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Goldoni M, 2004, FUNGAL GENET BIOL, V41, P1016, DOI 10.1016/j.fgb.2004.08.002; Guo M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001302; Harrison BR, 2009, BIOCHEM CELL BIOL, V87, P767, DOI 10.1139/O09-043; Hseu RS, 1996, APPL ENVIRON MICROB, V62, P1354, DOI 10.1128/AEM.62.4.1354-1363.1996; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Janus D, 2007, APPL ENVIRON MICROB, V73, P962, DOI 10.1128/AEM.02127-06; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Joo SS, 2008, MOL CELLS, V25, P112; Kemppainen M, 2009, ENVIRON MICROBIOL, V11, P1878, DOI 10.1111/j.1462-2920.2009.01912.x; Kemppainen MJ, 2010, MICROB BIOTECHNOL, V3, P178, DOI 10.1111/j.1751-7915.2009.00122.x; Keon JPR, 1999, ANTISENSE NUCLEIC A, V9, P101, DOI 10.1089/oli.1.1999.9.101; Kilaru S, 2009, APPL ENVIRON MICROB, V75, P7196, DOI 10.1128/AEM.01151-09; Kim S, 2004, FEMS MICROBIOL LETT, V233, P201, DOI 10.1016/j.femsle.2004.02.010; Kuo CY, 2008, J MICROBIOL METH, V72, P111, DOI 10.1016/j.mimet.2007.11.006; Lin CC, 2011, CANCER IMMUNOL IMMUN, V60, P1019, DOI 10.1007/s00262-011-1016-4; Lin KI, 2006, J BIOL CHEM, V281, P24111, DOI 10.1074/jbc.M601106200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mizushina Y, 1998, BIOCHEM BIOPH RES CO, V249, P17, DOI 10.1006/bbrc.1998.9091; MURASUGI A, 1991, J BIOL CHEM, V266, P2486; Nakade K, 2011, MICROBIOL RES, V166, P484, DOI 10.1016/j.micres.2010.09.004; Nakayashiki H, 2005, FEBS LETT, V579, P5950, DOI 10.1016/j.febslet.2005.08.016; Nakayashiki H, 2008, CURR OPIN MICROBIOL, V11, P494, DOI 10.1016/j.mib.2008.10.001; Namekawa SH, 2005, MICROBIOL-SGM, V151, P3669, DOI 10.1099/mic.0.28209-0; Nguyen QB, 2008, MOL MICROBIOL, V68, P1348, DOI 10.1111/j.1365-2958.2008.06242.x; Salame TM, 2011, APPL MICROBIOL BIOT, V89, P501, DOI 10.1007/s00253-010-2928-1; Shang CH, 2008, BIOSCI BIOTECH BIOCH, V72, P1333, DOI 10.1271/bbb.80011; Shang CH, 2010, BIOSCI BIOTECH BIOCH, V74, P974, DOI 10.1271/bbb.90833; Shi L, 2012, MOL BIOL REP, V39, P6149, DOI 10.1007/s11033-011-1431-9; Shi L, 2012, WORLD J MICROB BIOT, V28, P283, DOI 10.1007/s11274-011-0818-z; Shi LA, 2010, APPL MICROBIOL BIOT, V88, P1243, DOI 10.1007/s00253-010-2871-1; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; Staab JF, 2003, TRENDS MICROBIOL, V11, P69, DOI 10.1016/S0966-842X(02)00029-X; Sun Li, 2001, Plant Molecular Biology Reporter, V19, P383, DOI 10.1007/BF02772841; Sun SJ, 2006, APPL MICROBIOL BIOT, V72, P537, DOI 10.1007/s00253-005-0299-9; Tsai CC, 2012, J AGR FOOD CHEM, V60, P2830, DOI 10.1021/jf3000339; Wang HX, 2006, PEPTIDES, V27, P27, DOI 10.1016/j.peptides.2005.06.009; Wang SM, 2007, APPL ENVIRON MICROB, V73, P5048, DOI 10.1128/AEM.02973-06; Xu JW, 2012, MOL BIOL REP, V39, P3603, DOI 10.1007/s11033-011-1134-2; Xu JW, 2010, APPL MICROBIOL BIOT, V85, P941, DOI 10.1007/s00253-009-2106-5; Xu YN, 2018, BIOTECHNOL ADV; Zhao MW, 2007, J MICROBIOL BIOTECHN, V17, P1106	57	79	90	11	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43737	10.1371/journal.pone.0043737	http://dx.doi.org/10.1371/journal.pone.0043737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937087	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500089
J	Thompson, R; Montano, R; Eastman, A				Thompson, Ruth; Montano, Ryan; Eastman, Alan			The Mre11 Nuclease Is Critical for the Sensitivity of Cells to Chk1 Inhibition	PLOS ONE			English	Article							STRAND BREAK REPAIR; CISPLATIN-INDUCED CYTOTOXICITY; REPLICATION FORK PROGRESSION; DNA-REPLICATION; CHECKPOINT KINASE-1; ATM ACTIVATION; END RESECTION; PHOSPHORYLATION; COMPLEX; PROTEIN	The Chk1 kinase is required for the arrest of cell cycle progression when DNA is damaged, and for stabilizing stalled replication forks. As a consequence, many Chk1 inhibitors have been developed and tested for their potential to enhance DNA damage-induced tumor cell killing. However, inhibition of Chk1 alone, without any additional exogenous agent, can be cytotoxic. Understanding the underlying mechanisms of this sensitivity is critical for defining which patients might respond best to therapy with Chk1 inhibitors. We have investigated the mechanism of sensitivity in U2OS osteosarcoma cells. Upon incubation with the Chk1 inhibitor MK-8776, single-stranded DNA regions (ssDNA) and double-strand breaks (DSB) begin to appear within 6 h. These DSB have been attributed to the structure-specific DNA endonuclease, Mus81. The Mre11/Rad50/Nbs1 complex is known to be responsible for the resection of DSB to ssDNA. However, we show that inhibition of the Mre11 nuclease activity leads, not only to a decrease in the amount of ssDNA following Chk1 inhibition, but also inhibits the formation of DSB, suggesting that DSB are a consequence of ssDNA formation. These findings were corroborated by the discovery that Mre11-deficient ATLD1 cells are highly resistant to MK-8776 and form neither ssDNA nor DSB following treatment. However, once complimented with exogenous Mre11, the cells accumulate both ssDNA and DSB when incubated with MK-8776. Our findings suggest that Mre11 provides the link between aberrant activation of Cdc25A/Cdk2 and Mus81. The results highlight a novel role for Mre11 in the production of DSB and may help define which tumors are more sensitive to MK-8776 alone or in combination with DNA damaging agents.	[Thompson, Ruth; Montano, Ryan; Eastman, Alan] Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Hanover, NH USA; [Thompson, Ruth; Montano, Ryan; Eastman, Alan] Norris Cotton Canc Ctr, Lebanon, NH USA	Dartmouth College; Norris Cotton Cancer Center	Thompson, R (corresponding author), Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Hanover, NH USA.	Alan.R.Eastman@Dartmouth.edu	Thompson, Ruth/O-4381-2018	Thompson, Ruth/0000-0002-0828-4170	NIH [CA117874]; Cancer Center Support grant [CA23108]; NATIONAL CANCER INSTITUTE [R01CA117874, P30CA023108] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant CA117874 (A. Eastman), and Cancer Center Support grant CA23108 to the Norris Cotton Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KE, 2006, ONCOGENE, V25, P3894, DOI 10.1038/sj.onc.1209426; Bahassi EM, 2008, ONCOGENE, V27, P3977, DOI 10.1038/onc.2008.17; Beck H, 2010, J CELL BIOL, V188, P629, DOI 10.1083/jcb.200905059; Buis J, 2012, NAT STRUCT MOL BIOL, V19, P246, DOI 10.1038/nsmb.2212; Bunch RT, 1996, CLIN CANCER RES, V2, P791; Chen XF, 2011, NAT STRUCT MOL BIOL, V18, P1015, DOI 10.1038/nsmb.2105; Cho SH, 2005, CELL CYCLE, V4, P131, DOI 10.4161/cc.4.1.1299; Ciccia A, 2003, J BIOL CHEM, V278, P25172, DOI 10.1074/jbc.M302882200; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; Delia D, 2004, HUM MOL GENET, V13, P2155, DOI 10.1093/hmg/ddh221; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Flatten K, 2005, J BIOL CHEM, V280, P14349, DOI 10.1074/jbc.M411890200; Forment JV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023517; Gagou ME, 2010, MOL BIOL CELL, V21, P739, DOI 10.1091/mbc.E09-07-0618; Gao QL, 2006, APOPTOSIS, V11, P1789, DOI 10.1007/s10495-006-9421-4; Garner KM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-206; Garner KM, 2009, NAT CHEM BIOL, V5, P129, DOI 10.1038/nchembio0309-129; Guzi TJ, 2011, MOL CANCER THER, V10, P591, DOI 10.1158/1535-7163.MCT-10-0928; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Leung-Pineda V, 2006, MOL CELL BIOL, V26, P7529, DOI 10.1128/MCB.00447-06; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Maya-Mendoza A, 2007, EMBO J, V26, P2719, DOI 10.1038/sj.emboj.7601714; Montano R, 2012, MOL CANCER THER, V11, P427, DOI 10.1158/1535-7163.MCT-11-0406; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Petermann E, 2006, MOL CELL BIOL, V26, P3319, DOI 10.1128/MCB.26.8.3319-3326.2006; Petermann E, 2010, P NATL ACAD SCI USA, V107, P16090, DOI 10.1073/pnas.1005031107; Peterson SE, 2011, J CELL BIOL, V194, P705, DOI 10.1083/jcb.201103103; RAO J, 1992, ANAL BIOCHEM, V207, P186, DOI 10.1016/0003-2697(92)90521-8; Rodriguez R, 2006, MOL BIOL CELL, V17, P402, DOI 10.1091/mbc.E05-07-0594; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Scorah J, 2009, CELL CYCLE, V8, P1036, DOI 10.4161/cc.8.7.8040; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Sorensen CS, 2011, NUCL ACIDS RES; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stiff T, 2005, EMBO J, V24, P199, DOI 10.1038/sj.emboj.7600504; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Taylor ER, 2008, P NATL ACAD SCI USA, V105, P3757, DOI 10.1073/pnas.0710291105; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299; Zheng L, 2009, NUCLEIC ACIDS RES, V37, P2645, DOI 10.1093/nar/gkp147	47	44	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e44021	10.1371/journal.pone.0044021	http://dx.doi.org/10.1371/journal.pone.0044021			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937147	gold, Green Submitted, Green Published			2022-12-25	WOS:000308225500135
J	Engler, JR; Robinson, AE; Smirnov, I; Hodgson, JG; Berger, MS; Gupta, N; James, CD; Molinaro, A; Phillips, JJ				Engler, Jane R.; Robinson, Aaron E.; Smirnov, Ivan; Hodgson, J. Graeme; Berger, Mitchel S.; Gupta, Nalin; James, C. David; Molinaro, Annette; Phillips, Joanna J.			Increased Microglia/Macrophage Gene Expression in a Subset of Adult and Pediatric Astrocytomas	PLOS ONE			English	Article							REGULATORY T-CELLS; HIGH-GRADE GLIOMAS; K+ CHANNELS; GLIOBLASTOMA; MACROPHAGES; IDENTIFICATION; OSTEOPONTIN; SURVIVAL; PATTERN; VITRO	Glioblastoma (GBM) is a highly malignant brain tumor with a dismal prognosis. Gene expression profiling of GBM has revealed clinically relevant tumor subtypes, and this provides exciting opportunities to better understand disease pathogenesis. Results from an increasing number of studies demonstrate a role for the immune response in cancer progression, yet it is unclear how the immune response differs across tumor subtypes and how it affects outcome. Utilizing gene expression data from The Cancer Genome Atlas Project and the Gene Expression Omnibus database, we demonstrate an enrichment of immune response-related gene expression in the mesenchymal subtype of adult GBM (n = 173) and pediatric high-grade gliomas (n = 53). In an independent cohort of pediatric astrocytomas (n = 24) from UCSF, we stratified tumors into subtypes and confirmed these findings. Using novel immune cell-specific gene signatures we demonstrate selective enrichment of microglia/macrophage-related genes in adult and pediatric GBM tumors of the mesenchymal subtype. Furthermore, immunostaining of adult GBM tumors showed significantly higher cell numbers of microglia/macrophages in mesenchymal versus non-mesenchymal tumors (p = 0.04). Interestingly, adult GBM tumors with the shortest survival had significant enrichment of microglia/macrophage-related genes but this was not true for pediatric GBMs. Consistent with an association with poor outcome, immune response-related genes were highly represented in an adult poor prognosis gene signature, with the expression of genes related to macrophage recruitment and activation being most strongly associated with survival (p<0.05) using CoxBoost multivariate modeling. Using a microglia/macrophage high gene signature derived from quantification of tumor-infiltrating cells in adult GBM, we identified enrichment of genes characteristic of CD4 T cells, granulocytes, and microglia/macrophages (n = 573). These studies support a role for the immune response, particularly the microglia/macrophage response, in the biology of an important subset of GBM. Identification of this subset may be important for future therapeutic stratification.	[Engler, Jane R.; Robinson, Aaron E.; Smirnov, Ivan; Hodgson, J. Graeme; Berger, Mitchel S.; Gupta, Nalin; James, C. David; Molinaro, Annette; Phillips, Joanna J.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Phillips, Joanna J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Molinaro, Annette] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Engler, Jane R.; Robinson, Aaron E.; Berger, Mitchel S.; Gupta, Nalin; James, C. David; Phillips, Joanna J.] Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA 94143 USA; [Hodgson, J. Graeme] Pfizer, Div Oncol, La Jolla, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pfizer	Engler, JR (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	joanna.phillips@ucsf.edu			National Institue of Health [K08 NS063456]; UCSF Brain Tumor SPORE [CA097257]; Pediatric Brain Tumor Foundation; Preuss Foundation; NATIONAL CANCER INSTITUTE [P50CA097257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS063456] Funding Source: NIH RePORTER	National Institue of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Brain Tumor SPORE; Pediatric Brain Tumor Foundation; Preuss Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by the National Institue of Health (K08 NS063456 to JJP), the UCSF Brain Tumor SPORE (CA097257), the Pediatric Brain Tumor Foundation (NG, CDJ, JJP), and generous funds from the Preuss Foundation. The funders had no role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012304; Binder H, 2009, BIOINFORMATICS, V25, P890, DOI 10.1093/bioinformatics/btp088; Calboli FCF, 2011, J NATL CANCER I, V103, P1588, DOI 10.1093/jnci/djr361; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; Cooper LAD, 2012, AM J PATHOL, V180, P2108, DOI 10.1016/j.ajpath.2012.01.040; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; El Andaloussi A, 2006, NEURO-ONCOLOGY, V8, P234, DOI 10.1215/15228517-2006-006; El Andaloussi A, 2006, J NEUROSURG, V105, P430, DOI 10.3171/jns.2006.105.3.430; Fangusaro J, 2009, J CHILD NEUROL, V24, P1409, DOI 10.1177/0883073809338960; Gabrusiewicz K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023902; Gerds TA, 2006, BIOMETRICAL J, V48, P1029, DOI 10.1002/bimj.200610301; Giachelli CM, 1998, AM J PATHOL, V152, P353; Hatori K, 2011, J ENDODONT, V37, P781, DOI 10.1016/j.joen.2011.03.009; Heimberger AB, 2008, CLIN CANCER RES, V14, P5166, DOI 10.1158/1078-0432.CCR-08-0320; Horiba M, 2000, J CLIN INVEST, V105, P489, DOI 10.1172/JCI7208; Huse JT, 2011, GLIA, V59, P1190, DOI 10.1002/glia.21165; Hussain SF, 2006, NEURO-ONCOLOGY, V8, P261, DOI 10.1215/15228517-2006-008; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; JANSON RW, 1991, J IMMUNOL, V147, P4218; Kaczmarek M, 2011, TUMOR BIOL, V32, P1123, DOI 10.1007/s13277-011-0214-1; Kerrigan AM, 2012, J THROMB HAEMOST, V10, P484, DOI 10.1111/j.1538-7836.2011.04614.x; Khanna R, 2001, AM J PHYSIOL-CELL PH, V280, pC796, DOI 10.1152/ajpcell.2001.280.4.C796; Khorooshi R, 2010, J IMMUNOL, V185, P1258, DOI 10.4049/jimmunol.0901753; Lachance DH, 2011, AM J EPIDEMIOL, V174, P574, DOI 10.1093/aje/kwr124; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mischel PS, 2003, ONCOGENE, V22, P2361, DOI 10.1038/sj.onc.1206344; Murat A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005947; Ohki E, 2007, BIOL PHARM BULL, V30, P2217, DOI 10.1248/bpb.30.2217; Parney IF, 2009, J NEUROSURG, V110, P572, DOI 10.3171/2008.7.JNS08475; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pinteaux E, 2002, J NEUROCHEM, V83, P754, DOI 10.1046/j.1471-4159.2002.01184.x; Piperi C, 2011, CYTOKINE, V55, P387, DOI 10.1016/j.cyto.2011.05.012; Preusser M, 2011, ANN NEUROL, V70, P9, DOI 10.1002/ana.22425; Prins RM, 2011, CLIN CANCER RES, V17, P1603, DOI 10.1158/1078-0432.CCR-10-2563; Recalcati S, 2010, EUR J IMMUNOL, V40, P824, DOI 10.1002/eji.200939889; Rom S, 2010, FASEB J, V24, P2292, DOI 10.1096/fj.09-143503; Sampson JH, 2010, J CLIN ONCOL, V28, P4722, DOI 10.1200/JCO.2010.28.6963; Schiffman JD, 2010, CANCER RES, V70, P512, DOI 10.1158/0008-5472.CAN-09-1851; Schwartzbaum JA, 2010, CARCINOGENESIS, V31, P1770, DOI 10.1093/carcin/bgq152; Shin YJ, 2011, GLIA, V59, P413, DOI 10.1002/glia.21110; Simmons GW, 2011, J NEUROPATH EXP NEUR, V70, P51, DOI 10.1097/NEN.0b013e3182032d37; SINGH RP, 1990, J EXP MED, V171, P1931, DOI 10.1084/jem.171.6.1931; Sreekanthreddy P, 2010, CANCER EPIDEM BIOMAR, V19, P1409, DOI 10.1158/1055-9965.EPI-09-1077; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tajima N, 2006, J PHYSIOL-LONDON, V571, P349, DOI 10.1113/jphysiol.2005.096818; TARTOUR E, 1994, CANCER RES, V54, P6243; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Tuck AB, 1998, INT J CANCER, V79, P502, DOI 10.1002/(SICI)1097-0215(19981023)79:5<502::AID-IJC10>3.0.CO;2-3; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VANDAMME J, 1992, J EXP MED, V176, P59, DOI 10.1084/jem.176.1.59; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020	57	112	113	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43339	10.1371/journal.pone.0043339	http://dx.doi.org/10.1371/journal.pone.0043339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937035	Green Published, gold, Green Submitted			2022-12-25	WOS:000308286300043
J	Li, SY; Tietz, DR; Rutaganira, FU; Kells, PM; Anzai, Y; Kato, F; Pochapsky, TC; Sherman, DH; Podust, LM				Li, Shengying; Tietz, Drew R.; Rutaganira, Florentine U.; Kells, Petrea M.; Anzai, Yojiro; Kato, Fumio; Pochapsky, Thomas C.; Sherman, David H.; Podust, Larissa M.			Substrate Recognition by the Multifunctional Cytochrome P450 MycG in Mycinamicin Hydroxylation and Epoxidation Reactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHETIC GENE-CLUSTER; GIBBERELLA-FUJIKUROI ENCODES; MICROMONOSPORA-GRISEORUBIDA; MACROLIDE ANTIBIOTICS; FUSARIUM-VERTICILLIOIDES; ABSOLUTE-CONFIGURATION; AUREOTHIN BIOSYNTHESIS; CRYSTAL-STRUCTURE; ACTIVE-SITE; ENZYMES	The majority of characterized cytochrome P450 enzymes in actinomycete secondary metabolic pathways are strictly sub-strate-, regio-, and stereo-specific. Examples of multifunctional biosynthetic cytochromes P450 with broader substrate and regio-specificity are growing in number and are of particular interest for biosynthetic and chemoenzymatic applications. MycG is among the first P450 monooxygenases characterized that catalyzes both hydroxylation and epoxidation reactions in the final biosynthetic steps, leading to oxidative tailoring of the 16-membered ring macrolide antibiotic mycinamicin II in the actinomycete Micromonospora griseorubida. The ordering of steps to complete the biosynthetic process involves a complex substrate recognition pattern by the enzyme and interplay between three tailoring modifications as follows: glycosylation, methylation, and oxidation. To understand the catalytic properties of MycG, we structurally characterized the ligand-free enzyme and its complexes with three native metabolites. These include substrates mycinamicin IV and V and their biosynthetic precursor mycinamicin III, which carries the monomethoxy sugar javose instead of the dimethoxylated sugar mycinose. The two methoxy groups of mycinose serve as sensors that mediate initial recognition to discriminate between closely related substrates in the post-polyketide oxidative tailoring of mycinamicin metabolites. Because x-ray structures alone did not explain the mechanisms of macrolide hydroxylation and epoxidation, para-magnetic NMR relaxation measurements were conducted. Molecular modeling based on these data indicates that in solution substrate may penetrate the active site sufficiently to place the abstracted hydrogen atom of mycinamicin IV within 6 angstrom of the heme iron and similar to 4 angstrom of the oxygen of iron-ligated water.	[Podust, Larissa M.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94158 USA; [Li, Shengying; Sherman, David H.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Li, Shengying] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao 266101, Shandong, Peoples R China; [Tietz, Drew R.; Pochapsky, Thomas C.] Brandeis Univ, Dept Chem, Waltham, MA 02454 USA; [Tietz, Drew R.; Pochapsky, Thomas C.] Brandeis Univ, Rosenstiel Basic Med Sci Inst, Waltham, MA 02454 USA; [Rutaganira, Florentine U.; Kells, Petrea M.; Podust, Larissa M.] Univ Calif San Francisco, Ctr Discovery & Innovat Parasit Dis, San Francisco, CA 94158 USA; [Anzai, Yojiro; Kato, Fumio] Toho Univ, Fac Pharmaceut Sci, Chiba 2748510, Japan	University of California System; University of California San Francisco; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Brandeis University; Brandeis University; University of California System; University of California San Francisco; Toho University	Podust, LM (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94158 USA.	larissa.podust@ucsf.edu	Podust, Larissa/ABB-7940-2020	Podust, Larissa/0000-0002-8537-8760; Pochapsky, Thomas/0000-0001-8995-1088	National Institutes of Health [RO1 GM078553, GM44191, P41 RR001081]; Hans W. Vahlteich Professorship; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017269, P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044191, R01GM078553, R29GM044191, T32GM064337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hans W. Vahlteich Professorship; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM078553 (to D. H. S. and L. M. P.) and GM44191 (to T. C. P.). This work was also supported by the Hans W. Vahlteich Professorship (to D. H. S.).; We thank Potter Wickware for critical reading of the manuscript and the staff members James Holton, George Meigs, and Jane Tanamachi of beamline 8.3.1 at the Advanced Light Source, Lawrence Berkeley National Laboratory, for assistance with data collection. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231. Molecular graphics images were produced in part using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health Grant P41 RR001081).	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Anzai Y, 2003, FEMS MICROBIOL LETT, V218, P135, DOI 10.1111/j.1574-6968.2003.tb11509.x; Anzai Y, 2008, CHEM BIOL, V15, P950, DOI 10.1016/j.chembiol.2008.07.014; Anzai Y, 2012, ANTIMICROB AGENTS CH, V56, P3648, DOI 10.1128/AAC.06063-11; Asciutto EK, 2012, BIOCHEMISTRY-US, V51, P3383, DOI 10.1021/bi300007r; BLOEMBERGEN N, 1957, J CHEM PHYS, V27, P572, DOI 10.1063/1.1743771; Bojja RS, 2004, J AGR FOOD CHEM, V52, P2855, DOI 10.1021/jf035429z; Carlson JC, 2011, NAT CHEM, V3, P628, DOI [10.1038/NCHEM.1087, 10.1038/nchem.1087]; Carlson JC, 2010, CHEMBIOCHEM, V11, P564, DOI 10.1002/cbic.200900658; Carlson JC, 2009, J NAT PROD, V72, P2076, DOI 10.1021/np9005597; Case D.A., 2022, AMBER 2020; Chen MS, 2010, SCIENCE, V327, P566, DOI 10.1126/science.1183602; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cresnar B, 2011, BBA-PROTEINS PROTEOM, V1814, P29, DOI 10.1016/j.bbapap.2010.06.020; CuppVickery JR, 1996, NAT STRUCT BIOL, V3, P632, DOI 10.1038/nsb0796-632; CUPPVICKERY JR, 1995, NAT STRUCT BIOL, V2, P144, DOI 10.1038/nsb0295-144; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; He J, 2003, CHEM BIOL, V10, P1225, DOI 10.1016/j.chembiol.2003.11.009; Holton J, 2004, P NATL ACAD SCI USA, V101, P1537, DOI 10.1073/pnas.0306241101; INOUYE M, 1994, MOL GEN GENET, V245, P456, DOI 10.1007/BF00302258; Isin EM, 2008, ANAL BIOANAL CHEM, V392, P1019, DOI 10.1007/s00216-008-2244-0; Johnston JB, 2011, ARCH BIOCHEM BIOPHYS, V507, P86, DOI 10.1016/j.abb.2010.08.011; Kells PM, 2010, CHEM BIOL, V17, P841, DOI 10.1016/j.chembiol.2010.05.026; KINOSHITA K, 1992, J ANTIBIOT, V45, P1; KINOSHITA K, 1985, J ANTIBIOT, V38, P522, DOI 10.7164/antibiotics.38.522; KINOSHITA K, 1989, J ANTIBIOT, V42, P1869, DOI 10.7164/antibiotics.42.1869; KINOSHITA K, 1989, J ANTIBIOT, V42, P1003, DOI 10.7164/antibiotics.42.1003; Kudo F, 2010, CHEMBIOCHEM, V11, P1574, DOI 10.1002/cbic.201000214; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Li SY, 2007, J AM CHEM SOC, V129, P12940, DOI 10.1021/ja075842d; Li SY, 2009, P NATL ACAD SCI USA, V106, P18463, DOI 10.1073/pnas.0907203106; Li SY, 2009, J BIOL CHEM, V284, P5723, DOI 10.1074/jbc.M807592200; MODI S, 1995, BIOCHEMISTRY-US, V34, P8982, DOI 10.1021/bi00028a006; Muller M, 2006, CHEMBIOCHEM, V7, P37, DOI 10.1002/cbic.200500161; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagano S, 2003, J BIOL CHEM, V278, P44886, DOI 10.1074/jbc.M308115200; OMURA T, 1964, J BIOL CHEM, V239, P2379; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PHILSON SB, 1979, J BIOL CHEM, V254, P173; Podust LM, 2012, NAT PROD REP, V29, P1251, DOI 10.1039/c2np20020a; Proctor RH, 2006, J AGR FOOD CHEM, V54, P2424, DOI 10.1021/jf0527706; Rojas MC, 2001, P NATL ACAD SCI USA, V98, P5838, DOI 10.1073/pnas.091096298; SATOI S, 1980, J ANTIBIOT, V33, P364, DOI 10.7164/antibiotics.33.364; Savino C, 2009, J BIOL CHEM, V284, P29170, DOI 10.1074/jbc.M109.003590; Seo JA, 2001, FUNGAL GENET BIOL, V34, P155, DOI 10.1006/fgbi.2001.1299; Sherman DH, 2006, J BIOL CHEM, V281, P26289, DOI 10.1074/jbc.M605478200; SOLOMON I, 1955, PHYS REV, V99, P559, DOI 10.1103/PhysRev.99.559; SUZUKI H, 1990, J ANTIBIOT, V43, P1508, DOI 10.7164/antibiotics.43.1508; Takenaka S, 1998, FEMS MICROBIOL LETT, V167, P95, DOI 10.1111/j.1574-6968.1998.tb13213.x; Tokai T, 2007, BIOCHEM BIOPH RES CO, V353, P412, DOI 10.1016/j.bbrc.2006.12.033; Tsukada S, 2010, FEMS MICROBIOL LETT, V304, P148, DOI 10.1111/j.1574-6968.2010.01899.x; Tudzynski B, 2002, J BIOL CHEM, V277, P21246, DOI 10.1074/jbc.M201651200; Tudzynski B, 2001, APPL ENVIRON MICROB, V67, P3514, DOI 10.1128/AEM.67.8.3514-3522.2001; von Kries J. P., 2010, CURR PROTOC MICROBIO, V16; Wei JY, 2005, J AM CHEM SOC, V127, P6974, DOI 10.1021/ja051195j; Xu LH, 2010, J BIOL CHEM, V285, P16844, DOI 10.1074/jbc.M109.092460; Xu LH, 2009, J BACTERIOL, V191, P1211, DOI 10.1128/JB.01276-08; Yasutake Y, 2007, BIOCHEM BIOPH RES CO, V361, P876, DOI 10.1016/j.bbrc.2007.07.062; Zocher G, 2011, J AM CHEM SOC, V133, P2292, DOI 10.1021/ja110146z	60	43	44	2	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.410340	http://dx.doi.org/10.1074/jbc.M112.410340			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22952225	hybrid, Green Published			2022-12-25	WOS:000310642200024
J	Kondapalli, KC; Kallay, LM; Muszelik, M; Rao, R				Kondapalli, Kalyan C.; Kallay, Laura M.; Muszelik, Melanie; Rao, Rajini			Unconventional Chemiosmotic Coupling of NHA2, a Mammalian Na+/H+ Antiporter, to a Plasma Membrane H+ Gradient	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-LITHIUM COUNTERTRANSPORT; EVOLUTIONARY ORIGINS; CANDIDATE GENE; EXCHANGER; CELLS; NHE3	Human NHA2, a newly discovered cation proton antiporter, is implicated in essential hypertension by gene linkage analysis. We show that NHA2 mediates phloretin-sensitive Na+-Li+ counter-transport (SLC) activity, an established marker for hypertension. In contrast to bacteria and fungi where H+ gradients drive uptake of metabolites, secondary transport at the plasma membrane of mammalian cells is coupled to the Na+ electrochemical gradient. Our findings challenge this paradigm by showing coupling of NHA2 and V-type H+-ATPase at the plasma membrane of kidney-derived MDCK cells, resulting in a virtual Na+ efflux pump. Thus, NHA2 functionally recapitulates an ancient shared evolutionary origin with bacterial NhaA. Although plasma membrane H+ gradients have been observed in some specialized mammalian cells, the ubiquitous tissue distribution of NHA2 suggests that H+-coupled transport is more widespread. The coexistence of Na+ and H+-driven chemiosmotic circuits has implications for salt and pH regulation in the kidney.	[Kondapalli, Kalyan C.; Kallay, Laura M.; Muszelik, Melanie; Rao, Rajini] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University	Rao, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA.	rrao@jhmi.edu	Kondapalli, Kalyan C/N-8097-2019		National Institutes of Health [DK054214]; American Heart Association [11POST7380034]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK054214 (to R. R.) and American Heart Association Grant 11POST7380034 (to K. C. K.).	Akhter S, 2000, BIOCHEMISTRY-US, V39, P1990, DOI 10.1021/bi991739s; Anderson CMH, 2010, PHYSIOLOGY, V25, P364, DOI 10.1152/physiol.00027.2010; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; CANESSA M, 1980, NEW ENGL J MED, V302, P772, DOI 10.1056/NEJM198004033021403; CANESSA M, 1995, TRENDS CARDIOVAS MED, V5, P102, DOI 10.1016/1050-1738(95)00004-S; Carretero OA, 2000, CIRCULATION, V101, P329, DOI 10.1161/01.CIR.101.3.329; Ecelbarger CA, 2006, CURR HYPERTENS REP, V8, P158, DOI 10.1007/s11906-006-0013-z; Fuster DG, 2008, J AM SOC NEPHROL, V19, P1547, DOI 10.1681/ASN.2007111245; Harvey WR, 2009, J EXP BIOL, V212, P1620, DOI 10.1242/jeb.031534; HelmleKolb C, 1997, PFLUG ARCH EUR J PHY, V434, P123, DOI 10.1007/s004240050372; Jefferies KC, 2008, ARCH BIOCHEM BIOPHYS, V476, P33, DOI 10.1016/j.abb.2008.03.025; Kallay LM, 2006, J CELL BIOCHEM, V99, P647, DOI 10.1002/jcb.20992; Kammerer CM, 2001, HYPERTENSION, V37, P398, DOI 10.1161/01.HYP.37.2.398; Lahr TF, 2000, PFLUG ARCH EUR J PHY, V439, P610, DOI 10.1007/s004240050984; Lee BL, 2011, BIOCHEM CELL BIOL, V89, P189, DOI [10.1139/o10-140, 10.1139/O10-140]; LIFTON RP, 1991, HYPERTENSION, V17, P8, DOI 10.1161/01.HYP.17.1.8; Mager T, 2011, J BIOL CHEM, V286, P23570, DOI 10.1074/jbc.M111.230235; Mohan S, 2010, J BIOL CHEM, V285, P34566, DOI 10.1074/jbc.M110.165712; Morrison AC, 2005, AM J HYPERTENS, V18, P653, DOI 10.1016/j.amjhyper.2004.11.030; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Padan E, 2009, J EXP BIOL, V212, P1593, DOI 10.1242/jeb.026708; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; Saroussi S, 2009, PFLUG ARCH EUR J PHY, V457, P581, DOI 10.1007/s00424-008-0458-9; Schushan M, 2010, J MOL BIOL, V396, P1181, DOI 10.1016/j.jmb.2009.12.055; Verkoelen CF, 1999, KIDNEY INT, V55, P1426, DOI 10.1046/j.1523-1755.1999.00383.x; WEDER AB, 1986, NEW ENGL J MED, V314, P198, DOI 10.1056/NEJM198601233140402; Wegmann M, 2003, PROSTAG LEUKOTR ESS, V69, P315, DOI 10.1016/j.plefa.2003.06.002; Xiang MH, 2007, P NATL ACAD SCI USA, V104, P18677, DOI 10.1073/pnas.0707120104; Zerbini G, 1997, AM J PHYSIOL-CELL PH, V272, pC1373, DOI 10.1152/ajpcell.1997.272.4.C1373	29	23	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36239	36250		10.1074/jbc.M112.403550	http://dx.doi.org/10.1074/jbc.M112.403550			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948142	Green Published, hybrid			2022-12-25	WOS:000310364000045
J	Kishko, I; Harish, B; Zayats, V; Reha, D; Tenner, B; Beri, D; Gustavsson, T; Ettrich, R; Carey, J				Kishko, Iryna; Harish, Balasubramanian; Zayats, Vasilina; Reha, David; Tenner, Brian; Beri, Dhananjay; Gustavsson, Tobias; Ettrich, Ruediger; Carey, Jannette			Biphasic Kinetic Behavior of E. coli WrbA, an FMN-Dependent NAD(P)H: Quinone Oxidoreductase	PLOS ONE			English	Article							ESCHERICHIA-COLI; DT-DIAPHORASE; DEHYDROGENASE; MECHANISM; FAMILY	The E. coli protein WrbA is an FMN-dependent NAD(P)H: quinone oxidoreductase that has been implicated in oxidative defense. Three subunits of the tetrameric enzyme contribute to each of four identical, cavernous active sites that appear to accommodate NAD(P)H or various quinones, but not simultaneously, suggesting an obligate tetramer with a ping-pong mechanism in which NAD departs before oxidized quinone binds. The present work was undertaken to evaluate these suggestions and to characterize the kinetic behavior of WrbA. Steady-state kinetics results reveal that WrbA conforms to a ping-pong mechanism with respect to the constancy of the apparent Vmax to Km ratio with substrate concentration. However, the competitive/non-competitive patterns of product inhibition, though consistent with the general class of bisubstrate reactions, do not exclude a minor contribution from additional forms of the enzyme. NMR results support the presence of additional enzyme forms. Docking and energy calculations find that electron-transfer-competent binding sites for NADH and benzoquinone present severe steric overlap, consistent with the ping-pong mechanism. Unexpectedly, plots of initial velocity as a function of either NADH or benzoquinone concentration present one or two Michaelis-Menten phases depending on the temperature at which the enzyme is held prior to assay. The effect of temperature is reversible, suggesting an intramolecular conformational process. WrbA shares these and other details of its kinetic behavior with mammalian DT-diaphorase, an FAD-dependent NAD(P)H: quinone oxidoreductase. An extensive literature review reveals several other enzymes with two-plateau kinetic plots, but in no case has a molecular explanation been elucidated. Preliminary sedimentation velocity analysis of WrbA indicates a large shift in size of the multimer with temperature, suggesting that subunit assembly coupled to substrate binding may underlie the two-plateau behavior. An additional aim of this report is to bring under wider attention the apparently widespread phenomenon of two-plateau Michaelis-Menten plots.	[Kishko, Iryna; Zayats, Vasilina; Reha, David; Ettrich, Ruediger] Acad Sci Czech Republ, Global Change Res Ctr, Inst Nanobiol & Struct Biol, Nove Hrady, Czech Republic; [Kishko, Iryna; Zayats, Vasilina; Ettrich, Ruediger] Univ S Bohemia, Fac Sci, Nove Hrady, Czech Republic; [Harish, Balasubramanian; Tenner, Brian; Beri, Dhananjay; Carey, Jannette] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Gustavsson, Tobias] Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, Lund, Sweden	Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Princeton University; Lund University	Kishko, I (corresponding author), Acad Sci Czech Republ, Global Change Res Ctr, Inst Nanobiol & Struct Biol, Nove Hrady, Czech Republic.	ettrich@nh.cas.cz; jcarey@princeton.edu	Reha, David/ABB-9836-2021; Kiško, Irina/O-4840-2018; Ettrich, Rudi H/C-1463-2011; Zayats, Vasilina/H-7836-2014; Reha, David/D-7256-2016	Ettrich, Rudi H/0000-0001-8624-7706; , Harish/0000-0002-7672-0851; Zayats, Vasilina/0000-0002-9355-8171; Reha, David/0000-0002-9500-0569	Ministry of Education, Youth and Sports of the Czech Republic [MSM6007665808, Aktion 64p1]; Academy of Sciences of the Czech Republic [AVOZ60870520]; Grant Agency of the Czech Republic [P207/10/1934]; joint Czech - US National Science Foundation International Research Cooperation [OISE08-53423, ME09016]; University of South Bohemia [GAJU 170/2010/P]; Div Of Biological Infrastructure [1004830] Funding Source: National Science Foundation; Office Of Internatl Science &Engineering [0853423] Funding Source: National Science Foundation	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); joint Czech - US National Science Foundation International Research Cooperation; University of South Bohemia; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office Of Internatl Science &Engineering(National Science Foundation (NSF)NSF - Office of the Director (OD))	Access to METACentrum supercomputing facilities was provided under the research intent MSM6383917201. The authors thank Curt Hillegas, Director of Research Computing at the Princeton University Office of Information Technology, for access to the high-performance computing center, and Prof. James Cole, director of the national AUC facility, for assistance with the sedimentation velocity experiments and data analysis. The authors gratefully acknowledge support from the Ministry of Education, Youth and Sports of the Czech Republic (MSM6007665808, Aktion 64p1), Academy of Sciences of the Czech Republic (AVOZ60870520), Grant Agency of the Czech Republic (P207/10/1934 to R.E.), and joint Czech - US National Science Foundation International Research Cooperation (OISE08-53423 to J.C., and ME09016 to R.E.). Additionally, I. K. and V.Z. were supported by the University of South Bohemia, Grant GAJU 170/2010/P. I. K. would like to thank Alena Lukesova for sponsoring lab facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SLA, 2007, J BACTERIOL, V189, P9101, DOI 10.1128/JB.01336-07; [Anonymous], 2011, MAESTR 9 2; [Anonymous], 2011, GLID 5 7; BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561; Carey J, 2007, PROTEIN SCI, V16, P2301, DOI 10.1110/ps.073018907; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; CORWIN LM, 1968, J BIOL CHEM, V243, P3517; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; ERNSTER L, 1987, CHEM SCRIPTA, V27A, P1; Frisch M.J., 2016, GAUSSIAN 16 REVISION; GELB WG, 1970, BIOCHEMISTRY-US, V9, P3228, DOI 10.1021/bi00818a016; GRANDORI R, 1994, PROTEIN SCI, V3, P2185, DOI 10.1002/pro.5560031204; Grandori R, 1998, J BIOL CHEM, V273, P20960, DOI 10.1074/jbc.273.33.20960; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Hall JM, 1972, STRUCTURE FUNCTION O, P433; HOLLANDER PM, 1975, ARCH BIOCHEM BIOPHYS, V169, P568, DOI 10.1016/0003-9861(75)90201-5; HOSODA S, 1974, J BIOL CHEM, V249, P6416; Jensen KA, 2002, APPL ENVIRON MICROB, V68, P2699, DOI 10.1128/AEM.68.6.2699-2703.2002; Jorgensen WL, 2005, P NATL ACAD SCI USA, V102, P6665, DOI 10.1073/pnas.0408037102; KAGAN ZS, 1973, BIOCHIM BIOPHYS ACTA, V302, P110, DOI 10.1016/0005-2744(73)90014-4; KATO G, 1972, J BIOL CHEM, V247, P3186; LEJOHN HB, 1968, J BIOL CHEM, V243, P3447; LEVITZKI A, 1969, P NATL ACAD SCI USA, V62, P1121, DOI 10.1073/pnas.62.4.1121; LI RB, 1995, P NATL ACAD SCI USA, V92, P8846, DOI 10.1073/pnas.92.19.8846; MARCUS RA, 1956, J CHEM PHYS, V24, P966, DOI 10.1063/1.1742723; Noll G, 2006, LANGMUIR, V22, P2378, DOI 10.1021/la051423n; Patridge EV, 2006, J BACTERIOL, V188, P3498, DOI 10.1128/JB.188.10.3498-3506.2006; RUAN K, 1989, BIOCHEMISTRY-US, V28, P2144, DOI 10.1021/bi00431a028; Schrodinger LLC, 2011, IMP 5 7; Schrodinger LLC, 2011, QSIT 5 7; SOMERO GN, 1969, BIOCHEM J, V114, P237, DOI 10.1042/bj1140237; SOMERO GN, 1969, NATURE, V223, P194, DOI 10.1038/223194a0; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; WALSH CT, 1979, ENZYMATIC REACTION M; Wolfova J, 2009, BBA-PROTEINS PROTEOM, V1794, P1288, DOI 10.1016/j.bbapap.2009.08.001; YANG WP, 1993, P NATL ACAD SCI USA, V90, P5796, DOI 10.1073/pnas.90.12.5796; ZEIJLEMAKER WP, 1969, BIOCHIM BIOPHYS ACTA, V178, P213, DOI 10.1016/0005-2744(69)90391-X	37	18	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43902	10.1371/journal.pone.0043902	http://dx.doi.org/10.1371/journal.pone.0043902			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952804	Green Submitted, Green Published, gold			2022-12-25	WOS:000308206000058
J	Tull, SP; Bevins, A; Kuravi, SJ; Satchell, SC; Al-Ani, B; Young, SP; Harper, L; Williams, JM; Rainger, GE; Savage, COS				Tull, Samantha P.; Bevins, Anne; Kuravi, Sahithi Jyothsna; Satchell, Simon C.; Al-Ani, Bahjat; Young, Stephen P.; Harper, Lorraine; Williams, Julie M.; Rainger, George Ed; Savage, Caroline O. S.			PR3 and Elastase Alter PAR1 Signaling and Trigger vWF Release via a Calcium-Independent Mechanism from Glomerular Endothelial Cells	PLOS ONE			English	Article							PROTEINASE-ACTIVATED RECEPTOR-2; VON-WILLEBRAND-FACTOR; NEUTROPHIL SERINE PROTEINASES; FUNCTIONAL THROMBIN RECEPTOR; C RECEPTOR; SURFACE EXPRESSION; EPITHELIAL-CELLS; ALPHA-THROMBIN; TISSUE FACTOR; INTERNALIZATION	Neutrophil proteases, proteinase-3 (PR3) and elastase play key roles in glomerular endothelial cell (GEC) injury during glomerulonephritis. Endothelial protease-activated receptors (PARs) are potential serine protease targets in glomerulonephritis. We investigated whether PAR1/2 are required for alterations in GEC phenotype that are mediated by PR3 or elastase during active glomerulonephritis. Endothelial PARs were assessed by flow cytometry. Thrombin, trypsin and agonist peptides for PAR1 and PAR2, TFLLR-NH2 and SLIGKV-NH2, respectively, were used to assess alterations in PAR activation induced by PR3 or elastase. Endothelial von Willebrand Factor (vWF) release and calcium signaling were used as PAR activation markers. Both PR3 and elastase induced endothelial vWF release, with elastase inducing the highest response. PAR1 peptide induced GEC vWF release to the same extent as PR3. However, knockdown of PARs by small interfering RNA showed that neither PAR1 nor PAR2 activation caused PR3 or elastase-mediated vWF release. Both proteases interacted with and disarmed surface GEC PAR1, but there was no detectable interaction with cellular PAR2. Neither protease induced a calcium response in GEC. Therefore, PAR signaling and serine protease-induced alterations in endothelial function modulate glomerular inflammation via parallel but independent pathways.	[Tull, Samantha P.; Bevins, Anne; Kuravi, Sahithi Jyothsna; Young, Stephen P.; Harper, Lorraine; Savage, Caroline O. S.] Univ Birmingham, Sch Immun, Coll Med & Dent, Birmingham, W Midlands, England; [Williams, Julie M.] Queen Elizabeth Hosp, WTCRF, Birmingham B15 2TH, W Midlands, England; [Satchell, Simon C.; Williams, Julie M.] Univ Bristol, Acad Renal Unit, Bristol, Avon, England; [Al-Ani, Bahjat] King Khalid Univ, Coll Med, Dept Physiol, Abha, Saudi Arabia; [Tull, Samantha P.; Bevins, Anne; Kuravi, Sahithi Jyothsna; Young, Stephen P.; Harper, Lorraine; Savage, Caroline O. S.] Univ Birmingham, Sch Infect, Coll Med & Dent, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Bristol; King Khalid University; University of Birmingham	Tull, SP (corresponding author), Univ Birmingham, Sch Immun, Coll Med & Dent, Birmingham, W Midlands, England.	s.p.tull@bham.ac.uk	tull, samantha p/A-9825-2013; Young, Stephen P/A-7380-2008	Tull, Samantha/0000-0001-9337-4690; harper, lorraine/0000-0003-1343-9234; Young, Stephen P/0000-0002-6355-3361	Medical Research Council; Kidney Research UK; Medical Research Council [G9818340B, G0600069] Funding Source: researchfish; MRC [G0600069] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by external funding from Medical Research Council and Kidney Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ani B, 2003, J PHARMACOL EXP THER, V304, P1120, DOI 10.1124/jpet.102.043844; Asokananthan N, 2002, J IMMUNOL, V168, P3577, DOI 10.4049/jimmunol.168.7.3577; Bae JS, 2007, BLOOD, V110, P3909, DOI 10.1182/blood-2007-06-096651; Boehme MWJ, 2002, IMMUNOLOGY, V107, P340, DOI 10.1046/j.1365-2567.2002.01469.x; BRASS LF, 1994, J BIOL CHEM, V269, P2943; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Calderwood JW, 2005, J LEUKOCYTE BIOL, V77, P33, DOI 10.1189/jlb.0104054; Carruthers DM, 1996, CLIN EXP IMMUNOL, V105, P291, DOI 10.1046/j.1365-2249.1996.d01-768.x; Cirino G, 2006, CURR OPIN PHARMACOL, V6, P428, DOI 10.1016/j.coph.2006.05.001; COLLINS PW, 1993, THROMB HAEMOSTASIS, V70, P346; Compton SJ, 2002, BIOCHEM J, V368, P495, DOI 10.1042/BJ20020706; COOKE BM, 1993, MICROVASC RES, V45, P33, DOI 10.1006/mvre.1993.1004; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Cunningham MA, 2000, J EXP MED, V191, P455, DOI 10.1084/jem.191.3.455; Dulon S, 2003, AM J RESP CELL MOL, V28, P339, DOI 10.1165/rcmb.4908; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grandaliano G, 2003, J AM SOC NEPHROL, V14, P2072, DOI 10.1097/01.ASN.0000080315.37254.A1; Gupta A, 2009, FORM METHOD SYST DES, V35, P1, DOI 10.1007/s10703-009-0072-2; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Haubitz M, 1997, ARTHRITIS RHEUM, V40, P1680, DOI 10.1002/art.1780400918; HENSHAW TJ, 1994, ARTHRITIS RHEUM, V37, P104, DOI 10.1002/art.1780370116; HOXIE JA, 1993, J BIOL CHEM, V268, P13756; HUNG DT, 1992, J CLIN INVEST, V89, P1350, DOI 10.1172/JCI115721; Jiang B, 2010, CLIN EXP RHEUMATOL, V28, pS56; JOHNSON RJ, 1988, J EXP MED, V168, P1169, DOI 10.1084/jem.168.3.1169; Kawabata A, 1999, J PHARMACOL EXP THER, V288, P358; Kawamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034045; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Klarenbach SW, 2003, CIRC RES, V92, P272, DOI 10.1161/01.RES.0000057386.15390.A3; Kuravi SJ, 2012, NEPHROL DIA IN PRESS; Langer F, 1999, BRIT J HAEMATOL, V105, P542; LEVINE L, 1994, PROSTAGLANDINS, V47, P437, DOI 10.1016/0090-6980(94)90044-2; Loew D, 2000, BIOCHEMISTRY-US, V39, P10812, DOI 10.1021/bi0003341; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Massberg S, 2010, NAT MED; Moussa L, 2007, AM J PATHOL, V171, P800, DOI 10.2353/ajpath.2007.061155; Nomura K, 2007, LAB INVEST, V87, P150, DOI 10.1038/labinvest.3700502; Oh P, 2012, J BIOL CHEM, V287, P17353, DOI 10.1074/jbc.M111.338897; Preston GA, 2002, J AM SOC NEPHROL, V13, P2840, DOI 10.1097/01.ASN.0000034911.03334.C3; Ramachandran R, 2011, J BIOL CHEM, V286, P24638, DOI 10.1074/jbc.M110.201988; Ramachandran R, 2009, MOL PHARMACOL, V76, P791, DOI 10.1124/mol.109.055509; RASMUSSEN UB, 1991, FEBS LETT, V288, P123, DOI 10.1016/0014-5793(91)81017-3; Russo A, 2009, MOL INTERV, V9, P87, DOI 10.1124/mi.9.2.8; Russo A, 2009, P NATL ACAD SCI USA, V106, P6393, DOI 10.1073/pnas.0810687106; Sarangi PP, 2010, BRIT J HAEMATOL, V148, P817, DOI 10.1111/j.1365-2141.2009.08020.x; Satchell SC, 2006, KIDNEY INT, V69, P1633, DOI 10.1038/sj.ki.5000277; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; Steppich BA, 2008, THROMB HAEMOSTASIS, V100, P1068, DOI 10.1160/TH08-05-0293; STORCK J, 1995, THROMB RES, V77, P249, DOI 10.1016/0049-3848(95)91612-O; Suzuki T, 2009, AM J RESP CELL MOL, V41, P742, DOI 10.1165/rcmb.2008-0157OC; Tanaka M, 2005, KIDNEY INT, V67, P2123, DOI 10.1111/j.1523-1755.2005.00317.x; Tull SP, 2006, CIRC RES, V98, P98, DOI 10.1161/01.RES.0000198386.69355.87; Uehara A, 2003, J IMMUNOL, V170, P5690, DOI 10.4049/jimmunol.170.11.5690; Uehara A, 2002, J IMMUNOL, V169, P4594, DOI 10.4049/jimmunol.169.8.4594; Vesey DA, 2007, AM J PHYSIOL-RENAL, V293, pF1441, DOI 10.1152/ajprenal.00088.2007; Villegas-Mendez A, 2007, J THROMB HAEMOST, V5, P980, DOI 10.1111/j.1538-7836.2007.02480.x; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Xiao YP, 2011, J BIOL CHEM, V286, P22991, DOI 10.1074/jbc.M110.204271; XU YC, 1995, AM J PATHOL, V146, P101	59	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43916	10.1371/journal.pone.0043916	http://dx.doi.org/10.1371/journal.pone.0043916			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952809	Green Submitted, gold, Green Published			2022-12-25	WOS:000308206000060
J	Gallardo-Romero, NF; Drew, CP; Weiss, SL; Metcalfe, MG; Nakazawa, YJ; Smith, SK; Emerson, GL; Hutson, CL; Salzer, JS; Bartlett, JH; Olson, VA; Clemmons, CJ; Davidson, WB; Zaki, SR; Karem, KL; Damon, IK; Carroll, DS				Gallardo-Romero, Nadia F.; Drew, Clifton P.; Weiss, Sonja L.; Metcalfe, Maureen G.; Nakazawa, Yoshinori J.; Smith, Scott K.; Emerson, Ginny L.; Hutson, Christina L.; Salzer, Johanna S.; Bartlett, Jeanine H.; Olson, Victoria A.; Clemmons, Cody J.; Davidson, Whitni B.; Zaki, Sherif R.; Karem, Kevin L.; Damon, Inger K.; Carroll, Darin S.			The Pox in the North American Backyard: Volepox Virus Pathogenesis in California Mice (Peromyscus californicus)	PLOS ONE			English	Article							ORTHOPOXVIRUS; ANIMALS	Volepox virus (VPXV) was first isolated in 1985 from a hind foot scab of an otherwise healthy California vole (Microtus californicus). Subsequent surveys in San Mateo County, CA, revealed serological evidence suggesting that VPXV is endemic to this area, and a second viral isolate from a Pinyon mouse (Peromyscus truei) was collected in 1988. Since then, few studies have been conducted regarding the ecology, pathology, and pathogenicity of VPXV, and its prevalence and role as a potential zoonotic agent remain unknown. To increase our understanding of VPXV disease progression, we challenged 24 California mice (Peromyscus californicus) intranasally with 1.6x10(3) PFU of purified VPXV. By day five post infection (pi) we observed decreased activity level, conjunctivitis, ruffled hair, skin lesions, facial edema, and crusty noses. A mortality rate of 54% was noted by day eight pi. In addition, internal organ necrosis and hemorrhages were observed during necropsy of deceased or euthanized animals. Viral loads in tissues (brain, gonad, kidney, liver, lung, spleen, submandibular lymph node, and adrenal gland), bodily secretions (saliva, and tears), and excretions (urine, and/or feces) were evaluated and compared using real time-PCR and tissue culture. Viral loads measured as high as 2x10(9) PFU/mL in some organs. Our results suggest that VPXV can cause extreme morbidity and mortality within rodent populations sympatric with the known VPXV reservoirs.	[Gallardo-Romero, Nadia F.; Weiss, Sonja L.; Nakazawa, Yoshinori J.; Smith, Scott K.; Emerson, Ginny L.; Hutson, Christina L.; Salzer, Johanna S.; Olson, Victoria A.; Clemmons, Cody J.; Davidson, Whitni B.; Karem, Kevin L.; Damon, Inger K.; Carroll, Darin S.] Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Drew, Clifton P.; Metcalfe, Maureen G.; Bartlett, Jeanine H.; Zaki, Sherif R.] Ctr Dis Control & Prevent, Infect Dis Pathol Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Salzer, Johanna S.] Emory Univ, Program Populat Biol Ecol & Evolut, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University	Gallardo-Romero, NF (corresponding author), Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA.	hfa5@cdc.gov						Alexander A.D., 1972, Journal Wildl Dis, V8, P119; BAUER DF, 1972, J AM STAT ASSOC, V67, P687, DOI 10.2307/2284469; CAVALLARO KF, 1992, VIROLOGY, V190, P434, DOI 10.1016/0042-6822(92)91229-N; Che-Sheng C, 1998, J VIROL, V72, P1577; CHERRY JD, 1977, J INFECT DIS, V135, P176, DOI 10.1093/infdis/135.1.176; Damon IK, 2007, FIELDS VIROLOGY, P2947; DEMKOWICZ WE, 1992, J VIROL, V66, P386, DOI 10.1128/JVI.66.1.386-398.1992; Emerson GL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007666; ESPOSITO JJ, 1978, VIROLOGY, V89, P53, DOI 10.1016/0042-6822(78)90039-9; Fenner F, 1998, EPIDEMIOLOGY SAMLLPO, P169; Fenner Frank, 1994, V5, P27; Gallardo-Romero NF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-313; GORDON J, 1988, VIROLOGY, V167, P361, DOI 10.1016/S0042-6822(88)90096-7; Guarner J, 2004, EMERG INFECT DIS, V10, P426, DOI 10.3201/eid1003.030878; Hollander M., 1973, NONPARAMETRIC STAT M; Hutson CL, 2007, AM J TROP MED HYG, V76, P757, DOI 10.4269/ajtmh.2007.76.757; Hutson CL, 2010, VIROLOGY, V402, P72, DOI 10.1016/j.virol.2010.03.012; Hutson CL, 2009, J GEN VIROL, V90, P323, DOI 10.1099/vir.0.005108-0; Jacobs BL, 2009, ANTIVIR RES, V84, P1, DOI 10.1016/j.antiviral.2009.06.006; KNIGHT JC, 1992, VIROLOGY, V190, P423, DOI 10.1016/0042-6822(92)91228-M; Li Y, 2007, P NATL ACAD SCI USA, V104, P15787, DOI 10.1073/pnas.0609268104; REGNERY DC, 1987, ARCH VIROL, V94, P159, DOI 10.1007/BF01313734; Regnery RL, 2007, WILDLIFE EMERGING ZO, P522; SEKI M, 1990, VIROLOGY, V175, P372, DOI 10.1016/0042-6822(90)90422-N; Smith SK, 2011, J VIROL, V85, P9176, DOI 10.1128/JVI.02173-10; VANSLYKE JK, 1991, VIROLOGY, V183, P467, DOI 10.1016/0042-6822(91)90976-I; Wu PJ, 1999, J ZOO WILDLIFE MED, V30, P589	27	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43881	10.1371/journal.pone.0043881	http://dx.doi.org/10.1371/journal.pone.0043881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952799	Green Submitted, Green Published, gold			2022-12-25	WOS:000308213600053
J	Sage, J; Leblanc-Noblesse, E; Nizard, C; Sasaki, T; Schnebert, S; Perrier, E; Kurfurst, R; Bromme, D; Lalmanach, G; Lecaille, F				Sage, Juliette; Leblanc-Noblesse, Emmanuelle; Nizard, Carine; Sasaki, Takako; Schnebert, Sylvianne; Perrier, Eric; Kurfurst, Robin; Broemme, Dieter; Lalmanach, Gilles; Lecaille, Fabien			Cleavage of Nidogen-1 by Cathepsin S Impairs Its Binding to Basement Membrane Partners	PLOS ONE			English	Article							THYROGLOBULIN TYPE-1 DOMAIN; LYSOSOMAL CYSTEINE PROTEINASES; EXTRACELLULAR-MATRIX; SJOGRENS-SYNDROME; HUMAN MACROPHAGES; BASAL LAMINA; IN-VITRO; INHIBITOR; DEGRADATION; PROTEASES	Cathepsin S (catS), which is expressed in normal human keratinocytes and localized close to the dermal-epidermal junction (DEJ) degrades some of major basement membrane (BM) constituents. Among them, catS readily hydrolyzed in a time and dose dependent manner human nidogen-1 (nid-1) and nidogen-2, which are key proteins in the BM structure. CatS preferentially cleaved nid-1 at both acid and neutral pH. Hydrolysis of nid-1 was hampered in murine ctss(-/-) spleen lysates pretreated with inhibitors of other classes of proteases. Nid-1 was cleaved within its G2 and G3 globular domains that are both involved in interactions with other BM components. Binding assays with soluble and immobilized ligands indicated that catS altered the formation of complexes between nid-1 and other BM components. Assuming that the cleavage of nid-1 impairs its ability to crosslink with BM partners and perturbs the viscoelastic properties of BM matrix, these data indicate that catS may participate in BM proteolysis, in addition to already identified proteases.	[Sage, Juliette; Lalmanach, Gilles; Lecaille, Fabien] INSERM, UMR 1100, Ctr Etud Pathol Resp, Tours, France; [Sage, Juliette; Lalmanach, Gilles; Lecaille, Fabien] Univ Tours, UMR 1100, Tours, France; [Sage, Juliette; Leblanc-Noblesse, Emmanuelle; Nizard, Carine; Schnebert, Sylvianne; Perrier, Eric; Kurfurst, Robin] Louis Vuitton Moet Hennessy LVMH Rech, St Jean De Braye, France; [Nizard, Carine] Ctr Rech Cordeliers, Lab Pharmacol Cellulaire, Ecole Prat Hautes Etud, Paris, France; [Sasaki, Takako] Univ Erlangen Nurnberg, Dept Expt Med 1, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Germany; [Broemme, Dieter] Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V5Z 1M9, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Universite Paris Cite; University of Erlangen Nuremberg; University of British Columbia	Sage, J (corresponding author), INSERM, UMR 1100, Ctr Etud Pathol Resp, Tours, France.	fabien.lecaille@univ-tours.fr	Lecaille, Fabien/GRY-5313-2022	Lecaille, Fabien/0000-0003-1060-4222; Lalmanach, Gilles/0000-0001-8562-4821	LVMH Recherche (Saint Jean de Braye, France); Institut National de la Sante et de la Recherche Medicale (INSERM); Canada Research Chair award; Association Nationale de la Recherche Technique (ANRT, France; CIFRE)	LVMH Recherche (Saint Jean de Braye, France); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Association Nationale de la Recherche Technique (ANRT, France; CIFRE)	This work was financially supported by LVMH Recherche (Saint Jean de Braye, France) and by institutional funding from the Institut National de la Sante et de la Recherche Medicale (INSERM). DB was supported by a Canada Research Chair award. JS holds a doctoral fellowship from the Association Nationale de la Recherche Technique (ANRT, France; CIFRE PhD funding). The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; BATTAGLIA C, 1992, EUR J BIOCHEM, V208, P359, DOI 10.1111/j.1432-1033.1992.tb17195.x; Behrens DT, 2012, J BIOL CHEM, V287, P18700, DOI 10.1074/jbc.M111.336073; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Breitkreutz D, 2004, J CELL SCI, V117, P2611, DOI 10.1242/jcs.01127; Breitkreutz D, 2009, HISTOCHEM CELL BIOL, V132, P1, DOI 10.1007/s00418-009-0586-0; Buth H, 2004, EUR J CELL BIOL, V83, P781, DOI 10.1078/0171-9335-00428; Dalet-Fumeron V, 1998, ARCH BIOCHEM BIOPHYS, V358, P283, DOI 10.1006/abbi.1998.0868; DZIADEK M, 1985, EMBO J, V4, P2513, DOI 10.1002/j.1460-2075.1985.tb03964.x; DZIADEK M, 1988, EUR J BIOCHEM, V172, P219, DOI 10.1111/j.1432-1033.1988.tb13876.x; EKBLOM P, 1994, DEVELOPMENT, V120, P2003; ENGEL J, 1980, MOL IMMUNOL, V17, P675, DOI 10.1016/0161-5890(80)90166-2; FLEISCHMAJER R, 1995, J INVEST DERMATOL, V105, P597, DOI 10.1111/1523-1747.ep12323604; Fowlkes JL, 1997, ENDOCRINOLOGY, V138, P2280, DOI 10.1210/en.138.6.2280; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; Gillet L, 2009, J BIOL CHEM, V284, P8671, DOI 10.1074/jbc.M806891200; Gronski TJ, 1997, J BIOL CHEM, V272, P12189, DOI 10.1074/jbc.272.18.12189; GUINEC N, 1992, FEBS LETT, V308, P305, DOI 10.1016/0014-5793(92)81299-2; Ho MSP, 2008, MICROSC RES TECHNIQ, V71, P387, DOI 10.1002/jemt.20567; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Kohfeldt E, 1998, J MOL BIOL, V282, P99, DOI 10.1006/jmbi.1998.2004; Kruegel J, 2010, CELL MOL LIFE SCI, V67, P2879, DOI 10.1007/s00018-010-0367-x; Kruse MN, 2004, BIOCHEM J, V378, P383, DOI 10.1042/BJ20031163; Kwon YJ, 2006, ARTHRITIS RHEUM, V54, P3465, DOI 10.1002/art.22177; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; Lenarcic B, 1997, J BIOL CHEM, V272, P13899; Lenarcic B, 1999, J BIOL CHEM, V274, P563, DOI 10.1074/jbc.274.2.563; Lenarcic B, 1998, BIOL CHEM, V379, P105; Linnevers CJ, 1997, PROTEIN SCI, V6, P919; MAYER U, 1993, EUR J BIOCHEM, V217, P877, DOI 10.1111/j.1432-1033.1993.tb18316.x; MAYER U, 1995, EUR J BIOCHEM, V227, P681, DOI 10.1111/j.1432-1033.1995.tb20188.x; Meh P, 2005, BIOL CHEM, V386, P75, DOI 10.1515/BC.2005.010; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Molina F, 1996, EUR J BIOCHEM, V240, P125, DOI 10.1111/j.1432-1033.1996.0125h.x; NAGAYOSHI T, 1989, DNA-J MOLEC CELL BIO, V8, P581, DOI 10.1089/dna.1989.8.581; Novinec M, 2006, MOL BIOL EVOL, V23, P744, DOI 10.1093/molbev/msj082; OHMAN H, 1994, ACTA DERM-VENEREOL, V74, P375; PAULSSON M, 1986, EUR J BIOCHEM, V156, P467, DOI 10.1111/j.1432-1033.1986.tb09605.x; Pungercic G, 2002, BIOL CHEM, V383, P1809, DOI 10.1515/BC.2002.202; Punturieri A, 2000, J EXP MED, V192, P789, DOI 10.1084/jem.192.6.789; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Ries A, 2001, EUR J BIOCHEM, V268, P5119, DOI 10.1046/j.0014-2956.2001.02437.x; Schonefuss A, 2010, EXP DERMATOL, V19, pE80, DOI 10.1111/j.1600-0625.2009.00990.x; Shi GP, 2003, CIRC RES, V92, P493, DOI 10.1161/01.RES.0000060485.20318.96; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; SIRES UI, 1993, J BIOL CHEM, V268, P2069; Small DM, 2011, CLIN REV BONE MINER, V9, P122, DOI 10.1007/s12018-011-9095-5; Sohar N, 2005, CLIN BIOCHEM, V38, P1120, DOI 10.1016/j.clinbiochem.2005.09.003; Titz B, 2004, CELL MOL LIFE SCI, V61, P1826, DOI 10.1007/s00018-004-4105-0; Van Goethem E, 2010, J IMMUNOL, V184, P1049, DOI 10.4049/jimmunol.0902223; Wolters P J, 2000, Respir Res, V1, P170, DOI 10.1186/rr29; Yamashita M, 1996, J BIOL CHEM, V271, P1282, DOI 10.1074/jbc.271.3.1282; Zullani T, 2005, FREE RADICAL BIO MED, V38, P307, DOI 10.1016/j.freeradbiomed.2004.09.021	53	32	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43494	10.1371/journal.pone.0043494	http://dx.doi.org/10.1371/journal.pone.0043494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952693	Green Submitted, Green Published, gold			2022-12-25	WOS:000308213600027
J	Dave, SS; Copas, A; Richens, J; White, RG; Kosambiya, JK; Desai, VK; Stephenson, JM				Dave, Sangeeta S.; Copas, Andrew; Richens, John; White, Richard G.; Kosambiya, Jayendrakumar K.; Desai, Vikas K.; Stephenson, Judith M.			HIV and STI Prevalence and Determinants among Male Migrant Workers in India	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; HUMAN-IMMUNODEFICIENCY-VIRUS; MALE RURAL MIGRANTS; NEISSERIA-GONORRHOEAE; CHLAMYDIA-TRACHOMATIS; URINE SPECIMENS; SOUTH-AFRICA; RISK-FACTORS; INFECTION; MEN	Background: Our objective was to estimate for the first time the prevalence and determinants of human immunodeficiency virus type 1 (HIV-1) and sexually transmitted infections (STIs) among male migrants in India. Methodology/Principal Findings: We conducted a multi-stage stratified probability sample survey of migrant (defined as not born in Surat city) men aged 18 to 49 years working in the diamond and textile industries in Surat city. Behavioural and biological data were collected. Biological data included laboratory diagnosed herpes simplex virus type 2 (HSV-2), syphilis, chlamydia, gonorrhoea, Trichomonas vaginalis (together defined as 'any STI') and HIV-1. Likely recently acquired STIs included chlamydia, gonorrhoea, T. vaginalis and syphilis with rapid plasma reagin >= 1.8. The response rate was 77% (845/1099). Among 841 participants, HIV-1 prevalence was 1.0%, 'any STI' prevalence was 9.5% and 38.9% of these STIs were likely to have been recently acquired. Being a diamond worker, Surat resident for 10+ years and recent antibiotic use were each associated with higher odds of 'any STI' (aORs 1.83 (95% CI 1.09-3.09), 1.98 (95% CI 1.22-3.22) and 2.57 (95% CI 1.17-5.64), respectively) after adjusting for the other two factors and age. The main study limitation was social desirability bias for self-reported sexual behaviour; STIs were diagnosed in some self-reported virgins. Conclusions/Significance: HIV and STI prevalence were lower than expected, but prevention interventions remain necessary in Surat since almost 40% of STIs among participants were probably recently acquired and sentinel surveillance HIV prevalence remains high. The participants had a similar HIV prevalence to Surat antenatal clinic attendees, a proxy for the general population. This suggests migrants are not always at higher risk of HIV compared to the general population in their migration destination. Our findings highlight the need to contextualise research findings from a specific setting with other local information to guide HIV/STI prevention interventions.	[Dave, Sangeeta S.; Stephenson, Judith M.] UCL, Inst Womens Hlth, London, England; [Copas, Andrew; Richens, John] UCL, Ctr Sexual Hlth & HIV Res, London, England; [White, Richard G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Kosambiya, Jayendrakumar K.; Desai, Vikas K.] Govt Med Coll, Dept Community Med, Surat, Gujarat, India	University of London; University College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Dave, SS (corresponding author), UCL, Inst Womens Hlth, London, England.	sangeeta_s_dave@yahoo.co.uk	White, Richard G/D-5407-2009; Richens, John/C-1876-2008	White, Richard G/0000-0003-4410-6635; Copas, Andrew/0000-0001-8968-5963	Wellcome Trust Health Consequences of Population Change Fellowship [WT074061AIA]; Medical Research Council (UK) Methodology Research Fellowship [G0802414]; Bill & Melinda Gates Foundation [19790.01]; EU FP7 [242061]; MRC [G0802414] Funding Source: UKRI; Medical Research Council [G0802414] Funding Source: researchfish	Wellcome Trust Health Consequences of Population Change Fellowship(Wellcome Trust); Medical Research Council (UK) Methodology Research Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); EU FP7(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	SSD was funded by a Wellcome Trust Health Consequences of Population Change Fellowship (WT074061AIA, http://www.wellcome.ac.uk). RGW is funded by a Medical Research Council (UK) Methodology Research Fellowship (G0802414, www.mrc.ac.uk/), the Bill & Melinda Gates Foundation (19790.01, www.gatesfoundation.org/), and the EU FP7 (242061, http://ec.europa.eu/index_en.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARONGO LR, 1992, AIDS, V6, P1521, DOI 10.1097/00002030-199212000-00016; Boerma JT, 2005, J INFECT DIS, V191, pS61, DOI 10.1086/425282; Boerma JT, 2003, SEX TRANSM DIS, V30, P779, DOI 10.1097/01.OLQ.0000078820.62897.A6; Camlin CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011539; Coffee MP, 2005, J INFECT DIS, V191, pS159, DOI 10.1086/425270; Deering KN, 2008, AIDS, V22, pS165, DOI 10.1097/01.aids.0000343774.59776.95; Faisel A, 2006, SEX TRANSM INFECT, V82, P307, DOI 10.1136/sti.2005.018762; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Goh BT, 2005, SEX TRANSM INFECT, V81, P448, DOI 10.1136/sti.2005.015875; Hawkes S, 2002, SEX TRANSM INFECT, V78, pI31, DOI 10.1136/sti.78.suppl_1.i31; He N, 2009, INT J STD AIDS, V20, P112, DOI 10.1258/ijsa.2008.008217; He N, 2005, SEX TRANSM DIS, V32, P286, DOI 10.1097/01.olq.0000152219.58592.9b; Health & Family Welfare Department Government of Gujarat, 2006, GUJ STAT AIDS CONTR; Health & Family Welfare Department Government of Gujarat, 2005, GUJ STAT AIDS CONTR; Health & Family Welfare Department Government of Gujarat, 2008, GUJ STAT AIDS CONTR; Health & Family Welfare Department Government of Gujarat, 2007, GUJ STAT AIDS CONTR; IIPS, 2007, IND NAT FAM HLTH SUR, V1; KANE F, 1993, AIDS, V7, P1261, DOI 10.1097/00002030-199309000-00017; Lagarde E, 2003, INT J EPIDEMIOL, V32, P744, DOI 10.1093/ije/dyg111; Lindan C, 2005, J CLIN MICROBIOL, V43, P1674, DOI 10.1128/JCM.43.4.1674-1677.2005; Lowndes CM, 2012, AIDS BEHAV, V16, P1054, DOI 10.1007/s10461-011-0004-1; Lurie MN, 2003, SEX TRANSM DIS, V30, P149, DOI 10.1097/00007435-200302000-00011; Morre SA, 2000, J CLIN MICROBIOL, V38, P1679; National AIDS Control Organisation Ministry of Health and Family Welfare Government of India, 2006, D91 SECURESCM; National AIDS Control Organisation Ministry of Health and Family Welfare Government of India, 2006, NAT BEH SURV SURV BS; National AIDS Control Organization Department of AIDS Control Ministry of Health and Family Welfare Government of India, 2010, POL STRAT OP PLAN HI; Poudel KC, 2003, TROP MED INT HEALTH, V8, P933, DOI 10.1046/j.1365-3156.2003.01110.x; Quigley M, 1997, AIDS, V11, P237, DOI 10.1097/00002030-199702000-00015; Saggurti N, 2008, AIDS, V22, pS127, DOI 10.1097/01.aids.0000343771.75023.cc; Saggurti N, 2009, AIDS BEHAV, V13, P921, DOI 10.1007/s10461-009-9564-8; Todd J, 2001, SEX TRANSM INFECT, V77, P37, DOI 10.1136/sti.77.1.37; UNAIDS, 2010, REP GLOB AIDS EP; Van der Pol B, 2001, J CLIN MICROBIOL, V39, P3092, DOI 10.1128/JCM.39.9.3092-3098.2001; Wang W, 2010, INT J STD AIDS, V21, P410, DOI 10.1258/ijsa.2009.008518; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; White RG, 2003, INT J EPIDEMIOL, V32, P753, DOI 10.1093/ije/dyg265	37	4	4	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43576	10.1371/journal.pone.0043576	http://dx.doi.org/10.1371/journal.pone.0043576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952708	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000308044800039
J	Bergot, E; Haustraete, E; Malbruny, B; Magnier, R; Salaun, MA; Zalcman, G				Bergot, Emmanuel; Haustraete, Eglantine; Malbruny, Brigitte; Magnier, Romain; Salauen, Marie-Anne; Zalcman, Gerard			Observational Study of QuantiFERON (R)-TB Gold In-Tube Assay in Tuberculosis Contacts in a Low Incidence Area	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; WITHIN-SUBJECT VARIABILITY; LATENT TUBERCULOSIS; PREDICTIVE-VALUE; SKIN-TEST; MYCOBACTERIUM-TUBERCULOSIS; ACTIVE TUBERCULOSIS; IMMIGRANT CONTACTS; COST-EFFECTIVENESS; INFECTION	Background: QuantiFERON (R)-TB Gold in-Tube (QFT) assay is a recently developed test to assess latent tuberculosis infection in contagious tuberculosis (TB) contact subjects. To assess the QFT assay in recently exposed contacts of active tuberculosis patients in a French area with low TB incidence but high Bacille Calmette-Guerin coverage, and evaluate progression rates to TB disease. Methodology/Principal Findings: Between January 2007 and December 2009, 687 contacts of culture-confirmed tuberculosis cases underwent the QFT assay, with tuberculin skin test (TST) in 473, and a 34 months mean follow-up. Of 687 contacts, 148 were QFT positive, while 526 were negative and 13 indeterminate. QFT was positive in 35% of individuals with TST >= 10 mm, 47.5% with TST >= 15 mm or phlyctenular, but in 21% of cases in which two-step TST (M0 and M3) remained negative. Conversely, QFT was negative in 69% of cases with two-step TST showing conversion from negative to positive. All indeterminate QFT were associated with TST induration <10 mm in diameter. For 29 QFT-positive subjects, no chemoprophylaxis was given due to medical contraindications. Of the remaining 119 QFT-positive contacts, 97accepted chemoprophylaxis (81.5%), and 79 (81.4%) completed the treatment. Two contacts progressed to TB disease: one subject was QFT positive and had declined chemoprophylaxis, while the other one was QFT negative. QFT positive predictive value for progression to TB was 1.96% (1/51) with a 99.8% (525/526) negative predictive value. Conclusions/Significance: Our results confirm the safety of the QFT-based strategy for assessing the TB chemoprophylaxis indication, as only one contact developed TB disease out of 526 QFT-negative subjects.	[Bergot, Emmanuel; Haustraete, Eglantine; Magnier, Romain; Zalcman, Gerard] CHU Caen, Serv Pneumol, F-14000 Caen, France; [Bergot, Emmanuel; Zalcman, Gerard] CHU Caen, UMR Canc & Prevent 1086, F-14000 Caen, France; [Bergot, Emmanuel; Salauen, Marie-Anne] Ctr Prevent Malad Infect, Caen, France; [Malbruny, Brigitte] CHU Caen, Microbiol Serv, F-14000 Caen, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie	Bergot, E (corresponding author), CHU Caen, Serv Pneumol, F-14000 Caen, France.	bergot-e@chu-caen.fr	ZALCMAN, Gérard/L-7809-2015; ZALCMAN, Gerard/P-4150-2015; ZALCMAN, Gerard/M-8113-2019	ZALCMAN, Gérard/0000-0002-0343-9575; 	Regional Health Authority (DRASS); Centre de Prevention des Maladies Infectieuses (CPMI); Cellestis	Regional Health Authority (DRASS); Centre de Prevention des Maladies Infectieuses (CPMI); Cellestis	The Regional Health Authority (DRASS) and Centre de Prevention des Maladies Infectieuses (CPMI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. E. Bergot had three non-financially supported presentations for Cellestis scientific symposia, organized during French 2009 Annual Meeting of Pulmonology (CPLF), French 2009 Annual Meeting of Infectiology (JNI), and Specific French Cellestis meeting in Paris (2010). He also received partial financial compensation from Cellestis, for travel and accomodation for attending May 2009 International Meeting on IGRAs at Dubrovnik (Croatia). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. No other competing interest for the other authors.	Alfaro EM, 1998, MED CLIN-BARCELONA, V111, P401; *AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, pS221, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_; [Anonymous], 2001, MESURE COUVERTURE VA, P1; [Anonymous], 2007, MED MAL INFECT, V37, P689; [Anonymous], 2003, REV MAL RESPIR, V20, pS27; Arend SM, 2007, AM J RESP CRIT CARE, V175, P618, DOI 10.1164/rccm.200608-1099OC; Bradshaw L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020770; Deuffic-Burban S, 2010, INT J TUBERC LUNG D, V14, P471; Diel R, 2007, EUR RESPIR J, V30, P321, DOI 10.1183/09031936.00145906; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Diel R, 2012, CHEST; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Diel R, 2011, AM J RESP CRIT CARE, V183, P88, DOI 10.1164/rccm.201006-0974OC; Erkens CGM, 2010, EUR RESPIR J, V36, P925, DOI 10.1183/09031936.00201609; Figoni J, 2011, B EPIDEMIOL HEBD, V22, P258; Gershon AS, 2004, CLIN INFECT DIS, V39, P667, DOI 10.1086/422995; Kik SV, 2010, EUR RESPIR J, V35, P1346, DOI 10.1183/09031936.00098509; Kik SV, 2009, INT J TUBERC LUNG D, V13, P820; LoBue PA, 2003, AM J RESP CRIT CARE, V168, P443, DOI 10.1164/rccm.200303-390OC; Menzies D, 2004, AM J RESP CRIT CARE, V170, P445, DOI 10.1164/rccm.200404-478OC; Menzies D, 2008, ANN INTERN MED, V149, P689, DOI 10.7326/0003-4819-149-10-200811180-00003; Page KR, 2006, ARCH INTERN MED, V166, P1863, DOI 10.1001/archinte.166.17.1863; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Sauzullo I, 2011, TUBERCULOSIS, V91, P322, DOI 10.1016/j.tube.2011.05.004; van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517; van Zyl-Smit RN, 2009, AM J RESP CRIT CARE, V180, P49, DOI 10.1164/rccm.200811-1704OC; Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804	27	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43520	10.1371/journal.pone.0043520	http://dx.doi.org/10.1371/journal.pone.0043520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937059	Green Submitted, Green Published, gold			2022-12-25	WOS:000308225500060
J	Johannesson, B; Hirtz, S; Schatterny, J; Schultz, C; Mall, MA				Johannesson, Bjarki; Hirtz, Stephanie; Schatterny, Jolanthe; Schultz, Carsten; Mall, Marcus A.			CFTR Regulates Early Pathogenesis of Chronic Obstructive Lung Disease in beta ENaC-Overexpressing Mice	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; AIRWAY SURFACE LIQUID; EPITHELIAL NA+ CHANNEL; CYSTIC-FIBROSIS; ION-TRANSPORT; PULMONARY-DISEASE; MOUSE MODEL; EXPRESSION; MUCUS; INFLAMMATION	Background: Factors determining the onset and severity of chronic obstructive pulmonary disease remain poorly understood. Previous studies demonstrated that airway surface dehydration in beta ENaC-overexpressing (beta ENaC-Tg) mice on a mixed genetic background caused either neonatal mortality or chronic obstructive lung disease suggesting that the onset of lung disease was modulated by the genetic background. Methods: To test this hypothesis, we backcrossed beta ENaC-Tg mice onto two inbred strains (C57BL/6 and BALB/c) and studied effects of the genetic background on neonatal mortality, airway ion transport and airway morphology. Further, we crossed beta ENaC-Tg mice with CFTR-deficient mice to validate the role of CFTR in early lung disease. Results: We demonstrate that the C57BL/6 background conferred increased CFTR-mediated Cl- secretion, which was associated with decreased mucus plugging and mortality in neonatal beta ENaC-Tg C57BL/6 compared to beta ENaC-Tg BALB/c mice. Conversely, genetic deletion of CFTR increased early mucus obstruction and mortality in beta ENaC-Tg mice. Conclusions: We conclude that a decrease or absence of CFTR function in airway epithelia aggravates the severity of early airway mucus obstruction and related mortality in beta ENaC-Tg mice. These results suggest that genetic or environmental factors that reduce CFTR activity may contribute to the onset and severity of chronic obstructive pulmonary disease and that CFTR may serve as a novel therapeutic target.	[Johannesson, Bjarki; Hirtz, Stephanie; Schatterny, Jolanthe; Schultz, Carsten; Mall, Marcus A.] Heidelberg Univ, Dept Translat Pulmonol, Translat Lung Res Ctr Heidelberg TLRC, Heidelberg, Germany; [Mall, Marcus A.] Heidelberg Univ, Div Pediat Pulmonol & Allergy, Dept Pediat 3, Heidelberg, Germany; [Mall, Marcus A.] Heidelberg Univ, Cyst Fibrosis Ctr, Dept Pediat 3, Heidelberg, Germany; [Johannesson, Bjarki; Schultz, Carsten] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany; [Johannesson, Bjarki; Schultz, Carsten; Mall, Marcus A.] Heidelberg Univ, Mol Med Partnership Unit, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg	Johannesson, B (corresponding author), Heidelberg Univ, Dept Translat Pulmonol, Translat Lung Res Ctr Heidelberg TLRC, Heidelberg, Germany.	Marcus.Mall@med.uni-heidelberg.de	Mall, Marcus A./AAA-1498-2022	Mall, Marcus A./0000-0002-4057-2199; Schultz, Carsten/0000-0002-5824-2171	German Research Foundation [DFG MA 2081/3-3, MA 2081/4-1]; Federal Ministry of Education and Research (BMBF German Centre for Lung Research [DZL]); European Commission [MEXT-CT-2004-013666]	German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF German Centre for Lung Research [DZL]); European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by the German Research Foundation (DFG MA 2081/3-3 and MA 2081/4-1), the Federal Ministry of Education and Research (BMBF German Centre for Lung Research [DZL]), and the European Commission (MEXT-CT-2004-013666). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Anagnostopoulou P, 2010, EUR RESPIR J, V36, P1436, DOI 10.1183/09031936.00181209; Becq F, 2011, J CYST FIBROS, V10, pS129, DOI 10.1016/S1569-1993(11)60018-0; Bodas M, 2011, AM J PHYSIOL-LUNG C, V300, pL811, DOI 10.1152/ajplung.00408.2010; Bodas M, 2011, J IMMUNOL, V186, P602, DOI 10.4049/jimmunol.1002850; Boucher Richard C, 2004, Proc Am Thorac Soc, V1, P66, DOI 10.1513/pats.2306018; Cantin AM, 2006, AM J RESP CRIT CARE, V173, P1139, DOI 10.1164/rccm.200508-1330OC; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; Collawn JF, 2012, AM J PHYSIOL-LUNG C, V302, pL1141, DOI 10.1152/ajplung.00036.2012; Cookson William O C, 2011, Proc Am Thorac Soc, V8, P149, DOI 10.1513/pats.201101-003MS; Duerr J, 2011, AM J RESP CELL MOL, V44, P244, DOI 10.1165/rcmb.2009-0115OC; DUNNILL M. S., 1962, THORAX, V17, P320, DOI 10.1136/thx.17.4.320; GOODMAN RM, 1978, AM REV RESPIR DIS, V117, P205; Grubb BR, 2012, AM J PHYSIOL-LUNG C, V302, pL238, DOI 10.1152/ajplung.00083.2011; HARKEMA JR, 1987, J HISTOCHEM CYTOCHEM, V35, P279, DOI 10.1177/35.3.2434556; Hogg JC, 2009, ANNU REV PATHOL-MECH, V4, P435, DOI 10.1146/annurev.pathol.4.110807.092145; Hopf A, 1999, J BIOL CHEM, V274, P13894, DOI 10.1074/jbc.274.20.13894; KNOWLES MR, 1995, HUM GENE THER, V6, P445, DOI 10.1089/hum.1995.6.4-445; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Kunzelmann K, 2001, CLIN EXP PHARMACOL P, V28, P857, DOI 10.1046/j.1440-1681.2001.03541.x; Livraghi-Butrico A, 2012, PHYSIOL GENOMICS, V44, P470, DOI 10.1152/physiolgenomics.00185.2011; Mall M, 1996, FEBS LETT, V381, P47, DOI 10.1016/0014-5793(96)00079-8; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mall M, 1998, J CLIN INVEST, V102, P15, DOI 10.1172/JCI2729; Mall MA, 2008, J AEROSOL MED PULM D, V21, P13, DOI 10.1089/jamp.2007.0659; Mall MA, 2008, AM J RESP CRIT CARE, V177, P730, DOI 10.1164/rccm.200708-1233OC; Mall MA, 2010, J BIOL CHEM, V285, P26945, DOI 10.1074/jbc.M110.151803; Mall MA, 2009, EXP PHYSIOL, V94, P171, DOI 10.1113/expphysiol.2008.042994; McNicholas CM, 1997, J GEN PHYSIOL, V109, P681, DOI 10.1085/jgp.109.6.681; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Roth EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024445; Rubenstein RC, 2011, AM J PHYSIOL-LUNG C, V300, pL88, DOI 10.1152/ajplung.00142.2010; SCHERLE W, 1970, Mikroskopie, V26, P57; Silverman Edwin K, 2006, Proc Am Thorac Soc, V3, P405, DOI 10.1513/pats.200603-092AW; Sloane PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039809; Sly PD, 2009, AM J RESP CRIT CARE, V180, P146, DOI 10.1164/rccm.200901-0069OC; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; WELSH MJ, 1983, J CLIN INVEST, V71, P1614, DOI 10.1172/JCI110917; Welsh MJ, 2001, METABOLIC MOL BASES, P5121; Wielputz MO, 2011, EUR RESPIR J, V38, P1060, DOI 10.1183/09031936.00149810; ZHOU L, 1994, SCIENCE, V266, P1705, DOI 10.1126/science.7527588; Zhou Z, 2011, J CYST FIBROS, V10, pS172, DOI 10.1016/S1569-1993(11)60021-0; Zhou Z, 2008, AM J RESP CRIT CARE, V178, P1245, DOI 10.1164/rccm.200803-442OC	50	40	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e44059	10.1371/journal.pone.0044059	http://dx.doi.org/10.1371/journal.pone.0044059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937152	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500138
J	Sabag, AD; Bode, J; Fink, D; Kigel, B; Kugler, W; Neufeld, G				Sabag, Adi D.; Bode, Julia; Fink, Dorit; Kigel, Boaz; Kugler, Wilfried; Neufeld, Gera			Semaphorin-3D and Semaphorin-3E Inhibit the Development of Tumors from Glioblastoma Cells Implanted in the Cortex of the Brain	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ANGIOGENESIS; RECEPTORS; VEGF; NEUROPILIN-1; PROGRESSION; INDUCTION; APOPTOSIS; ISOFORM; GENE	Class-3 semaphorins are secreted axon guidance factors. Some of these semaphorins have recently been characterized as suppressors of tumor progression. To determine if class-3 semaphorins can be used to inhibit the development of glioblastoma-multiforme tumors, we expressed recombinant sema-3A, 3B, 3D, 3E, 3F or 3G in U87MG glioblastoma cells. Sema3A and sema3B expressing cells contracted and changed shape persistently while cells expressing other semaphorins did not. Sema3A and sema3F differed from other semaphorins including sema3B as they also inhibited the proliferation of the cells and the formation of soft agar colonies. With the exception of sema3G and sema3B, expression of these semaphorins in U87MG cells inhibited significantly tumor development from subcutaneously implanted cells. Strong inhibition of tumor development was also observed following implantation of U87MG cells expressing each of the class-3 semaphorins in the cortex of mouse brains. Sema3D and sema3E displayed the strongest inhibitory effects and their expression in U373MG or in U87MG glioblastoma cells implanted in the brains of mice prolonged the survival of the mice by more then two folds. Furthermore, most of the mice that died prior to the end of the experiment did not develop detectable tumors and many of the mice survived to the end of the experiment. Most of the semaphorins that we have used here with the exception of sema3D were characterized previously as inhibitors of angiogenesis. Our results indicate that sema3D also functions as an inhibitor of angiogenesis and suggest that the anti-tumorigenic effects are due primarily to inhibition of tumor angiogenesis. These results indicate that class-3 semaphorins such as sema3D and sema3E could perhaps be used to treat glioblastoma patients.	[Sabag, Adi D.; Fink, Dorit; Kigel, Boaz; Neufeld, Gera] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc Res & Vasc Biol Ctr, IL-31096 Haifa, Israel; [Bode, Julia; Kugler, Wilfried] Univ Gottingen, Dept Pediat Hematol & Oncol, Gottingen, Germany	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Gottingen	Sabag, AD (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc Res & Vasc Biol Ctr, POB 9649, IL-31096 Haifa, Israel.	wkugler@med.uni-goettingen.de; gera@tx.technion.ac.il	Neufeld, Gera/F-1524-2019	Bode, Julia/0000-0002-8081-2425	McDonnel Foundation; Israel-Germany Niedersachsen Foundation; Rappaport Institute for Medical Research	McDonnel Foundation; Israel-Germany Niedersachsen Foundation; Rappaport Institute for Medical Research	This work was funded by grants from the McDonnel Foundation (to GN), Israel-Germany Niedersachsen Foundation (to GN and WK) and the Rappaport Institute for Medical Research (to GN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo LM, 2008, BLOOD, V111, P2674, DOI 10.1182/blood-2007-08-110205; Akiri G, 2009, ONCOGENE, V28, P2163, DOI 10.1038/onc.2009.82; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Bagci T, 2009, ONCOGENE, V28, P3537, DOI 10.1038/onc.2009.204; Casazza A, 2012, EMBO MOL MED, V4, P234, DOI 10.1002/emmm.201100205; Casazza A, 2011, ARTERIOSCL THROM VAS, V31, P741, DOI 10.1161/ATVBAHA.110.211920; GitayGoren H, 1996, J BIOL CHEM, V271, P5519, DOI 10.1074/jbc.271.10.5519; Gluzman-Poltorak Z, 2000, J BIOL CHEM, V275, P18040, DOI 10.1074/jbc.M909259199; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Guttmann-Raviv N, 2007, J BIOL CHEM, V282, P26294, DOI 10.1074/jbc.M609711200; Kaur B, 2004, J NEURO-ONCOL, V70, P229, DOI 10.1007/s11060-004-2752-5; Kessler O, 2004, CANCER RES, V64, P1008, DOI 10.1158/0008-5472.CAN-03-3090; Kigel B, 2011, BLOOD, V118, P4285, DOI 10.1182/blood-2011-03-341388; Kigel B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003287; Maione F, 2009, J CLIN INVEST, V119, P3356, DOI 10.1172/JCI36308; Moriya J, 2010, CIRC RES, V106, P391, DOI 10.1161/CIRCRESAHA.109.210815; Neufeld G, 2002, TRENDS CARDIOVAS MED, V12, P13, DOI 10.1016/S1050-1738(01)00140-2; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Sakurai A, 2010, MOL CELL BIOL, V30, P3086, DOI 10.1128/MCB.01652-09; Salmaggi A, 2003, J NEURO-ONCOL, V62, P297, DOI 10.1023/A:1023367223575; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Sulpice E, 2008, BLOOD, V111, P2036, DOI 10.1182/blood-2007-04-084269; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tomizawa Y, 2001, P NATL ACAD SCI USA, V98, P13954, DOI 10.1073/pnas.231490898; Vacca A, 2006, BLOOD, V108, P1661, DOI 10.1182/blood-2006-04-014563; Vamesu S, 2007, Rom J Morphol Embryol, V48, P25; Varshavsky A, 2008, CANCER RES, V68, P6922, DOI 10.1158/0008-5472.CAN-07-5408; Vermeulen PB, 1996, EUR J CANCER, V32A, P2474, DOI 10.1016/S0959-8049(96)00379-6; Xiang RH, 2002, CANCER RES, V62, P2637	30	48	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42912	10.1371/journal.pone.0042912	http://dx.doi.org/10.1371/journal.pone.0042912			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936999	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500020
J	Divakaruni, AS; Humphrey, DM; Brand, MD				Divakaruni, Ajit S.; Humphrey, Dickon M.; Brand, Martin D.			Fatty Acids Change the Conformation of Uncoupling Protein 1 (UCP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWN-ADIPOSE-TISSUE; NUCLEOTIDE-BINDING; PROTON CONDUCTANCE; NONSHIVERING THERMOGENESIS; PURINE NUCLEOTIDES; MITOCHONDRIAL; MECHANISM; TRANSPORT; MEMBRANE; PROTEOLYSIS	UCP1 catalyzes proton leak across the mitochondrial inner membrane to disengage substrate oxidation from ATP production. It is well established that UCP1 is activated by fatty acids and inhibited by purine nucleotides, but precisely how this regulation occurs remains unsettled. Although fatty acids can competitively overcome nucleotide inhibition in functional assays, fatty acids have little effect on purine nucleotide binding. Here, we present the first demonstration that fatty acids induce a conformational change in UCP1. Palmitate dramatically changed the binding kinetics of 2'/3'-O-(N-methylanthraniloyl)-GDP, a fluorescently labeled nucleotide analog, for UCP1. Furthermore, palmitate accelerated the rate of enzymatic proteolysis of UCP1. The altered kinetics of both processes indicate that fatty acids change the conformation of UCP1, reconciling the apparent discrepancy between existing functional and ligand binding data. Our results provide a framework for how fatty acids and nucleotides compete to regulate the activity of UCP1.	[Divakaruni, Ajit S.; Humphrey, Dickon M.; Brand, Martin D.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Divakaruni, Ajit S.; Brand, Martin D.] Buck Inst Res Aging, Novato, CA 94945 USA	Buck Institute for Research on Aging	Divakaruni, AS (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	adivakaruni@ucsd.edu	Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153	National Institutes of Health [P01 AG025901, PL1 AG032118]; Medical Research Council (United Kingdom); British Marshall scholarship; National Science Foundation graduate research fellowship; NATIONAL INSTITUTE ON AGING [P01AG025901, PL1AG032118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Marshall scholarship; National Science Foundation graduate research fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 AG025901 and PL1 AG032118 (to M. D. B.). This work was also supported by the Medical Research Council (United Kingdom) and a British Marshall scholarship and a National Science Foundation graduate research fellowship (to A. S. D.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams AE, 2008, BBA-BIOENERGETICS, V1777, P115, DOI 10.1016/j.bbabio.2007.10.003; Aksamitiene E, 2007, ELECTROPHORESIS, V28, P3163, DOI 10.1002/elps.200700002; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Blesneac I, 2012, BBA-BIOMEMBRANES, V1818, P798, DOI 10.1016/j.bbamem.2011.12.016; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brand M. D., 1995, BIOENERGETICS, V154, P62; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Breen EP, 2006, J BIOL CHEM, V281, P2114, DOI 10.1074/jbc.M511575200; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carroll AM, 2005, J BIOL CHEM, V280, P15534, DOI 10.1074/jbc.M413315200; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; ECKERSKORN C, 1987, FEBS LETT, V226, P166, DOI 10.1016/0014-5793(87)80572-0; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Esteves TC, 2006, BIOCHEM J, V395, P619, DOI 10.1042/BJ20052004; Garlid KD, 1998, FEBS LETT, V438, P10, DOI 10.1016/S0014-5793(98)01246-0; Gonzalez-Barroso MM, 1998, J BIOL CHEM, V273, P15528, DOI 10.1074/jbc.273.25.15528; GORNALL AG, 1949, J BIOL CHEM, V177, P751; HEATON GM, 1978, EUR J BIOCHEM, V82, P515, DOI 10.1111/j.1432-1033.1978.tb12045.x; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Huang SG, 2003, ARCH BIOCHEM BIOPHYS, V420, P40, DOI 10.1016/j.abb.2003.07.005; HUANG SG, 1995, BIOCHEMISTRY-US, V34, P349, DOI 10.1021/bi00001a043; Huang SG, 1996, BIOCHEMISTRY-US, V35, P7846, DOI 10.1021/bi960244p; Hughes DA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-4; Jastroch M, 2007, J COMP PHYSIOL B, V177, P743, DOI 10.1007/s00360-007-0171-6; Jekabsons MB, 2002, BIOCHEM J, V366, P565, DOI 10.1042/BJ20020469; JEZEK P, 1994, J BIOL CHEM, V269, P26184; Khailova LS, 2006, BBA-BIOENERGETICS, V1757, P1324, DOI 10.1016/j.bbabio.2006.04.024; KLINGENBERG M, 1988, BIOCHEMISTRY-US, V27, P781, DOI 10.1021/bi00402a044; KLINGENBERG M, 1985, EMBO J, V4, P3087, DOI 10.1002/j.1460-2075.1985.tb04049.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN CS, 1982, BIOCHEMISTRY-US, V21, P2950, DOI 10.1021/bi00541a023; LIN CS, 1980, FEBS LETT, V113, P299, DOI 10.1016/0014-5793(80)80613-2; MARTY I, 1992, BIOCHEMISTRY-US, V31, P4058, DOI 10.1021/bi00131a023; Parker N, 2008, BIOCHEM J, V412, P131, DOI 10.1042/BJ20080006; Parker N, 2009, J BIOENERG BIOMEMBR, V41, P335, DOI 10.1007/s10863-009-9232-8; REYNAFARJE B, 1985, ANAL BIOCHEM, V145, P406, DOI 10.1016/0003-2697(85)90381-1; RIAL E, 1983, EUR J BIOCHEM, V137, P197, DOI 10.1111/j.1432-1033.1983.tb07815.x; RICHIERI GV, 1993, BIOCHEMISTRY-US, V32, P7574, DOI 10.1021/bi00080a032; Saito S, 2008, GENE, V408, P37, DOI 10.1016/j.gene.2007.10.018; Shabalina IG, 2004, J BIOL CHEM, V279, P38236, DOI 10.1074/jbc.M402375200; Stuart JA, 2001, BIOCHEM J, V356, P779, DOI 10.1042/0264-6021:3560779; WINKLER E, 1994, J BIOL CHEM, V269, P2508	43	37	38	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36845	36853		10.1074/jbc.M112.381780	http://dx.doi.org/10.1074/jbc.M112.381780			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22952235	hybrid, Green Published			2022-12-25	WOS:000310588500021
J	Por, ED; Bierbower, SM; Berg, KA; Gomez, R; Akopian, AN; Wetsel, WC; Jeske, NA				Por, Elaine D.; Bierbower, Sonya M.; Berg, Kelly A.; Gomez, Ruben; Akopian, Armen N.; Wetsel, William C.; Jeske, Nathaniel A.			beta-Arrestin-2 Desensitizes the Transient Receptor Potential Vanilloid 1 (TRPV1) Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CAPSAICIN-ACTIVATED CURRENTS; BETA-ARRESTIN RECRUITMENT; BONE CANCER PAIN; SENSORY NEURONS; BETA-2-ADRENERGIC RECEPTOR; PKA PHOSPHORYLATION; COUPLED RECEPTORS; ERK1/2 ACTIVATION; AGONIST AFFINITY	Transient receptor potential vanilloid 1 (TRPV1) is a nonselective cation channel activated by multiple stimuli and is implicated in a variety of pain disorders. Dynamic sensitization of TRPV1 activity by A-kinase anchoring protein 150 demonstrates a critical role for scaffolding proteins in nociception, yet few studies have investigated scaffolding proteins capable of mediating receptor desensitization. In this study, we identify beta-arrestin-2 as a scaffolding protein that regulates TRPV1 receptor activity. We report beta-arrestin-2 association with TRPV1 in multiple cell models. Moreover, siRNA-mediated knockdown of beta-arrestin-2 in primary cultures resulted in a significant increase in both initial and repeated responses to capsaicin. Electrophysiological analysis further revealed significant deficits in TRPV1 desensitization in primary cultures from beta-arrestin-2 knock-out mice compared with wild type. In addition, we found that beta-arrestin-2 scaffolding of phosphodiesterase PDE4D5 to the plasma membrane was required for TRPV1 desensitization. Importantly, inhibition of PDE4D5 activity reversed beta-arrestin-2 desensitization of TRPV1. Together, these results identify a new endogenous scaffolding mechanism that regulates TRPV1 ligand binding and activation.	[Gomez, Ruben; Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Oral & Maxillofacial Surg, San Antonio, TX 78229 USA; [Por, Elaine D.; Berg, Kelly A.; Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Bierbower, Sonya M.; Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Akopian, Armen N.] Univ Texas Hlth Sci Ctr San Antonio, Dept Endodont, San Antonio, TX 78229 USA; [Wetsel, William C.] Duke Univ, Dept Psychiat & Behav Sci Cell Biol & Neurobiol, Durham, NC 27710 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Duke University	Jeske, NA (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Oral & Maxillofacial Surg, MC 7908,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	jeske@UTHSCSA.edu		Por, Elaine/0000-0001-8025-5713	National Institutes of Health [T32 HL07446-29, R21 NS055835, F31 DE022517-01, RO1 NS061884]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F31DE022517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061884, R01NS055835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 HL07446-29 (to S. M. B.), R21 NS055835 (to K. A. B.), F31 DE022517-01 (to E. D. P), and RO1 NS061884 (to N. A. J.).	Baillie GS, 2007, BIOCHEM J, V404, P71, DOI 10.1042/BJ20070005; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Bohn LM, 2002, J NEUROSCI, V22, P10494; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; Dasgupta P, 2006, J CLIN INVEST, V116, P3083, DOI 10.1172/JCI28164C1; DeFea KA, 2011, CELL SIGNAL, V23, P621, DOI 10.1016/j.cellsig.2010.10.004; Docherty RJ, 1996, PFLUG ARCH EUR J PHY, V431, P828, DOI 10.1007/BF02332166; Ghilardi JR, 2005, J NEUROSCI, V25, P3126, DOI 10.1523/JNEUROSCI.3815-04.2005; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Houslay MD, 2005, BIOCHEM SOC T, V33, P1333, DOI 10.1042/BST0331333; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Jala VR, 2005, J BIOL CHEM, V280, P4880, DOI 10.1074/jbc.M409821200; Jeske NA, 2008, PAIN, V138, P604, DOI 10.1016/j.pain.2008.02.022; Jeske NA, 2006, J BIOL CHEM, V281, P32879, DOI 10.1074/jbc.M603220200; Jeske NA, 2009, PAIN, V146, P301, DOI 10.1016/j.pain.2009.08.002; Jeske NA, 2009, J NEUROCHEM, V108, P591, DOI 10.1111/j.1471-4159.2008.05779.x; Jin SLC, 1998, J BIOL CHEM, V273, P19672, DOI 10.1074/jbc.273.31.19672; Jung JY, 2004, J BIOL CHEM, V279, P7048, DOI 10.1074/jbc.M311448200; Key TA, 2003, J BIOL CHEM, V278, P4041, DOI 10.1074/jbc.M204687200; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Li X, 2006, BIOCHEM J, V394, P427, DOI 10.1042/BJ20051560; Li X, 2009, J BIOL CHEM, V284, P16170, DOI 10.1074/jbc.M109.008078; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lin FT, 1998, J BIOL CHEM, V273, P31640, DOI 10.1074/jbc.273.48.31640; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; LOHSE MJ, 1992, J BIOL CHEM, V267, P8558; Luttrell LM, 1997, ADV SEC MESS PHOSPH, V31, P263; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Mandadi S, 2004, CELL CALCIUM, V35, P471, DOI 10.1016/j.ceca.2003.11.003; Mohapatra DP, 2005, J BIOL CHEM, V280, P13424, DOI 10.1074/jbc.M410917200; Mohapatra DP, 2003, J BIOL CHEM, V278, P50080, DOI 10.1074/jbc.M306619200; Mohapatra DP, 2003, MOL CELL NEUROSCI, V23, P314, DOI 10.1016/S1044-7431(03)00054-X; Mundell SJ, 2000, J BIOL CHEM, V275, P12900, DOI 10.1074/jbc.275.17.12900; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Patwardhan AM, 2006, P NATL ACAD SCI USA, V103, P11393, DOI 10.1073/pnas.0603861103; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Schnizler K, 2008, J NEUROSCI, V28, P4904, DOI 10.1523/JNEUROSCI.0233-08.2008; Sevcik MA, 2005, PAIN, V115, P128, DOI 10.1016/j.pain.2005.02.022; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shukla AK, 2010, J BIOL CHEM, V285, P30115, DOI 10.1074/jbc.M110.141549; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Studer M, 2010, J PHYSIOL-LONDON, V588, P3743, DOI 10.1113/jphysiol.2010.190611; SZALLASI A, 1990, BRAIN RES, V524, P106, DOI 10.1016/0006-8993(90)90498-Z; SZALLASI A, 1990, LIFE SCI, V47, P1399, DOI 10.1016/0024-3205(90)90518-V; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tominaga M, 2005, PFLUG ARCH EUR J PHY, V451, P143, DOI 10.1007/s00424-005-1457-8; Tominaga Makoto, 2004, Novartis Found Symp, V261, P4; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Vogler O, 1999, J BIOL CHEM, V274, P12333, DOI 10.1074/jbc.274.18.12333; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Zhang XM, 2008, NEURON, V59, P450, DOI 10.1016/j.neuron.2008.05.015	60	34	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37552	37563		10.1074/jbc.M112.391847	http://dx.doi.org/10.1074/jbc.M112.391847			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22952227	Green Published, hybrid			2022-12-25	WOS:000310588500083
J	Payne, CM; Baban, J; Horn, SJ; Backe, PH; Arvai, AS; Dalhus, B; Bjoras, M; Eijsink, VGH; Sorlie, M; Beckham, GT; Vaaje-Kolstad, G				Payne, Christina M.; Baban, Jamil; Horn, Svein J.; Backe, Paul H.; Arvai, Andrew S.; Dalhus, Bjorn; Bjoras, Magnar; Eijsink, Vincent G. H.; Sorlie, Morten; Beckham, Gregg T.; Vaaje-Kolstad, Gustav			Hallmarks of Processivity in Glycoside Hydrolases from Crystallographic and Computational Studies of the Serratia marcescens Chitinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI CELLOBIOHYDROLASE; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; FAMILY-18 CHITINASE; BIOMASS RECALCITRANCE; CATALYTIC MECHANISM; AROMATIC RESIDUES; ACTIVE-SITE; DEGRADATION; RESOLUTION	Degradation of recalcitrant polysaccharides in nature is typically accomplished by mixtures of processive and nonprocessive glycoside hydrolases (GHs), which exhibit synergistic activity wherein nonprocessive enzymes provide new sites for productive attachment of processive enzymes. GH processivity is typically attributed to active site geometry, but previous work has demonstrated that processivity can be tuned by point mutations or removal of single loops. To gain additional insights into the differences between processive and nonprocessive enzymes that give rise to their synergistic activities, this study reports the crystal structure of the catalytic domain of the GH family 18 nonprocessive endochitinase, ChiC, from Serratia marcescens. This completes the structural characterization of the co-evolved chitinolytic enzymes from this bacterium and enables structural analysis of their complementary functions. The ChiC catalytic module reveals a shallow substrate-binding cleft that lacks aromatic residues vital for processivity, a calcium-binding site not previously seen in GH18 chitinases, and, importantly, a displaced catalytic acid (Glu-141), suggesting flexibility in the catalytic center. Molecular dynamics simulations of two processive chitinases (ChiA and ChiB), the ChiC catalytic module, and an endochitinase from Lactococcus lactis show that the nonprocessive enzymes have more flexible catalytic machineries and that their bound ligands are more solvated and flexible. These three features, which relate to the more dynamic on-off ligand binding processes associated with nonprocessive action, correlate to experimentally measured differences in processivity of the S. marcescens chitinases. These newly defined hallmarks thus appear to be key dynamic metrics in determining processivity in GH enzymes complementing structural insights.	[Beckham, Gregg T.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Payne, Christina M.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Baban, Jamil; Horn, Svein J.; Eijsink, Vincent G. H.; Sorlie, Morten; Vaaje-Kolstad, Gustav] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway; [Backe, Paul H.; Dalhus, Bjorn; Bjoras, Magnar] Natl Hosp Norway, Dept Microbiol, Oslo Univ Hosp, N-0424 Oslo, Norway; [Backe, Paul H.; Dalhus, Bjorn; Bjoras, Magnar] Natl Hosp Norway, Dept Med Biochem, Oslo Univ Hosp, N-0424 Oslo, Norway; [Arvai, Andrew S.] Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Beckham, Gregg T.] Colorado Sch Mines, Dept Chem Engn, Golden, CO 80401 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Norwegian University of Life Sciences; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; Scripps Research Institute; Colorado School of Mines	Beckham, GT (corresponding author), Natl Renewable Energy Lab, Natl Bioenergy Ctr, 15013 Denver W Pkwy,MS 3322, Golden, CO 80401 USA.	gregg.beckham@nrel.gov; gustko@umb.no	Horn, Svein Jarle/C-6258-2008; Payne, Christina M/C-7338-2011; Bjørås, Magnar/N-9286-2017; Dalhus, Bjørn/AAK-2895-2020; Payne, Christina/ABE-8330-2020	Horn, Svein Jarle/0000-0002-1590-9001; Payne, Christina M/0000-0001-5264-0964; Payne, Christina/0000-0001-5264-0964; Vaaje-Kolstad, Gustav/0000-0002-3077-8003	Norwegian Research Council [218425, 186946, 196885, 209335]; United States Department of Energy; South-Eastern Norway Regional Health Authority [2009100, 2011040]; United States Office of Energy Efficiency and Renewable Energy [DE-AC36-08GO28308]; Texas Advanced Computing Center Ranger cluster; National Institute for Computational Sciences Kraken cluster under the National Science Foundation XSEDE [MCB090159]	Norwegian Research Council(Research Council of NorwayEuropean Commission); United States Department of Energy(United States Department of Energy (DOE)); South-Eastern Norway Regional Health Authority; United States Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE)); Texas Advanced Computing Center Ranger cluster; National Institute for Computational Sciences Kraken cluster under the National Science Foundation XSEDE	Supported by the Norwegian Research Council (Grant 218425) and the United States Department of Energy Biomass Program.; Supported by the Norwegian Research Council (Grants 186946, 196885, and 209335).; Supported by the South-Eastern Norway Regional Health Authority (Grants 2009100 and 2011040 for establishing the Regional Core Facility for Structural Biology and Bioinformatics).; Computer time for this research was provided by the National Renewable Energy Laboratory Computational Sciences Center supported by the United States Office of Energy Efficiency and Renewable Energy under Contract Number DE-AC36-08GO28308 and by the Texas Advanced Computing Center Ranger cluster and the National Institute for Computational Sciences Kraken cluster under the National Science Foundation XSEDE Grant MCB090159. We are grateful to the beamline staff at the ESRF, Grenoble, France for providing assistance in using beamline ID14-2.	Aronson NN, 2006, BIOSCI BIOTECH BIOCH, V70, P243, DOI 10.1271/bbb.70.243; Aronson NN, 2003, BIOCHEM J, V376, P87, DOI 10.1042/bj20030273; Baban J, 2010, J PHYS CHEM B, V114, P6144, DOI 10.1021/jp909801x; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Bokma E, 2002, EUR J BIOCHEM, V269, P893, DOI 10.1046/j.0014-2956.2001.02721.x; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brameld KA, 1998, J AM CHEM SOC, V120, P3571, DOI 10.1021/ja972282h; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brurberg MB, 1996, MICROBIOL-SGM, V142, P1581, DOI 10.1099/13500872-142-7-1581; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 2000, BIOCHEM J, V348, P201, DOI 10.1042/0264-6021:3480201; Demain AL, 2005, MICROBIOL MOL BIOL R, V69, P124, DOI 10.1128/MMBR.69.1.124-154.2005; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Eijsink VGH, 2008, TRENDS BIOTECHNOL, V26, P228, DOI 10.1016/j.tibtech.2008.02.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Guimaraes BG, 2002, J MOL BIOL, V320, P587, DOI 10.1016/S0022-2836(02)00497-7; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2006, BIOCATAL BIOTRANSFOR, V24, P39, DOI 10.1080/10242420500518482; Horn SJ, 2006, FEBS J, V273, P491, DOI 10.1111/j.1742-4658.2005.05079.x; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Houston DR, 2004, J MED CHEM, V47, P5713, DOI 10.1021/jm049940a; Houston DR, 2002, BIOCHEM J, V368, P23, DOI 10.1042/BJ20021034; Houston DR, 2002, P NATL ACAD SCI USA, V99, P9127, DOI 10.1073/pnas.132060599; Hsieh YC, 2010, J BIOL CHEM, V285, P31603, DOI 10.1074/jbc.M110.149310; Hult EL, 2005, BIOCHEM J, V388, P851, DOI 10.1042/BJ20050090; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Koivula A, 1998, FEBS LETT, V429, P341, DOI 10.1016/S0014-5793(98)00596-1; Medie FM, 2012, NAT REV MICROBIOL, V10, P227, DOI 10.1038/nrmicro2729; MEINKE A, 1995, J BIOL CHEM, V270, P4383, DOI 10.1074/jbc.270.9.4383; Murphy L, 2012, J BIOL CHEM, V287, P1252, DOI 10.1074/jbc.M111.276485; Nakamura T, 2007, ACTA CRYSTALLOGR F, V63, P7, DOI 10.1107/S1744309106051773; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Nimlos MR, 2012, J BIOL CHEM, V287, P20603, DOI 10.1074/jbc.M112.358184; Norberg AL, 2010, FEBS LETT, V584, P4581, DOI 10.1016/j.febslet.2010.10.017; Pages S, 2001, J BIOL CHEM, V276, P33652, DOI 10.1074/jbc.M105770200; Payne CM, 2011, J BIOL CHEM, V286, P41028, DOI 10.1074/jbc.M111.297713; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Proctor MR, 2005, P NATL ACAD SCI USA, V102, P2697, DOI 10.1073/pnas.0500051102; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; Sikorski P, 2006, BIOCHEMISTRY-US, V45, P9566, DOI 10.1021/bi060370l; Stern R, 2008, CHEM REV, V108, P5061, DOI 10.1021/cr078240l; Suzuki K, 1999, BIOCHEM J, V343, P587, DOI 10.1042/0264-6021:3430587; Synstad B, 2004, EUR J BIOCHEM, V271, P253, DOI 10.1046/j.1432-1033.2003.03923.x; Synstad B, 2008, BIOSCI BIOTECH BIOCH, V72, P715, DOI 10.1271/bbb.70594; Tews I, 1997, J AM CHEM SOC, V119, P7954, DOI 10.1021/ja970674i; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2004, J BIOL CHEM, V279, P3612, DOI 10.1074/jbc.M310057200; Vaaje-Kolstad G, 2004, BBA-PROTEINS PROTEOM, V1696, P103, DOI 10.1016/j.bbapap.2003.09.014; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; VANSCHELTINGA ACT, 1994, STRUCTURE, V2, P1181, DOI 10.1016/S0969-2126(94)00120-0; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Vuong TV, 2009, APPL ENVIRON MICROB, V75, P6655, DOI 10.1128/AEM.01260-09; Watanabe T, 1997, J BACTERIOL, V179, P7111, DOI 10.1128/jb.179.22.7111-7117.1997; WATANABE T, 1994, J BACTERIOL, V176, P4465, DOI 10.1128/JB.176.15.4465-4472.1994; Watanabe T, 2003, BIOCHEM J, V376, P237, DOI 10.1042/BJ20030419; Zakariassen H, 2009, J BIOL CHEM, V284, P10610, DOI 10.1074/jbc.M900092200	68	76	76	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36322	36330		10.1074/jbc.M112.402149	http://dx.doi.org/10.1074/jbc.M112.402149			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22952223	hybrid, Green Published			2022-12-25	WOS:000310364000053
J	Zhang, T; Mu, YG				Zhang, Tong; Mu, Yuguang			Initial Binding of Ions to the Interhelical Loops of Divalent Ion Transporter CorA: Replica Exchange Molecular Dynamics Simulation Study	PLOS ONE			English	Article							MAGNESIUM TRANSPORT; CRYSTAL-STRUCTURE; MG2+; CHEMISTRY; CATION; DNA	Crystal structures of Thermotoga maritima magnesium transporter CorA, reported in 2006, revealed its homo-pentameric constructions. However, the structure of the highly conserved extracellular interhelical loops remains unsolved, due to its high flexibility. We have explored the configurations of the loops through extensive replica exchange molecular dynamics simulations in explicit solvent model with the presence of either Co(III) Hexamine ions or Mg2+ ions. We found that there are multiple binding sites available on the interhelical loops in which the negatively charged residues, E316 and E320, are located notably close to the positively charged ions during the simulations. Our simulations resolved the distinct binding patterns of the two kinds of ions: Co(III) Hexamine ions were found to bind stronger with the loop than Mg2+ ions with binding free energy -7.3 kJ/mol lower, which is nicely consistent with the previous data. Our study provides an atomic basis description of the initial binding process of Mg2+ ions on the extracellular interhelical loops of CorA and the detailed inhibition mechanism of Co(III) Hexamine ions on CorA ions transportation.	[Zhang, Tong; Mu, Yuguang] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Zhang, T (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	ygmu@ntu.edu.sg		Zhang, Tong/0000-0003-1011-5189; Zhang, Tong/0000-0002-2046-4502	Nanyang Technological University Tier 1 grant [RG23/11]; Info-communications Development Authority of Singapore Cloud Computing Call 4	Nanyang Technological University Tier 1 grant(Nanyang Technological University); Info-communications Development Authority of Singapore Cloud Computing Call 4	This work is supported by Nanyang Technological University Tier 1 grant RG23/11 and the Info-communications Development Authority of Singapore Cloud Computing Call 4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELYAEV ND, 1988, MOL BIOL+, V22, P1332; Case D, 2006, AMBER 9; Cheatham TE, 1997, STRUCTURE, V5, P1297, DOI 10.1016/S0969-2126(97)00282-7; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Dalmas O, 2010, STRUCTURE, V18, P868, DOI 10.1016/j.str.2010.04.009; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; Eshaghi S, 2006, SCIENCE, V313, P354, DOI 10.1126/science.1127121; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Hansmann UHE, 1997, CHEM PHYS LETT, V281, P140, DOI 10.1016/S0009-2614(97)01198-6; HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HMIEL SP, 1986, J BACTERIOL, V168, P1444, DOI 10.1128/jb.168.3.1444-1450.1986; Hu J, 2009, J BIOL CHEM, V284, P15619, DOI 10.1074/jbc.M901581200; Kiriukhin MY, 2002, BIOPHYS CHEM, V99, P155, DOI 10.1016/S0301-4622(02)00153-9; Kucharski LM, 2000, J BIOL CHEM, V275, P16767, DOI 10.1074/jbc.M001507200; Lunin VV, 2006, NATURE, V440, P833, DOI 10.1038/nature04642; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; Moomaw AS, 2010, BIOCHEMISTRY-US, V49, P5998, DOI 10.1021/bi1005656; Niegowski D, 2007, CELL MOL LIFE SCI, V64, P2564, DOI 10.1007/s00018-007-7174-z; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Payandeh J, 2006, EMBO J, V25, P3762, DOI 10.1038/sj.emboj.7601269; Pittman YR, 2006, J BIOL CHEM, V281, P19457, DOI 10.1074/jbc.M601076200; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Shao Y, 2006, PHYS CHEM CHEM PHYS, V8, P3172, DOI 10.1039/b517914a; SILVER S, 1969, P NATL ACAD SCI USA, V62, P764, DOI 10.1073/pnas.62.3.764; Smith RL, 1998, MOL MICROBIOL, V28, P217, DOI 10.1046/j.1365-2958.1998.00810.x; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Xia Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.222166	32	8	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43872	10.1371/journal.pone.0043872	http://dx.doi.org/10.1371/journal.pone.0043872			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952795	Green Published, gold			2022-12-25	WOS:000308206500025
J	Colas, S; Afoufa-Bastien, D; Jacquens, L; Clement, C; Baillieul, F; Mazeyrat-Gourbeyre, F; Monti-Dedieu, L				Colas, Steven; Afoufa-Bastien, Damien; Jacquens, Lucile; Clement, Christophe; Baillieul, Fabienne; Mazeyrat-Gourbeyre, Florence; Monti-Dedieu, Laurence			Expression and In Situ Localization of Two Major PR Proteins of Grapevine Berries during Development and after UV-C Exposition	PLOS ONE			English	Article							THAUMATIN-LIKE PROTEINS; DEFENSE-RELATED PROTEINS; PROTEOMIC ANALYSIS; GENE-EXPRESSION; STRUCTURAL-ANALYSIS; XYLEM SAP; CHITINASE; FRUIT; ACCUMULATION; PURIFICATION	In grapevine Vitis vinifera L. cv Pinot noir, the Pathogenesis-Related (PR) proteins CHI4D and TL3 are among the most abundant extractable PR proteins of ripe berries and accumulate during berry ripening from veraison until full maturation. Evidence was supplied in favor of the involvement of these two protein families in plant defense mechanisms and plant development. In order to better understand CHI4D and TL3 function in grapevine, we analyzed their temporal and spatial pattern of expression during maturation and after an abiotic stress (UV-C) by in situ hybridization (ISH) and immunohistolocalization. In ripening berries, CHI4D and TL3 genes were mainly expressed in the exocarp and around vascular bundles of the mesocarp. In UV-C exposed berries, CHI4D and TL3 gene expression was strongly induced before veraison. Corresponding proteins localized in the exocarp and, to a lesser extent, around vascular bundles of the mesocarp. The spatial and temporal accumulation of the two PR proteins during berry maturation and after an abiotic stress is discussed in relation to their putative roles in plant defense.	[Colas, Steven; Afoufa-Bastien, Damien; Jacquens, Lucile; Clement, Christophe; Baillieul, Fabienne; Mazeyrat-Gourbeyre, Florence; Monti-Dedieu, Laurence] Univ Reims, UFR Sci Exactes & Nat, Lab Stress Def & Reprod Plantes, Unite Rech Vignes & Vins Champagne,EA 4707, Reims, France	Universite de Reims Champagne-Ardenne	Colas, S (corresponding author), Univ Reims, UFR Sci Exactes & Nat, Lab Stress Def & Reprod Plantes, Unite Rech Vignes & Vins Champagne,EA 4707, BP 1039, Reims, France.	florence.gourbeyre@univ-reims.fr		JACQUENS, Lucile/0000-0001-7102-5836	Champagne Ardenne Area; FEDER (Fonds Europeen de Developpement Regional)	Champagne Ardenne Area; FEDER (Fonds Europeen de Developpement Regional)(European Commission)	This work was supported by a fund from the Champagne Ardenne Area and the FEDER (Fonds Europeen de Developpement Regional). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad LR, 1996, PLANT SCI, V118, P11, DOI 10.1016/0168-9452(96)04420-2; Aguero CB, 2008, AM J ENOL VITICULT, V59, P306; Anzlovar S, 2003, PLANT BIOLOGY, V5, P116, DOI 10.1055/s-2003-40723; Barre A, 2000, PLANTA, V211, P791, DOI 10.1007/s004250000354; Castro AJ, 2005, J EXP BOT, V56, P2783, DOI 10.1093/jxb/eri271; Castro AJ, 2008, PHYSIOL PLANTARUM, V134, P453, DOI 10.1111/j.1399-3054.2008.01151.x; Chatelet DS, 2011, ANN BOT-LONDON, V108, P73, DOI 10.1093/aob/mcr106; CHELLEMI DO, 1992, AM J ENOL VITICULT, V43, P53; Choudhury SR, 2009, PLANT CELL REP, V28, P1641, DOI 10.1007/s00299-009-0764-5; Colas S, 2010, METHODOLOGIES AND RESULTS IN GRAPEVINE RESEARCH, P361, DOI 10.1007/978-90-481-9283-0_26; Dafoe NJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-191; Dafoe NJ, 2009, PHYTOCHEMISTRY, V70, P856, DOI 10.1016/j.phytochem.2009.04.016; Davies C, 2000, PLANT PHYSIOL, V122, P803, DOI 10.1104/pp.122.3.803; DELP CJ, 1954, PHYTOPATHOLOGY, V44, P615; Derckel JP, 1996, PLANT SCI, V119, P31, DOI 10.1016/0168-9452(96)04459-7; Derckel JP, 1998, PHYSIOL PLANTARUM, V104, P56, DOI 10.1034/j.1399-3054.1998.1040108.x; Deytieux C, 2007, J EXP BOT, V58, P1851, DOI 10.1093/jxb/erm049; Dhekney SA, 2011, IN VITRO CELL DEV-PL, V47, P458, DOI 10.1007/s11627-011-9358-3; Edreva A., 2005, General and Applied Plant Physiology, V31, P105; Elad Y., 2004, BOTRYTIS BIOL PATHOL, P119, DOI [10.1007/978-1-4020-2626-3, DOI 10.1007/978-1-4020-2626-3]; Fey SJ, 1997, ELECTROPHORESIS, V18, P1361, DOI 10.1002/elps.1150180811; FilsLycaon BR, 1996, PLANT PHYSIOL, V111, P269, DOI 10.1104/pp.111.1.269; GIANINAZZI S, 1970, CR ACAD SCI D NAT, V270, P2383; Goni O, 2010, POSTHARVEST BIOL TEC, V55, P169, DOI 10.1016/j.postharvbio.2009.11.001; GRAHAM LS, 1994, CAN J BOT, V72, P1057, DOI 10.1139/b94-132; Grenier J, 1999, PLANT J, V19, P473, DOI 10.1046/j.1365-313X.1999.00551.x; Grimplet J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-187; Jacobs AK, 1999, PLANT PATHOL, V48, P325, DOI 10.1046/j.1365-3059.1999.00343.x; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; Kavroulakis N, 2006, ANN BOT-LONDON, V98, P555, DOI 10.1093/aob/mcl149; Kim YS, 2002, PLANT MOL BIOL, V49, P125, DOI 10.1023/A:1014995732171; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Libantova J, 2009, MOL BIOL REP, V36, P851, DOI 10.1007/s11033-008-9254-z; Liljeroth E, 2005, J PHYTOPATHOL, V153, P702, DOI 10.1111/j.1439-0434.2005.01043.x; Liu JJ, 2010, PLANT CELL REP, V29, P419, DOI 10.1007/s00299-010-0826-8; Manteau S, 2003, AM J ENOL VITICULT, V54, P267; Manteau S, 2003, THESIS U REIMS CHAMP; MAUCH F, 1989, PLANT CELL, V1, P447, DOI 10.2307/3869105; Meier U., 2001, BBCH MONOGRAFIE, P93; Monteiro S, 2003, PHYTOPATHOLOGY, V93, P1505, DOI 10.1094/PHYTO.2003.93.12.1505; Monteiro S, 2003, J AGR FOOD CHEM, V51, P4046, DOI 10.1021/jf020456v; Negri AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-378; Nobrega FM, 2005, PLANT SOIL, V272, P223, DOI 10.1007/s11104-004-4954-1; Palmisano G, 2010, J PROTEOME RES, V9, P6148, DOI 10.1021/pr100298j; Petit AN, 2009, J EXP BOT, V60, P1155, DOI 10.1093/jxb/ern361; Peumans WJ, 2000, EUR J BIOCHEM, V267, P1188, DOI 10.1046/j.1432-1327.2000.01117.x; Pezet R, 2004, ADV PLANT PHYSIOL, V7, P71; Pocock K. F., 1998, Australian Journal of Grape and Wine Research, V4, P23, DOI 10.1111/j.1755-0238.1998.tb00131.x; Pocock KF, 2000, J AGR FOOD CHEM, V48, P1637, DOI 10.1021/jf9905626; Rep M, 2002, PLANT PHYSIOL, V130, P904, DOI 10.1104/pp.007427; Robert N, 2002, PLANT SCI, V162, P389, DOI 10.1016/S0168-9452(01)00576-3; Robinson SP, 1997, PLANT PHYSIOL, V114, P771, DOI 10.1104/pp.114.3.771; Roper MC, 2011, MOL PLANT PATHOL, V12, P628, DOI [10.1111/j.1364-3703.2010.00698.x, 10.1111/J.1364-3703.2010.00698.X]; Salzman RA, 1998, PLANT PHYSIOL, V117, P465, DOI 10.1104/pp.117.2.465; Sarry JE, 2004, PROTEOMICS, V4, P201, DOI 10.1002/pmic.200300499; Sassa H, 1998, PLANTA, V205, P514, DOI 10.1007/s004250050350; Seo PJ, 2008, PLANT CELL PHYSIOL, V49, P334, DOI 10.1093/pcp/pcn011; Taira T, 2005, BIOSCI BIOTECH BIOCH, V69, P852, DOI 10.1271/bbb.69.852; Tattersall DB, 1997, PLANT PHYSIOL, V114, P759, DOI 10.1104/pp.114.3.759; ten Have A, 2010, FUNGAL GENET BIOL, V47, P53, DOI 10.1016/j.fgb.2009.10.008; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; VANLOON LC, 1970, VIROLOGY, V40, P199, DOI 10.1016/0042-6822(70)90395-8; Waters EJ, 1996, J AGR FOOD CHEM, V44, P3, DOI 10.1021/jf9505584; Waters EJ, 1998, J AGR FOOD CHEM, V46, P4950, DOI 10.1021/jf980421o; Yamamoto T, 2000, PLANT CELL REP, V19, P639, DOI 10.1007/s002999900174; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716	66	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43681	10.1371/journal.pone.0043681	http://dx.doi.org/10.1371/journal.pone.0043681			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937077	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500079
J	Han, XB; Tachado, SD; Koziel, H; Boisvert, WA				Han, Xinbing; Tachado, Souvenir D.; Koziel, Henry; Boisvert, William A.			Leu128(3.43) (L128) and Val247(6.40) (V247) of CXCR1 Are Critical Amino Acid Residues for G Protein Coupling and Receptor Activation	PLOS ONE			English	Article							SMALL-MOLECULE ANTAGONISTS; CHEMOKINE RECEPTORS; CONSTITUTIVE ACTIVATION; CRYSTAL-STRUCTURE; IN-VITRO; INTERLEUKIN-8; IDENTIFICATION; RHODOPSIN; TARGETS; BINDING	CXCR1, a classic GPCR that binds IL-8, plays a key role in neutrophil activation and migration by activating phospholipase C (PLC)beta through G alpha(15) and G alpha(i) which generates diacylglycerol and inositol phosphates (IPs). In this study, two conserved amino acid residues of CXCR1 on the transmembrane domain (TM) 3 and TM6, Leu128(3.43) (L128) and Val247(6.40) (V247), respectively, were selectively substituted with other amino acids to investigate the role of these conserved residues in CXCR1 activation. Although two selective mutants on Leu128, Leu128Ala (L128A) and Leu128Arg (L128R), demonstrated high binding affinity to IL-8, they were not capable of coupling to G proteins and consequently lost the functional response of the receptors. By contrast, among the four mutants at residue Val247 (TM6.40), replacing Val247 with Ala (V247A) and Asn (V247N) led to constitutive activation of mutant receptors when cotransfected with G alpha(15). The V247N mutant also constitutively activated the G alpha(i) protein. These results indicate that L128 on TM3.43 is involved in G protein coupling and receptor activation but is unimportant for ligand binding. On the other hand, V247 on TM6.40 plays a critical role in maintaining the receptor in the inactive state, and the substitution of V247 impaired the receptor constraint and stabilized an active conformation. Functionally, there was an increase in chemotaxis in response to IL-8 in cells expressing V247A and V247N. Our findings indicate that Leu128(3.43) and Val247(6.40) are critical for G protein coupling and activation of signaling effectors, providing a valuable insight into the mechanism of CXCR1 activation.	[Han, Xinbing; Tachado, Souvenir D.; Koziel, Henry] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Sch Med, Boston, MA 02215 USA; [Han, Xinbing; Boisvert, William A.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Vasc Med, Cambridge, MA 02138 USA; [Boisvert, William A.] Univ Hawaii, Cardiovasc Res Ctr, John A Burns Sch Med, Honolulu, HI 96822 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Hawaii System	Han, XB (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Sch Med, Boston, MA 02215 USA.	xhan@rics.bwh.harvard.edu; wab@hawaii.edu		Tachado, Souvenir/0000-0002-8368-6102	National Institutes of Health [R01HL081863, R01HL075677, R01HL063655, R01HL092811]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092811, R01HL063655, R01HL081863, R01HL075677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health grants (R01HL081863 and R01HL075677 to WAB, R01HL063655 to HK, and R01HL092811 to ST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker RA, 2008, MOL PHARMACOL, V73, P94, DOI 10.1124/mol.107.038547; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; Bergin DA, 2010, J CLIN INVEST, V120, P4236, DOI 10.1172/JCI41196; Bertini R, 2004, P NATL ACAD SCI USA, V101, P11791, DOI 10.1073/pnas.0402090101; Bizzarri C, 2006, PHARMACOL THERAPEUT, V112, P139, DOI 10.1016/j.pharmthera.2006.04.002; Burke SM, 2008, BLOOD, V111, P5467, DOI 10.1182/blood-2007-10-118547; Burnett LA, 2010, J BIOL CHEM, V285, P33662, DOI 10.1074/jbc.M110.156075; Busch-Petersen J, 2006, CURR TOP MED CHEM, V6, P1345, DOI 10.2174/15680266106061345; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Damaj BB, 1996, FASEB J, V10, P1426, DOI 10.1096/fasebj.10.12.8903513; Feniger-Barish R, 1999, CYTOKINE, V11, P996, DOI 10.1006/cyto.1999.0510; Fuhrer D, 1997, J CLIN ENDOCR METAB, V82, P4234, DOI 10.1210/jc.82.12.4234; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Han M, 1998, BIOCHEMISTRY-US, V37, P8253, DOI 10.1021/bi980147r; Han XB, 2009, J BIOL CHEM, V284, P32950, DOI 10.1074/jbc.M109.040899; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Jiao XM, 2005, MOL CELL BIOL, V25, P5752, DOI 10.1128/MCB.25.13.5752-5762.2005; Joseph PRB, 2010, J BIOL CHEM, V285, P29262, DOI 10.1074/jbc.M110.146555; Kim JM, 2004, P NATL ACAD SCI USA, V101, P12508, DOI 10.1073/pnas.0404519101; Latronico AC, 2007, MOL CELL ENDOCRINOL, V260, P287, DOI 10.1016/j.mce.2005.11.053; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Luttichau HR, 2010, J BIOL CHEM, V285, P9137, DOI 10.1074/jbc.M109.002774; Munoz LM, 2009, J IMMUNOL, V183, P7337, DOI 10.4049/jimmunol.0901802; Milligan G, 1996, TRENDS PHARMACOL SCI, V17, P235, DOI 10.1016/0165-6147(96)10026-2; Moukhametzianov R, 2011, P NATL ACAD SCI USA, V108, P8228, DOI 10.1073/pnas.1100185108; Nasser MW, 2007, J BIOL CHEM, V282, P6906, DOI 10.1074/jbc.M610289200; Nasser MW, 2009, J IMMUNOL, V183, P3425, DOI 10.4049/jimmunol.0900305; Nicholls DJ, 2008, MOL PHARMACOL, V74, P1193, DOI 10.1124/mol.107.044610; Panina P, 2006, CURR DRUG TARGETS, V7, P669, DOI 10.2174/138945006777435272; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Rajagopalan L, 2004, J BIOL CHEM, V279, P30000, DOI 10.1074/jbc.M313883200; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Richardson RM, 2003, J IMMUNOL, V170, P2904, DOI 10.4049/jimmunol.170.6.2904; Robinson SW, 1996, J NEUROCHEM, V67, P212; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sabroe I, 2007, NAT MED, V13, P1417, DOI 10.1038/nm1207-1417; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shamaladevi N, 2009, CANCER RES, V69, P8265, DOI 10.1158/0008-5472.CAN-09-0374; Sharma B, 2010, EXPERT OPIN THER TAR, V14, P435, DOI 10.1517/14728221003652471; Singh RK, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-57; Singh S, 2009, BRIT J CANCER, V100, P1638, DOI 10.1038/sj.bjc.6605055; Singh S, 2009, CLIN CANCER RES, V15, P2380, DOI 10.1158/1078-0432.CCR-08-2387; Snelgrove RJ, 2011, EUR J PHARMACOL, V667, P1, DOI 10.1016/j.ejphar.2011.05.073; Spalding TA, 1998, J BIOL CHEM, V273, P21563, DOI 10.1074/jbc.273.34.21563; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Stillie R, 2009, J LEUKOCYTE BIOL, V86, P529, DOI 10.1189/jlb.0208125; Tao YX, 2008, PHARMACOL THERAPEUT, V120, P129, DOI 10.1016/j.pharmthera.2008.07.005; Tharp WG, 2006, J LEUKOCYTE BIOL, V79, P539, DOI 10.1189/jlb.0905516; Vauquelin G, 2005, FUND CLIN PHARMACOL, V19, P45, DOI 10.1111/j.1472-8206.2005.00319.x; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; White CD, 2008, MOL ENDOCRINOL, V22, P2520, DOI 10.1210/me.2008-0122; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840; Xie W, 1997, J BIOL CHEM, V272, P24948, DOI 10.1074/jbc.272.40.24948; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Zhao XX, 2009, J IMMUNOL, V182, P3213, DOI 10.4049/jimmunol.0800551	60	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42765	10.1371/journal.pone.0042765	http://dx.doi.org/10.1371/journal.pone.0042765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936990	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500016
J	Lu, K; Chakroborty, D; Sarkar, C; Lu, TT; Xie, ZL; Liu, ZF; Basu, S				Lu, Kai; Chakroborty, Debanjan; Sarkar, Chandrani; Lu, Tingting; Xie, Zhiliang; Liu, Zhongfa; Basu, Sujit			Triphala and Its Active Constituent Chebulinic Acid Are Natural Inhibitors of Vascular Endothelial Growth Factor-A Mediated Angiogenesis	PLOS ONE			English	Article							AYURVEDIC FORMULATION; ELLAGIC ACID; GALLIC ACID; CANCER; PERMEABILITY; CELLS; BIOAVAILABILITY; COMPOUND; DISEASE; BREAST	Triphala churna (THL) is a combination of three fruits that has been used for many years in India for the treatment of various diseases. There are now reports which indicate that THL can inhibit growth of malignant tumors in animals. However, the mechanisms by which THL mediates its anti-tumor actions are still being explored. Because vascular endothelial growth factor-A (VEGF) induced angiogenesis plays a critical role in the pathogenesis of cancer, we therefore investigated whether tumor inhibitory effects of THL or its active constituents are through suppression of VEGF actions. We herein report that THL and chebulinic (CI) present in THL can significantly and specifically inhibit VEGF induced angiogenesis by suppressing VEGF receptor-2 (VEGFR-2) phosphorylation. These results are of clinical significance as these inexpensive and non-toxic natural products can be used for the prevention and treatment of diseases where VEGF induced angiogenesis has an important role.	[Lu, Kai; Chakroborty, Debanjan; Sarkar, Chandrani; Lu, Tingting; Basu, Sujit] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Xie, Zhiliang; Liu, Zhongfa] Ohio State Univ, Coll Pharm, Div Pharmaceut, Columbus, OH 43210 USA; [Liu, Zhongfa; Basu, Sujit] Ohio State Univ, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Basu, Sujit] Ohio State Univ, Dorthy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Lu, K (corresponding author), Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA.	sujit.basu@osumc.edu	Liu, Zhongfa/G-8549-2013		National Institutes of Health, United States of America [R01 CA124763]; NATIONAL CANCER INSTITUTE [R01CA124763] Funding Source: NIH RePORTER	National Institutes of Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health, United States of America Grant R01 CA124763 to SB. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonescu CR, 2009, CANCER RES, V69, P7175, DOI 10.1158/0008-5472.CAN-09-2068; Baliga MS, 2010, J ALTERN COMPLEM MED, V16, P1301, DOI 10.1089/acm.2009.0633; Basu S, 2001, NAT MED, V7, P569, DOI 10.1038/87895; Bhattacharya Resham, 2008, J Mol Signal, V3, P14, DOI 10.1186/1750-2187-3-14; Blanchet B, 2010, EXPERT OPIN DRUG SAF, V9, P275, DOI 10.1517/14740330903510608; Chakroborty D, 2011, P NATL ACAD SCI USA, V108, P20730, DOI 10.1073/pnas.1108696108; Deep G, 2005, J EXP CLIN CANC RES, V24, P555; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663; Ferruzzi MG, 2009, J ALZHEIMERS DIS, V18, P113, DOI 10.3233/JAD-2009-1135; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Hussain S, 2008, ANGIOGENESIS, V11, P245, DOI 10.1007/s10456-008-9108-2; Istivan TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024809; Konishi Y, 2004, J AGR FOOD CHEM, V52, P2527, DOI 10.1021/jf035366k; Kumar B, 2011, ANGIOGENESIS, V14, P371, DOI 10.1007/s10456-011-9221-5; Labrecque L, 2005, CARCINOGENESIS, V26, P821, DOI 10.1093/carcin/bgi024; Li LX, 2011, APPL ENVIRON MICROB, V77, P2640, DOI 10.1128/AEM.01460-10; London CA, 2003, CANCER GENE THER, V10, P823, DOI 10.1038/sj.cgt.7700642; Mulder K, 2011, EXPERT OPIN BIOL TH, V11, P405, DOI 10.1517/14712598.2011.557657; Nadler E, 2006, ONCOLOGIST, V11, P90, DOI 10.1634/theoncologist.11-2-90; Pal S, 2000, MICROVASC RES, V60, P112, DOI 10.1006/mvre.2000.2246; Pawar V, 2009, INDIAN J PHARM SCI, V71, P382, DOI 10.4103/0250-474X.57286; Pyun BJ, 2008, CANCER RES, V68, P227, DOI 10.1158/0008-5472.CAN-07-2799; Ribatti D, 2006, NAT PROTOC, V1, P85, DOI 10.1038/nprot.2006.13; Russell LH, 2011, ANTICANCER RES, V31, P3739; Sandhya T, 2006, CANCER LETT, V231, P206, DOI 10.1016/j.canlet.2005.01.035; Sarkar C, 2008, CLIN CANCER RES, V14, P2502, DOI 10.1158/1078-0432.CCR-07-1778; Seeram NP, 2004, CLIN CHIM ACTA, V348, P63, DOI 10.1016/j.cccn.2004.04.029; Shi Y, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-294; Singh DP, 2008, PHYTOCHEM ANALYSIS, V19, P164, DOI 10.1002/pca.1032; SMART RC, 1986, CARCINOGENESIS, V7, P1663, DOI 10.1093/carcin/7.10.1663; Wang ZY, 2012, EXPERT OPIN THER TAR, V16, pS79, DOI 10.1517/14728222.2011.642371; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421	33	32	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43934	10.1371/journal.pone.0043934	http://dx.doi.org/10.1371/journal.pone.0043934			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937129	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500125
J	Manceau, V; Kremmer, E; Nabel, EG; Maucuer, A				Manceau, Valerie; Kremmer, Elisabeth; Nabel, Elizabeth G.; Maucuer, Alexandre			The Protein Kinase KIS Impacts Gene Expression during Development and Fear Conditioning in Adult Mice	PLOS ONE			English	Article							SPLICING FACTOR SF1; PREPULSE INHIBITION; RNA; SCHIZOPHRENIA; RECOGNITION; SUSCEPTIBILITY; COMPLEX; UHMK1; U2AF; TRANSCRIPTION	The brain-enriched protein kinase KIS (product of the gene UHMK1) has been shown to phosphorylate the human splicing factor SF1 in vitro. This phosphorylation in turn favors the formation of a U2AF(65)-SF1-RNA complex which occurs at the 3' end of introns at an early stage of spliceosome assembly. Here, we analyzed the effects of KIS knockout on mouse SF1 phosphorylation, physiology, adult behavior, and gene expression in the neonate brain. We found SF1 isoforms are differently expressed in KIS-ko mouse brains and fibroblasts. Re-expression of KIS in fibroblasts restores a wild type distribution of SF1 isoforms, confirming the link between KIS and SF1. Microarray analysis of transcripts in the neonate brain revealed a subtle down-regulation of brain specific genes including cys-loop ligand-gated ion channels and metabolic enzymes. Q-PCR analyses confirmed these defects and point to an increase of pre-mRNA over mRNA ratios, likely due to changes in splicing efficiency. While performing similarly in prepulse inhibition and most other behavioral tests, KIS-ko mice differ in spontaneous activity and contextual fear conditioning. This difference suggests that disregulation of gene expression due to KIS inactivation affects specific brain functions.	[Manceau, Valerie; Maucuer, Alexandre] INSERM, UMR S 839, Paris, France; [Manceau, Valerie; Maucuer, Alexandre] Univ Paris 06, Paris, France; [Manceau, Valerie; Maucuer, Alexandre] Inst Fer Moulin, Paris, France; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Inst Mol Immunol, Munich, Germany; [Nabel, Elizabeth G.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Nabel, Elizabeth G.] Harvard Univ, Sch Med, Boston, MA USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Manceau, V (corresponding author), INSERM, UMR S 839, Paris, France.	alexandre.maucuer@inserm.fr	Maucuer, Alexandre/B-1069-2019	Maucuer, Alexandre/0000-0003-2947-6654	Institut National de la Sante et de la Recherche Medicale (INSERM); University Pierre et Marie Curie; Brain and Behavior Research Foundation	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University Pierre et Marie Curie; Brain and Behavior Research Foundation	This work was funded by the Institut National de la Sante et de la Recherche Medicale (INSERM), the University Pierre et Marie Curie and The Brain and Behavior Research Foundation (NARSAD 2007 award to AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abovich N, 1997, CELL, V89, P403, DOI 10.1016/S0092-8674(00)80221-4; Alexander R, 2010, BIOCHEM SOC T, V38, P1251, DOI 10.1042/BST0381251; Arning S, 1996, RNA, V2, P794; Begou M, 2008, NEUROSCIENCE, V157, P29, DOI 10.1016/j.neuroscience.2008.07.080; Berglund JA, 1997, CELL, V89, P781, DOI 10.1016/S0092-8674(00)80261-5; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; Betcheva ET, 2009, J HUM GENET, V54, P98, DOI 10.1038/jhg.2008.14; Bieche I, 2003, MOL BRAIN RES, V114, P55, DOI 10.1016/S0169-328X(03)00132-3; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Bristow GC, 2009, BRAIN RES, V1301, P197, DOI 10.1016/j.brainres.2009.08.090; Caldwell BD, 1999, J BIOL CHEM, V274, P34646, DOI 10.1074/jbc.274.49.34646; Cambray S, 2009, MOL CELL BIOL, V29, P726, DOI 10.1128/MCB.01180-08; Dumaine A, 2011, PSYCHIAT GENET, V21, P315, DOI 10.1097/YPG.0b013e3283458a37; Ferguson RE, 2005, PROTEOMICS, V5, P566, DOI 10.1002/pmic.200400941; Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752; Guth S, 2000, J BIOL CHEM, V275, P38059, DOI 10.1074/jbc.M001483200; Joyce CJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-203; Kent OA, 2003, J BIOL CHEM, V278, P50572, DOI 10.1074/jbc.M307976200; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; KRAMER A, 1991, EMBO J, V10, P1503, DOI 10.1002/j.1460-2075.1991.tb07670.x; KRAMER A, 1992, MOL CELL BIOL, V12, P4545; Langenickel TH, 2008, J CLIN INVEST, V118, P3848, DOI 10.1172/JCI33206; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Manceau V, 2006, FEBS J, V273, P577, DOI 10.1111/j.1742-4658.2005.05091.x; Manceau V, 2008, J MOL BIOL, V381, P748, DOI 10.1016/j.jmb.2008.06.026; Maucuer A, 1997, J BIOL CHEM, V272, P23151, DOI 10.1074/jbc.272.37.23151; MAUCUER A, 1995, P NATL ACAD SCI USA, V92, P3100, DOI 10.1073/pnas.92.8.3100; Mazroui R, 1999, RNA, V5, P1615, DOI 10.1017/S1355838299991872; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Powell SB, 2009, BEHAV BRAIN RES, V204, P282, DOI 10.1016/j.bbr.2009.04.021; Puri V, 2008, EUR J HUM GENET; Puri V, 2007, BIOL PSYCHIAT, V61, P873, DOI 10.1016/j.biopsych.2006.06.014; Qiu Z, 2008, NEURON, V60, P449, DOI 10.1016/j.neuron.2008.10.039; Rutz B, 2000, EMBO J, V19, P1873, DOI 10.1093/emboj/19.8.1873; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; Shitashige M, 2007, CANCER SCI, V98, P1862, DOI 10.1111/j.1349-7006.2007.00629.x; Spooren W, 2004, PSYCHOPHARMACOLOGY, V175, P99, DOI 10.1007/s00213-004-1785-y; Steiger JL, 2004, PHARMACOL THERAPEUT, V101, P259, DOI 10.1016/j.pharmthera.2003.12.002; Tanackovic G, 2005, MOL BIOL CELL, V16, P1366, DOI 10.1091/mbc.E04-11-1034; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Valjent E, 2006, P NATL ACAD SCI USA, V103, P2932, DOI 10.1073/pnas.0511030103; Zhu R, 2010, CANCER RES, V70, P7264, DOI 10.1158/0008-5472.CAN-10-0820	42	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43946	10.1371/journal.pone.0043946	http://dx.doi.org/10.1371/journal.pone.0043946			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937132	Green Submitted, gold, Green Published			2022-12-25	WOS:000308225500127
J	Okamoto, H; Matsumi, Y; Hoshikawa, Y; Takubo, K; Ryoke, K; Shiota, G				Okamoto, Hideharu; Matsumi, Yoshiaki; Hoshikawa, Yoshiko; Takubo, Kazuko; Ryoke, Kazuo; Shiota, Goshi			Involvement of MicroRNAs in Regulation of Osteoblastic Differentiation in Mouse Induced Pluripotent Stem Cells	PLOS ONE			English	Article							OSTERIX EXPRESSION; RUNX2 EXPRESSION; IN-VITRO; DLX5; MSX2; ACTIVATION; OSTEOGENESIS; COMMITMENT; PROTEINS; PATHWAY	Backgoround: MicroRNAs (miRNAs), which regulate biological processes by annealing to the 3'-untranslated region (3'-UTR) of mRNAs to reduce protein synthesis, have been the subject of recent attention as a key regulatory factor in cell differentiation. The effects of some miRNAs during osteoblastic differentiation have been investigated in mesenchymal stem cells, however they still remains to be determined in pluripotent stem cells. Methodology/Principal Findings: Bone morphogenic proteins (BMPs) are potent activators of osteoblastic differentiation. In the present study, we profiled miRNAs during osteoblastic differentiation of mouse induced pluripotent stem (iPS) cells by BMP-4, in which expression of important osteoblastic markers such as Rux2, osterix, osteopontin, osteocalcin, PTHR1 and RANKL were significantly increased. A miRNA array analysis revealed that six miRNAs including miR-10a, miR-10b, miR-19b, miR-9-3p, miR-124a and miR-181a were significantly downregulated. Interestingly, miR-124a and miR-181a directly target the transcription factors Dlx5 and Msx2, both of which were increased by about 80-and 30-fold, respectively. In addition, transfection of miR-124a and miR-181a into mouse osteo-progenitor MC3T3-E1 cells significantly reduced expression of Dlx5, Runx2, osteocalcin and ALP, and Msx2 and osteocalcin, respectively. Finally, transfection of the anti-miRNAs of these six miRNAs, which are predicted to target Dlx5 and Msx2, into mouse iPS cells resulted in a significant increase in several osteoblastic differentiation markers such as Rux2, Msx2 and osteopontin. Conclusions/Significance: In the present study, we demonstrate that six miRNAs including miR-10a, miR-10b, miR-19b, miR9-3p, miR-124a and miR-181a miRNAs, especially miR-124a and miR-181a, are important regulatory factors in osteoblastic differentiation of mouse iPS cells.	[Okamoto, Hideharu; Matsumi, Yoshiaki; Hoshikawa, Yoshiko; Shiota, Goshi] Tottori Univ, Div Mol & Genet Med, Dept Genet Med & Regenerat Therapeut, Grad Sch Med, Yonago, Tottori, Japan; [Okamoto, Hideharu; Takubo, Kazuko; Ryoke, Kazuo] Tottori Univ, Fac Med, Div Oral & Maxillofacial Biopathol Surg, Dept Med Sensory & Motor Organs,Sch Med, Yonago, Tottori 683, Japan	Tottori University; Tottori University	Okamoto, H (corresponding author), Tottori Univ, Div Mol & Genet Med, Dept Genet Med & Regenerat Therapeut, Grad Sch Med, Yonago, Tottori, Japan.	gshiota@med.tottori-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [23792280]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Grant-in-Aid for Young Scientists (B) (23792280) from The Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Bellido T, 1997, ENDOCRINOLOGY, V138, P3666, DOI 10.1210/en.138.9.3666; Bilousova G, 2011, STEM CELLS, V29, P206, DOI 10.1002/stem.566; Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200; Dani C, 1997, J CELL SCI, V110, P1279; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Gotoh M, 2002, EUR J PHARMACOL, V451, P19, DOI 10.1016/S0014-2999(02)02183-0; Guan YJ, 2011, FASEB J, V25, P4457, DOI 10.1096/fj.11-185132; Hassan MQ, 2007, MOL CELL BIOL, V27, P3337, DOI 10.1128/MCB.01544-06; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Hu R, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176099; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Itoh T, 2009, J BIOL CHEM, V284, P19272, DOI 10.1074/jbc.M109.014001; Karbiener M, 2011, RNA BIOL, V8, P850, DOI 10.4161/rna.8.5.16153; Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mizuno Y, 2008, BIOCHEM BIOPH RES CO, V368, P267, DOI 10.1016/j.bbrc.2008.01.073; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Rendl M, 2008, GENE DEV, V22, P543, DOI 10.1101/gad.1614408; Shirakabe K, 2001, GENES CELLS, V6, P851, DOI 10.1046/j.1365-2443.2001.00466.x; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Tokuzawa Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001019; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Wang F, 2011, CELL RES, V21, P1196, DOI 10.1038/cr.2011.79; Wu XW, 2007, ANN NY ACAD SCI, V1116, P29, DOI 10.1196/annals.1402.053; Yang L, 2012, J BONE MINER RES, V27, P1598, DOI 10.1002/jbmr.1621; Yoshizawa T, 2004, MOL CELL BIOL, V24, P3460, DOI 10.1128/MCB.24.8.3460-3472.2004; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018	43	48	49	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43800	10.1371/journal.pone.0043800	http://dx.doi.org/10.1371/journal.pone.0043800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937097	Green Published, Green Submitted, gold			2022-12-25	WOS:000308225500099
J	Volpato, V; Macchiarelli, R; Guatelli-Steinberg, D; Fiore, I; Bondioli, L; Frayer, DW				Volpato, Virginie; Macchiarelli, Roberto; Guatelli-Steinberg, Debbie; Fiore, Ivana; Bondioli, Luca; Frayer, David W.			Hand to Mouth in a Neandertal: Right-Handedness in Regourdou 1	PLOS ONE			English	Article							HUMAN ANTERIOR TEETH; BILATERAL ASYMMETRY; MODERN HUMANS; ATAPUERCA; MIDDLE; EVOLUTION; SIERRA; SIMA; STRIATIONS; LANGUAGE	We describe and analyze a Neandertal postcranial skeleton and dentition, which together show unambiguous signs of right-handedness. Asymmetries between the left and right upper arm in Regourdou 1 were identified nearly 20 years ago, then confirmed by more detailed analyses of the inner bone structure for the clavicle, humerus, radius and ulna. The total pattern of all bones in the shoulder and arm reveals that Regourdou 1 was a right-hander. Confirmatory evidence comes from the mandibular incisors, which display a distinct pattern of right oblique scratches, typical of right-handed manipulations performed at the front of the mouth. Regourdou's right handedness is consistent with the strong pattern of manual lateralization in Neandertals and further confirms a modern pattern of left brain dominance, presumably signally linguistic competence. These observations along with cultural, genetic and morphological evidence indicate language competence in Neandertals and their European precursors.	[Volpato, Virginie] Senckenberg Res Inst Frankfurt, Dept Paleoanthropol & Messel Res, Frankfurt, Germany; [Macchiarelli, Roberto] MNHN, UMR 7194, Dept Prehist, Paris, France; [Macchiarelli, Roberto] Univ Poitiers, Dept Geosci, Poitiers, France; [Guatelli-Steinberg, Debbie] Ohio State Univ, Dept Anthropol, Columbus, OH 43210 USA; [Fiore, Ivana; Bondioli, Luca; Frayer, David W.] Soprintendenza Museo Nazl Preistor Etnog L Pigori, Rome, Italy; [Frayer, David W.] Univ Kansas, Dept Anthropol, Lawrence, KS 66045 USA	Senckenberg Gesellschaft fur Naturforschung (SGN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Universite de Poitiers; University System of Ohio; Ohio State University; University of Kansas	Volpato, V (corresponding author), Senckenberg Res Inst Frankfurt, Dept Paleoanthropol & Messel Res, Frankfurt, Germany.	frayer@ku.edu		Bondlioli, Luca/0000-0002-8511-7667; Fiore, Ivana/0000-0001-5721-0760	TNT European project; French CNRS; Region Poitou-Charentes; Nespos Society; Leakey Foundation	TNT European project; French CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Poitou-Charentes(Region Nouvelle-Aquitaine); Nespos Society; Leakey Foundation	The TNT European project, French CNRS, Region Poitou-Charentes, Nespos Society, and Leakey Foundation provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JE, 1972, HUMAN SKELETON; Bax JS, 1999, INT J OSTEOARCHAEOL, V9, P189, DOI 10.1002/(SICI)1099-1212(199905/06)9:3<189::AID-OA474>3.0.CO;2-N; Bayle P., 2011, WISSENSCHAFTLICHE SC, P29; BEDNARIK RG, 1992, CAMB ARCHAEOL J, V2, P27; Blackburn A, 2011, AM J PHYS ANTHROPOL, V145, P639, DOI 10.1002/ajpa.21555; BONIFAY E, 1962, CR HEBD ACAD SCI, V255, P1635; Brace CL, 1991, STATES HUMAN EVOLUTI; Caron F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021545; Cashmore L, 2009, ANN HUM BIOL, V36, P624, DOI 10.1080/03014460902956733; Cashmore L, 2008, J ANTHROPOL SCI, V86, P7; Cavanhie N., 2009, PALEO, V21, P39, DOI DOI 10.4000/PALEO.1742; Chapelain AS, 2011, INT J PRIMATOL, V32, P491, DOI 10.1007/s10764-010-9484-5; Churchill SE, 1997, INT J OSTEOARCHAEOL, V7, P18, DOI 10.1002/(SICI)1099-1212(199701)7:1<18::AID-OA303>3.0.CO;2-R; Corballis MC, 1997, PSYCHOL REV, V104, P714, DOI 10.1037/0033-295X.104.4.714; de Lumley MA, 1973, ETUDES Q, V2, P1; DECASTRO JMB, 1988, J HUM EVOL, V17, P403, DOI 10.1016/0047-2484(88)90029-2; Dubois J, 2009, CEREB CORTEX, V19, P414, DOI 10.1093/cercor/bhn097; Fisher J.W., 1995, J ARCHAEOL METHOD TH, V2, P7, DOI [10.1007/bf02228434, DOI 10.1007/BF02228434]; FLANDER LB, 1978, AM J PHYS ANTHROPOL, V49, P103, DOI 10.1002/ajpa.1330490116; Fox CL, 1997, INT J OSTEOARCHAEOL, V7, P133, DOI 10.1002/(SICI)1099-1212(199703)7:2<133::AID-OA326>3.0.CO;2-4; Frayer DW, 2006, PERIOD BIOL, V108, P519; Frayer DW, 2012, LATERALITY, V17, P51, DOI 10.1080/1357650X.2010.529451; Frayer DW, 2010, J ANTHROPOL SCI, V88, P113; Frayer DW, 2000, ORIGINS OF MUSIC, P217; Froehle Andrew W., 2009, Paleoanthropology, V2009, P96; HARDYCK C, 1975, HUM BIOL, V47, P369; Hayden B, 2012, OXFORD J ARCHAEOL, V31, P1, DOI 10.1111/j.1468-0092.2011.00376.x; Henri-Martin H, 1923, HOMMES FOSSILES QUIN; Hepper PG, 2005, NEUROPSYCHOLOGIA, V43, P313, DOI 10.1016/j.neuropsychologia.2004.08.009; Hepper PG, 1998, NEUROPSYCHOLOGIA, V36, P531, DOI 10.1016/S0028-3932(97)00156-5; HEPPER PG, 1991, NEUROPSYCHOLOGIA, V29, P1107, DOI 10.1016/0028-3932(91)90080-R; Holloway R.L., 1985, P319; Kasprian G, 2011, CEREB CORTEX, V21, P1076, DOI 10.1093/cercor/bhq179; Koby F. E., 1956, Verhandlungen der Naturforschenden Gesellschaft in Basel, V67, P1; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; Lalueza-Fox C., 1992, INT J OSTEOARCHAEOL, V2, P155, DOI DOI 10.1002/0A.1390020207; Lazuen T, 2012, J ARCHAEOL SCI, V39, P2304, DOI 10.1016/j.jas.2012.02.032; Lozano M, 2008, J HUM EVOL, V55, P713, DOI 10.1016/j.jhevol.2008.04.007; Lozano M, 2009, EVOL HUM BEHAV, V30, P369, DOI 10.1016/j.evolhumbehav.2009.03.001; Lozano-Ruiz M, 2004, J ARCHAEOL SCI, V31, P1127, DOI 10.1016/j.jas.2004.02.005; Lyman R.L., 1994, CAMBRIDGE MANUALS AR; Madelaine S., 2008, PALEO, V20, P101; Martinez I, 2008, J HUM EVOL, V54, P118, DOI 10.1016/j.jhevol.2007.07.006; Martinez I, 2004, P NATL ACAD SCI USA, V101, P9976, DOI 10.1073/pnas.0403595101; Martinez I, 2009, ANTHROPOLOGIE, V113, P255, DOI 10.1016/j.anthro.2009.01.003; Maureille B, 2001, PALEO, V13, P183, DOI DOI 10.4000/PALEO.1043; McGrew WC, 1997, YEARB PHYS ANTHROPOL, V40, P201; McManus IC, 2009, LANGUAGE LATERALIZATION AND PSYCHOSIS, P37, DOI 10.1017/CBO9780511576744.004; McManus IC, 1992, HDB NEUROPSYCHOLOGY, V6, P116; Meyer V, 2011, AM J PHYS ANTHROPOL, V144, P214; MOLNAR S, 1971, AM J PHYS ANTHROPOL, V34, P175, DOI 10.1002/ajpa.1330340204; Morin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032856; OLSEN LS, 1988, J ARCHAEOL SCI, V15, P335; Patte E., 1960, ANTHROPOL, V64, P512; PERELLE IB, 1994, BEHAV GENET, V24, P217, DOI 10.1007/BF01067189; Peresani M, 2011, P NATL ACAD SCI USA, V108, P3888, DOI 10.1073/pnas.1016212108; Puech PF, 1987, HOMINIDAE, P247; Roebroeks W, 2012, P NATL ACAD SCI USA, V109, P1889, DOI 10.1073/pnas.1112261109; RUFF CB, 2008, BIOL ANTHR HUMAN SKE, P183, DOI DOI 10.1002/9780470245842.CH6; Shaw CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040349; TRINKAUS E, 1994, AM J PHYS ANTHROPOL, V93, P1, DOI 10.1002/ajpa.1330930102; Turq A., 2008, PREMIERE HUMANITE GE, P40; Uomini NT, 2009, J HUM EVOL, V57, P411, DOI 10.1016/j.jhevol.2009.02.012; VANDERMEERSCH B, 1995, J HUM EVOL, V28, P439, DOI 10.1006/jhev.1995.1034; Volpato V, 2011, VERTEBR PALEOBIOL PA, P175, DOI 10.1007/978-94-007-0492-3_15; White T.D., 2000, HUMAN OSTEOLOGY; Wolpoff M. H., 1999, PALEOANTHROPOLOGY; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107	68	58	58	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43949	10.1371/journal.pone.0043949	http://dx.doi.org/10.1371/journal.pone.0043949			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937134	Green Published, gold, Green Submitted			2022-12-25	WOS:000308286300099
J	Ma, WN; Lu, S; Pan, P; Sadatmousavi, P; Yuan, YF; Chen, P				Ma, Weina; Lu, Sheng; Pan, Pei; Sadatmousavi, Parisa; Yuan, Yongfang; Chen, P.			Pharmacokinetics of Peptide Mediated Delivery of Anticancer Drug Ellipticine	PLOS ONE			English	Article							INDUCED APOPTOSIS; CANCER-CELLS	The amino acid pairing peptide EAK16-II (EAK) has shown the ability to stabilize the hydrophobic anticancer agent ellipticine (EPT) in aqueous solution. In this study, we investigate pharmacokinetics of the formulation of EAK-EPT complexes in vivo. The developed formulation can achieve a sufficiently high drug concentration required in vivo animal models. The nanostructure and surface properties of EAK-EPT complexes or nanoparticle were characterized by transmission electron microscopy (TEM) and zeta potential measurements, respectively. 12 healthy male SD rats were divided into EPT group and EAK-EPT group randomly. Rats in EPT group were tail intravenously injected with the EPT (20 mg/kg); rats in EAK-EPT group were injected with EAK-EPT complexes (EPT's concentration is 20 mg/kg). EPT was extracted from rat plasma with dexamethasone sodium phosphate as internal standards (IS). The pharmacokinetic parameters were obtained using high pressure liquid chromatography (HPLC). Significant differences in main pharmacokinetic parameters between EPT and EAK-EPT complexes were observed, demonstrating that the complexation with EAK prolongs the residence time of the drug and enlarges the area under the concentration-time curve (AUC). This means that EAK can serve as a suitable carrier to increase the bioavailability of EPT.	[Ma, Weina; Pan, Pei; Yuan, Yongfang] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 3, Dept Pharm, Shanghai 200030, Peoples R China; [Lu, Sheng; Sadatmousavi, Parisa; Chen, P.] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada	Shanghai Jiao Tong University; University of Waterloo	Ma, WN (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 3, Dept Pharm, Shanghai 200030, Peoples R China.	nmxyyf@yahoo.cn			Shanghai Committee of Science and Technology, China [10410711300]; Natural Sciences and Engineering Research Council of Canada; Canadian Foundation for Innovation; Canada Research Chairs Program	Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation); Canada Research Chairs Program(Canada Research Chairs)	This project was supported by the Shanghai Committee of Science and Technology, China (Grant No. 10410711300). This research was financially supported by the Natural Sciences and Engineering Research Council of Canada, Canadian Foundation for Innovation and the Canada Research Chairs Program for one of the co-authors (PC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bawa R, 2011, NANOMEDICIN IN PRESS; Fang K, 2009, LUNG CANCER, V63, P227, DOI 10.1016/j.lungcan.2008.05.026; Fung SY, 2006, J PHYS CHEM A, V110, P11446, DOI 10.1021/jp062778y; Fung SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001956; Fung SY, 2011, BIOMATERIALS, V32, P4000, DOI 10.1016/j.biomaterials.2011.02.005; FUNG SY, 2005, HDB NANOSTRUCTURED B, P1; Garbett Nichola C., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P149, DOI 10.2174/1568011043482070; Kuo PL, 2005, CANCER LETT, V223, P293, DOI 10.1016/j.canlet.2004.09.046; Kuo YC, 2006, LIFE SCI, V78, P2550, DOI 10.1016/j.lfs.2005.10.041; Peng YH, 2003, ONCOGENE, V22, P4478, DOI 10.1038/sj.onc.1206777; Stiborova M, 2006, GEN PHYSIOL BIOPHYS, V25, P245; Stiborova Marie, 2006, Biomedical Papers (Olomouc), V150, P13; SUREAU F, 1993, BIOPHYS J, V65, P1767, DOI 10.1016/S0006-3495(93)81273-6; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874	14	44	44	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43684	10.1371/journal.pone.0043684	http://dx.doi.org/10.1371/journal.pone.0043684			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	23236514	Green Published, gold, Green Submitted			2022-12-25	WOS:000308221300022
J	Xu, Q; Ma, PQ; Hu, CF; Chen, LC; Xue, LY; Wang, ZZ; Liu, M; Zhu, HX; Xu, NZ; Lu, N				Xu, Qing; Ma, Peiqing; Hu, Chenfei; Chen, Lechuang; Xue, Liyan; Wang, Zaozao; Liu, Mei; Zhu, Hongxia; Xu, Ningzhi; Lu, Ning			Overexpression of the DEC1 Protein Induces Senescence In Vitro and Is Related to Better Survival in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							ONCOGENE-INDUCED SENESCENCE; TRANSCRIPTION FACTOR; EXPRESSION; STRA13; CANCER; BARRIER; P21(WAF1/CIP1); GENE; DIFFERENTIATION; TUMORIGENESIS	Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related death in China and has limited effective therapeutic options except for early surgery, since the underlying molecular mechanism driving its precursor lesions towards invasive ESCC is not fully understood. Cellular senescence is the state of the permanent growth arrest of a cell, and is considered as the initial barrier of tumor development. Human differentiated embryo chondrocyte expressed gene 1 (Dec1) is an important transcription factor that related to senescence. In this study, DEC1 immunohistochemical analysis was performed on tissue microarray blocks constructed from ESCC combined with adjacent precursor tissues of 241 patients. Compared with normal epithelia, DEC1 expression was significantly increased in intraepithelial neoplasia and DEC1 expression was significantly decreased in ESCC in comparison with intraepithelial neoplasia. In vitro, DEC1 overexpression induced cellular senescence, and it inhibited cell growth and colony formation in ESCC cell line EC9706. Fresh esophagectomy tissue sections from five ESCC patients were detected by immunohistochemistry of DEC1 and senescence-associated beta-galactosidase (SA-beta-Gal) activity, and strongly positive expression of DEC1 was correlated to more senescent cells in these fresh tissue sections. Kaplan - Meier method analysis of the 241 patients revealed that DEC1 expression levels were significantly correlated with the survival of ESCC patients after surgery. The expression levels of DEC1 were also correlated with age, tumor embolus, depth of invasion of ESCC, lymph metastasis status and pTNMs. These results suggest that DEC1 overexpression in precursor lesions of ESCC is a protective mechanism by inducing cellular senescence in ESCC initiation, and DEC1 may be a potential prognostic marker of ESCC.	[Xu, Qing; Hu, Chenfei; Chen, Lechuang; Wang, Zaozao; Liu, Mei; Zhu, Hongxia; Xu, Ningzhi] Chinese Acad Med Sci, Canc Inst & Canc Hosp, Lab Cell & Mol Biol, Beijing 100730, Peoples R China; [Xu, Qing; Hu, Chenfei; Chen, Lechuang; Wang, Zaozao; Liu, Mei; Zhu, Hongxia; Xu, Ningzhi] Chinese Acad Med Sci, Canc Inst & Canc Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Xu, Qing; Ma, Peiqing; Hu, Chenfei; Chen, Lechuang; Xue, Liyan; Wang, Zaozao; Liu, Mei; Zhu, Hongxia; Xu, Ningzhi; Lu, Ning] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ma, Peiqing; Xue, Liyan; Lu, Ning] Chinese Acad Med Sci, Canc Inst & Canc Hosp, Dept Pathol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Xu, Q (corresponding author), Chinese Acad Med Sci, Canc Inst & Canc Hosp, Lab Cell & Mol Biol, Beijing 100730, Peoples R China.	ningzhi.xu@gmail.com; nlu03@126.com	Chen, Lechuang/AAF-8351-2020; Wang, Chengshu/A-1656-2011; Xiao, Guohua/G-3083-2013	Wang, Chengshu/0000-0003-1477-1466; Xiao, Guohua/0000-0003-3407-2734	National Natural Science Foundation [81021061, 31171322, 30770973, 39925020]; 863 Project grant [2006AA02A403]; Basic Research Program of CICAMS [JK2011B26]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); 863 Project grant; Basic Research Program of CICAMS	This work was funded by National Natural Science Foundation (81021061, 31171322, 30770973, 39925020) (http://www.nsfc.gov.cn/), 863 Project grant (2006AA02A403) (http://www.863.gov.cn/), Basic Research Program of CICAMS (JK2011B26) (http://www.cicams.ac.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Braig M, 2006, CANCER RES, V66, P2881, DOI 10.1158/0008-5472.CAN-05-4006; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Campo-Trapero J, 2008, ACTA ONCOL, V47, P1464, DOI 10.1080/02841860802183612; Chakrabarti J, 2004, BRIT J CANCER, V91, P954, DOI 10.1038/sj.bjc.6602059; Chandeck C, 2010, ADV ANAT PATHOL, V17, P42, DOI 10.1097/PAP.0b013e3181c66f4e; Chang MS, 2005, PATHOL RES PRACT, V201, P417, DOI 10.1016/j.prp.2005.04.005; Chen X, 2002, CELL RES, V12, P229, DOI 10.1038/sj.cr.7290129; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cohen DJ, 2011, EXPERT OPIN PHARMACO, V12, P225, DOI 10.1517/14656566.2010.517748; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Decottignies A, 2011, SEMIN CANCER BIOL, V21, P360, DOI 10.1016/j.semcancer.2011.09.003; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gewirtz DA, 2008, BIOCHEM PHARMACOL, V76, P947, DOI 10.1016/j.bcp.2008.06.024; Giatromanolaki A, 2003, J PATHOL, V200, P222, DOI 10.1002/path.1330; Gorgoulis VG, 2010, CURR OPIN CELL BIOL, V22, P816, DOI 10.1016/j.ceb.2010.07.013; Guillaumond F, 2008, BIOCHEM BIOPH RES CO, V369, P1184, DOI 10.1016/j.bbrc.2008.03.009; Han Yaling, 2002, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V19, P455; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hiyoshi Y, 2009, CLIN CANCER RES, V15, P1915, DOI 10.1158/1078-0432.CCR-08-2545; Holmes RS, 2007, SEMIN RADIAT ONCOL, V17, P2, DOI 10.1016/j.semradonc.2006.09.003; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kashyap MK, 2009, CANCER BIOL THER, V8, P36, DOI 10.4161/cbt.8.1.7090; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Li YX, 2002, BIOCHEM J, V367, P413, DOI 10.1042/BJ20020514; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; OGASAWARA S, 1995, CANCER RES, V55, P891; Ohbu M, 2001, HISTOPATHOLOGY, V39, P589, DOI 10.1046/j.1365-2559.2001.01279.x; Ohtani N, 2012, EXP DERMATOL, V21, P1, DOI 10.1111/j.1600-0625.2012.01493.x; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; Sakai N, 2010, DIS ESOPHAGUS, V23, P415, DOI 10.1111/j.1442-2050.2009.01026.x; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Shen M, 1997, BIOCHEM BIOPH RES CO, V236, P294, DOI 10.1006/bbrc.1997.6960; Shi XH, 2011, WORLD J GASTROENTERO, V17, P2037, DOI 10.3748/wjg.v17.i15.2037; Shirakawa Y, 2000, CLIN CANCER RES, V6, P541; Skinner HD, 2012, CLIN CANCER RES, V18, P290, DOI 10.1158/1078-0432.CCR-11-2260; Sun H, 2000, P NATL ACAD SCI USA, V97, P4058, DOI 10.1073/pnas.070526297; Tsai MH, 2011, ANN SURG ONCOL, V18, P2662, DOI 10.1245/s10434-011-1603-9; Turley H, 2004, J PATHOL, V203, P808, DOI 10.1002/path.1585; Umar SB, 2008, NAT CLIN PRACT GASTR, V5, P517, DOI 10.1038/ncpgasthep1223; Vallbohmer D, 2006, DIS ESOPHAGUS, V19, P425, DOI 10.1111/j.1442-2050.2006.00622.x; Wang GQ, 2005, GUT, V54, P187, DOI 10.1136/gut.2004.046631; Wang WB, 2010, BIOCHEM BIOPH RES CO, V401, P422, DOI 10.1016/j.bbrc.2010.09.070; Xue L, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-296; Zheng Y, 2009, OMICS, V13, P301, DOI 10.1089/omi.2009.0014	57	34	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41862	10.1371/journal.pone.0041862	http://dx.doi.org/10.1371/journal.pone.0041862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22937093	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700160
J	Li, CY; Zhang, XT; Cao, RL; Yu, BH; Liang, HS; Zhou, M; Li, DY; Wang, YH; Liu, EZ				Li, Changyu; Zhang, Xiangtong; Cao, Ronglong; Yu, Bohai; Liang, Hongsheng; Zhou, Min; Li, Dayong; Wang, Yuehua; Liu, Enzhong			Allografts of the Acellular Sciatic Nerve and Brain-Derived Neurotrophic Factor Repair Spinal Cord Injury in Adult Rats	PLOS ONE			English	Article							SUPERIOR COLLICULUS; CHEMICAL-EXTRACTION; REGENERATION; GRAFTS; CELLS; MOTOR; TRANSECTION; IMPROVEMENT; SCAFFOLDS; MEMBRANE	Objective: We aimed to investigate whether an innovative growth factor-laden scaffold composed of acellular sciatic nerve (ASN) and brain-derived neurotrophic factor (BDNF) could promote axonal regeneration and functional recovery after spinal cord injury (SCI). Methods: Following complete transection at the thoracic level (T9), we immediately transplanted the grafts between the stumps of the severed spinal cords. We evaluated the functional recovery of the hindlimbs of the operated rats using the BBB locomotor rating scale system every week. Eight weeks after surgery, axonal regeneration was examined using the fluorogold (FG) retrograde tracing method. Electrophysiological analysis was carried out to evaluate the improvement in the neuronal circuits. Immunohistochemistry was employed to identify local injuries and recovery. Results: The results of the Basso-Beattie-Bresnahan (BBB) scale indicated that there was no significant difference between the individual groups. The FG retrograde tracing and electrophysiological analyses indicated that the transplantation of ASN-BDNF provided a permissive environment to support neuron regeneration. Conclusion: The ASN-BDNF transplantation provided a promising therapeutic approach to promote axonal regeneration and recovery after SCI, and can be used as part of a combinatory treatment strategy for SCI management.	[Li, Changyu; Zhang, Xiangtong; Cao, Ronglong; Liang, Hongsheng; Wang, Yuehua; Liu, Enzhong] Harbin Med Univ, Affiliated Hosp 1, Key Lab Cell Transplantat, Minist Hlth China,Dept Neurosurg, Harbin, Heilongjiang Pr, Peoples R China; [Yu, Bohai] Harbin Med Univ, Dept Microbiol, Immun & Infect Pathogen Biol Key Lab, Harbin, Heilongjiang Pr, Peoples R China; [Zhou, Min] Harbin Med Univ, Affiliated Hosp 1, Dept Pathol, Harbin, Heilongjiang Pr, Peoples R China; [Li, Dayong] Harbin Med Univ, Affiliated Hosp 2, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Li, CY (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Key Lab Cell Transplantat, Minist Hlth China,Dept Neurosurg, Harbin, Heilongjiang Pr, Peoples R China.	enzhongliu@163.com			HeiLongJiang Province Sanitation Department Scientific Research Topic [2010-027]; Science Foundation of the China Postdoctor [2011M500687]	HeiLongJiang Province Sanitation Department Scientific Research Topic; Science Foundation of the China Postdoctor	This work was supported by HeiLongJiang Province Sanitation Department Scientific Research Topic (2010-027), and the Science Foundation of the China Postdoctor (2011M500687). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; CARTER DA, 1989, J NEUROSCI, V9, P4042; Cigognini D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019782; Cote MP, 2011, NEUROTHERAPEUTICS, V8, P294, DOI 10.1007/s13311-011-0024-6; Cote MP, 2010, EXP NEUROL, V225, P173, DOI 10.1016/j.expneurol.2010.06.011; Fang MR, 2011, ANAT REC, V294, P24, DOI 10.1002/ar.21281; Guzen FP, 2012, RESTOR NEUROL NEUROS, V30, P265, DOI 10.3233/RNN-2012-110184; Horste GMZ, 2008, MUSCLE NERVE, V37, P3, DOI 10.1002/mus.20893; Kataoka K, 2004, TISSUE ENG, V10, P493, DOI 10.1089/107632704323061852; Kloos AD, 2005, EXP NEUROL, V191, P251, DOI 10.1016/j.expneurol.2004.09.016; Koopmans G, 2009, INT REV NEUROBIOL, V87, P363, DOI 10.1016/S0074-7742(09)87019-0; Lee YS, 2010, EXP NEUROL, V224, P429, DOI 10.1016/j.expneurol.2010.05.003; Levi ADO, 2002, J NEUROSURG, V96, P197, DOI 10.3171/spi.2002.96.2.0197; Liang HS, 2009, ACTA NEUROCHIR, V151, P1113, DOI 10.1007/s00701-009-0322-5; Nordblom J, 2009, RESTOR NEUROL NEUROS, V27, P285, DOI 10.3233/RNN-2009-0478; Ribatti D, 2003, BRAIN RES, V989, P9, DOI 10.1016/S0006-8993(03)03225-6; Sieck GC, 2009, RESP PHYSIOL NEUROBI, V169, P218, DOI 10.1016/j.resp.2009.08.008; Sondell M, 1998, BRAIN RES, V795, P44, DOI 10.1016/S0006-8993(98)00251-0; Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039; Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948; VIDALSANZ M, 1987, J NEUROSCI, V7, P2894; Zhang YJ, 2010, BIOMATERIALS, V31, P5312, DOI 10.1016/j.biomaterials.2010.03.029; Zhong HB, 2007, J RECONSTR MICROSURG, V23, P479, DOI 10.1055/s-2007-992340	23	45	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e42813	10.1371/journal.pone.0042813	http://dx.doi.org/10.1371/journal.pone.0042813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	23028587	gold, Green Published, Green Submitted			2022-12-25	WOS:000308213600008
J	Sanchez-Vidal, A; Canals, M; Calafat, AM; Lastras, G; Pedrosa-Pamies, R; Menendez, M; Medina, R; Company, JB; Hereu, B; Romero, J; Alcoverro, T				Sanchez-Vidal, Anna; Canals, Miquel; Calafat, Antoni M.; Lastras, Galderic; Pedrosa-Pamies, Rut; Menendez, Melisa; Medina, Raul; Company, Joan B.; Hereu, Bernat; Romero, Javier; Alcoverro, Teresa			Impacts on the Deep-Sea Ecosystem by a Severe Coastal Storm	PLOS ONE			English	Article							MARINE-SEDIMENTS; ORGANIC-MATTER; INNER-SHELF; DYNAMICS; MODEL; PRESERVATION; OCEAN; GULF; SIZE	Major coastal storms, associated with strong winds, high waves and intensified currents, and occasionally with heavy rains and flash floods, are mostly known because of the serious damage they can cause along the shoreline and the threats they pose to navigation. However, there is a profound lack of knowledge on the deep-sea impacts of severe coastal storms. Concurrent measurements of key parameters along the coast and in the deep-sea are extremely rare. Here we present a unique data set showing how one of the most extreme coastal storms of the last decades lashing the Western Mediterranean Sea rapidly impacted the deep-sea ecosystem. The storm peaked the 26th of December 2008 leading to the remobilization of a shallow-water reservoir of marine organic carbon associated with fine particles and resulting in its redistribution across the deep basin. The storm also initiated the movement of large amounts of coarse shelf sediment, which abraded and buried benthic communities. Our findings demonstrate, first, that severe coastal storms are highly efficient in transporting organic carbon from shallow water to deep water, thus contributing to its sequestration and, second, that natural, intermittent atmospheric drivers sensitive to global climate change have the potential to tremendously impact the largest and least known ecosystem on Earth, the deep-sea ecosystem.	[Sanchez-Vidal, Anna; Canals, Miquel; Calafat, Antoni M.; Lastras, Galderic; Pedrosa-Pamies, Rut] Univ Barcelona, Grp Recerca Consilidat GRC Geociencies Marines, Dept Estratig Paleontol & Geociencies Marines, Barcelona, Spain; [Menendez, Melisa; Medina, Raul] Univ Cantabria, Inst Hidraul Ambiental IH Cantabria, E-39005 Santander, Spain; [Company, Joan B.] CSIC, Inst Ciencies Mar, Barcelona, Spain; [Hereu, Bernat; Romero, Javier] Univ Barcelona, Dept Ecol, E-08028 Barcelona, Spain; [Alcoverro, Teresa] CSIC, Ctr Estudis Avancats Blanes, Blanes, Spain	University of Barcelona; Universidad de Cantabria; IHCantabria - Instituto de Hidraulica Ambiental de la Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Sanchez-Vidal, A (corresponding author), Univ Barcelona, Grp Recerca Consilidat GRC Geociencies Marines, Dept Estratig Paleontol & Geociencies Marines, Barcelona, Spain.	anna.sanchez@ub.edu	Romero, Javier/A-8905-2013; Sanchez-Vidal, Anna/B-6919-2016; Menendez, Melisa/L-4600-2014; Pamies, Rut Pedrosa/I-1119-2015; Hereu, Bernat/K-9150-2015; Company, Joan B./K-7274-2014; Lastras, Galderic/A-6487-2013; Alcoverro, Teresa/J-9258-2012; Medina, Raul/L-2456-2014; Calafat, Antoni/J-5848-2017; Canals, Miquel/F-4922-2013; Etter, Andres/E-1860-2011	Romero, Javier/0000-0002-2772-8486; Sanchez-Vidal, Anna/0000-0002-8209-1959; Menendez, Melisa/0000-0002-5168-257X; Pamies, Rut Pedrosa/0000-0003-3504-4727; Hereu, Bernat/0000-0001-6247-7638; Company, Joan B./0000-0002-5878-7155; Lastras, Galderic/0000-0002-8756-3855; Alcoverro, Teresa/0000-0002-3910-9594; Medina, Raul/0000-0002-0126-2710; Calafat, Antoni/0000-0001-7927-3105; Canals, Miquel/0000-0001-5267-7601; Etter, Andres/0000-0003-0665-9300	European Community [226354, PERG04-GA-2008-239175]; Spanish project ROV-CANONES [CTM2009-06778]; Spanish project GRACCIE-CONSOLIDER [CSD2007-00067]; Spanish project DOS MARES [CTM2010-21810-C03]; Spanish project REDECO [CTM2008-04973-E]; Spanish project PIE-CSIC [200430E599]; Catalan Government Grups de Recerca Consolidats [2009 SGR 1305]	European Community(European Commission); Spanish project ROV-CANONES; Spanish project GRACCIE-CONSOLIDER; Spanish project DOS MARES; Spanish project REDECO; Spanish project PIE-CSIC; Catalan Government Grups de Recerca Consolidats	This work was supported by the European Community's Seventh Framework Programme projects HERMIONE (226354) and ARISTEUS (PERG04-GA-2008-239175), the Spanish projects ROV-CANONES (CTM2009-06778), GRACCIE-CONSOLIDER (CSD2007-00067), DOS MARES (CTM2010-21810-C03), REDECO (CTM2008-04973-E) and PIE-CSIC (200430E599) and a Catalan Government Grups de Recerca Consolidats grant (2009 SGR 1305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnarson TS, 2007, GEOCHIM COSMOCHIM AC, V71, P3545, DOI 10.1016/j.gca.2007.04.027; Bolanos R, 2009, J MARINE SYST, V77, P237, DOI 10.1016/j.jmarsys.2007.12.018; Canals M, 2004, MAR GEOL, V213, P9, DOI 10.1016/j.margeo.2004.10.001; Canals M, 2006, NATURE, V444, P354, DOI 10.1038/nature05271; Company JB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001431; Dee DP, 2009, Q J ROY METEOR SOC, V135, P1830, DOI 10.1002/qj.493; Dickens AF, 2006, GEOCHIM COSMOCHIM AC, V70, P666, DOI 10.1016/j.gca.2005.10.024; Ferre B, 2005, CONT SHELF RES, V25, P2410, DOI 10.1016/j.csr.2005.08.017; FRY B, 1984, CONTRIB MAR SCI, V27, P13; Galy V, 2007, NATURE, V450, P407, DOI 10.1038/nature06273; Garcia-Rubies A, 2009, PLIN C; Guillen J, 2006, MAR GEOL, V234, P129, DOI 10.1016/j.margeo.2006.09.018; Guillen J, 2000, SCI MAR, V64, P427, DOI 10.3989/scimar.2000.64n4427; HEDGES JI, 1995, MAR CHEM, V49, P81, DOI 10.1016/0304-4203(95)00008-F; Hedges JI, 1997, ORG GEOCHEM, V27, P195, DOI 10.1016/S0146-6380(97)00066-1; HEUSSNER S, 1990, CONT SHELF RES, V10, P943, DOI 10.1016/0278-4343(90)90069-X; Hilton RG, 2008, NAT GEOSCI, V1, P759, DOI 10.1038/ngeo333; Keil RG, 1998, GEOCHIM COSMOCHIM AC, V62, P1347, DOI 10.1016/S0016-7037(98)00080-5; Kennedy H, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003848; Lastras G, 2011, MAR GEOL, V280, P20, DOI 10.1016/j.margeo.2010.11.005; Li MZ, 2001, COMPUT GEOSCI-UK, V27, P619, DOI 10.1016/S0098-3004(00)00120-5; Lionello P, 2006, DEV EARTH ENV SCI, V4, P5463; Marcos M, 2011, GLOBAL PLANET CHANGE, V77, P116, DOI 10.1016/j.gloplacha.2011.04.002; MAYER LM, 1994, GEOCHIM COSMOCHIM AC, V58, P1271, DOI 10.1016/0016-7037(94)90381-6; Mendoza ET, 2009, P I CIVIL ENG-MAR EN, V162, P127, DOI 10.1680/maen.2009.162.3.127; Navarro L, 2011, ESTUAR COAST SHELF S, V95, P52, DOI 10.1016/j.ecss.2011.08.002; Skamarock W.C., 2008, NCARTN475STR, DOI [10.5065/D68S4MVH, DOI 10.5065/D68S4MVH]; Somot S, 2006, CLIM DYNAM, V27, P851, DOI 10.1007/s00382-006-0167-z; Tolman HL, 2002, 222 NOAA NWS NCEP MM, P133; Ulbrich U, 2009, THEOR APPL CLIMATOL, V96, P117, DOI 10.1007/s00704-008-0083-8; Young IR, 2011, SCIENCE, V332, P451, DOI 10.1126/science.1197219	31	158	166	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30395	10.1371/journal.pone.0030395	http://dx.doi.org/10.1371/journal.pone.0030395			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22952816	Green Published, gold			2022-12-25	WOS:000301640600029
J	Zeng, YJ; Yang, X; Wang, J; Fan, JJ; Kong, QY; Yu, XQ				Zeng, Youjia; Yang, Xiao; Wang, Juan; Fan, Jinjin; Kong, Qingyu; Yu, Xueqing			Aristolochic Acid I Induced Autophagy Extenuates Cell Apoptosis via ERK 1/2 Pathway in Renal Tubular Epithelial Cells	PLOS ONE			English	Article							HT-29 CELLS; INHIBITION; DEATH; MACROAUTOPHAGY; TOXICITY; INJURY; VITRO	Autophagy is a lysosomal degradation pathway that is essential for cell survival and tissue homeostasis. However, limited information is available about autophagy in aristolochic acid (AA) nephropathy. In this study, we investigated the role of autophagy and related signaling pathway during progression of AAI-induced injury to renal tubular epithelial cells (NRK52E cells). The results showed that autophagy in NRK52E cells was detected as early as 3-6 hrs after low dose of AAI (10 mu M) exposure as indicated by an up-regulated expression of LC3-II and Beclin 1 proteins. The appearance of AAI-induced punctated staining of autophagosome-associated LC3-II upon GFP-LC3 transfection in NRK52E cells provided further evidence for autophagy. However, cell apoptosis was not detected until 12 hrs after AAI treatment. Blockade of autophagy with Wortmannin or 3-Methyladenine (two inhibitors of phosphoinositede 3-kinases) or small-interfering RNA knockdown of Beclin 1 or Atg7 sensitized the tubular cells to apoptosis. Treatment of NRK52E cells with AAI caused a time-dependent increase in extracellular signal-regulated kinase 1 and 2 (ERK1/2) activity, but not c-Jun N-terminal kinase (JNK) and p38. Pharmacological inhibition of ERK1/2 phosphorylation with U0126 resulted in a decreased AAI-induced autophagy that was accompanied by an increased apoptosis. Taken together, our study demonstrated for the first time that autophagy occurred earlier than apoptosis during AAI-induced tubular epithelial cell injury. Autophagy induced by AAI via ERK1/2 pathway might attenuate apoptosis, which may provide a protective mechanism for cell survival under AAI-induced pathological condition.	[Zeng, Youjia; Yang, Xiao; Wang, Juan; Fan, Jinjin; Kong, Qingyu; Yu, Xueqing] Sun Yat Sen Univ, Dept Nephrol, Affiliated Hosp 1, Key Lab Nephrol,Minist Hlth, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zeng, YJ (corresponding author), Sun Yat Sen Univ, Dept Nephrol, Affiliated Hosp 1, Key Lab Nephrol,Minist Hlth, Guangzhou 510275, Guangdong, Peoples R China.	yangx826@yahoo.com.cn	; Zhao, Xiubo/AAZ-9058-2021	Yu, Hai/0000-0002-6386-9761; Wang, Jiqian/0000-0002-7525-5943; Zhao, Xiubo/0000-0002-4620-2893	Chinese National Natural Science Research Grant [30873432, 81073138]	Chinese National Natural Science Research Grant	This work is supported by the Chinese National Natural Science Research Grant (Grant number 30873432, 81073138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baehrecke EH, 2003, CELL DEATH DIFFER, V10, P940, DOI 10.1038/sj.cdd.4401280; Bakhiya N, 2009, TOXICOLOGY, V264, P74, DOI 10.1016/j.tox.2009.07.014; Balachandran P, 2005, KIDNEY INT, V67, P1797, DOI 10.1111/j.1523-1755.2005.00277.x; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Gao RT, 2000, CHINESE MED J-PEKING, V113, P418; Hsin YH, 2006, APOPTOSIS, V11, P2167, DOI 10.1007/s10495-006-0289-0; Inoue K, 2010, CLIN EXP NEPHROL, V14, P112, DOI 10.1007/s10157-009-0254-7; Ioset JR, 2003, FOOD CHEM TOXICOL, V41, P29, DOI 10.1016/S0278-6915(02)00219-3; Ito M, 2010, CANCER GENE THER, V17, P633, DOI 10.1038/cgt.2010.20; Jiang M, 2010, AM J PATHOL, V176, P1181, DOI 10.2353/ajpath.2010.090594; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Kovacs AL, 2000, CELL TISSUE RES, V302, P253, DOI 10.1007/s004410000275; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Li J, 2010, TOXICOL IN VITRO, V24, P1092, DOI 10.1016/j.tiv.2010.03.012; Li L, 2010, AM J PATHOL, V176, P1767, DOI 10.2353/ajpath.2010.090345; Pallet N, 2008, AUTOPHAGY, V4, P783, DOI 10.4161/auto.6477; Pattingre S, 2003, J BIOL CHEM, V278, P16667, DOI 10.1074/jbc.M210998200; Periyasamy-Thandavan S, 2009, AM J PHYSIOL-RENAL, V297, pF244, DOI 10.1152/ajprenal.00033.2009; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Pozdzik AA, 2008, KIDNEY INT, V73, P595, DOI 10.1038/sj.ki.5002714; Qi XM, 2007, TOXICOL APPL PHARM, V222, P105, DOI 10.1016/j.taap.2007.03.029; Sivaprasad U, 2008, J CELL MOL MED, V12, P1265, DOI 10.1111/j.1582-4934.2008.00282.x; VOM DS, 2001, BIOCHEM J, V354, P31; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Yang C, 2008, AM J PHYSIOL-RENAL, V294, pF777, DOI 10.1152/ajprenal.00590.2007; Yla-Anttila P, 2009, METHOD ENZYMOL, V452, P143, DOI 10.1016/S0076-6879(08)03610-0; Yu FY, 2011, TOXICOL IN VITRO, V25, P810, DOI 10.1016/j.tiv.2011.01.016	29	128	136	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30312	10.1371/journal.pone.0030312	http://dx.doi.org/10.1371/journal.pone.0030312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276178	Green Published, Green Submitted, gold			2022-12-25	WOS:000301568100034
J	Aaltonen, KJ; Virkki, LM; Malmivaara, A; Konttinen, YT; Nordstrom, DC; Blom, M				Aaltonen, Kalle J.; Virkki, Liisa M.; Malmivaara, Antti; Konttinen, Yrjo T.; Nordstrom, Dan C.; Blom, Marja			Systematic Review and Meta-Analysis of the Efficacy and Safety of Existing TNF Blocking Agents in Treatment of Rheumatoid Arthritis	PLOS ONE			English	Review							ANTITUMOR NECROSIS FACTOR; ALPHA MONOCLONAL-ANTIBODY; RECEIVING CONCOMITANT METHOTREXATE; DOUBLE-BLIND; PLUS METHOTREXATE; PHASE-III; COMBINATION ETANERCEPT; INADEQUATE RESPONSE; TAIWANESE PATIENTS; DOSE METHOTREXATE	Background and Objectives: Five-tumour necrosis factor (TNF)-blockers (infliximab, etanercept, adalimumab, certolizumab pegol and golimumab) are available for treatment of rheumatoid arthritis. Only few clinical trials compare one TNF-blocker to another. Hence, a systematic review is required to indirectly compare the substances. The aim of our study is to estimate the efficacy and the safety of TNF-blockers in the treatment of rheumatoid arthritis (RA) and indirectly compare all five currently available blockers by combining the results from included randomized clinical trials (RCT). Methods: A systematic literature review was conducted using databases including: MEDLINE, SCOPUS (including EMBASE), Cochrane library and electronic search alerts. Only articles reporting double-blind RCTs of TNF-blockers vs. placebo, with or without concomitant methotrexate (MTX), in treatment of RA were selected. Data collected were information of patients, interventions, controls, outcomes, study methods and eventual sources of bias. Results: Forty-one articles reporting on 26 RCTs were included in the systematic review and meta-analysis. Five RCTs studied infliximab, seven etanercept, eight adalimumab, three golimumab and three certolizumab. TNF-blockers were more efficacious than placebo at all time points but were comparable to MTX. TNF-blocker and MTX combination was superior to either MTX or TNF-blocker alone. Increasing doses did not improve the efficacy. TNF-blockers were relatively safe compared to either MTX or placebo. Conclusions: No single substance clearly rose above others in efficacy, but the results of the safety analyses suggest that etanercept might be the safest alternative. Interestingly, MTX performs nearly identically considering both efficacy and safety aspects with a margin of costs.	[Aaltonen, Kalle J.; Blom, Marja] Univ Helsinki, Fac Pharm, Helsinki, Finland; [Aaltonen, Kalle J.; Virkki, Liisa M.; Konttinen, Yrjo T.] Univ Helsinki, Fac Med, Helsinki, Finland; [Malmivaara, Antti] Natl Inst Hlth & Welf THL, Ctr Hlth & Social Econ, Helsinki, Finland; [Konttinen, Yrjo T.] COXA Hosp Joint Replacement, Tampere, Finland; [Nordstrom, Dan C.] Univ Helsinki, Cent Hosp HUCH, Helsinki, Finland	University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; Coxa Hospital for Joint Replacement; University of Helsinki	Aaltonen, KJ (corresponding author), Univ Helsinki, Fac Pharm, Helsinki, Finland.	yrjo.konttinen@helsinki.fi	; li, jiong/L-6534-2014; Obel, Carsten/H-9605-2016	li, jiong/0000-0003-1125-026X; li, jiong/0000-0002-1716-8067; Obel, Carsten/0000-0001-5004-1933; Kristensen, Jette Kolding/0000-0002-2648-5750	ORTON Orthopaedic Hospital of the ORTON Foundation; National PhD Graduate School in Musculoskeletal Diseases and Biomaterials	ORTON Orthopaedic Hospital of the ORTON Foundation; National PhD Graduate School in Musculoskeletal Diseases and Biomaterials	This study was supported by an unlimited grant from the ORTON Orthopaedic Hospital of the ORTON Foundation and by the National PhD Graduate School in Musculoskeletal Diseases and Biomaterials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2006, J RHEUMATOL, V33, P37; Aho K, 1998, SEMIN ARTHRITIS RHEU, V27, P325, DOI 10.1016/S0049-0172(98)80053-X; Allaart CF, 2006, CLIN EXP RHEUMATOL, V24, pS77; Alonso-Ruiz A, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-52; Antoni C, 1999, CLIN EXP RHEUMATOL, V17, pS73; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bankhurst AD, 1999, CLIN EXP RHEUMATOL, V17, pS69; Bathon JM, 2003, CLIN EXP RHEUMATOL, V21, pS195; Bathon JM, 2000, NEW ENGL J MED, V343, P1586, DOI 10.1056/NEJM200011303432201; Bessette L, 2007, J RHEUMATOL, V34, P1627; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Chen DY, 2009, J FORMOS MED ASSOC, V108, P310, DOI 10.1016/S0929-6646(09)60071-1; Chen Y-F, 2006, HEALTH TECHNOL ASSES, V10, P248; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; Durez P, 2004, ANN RHEUM DIS, V63, P1069, DOI 10.1136/ard.2003.012914; Durez P, 2007, ARTHRITIS RHEUM-US, V56, P3919, DOI 10.1002/art.23055; ELLIOTT MJ, 1994, LANCET, V344, P1105, DOI 10.1016/S0140-6736(94)90628-9; Emery P, 2008, LANCET, V372, P375, DOI 10.1016/S0140-6736(08)61000-4; Emery P, 2010, ARTHRITIS RHEUM-US, V62, P674, DOI 10.1002/art.27268; Emery P, 2009, ARTHRITIS RHEUM-US, V60, P2272, DOI 10.1002/art.24638; Ericson ML, 1999, ARTHRITIS RHEUM, V42, pS82; FELSON DT, 1993, ARTHRITIS RHEUM-US, V36, P729, DOI 10.1002/art.1780360601; Fleischmann R, 2009, ANN RHEUM DIS, V68, P805, DOI 10.1136/ard.2008.099291; Fleischmann RM, 2008, ARTHRITIS RHEUM, V58, pS530; Furst DE, 2003, J RHEUMATOL, V30, P2563; Gao Guo-hua, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P724; Genovese MC, 2002, ARTHRITIS RHEUM, V46, P1443, DOI 10.1002/art.10308; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Huang Feng, 2009, Zhonghua Nei Ke Za Zhi, V48, P916; Jamal S, 2009, CLIN RHEUMATOL, V28, P413, DOI 10.1007/s10067-008-1064-0; Kavanaugh A, 2008, ANN RHEUM DIS, V67, P1444, DOI 10.1136/ard.2008.094524; Kavanaugh A, 2000, J RHEUMATOL, V27, P841; Kavanaugh AF, 1996, ARTHRITIS RHEUM, V39, P575; Kay J, 2007, ANN RHEUM DIS, V66, P175; Kay J, 2006, ANN RHEUM DIS, V65, P323; Kay J, 2008, ARTHRITIS RHEUM-US, V58, P964, DOI 10.1002/art.23383; Keystone, 2009, ARTHRITIS RHEUM, V60, P1249, DOI 10.1002/art.24667; Keystone E, 2001, ARTHRITIS RHEUM, V44, pS213; Keystone EC, 2009, ANN RHEUM DIS, V68, P789, DOI 10.1136/ard.2008.099010; Keystone EC, 2003, CLIN EXP RHEUMATOL, V21, pS198; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P353, DOI 10.1002/art.20019; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Keystone E, 2008, ARTHRITIS RHEUM, V58, P3319, DOI 10.1002/art.23964; KIM HY, 2007, APLAR J RHEUMATOL, V10, P9, DOI DOI 10.1111/J.1479-8077.2007.00248.X; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Kristensen LE, 2007, SCAND J RHEUMATOL, V36, P411, DOI 10.1080/03009740701607067; Lan JL, 2004, J FORMOS MED ASSOC, V103, P618; Launois R, 2011, J RHEUMATOL, V38, P835, DOI 10.3899/jrheum.100665; Leombruno JP, 2009, ANN RHEUM DIS, V68, P1136, DOI 10.1136/ard.2008.091025; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W; Maini RN, 2004, ARTHRITIS RHEUM-US, V50, P1051, DOI 10.1002/art.20159; Miceli-Richard C, 2008, ANN RHEUM DIS, V67, P478, DOI 10.1136/ard.2007.074104; Miyasaka N, 2008, MOD RHEUMATOL, V18, P252, DOI 10.1007/s10165-008-0045-0; Moreland LW, 1999, ANN INTERN MED, V130, P478, DOI 10.7326/0003-4819-130-6-199903160-00004; Moreland LW, 1997, NEW ENGL J MED, V337, P141, DOI 10.1056/NEJM199707173370301; Neovius M, 2011, ANN RHEUM DIS, V70, P624, DOI 10.1136/ard.2010.133371; Quinn MA, 2005, ARTHRITIS RHEUM-US, V52, P27, DOI 10.1002/art.20712; Rahman MU, 2007, ANN RHEUM DIS, V66, P1233, DOI 10.1136/ard.2006.065995; Ronald VV, 2008, SCAND J RHEUMATOL, V37, P52; Schiff M, 2008, ANN RHEUM DIS, V67, P1096, DOI 10.1136/ard.2007.080002; Singh JA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007848.pub2; Smolen J, 2009, ANN RHEUM DIS, V68, P797, DOI 10.1136/ard.2008.101659; Smolen JS, 2009, LANCET, V374, P210, DOI 10.1016/S0140-6736(09)60506-7; Smolen JS, 2005, ARTHRITIS RHEUM, V52, P1020, DOI 10.1002/art.20982; Smolen JS, 2006, ARTHRITIS RHEUM-US, V54, P702, DOI 10.1002/art.21678; Symmons D, 2002, RHEUMATOLOGY, V41, P793, DOI 10.1093/rheumatology/41.7.793; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; van de Putte BA, 2004, ANN RHEUM DIS, V63, P508, DOI 10.1136/ard.2003.013052; van de Putte LBA, 2003, ANN RHEUM DIS, V62, P1168, DOI 10.1136/ard.2003.009563; van der Bijl AE, 2007, ARTHRITIS RHEUM-US, V56, P2129, DOI 10.1002/art.22718; van der Heijde D, 2007, ARTHRITIS RHEUM, V56, P3928, DOI 10.1002/art.23141; van der Heijde D, 2006, ARTHRITIS RHEUM-US, V54, P1063, DOI 10.1002/art.21655; van Riel PLCM, 2006, ANN RHEUM DIS, V65, P1478, DOI 10.1136/ard.2005.043299; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Weisman MH, 2007, RHEUMATOLOGY, V46, P1122, DOI 10.1093/rheumatology/kem033; Westhovens R, 2006, ARTHRITIS RHEUM-US, V54, P1075, DOI 10.1002/art.21734; Wiens A, 2010, PHARMACOTHERAPY, V30, P339, DOI 10.1592/phco.30.4.339; Wiens A, 2009, CLIN RHEUMATOL, V28, P1365, DOI 10.1007/s10067-009-1233-9; Wiens A, 2009, SCAND J IMMUNOL, V70, P337, DOI 10.1111/j.1365-3083.2009.02296.x; Yocum D, 2004, ARTHRITIS RHEUM, V50, pS659; Zhang F, 2006, APLAR J RHEUMATOL, V9, P127, DOI DOI 10.1111/J.1479-8077.2006.00186.X; Zhang Wen, 2009, Zhonghua Yi Xue Za Zhi, V89, P1876	87	197	206	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30275	10.1371/journal.pone.0030275	http://dx.doi.org/10.1371/journal.pone.0030275			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22952698	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400100
J	Zhao, MR; Wang, C; Zhang, CL; Wen, YZ; Liu, WP				Zhao, Meirong; Wang, Cui; Zhang, Chunlong; Wen, Yuezhong; Liu, Weiping			Enantioselective Cytotoxicity Profile of o,p '-DDT in PC 12 Cells	PLOS ONE			English	Article							DDT INDUCES APOPTOSIS; IN-VITRO; ORGANOCHLORINE PESTICIDES; OXIDATIVE STRESS; INSECTICIDE ACETOFENATE; NEUROBLASTOMA-CELLS; ESTROGENIC ACTIVITY; MONONUCLEAR-CELLS; RISK-ASSESSMENT; EXPRESSION	Background: The continued uses of dichlordiphenyltrichloroethane (DDT) for indoor vector control in some developing countries have recently fueled intensive debates toward the global ban of this persistent legacy contaminant. Current approaches for ecological and health risk assessment has ignored the chiral nature of DDT. In this study by employing an array of cytotoxicity related endpoints, we investigated the enantioselective cytotoxicity of o,p'-DDT. Principal Findings: we demonstrated for the first time that R-(2)-o,p'-DDT caused more neuron cell death by inducing more severe oxidative stress, which selectively imbalanced the transcription of stress-related genes (SOD1, SOD2, HSP70) and enzyme (superoxide dismutase and lactate dehydrogenase) activities, and greater cellular apoptosis compared to its enantiomer S-(+)-o,p'-DDT at the level comparable to malaria area exposure (parts per million). We further elucidated enantioselective modes of action using microarray combined with enzyme-linked immunosorbent assay. The enantioselective apoptosis might involve three signaling pathways via caspase 3, tumor protein 53 (p53) and NFkB. Conclusions: Based on DDT stereochemistry and results reported for other chiral pesticides, our results pointed to the same directional enantioselectivity of chiral DDT toward mammalian cells. We proposed that risk assessment on DDT should consider the enantiomer ratio and enantioselectivities.	[Zhao, Meirong; Wang, Cui] Zhejiang Univ Technol, Res Ctr Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Zhang, Chunlong] Univ Houston Clear Lake City, Houston, TX 77058 USA; [Wen, Yuezhong; Liu, Weiping] Zhejiang Univ, Inst Environm Sci, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University of Technology; University of Houston System; University of Houston; University of Houston Clear Lake; Zhejiang University	Zhao, MR (corresponding author), Zhejiang Univ Technol, Res Ctr Environm Sci, Hangzhou, Zhejiang, Peoples R China.	Wliu@zju.edu.cn	Zhang, Chunlong/N-2564-2014; Liu, Weiping/E-9208-2010; Wen, Yue/GYQ-5844-2022; wen, Yuezhong/A-7651-2011; Zhao, Meirong/E-9679-2014	Zhang, Chunlong/0000-0003-4782-5424; Liu, Weiping/0000-0002-1173-892X; Zhao, Meirong/0000-0003-3132-9223; Zhang, Chun-Lei/0000-0003-1296-1370; zhen, xuechu/0000-0001-7458-2566	National Basic Research Program of China [2009CB421603]; National Natural Science Foundations of China [21077094, 20837002]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Basic Research Program of China (2009CB421603) and the National Natural Science Foundations of China (21077094,20837002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegria-Torres JA, 2009, TOXICOL IN VITRO, V23, P1000, DOI 10.1016/j.tiv.2009.06.021; Anantharam V, 2007, NEUROCHEM INT, V50, P834, DOI 10.1016/j.neuint.2007.02.003; Bagchi D, 1995, TOXICOLOGY, V104, P129, DOI 10.1016/0300-483X(95)03156-A; Baker SJ, 1998, ONCOGENE, V17, P3261, DOI 10.1038/sj.onc.1202568; Bollimuntha S, 2005, J BIOL CHEM, V280, P2132, DOI 10.1074/jbc.M407384200; Bosma H, 2000, LANCET, V356, P912, DOI 10.1016/S0140-6736(00)02685-4; BUSER HR, 1995, ANAL CHEM, V67, P2691, DOI 10.1021/ac00111a030; Carlson K, 2000, TOXICOL APPL PHARM, V168, P102, DOI 10.1006/taap.2000.8997; Cohn BA, 2007, ENVIRON HEALTH PERSP, V115, P1406, DOI 10.1289/ehp.10260; de Joode BV, 2001, LANCET, V357, P1014, DOI 10.1016/S0140-6736(00)04249-5; Ennaceur S, 2008, ENVIRON RES, V108, P86, DOI 10.1016/j.envres.2008.05.005; Ennaceur S, 2010, INT J ENVIRON AN CH, V90, P821, DOI 10.1080/03067311003778615; Forsyth D J, 1973, Arch Environ Contam Toxicol, V1, P1, DOI 10.1007/BF02030141; Frigo DE, 2005, TOXICOL LETT, V155, P227, DOI 10.1016/j.toxlet.2004.09.008; Hemish J, 2003, J BIOL CHEM, V278, P42321, DOI 10.1074/jbc.M308192200; Hoekstra PF, 2001, TOXICOL LETT, V125, P75, DOI 10.1016/S0378-4274(01)00410-6; Hu F, 2010, ENVIRON TOXICOL CHEM, V29, P683, DOI 10.1002/etc.73; Jia Z, 2007, FREE RADICAL BIO MED, V42, P288, DOI 10.1016/j.freeradbiomed.2006.10.047; Kedziora-Kornatowska KZ, 2000, IUBMB LIFE, V49, P303; Kurt-Karakus PB, 2007, ENVIRON SCI TECHNOL, V41, P4965, DOI 10.1021/es0620787; Lascombe I, 2000, ENVIRON HEALTH PERSP, V108, P621, DOI 10.2307/3434882; Leber ER, 1994, PATTYS IND HYGIENE B, V2, P1503; Li L, 2010, J ENVIRON SCI-CHINA, V22, P1980, DOI 10.1016/S1001-0742(09)60349-1; Liu HG, 2010, TOXICOLOGY, V276, P115, DOI 10.1016/j.tox.2010.07.018; Liu HG, 2008, TOXICOLOGY, V253, P89, DOI 10.1016/j.tox.2008.08.015; Liu WP, 2005, P NATL ACAD SCI USA, V102, P701, DOI 10.1073/pnas.0408847102; Lu XT, 2011, ENVIRON TOXICOL, V26, P271, DOI 10.1002/tox.20553; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MCBLAIN WA, 1987, LIFE SCI, V40, P215, DOI 10.1016/0024-3205(87)90361-4; MCBLAIN WA, 1977, CAN J ZOOL, V55, P562, DOI 10.1139/z77-071; Moran JM, 2008, J TOXICOL ENV HEAL A, V71, P1457, DOI 10.1080/15287390802329364; OEHME M, 1994, HRC-J HIGH RES CHROM, V17, P583; Perez-Maldonado IN, 2004, ENVIRON RES, V94, P38, DOI 10.1016/S0013-9351(03)00112-9; Qian HF, 2009, CHEMOSPHERE, V76, P885, DOI 10.1016/j.chemosphere.2009.05.009; Qiu XH, 2004, ENVIRON SCI TECHNOL, V38, P1368, DOI 10.1021/es035052d; Rohrdanz E, 1998, FREE RADICAL BIO MED, V24, P27, DOI 10.1016/S0891-5849(97)00159-7; Shi YQ, 2010, TOXICOL LETT, V193, P79, DOI 10.1016/j.toxlet.2009.12.008; Shinomiya N, 2003, TOXICOL LETT, V137, P175, DOI 10.1016/S0378-4274(02)00401-0; Slater AFG, 1995, TOXICOL LETT, V82-3, P149, DOI 10.1016/0378-4274(95)03474-9; Song Y, 2008, TOXICOLOGY, V253, P53, DOI 10.1016/j.tox.2008.08.013; Stanley Jacob K., 2009, Integrated Environmental Assessment and Management, V5, P364, DOI 10.1897/IEAM_2008-076.1; Stemmler I, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041340; Tebourbi O, 1998, B ENVIRON CONTAM TOX, V61, P216, DOI 10.1007/s001289900751; UNEP, 2002, STOCKH CONV PERS ORG; van den Berg H, 2009, ENVIRON HEALTH PERSP, V117, P1656, DOI 10.1289/ehp.0900785; Van Dyk JC, 2010, SCI TOTAL ENVIRON, V408, P2745, DOI 10.1016/j.scitotenv.2010.03.002; Wang C, 2010, CHIRALITY, V22, P612, DOI 10.1002/chir.20800; Wang LM, 2009, ENVIRON TOXICOL CHEM, V28, P1, DOI 10.1897/08-055.1; Xu C, 2008, CHEM RES TOXICOL, V21, P1050, DOI 10.1021/tx8000016; Yang HY, 2010, CHEMOSPHERE, V80, P652, DOI 10.1016/j.chemosphere.2010.04.052; Zhao MR, 2008, ENVIRON TOXICOL CHEM, V27, P1194, DOI 10.1897/07-482.1; Zhao MR, 2010, ENVIRON POLLUT, V158, P1968, DOI 10.1016/j.envpol.2009.10.027; Zhao MR, 2009, ENVIRON TOXICOL CHEM, V28, P578, DOI 10.1897/08-246.1	54	45	46	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43823	10.1371/journal.pone.0043823	http://dx.doi.org/10.1371/journal.pone.0043823			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937105	gold, Green Published, Green Submitted			2022-12-25	WOS:000308225500107
J	Chen, QY; Wang, H; Liu, Y; Song, YJ; Lai, LH; Han, Q; Cao, XT; Wang, QQ				Chen, Qingyun; Wang, Hui; Liu, Yang; Song, Yinjing; Lai, Lihua; Han, Quan; Cao, Xuetao; Wang, Qingqing			Inducible MicroRNA-223 Down-Regulation Promotes TLR-Triggered IL-6 and IL-1 beta Production in Macrophages by Targeting STAT3	PLOS ONE			English	Article							NF-KAPPA-B; SIGNAL TRANSDUCER; IN-VIVO; TRANSCRIPTION; EXPRESSION; INTERLEUKIN-6; INFLAMMATION; ALPHA; LIPOPOLYSACCHARIDE; DIFFERENTIATION	MicroRNAs are small non-coding RNA molecules that regulate gene expression by either translational inhibition or mRNA degradation. MicroRNAs play pivotal roles in the regulation of both innate and adaptive immune responses, including TLR-triggered inflammatory response. Here we reported that the expression of microRNA-223 (miR-223) was significantly decreased in murine macrophages during activation by lipopolysaccharide (LPS) or poly (I:C) stimulation. The inducible miR-223 down-regulation resulted in the activation of signal transducer and activator of transcription 3 (STAT3), which is directly targeted by miR-223, thus promoting the production of pro-inflammatory cytokines IL-6 and IL-1 beta, but not TNF-alpha. Interestingly, IL-6 was found to be a main factor in inducing the decrease in miR-223 expression after LPS stimulation, which formed a positive feedback loop to regulate IL-6 and IL-1 beta. Herein, our findings provide a new explanation characterizing the molecular mechanism responsible for the regulation of IL-6 production after TLR-triggered macrophage activation.	[Chen, Qingyun; Liu, Yang; Song, Yinjing; Lai, Lihua; Han, Quan; Cao, Xuetao; Wang, Qingqing] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Hui] Chinese Peoples Armed Police Force, Coll Med, Tianjin, Peoples R China; [Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China	Zhejiang University; Naval Medical University; Naval Medical University	Chen, QY (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China.	wqq@zju.edu.cn	yang, liu/GVU-8760-2022; wei, jiang/GRX-7907-2022		National Natural Science Foundation of China [81072405]; Program for New Century Excellent Talents in University from Ministry of Education of People's Republic of China [NCET-08-0486]; Zhejiang Provincial Natural Science Foundation of China [R2100528]; Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University from Ministry of Education of People's Republic of China; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents	This work was supported by grants from the National Natural Science Foundation of China (81072405), Program for New Century Excellent Talents in University from Ministry of Education of People's Republic of China (NCET-08-0486), grant from Zhejiang Provincial Natural Science Foundation of China (R2100528) and also sponsored by Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Greenhill CJ, 2011, J IMMUNOL, V186, P1199, DOI 10.4049/jimmunol.1002971; HACK CE, 1989, BLOOD, V74, P1704; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; HIRANO T, 1988, EUR J IMMUNOL, V18, P1797, DOI 10.1002/eji.1830181122; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Ichiba M, 1998, J BIOL CHEM, V273, P6132, DOI 10.1074/jbc.273.11.6132; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Jones SA, 2005, J INTERF CYTOK RES, V25, P241, DOI 10.1089/jir.2005.25.241; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Lee C, 2006, MOL PHARMACOL, V69, P1041, DOI 10.1124/mol.105.018481; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Liu Y, 2011, FEBS LETT, V585, P1963, DOI 10.1016/j.febslet.2011.05.029; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nguyen-Jackson H, 2010, BLOOD, V115, P3354, DOI 10.1182/blood-2009-08-240317; O'Connell RM., 2011, ANN REV IMMUNOL; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Okugawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC399, DOI 10.1152/ajpcell.00026.2003; Prele CM, 2007, CLIN EXP IMMUNOL, V147, P564, DOI 10.1111/j.1365-2249.2006.03291.x; Samavati L, 2009, MOL IMMUNOL, V46, P1867, DOI 10.1016/j.molimm.2009.02.018; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Wang QQ, 2008, J IMMUNOL, V180, P2419, DOI 10.4049/jimmunol.180.4.2419; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yoon S, 2010, AUTOPHAGY, V6, P1125, DOI 10.4161/auto.6.8.13547	35	231	245	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42971	10.1371/journal.pone.0042971	http://dx.doi.org/10.1371/journal.pone.0042971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22723833	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500025
J	Chen, QY; Park, HC; Goligorsky, MS; Chander, P; Fischer, SM; Gross, SS				Chen, Qiuying; Park, Hyeong-Cheon; Goligorsky, Michael S.; Chander, Praveen; Fischer, Steven M.; Gross, Steven S.			Untargeted Plasma Metabolite Profiling Reveals the Broad Systemic Consequences of Xanthine Oxidoreductase Inactivation in Mice	PLOS ONE			English	Article							KYNURENINE PATHWAY ENZYMES; CHRONIC KIDNEY-DISEASE; REPERFUSION INJURY; METABOLOMICS; ALLOPURINOL; OXIDASE; IDENTIFICATION; CHROMATOGRAPHY; DEHYDROGENASE; ERYTHROCYTE	A major challenge in systems biology is integration of molecular findings for individual enzyme activities into a cohesive high-level understanding of cellular metabolism and physiology/pathophysiology. However, meaningful prediction for how a perturbed enzyme activity will globally impact metabolism in a cell, tissue or intact organisms is precluded by multiple unknowns, including in vivo enzymatic rates, subcellular distribution and pathway interactions. To address this challenge, metabolomics offers the potential to simultaneously survey changes in thousands of structurally diverse metabolites within complex biological matrices. The present study assessed the capability of untargeted plasma metabolite profiling to discover systemic changes arising from inactivation of xanthine oxidoreductase (XOR), an enzyme that catalyzes the final steps in purine degradation. Using LC-MS coupled with a multivariate statistical data analysis platform, we confidently surveyed >3,700 plasma metabolites (50-1,000 Da) for differential expression in XOR wildtype vs. mice with inactivated XOR, arising from gene deletion or pharmacological inhibition. Results confirmed the predicted derangements in purine metabolism, but also revealed unanticipated perturbations in metabolism of pyrimidines, nicotinamides, tryptophan, phospholipids, Krebs and urea cycles, and revealed kidney dysfunction biomarkers. Histochemical studies confirmed and characterized kidney failure in xor-nullizygous mice. These findings provide new insight into XOR functions and demonstrate the power of untargeted metabolite profiling for systemic discovery of direct and indirect consequences of gene mutations and drug treatments.	[Chen, Qiuying; Gross, Steven S.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA; [Park, Hyeong-Cheon; Goligorsky, Michael S.; Chander, Praveen] New York Med Coll, Dept Med, Renal Res Inst, Valhalla, NY 10595 USA; [Park, Hyeong-Cheon; Goligorsky, Michael S.; Chander, Praveen] New York Med Coll, Dept Pathol, Renal Res Inst, Valhalla, NY 10595 USA; [Park, Hyeong-Cheon; Goligorsky, Michael S.; Chander, Praveen] New York Med Coll, Dept Pharmacol, Renal Res Inst, Valhalla, NY 10595 USA; [Fischer, Steven M.] Agilent Technol, Metab Lab, Santa Clara, CA USA	Cornell University; New York Medical College; Renal Research Institute; New York Medical College; Renal Research Institute; New York Medical College; Renal Research Institute; Agilent Technologies	Chen, QY (corresponding author), Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA.	ssgross@med.cornell.edu	yang, liu/GVU-8760-2022; wei, jiang/GRX-7907-2022		NIH (National Institute of Health) [HL87062, HD067244, K45462, tDK84394]	NIH (National Institute of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were supported by NIH (National Institute of Health) grants HL87062 (SSG), HD067244 (SSG), K45462 (MSG) and tDK84394 (MSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2011, CRIT REV BIOTECHNOL, V31, P264, DOI 10.3109/07388551.2010.527823; Barbas C, 2011, J PHARMACEUT BIOMED, V55, P823, DOI 10.1016/j.jpba.2011.02.001; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Battelli MG, 2011, J BIOL REG HOMEOS AG, V25, P77; Biasioli S, 1987, Nephrol Dial Transplant, V2, P313; Cheung KJ, 2007, CELL METAB, V5, P115, DOI 10.1016/j.cmet.2007.01.005; Chohan S, 2009, CURR OPIN RHEUMATOL, V21, P143, DOI 10.1097/BOR.0b013e328325bd94; Cubbon S, 2010, MASS SPECTROM REV, V29, P671, DOI 10.1002/mas.20252; Dawson J, 2009, BRIT J CLIN PHARMACO, V68, P662, DOI 10.1111/j.1365-2125.2009.03497.x; Dewan AK, 2010, PEDIATR DERMATOL, V27, P270, DOI 10.1111/j.1525-1470.2009.00983.x; Drexler DM, 2011, ANAL BIOANAL CHEM, V399, P2645, DOI 10.1007/s00216-010-4370-8; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fiehn O, 2009, QUALITY CONTROL META; Fini MA, 2011, MOL CANCER RES, V9, P1242, DOI 10.1158/1541-7786.MCR-11-0176; Ganti S, 2011, UROL ONCOL-SEMIN ORI, V29, P551, DOI 10.1016/j.urolonc.2011.05.013; George J, 2006, CIRCULATION, V114, P2508, DOI 10.1161/CIRCULATIONAHA.106.651117; George Jacob, 2009, Ther Clin Risk Manag, V5, P799; Gibbings S, 2011, J BIOL CHEM, V286, P961, DOI 10.1074/jbc.M110.150847; Gierasch LM, 2009, NAT CHEM BIOL, V5, P774, DOI 10.1038/nchembio.241; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Govani SM, 2010, J CROHNS COLITIS, V4, P444, DOI 10.1016/j.crohns.2010.02.009; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Huang LY, 2010, NITRIC OXIDE-BIOL CH, V22, P191, DOI 10.1016/j.niox.2010.01.004; Igarashi K, 2006, AMINO ACIDS, V31, P477, DOI 10.1007/s00726-006-0264-7; Issaq HJ, 2009, J SEP SCI, V32, P2183, DOI 10.1002/jssc.200900152; Joel D.KoppleSGM, 2004, UREMIC TOXICITY ITS, P682; Kamleh MA, 2008, FEBS LETT, V582, P2916, DOI 10.1016/j.febslet.2008.07.029; Kim AW, 2011, LUNG CANCER, V71, P186, DOI 10.1016/j.lungcan.2010.05.006; Kosugi T, 2009, AM J PHYSIOL-RENAL, V297, pF481, DOI 10.1152/ajprenal.00092.2009; Linder N, 2011, GYNECOL ONCOL; Mamas M, 2011, ARCH TOXICOL, V85, P5, DOI 10.1007/s00204-010-0609-6; Martelin E, 2002, AM J PHYSIOL-CELL PH, V283, pC1722, DOI 10.1152/ajpcell.00280.2002; McManaman JL, 2002, J BIOL CHEM, V277, P21261, DOI 10.1074/jbc.M200828200; Meneshian A, 2002, MICROCIRCULATION, V9, P161, DOI 10.1038/sj.mn.7800136; Michopoulos F, 2009, J PROTEOME RES, V8, P2114, DOI 10.1021/pr801045q; Nagrath D, 2011, BBA-BIOENERGETICS, V1807, P650, DOI 10.1016/j.bbabio.2011.03.006; Nishino T, 2002, J BIOCHEM, V132, P597, DOI 10.1093/oxfordjournals.jbchem.a003262; Noman A, 2010, LANCET, V375, P2161, DOI 10.1016/S0140-6736(10)60391-1; Ohtsubo T, 2004, CIRC RES, V95, P1118, DOI 10.1161/01.RES.0000149571.96304.36; Ohtsubo T, 2009, HYPERTENSION, V54, P868, DOI 10.1161/HYPERTENSIONAHA.109.135152; Pawlak D, 2003, J PHYSIOL PHARMACOL, V54, P175; Pesek JJ, 2009, J SEP SCI, V32, P2200, DOI 10.1002/jssc.200900270; Reaves ML, 2011, CURR OPIN BIOTECH, V22, P17, DOI 10.1016/j.copbio.2010.10.001; Roux A, 2011, CLIN BIOCHEM, V44, P119, DOI 10.1016/j.clinbiochem.2010.08.016; Sana TR, 2008, J CHROMATOGR B, V871, P314, DOI 10.1016/j.jchromb.2008.04.030; Sana Theodore R, 2008, J Biomol Tech, V19, P258; Sanders SA, 1999, ANTIOXID REDOX SIGN, V1, P371, DOI 10.1089/ars.1999.1.3-371; Schefold JC, 2009, NEPHROL DIAL TRANSPL, V24, P1901, DOI 10.1093/ndt/gfn739; SPECTOR T, 1986, BIOCHEM PHARMACOL, V35, P3109, DOI 10.1016/0006-2952(86)90394-1; Stamp LK, 2010, ARTHRITIS RHEUM; SWENDSEID ME, 1978, AM J CLIN NUTR, V31, P1581, DOI 10.1093/ajcn/31.9.1581; Tanaka T, 2009, AM J PATHOL, V174, P1203, DOI 10.2353/ajpath.2009.080511; Tankiewicz A, 2003, ADV EXP MED BIOL, V527, P409; Webb AJ, 2008, CIRC RES, V103, P957, DOI 10.1161/CIRCRESAHA.108.175810; Wei XL, 2011, ANAL CHEM, V83, P7668, DOI 10.1021/ac2017025; Weisenberg SA, 2009, J SEP SCI, V32, P2262, DOI 10.1002/jssc.200900256; Yamaoka K, 2006, BIOCHEM BIOPH RES CO, V345, P1240, DOI 10.1016/j.bbrc.2006.04.183; Zhang GF, 2011, J BIOL CHEM, V286, P23631, DOI 10.1074/jbc.R110.171405; Zhang RL, 1998, FREE RADICAL BIO MED, V24, P66, DOI 10.1016/S0891-5849(97)00165-2; Zhang Z, 1998, FREE RADICAL RES, V28, P151, DOI 10.3109/10715769809065801	60	231	245	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e37149	10.1371/journal.pone.0037149	http://dx.doi.org/10.1371/journal.pone.0037149			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723833	Green Submitted, gold, Green Published			2022-12-25	WOS:000305583300005
